<SEC-DOCUMENT>0000014272-21-000186.txt : 20210728
<SEC-HEADER>0000014272-21-000186.hdr.sgml : 20210728
<ACCEPTANCE-DATETIME>20210728103742
ACCESSION NUMBER:		0000014272-21-000186
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		92
CONFORMED PERIOD OF REPORT:	20210630
FILED AS OF DATE:		20210728
DATE AS OF CHANGE:		20210728

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BRISTOL MYERS SQUIBB CO
		CENTRAL INDEX KEY:			0000014272
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				220790350
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-01136
		FILM NUMBER:		211120522

	BUSINESS ADDRESS:	
		STREET 1:		430 E. 29TH STREET
		STREET 2:		14 FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016
		BUSINESS PHONE:		2125464000

	MAIL ADDRESS:	
		STREET 1:		430 E. 29TH STREET
		STREET 2:		14 FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BRISTOL MYERS CO
		DATE OF NAME CHANGE:	19891012
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>bmy-20210630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:744431a9-b3ff-43bd-afc9-1af61fbf126c,g:9fbce200-03f4-4882-8b59-75e21adfdbca,d:d66f4ecc89aa45bca7756420c60966f5--><html xmlns:bmy="http://www.bms.com/20210630" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:utr="http://www.xbrl.org/2009/utr" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bmy-20210630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80L2ZyYWc6MjhhMTI3MWEzMjZkNGU1NzgwYjc1NTY5ZGE0MDViY2IvdGFibGU6ZGY0ZDBkYzU5YzUzNDZkNzk2MTg5YWM0OGNmN2I2ZWQvdGFibGVyYW5nZTpkZjRkMGRjNTljNTM0NmQ3OTYxODlhYzQ4Y2Y3YjZlZF8zLTEtMS0xLTA_cae95193-8d1d-464a-af34-21114a58d4a8">BRISTOL MYERS SQUIBB CO</ix:nonNumeric><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80L2ZyYWc6MjhhMTI3MWEzMjZkNGU1NzgwYjc1NTY5ZGE0MDViY2IvdGFibGU6ZGY0ZDBkYzU5YzUzNDZkNzk2MTg5YWM0OGNmN2I2ZWQvdGFibGVyYW5nZTpkZjRkMGRjNTljNTM0NmQ3OTYxODlhYzQ4Y2Y3YjZlZF80LTEtMS0xLTA_c11e1e0a-7c55-4bd4-9c31-bfd0a62836b2">0000014272</ix:nonNumeric><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80L2ZyYWc6MjhhMTI3MWEzMjZkNGU1NzgwYjc1NTY5ZGE0MDViY2IvdGFibGU6ZGY0ZDBkYzU5YzUzNDZkNzk2MTg5YWM0OGNmN2I2ZWQvdGFibGVyYW5nZTpkZjRkMGRjNTljNTM0NmQ3OTYxODlhYzQ4Y2Y3YjZlZF82LTEtMS0xLTA_fd849ec4-327b-4d10-99b3-2147c6c901ac">2021</ix:nonNumeric><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80L2ZyYWc6MjhhMTI3MWEzMjZkNGU1NzgwYjc1NTY5ZGE0MDViY2IvdGFibGU6ZGY0ZDBkYzU5YzUzNDZkNzk2MTg5YWM0OGNmN2I2ZWQvdGFibGVyYW5nZTpkZjRkMGRjNTljNTM0NmQ3OTYxODlhYzQ4Y2Y3YjZlZF83LTEtMS0xLTA_4f851c64-d88c-4668-a1b7-c43b8179f555">Q2</ix:nonNumeric><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80L2ZyYWc6MjhhMTI3MWEzMjZkNGU1NzgwYjc1NTY5ZGE0MDViY2IvdGFibGU6ZGY0ZDBkYzU5YzUzNDZkNzk2MTg5YWM0OGNmN2I2ZWQvdGFibGVyYW5nZTpkZjRkMGRjNTljNTM0NmQ3OTYxODlhYzQ4Y2Y3YjZlZF84LTEtMS0xLTA_18d73d25-4594-477f-89b9-c08547201f40">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80L2ZyYWc6MjhhMTI3MWEzMjZkNGU1NzgwYjc1NTY5ZGE0MDViY2IvdGFibGU6ZGY0ZDBkYzU5YzUzNDZkNzk2MTg5YWM0OGNmN2I2ZWQvdGFibGVyYW5nZTpkZjRkMGRjNTljNTM0NmQ3OTYxODlhYzQ4Y2Y3YjZlZF85LTEtMS0xLTA_ef75446d-e263-4d8e-bcde-201f2c3d3318">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" format="ixt:booleanfalse" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80L2ZyYWc6MjhhMTI3MWEzMjZkNGU1NzgwYjc1NTY5ZGE0MDViY2IvdGFibGU6ZGY0ZDBkYzU5YzUzNDZkNzk2MTg5YWM0OGNmN2I2ZWQvdGFibGVyYW5nZTpkZjRkMGRjNTljNTM0NmQ3OTYxODlhYzQ4Y2Y3YjZlZF8xMC0xLTEtMS0w_ae467df2-c748-45d9-851c-3a7bd5a9ad6e">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bmy-20210630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i650335fbf368429d829c268d43369fd3_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:CommonStock0.10ParValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09e7550d3d6747878d9932ee8f7b6612_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:A1.000Notesdue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8f5c380201f42d0b61df63f743953bd_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:A1.750Notesdue2035Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6d0ddad70114b6a83f55355ff735cf0_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:CelgeneContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i84644a54c37541aab600ef4e9aeb7365_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i8d9276ebf40046b4a41a5f19262377b1_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i693b996ab36a4cebaefd928a05970180_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie656e6b5b421495887e8721375eae829_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70262bb79f2b4fb682856a49e0942b2a_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie92d7cecd5b8445a9169fd5dbf526e4c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb180892039d4e5b82c0a8f7673aa38a_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if28849fb4b9345149f1a1b15340c1cee_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4be7577ef3cc4c838eb6fc6d157858b7_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i4021bf9acd814a3785a7b2ac9255f519_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i519bf72bf2984b599bef546963ea4f65_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i711a50adb808497c9daf76647502dad6_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d96ff885f0c4029b9c659eb21e32c98_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationTypeAxis">bmy:LicensingArrangementsCashFlowsReclassificationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ead8ffbd6a943f58695765106933642_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74364a7590b441a4afd4e5e67a3b406e_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87185b42e332422389a23e672417b431_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if25b0239054048e3b55eeb8500972cdf_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2fb12a3531e4873be7be194483607ee_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:OtherrevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i688d430df875454b84b14f79015b6cf6_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:OtherrevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ba774a2df9f40a8b6d19e1fba5043b7_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:OtherrevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43a13af27d1448f7993f34c3dd68a67d_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:OtherrevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02cc001651e94e7295b1dcc33d5daaa2_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba96fdc39cdc460db86d38cae38883fe_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3be3517a7304e72b770f702ef97ea11_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i866d2af294a649c284a0a90628fcb561_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if22a4fc3cd8c4d6c8f43d5db96fc3d2b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6aeff8b93aa4e498214da65e668a5e7_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e43c6a8382640da95ba7937bc7cb901_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa953030056e4436b2eccb65049c20bd_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf1613c94e7c4ae1a97bd33c34b116b9_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i245bc87a8ea146ff89ba47f0050ab6cd_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc81985d98e0407586fee97e68186a0c_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ee340e61c044b3ba36660dccc49b13e_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8447393acf44143ae8dfb8c7ec2d04a_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie762049c148a4949bccc2fc010d4f185_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48a97ba1d3f24c95846c59ad03ad5eb4_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5651bce30274abea8e9658ea1ea4128_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0049dfb3f51e491da124b097da74b773_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1059bee7d7c24aa5bf63443d6b0b117e_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36a7c570203a43c085160c5d69d6dca2_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5926634a97d45b588e22bc868140a71_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8f5ba386b86453aa8abbb8d97ca5741_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i164732664a0649a0a6b4e3ec9a6ea675_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b6d5b28fdeb4f539683764cb03f85e8_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbc7c626226146c8acb2e1f9248526b5_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7d7effc4e044286927c0d4994433271_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i883c2662484643f9900deb185df3f0b5_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia891b42d1c254df7ac3ac05d31574021_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if68d20cca08041c5aeb33c4b926b82ab_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57080e1dcd264f6e99cf8bdd5c21742e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ff9b249fad642bba5144d42b9faf6b5_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe37cb6ae8364432a34654315cc6e007_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0261661a5a7844cea6463d344c58d900_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i769e4009608641aca49eb76faa4ac197_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73d23b416f674420956ecd71cdcf6b4c_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f619ca1063a4a07992394e7c68f32ac_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibaf296c2ee0943818ce82515cb333687_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf093353fcce47c7993eff7bebb89352_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ee1d7e1f63643b884515b06a03e4c60_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0c81db46fa34735a7f2f312ec65bfc9_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i355ae2718e5a4c6c8a6e24afd38df6db_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45aeed9ec2cc49a590adb6b58fd89ece_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5978a453566e4231add46eb89d653450_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58d693cbcafe4995b93648810c7cae27_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40a1ad24197f4b86a309b538c9a3c23c_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a2c60c75c4141639d1b36723b3c4440_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62694ce91ad14828b9c165bf7fa9940e_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2704f69ab750451ab3fb0492a99094c5_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c439fd5488544099358a43dd1238104_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd53acf464ca462ab494301989157627_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EmplicitiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i758c9da23c8b4231951c6795184b15e5_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EmplicitiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c7448d91de34141b4df1bd539a6dd86_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EmplicitiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d84ed280193426fa6af996eda8b4c98_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EmplicitiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i563b393825ee449d9c71d5d4b26b3ddb_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fd358ca344f4bf29febc48585056f4c_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48e38a9edee64731bac94495a43d3800_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if45515056fde4687b5647faafd13b1a0_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a59b7d82fa145d6928ff7f7639b512e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i635f3e7e28714d6681e5a0d547475b27_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae2dcbf6bdff462caf99391d57dcb930_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4015345e26eb4c5c9aec15be9286e3cc_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i402f96e6f47248c3840081511c31fb5b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59e2e714bfff471ab06edb2942342e5d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedaae601ed8c4bf0b43e79604ef7f8c3_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18b9ec08663241d5baf4a36c323d25b0_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27c89651aa0f44449997627d1aeada5d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ec04d6ebd5c416faf3fedff56490ed1_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8f8d1746aa7460c854e59b73c091120_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7639067ff20c40aa9d69bd876327d377_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65b1ff42f2504ce7ba28f0134f6df309_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i990e509044b44824a03594bbc939cd4f_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94349bb9edeb4c06824d9d4dec376cdc_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia84f257000384cca8728724dd08e6d64_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72da1784020e4fe5a077a56e08ed0e60_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icae526ef104c4610be5401f06e776271_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i954298aa47d340e4928578d10e3c2afb_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie64f9c3e74d24536bc5324f5a27f3f62_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30700517c2d846dfaabb9f4e49100061_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:VidazaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4000e7937fbb4330b97ca4837c84abcf_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:VidazaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc46b46a188943daabd54f0555343036_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:VidazaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie163b63bb39b41b2a99d3894f000a52e_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:VidazaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47d887259489478d9fb5e61b10d58a21_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BaracludeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21b554fbfbe54be4938770b47e7e814e_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BaracludeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8752706d4f1046619f751bca78fe5b04_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BaracludeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf8cc33c03864e6eb80a62a2becd8529_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BaracludeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id17f257f5a7c4dbc8345593202162a88_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureProductsAndAllOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4424c6dea9c7491f8f20e9c0433f13be_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureProductsAndAllOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id047abc4cf2849648778e6a0d818e9c3_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureProductsAndAllOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib254059b72c444bda04963c50ac8c3da_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureProductsAndAllOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica56fd0d45ed404fb6d997d7a91e781b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c042daa885246149bd4021e6291c95b_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id685a03ea1c045aaa5b4626cdeefcaeb_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0fb978e8fe747c9942de2c291d92e42_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i672de761cf0f4f38b3c9fcf5888c38d2_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6096b3e3535b498a93924c5913231bb7_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd5c352a490f4e2d80f9f07d00ca9ed4_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22bc054236924180897608070e385339_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3e30ddc627e420a994afe10df2aeb8d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie307dc58932a4abc95b857fff6abe287_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c1f985c4a994e87afcfa3b123c94fb3_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i736f109d294c4ccf9f1668181dc764f4_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:RestOfWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i930c547a007949018cbf51ca4060480c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i903cb47a089e41dbbdc585ba01f93a76_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99e18e918d4a4472baa5e49400a3c3fe_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21843a9ab91b446ca3cce0aa09d0bc13_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bfd0c3b7ba94dc99db7d1c79cf4109e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaad82054f6c24b28998fd0cc54e5f466_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f4e8798cace48da8096f3940c34286f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62270f651833483897b7a99025a3c056_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0056c94875c46578f2a3c81dbf029ef_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied2b977f33414172a10da815fe24fa5e_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i959465a12b7a4107bdb5a01d7bfcc532_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i987d81167423465fad588659146ecff3_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i883fc4c8bc0f4255aec7223cc0f262b4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia927d1d44e99489ca715bf69330b08ab_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa8c668e967e4f73affcc1b178e53fd6_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bmy:AlliancesAndCollaborationCompaniesAxis">bmy:EisaiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1726e9653791462e88d1e8fa6b55d2bf_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="bmy:AlliancesAndCollaborationCompaniesAxis">bmy:EisaiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97d8d3703ed04fed8d1982e8631612c5_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesbusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9130fda1c97a4512869f8c40ceda43a3_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesbusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i874255d4051145ffb584d5ace4120829_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:ErbituxBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b10d04730ab481fa4a091d91c386131_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:ErbituxBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic600cede908c45fd9de219d601e19f65_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia149c1d5e9ac4dea84e8c70a697500b0_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib432c7d456164aba93e919e08338e013_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb48dbce12f842488d8e56ebc0551af8_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie92eb5d3a8224bf48b897ca58fe4dc15_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesbusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e04e6f0f1cb48e8ad1a548c38f665dc_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesbusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7f237dfaf294517a6c993c23a19c5a8_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:ErbituxBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e3fa03c07574d4fae920e7935e8a621_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:ErbituxBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica3960bd33c645d1bf92833258f53c54_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ff17e3e1d554be8a5a2f24d9b41e2a6_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c7d34b293eb4396be52fdac70722a24_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:AvaproAvalideAndPlavixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia34fe71a86434a37a78799df75ebb670_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:AvaproAvalideAndPlavixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i766f66d3a5564477a5cee03c3f5dbfe4_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51508ada4a88448fa0d47dbd056ce19f_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5168aa9c0f548cf89708d739d0fbf68_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33dbe127e2a8431a8d4df6ef930b3c47_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic81b26b07c5c4e61941a1674d76cfe98_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica7f052bd75f40ccbb4445d5f8e47381_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a4f553f8932405197ea119b17e8eca1_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77b50711d0f2426ab381586aa8a781f4_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib483860a3a46419ea7cade23a1f57af8_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4f9948a6cc44875bca5c798572cafe7_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i652d5c5a16f54d499f777b18da32cbf1_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac41a45cb93d4b57847364ccda78f7ea_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14b8f5fa9564459e9343a7fbfae773f2_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1b8cdf4c8fd43e5940c861fd7075cc7_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fb344c7b5984689b0e077d03d0f5e83_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:AgenusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93047c5690bd4da0b6566915947d0bb6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="icb6143c62bc94de08946b50699d69bcf_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide8bf9df7627455e8b1decf3f9977ac6_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75070985c9424f3586afbe7c4c8bf69b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic41a1bc571fe4873a7258b43472f3a1e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CompanyTransformationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c68d9932836432cae27f5f3320513f4_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd2855f0217247dfb6ab35e107cd3274_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e3436bd7185495999f6d1496751f496_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f59683c007c4e6b9b0b8bc87e2e9c64_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2bf4fd36e0b487cb4bc3cf29adddd55_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52b957a2c68f452c8ed0ce9191019247_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecfdd1291eba4609ac0bb3efec2bf1de_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CompanyTransformationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92805409d0e6445bb29744ae8cb018b8_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CompanyTransformationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd4eecd0bba84eb6a04beb957de7a224_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CompanyTransformationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic77161109800434da68b989c381905e7_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CompanyTransformationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5f7660b6eca475a9df8e628fa445af7_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i635494ce148e4ad7bd650508b31a47f5_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i458d77e2e80747db91d6733fb12cc6f3_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic61bae9f14c94630811f2853573f8ff6_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dec6245873f4d98820e4a2b35667387_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6778a15e516498f97f88c860749c6a2_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d23efb083df4012b861cdd74c430462_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33981b78822f4f77be3c382064085973_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c126874d2714146b7bf5cbc485c1cf8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41d5a334a6e142f8bd67b8e51060b87f_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4662da4bb2b6479993d2a5b55ba2078b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5431747aab134732bd974c5723251eef_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i704336f4184942a3983f50159a480277_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1232e4b20d8401ba7060d232ed7fe2f_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8689b4d5000b4d5b8e0fc3554738970e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6931cd74ebe9437fa587ab6b851ccf58_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5b48843789843e59015f89cfb97e96a_I20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b7251412f7b43c9817b299748e1d079_I20200101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a5a5daa7bb24250bb98daa1532976bb_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bmy:AcceleratedStockBasedCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12fc955bf6c34929ae7dc5a546b6e0e2_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bmy:AcceleratedStockBasedCompensationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b0b5444987e49eba4f8bafbffef80f3_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:DeferredIncomeTaxExpenseBenefitComponentAxis">bmy:InternalTransferOfProductRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7fd398a275d49b7ac8db542e423dabb_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:DeferredIncomeTaxExpenseBenefitComponentAxis">bmy:OtezlaDivestitureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3a7e6213d5a4e98bdeddda2ad09db70_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i007d2ce5a6594dc2b97f4d6dde2a3170_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e8abfc7c4684a2e80153d093765a7b0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife50b98ec7264eb7a37a0b687539d4dd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i281eaf8778b946efa6523d049bb63601_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19f789ba573d4f3ea505980fcb78be12_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7c1be369f724e7a955da101f61cd0cb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0afe166f4d814c949b6b416e46eb5544_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i295633493d6b475f86d6737b887dba92_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45f649e8a6934c6bae4029abbff213fc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7b083b368d44b519124184b6c12db87_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa523e1aa7274232a186fcca3656cab6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc71b68bc0be4ab58521b097b145bced_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7be4a1f26072441e8e2c3e8802de46f0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06a7cf8e55bc4f11ae11dd2f4e67ba53_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27ebf9edff0b44398e9b44f2f4a6f076_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e46d25a491547498b733410813929a0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie66cb746be9f47e7ac4434960e977507_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c8c40a0c0854d7fad1b783d8d1ad346_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e8619d5b7674406b0c8e75b507643be_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9778045c333646e8abc7df95736d6051_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5047f95b2d744b4b59d1b78d6a742f4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4783faea57834d3faef3b5be5df299e6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic82867d41cc6438396b8ea9165e07f1e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0603128401446e3b0ba870450ab65d1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9be6d10579a84d6ba5f91b6e23177b72_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39a1379770a94344b49dfe53b78ea4c4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i890225c6ebb14bdaa4c35b58daa47553_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85ae89b3bbca4fbdae10aba3669ee6dc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f39bf27565748b9ad84356a93cb08c7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9602884451440a58383e854523622d4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bacf915b38e4bef995b2dd60b16d847_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="percentage"><xbrli:measure>bmy:percentage</xbrli:measure></xbrli:unit><xbrli:context id="id75c7a7e91df4d63a4260a384377a6a3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice980dd1a7be4e65a57342c85ac3474a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id818743065664bfbb207dcd02dc3e2b8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d8a4ac8110a40668a2b2d95ce32cc86_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bmy:ProbabilityofpaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if862182d7eed4a4e9ea6d6d9a6f57901_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bmy:ProbabilityofpaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11aaa3096c4a45f28755610b228eadd2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bmy:ProbabilityofpaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="y"><xbrli:measure>utr:Y</xbrli:measure></xbrli:unit><xbrli:context id="i8707328f1c9f418da8c326940d5bd515_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bmy:ProjectedYearOfPaymentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb8b81529e9f4bf98e414922640a88dd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bmy:ProjectedYearOfPaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42b5dbab27a246b580a0579f0d96dee6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b39484540fe4cbc883405fbdd50a2a3_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i223b2b374fb24a7d8be48fea190eedba_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d5fac886ff9468f8c6b82d4defc7d36_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f6352735c144034ac2187ca79647025_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fe27ed6226d4cfebeb1acc8eb2bb428_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94c67e9d77694b95b51eb292c0bbabf3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idea685dade76458eab354edd649e002b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49d5fe3c29f447488503ee61f2d0f306_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d350c2a507842a4a422ebe184b11256_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0001595c39db4736ad8e580f9c067231_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia798a6fcbfcc42a0999608b439adcc0c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="ib8f2c3191d174bad82233a9c00d673f4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a0fef7903e64aceba3bf6ce6985f3f8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1711123502af4500920896ecd1971e9f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i503baf5ee2d04e92a42c2e74373c367f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51131dd320a4460191e1c989fc55992f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2128b1046e77449aa3d997f0af1b147f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc20d792e8ad475b8810d5c836c79acb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia84e2ffbd828434c81d0e6e257c9513f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i720683b7e67645e39106e79e4bb6820e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c833d9f2fd046aabaf2cff398ab0295_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9a0e466309e459caa62b42f8c64930f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbdf809d037e43b7a052e7b6ab343594_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d2f391e801c437fa61b6d9d96a8e0b9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4b905331bfb45eca6d2a44c4ebd6cac_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i169cfb4fb02c4b9893207821ae8f03d6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icaa06a3db7a24003a0dd163a30a2bef2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b5f2855511343508c746e24df19dd1d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0eae85fd04334a66abd5610c6363b26e_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24cf699361b744ed89ad8d71f69dd889_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9865149104a462288aa6782497c61f0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e53811b7cb644a29bf23fbcea6510f9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87f0786ba2604a61a85c170d713e9a62_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75483d744b7c4203b5ed365f7d3b3487_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f35f618e55b455cae0cb2a21eedc388_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8954d0e37bc949059fbcfb86b9342723_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47aba9a8009e43b09b026ddb97e17378_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11a8aa24b66f48fa9bbbfce49c6808f3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieba83eb6b5174206bc5a3b89f15c45f9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic978b78a584f466288031da3261d83d1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1241abc16f54f05b6af70bc4b195625_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49e79afcda54470890d42c058ee6dc8c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6b878c72f514738ab932426ec0acf2a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i999b17f195aa48cb93d5044e50370923_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a01cd6e61f342ecb975f4ae6f8d59b1_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e7f71ec07cc4f4c9afc10bc72f6c0e5_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i040292e730b343eb80b604d175386271_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35ce00fcc7a44969901d544fba9f7b94_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i508f07be751744a09a404b382976e275_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4696e702fafb4492b4c7d9e523e4af6d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7f3a7ad072c43a08ec6727c68cc2efd_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id07c76256d36464aa236c8edf59250ae_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00823395d1374179823132245b682350_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf03f7c455ce4b9d89fbb72f7c41488d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ed527429005415da9fb10074bfa1097_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie95af335802a4c1e92654a4464170a9a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d2fe3e02fb94bb984fa1b11e225751c_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i486c191850aa49a682074690ecb19563_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i077b4ec5d45b4aa3a708e5adcef3cb7c_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dd4ff55ae1249c1ad68411a97f3e848_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i245e38fca4f8467e86cdbf4e1e5cc67b_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21fe606592d3458e808226e33cf944a6_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i151fe4a021694b3b93a3419d9cc35d09_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieec4fe8c5b2b4a388f9c647f9b3c0879_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i229107cac324432f8447407f665ddee5_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if631f8e8a60942b4802fe350a6de182a_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife8a0faa825047398cc2bc639c58ec3a_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b690964ca6348bc97ef500ba4781adf_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i660d02e3c5404f8c82f9d6bffa9d69a2_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bmy:ZeroCostCollarCurrencyContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecad268758bf4f57961916a30d5b23bb_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bmy:ZeroCostCollarCurrencyContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49ecccdb7d504e33ad7566e82d10b7af_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bmy:ZeroCostCollarCurrencyContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97351a916177459f9564953cbd8db5b7_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bmy:ZeroCostCollarCurrencyContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7532fb922404416bf6c1a4f59828fc3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a94a414c588439da957589012a52bce_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b8a19e9be6947c29fae71035f799b8b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9967a3c6dc845d9ac2ae782bd268a81_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i907aadccc2844fa8b86616d86e1395f8_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d7cbfcfe0e044538ff7a63b3ad018c3_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85dd208285f94cd6aff62add53ee5706_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47b91d980e0a450fa568fc15b6e2b9b0_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f3f06024f654b51b3f6b0bca6aaa058_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5604822aa0b342079d2242f61089bf43_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a7cece24b0c44179822ebe709140263_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7daf934932b4999a9e8c82bfe559ddf_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i836ec8a900f94ab2a0cd3662c33ba2d1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i816b15b9810f468d87ef913a5c6b3461_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib87554b0ae72494ba6568a952ddc9510_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A2.875SeniorNotesdue2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18088008a5b7409bb866ff840040d19a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A2550SeniorNotesDue2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i643fc6ba1c2a4f778dbb32207ff363ed_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A2BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d62c55572e74536af7ed82dceb0ea9d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A1BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48e73501dc964ac8b84b67b3240d49b3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A1.5BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85e0ac7571b54abf896103b5b9c3df12_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7913fb01092e4ed1a1dc7490f44c3094_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i930ff8105ccb4bfdb0a95257468399ad_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:InventorypurchasepricefairvalueadjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d1422bf6081497aa35d71735c851dc2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:InventorypurchasepricefairvalueadjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63f5d7d2d5cf421986ebe6aec3d0d063_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if78324cfda1641a185f98458b48b3ecb_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc8f651960ff49fb8e4847dbc3db39c8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a2b2474f0d2424ba498502d3afdf9ac_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d8e439af78d4f5092229ec245f1b0a5_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i626ddd6ff5464b57a8e4e7c44e82a64a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i102ed3efbe22488096250a07cec1ae7c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic566d16d5a584f8ba82df664242cf607_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e217c9f1d8b4cc69ebcdebb33546c57_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56178daf0b264e019ba2dccbd26473ad_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i815f8cb9efb94a46b64a44a73c8875bc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cef45113fe040d78e64dcc2d006f97b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d6ab1d8fecd41948785ff0b6c9a68b3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i290ccdb912fe48f08d595add1473c16b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52bd0855efcc4aeeae1fe88706edf18e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:IntangibleAssetNameAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieff455ef39df4956a451fdaf9767810c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:IntangibleAssetNameAxis">bmy:InrebicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i640a43d1b691485e977b3192bef77d58_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:IntangibleAssetNameAxis">bmy:InrebicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i934da5addaea4028be7894d0babddfe5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11d3b9fc864643c6963d52987b8077d1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i740f1c260f5842e38801cdbe44935148_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i067540008559441b824143d0812aef90_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if693f3f9e803446e93591493d837c4d2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e5310947a3340a3a0bcf32e64131e15_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2634a7150984700b4940996575435e4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6796f93ba1454a58aa1ce90e9373d79e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3a03601e6ad43e8a39684c20e526fc0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab66f12d5bc4445bbf732048a5db1c7c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bb4376df4e144078f75533316d9e77e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c3370e41cf9405a9a160e64209a8f68_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d8bd1acba944731b23be9a517a5eeb0_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice500bf4ba6c4e908a4b5c93b15b7a60_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2be8a05661504ad99b17ef9c22efd9f7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib89fb11161f146d2a6fb0b08fa2ddbd7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60e4a51934264054a72db8bb72b4bc16_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief956f040cf142c48a760f89d051c7ba_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a550b5d610e43ddacb1196fc31b2232_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01588a18f30f4fa1ad0bd69b5101f669_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e1bc2ac43bb413ca28382700af763ae_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a4b6a65d77842f48e59e61b100ac7d3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9407dc04bd514a50a293bf46404d43d3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id929872bbc96437d9c359988e5567a7c_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2148fb9192764819b1bc0f8addaa98cb_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a9500eccacc46d69322333bfa03f25d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60767f8375e34e8a8c2ea7e77e7f3ec5_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied5e0053e2f04982aa1a2cd60b3e95b3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0daf74a0447c4e5786bd5ce58b6cc832_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i737d30e7e58d4ea790fbbd242d2423fd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bffcc25a557427c9a4c65a954674dca_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43239b9f5ca7485fa0251240b365648a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc37ebada08d41f5b8cef803d7d03074_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2981a3b1644448f6af2e5cb8836ff464_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i725849a6245d4c18813876f45d26ebdb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifca693e8a4cf43a3b6314d8fd10f8054_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacdee3fad3484ddab95c12653c99c649_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8ddca453e0f43dfa8c50a7b44bba5fa_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6cc956e9fbd48ceb2f65194ea049395_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i003da07e864e44a69c31e7e8a1d52e15_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5984e1f2ba843eb986403e94d6961c1_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e4590ddb4bf4965b0a342ff22eaa166_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e96ce8b1bb142a2a63dcf6656d59225_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5969c9dafdd447f18f7192246fac8838_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5504708828644783aaf1fb1bdfaac8b9_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6451959c27fd4a229abd87573f36e73a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf435eb9cba84175bb13fd5a7add0851_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb8aad97592342f69c4ee4f99b65f30e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i907bc8e8b73443428348fce6c8e4d9f2_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7672c07fdb549a49def19893f3bd52d_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35a526307c454beb9945dbdb361e919a_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf55f775dda94251ae451da6e98bfa21_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if63b4ca36e134e4c93b3e20bfbe40fe3_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4a97b03d1a440f9a8664a3da44ee846_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ab20791a5084b878272689919dd7486_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30ce3f779b954838bbbf7b6ff1bbd7e9_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20caf63fbd6041669bb1f806943db28d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i695a7cf7ff314bec908a24d933d5cf63_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i235fc5676d984fff868b737072a6d629_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4185f4aac2534ed88f533f59619f62a5_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4276b9e3a3cd4405967f02d58a3d681d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac2000f1209140fe919895b22d38de16_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbd79ec1a2164f3d8aefdbe1d165744d_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id74cc59095d040258cf00ef2e809efa0_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ec7443f41ce4644b7444730381aeb04_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2da4dc33dbfe427290747f6b3396e0bc_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c94d13219ab428992afd3b5b0c2e8aa_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i802d457ae3ce494fba78c18db7fb4724_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae0c6db08abe4f8aaa95195fc68dcb83_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmy:MarketShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a0d23cf191d49859d545cf81fc83b99_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb9926c1623d4307b449847e25ccb9a6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a59bc20a4164faa942cd6df346323f9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2259fe062d9455c84a896e821c65d2f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmy:MarketShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8621d1eb8ad941d1b61fc0b3eb0c0104_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d714c61f30d48e6a0408831871d837e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00042bb08bc247c88f649c75d7bbb73f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AntiPD1AntibodyLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f6c2befa4b34a0a81ba3b0e9556df39_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmy:UpfrontmilestoneandotherlicensingreceiptsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2468cf0aaf4c49ab87c383ed553537e0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64a8873ecda74aafb2ceeed0be390c87_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:EliquisPatentLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd94bed0537c407e93ce5a3d80b707af_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:AUD</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:PlavixAustraliaIntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4e7cac4d7fc407bbf7a0cfcc8e6a83f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:PlavixAustraliaIntellectualPropertyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="lawsuits"><xbrli:measure>bmy:lawsuits</xbrli:measure></xbrli:unit><xbrli:context id="i86db086f990f485eae2c529279a9b3be_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AbilifyProductLiabilityLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69bcd074cc8f40729d45455b3b8c32f0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AbilifyProductLiabilityLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">bmy:DismissedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="numberofplaintiffs"><xbrli:measure>bmy:numberOfPlaintiffs</xbrli:measure></xbrli:unit><xbrli:context id="ic26045979d2740d8b8904c0387c53e4a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AbilifyProductLiabilityLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">bmy:DismissedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9edbfdefa9f4c869623f5989777a4d3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AbilifyProductLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0ca0adab86748b08591cb41bae7063a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:ByettaProductLiabilityLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbb5732de29d4e31bb981cab01299d47_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:ByettaProductLiabilityLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic175769943af4209805f2855da447a24_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:OnglyzaProductLiabilityLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdc726e72d84409b8ca5e19dbe8e141c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:BMSSecuritiesLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie36b4dda4d274314992050f1a7686ae7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CelgeneSecuritiesLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5d797c7be774aa39277765dc8964e48_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CerclaMattersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNi0zLTEtMS0w_7ec21314-9a79-4478-9828-3ae79b144f31 id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNi0xLTEtMS0w_854dcc1c-daf5-4493-b28a-375e5aa89e7a" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RleHRyZWdpb246ODk5ZTdlNGQyZjRhNGI4YTg5NjA1NzdiMWNiODY3ZTlfMzY0_a4610352-7756-429b-a9c8-7581cfff2dd4" order="1"></ix:relationship></ix:resources></ix:header></div><div id="id66f4ecc89aa45bca7756420c60966f5_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2.5pt solid #000000;border-top:2.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">FORM <ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDcx_bdce5614-0585-44bf-8031-ab8bf08d549b">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">___________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDY3_e49b2958-dd05-428b-ac1a-2f376f39ccb8">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNjg_3277279d-d96a-4899-be2c-11d875fffc6c">June&#160;30, 2021</ix:nonNumeric></span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDcy_9adfbd05-a8f8-40d4-87a9-34a1c61b5a08">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from ______ to _______</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDYx_428b93d8-9ff0-41c7-a59b-258f02043860">001-01136</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">___________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">BRISTOL-MYERS SQUIBB COMPANY </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6YjE1MTE4NzA5NzViNDRkMmE0NWYyNjY3NTMzOTAzOGUvdGFibGVyYW5nZTpiMTUxMTg3MDk3NWI0NGQyYTQ1ZjI2Njc1MzM5MDM4ZV8wLTAtMS0xLTA_71b59a21-a6fe-4490-9e19-4e653f190ecf">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6YjE1MTE4NzA5NzViNDRkMmE0NWYyNjY3NTMzOTAzOGUvdGFibGVyYW5nZTpiMTUxMTg3MDk3NWI0NGQyYTQ1ZjI2Njc1MzM5MDM4ZV8wLTItMS0xLTA_4637fe8f-6aec-4aed-ad14-b1c4ae88544f">22-0790350</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">I.R.S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"> Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Identification No.)</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDYy_6b01a61b-459f-43da-bb11-1b85d3fac6e3">430 E. 29th Street, 14FL</ix:nonNumeric>, <ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDY4_75238035-c208-4430-8f3d-a0729e895fba">New York</ix:nonNumeric>, <ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDY2_51ed6a24-7152-46dd-b7a9-1c5d0724de53">NY</ix:nonNumeric> <ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDY5_8b093843-f34c-4da8-915d-2d160e851df3">10016</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDcw_c3e01ead-6063-4489-a096-e1e85f46bbdb">212</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDcz_2447019e-74ff-4313-b5a9-cd38901d28ce">546-4000</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">___________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Former name, former address and former fiscal year, if changed since last report)</span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i650335fbf368429d829c268d43369fd3_D20210101-20210630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6ZTE5NjhkYjU4MmQ4NDhlMzgwZGQ3ZDMyZTg4YjNjNWYvdGFibGVyYW5nZTplMTk2OGRiNTgyZDg0OGUzODBkZDdkMzJlODhiM2M1Zl8xLTAtMS0xLTA_713cb790-ac6f-4a8e-8d0f-1baa08c33676">Common Stock, $0.10 Par Value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i650335fbf368429d829c268d43369fd3_D20210101-20210630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6ZTE5NjhkYjU4MmQ4NDhlMzgwZGQ3ZDMyZTg4YjNjNWYvdGFibGVyYW5nZTplMTk2OGRiNTgyZDg0OGUzODBkZDdkMzJlODhiM2M1Zl8xLTEtMS0xLTA_44ef61b3-2ca3-410e-8c31-f1ccc9c0d5d3">BMY</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i650335fbf368429d829c268d43369fd3_D20210101-20210630" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6ZTE5NjhkYjU4MmQ4NDhlMzgwZGQ3ZDMyZTg4YjNjNWYvdGFibGVyYW5nZTplMTk2OGRiNTgyZDg0OGUzODBkZDdkMzJlODhiM2M1Zl8xLTItMS0xLTA_8b75f6cb-6d28-476c-b6e7-15db093971e2">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09e7550d3d6747878d9932ee8f7b6612_D20210101-20210630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6ZTE5NjhkYjU4MmQ4NDhlMzgwZGQ3ZDMyZTg4YjNjNWYvdGFibGVyYW5nZTplMTk2OGRiNTgyZDg0OGUzODBkZDdkMzJlODhiM2M1Zl8yLTAtMS0xLTA_f31f227c-c2f3-47a3-8698-48d60a6b97fc">1.000% Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09e7550d3d6747878d9932ee8f7b6612_D20210101-20210630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6ZTE5NjhkYjU4MmQ4NDhlMzgwZGQ3ZDMyZTg4YjNjNWYvdGFibGVyYW5nZTplMTk2OGRiNTgyZDg0OGUzODBkZDdkMzJlODhiM2M1Zl8yLTEtMS0xLTA_dd8abae2-73c4-484f-8fab-2cfa684547b2">BMY25</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i09e7550d3d6747878d9932ee8f7b6612_D20210101-20210630" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6ZTE5NjhkYjU4MmQ4NDhlMzgwZGQ3ZDMyZTg4YjNjNWYvdGFibGVyYW5nZTplMTk2OGRiNTgyZDg0OGUzODBkZDdkMzJlODhiM2M1Zl8yLTItMS0xLTA_8b5816bc-d595-4f6c-9dfc-bbea2eefb935">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie8f5c380201f42d0b61df63f743953bd_D20210101-20210630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6ZTE5NjhkYjU4MmQ4NDhlMzgwZGQ3ZDMyZTg4YjNjNWYvdGFibGVyYW5nZTplMTk2OGRiNTgyZDg0OGUzODBkZDdkMzJlODhiM2M1Zl8zLTAtMS0xLTA_4705c3cb-6d95-44ab-86f5-52d8c585ca79">1.750% Notes due 2035</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie8f5c380201f42d0b61df63f743953bd_D20210101-20210630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6ZTE5NjhkYjU4MmQ4NDhlMzgwZGQ3ZDMyZTg4YjNjNWYvdGFibGVyYW5nZTplMTk2OGRiNTgyZDg0OGUzODBkZDdkMzJlODhiM2M1Zl8zLTEtMS0xLTA_a760befe-64a5-4091-94da-01ae1ceb9aa3">BMY35</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie8f5c380201f42d0b61df63f743953bd_D20210101-20210630" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6ZTE5NjhkYjU4MmQ4NDhlMzgwZGQ3ZDMyZTg4YjNjNWYvdGFibGVyYW5nZTplMTk2OGRiNTgyZDg0OGUzODBkZDdkMzJlODhiM2M1Zl8zLTItMS0xLTA_79f1ed29-76e4-42c7-bad2-80fe9a7ed14a">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia6d0ddad70114b6a83f55355ff735cf0_D20210101-20210630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6ZTE5NjhkYjU4MmQ4NDhlMzgwZGQ3ZDMyZTg4YjNjNWYvdGFibGVyYW5nZTplMTk2OGRiNTgyZDg0OGUzODBkZDdkMzJlODhiM2M1Zl80LTAtMS0xLTA_d142208c-1a62-4b86-af26-49e164bb4098">Celgene Contingent Value Rights</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia6d0ddad70114b6a83f55355ff735cf0_D20210101-20210630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6ZTE5NjhkYjU4MmQ4NDhlMzgwZGQ3ZDMyZTg4YjNjNWYvdGFibGVyYW5nZTplMTk2OGRiNTgyZDg0OGUzODBkZDdkMzJlODhiM2M1Zl80LTEtMS0xLTA_c97cfb11-1606-41e0-aa00-bee3f338e9c0">CELG RT</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia6d0ddad70114b6a83f55355ff735cf0_D20210101-20210630" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6ZTE5NjhkYjU4MmQ4NDhlMzgwZGQ3ZDMyZTg4YjNjNWYvdGFibGVyYW5nZTplMTk2OGRiNTgyZDg0OGUzODBkZDdkMzJlODhiM2M1Zl80LTItMS0xLTA_6ff69a9d-25e2-4a11-bf28-b4b0cf56ddff">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to the filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDc0_b757ca3c-50dd-4e49-ae65-62534925c4f5">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160; No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDYz_d227e917-265e-40e1-8eda-57dbea834617">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definition of &#8220;<ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDY0_72cede2f-df28-4007-b486-a2490de41378">large accelerated filer</ix:nonNumeric>,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.69pt;font-weight:700;line-height:100%">Large accelerated filer&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.69pt;font-weight:700;line-height:100%">Accelerated filer&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.69pt;font-weight:700;line-height:100%">Non-accelerated filer&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.69pt;font-weight:700;line-height:100%">Smaller&#160;reporting&#160;company&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.69pt;font-weight:700;line-height:100%">Emerging growth company&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDc1_b7b7551d-519d-4754-a8f2-26879e281934">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   &#160;Yes&#160; </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDY1_92a73013-cf9a-4437-818d-24a5af9a02cf">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">  &#160; No &#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">APPLICABLE ONLY TO CORPORATE ISSUERS:</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">At June&#160;30, 2021, there were <ix:nonFraction unitRef="shares" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="0" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yMzg4_9d23fc3b-2963-4bda-b9f3-4607cd642c33">2,222,113,553</ix:nonFraction> shares outstanding of the Registrant&#8217;s $0.10 par value common stock.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2.5pt solid #000000;border-top:2.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="id66f4ecc89aa45bca7756420c60966f5_7"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BRISTOL-MYERS SQUIBB COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">June&#160;30, 2021</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:90.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.650%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I&#8212;FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_13">Financial Statements:</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_16">Consolidated Statements of Earnings and Comprehensive Income/(Loss)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_19">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_25">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_25">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_28">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_28">6</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_94">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_94">30</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_166">Quantitative and Qualitative Disclosure About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_166">52</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_169">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_169">52</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II&#8212;OTHER INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_175">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_175">53</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_178">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_178">53</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_181">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_181">53</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_184">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_184">54</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_187">Summary of Abbreviated Terms</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_187">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_190">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#id66f4ecc89aa45bca7756420c60966f5_190">56</a></span></div></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Indicates brand names of products which are trademarks not owned by BMS. Specific trademark ownership information is included in the Exhibit Index at the end of this Quarterly Report on Form 10-Q.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="id66f4ecc89aa45bca7756420c60966f5_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I&#8212;FINANCIAL INFORMATION</span></div><div><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_13"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. FINANCIAL STATEMENTS</span></div><div id="id66f4ecc89aa45bca7756420c60966f5_16"></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BRISTOL-MYERS SQUIBB COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF EARNINGS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dollars in Millions, Except Per Share Data</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EARNINGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9276ebf40046b4a41a5f19262377b1_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMi0xLTEtMS0w_00e69cfa-9372-49f2-8519-a9501ab4fa3f">11,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i693b996ab36a4cebaefd928a05970180_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMi0zLTEtMS0w_ab59e6bd-730c-4494-9b56-e8fa70a4c7e3">9,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie656e6b5b421495887e8721375eae829_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMi01LTEtMS0w_d6987c1f-0a18-4f63-b075-7dd3290c1e5a">22,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70262bb79f2b4fb682856a49e0942b2a_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMi03LTEtMS0w_df9276c7-9ba1-43d0-9d2f-0390342687df">20,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance and other revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie92d7cecd5b8445a9169fd5dbf526e4c_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMy0xLTEtMS0w_0758d695-f101-4f35-90ef-26fa421cc73e">298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb180892039d4e5b82c0a8f7673aa38a_D20200401-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMy0zLTEtMS0w_e13966f3-7ab5-4a81-9040-a7825fc871aa">312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28849fb4b9345149f1a1b15340c1cee_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMy01LTEtMS0w_a283617d-7542-4048-b192-d391ba01f3e3">573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4be7577ef3cc4c838eb6fc6d157858b7_D20200101-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMy03LTEtMS0w_4bcf83e5-92e7-4431-be7c-454b64c8a3c1">552</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNC0xLTEtMS0w_99e5cbf6-b199-4b55-94f7-8a3832cefa61">11,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNC0zLTEtMS0w_b8628e5c-b814-40da-a20f-fb8e7f7f6857">10,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNC01LTEtMS0w_1a56576c-5ec3-46ee-8bab-ee488a2d6c7f">22,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNC03LTEtMS0w_56075369-fd1d-46b4-9ad6-512bf564883c">20,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNi0xLTEtMS0w_854dcc1c-daf5-4493-b28a-375e5aa89e7a">2,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNi0zLTEtMS0w_7ec21314-9a79-4478-9828-3ae79b144f31">2,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNi01LTEtMS0w_36d7e790-1e53-4df5-b2f7-b7fd854fcc84">5,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNi03LTEtMS0w_3d14026d-5421-48f7-b0e4-36459f872b48">6,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNy0xLTEtMS0w_1f29284a-2660-4fd6-895c-1190af92e23d">1,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNy0zLTEtMS0w_f34f9f36-d14d-4a7f-9a1d-0fb3d0e398c4">1,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNy01LTEtMS0w_9ff183b5-17b9-4829-8309-3cee1d3892fe">3,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNy03LTEtMS0w_dc4b1b68-2647-43ee-9983-d7d29369017f">3,234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfOC0xLTEtMS0w_89a13833-3940-4ad4-b82b-0771f519e369">3,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfOC0zLTEtMS0w_a89e9625-8179-4c5e-a836-bcf29ba4c22c">2,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfOC01LTEtMS0w_96945ef2-2542-4116-bbd4-061f7e285cfc">5,496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfOC03LTEtMS0w_1b403d95-f536-4c45-b0b7-11662866b467">4,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="bmy:AmortizationofAcquiredIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfOS0xLTEtMS0w_328e84dc-6ab0-4ff2-89cb-794d5626e480">2,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="bmy:AmortizationofAcquiredIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfOS0zLTEtMS0w_12895560-7493-490a-bd5a-5f47ca93007e">2,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="bmy:AmortizationofAcquiredIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfOS01LTEtMS0w_961d1f9c-50d8-463d-be5f-44a2786e11ae">5,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="bmy:AmortizationofAcquiredIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfOS03LTEtMS0w_93f9f5d6-8c4f-40ad-be39-8c14c01b3e63">4,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTAtMS0xLTEtMA_06bdd6ca-8eba-46c7-a8fa-4c542fff63ca">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTAtMy0xLTEtMA_02bc786f-ee8e-4e9e-95ba-21a7e06dbaec">736</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTAtNS0xLTEtMA_b71666d3-fd4a-4982-852e-3f30bb750e5b">704</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTAtNy0xLTEtMA_4b4f46e6-a619-4fd7-8a61-4cdfd7799474">427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTEtMS0xLTEtMA_9c5ab519-eab0-462b-b03f-46df93458296">10,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTEtMy0xLTEtMA_13a98c3f-222a-45c4-9771-ebfd48638f56">8,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTEtNS0xLTEtMTk3NA_aad35898-00e5-488f-b2b3-aaa360537f1d">18,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTEtNy0xLTEtMTk3NA_f83af609-4029-4753-89b4-c42c3391bda2">19,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings Before Income Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTMtMS0xLTEtMA_e3536a23-0a27-4495-bfd1-f5d17abde2e4">1,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTMtMy0xLTEtMA_f818e0a5-250a-4923-8021-699a0da4e4f8">1,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTMtNS0xLTEtMA_48a8b3af-3b50-4dff-9865-aefaa5bd7d3d">4,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTMtNy0xLTEtMA_ecd22322-9894-45b4-8889-ab8a04348ce4">1,323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for Income Taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTQtMS0xLTEtMA_13015e9e-a15e-4f01-9f3f-98bf300c5398">492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTQtMy0xLTEtMA_e45c1c64-af44-4d9b-97bb-27ebe850fc4b">1,707</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTQtNS0xLTEtMA_faa2a2ed-f5bf-44d1-a782-4330947e166e">993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTQtNy0xLTEtMA_042ed61b-2ca8-44ed-a65e-8fe7a7d1ac11">2,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings/(Loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTUtMS0xLTEtMA_e466d26a-d02c-4dcf-ae2f-9e79283b0793">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTUtMy0xLTEtMA_1f19d942-3da6-4e76-a2ce-b69a457b7f55">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTUtNS0xLTEtMTk3Ng_ddf52a24-9db9-479d-b558-0916c0709791">3,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTUtNy0xLTEtMTk3Ng_731b895f-9ce9-42c1-ae57-986e311d74d8">846</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling Interest</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTYtMS0xLTEtMA_da047a4b-8bfa-4355-9bcd-e9fb77b2623e">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTYtMy0xLTEtMA_c6c258fd-1aa2-43d3-a163-86491af640b7">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTYtNS0xLTEtMA_7d32ad19-1d1e-42bd-bc84-412497d12355">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTYtNy0xLTEtMA_931571d7-27d7-4df3-b1f7-deec15db1dbe">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings/(Loss) Attributable to BMS</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTctMS0xLTEtMA_1e29fbe5-c968-409b-b997-4ff8aefe8c74">1,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTctMy0xLTEtMA_2b15a518-5373-4175-94e9-a958b15e77ac">85</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTctNS0xLTEtMTk3Ng_549f42f7-bdcd-412b-8916-1d0f2c027fc9">3,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTctNy0xLTEtMTk3Ng_825e3536-266f-47cc-a032-97563c08ca85">860</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings/(Loss) per Common Share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMjAtMS0xLTEtMA_6b7581d9-4899-4cb4-8c27-b25889d894b9">0.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMjAtMy0xLTEtMA_4a2dc41c-493b-42cc-9dfb-aed68b3ab8a0">0.04</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMjAtNS0xLTEtMA_ed7942be-b29e-40c2-929c-2876edcf6597">1.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMjAtNy0xLTEtMA_e38afe39-b228-4235-a93c-15b5aa2a71f5">0.38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMjEtMS0xLTEtMA_71b34a20-723e-477a-8806-759714c762ba">0.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMjEtMy0xLTEtMA_d7c5265c-672e-4595-a9e6-754a34e2aec4">0.04</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMjEtNS0xLTEtMA_7d3e0dd6-b4df-47a8-b7d6-8243c34eb9f9">1.36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMjEtNy0xLTEtMA_79b8446f-4884-4529-b8bc-523d62c9b9f2">0.38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;<ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RleHRyZWdpb246ODk5ZTdlNGQyZjRhNGI4YTg5NjA1NzdiMWNiODY3ZTlfMzY0_a4610352-7756-429b-a9c8-7581cfff2dd4" footnoteRole="http://www.xbrl.org/2003/role/footnote">Excludes amortization of acquired intangible assets</ix:footnote>.</span></div><div style="margin-top:9pt"><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/(LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dollars in Millions</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">COMPREHENSIVE INCOME/(LOSS)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings/(Loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMi0xLTEtMS0w_a03e1731-5ae2-4fba-bd7c-eabebce1e536">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMi0zLTEtMS0w_f080e8d3-cf58-4348-8219-b020c18dfc5b">80</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMi01LTEtMS0w_12674bf0-8190-4fb9-9a48-fc16a5db92e4">3,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMi03LTEtMS0w_7cca3464-ac31-4112-b05e-d5646473c713">846</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="24" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income/(Loss), net of taxes and reclassifications to earnings:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNC0xLTEtMS0w_189a29e0-6f7d-47b7-9df7-eff3ed42167e">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNC0zLTEtMS0w_0fed6999-26f5-456f-9658-68d8ccc2e3f0">59</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNC01LTEtMS0w_1931ef34-1233-4909-8225-583f48e5e90c">286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNC03LTEtMS0w_abef496a-2cca-4f83-8bd3-b286b8f17721">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNS0xLTEtMS0w_5137ba05-4e7b-4188-9483-d06f9147ae06">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNS0zLTEtMS0w_d05b9f01-ca80-47ba-80f1-985314a375a4">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNS01LTEtMS0w_06ff238e-fac6-4f98-8630-931452dd7603">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNS03LTEtMS0w_8d1af88f-2efb-4c8a-ad21-8b523d16f358">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNi0xLTEtMS0w_506cab50-5a86-4bd0-aac3-8fd1687d46d8">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNi0zLTEtMS0w_e8111a84-5428-4fc5-a0c5-f1e8d0a5b8d1">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNi01LTEtMS0w_9e87e7e1-c5bf-4202-942b-e981de586b98">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNi03LTEtMS0w_98c58f40-9ae5-41d8-9423-8ec0abf559fb">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNy0xLTEtMS0w_3fb3e4f8-3762-4f8e-8889-0a3d38b47333">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNy0zLTEtMS0w_5e782b0e-cb12-4bcb-8d5b-7e9e9f1b6161">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNy01LTEtMS0w_45de0912-ad22-4901-8924-779558734ede">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNy03LTEtMS0w_18060ea7-6d97-44a5-b79c-9155e12de7b9">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Other Comprehensive Income/(Loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfOC0xLTEtMS0w_1791d68c-c762-4e4b-a43d-6d33b3a60860">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfOC0zLTEtMS0w_1dd52f07-459f-44d3-84ed-b8c3ef7e1810">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfOC01LTEtMS0xOTgw_2e6b1085-cce9-410c-a6c2-11c42fab6915">321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfOC03LTEtMS0xOTgw_06b96e0c-b628-4c91-901b-c4d55b76cb2b">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive Income/(Loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMTAtMS0xLTEtMA_9867e740-d7ea-47c8-a579-7745123926c5">1,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMTAtMy0xLTEtMA_5a8d46ff-93fb-4bee-9bef-95fbc370cbd4">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMTAtNS0xLTEtMTk4MA_bcd6c8cf-866b-4106-acd3-7cfcdbb91abd">3,411</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMTAtNy0xLTEtMTk4MA_6ec263fd-9e40-4b6f-ab4c-3bb18ac385e0">882</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive Income Attributable to Noncontrolling Interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMTEtMS0xLTEtMA_da047a4b-8bfa-4355-9bcd-e9fb77b2623e">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMTEtMy0xLTEtMA_c6c258fd-1aa2-43d3-a163-86491af640b7">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMTEtNS0xLTEtMA_7d32ad19-1d1e-42bd-bc84-412497d12355">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMTEtNy0xLTEtMA_931571d7-27d7-4df3-b1f7-deec15db1dbe">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive Income/(Loss) Attributable to BMS</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMTItMS0xLTEtMA_2ac7955f-3f96-49cb-ac0c-77e37ed26dc9">1,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMTItMy0xLTEtMA_2b027f1c-d1ed-40a6-ab80-895fe841fc09">92</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMTItNS0xLTEtMTk4MA_9e5030ac-cabd-4a53-a5ff-4c9fffd186bf">3,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMTItNy0xLTEtMTk4MA_5f6fc544-876c-419e-9d38-33f11a31dd9f">896</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="id66f4ecc89aa45bca7756420c60966f5_19"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BRISTOL-MYERS SQUIBB COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dollars in Millions</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMi0xLTEtMS0w_64efd3a5-e606-42cf-bc9e-bb0b03df3e81">11,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMi0zLTEtMS0w_d3c55a1f-9973-412f-af3b-b3052aff7033">14,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMy0xLTEtMS0w_6eb75c71-5af7-4d44-9d88-99679f268336">1,946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMy0zLTEtMS0w_c381f28c-504e-49f1-830e-fcbf6202624b">1,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfNC0xLTEtMS0w_1e0e24b7-0b84-454f-ae7c-ae8b9c968e36">9,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfNC0zLTEtMS0w_4b6d3806-f23b-41bd-ba57-9614bdb1a37b">8,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfNS0xLTEtMS0w_032f8c46-2853-41e4-b1d8-67521bf5d361">2,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfNS0zLTEtMS0w_f3584fa6-fa80-4900-8d26-c74c75b0cdd7">2,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfNi0xLTEtMS0w_1e632ce8-be3a-4039-99e6-0eee3ee16e36">5,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfNi0zLTEtMS0w_80c419d4-ba8b-4f74-b434-7b6343344b82">3,786</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current Assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfNy0xLTEtMS0w_3c7f6eea-b0e5-45ac-91e1-f5fef93cd3af">29,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfNy0zLTEtMS0w_8e21561b-3614-425c-ace9-a202c5cb2a7f">30,192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfOC0xLTEtMS0w_1cedc368-81ca-4d78-9b72-d6cff5610d36">5,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfOC0zLTEtMS0w_23f5faaf-a2ea-4843-81e7-2bcf52ce2575">5,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfOS0xLTEtMS0w_6d36e51c-0c46-4341-9008-ed5c7abf006b">20,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfOS0zLTEtMS0w_6713e13c-a880-4d5f-b117-59e915abc5d4">20,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTAtMS0xLTEtMA_563c8836-e00f-4afa-9651-e413b6bf7b77">48,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTAtMy0xLTEtMA_aaa31a4d-0dd4-40ee-b152-45bf24b02880">53,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTEtMS0xLTEtMA_6b5dc4cd-06dc-48be-8607-312d0c818cea">650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTEtMy0xLTEtMA_8252925f-d5d3-486b-8f81-80d71f27c05e">1,161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTItMS0xLTEtMA_6529495d-eecb-4ecd-8f4c-fa07bee2b09b">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTItMy0xLTEtMA_77211637-564f-4816-9e5b-ed942d38d467">433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTMtMS0xLTEtMA_b048afa8-c44a-4964-8843-88a658b22c75">6,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTMtMy0xLTEtMA_b7a39c74-4a9b-4514-9186-50d4aae8c848">7,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTQtMS0xLTEtMA_9217d715-227b-4179-a081-e1940b69a0ae">110,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTQtMy0xLTEtMA_d3133591-d3d2-4106-8ef7-68cfcdef0c26">118,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTgtMS0xLTEtMA_82d6b2c8-8333-48cb-b865-967c4f2d62e4">2,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTgtMy0xLTEtMA_c6e7b535-2938-4f4e-8a17-ff164f5cfdb8">2,340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTktMS0xLTEtMA_119f1a9d-78a4-4f6e-992c-2a31da6ea421">3,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTktMy0xLTEtMA_6e827e29-4a31-46e5-96e0-b026ba4e0ced">2,713</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMjAtMS0xLTEtMA_70321243-ac5d-43b6-9849-0574a0166b3d">12,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMjAtMy0xLTEtMA_a25c16d2-7b1f-40b5-9d34-22119894be54">14,027</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current Liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMjEtMS0xLTEtMA_88681502-7247-4fa7-a4c3-4d6f04e7abc5">18,991</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMjEtMy0xLTEtMA_8c666aa3-bf30-4041-a113-9d212e92488a">19,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMjItMS0xLTEtMA_be1a5bf9-3042-453c-9e8c-b0a6e80f3d91">4,931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMjItMy0xLTEtMA_2ef13a4d-900a-4d18-a6e5-bb82d63698a6">5,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMjMtMS0xLTEtMA_dca240ed-a396-40b8-89b4-42e27db867e0">42,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMjMtMy0xLTEtMA_555e0e02-ab25-4a70-8164-48d6cdb60e0d">48,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMjQtMS0xLTEtMA_63204836-abc5-496d-b368-550114784be0">7,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMjQtMy0xLTEtMA_e4711ebe-4381-468a-abba-f2289aa27b4d">7,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMjUtMS0xLTEtMA_965e455d-4878-4a6e-b118-ea6164666ad6">73,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMjUtMy0xLTEtMA_0e73fde9-abc7-45d2-abd3-7703fa7a91c4">80,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bristol-Myers Squibb Company Shareholders&#8217; Equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzEtMS0xLTEtMA_11652c3d-e931-4c9c-a8a2-5bbd8d414661">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzEtMy0xLTEtMA_e4d44544-2bca-49af-8180-2e28307da9d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzItMS0xLTEtMA_f6fd9229-2923-4342-8f07-7dac4204d3d1">292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzItMy0xLTEtMA_53aa8ea1-8d45-445a-a71e-ae8157e1b19e">292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in excess of par value of stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzMtMS0xLTEtMA_34987a66-697e-4c61-ba13-c67f1f859e3c">44,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzMtMy0xLTEtMA_b8c88fda-912d-4a52-a2c2-3882636964c8">44,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzQtMS0xLTEtMA_c7583258-a43a-4f7f-87b0-505f82ee582b">1,518</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzQtMy0xLTEtMA_ac6f1958-c269-47cf-b11e-ff611ee1438d">1,839</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzUtMS0xLTEtMA_8928b40e-7a83-420e-8321-2a97f388d924">22,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzUtMy0xLTEtMA_f8ea6feb-ec98-4ea4-ba5a-dc4e9ae8ac85">21,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less cost of treasury stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzYtMS0xLTEtMA_6635fc2c-a4fb-447d-b3c6-1991808e1125">28,198</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzYtMy0xLTEtMA_7571a9ff-a9c6-49ed-a20e-214fdd71a720">26,237</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Bristol-Myers Squibb Company Shareholders&#8217; Equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzctMS0xLTEtMA_018d5543-3f03-4def-b9bd-fde38266da6c">36,808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzctMy0xLTEtMA_e0a27ced-a25a-4c3a-8489-ca930f168c77">37,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzgtMS0xLTEtMA_3a08cef9-b3f1-4696-a576-e612b46c06af">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzgtMy0xLTEtMA_4453ccef-abce-4f72-a5c0-a88fb4483443">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzktMS0xLTEtMA_833a78a9-1235-4a1d-9cbd-ff74cce3f579">36,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzktMy0xLTEtMA_4d7a1a9b-dcc5-4678-a349-a865870bffe2">37,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities and Equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfNDAtMS0xLTEtMA_759619d9-807b-4b47-8464-789f21f71ddf">110,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfNDAtMy0xLTEtMA_53f7253e-619e-4142-a82c-567e74e0c85c">118,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="id66f4ecc89aa45bca7756420c60966f5_25"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BRISTOL-MYERS SQUIBB COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dollars in Millions</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows From Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings/(loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMy0xLTEtMS0w_fff4522e-3807-4c4f-a064-8cf348190b72">3,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMy0zLTEtMS0w_1ef8c29b-809e-4675-b2dd-493554a72162">846</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings/(loss) to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfNS0xLTEtMS0w_d51c519e-26f3-4dcc-81b9-3a8c1ecfd128">5,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfNS0zLTEtMS0w_ab21575e-6014-41c0-b7ab-2cf219b18c69">5,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfNi0xLTEtMS0w_ad54ecc6-a5d0-483f-b6f2-250dd940c9a3">95</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfNi0zLTEtMS0w_207b45c6-05fe-4ce0-afef-6552c8c2f2ca">1,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfNy0xLTEtMS0w_6d9c15bf-acee-4597-9986-294168ed2894">308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfNy0zLTEtMS0w_c66e5d2e-fab5-4848-a8c0-69cda34bf955">423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfOC0xLTEtMS0w_f624cb80-4024-45fc-8e54-5a6aaa6c21cf">579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfOC0zLTEtMS0w_21449525-acb1-444e-b1c9-a3093f0548c8">116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension settlements and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="bmy:Pensionsettlementsandamortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfOS0xLTEtMS0w_fb533a9a-7dbd-4441-b596-c061b7912390">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="bmy:Pensionsettlementsandamortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfOS0zLTEtMS0w_a875007f-ce65-4fbc-b5cb-1068170c50bb">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture gains and royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="bmy:Divestituregainsandroyalties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTAtMS0xLTEtMA_c4594511-3f65-4ab7-9f22-df1a8c27ca67">302</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="bmy:Divestituregainsandroyalties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTAtMy0xLTEtMA_3da988bb-c1d3-4407-aea3-b095b9a4e433">295</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset acquisition charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="bmy:Assetacquisitioncharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTEtMS0xLTEtMA_5be6760e-be16-4491-87a4-97077b6b3f75">801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="bmy:Assetacquisitioncharge" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTEtMy0xLTEtMA_a073fe5c-7e36-4e31-b7bf-15b30fc1af3f">361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment gains</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTItMS0xLTEtMA_eabeb055-cb91-460d-946a-5e28d913caaa">749</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTItMy0xLTEtMA_c9cab140-3de1-4c50-ab6a-3e0c986b9abe">480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration fair value adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTMtMS0xLTEtMA_910a2cf5-2c0f-490a-b442-71c8e200e260">510</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTMtMy0xLTEtMA_fa7cd7ca-75eb-4191-814f-6ed3cd68f578">391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTQtMS0xLTEtMA_3becd959-0b62-4668-9aac-c3476127c2dc">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTQtMy0xLTEtMA_15f5e469-e999-46fe-bb50-4a0073af57e8">91</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTYtMS0xLTEtMA_6980d775-2c9f-4171-8a49-52809cf43042">626</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTYtMy0xLTEtMA_c87200ab-7ca9-4a54-892b-a16f51b503bb">197</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTctMS0xLTEtMA_c1007294-0aed-46cb-8530-d6c9bab34584">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTctMy0xLTEtMA_687b1643-2d82-45dc-b428-88f3376df400">2,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTgtMS0xLTEtMA_8fb30e59-f340-432a-9192-36405e6d25ac">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTgtMy0xLTEtMA_d89d1109-85b1-4c31-88c4-d1a9ecc95355">480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTktMS0xLTEtMA_eee3638a-5ec2-4c00-8329-8a8ecd6cb8aa">795</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTktMy0xLTEtMA_9439dc5c-a5fb-4ea1-bae4-11df2ae9f431">185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjAtMS0xLTEtMA_84fef887-d313-4030-9713-7e5b2ef16b3e">695</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjAtMy0xLTEtMA_a9f8d5a0-0f9c-4274-aab3-1237997b706c">129</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Cash Provided by Operating Activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjEtMS0xLTEtMA_93e06302-8d92-4e2d-b54f-12ebd84a8f21">6,884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjEtMy0xLTEtMA_57b67ee5-b04a-4597-b782-43ee4aa30ee9">8,430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows From Investing Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale and maturities of marketable debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjMtMS0xLTEtMA_ed40c69b-bc96-4cdc-8651-8c193bd49d03">1,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjMtMy0xLTEtMA_18740c94-d8de-4d7f-b081-f3e90b1e7d31">3,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of marketable debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjQtMS0xLTEtMA_3ea7d21f-af35-424d-9d9a-0c8c81d14904">2,343</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjQtMy0xLTEtMA_02e50c76-e59e-447f-be17-51f48a1d11e0">1,957</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales of equity investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjUtMS0xLTEtMjQzNg_539637ac-1015-4179-82bd-05c428cce409">814</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjUtMy0xLTEtMjQ0MA_0e984132-3674-46ab-be0a-72a15d54bac1">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjUtMS0xLTEtMA_50cb68ce-89bb-47ac-acc7-68acd3a852b3">383</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjUtMy0xLTEtMA_a8aa80b6-e5c0-4bcb-9b8f-9298311e5878">317</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture and other proceeds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="bmy:Divestitureandotherproceeds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjYtMS0xLTEtMA_f498d7d8-d09c-4a96-9c30-a2af384f3961">382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="bmy:Divestitureandotherproceeds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjYtMy0xLTEtMA_9ba4b3a8-2f80-4d41-a592-c81b523e35dd">336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and other payments, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjctMS0xLTEtMA_e1a4eec3-1736-403d-a74a-9cf24227f07a">401</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjctMy0xLTEtMA_a9b281e9-2e77-4708-86a3-280dea479b71">445</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Cash Provided by Investing Activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjgtMS0xLTEtMA_3c5589d4-a9c4-4e45-9eb1-6faddf5c4103">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjgtMy0xLTEtMA_abce6739-9d37-4330-ae89-9b0e1476bb87">1,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows From Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt obligations, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzAtMS0xLTEtMA_becb34eb-f9cb-4e9b-b193-30034d166495">185</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzAtMy0xLTEtMA_20ea2c92-5365-41ae-b36a-94e2b7d78aea">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzItMS0xLTEtMA_7dee6cd1-21e7-4df5-947d-455f74b57dca">5,522</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzItMy0xLTEtMA_1177075a-cb5c-418a-90e1-680df6b678c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzMtMS0xLTEtMA_49960715-a445-4244-91f1-d67d9cf12ff5">3,011</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzMtMy0xLTEtMA_df7e9ec8-6b21-4f61-acf8-77a3036aa383">81</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzQtMS0xLTEtMA_22308b7f-f707-408c-9b88-ef0a8c69fad4">2,207</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzQtMy0xLTEtMA_7bb3f585-d4f2-4a9c-ae31-59decb29d35d">2,038</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzUtMS0xLTEtMA_b92795d7-f047-4c50-bae3-c7d3b8f18c57">448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzUtMy0xLTEtMA_dc2488b1-704e-4af4-982e-c8d11aac0d42">94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Cash Used in Financing Activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzYtMS0xLTEtMA_64620982-280b-4fdd-b7fd-8ebd50125904">10,477</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzYtMy0xLTEtMA_a6ed9e4b-2f9c-42c0-b99a-3cd686b73c77">2,047</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of Exchange Rates on Cash, Cash Equivalents and Restricted Cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzctMS0xLTEtMA_4d49d715-a654-433f-98f3-7e705df65723">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzctMy0xLTEtMA_e122f5ff-591e-4a0f-8cd0-23e94d009891">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease)/Increase in Cash, Cash Equivalents and Restricted Cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzgtMS0xLTEtMA_48bcaf50-75ee-4e3d-8000-931df37c530f">3,576</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzgtMy0xLTEtMA_0996e052-95bc-45b9-8620-1eddf50e14f3">7,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, Cash Equivalents and Restricted Cash at Beginning of Period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzktMS0xLTEtMA_b280771a-a1fe-4ac5-aba0-7fcb73a8b534">14,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i519bf72bf2984b599bef546963ea4f65_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzktMy0xLTEtMA_c1952529-9756-494e-9283-313b6db02a43">12,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, Cash Equivalents and Restricted Cash at End of Period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfNDAtMS0xLTEtMA_a720f179-1c6a-4127-b163-819b26cad7e3">11,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i711a50adb808497c9daf76647502dad6_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfNDAtMy0xLTEtMA_b7999008-04af-4cf1-bc11-98493b991176">20,362</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="id66f4ecc89aa45bca7756420c60966f5_28"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note 1. BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS</span></div><div><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_31"></div><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zMS9mcmFnOmViNjU3ZjAxOTNiNTRlZTM4YTAwMDBiMDhmZjFjMDk1L3RleHRyZWdpb246ZWI2NTdmMDE5M2I1NGVlMzhhMDAwMGIwOGZmMWMwOTVfNDQwMw_b8dd7f11-403f-47df-b0b9-64298f005541" escape="true"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zMS9mcmFnOmViNjU3ZjAxOTNiNTRlZTM4YTAwMDBiMDhmZjFjMDk1L3RleHRyZWdpb246ZWI2NTdmMDE5M2I1NGVlMzhhMDAwMGIwOGZmMWMwOTVfNDQyNA_4683c3d7-8c12-4435-952e-9c22ad95d66e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Consolidation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bristol-Myers Squibb Company (&#8220;BMS&#8221;) prepared these unaudited consolidated financial statements following the requirements of the SEC and U.S. GAAP for interim reporting. Under those rules, certain footnotes and other financial information that are normally required for annual financial statements can be condensed or omitted. The Company is responsible for the consolidated financial statements included in this Quarterly Report on Form 10-Q, which include all adjustments necessary for a fair presentation of the financial position at June&#160;30, 2021 and December&#160;31, 2020, the results of operations for the three and six months ended June&#160;30, 2021 and 2020, and cash flows for the six months ended June&#160;30, 2021 and 2020. All intercompany balances and transactions have been eliminated. These financial statements and the related notes should be read in conjunction with the audited consolidated financial statements for the year ended December&#160;31, 2020 included in the 2020 Form&#160;10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zMS9mcmFnOmViNjU3ZjAxOTNiNTRlZTM4YTAwMDBiMDhmZjFjMDk1L3RleHRyZWdpb246ZWI2NTdmMDE5M2I1NGVlMzhhMDAwMGIwOGZmMWMwOTVfNDQzMA_896867d8-5571-4efe-bccf-2b7c68af76ab" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Segment Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS operates in a single segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of innovative medicines that help patients prevail over serious diseases. A global research and development organization and supply chain organization are responsible for the discovery, development, manufacturing and supply of products. Regional commercial organizations market, distribute and sell the products. The business is also supported by global corporate staff functions. Consistent with BMS&#8217;s operational structure, the Chief Executive Officer (&#8220;CEO&#8221;), as the chief operating decision maker, manages and allocates resources at the global corporate level. Managing and allocating resources at the global corporate level enables the CEO to assess both the overall level of resources available and how to best deploy these resources across functions, therapeutic areas, regional commercial organizations and research and development projects in line with our overarching long-term corporate-wide strategic goals, rather than on a product or franchise basis. The determination of a single segment is consistent with the financial information regularly reviewed by the CEO for purposes of evaluating performance, allocating resources, setting incentive compensation targets, and planning and forecasting future periods. For further information on product and regional revenue, see &#8220;&#8212;Note 2. Revenue.&#8221;</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zMS9mcmFnOmViNjU3ZjAxOTNiNTRlZTM4YTAwMDBiMDhmZjFjMDk1L3RleHRyZWdpb246ZWI2NTdmMDE5M2I1NGVlMzhhMDAwMGIwOGZmMWMwOTVfNDQwNA_9d1fa8c8-4b6b-46c0-b6a3-aa25b816b65a" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates and Judgments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues, expenses, assets and liabilities can vary during each quarter of the year. Accordingly, the results and trends in these unaudited consolidated financial statements may not be indicative of full year operating results. The preparation of financial statements requires the use of management estimates, judgments and assumptions. The most significant assumptions are estimates used in determining accounting for business combinations; impairments of intangible assets; sales rebate and return accruals; legal contingencies; and income taxes. Actual results may differ from estimates.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zMS9mcmFnOmViNjU3ZjAxOTNiNTRlZTM4YTAwMDBiMDhmZjFjMDk1L3RleHRyZWdpb246ZWI2NTdmMDE5M2I1NGVlMzhhMDAwMGIwOGZmMWMwOTVfNDQyMw_3d5effe0-7926-4ed7-be8d-8ec85e4dbbb2" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications were made to conform the prior period consolidated financial statements to the current period presentation. Cash payments resulting from licensing arrangements, including upfront and contingent milestones previously included in operating activities in the consolidated statements of cash flows are now presented in investing activities. The adjustment resulted in an increase to net cash provided by operating activities and net cash used in investing activities of $<ix:nonFraction unitRef="usd" contextRef="i1d96ff885f0c4029b9c659eb21e32c98_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PriorPeriodReclassificationAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zMS9mcmFnOmViNjU3ZjAxOTNiNTRlZTM4YTAwMDBiMDhmZjFjMDk1L3RleHRyZWdpb246ZWI2NTdmMDE5M2I1NGVlMzhhMDAwMGIwOGZmMWMwOTVfMzYzMQ_f7fb758b-fd59-4228-93be-f0cd5c5c7a28">267</ix:nonFraction>&#160;million in the six months ended June 30, 2020. Proceeds received from the sale of equity investment securities previously presented in Divestiture and other proceeds in the consolidated statements of cash flows is now presented separately in Proceeds from sales of equity investment securities. These reclassifications did not have an impact on net assets or net earnings.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zMS9mcmFnOmViNjU3ZjAxOTNiNTRlZTM4YTAwMDBiMDhmZjFjMDk1L3RleHRyZWdpb246ZWI2NTdmMDE5M2I1NGVlMzhhMDAwMGIwOGZmMWMwOTVfNDQxNw_cc1d8e7d-18f2-4bc8-9c78-2f652715a617" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued amended guidance on the accounting and reporting of income taxes. The guidance is intended to simplify the accounting for income taxes by removing exceptions related to certain intraperiod tax allocations and deferred tax liabilities; clarifying guidance primarily related to evaluating the step-up tax basis for goodwill in a business combination; and reflecting enacted changes in tax laws or rates in the annual effective tax rate. BMS adopted the new guidance effective January 1, 2021. The amended guidance did not have a material impact on BMS&#8217;s results of operations.</span></div></ix:nonNumeric></ix:nonNumeric><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="id66f4ecc89aa45bca7756420c60966f5_34"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2. <ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RleHRyZWdpb246MDA4ZjY0YzkyYzk5NDNjYTllNTcyYTQ2YWNiODNiNGRfODU4_e744fa3f-3138-493b-a6f9-a990b85fc14f" continuedAt="ifd7fd8a138f54b9d9b65ffc6c62d04ae" escape="true">REVENUE</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ifd7fd8a138f54b9d9b65ffc6c62d04ae" continuedAt="i1bd92671bb57417c967d5d69a1276ff2"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RleHRyZWdpb246MDA4ZjY0YzkyYzk5NDNjYTllNTcyYTQ2YWNiODNiNGRfODQ1_d8f8c6c4-c254-46d8-8dd2-eee5bf24053c" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by nature:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9276ebf40046b4a41a5f19262377b1_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfMi0xLTEtMS0w_00e69cfa-9372-49f2-8519-a9501ab4fa3f">11,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i693b996ab36a4cebaefd928a05970180_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfMi0zLTEtMS0w_ab59e6bd-730c-4494-9b56-e8fa70a4c7e3">9,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie656e6b5b421495887e8721375eae829_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfMi01LTEtMS0w_d6987c1f-0a18-4f63-b075-7dd3290c1e5a">22,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70262bb79f2b4fb682856a49e0942b2a_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfMi03LTEtMS0w_df9276c7-9ba1-43d0-9d2f-0390342687df">20,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ead8ffbd6a943f58695765106933642_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfMy0xLTEtMS0w_3bb7d100-f222-43bb-9d76-983ed49b8a98">159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74364a7590b441a4afd4e5e67a3b406e_D20200401-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfMy0zLTEtMS0w_9e9613a0-1aaa-433b-8483-2de37ada0012">163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87185b42e332422389a23e672417b431_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfMy01LTEtMS0w_1d2f9d10-a312-4e4a-a71b-86941aa50eda">301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if25b0239054048e3b55eeb8500972cdf_D20200101-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfMy03LTEtMS0w_7f61ef31-9bfd-4037-b924-fda56e998cfc">268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2fb12a3531e4873be7be194483607ee_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfNC0xLTEtMS0w_2709dcfd-0e4b-4a12-8605-40ff85c7d2b4">139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i688d430df875454b84b14f79015b6cf6_D20200401-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfNC0zLTEtMS0w_70b1de46-d0fc-4666-83eb-657b5ae823b9">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ba774a2df9f40a8b6d19e1fba5043b7_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfNC01LTEtMS0xNjM5_1efa5a97-0e9a-4419-a3a8-8a41f6c31850">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43a13af27d1448f7993f34c3dd68a67d_D20200101-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfNC03LTEtMS0xNjM1_6b12c116-a527-4a5b-829d-2d51e7ec3a09">284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfNS0xLTEtMS0w_1460720a-b22d-4def-b4f3-f4b5704bf503">11,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfNS0zLTEtMS0w_4ab48f03-ffb9-4395-983d-9dd678728c99">10,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfNS01LTEtMS0w_71d12675-2889-4379-89c8-219988c4f6a7">22,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfNS03LTEtMS0w_cb84eed0-75b3-4675-be5c-c3eeb8698501">20,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products are sold principally to wholesalers, distributors, specialty pharmacies, and to a lesser extent, directly to retailers, hospitals, clinics and government agencies. Customer orders are generally fulfilled within a few days of receipt resulting in minimal order backlog. Contractual performance obligations are usually limited to transfer of control of the product to the customer. The transfer occurs either upon shipment, upon receipt of the product after considering when the customer obtains legal title to the product, or upon infusion for cell therapies and when BMS obtains a right of payment. At these points, customers are able to direct the use of and obtain substantially all of the remaining benefits of the product.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="bmy:ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RleHRyZWdpb246MDA4ZjY0YzkyYzk5NDNjYTllNTcyYTQ2YWNiODNiNGRfODQ2_ab891f39-0c3b-469d-99e1-23e6d63d2721" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes GTN adjustments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02cc001651e94e7295b1dcc33d5daaa2_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfMi0xLTEtMS0w_8a438049-f14c-4b12-b03c-c8e28e59e9d8">16,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba96fdc39cdc460db86d38cae38883fe_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfMi0zLTEtMS0w_c1089e9f-9b17-4143-8299-7205b5963918">13,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3be3517a7304e72b770f702ef97ea11_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfMi01LTEtMS0w_7bd2f12c-5aea-4801-8aba-096f4f7402a0">32,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i866d2af294a649c284a0a90628fcb561_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfMi03LTEtMS0w_00b9e92a-d13c-4eb6-9b38-cbe2f8034278">28,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if22a4fc3cd8c4d6c8f43d5db96fc3d2b_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="bmy:GrosstoNetAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNC0xLTEtMS0w_78a56f8b-4c55-4dac-9ffd-3f5319a8a368">1,720</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6aeff8b93aa4e498214da65e668a5e7_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="bmy:GrosstoNetAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNC0zLTEtMS0w_69636cf2-fef0-46ab-933a-a28bb8c26656">1,292</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e43c6a8382640da95ba7937bc7cb901_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="bmy:GrosstoNetAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNC01LTEtMS0w_b8f42e15-93e8-4d1f-8dba-c479b564e117">3,306</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa953030056e4436b2eccb65049c20bd_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="bmy:GrosstoNetAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNC03LTEtMS0w_c6ad15c7-c7bd-4570-adfb-1d37251fd29d">2,632</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Medicare rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf1613c94e7c4ae1a97bd33c34b116b9_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="bmy:GrosstoNetAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNS0xLTEtMS0w_80c7e5d4-bdbf-41ed-b644-995af7d9a146">2,139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i245bc87a8ea146ff89ba47f0050ab6cd_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="bmy:GrosstoNetAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNS0zLTEtMS0w_99c51840-ba01-402e-85fc-64a749e4f0a5">1,482</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc81985d98e0407586fee97e68186a0c_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="bmy:GrosstoNetAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNS01LTEtMS0w_658195d4-1024-485c-ade1-bb2bd14ef281">3,857</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ee340e61c044b3ba36660dccc49b13e_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="bmy:GrosstoNetAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNS03LTEtMS0w_20596267-b099-4aea-91e9-559e2d31bea8">2,980</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other rebates, returns, discounts and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8447393acf44143ae8dfb8c7ec2d04a_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="bmy:GrosstoNetAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNi0xLTEtMS0w_684c07dc-c098-4e82-ac14-edc758375748">1,518</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie762049c148a4949bccc2fc010d4f185_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="bmy:GrosstoNetAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNi0zLTEtMS0w_4dcadfb2-3673-4f97-8580-204dade26b1c">1,197</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48a97ba1d3f24c95846c59ad03ad5eb4_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="bmy:GrosstoNetAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNi01LTEtMS0w_ecce2679-92f5-4121-b5af-9833fba6345b">2,975</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5651bce30274abea8e9658ea1ea4128_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="bmy:GrosstoNetAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNi03LTEtMS0w_fe458f8a-651d-4290-bbaa-d43efc1e8e3a">2,504</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total GTN adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="bmy:GrosstoNetAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNy0xLTEtMS0w_eb5e1d46-f4d0-48d6-83b2-adeb2950dd10">5,377</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="bmy:GrosstoNetAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNy0zLTEtMS0w_ee0f39ea-173e-4af6-a0c8-c544c68dea51">3,971</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="bmy:GrosstoNetAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNy01LTEtMS0xNjQ5_90af67f4-d859-47c5-a946-1526d2ce1acd">10,138</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="bmy:GrosstoNetAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNy03LTEtMS0xNjQz_d30c23f9-a0cd-460f-bf3e-611a83053931">8,116</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d9276ebf40046b4a41a5f19262377b1_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfOC0xLTEtMS0w_ab230377-01bd-42a1-abcb-546090a6e2ea">11,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i693b996ab36a4cebaefd928a05970180_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfOC0zLTEtMS0w_e168e053-61b7-442e-9305-9e2d24559168">9,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie656e6b5b421495887e8721375eae829_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfOC01LTEtMS0xNjU0_06728e4c-c25b-4f52-a6a7-2be1922e94c5">22,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70262bb79f2b4fb682856a49e0942b2a_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfOC03LTEtMS0xNjQ3_b131672c-77a8-4ed4-8b15-281fda6d1391">20,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes adjustments for provisions for product sales made in prior periods resulting from changes in estimates of $<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RleHRyZWdpb246MDA4ZjY0YzkyYzk5NDNjYTllNTcyYTQ2YWNiODNiNGRfMjY4_397c6911-ed57-4165-a8c5-28849a05f5e4">85</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RleHRyZWdpb246MDA4ZjY0YzkyYzk5NDNjYTllNTcyYTQ2YWNiODNiNGRfMjc1_d077c49d-1bf3-40a2-bcbd-5c52d544ef72">302</ix:nonFraction> million for the three and six months ended June&#160;30, 2021, and $<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RleHRyZWdpb246MDA4ZjY0YzkyYzk5NDNjYTllNTcyYTQ2YWNiODNiNGRfMTA5OTUxMTYyODc2NQ_6c18ebb6-28c2-4498-a883-9dd03f58738b">44</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RleHRyZWdpb246MDA4ZjY0YzkyYzk5NDNjYTllNTcyYTQ2YWNiODNiNGRfMTA5OTUxMTYyODgxMQ_61949b6f-8bbe-4c24-925b-ca8e8f21f684">116</ix:nonFraction> million for the three and six months ended June&#160;30, 2020, respectively.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i1bd92671bb57417c967d5d69a1276ff2"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RleHRyZWdpb246MDA4ZjY0YzkyYzk5NDNjYTllNTcyYTQ2YWNiODNiNGRfODY0_cc9491df-0d0c-40f3-b9b5-ef69e41de294" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by product and region:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prioritized Brands</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Revlimid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0049dfb3f51e491da124b097da74b773_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMy0xLTEtMS0w_016bf866-bee3-4d21-8ff9-64b649578bea">3,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1059bee7d7c24aa5bf63443d6b0b117e_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMy0zLTEtMS0w_5ef37ae7-efd1-42e0-86ee-862d1ac67666">2,884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36a7c570203a43c085160c5d69d6dca2_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMy01LTEtMS0w_277ce485-cf6c-4ce5-82c9-891fbd273be1">6,146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5926634a97d45b588e22bc868140a71_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMy03LTEtMS0w_d3165cc2-fd84-456d-8942-17f56a93406c">5,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Eliquis</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8f5ba386b86453aa8abbb8d97ca5741_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNC0xLTEtMS0w_de290125-1e6c-4865-a58f-02a711eff86b">2,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i164732664a0649a0a6b4e3ec9a6ea675_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNC0zLTEtMS0w_c4075d1d-643a-4d4f-ae82-26d5b8fb81de">2,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b6d5b28fdeb4f539683764cb03f85e8_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNC01LTEtMS0w_aa898a27-78a4-40cf-9588-fdd6dec2042e">5,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbc7c626226146c8acb2e1f9248526b5_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNC03LTEtMS0w_7b79bb5c-e29b-41ec-8d27-4ea4e9652ceb">4,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7d7effc4e044286927c0d4994433271_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNS0xLTEtMS0w_86b21eef-bae5-4901-8f93-9b694660f63c">1,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i883c2662484643f9900deb185df3f0b5_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNS0zLTEtMS0w_ff1cdb07-8379-43e8-870e-1081a8759558">1,653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia891b42d1c254df7ac3ac05d31574021_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNS01LTEtMS0w_92dfcf35-69d8-47c0-8435-9ed3129c9e19">3,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if68d20cca08041c5aeb33c4b926b82ab_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNS03LTEtMS0w_819e057c-729e-4fc1-82ba-57cf43e14630">3,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Orencia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57080e1dcd264f6e99cf8bdd5c21742e_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNi0xLTEtMS0w_bc162fd4-efab-4de2-86c4-2b75b7907d53">814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ff9b249fad642bba5144d42b9faf6b5_D20200401-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNi0zLTEtMS0w_b38edacb-5272-46b1-a887-50a1599d0848">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe37cb6ae8364432a34654315cc6e007_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNi01LTEtMS0w_b0e02c41-48ef-4162-b7af-686bc3404b9c">1,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0261661a5a7844cea6463d344c58d900_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNi03LTEtMS0w_b11e750e-a83d-4811-aaa0-c0a2b8dba5a5">1,464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pomalyst/Imnovid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i769e4009608641aca49eb76faa4ac197_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNy0xLTEtMS0w_c30de88d-9ac0-4f8b-9249-ce59e29fa1cb">854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73d23b416f674420956ecd71cdcf6b4c_D20200401-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNy0zLTEtMS0w_5b53eccd-4bf8-4f98-8692-c7159a7791a8">745</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f619ca1063a4a07992394e7c68f32ac_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNy01LTEtMS0w_a035020a-2df0-4ea7-8e40-d491e5050a66">1,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaf296c2ee0943818ce82515cb333687_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNy03LTEtMS0w_99f822de-6f1d-4498-88bc-5d71a012bf51">1,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sprycel</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf093353fcce47c7993eff7bebb89352_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfOC0xLTEtMS0w_d8427a61-46f4-4a2d-bc64-f3674cdf19e9">541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee1d7e1f63643b884515b06a03e4c60_D20200401-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfOC0zLTEtMS0w_deac8009-c9a2-4b9e-a5f6-594a1f86ec48">511</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0c81db46fa34735a7f2f312ec65bfc9_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfOC01LTEtMS0w_41ac5602-24b9-4f95-9c95-e798d498bfb9">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i355ae2718e5a4c6c8a6e24afd38df6db_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfOC03LTEtMS0w_c4652bf9-bb74-4170-9396-cd4af79af31a">1,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yervoy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45aeed9ec2cc49a590adb6b58fd89ece_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfOS0xLTEtMS0w_3cc5e370-8599-4b06-ba25-49bfb0b60fdc">510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5978a453566e4231add46eb89d653450_D20200401-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfOS0zLTEtMS0w_905684bb-9304-43f7-84bd-2aa68443a4a2">369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58d693cbcafe4995b93648810c7cae27_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfOS01LTEtMS0w_905c527a-cd39-4994-8d2d-b932a5d8d6ab">966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40a1ad24197f4b86a309b538c9a3c23c_D20200101-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfOS03LTEtMS0w_084c7232-34b9-4448-82ad-d2953b4d25a0">765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abraxane</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a2c60c75c4141639d1b36723b3c4440_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTAtMS0xLTEtMA_90ef16e4-6859-4647-aedc-a5878942b2e7">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62694ce91ad14828b9c165bf7fa9940e_D20200401-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTAtMy0xLTEtMA_86cd0dab-4a95-4efd-a30e-3c82e88e3c85">308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2704f69ab750451ab3fb0492a99094c5_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTAtNS0xLTEtMA_b659c307-1073-47ee-a68b-e809cd11acff">610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c439fd5488544099358a43dd1238104_D20200101-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTAtNy0xLTEtMA_6efca90d-d739-41d9-9c68-0a82621d0827">608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Empliciti</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd53acf464ca462ab494301989157627_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTEtMS0xLTEtMA_39975505-8740-4bfd-ac80-52a981ea78a0">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i758c9da23c8b4231951c6795184b15e5_D20200401-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTEtMy0xLTEtMA_b4494226-db88-482c-aff3-160f7c4046f6">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7448d91de34141b4df1bd539a6dd86_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTEtNS0xLTEtMA_e97da34c-1fc4-42c5-addd-5fe61e4ad46d">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d84ed280193426fa6af996eda8b4c98_D20200101-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTEtNy0xLTEtMA_bd8baa97-ce19-4681-8c47-c24a3fcd0240">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Reblozyl</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i563b393825ee449d9c71d5d4b26b3ddb_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTItMS0xLTEtMA_da405b33-87d4-4a53-9e9b-6876366db8c6">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fd358ca344f4bf29febc48585056f4c_D20200401-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTItMy0xLTEtMA_a83b0b75-884c-4a97-b4ba-a0ff6fedbf64">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48e38a9edee64731bac94495a43d3800_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTItNS0xLTEtMA_28d8ff82-7cb9-41e2-9f84-31ff4920900f">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if45515056fde4687b5647faafd13b1a0_D20200101-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTItNy0xLTEtMA_9a53a99e-8c52-46bf-ba5b-9bd31c3bcec2">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Inrebic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a59b7d82fa145d6928ff7f7639b512e_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTMtMS0xLTEtMA_41ef34cd-3a14-4a15-973b-4e5a0a35f2f0">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635f3e7e28714d6681e5a0d547475b27_D20200401-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTMtMy0xLTEtMA_7bae3252-125a-48b1-8de1-df0eae113c2d">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae2dcbf6bdff462caf99391d57dcb930_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTMtNS0xLTEtMA_46037a03-11f9-4272-a6c2-a828152007f7">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4015345e26eb4c5c9aec15be9286e3cc_D20200101-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTMtNy0xLTEtMA_1adaf35f-cb41-480a-80b3-ed109df83527">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Onureg</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i402f96e6f47248c3840081511c31fb5b_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTQtMS0xLTEtMA_4f2d49bb-a6a4-42d1-8085-c225d82c547b">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59e2e714bfff471ab06edb2942342e5d_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTQtMy0xLTEtMA_b85df81d-71dc-466b-ad0a-9e0422285a12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedaae601ed8c4bf0b43e79604ef7f8c3_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTQtNS0xLTEtMA_c55ba3b9-3d7b-4d58-8f39-836332aac498">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18b9ec08663241d5baf4a36c323d25b0_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTQtNy0xLTEtMA_ba713a7a-a123-48ea-986b-ad8c702549e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Zeposia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c89651aa0f44449997627d1aeada5d_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTUtMS0xLTEtMA_a99417a3-28c4-4a67-a26b-6e25b5bcea6e">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ec04d6ebd5c416faf3fedff56490ed1_D20200401-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTUtMy0xLTEtMA_2125a067-485d-4eae-a57b-25b6514b0cd9">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8f8d1746aa7460c854e59b73c091120_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTUtNS0xLTEtMA_6ec14a24-022c-443d-a0fe-949f101e6b12">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7639067ff20c40aa9d69bd876327d377_D20200101-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTUtNy0xLTEtMA_b4630e3b-8cde-4709-8f36-c73d5af76eb7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Breyanzi</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65b1ff42f2504ce7ba28f0134f6df309_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTYtMS0xLTEtMA_6faeec70-107f-40a2-80b4-62ab1454b43d">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i990e509044b44824a03594bbc939cd4f_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTYtMy0xLTEtMA_0ee21838-2917-4ebb-8f2b-75b0bb94600b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94349bb9edeb4c06824d9d4dec376cdc_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTYtNS0xLTEtMTU2Mg_da97f0bf-6952-49cd-a69c-16797a59c5ef">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia84f257000384cca8728724dd08e6d64_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTYtNy0xLTEtMTU3MA_5f26f010-20b6-4854-886c-b84034123eeb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abecma</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72da1784020e4fe5a077a56e08ed0e60_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTctMS0xLTEtMTU1Nw_dad5b93c-87b0-4a80-b039-f3e796ba8506">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae526ef104c4610be5401f06e776271_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTctMy0xLTEtMTU2NQ_e23032c7-5d80-466f-bca4-08836d996030">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i954298aa47d340e4928578d10e3c2afb_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTctNS0xLTEtMTU2Mg_183ff888-516e-4ce9-a451-ac2a2ea31ff8">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie64f9c3e74d24536bc5324f5a27f3f62_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTctNy0xLTEtMTU3MA_072664cb-d34f-489b-b8cb-14e5c6fa3ca4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Established Brands</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Vidaza</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30700517c2d846dfaabb9f4e49100061_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTktMS0xLTEtMA_7c3ace79-b2c9-4070-a50b-a8865f064de6">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4000e7937fbb4330b97ca4837c84abcf_D20200401-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTktMy0xLTEtMA_a63902ee-143a-4a80-a8cb-cee8d56aa4d9">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc46b46a188943daabd54f0555343036_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTktNS0xLTEtMA_0625ff51-4638-45e2-a9cd-363f919a28cc">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie163b63bb39b41b2a99d3894f000a52e_D20200101-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTktNy0xLTEtMA_7bbc276a-f4cc-46c4-8946-ca104ac761ad">284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Baraclude</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47d887259489478d9fb5e61b10d58a21_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjAtMS0xLTEtMA_6b3f8efe-fb2c-403c-9d4f-9b938fe6a4e2">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b554fbfbe54be4938770b47e7e814e_D20200401-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjAtMy0xLTEtMA_62db6db1-0f97-41cf-bc35-e086023892f3">121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8752706d4f1046619f751bca78fe5b04_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjAtNS0xLTEtMA_73ad5c26-171a-4177-a484-6f27e37e311c">222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf8cc33c03864e6eb80a62a2becd8529_D20200101-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjAtNy0xLTEtMA_4254be73-dfa7-4e77-b25c-6e1f58f8a31a">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id17f257f5a7c4dbc8345593202162a88_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjEtMS0xLTEtMA_9aa1d308-f18d-40c3-bd21-51fb686642fe">319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4424c6dea9c7491f8f20e9c0433f13be_D20200401-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjEtMy0xLTEtMA_9278e9fb-d721-4d08-a244-6810244a0308">331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id047abc4cf2849648778e6a0d818e9c3_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjEtNS0xLTEtMA_c93e74c3-dc1d-4019-9ec2-f659aa973508">658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib254059b72c444bda04963c50ac8c3da_D20200101-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjEtNy0xLTEtMA_50185a3b-7870-49bd-97bf-455935646f4d">749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjItMS0xLTEtMA_ec38d4ed-881d-44e6-9872-367db7fb4c07">11,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjItMy0xLTEtMA_37057d2e-341c-4ba3-a8c1-948a4c04ccfe">10,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjMtNS0xLTEtMTY2Ng_2060671c-0ca0-467a-b16f-05120fe3b085">22,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjMtNy0xLTEtMTY2MQ_cd1edb18-7b9f-4fae-a441-72c080990ea5">20,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica56fd0d45ed404fb6d997d7a91e781b_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjQtMS0xLTEtMA_f74dd2ef-788b-48cd-8059-64685d25fd58">7,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c042daa885246149bd4021e6291c95b_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjQtMy0xLTEtMA_561ddf9b-77db-479a-b089-d8c1a06340ca">6,487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id685a03ea1c045aaa5b4626cdeefcaeb_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjQtNS0xLTEtMA_d7017730-1685-47f9-acb3-2af83ee7046c">14,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0fb978e8fe747c9942de2c291d92e42_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjQtNy0xLTEtMA_220e8909-bb48-4f7b-8a3d-371e526fb172">13,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i672de761cf0f4f38b3c9fcf5888c38d2_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjUtMS0xLTEtMA_bf94c0b1-a2e2-4bc5-b4ee-4a7fe8412dd4">2,689</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6096b3e3535b498a93924c5913231bb7_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjUtMy0xLTEtMA_3de065bd-8414-4bae-8baa-d7a9af33f0e1">2,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd5c352a490f4e2d80f9f07d00ca9ed4_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjUtNS0xLTEtMA_75972d4f-d6ce-4e81-9361-f422bf0eb8b0">5,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22bc054236924180897608070e385339_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjUtNy0xLTEtMA_664552be-c737-4a23-8bc7-62ef9805a5b9">4,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of the World</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3e30ddc627e420a994afe10df2aeb8d_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjYtMS0xLTEtMA_e6a6421a-ab1f-45ef-a2d8-dcb0aa02ede7">1,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie307dc58932a4abc95b857fff6abe287_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjYtMy0xLTEtMA_9b2162d1-e9e7-40c6-9d18-18a1eaf9326d">1,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c1f985c4a994e87afcfa3b123c94fb3_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjYtNS0xLTEtMA_ec86bc95-130d-4257-a6db-81572f98c3b6">2,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i736f109d294c4ccf9f1668181dc764f4_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjYtNy0xLTEtMA_8ada9a30-a4a6-4e6f-9f73-b371c49ee5fa">2,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i930c547a007949018cbf51ca4060480c_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjctMS0xLTEtMA_32ef169f-341e-4a78-8189-fb82002b9bfb">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i903cb47a089e41dbbdc585ba01f93a76_D20200401-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjctMy0xLTEtMA_e2e873f8-7e00-407a-b567-d1f466798510">172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99e18e918d4a4472baa5e49400a3c3fe_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjctNS0xLTEtMA_d5dbbb7c-d822-4bec-bec4-552d38b341dd">355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21843a9ab91b446ca3cce0aa09d0bc13_D20200101-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjctNy0xLTEtMA_3fcc5cb3-1da4-4447-a778-4c9329f4dd65">285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjgtMS0xLTEtMA_9eee9823-1d76-444c-bf80-cfa4b55b1cbf">11,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjgtMy0xLTEtMA_241a5575-1da3-49fc-b9b2-a0da39490cc6">10,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjktNS0xLTEtMTY3Mg_159af4d0-806e-4a2e-a144-41b988f18777">22,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjktNy0xLTEtMTY2OQ_cdde7bef-dd88-4341-acf0-ed348cad6ac5">20,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by BMS&#8217;s regional commercial organizations.</span></div></ix:nonNumeric><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized from performance obligations satisfied in prior periods was $<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RleHRyZWdpb246MDA4ZjY0YzkyYzk5NDNjYTllNTcyYTQ2YWNiODNiNGRfNjE0_c65b2126-f699-4ec2-9b2a-1327e16ce5a9">146</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RleHRyZWdpb246MDA4ZjY0YzkyYzk5NDNjYTllNTcyYTQ2YWNiODNiNGRfNjIx_f2d76f7a-c04c-4ce5-8605-e8f1f0fc39fb">430</ix:nonFraction> million for the three and six months ended June&#160;30, 2021 and $<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RleHRyZWdpb246MDA4ZjY0YzkyYzk5NDNjYTllNTcyYTQ2YWNiODNiNGRfMTA5OTUxMTYyODg3MA_1714ff2f-5d06-4875-a20c-d9784014f9b3">98</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RleHRyZWdpb246MDA4ZjY0YzkyYzk5NDNjYTllNTcyYTQ2YWNiODNiNGRfMTA5OTUxMTYyODg3OQ_2e394a2f-27a3-480e-aa75-bb91d3fa76af">228</ix:nonFraction> million for the three and six months ended June&#160;30, 2020, respectively, consisting primarily of revised estimates for GTN adjustments related to prior period sales and royalties for out-licensing arrangements. Contract assets were not material at June&#160;30, 2021 and December&#160;31, 2020.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_40"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3. <ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RleHRyZWdpb246OTE4NTkwZDFiYmNhNDQzZjgyMGYxN2VhMjliYmFhM2RfMTY4MQ_cf559bad-e0a5-46f7-b146-c844caae7bf5" continuedAt="i60a50995f81e429ea8e4a6fe4d1a70b9" escape="true">ALLIANCES</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i60a50995f81e429ea8e4a6fe4d1a70b9" continuedAt="if0e49703856449afbcc19e2e6db96628"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:CollaborativeArrangementAccountingPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RleHRyZWdpb246OTE4NTkwZDFiYmNhNDQzZjgyMGYxN2VhMjliYmFhM2RfMTY5Ng_370b013f-d6e4-459b-9a31-8d538f8a5d6b" escape="true">BMS enters into collaboration arrangements with third parties for the development and commercialization of certain products. Although each of these arrangements is unique in nature, both parties are active participants in the operating activities of the collaboration and exposed to significant risks and rewards depending on the commercial success of the activities. BMS may either in-license intellectual property owned by the other party or out-license its intellectual property to the other party. These arrangements also typically include research, development, manufacturing, and/or commercial activities and can cover a single investigational compound or commercial product or multiple compounds and/or products in various life cycle stages. The rights and obligations of the parties can be global or limited to geographic regions. BMS refers to these collaborations as alliances and its partners as alliance partners.</ix:nonNumeric></ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if0e49703856449afbcc19e2e6db96628"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RleHRyZWdpb246OTE4NTkwZDFiYmNhNDQzZjgyMGYxN2VhMjliYmFhM2RfMjE5OTAyMzI5MjI0Ng_d1b741d6-1c56-4706-8ea1-bc411411f250" continuedAt="i293b5f63215a4220a9d8f28d64497714" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected financial information pertaining to alliances was as follows, including net product sales when BMS is the principal in the third-party customer sale for products subject to the alliance. Expenses summarized below do not include all amounts attributed to the activities for the products in the alliance, but only the payments between the alliance partners or the related amortization if the payments were deferred or capitalized.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues from alliances:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bfd0c3b7ba94dc99db7d1c79cf4109e_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfMy0xLTEtMS0w_b11c627a-1696-4aba-bb5b-95fc703fa5ed">2,805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaad82054f6c24b28998fd0cc54e5f466_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfMy0zLTEtMS0w_a257b006-4317-4d48-8b1f-431480d12044">2,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f4e8798cace48da8096f3940c34286f_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfMy01LTEtMS0w_fdab806d-daaf-48b9-81bb-6a00826de3eb">5,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62270f651833483897b7a99025a3c056_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfMy03LTEtMS0w_9ddd7378-1a95-47a8-8370-d5d2430225d4">4,924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ead8ffbd6a943f58695765106933642_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfNC0xLTEtMS0w_3bb7d100-f222-43bb-9d76-983ed49b8a98">159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74364a7590b441a4afd4e5e67a3b406e_D20200401-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfNC0zLTEtMS0w_9e9613a0-1aaa-433b-8483-2de37ada0012">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87185b42e332422389a23e672417b431_D20210101-20210630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfNC01LTEtMS0w_1d2f9d10-a312-4e4a-a71b-86941aa50eda">301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if25b0239054048e3b55eeb8500972cdf_D20200101-20200630" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfNC03LTEtMS0w_7f61ef31-9bfd-4037-b924-fda56e998cfc">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0056c94875c46578f2a3c81dbf029ef_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfNS0xLTEtMS0w_fb73c904-8fbf-405a-afc4-e232d6f8b1a3">2,964</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied2b977f33414172a10da815fe24fa5e_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfNS0zLTEtMS0w_3008ee12-92f8-4522-813a-c4cd6fc07321">2,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i959465a12b7a4107bdb5a01d7bfcc532_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfNS01LTEtMS0xOTg0_4c917af3-7fe9-4a7f-ade0-5df13fcabfed">5,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i987d81167423465fad588659146ecff3_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfNS03LTEtMS0xOTg0_a337a2fd-229c-44c6-a460-a762233f7f9a">5,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payments to/(from) alliance partners:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0056c94875c46578f2a3c81dbf029ef_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfOC0xLTEtMS0w_64a91ed7-7844-4bdb-b9cc-b0f1fac8c99f">1,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied2b977f33414172a10da815fe24fa5e_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfOC0zLTEtMS0w_3e8b8335-250a-4115-b772-143eb303740f">1,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i959465a12b7a4107bdb5a01d7bfcc532_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfOC01LTEtMS0w_c56fdeb4-b0ac-478a-96b6-5d3393004312">2,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i987d81167423465fad588659146ecff3_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfOC03LTEtMS0w_5bc3fb1f-9f40-41c1-96e1-37af5dffca93">2,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0056c94875c46578f2a3c81dbf029ef_D20210401-20210630" decimals="-6" sign="-" name="bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfOS0xLTEtMS0w_5ea45fe4-98b0-47f8-8c9e-b1910bf62caf">48</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied2b977f33414172a10da815fe24fa5e_D20200401-20200630" decimals="-6" sign="-" name="bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfOS0zLTEtMS0w_475b4ac1-199d-4320-a1a1-ca96081586f2">38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i959465a12b7a4107bdb5a01d7bfcc532_D20210101-20210630" decimals="-6" sign="-" name="bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfOS01LTEtMS0w_06584e9e-5e35-4e71-95fd-c8050195a88d">97</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i987d81167423465fad588659146ecff3_D20200101-20200630" decimals="-6" sign="-" name="bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfOS03LTEtMS0w_f9626947-2328-4ec7-ab62-3ea34ff7d8d8">78</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0056c94875c46578f2a3c81dbf029ef_D20210401-20210630" decimals="-6" name="bmy:ResearchandDevelopmentExpenseCollaborativeArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfMTAtMS0xLTEtMA_6c67b4c2-3d06-4b3c-aa30-4577bd69ffeb">736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied2b977f33414172a10da815fe24fa5e_D20200401-20200630" decimals="-6" name="bmy:ResearchandDevelopmentExpenseCollaborativeArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfMTAtMy0xLTEtMA_36f91927-a177-422e-97dc-886fcbdf7cd3">233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i959465a12b7a4107bdb5a01d7bfcc532_D20210101-20210630" decimals="-6" name="bmy:ResearchandDevelopmentExpenseCollaborativeArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfMTAtNS0xLTEtMA_86ed7991-c293-408b-98e7-b599259336bb">743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i987d81167423465fad588659146ecff3_D20200101-20200630" decimals="-6" name="bmy:ResearchandDevelopmentExpenseCollaborativeArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfMTAtNy0xLTEtMA_43fd7f38-7ee2-4f97-aed6-fbd32c18d6b8">279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0056c94875c46578f2a3c81dbf029ef_D20210401-20210630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfMTEtMS0xLTEtMA_03ef8837-6f71-486c-9c18-9f136e98f802">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied2b977f33414172a10da815fe24fa5e_D20200401-20200630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfMTEtMy0xLTEtMA_aaa5cce7-66da-4b28-a2ea-c7d8e89f5117">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i959465a12b7a4107bdb5a01d7bfcc532_D20210101-20210630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfMTEtNS0xLTEtMA_fe7c3787-122d-4210-a8ff-faa95499b9b5">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i987d81167423465fad588659146ecff3_D20200101-20200630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfMTEtNy0xLTEtMA_aa10fd35-9ee5-4dcf-bc00-2239bd6c7d52">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Selected Alliance Balance Sheet information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables &#8211; from alliance partners</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i883fc4c8bc0f4255aec7223cc0f262b4_I20210630" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjBmY2VkZWI1N2QwMDQ2YmZiYzIxNDFkNDNlM2FmNDQ1L3RhYmxlcmFuZ2U6MGZjZWRlYjU3ZDAwNDZiZmJjMjE0MWQ0M2UzYWY0NDVfMi0xLTEtMS0w_ed659fa6-ed02-43d2-9d00-a95d6dd68b3d">349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia927d1d44e99489ca715bf69330b08ab_I20201231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjBmY2VkZWI1N2QwMDQ2YmZiYzIxNDFkNDNlM2FmNDQ1L3RhYmxlcmFuZ2U6MGZjZWRlYjU3ZDAwNDZiZmJjMjE0MWQ0M2UzYWY0NDVfMi0zLTEtMS0w_b97d3768-d9ab-42b4-b7e9-3e9d9508c639">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable &#8211; to alliance partners</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i883fc4c8bc0f4255aec7223cc0f262b4_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjBmY2VkZWI1N2QwMDQ2YmZiYzIxNDFkNDNlM2FmNDQ1L3RhYmxlcmFuZ2U6MGZjZWRlYjU3ZDAwNDZiZmJjMjE0MWQ0M2UzYWY0NDVfMy0xLTEtMS0w_58927130-815e-435b-87e9-abc49f7e640e">2,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia927d1d44e99489ca715bf69330b08ab_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjBmY2VkZWI1N2QwMDQ2YmZiYzIxNDFkNDNlM2FmNDQ1L3RhYmxlcmFuZ2U6MGZjZWRlYjU3ZDAwNDZiZmJjMjE0MWQ0M2UzYWY0NDVfMy0zLTEtMS0w_71e681ab-2b0a-4335-bd6e-1833a810bf57">1,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income from alliances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i883fc4c8bc0f4255aec7223cc0f262b4_I20210630" decimals="-6" name="us-gaap:DeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjBmY2VkZWI1N2QwMDQ2YmZiYzIxNDFkNDNlM2FmNDQ1L3RhYmxlcmFuZ2U6MGZjZWRlYjU3ZDAwNDZiZmJjMjE0MWQ0M2UzYWY0NDVfNC0xLTEtMS0w_824119d2-a45a-494e-9b3a-3f4f4cea8229">349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia927d1d44e99489ca715bf69330b08ab_I20201231" decimals="-6" name="us-gaap:DeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjBmY2VkZWI1N2QwMDQ2YmZiYzIxNDFkNDNlM2FmNDQ1L3RhYmxlcmFuZ2U6MGZjZWRlYjU3ZDAwNDZiZmJjMjE0MWQ0M2UzYWY0NDVfNC0zLTEtMS0w_6003c6be-e758-4151-939a-6ccdb6cde18b">366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i293b5f63215a4220a9d8f28d64497714">(a)&#160;&#160;&#160;&#160;Includes unamortized upfront and milestone payments.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specific information pertaining to significant alliances including their nature and purpose; the significant rights and obligations of the parties; and specific accounting policy elections are discussed in the 2020 Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Eisai</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the second quarter of 2021, BMS and Eisai commenced an exclusive global strategic collaboration for the co-development and co-commercialization of MORAb-202, a selective folate receptor alpha antibody-drug conjugate being investigated in endometrial, ovarian, lung and breast cancers. MORAb-202 is currently in Phase I/II clinical trials for solid tumors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">BMS and Eisai will jointly develop and commercialize MORAb-202 in the U.S., Canada, Europe, Russia, Japan, China and certain other countries in the Asia-Pacific region (the &#8220;collaboration territory&#8221;). Eisai will be responsible for the global manufacturing and supply. Profits, research and development and commercialization costs are shared in the collaboration territories. BMS will be responsible for development and commercialization outside of the collaboration territory and will pay a royalty on those sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A $<ix:nonFraction unitRef="usd" contextRef="iaa8c668e967e4f73affcc1b178e53fd6_D20200101-20200630" decimals="-7" format="ixt:numdotdecimal" name="bmy:UpfrontPaymentsMadeToCollaborativePartner" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RleHRyZWdpb246OTE4NTkwZDFiYmNhNDQzZjgyMGYxN2VhMjliYmFhM2RfMjE5OTAyMzI4Nzk5Mg_5988cafc-f737-4422-8273-9f42a3b4c244">650</ix:nonFraction>&#160;million upfront collaboration fee was included in Research and development expense in the second quarter of 2021 and paid in the third quarter of 2021. BMS is also obligated to pay up to $<ix:nonFraction unitRef="usd" contextRef="i1726e9653791462e88d1e8fa6b55d2bf_D20210101-20210630" decimals="-8" format="ixt:numdotdecimal" name="bmy:Considerationforcontingentdevelopmentandregulatoryapproval" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RleHRyZWdpb246OTE4NTkwZDFiYmNhNDQzZjgyMGYxN2VhMjliYmFhM2RfMjE5OTAyMzI4ODAwNg_5cd7fbf6-c7e2-42b1-9d02-a657cfdc962a">2.5</ix:nonFraction>&#160;billion upon the achievement of contingent development, regulatory and sales-based milestones.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_43"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4. <ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RleHRyZWdpb246ZmJkNzU0NGYxZDQwNGNiZjljYTY0ZmQzZjNiMmRhNzdfNzQ0_977238f6-32a7-4698-830f-d9d4c304f8e6" continuedAt="i5bfb101504d6459c9037fbfae58a759b" escape="true">DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i5bfb101504d6459c9037fbfae58a759b" continuedAt="ia3bf1ae591bf4f56902402673f5e0454"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Divestitures</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RleHRyZWdpb246ZmJkNzU0NGYxZDQwNGNiZjljYTY0ZmQzZjNiMmRhNzdfNzQw_d53471c9-7052-4975-a218-f0d0e0d1f07b" continuedAt="iec80bb11d50c4014871130f464cbe137" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of divestitures including royalties, which are included in Other (income)/expense, net. Revenue and pretax earnings related to all divestitures were not material in all periods presented (excluding divestiture gains or losses).</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Proceeds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divestiture (Gains)/Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Royalty Income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Business</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97d8d3703ed04fed8d1982e8631612c5_D20210401-20210630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfMy0xLTEtMS0w_16ab7098-761a-41b4-832f-f30ac16b4464">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9130fda1c97a4512869f8c40ceda43a3_D20200401-20200630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfMy0zLTEtMS0w_38719b20-52ec-4437-91bd-9f37d1a3e9e8">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97d8d3703ed04fed8d1982e8631612c5_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfMy01LTEtMS0w_e51458ab-7e7b-40e4-bc99-960209465df2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9130fda1c97a4512869f8c40ceda43a3_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfMy03LTEtMS0w_040c770d-757a-4045-9bd5-4ab1e37c19c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97d8d3703ed04fed8d1982e8631612c5_D20210401-20210630" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfMy05LTEtMS0w_4e796959-db25-4297-a072-498deaeaf0a8">152</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9130fda1c97a4512869f8c40ceda43a3_D20200401-20200630" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfMy0xMS0xLTEtMA_92b85d8f-4eac-4f36-9620-f468d3229870">129</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Erbitux</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* Business</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i874255d4051145ffb584d5ace4120829_D20210401-20210630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNC0xLTEtMS0w_e1443495-d604-498e-af54-713c7b7c1248">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b10d04730ab481fa4a091d91c386131_D20200401-20200630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNC0zLTEtMS0w_54d3a940-101d-413b-8adf-d53d623e5a1f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i874255d4051145ffb584d5ace4120829_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNC01LTEtMS0w_7d2026f1-fe29-4452-a578-d27411f513ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b10d04730ab481fa4a091d91c386131_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNC03LTEtMS0w_448e19eb-7bf7-412e-aa5d-520925dd32bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i874255d4051145ffb584d5ace4120829_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNC05LTEtMS0w_2d2d6418-0fc6-4fbe-921b-f51e4cbc3098">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b10d04730ab481fa4a091d91c386131_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNC0xMS0xLTEtMA_38ac461c-b43c-4ae5-b0f0-8b8c6fc5032d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing Operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic600cede908c45fd9de219d601e19f65_D20210401-20210630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNS0xLTEtMS0w_5b0046c1-a2ab-4551-bb07-fc8a843c0fe9">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia149c1d5e9ac4dea84e8c70a697500b0_D20200401-20200630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNS0zLTEtMS0w_de7291da-1489-4532-92ae-ff45b00ee307">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic600cede908c45fd9de219d601e19f65_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNS01LTEtMS0w_18122dc7-bd4f-4e90-a324-9ffdb26e185c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia149c1d5e9ac4dea84e8c70a697500b0_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNS03LTEtMS0w_a9c58ff9-4d3b-47dd-80b6-9e2cbb5c3b3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic600cede908c45fd9de219d601e19f65_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNS05LTEtMS0w_189a7373-43a2-4b46-be7e-b1c1927dda2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia149c1d5e9ac4dea84e8c70a697500b0_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNS0xMS0xLTEtMA_618332c1-1298-457f-a2c8-b01c7af3a733">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature Brands and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib432c7d456164aba93e919e08338e013_D20210401-20210630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNy0xLTEtMS0w_3260623e-d93e-4226-abd7-388f5d5ad124">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb48dbce12f842488d8e56ebc0551af8_D20200401-20200630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNy0zLTEtMS0w_3823ceca-f7e2-4505-a4d4-d6ada385b614">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib432c7d456164aba93e919e08338e013_D20210401-20210630" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNy01LTEtMS0w_98d6c73c-5a62-426d-b6f8-bec4cc19b6db">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb48dbce12f842488d8e56ebc0551af8_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNy03LTEtMS0w_5a08ad3c-afbf-4f94-84a1-078a641c5099">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib432c7d456164aba93e919e08338e013_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNy05LTEtMS0w_63cb6301-6f5b-4ea9-a756-6c03cd58d366">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb48dbce12f842488d8e56ebc0551af8_D20200401-20200630" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNy0xMS0xLTEtMA_65170afb-71f1-423b-b9be-28fa1924923f">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfOC0xLTEtMS0w_1a18231e-e1fa-450f-a7fe-72f66d5e8738">202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfOC0zLTEtMS0w_bccb960a-99bd-4c87-959d-d9a132c6c8cf">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfOC01LTEtMS0w_3b2c5164-576d-402d-895b-c8c939c69ead">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfOC03LTEtMS0w_d9f40eab-9dab-4c4e-b939-909a7ffa4c5a">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfOC05LTEtMS0w_82085923-df99-4212-ba68-af6c5c229f13">152</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfOC0xMS0xLTEtMA_fe200dc3-8f74-423c-9c05-67351f11a25a">130</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia3bf1ae591bf4f56902402673f5e0454"><ix:continuation id="iec80bb11d50c4014871130f464cbe137"><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Proceeds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divestiture (Gains)/Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Royalty Income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Business</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie92eb5d3a8224bf48b897ca58fe4dc15_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfMy0xLTEtMS0zNjA_4970dfa0-ab47-472a-8b43-a152e985985e">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e04e6f0f1cb48e8ad1a548c38f665dc_D20200101-20200630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfMy0zLTEtMS0zNzc_284fb370-b81d-45d0-9c15-b1b668520ad5">280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie92eb5d3a8224bf48b897ca58fe4dc15_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfMy01LTEtMS0zODE_7a192e19-2be7-4134-8eb8-600c22f6ce46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e04e6f0f1cb48e8ad1a548c38f665dc_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfMy03LTEtMS0zODU_471700d4-f6b7-49b3-9752-859983f82b23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie92eb5d3a8224bf48b897ca58fe4dc15_D20210101-20210630" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfMy05LTEtMS0zODk_73e0bf4f-3c0d-49a9-aebd-b1d049181093">286</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9e04e6f0f1cb48e8ad1a548c38f665dc_D20200101-20200630" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfMy0xMS0xLTEtMzk0_6f1c9935-265e-48b5-9c33-c0c4bcdefa1a">256</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Erbitux</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* Business</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7f237dfaf294517a6c993c23a19c5a8_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNC0xLTEtMS0zNjk_c576d96c-eb0d-4995-b800-6e5f85b0ebd8">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e3fa03c07574d4fae920e7935e8a621_D20200101-20200630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNC0zLTEtMS0zNzc_831c46b8-2bd7-47b4-8f4f-461fb0393a85">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7f237dfaf294517a6c993c23a19c5a8_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNC01LTEtMS0zODE_8f7cb505-7b27-4514-b3bb-b0943695a375">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e3fa03c07574d4fae920e7935e8a621_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNC03LTEtMS0zODU_a38f1ce3-6b00-4852-ab5e-43ae6d2da256">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7f237dfaf294517a6c993c23a19c5a8_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNC05LTEtMS0zODk_3fa9ff62-2f0b-4110-b172-3a4601f6920d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e3fa03c07574d4fae920e7935e8a621_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNC0xMS0xLTEtMzk0_5fa4c782-8d14-4061-a812-b1756bad416a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing Operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica3960bd33c645d1bf92833258f53c54_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNS0xLTEtMS0zNzM_e8312874-236d-4660-a01f-c9e94930e3ca">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ff17e3e1d554be8a5a2f24d9b41e2a6_D20200101-20200630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNS0zLTEtMS0zNzc_23e4dd93-04f8-4f48-9f7f-d3c1201e9331">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica3960bd33c645d1bf92833258f53c54_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNS01LTEtMS0zODE_b297bc00-3e9c-462e-8550-508be8b1d7f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ff17e3e1d554be8a5a2f24d9b41e2a6_D20200101-20200630" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNS03LTEtMS0zODU_70f05e83-0169-4d86-ade4-66c672a7358b">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica3960bd33c645d1bf92833258f53c54_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNS05LTEtMS0zODk_b8edd32f-1797-4d57-a90d-b4df5921d740">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ff17e3e1d554be8a5a2f24d9b41e2a6_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNS0xMS0xLTEtMzk0_0e40a02e-989d-4039-bb61-62714f2c3b93">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Plavix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Avapro*/Avalide*</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c7d34b293eb4396be52fdac70722a24_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNi0xLTEtMS0zNzM_c4559604-d78d-4251-9fcb-27320a02531d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia34fe71a86434a37a78799df75ebb670_D20200101-20200630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNi0zLTEtMS0zNzc_14b31651-cd70-42e3-a878-c1b03912fdf4">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c7d34b293eb4396be52fdac70722a24_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNi01LTEtMS0zODE_808d24e6-b37b-4c5b-bc6a-4faa50b62dfb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia34fe71a86434a37a78799df75ebb670_D20200101-20200630" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNi03LTEtMS0zODU_497b5f21-1854-4796-9286-7e8a9a029fa6">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c7d34b293eb4396be52fdac70722a24_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNi05LTEtMS0zODk_4ac1aac5-d402-466e-a714-1c891e17452a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia34fe71a86434a37a78799df75ebb670_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNi0xMS0xLTEtMzk0_0290b82e-47b4-4d37-ab2a-1ca78e51c2fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature Brands and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i766f66d3a5564477a5cee03c3f5dbfe4_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNy0xLTEtMS0zNzM_6cfad305-e392-42d5-9326-b70bf90444f0">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51508ada4a88448fa0d47dbd056ce19f_D20200101-20200630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNy0zLTEtMS0zNzc_72a9f9c0-e43b-4e90-a8de-b633d42ddd2c">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766f66d3a5564477a5cee03c3f5dbfe4_D20210101-20210630" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNy01LTEtMS0zODE_cf6cd419-b16a-47ae-a823-fb7b02c19e32">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51508ada4a88448fa0d47dbd056ce19f_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNy03LTEtMS0zODU_605d248c-b150-4285-abbe-5c20b83fc871">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i766f66d3a5564477a5cee03c3f5dbfe4_D20210101-20210630" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNy05LTEtMS0zODk_28e6fa7b-9dfa-40f1-9e81-e265ef5e9280">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51508ada4a88448fa0d47dbd056ce19f_D20200101-20200630" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNy0xMS0xLTEtMzk0_7a8c5452-09f0-4b3a-9ae2-b098d7999d1f">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfOC0xLTEtMS0xOTg3_d9ab0a15-f610-4df3-b350-6502dd4a0e89">382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfOC0zLTEtMS0xOTg3_d62ad68d-6d6c-4b0b-b05d-64e75c36002a">336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfOC01LTEtMS0xOTg3_23eab65a-bd5e-4e84-ba5f-c80f2bd5344f">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfOC03LTEtMS0xOTg3_4dd3f818-7985-4d25-b06e-8ca7881d8dc3">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfOC05LTEtMS0xOTg3_3233a65b-515c-4ac6-8cc9-8502ee80c104">287</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfOC0xMS0xLTEtMTk4Nw_96c0e7f9-77c1-4ab1-801d-b6a1f34e2a47">288</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes royalties received subsequent to the related sale of the asset or business.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Licensing and Other Arrangements</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="bmy:LicensingAndOtherArrangementsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RleHRyZWdpb246ZmJkNzU0NGYxZDQwNGNiZjljYTY0ZmQzZjNiMmRhNzdfNzUx_af0a3ba9-36d6-4876-a774-137f53c8e199" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Keytruda*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> royalties, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* royalties, up-front licensing fees and milestones for products that have not obtained commercial approval, which are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Keytruda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5168aa9c0f548cf89708d739d0fbf68_D20210401-20210630" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfMi0xLTEtMS0w_8408c4ba-4a48-47c1-a2c6-8bd4e0801029">204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33dbe127e2a8431a8d4df6ef930b3c47_D20200401-20200630" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfMi0zLTEtMS0w_c2efffcb-1f5b-4efd-b457-f977aea1df01">155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic81b26b07c5c4e61941a1674d76cfe98_D20210101-20210630" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfMi01LTEtMS0w_ba722ff5-3968-4594-9000-fb3ae55d14ba">396</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica7f052bd75f40ccbb4445d5f8e47381_D20200101-20200630" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfMi03LTEtMS0w_a4851e99-04e3-425d-8099-3483b3c3fd47">316</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a4f553f8932405197ea119b17e8eca1_D20210401-20210630" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfMy0xLTEtMS0w_a9c8c4b0-30f6-4aaf-b4fc-52a14f93f70d">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77b50711d0f2426ab381586aa8a781f4_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfMy0zLTEtMS0w_165c4d01-8c0d-47b1-9fc2-bfa94e70ea47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib483860a3a46419ea7cade23a1f57af8_D20210101-20210630" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfMy01LTEtMS0w_95dbd612-d9e0-4ab6-b718-77f9ff3fdb47">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4f9948a6cc44875bca5c798572cafe7_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfMy03LTEtMS0w_cad98ae2-0cae-43ca-8e7e-c1eef61a37f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up-front licensing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="bmy:UpFrontLicensingFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNC0xLTEtMS0w_b1bcdddf-9d07-4e56-9781-c7c88ba3f11e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="bmy:UpFrontLicensingFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNC0zLTEtMS0w_111affc8-20ec-4079-b138-a51317104870">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="bmy:UpFrontLicensingFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNC01LTEtMS0w_3fda1801-66f1-4dac-9efd-885f6ea9621e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="bmy:UpFrontLicensingFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNC03LTEtMS0w_54b952af-fbb6-47bc-b39f-3635610de198">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent milestone income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="bmy:ContingentRegulatoryMilestoneIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNS0xLTEtMS0w_16fb4e69-d318-420a-8699-c467d0d580fd">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="bmy:ContingentRegulatoryMilestoneIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNS0zLTEtMS0w_d26fc360-4398-4c0d-8656-495d176571c7">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="bmy:ContingentRegulatoryMilestoneIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNS01LTEtMS0w_96a4e5ab-18d8-41e0-afd2-e97408792017">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="bmy:ContingentRegulatoryMilestoneIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNS03LTEtMS0w_54310ba0-588f-4ae4-b94c-5265d7e32b87">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:OtherAmortizationOfDeferredCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNi0xLTEtMS0w_cd66f06d-1df2-40a9-bff4-aaf33cf882df">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherAmortizationOfDeferredCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNi0zLTEtMS0w_cc8c5330-3d02-44d5-a906-6ab7bd6adf56">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:OtherAmortizationOfDeferredCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNi01LTEtMS0w_d0f7e8b6-e8e7-49c5-b1ed-aba36482d885">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:OtherAmortizationOfDeferredCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNi03LTEtMS0w_ee00de3d-3a68-4fdf-932e-ab3c564e7f5a">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other royalties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i652d5c5a16f54d499f777b18da32cbf1_D20210401-20210630" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNy0xLTEtMS0w_190c27c4-52c9-4a71-9d78-3b554b40d29d">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac41a45cb93d4b57847364ccda78f7ea_D20200401-20200630" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNy0zLTEtMS0w_b0ceb005-e742-4e7a-8494-2b581bffde33">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14b8f5fa9564459e9343a7fbfae773f2_D20210101-20210630" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNy01LTEtMS0w_7a91d90f-2ede-4e3b-89bc-e76300247aa4">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1b8cdf4c8fd43e5940c861fd7075cc7_D20200101-20200630" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNy03LTEtMS0w_8de37c58-04bf-4939-a1d5-c11bd47763ec">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="bmy:LicensingAndOtherArrangementsIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfOC0xLTEtMS0w_6a7725d6-0ded-4b81-ae54-02fc679dd94f">253</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="bmy:LicensingAndOtherArrangementsIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfOC0zLTEtMS0w_9e3a783f-a598-4af0-906e-94e6d83c547c">181</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="bmy:LicensingAndOtherArrangementsIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfOC01LTEtMS0xOTk0_5440cfdc-17a0-400e-ad55-9263ed9993b6">485</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="bmy:LicensingAndOtherArrangementsIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfOC03LTEtMS0xOTk2_dc57f83a-d88b-4706-8b1c-1b22b67bb0c5">433</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Agenus</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, BMS obtained a global exclusive license to Agenus&#8217; proprietary AGEN1777 bispecific antibody program that blocks TIGIT and an additional target. AGEN1777 is being studied in oncology and is in preclinical development. BMS will be responsible for the development and any subsequent commercialization of AGEN1777 and its related products worldwide, including strategic decisions, regulatory responsibilities, funding and manufacturing. BMS paid a $<ix:nonFraction unitRef="usd" contextRef="i3fb344c7b5984689b0e077d03d0f5e83_I20210630" decimals="-6" format="ixt:numdotdecimal" name="bmy:LicenseAndOtherArrangementsUpfrontPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RleHRyZWdpb246ZmJkNzU0NGYxZDQwNGNiZjljYTY0ZmQzZjNiMmRhNzdfMjE5OTAyMzI2MjE4OA_3b095b05-eda5-4c04-884a-b80472ca8edb">200</ix:nonFraction>&#160;million upfront licensing fee to Agenus and is obligated to pay up to $<ix:nonFraction unitRef="usd" contextRef="i3fb344c7b5984689b0e077d03d0f5e83_I20210630" decimals="-6" format="ixt:numdotdecimal" name="bmy:ContingentAndRegulatoryMilestonePayments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RleHRyZWdpb246ZmJkNzU0NGYxZDQwNGNiZjljYTY0ZmQzZjNiMmRhNzdfMjE5OTAyMzI2MjIwMg_9fc4ca50-ed75-493f-9a27-82c78bbbd0b8">1.4</ix:nonFraction>&#160;billion upon achievement of contingent development, regulatory and sales-based milestones as well as royalties on global net sales.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_46"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5. <ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RleHRyZWdpb246MjFjNDNjOTc2NGY1NGY1NGFlMGU4ZmY3NzE0YWZiMTVfNDY_4a448523-c922-410e-876b-87821ac7aa1f" continuedAt="idb9fc077b9a44997a5983a3b88cf81a6" escape="true">OTHER (INCOME)/EXPENSE, NET</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><ix:continuation id="idb9fc077b9a44997a5983a3b88cf81a6"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="bmy:ScheduleOfOtherIncomeExpenseTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RleHRyZWdpb246MjFjNDNjOTc2NGY1NGY1NGFlMGU4ZmY3NzE0YWZiMTVfNjA_ac71386d-2d0c-447f-937b-569a41ca6a84" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMi0xLTEtMS0w_1ab64f5a-ec63-4287-b377-2f995e1e9e7e">330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMi0zLTEtMS0w_9d7e69c7-b005-41d4-bbed-2edf6270182f">357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMi01LTEtMS0w_16731b61-bbc3-4df8-b14c-318cadd531ba">683</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMi03LTEtMS0w_cec33306-9a73-4525-b127-1b3632b88c06">719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMy0xLTEtMS0w_7f700dc1-fd34-4bfa-958c-2e6325bb3eb6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMy0zLTEtMS0w_10890dd8-2a60-4dc2-b105-935e41ecf3ff">165</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMy01LTEtMS0w_85402ee0-8b6d-43b0-9df6-4a15781671e8">510</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMy03LTEtMS0w_6bce7e90-584b-47c1-a316-f4eedb63d39b">391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties and licensing income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="bmy:OtherIncomeReceivedFromAlliancePartners" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNC0xLTEtMS0w_bc26c90d-03e6-4026-8556-984de8ccfdac">405</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="bmy:OtherIncomeReceivedFromAlliancePartners" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNC0zLTEtMS0w_dbdac158-30a6-4605-a12b-ec23b68f22b1">311</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="bmy:OtherIncomeReceivedFromAlliancePartners" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNC01LTEtMS0w_3b938571-ec2b-4b15-ac00-7a98d789d9a8">772</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="bmy:OtherIncomeReceivedFromAlliancePartners" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNC03LTEtMS0w_9771ae80-7bdd-40e6-9e1a-311cfdf1d1ca">721</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNS0xLTEtMS0w_3b4d20ea-17d3-4b95-afb2-c08930ee236c">148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNS0zLTEtMS0w_f96fde91-e595-4589-ba0b-83ef54165155">818</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNS01LTEtMS0w_c2327653-ecce-40dd-b71a-0e3f4547c4de">749</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNS03LTEtMS0w_e3dc9bbf-fc37-4910-8ebe-8debedc48424">480</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNi0xLTEtMS0w_61548b8e-bf1b-40b4-b4d1-04236b680d42">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNi0zLTEtMS0w_8d1d8050-c7b0-4719-af12-7db61b13fb08">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNi01LTEtMS0w_b10cd87a-fdda-4c34-b6cf-168c6ad703be">293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNi03LTEtMS0w_046aa7f5-cb1c-463e-86ff-5fa74a16fd60">340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNy0xLTEtMS0w_0fac08a4-5d18-45c1-b104-57c914ea2127">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNy0zLTEtMS0w_e10f92d5-f23a-4b00-af5c-c4cd1273d0d6">115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNy01LTEtMS0w_59dd5b00-e29a-4129-8226-74b089b07680">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNy03LTEtMS0w_c6dde0f7-ca19-4372-a689-44ec2f1cd8ed">275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and other settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfOC0xLTEtMS0w_d57a4f56-1364-402f-87b7-d4d8bdd0a815">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfOC0zLTEtMS0w_5d2d84de-55b4-4960-a6a7-29de09a7420f">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfOC01LTEtMS0w_be4ef093-600f-45b2-9aab-e6cb7cd7b6cb">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfOC03LTEtMS0w_372d7ba4-8928-4c01-b473-d3360b0465f0">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition and other service fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="bmy:AllianceTransitionalServices" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfOS0xLTEtMS0w_5d520fa3-447b-490c-a7b7-a60d16f86843">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="bmy:AllianceTransitionalServices" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfOS0zLTEtMS0w_3e3823ae-ffad-4023-a4f8-157299c503be">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="bmy:AllianceTransitionalServices" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfOS01LTEtMS0w_a82960c2-22a4-49e1-8502-eb43075b4f4d">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="bmy:AllianceTransitionalServices" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfOS03LTEtMS0w_21b23da0-d5de-451c-99b0-28c5100176e6">111</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTAtMS0xLTEtMA_e849c9bf-fcc1-421c-8cdf-2c1560cfed4d">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTAtMy0xLTEtMA_595a7d3c-207b-42f3-800b-6ea5b36320e7">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTAtNS0xLTEtMA_831ba960-2420-4893-9bfc-62f565d6d183">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTAtNy0xLTEtMA_f2a962e5-9506-4b08-9d11-c1ab42d03ba8">86</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reversion excise tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="bmy:Reversionexcisetax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTEtMS0xLTEtMA_58c03eda-befe-411a-a39c-2610e60286e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="bmy:Reversionexcisetax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTEtMy0xLTEtMA_e661ba2a-bd06-49b7-b050-50ef1a32013c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="bmy:Reversionexcisetax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTEtNS0xLTEtMA_22dcbdfe-9414-440d-b9f0-49104fb44fce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="bmy:Reversionexcisetax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTEtNy0xLTEtMA_fcac7b99-9329-4042-b4d1-4ba82bceb6db">76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture (gains)/losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTItMS0xLTEtMA_baf74cc0-b506-4416-b89c-fdb6895723f5">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTItMy0xLTEtMA_f343ef3d-84a8-49e1-b7a1-c77ba398f593">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTItNS0xLTEtMA_60554f3d-dab6-4afe-9693-ea279b7b65dd">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTItNy0xLTEtMA_ec995a43-40f2-4e65-b21e-738ce4bf4174">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTMtMS0xLTEtMA_d3f75c37-16b2-4b2a-b83c-f475ffb40832">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTMtMy0xLTEtMA_fb028801-bc6b-4241-a308-fe048f4bb556">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTMtNS0xLTEtMA_c380f3f4-d1b1-4988-aa1f-36d0c3bbc7c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTMtNy0xLTEtMA_f0859d82-091b-4d1d-810e-dd025273c37b">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt redemption</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTUtMS0xLTEtMA_9d3b1ca0-6715-485f-a467-906d401e13a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTUtMy0xLTEtMA_6018c637-b813-4f17-9873-714b998432d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTUtNS0xLTEtMTYyNg_bdfe74ab-f4aa-4924-b957-eb66b5c7dba2">281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTUtNy0xLTEtMTYyOQ_dfe3c680-1df0-47b0-85cd-84a9c77690e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="bmy:OtherOtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTgtMS0xLTEtMA_f984dba1-90e5-4724-93d1-0454765194e7">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="bmy:OtherOtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTgtMy0xLTEtMA_0c9bc33b-8178-4c80-ab0e-1140e7c87e57">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="bmy:OtherOtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTgtNS0xLTEtMA_473b5635-58e4-47ac-819e-76080df9fe59">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="bmy:OtherOtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTgtNy0xLTEtMA_adae831b-a835-41fd-9beb-cdefc68786e2">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTktMS0xLTEtMA_bbf5c36d-136b-431d-82d8-95ef62245713">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTktMy0xLTEtMA_fc75c0a4-ca47-492e-b725-6450c7c9e7bb">736</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTktNS0xLTEtMjA1MA_f6b7e5eb-aa1d-4aa7-85ab-5a0a68938e0c">704</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTktNy0xLTEtMjA1Mg_59d43da5-e430-4cf0-922d-e0320007fe7f">427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="id66f4ecc89aa45bca7756420c60966f5_49"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6. <ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfMjE2Ng_163a1986-c282-4f6c-9370-e678b9435089" continuedAt="i2c6d322a4b8f4100a916eba5a2a49aa4" escape="true">RESTRUCTURING</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i2c6d322a4b8f4100a916eba5a2a49aa4" continuedAt="i310ee8fb67b541ac8bf2f17a4f3c75fc"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Celgene Acquisition Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, a restructuring and integration plan was implemented as an initiative to realize sustainable run rate synergies resulting from cost savings and avoidance from the Celgene acquisition which is currently expected to be approximately $3.0&#160;billion. The synergies are expected to be realized in Cost of products sold (10%), Marketing, selling and administrative expenses (55%) and Research and development expenses (35%). Charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i93047c5690bd4da0b6566915947d0bb6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfNDk2_74144404-f62d-4269-b0b2-46512caa0100">3.0</ix:nonFraction>&#160;billion are expected to be incurred through 2022. Cumulative charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i93047c5690bd4da0b6566915947d0bb6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfNTc3_db118c7a-beba-47db-a5e4-4ac1a8a190ee">2.3</ix:nonFraction>&#160;billion have been recognized including integration planning and execution expenses, employee termination benefit costs and accelerated stock-based compensation, contract termination costs and other shutdown costs associated with site exits. Cash outlays in connection with these actions are expected to be approximately $<ix:nonFraction unitRef="usd" contextRef="i93047c5690bd4da0b6566915947d0bb6_I20210630" decimals="-6" format="ixt:numdotdecimal" name="bmy:Cashoutlays" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfODky_541b447a-f1d6-4122-832b-7fc1d9441295">2.5</ix:nonFraction>&#160;billion. Employee workforce reductions were approximately <ix:nonFraction unitRef="number" contextRef="icb6143c62bc94de08946b50699d69bcf_D20210101-20210630" decimals="INF" name="us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfOTQ1_3e255c43-d9e8-4ed2-b99a-f1f7dc789214">240</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="ide8bf9df7627455e8b1decf3f9977ac6_D20200101-20200630" decimals="INF" name="us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfOTUy_832ef274-fe51-4cc5-88bf-62bcd88f936b">900</ix:nonFraction> for the six months ended June&#160;30, 2021 and 2020, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">MyoKardia Acquisition Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, a restructuring and integration plan was initiated to realize expected cost synergies resulting from cost savings and avoidance from the MyoKardia acquisition. Charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i75070985c9424f3586afbe7c4c8bf69b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfMTIxNA_05c90f75-9882-411f-9a04-4aacd2316304">150</ix:nonFraction>&#160;million are expected to be incurred through 2022, and consist of integration planning and execution expenses, employee termination benefit costs and other costs. Cumulative charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i75070985c9424f3586afbe7c4c8bf69b_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfMTQwNw_741fff74-3350-4969-9e76-57b9b9ca4439">95</ix:nonFraction> million have been recognized for these actions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Transformation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2016, a restructuring plan was announced to evolve and streamline BMS&#8217;s operating model. Cumulative charges of approximately $<ix:nonFraction unitRef="usd" contextRef="ic41a1bc571fe4873a7258b43472f3a1e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfMTYwMw_6a1427cf-ebc9-48cd-958a-90e1129f0b24">1.5</ix:nonFraction>&#160;billion were recognized for these actions since the announcement. Actions under the plan were completed as of December 31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfMjE2NA_e3b273cc-2060-43be-b708-d7a32ee9c8c5" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following provides the charges related to restructuring initiatives by type of cost:</span></div><div style="margin-bottom:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celgene Acquisition Plan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c68d9932836432cae27f5f3320513f4_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMi0xLTEtMS0w_ed91372a-27e2-45d9-9f94-15613fbfdfc2">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd2855f0217247dfb6ab35e107cd3274_D20200401-20200630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMi0zLTEtMS0w_476f2287-251f-4bd5-b342-7bbe69ca318f">317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6143c62bc94de08946b50699d69bcf_D20210101-20210630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMi01LTEtMS0w_8e3cec95-0d58-4d3f-8459-3ed8b1941ddc">373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide8bf9df7627455e8b1decf3f9977ac6_D20200101-20200630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMi03LTEtMS0w_40c87a82-db66-4eea-b99b-f6473b43886a">641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MyoKardia Acquisition Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e3436bd7185495999f6d1496751f496_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMy0xLTEtMS0w_cfaadfac-379b-424f-91b6-acf424e0ac32">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f59683c007c4e6b9b0b8bc87e2e9c64_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMy0zLTEtMS0w_8c74ffd4-0752-4f6a-8787-63d3650a4046">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2bf4fd36e0b487cb4bc3cf29adddd55_D20210101-20210630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMy01LTEtMS0w_272e94ac-1e3a-4ded-a38b-8d3f85ac56c3">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52b957a2c68f452c8ed0ce9191019247_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMy03LTEtMS0w_0a53f11b-a2d3-4a31-ac24-15e5dcbe75dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company Transformation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecfdd1291eba4609ac0bb3efec2bf1de_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfNC0xLTEtMS0w_9147f679-688d-4d0d-8e4d-2065c6993084">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92805409d0e6445bb29744ae8cb018b8_D20200401-20200630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfNC0zLTEtMS0w_465f4b33-82ba-48d7-9f72-28be8f47689a">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd4eecd0bba84eb6a04beb957de7a224_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfNC01LTEtMS0w_185f454c-f6c0-4cd3-b9ae-ddf8cb6b6b3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic77161109800434da68b989c381905e7_D20200101-20200630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfNC03LTEtMS0w_0160ccc1-94e6-497b-b83a-7883f69ce9f3">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfNS0xLTEtMS0w_8eb4a3e0-8ffc-43f8-8f8f-5e50413a00fc">219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfNS0zLTEtMS0w_077141d0-6310-4ef0-a3d4-28e7a6ff428b">340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfNS01LTEtMS0yMDgz_03d64a83-aa23-44a5-8066-36c05c781b6e">429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfNS03LTEtMS0yMDgz_94d391c8-1a89-47d3-b0bb-a83b3e9d06bd">746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfNy0xLTEtMS0w_1f6c03c4-34ca-4bb7-ba21-323134196df5">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfNy0zLTEtMS0w_f86b0358-729c-44b9-9629-1094446d7583">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfNy01LTEtMS0w_1ad64eae-1472-4dbf-b351-5453cbeadf70">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfNy03LTEtMS0w_7290c3d0-63a7-483f-9aaa-35b2c34234e7">256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other termination costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfOC0xLTEtMS0w_c79d2659-2b8d-4f45-8042-faa6e242ee00">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfOC0zLTEtMS0w_1f68e1f3-ef67-44a7-b4e7-e71018492d87">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfOC01LTEtMS0w_77a483d6-c0ec-4894-ae80-4ae25224e1d6">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfOC03LTEtMS0w_102b36a2-2ffe-4e0a-a75d-c4fa6ab94abd">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfOS0xLTEtMS0w_4a2b88c2-0650-4ebd-a3f0-039582f5c6f0">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfOS0zLTEtMS0w_27b0ce9a-7e95-4e96-87c6-f216cdd520d7">115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfOS01LTEtMS0yMDgz_11e03b4e-ba51-4990-aa0d-cbce2263b6fa">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfOS03LTEtMS0yMDgz_806705fb-e623-4ef6-a93b-aa3d59d5cd99">275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTAtMS0xLTEtMA_bc13bff4-5cf2-4960-8834-47dca7c2e123">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTAtMy0xLTEtMA_336dca46-5ff3-48f2-9cf9-e383e808baec">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTAtNS0xLTEtMA_e133709d-37fd-4182-ae58-2588be128f5d">293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTAtNy0xLTEtMA_89743023-5664-41c1-ad94-afe432741339">340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserveAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTEtMS0xLTEtMA_f6284577-3110-46b0-af8d-001c9f891f5b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:RestructuringReserveAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTEtMy0xLTEtMA_16cd7266-4fa9-43a6-a7dc-de1cdd87220c">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserveAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTEtNS0xLTEtMA_abb684b0-a835-4634-8168-19700b24168d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:RestructuringReserveAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTEtNy0xLTEtMA_3e295899-bc33-4339-9b8d-6deda14dd902">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="bmy:RestructuringRelatedCostsAssetImpairments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTItMS0xLTEtMA_033bb658-6104-4655-a687-2df06e378420">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="bmy:RestructuringRelatedCostsAssetImpairments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTItMy0xLTEtMA_5af51aad-06d1-438b-9db8-81e7b245eacf">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="bmy:RestructuringRelatedCostsAssetImpairments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTItNS0xLTEtMA_fdd2c867-7358-4c1b-9106-0d4f5f1758ac">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="bmy:RestructuringRelatedCostsAssetImpairments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTItNy0xLTEtMA_fdba13bd-e947-4728-aa50-b47908ba60ba">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other shutdown costs, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" sign="-" name="bmy:OtherShutdownCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTMtMS0xLTEtMA_99896842-5558-4f20-96bb-8a4ea5a033a0">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="bmy:OtherShutdownCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTMtMy0xLTEtMA_2ddf0a72-4611-4089-bfa6-926904958966">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="bmy:OtherShutdownCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTMtNS0xLTEtMA_1ec7ad53-3dbf-4056-830c-628238e056fc">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="bmy:OtherShutdownCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTMtNy0xLTEtMA_1d55f634-a3c1-45f3-87a9-3f9b335648bd">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTQtMS0xLTEtMA_2dc8ba0d-9a6a-4f79-9406-3276e176e76b">219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTQtMy0xLTEtMA_74d12856-e2ed-458e-96fd-f0a780b0cbda">340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTQtNS0xLTEtMjA4Mw_ecb2d6cc-24cf-40b9-82d7-86efba981a60">429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTQtNy0xLTEtMjA4Mw_86e14434-aa43-461c-aa3f-ece66bceb0b4">746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5f7660b6eca475a9df8e628fa445af7_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTYtMS0xLTEtMA_87ee1fc0-2324-4eed-9931-6e02e50e4c1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635494ce148e4ad7bd650508b31a47f5_D20200401-20200630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTYtMy0xLTEtMA_e40d204f-9aa2-43df-8407-203b4abfd0af">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i458d77e2e80747db91d6733fb12cc6f3_D20210101-20210630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTYtNS0xLTEtMA_9a73f512-50af-4d55-b654-621ff5402fde">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic61bae9f14c94630811f2853573f8ff6_D20200101-20200630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTYtNy0xLTEtMA_d8ff5c83-39f9-4e70-bb8b-c0b91a33da08">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dec6245873f4d98820e4a2b35667387_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTctMS0xLTEtMA_e12c6da5-7e95-4a75-b69b-9b620ed57d06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6778a15e516498f97f88c860749c6a2_D20200401-20200630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTctMy0xLTEtMA_2da03da6-9673-463f-9aee-15942816316f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d23efb083df4012b861cdd74c430462_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTctNS0xLTEtMA_54060071-5fac-47d5-8759-bbb7600a0481">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33981b78822f4f77be3c382064085973_D20200101-20200630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTctNy0xLTEtMA_2d69a870-d059-4718-996d-968c1a137edf">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c126874d2714146b7bf5cbc485c1cf8_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTgtMS0xLTEtMA_25b83239-94fe-486f-94ec-2043131fac9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41d5a334a6e142f8bd67b8e51060b87f_D20200401-20200630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTgtMy0xLTEtMA_d624ea56-f203-43da-9522-1b794688f94d">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4662da4bb2b6479993d2a5b55ba2078b_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTgtNS0xLTEtMA_a1a705eb-4b51-4dd0-9351-f4f56ae72abd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5431747aab134732bd974c5723251eef_D20200101-20200630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTgtNy0xLTEtMA_adf8c561-aa24-4210-9e50-aef647111d61">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i704336f4184942a3983f50159a480277_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTktMS0xLTEtMA_27e0346f-6dd9-4366-b16e-d9de233eba67">219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1232e4b20d8401ba7060d232ed7fe2f_D20200401-20200630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTktMy0xLTEtMA_ee47d1f4-2517-4b13-97eb-303ac56cf107">289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8689b4d5000b4d5b8e0fc3554738970e_D20210101-20210630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTktNS0xLTEtMA_2315ac6f-76ad-4ea2-9b5d-cdfb87fd1c92">405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6931cd74ebe9437fa587ab6b851ccf58_D20200101-20200630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTktNy0xLTEtMA_2f5f6567-e639-4e0d-a18a-cc5599f1dddd">623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMjAtMS0xLTEtMA_e76d81c3-64ea-43cd-9096-46f5fbe456bb">219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMjAtMy0xLTEtMA_778b6396-1d23-4214-9993-5c5f2cc2d97d">340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMjAtNS0xLTEtMjA4NQ_61ab5b30-b563-43e6-bacb-b0267db6db7e">429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMjAtNy0xLTEtMjA4NQ_e352d5e6-c28e-4bcc-b7a2-2a28e7cc7ba0">746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i310ee8fb67b541ac8bf2f17a4f3c75fc"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfMjE2NQ_c8b5150b-da3c-4f04-8f36-075a2e768d0c" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the charges and spending related to restructuring plan activities:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability at December 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5b48843789843e59015f89cfb97e96a_I20210101" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjE1NjE2Y2I5ZTc5MzQ2YzI5YTM0ZmQ0YzZmNzA3MDU2L3RhYmxlcmFuZ2U6MTU2MTZjYjllNzkzNDZjMjlhMzRmZDRjNmY3MDcwNTZfMi0xLTEtMS0w_cca48afd-377a-462e-8707-624899954485">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b7251412f7b43c9817b299748e1d079_I20200101" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjE1NjE2Y2I5ZTc5MzQ2YzI5YTM0ZmQ0YzZmNzA3MDU2L3RhYmxlcmFuZ2U6MTU2MTZjYjllNzkzNDZjMjlhMzRmZDRjNmY3MDcwNTZfMi0zLTEtMS0w_b5db83a2-2e92-4455-9245-a54d05107687">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjE1NjE2Y2I5ZTc5MzQ2YzI5YTM0ZmQ0YzZmNzA3MDU2L3RhYmxlcmFuZ2U6MTU2MTZjYjllNzkzNDZjMjlhMzRmZDRjNmY3MDcwNTZfMy0xLTEtMS0w_ed302a94-9496-422c-a258-e6219b94175f">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjE1NjE2Y2I5ZTc5MzQ2YzI5YTM0ZmQ0YzZmNzA3MDU2L3RhYmxlcmFuZ2U6MTU2MTZjYjllNzkzNDZjMjlhMzRmZDRjNmY3MDcwNTZfMy0zLTEtMS0w_d902a8ab-59ff-41b7-9cb5-805389405698">228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjE1NjE2Y2I5ZTc5MzQ2YzI5YTM0ZmQ0YzZmNzA3MDU2L3RhYmxlcmFuZ2U6MTU2MTZjYjllNzkzNDZjMjlhMzRmZDRjNmY3MDcwNTZfNC0xLTEtMS0w_6170ece0-8c3e-43d0-b360-72c341b4596d">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjE1NjE2Y2I5ZTc5MzQ2YzI5YTM0ZmQ0YzZmNzA3MDU2L3RhYmxlcmFuZ2U6MTU2MTZjYjllNzkzNDZjMjlhMzRmZDRjNmY3MDcwNTZfNC0zLTEtMS0w_281ef0b2-f5ca-4d20-8f2a-1c02335bf238">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjE1NjE2Y2I5ZTc5MzQ2YzI5YTM0ZmQ0YzZmNzA3MDU2L3RhYmxlcmFuZ2U6MTU2MTZjYjllNzkzNDZjMjlhMzRmZDRjNmY3MDcwNTZfNS0xLTEtMS0w_072d74d3-676b-4e5f-b0bc-56db21c3e849">134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjE1NjE2Y2I5ZTc5MzQ2YzI5YTM0ZmQ0YzZmNzA3MDU2L3RhYmxlcmFuZ2U6MTU2MTZjYjllNzkzNDZjMjlhMzRmZDRjNmY3MDcwNTZfNS0zLTEtMS0w_8f20a69b-3fae-4f21-8261-ff3abcda209d">188</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability at June 30</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjE1NjE2Y2I5ZTc5MzQ2YzI5YTM0ZmQ0YzZmNzA3MDU2L3RhYmxlcmFuZ2U6MTU2MTZjYjllNzkzNDZjMjlhMzRmZDRjNmY3MDcwNTZfNi0xLTEtMS0w_ff77c6f5-5bbf-4023-b9ab-9c08bb12b31d">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i711a50adb808497c9daf76647502dad6_I20200630" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjE1NjE2Y2I5ZTc5MzQ2YzI5YTM0ZmQ0YzZmNzA3MDU2L3RhYmxlcmFuZ2U6MTU2MTZjYjllNzkzNDZjMjlhMzRmZDRjNmY3MDcwNTZfNi0zLTEtMS0w_79888a1a-2aa6-4e7e-b2f4-55668fa5865c">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes a reduction of the liability resulting from changes in estimates of $<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfMTA5OTUxMTYzMDA2OA_7c1efe0c-02d2-44f0-b3ba-8faaa1045ef1">8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringReserveAccrualAdjustment1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfMTA5OTUxMTYzMDA2Mg_c7e5abf2-88fb-45a7-b15f-e773d03ab3f7">6</ix:nonFraction> million for the six months ended June 30, 2021 and 2020, respectively. Excludes $<ix:nonFraction unitRef="usd" contextRef="i0a5a5daa7bb24250bb98daa1532976bb_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfMTA5OTUxMTYzMDA3NQ_e28684ac-b9f2-49a2-bcf7-63266359403e">9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i12fc955bf6c34929ae7dc5a546b6e0e2_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfMTA5OTUxMTYzMDA4Mg_fc5ed412-0198-47d2-b17b-602216ece371">47</ix:nonFraction> million for the six months ended June 30, 2021 and 2020, respectively, of accelerated stock-based compensation relating to the Celgene Acquisition Plan.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_52"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7. <ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RleHRyZWdpb246MjY4NzhlNjA2ZmQ0NDY5NThhNjRhNTlmN2Q4YjJmYTBfMjA1NA_ae3e8d41-e0f9-425a-b135-e0e50d71e0b0" continuedAt="i3faf04d4c17b4f42880ce09e03eeedc6" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="i3faf04d4c17b4f42880ce09e03eeedc6"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RleHRyZWdpb246MjY4NzhlNjA2ZmQ0NDY5NThhNjRhNTlmN2Q4YjJmYTBfMjA0Ng_134ca38c-f330-41ae-822f-2b8823575bcf" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings Before Income Taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RhYmxlOmRhMTE1OTFiNTdiYTRjYzk4MTAzMmZmNGNkN2E0NWFmL3RhYmxlcmFuZ2U6ZGExMTU5MWI1N2JhNGNjOTgxMDMyZmY0Y2Q3YTQ1YWZfMi0xLTEtMS0w_e3536a23-0a27-4495-bfd1-f5d17abde2e4">1,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RhYmxlOmRhMTE1OTFiNTdiYTRjYzk4MTAzMmZmNGNkN2E0NWFmL3RhYmxlcmFuZ2U6ZGExMTU5MWI1N2JhNGNjOTgxMDMyZmY0Y2Q3YTQ1YWZfMi0zLTEtMS0w_f818e0a5-250a-4923-8021-699a0da4e4f8">1,627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RhYmxlOmRhMTE1OTFiNTdiYTRjYzk4MTAzMmZmNGNkN2E0NWFmL3RhYmxlcmFuZ2U6ZGExMTU5MWI1N2JhNGNjOTgxMDMyZmY0Y2Q3YTQ1YWZfMi01LTEtMS0w_48a8b3af-3b50-4dff-9865-aefaa5bd7d3d">4,083</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RhYmxlOmRhMTE1OTFiNTdiYTRjYzk4MTAzMmZmNGNkN2E0NWFmL3RhYmxlcmFuZ2U6ZGExMTU5MWI1N2JhNGNjOTgxMDMyZmY0Y2Q3YTQ1YWZfMi03LTEtMS0w_ecd22322-9894-45b4-8889-ab8a04348ce4">1,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for Income Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RhYmxlOmRhMTE1OTFiNTdiYTRjYzk4MTAzMmZmNGNkN2E0NWFmL3RhYmxlcmFuZ2U6ZGExMTU5MWI1N2JhNGNjOTgxMDMyZmY0Y2Q3YTQ1YWZfMy0xLTEtMS0w_13015e9e-a15e-4f01-9f3f-98bf300c5398">492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RhYmxlOmRhMTE1OTFiNTdiYTRjYzk4MTAzMmZmNGNkN2E0NWFmL3RhYmxlcmFuZ2U6ZGExMTU5MWI1N2JhNGNjOTgxMDMyZmY0Y2Q3YTQ1YWZfMy0zLTEtMS0w_e45c1c64-af44-4d9b-97bb-27ebe850fc4b">1,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RhYmxlOmRhMTE1OTFiNTdiYTRjYzk4MTAzMmZmNGNkN2E0NWFmL3RhYmxlcmFuZ2U6ZGExMTU5MWI1N2JhNGNjOTgxMDMyZmY0Y2Q3YTQ1YWZfMy01LTEtMS0w_faa2a2ed-f5bf-44d1-a782-4330947e166e">993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RhYmxlOmRhMTE1OTFiNTdiYTRjYzk4MTAzMmZmNGNkN2E0NWFmL3RhYmxlcmFuZ2U6ZGExMTU5MWI1N2JhNGNjOTgxMDMyZmY0Y2Q3YTQ1YWZfMy03LTEtMS0w_042ed61b-2ca8-44ed-a65e-8fe7a7d1ac11">2,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Tax Rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RhYmxlOmRhMTE1OTFiNTdiYTRjYzk4MTAzMmZmNGNkN2E0NWFmL3RhYmxlcmFuZ2U6ZGExMTU5MWI1N2JhNGNjOTgxMDMyZmY0Y2Q3YTQ1YWZfNC0xLTEtMS0w_3a9d2f8a-b128-44e6-b4d0-5bd7006b1f40">31.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RhYmxlOmRhMTE1OTFiNTdiYTRjYzk4MTAzMmZmNGNkN2E0NWFmL3RhYmxlcmFuZ2U6ZGExMTU5MWI1N2JhNGNjOTgxMDMyZmY0Y2Q3YTQ1YWZfNC0zLTEtMS0w_beb6bb47-0789-4bcb-8a31-3d80de6d880b">104.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RhYmxlOmRhMTE1OTFiNTdiYTRjYzk4MTAzMmZmNGNkN2E0NWFmL3RhYmxlcmFuZ2U6ZGExMTU5MWI1N2JhNGNjOTgxMDMyZmY0Y2Q3YTQ1YWZfNC01LTEtMS0yMDg5_8d288f96-b8fe-40c6-8a04-a2d185c75b3c">24.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RhYmxlOmRhMTE1OTFiNTdiYTRjYzk4MTAzMmZmNGNkN2E0NWFmL3RhYmxlcmFuZ2U6ZGExMTU5MWI1N2JhNGNjOTgxMDMyZmY0Y2Q3YTQ1YWZfNC03LTEtMS0yMDg5_e635f4bc-eb72-4130-845c-9394837ad8cd">163.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes in interim periods are determined based on the estimated annual effective tax rates and the tax impact of discrete items that are reflected immediately. The effective tax rates in 2021 and 2020 were impacted by low jurisdictional tax rates attributed to the unwinding of inventory fair value adjustments and intangible asset amortization and contingent value rights fair value adjustments that are not taxable or deductible. The three and six months ended June&#160;30, 2020 includes an $<ix:nonFraction unitRef="usd" contextRef="i4b0b5444987e49eba4f8bafbffef80f3_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RleHRyZWdpb246MjY4NzhlNjA2ZmQ0NDY5NThhNjRhNTlmN2Q4YjJmYTBfMjE5OTAyMzI1ODY0Mw_e655a2f1-7d56-4b49-8e45-d7d1f71c7175">853</ix:nonFraction>&#160;million deferred tax charge resulting from an internal transfer of certain intangible assets to the U.S. and an additional $<ix:nonFraction unitRef="usd" contextRef="if7fd398a275d49b7ac8db542e423dabb_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RleHRyZWdpb246MjY4NzhlNjA2ZmQ0NDY5NThhNjRhNTlmN2Q4YjJmYTBfMjE5OTAyMzI1ODY1Nw_93fc9163-e3d3-41ab-b902-feda9df76fb5">255</ix:nonFraction>&#160;million GILTI tax charge upon finalization of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Otezla</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* divestiture tax consequences with tax authorities. Additional changes to the effective tax rate may occur in future periods due to various reasons, including changes to the estimated pretax earnings mix and tax reserves and revised interpretations or changes to the relevant tax code.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that the amount of unrecognized tax benefits at June&#160;30, 2021 could decrease in the range of approximately $<ix:nonFraction unitRef="usd" contextRef="id3a7e6213d5a4e98bdeddda2ad09db70_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RleHRyZWdpb246MjY4NzhlNjA2ZmQ0NDY5NThhNjRhNTlmN2Q4YjJmYTBfOTI4_894c6136-6290-48c7-823a-c467bc9c6d34">430</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i007d2ce5a6594dc2b97f4d6dde2a3170_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RleHRyZWdpb246MjY4NzhlNjA2ZmQ0NDY5NThhNjRhNTlmN2Q4YjJmYTBfOTM0_1711259f-005d-47cb-8002-27d9f753fbc4">480</ix:nonFraction> million in the next twelve months as a result of the settlement of certain tax audits and other events. The expected change in unrecognized tax benefits may result in the payment of additional taxes, adjustment of certain deferred taxes and/or recognition of tax benefits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS is currently under examination by a number of tax authorities, which have proposed or are considering proposing material adjustments to tax positions for issues such as transfer pricing, certain tax credits and the deductibility of certain expenses. As previously disclosed, BMS received several notices of proposed adjustments from the IRS related to transfer pricing and other tax positions for the 2008 to 2012 tax years. BMS disagrees with the IRS&#8217;s positions and continues to work cooperatively with the IRS to resolve these open tax audits. It is reasonably possible that new issues will be raised by tax authorities that may increase unrecognized tax benefits; however, an estimate of such increases cannot reasonably be made at this time. BMS believes that it has adequately provided for all open tax years by tax jurisdiction.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_55"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8. <ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RleHRyZWdpb246NjcwNDQ0MDQxOWZlNDg2YWEzYWY2NmQ3MDg3Nzc3MWFfMjYy_084bfd00-b01b-4b45-8b20-6d0fc806aa2e" continuedAt="i5eedbde8ec6c4739b635df41d6485a32" escape="true">EARNINGS/(LOSS) PER SHARE</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><ix:continuation id="i5eedbde8ec6c4739b635df41d6485a32" continuedAt="i197d5972537d466ba41eaf0bf3c27bc6"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RleHRyZWdpb246NjcwNDQ0MDQxOWZlNDg2YWEzYWY2NmQ3MDg3Nzc3MWFfMjY2_ea4f84b6-403b-4586-8706-31dc16dadcf5" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts in Millions, Except Per Share Data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings/(Loss) Attributable to BMS Used for Basic and Diluted EPS Calculation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfMi0xLTEtMS0w_0594d7fd-8c73-45ce-bfff-9a0880f3ab5a">1,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfMi0zLTEtMS0w_22e13f80-f76c-4f6d-ab6b-d1f977d07205">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfMi01LTEtMS0w_5e3a9384-e2dd-4ddc-a436-3b0826748228">3,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfMi03LTEtMS0w_743bcc1e-114c-4fe4-b60d-bb6cfb5197f5">860</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Common Shares Outstanding &#8211; Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfNC0xLTEtMS0w_4531a4d6-3962-4dfc-b121-b2601fca2b53">2,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfNC0zLTEtMS0w_95b53912-8c93-485b-b3b0-52aa821d6bf9">2,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfNC01LTEtMS0w_8103b444-45a2-48a7-bad7-320b12bda596">2,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfNC03LTEtMS0w_08b52e60-02b7-4b16-a0f9-6c067247efc3">2,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental Shares Attributable to Share-Based Compensation Plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfNS0xLTEtMS0w_0335d11d-c2fe-4970-8882-7b883c80507d">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfNS0zLTEtMS0w_d0aab245-58fc-4541-a3d0-580e4589da06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfNS01LTEtMS0w_8a83ca3a-423a-451f-9309-01b565616cac">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfNS03LTEtMS0w_6f2cba0f-5cb0-451d-9afe-6d17ad90fcf6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Common Shares Outstanding &#8211; Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfNi0xLTEtMS0w_59db19ae-50a7-4685-ae3b-79ce1135897b">2,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfNi0zLTEtMS0w_9bba0b34-2d85-4582-b7df-6422565713ab">2,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfNi01LTEtMS0yMDk0_ea38b841-faa5-453d-9aa5-c645fc5a0dcf">2,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfNi03LTEtMS0yMDk0_556fa5e7-0f1a-4a58-80cd-a3b0ce1d8ddc">2,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings/(Loss) per Common Share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfOS0xLTEtMS0w_6b7581d9-4899-4cb4-8c27-b25889d894b9">0.47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfOS0zLTEtMS0w_4a2dc41c-493b-42cc-9dfb-aed68b3ab8a0">0.04</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfOS01LTEtMS0w_ed7942be-b29e-40c2-929c-2876edcf6597">1.38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfOS03LTEtMS0w_e38afe39-b228-4235-a93c-15b5aa2a71f5">0.38</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfMTAtMS0xLTEtMA_71b34a20-723e-477a-8806-759714c762ba">0.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfMTAtMy0xLTEtMA_d7c5265c-672e-4595-a9e6-754a34e2aec4">0.04</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfMTAtNS0xLTEtMA_7d3e0dd6-b4df-47a8-b7d6-8243c34eb9f9">1.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfMTAtNy0xLTEtMA_79b8446f-4884-4529-b8bc-523d62c9b9f2">0.38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i197d5972537d466ba41eaf0bf3c27bc6">The total number of potential shares of common stock excluded from the diluted earnings/(loss) per common share computation because of the antidilutive impact was <ix:nonFraction unitRef="shares" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RleHRyZWdpb246NjcwNDQ0MDQxOWZlNDg2YWEzYWY2NmQ3MDg3Nzc3MWFfMjA3_9987ff36-b717-4cd2-a4c0-7a38f8fee1ee"><ix:nonFraction unitRef="shares" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RleHRyZWdpb246NjcwNDQ0MDQxOWZlNDg2YWEzYWY2NmQ3MDg3Nzc3MWFfMjA3_a12f918f-c409-42a4-bc88-dd2562f9b0fc">9</ix:nonFraction></ix:nonFraction>&#160;million for both the three and six months ended June&#160;30, 2021 and <ix:nonFraction unitRef="shares" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RleHRyZWdpb246NjcwNDQ0MDQxOWZlNDg2YWEzYWY2NmQ3MDg3Nzc3MWFfMjE5OTAyMzI1NTkyMw_86d5b589-bee7-4686-8d29-647c5f526b71"><ix:nonFraction unitRef="shares" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RleHRyZWdpb246NjcwNDQ0MDQxOWZlNDg2YWEzYWY2NmQ3MDg3Nzc3MWFfMjE5OTAyMzI1NTkyMw_f25b1cce-ada4-4ec2-b41a-22d88aafdd43">127</ix:nonFraction></ix:nonFraction>&#160;million for both the three and six months ended June&#160;30, 2020.</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_58"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9. <ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfMjE5OTAyMzI2NjgwMQ_775a9682-3449-4802-8acb-f0b46eae7dc6" continuedAt="if0273cc22edf4a269ca716fcf7088ea9" escape="true">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="if0273cc22edf4a269ca716fcf7088ea9" continuedAt="i9a7e57643e4c4e44a84f3c40bafee61f"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTc0MA_b2a19428-ff76-4c31-a9f7-736aa2f576b8" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis are summarized below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents - money market and other securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e8abfc7c4684a2e80153d093765a7b0_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMi0xLTEtMS0w_82d5b727-4938-46b4-93ba-e4817544c04c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife50b98ec7264eb7a37a0b687539d4dd_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMi0zLTEtMS0w_4a2acf95-0537-4bb7-b6f5-eba0241d5b4c">9,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281eaf8778b946efa6523d049bb63601_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMi01LTEtMS0w_efdb1e21-00ad-4ee1-8a7a-e1b559d3bb62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19f789ba573d4f3ea505980fcb78be12_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMi03LTEtMS0w_bd535e7e-1324-44a1-b2ff-9b69c0d8f469">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7c1be369f724e7a955da101f61cd0cb_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMi05LTEtMS0w_15ac7fc2-565a-4022-8c20-3a02b92baaa8">12,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0afe166f4d814c949b6b416e46eb5544_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMi0xMS0xLTEtMA_2db289ad-48d0-41f7-9a01-9ee52e245aac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i295633493d6b475f86d6737b887dba92_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNC0xLTEtMS0w_48568199-fe1b-4661-8cba-fa724000ca08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45f649e8a6934c6bae4029abbff213fc_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNC0zLTEtMS0w_71a872b3-878e-41fe-96a9-fc0257a8e4d2">1,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7b083b368d44b519124184b6c12db87_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNC01LTEtMS0w_efd872d3-e70d-4d87-bb6a-8a1d1dc350dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa523e1aa7274232a186fcca3656cab6_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNC03LTEtMS0w_e890ce49-6149-49c0-9be8-0da69a537ebe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc71b68bc0be4ab58521b097b145bced_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNC05LTEtMS0w_1a30f4f5-81b2-4b46-99ae-7365683d60f2">1,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7be4a1f26072441e8e2c3e8802de46f0_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNC0xMS0xLTEtMA_45256d37-133e-4743-b914-13301d7737e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06a7cf8e55bc4f11ae11dd2f4e67ba53_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNi0xLTEtMS0w_24e3f296-01eb-4300-bec3-485f23add6ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27ebf9edff0b44398e9b44f2f4a6f076_I20210630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNi0zLTEtMS0w_959e62cf-3583-48dc-a86e-284f2e87f93b">498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e46d25a491547498b733410813929a0_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNi01LTEtMS0w_ea457fc1-a937-4709-9c7c-1b4a30ad33e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie66cb746be9f47e7ac4434960e977507_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNi03LTEtMS0w_65772f34-27fe-4961-8f94-9dba7aeb63ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8c40a0c0854d7fad1b783d8d1ad346_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNi05LTEtMS0w_8a6b176d-fc6f-4e41-8f9e-0498683ae595">698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e8619d5b7674406b0c8e75b507643be_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNi0xMS0xLTEtMA_69c48c6d-bf35-42b0-aab2-8755a3549a4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e8abfc7c4684a2e80153d093765a7b0_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNy0xLTEtMS0w_6436546b-dce5-420d-8e47-799016c38622">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife50b98ec7264eb7a37a0b687539d4dd_I20210630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNy0zLTEtMS0w_747b8244-65de-425c-b3c5-a00458ea92a3">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281eaf8778b946efa6523d049bb63601_I20210630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNy01LTEtMS0w_65dbdb65-d528-491b-849f-89db639b6387">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19f789ba573d4f3ea505980fcb78be12_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNy03LTEtMS0w_913e94aa-abf9-495e-8c32-366841d911af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7c1be369f724e7a955da101f61cd0cb_I20201231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNy05LTEtMS0w_704d2140-c857-40fd-b768-7743f4410a1e">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0afe166f4d814c949b6b416e46eb5544_I20201231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNy0xMS0xLTEtMA_cf86e0ed-d920-4c70-811c-dd6b8ae5d18b">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9778045c333646e8abc7df95736d6051_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfOC0xLTEtMS0w_3d331e8a-8d76-4577-8760-dd65ea265fc4">3,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5047f95b2d744b4b59d1b78d6a742f4_I20210630" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfOC0zLTEtMS0w_0be60793-9210-4b72-b200-00e2533910fb">139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4783faea57834d3faef3b5be5df299e6_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfOC01LTEtMS0w_9086d769-030b-4ae2-a16f-974dea13813b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic82867d41cc6438396b8ea9165e07f1e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfOC03LTEtMS0w_7a9f2018-491b-4053-a063-ea82dd2c9d08">3,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0603128401446e3b0ba870450ab65d1_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfOC05LTEtMS0w_02c731bc-3031-4768-bb4a-75fa7358bfa7">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9be6d10579a84d6ba5f91b6e23177b72_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfOC0xMS0xLTEtMA_11f081ac-6315-49be-928e-05edf85472ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e8abfc7c4684a2e80153d093765a7b0_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfOS0xLTEtMS0w_f2364199-0c32-44af-bb94-e3fc64d15530">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife50b98ec7264eb7a37a0b687539d4dd_I20210630" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfOS0zLTEtMS0w_33ed9dce-6ff8-4b58-938d-c43a625225ed">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281eaf8778b946efa6523d049bb63601_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfOS01LTEtMS0w_7266d44e-27b0-4bc7-836b-6cab34286fb9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19f789ba573d4f3ea505980fcb78be12_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfOS03LTEtMS0w_b8caa995-d94a-4be9-a700-dcfc759158c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7c1be369f724e7a955da101f61cd0cb_I20201231" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfOS05LTEtMS0w_e89d60e3-19f1-46d6-b44b-a11401ffc9b9">270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0afe166f4d814c949b6b416e46eb5544_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfOS0xMS0xLTEtMA_47e11ee1-9493-4cf8-8b3e-1e9037159635">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent value rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39a1379770a94344b49dfe53b78ea4c4_I20210630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMTEtMS0xLTEtMA_d14393df-5393-44a6-a6ce-d46e478a7214">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i890225c6ebb14bdaa4c35b58daa47553_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMTEtMy0xLTEtMA_3c492d27-f070-4f8b-aa08-ec60392fec32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85ae89b3bbca4fbdae10aba3669ee6dc_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMTEtNS0xLTEtMA_c6fefdbc-c13b-4813-bab1-d32705d611de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f39bf27565748b9ad84356a93cb08c7_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMTEtNy0xLTEtMA_a9447767-64f8-4be1-8083-7546948a7ca1">530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9602884451440a58383e854523622d4_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMTEtOS0xLTEtMA_eb52d2aa-4ddb-49db-9451-edc5ebdbe533">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bacf915b38e4bef995b2dd60b16d847_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMTEtMTEtMS0xLTA_2d905b42-177d-4a1a-acbe-5d0d8e991aa6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other acquisition related contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e8abfc7c4684a2e80153d093765a7b0_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMTItMS0xLTEtMA_266000e0-7aa8-4a7b-b58e-45c5675de693">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife50b98ec7264eb7a37a0b687539d4dd_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMTItMy0xLTEtMA_bda0a635-0d8f-4c73-8262-c479ba974a35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281eaf8778b946efa6523d049bb63601_I20210630" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMTItNS0xLTEtMA_3fce6e78-f063-4259-8d15-f7e0e4bc433a">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19f789ba573d4f3ea505980fcb78be12_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMTItNy0xLTEtMA_d60a6373-7cbb-4aec-b911-539058374d3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7c1be369f724e7a955da101f61cd0cb_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMTItOS0xLTEtMA_52d673a1-eeaf-461e-a813-60260c91f112">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0afe166f4d814c949b6b416e46eb5544_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMTItMTEtMS0xLTA_a661669e-69a8-431f-995a-98bf1ea5da18">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in &#8220;Item 8. Financial Statements and Supplementary Data&#8212;Note 9. Financial Instruments and Fair Value Measurements&#8221; in the Company&#8217;s 2020 Form 10-K, the Company&#8217;s fair value estimates use inputs that are either (1) quoted prices for identical assets or liabilities in active markets (Level 1 inputs); (2) observable prices for similar assets or liabilities in active markets or for identical or similar assets or liabilities in markets that are not active (Level 2 inputs); or (3) unobservable inputs (Level 3 inputs).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration obligations are recorded at their estimated fair values and these obligations are revalued each reporting period until the related contingencies are resolved. The contingent value rights are adjusted to fair value using the traded price of the securities at the end of each reporting period. The fair value measurements for other contingent consideration liabilities are estimated using probability-weighted discounted cash flow approaches that are based on significant unobservable inputs related to product candidates acquired in business combinations and are reviewed quarterly. These inputs include, as applicable, estimated probabilities and timing of achieving specified development and regulatory milestones and the discount rate used to calculate the present value of estimated future payments. Significant changes which increase or decrease the probabilities of achieving the related development and regulatory events or shorten or lengthen the time required to achieve such events would result in corresponding increases or decreases in the fair values of these obligations. <ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTc4NA_bdeae40d-3623-4307-9a38-49512d6cf9c6" continuedAt="i48d82216dace4c7db141075eb32bab3e" escape="true">The fair value of other acquisition related contingent consideration as of June&#160;30, 2021 was calculated using the following significant unobservable inputs:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><ix:continuation id="i48d82216dace4c7db141075eb32bab3e"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:80.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.373%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ranges (weighted average) utilized as of:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="percentage" contextRef="id75c7a7e91df4d63a4260a384377a6a3_I20210630" decimals="INF" name="us-gaap:DebtInstrumentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjU1NTEzZTRiZGZhMjQ4MGQ4MGM0MDRlNTU4ZWU1M2ViL3RhYmxlcmFuZ2U6NTU1MTNlNGJkZmEyNDgwZDgwYzQwNGU1NThlZTUzZWJfMi0xLTEtMS0wL3RleHRyZWdpb246NTgxMDNmNDY4MTgwNGEyZDg3ODE0MTFkMGE3ZjI1MWZfNA_e7c02495-7740-4d83-94bd-96e5bee5bbfe">0.3</ix:nonFraction>% to <ix:nonFraction unitRef="percentage" contextRef="ice980dd1a7be4e65a57342c85ac3474a_I20210630" decimals="INF" name="us-gaap:DebtInstrumentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjU1NTEzZTRiZGZhMjQ4MGQ4MGM0MDRlNTU4ZWU1M2ViL3RhYmxlcmFuZ2U6NTU1MTNlNGJkZmEyNDgwZDgwYzQwNGU1NThlZTUzZWJfMi0xLTEtMS0wL3RleHRyZWdpb246NTgxMDNmNDY4MTgwNGEyZDg3ODE0MTFkMGE3ZjI1MWZfMTA_3af6b760-4b16-4197-a1ce-907ec61479c4">1.3</ix:nonFraction>% (<ix:nonFraction unitRef="percentage" contextRef="id818743065664bfbb207dcd02dc3e2b8_I20210630" decimals="INF" name="us-gaap:DebtInstrumentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjU1NTEzZTRiZGZhMjQ4MGQ4MGM0MDRlNTU4ZWU1M2ViL3RhYmxlcmFuZ2U6NTU1MTNlNGJkZmEyNDgwZDgwYzQwNGU1NThlZTUzZWJfMi0xLTEtMS0wL3RleHRyZWdpb246NTgxMDNmNDY4MTgwNGEyZDg3ODE0MTFkMGE3ZjI1MWZfMTQ_95c19ba9-0c55-4fe2-824b-91af40b1679c">0.6</ix:nonFraction>%)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="percentage" contextRef="i9d8a4ac8110a40668a2b2d95ce32cc86_I20210630" decimals="INF" name="us-gaap:DebtInstrumentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjU1NTEzZTRiZGZhMjQ4MGQ4MGM0MDRlNTU4ZWU1M2ViL3RhYmxlcmFuZ2U6NTU1MTNlNGJkZmEyNDgwZDgwYzQwNGU1NThlZTUzZWJfMy0xLTEtMS0wL3RleHRyZWdpb246M2QzYzdhMWFiZGFmNDk5ODg0MDE4ZTc5OWZlZDc1NDhfNA_089607b8-61d7-4877-8432-87be738037b0">0</ix:nonFraction>% to <ix:nonFraction unitRef="percentage" contextRef="if862182d7eed4a4e9ea6d6d9a6f57901_I20210630" decimals="INF" name="us-gaap:DebtInstrumentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjU1NTEzZTRiZGZhMjQ4MGQ4MGM0MDRlNTU4ZWU1M2ViL3RhYmxlcmFuZ2U6NTU1MTNlNGJkZmEyNDgwZDgwYzQwNGU1NThlZTUzZWJfMy0xLTEtMS0wL3RleHRyZWdpb246M2QzYzdhMWFiZGFmNDk5ODg0MDE4ZTc5OWZlZDc1NDhfMTA_ea81daa1-e7ce-420e-9c54-204c8bb90318">80</ix:nonFraction>% (<ix:nonFraction unitRef="percentage" contextRef="i11aaa3096c4a45f28755610b228eadd2_I20210630" decimals="INF" name="us-gaap:DebtInstrumentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjU1NTEzZTRiZGZhMjQ4MGQ4MGM0MDRlNTU4ZWU1M2ViL3RhYmxlcmFuZ2U6NTU1MTNlNGJkZmEyNDgwZDgwYzQwNGU1NThlZTUzZWJfMy0xLTEtMS0wL3RleHRyZWdpb246M2QzYzdhMWFiZGFmNDk5ODg0MDE4ZTc5OWZlZDc1NDhfMTQ_d708d6fb-c17f-4e26-a322-a3eaa03292dc">2.4</ix:nonFraction>%)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected year of payment for development and regulatory milestones</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="y" contextRef="i8707328f1c9f418da8c326940d5bd515_I20210630" decimals="0" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjU1NTEzZTRiZGZhMjQ4MGQ4MGM0MDRlNTU4ZWU1M2ViL3RhYmxlcmFuZ2U6NTU1MTNlNGJkZmEyNDgwZDgwYzQwNGU1NThlZTUzZWJfNC0xLTEtMS0wL3RleHRyZWdpb246MzM1YTRhOGFlNjFhNGQzYmI5ZDY0NzBkZDJlZjU0NWRfNA_ee2857dc-bce9-4865-b16b-8a2f3b8d809d">2022</ix:nonFraction> to <ix:nonFraction unitRef="y" contextRef="ifb8b81529e9f4bf98e414922640a88dd_I20210630" decimals="0" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjU1NTEzZTRiZGZhMjQ4MGQ4MGM0MDRlNTU4ZWU1M2ViL3RhYmxlcmFuZ2U6NTU1MTNlNGJkZmEyNDgwZDgwYzQwNGU1NThlZTUzZWJfNC0xLTEtMS0wL3RleHRyZWdpb246MzM1YTRhOGFlNjFhNGQzYmI5ZDY0NzBkZDJlZjU0NWRfMTA_2c395d54-5782-4243-9c43-d506b2f670fe">2028</ix:nonFraction></span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers between levels 1, 2 and 3 during the six months ended&#160;June&#160;30, 2021. <ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTc3Mg_54f29a64-6e65-4d12-ae4e-69dd85ed4d02" continuedAt="ic405b187981647a980e9607e3bcd2e30" escape="true">The following table represents a roll-forward of the fair value of level 3 instruments:</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><ix:continuation id="ic405b187981647a980e9607e3bcd2e30"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value as of January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0afe166f4d814c949b6b416e46eb5544_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjQyNWRmYjE0NmZlNzQ3NGY4ODYyMGJkODFkNzlmMDM2L3RhYmxlcmFuZ2U6NDI1ZGZiMTQ2ZmU3NDc0Zjg4NjIwYmQ4MWQ3OWYwMzZfMi0xLTEtMS0w_c7061f33-a914-44ed-bd4c-96c7dc8abeeb">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0afe166f4d814c949b6b416e46eb5544_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjQyNWRmYjE0NmZlNzQ3NGY4ODYyMGJkODFkNzlmMDM2L3RhYmxlcmFuZ2U6NDI1ZGZiMTQ2ZmU3NDc0Zjg4NjIwYmQ4MWQ3OWYwMzZfMi0zLTEtMS0w_8efb703d-4ba6-4747-b3bd-2c95ba3e7497">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42b5dbab27a246b580a0579f0d96dee6_I20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjQyNWRmYjE0NmZlNzQ3NGY4ODYyMGJkODFkNzlmMDM2L3RhYmxlcmFuZ2U6NDI1ZGZiMTQ2ZmU3NDc0Zjg4NjIwYmQ4MWQ3OWYwMzZfMi03LTEtMS0w_e41dc293-abcf-4445-adf8-0bf94e14d156">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in estimated fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjQyNWRmYjE0NmZlNzQ3NGY4ODYyMGJkODFkNzlmMDM2L3RhYmxlcmFuZ2U6NDI1ZGZiMTQ2ZmU3NDc0Zjg4NjIwYmQ4MWQ3OWYwMzZfNC0xLTEtMS0w_21361e1e-8b68-4901-af75-e5c33dc1ccd0">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b39484540fe4cbc883405fbdd50a2a3_D20210101-20210630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjQyNWRmYjE0NmZlNzQ3NGY4ODYyMGJkODFkNzlmMDM2L3RhYmxlcmFuZ2U6NDI1ZGZiMTQ2ZmU3NDc0Zjg4NjIwYmQ4MWQ3OWYwMzZfNC0zLTEtMS0w_a5468540-b1cc-42a5-b2e9-a36db3208fa0">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i223b2b374fb24a7d8be48fea190eedba_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjQyNWRmYjE0NmZlNzQ3NGY4ODYyMGJkODFkNzlmMDM2L3RhYmxlcmFuZ2U6NDI1ZGZiMTQ2ZmU3NDc0Zjg4NjIwYmQ4MWQ3OWYwMzZfNC03LTEtMS0w_67ab132e-0f94-4c48-b260-cf2501f7b3a0">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b39484540fe4cbc883405fbdd50a2a3_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjQyNWRmYjE0NmZlNzQ3NGY4ODYyMGJkODFkNzlmMDM2L3RhYmxlcmFuZ2U6NDI1ZGZiMTQ2ZmU3NDc0Zjg4NjIwYmQ4MWQ3OWYwMzZfNS0zLTEtMS0w_90322471-88f7-42f6-b7ad-64d3d101e8b4">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b39484540fe4cbc883405fbdd50a2a3_D20210101-20210630" decimals="-6" sign="-" name="bmy:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjQyNWRmYjE0NmZlNzQ3NGY4ODYyMGJkODFkNzlmMDM2L3RhYmxlcmFuZ2U6NDI1ZGZiMTQ2ZmU3NDc0Zjg4NjIwYmQ4MWQ3OWYwMzZfNi0zLTEtMS0w_806be619-d8db-4e1a-8a7a-9c09c4bf4678">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223b2b374fb24a7d8be48fea190eedba_D20200101-20200630" decimals="-6" name="bmy:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjQyNWRmYjE0NmZlNzQ3NGY4ODYyMGJkODFkNzlmMDM2L3RhYmxlcmFuZ2U6NDI1ZGZiMTQ2ZmU3NDc0Zjg4NjIwYmQ4MWQ3OWYwMzZfNi03LTEtMS0w_9857486f-dd31-4a8e-8ef3-fcf22f99ad0e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value as of June 30</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281eaf8778b946efa6523d049bb63601_I20210630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjQyNWRmYjE0NmZlNzQ3NGY4ODYyMGJkODFkNzlmMDM2L3RhYmxlcmFuZ2U6NDI1ZGZiMTQ2ZmU3NDc0Zjg4NjIwYmQ4MWQ3OWYwMzZfNy0xLTEtMS0w_43bf8864-11d3-484b-a914-c984004971fb">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i281eaf8778b946efa6523d049bb63601_I20210630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjQyNWRmYjE0NmZlNzQ3NGY4ODYyMGJkODFkNzlmMDM2L3RhYmxlcmFuZ2U6NDI1ZGZiMTQ2ZmU3NDc0Zjg4NjIwYmQ4MWQ3OWYwMzZfNy0zLTEtMS0w_e9e980f7-84b3-47c3-bcd7-b6084865e26f">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d5fac886ff9468f8c6b82d4defc7d36_I20200630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjQyNWRmYjE0NmZlNzQ3NGY4ODYyMGJkODFkNzlmMDM2L3RhYmxlcmFuZ2U6NDI1ZGZiMTQ2ZmU3NDc0Zjg4NjIwYmQ4MWQ3OWYwMzZfNy03LTEtMS0w_440cc4cf-1011-4f4c-82a8-3dd75bfe1738">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9a7e57643e4c4e44a84f3c40bafee61f" continuedAt="ic0401679c9124f0c8a3779ccec2ce551"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available-for-sale Debt Securities and Equity Investments</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:AvailableForSaleSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTc1OQ_e848bf49-abe7-4fbc-8e06-3b23665f199c" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes available-for-sale debt securities:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.799%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6352735c144034ac2187ca79647025_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfMy0xLTEtMS0w_45ae3b02-8da6-45e0-bf09-479ef2d54caf">1,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6352735c144034ac2187ca79647025_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfMy0zLTEtMS0w_3ddaedf1-ca45-4f9d-a3e8-6096d6e84e30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6352735c144034ac2187ca79647025_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfMy01LTEtMS0w_3d29f6bb-79c5-4e79-b73e-5d774bed9e4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f6352735c144034ac2187ca79647025_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfMy03LTEtMS0w_46c31313-02e1-47c3-8284-2ae1900c2f66">1,591</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fe27ed6226d4cfebeb1acc8eb2bb428_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfMy05LTEtMS0w_181d9cfa-b755-4b1c-9e40-e8e50589e235">1,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fe27ed6226d4cfebeb1acc8eb2bb428_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfMy0xMS0xLTEtMA_d6207b78-f1a3-41da-9e25-e9dea2e25151">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fe27ed6226d4cfebeb1acc8eb2bb428_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfMy0xMy0xLTEtMA_322e116d-5fb6-4346-a853-e735d1bc7d8b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fe27ed6226d4cfebeb1acc8eb2bb428_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfMy0xNS0xLTEtMA_f0c8c1ac-ef83-41c1-a23c-7e35dc8772f7">1,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94c67e9d77694b95b51eb292c0bbabf3_I20210630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNS0xLTEtMS0w_82404bbc-b217-4904-80b3-1972f5ad15bb">490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94c67e9d77694b95b51eb292c0bbabf3_I20210630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNS0zLTEtMS0w_515de4db-09ee-46cb-a8b6-f1833c29d636">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94c67e9d77694b95b51eb292c0bbabf3_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNS01LTEtMS0w_c6346f56-0ca3-4630-a2ab-c92076998eb6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94c67e9d77694b95b51eb292c0bbabf3_I20210630" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNS03LTEtMS0w_9e4e6868-77d8-4077-9efd-c67736ad96db">498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idea685dade76458eab354edd649e002b_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNS05LTEtMS0w_6eaa6fef-6878-4133-b4dd-2bbaeaa4839e">684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idea685dade76458eab354edd649e002b_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNS0xMS0xLTEtMA_ff9ee8c9-9f7a-4260-ba33-101071e7baf0">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idea685dade76458eab354edd649e002b_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNS0xMy0xLTEtMA_6e6b82a2-01ad-4eaf-8305-de99fba34154">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idea685dade76458eab354edd649e002b_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNS0xNS0xLTEtMA_65ed8dc3-09b2-46c2-9311-b905611cefaa">698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale debt securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNi0xLTEtMS0w_90aa5ea4-4431-4e25-b1df-6d482721934f">2,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNi0zLTEtMS0w_c90d3de6-e650-44b1-ba89-748ab7569c69">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNi01LTEtMS0w_5fd772d6-141a-428c-96a5-fe69fea638ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNi03LTEtMS0w_96caa554-f858-4289-b75f-a5b9f0c3d316">2,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNi05LTEtMS0w_5a934acd-2522-494a-8001-db918af7d88c">1,704</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNi0xMS0xLTEtMA_e3230a24-1bbe-4c62-8a59-3564fff60f47">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNi0xMy0xLTEtMA_4af5bebf-4099-453a-aa61-09ad66e98759">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNi0xNS0xLTEtMA_e59802b7-b24c-46a2-9961-3667afd4e8f7">1,718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All marketable debt securities mature within two years as of June&#160;30, 2021 and December&#160;31, 2020.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="bmy:ScheduleOfEquityInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTc2Mg_0edfa005-3c71-4e1e-a661-d65acd363a41" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the carrying amount of equity investments:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments with readily determinable fair values</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmQyNjQ0NDRjNDhhYjRjOThhZDRmZjhkNzg5YTczZTQwL3RhYmxlcmFuZ2U6ZDI2NDQ0NGM0OGFiNGM5OGFkNGZmOGQ3ODlhNzNlNDBfMS0xLTEtMS0w_d74dfdd4-468b-4502-9ed8-df8bceeb3e58">3,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmQyNjQ0NDRjNDhhYjRjOThhZDRmZjhkNzg5YTczZTQwL3RhYmxlcmFuZ2U6ZDI2NDQ0NGM0OGFiNGM5OGFkNGZmOGQ3ODlhNzNlNDBfMS0zLTEtMS0w_450bac33-b96e-44e9-9707-5f494f909e86">3,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmQyNjQ0NDRjNDhhYjRjOThhZDRmZjhkNzg5YTczZTQwL3RhYmxlcmFuZ2U6ZDI2NDQ0NGM0OGFiNGM5OGFkNGZmOGQ3ODlhNzNlNDBfMi0xLTEtMS0w_11062c03-e795-4bb5-827f-137f6d424382">616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmQyNjQ0NDRjNDhhYjRjOThhZDRmZjhkNzg5YTczZTQwL3RhYmxlcmFuZ2U6ZDI2NDQ0NGM0OGFiNGM5OGFkNGZmOGQ3ODlhNzNlNDBfMi0zLTEtMS0w_9d13beb1-e489-417a-a81e-bb7e671772ed">694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49d5fe3c29f447488503ee61f2d0f306_I20210630" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmQyNjQ0NDRjNDhhYjRjOThhZDRmZjhkNzg5YTczZTQwL3RhYmxlcmFuZ2U6ZDI2NDQ0NGM0OGFiNGM5OGFkNGZmOGQ3ODlhNzNlNDBfMy0xLTEtMS0w_b99bd78f-726e-4999-9cc8-2267f9454578">638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d350c2a507842a4a422ebe184b11256_I20201231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmQyNjQ0NDRjNDhhYjRjOThhZDRmZjhkNzg5YTczZTQwL3RhYmxlcmFuZ2U6ZDI2NDQ0NGM0OGFiNGM5OGFkNGZmOGQ3ODlhNzNlNDBfMy0zLTEtMS0w_2b07709e-c1fc-4cab-9030-a780ab4fe49b">549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="bmy:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmQyNjQ0NDRjNDhhYjRjOThhZDRmZjhkNzg5YTczZTQwL3RhYmxlcmFuZ2U6ZDI2NDQ0NGM0OGFiNGM5OGFkNGZmOGQ3ODlhNzNlNDBfNC0xLTEtMS0w_6169ea65-ee38-420a-bb0c-118a3e3faa48">4,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="bmy:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmQyNjQ0NDRjNDhhYjRjOThhZDRmZjhkNzg5YTczZTQwL3RhYmxlcmFuZ2U6ZDI2NDQ0NGM0OGFiNGM5OGFkNGZmOGQ3ODlhNzNlNDBfNC0zLTEtMS0w_32b1312d-31ff-4a3e-9312-cbb4430ebabf">4,695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTczNw_86018c66-6105-47b1-b628-60315e990656" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the activity related to equity investments. Changes in fair value of equity investments are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain/(loss) recognized on equity investments with readily determinable fair values</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfMi0xLTEtMS0w_ee1a5f12-caa7-40be-bb91-13d891d383e3">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfMi0zLTEtMS0w_775c49a2-38e3-4425-b452-675f870734f5">778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfMi01LTEtMS0w_2d59d3b3-258e-4262-8bb8-431e9d99e53d">448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfMi03LTEtMS0w_67aa92bd-26de-4b7d-ae7a-97396c82ae2b">550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized gain/(loss) recognized on equity investments with readily determinable fair value sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfMy0xLTEtMS0w_b2379a6b-5b51-48cb-b377-30e32fa1c186">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfMy0zLTEtMS0w_273c33ca-7b0f-47e6-9d80-5dd8a31e4cf9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfMy01LTEtMS0w_d8b21f73-c3e0-4989-b09e-77133d1e088a">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfMy03LTEtMS0w_a00a7dc5-f8c0-4b75-a760-729efb0448c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upward adjustments on equity investments without readily determinable fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfNS0xLTEtMS0w_a665f001-7cdc-45c2-aa23-4f5474516984">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfNS0zLTEtMS0w_ea1f8ad1-f75e-406e-8f88-0202c4d272ad">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfNS01LTEtMS0w_d0a3d0ff-11ca-4837-8998-5c2ee78c5069">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfNS03LTEtMS0w_e0875e24-957d-49e8-a688-730ed42ecea5">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments and downward adjustments on equity investments without readily determinable fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfNi0xLTEtMS0w_c1518164-dcee-4a88-ac1e-9e7263df762b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfNi0zLTEtMS0w_0e85c5fb-01c2-4020-8a9c-e9c066ec0653">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfNi01LTEtMS0w_72e93da3-65e3-4d16-9e88-2a60d80b9fce">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfNi03LTEtMS0w_d6a0ba24-f2ad-4c7d-b5fe-86269fed172f">202</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative upward adjustments on equity investments without readily determinable fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfOC01LTEtMS0yMDA3_f38f5487-28e5-4264-9351-b9889bf7d112">243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative impairments and downward adjustments on equity investments without readily determinable fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfOS01LTEtMS0yMDA3_78235b54-29f1-4830-bc0a-868cf97f7cc2">142</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Net unrealized net gains on equity investments still held were $<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfMjY0NA_bd1ffd7e-ed12-4ada-8c62-488671299d7b">11</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfMTA5OTUxMTYzNzYwNg_7d8c71e8-8135-4a54-91e3-4e84efc9b287">353</ix:nonFraction> million for the three and six months ended June&#160;30, 2021 and $<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfMTA5OTUxMTYzNzYxNQ_69a513f5-ee41-4a03-942d-7cc9213acba3">778</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfMTA5OTUxMTYzNzYyMg_fc9ee54b-47fc-4c7f-b7d7-4eb56cb88128">550</ix:nonFraction> million for the three and six months ended June&#160;30, 2020, respectively.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Qualifying Hedges and Non-Qualifying Derivatives</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges &#8212; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency forward contracts are used to hedge certain forecasted intercompany inventory purchases and sales transactions and certain foreign currency transactions. The fair value for contracts designated as cash flow hedges are temporarily reported in Accumulated other comprehensive loss and included in earnings when the hedged item affects earnings. The net gain or loss on foreign currency forward contracts is expected to be reclassified to net earnings (primarily included in Cost of products sold and Other (income)/expense, net) within the next 12 months. The notional amount of outstanding foreign currency forward contracts was primarily attributed to the euro of $<ix:nonFraction unitRef="usd" contextRef="i0001595c39db4736ad8e580f9c067231_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfMzQzOA_ed89674c-bc40-4bc3-aa07-f6c47d6076d4">3.1</ix:nonFraction> billion and Japanese yen of $<ix:nonFraction unitRef="usd" contextRef="ia798a6fcbfcc42a0999608b439adcc0c_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfMzQ2MQ_1eaa2bfa-1fbb-406d-b575-f423b2652dd5">1.1</ix:nonFraction> billion at June&#160;30, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The earnings impact related to discontinued cash flow hedges and hedge ineffectiveness was not material during all periods presented. Cash flow hedge accounting is discontinued when the forecasted transaction is no longer probable of occurring within 60 days after the originally forecasted date or when the hedge is no longer effective. Assessments to determine whether derivatives designated as qualifying hedges are highly effective in offsetting changes in the cash flows of hedged items are performed at inception and on a quarterly basis. Foreign currency forward contracts not designated as hedging instruments are used to offset exposures in certain foreign currency denominated assets, liabilities and earnings. Changes in the fair value of these derivatives are recognized in earnings as they occur.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic0401679c9124f0c8a3779ccec2ce551" continuedAt="i4303f8fb768a43278c0d5c394bf56ac1"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS may hedge a portion of its future foreign currency exposure by utilizing a strategy that involves both a purchased local currency put option and a written local currency call option that are accounted for as hedges of future sales denominated in that local currency. Specifically, BMS sells (or writes) a local currency call option and purchases a local currency put option with the same expiration dates and local currency notional amounts but with different strike prices. The premium collected from the sale of the call option is equal to the premium paid for the purchased put option, resulting in no net premium being paid. This combination of transactions is generally referred to as a &#8220;zero-cost collar.&#8221; The expiration dates and notional amounts correspond to the amount and timing of forecasted foreign currency sales. If the U.S. Dollar weakens relative to the currency of the hedged anticipated sales, the purchased put option value reduces to zero and BMS benefits from the increase in the U.S. Dollar equivalent value of our anticipated foreign currency cash flows; however, this benefit would be capped at the strike level of the written call, which forms the upper end of the collar.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Hedges &#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Non-U.S. Dollar borrowings of &#8364;<ix:nonFraction unitRef="eur" contextRef="ib8f2c3191d174bad82233a9c00d673f4_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfNTU0Mg_024ca388-926d-45da-9a26-d26968e57173">950</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="ib8f2c3191d174bad82233a9c00d673f4_I20210630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfNTU0Ng_d8479a66-ecef-4637-9ddc-fd5cd9539a5e">1.1</ix:nonFraction> billion) at June&#160;30, 2021 are designated as net investment hedges to hedge euro currency exposures of the net investment in certain foreign affiliates and are recognized in long-term debt. The effective portion of foreign exchange gain on the remeasurement of euro debt was included in the foreign currency translation component of Accumulated other comprehensive loss with the related offset in long-term debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cross-currency interest rate swap contracts of $<ix:nonFraction unitRef="usd" contextRef="i1a0fef7903e64aceba3bf6ce6985f3f8_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfNTk5MA_c6280224-ed12-42dd-8783-158d0be99c0f">400</ix:nonFraction> million at June&#160;30, 2021 are designated to hedge Japanese yen currency exposure of BMS&#8217;s net investment in its Japan subsidiaries. Contract fair value changes are recorded in the foreign currency translation component of Other Comprehensive Income/(Loss) with a related offset in Other non-current assets or Other non-current liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hedges &#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fixed to floating interest rate swap contracts are designated as fair value hedges and used as an interest rate risk management strategy to create an appropriate balance of fixed and floating rate debt. The contracts and underlying debt for the hedged benchmark risk are recorded at fair value. The effective interest rate for the contracts is one-month LIBOR (<ix:nonFraction unitRef="number" contextRef="i1711123502af4500920896ecd1971e9f_I20210630" decimals="4" name="us-gaap:DerivativeVariableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfNjY5NQ_538ca8ec-7c06-4cbf-b1db-5fcb5d8c1a82">0.10</ix:nonFraction>% as of June&#160;30, 2021) plus an interest rate spread of <ix:nonFraction unitRef="number" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="3" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfNjc0MA_f9e15b44-bdfa-4012-b136-4300c911f698">4.6</ix:nonFraction>%. Gains or losses resulting from changes in fair value of the underlying debt attributable to the hedged benchmark interest rate risk are recorded in interest expense with an associated offset to the carrying value of debt. Since the specific terms and notional amount of the swap are intended to align with the debt being hedged, all changes in fair value of the swap are recorded in interest expense with an associated offset to the derivative asset or liability on the consolidated balance sheet. As a result, there was no net impact in earnings. If the underlying swap is terminated prior to maturity, then the fair value adjustment to the underlying debt is amortized as a reduction to interest expense over the remaining term of the debt.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTczOA_2055c7f0-a3ed-4552-94c6-f4f4afa45e5e" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of outstanding derivatives:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:34.704%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i503baf5ee2d04e92a42c2e74373c367f_I20210630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNC0xLTEtMS0w_7b157dc8-2a4d-43f5-a18b-843ab41575e6">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51131dd320a4460191e1c989fc55992f_I20210630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNC0zLTEtMS0w_cc24b861-4aa8-4dfb-a8a4-068decd75a98">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2128b1046e77449aa3d997f0af1b147f_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNC01LTEtMS0w_37faa980-b28a-4ddd-8a8a-ceedad5158e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51131dd320a4460191e1c989fc55992f_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNC03LTEtMS0w_e737d7fe-ac4c-4d04-b17b-9a8964a6f9c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc20d792e8ad475b8810d5c836c79acb_I20201231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNC05LTEtMS0w_c45f87e0-ac58-422d-a4e8-b42df1c8a855">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia84e2ffbd828434c81d0e6e257c9513f_I20201231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNC0xMS0xLTEtMA_bba65b6a-e544-46e7-9a56-de166599f0b6">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i720683b7e67645e39106e79e4bb6820e_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNC0xMy0xLTEtMA_df29ea90-a92b-4082-9274-4594e5184770">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia84e2ffbd828434c81d0e6e257c9513f_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNC0xNS0xLTEtMA_b3c536fe-05eb-4f1e-8275-2fd2147add84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c833d9f2fd046aabaf2cff398ab0295_I20210630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNS0xLTEtMS0w_d14d525a-ed56-4cd1-ac21-ab82354c6e1f">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9a0e466309e459caa62b42f8c64930f_I20210630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNS0zLTEtMS0w_b5dfa873-5e5c-4a11-9026-46666e354ed9">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbdf809d037e43b7a052e7b6ab343594_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNS01LTEtMS0w_40eba0ec-277c-412b-a0be-66eb347ba9c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9a0e466309e459caa62b42f8c64930f_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNS03LTEtMS0w_654d5a2d-91ef-41d0-b0a2-b85b05b1a800">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d2f391e801c437fa61b6d9d96a8e0b9_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNS05LTEtMS0w_60c02475-9a30-483f-8944-66e0e586f79c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4b905331bfb45eca6d2a44c4ebd6cac_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNS0xMS0xLTEtMA_fe217f6e-c7bb-4131-9687-719d52498f13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i169cfb4fb02c4b9893207821ae8f03d6_I20201231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNS0xMy0xLTEtMA_bbb757d9-0f97-48dc-b145-8ad5ff6a07b3">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib4b905331bfb45eca6d2a44c4ebd6cac_I20201231" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNS0xNS0xLTEtMA_4bfa0595-80cb-4573-a135-44ced7f56e6d">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icaa06a3db7a24003a0dd163a30a2bef2_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNi0xLTEtMS0w_8a485a59-b3ea-4fe3-9c12-9b297d21afe4">3,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b5f2855511343508c746e24df19dd1d_I20210630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNi0zLTEtMS0w_3d078fef-5d5b-4cba-b252-2d6f0cc94cee">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eae85fd04334a66abd5610c6363b26e_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNi01LTEtMS0w_6a47ca76-ad03-402a-a07c-3d7e016d66cb">1,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b5f2855511343508c746e24df19dd1d_I20210630" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNi03LTEtMS0w_4321b1c3-6f5a-4516-ab8c-9282746f4b74">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24cf699361b744ed89ad8d71f69dd889_I20201231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNi05LTEtMS0w_3109688c-e3f4-405d-be00-0e2991c6723d">231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9865149104a462288aa6782497c61f0_I20201231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNi0xMS0xLTEtMA_f8784f08-b300-4ed1-ae9b-02558341a3fd">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e53811b7cb644a29bf23fbcea6510f9_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNi0xMy0xLTEtMA_24041975-f6dc-494a-bac7-e1781fae9024">5,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9865149104a462288aa6782497c61f0_I20201231" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNi0xNS0xLTEtMA_86a73ef5-1696-42b5-86d3-144ad25311b7">259</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87f0786ba2604a61a85c170d713e9a62_I20210630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfOS0xLTEtMS0w_4716678a-ab86-41ad-ab20-69982bfc99dc">932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75483d744b7c4203b5ed365f7d3b3487_I20210630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfOS0zLTEtMS0w_89a22982-2fec-4fb3-83f8-5144fd710c53">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f35f618e55b455cae0cb2a21eedc388_I20210630" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfOS01LTEtMS0w_5a61732b-23e9-4ea5-b5a0-6fd31dd97c7e">531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i75483d744b7c4203b5ed365f7d3b3487_I20210630" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfOS03LTEtMS0w_ef38d30e-5a1f-454f-a9d8-d7e6557beba6">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8954d0e37bc949059fbcfb86b9342723_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfOS05LTEtMS0w_8361fde6-b7d0-44a7-bf19-80d353d0c525">1,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47aba9a8009e43b09b026ddb97e17378_I20201231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfOS0xMS0xLTEtMA_e55f64d3-4e98-4d8d-a0eb-6d50969adb6b">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11a8aa24b66f48fa9bbbfce49c6808f3_I20201231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfOS0xMy0xLTEtMA_e54c1242-37d6-4b86-91ea-a9f2f536892f">336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47aba9a8009e43b09b026ddb97e17378_I20201231" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfOS0xNS0xLTEtMA_cb314eab-e55f-44a3-ae8f-e3a4931713e0">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieba83eb6b5174206bc5a3b89f15c45f9_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfMTEtMS0xLTEtMA_c8de99d5-8aea-435f-a0b6-e20180ce4351">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic978b78a584f466288031da3261d83d1_I20210630" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfMTEtMy0xLTEtMA_f6efad9a-88ed-46d6-ae28-dca249c1ddc0">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1241abc16f54f05b6af70bc4b195625_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfMTEtNS0xLTEtMA_7e2dcca3-6dbb-4f95-8477-c1e6a08e34aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic978b78a584f466288031da3261d83d1_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfMTEtNy0xLTEtMA_4fb47595-3098-47a1-88f7-377ee99e7978">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49e79afcda54470890d42c058ee6dc8c_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfMTEtOS0xLTEtMA_1e2ca919-b8ba-4bc3-ab92-e0f5acd0b4c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6b878c72f514738ab932426ec0acf2a_I20201231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfMTEtMTEtMS0xLTA_33c268e5-604c-4c2d-b72e-021ed0fb5821">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i999b17f195aa48cb93d5044e50370923_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfMTEtMTMtMS0xLTA_05d39c7d-741f-4b8f-b9a7-a99cedce3d1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6b878c72f514738ab932426ec0acf2a_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfMTEtMTUtMS0xLTA_86071b61-d469-436e-a865-c587e084acb5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Included in Other current assets and Other non-current assets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Included in Other current liabilities and Other non-current liabilities.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTc2Mw_ed5c46bd-28dc-429b-818a-c6294d8053f8" continuedAt="i6f88a68edaa946d18812f97029f6b701" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial statement classification and amount of (gain)/loss recognized on hedging instruments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a01cd6e61f342ecb975f4ae6f8d59b1_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmI0ODAxMTFiMTI2NTQxYWI5M2ZlNjhiYTVmMWMyZDJmL3RhYmxlcmFuZ2U6YjQ4MDExMWIxMjY1NDFhYjkzZmU2OGJhNWYxYzJkMmZfMi0xLTEtMS0w_3e1b43e6-b90b-42c7-a5f7-90c158175d28">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e7f71ec07cc4f4c9afc10bc72f6c0e5_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmI0ODAxMTFiMTI2NTQxYWI5M2ZlNjhiYTVmMWMyZDJmL3RhYmxlcmFuZ2U6YjQ4MDExMWIxMjY1NDFhYjkzZmU2OGJhNWYxYzJkMmZfMi0zLTEtMS0w_b7a7b83c-9f71-495b-8b23-4056b2e32c51">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i040292e730b343eb80b604d175386271_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmI0ODAxMTFiMTI2NTQxYWI5M2ZlNjhiYTVmMWMyZDJmL3RhYmxlcmFuZ2U6YjQ4MDExMWIxMjY1NDFhYjkzZmU2OGJhNWYxYzJkMmZfMi01LTEtMS0w_d77776fe-ad0e-4e21-b95b-36a74c4fa994">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35ce00fcc7a44969901d544fba9f7b94_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmI0ODAxMTFiMTI2NTQxYWI5M2ZlNjhiYTVmMWMyZDJmL3RhYmxlcmFuZ2U6YjQ4MDExMWIxMjY1NDFhYjkzZmU2OGJhNWYxYzJkMmZfMi03LTEtMS0w_86326a11-d7b9-4a39-bfc6-8e0a2a961102">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i508f07be751744a09a404b382976e275_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmI0ODAxMTFiMTI2NTQxYWI5M2ZlNjhiYTVmMWMyZDJmL3RhYmxlcmFuZ2U6YjQ4MDExMWIxMjY1NDFhYjkzZmU2OGJhNWYxYzJkMmZfMy0xLTEtMS0w_624ffb64-518f-4192-9678-718d365323c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4696e702fafb4492b4c7d9e523e4af6d_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmI0ODAxMTFiMTI2NTQxYWI5M2ZlNjhiYTVmMWMyZDJmL3RhYmxlcmFuZ2U6YjQ4MDExMWIxMjY1NDFhYjkzZmU2OGJhNWYxYzJkMmZfMy0zLTEtMS0w_4764f549-a818-4cc0-8b54-f862565cc9a5">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7f3a7ad072c43a08ec6727c68cc2efd_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmI0ODAxMTFiMTI2NTQxYWI5M2ZlNjhiYTVmMWMyZDJmL3RhYmxlcmFuZ2U6YjQ4MDExMWIxMjY1NDFhYjkzZmU2OGJhNWYxYzJkMmZfMy01LTEtMS0w_8b845e4b-e6c2-4bb9-9684-c3a89aa1cfc8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id07c76256d36464aa236c8edf59250ae_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmI0ODAxMTFiMTI2NTQxYWI5M2ZlNjhiYTVmMWMyZDJmL3RhYmxlcmFuZ2U6YjQ4MDExMWIxMjY1NDFhYjkzZmU2OGJhNWYxYzJkMmZfMy03LTEtMS0w_db21c030-74aa-4c85-8762-252fb163f9fc">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00823395d1374179823132245b682350_D20210401-20210630" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmI0ODAxMTFiMTI2NTQxYWI5M2ZlNjhiYTVmMWMyZDJmL3RhYmxlcmFuZ2U6YjQ4MDExMWIxMjY1NDFhYjkzZmU2OGJhNWYxYzJkMmZfNC0xLTEtMS0w_010d4e92-b16f-4679-b759-3d013d97ce6b">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf03f7c455ce4b9d89fbb72f7c41488d_D20210401-20210630" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmI0ODAxMTFiMTI2NTQxYWI5M2ZlNjhiYTVmMWMyZDJmL3RhYmxlcmFuZ2U6YjQ4MDExMWIxMjY1NDFhYjkzZmU2OGJhNWYxYzJkMmZfNC0zLTEtMS0w_0ad288f7-430b-4d17-9f52-f70a4638b88e">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed527429005415da9fb10074bfa1097_D20210101-20210630" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmI0ODAxMTFiMTI2NTQxYWI5M2ZlNjhiYTVmMWMyZDJmL3RhYmxlcmFuZ2U6YjQ4MDExMWIxMjY1NDFhYjkzZmU2OGJhNWYxYzJkMmZfNC01LTEtMS0w_48fbb0e7-c176-48ea-93ce-fcf3f37da452">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie95af335802a4c1e92654a4464170a9a_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmI0ODAxMTFiMTI2NTQxYWI5M2ZlNjhiYTVmMWMyZDJmL3RhYmxlcmFuZ2U6YjQ4MDExMWIxMjY1NDFhYjkzZmU2OGJhNWYxYzJkMmZfNC03LTEtMS0w_bf44f3cf-b1f7-4133-80ff-0c43dfa9bf14">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4303f8fb768a43278c0d5c394bf56ac1" continuedAt="ie7663a3b40aa42c3979cfeda45171ae0"><div style="text-align:justify"><ix:continuation id="i6f88a68edaa946d18812f97029f6b701"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d2fe3e02fb94bb984fa1b11e225751c_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfMi0xLTEtMS02MDk_bf37e4b5-4af6-4671-9cc3-1f0c162fdef4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i486c191850aa49a682074690ecb19563_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfMi0zLTEtMS02MTI_a16cfd7e-3a11-46fc-a1a4-63bd54d0f089">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i077b4ec5d45b4aa3a708e5adcef3cb7c_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfMi01LTEtMS02MTU_af0aa673-a26d-489c-b821-c5e0b6ff7046">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6dd4ff55ae1249c1ad68411a97f3e848_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfMi03LTEtMS02MTk_665cfb87-80ca-4322-b008-ab99c82eb655">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i245e38fca4f8467e86cdbf4e1e5cc67b_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfMy0xLTEtMS02MDk_23f05b70-1a4d-4167-9d56-07852afbe981">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i21fe606592d3458e808226e33cf944a6_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfMy0zLTEtMS02MTI_8789f7e3-2b75-48ec-8005-6619991fd18d">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i151fe4a021694b3b93a3419d9cc35d09_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfMy01LTEtMS02MTU_2be69845-2e19-4f6c-b6cf-aefec4aaa9fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieec4fe8c5b2b4a388f9c647f9b3c0879_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfMy03LTEtMS02MTk_3b43219c-f102-4cb6-a95a-a2c00812f3ca">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i229107cac324432f8447407f665ddee5_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfNC0xLTEtMS02MDk_7b5d1dca-78e5-4374-8e62-a16af9b06054">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if631f8e8a60942b4802fe350a6de182a_D20200401-20200630" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfNC0zLTEtMS02MTI_99d0baed-b3cc-46ed-a3b7-a77f01b57cd7">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife8a0faa825047398cc2bc639c58ec3a_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfNC01LTEtMS02MTU_2f5130c4-8368-43e2-874a-fbdd6516a35f">58</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b690964ca6348bc97ef500ba4781adf_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfNC03LTEtMS02MTk_9393ad51-c852-447b-8d05-21ac94e910f8">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency zero-cost collar contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i660d02e3c5404f8c82f9d6bffa9d69a2_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfNS0xLTEtMS02MDk_ce56daa6-24ba-4cd1-8a3f-52180e2abee7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecad268758bf4f57961916a30d5b23bb_D20200401-20200630" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfNS0zLTEtMS02MTI_853ae207-9f81-4a66-ac1d-450f23854021">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49ecccdb7d504e33ad7566e82d10b7af_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfNS01LTEtMS02MTU_addedabf-2dd9-4beb-9775-8e061a9245b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97351a916177459f9564953cbd8db5b7_D20200101-20200630" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfNS03LTEtMS02MTk_cc0876ce-4d80-4124-94c1-fdef17ef7e64">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTc3NA_ae567c36-6f75-4716-94cf-abe40b7eb9e2" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effect of derivative and non-derivative instruments designated as hedging instruments in Other Comprehensive Income/(Loss):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts gain/(loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income/(Loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7532fb922404416bf6c1a4f59828fc3_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfNC0xLTEtMS0w_2c2c90b5-6abc-4f91-8c99-4afe5a21a2e7">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a94a414c588439da957589012a52bce_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfNC0zLTEtMS0w_f651b90a-b98b-49ba-b127-67787947c910">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b8a19e9be6947c29fae71035f799b8b_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfNC01LTEtMS0w_1156cf70-4938-47cf-8f33-cc22ced84aba">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9967a3c6dc845d9ac2ae782bd268a81_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfNC03LTEtMS0w_130e4035-2f0d-42c6-ac74-403f82686e42">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00823395d1374179823132245b682350_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfNS0xLTEtMS0w_b6f5ebf8-8a94-4a20-8d17-2958be6fbaa8">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i229107cac324432f8447407f665ddee5_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfNS0zLTEtMS0w_377407db-b141-4d44-9a3b-bcd13301dcfd">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed527429005415da9fb10074bfa1097_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfNS01LTEtMS0w_015789b4-6360-48c6-85c1-c0d717e8b227">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife8a0faa825047398cc2bc639c58ec3a_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfNS03LTEtMS0w_20245747-6962-4b97-9930-066b1ce5ac2a">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives qualifying as net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts gain:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income/(Loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i907aadccc2844fa8b86616d86e1395f8_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfMTItMS0xLTEtMA_2d5a8b2f-ff48-4bf9-b380-7ebbb1f6e338">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d7cbfcfe0e044538ff7a63b3ad018c3_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfMTItMy0xLTEtMA_1186681c-efcc-4eca-bf96-3da3269f8fd3">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85dd208285f94cd6aff62add53ee5706_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfMTItNS0xLTEtMA_48b7129b-8adf-459f-bb92-d85eb9149323">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47b91d980e0a450fa568fc15b6e2b9b0_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfMTItNy0xLTEtMA_942d220c-c179-484f-9016-c1aaef5f7a10">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-derivatives qualifying as net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. dollar borrowings gain:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income/(Loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f3f06024f654b51b3f6b0bca6aaa058_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfMTYtMS0xLTEtMA_834d233e-a947-42a5-8d19-00853ea06fa1">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5604822aa0b342079d2242f61089bf43_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfMTYtMy0xLTEtMA_4c7b313f-f5e2-4470-bb4e-0d837705b4eb">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a7cece24b0c44179822ebe709140263_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfMTYtNS0xLTEtMA_d84a674f-a607-44ae-88d0-54952aee50bc">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7daf934932b4999a9e8c82bfe559ddf_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfMTYtNy0xLTEtMA_f208fb50-ac4b-4120-86ad-99488cc0349b">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The majority is expected to be reclassified into earnings in the next 12 months.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Obligations</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:ScheduleOfShortTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTc4Nw_f0c7f847-c0aa-4a45-be76-9b03e68f5f2b" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term debt obligations include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. short-term borrowings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:ShortTermBankLoansAndNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjllMzA0ZmY5NmU2ODQ4Mjk4MGE1ZWRjNDc1OTE0YTRmL3RhYmxlcmFuZ2U6OWUzMDRmZjk2ZTY4NDgyOTgwYTVlZGM0NzU5MTRhNGZfMS0xLTEtMS0w_6fea31e4-ed14-41c1-8144-6a182d92042b">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:ShortTermBankLoansAndNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjllMzA0ZmY5NmU2ODQ4Mjk4MGE1ZWRjNDc1OTE0YTRmL3RhYmxlcmFuZ2U6OWUzMDRmZjk2ZTY4NDgyOTgwYTVlZGM0NzU5MTRhNGZfMS0zLTEtMS0w_889b5399-5bae-4c36-aff4-51dd9c10577b">176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjllMzA0ZmY5NmU2ODQ4Mjk4MGE1ZWRjNDc1OTE0YTRmL3RhYmxlcmFuZ2U6OWUzMDRmZjk2ZTY4NDgyOTgwYTVlZGM0NzU5MTRhNGZfMi0xLTEtMS0w_5a937dcd-cae5-41ea-9187-d145ee34c464">2,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjllMzA0ZmY5NmU2ODQ4Mjk4MGE1ZWRjNDc1OTE0YTRmL3RhYmxlcmFuZ2U6OWUzMDRmZjk2ZTY4NDgyOTgwYTVlZGM0NzU5MTRhNGZfMi0zLTEtMS0w_65ffed4f-f500-4541-a191-121ac9987497">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:OtherShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjllMzA0ZmY5NmU2ODQ4Mjk4MGE1ZWRjNDc1OTE0YTRmL3RhYmxlcmFuZ2U6OWUzMDRmZjk2ZTY4NDgyOTgwYTVlZGM0NzU5MTRhNGZfMy0xLTEtMS0w_00bfe6b8-50c3-4f3f-b0bc-062e988c6c75">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:OtherShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjllMzA0ZmY5NmU2ODQ4Mjk4MGE1ZWRjNDc1OTE0YTRmL3RhYmxlcmFuZ2U6OWUzMDRmZjk2ZTY4NDgyOTgwYTVlZGM0NzU5MTRhNGZfMy0zLTEtMS0w_51a785bb-103a-4093-b6d1-dc23f7d44eaa">164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjllMzA0ZmY5NmU2ODQ4Mjk4MGE1ZWRjNDc1OTE0YTRmL3RhYmxlcmFuZ2U6OWUzMDRmZjk2ZTY4NDgyOTgwYTVlZGM0NzU5MTRhNGZfNC0xLTEtMS0w_1875758e-edbf-4ffc-8ed5-eb01a9f6bb8d">2,655</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjllMzA0ZmY5NmU2ODQ4Mjk4MGE1ZWRjNDc1OTE0YTRmL3RhYmxlcmFuZ2U6OWUzMDRmZjk2ZTY4NDgyOTgwYTVlZGM0NzU5MTRhNGZfNC0zLTEtMS0w_4e5a7ee5-2c68-401f-b5d3-76e879415cd9">2,340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTcxNA_4fb2252c-8470-4a65-abc1-15a37c024ced" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt and the current portion of long-term debt include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfMS0xLTEtMS0w_43883987-89a1-41e6-97c7-25d8a745d7bb">43,666</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfMS0zLTEtMS0w_81cb07ed-b4fe-4f97-a416-c4c07afb956a">48,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to Principal Value:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i836ec8a900f94ab2a0cd3662c33ba2d1_I20210630" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfNC0xLTEtMS0w_772c72bb-dc51-4c00-8873-342ec4c71eb0">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i816b15b9810f468d87ef913a5c6b3461_I20201231" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfNC0zLTEtMS0w_a629198f-fc4b-4495-9ffc-77ec56fa4d63">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized basis adjustment from swap terminations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="bmy:UnamortizedBasisAdjustmentFromSwapTerminations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfNS0xLTEtMS0w_5970bf61-b3b6-4747-9977-39746756d6f6">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="bmy:UnamortizedBasisAdjustmentFromSwapTerminations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfNS0zLTEtMS0w_4e94f87e-e31f-42c7-b116-2065e25073cc">149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized bond discounts and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfNi0xLTEtMS0w_9a008a4e-51dd-401a-af4d-39e6e5a42376">279</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfNi0zLTEtMS0w_3f91b3fb-3666-459d-abc4-1a21d6a4b367">303</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized purchase price adjustments of Celgene debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfNy0xLTEtMS0w_a2164a8b-2acf-41bb-a7ff-d4f0279daa79">1,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfNy0zLTEtMS0w_c004a2e6-e8b1-45c9-b067-fca7b7979db1">1,755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfOC0xLTEtMS0w_57920864-7629-43a2-b80c-debc8e44899f">45,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfOC0zLTEtMS0w_4a70a8b9-f47c-481c-9df5-5d5ee585915d">50,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfMTAtMS0xLTEtMA_863d8e25-41ab-4f55-b97e-f6aac7554340">2,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfMTAtMy0xLTEtMA_def720c6-ffbe-42ff-a2de-c2cd4c74c558">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfMTEtMS0xLTEtMA_3c47cf6f-d7bc-403d-a4aa-f5b3cf07f226">42,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfMTEtMy0xLTEtMA_d096aa7c-8d8d-44a1-86ab-0232da4d13d1">48,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfMTItMS0xLTEtMA_99164458-72f1-49bf-82f8-2c5f172afa6f">45,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfMTItMy0xLTEtMA_2b2d6c0d-04da-4986-9701-01f83b4ee3e0">50,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of long-term debt was $<ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfODI1NA_49500257-39b6-4be8-b2b3-2c4fafcd08b6">50.6</ix:nonFraction> billion at June&#160;30, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfODI2Nw_883e3d51-afde-4a28-8b68-4bb6d4affd95">58.5</ix:nonFraction> billion at December&#160;31, 2020 valued using Level&#160;2 inputs, which are based upon the quoted market prices for the same or similar debt instruments. The fair value of short-term borrowings approximates the carrying value due to the short maturities of the debt instruments. </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ie7663a3b40aa42c3979cfeda45171ae0"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, BMS purchased aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfODYwNg_46dac7f7-5459-4b97-a1d5-f982f00b7733">3.5</ix:nonFraction>&#160;billion of certain of its debt securities for approximately $<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfODY2MQ_d32110c6-5d99-4b83-896f-ac625a6159dd">4.0</ix:nonFraction>&#160;billion of cash in a series of tender offers and &#8220;make whole&#8221; redemptions. In connection with these transactions, a $<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfODc3Mg_21f2c3b9-b6ac-4f89-833c-c1da5ea0fe3b">281</ix:nonFraction>&#160;million loss on debt redemption was recognized based on the carrying value of the debt and included in Other (income)/expense, net. In addition, the $<ix:nonFraction unitRef="usd" contextRef="ib87554b0ae72494ba6568a952ddc9510_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfODkxNg_62d348ea-3914-4fbc-84dd-70a936c3963b">500</ix:nonFraction>&#160;million 2.875% Notes matured and were repaid.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2021, the $<ix:nonFraction unitRef="usd" contextRef="i18088008a5b7409bb866ff840040d19a_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfMjE5OTAyMzI2NjY3OA_66d52076-5bc9-4550-9d67-176a1035ba91">1.0</ix:nonFraction>&#160;billion 2.550% Notes matured and were repaid.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest payments were $<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfODk4MQ_3e5626ec-cb1d-4ae1-82d5-4dbf2b22b6fe">807</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfODk4OA_158353e1-454b-4d99-928d-c44f656f1bb1">845</ix:nonFraction> million for the six months ended June 30, 2021 and 2020, respectively, net of amounts related to interest rate swap contracts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, BMS had <ix:nonFraction unitRef="number" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="0" format="ixt-sec:numwordsen" name="bmy:NumberofRevolvingCreditFacilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTA5OQ_828d43e1-f2f2-466c-84ab-6455a7bcef6f">four</ix:nonFraction> separate revolving credit facilities totaling $<ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTE0OA_c044e8b2-7887-495e-8aca-206be7de98e3">6.0</ix:nonFraction>&#160;billion, which consisted of a 364-day $<ix:nonFraction unitRef="usd" contextRef="i643fc6ba1c2a4f778dbb32207ff363ed_I20210630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTE4MQ_c4e960a0-2fb1-4973-85e5-20f11885a137">2.0</ix:nonFraction>&#160;billion facility expiring in January 2022, a three-year $<ix:nonFraction unitRef="usd" contextRef="i3d62c55572e74536af7ed82dceb0ea9d_I20210630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTIzMg_84df0275-c215-4d8b-8fae-dc294f97aed8">1.0</ix:nonFraction>&#160;billion facility expiring in January 2022 and two five-year $<ix:nonFraction unitRef="usd" contextRef="i48e73501dc964ac8b84b67b3240d49b3_I20210630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTI4Nw_5c507fbf-5167-41a9-b3ff-b024cef50974">1.5</ix:nonFraction>&#160;billion facilities that were extended to September 2025 and July 2026, respectively. The facilities provide for customary terms and conditions with no financial covenants and may be used to provide backup liquidity for BMS&#8217;s commercial paper borrowings and are extendable annually by one year on the anniversary date with the consent of the lenders. No borrowings were outstanding under any revolving credit facility at June&#160;30, 2021 or December&#160;31, 2020.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_64"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10. <ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RleHRyZWdpb246NzlmYjIxMjAzZTAyNDJiOWE3OTBjYjAwNTdiODRjODhfMjgy_ddc26e55-59ff-4978-aee9-15b1a94d0b1a" continuedAt="if97a9c82eda04a21b47ef96bccaa5f2d" escape="true">RECEIVABLES</ix:nonNumeric></span></div><ix:continuation id="if97a9c82eda04a21b47ef96bccaa5f2d"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RleHRyZWdpb246NzlmYjIxMjAzZTAyNDJiOWE3OTBjYjAwNTdiODRjODhfMjgx_059c3ad9-c969-45ef-8019-107ab0b25ad0" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableGrossCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RhYmxlOjk2ODIyODUxNmMyZjQ1YjA4NzU5YWRlNTIyYjU2OThlL3RhYmxlcmFuZ2U6OTY4MjI4NTE2YzJmNDViMDg3NTlhZGU1MjJiNTY5OGVfMS0xLTEtMS0w_aa822b36-4176-48df-aa3f-b757e0013d59">8,309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableGrossCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RhYmxlOjk2ODIyODUxNmMyZjQ1YjA4NzU5YWRlNTIyYjU2OThlL3RhYmxlcmFuZ2U6OTY4MjI4NTE2YzJmNDViMDg3NTlhZGU1MjJiNTY5OGVfMS0zLTEtMS0w_ae5322c4-6581-46a3-989b-c9fb716d62ec">7,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="bmy:CashDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RhYmxlOjk2ODIyODUxNmMyZjQ1YjA4NzU5YWRlNTIyYjU2OThlL3RhYmxlcmFuZ2U6OTY4MjI4NTE2YzJmNDViMDg3NTlhZGU1MjJiNTY5OGVfMi0xLTEtMS0w_eef2afb4-b6a6-4f76-8605-36ec460d3b1d">569</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="bmy:CashDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RhYmxlOjk2ODIyODUxNmMyZjQ1YjA4NzU5YWRlNTIyYjU2OThlL3RhYmxlcmFuZ2U6OTY4MjI4NTE2YzJmNDViMDg3NTlhZGU1MjJiNTY5OGVfMi0zLTEtMS0w_c471aa18-372a-4d1c-aced-cb8861b48f40">645</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less allowance for expected credit loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RhYmxlOjk2ODIyODUxNmMyZjQ1YjA4NzU5YWRlNTIyYjU2OThlL3RhYmxlcmFuZ2U6OTY4MjI4NTE2YzJmNDViMDg3NTlhZGU1MjJiNTY5OGVfMy0xLTEtMS0w_a792d2cc-1f6a-4e8d-8ba7-914ae6690dba">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RhYmxlOjk2ODIyODUxNmMyZjQ1YjA4NzU5YWRlNTIyYjU2OThlL3RhYmxlcmFuZ2U6OTY4MjI4NTE2YzJmNDViMDg3NTlhZGU1MjJiNTY5OGVfMy0zLTEtMS0w_e07ebccc-4ffb-462b-abc6-91b93d38bc1b">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net trade receivables</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RhYmxlOjk2ODIyODUxNmMyZjQ1YjA4NzU5YWRlNTIyYjU2OThlL3RhYmxlcmFuZ2U6OTY4MjI4NTE2YzJmNDViMDg3NTlhZGU1MjJiNTY5OGVfNC0xLTEtMS0w_4b794121-f86b-4c40-8104-227ad6bb198e">7,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RhYmxlOjk2ODIyODUxNmMyZjQ1YjA4NzU5YWRlNTIyYjU2OThlL3RhYmxlcmFuZ2U6OTY4MjI4NTE2YzJmNDViMDg3NTlhZGU1MjJiNTY5OGVfNC0zLTEtMS0w_665b3fb2-b47e-4cb6-b4b3-37fa20255746">7,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance, royalties, VAT and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RhYmxlOjk2ODIyODUxNmMyZjQ1YjA4NzU5YWRlNTIyYjU2OThlL3RhYmxlcmFuZ2U6OTY4MjI4NTE2YzJmNDViMDg3NTlhZGU1MjJiNTY5OGVfNS0xLTEtMS0w_db32a00f-b6f3-45ac-8303-e1c862d21c38">1,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RhYmxlOjk2ODIyODUxNmMyZjQ1YjA4NzU5YWRlNTIyYjU2OThlL3RhYmxlcmFuZ2U6OTY4MjI4NTE2YzJmNDViMDg3NTlhZGU1MjJiNTY5OGVfNS0zLTEtMS0w_f3e209ff-8a71-469c-8412-321e49ae2bdd">1,282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RhYmxlOjk2ODIyODUxNmMyZjQ1YjA4NzU5YWRlNTIyYjU2OThlL3RhYmxlcmFuZ2U6OTY4MjI4NTE2YzJmNDViMDg3NTlhZGU1MjJiNTY5OGVfNi0xLTEtMS0w_4c749f0a-269c-43df-8240-20d57b86dbd0">9,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RhYmxlOjk2ODIyODUxNmMyZjQ1YjA4NzU5YWRlNTIyYjU2OThlL3RhYmxlcmFuZ2U6OTY4MjI4NTE2YzJmNDViMDg3NTlhZGU1MjJiNTY5OGVfNi0zLTEtMS0w_d4c53e65-a3da-46bd-bb38-73a443e6fea4">8,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-U.S. receivables sold on a nonrecourse basis were $<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="bmy:ReceivablesSoldOnNonrecourseBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RleHRyZWdpb246NzlmYjIxMjAzZTAyNDJiOWE3OTBjYjAwNTdiODRjODhfODQ_367314e0-36a8-4a82-b831-1e5ef9406b16">638</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="bmy:ReceivablesSoldOnNonrecourseBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RleHRyZWdpb246NzlmYjIxMjAzZTAyNDJiOWE3OTBjYjAwNTdiODRjODhfOTE_5e3677f6-ed02-46de-b675-3a49ccb88a2f">464</ix:nonFraction> million for the six months ended June 30, 2021 and 2020, respectively. Receivables from the <ix:nonFraction unitRef="number" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="0" format="ixt-sec:numwordsen" name="bmy:NumberOfLargestPharmaceuticalWholesalers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RleHRyZWdpb246NzlmYjIxMjAzZTAyNDJiOWE3OTBjYjAwNTdiODRjODhfMTQ4_d0cd705b-04e6-46be-b51d-183e2613956a">three</ix:nonFraction> largest customers in the U.S. represented approximately <ix:nonFraction unitRef="number" contextRef="i85e0ac7571b54abf896103b5b9c3df12_I20210630" decimals="2" name="bmy:PercentageOfAggregateTotalTradeReceivablesDue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RleHRyZWdpb246NzlmYjIxMjAzZTAyNDJiOWE3OTBjYjAwNTdiODRjODhfMjA3_c501a82b-de7b-4ffa-bdfe-5e55bb81f313">58</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i7913fb01092e4ed1a1dc7490f44c3094_I20201231" decimals="2" name="bmy:PercentageOfAggregateTotalTradeReceivablesDue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RleHRyZWdpb246NzlmYjIxMjAzZTAyNDJiOWE3OTBjYjAwNTdiODRjODhfMjE0_b4656099-5bbd-4a97-a307-5777661fc0ce">56</ix:nonFraction>% of total trade receivables at June&#160;30, 2021 and December&#160;31, 2020, respectively.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_67"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11. <ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RleHRyZWdpb246OTk5MmNhNWZiMTM3NGRhODk4YmZmMmQyNDk4MjY3YjFfMjUx_7d8a1d3b-77aa-41b3-bb36-b4e6d9693337" continuedAt="ie4bc97f9487c46b08aaf568a451004c2" escape="true">INVENTORIES</ix:nonNumeric></span></div><ix:continuation id="ie4bc97f9487c46b08aaf568a451004c2"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RleHRyZWdpb246OTk5MmNhNWZiMTM3NGRhODk4YmZmMmQyNDk4MjY3YjFfMjU3_02d052bb-1a18-44a1-9bca-0cb89dabd4a3" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RhYmxlOjlhMmEyNmFlYzlkZTRiM2Q4M2ExZGNhYmEyOTU0MzZiL3RhYmxlcmFuZ2U6OWEyYTI2YWVjOWRlNGIzZDgzYTFkY2FiYTI5NTQzNmJfMS0xLTEtMS0w_ae5d1f93-4456-4ce1-8242-d73442b2b466">891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RhYmxlOjlhMmEyNmFlYzlkZTRiM2Q4M2ExZGNhYmEyOTU0MzZiL3RhYmxlcmFuZ2U6OWEyYTI2YWVjOWRlNGIzZDgzYTFkY2FiYTI5NTQzNmJfMS0zLTEtMS0w_5b0100fc-125d-46e6-8cd4-0f08bcdebb24">932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RhYmxlOjlhMmEyNmFlYzlkZTRiM2Q4M2ExZGNhYmEyOTU0MzZiL3RhYmxlcmFuZ2U6OWEyYTI2YWVjOWRlNGIzZDgzYTFkY2FiYTI5NTQzNmJfMi0xLTEtMS0w_e22bc4c6-1dea-4961-a5b4-01b8de7330ea">1,852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RhYmxlOjlhMmEyNmFlYzlkZTRiM2Q4M2ExZGNhYmEyOTU0MzZiL3RhYmxlcmFuZ2U6OWEyYTI2YWVjOWRlNGIzZDgzYTFkY2FiYTI5NTQzNmJfMi0zLTEtMS0w_527a2b20-d948-437a-a54d-56111cfaa617">2,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw and packaging materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RhYmxlOjlhMmEyNmFlYzlkZTRiM2Q4M2ExZGNhYmEyOTU0MzZiL3RhYmxlcmFuZ2U6OWEyYTI2YWVjOWRlNGIzZDgzYTFkY2FiYTI5NTQzNmJfMy0xLTEtMS0w_935d93f0-92c3-4a30-b6e4-b5f0841fd0c5">270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RhYmxlOjlhMmEyNmFlYzlkZTRiM2Q4M2ExZGNhYmEyOTU0MzZiL3RhYmxlcmFuZ2U6OWEyYTI2YWVjOWRlNGIzZDgzYTFkY2FiYTI5NTQzNmJfMy0zLTEtMS0w_b3336f24-8bd4-4895-8596-cfd3d22a45a2">207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="bmy:Totalinventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RhYmxlOjlhMmEyNmFlYzlkZTRiM2Q4M2ExZGNhYmEyOTU0MzZiL3RhYmxlcmFuZ2U6OWEyYTI2YWVjOWRlNGIzZDgzYTFkY2FiYTI5NTQzNmJfNC0xLTEtMS0w_6db8076a-08e6-4735-aaae-eaacadb70c60">3,013</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="bmy:Totalinventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RhYmxlOjlhMmEyNmFlYzlkZTRiM2Q4M2ExZGNhYmEyOTU0MzZiL3RhYmxlcmFuZ2U6OWEyYTI2YWVjOWRlNGIzZDgzYTFkY2FiYTI5NTQzNmJfNC0zLTEtMS0w_ecdfa645-dc87-444b-a49b-b5271d0a7a12">3,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RhYmxlOjlhMmEyNmFlYzlkZTRiM2Q4M2ExZGNhYmEyOTU0MzZiL3RhYmxlcmFuZ2U6OWEyYTI2YWVjOWRlNGIzZDgzYTFkY2FiYTI5NTQzNmJfNi0xLTEtMS0w_032f8c46-2853-41e4-b1d8-67521bf5d361">2,137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RhYmxlOjlhMmEyNmFlYzlkZTRiM2Q4M2ExZGNhYmEyOTU0MzZiL3RhYmxlcmFuZ2U6OWEyYTI2YWVjOWRlNGIzZDgzYTFkY2FiYTI5NTQzNmJfNi0zLTEtMS0w_f3584fa6-fa80-4900-8d26-c74c75b0cdd7">2,074</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RhYmxlOjlhMmEyNmFlYzlkZTRiM2Q4M2ExZGNhYmEyOTU0MzZiL3RhYmxlcmFuZ2U6OWEyYTI2YWVjOWRlNGIzZDgzYTFkY2FiYTI5NTQzNmJfNy0xLTEtMS0w_a1702756-d193-4141-9c16-89c80c7a7db7">876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RhYmxlOjlhMmEyNmFlYzlkZTRiM2Q4M2ExZGNhYmEyOTU0MzZiL3RhYmxlcmFuZ2U6OWEyYTI2YWVjOWRlNGIzZDgzYTFkY2FiYTI5NTQzNmJfNy0zLTEtMS0w_95ee907f-bb72-4d6e-a82a-f59c1fed2b1a">1,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total inventories include fair value adjustments resulting from the Celgene acquisition of $<ix:nonFraction unitRef="usd" contextRef="i930ff8105ccb4bfdb0a95257468399ad_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RleHRyZWdpb246OTk5MmNhNWZiMTM3NGRhODk4YmZmMmQyNDk4MjY3YjFfMTIx_6e1f10c1-dec4-4455-bef4-ddc48256aa15">606</ix:nonFraction> million at June&#160;30, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i4d1422bf6081497aa35d71735c851dc2_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RleHRyZWdpb246OTk5MmNhNWZiMTM3NGRhODk4YmZmMmQyNDk4MjY3YjFfMTM0_361f835f-dda4-46a9-8028-cd6e159eb0c7">774</ix:nonFraction> million at December&#160;31, 2020. Other non-current assets include inventory expected to remain on hand beyond one year in both periods.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="id66f4ecc89aa45bca7756420c60966f5_70"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12. <ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RleHRyZWdpb246Nzg1ZDYwODI3NWJhNGFhYTgyOTMxN2UwMWEwZmExZTBfMTI4_716bb957-74e6-42f8-8fab-ef82bed7c561" continuedAt="i65f4c443350646b2af3c870a9737b38d" escape="true">PROPERTY, PLANT AND EQUIPMENT</ix:nonNumeric></span></div><ix:continuation id="i65f4c443350646b2af3c870a9737b38d"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RleHRyZWdpb246Nzg1ZDYwODI3NWJhNGFhYTgyOTMxN2UwMWEwZmExZTBfMTI1_7b1e2761-0069-4a76-a6ac-557a4b97131f" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfMS0xLTEtMS0w_9667b99e-7978-403c-828f-34daf3d6ca7b">169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfMS0zLTEtMS0w_9db7d592-b837-454a-9502-09df6eae74ec">189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfMi0xLTEtMS0w_5af97e6b-2308-4656-a5e5-0ece1d4e2853">5,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfMi0zLTEtMS0w_281e5799-2b3b-43ea-89d0-5698d00a12f6">5,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MachineryAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfMy0xLTEtMS0w_a58c17d3-4595-4a94-805c-b2737472a91a">3,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MachineryAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfMy0zLTEtMS0w_bef35ec6-e5a0-4f47-81f6-0de72df21366">3,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfNC0xLTEtMS0w_4a71e81d-e115-404b-b633-ba4f8ad0cea1">565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfNC0zLTEtMS0w_aee3ddd0-23e0-478c-b8c2-68b610558e30">487</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfNS0xLTEtMS0w_fb52ea7b-d0fc-4b32-81fa-abca70907840">9,633</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfNS0zLTEtMS0w_ec261b92-4826-403d-96bf-71a9772372b3">9,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfNi0xLTEtMS0w_9a32b891-20b4-4e22-bbee-f80d4382e1de">3,838</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfNi0zLTEtMS0w_17744ce5-f717-4920-88d9-6f11ba54da14">3,585</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfNy0xLTEtMS0w_bfc4062e-27d4-4523-84ce-0ef643d1b438">5,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfNy0zLTEtMS0w_045faca5-4f7c-4ecf-8107-dc9004245a28">5,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RleHRyZWdpb246Nzg1ZDYwODI3NWJhNGFhYTgyOTMxN2UwMWEwZmExZTBfNzM_b264ed55-5cd1-4ee5-ab52-0c274cea10b7">143</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RleHRyZWdpb246Nzg1ZDYwODI3NWJhNGFhYTgyOTMxN2UwMWEwZmExZTBfMTA5OTUxMTYyNzk1Mw_1901405e-1b08-4aa4-82c5-2eafe25f1b1e">278</ix:nonFraction> million for the three and six months ended June&#160;30, 2021 and $<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RleHRyZWdpb246Nzg1ZDYwODI3NWJhNGFhYTgyOTMxN2UwMWEwZmExZTBfMTA5OTUxMTYyNzkxNw_71072c84-cf0c-40a7-ae32-a2cd75685388">145</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RleHRyZWdpb246Nzg1ZDYwODI3NWJhNGFhYTgyOTMxN2UwMWEwZmExZTBfMTA5OTUxMTYyNzkzMA_30e50537-3d2c-45a5-9b8d-7c4b615ffe6d">315</ix:nonFraction> million for the three and six months ended June&#160;30, 2020, respectively.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_76"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 13. <ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RleHRyZWdpb246ZGM0YWE3MzhkNWQzNGU3NDg2NWE5NjJmNjM5NDFmODVfODQy_18c3e03e-dba7-4bf3-b0f9-436b1456b468" continuedAt="i3ffd6765663c4e70acd5f5ed051f9330" escape="true">GOODWILL AND OTHER INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="i3ffd6765663c4e70acd5f5ed051f9330"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RleHRyZWdpb246ZGM0YWE3MzhkNWQzNGU3NDg2NWE5NjJmNjM5NDFmODVfODMx_350f55ef-99ce-418b-9ca5-3f644620e526" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:62.460%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.586%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Lives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfMS0zLTEtMS0w_e5f3787a-b5b3-4e0c-bf23-df3e117e868d">20,529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfMS01LTEtMS0w_9ee18329-c19b-4abd-a430-3714653b4674">20,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i63f5d7d2d5cf421986ebe6aec3d0d063_D20210101-20210630" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNC0xLTEtMS0wL3RleHRyZWdpb246ZjdjYzE0MDU3ZDQ2NDVjNWE4ZmM0ODA5YWYwY2FmMTBfNA_10e9a543-117e-4bc4-852e-be08d20c16c5">5</ix:nonNumeric>&#160;&#8211;&#160;<ix:nonNumeric contextRef="if78324cfda1641a185f98458b48b3ecb_D20210101-20210630" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNC0xLTEtMS0wL3RleHRyZWdpb246ZjdjYzE0MDU3ZDQ2NDVjNWE4ZmM0ODA5YWYwY2FmMTBfOQ_76bc5d03-a405-43ce-8b25-7dcc8a120957">15</ix:nonNumeric>&#160;years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc8f651960ff49fb8e4847dbc3db39c8_I20210630" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNC0zLTEtMS0w_f2222419-8a6c-42ad-85a1-5e2fe30e51a9">327</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a2b2474f0d2424ba498502d3afdf9ac_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNC01LTEtMS0w_1d3a20f8-222f-4731-91c2-825948bca7ab">328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired marketed product rights</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5d8e439af78d4f5092229ec245f1b0a5_D20210101-20210630" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNS0xLTEtMS0wL3RleHRyZWdpb246NTUzZTYwYzk5YjNjNGNhODg4Nzk4NWNlZDVhMzVlYWVfNA_b4474111-1f52-4aa8-9aa7-176afb3d985f">3</ix:nonNumeric>&#160;&#8211;&#160;<ix:nonNumeric contextRef="i626ddd6ff5464b57a8e4e7c44e82a64a_D20210101-20210630" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNS0xLTEtMS0wL3RleHRyZWdpb246NTUzZTYwYzk5YjNjNGNhODg4Nzk4NWNlZDVhMzVlYWVfOQ_c84a4a7d-7e3b-4c9c-b1dc-caba1d50511b">15</ix:nonNumeric>&#160;years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i102ed3efbe22488096250a07cec1ae7c_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNS0zLTEtMS0w_0441a409-ba2e-4415-9c50-abcfc9a72516">60,712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic566d16d5a584f8ba82df664242cf607_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNS01LTEtMS0w_172271bc-7b0c-483f-b942-f78ed14228ce">59,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5e217c9f1d8b4cc69ebcdebb33546c57_D20210101-20210630" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNi0xLTEtMS0wL3RleHRyZWdpb246MGVjZTg1YmNhY2M2NGI0MDhlMzQ3OWQxOGUzMTA1Y2RfNA_0ee70999-5019-4dcb-b698-4a1489ea4179">3</ix:nonNumeric>&#160;&#8211;&#160;<ix:nonNumeric contextRef="i56178daf0b264e019ba2dccbd26473ad_D20210101-20210630" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNi0xLTEtMS0wL3RleHRyZWdpb246MGVjZTg1YmNhY2M2NGI0MDhlMzQ3OWQxOGUzMTA1Y2RfOQ_0983f3ae-2c67-479a-9a7c-f598ab0443c9">10</ix:nonNumeric>&#160;years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i815f8cb9efb94a46b64a44a73c8875bc_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNi0zLTEtMS0w_10ad6c31-52d5-4332-aff5-23c726e52ef5">1,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cef45113fe040d78e64dcc2d006f97b_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNi01LTEtMS0w_2a064ca5-4ee1-4e6f-98c6-d06496b3a96a">1,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPRD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d6ab1d8fecd41948785ff0b6c9a68b3_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNy0zLTEtMS0w_2b1ccf41-6d58-438b-9a90-4580b7604c80">4,360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i290ccdb912fe48f08d595add1473c16b_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNy01LTEtMS0w_bd8559df-e92b-4ee7-b6b7-80a5d2ec5a32">6,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfOC0zLTEtMS0w_e2d04002-e69d-49cb-89d3-1263982a4d6a">66,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfOC01LTEtMS0w_72ae9013-1fbe-49cd-b17c-db5a8d421e39">66,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfOS0zLTEtMS0w_f93dbda3-e0c5-4b84-afe0-c05800dacccd">18,739</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfOS01LTEtMS0w_d3d3a1a4-ca27-4621-ae2a-889f11e6beff">13,616</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfMTAtMy0xLTEtMA_d6d84ea2-fc03-4c5d-ba37-6350ad33046f">48,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfMTAtNS0xLTEtMA_0d5abaec-210e-4b2e-a11d-d953ebab26db">53,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the six months ended June&#160;30, 2021, $<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="bmy:AcquiredDevelopedProductRightsReclassedFromIPRD" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RleHRyZWdpb246ZGM0YWE3MzhkNWQzNGU3NDg2NWE5NjJmNjM5NDFmODVfODU_ca052351-7e09-4355-9148-b75dffa75d61">1.5</ix:nonFraction>&#160;billion of IPRD was reclassified to acquired marketed product rights upon approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. Amortization expense of other intangible assets was $<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RleHRyZWdpb246ZGM0YWE3MzhkNWQzNGU3NDg2NWE5NjJmNjM5NDFmODVfMjUw_6ac6c03f-0b1c-4ed6-8b66-d5260cab3cf1">2.5</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RleHRyZWdpb246ZGM0YWE3MzhkNWQzNGU3NDg2NWE5NjJmNjM5NDFmODVfMTA5OTUxMTYyODY3Mw_74359d75-462f-407d-8a0f-3bc8ecc65208">5.1</ix:nonFraction> billion for the three and six months ended June&#160;30, 2021 and $<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RleHRyZWdpb246ZGM0YWE3MzhkNWQzNGU3NDg2NWE5NjJmNjM5NDFmODVfMTA5OTUxMTYyODY0NA_52a440ee-9ff4-40cb-af2e-c089303fecb0">2.5</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RleHRyZWdpb246ZGM0YWE3MzhkNWQzNGU3NDg2NWE5NjJmNjM5NDFmODVfMTA5OTUxMTYyODYyOQ_754970bb-2bb4-48a6-8f07-456ec681d798">4.8</ix:nonFraction> billion for the three and six months ended June&#160;30, 2020, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2021, a $<ix:nonFraction unitRef="usd" contextRef="i52bd0855efcc4aeeae1fe88706edf18e_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RleHRyZWdpb246ZGM0YWE3MzhkNWQzNGU3NDg2NWE5NjJmNjM5NDFmODVfMjE5OTAyMzI1ODA3NQ_9d3c2164-619a-47f6-a5e1-1027bf5879eb">230</ix:nonFraction>&#160;million IPRD impairment charge was recorded in Research and development expense following a decision to discontinue development of an investigational compound in connection with the prioritization of current pipeline opportunities. The compound was being studied as a potential treatment for fibrotic diseases and was acquired in the acquisition of Celgene. The charge represented a full write-down based on the estimated fair value determined using discounted cash flow projections.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inrebic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> EU regulatory approval milestones of $<ix:nonFraction unitRef="usd" contextRef="ieff455ef39df4956a451fdaf9767810c_I20210630" decimals="-6" format="ixt:numdotdecimal" name="bmy:ContingentAndRegulatoryMilestoneNonCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RleHRyZWdpb246ZGM0YWE3MzhkNWQzNGU3NDg2NWE5NjJmNjM5NDFmODVfMzcy_17e5bad1-f3aa-4d29-a1a5-a7628db4acc7">300</ix:nonFraction>&#160;million were achieved resulting in a $<ix:nonFraction unitRef="usd" contextRef="i640a43d1b691485e977b3192bef77d58_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RleHRyZWdpb246ZGM0YWE3MzhkNWQzNGU3NDg2NWE5NjJmNjM5NDFmODVfNDA0_eaf6b4be-a2f7-41c7-9fe8-fd211d86976d">385</ix:nonFraction>&#160;million increase to the acquired marketed product rights intangible asset, after establishing the applicable deferred tax liability. An impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i640a43d1b691485e977b3192bef77d58_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RleHRyZWdpb246ZGM0YWE3MzhkNWQzNGU3NDg2NWE5NjJmNjM5NDFmODVfNTU2_2dd5eecd-4677-4ed9-8513-7c144bb194e1">315</ix:nonFraction>&#160;million was recognized in Cost of products sold as the carrying value of this asset exceeded the projected undiscounted cash flows of the asset. The charge was equal to the excess of the asset's carrying value over its estimated fair value using discounted cash flow projections.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_79"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 14. <ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RleHRyZWdpb246ZTFlYTgxODdiMzg5NDA5NWFkZDkxMGRmYThkMzBiNmNfMzk4_8103c2b6-ba11-4114-8fbf-88166098afa6" continuedAt="i235075fa50d94d398bf29c292d954990" escape="true">SUPPLEMENTAL FINANCIAL INFORMATION</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><ix:continuation id="i235075fa50d94d398bf29c292d954990" continuedAt="i0f195d0b1ab0435c886be5a075c92ffd"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RleHRyZWdpb246ZTFlYTgxODdiMzg5NDA5NWFkZDkxMGRmYThkMzBiNmNfNDA2_a7603052-dd20-418c-b3a7-4b6238510600" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmNmZDNjN2MxNGU0YTQyMmFiYmU0NTE0YWJmMDJmNTRhL3RhYmxlcmFuZ2U6Y2ZkM2M3YzE0ZTRhNDIyYWJiZTQ1MTRhYmYwMmY1NGFfMS0xLTEtMS0w_3ea898ad-2499-4981-8440-a46388d88c61">2,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmNmZDNjN2MxNGU0YTQyMmFiYmU0NTE0YWJmMDJmNTRhL3RhYmxlcmFuZ2U6Y2ZkM2M3YzE0ZTRhNDIyYWJiZTQ1MTRhYmYwMmY1NGFfMS0zLTEtMS0w_32cd6d31-7314-4f7f-b0d0-11d8fb79157b">1,799</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="bmy:ResearchandDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmNmZDNjN2MxNGU0YTQyMmFiYmU0NTE0YWJmMDJmNTRhL3RhYmxlcmFuZ2U6Y2ZkM2M3YzE0ZTRhNDIyYWJiZTQ1MTRhYmYwMmY1NGFfMi0xLTEtMS0w_e37f3c8e-bffd-49ce-b330-1a07c84b3062">576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="bmy:ResearchandDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmNmZDNjN2MxNGU0YTQyMmFiYmU0NTE0YWJmMDJmNTRhL3RhYmxlcmFuZ2U6Y2ZkM2M3YzE0ZTRhNDIyYWJiZTQ1MTRhYmYwMmY1NGFfMi0zLTEtMS0w_87bd084e-f886-41de-a2c3-425996b8be92">492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="bmy:EquityInvestmentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmNmZDNjN2MxNGU0YTQyMmFiYmU0NTE0YWJmMDJmNTRhL3RhYmxlcmFuZ2U6Y2ZkM2M3YzE0ZTRhNDIyYWJiZTQ1MTRhYmYwMmY1NGFfMy0xLTEtMS0w_d6923c77-d99a-4790-875a-7b5525cc0fc5">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="bmy:EquityInvestmentsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmNmZDNjN2MxNGU0YTQyMmFiYmU0NTE0YWJmMDJmNTRhL3RhYmxlcmFuZ2U6Y2ZkM2M3YzE0ZTRhNDIyYWJiZTQ1MTRhYmYwMmY1NGFfMy0zLTEtMS0w_4f34a8a9-1076-44f1-b435-414536da96e6">619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i934da5addaea4028be7894d0babddfe5_I20210630" decimals="-6" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmNmZDNjN2MxNGU0YTQyMmFiYmU0NTE0YWJmMDJmNTRhL3RhYmxlcmFuZ2U6Y2ZkM2M3YzE0ZTRhNDIyYWJiZTQ1MTRhYmYwMmY1NGFfNC0xLTEtMS0w_45beff5c-3c6a-48c6-9f01-e30207b41d6e">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11d3b9fc864643c6963d52987b8077d1_I20201231" decimals="-6" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmNmZDNjN2MxNGU0YTQyMmFiYmU0NTE0YWJmMDJmNTRhL3RhYmxlcmFuZ2U6Y2ZkM2M3YzE0ZTRhNDIyYWJiZTQ1MTRhYmYwMmY1NGFfNC0zLTEtMS0w_0927c470-b4b6-4678-88d6-990b7eaf7b09">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:OtherPrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmNmZDNjN2MxNGU0YTQyMmFiYmU0NTE0YWJmMDJmNTRhL3RhYmxlcmFuZ2U6Y2ZkM2M3YzE0ZTRhNDIyYWJiZTQ1MTRhYmYwMmY1NGFfNS0xLTEtMS0w_b9d8eea4-b7d5-4cf9-9159-a2f86f7140ab">983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:OtherPrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmNmZDNjN2MxNGU0YTQyMmFiYmU0NTE0YWJmMDJmNTRhL3RhYmxlcmFuZ2U6Y2ZkM2M3YzE0ZTRhNDIyYWJiZTQ1MTRhYmYwMmY1NGFfNS0zLTEtMS0w_8171db65-b50e-40c4-878d-69ae84b985e1">787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmNmZDNjN2MxNGU0YTQyMmFiYmU0NTE0YWJmMDJmNTRhL3RhYmxlcmFuZ2U6Y2ZkM2M3YzE0ZTRhNDIyYWJiZTQ1MTRhYmYwMmY1NGFfNi0xLTEtMS0w_b3e1a7fa-15d5-4f65-8b84-3120e3399a56">5,037</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmNmZDNjN2MxNGU0YTQyMmFiYmU0NTE0YWJmMDJmNTRhL3RhYmxlcmFuZ2U6Y2ZkM2M3YzE0ZTRhNDIyYWJiZTQ1MTRhYmYwMmY1NGFfNi0zLTEtMS0w_c0fc3290-ac99-409c-8008-456099e1c4fa">3,786</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0f195d0b1ab0435c886be5a075c92ffd"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RleHRyZWdpb246ZTFlYTgxODdiMzg5NDA5NWFkZDkxMGRmYThkMzBiNmNfMzky_d45721eb-cf09-4a49-9c90-28ed9d087b97" escape="true"><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="bmy:EquityInvestmentsNonCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfMS0xLTEtMS0w_9aa40600-6a48-4357-824c-fe7b92f14f4f">3,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="bmy:EquityInvestmentsNonCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfMS0zLTEtMS0w_9f7dccec-cfad-4f8a-ba60-71d8ddf261a0">4,076</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfMi0xLTEtMS0w_5153ba19-03d5-457e-8208-a6746c4fafc5">876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfMi0zLTEtMS0w_1eef57de-8365-4e74-a02b-89583f3ec6b0">1,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfMy0xLTEtMS0w_b37998e8-2fcb-4898-81be-625b860e6671">1,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfMy0zLTEtMS0w_d4886091-950c-4446-b6cc-e95912c178a2">859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfNC0xLTEtMS0w_97a17c2f-1a4c-410c-b59a-3d3818b40f0a">234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfNC0zLTEtMS0w_cd1e5f0d-fb70-495d-8e6b-7b2954b53580">208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfNS0xLTEtMS0w_c4433135-4f49-4580-b08c-a7e55f81a939">199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfNS0zLTEtMS0w_0aba5669-a3ec-4346-beb5-401f64d8d70a">338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfNi0xLTEtMS0w_3c4700ec-b681-4a4b-81cc-be06bff1098c">517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfNi0zLTEtMS0w_e44d3aaa-846c-4e81-ab53-731c7b0256b3">458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfNy0xLTEtMS0w_420fa375-10db-4560-a584-7b9ad56331ab">6,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfNy0zLTEtMS0w_e619cb49-f5ee-445c-9273-46f6b120bd8d">7,019</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Restricted cash consists of funds restricted for annual Company contributions to the defined contribution plan in the U.S. and escrow for litigation settlements. Restricted cash of $<ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RleHRyZWdpb246ZTFlYTgxODdiMzg5NDA5NWFkZDkxMGRmYThkMzBiNmNfMjQy_0351fb18-a4df-4a94-9d42-370ccf2c7ac3">373</ix:nonFraction> million at June&#160;30, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i711a50adb808497c9daf76647502dad6_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RleHRyZWdpb246ZTFlYTgxODdiMzg5NDA5NWFkZDkxMGRmYThkMzBiNmNfMjU1_cb5bda2e-7078-434e-bbba-d1df214ed6a4">428</ix:nonFraction>&#160;million at June&#160;30, 2020 was included in cash, cash equivalents and restricted cash in the consolidated statements of cash flows.</span></div></ix:nonNumeric><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RleHRyZWdpb246ZTFlYTgxODdiMzg5NDA5NWFkZDkxMGRmYThkMzBiNmNfMzk3_6d02b977-f346-4e4d-8983-277b1857794d" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates and returns</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="bmy:AccruedRebatesAndReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfMS0xLTEtMS0w_a1fe1bce-5321-4127-a9d0-bd66be2bafd9">5,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="bmy:AccruedRebatesAndReturns" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfMS0zLTEtMS0w_af67b859-7ad1-45da-8449-18a94665bd46">5,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfMi0xLTEtMS0w_d1409e7a-fcf9-4bee-8cf4-abc3fbdca032">638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfMi0zLTEtMS0w_702a30ea-1878-41b7-b650-fcda8d047af9">647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfMy0xLTEtMS0w_4488a901-cfe2-4328-884a-f762e211f160">896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfMy0zLTEtMS0w_3be9d4c7-27a3-45c4-b655-99927e174d7d">1,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="bmy:AccruedResearchAndDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfNC0xLTEtMS0w_f23feb13-e449-47e4-903c-eee426c25047">1,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="bmy:AccruedResearchAndDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfNC0zLTEtMS0w_0fbb18c6-8f56-4fcd-89ab-8e0278994da2">1,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfNS0xLTEtMS0w_feab83b4-2d5c-4388-bb85-83409dfcfa6a">1,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfNS0zLTEtMS0w_c2b778e4-fb29-432c-bc93-fd968d771a19">1,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="bmy:AccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfNi0xLTEtMS0w_7ae80f1e-6804-408d-bf4c-e0de403b121f">373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="bmy:AccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfNi0zLTEtMS0w_4d811496-4dbe-4e5b-8c3a-9f06fe588eaa">434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:AccruedRoyaltiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfNy0xLTEtMS0w_bd528e88-118b-40cc-8678-81ad7e4a5658">386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:AccruedRoyaltiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfNy0zLTEtMS0w_05c1eca8-b336-432d-a108-11ee0b131777">461</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfOC0xLTEtMS0w_9cbcefbc-7139-49c8-8eb9-5d6d9eb9f5a4">173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfOC0zLTEtMS0w_05db83fd-cc80-4744-87fd-1264c154ea83">164</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent value rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i740f1c260f5842e38801cdbe44935148_I20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfOS0xLTEtMS0w_7623f89d-853d-4b1c-91de-618ee5051827">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i067540008559441b824143d0812aef90_I20201231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfOS0zLTEtMS0w_af7d7ece-594a-4da9-bfd5-860d2f9e7b7d">515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfMTAtMS0xLTEtMA_a752218a-864b-4098-884e-61d8962229e1">2,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfMTAtMy0xLTEtMA_9d5f2592-ba47-4a3b-a496-a2b8a05ffd80">2,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfMTEtMS0xLTEtMA_ba749d42-6cc0-46cd-99b2-09640527fb26">12,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfMTEtMy0xLTEtMA_35096a1c-7c63-4d4f-b167-b6e12214a757">14,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RleHRyZWdpb246ZTFlYTgxODdiMzg5NDA5NWFkZDkxMGRmYThkMzBiNmNfNDA0_ffa6dc5c-9a7a-464a-8061-9de014a7ba6c" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfMS0xLTEtMS0w_bc939634-358a-4186-a0a0-8f23c87ead67">4,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfMS0zLTEtMS0w_4a52c32a-8b55-4ef8-8633-07f2762b93ec">5,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfMi0xLTEtMS0w_ad30ec3b-02bb-4891-a74e-b1c2fdfdf203">838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfMi0zLTEtMS0w_0abb7302-3ffd-493d-a75b-49417bba2174">899</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfMy0xLTEtMS0w_0c7556e6-b6f5-4a91-a2b4-bdfcf1e03466">962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfMy0zLTEtMS0w_fdb5d31d-861d-4ce4-87bc-08707da4318b">833</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:DeferredIncomeNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfNC0xLTEtMS0w_89159b6b-05f7-4dee-98ab-c5b5752dbbd4">324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:DeferredIncomeNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfNC0zLTEtMS0w_d4fe58d1-511f-4197-883d-d9c65d63f6b6">357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfNS0xLTEtMS0w_53e3cbdf-d4fb-4cab-aa24-e94293a59a5d">416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfNS0zLTEtMS0w_176a2266-eb34-4815-bf29-ca505f3ab96d">344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfNi0xLTEtMS0w_98e77e71-409d-420d-9641-b764ad05f503">268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfNi0zLTEtMS0w_a06e3088-8475-4113-8d85-c35872a72821">326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfNy0xLTEtMS0w_d7c3526b-ed04-45da-a742-d11956b2cd58">7,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfNy0zLTEtMS0w_d64ef0dd-ed8c-46ca-af9d-c4affaeefffe">7,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="id66f4ecc89aa45bca7756420c60966f5_82"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 15. <ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMTU1Mw_3798661f-a2a5-49a5-8778-d1b95535ee09" continuedAt="idcdef78e04cf4911bb79ac688b9e4f9b" escape="true">EQUITY</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="idcdef78e04cf4911bb79ac688b9e4f9b" continuedAt="i4e9d25ba0bcb49fd84f8dc90f83c1b7d"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:ScheduleOfStockholdersEquityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMTU1OA_e69b5f9c-e477-4e6a-a6d8-e570cbc3941f" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the six months ended June 30, 2021:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"></td><td style="width:30.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.626%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.721%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.073%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.860%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.660%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and Shares in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if693f3f9e803446e93591493d837c4d2_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMi0xLTEtMS0w_98fdc0d5-bf24-4c6c-8220-cdbb2f462439">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if693f3f9e803446e93591493d837c4d2_I20201231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMi0zLTEtMS0w_1ed3750d-715c-4236-9a01-73904f363125">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5310947a3340a3a0bcf32e64131e15_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMi01LTEtMS0w_56ec4a4a-8d88-40d6-8e14-bc411b098b1f">44,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic2634a7150984700b4940996575435e4_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMi03LTEtMS0w_8c7f4c1e-fd13-4631-ad4a-ce70a76585a7">1,839</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6796f93ba1454a58aa1ce90e9373d79e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMi05LTEtMS0w_036f2f85-338d-4f65-849e-c2ddfda1f6f5">21,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib3a03601e6ad43e8a39684c20e526fc0_I20201231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMi0xMS0xLTEtMA_181cf245-0871-460f-a525-619103e2b0af">679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib3a03601e6ad43e8a39684c20e526fc0_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMi0xMy0xLTEtMA_507db415-b9b1-48d2-8d44-90b628cb2182">26,237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab66f12d5bc4445bbf732048a5db1c7c_I20201231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMi0xNS0xLTEtMA_ec3c2eb3-04cd-413e-a6f0-7d8576029766">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bb4376df4e144078f75533316d9e77e_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMy05LTEtMS0w_b8091bef-aaee-4945-8d2f-2e1fe04030ed">2,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c3370e41cf9405a9a160e64209a8f68_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMy0xNS0xLTEtMA_035b92e6-7805-43c1-98c2-7569eca21442">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d8bd1acba944731b23be9a517a5eeb0_D20210101-20210331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfNC03LTEtMS0w_db00e584-119f-40be-bdfa-d197435a9546">295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bb4376df4e144078f75533316d9e77e_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfNS05LTEtMS0w_46087d9f-ba2a-4b5c-b7b0-d9f17f82749b">1,098</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ice500bf4ba6c4e908a4b5c93b15b7a60_D20210101-20210331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfNi0xMS0xLTEtMA_ee318bec-bfd0-444d-bb0e-6aafcb4d4238">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice500bf4ba6c4e908a4b5c93b15b7a60_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfNi0xMy0xLTEtMA_672f95bb-f960-4ee3-8f9e-ee615faaf954">1,768</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2be8a05661504ad99b17ef9c22efd9f7_D20210101-20210331" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfNy01LTEtMS0w_7cfc3cc8-4b7c-47eb-9c09-7ba9b853ba06">473</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ice500bf4ba6c4e908a4b5c93b15b7a60_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfNy0xMS0xLTEtMA_5c12f8bf-2998-45bb-b0b8-8cc6e8e24b17">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice500bf4ba6c4e908a4b5c93b15b7a60_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfNy0xMy0xLTEtMA_3d2dea02-ae2d-4838-80e3-aeab07c6f8ba">806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib89fb11161f146d2a6fb0b08fa2ddbd7_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfOS0xLTEtMS0w_9fa4d2c0-9cf1-4dbc-97ed-a4142a420430">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib89fb11161f146d2a6fb0b08fa2ddbd7_I20210331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfOS0zLTEtMS0w_61e5c9c1-6e5b-45cd-8b15-c1bb8c0a07f2">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60e4a51934264054a72db8bb72b4bc16_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfOS01LTEtMS0w_07e6efb1-89a0-47b9-b95e-0e4975e7773d">43,852</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief956f040cf142c48a760f89d051c7ba_I20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfOS03LTEtMS0w_3deadf2d-00b6-4ac7-8a48-69bad2c99eae">1,544</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a550b5d610e43ddacb1196fc31b2232_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfOS05LTEtMS0w_303ea937-ff85-4213-9347-1626a622e205">22,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i01588a18f30f4fa1ad0bd69b5101f669_I20210331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfOS0xMS0xLTEtMA_03e0fa4e-22aa-4269-ae2a-364113e1a062">692</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01588a18f30f4fa1ad0bd69b5101f669_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfOS0xMy0xLTEtMA_50834b13-c743-4eeb-af91-dd3ded8ef0ef">27,199</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e1bc2ac43bb413ca28382700af763ae_I20210331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfOS0xNS0xLTEtMA_7a1ef1e0-84e9-47bd-90bb-1b2537372da5">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a4b6a65d77842f48e59e61b100ac7d3_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTAtOS0xLTEtMA_9aa95e75-8d0b-4fc4-8b5b-6455551c852e">1,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9407dc04bd514a50a293bf46404d43d3_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTAtMTUtMS0xLTA_ed2cc7b7-38f6-4163-8737-82e559f16d0c">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id929872bbc96437d9c359988e5567a7c_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTEtNy0xLTEtMA_b773d7ad-b426-4fe6-9a47-8903d4cf6a97">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a4b6a65d77842f48e59e61b100ac7d3_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTItOS0xLTEtMA_0ca76b55-5ea5-4602-b583-b9c77be7d279">1,091</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2148fb9192764819b1bc0f8addaa98cb_D20210401-20210630" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTMtMTEtMS0xLTA_a1b875d2-e3f3-4d2a-bcf0-e8605379dad8">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2148fb9192764819b1bc0f8addaa98cb_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTMtMTMtMS0xLTA_3a3e30a7-f604-4865-b31d-2e363e8870d7">1,235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a9500eccacc46d69322333bfa03f25d_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTQtNS0xLTEtMA_95e0de11-ee49-4a44-9b2c-e13bfd8bf783">212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2148fb9192764819b1bc0f8addaa98cb_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTQtMTEtMS0xLTA_89623b56-3b08-4d5a-941e-a4690a199010">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2148fb9192764819b1bc0f8addaa98cb_D20210401-20210630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTQtMTMtMS0xLTA_72d95aea-46ab-4829-8b2c-5b6024ad4507">236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9407dc04bd514a50a293bf46404d43d3_D20210401-20210630" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTUtMTUtMS0xLTA_c22193ae-c5b6-4b34-9a2e-dc8050903210">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i60767f8375e34e8a8c2ea7e77e7f3ec5_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTYtMS0xLTEtMjEwOA_254a8583-8718-410e-9e65-4ae1da8dd1ed">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60767f8375e34e8a8c2ea7e77e7f3ec5_I20210630" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTYtMy0xLTEtMjEwOA_bc9ac7f3-a0f1-4263-866d-c84ee69df3b7">292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied5e0053e2f04982aa1a2cd60b3e95b3_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTYtNS0xLTEtMjEwOA_52e139f1-7655-4321-906b-fbe558e63b91">44,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0daf74a0447c4e5786bd5ce58b6cc832_I20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTYtNy0xLTEtMjEwOA_a3b06d5a-60d6-4c66-8d2c-4cc816b713ae">1,518</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i737d30e7e58d4ea790fbbd242d2423fd_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTYtOS0xLTEtMjEwOA_167a62e4-99fe-4bc2-b4b9-d01037be64d7">22,168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4bffcc25a557427c9a4c65a954674dca_I20210630" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTYtMTEtMS0xLTIxMDg_cb1e9590-90f1-490e-b33f-751e43dcfa39">701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bffcc25a557427c9a4c65a954674dca_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTYtMTMtMS0xLTIxMDg_2a58d506-add5-4a6b-9510-d795b938f480">28,198</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43239b9f5ca7485fa0251240b365648a_I20210630" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTYtMTUtMS0xLTIxMDg_1e66821f-dacc-408d-a9c0-eece5cd76947">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $<ix:nonFraction unitRef="usdPerShare" contextRef="ifc37ebada08d41f5b8cef803d7d03074_D20210101-20210331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMTM1_262e3d1c-e0ab-4312-bcd6-e04902b90c9e"><ix:nonFraction unitRef="usdPerShare" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMTM1_38042128-2dba-4b1b-b582-291bd830a0ca">0.49</ix:nonFraction></ix:nonFraction> for the three months ended March 31, 2021 and June&#160;30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the six months ended June 30, 2020:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"></td><td style="width:30.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.626%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.721%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.073%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.860%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.660%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and Shares in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2981a3b1644448f6af2e5cb8836ff464_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMi0xLTEtMS0w_c1c2ac55-df2f-4d68-83f2-967332b094de">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2981a3b1644448f6af2e5cb8836ff464_I20191231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMi0zLTEtMS0w_4c0fb983-1ed9-43ab-92ce-99d90d109583">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i725849a6245d4c18813876f45d26ebdb_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMi01LTEtMS0w_70af48cc-1623-4ebf-af6a-cd87ab07fb22">43,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifca693e8a4cf43a3b6314d8fd10f8054_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMi03LTEtMS0w_67650b53-3127-4929-bb2b-e5e016b7b056">1,520</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacdee3fad3484ddab95c12653c99c649_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMi05LTEtMS0w_49e988fe-a907-4917-b34c-fb29b8fc2b00">34,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic8ddca453e0f43dfa8c50a7b44bba5fa_I20191231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMi0xMS0xLTEtMA_2e7e7e02-249e-458f-98ee-31dc83417a51">672</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8ddca453e0f43dfa8c50a7b44bba5fa_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMi0xMy0xLTEtMA_5ff30b6b-88eb-45e0-804e-ea41ebcab3fe">25,357</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6cc956e9fbd48ceb2f65194ea049395_I20191231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMi0xNS0xLTEtMA_4a401f80-f529-4dc8-943c-274cf858228a">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i003da07e864e44a69c31e7e8a1d52e15_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMy05LTEtMS0w_a8b5dc2e-a54f-433d-b32e-8b808d54455d">775</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5984e1f2ba843eb986403e94d6961c1_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMy0xNS0xLTEtMA_4700f823-6fcb-4f08-9b22-012fdb3eabc5">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e4590ddb4bf4965b0a342ff22eaa166_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfNC03LTEtMS0w_e4ded8b1-14e1-416d-bff6-a4496b46a270">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i003da07e864e44a69c31e7e8a1d52e15_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfNS05LTEtMS0w_1977ae01-1ef5-4ad1-b795-6dc236a8040c">1,028</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0e96ce8b1bb142a2a63dcf6656d59225_D20200101-20200331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfNi0xMS0xLTEtMA_1c8a0a02-b50e-454a-9fa4-097627538dae">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e96ce8b1bb142a2a63dcf6656d59225_D20200101-20200331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfNi0xMy0xLTEtMA_4a8f0f2b-a42b-410c-9476-20dfe2629e3c">81</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5969c9dafdd447f18f7192246fac8838_D20200101-20200331" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfNy01LTEtMS0w_f4e4159d-3b54-4451-9625-47289446cc9f">455</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0e96ce8b1bb142a2a63dcf6656d59225_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfNy0xMS0xLTEtMA_2ff446b7-461f-4176-a9cb-c8810b0d520c">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e96ce8b1bb142a2a63dcf6656d59225_D20200101-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfNy0xMy0xLTEtMA_9dd2d120-ef3b-4a5a-8b01-3a8c164e0a15">681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5984e1f2ba843eb986403e94d6961c1_D20200101-20200331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfOC0xNS0xLTEtMA_fc0d1145-4cea-48b2-a5be-1959f5216ccf">43</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5504708828644783aaf1fb1bdfaac8b9_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfOS0xLTEtMS0w_8d7aaf1b-843e-4e55-a77f-829cfb09bedd">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5504708828644783aaf1fb1bdfaac8b9_I20200331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfOS0zLTEtMS0w_d11dd71e-e3b3-49a8-92c3-32b35db491dd">292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6451959c27fd4a229abd87573f36e73a_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfOS01LTEtMS0w_53b792fa-f776-4b71-9fc5-7c886c463402">43,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf435eb9cba84175bb13fd5a7add0851_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfOS03LTEtMS0w_dbf5b01a-673c-4dc5-b361-cdecacf274cc">1,549</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb8aad97592342f69c4ee4f99b65f30e_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfOS05LTEtMS0w_49b3cc07-ce0e-489d-ad1b-06cf7107ee66">32,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i907bc8e8b73443428348fce6c8e4d9f2_I20200331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfOS0xMS0xLTEtMA_decef44f-f728-4bf8-9e0a-bbb688d411af">660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i907bc8e8b73443428348fce6c8e4d9f2_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfOS0xMy0xLTEtMA_9b77533a-c4bb-4840-9157-ae90aa5ee6db">24,757</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7672c07fdb549a49def19893f3bd52d_I20200331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfOS0xNS0xLTEtMA_319c8c62-9b42-466d-a0e4-d92c45138b0a">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35a526307c454beb9945dbdb361e919a_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTAtOS0xLTEtMA_e256a4c1-99ab-4e07-a5d0-31d67e76fd8c">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf55f775dda94251ae451da6e98bfa21_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTAtMTUtMS0xLTA_4a631d35-fc55-4098-a075-749c2135970d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if63b4ca36e134e4c93b3e20bfbe40fe3_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTEtNy0xLTEtMA_3191d03b-454d-498c-9073-5cec718c5688">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35a526307c454beb9945dbdb361e919a_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTItOS0xLTEtMA_39a781a9-167f-4659-88da-3aec96fd1428">1,021</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock repurchase program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTMtNS0xLTEtMA_b251983e-efd3-414e-b161-15b25c9d710e">1,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id4a97b03d1a440f9a8664a3da44ee846_D20200401-20200630" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTMtMTEtMS0xLTA_a1087027-72d2-4953-9d25-a380d6eaeb8b">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4a97b03d1a440f9a8664a3da44ee846_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTMtMTMtMS0xLTA_fc69e98a-78ba-49f2-94b8-8ba5d5e18451">1,400</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ab20791a5084b878272689919dd7486_D20200401-20200630" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTQtNS0xLTEtMA_25aecc7e-89f9-4983-bd93-82df0ff3aae6">210</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id4a97b03d1a440f9a8664a3da44ee846_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTQtMTEtMS0xLTA_943a1e48-6419-4f11-9b96-1d0829f424ea">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4a97b03d1a440f9a8664a3da44ee846_D20200401-20200630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTQtMTMtMS0xLTA_5b73a4d3-e9e3-4511-a1cf-a2dd1b251715">506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf55f775dda94251ae451da6e98bfa21_D20200401-20200630" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTUtMTUtMS0xLTA_85ce605e-8a07-41e9-ae8f-00791e301d9a">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i30ce3f779b954838bbbf7b6ff1bbd7e9_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTYtMS0xLTEtMjExMg_6652c6fc-bfe1-495e-81d3-6192d8513de6">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30ce3f779b954838bbbf7b6ff1bbd7e9_I20200630" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTYtMy0xLTEtMjExMg_ab2a5655-98f1-45d4-bd09-eaae332e1642">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20caf63fbd6041669bb1f806943db28d_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTYtNS0xLTEtMjExMg_19d2e492-ea06-467b-bb34-b5b459159ab4">44,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i695a7cf7ff314bec908a24d933d5cf63_I20200630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTYtNy0xLTEtMjExMg_3bac38e5-b235-489e-8960-ee386448feea">1,556</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i235fc5676d984fff868b737072a6d629_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTYtOS0xLTEtMjExMg_f883fe05-339a-4671-aeb4-d15adf963e75">31,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4185f4aac2534ed88f533f59619f62a5_I20200630" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTYtMTEtMS0xLTIxMTI_edc147ba-3f7f-44e9-bd50-c83473d9d4ff">669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4185f4aac2534ed88f533f59619f62a5_I20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTYtMTMtMS0xLTIxMTI_bd9b9e17-944f-483f-a0d8-9627a200a9fc">25,651</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4276b9e3a3cd4405967f02d58a3d681d_I20200630" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTYtMTUtMS0xLTIxMTI_8a7d8689-a279-4bb3-9992-cfe329a6bda3">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $<ix:nonFraction unitRef="usdPerShare" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMjY0_a3605531-32c6-48de-b32d-0919b53c9c84"><ix:nonFraction unitRef="usdPerShare" contextRef="iac2000f1209140fe919895b22d38de16_D20200101-20200331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMjY0_e3d6ee26-ffc4-4227-9d75-d2acb356f63c">0.45</ix:nonFraction></ix:nonFraction> for the three months ended March 31, 2020 and June&#160;30, 2020.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS has a share repurchase program, authorized by its Board of Directors, allowing for repurchases of its shares. The share repurchase program does not obligate us to repurchase any specific number of shares, does not have a specific expiration date and may be suspended or discontinued at any time. Treasury stock is recognized at the cost to reacquire the shares. Shares issued from treasury are recognized utilizing the first-in first-out method.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The outstanding share repurchase authority authorization under the program was $<ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfODEw_aa9ee3ab-a0ef-4595-81e3-a5774c4952e9">4.4</ix:nonFraction> billion as of December 31, 2020. In January 2021, the Board of Directors approved an increase of $<ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfODg3_ec3a0b15-e588-462d-874f-8e9113402738">2.0</ix:nonFraction>&#160;billion to the share repurchase authorization for BMS&#8217;s common stock. BMS repurchased approximately <ix:nonFraction unitRef="shares" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfOTgy_2e3d8ee5-2947-4164-a588-2bc48060d285">47</ix:nonFraction> million shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMTAxNg_c433e56e-2646-4984-8b9a-1dad48e6299d">3.0</ix:nonFraction> billion during the six months ended June&#160;30, 2021. The remaining share repurchase capacity under the share repurchase program was approximately $<ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMTE0Ng_755433be-ab4e-403d-abb4-9e47a5cd89d8">3.4</ix:nonFraction> billion as of June&#160;30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS repurchased <ix:nonFraction unitRef="shares" contextRef="iac2000f1209140fe919895b22d38de16_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMTE3Ng_d10f1cbf-3afb-40f3-8dbe-b1f3136e2541">1.4</ix:nonFraction>&#160;million shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMTIxMA_e3aa7915-8340-464d-bc36-3c238b6c3e1b">81</ix:nonFraction>&#160;million in the six months ended June&#160;30, 2020.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4e9d25ba0bcb49fd84f8dc90f83c1b7d" continuedAt="i993236ba82cf48079f5b8c634d6c66bd"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2019, BMS executed accelerated share repurchase (&#8220;ASR&#8221;) agreements to repurchase an aggregate $<ix:nonFraction unitRef="usd" contextRef="i519bf72bf2984b599bef546963ea4f65_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMjE5OTAyMzI1Nzc4NQ_45257b2f-a9d0-4378-8f60-1d15b17e517d">7</ix:nonFraction>&#160;billion of common stock. The ASR was funded with cash on-hand. In the fourth quarter of 2019, approximately <ix:nonFraction unitRef="shares" contextRef="ifbd79ec1a2164f3d8aefdbe1d165744d_D20191001-20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMjE5OTAyMzI1Nzc5Nw_396eab6f-8c2c-4374-a53a-bdfa1913fc18">99</ix:nonFraction>&#160;million shares of common stock (80% of the $<ix:nonFraction unitRef="usd" contextRef="i519bf72bf2984b599bef546963ea4f65_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMjc0ODc3OTA3MTcyMg_45257b2f-a9d0-4378-8f60-1d15b17e517d">7</ix:nonFraction>&#160;billion aggregate repurchase price) were received by BMS and included in treasury stock. In the second quarter of 2020, the agreement was settled and approximately <ix:nonFraction unitRef="shares" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMjE5OTAyMzI1NzgyMQ_63519ebb-1c01-4ef0-a439-3df30a8f4f93">16</ix:nonFraction>&#160;million shares of common stock were received by BMS and transferred to treasury stock.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMTU1NQ_4fcd75fd-8387-4c1a-b6e7-e3bbf32f73c7" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of Other Comprehensive Income/(Loss) were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain/(losses)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNC0xLTEtMS0w_d8ca2126-c814-437e-bf1d-1062bf1f08c4">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNC0zLTEtMS0w_19f8b6f5-05ef-4daf-824c-bc5d10ff92ca">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNC01LTEtMS0w_7a91cabc-ce0a-40f3-a1f4-08368a64bc5d">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNC03LTEtMS0w_c3240d64-5577-4dbf-8687-90731a3e773b">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNC05LTEtMS0w_0ab4ac40-2ac6-40f0-a45b-c16152e6cd0f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNC0xMS0xLTEtMA_42f5eeb9-573e-446a-9577-95ec32d47ffe">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to net earnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNS0xLTEtMS0w_eba70928-784b-40db-95e3-dd9f9ad09f82">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNS0zLTEtMS0w_03f3346a-0031-4ad3-8117-9d74bd42fdf4">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNS01LTEtMS0w_29a1e586-5e22-45f1-a38e-45518f4210bc">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNS03LTEtMS0w_dcff0953-e03e-4e5c-8dd1-569ba527b7ee">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNS05LTEtMS0w_92189f44-9468-4c6f-a009-a3edb735b78c">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNS0xMS0xLTEtMA_d1130e94-9244-4545-be92-26f740178f12">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNi0xLTEtMS0w_fd0e7444-2098-40b8-9a41-4b0e18c45c41">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNi0zLTEtMS0w_8a38dac9-ce1f-42f1-89cc-dec9e0938e60">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNi01LTEtMS0w_39e96af6-8c39-41c9-9909-4e5d947d8683">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNi03LTEtMS0w_8e4ab0e7-f652-4ec9-a44a-898cd54f7e6f">66</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNi05LTEtMS0w_71e8db7f-966d-4c81-8e4d-73fb308797ed">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNi0xMS0xLTEtMA_12e2c36c-28aa-4d29-906f-69580d0fb9e0">59</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfOS0xLTEtMS0w_d08b2199-5d0a-44c2-b32b-287c52a3e806">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfOS0zLTEtMS0w_ff07c9f7-9934-40bb-86ed-0cc34f33544e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfOS01LTEtMS0w_7d7a62b4-2579-4086-ac07-9aa84ba942be">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfOS03LTEtMS0w_a8ddf4d8-8351-4e7d-a0f6-5c420f28cbab">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfOS05LTEtMS0w_145e6fd4-219a-4c97-b089-4d59d20437d3">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfOS0xMS0xLTEtMA_01f2d380-221e-49a7-82ef-82e965a18bcd">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTAtMS0xLTEtMA_3c4f3e1c-0e13-4c8c-a3d5-7f98a95e2d01">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTAtMy0xLTEtMA_843a4224-ac2c-43da-8eb9-7fe75f697230">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTAtNS0xLTEtMA_46045492-66a0-4795-988a-f751adcb7a7a">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTAtNy0xLTEtMA_d924b416-bd4f-4fb2-8911-ae2cbbd4f5bd">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTAtOS0xLTEtMA_aefb8369-68cb-49b1-9de3-4365dcf3d4cd">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTAtMTEtMS0xLTA_580c0ab5-41b9-483b-ac17-5eeb04585235">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTEtMS0xLTEtMA_20440847-9506-4880-a847-d0b39e7ab4f5">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTEtMy0xLTEtMA_4af6d190-7b76-4559-b9ac-a30f5e385080">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTEtNS0xLTEtMA_7da8de85-0781-4bcb-9066-ca035343380b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTEtNy0xLTEtMA_200b8ef2-e790-45fa-98e3-c29c6b047397">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTEtOS0xLTEtMA_72cf7309-22a7-47ac-b5f3-6b02e87456c9">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTEtMTEtMS0xLTA_9ab83db9-2c1a-4f62-a246-f7e71e48103b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTItMS0xLTEtMA_61405dba-359d-4dc4-9ac9-b9e570d7f2e3">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTItMy0xLTEtMA_956fd72b-1b02-4484-beef-f3ae87e8a307">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTItNS0xLTEtMA_28cfff84-c1e1-4248-93bf-10939978de7a">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTItNy0xLTEtMA_094e76cf-d0c3-47d9-8543-ff0d775b6889">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTItOS0xLTEtMA_3e2c4e95-0de1-4278-bc1f-5438f375d052">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTItMTEtMS0xLTA_36f2e623-d3d6-47c2-9005-cd65522a4ee4">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains/(losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTUtMS0xLTEtMA_681e114b-e84a-417f-9f75-004e79b0ca3a">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTUtMy0xLTEtMA_1622f5d1-b39a-4520-934e-76820ebef687">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTUtNS0xLTEtMA_0a5ebf53-96c8-48f0-a8d3-81d200b92650">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTUtNy0xLTEtMA_fd1c51a4-79f5-403e-9cf2-a22ced4837b8">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTUtOS0xLTEtMA_a096ca22-4158-4b51-a295-710a4cdf6a4f">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTUtMTEtMS0xLTA_4ac817e4-1468-466f-8bc5-4b3aec66bbba">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized Losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTYtMS0xLTEtODMy_6ed7307f-01ef-45c0-9177-90ac34ddc6c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTYtMy0xLTEtODM2_a6dadd59-4249-40dd-b075-10ec33980abb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTYtNS0xLTEtODQw_10d4c443-56aa-495e-92d2-850fc7d8dde4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTYtNy0xLTEtODEw_701d1108-432a-440a-89f2-a173e8311aa4">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTYtOS0xLTEtODE0_d166ac42-1314-45cf-a89a-35818117ff1d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTYtMTEtMS0xLTIxMTk_ba0f800c-356f-4b12-a641-cca3208256fb">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTctMS0xLTEtMjM0Nw_fd974b85-9875-4534-8b36-36afe4bf97ff">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTctMy0xLTEtMjM0Nw_1595262b-8136-4f8b-acaa-fb5e3490bd84">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTctNS0xLTEtMjM0Nw_be92dbf4-e046-4e48-b4ab-63374eed6191">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTctNy0xLTEtMjEyMQ_399e152d-a822-4db1-b6f7-630735e06ba4">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTctOS0xLTEtMjEyMQ_7b9e664d-c979-4253-bd23-8b3c5fdf9d0a">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTctMTEtMS0xLTIxMjE_90c62760-357f-4f6b-928d-6cde4edc1c80">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTctMS0xLTEtMA_719cf28a-7460-428f-9fc1-fe3d4e56e826">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTctMy0xLTEtMA_cf0312a0-8ccf-4ee5-9eaf-9b6ab14cf3a6">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTctNS0xLTEtMA_e060a756-93ab-4302-b36b-14f74650c0d2">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTctNy0xLTEtMA_cf315955-43e7-4e2d-9930-9eb23d326b4f">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTctOS0xLTEtMA_b1f6f69e-7e5b-4b56-a1a8-7ff71f734f01">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTctMTEtMS0xLTA_ed40721f-d82b-4d69-8616-e0ecd2b02789">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income/(Loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTktMS0xLTEtMA_398aa620-cfbf-46a4-b003-b707abb557f1">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTktMy0xLTEtMA_da9a91a2-4dfe-4c0f-8bd3-41ce90695fec">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTktNS0xLTEtMA_0c4dec67-dd9a-46ea-9865-3d9fd15ebb24">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTktNy0xLTEtMA_d924372c-b106-4f6e-9d8f-81f03bcbef73">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTktOS0xLTEtMA_d45fabbf-f39a-4d61-9ca0-19b3699abc14">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTktMTEtMS0xLTA_d90604a7-54de-4351-9faf-2cfee6452a5e">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain/(losses)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNC0xLTEtMS04NzY_f3a078a0-5b75-464d-bbc4-b38a4b4e442c">221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNC0zLTEtMS04Nzk_35813e1a-6e71-435a-bc4c-fa779624b1a9">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNC01LTEtMS0yMTI0_1eefc209-ecb8-46bd-80c5-dccae4d6b3a1">207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNC03LTEtMS03Mzk_7a140d88-49c8-4509-baee-fa90ddb4bd8a">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNC05LTEtMS04NzM_13f254d9-8466-4e83-8101-c1c0dd21073e">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNC0xMS0xLTEtMjEyNA_3dea4fb9-14f6-4bbf-8f78-78fca1979a99">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to net earnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNS0xLTEtMS04NzY_99e1f722-4b79-44a6-8830-6a0605f2e012">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNS0zLTEtMS04Nzk_0e04073e-1ffd-458d-917b-0d65fcef72a9">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNS01LTEtMS0yMTI0_610dbc0e-b360-4955-9a92-84713ec1fe3d">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNS03LTEtMS03Mzk_01fab043-1bec-472d-8785-2c2fc1721afd">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNS05LTEtMS04NzM_a730c8f4-7532-478f-b962-8a155734286a">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNS0xMS0xLTEtMjEyNA_7a6bf37c-854e-448a-b5e1-b95ae83c16f1">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNi0xLTEtMS0yMTI0_d8c98b64-ecef-4cb5-a9c3-2c8545be13a8">310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNi0zLTEtMS0yMTI0_5af29e19-334e-4d09-8163-aa2d8283ef3f">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNi01LTEtMS0yMTI0_49447977-9158-40de-9cbf-751ebf24e859">286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNi03LTEtMS0yMTI0_3e00c352-0382-4321-81cb-c1efa6c0bf41">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNi05LTEtMS0yMTI0_cfba9907-f7f8-47e2-9c8a-a3a236a60bb7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNi0xMS0xLTEtMjEyNA_8f4a73cb-7d8f-4ace-b7af-d805a4968c7e">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfOS0xLTEtMS04ODI_44d24947-7edd-42f8-b520-e0e29695acc6">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfOS0zLTEtMS04ODU_2e51a5be-bdc4-42d1-9007-2aefc7b5a134">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfOS01LTEtMS0yMTI2_f496bc65-e445-44e8-a51a-35dfd313832a">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfOS03LTEtMS03NDI_8162d4a6-d189-49c7-a950-1d00906f0194">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfOS05LTEtMS04NDk_4d989bf8-c8ed-4fc4-a983-d10c83c5ac1b">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfOS0xMS0xLTEtMjEyNg_073527b8-f184-465b-b78e-dce7f752c55c">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTAtMS0xLTEtODgy_5a7b06a3-bcde-48b3-b6cb-36bd5a944e55">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTAtMy0xLTEtODg1_bf6df821-3f5d-4d77-8e6f-4df47940ebf9">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTAtNS0xLTEtMjEyNg_6d20929c-4b42-4ee8-9228-290184b1f5a6">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTAtNy0xLTEtNzQy_dcdaf23b-3daf-45a1-9a16-984725ad98d2">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTAtOS0xLTEtODQ5_02117eba-cdad-4182-bfa3-edeab28f7381">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTAtMTEtMS0xLTIxMjY_d92341c1-a6c9-44b8-824a-a96273a64ada">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTEtMS0xLTEtODgy_0ffc43b2-48f5-43c6-b91c-66e92f2eba25">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTEtMy0xLTEtODg1_6ffb5f1e-bc13-45de-9390-e032889badeb">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTEtNS0xLTEtMjEyNg_881c2308-104f-43db-8b4a-8597e2f9c5ca">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTEtNy0xLTEtNzQy_4c7892aa-4be2-4f99-8df9-6ac44a5c2f0e">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTEtOS0xLTEtODQ5_fd4a50b3-e8c9-4a66-8bee-9eceeff7b253">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTEtMTEtMS0xLTIxMjY_78caa8df-6375-4f57-aa17-89c65b56adc7">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTItMS0xLTEtMjEyNg_5c0b896f-d877-4425-86b7-396be1c619ec">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTItMy0xLTEtMjEyNg_ba07c33f-2453-4f54-92e9-a3b32669a85f">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTItNS0xLTEtMjEyNg_e7d52837-6954-47fc-93a3-bb7d186ddfcf">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTItNy0xLTEtMjEyNg_8375f3e4-1110-4145-9fae-9996ac3b508b">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTItOS0xLTEtMjEyNg_01166415-f745-4024-b0f8-7afb8f502b96">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTItMTEtMS0xLTIxMjY_12138cd0-57f6-4802-bc95-7e727d783d99">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains/(losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTUtMS0xLTEtODg4_fd0f362d-de99-4f80-acb9-58a0a45fc568">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTUtMy0xLTEtODkx_304e48b2-a350-4e77-93c2-dc93a8171d81">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTUtNS0xLTEtODk0_ba13611c-2e1b-42c2-b2a9-70b47e482229">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTUtNy0xLTEtODUy_3f19d5b0-e7c8-4291-bd56-70f670fba781">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTUtOS0xLTEtODU4_e7449d60-fc1e-408c-acaa-b45031ca91d6">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTUtMTEtMS0xLTg2MQ_1cf6efd9-e006-4c68-b92d-210577cdfaca">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTYtMS0xLTEtODg4_ce591d06-ada6-434f-a8cf-b477f436273d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTYtMy0xLTEtODkx_2fbf743e-9afb-4a3f-aa74-5889430ad7ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTYtNS0xLTEtODk0_91f367fe-b225-43f0-a808-5a9e864d5a44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTYtNy0xLTEtODUy_2d27852b-3fe8-42f3-8e87-f07cda2c9fdd">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTYtOS0xLTEtODU4_e69d5019-8043-4b56-9bf6-5882731b30af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTYtMTEtMS0xLTg2MQ_b8de9899-3889-4f33-9d05-3d7977a65b81">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTctMS0xLTEtMjEyOA_5e163283-2e98-4051-a289-fa985b623319">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTctMy0xLTEtMjEyOA_fe809c00-d43b-4069-8eec-7a14078e2beb">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTctNS0xLTEtMjEyOA_30778ba1-b279-4d8c-b7a4-1cd9ad3e69c2">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTctNy0xLTEtMjEyOA_806ff115-c799-4b22-b806-b0a4f5ad70f3">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTctOS0xLTEtMjEyOA_b5d10837-3f52-413b-a164-53881d46aec6">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTctMTEtMS0xLTIxMjg_24c1e161-1d54-4cb0-8b97-62dfc8912c55">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTktMS0xLTEtOTAx_04e63f78-29ad-43ea-b965-5e158cba93f2">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTktMy0xLTEtOTA0_bf4bc0da-88e2-4d3f-8a11-a05273a8ac0f">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTktNS0xLTEtOTA3_45de0912-ad22-4901-8924-779558734ede">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTctNy0xLTEtNzQ0_955035a3-0197-4983-8b13-5204e2d8ed70">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTktOS0xLTEtODY1_42a8eecc-844e-49e3-8808-d21e5570a0e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTktMTEtMS0xLTIxMzA_01b9b645-1d8f-4237-b8ca-32dd42ca562a">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income/(Loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMjEtMS0xLTEtMjEzMA_c62dc9f1-f567-4819-8ea9-88eaeff54988">363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMjEtMy0xLTEtMjEzMA_6026c026-21ad-4070-ae00-8dddd972e13a">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMjEtNS0xLTEtMjEzMA_788dea03-9281-41fb-bedc-c720e6821694">321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMjEtNy0xLTEtMjEzMA_3bb7fd92-d104-45f2-a3ab-d32b7ceca437">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMjEtOS0xLTEtMjEzMA_1592399c-120c-4fc5-bc50-d51c6d5e9c99">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMjEtMTEtMS0xLTIxMzA_773726c1-6250-48a4-906c-3665863f5297">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Included in Cost of products sold.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Included in Other (income)/expense, net.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i993236ba82cf48079f5b8c634d6c66bd"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMTU1MQ_eae4d2ad-089e-4ece-8073-635ac4eac045" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accumulated balances related to each component of Other Comprehensive Income/(Loss), net of taxes, were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjkzMmFkOGIwMjMwMDRhOWZiMWZkYmEwZTg1OGZhOWJjL3RhYmxlcmFuZ2U6OTMyYWQ4YjAyMzAwNGE5ZmIxZmRiYTBlODU4ZmE5YmNfMS0xLTEtMS0w_2c08c082-34d0-4d47-b571-8b372a260658">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjkzMmFkOGIwMjMwMDRhOWZiMWZkYmEwZTg1OGZhOWJjL3RhYmxlcmFuZ2U6OTMyYWQ4YjAyMzAwNGE5ZmIxZmRiYTBlODU4ZmE5YmNfMS0zLTEtMS0w_4dd85c4d-c35c-44f3-a16a-b8faaf43b8fb">237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjkzMmFkOGIwMjMwMDRhOWZiMWZkYmEwZTg1OGZhOWJjL3RhYmxlcmFuZ2U6OTMyYWQ4YjAyMzAwNGE5ZmIxZmRiYTBlODU4ZmE5YmNfMi0xLTEtMS0w_be4a5e7c-24b1-4c7b-96f1-42cee5634c38">936</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjkzMmFkOGIwMjMwMDRhOWZiMWZkYmEwZTg1OGZhOWJjL3RhYmxlcmFuZ2U6OTMyYWQ4YjAyMzAwNGE5ZmIxZmRiYTBlODU4ZmE5YmNfMi0zLTEtMS0w_ad774f40-bf62-4993-a97a-48c831a2afb5">974</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjkzMmFkOGIwMjMwMDRhOWZiMWZkYmEwZTg1OGZhOWJjL3RhYmxlcmFuZ2U6OTMyYWQ4YjAyMzAwNGE5ZmIxZmRiYTBlODU4ZmE5YmNfMy0xLTEtMS0w_b48ac37e-2219-4c74-b5d7-7ca915a27625">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjkzMmFkOGIwMjMwMDRhOWZiMWZkYmEwZTg1OGZhOWJjL3RhYmxlcmFuZ2U6OTMyYWQ4YjAyMzAwNGE5ZmIxZmRiYTBlODU4ZmE5YmNfMy0zLTEtMS0w_ed1d6d9a-8029-4eb0-8323-fc87a2bfbdf6">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjkzMmFkOGIwMjMwMDRhOWZiMWZkYmEwZTg1OGZhOWJjL3RhYmxlcmFuZ2U6OTMyYWQ4YjAyMzAwNGE5ZmIxZmRiYTBlODU4ZmE5YmNfNC0xLTEtMS0w_1facffcb-f82e-4254-9128-b9ac8884bb61">638</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjkzMmFkOGIwMjMwMDRhOWZiMWZkYmEwZTg1OGZhOWJjL3RhYmxlcmFuZ2U6OTMyYWQ4YjAyMzAwNGE5ZmIxZmRiYTBlODU4ZmE5YmNfNC0zLTEtMS0w_b3ed0033-f387-481a-bb3a-9426db454f68">639</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjkzMmFkOGIwMjMwMDRhOWZiMWZkYmEwZTg1OGZhOWJjL3RhYmxlcmFuZ2U6OTMyYWQ4YjAyMzAwNGE5ZmIxZmRiYTBlODU4ZmE5YmNfNS0xLTEtMS0w_6ca4f1d7-cafd-4ef1-ac8d-e73869d2f358">1,518</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjkzMmFkOGIwMjMwMDRhOWZiMWZkYmEwZTg1OGZhOWJjL3RhYmxlcmFuZ2U6OTMyYWQ4YjAyMzAwNGE5ZmIxZmRiYTBlODU4ZmE5YmNfNS0zLTEtMS0w_46442cb6-95ff-47c7-9c52-fe28f973b0e7">1,839</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_88"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 16. <ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RleHRyZWdpb246YjcyOTg1NTI3ZjJjNDExMTk5YmIyNDdhMTM5ZjA3OTRfMzg1_82b3283e-62a6-4420-a643-d53d2cc90125" continuedAt="icaf1e15b462e48829813879621db744d" escape="true">EMPLOYEE STOCK BENEFIT PLANS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="icaf1e15b462e48829813879621db744d"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RleHRyZWdpb246YjcyOTg1NTI3ZjJjNDExMTk5YmIyNDdhMTM5ZjA3OTRfMzg5_024dcda9-2768-4ba9-b435-10b5ce15018a" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense was as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.571%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5f7660b6eca475a9df8e628fa445af7_D20210401-20210630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfMi0xLTEtMS0w_b3a0dcb8-4ab5-46cf-8d3d-450a9dd51382">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i635494ce148e4ad7bd650508b31a47f5_D20200401-20200630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfMi0zLTEtMS0w_16506dc5-e46a-410b-b399-6a8f473c6398">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i458d77e2e80747db91d6733fb12cc6f3_D20210101-20210630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfMi01LTEtMS0w_93e6c1ef-9a1b-4262-95fe-51786c0be242">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic61bae9f14c94630811f2853573f8ff6_D20200101-20200630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfMi03LTEtMS0w_59dc588b-48f7-438f-8e88-d8504ae2c9f9">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dec6245873f4d98820e4a2b35667387_D20210401-20210630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfMy0xLTEtMS0w_b4c3969d-d133-4a3f-bac2-0027b97179cb">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6778a15e516498f97f88c860749c6a2_D20200401-20200630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfMy0zLTEtMS0w_e87fc75e-7761-4084-a109-a5905dafd0be">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d23efb083df4012b861cdd74c430462_D20210101-20210630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfMy01LTEtMS0w_bca217aa-8464-4db9-83a7-e3123ee78cc2">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33981b78822f4f77be3c382064085973_D20200101-20200630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfMy03LTEtMS0w_6abc0c5b-51b6-43f4-8caa-b2e89f79deb9">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c126874d2714146b7bf5cbc485c1cf8_D20210401-20210630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfNC0xLTEtMS0w_d859ff73-c95e-462e-9953-7a88be05c683">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41d5a334a6e142f8bd67b8e51060b87f_D20200401-20200630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfNC0zLTEtMS0w_cc6dd573-81a0-4046-a3f0-ffe86a6390aa">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4662da4bb2b6479993d2a5b55ba2078b_D20210101-20210630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfNC01LTEtMS0w_2e6756fd-8269-4c10-9157-9ee5f07aad29">144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5431747aab134732bd974c5723251eef_D20200101-20200630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfNC03LTEtMS0w_ffd26b92-e251-4e24-8551-63c54d70c2d3">183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id74cc59095d040258cf00ef2e809efa0_D20210401-20210630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfNS0xLTEtMS0w_1da6464d-ece6-418c-9741-0e86187cf9c2">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ec7443f41ce4644b7444730381aeb04_D20200401-20200630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfNS0zLTEtMS0w_e119bb04-3262-487b-a2e6-b275cd459298">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2da4dc33dbfe427290747f6b3396e0bc_D20210101-20210630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfNS01LTEtMS0w_ebb62f39-bf32-4736-94e5-c763148f19f9">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c94d13219ab428992afd3b5b0c2e8aa_D20200101-20200630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfNS03LTEtMS0w_f1a05bd1-80f4-4961-82b6-615875fabdbf">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfNi0xLTEtMS0w_6d306dfe-4e90-4a0f-9707-6bc3a6748271">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfNi0zLTEtMS0w_c26ae1d7-14ca-429c-82e4-975d0dbe70f8">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfNi01LTEtMS0yMTM1_850193e6-7759-43b1-b046-0f3f3cf39abb">308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfNi03LTEtMS0yMTM1_86333117-39c7-415a-847b-93b21519f6cb">423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfOC0xLTEtMS0w_216b9752-2bd2-4018-92d9-f6227f7144f4">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfOC0zLTEtMS0w_8e8cfa2f-54b6-4772-b491-20c0ae355b61">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfOC01LTEtMS0w_feaa5b1b-f3c5-4de8-957c-ca67d89bf4ea">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfOC03LTEtMS0w_d61244ed-822b-4ea1-89d0-00dfd0572c69">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Income tax benefit excludes excess tax benefits from share-based compensation awards that were vested or exercised of $<ix:nonFraction unitRef="usd" contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsAndExcessTaxBenefitFromSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RleHRyZWdpb246YjcyOTg1NTI3ZjJjNDExMTk5YmIyNDdhMTM5ZjA3OTRfMjE3_bbfb83bb-6370-4239-beb5-194a7bed93e6">12</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsAndExcessTaxBenefitFromSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RleHRyZWdpb246YjcyOTg1NTI3ZjJjNDExMTk5YmIyNDdhMTM5ZjA3OTRfMjI0_b2ad16e5-f918-483e-9b2f-bf18cd177c10">29</ix:nonFraction> million for the three and six months ended June&#160;30, 2021 and $<ix:nonFraction unitRef="usd" contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsAndExcessTaxBenefitFromSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RleHRyZWdpb246YjcyOTg1NTI3ZjJjNDExMTk5YmIyNDdhMTM5ZjA3OTRfMTA5OTUxMTYyODIxMA_fc133dad-9a06-4293-afb9-e5927aea4996">5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsAndExcessTaxBenefitFromSharebasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RleHRyZWdpb246YjcyOTg1NTI3ZjJjNDExMTk5YmIyNDdhMTM5ZjA3OTRfMTA5OTUxMTYyODIwMQ_13082c1b-b1c3-4af6-adaf-ce0ad95aec13">28</ix:nonFraction> million for the three and six months ended June&#160;30, 2020, respectively.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="bmy:ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RleHRyZWdpb246YjcyOTg1NTI3ZjJjNDExMTk5YmIyNDdhMTM5ZjA3OTRfMzg3_7f75c764-fc8a-4638-a0d0-d39939adc459" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of units granted and the weighted-average fair value on the grant date for the six months ended June 30, 2021 were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Units in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Fair Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i802d457ae3ce494fba78c18db7fb4724_D20210401-20210630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjk5YzA0NWMyYzg5MDRhNTJhOGI4MGUwMzFiMWY2ZThhL3RhYmxlcmFuZ2U6OTljMDQ1YzJjODkwNGE1MmE4YjgwZTAzMWIxZjZlOGFfMi0xLTEtMS0w_6bda3707-23fa-4876-b387-e6fa377d12f0">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i802d457ae3ce494fba78c18db7fb4724_D20210401-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjk5YzA0NWMyYzg5MDRhNTJhOGI4MGUwMzFiMWY2ZThhL3RhYmxlcmFuZ2U6OTljMDQ1YzJjODkwNGE1MmE4YjgwZTAzMWIxZjZlOGFfMi0zLTEtMS0w_72e8ae24-6f26-422c-9dfa-b56ae3dbdabe">56.62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iae0c6db08abe4f8aaa95195fc68dcb83_D20210401-20210630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjk5YzA0NWMyYzg5MDRhNTJhOGI4MGUwMzFiMWY2ZThhL3RhYmxlcmFuZ2U6OTljMDQ1YzJjODkwNGE1MmE4YjgwZTAzMWIxZjZlOGFfMy0xLTEtMS0w_d48bf36e-f436-48f1-816c-43cca8ed42e0">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iae0c6db08abe4f8aaa95195fc68dcb83_D20210401-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjk5YzA0NWMyYzg5MDRhNTJhOGI4MGUwMzFiMWY2ZThhL3RhYmxlcmFuZ2U6OTljMDQ1YzJjODkwNGE1MmE4YjgwZTAzMWIxZjZlOGFfMy0zLTEtMS0w_e23697e6-d1c1-4d23-ab55-f9ba303c3a7d">58.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8a0d23cf191d49859d545cf81fc83b99_D20210401-20210630" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjk5YzA0NWMyYzg5MDRhNTJhOGI4MGUwMzFiMWY2ZThhL3RhYmxlcmFuZ2U6OTljMDQ1YzJjODkwNGE1MmE4YjgwZTAzMWIxZjZlOGFfNC0xLTEtMS0w_da0a9dfc-cf30-4295-81be-2906fa5bc8e9">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8a0d23cf191d49859d545cf81fc83b99_D20210401-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjk5YzA0NWMyYzg5MDRhNTJhOGI4MGUwMzFiMWY2ZThhL3RhYmxlcmFuZ2U6OTljMDQ1YzJjODkwNGE1MmE4YjgwZTAzMWIxZjZlOGFfNC0zLTEtMS0w_c8c5e5d5-5fd0-4916-bec0-3fb59a572a0d">59.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RleHRyZWdpb246YjcyOTg1NTI3ZjJjNDExMTk5YmIyNDdhMTM5ZjA3OTRfMzg4_1173e4cc-2d2f-4974-b723-1680ac1c9163" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:50.082%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.587%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock&#160;Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Market Share&#160;Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Share Units</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized compensation cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb9926c1623d4307b449847e25ccb9a6_I20210630" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjY5ZDUxMTg4ZTgxMDQ4MTJiMTFiZDlhMjg1OThhYzdkL3RhYmxlcmFuZ2U6NjlkNTExODhlODEwNDgxMmIxMWJkOWEyODU5OGFjN2RfMS0xLTEtMS0w_39d19951-dbe8-4f9b-9d94-001138a0be90">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a59bc20a4164faa942cd6df346323f9_I20210630" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjY5ZDUxMTg4ZTgxMDQ4MTJiMTFiZDlhMjg1OThhYzdkL3RhYmxlcmFuZ2U6NjlkNTExODhlODEwNDgxMmIxMWJkOWEyODU5OGFjN2RfMS0zLTEtMS0w_742015a4-0792-4b85-ba95-8c30cf389ef4">953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2259fe062d9455c84a896e821c65d2f_I20210630" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjY5ZDUxMTg4ZTgxMDQ4MTJiMTFiZDlhMjg1OThhYzdkL3RhYmxlcmFuZ2U6NjlkNTExODhlODEwNDgxMmIxMWJkOWEyODU5OGFjN2RfMS01LTEtMS0w_aea0570a-e1e2-4850-a02a-ef2f73e3629b">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8621d1eb8ad941d1b61fc0b3eb0c0104_I20210630" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjY5ZDUxMTg4ZTgxMDQ4MTJiMTFiZDlhMjg1OThhYzdkL3RhYmxlcmFuZ2U6NjlkNTExODhlODEwNDgxMmIxMWJkOWEyODU5OGFjN2RfMS03LTEtMS0w_5796d1b9-9d80-4d2e-a391-947a94c0361b">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected weighted-average period in years of compensation cost to be recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5d714c61f30d48e6a0408831871d837e_D20210401-20210630" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjY5ZDUxMTg4ZTgxMDQ4MTJiMTFiZDlhMjg1OThhYzdkL3RhYmxlcmFuZ2U6NjlkNTExODhlODEwNDgxMmIxMWJkOWEyODU5OGFjN2RfMi0xLTEtMS0w_72635115-7a2c-436b-91c3-1f2373cbc138">0.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i802d457ae3ce494fba78c18db7fb4724_D20210401-20210630" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjY5ZDUxMTg4ZTgxMDQ4MTJiMTFiZDlhMjg1OThhYzdkL3RhYmxlcmFuZ2U6NjlkNTExODhlODEwNDgxMmIxMWJkOWEyODU5OGFjN2RfMi0zLTEtMS0w_c7056674-ca36-4a3a-ad1b-c9af4b93484e">2.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iae0c6db08abe4f8aaa95195fc68dcb83_D20210401-20210630" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjY5ZDUxMTg4ZTgxMDQ4MTJiMTFiZDlhMjg1OThhYzdkL3RhYmxlcmFuZ2U6NjlkNTExODhlODEwNDgxMmIxMWJkOWEyODU5OGFjN2RfMi01LTEtMS0w_1fcab79b-426f-4482-b1d3-91318e1bc248">3.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8a0d23cf191d49859d545cf81fc83b99_D20210401-20210630" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjY5ZDUxMTg4ZTgxMDQ4MTJiMTFiZDlhMjg1OThhYzdkL3RhYmxlcmFuZ2U6NjlkNTExODhlODEwNDgxMmIxMWJkOWEyODU5OGFjN2RfMi03LTEtMS0w_4785df13-eaa6-4c3f-bdc0-68bfed572abc">2.0</ix:nonNumeric></span></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_91"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 17. <ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="us-gaap:LegalMattersAndContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfMzgxNzk_5cf39342-a887-4029-838e-13b82c14b850" continuedAt="i636666a40064428c84c93e23a6e74864" escape="true">LEGAL PROCEEDINGS AND CONTINGENCIES</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i636666a40064428c84c93e23a6e74864" continuedAt="i758cf8bf4d8044eeb15568903dfce7eb"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and certain of its subsidiaries are involved in various lawsuits, claims, government investigations and other legal proceedings that arise in the ordinary course of business. These claims or proceedings can involve various types of parties, including governments, competitors, customers, suppliers, service providers, licensees, employees, or shareholders, among others. These matters may involve patent infringement, antitrust, securities, pricing, sales and marketing practices, environmental, commercial, contractual rights, licensing obligations, health and safety matters, consumer fraud, employment matters, product liability and insurance coverage, among others. The resolution of these matters often develops over a long period of time and expectations can change as a result of new findings, rulings, appeals or settlement arrangements. Legal proceedings that are significant or that BMS believes could become significant or material are described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While BMS does not believe that any of these matters, except as otherwise specifically noted below, will have a material adverse effect on its financial position or liquidity as BMS believes it has substantial defenses in the matters, the outcomes of BMS&#8217;s legal proceedings and other contingencies are inherently unpredictable and subject to significant uncertainties. There can be no assurance that there will not be an increase in the scope of one or more of these pending matters or any other or future lawsuits, claims, government investigations or other legal proceedings will not be material to BMS&#8217;s financial position, results of operations or cash flows for a particular period. Furthermore, failure to enforce BMS&#8217;s patent rights would likely result in substantial decreases in the respective product revenues from generic competition.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i758cf8bf4d8044eeb15568903dfce7eb" continuedAt="i0cda24064f6445ddb946486eb2360885"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise noted, BMS is unable to assess the outcome of the respective matters nor is it able to estimate the possible loss or range of losses that could potentially result for such matters. Contingency accruals are recognized when it is probable that a liability will be incurred and the amount of the related loss can be reasonably estimated. Developments in legal proceedings and other matters that could cause changes in the amounts previously accrued are evaluated each reporting period. For a discussion of BMS&#8217;s tax contingencies, see &#8220;&#8212;Note&#160;7. Income Taxes&#8221;.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTELLECTUAL PROPERTY</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-PD-1 Antibody Litigation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2015, Dana-Farber Cancer Institute (&#8220;Dana-Farber&#8221;) filed a complaint in the U.S. District Court for the District of Massachusetts seeking to correct the inventorship on up to <ix:nonFraction unitRef="number" contextRef="i00042bb08bc247c88f649c75d7bbb73f_D20210401-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPatentsAllegedlyInfringedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfMjY4NA_cea46598-0c06-48cd-8f23-601a38556fa1">six</ix:nonFraction> related U.S. patents directed to methods of treating cancer using PD-1 and PD-L1 antibodies. Specifically, Dana-Farber is seeking to add two scientists as inventors to these patents. In October 2017, Pfizer was allowed to intervene in this case alleging that one of the scientists identified by Dana-Farber was employed by a company eventually acquired by Pfizer during the relevant period. In February 2019, BMS settled the lawsuit with Pfizer. A bench trial in the lawsuit with Dana-Farber took place in February 2019. In May 2019, the District Court issued an opinion ruling that the two scientists should be added as inventors to the patents, which was affirmed on appeal. In May 2021, the U.S. Supreme Court declined to consider the case. In June 2019, Dana-Farber filed a new lawsuit in the District of Massachusetts against BMS seeking damages as a result of the Court&#8217;s decision adding the scientists as inventors. In February 2021, BMS filed a motion to dismiss the complaint.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAR T</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2017, Juno and Sloan Kettering Institute for Cancer Research (&#8220;SKI&#8221;) filed a complaint for patent infringement against Kite Pharma, Inc. (&#8220;Kite&#8221;) in the U.S. District Court for the Central District of California. The complaint alleged that Kite&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product infringes certain claims of U.S. Patent No. 7,446,190 (the &#8220;&#8217;190 Patent&#8221;) concerning CAR T cell technologies. Kite filed an answer and counterclaims asserting non-infringement and invalidity of the &#8217;190 Patent. In December 2019, following an eight-day trial, the jury rejected Kite&#8217;s defenses, finding that Kite willfully infringed the &#8217;190 Patent and awarding to Juno and SKI a reasonable royalty consisting of a $585 million upfront payment and a 27.6% running royalty on Kite&#8217;s sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> through the expiration of the &#8217;190 Patent in August 2024. In January 2020, Kite renewed its previous motion for judgment as a matter of law and also moved for a new trial, and Juno filed a motion seeking enhanced damages, supplemental damages, ongoing royalties, and prejudgment interest. In March 2020, the Court denied both of Kite&#8217;s motions in their entirety. In April 2020, the Court granted in part Juno&#8217;s motion and entered a final judgment awarding to Juno and SKI approximately $<ix:nonFraction unitRef="usd" contextRef="i6f6c2befa4b34a0a81ba3b0e9556df39_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfNTE4Ng_a5b78ab3-2894-4e30-8158-9d41755897f4">1.2</ix:nonFraction> billion in royalties, interest and enhanced damages and a <ix:nonFraction unitRef="usd" contextRef="i2468cf0aaf4c49ab87c383ed553537e0_I20210630" decimals="3" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfNTIzOQ_8b4bc53e-ce71-4836-9f9b-18552d6858d3">27.6</ix:nonFraction>% running royalty on Kite&#8217;s sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* from December 13, 2019 through the expiration of the &#8217;190 Patent in August 2024. In April 2020, Kite appealed the final judgment to the U.S. Court of Appeals for the Federal Circuit and the Court held an oral hearing on July 6, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8211; Europe</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020 and January 2021, Sandoz Limited (&#8220;Sandoz&#8221;) and Teva Pharmaceutical Industries Ltd. (&#8220;Teva Limited&#8221;), respectively, filed lawsuits in the United Kingdom seeking revocation of the UK apixaban composition of matter patent and related Supplementary Protection Certificate. BMS subsequently filed counterclaims for infringement in both actions. A trial is scheduled to begin in early 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are similar lawsuits filed in the Republic of Ireland, the Netherlands and Sweden seeking revocation of a composition of matter patent relating to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional infringement and invalidity actions involving </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patents may be filed in various countries in Europe in the coming months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, BMS received Notice Letters from <ix:nonFraction unitRef="number" contextRef="i64a8873ecda74aafb2ceeed0be390c87_D20210401-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfNjA5Ng_159473ed-6a66-4df2-b02c-8932a78ce777">twenty-five</ix:nonFraction>&#160;generic companies notifying BMS that they had filed aNDAs containing paragraph IV certifications seeking approval of generic versions of&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As a result, <ix:nonFraction unitRef="number" contextRef="i64a8873ecda74aafb2ceeed0be390c87_D20210401-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPatentsAllegedlyInfringedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfNjI1OA_912c8422-cf75-414e-9fa6-ab9abf1a0e24">two</ix:nonFraction>&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;patents listed in the FDA Orange Book are being challenged: the composition of matter patent claiming apixaban specifically and a formulation patent. In response, BMS, along with its partner Pfizer, initiated patent infringement actions under the Hatch-Waxman Act against all generic filers in the U.S. District Court for the District of Delaware in April 2017. In August 2017, the U.S. Patent and Trademark Office granted patent term restoration to the composition of matter patent to November 2026, thereby restoring the term of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> composition of matter patent, which is BMS&#8217;s basis for projected LOE. BMS settled with a number of aNDA filers. These settlements do not affect BMS&#8217;s projected LOE for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A trial with the remaining aNDA filers took place in late 2019. In August 2020, the U.S. District Court issued a decision finding that the remaining aNDA filers&#8217; products infringed the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> composition of matter and formulation patents and that both </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patents are not invalid. The remaining aNDA filers have appealed to the U.S. Court of Appeals for the Federal Circuit. The oral argument for the appeal is scheduled to occur in September 2021.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0cda24064f6445ddb946486eb2360885" continuedAt="ic853a3eb97224d8f89c64c82f5b17d69"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - Australia</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sanofi was notified that, in August 2007, GenRx Proprietary Limited (&#8220;GenRx&#8221;) obtained regulatory approval of an application for clopidogrel bisulfate 75mg tablets in Australia. GenRx, formerly a subsidiary of Apotex Inc., subsequently changed its name to Apotex (&#8220;GenRx-Apotex&#8221;). In August 2007, GenRx-Apotex filed an application in the Federal Court of Australia seeking revocation of Sanofi&#8217;s Australian Patent No.&#160;597784 (Case No. NSD 1639 of 2007). Sanofi filed counterclaims of infringement and sought an injunction. On September&#160;21, 2007, the Federal Court of Australia granted Sanofi&#8217;s injunction. A subsidiary of BMS was subsequently added as a party to the proceedings. In February 2008, a second company, Spirit Pharmaceuticals Pty. Ltd., also filed a revocation suit against the same patent. This case was consolidated with the GenRx-Apotex case. On August&#160;12, 2008, the Federal Court of Australia held that claims of Patent No.&#160;597784 covering clopidogrel bisulfate, hydrochloride, hydrobromide, and taurocholate salts were valid. The Federal Court also held that the process claims, pharmaceutical composition claims, and claim directed to clopidogrel and its pharmaceutically acceptable salts were invalid. BMS and Sanofi filed notices of appeal in the Full Court of the Federal Court of Australia (&#8220;Full Court&#8221;) appealing the holding of invalidity of the claim covering clopidogrel and its pharmaceutically acceptable salts, process claims, and pharmaceutical composition claims. GenRx-Apotex appealed the holding of validity of the clopidogrel bisulfate, hydrochloride, hydrobromide, and taurocholate claims. On September&#160;29, 2009, the Full Court held all of the claims of Patent No.&#160;597784 invalid. In March 2010, the High Court of Australia denied a request by BMS and Sanofi to hear an appeal of the Full Court decision. The case was remanded to the Federal Court for further proceedings related to damages sought by GenRx-Apotex. BMS and GenRx-Apotex settled, and the GenRx-Apotex case was dismissed. The Australian government intervened in this matter seeking maximum damages up to <ix:nonFraction unitRef="usd" contextRef="ibd94bed0537c407e93ce5a3d80b707af_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfOTQ5NA_97f19b97-706c-4266-b586-9376d620b369">449</ix:nonFraction> million AUD ($<ix:nonFraction unitRef="usd" contextRef="ia4e7cac4d7fc407bbf7a0cfcc8e6a83f_I20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfOTUwMg_6e9e094f-ba8b-4450-9a1f-29f265dbc4c0">341</ix:nonFraction> million), plus interest, which would be split between BMS and Sanofi, for alleged losses experienced for paying a higher price for branded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> during the period when the injunction was in place. BMS and Sanofi dispute that the Australian government is entitled to any damages. A trial was concluded in September 2017. In April 2020, the Federal Court issued a decision dismissing the Australian government&#8217;s claim for damages. In May 2020, the Australian government appealed the Federal Court&#8217;s decision and an appeal hearing concluded in February 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pomalyst </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">- Canada</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Celgene received a Notice of Allegation in January 2020 from Natco Pharma (Canada) Inc. (&#8220;Natco Canada&#8221;) notifying Celgene that it had filed an Abbreviated New Drug Submission (&#8220;aNDS&#8221;) with Canada&#8217;s Minister of Health with respect to certain of Celgene&#8217;s Canadian patents. Natco Canada is seeking to market a generic version of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Canada. In response, Celgene initiated a patent infringement action in the Federal Court of Canada. Natco Canada alleges that the asserted patents are invalid and/or not infringed. A trial is scheduled to begin in November 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Celgene received a second Notice of Allegation in November 2020 from Natco Canada notifying Celgene that it had filed a second aNDS with Canada&#8217;s Minister of Health with respect to certain of Celgene&#8217;s Canadian patents. In response, Celgene initiated a patent infringement action in the Federal Court of Canada. Natco Canada alleges that the asserted patents are invalid and/or not infringed. A trial is scheduled to begin in May 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Celgene received four Notices of Allegation in February 2021 from Apotex Inc. notifying Celgene that it had filed two aNDSs with Canada&#8217;s Minister of Health with respect to certain of Celgene&#8217;s Canadian patents. Apotex Inc. is seeking to market a generic version of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Canada. In response, in April 2021, Celgene initiated patent infringement actions against Apotex Inc. in the Federal Court of Canada. In July 2021, Celgene and Apotex Inc. entered into a confidential settlement agreement and the cases were discontinued.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in 2017, Celgene received Notice letters on behalf of Apotex Inc. and Apotex Corp. (together, &#8220;Apotex&#8221;); Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero Drugs Limited, Hetero USA, Inc. (collectively, &#8220;Hetero&#8221;); Eugia Pharma Specialities Limited, Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., and Aurolife Pharma LLC (collectively, &#8220;Aurobindo&#8221;); and Mylan Pharmaceuticals Inc. notifying Celgene that they had filed aNDAs containing paragraph IV certifications seeking approval to market generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. In response, Celgene filed patent infringement actions against the companies in the U.S. District Court for the District of New Jersey asserting certain FDA Orange Book-listed patents and the companies filed answers, counterclaims and declaratory judgment actions alleging that the asserted patents are invalid, unenforceable, and not infringed. These litigations were subsequently consolidated. In March 2020, Celgene subsequently filed additional patent infringement actions in the U.S. District Court for the District of New Jersey against each of the companies asserting a newly-issued patent that is listed in the FDA Orange Book and that covers formulations comprising pomalidomide. The companies each filed responsive pleadings alleging that the patent is invalid and not infringed. The Court has consolidated these additional litigations with the previously-consolidated litigations. In September 2020, the Court granted Mylan Pharmaceuticals Inc.&#8217;s motion to dismiss, which decision Celgene has appealed. In October 2020, Aurobindo received final approval from the FDA of its aNDA. In April and July 2021, Celgene entered into confidential settlement agreements with Apotex and Aurobindo, respectively, settling all outstanding claims in the litigation with Apotex and Aurobindo. Trial against the remaining defendant, Hetero, is set for November 2021.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic853a3eb97224d8f89c64c82f5b17d69" continuedAt="if3204d6502de489a8cf186c26e388e3d"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February and March 2019, Celgene filed additional patent infringement actions in the U.S. District Court for the District of New Jersey against the companies asserting certain patents that are not listed in the FDA Orange Book and that cover polymorphic forms of pomalidomide, and the companies filed answers and/or counterclaims alleging that each of these patents is invalid and/or not infringed. These actions have been consolidated with the earlier-filed actions against the companies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2019, Celgene received a Notice Letter from Dr. Reddy&#8217;s Laboratories, Ltd. and Dr. Reddy&#8217;s Laboratories, Inc. (together, &#8220;DRL&#8221;) notifying Celgene that they had filed an aNDA containing paragraph IV certifications seeking approval to market a generic version of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. In response, Celgene initiated a patent infringement action against DRL in the U.S. District Court for the District of New Jersey asserting certain FDA Orange Book-listed patents, and DRL filed an answer and counterclaims alleging that each of the patents is invalid and/or not infringed. In March 2020, Celgene filed an additional patent infringement action in the U.S. District Court for the District of New Jersey against DRL asserting a newly-issued patent that is listed in the FDA Orange Book and that covers formulations comprising pomalidomide, which has been consolidated with the above DRL case. In April 2021, DRL received tentative approval from the FDA of its aNDA. The Court has not set a trial date in this consolidated action.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, Celgene filed an additional patent infringement action in the U.S. District Court for the District of New Jersey against DRL asserting certain patents that are not listed in the FDA Orange Book and that cover polymorphic forms of pomalidomide. No trial date has been set for this matter.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Celgene has received Notice Letters on behalf of Sun Pharma Global FZE, Sun Pharma Global Inc., Sun Pharmaceutical Industries, Inc., and Sun Pharmaceutical Industries Limited (collectively, &#8220;Sun&#8221;); Hetero; Mylan Pharmaceuticals Inc., Mylan Inc., and Mylan N.V. (collectively, &#8220;Mylan&#8221;); Aurobindo; Lupin Limited (&#8220;Lupin&#8221;); Hikma Pharmaceuticals USA, Inc.; Biocon Pharma Limited, Biocon Limited, and Biocon Pharma, Inc.; and Torrent Pharmaceuticals Limited and Torrent Pharma Inc. notifying Celgene that they had filed aNDAs containing paragraph IV certifications seeking approval to market generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. In response, Celgene filed patent infringement actions against the companies in the U.S. District Court for the District of New Jersey asserting certain FDA Orange Book-listed patents as well as other litigations asserting other non-FDA Orange Book-listed patents against certain defendants, who have filed answers and/or counterclaims alleging that the asserted patents are invalid and/or not infringed. No trial date has been scheduled in any of these New Jersey actions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Celgene also filed a patent infringement action against Mylan in the U.S. District Court for the Northern District of West Virginia asserting certain FDA Orange Book-listed patents and other non-FDA Orange Book-listed patents. Mylan filed its answer and counterclaims alleging that the patents are invalid and/or not infringed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June and July 2021, Celgene entered into confidential settlement agreements with Sun, Aurobindo, and Mylan, respectively, settling all outstanding claims in the litigations with Sun, Aurobindo, and Mylan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sprycel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, BMS received a Notice Letter from Dr. Reddy&#8217;s Laboratories, Inc. notifying BMS that it had filed an aNDA containing paragraph IV certifications seeking approval of a generic version of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sprycel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. and challenging two FDA Orange Book-listed monohydrate form patents expiring in 2025 and 2026. In response, BMS filed a patent infringement action in the U.S. District Court for the District of New Jersey.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, BMS received a Notice Letter from Lupin notifying BMS that it had filed an aNDA containing paragraph IV certifications seeking approval of a generic version of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sprycel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. and challenging two FDA Orange Book-listed monohydrate form patents expiring in 2025 and 2026. In response, BMS filed patent infringement actions in the U.S. District Courts for the District of New Jersey and Delaware. The case in Delaware has been dismissed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, BMS entered into confidential settlement agreements with Dr. Reddy&#8217;s Laboratories, Inc. and Lupin, settling all outstanding claims in the litigations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRICING, SALES AND PROMOTIONAL PRACTICES LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> State Attorneys General Lawsuits</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and certain Sanofi entities are defendants in consumer protection actions brought by the attorneys general of Hawaii and New Mexico relating to the labeling, sales and/or promotion of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*. A trial in the Hawaii matter occurred in 2020. In February 2021, the Court issued a decision against Sanofi and BMS, imposing penalties in the total amount of $834 million, with $417&#160;million attributed to BMS. Sanofi and BMS disagree with the decision and are appealing it. BMS remains confident in the merits of its case and its likelihood of success on appeal and BMS does not believe establishing a reserve is warranted for this matter. A trial in the New Mexico matter is scheduled to begin in April 2022.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="if3204d6502de489a8cf186c26e388e3d" continuedAt="i7751004810d54eaa80959b5c7e1303a3"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRODUCT LIABILITY LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS is a party to various product liability lawsuits. Plaintiffs in these cases seek damages and other relief on various grounds for alleged personal injury and economic loss. As previously disclosed, in addition to lawsuits, BMS also faces unfiled claims involving its products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Abilify*</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and Otsuka are co-defendants in product liability litigation related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Plaintiffs allege </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> caused them to engage in compulsive gambling and other impulse control disorders. There have been over <ix:nonFraction unitRef="lawsuits" contextRef="i86db086f990f485eae2c529279a9b3be_I20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfMjAyNjQ_8d857132-034b-45b3-b447-55bfa98da6bf">2,500</ix:nonFraction> cases filed in state and federal courts and additional cases are pending in Canada. The Judicial Panel on Multidistrict Litigation consolidated the federal court cases for pretrial purposes in the U.S. District Court for the Northern District of Florida. In February 2019, BMS and Otsuka entered into a master settlement agreement establishing a proposed settlement program to resolve all </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> compulsivity claims filed as of January 28, 2019 in the MDL as well as various state courts, including California and New Jersey. To date, approximately <ix:nonFraction unitRef="lawsuits" contextRef="i69bcd074cc8f40729d45455b3b8c32f0_I20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfMjA4MTg_8dfff0d2-57d4-443b-bbb6-be7eba6b3ce5">2,700</ix:nonFraction> cases, comprising approximately <ix:nonFraction unitRef="numberofplaintiffs" contextRef="ic26045979d2740d8b8904c0387c53e4a_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfMjA4NTM_ec548410-ebde-4ca6-baca-6f65f3c221ad">3,900</ix:nonFraction> plaintiffs, have been dismissed based on participation in the settlement program or failure to comply with settlement related court orders. In the U.S., less than <ix:nonFraction unitRef="lawsuits" contextRef="if9edbfdefa9f4c869623f5989777a4d3_I20210630" decimals="0" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfMjEwMTk_88821249-11e8-4834-a0c3-3a5971a98366">20</ix:nonFraction> cases remain pending on behalf of plaintiffs, who either chose not to participate in the settlement program or filed their claims after the settlement cut-off date. There are eleven cases pending in Canada (four class actions, seven individual injury claims). Out of the eleven cases, only two are active (the class actions in Quebec and Ontario). Both class actions have now been certified and will proceed separately, subject to a pending appeal of the Ontario class certification decision.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Byetta*</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amylin, a former subsidiary of BMS, and Lilly are co-defendants in product liability litigation related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta*.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of June 2021, there are approximately <ix:nonFraction unitRef="lawsuits" contextRef="if0ca0adab86748b08591cb41bae7063a_I20210630" decimals="0" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfMjE3MDQ_de0936c5-0dd6-4673-bc03-9a8fa1badfd0">590</ix:nonFraction> separate lawsuits pending on behalf of approximately <ix:nonFraction unitRef="numberofplaintiffs" contextRef="icbb5732de29d4e31bb981cab01299d47_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfMjE3NjA_a9778d1f-cbd4-4db1-bcb5-dff09ef0f948">2,250</ix:nonFraction> active plaintiffs (including pending settlements), which include injury plaintiffs as well as claims by spouses and/or other beneficiaries, in various courts in the U.S. The majority of these cases have been brought by individuals who allege personal injury sustained after using </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*, primarily pancreatic cancer, and, in some cases, claiming alleged wrongful death. The majority of cases are pending in Federal Court in San Diego in an MDL or in a coordinated proceeding in California Superior Court in Los Angeles (&#8220;JCCP&#8221;). In April 2020 the defendants filed a motion for summary judgment based on federal preemption and a motion for summary judgment based on the absence of general causation evidence in the MDL and JCCP. Both motions were granted in March 2021 and April 2021, respectively. The orders will result in the dismissal of all claims alleging an injury of pancreatic cancer in the MDL and JCCP. Plaintiffs have appealed the MDL order and may seek appeals in the JCCP. BMS sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* to AstraZeneca in February 2014 as part of BMS&#8217;s global diabetes business divestiture and any additional liability to Amylin with respect to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* is expected to be shared with AstraZeneca.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Onglyza*</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and AstraZeneca are co-defendants in product liability litigation related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Plaintiffs assert claims, including claims for wrongful death, as a result of heart failure or other cardiovascular injuries they allege were caused by their use of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of June 2021, claims are pending in state and federal court on behalf of approximately <ix:nonFraction unitRef="numberofplaintiffs" contextRef="ic175769943af4209805f2855da447a24_D20210101-20210630" decimals="0" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfMjM0NTE_89c01ecf-58c4-441f-b31e-1815aee376c5">270</ix:nonFraction> individuals who allege they ingested the product and suffered an injury. In February 2018, the Judicial Panel on Multidistrict Litigation ordered all federal cases to be transferred to an MDL in the U.S. District Court for the Eastern District of Kentucky. A significant majority of the claims are pending in the MDL.&#160;As part of BMS&#8217;s global diabetes business divestiture, BMS sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to AstraZeneca in February 2014 and any potential liability with respect to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is expected to be shared with AstraZeneca.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BMS Securities Class Action</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since February 2018, <ix:nonFraction unitRef="lawsuits" contextRef="icdc726e72d84409b8ca5e19dbe8e141c_I20210630" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfMjQwNDY_a280a248-8b86-4357-ac65-25a62afdcc10">two</ix:nonFraction> separate putative class action complaints were filed in the U.S. District for the Northern District of California and in the U.S. District Court for the Southern District of New York against BMS, BMS&#8217;s Chief Executive Officer, Giovanni Caforio, BMS&#8217;s Chief Financial Officer at the time, Charles A. Bancroft and certain former and current executives of BMS.&#160;The case in California has been voluntarily dismissed. The remaining complaint alleges violations of securities laws for BMS&#8217;s disclosures related to the CheckMate-026 clinical trial in lung cancer. In September 2019, the Court granted BMS&#8217;s motion to dismiss, but allowed the plaintiffs leave to file an amended complaint. In October 2019, the plaintiffs filed an amended complaint. In September 2020, the Court granted BMS&#8217;s motion to dismiss the amended complaint with prejudice. The plaintiffs appealed the Court&#8217;s decision in October 2020.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7751004810d54eaa80959b5c7e1303a3" continuedAt="ia2f17d8e471c4257a7e60b2f6dfa16a4"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Celgene Securities Class Action</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in March 2018, <ix:nonFraction unitRef="lawsuits" contextRef="ie36b4dda4d274314992050f1a7686ae7_I20210630" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfMjUwMzI_bfb9aa8a-d3e4-431d-86d8-50c5491df3bd">two</ix:nonFraction> putative class actions were filed against Celgene and certain of its officers in the U.S. District Court for the District of New Jersey (the &#8220;Celgene Securities Class Action&#8221;).&#160;The complaints allege that the defendants violated federal securities laws by making misstatements and/or omissions concerning (1) trials of GED-0301, (2) Celgene&#8217;s 2020 outlook and projected sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Otezla*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and (3) the new drug application for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Court consolidated the two actions and appointed a lead plaintiff, lead counsel, and co-liaison counsel for the putative class. In February 2019, the defendants filed a motion to dismiss plaintiff&#8217;s amended complaint in full. In December 2019, the Court denied the motion to dismiss in part and granted the motion to dismiss in part (including all claims arising from alleged misstatements regarding GED-0301). Although the Court gave the plaintiff leave to re-plead the dismissed claims, it elected not to do so, and the dismissed claims are now dismissed with prejudice. In November 2020, the Court granted class certification with respect to the remaining claims. In December 2020, the defendants sought leave to appeal the Court&#8217;s class certification decision, which was denied without prejudice in March 2021. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, certain Schwab management investment companies on behalf of certain Schwab funds filed an individual action in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action against the same remaining defendants in that action. In July 2020, the defendants filed a motion to dismiss the plaintiffs&#8217; complaint in full. In March 2021, the Court granted in part and denied in part defendants&#8217; motion to dismiss consistent with its decision in the Celgene Securities Class Action.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The California Public Employees&#8217; Retirement System in April 2021 and DFA Investment Dimensions Group Inc., on behalf of certain of its funds, and American Century Mutual Funds, Inc., on behalf of certain of its funds, in July 2021 filed separate individual actions in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action and the Schwab individual action against the same remaining defendants in those actions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Value Rights Litigation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, an action was filed against BMS in the U.S. District Court for the Southern District of New York asserting claims of alleged breaches of a Contingent Value Rights Agreement (&#8220;CVR Agreement&#8221;) entered into in connection with the closing of BMS&#8217;s acquisition of Celgene Corporation in November 2019. The successor trustee under the CVR Agreement alleges that BMS breached the CVR Agreement by allegedly failing to use &#8220;diligent efforts&#8221; to obtain FDA approval of liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) before a contractual milestone date, thereby avoiding a $6.4 billion potential obligation to holders of the contingent value rights governed by the CVR Agreement and by allegedly failing to permit inspection of records in response to a request by the successor trustee. The successor trustee seeks damages in an amount to be determined at trial and other relief, including interest and attorneys&#8217; fees. BMS disputes the successor trustee&#8217;s allegations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Average Manufacturer Price Litigation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS is a defendant in a qui tam (whistleblower) lawsuit in the U.S. District Court for the Eastern District of Pennsylvania, in which the U.S. Government declined to intervene. The complaint alleges that BMS inaccurately reported its average manufacturer prices to the Centers for Medicare and Medicaid Services to lower what it owed. Similar claims have been filed against other companies. In January 2020, BMS reached an agreement in principle to resolve this matter subject to the negotiation of a definitive settlement agreement and other contingencies. In March 2021, BMS finalized an agreement with the U.S. government and qui tam relator to resolve the claims asserted in the lawsuit. BMS has paid $75 million plus interest to the federal and state governments. Individual agreements will be negotiated with participating states based on the federal agreement. To the extent BMS does not finalize a settlement agreement with any state, that state&#8217;s share of the settlement will revert to BMS.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HIV Medication Antitrust Lawsuits</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and two other manufacturers of HIV medications are defendants in related lawsuits pending in the Northern District of California. The lawsuits allege that the defendants&#8217; agreements to develop and sell fixed-dose combination products for the treatment of HIV, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Atripla*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evotaz</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, violate antitrust laws. The currently pending actions, asserted on behalf of indirect purchasers, were initiated in 2019 in the Northern District of California and in 2020 in the Southern District of Florida. The Florida matter was transferred to the Northern District of California. In July 2020, the Court granted in part defendants&#8217; motion to dismiss, including dismissing with prejudice plaintiffs&#8217; claims as to an overarching conspiracy and plaintiffs&#8217; theories based on the alleged payment of royalties after patent expiration. Other claims, however, remain. In September and October 2020, two purported class actions have also been filed asserting similar claims on behalf of direct purchasers. In March 2021, the Court dismissed one of the direct purchaser cases and limited the claims of the remaining direct purchaser case to those arising in 2016 or later. However, the Court gave plaintiffs leave to amend their complaints, and one plaintiff filed an amended complaint on March 16, 2021. A trial on both the direct and indirect purchaser claims is scheduled for November 2022.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia2f17d8e471c4257a7e60b2f6dfa16a4" continuedAt="i9f6bcae558d245be9645b4eb6ed00716"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, BMS and two other manufacturers of HIV medications were sued in State Court in New Mexico by the Attorney General of the State of New Mexico in a case alleging that the defendants&#8217; agreements to develop and sell various fixed-dose combination products for the treatment of HIV, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Atripla*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and agreements to settle certain patent litigation violate the antitrust laws of the State of New Mexico. No schedule has been set for the case.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Litigations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in November 2014, certain putative class action lawsuits were filed against Celgene in the U.S. District Court for the District of New Jersey alleging that Celgene violated various antitrust, consumer protection, and unfair competition laws by (a) allegedly securing an exclusive supply contract for the alleged purpose of preventing a generic manufacturer from securing its own supply of thalidomide active pharmaceutical ingredient, (b) allegedly refusing to sell samples of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand drugs to various generic manufacturers for the alleged purpose of bioequivalence testing necessary for aNDAs to be submitted to the FDA for approval to market generic versions of these products, (c) allegedly bringing unjustified patent infringement lawsuits in order to allegedly delay approval for proposed generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and/or (d) allegedly entering into settlements of patent infringement lawsuits with certain generic manufacturers that allegedly have had anticompetitive effects. The plaintiffs, on behalf of themselves and putative classes of third-party payers, sought injunctive relief and damages. The various lawsuits were consolidated into a master action for all purposes. In March 2020, Celgene reached a settlement with the class plaintiffs. In October 2020, the Court entered a final order approving the settlement and dismissed the matter. That settlement does not resolve the claims of certain entities that opted out of the settlement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, Humana, Inc. (&#8220;Humana&#8221;) filed a lawsuit against Celgene in the Pike County Circuit Court of the Commonwealth of Kentucky.&#160;Humana&#8217;s complaint alleges Celgene engaged in unlawful off-label marketing in connection with sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and asserts claims against Celgene for fraud, breach of contract, negligent misrepresentation, unjust enrichment and violations of New Jersey&#8217;s Racketeer Influenced and Corrupt Organizations Act. The complaint seeks, among other things, treble and punitive damages, injunctive relief and attorneys&#8217; fees and costs. In April 2019, Celgene filed a motion to dismiss Humana&#8217;s complaint, which the Court denied in January 2020. No trial date has been scheduled. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, Humana filed a lawsuit against Celgene in the U.S. District Court for the District of New Jersey. Humana&#8217;s complaint makes largely the same claims and allegations as were made in the class action litigation. The complaint purports to assert claims on behalf of Humana and its subsidiaries in several capacities, including as a direct purchaser and as an indirect purchaser, and seeks, among other things, treble and punitive damages, injunctive relief and attorneys&#8217; fees and costs. In May 2019, Celgene filed a motion to dismiss Humana&#8217;s complaint, and the Court has stayed discovery pending adjudication of that motion. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, United HealthCare Services, Inc. (&#8220;UHS&#8221;), affiliates of which opted out of the first settlement in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Antitrust Class Action Litigation, filed a lawsuit against Celgene in the U.S. District Court for the District of Minnesota. UHS&#8217;s complaint makes largely the same claims and allegations as were made in the class action litigation in addition to certain claims regarding donations directed to copay assistance. The complaint purports to assert claims on behalf of UHS and its subsidiaries in several capacities, including as a direct purchaser and as an indirect purchaser, and seeks, among other things, treble and punitive damages, injunctive relief and attorneys&#8217; fees and costs. In December 2020, Celgene&#8217;s motion to transfer the action to the District of New Jersey was granted and the case is now pending in that Court. In January 2021, Celgene filed a motion to dismiss UHS&#8217;s complaint, which the Court administratively terminated in June 2021 pending its decision on Celgene&#8217;s pending motion to dismiss Humana&#8217;s complaint. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, Celgene filed suit against Humana Pharmacy, Inc. (&#8220;HPI&#8221;), a Humana subsidiary, in Delaware Superior Court. Celgene&#8217;s complaint alleges that HPI breached its contractual obligations to Celgene by assigning claims to Humana that Humana is now asserting. The complaint seeks damages for HPI&#8217;s breach as well as a declaratory judgment. In September 2020, HPI filed a motion to dismiss Celgene&#8217;s complaint, which was denied in February 2021. A trial has been scheduled for March 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, Blue Cross Blue Shield Association (&#8220;BCBSA&#8221;) sued Celgene and BMS on behalf of the Federal Employee Program in the U.S. District Court for the District of Columbia. BCBSA&#8217;s complaint makes largely the same claims and allegations as were made in the class action litigation. In April 2021, the parties&#8217; joint motion to transfer the action to the District of New Jersey was granted and the case is now pending in that Court. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, BCBSM Inc., Health Care Service Corporation (&#8220;HCSC&#8221;), Blue Cross and Blue Shield of Florida Inc.,  and Molina Healthcare, Inc. (&#8220;Molina&#8221;) sued Celgene and BMS in a Minnesota state court. The complaint makes largely the same claims and allegations as were made in the class action litigation but adds allegations on behalf of HCSC only as to alleged off-label marketing of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In September 2020, Celgene and BMS removed the action to the U.S. District Court for the District of Minnesota. In March 2021, that Court denied plaintiffs&#8217; motion to remand the action to state court, dismissed Molina for lack of personal jurisdiction and granted defendants&#8217; motion to transfer the action to the District of New Jersey. The case is now pending in the District of New Jersey. No trial date has been scheduled.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i9f6bcae558d245be9645b4eb6ed00716"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, Cigna Corporation (&#8220;Cigna&#8221;) sued Celgene and BMS in the U.S. District Court for the Eastern District of Pennsylvania. Cigna&#8217;s complaint makes largely the same claims and allegations as were made in the class action litigation. Cigna&#8217;s complaint purports to assert claims on behalf of Cigna and its subsidiaries in several capacities, including as a direct purchaser and as an indirect purchaser. In May 2021, the parties&#8217; joint motion to transfer the action to the District of New Jersey was granted and the case is now pending in that Court. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, Molina sued Celgene and BMS in San Francisco Superior Court. Molina&#8217;s complaint makes largely the same claims and allegations as were made in the class action litigation. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOVERNMENT INVESTIGATIONS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Like other pharmaceutical companies, BMS and certain of its subsidiaries are subject to extensive regulation by national, state and local authorities in the U.S. and other countries in which BMS operates. As a result, BMS, from time to time, is subject to various governmental and regulatory inquiries and investigations as well as threatened legal actions and proceedings. It is possible that criminal charges, substantial fines and/or civil penalties, could result from government or regulatory investigations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ENVIRONMENTAL PROCEEDINGS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously reported, BMS is a party to several environmental proceedings and other matters, and is responsible under various state, federal and foreign laws, including CERCLA, for certain costs of investigating and/or remediating contamination resulting from past industrial activity at BMS&#8217;s current or former sites or at waste disposal or reprocessing facilities operated by third parties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERCLA Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to CERCLA matters for which BMS is responsible under various state, federal and foreign laws, BMS typically estimates potential costs based on information obtained from the U.S. Environmental Protection Agency, or counterpart state or foreign agency and/or studies prepared by independent consultants, including the total estimated costs for the site and the expected cost-sharing, if any, with other &#8220;potentially responsible parties,&#8221; and BMS accrues liabilities when they are probable and reasonably estimable. BMS estimated its share of future costs for these sites to be $<ix:nonFraction unitRef="usd" contextRef="ie5d797c7be774aa39277765dc8964e48_I20210630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfMzc3NTk_adb274f2-6288-4e47-92cd-baf2f1d03fd0">75</ix:nonFraction> million at June&#160;30, 2021, which represents the sum of best estimates or, where no best estimate can reasonably be made, estimates of the minimal probable amount among a range of such costs (without taking into account any potential recoveries from other parties). The amount includes the estimated costs for any additional probable loss associated with the previously disclosed North Brunswick Township High School Remediation Site.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="id66f4ecc89aa45bca7756420c60966f5_94"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s discussion and analysis of results of operations and financial condition is provided as a supplement to and should be read in conjunction with the consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q to enhance the understanding of our results of operations, financial condition and cash flows.</span></div><div><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_97"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE SUMMARY</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bristol-Myers Squibb Company is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Our principal strategy is to combine the resources, scale and capability of a pharmaceutical company with the speed and focus on innovation of the biotech industry. Our focus as a biopharmaceutical company is on discovering, developing and delivering transformational medicines for patients facing serious diseases in areas where we believe that we have an opportunity to make a meaningful difference: oncology (both solid tumors and hematology), immunology, cardiovascular and fibrosis. Our four strategic priorities are to drive enterprise performance, maximize the value of our commercial portfolio, ensure the long-term sustainability of our pipeline through combined internal and external innovation and establish our new culture and embed our people strategy. For further information on our strategy, see &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations-Executive Summary-Strategy&#8221; in our 2020 Form 10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we received 13 approvals for new medicines and additional indications and formulations of currently marketed medicines in major markets (the U.S., EU and Japan), including advancement in hematology malignancies through regulatory approvals of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the first approvals of our cell therapy portfolio. In support of our continued investment in our cell therapy portfolio, we are expanding our manufacturing capabilities through the construction of new state-of-the-art cell therapy manufacturing facilities in Devens, Massachusetts and Leiden, Netherlands. We continue to see momentum in our oncology portfolio with the approvals for both </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in various indications. We continue to expand our portfolio in immunology with the FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment of adults with moderately to severely active UC and an important opportunity for deucravacitinib, our TYK2 inhibitor, for the treatment of psoriasis and other diseases. We bolstered our leading cardiovascular franchise by adding mavacamten with the acquisition of MyoKardia in 2020. In March 2021, the FDA accepted the NDA for mavacamten for patients with symptomatic obstructive HCM with an assigned PDUFA goal date of January 28, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues increased by 9% for the six months ended June&#160;30, 2021 due to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis, Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our IO and new product portfolios</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and foreign exchange, partially offset by lower demand for established brands. The $1.74 change in GAAP EPS primarily resulted from specified items including, lower unwinding of inventory fair value adjustments, contingent value rights and lower tax charges, partially offset by higher research and development, impairment and debt redemption charges. After adjusting for specified items, non-GAAP EPS increased $0.32 as a result of higher revenues, partially offset by higher costs and expenses to support product launches and the broader portfolio.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions, except per share data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,703&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,129&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,776&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,910&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Earnings/(Loss) Per Share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-GAAP financial measures, including non-GAAP earnings and related EPS information, are adjusted to exclude specified items that represent certain costs, expenses, gains and losses and other items impacting the comparability of financial results. For a detailed listing of all specified items and further information and reconciliations of non-GAAP financial measures refer to &#8220;&#8212;Non-GAAP Financial Measures.&#8221;</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="id66f4ecc89aa45bca7756420c60966f5_100"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Economic and Market Factors</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, COVID-19 emerged and subsequently expanded to a pandemic, resulting in international, federal, state and local public health and governmental authorities taking a number of actions to limit the spread of COVID-19 and address material disruptions in the U.S. and global economy. Against this background, we benefited from the impact of COVID-19 related buying patterns in the first quarter of 2020 but experienced sales channel inventory workdowns for our products during second quarter of 2020. We began to note improvement in the demand for certain products during the third and fourth quarters in 2020 but continue to experience impacts on revenues from COVID-19 primarily due to lower new patient starts and patient visits. Although the pandemic has not significantly impacted our results of operations, it remains difficult to reasonably assess or predict the full extent of the negative impact that the COVID-19 pandemic may have on our business, financial condition, results of operations and cash flows. The future financial and operational impact of the COVID-19 pandemic on BMS will depend on developments such as the ultimate duration and recovery from the pandemic, government actions, impact on the U.S. and global economies, customer behavior changes and timing for resumption to our normal operations, among others. See risk factor on the Company&#8217;s risk factors resulting from the COVID-19 pandemic included under &#8220;Part I&#8212;Item 1A. Risk Factors&#8212;The COVID-19 pandemic is affecting our business and could have a material adverse effect on us&#8221; in our 2020 Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the COVID-19 pandemic affected global healthcare systems as well as major economic and financial markets, we adopted several procedures focused on ensuring the continued supply of our medicines to our patients and protecting the health, wellbeing and safety of our workforce:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Workplace and Community</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are maintaining our steadfast commitment to protecting the health and safety of our workforce and our communities while ensuring uninterrupted supply of medicines to patients and building on our competitive advantage.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our manufacturing sites have remained open throughout the pandemic supported by on site personnel. We have taken a thoughtful and phased approach to bringing the rest of our workforce back to our 250 plus sites around the world and into the field, guided by the following principles:</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Serving the needs of our patients and customers</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Prioritizing health and safety</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Following medical advice and government direction</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Leading with compassion and flexibility</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Modeling key learnings</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our timelines and circumstances have varied across the globe. We are monitoring local conditions and government direction closely and adjusting our plans as appropriate acting in a nimble and flexible manner.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We continue to take significant measures to protect the safety of our colleagues on site, including providing protective equipment, ensuring physical distancing, enhanced cleaning and creating a robust COVID-19 website to assist our workforce.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Supply of Our Medicines and Support to Patients, Physicians and Advocacy Groups</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">An important element of keeping our promise to patients, their families and our healthcare providers is to ensure that our supply chain is robust and carefully managed. Our clinical and commercial supply chain teams have proactively identified alternative means for moving our raw materials and products to our markets and clinical sites over the past months. As a result of these efforts, we have not seen any disruption in our clinical or commercial supply chain due to the pandemic.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our customer-facing personnel are employing a combination of in-person and remote interactions to ensure continued support for healthcare professionals, patient care, and access to our medicines across our global markets. The balance between in-person and remote engagement is varying market to market based on local conditions and government direction.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Our Clinical Trials and Research</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are working with health authorities and investigators to protect our trial participants and personnel at BMS and our clinical trial sites, while ensuring regulatory compliance and the integrity of our science.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have provided clinical trial investigators with overarching principles and guidance regarding the conduct of our clinical trials worldwide in light of COVID-19, and are taking into account guidance from health authorities, where applicable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Governmental Actions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional regulations in the U.S. may occur in the future, including healthcare reform initiatives, further changes to tax laws and pricing laws and potential importation restrictions, that may reduce our results of operations, operating cash flow, liquidity and financial flexibility. For example, in November 2020 the U.S. federal government issued regulations regarding U.S. drug prices and payment for pharmaceutical products, including regulations that: (i) would reduce physician reimbursement for certain Medicare Part B drugs administered in doctors&#8217; offices or hospitals to a &#8220;most favored nation price&#8221; drawn from the lowest price paid by certain countries in the Organisation for Economic Co-operation and Development, which would apply to many cancer medications; (ii) would authorize states and private parties to develop and implement programs to import certain prescription drugs from Canada and sell them in the U.S.; and (iii) would reform the use of rebates in Medicare Part D. The outcome of these regulations remains uncertain as a result of ongoing litigation and other factors. See risk factor on the Company&#8217;s risk factors on the executive orders included under &#8220;Part I&#8212;Item 1A. Risk Factors&#8212;Increased pricing pressure and other restrictions in the U.S. and abroad continue to negatively affect our revenues and profit margins&#8221; in our 2020 Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="id66f4ecc89aa45bca7756420c60966f5_106"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Product and Pipeline Approvals</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the significant approvals received in 2021:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Product</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approval</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdivo+Yervoy</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> for the treatment of adult patients with mismatch repair deficient or microsatellite instability-high mCRC after prior fluoropyrimidine-based combination chemotherapy.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Onureg</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> as a maintenance therapy in adult patients with AML who achieved complete remission or complete remission with incomplete blood count recovery following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdivo+Yervoy</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> for the first-line treatment of adults with unresectable malignant pleural mesothelioma.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.679%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Zeposia</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> for the treatment of adults with moderately to severely active UC.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.679%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdivo</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Announced Japan&#8217;s Ministry of Health, Labour and Welfare approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdivo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> in combination therapy for the first-line treatment of unresectable advanced or recurrent malignant pleural mesothelioma.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.679%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdivo</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> for the adjuvant treatment of patients with completely resected esophageal or gastroesophageal junction cancer with residual pathologic disease after neoadjuvant chemoradiotherapy.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdivo</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> in combination with chemotherapy for patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma, regardless of PD-L1 expression status.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdivo</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> in combination with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cabometyx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* for the first-line treatment of patients with advanced RCC.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Abecma</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (idecabtagene vicleucel; ide-cel) for the treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Breyanzi</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Announced Japan&#8217;s Ministry of Health, Labour and Welfare approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (lisocabtagene maraleucel: liso-cel) for the treatment of patients with relapsed or refractory large B-cell lymphoma and relapsed or refractory follicular lymphoma.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Inrebic</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Inrebic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post-polycythaemia vera myelofibrosis or post-essential thrombocythaemia myelofibrosis, who are Janus Associated Kinase inhibitor na&#239;ve or have been treated with ruxolitinib.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Breyanzi</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> (lisocabtagene maraleucel; liso-cel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdivo</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> in combination with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Cabometyx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* for the first-line treatment of patients with advanced RCC.</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The FDA has indicated it is undertaking an industry-wide review of indications that received accelerated approval and for which the confirmatory studies did not meet their primary endpoints. This is not specific to BMS, but we have two </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> indications that are subject to this review by the FDA in the third-line treatment of SCLC and second-line treatment of HCC. In consultation with the FDA, we have withdrawn the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> indication in the third-line treatment of SCLC. Additionally, we decided to withdraw the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> indication in the second-line treatment of HCC.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to &#8220;&#8212;Product and Pipeline Developments&#8221; for all of the developments in our marketed products and late-stage pipeline in 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="id66f4ecc89aa45bca7756420c60966f5_109"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Divestitures, Licensing and Other Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Divestitures, licensing and other arrangements allow us to focus our resources behind our growth opportunities that drive the greatest long-term value. Significant transactions entered into in <ix:nonNumeric contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xMDkvZnJhZzpkMTQ3N2FlN2JmZWE0MDQ1YWJhZWFhZTg1OGFmYjg1My90ZXh0cmVnaW9uOmQxNDc3YWU3YmZlYTQwNDVhYmFlYWFlODU4YWZiODUzXzI2MA_fd849ec4-327b-4d10-99b3-2147c6c901ac">2021</ix:nonNumeric> are summarized below. Refer to &#8220;Item 1. Financial Statements&#8212;Note 3. Alliances&#8221; and &#8220;&#8212;Note 4. Divestitures, Licensing and Other Arrangements&#8221; for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Agenus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> - We obtained a global exclusive license to Agenus&#8217; proprietary bispecific antibody program, AGEN1777, that blocks TIGIT and an additional target. AGEN1777 is being studied in oncology and is in preclinical development.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Eisai</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - We commenced an exclusive global strategic collaboration with Eisai for the co-development and co-commercialization of MORAb-202, a selective folate receptor alpha antibody-drug conjugate being investigated in endometrial, ovarian, lung and breast cancers. MORAb-202 is currently in Phase I/II clinical trials for solid tumors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline">Prothena</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> - We exercised our option under the global neuroscience research and development collaboration to enter into an exclusive U.S. license for PRX005, an anti-tau antibody that specifically targets an area within the microtubule binding region for the potential treatment of Alzheimer&#8217;s disease. A Phase I clinical trial with PRX005 has been initiated.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Rockefeller University</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - We entered into an agreement with Rockefeller University, granting us the global exclusive license to develop, manufacture and commercialize Rockefeller&#8217;s novel monoclonal antibody duo treatment that neutralizes the SARS-CoV-2 virus for therapy, or prevents in certain patients, of COVID-19. Phase I clinical trials to assess dosing for IV and subcutaneous formulations and to assess safety have been completed by Rockefeller. In May 2021, enrollment initiated in the Phase II study within the NIH ACTIV-2 protocol at a network of sites within the U.S.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="id66f4ecc89aa45bca7756420c60966f5_112"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_115"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regional Revenues</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of the changes in revenues was as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Exchange</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Exchange</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,487&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,398&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,253&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of the World</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,781&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,703&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,129&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,776&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,910&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by our regional commercial organizations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Foreign exchange impacts were derived by applying the prior period average currency rates to the current period sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">United States</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues for the second quarter 2021 and year-to-date increased due to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">higher demand for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our IO and new product portfolios and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The second quarter 2020 was negatively impacted from sales channel inventory work downs and lower new patient starts due to the COVID-19 pandemic. Average U.S. net selling prices increased 1% year-to-date compared to the same period a year ago.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Europe</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Europe revenues for the second quarter 2021 and year-to-date increased due to higher demand for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our IO portfolio and foreign exchange, partially offset by lower demand for established brands. The second quarter 2020 was negatively impacted from sales channel inventory work downs and lower new patient starts due to the COVID-19 pandemic. Average net selling prices decreased year-to-date compared to the same period a year ago.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rest of the World</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Rest of the World revenues for the second quarter 2021 and year-to-date increased due to higher demand for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Pomalyst/Imnovid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our IO portfolio, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and foreign exchange, partially offset by lower demand for established brands. The second quarter 2020 was negatively impacted from sales channel inventory work downs and lower new patient starts due to the COVID-19 pandemic. Average net selling prices decreased year-to-date compared to the same period a year ago.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No single country outside the U.S. contributed more than 10% of total revenues during the six months ended June 30, 2021 or 2020. Our business is typically not seasonal.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="id66f4ecc89aa45bca7756420c60966f5_118"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GTN Adjustments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of gross product sales to net product sales by each significant category of GTN adjustments was as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,782&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,788&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,341&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,474&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,720)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,292)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,632)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Medicare rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,482)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,857)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,980)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other rebates, returns, discounts and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,518)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,197)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,975)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,504)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total GTN adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,377)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,971)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,138)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,116)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,405&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,817&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,358&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN adjustments percentage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reductions to provisions for product sales made in prior periods resulting from changes in estimates were $302 million and $116 million for the six months ended June 30, 2021 and 2020, respectively. The reductions to provisions in 2021 was primarily related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> coverage gap discounts. GTN adjustments are primarily a function of product sales volume, regional and payer channel mix, contractual or legislative discounts and rebates. U.S. GTN adjustments percentage increased primarily due to higher government channel mix, which has higher GTN adjustment percentages.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="id66f4ecc89aa45bca7756420c60966f5_121"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Revenues</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prioritized Brands</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Revlimid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,884&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,048&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,014&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,038&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">836&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Eliquis </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,678&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdivo </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">956&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,455&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Orencia </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pomalyst/Imnovid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sprycel </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yervoy </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abraxane</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Empliciti </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Reblozyl</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Inrebic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Onureg</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Zeposia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prioritized Brands</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Breyanzi</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abecma</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Established Brands</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Vidaza</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Baraclude </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,703</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,129</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,776</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,910</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,388</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,487</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14,398</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,253</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,315</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,642</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,378</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,657</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">** Change in excess of 100%.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_124"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(lenalidomide)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an oral immunomodulatory drug that in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;as a single agent is also indicated as a maintenance therapy in patients with multiple myeloma following autologous hematopoietic stem cell transplant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 6% in the second quarter 2021 due to higher demand and higher average net selling prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. revenues increased 3% year-to-date due to higher average net selling prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues increased 24% in the second quarter 2021 due to higher demand and foreign exchange of 8%. Excluding foreign exchange impacts, revenues increased by 16%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International revenues increased 13% year-to-date due to foreign exchange of 7% and higher demand. Excluding foreign exchange impacts, revenues increased 6%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (apixaban)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; an oral Factor Xa inhibitor targeted at stroke prevention in adult patients with NVAF and the prevention and treatment of VTE disorders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">U.S. revenues increased 26% in the second quarter 2021 due to higher demand and a second quarter 2020 inventory work down resulting from the COVID-19 pandemic (primarily sales channel inventory work down), partially offset by lower average net selling prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">U.S. revenues increased 16% year-to-date due to higher demand, partially offset by lower average net selling prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues increased 34% in the second quarter 2021 and 22% year-to-date due to higher demand and foreign exchange of 10% and 9%, respectively. The second quarter 2020 was negatively affected from the COVID-19 pandemic (primarily sales channel inventory work down). Excluding foreign exchange impacts, revenues increased by 24% and 13%, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Following the May 2021 expiration of regulatory exclusivity for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> in Europe, generic manufacturers may seek to market generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> in Europe prior to the expiration of our patents, which may lead to additional, infringement and invalidity actions involving our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> patents being filed in various countries in Europe. We believe in the innovative science behind </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and the strength of our intellectual property, which we will defend against infringement. Refer to &#8220;Item 1. Financial Statements&#8212;Note 17. Legal Proceedings and Contingencies&#8212;Intellectual Property&#8212;&#8221; for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(nivolumab)&#160;&#8212;&#160;a fully human monoclonal antibody that binds to the PD-1 on T and NKT cells that has been approved for several anti-cancer indications including bladder, blood, colon, head and neck, kidney, liver, lung, melanoma and stomach. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> regimen also is approved in multiple markets for the treatment of NSCLC, melanoma, RCC, and CRC. There are several ongoing potentially registrational studies for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> across other tumor types and disease areas, in monotherapy and in combination with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and various anti-cancer agents.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">U.S. revenues increased 13% in the second quarter 2021 and 3% year-to-date due to higher demand across multiple therapies including the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> combinations in NSCLC (launched in the second quarter 2020), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Cabometyx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">* combination in kidney cancer and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> in various gastric and esophageal cancers, partially offset by declining second-line eligibility across tumor indications and increased competition. The second quarter 2020 was negatively affected from the COVID-19 pandemic (primarily lower new patient starts and patient visits).</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt">International revenues increased 20% in the second quarter 2021 and 11% year-to-date due to higher demand and foreign exchange of 7% and 5%, respectively. Excluding foreign exchange impacts, revenues increased by 13% and 6%, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Orencia </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(abatacept) &#8212; a fusion protein indicated for adult patients with moderate to severe active RA and PsA and is also indicated for reducing signs and symptoms in certain pediatric patients with moderately to severely active polyarticular JIA.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 7% in the second quarter 2021 and year-to-date due to higher demand. The second quarter 2020 was negatively impacted by lower demand from the COVID-19 pandemic.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues increased 13% in the second quarter 2021 and 8% year-to-date due to foreign exchange of 6% and 5%, respectively, higher demand and higher average net selling prices. The second quarter 2020 was negatively impacted by lower demand from the COVID-19 pandemic. Excluding foreign exchange impacts, revenues increased by 7% and 3%, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst/Imnovid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(pomalidomide) &#8212; a proprietary, distinct, small molecule that is administered orally and modulates the immune system and other biologically important targets. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst/Imnovid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is indicated for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 9% in the second quarter 2021 and 7% year-to-date due to higher demand and higher average net selling prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues increased 29% in the second quarter 2021 and 23% year-to-date, due to higher demand and foreign exchange of 6% for both periods, partially offset by lower average net selling prices. Excluding foreign exchange impacts, revenues increased by 23% and 17%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sprycel </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dasatinib)&#160;&#8212;&#160;an oral inhibitor of multiple tyrosine kinase indicated for the first-line treatment of patients with Philadelphia chromosome-positive CML in chronic phase and the treatment of adults with chronic, accelerated, or myeloid or lymphoid blast phase CML with resistance or intolerance to prior therapy, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gleevec</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* (imatinib mesylate) and the treatment of children and adolescents aged 1 year to 18 years with chronic phase Philadelphia chromosome-positive CML.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 6% in the second quarter 2021 due to higher demand.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. revenues decreased 1% year-to-date due lower average net selling prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues increased 6% in the second quarter 2021 due to foreign exchange of 4%, and to a lesser extent, higher demand. Excluding foreign exchange impacts, revenues increased by 2%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International revenues decreased 3% year-to-date due to lower demand as a result of increased generic competition and lower average net selling prices, partially offset by foreign exchange of 4%. Excluding foreign exchange impacts, revenues decreased by 7%.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ipilimumab)&#160;&#8212;&#160;a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> regimen also is approved in multiple markets for the treatment of NSCLC, melanoma, RCC, and CRC.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 29% in the second quarter 2021 and 22% year-to-date due to higher demand primarily from the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> combination for NSCLC (launched in the second quarter 2020).</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues increased 58% in the second quarter 2021 and 35% year-to-date due to higher demand and foreign exchange of 10% and 7%, respectively, partially offset by lower average net selling prices. Excluding foreign exchange impacts, revenues increased by 48% and 28%, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abraxane </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(paclitaxel albumin-bound particles for injectable suspension)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a solvent-free protein-bound chemotherapy product that combines paclitaxel with albumin using our proprietary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nab</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology platform, and is used to treat breast cancer, NSCLC and pancreatic cancer, among others.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 7% in the second quarter 2021 due to higher demand, partially offset by lower average net selling prices and 9% year-to-date due to higher demand.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 31% in the second quarter 2021 and 18% year-to-date due to supply chain delays, partially offset by foreign exchange of 5% and 4%, respectively. Excluding foreign exchange impacts, revenues decreased by 36% and 22%, respectively. We expect that the supply chain delays will continue into the third or fourth quarter 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Empliciti</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (elotuzumab) &#8212; a humanized monoclonal antibody for the treatment of multiple myeloma.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reblozyl </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(luspatercept-aamt) &#8212; an erythroid maturation agent indicated for the treatment of anemia in adult patients with beta thalassemia who require regular red blood cell transfusions and for the treatment of anemia failing an erythropoiesis stimulating agent (&#8220;ESA&#8221;) in adult patients with very low- to intermediate-risk MDS who have ring sideroblasts and require RBC transfusions. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reblozyl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched for adult patients with MDS previously treated with ESA in April 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inrebic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (fedratinib) &#8212; an oral kinase inhibitor indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inrebic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in August 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (azacitidine) &#8212; an oral hypomethylating agent that incorporates into DNA and RNA, indicated for continued treatment of adult patients with AML who achieved first complete remission or complete remission with incomplete blood count recovery following intensive induction chemotherapy and are not able to complete intensive curative therapy. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in September 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ozanimod) &#8212; an oral immunomodulatory drug used to treat relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults and to treat moderately to severely active UC in adults. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in June 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (lisocabtagene maraleucel) &#8212; a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in April 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (idecabtagene vicleucel) &#8212; a B-cell maturation antigen-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in May 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vidaza </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(azacitidine for injection)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a hypomethylating agent with several approved indications worldwide for frontline treatment of patients with myelodysplastic syndromes, chronic myelomonocytic leukemia (CMMoL), and acute myeloid leukemia.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased due to lower demand and lower average net selling prices resulting from generic competition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Baraclude </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(entecavir)&#160;&#8212;&#160;an oral antiviral agent for the treatment of chronic hepatitis B.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased due to lower demand resulting from generic competition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Brands &#8212; includes all other brands, including those which have lost exclusivity in major markets, OTC brands and royalty revenue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased primarily due to continued generic erosion.</span></div><div style="text-align:justify"><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_127"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Estimated End-User Demand</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the SEC Consent Order described in our 2020 Form 10-K, we monitor inventory levels on hand in the U.S. wholesaler distribution channel and outside of the U.S. in the direct customer distribution channel. We are obligated to disclose products with levels of inventory in excess of one month on hand or expected demand, subject to a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de minimis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> exception. There were no products in the U.S. wholesaler distribution channel and outside of the U.S. in the direct customer distribution channel with estimated levels of inventory in excess of one month at June 30, 2021 (U.S.) and March 31, 2021 (outside of the U.S.).</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., we generally determine our months on hand estimates using inventory levels of product on hand and the amount of out-movement provided by our three largest wholesalers, which account for approximately 85% of total gross sales of U.S. products for the six months ended June 30, 2021. Factors that may influence our estimates include generic competition, seasonality of products, wholesaler purchases in light of increases in wholesaler list prices, new product launches, new warehouse openings by wholesalers and new customer stockings by wholesalers. In addition, these estimates are calculated using third-party data, which may be impacted by their recordkeeping processes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;are distributed in the U.S. primarily through contracted pharmacies under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;REMS and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> REMS&#160;programs, respectively. These are proprietary risk-management distribution programs tailored specifically to provide for the safe and appropriate distribution and use of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internationally, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Imnovid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;are distributed under mandatory risk-management distribution programs tailored to meet local authorities&#8217; specifications to provide for the products&#8217; safe and appropriate distribution and use. These programs may vary by country and, depending upon the country and the design of the risk-management program, the product may be sold through hospitals or retail pharmacies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-U.S. businesses have significantly more direct customers. Information on available direct customer product level inventory and corresponding out-movement information and the reliability of third-party demand information varies widely. We limit our direct customer sales channel inventory reporting to where we can influence demand. When this information does not exist or is otherwise not available, we have developed a variety of methodologies to estimate such data, including using historical sales made to direct customers and third-party market research data related to prescription trends and end-user demand. Given the difficulties inherent in estimating third-party demand information, we evaluate our methodologies to estimate direct customer product level inventory and to calculate months on hand on an ongoing basis and make changes as necessary. Factors that may affect our estimates include generic competition, seasonality of products, price increases, new product launches, new warehouse openings by direct customers, new customer stockings by direct customers and expected direct customer purchases for governmental bidding situations. As such, all of the information required to estimate months on hand in the direct customer distribution channel for non-U.S. business for the quarter ended June&#160;30, 2021 is not available prior to the filing of this Quarterly Report on Form 10-Q. We will disclose any product with levels of inventory in excess of one month on hand or expected demand for the current quarter, subject to a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de minimis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> exception, in our next quarterly report on Form 10-Q.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="id66f4ecc89aa45bca7756420c60966f5_130"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expenses</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,452&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,699&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,671&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(736)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(704)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,150&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,502&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,693&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,587&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;In excess of +/- 100%.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Excludes amortization of acquired intangible assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Products Sold</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cost of products sold decreased by $247&#160;million in the second quarter 2021 primarily due to lower unwinding of inventory fair value adjustments ($626&#160;million), partially offset by higher </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> profit sharing ($303&#160;million) and foreign exchange.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cost of products sold decreased by $1.1&#160;billion year-to-date primarily due to lower unwinding of inventory fair value adjustments ($2.0&#160;billion), partially offset by higher </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> profit sharing ($395&#160;million), charges related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inrebic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> regulatory approval milestones in the EU ($315&#160;million) and foreign exchange.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketing, Selling and Administrative</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Marketing, selling and administrative expenses increased by $254&#160;million in the second quarter 2021 and $314 million year-to-date, primarily due to higher advertising and promotion expenses and higher costs to support new product launches.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Research and development expense increased by $749&#160;million in the second quarter 2021 and $602 million year-to-date, primarily due to license and asset acquisition charges of $780 million in the second quarter 2021 primarily relating to Eisai ($650 million) and Prothena ($80 million) and a $230 million IPRD impairment charge resulting from the decision to discontinue further development of an investigational compound. The second quarter 2020 included license and asset acquisition charges of $300 million relating to bluebird ($200 million) and Cormorant ($100 million).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of Acquired Intangible Assets</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Amortization of acquired intangible assets increased by $158&#160;million in the second quarter 2021 and $389 million year-to-date, due to additional product approvals.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other (Income)/Expense, Net</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other (income)/expense, net changed by $734&#160;million in the second quarter 2021 and $1.1 billion year-to-date, primarily due to fair value adjustments to contingent value rights and equity investments and other items discussed below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(510)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties and licensing income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(405)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(772)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(721)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(818)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(749)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(480)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and other settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition and other service fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reversion excise tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture (gains)/losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt redemption</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(736)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(704)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Contingent consideration primarily includes fair value adjustments resulting from the change in the traded price of contingent value rights issued with the Celgene acquisition. The contractual obligation to pay the contingent value rights terminated in January 2021 because the FDA did not approve liso-cel (JCAR017) by December 31, 2020.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Royalties and licensing income includes diabetes business royalties, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Keytruda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* royalties, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* royalties, up-front licensing fees and milestones for products that have not obtained commercial approval. Refer to &#8220;Item 1. Financial Statements&#8212;Note 4. Divestitures, Licensing and Other Arrangements&#8221; for further information.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Equity investment gains includes fair value adjustments on equity investments that have readily determinable fair value and other observable price changes on equity investments without readily determinable fair values. The fair value of equity investments with or without readily determinable fair values in the first quarter 2020 were significantly negatively impacted by changes in market conditions primarily caused by the COVID-19 pandemic and subsequently recovered in the second quarter 2020. Refer to &#8220;Item 1. Financial Statements&#8212;Note 9. Financial Instruments and Fair Value Measurements&#8221; for more information. Our share of income from equity method investments of $37&#160;million in the second quarter 2021 and $174&#160;million year-to-date are primarily due to fair value adjustments attributed to limited partnerships.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Integration expenses primarily includes consulting fees to implement Celgene integration initiatives related to processes and systems.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Provision for restructuring includes exit and other costs primarily related to the Celgene acquisition plan. We are on track to achieve the annualized pre-tax cost savings of approximately $3.0 billion through 2022 as detailed in the restructuring activities. Refer to &#8220;Item 1. Financial Statements&#8212;Note 6. Restructuring&#8221; for further information.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Investment income decreased primarily due to lower interest rates in the second quarter and year-to-date 2021.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reversion excise tax resulted from the transfer of the retiree medical plan assets back to the Company in the first quarter 2020.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A loss on debt redemption resulted from the early redemption of $3.5 billion long-term debt obligations in the first quarter 2021.</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="id66f4ecc89aa45bca7756420c60966f5_133"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings Before Income Taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,553&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,627&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,083&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for Income Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Tax Rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of Specified Items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Tax Rate Excluding Specified Items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax impact attributed to specified items was primarily due to low jurisdictional tax rates attributed to the unwinding of inventory fair value adjustments and intangible asset amortization and contingent value rights fair value adjustments that are not taxable or deductible. The three and six months ended June&#160;30, 2020 includes an $853&#160;million deferred tax charge resulting from an internal transfer of certain intangible assets to the U.S. and an additional $255&#160;million GILTI tax charge upon finalization of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Otezla</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* divestiture tax consequences with tax authorities. The effective tax rate excluding specified items increased by 3.1% in the second quarter 2021 and 1.9% year-to-date due to unfavorable earnings mix and the catch-up effect of a decrease to the estimated annual effective tax rate in the second quarter 2020. Refer to &#8220;Item 1. Financial Statements&#8212;Note 7. Income Taxes&#8221; for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_136"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-GAAP financial measures, such as non-GAAP earnings and related EPS information, are adjusted to exclude certain costs, expenses, gains and losses and other specified items that are evaluated on an individual basis. These items are adjusted after considering their quantitative and qualitative aspects and typically have one or more of the following characteristics, such as being highly variable, difficult to project, unusual in nature, significant to the results of a particular period or not indicative of future operating results. Similar charges or gains were recognized in prior periods and will likely reoccur in future periods including (i) amortization of acquired intangible assets, including product rights that generate a significant portion of our ongoing revenue and will recur until the intangible assets are fully amortized, (ii) unwind of inventory fair value adjustments, (iii) acquisition and integration expenses, (iv) restructuring costs, (v) accelerated depreciation and impairment of property, plant and equipment and intangible assets, (vi) R&amp;D charges or other income resulting from upfront or contingent milestone payments in connection with the acquisition or licensing of third-party intellectual property rights, (vii) divestiture gains or losses, (viii) stock compensation resulting from accelerated vesting of Celgene awards and certain retention-related employee compensation charges related to the Celgene transaction, (ix) pension, legal and other contractual settlement charges, (x) equity investment and contingent value rights fair value adjustments, including fair value adjustments attributed to limited partnership equity method investments and (xi) amortization of fair value adjustments of debt acquired from Celgene in our 2019 exchange offer, among other items. Deferred and current income taxes attributed to these items are also adjusted for considering their individual impact to the overall tax expense, deductibility and jurisdictional tax rates. Certain other significant tax items are also excluded such as the impact resulting from internal transfer of intangible assets and the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Otezla</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* divestiture in the second quarter 2020. We also provide international revenues for our priority products excluding the impact of foreign exchange. We calculate foreign exchange impacts by converting our current-period local currency financial results using the prior period average currency rates and comparing these adjusted amounts to our current-period results. Reconciliations of these non-GAAP measures to the most comparable GAAP measures are included in Exhibit 99.2 to our Form 8-K filed on July&#160;28, 2021 and are incorporated herein by reference.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-GAAP information is intended to portray the results of our baseline performance, supplement or enhance management, analysts and investors&#8217; overall understanding of our underlying financial performance and facilitate comparisons among current, past and future periods. For example, non-GAAP earnings and EPS information is an indication of our baseline performance before items that are considered by us to not be reflective of our ongoing results. In addition, this information is among the primary indicators that we use as a basis for evaluating performance, allocating resources, setting incentive compensation targets and planning and forecasting for future periods. This information is not intended to be considered in isolation or as a substitute for net earnings or diluted EPS prepared in accordance with GAAP and may not be the same as or comparable to similarly titled measures presented by other companies due to possible differences in method and in the items being adjusted. We encourage investors to review our financial statements and publicly-filed reports in their entirety and not to rely on any single financial measure.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specified items were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory purchase price accounting adjustments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">714&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,134&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Site exit and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,166&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Site exit and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License and asset acquisition charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPRD impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory purchase price accounting adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Site exit and other costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,010&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,389&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,671&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(510)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties and licensing income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment gains</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(818)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(762)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(479)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reversion excise tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture (gains)/losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt redemption</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(752)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(677)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase to pretax income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,669&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,730&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes on items above</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(688)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(294)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes attributed to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Otezla*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> divestiture</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes attributed to internal transfer of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(388)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(688)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase to net earnings</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,281&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,835&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,212&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,566&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes amortization of purchase price adjustments to Celgene debt.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="id66f4ecc89aa45bca7756420c60966f5_139"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliations from GAAP to Non-GAAP were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions, except per share data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings/(Loss) Attributable to BMS Used for Diluted EPS Calculation &#8211; GAAP</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(860)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specified Items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,281&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings Attributable to BMS Used for Diluted EPS Calculation &#8211; Non-GAAP</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,706&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Common Shares Outstanding &#8211; Diluted &#8211; GAAP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,252&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental Shares Attributable to Share-Based Compensation Plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Common Shares Outstanding &#8211; Diluted &#8211; Non-GAAP</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,297&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,258&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,298&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted Earnings/(Loss) Per Share Attributable to BMS &#8211; GAAP</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS Attributable to Specified Items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS Attributable to BMS &#8211; Non-GAAP</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.93&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.63&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.67&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.35&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="id66f4ecc89aa45bca7756420c60966f5_142"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL POSITION, LIQUIDITY AND CAPITAL RESOURCES</span></div><div><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_145"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net debt position was as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,024&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,546&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities &#8211; current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities &#8211; non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and marketable debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,113&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,264&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,655)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,340)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,503)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,336)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net debt position</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,045)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,412)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_148"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly assess our anticipated working capital needs, debt and leverage levels, debt maturities, capital expenditure requirements, dividend payouts, potential share repurchases and future investments or acquisitions in order to maximize shareholder return, efficiently finance our ongoing operations and maintain flexibility for future strategic transactions. We also regularly evaluate our capital structure to ensure financial risks, adequate liquidity access and lower cost of capital are efficiently managed, which may lead to the issuance of additional debt securities, the repurchase of debt securities prior to maturity or the issuance or repurchase of common stock. We believe that our existing cash, cash equivalents and marketable debt securities together with cash generated from operations and, if required, from the issuance of commercial paper will be sufficient to satisfy our anticipated cash needs for at least the next few years, including dividends, capital expenditures, milestone payments, working capital, restructuring initiatives, business development, debt maturities of approximately $12.0&#160;billion through 2024 as well as any debt repurchases through redemptions or tender offers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a share repurchase program authorized by our Board of Directors allowing for repurchases of our shares. The specific timing and number of shares repurchased will be determined by our management at its discretion and will vary based on market conditions, securities law limitations and other factors. The share repurchase program does not obligate us to repurchase any specific number of shares, does not have a specific expiration date and may be suspended or discontinued at any time. The repurchases may be effected through a combination of one or more open market repurchases, privately negotiated transactions, transactions structured through investment banking institutions and other derivative transactions, relying on Rule 10b-18 and Rule 10b5-1 under the Exchange Act. The outstanding share repurchase authority authorization under the program was $4.4 billion as of December 31, 2020. In January 2021, our Board of Directors approved an increase of $2.0&#160;billion to the share repurchase authorization for our common stock, increasing the total outstanding share repurchase authorization to approximately $6.4 billion. We repurchased approximately 47 million shares of our common stock for $3.0 billion during the six months ended June&#160;30, 2021 reducing the remaining share repurchase capacity under the share repurchase program to approximately $3.4 billion as of June&#160;30, 2021. Refer to &#8220;Item 1. Financial Statements&#8212;Note 15. Equity&#8221; for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend payments were $2.2 billion in the six months ended June 30, 2021. Dividends declared per common share were $0.98 in the six months ended June 30, 2021. Dividend decisions are made on a quarterly basis by our Board of Directors. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annual capital expenditures were approximately $750 million in 2020 and are expected to be approximately $1.1 billion in 2021 and $1.2 billion in 2022. We continue to make capital expenditures in connection with the expansion of our manufacturing capabilities, research and development and other facility-related activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our commercial paper program, we may issue a maximum of $5.0 billion unsecured notes that have maturities of not more than 366 days from the date of issuance. There were no commercial paper borrowings outstanding as of June&#160;30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we purchased aggregate principal amount of $3.5&#160;billion of certain of our debt securities for approximately $4.0&#160;billion of cash in a series of tender offers and &#8220;make whole&#8221; redemptions and $1.5 billion of notes matured and were repaid.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2021, we had four separate revolving credit facilities totaling $6.0 billion, which consisted of a 364-day $2.0 billion facility expiring in January 2022, a three-year $1.0 billion facility expiring in January 2022 and two five-year $1.5 billion facilities that were extended to September 2025 and July 2026, respectively. The revolving facilities provide for customary terms and conditions with no financial covenants, may be used to provide backup liquidity for our commercial paper borrowings and are extendable annually by one year on the anniversary date with the consent of the lenders. No borrowings were outstanding under revolving credit facilities at June&#160;30, 2021 or December 31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, we entered into a $4.0&#160;billion delayed draw term loan credit agreement which was terminated in February 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment portfolio includes non-current marketable debt securities, which are subject to changes in fair value as a result of interest rate fluctuations and other market factors. Our investment policy establishes limits on the amount and time to maturity of investments with any institution. The policy also requires that investments are only entered into with corporate and financial institutions that meet high credit quality standards. Refer to &#8220;Item 1. Financial Statements&#8212;Note 9. Financial Instruments and Fair Value Measurements&#8221; for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_151"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Ratings</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current long-term and short-term credit ratings assigned by Moody&#8217;s Investors Service are A2 and Prime-1, respectively, with a stable long-term credit outlook, and our current long-term and short-term credit ratings assigned by Standard &amp; Poor&#8217;s are A+ and A-1, respectively with a negative long-term credit outlook. The long-term ratings reflect the agencies&#8217; opinion that we have a low default risk but are somewhat susceptible to adverse effects of changes in circumstances and economic conditions. The short-term ratings reflect the agencies&#8217; opinion that we have good to extremely strong capacity for timely repayment. Any credit rating downgrade may affect the interest rate of any debt we may incur, the fair market value of existing debt and our ability to access the capital markets generally.</span></div><div style="text-align:justify"><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_154"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a discussion of cash flow activities:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow provided by/(used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,884&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,477)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,047)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flow from operating activities represents the cash receipts and disbursements from all of our activities other than investing and financing activities. Operating cash flow is derived by adjusting net earnings for noncontrolling interest, non-cash operating items, gains and losses attributed to investing and financing activities and changes in operating assets and liabilities resulting from timing differences between the receipts and payments of cash and when the transactions are recognized in our results of operations. As a result, changes in cash from operating activities reflect the timing of cash collections from customers and alliance partners; payments to suppliers, alliance partners and employees; customer discounts and rebates; and tax payments in the ordinary course of business. For example, annual employee bonuses are typically paid in the first quarter of the subsequent year.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The $1.5&#160;billion change in cash flow from operating activities compared to 2020 was primarily due to higher tax payments of approximately $1.3&#160;billion in 2021, the timing of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Otezla</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">* receivable collection reimbursements to Amgen of $500&#160;million in 2020 and the reversion of retirement medical plan assets of approximately $300&#160;million (net of excise taxes) in 2020, partially offset by cash collections and timing of payments in the ordinary course of business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash requirements from investing activities include cash used for acquisitions, manufacturing and facility-related capital expenditures and purchases of marketable securities with original maturities greater than 90 days at the time of purchase, proceeds from business divestitures (including royalties), the sale and maturity of marketable securities, sale of equity investments and upfront and contingent milestones from licensing arrangements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The $1.1&#160;billion change in cash flow from investing activities compared to 2020 was primarily due to changes in the amount of marketable debt securities held of $2.0&#160;billion, partially offset by higher proceeds from sales of equity investments of approximately $800&#160;million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash requirements from financing activities include cash used to pay dividends, repurchase common stock and repay long-term debt and other borrowings reduced by proceeds from the exercise of stock options and issuance of long-term debt and other borrowings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The $8.4&#160;billion change in cash flow from financing activities compared to 2020 was primarily due to higher debt repayments of $5.7&#160;billion, including a series of tender offers and &#8220;make whole&#8221; redemptions, and higher share repurchases of $2.9&#160;billion in 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="id66f4ecc89aa45bca7756420c60966f5_157"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product and Pipeline Developments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our R&amp;D programs are managed on a portfolio basis from early discovery through late-stage development and include a balance of early-stage and late-stage programs to support future growth. Our late stage R&amp;D programs in Phase III development include both investigational compounds for initial indications and additional indications or formulations for marketed products. The following are the developments in our marketed products and our late-stage pipeline since the start of the second quarter:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Product</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indication</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Developments</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr style="height:42pt"><td colspan="3" rowspan="7" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Opdivo</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bladder</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Announced that the FDA accepted the sBLA for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> for the adjuvant treatment of patients with surgically resected, high-risk muscle-invasive urothelial carcinoma. The FDA granted the application Priority Review and assigned a PDUFA goal date of September 3, 2021. The application is based on results from the Phase III CheckMate-274 trial.</span></div></td></tr><tr style="height:41pt"><td colspan="3" rowspan="4" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gastric and Esophageal Cancers</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Received a positive CHMP opinion of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> for the adjuvant treatment of adult patients with esophageal or gastroesophageal junction cancer who have residual pathologic disease following prior neoadjuvant chemoradiotherapy. The opinion is based on data from the Phase III CheckMate-577 trial.</span></div></td></tr><tr style="height:41pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Announced FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> for the adjuvant treatment of patients with completely resected esophageal or gastroesophageal junction cancer with residual pathologic disease who have received neoadjuvant chemoradiotherapy. The approval is based on results from the Phase III CheckMate-577 trial. </span></div></td></tr><tr style="height:50pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Announced FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> in combination with combination with fluoropyrimidine- and platinum-containing chemotherapy for the treatment of patients with advanced or metastatic gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma, regardless of PD-L1 expression status. The approval is based on the Phase III CheckMate-649 trial.</span></div></td></tr><tr style="height:77pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Announced positive topline results from the Phase III CheckMate-648 trial evaluating treatment with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> plus chemotherapy or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> in patients with unresectable advanced or metastatic ESCC. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> plus chemotherapy met primary and secondary endpoints of overall survival in patients with tumors expressing PD-L1 and in the all-randomized patient population, and also the primary endpoint of progression free survival in the PD-L1+ population. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> met primary and secondary endpoints of overall survival in both populations, whereas the other primary endpoint of progression free survival in the PD-L1+ population was not met.</span></div></td></tr><tr style="height:59pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">HCC</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Announced that in consultation with the FDA, we withdrew the U.S. indication for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> in HCC who were previously treated with sorafenib. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> was granted accelerated approval for this indication in 2017 based on tumor responses from the Phase I/II CheckMate-040 trial. CheckMate-459, the confirmatory randomized study of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> versus sorafenib in the first-line setting, did not achieve statistical significance for its primary endpoint of overall survival per the pre-specified analysis.</span></div></td></tr><tr style="height:32pt"><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RCC</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Announced EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> in combination with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cabometyx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">* for the first-line treatment of adults with advanced RCC. The approval is based on results from the Phase III CheckMate-9ER trial.</span></div></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr style="height:41pt"><td colspan="3" rowspan="7" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Opdivo + Yervoy</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">CRC</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Announced EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> for the treatment of adult patients with mismatch repair deficient (dMMR) or microsatellite instability-high mCRC after prior fluoropyrimidine-based combination chemotherapy. The approval is based on results from the Phase II CheckMate-142 trial.</span></div></td></tr><tr style="height:32pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Melanoma</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Announced new six-and-a-half year data from the Phase III CheckMate-067 trial demonstrating durable improvement in survival with first-line </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> therapy and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> monotherapy, versus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> alone, in patients with advanced melanoma.</span></div></td></tr><tr style="height:32pt"><td colspan="3" rowspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Malignant Pleural Mesothelioma</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Announced EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> for the first line treatment of adults with unresectable malignant pleural mesothelioma. The approval is based on results from the Phase III CheckMate-743 trial.</span></div></td></tr><tr style="height:50pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ono, our alliance partner for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> in Japan, announced that the companies received approval for combination therapy of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> in Japan for the first-line treatment of unresectable advanced or recurrent malignant pleural mesothelioma, for a partial change in approved items of the manufacturing and marketing approval. The approval is based on results from the Phase III CheckMate-743 trial.</span></div></td></tr><tr style="height:41pt"><td colspan="3" rowspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NSCLC</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Announced that Part 1 of the Phase III CheckMate-227 trial continues to demonstrate the long-term survival benefits of first-line treatment with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Yervoy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">compared to chemotherapy in patients with advanced NSCLC, regardless of PD-L1 expression level or histology, with a minimum follow-up of over four years.</span></div></td></tr><tr style="height:32pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2021</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Announced that </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> with two cycles of chemotherapy showed a durable survival benefit compared to four cycles of chemotherapy alone after two years of follow-up in previously untreated patients with advanced NSCLC in the Phase III CheckMate-9LA trial.</span></div></td></tr><tr style="height:59pt"><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">SCCHN</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Announced an update on the Phase III CheckMate-651 trial comparing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> to the EXTREME regimen (cetuximab, cisplatin/carboplatin and fluorouracil) as a first-line treatment in platinum-eligible patients with recurrent or metastatic SCCHN. Although </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"> Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> showed a clear, positive trend towards overall survival in patients whose tumors express PD-L1 with a combined positive score &#8805; 20, the study did not meet its primary endpoints.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Reblozyl</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beta Thalassemia</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Announced with Acceleron, that Phase II BEYOND study evaluating </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Reblozyl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> plus best supportive care in adult patients with non-transfusion dependent beta thalassemia demonstrated that 77.7% of patients treated with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Reblozyl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> achieved a hemoglobin increase (&#8805;1.0 gram/deciliter) compared to 0% of patients in the placebo arm.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Onureg</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">AML</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Announced EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> as a maintenance therapy in adult patients with AML who achieved complete remission or complete remission with incomplete blood count recovery following induction therapy with or without consolidation treatment and who are not candidates for, including those who choose not to proceed to, hematopoietic stem cell transplantation. The approval is based on data from the Phase III QUAZAR AML-001 study.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Zeposia</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">UC</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Announced FDA approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> for the treatment of adults with moderately to severely active UC. The approval is based on data from the pivotal Phase III True North trial.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:11.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.000%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.435%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Breyanzi</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lymphoma</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Announced positive topline results from the Phase III TRANSFORM trial evaluating </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Breyanzi </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">as a second-line treatment in adults with relapsed or refractory large B-cell lymphoma compared to salvage therapy followed by high-dose chemotherapy and hematopoietic stem cell transplant. Results of a pre-specified interim analysis conducted by an independent review committee showed the study met its primary endpoint of demonstrating a clinically meaningful and highly statistically significant improvement in event-free survival, as well as key secondary endpoints of complete response rate and progression-free survival compared to standard of care.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Abecma</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Multiple Myeloma</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Received a positive CHMP opinion of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> for the treatment of adult patients with RRMM who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-CD38 antibody and have demonstrated disease progression on the last therapy. The opinion is based on data from the Phase II KarMMa trial.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">mavacamten</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Obstructive HCM</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Announced a new analysis of data from the Phase III EXPLORER-HCM study evaluating mavacamten, an investigational, first-in-class cardiac myosin inhibitor, in patients with oHCM. At 30 weeks, the change in Kansas City Cardiomyopathy Questionnaire Overall Summary Score (KCCQ OSS) was greater in mavacamten patients than placebo, with similar benefits across all KCCQ subscales</span></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_160"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenue and expenses. Our critical accounting policies are those that significantly impact our financial condition and results of operations and require the most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Because of this uncertainty, actual results may vary from these estimates. For a discussion of our critical accounting policies, refer to &#8220;Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in our 2020 Form 10-K. There have been no material changes to our critical accounting policies during the six months ended June 30, 2021. For information regarding the impact of recently adopted accounting standards, refer to &#8220;Item 1. Financial Statements&#8212;Note.1 Basis of Presentation and Recently Issued Accounting Standards.&#8221;</span></div><div style="text-align:justify"><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_163"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Special Note Regarding Forward-Looking Statements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q (including documents incorporated by reference) and other written and oral statements we make from time to time contain certain &#8220;forward-looking&#8221; statements within the meaning of Section&#160;27A of the Securities Act, and Section&#160;21E of the Exchange Act. You can identify these forward-looking statements by the fact they use words such as &#8220;should,&#8221; &#8220;could,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;target,&#8221; &#8220;may,&#8221; &#8220;project,&#8221; &#8220;guidance,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;believe,&#8221; &#8220;will&#8221; and other words and terms of similar meaning and expression in connection with any discussion of future operating or financial performance. One can also identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. Such forward-looking statements are based on historical performance and current expectations and projections about our future financial results, goals, plans and objectives and involve inherent risks, assumptions and uncertainties, including internal or external factors that could delay, divert or change any of them in the next several years, and could cause our future financial results, goals, plans and objectives to differ materially from those expressed in, or implied by, the statements. These statements are likely to relate to, among other things, our goals, plans and objectives regarding our financial position, results of operations, cash flows, market position, product development, product approvals, sales efforts, expenses, performance or results of current and anticipated products, our business development strategy generally and in relation to our ability to realize the projected benefits of our acquisitions of Celgene and MyoKardia, the full extent of the impact of the COVID-19 pandemic on our operations and the development and commercialization of our products, potential laws and regulations to lower drug costs, market actions taken by private and government payers to manage drug utilization and contain costs, the expiration of patents or data protection on certain products, including assumptions about our ability to retain patent exclusivity of certain products, and the outcome of contingencies such as legal proceedings and financial results. No forward-looking statement can be guaranteed. We included in this Quarterly Report on Form 10-Q, in the 2020 Form 10-K, particularly under the caption &#8220;Item 1A. Risk Factors,&#8221; and in our other filings with the SEC additional information on the factors that we believe could cause actual results to differ materially from any forward-looking statement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we believe that we have been prudent in our plans and assumptions, no assurance can be given that any goal or plan set forth in forward-looking statements can be achieved and readers are cautioned not to place undue reliance on such statements, which speak only as of the date made. Additional risks that we may currently deem immaterial or that are not presently known to us could also cause the forward-looking events discussed in this Quarterly Report on Form 10-Q not to occur. Except as otherwise required by applicable law, we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, changed circumstances or otherwise after the date of this Quarterly Report on Form 10-Q.</span></div><div style="text-align:justify"><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_166"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of our market risk, refer to &#8220;Item 7A. Quantitative and Qualitative Disclosures about Market Risk&#8221; in our 2020 Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_169"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. CONTROLS AND PROCEDURES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management carried out an evaluation, under the supervision and with the participation of its chief executive officer and chief financial officer, of the effectiveness of the design and operation of its disclosure controls and procedures, as defined in Exchange Act Rules 13a-15(e) and 15d-15(e), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our principal executive officer and principal financial officer concluded that as of June&#160;30, 2021, such disclosure controls and procedures are effective.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in the Company&#8217;s internal control over financial reporting during the quarter ended June&#160;30, 2021 that have materially affected, or are reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="id66f4ecc89aa45bca7756420c60966f5_172"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II&#8212;OTHER INFORMATION</span></div><div><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_175"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. LEGAL PROCEEDINGS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information pertaining to legal proceedings can be found in &#8220;Item 1. Financial Statements&#8212;Note 17. Legal Proceedings and Contingencies,&#8221; to the interim consolidated financial statements, and is incorporated by reference herein.</span></div><div style="text-align:justify"><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_178"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A. RISK FACTORS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes from the risk factors disclosed in the Company&#8217;s 2020 Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div id="id66f4ecc89aa45bca7756420c60966f5_181"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the surrenders of our equity securities during the three months ended June 30, 2021:&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:34.505%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.477%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.477%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.477%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.479%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of Shares&#160;Purchased</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average&#160;Price Paid per&#160;Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares&#160;Purchased&#160;as Part of Publicly Announced Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate Dollar Value of Shares&#160;that May Yet Be Purchased Under the Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions, Except Per Share Data</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 1 to 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,542,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,443,618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 1 to 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,553,060&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,001,116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 1 to 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,578,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,501,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,674,195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,946,145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Includes shares repurchased as part of publicly announced programs and shares of common stock surrendered to the Company to satisfy tax-withholding obligations in connection with the vesting of awards under our long-term incentive program.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In May 2010, the Board of Directors authorized the repurchase of up to $3.0 billion of our common stock and in June 2012 increased its authorization for the repurchase of our common stock by an additional $3.0 billion. The Board of Directors approved a new share repurchase program authorizing the repurchase of an additional $3.0 billion of our common stock in October 2016 and further increased its authorization for the repurchase of our common stock by approximately $7.0 billion in November 2019 and $5.0 billion in February 2020. In January 2021, the Board of Directors approved an increase of $2.0 billion to the share repurchase authorization for our common stock. The remaining share repurchase capacity under the program was approximately $3.4 billion as of June 30, 2021. Refer to &#8220;Item 1. Financial Statements-Note 15. Equity&#8221; for information on the share repurchase program.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="id66f4ecc89aa45bca7756420c60966f5_184"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6. EXHIBITS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits (listed by number corresponding to the Exhibit Table of Item&#160;601 in Regulation S-K).</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.721%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3a.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/14272/000114036121015721/brhc10024000_ex3a.htm">Certificate of Amendment to the Amended and Restated Certificate of Incorporation, effective as of May 4, 2021 (incorporated herein by reference to Exhibit 3a to the Form 8-K dated and filed on May 4, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3b.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/14272/000114036121015721/brhc10024000_ex3b.htm">Amended and Restated Bylaws, effective as of May 4, 2021 (incorporated herein by reference to Exhibit 3b to the Form 8-K dated and filed on May 4, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10a.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/14272/000114036121015721/brhc10024000_ex10-1.htm">Form of Restricted Stock Units Agreement with 3-year vesting under the 2021 Stock Award and Incentive Plan (incorporated herein by reference to Exhibit 10.1 to the Form 8-K dated and filed on May 4, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10b.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/14272/000114036121015721/brhc10024000_ex10-2.htm">Form of Restricted Stock Units Agreement with 4-year vesting under the 2021 Stock Award and Incentive Plan (incorporated herein by reference to Exhibit 10.2 to the Form 8-K dated and filed on May 4, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10c.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/14272/000114036121015721/brhc10024000_ex10-3.htm">Form of Restricted Stock Units Agreement with 5-year vesting under the 2021 Stock Award and Incentive Plan (incorporated herein by reference to Exhibit 10.3 to the Form 8-K dated and filed on May 4, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10d.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/14272/000114036121015721/brhc10024000_ex10-4.htm">Form of Restricted Stock Units Agreement with 2-year cliff vesting under the 2021 Stock Award and Incentive Plan (incorporated herein by reference to Exhibit 10.4 to the Form 8-K dated and filed on May 4, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10e.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/14272/000114036121015721/brhc10024000_ex10-5.htm">Form of Restricted Stock Units Agreement with 1-year vesting under the 2021 Stock Award and Incentive Plan (incorporated herein by reference to Exhibit 10.5 to the Form 8-K dated and filed on May 4, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10f.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bmyex10f20210630.htm">Extension Notice, dated June 1, 2021, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10g.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bmyex10g20210620.htm">Amendment and Waiver, dated as of June 22, 2021, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of September 29, 2011 among Bristol-Myers Squibb Company, the several financial institutions from time to time party to the agreement, and JPMorgan Chase Bank, N.A. and Citibank N.A. as administrative agents.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10h.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bmyex10h20210630.htm">Extension Notice, dated June 1, 2021, for the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10i.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bmyex10i20210630.htm">Amendment, dated as of June 22, 2021, to the Five Year Competitive Advance and Revolving Credit Facility Agreement dated as of July 30, 2012 among Bristol-Myers Squibb Company, the several financial institutions from time to time party to the agreement, and JPMorgan Chase Bank, N.A. and Citibank N.A. as administrative agents.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31a.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bmyex31a_20210630.htm">Section 302 Certification Letter.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31b.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bmyex31b_20210630.htm">Section 302 Certification Letter.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32a.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bmyex32a_20210630.htm">Section 906 Certification Letter.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32b.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bmyex32b_20210630.htm">Section 906 Certification Letter.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Indicates, in this Quarterly Report on Form 10-Q, brand names of products, which are registered trademarks not solely owned by the Company or its subsidiaries.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;is a trademark of Otsuka Pharmaceutical Co., Ltd.;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Atripla</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Gilead Sciences, LLC.; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Avapro/Avalide</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (known in the EU as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aprovel/Karvea</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are trademarks of Sanofi; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;is a trademark of Amylin Pharmaceuticals, LLC; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cabometyx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Exelixis, Inc.;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Erbitux</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;is a trademark of ImClone LLC;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of AstraZeneca AB; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gleevec</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;is a trademark of Novartis AG;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Keytruda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;is a trademark of Merck Sharp &amp; Dohme Corp; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Otezla</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Amgen Inc.; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Sanofi-aventis U.S. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Genentech, Inc.; and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;is a trademark of Kite Pharma, Inc. Brand names of products that are in all italicized letters, without an asterisk, are registered trademarks of BMS and/or one of its subsidiaries.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="id66f4ecc89aa45bca7756420c60966f5_187"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUMMARY OF ABBREVIATED TERMS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bristol-Myers Squibb Company and its consolidated subsidiaries may be referred to as Bristol Myers Squibb, BMS, the Company, we, our or us in this Quarterly Report on Form 10-Q, unless the context otherwise indicates. Throughout this Quarterly Report on Form 10-Q we have used terms which are defined below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.040%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Form 10-K</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annual Report on Form 10-K for the fiscal year ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lilly</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eli Lilly and Company</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agenus</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agenus Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LOE</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">loss of exclusivity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amgen</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amgen Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MDL</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">multi-district litigation</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AML</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">acute myeloid leukemia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MDS</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">myelodysplastic syndromes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amylin</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amylin Pharmaceuticals, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MPM</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">malignant pleural mesothelioma</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">aNDA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">abbreviated new drug applications</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MyoKardia</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MyoKardia, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AstraZeneca</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AstraZeneca PLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NKT</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">natural killer T cells</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BCMA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">B-cell maturation antigen</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NSCLC</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">non-small cell lung cancer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BLA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">biologics license application</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NVAF</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">non-valvular atrial fibrillation</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">bluebird</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">bluebird bio, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">oHCM</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">obstructive hypertrophic cardiomyopathy</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAR T</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">chimeric antigen receptor T-cell</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ono</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ono Pharmaceutical Co., Ltd.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celgene</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celgene Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OTC</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">over-the-counter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CERCLA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Comprehensive Environmental Response, Compensation and Liability Act</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Otsuka</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Otsuka Pharmaceutical Co., Ltd.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CML</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">chronic myeloid leukemia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PD-1</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">programmed cell death protein 1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cormorant</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cormorant Pharmaceuticals</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PD-L1</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">programmed death-ligand 1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CRC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorectal carcinoma</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PDUFA</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Prescription Drug User Fee Act</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CVR</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">contingent value rights</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Commission</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prothena</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prothena Corporation plc</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eisai</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eisai Co., Ltd.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PsA</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">psoriatic arthritis</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Medicines Agency</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarterly Report on Form 10-Q</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">earnings per share</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">research and development</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESCC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">esophageal squamous cell carcinoma</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RA</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">rheumatoid arthritis</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EU</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Union</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RBC</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">red blood cell</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FASB</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Accounting Standards Board</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RCC</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">renal cell carcinoma</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FDA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Food and Drug Administration</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">REMS</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">risk evaluation and mitigation strategy</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. generally accepted accounting principles</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RRMM</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">relapsed and refractory multiple myeloma</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GILTI</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Global intangible low-taxed income</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanofi S.A.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">gross-to-net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">sBLA</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">supplemental Biologics License Application</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HCC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">hepatocellular carcinoma</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCLC</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">small cell lung cancer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HIV</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">human immunodeficiency viruses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SEC</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities and Exchange Commission</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IO</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">immuno-oncology</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TNBC</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">triple-negative breast cancer</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPRD</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">in-process research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UC</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ulcerative colitis</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IRS</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal Revenue Service</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JIA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">juvenile idiopathic arthritis</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UK</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Juno</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Juno Therapeutics, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAT</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">value added tax</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">London Interbank Offered Rate</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VTE</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">venous thromboembolic</span></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div><div style="text-align:center"><span><br/></span></div></div></div><div id="id66f4ecc89aa45bca7756420c60966f5_190"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BRISTOL-MYERS SQUIBB COMPANY<br/>(REGISTRANT)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 28, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Giovanni Caforio, M.D.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Giovanni Caforio, M.D.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chairman of the Board and Chief Executive Officer</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 28, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ David V. Elkins</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David V. Elkins</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</span></div></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.F
<SEQUENCE>2
<FILENAME>bmyex10f20210630.htm
<DESCRIPTION>EXTENSION NOTICE FOR REVOLVING CREDIT FACILITY DATED SEPTEMBER 29, 2011
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i044225a73f224eedb97ad81e452fa110_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10f</font></div></div><div style="text-align:center"><font><br></font></div><div><img alt="bmslogo2021.jpg" src="bmslogo2021.jpg" style="height:50px;margin-bottom:5pt;vertical-align:text-bottom;width:270px"></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Citibank, N.A., as Administrative Agent</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">388 Greenwich Street</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">New York, New York 10013</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Attention&#58; Richard Rivera</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:0.2pt;text-align:justify"><font><br></font></div><div style="margin-top:2.9pt;padding-right:6.75pt;text-align:right"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">June 1, 2021</font></div><div style="margin-top:0.2pt;text-align:justify"><font><br></font></div><div style="padding-left:4.5pt;text-align:justify"><font style="color:#020202;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58;</font></div><div style="padding-left:4.5pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#030303;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Re&#58; </font><font style="color:#030303;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Extension of Maturity Date</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">Reference is made to the Five Year Competitive Ad</font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">v</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">ance and Revolving Credit Facility Agreement</font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">dated as of September 29</font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">2011 </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">(as amended</font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">supplemented or otherwise modified prior to the date hereof</font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8220;</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">Credit Agreement</font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8221;</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">) among Bristol-Myers Squibb Company</font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">a Delaware corporation  (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8220;</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">Company</font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8221;</font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">)</font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">the Borrowing Subsidiaries</font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">the lenders parties </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">thereto </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">(the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8220;</font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">Lenders</font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8221;</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">)</font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">certain Agents</font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">Citibank </font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">N.A.</font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">as an Administrative Agent</font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">and JPMorgan Chase Bank</font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">N.A.</font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">as an Administrative </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">Agent. </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">Capitalized terms used but not defined herein shall have the meaning </font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">as</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">signed to such </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">terms in </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">the Credit Agreement.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">Pursuant to Section </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">2.5 </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">of the Credit </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">Agreement</font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">the </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">Company </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">hereby </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">requests that </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">the Lenders </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">extend </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">the Maturity Date in </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">effect </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">on the date hereof </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">(i</font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">.</font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">e</font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">.</font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">September 29</font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">, </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">2024) </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">such that </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">the extended </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">Maturity Date </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">under </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">the </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">Credit Agreement will </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">be September 29</font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">, </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">2025</font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">. </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">This letter shall constitute an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">&#8220;</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">Extension Letter&#8221;</font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%"> </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">as </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">referred to in Section 2.5 of the Credit Agreement. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.444%"><tr><td style="width:1.0%"></td><td style="width:8.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.361%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BRISTOL-MYERS SQUIBB COMPANY</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Sandra Ramos-Alves</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Sandra Ramos-Alves</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Vice President and Assistant Treasurer</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.G
<SEQUENCE>3
<FILENAME>bmyex10g20210620.htm
<DESCRIPTION>AMENDMENT AND WAIVER TO REVOLVING CREDIT FACILITY DATED SEPTEMBER 29, 2011
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i6385d022fa7b4c589384aebf5bb35507_1"></div><div style="min-height:67.5pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10g</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXECUTION VERSION</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AMENDMENT AND WAIVER</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">AMENDMENT AND WAIVER  (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Amendment and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), dated as of June 22, 2021, by and among BRISTOL-MYERS SQUIBB COMPANY, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), the Lenders (as defined below) party hereto and the Administrative Agent (as defined below), which amends that certain FIVE YEAR COMPETITIVE ADVANCE AND REVOLVING CREDIT FACILITY AGREEMENT (as amended, supplemented or otherwise modified from time to time prior to the effectiveness of this Amendment and Waiver, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Existing Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; and as modified by this Amendment and Waiver, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) dated as of September 29, 2011, among the Company, the BORROWING SUBSIDIARIES (as defined in the Credit Agreement) from time to time party thereto, the lenders from time to time party thereto (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), certain Agents, JPMORGAN CHASE BANK, N.A., as Administrative Agent (in such capacity, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">JPMCB</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and CITIBANK, N.A., as Administrative Agent (in such capacity, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CBNA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;&#59; JPMCB and CBNA are referred to herein individually as an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; and collectively as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Administrative Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and as competitive advance facility agent.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">W I T N E S S E T H&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company has requested that the Lenders agree to amend or waive certain provisions of the Existing Credit Agreement as set forth herein&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, Section 8.7 of the Existing Credit Agreement permits the Existing Credit Agreement to be amended from time to time by the Company and the Lenders&#59; and </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company and each Lender desire to amend the Existing Credit Agreement on the terms set forth herein&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, it is agreed&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Capitalized terms used but not defined herein shall have the meaning assigned to such terms in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt;text-decoration:underline">Waiver.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding anything to the contrary contained in Section 2.5(a) of the Existing Credit Agreement, solely with respect to the anniversary of the Effective Date occurring on September 19, 2021, the Company may submit an Extension Letter on or prior to June 30, 2021 requesting an extension of the Maturity Date to September 29, 2025.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt;text-decoration:underline">Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Effective as of the Amendment and Waiver Effective Date (as defined below), the Existing Credit Agreement (excluding the Exhibits and </font></div><div style="height:56.7pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Schedules thereto, which shall continue to be the Exhibits and Schedules under the Existing Credit Agreement, as amended hereby) is hereby amended as follows&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:46.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.9pt">Section 1.1 of the Existing Credit Agreement is hereby amended by adding the following definitions in appropriate alphabetical order&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Erroneous Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning assigned to such term in Section 8.22(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Erroneous Payment Deficiency Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning assigned to such term in Section 8.22(d).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Erroneous Payment Impacted Class</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning assigned to such term in Section 8.22(d).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Erroneous Payment Return Deficiency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning assigned to such term in Section 8.22(d).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Erroneous Payment Subrogation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning assigned to such term in Section 8.22(d). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Payment Recipient</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning assigned to such term in Section 8.22(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:46.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.22pt">The definition of &#8220;Obligations&#8221; is hereby amended by (i) removing the word &#8220;and&#8221; from before clause (ii) thereof and (ii) adding the following at the end of such definition&#58; &#8220;and (iii) Erroneous Payment Subrogation Rights.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:46.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.9pt">Section 2.1 of the Existing Credit Agreement is hereby amended and restated to read as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 2.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.&#160; Subject to the terms and conditions set forth herein, each Lender agrees to make Revolving Loans to the Company and any Borrowing Subsidiary from time to time during the Availability Period in Dollars</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">in an aggregate principal amount that will not result in (a)&#160;such Lender&#8217;s Revolving Credit Exposure exceeding such Lender&#8217;s Commitment or (b)&#160;the sum of the total Revolving Credit Exposures plus the total Competitive Loan Exposures exceeding the total Commitments.&#160; Within the foregoing limits and subject to the terms and conditions set forth herein, the Company and each applicable Borrowing Subsidiary may borrow, prepay and reborrow Revolving Loans. Notwithstanding anything set forth in this Agreement to the contrary, no Loans shall be made hereunder in any Currency other than Dollars.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:46.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.22pt">Section 2.4(a) of the Existing Credit Agreement is hereby amended to include as the penultimate sentence the following&#58; </font></div><div style="height:56.7pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:46.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding anything set forth in this Agreement to the contrary, no Competitive Loans shall be made hereunder in any Currency other than Dollars.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:46.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.9pt;text-decoration:underline">Article VIII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of the Existing Credit Agreement is hereby amended by adding a new Section 8.22 thereto, which shall read as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:46.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 8.22. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Erroneous Payments.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.7pt"> If CBNA notifies&#160;a Lender or any Person who has received funds on behalf of a Lender, such Lender (any such Lender or other recipient, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Payment Recipient&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) that CBNA has determined&#160;in its sole discretion (whether or not after receipt of any notice under immediately succeeding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">clause (b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) that any funds received by such Payment Recipient from CBNA or any of its Affiliates were erroneously transmitted to, or otherwise erroneously or mistakenly received by, such Payment Recipient (whether or not known to such Lender or other Payment Recipient on its behalf)  (any such funds, whether received as a payment, prepayment or repayment of principal, interest, fees, distribution or otherwise, individually and collectively, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Erroneous Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and demands the return of such Erroneous Payment (or a portion thereof), such Erroneous Payment shall at all times remain the property of CBNA and shall be segregated by the Payment Recipient and held in trust for the benefit of CBNA, and such Lender shall (or, with respect to any Payment Recipient who received such funds on its behalf, shall cause such Payment Recipient to) promptly, but in no event later than two Business Days thereafter, return to CBNA the amount of any such Erroneous Payment (or portion thereof) as to which such a demand was made, in same day funds (in the currency so received), together with interest thereon in respect of each day from and including the date such Erroneous Payment (or portion thereof) was received by such Payment Recipient to the date such amount is repaid to CBNA in same day funds at the greater of the Federal Funds Effective Rate and a rate determined by CBNA in accordance with banking industry rules on interbank compensation from time to time in effect. A notice of CBNA to any Payment Recipient under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">clause (a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be conclusive, absent manifest error.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.02pt">Without limiting immediately preceding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">clause (a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, each Lender, or any Person who has received funds on behalf of a Lender, hereby further agrees that if it&#160;receives a payment, prepayment or repayment (whether received as a payment, prepayment or repayment of principal, interest, fees, distribution or otherwise) from CBNA (or any of its Affiliates) (x) that is in a different amount than, or on a different date from, that specified in a notice of payment, prepayment or repayment sent by CBNA (or any of its Affiliates) with respect to such payment, prepayment or repayment, (y) that was not preceded or accompanied by a notice of payment, prepayment or repayment sent by CBNA (or any of its Affiliates), or (z) that such Lender, or other such recipient, otherwise becomes aware was transmitted, or received, in error or by mistake (in whole or in part) in each case&#58;</font></div><div style="height:56.7pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:57.6pt;text-align:justify;text-indent:43.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.89pt"> (A) in the case of immediately preceding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">clauses (x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">(y)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, an error shall be presumed to have been made (absent written confirmation from CBNA to the contrary) or (B) an error has been made (in the case of immediately preceding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">clause (z)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), in each case, with respect to such payment, prepayment or repayment&#59; and</font></div><div style="margin-bottom:12pt;padding-left:57.6pt;text-align:justify;text-indent:43.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:28.56pt">such Lender shall (and shall cause any other recipient that receives funds on its behalf to) promptly (and, in all events, within one Business Day of its knowledge of such error) notify CBNA of its receipt of such payment, prepayment or repayment, the details thereof (in reasonable detail) and that it is so notifying CBNA pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.22(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.7pt">Each Lender hereby authorizes CBNA to set off, net and apply any and all amounts at any time owing to such Lender under any Loan Document, or otherwise payable or distributable by CBNA to such Lender from any source, against any amount due to CBNA under immediately preceding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">clause (a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or under the indemnification provisions of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.02pt">In the event that an Erroneous Payment (or portion thereof) is not recovered by CBNA for any reason, after demand therefor by CBNA in accordance with immediately preceding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">clause (a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, from any Lender that has received such Erroneous Payment (or portion thereof) (and&#47;or from any Payment Recipient who received such Erroneous Payment (or portion thereof) on its behalf)  (such unrecovered amount, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Erroneous Payment Return Deficiency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), upon CBNA&#8217;s notice to such Lender at any time, (i) such Lender shall be deemed to have assigned its Loans (but not its Commitments) of the relevant Class with respect to which such Erroneous Payment was made (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Erroneous Payment Impacted Class</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) in an amount equal to the Erroneous Payment Return Deficiency (or such lesser amount as CBNA may specify) (such assignment of the Loans (but not Commitments) of the Erroneous Payment  Impacted Class, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Erroneous Payment Deficiency Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) at par plus any accrued and unpaid interest (with the assignment fee to be waived by CBNA in such instance), and is hereby (together with the Borrowers) deemed to execute and deliver an Assignment and Assumption (or, to the extent applicable, an agreement incorporating an Assignment and Assumption by reference pursuant to a Platform as to which CBNA and such parties are participants) with respect to such Erroneous Payment Deficiency Assignment, and such Lender shall deliver any promissory notes evidencing such Loans to the Borrowers or CBNA, (ii) CBNA as the assignee Lender shall be deemed to acquire the Erroneous Payment Deficiency Assignment, (iii) upon such deemed acquisition, CBNA as the assignee Lender shall become a Lender hereunder with respect to such Erroneous Payment Deficiency Assignment and the assigning Lender shall cease to be a Lender hereunder with respect to such Erroneous Payment Deficiency Assignment, excluding, for the avoidance of doubt, its obligations under the indemnification provisions of this Agreement and its applicable Commitments which shall survive as to such assigning Lender and (iv) CBNA may reflect in the Register its ownership interest in the Loans subject to the Erroneous Payment </font></div><div style="height:56.7pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:0.54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Deficiency Assignment. CBNA may, in its discretion, sell any Loans acquired pursuant to an Erroneous Payment Deficiency Assignment and upon receipt of the proceeds of such sale, the Erroneous Payment Return Deficiency owing by the applicable Lender shall be reduced by the net proceeds of the sale of such Loan (or portion thereof), and CBNA shall retain all other rights, remedies and claims against such Lender (and&#47;or against any recipient that receives funds on its behalf). For the avoidance of doubt, no Erroneous Payment Deficiency Assignment will reduce the Commitments of any Lender and such Commitments shall remain available in accordance with the terms of this Agreement. In addition, each party hereto agrees that, except to the extent that CBNA has sold a Loan (or portion thereof) acquired pursuant to an Erroneous Payment Deficiency Assignment, and irrespective of whether CBNA may be equitably subrogated, CBNA shall be contractually subrogated to all the rights and interests of the applicable Lender under the Loan Documents with respect to each Erroneous Payment Return Deficiency (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Erroneous Payment Subrogation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.7pt">The parties hereto agree that an Erroneous Payment shall not pay, prepay, repay, discharge or otherwise satisfy any Obligations owed by any Borrower or any Guarantor, except, in each case, to the extent such Erroneous Payment is, and solely with respect to the amount of such Erroneous Payment that is, comprised of funds received by CBNA from any Borrower or any Guarantor for the purpose of making such Erroneous Payment. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:6.03pt">To the extent permitted by applicable law, no Payment Recipient shall assert any right or claim to an Erroneous Payment, and hereby waives, and is deemed to waive, any claim, counterclaim, defense or right of set-off or recoupment with respect to any demand, claim or counterclaim by CBNA for the return of any Erroneous Payment received, including without limitation waiver of any defense based on &#8220;discharge for value&#8221; or any similar doctrine.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.02pt">Each party&#8217;s obligations, agreements and waivers under this Section 8.22 shall survive the resignation or replacement of CBNA as Administrative Agent, any transfer of rights or obligations by, or the replacement of, a Lender,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the termination of the Commitments and&#47;or the repayment, satisfaction or discharge of all Obligations (or any portion thereof) under any Loan Document.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt;text-decoration:underline">Conditions to Effectiveness of Amendment and Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Amendment and Waiver shall become effective on the date on which CBNA (or its counsel) shall have received from the Company and the Lenders either (a) a counterpart of this Amendment and Waiver signed on behalf of such party or (b) written evidence satisfactory to CBNA (which may include email or facsimile transmission of a signed signature page of this Amendment and Waiver) that such party has signed a counterpart of this Amendment and Waiver (such date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Amendment and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Waiver Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;). </font></div><div style="height:56.7pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CBNA shall notify the Company and the Lenders of the Amendment and Waiver Effective Date, and such notice shall be conclusive and binding absent manifest error.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt;text-decoration:underline">Effects on Loan Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Amendment and Waiver shall constitute a &#8220;Loan Document&#8221; for purposes of the Credit Agreement and the other Loan Documents. From and after the Amendment and Waiver Effective Date, all references to the Existing Credit Agreement and each of the other Loan Documents shall be deemed to be references to the Credit Agreement. Except as expressly amended or waived pursuant to the terms hereof, all of the representations, warranties, terms, covenants and conditions of the Loan Documents shall remain unamended and not waived and shall continue to be in full force and effect. The execution, delivery and effectiveness of this Amendment and Waiver shall not, except as expressly provided herein, operate as a waiver of any right, power or remedy of any Lender or the Administrative Agents under any of the Loan Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:46.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.9pt">The Company represents and warrants to the Lenders and the Administrative Agents that (i) the representations and warranties set forth in Article III of the Credit Agreement are true and correct in all material respects (provided that such representations and warranties qualified as to materiality shall be true and correct in all respects) on the date hereof, except to the extent such representations and warranties expressly relate to an earlier date, in which case such representations and warranties were true and correct in all material respects (provided that such representations and warranties qualified as to materiality shall be true and correct in all respects) as of such earlier date and (ii) no Default or Event of Default exists on the  Amendment and Waiver Effective Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:46.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.22pt">This Amendment and Waiver may be executed in multiple counterparts, each of which shall constitute an original but all of which taken together shall constitute but one contract. A counterpart hereof, or signature page hereto, delivered to the Administrative Agent by facsimile or e-mail shall be effective as delivery of an original manually-signed counterpart.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:46.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.9pt">The provisions of Sections 8.5, 8.11, 8.13 and 8.14 of the Credit Agreement are incorporated herein by reference as if fully set forth herein, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">mutatis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">mutandis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt;text-decoration:underline">Applicable Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;THIS AMENDMENT AND WAIVER SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NEW YORK.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:56.7pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt;text-decoration:underline">Electronic Execution. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The words &#8220;execution,&#8221; &#8220;signed,&#8221; &#8220;signature,&#8221; and words of like import in this Amendment and Waiver or in any amendment or other modification hereof (including waivers and consents) shall be deemed to include electronic signatures or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable Law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Signature pages follow</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div style="height:56.7pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div></div></div><div id="i6385d022fa7b4c589384aebf5bb35507_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties hereto have caused this  Amendment and Waiver to be duly executed by their respective authorized officers as of the day and year first above written.</font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.208%"><tr><td style="width:1.0%"></td><td style="width:12.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.378%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">BRISTOL-MYERS SQUIBB COMPANY</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Sandra Ramos-Alves</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Sandra Ramos-Alves</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Vice President, Assistant Treasurer</font></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment and Waiver under Bristol-Myers Squibb 2011 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div></div></div><div id="i6385d022fa7b4c589384aebf5bb35507_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CITIBANK, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, as Administrative Agent and as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Richard Rivera</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Richard Rivera</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Vice President</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment and Waiver under Bristol-Myers Squibb 2011 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div></div></div><div id="i6385d022fa7b4c589384aebf5bb35507_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">JPMORGAN CHASE BANK, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, as Administrative Agent and as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Stacey Zoland</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Stacey Zoland</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Executive Director</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment and Waiver under Bristol-Myers Squibb 2011 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div></div></div><div id="i6385d022fa7b4c589384aebf5bb35507_129"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">BANK OF AMERICA, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, as Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Darren Merten</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Darren Merten</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Director</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment and Waiver under Bristol-Myers Squibb 2011 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div></div></div><div id="i6385d022fa7b4c589384aebf5bb35507_124"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">BNP Paribas, as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Michael Pearce</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Michael Pearce</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Managing Director</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:right;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; John Bosco</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; John Bosco</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Managing Director</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment and Waiver under Bristol-Myers Squibb 2011 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div></div></div><div id="i6385d022fa7b4c589384aebf5bb35507_119"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">MIZUHO BANK, LTD., as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; John Davies</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; John Davies</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Authorized Signatory</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment and Waiver under Bristol-Myers Squibb 2011 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div></div></div><div id="i6385d022fa7b4c589384aebf5bb35507_114"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Morgan Stanley Bank, N.A., as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Michael King</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Michael King</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Authorized Signatory</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment and Waiver under Bristol-Myers Squibb 2011 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div></div></div><div id="i6385d022fa7b4c589384aebf5bb35507_109"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">MUFG Bank, LTD., as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Jack Lonker</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Jack Lonker</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Director</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment and Waiver under Bristol-Myers Squibb 2011 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div></div></div><div id="i6385d022fa7b4c589384aebf5bb35507_104"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WELLS FARGO BANK, NATIONAL ASSOCIATION, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Jordan Harris</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Jordan Harris</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Managing Director</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment and Waiver under Bristol-Myers Squibb 2011 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div></div></div><div id="i6385d022fa7b4c589384aebf5bb35507_174"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">BARCLAYS BANK PLC, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Ronnie Glenn</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Ronnie Glenn</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Director</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment and Waiver under Bristol-Myers Squibb 2011 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div></div></div><div id="i6385d022fa7b4c589384aebf5bb35507_169"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Credit Suisse AG, New York Branch, as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Judith Smith</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Judith Smith</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Authorized Signatory</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:right;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Andrew Griffin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Andrew Griffin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Authorized Signatory</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment and Waiver under Bristol-Myers Squibb 2011 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div></div></div><div id="i6385d022fa7b4c589384aebf5bb35507_164"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DEUTSCHE BANK AG NEW YORK BRANCH, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Ming K. Chu</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Ming K. Chu</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Director</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ming.k.chu&#64;db.com</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">+1-212-250-5451</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:right;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#91;FOR LENDERS REQUIRING TWO SIGNATURE BLOCKS&#93;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Marko Lukin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Marko Lukin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Vice President</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">marko.lukin&#64;db.com</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">+1-212-250-7283</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment and Waiver under Bristol-Myers Squibb 2011 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div></div></div><div id="i6385d022fa7b4c589384aebf5bb35507_159"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GOLDMAN SACHS BANK USA, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Jacob Elder</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Jacob Elder</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Authorized Signatory</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment and Waiver under Bristol-Myers Squibb 2011 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div></div></div><div id="i6385d022fa7b4c589384aebf5bb35507_154"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">HSBC Bank USA, N.A., as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Iain P. Stewart</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Iain P. Stewart</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Managing Director</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment and Waiver under Bristol-Myers Squibb 2011 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div></div></div><div id="i6385d022fa7b4c589384aebf5bb35507_193"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SOCIETE GENERALE,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Kimberly Metzger</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Kimberly Metzger</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Director</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment and Waiver under Bristol-Myers Squibb 2011 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div></div></div><div id="i6385d022fa7b4c589384aebf5bb35507_188"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SUMITOMO MITSUI BANKING CORPORATION,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Gail Motonaga</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Gail Motonaga</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Executive Director</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment and Waiver under Bristol-Myers Squibb 2011 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div></div></div><div id="i6385d022fa7b4c589384aebf5bb35507_13"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">STANDARD CHARTERED BANK, as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Kristopher Tracy</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Kristopher Tracy</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Director, Financing Solutions</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:right;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment and Waiver under Bristol-Myers Squibb 2011 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.H
<SEQUENCE>4
<FILENAME>bmyex10h20210630.htm
<DESCRIPTION>EXTENSION NOTICE FOR REVOLVING CREDIT FACILITY AGREEMENT DATED JULY 30, 2012
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ic4f29b2b5a1e4041b119ab37e6522ffb_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 10h</font></div></div><div style="text-align:center"><font><br></font></div><div><img alt="bmslogo2021.jpg" src="bmslogo2021.jpg" style="height:50px;margin-bottom:5pt;vertical-align:text-bottom;width:270px"></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Citibank, N.A., as Administrative Agent</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">388 Greenwich Street</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">New York, New York 10013</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Attention&#58; Richard Rivera</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:0.2pt;text-align:justify"><font><br></font></div><div style="margin-top:2.9pt;padding-right:6.75pt;text-align:right"><font style="color:#010101;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">June 1, 2021</font></div><div style="margin-top:0.2pt;text-align:justify"><font><br></font></div><div style="padding-left:4.5pt;text-align:justify"><font style="color:#020202;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58;</font></div><div style="padding-left:4.5pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#030303;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Re&#58; </font><font style="color:#030303;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Extension of Maturity Date</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">Reference is made to the Five Year Competitive Ad</font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">v</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">ance and Revolving Credit Facility Agreement</font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">dated as of July 30</font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">2012 </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">(as amended</font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">supplemented or otherwise modified prior to the date hereof</font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8220;</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">Credit Agreement</font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8221;</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">) among Bristol-Myers Squibb Company</font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">a Delaware corporation  (the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8220;</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">Company</font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8221;</font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">)</font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">the Borrowing Subsidiaries</font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">the lenders parties </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">thereto </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">(the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8220;</font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">Lenders</font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">&#8221;</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">)</font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">certain Agents</font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">Citibank </font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">N.A.</font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">as an Administrative Agent</font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">and JPMorgan Chase Bank</font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">N.A.</font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">as an Administrative </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">Agent. </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">Capitalized terms used but not defined herein shall have the meaning </font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">as</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">signed to such </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">terms in </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%">the Credit Agreement.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">Pursuant to Section </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">2.5 </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">of the Credit </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">Agreement</font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">the </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">Company </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">hereby </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">requests that </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">the Lenders </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">extend </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">the Maturity Date in </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">effect </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">on the date hereof </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">(i</font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">.</font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">e</font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">.</font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">, </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">July 30</font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">, </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">2025) </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">such that </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">the extended </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">Maturity Date </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">under </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">the </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">Credit Agreement will </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">be July 30</font><font style="color:#4f4f4f;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">, </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">2026</font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">. </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">This letter shall constitute an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">&#8220;</font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">Extension Letter&#8221;</font><font style="color:#3d3b3b;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%"> </font><font style="color:#232323;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">as </font><font style="color:#131313;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:102%">referred to in Section 2.5 of the Credit Agreement. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:44.444%"><tr><td style="width:1.0%"></td><td style="width:8.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.361%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BRISTOL-MYERS SQUIBB COMPANY</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Sandra Ramos-Alves</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Sandra Ramos-Alves</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Vice President and Assistant Treasurer</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.I
<SEQUENCE>5
<FILENAME>bmyex10i20210630.htm
<DESCRIPTION>AMENDMENT TO REVOLVING CREDIT FACILITY DATED JULY 30, 2012
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="idf03dc7721b74624861dc941b5a4b80d_1"></div><div style="min-height:63pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10i</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXECUTION VERSION</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AMENDMENT</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">AMENDMENT (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), dated as of June 22, 2021, by and among BRISTOL-MYERS SQUIBB COMPANY, a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), the Lenders (as defined below) party hereto and the Administrative Agent (as defined below), which amends that certain FIVE YEAR COMPETITIVE ADVANCE AND REVOLVING CREDIT FACILITY AGREEMENT (as amended, supplemented or otherwise modified from time to time prior to the effectiveness of this Amendment, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Existing Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; and as modified by this Amendment, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) dated as of July 30, 2012, among the Company, the BORROWING SUBSIDIARIES (as defined in the Credit Agreement) from time to time party thereto, the lenders from time to time party thereto (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Lenders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), certain Agents, JPMORGAN CHASE BANK, N.A., as Administrative Agent (in such capacity, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">JPMCB</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and CITIBANK, N.A., as Administrative Agent (in such capacity, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CBNA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;&#59; JPMCB and CBNA are referred to herein individually as an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Administrative Agent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; and collectively as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Administrative Agents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and as competitive advance facility agent.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">W I T N E S S E T H&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company has requested that the Lenders agree to amend certain provisions of the Existing Credit Agreement as set forth herein&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, Section 8.7 of the Existing Credit Agreement permits the Existing Credit Agreement to be amended from time to time by the Company and the Lenders&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company and each Lender desire to amend the Existing Credit Agreement on the terms set forth herein&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, it is agreed&#58; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Capitalized terms used but not defined herein shall have the meaning assigned to such terms in the Credit Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Effective as of the Amendment Effective Date (as defined below), the Existing Credit Agreement (excluding the Exhibits and Schedules thereto, which shall continue to be the Exhibits and Schedules under the Existing Credit Agreement, as amended hereby) is hereby amended as follows&#58; </font></div><div style="text-align:justify;text-indent:46.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.9pt">Section 1.1 of the Existing Credit Agreement is hereby amended by adding the following definitions in appropriate alphabetical order&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Erroneous Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning assigned to such term in Section 8.22(a).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Erroneous Payment Deficiency Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning assigned to such term in Section 8.22(d).</font></div><div style="height:56.7pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Erroneous Payment Impacted Class</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning assigned to such term in Section 8.22(d).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Erroneous Payment Return Deficiency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning assigned to such term in Section 8.22(d).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Erroneous Payment Subrogation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning assigned to such term in&#160;Section&#160;8.22(d).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Payment Recipient</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; shall have the meaning assigned to such term in Section 8.22(a).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:46.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.22pt">The definition of &#8220;Obligations&#8221; is hereby amended by (i) removing the word &#8220;and&#8221; from before clause (ii) thereof and (ii) adding the following at the end of such definition&#58; &#8220;and (iii) Erroneous Payment Subrogation Rights.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:46.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.9pt">Section 2.1 of the Existing Credit Agreement is hereby amended and restated to read as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 2.1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Commitments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.&#160; Subject to the terms and conditions set forth herein, each Lender agrees to make Revolving Loans to the Company and any Borrowing Subsidiary from time to time during the Availability Period in Dollars</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">in an aggregate principal amount that will not result in (a)&#160;such Lender&#8217;s Revolving Credit Exposure exceeding such Lender&#8217;s Commitment or (b)&#160;the sum of the total Revolving Credit Exposures plus the total Competitive Loan Exposures exceeding the total Commitments.&#160; Within the foregoing limits and subject to the terms and conditions set forth herein, the Company and each applicable Borrowing Subsidiary may borrow, prepay and reborrow Revolving Loans. Notwithstanding anything set forth in this Agreement to the contrary, no Loans shall be made hereunder in any Currency other than Dollars.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:46.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.22pt">Section 2.4(a) of the Existing Credit Agreement is hereby amended to include as the penultimate sentence the following&#58; </font></div><div style="margin-bottom:12pt;padding-left:46.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding anything set forth in this Agreement to the contrary, no Competitive Loans shall be made hereunder in any Currency other than Dollars.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:46.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:11.9pt;text-decoration:underline">Article VIII</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> of the Existing Credit Agreement is hereby amended by adding a new Section 8.22 thereto, which shall read as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:46.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 8.22. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Erroneous Payments.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.7pt"> If CBNA notifies&#160;a Lender or any Person who has received funds on behalf of a Lender, such Lender (any such Lender or other recipient, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Payment Recipient&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) that CBNA has determined&#160;in its sole discretion (whether or not after receipt of any notice under immediately succeeding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">clause (b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) that any funds received by such Payment Recipient from CBNA or any of its </font></div><div style="height:56.7pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Affiliates were erroneously transmitted to, or otherwise erroneously or mistakenly received by, such Payment Recipient (whether or not known to such Lender or other Payment Recipient on its behalf)  (any such funds, whether received as a payment, prepayment or repayment of principal, interest, fees, distribution or otherwise, individually and collectively, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Erroneous Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and demands the return of such Erroneous Payment (or a portion thereof), such Erroneous Payment shall at all times remain the property of CBNA and shall be segregated by the Payment Recipient and held in trust for the benefit of CBNA, and such Lender shall (or, with respect to any Payment Recipient who received such funds on its behalf, shall cause such Payment Recipient to) promptly, but in no event later than two Business Days thereafter, return to CBNA the amount of any such Erroneous Payment (or portion thereof) as to which such a demand was made, in same day funds (in the currency so received), together with interest thereon in respect of each day from and including the date such Erroneous Payment (or portion thereof) was received by such Payment Recipient to the date such amount is repaid to CBNA in same day funds at the greater of the Federal Funds Effective Rate and a rate determined by CBNA in accordance with banking industry rules on interbank compensation from time to time in effect. A notice of CBNA to any Payment Recipient under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">clause (a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> shall be conclusive, absent manifest error.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.02pt">Without limiting immediately preceding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">clause (a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, each Lender, or any Person who has received funds on behalf of a Lender, hereby further agrees that if it&#160;receives a payment, prepayment or repayment (whether received as a payment, prepayment or repayment of principal, interest, fees, distribution or otherwise) from CBNA (or any of its Affiliates) (x) that is in a different amount than, or on a different date from, that specified in a notice of payment, prepayment or repayment sent by CBNA (or any of its Affiliates) with respect to such payment, prepayment or repayment, (y) that was not preceded or accompanied by a notice of payment, prepayment or repayment sent by CBNA (or any of its Affiliates), or (z) that such Lender, or other such recipient, otherwise becomes aware was transmitted, or received, in error or by mistake (in whole or in part) in each case&#58;</font></div><div style="margin-bottom:12pt;padding-left:57.6pt;text-align:justify;text-indent:43.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:31.89pt"> (A) in the case of immediately preceding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">clauses (x)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">(y)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, an error shall be presumed to have been made (absent written confirmation from CBNA to the contrary) or (B) an error has been made (in the case of immediately preceding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">clause (z)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">), in each case, with respect to such payment, prepayment or repayment&#59; and</font></div><div style="margin-bottom:12pt;padding-left:57.6pt;text-align:justify;text-indent:43.2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:28.56pt">such Lender shall (and shall cause any other recipient that receives funds on its behalf to) promptly (and, in all events, within one Business Day of its knowledge of such error) notify CBNA of its receipt of such payment, prepayment or repayment, the details thereof (in reasonable detail) and that it is so notifying CBNA pursuant to this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.22(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.7pt">Each Lender hereby authorizes CBNA to set off, net and apply any and all amounts at any time owing to such Lender under any Loan Document, or </font></div><div style="height:56.7pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">otherwise payable or distributable by CBNA to such Lender from any source, against any amount due to CBNA under immediately preceding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">clause (a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> or under the indemnification provisions of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.02pt">In the event that an Erroneous Payment (or portion thereof) is not recovered by CBNA for any reason, after demand therefor by CBNA in accordance with immediately preceding </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">clause (a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, from any Lender that has received such Erroneous Payment (or portion thereof) (and&#47;or from any Payment Recipient who received such Erroneous Payment (or portion thereof) on its behalf)  (such unrecovered amount, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Erroneous Payment Return Deficiency</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), upon CBNA&#8217;s notice to such Lender at any time, (i) such Lender shall be deemed to have assigned its Loans (but not its Commitments) of the relevant Class with respect to which such Erroneous Payment was made (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Erroneous Payment Impacted Class</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) in an amount equal to the Erroneous Payment Return Deficiency (or such lesser amount as CBNA may specify) (such assignment of the Loans (but not Commitments) of the Erroneous Payment  Impacted Class, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Erroneous Payment Deficiency Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) at par plus any accrued and unpaid interest (with the assignment fee to be waived by CBNA in such instance), and is hereby (together with the Borrowers) deemed to execute and deliver an Assignment and Assumption (or, to the extent applicable, an agreement incorporating an Assignment and Assumption by reference pursuant to a Platform as to which CBNA and such parties are participants) with respect to such Erroneous Payment Deficiency Assignment, and such Lender shall deliver any promissory notes evidencing such Loans to the Borrowers or CBNA, (ii) CBNA as the assignee Lender shall be deemed to acquire the Erroneous Payment Deficiency Assignment, (iii) upon such deemed acquisition, CBNA as the assignee Lender shall become a Lender hereunder with respect to such Erroneous Payment Deficiency Assignment and the assigning Lender shall cease to be a Lender hereunder with respect to such Erroneous Payment Deficiency Assignment, excluding, for the avoidance of doubt, its obligations under the indemnification provisions of this Agreement and its applicable Commitments which shall survive as to such assigning Lender and (iv) CBNA may reflect in the Register its ownership interest in the Loans subject to the Erroneous Payment Deficiency Assignment. CBNA may, in its discretion, sell any Loans acquired pursuant to an Erroneous Payment Deficiency Assignment and upon receipt of the proceeds of such sale, the Erroneous Payment Return Deficiency owing by the applicable Lender shall be reduced by the net proceeds of the sale of such Loan (or portion thereof), and CBNA shall retain all other rights, remedies and claims against such Lender (and&#47;or against any recipient that receives funds on its behalf). For the avoidance of doubt, no Erroneous Payment Deficiency Assignment will reduce the Commitments of any Lender and such Commitments shall remain available in accordance with the terms of this Agreement. In addition, each party hereto agrees that, except to the extent that CBNA has sold a Loan (or portion thereof) acquired pursuant to an Erroneous Payment Deficiency Assignment, and irrespective of whether CBNA may be equitably subrogated, CBNA shall be contractually subrogated to all the rights and interests of the </font></div><div style="height:56.7pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">applicable Lender under the Loan Documents with respect to each Erroneous Payment Return Deficiency (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Erroneous Payment Subrogation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.7pt">The parties hereto agree that an Erroneous Payment shall not pay, prepay, repay, discharge or otherwise satisfy any Obligations owed by any Borrower or any Guarantor, except, in each case, to the extent such Erroneous Payment is, and solely with respect to the amount of such Erroneous Payment that is, comprised of funds received by CBNA from any Borrower or any Guarantor for the purpose of making such Erroneous Payment. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:6.03pt">To the extent permitted by applicable law, no Payment Recipient shall assert any right or claim to an Erroneous Payment, and hereby waives, and is deemed to waive, any claim, counterclaim, defense or right of set-off or recoupment with respect to any demand, claim or counterclaim by CBNA for the return of any Erroneous Payment received, including without limitation waiver of any defense based on &#8220;discharge for value&#8221; or any similar doctrine.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:4.02pt">Each party&#8217;s obligations, agreements and waivers under this Section 8.22 shall survive the resignation or replacement of CBNA as Administrative Agent, any transfer of rights or obligations by, or the replacement of, a Lender,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the termination of the Commitments and&#47;or the repayment, satisfaction or discharge of all Obligations (or any portion thereof) under any Loan Document.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Conditions to Effectiveness of Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Amendment shall become effective on the date on which CBNA (or its counsel) shall have received from the Company and the Lenders either (a) a counterpart of this Amendment signed on behalf of such party or (b) written evidence satisfactory to CBNA (which may include email or facsimile transmission of a signed signature page of this Amendment) that such party has signed a counterpart of this Amendment (such date, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Amendment Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CBNA shall notify the Company and the Lenders of the Amendment Effective Date, and such notice shall be conclusive and binding absent manifest error.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Effects on Loan Documents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Amendment shall constitute a &#8220;Loan Document&#8221; for purposes of the Credit Agreement and the other Loan Documents. From and after the Amendment Effective Date, all references to the Existing Credit Agreement and each of the other Loan Documents shall be deemed to be references to the Credit Agreement. Except as expressly amended pursuant to the terms hereof, all of the representations, warranties, terms, covenants and conditions of the Loan Documents shall remain unamended and not waived and shall continue to be in full force and effect. The execution, delivery and effectiveness of this Amendment shall not, except as expressly provided herein, operate as a waiver of any right, power or remedy of any Lender or the Administrative Agents under any of the Loan Documents.</font></div><div style="height:56.7pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:63pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Company represents and warrants to the Lenders and the Administrative Agents that (i) the representations and warranties set forth in Article III of the Credit Agreement are true and correct in all material respects (provided that such representations and warranties qualified as to materiality shall be true and correct in all respects) on the date hereof, except to the extent such representations and warranties expressly relate to an earlier date, in which case such representations and warranties were true and correct in all material respects (provided that such representations and warranties qualified as to materiality shall be true and correct in all respects) as of such earlier date and (ii) no Default or Event of Default exists on the Amendment Effective Date.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;This Amendment may be executed in multiple counterparts, each of which shall constitute an original but all of which taken together shall constitute but one contract. A counterpart hereof, or signature page hereto, delivered to the Administrative Agent by facsimile or e-mail shall be effective as delivery of an original manually-signed counterpart.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The provisions of Sections 8.5, 8.11, 8.13 and 8.14 of the Credit Agreement are incorporated herein by reference as if fully set forth herein, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">mutatis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">mutandis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Applicable Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">THIS AMENDMENT SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NEW YORK.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Electronic Execution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The words &#8220;execution,&#8221; &#8220;signed,&#8221; &#8220;signature,&#8221; and words of like import in this Amendment or in any amendment or other modification hereof (including waivers and consents) shall be deemed to include electronic signatures or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable Law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act.</font></div><div style="margin-bottom:12pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#91;Signature pages follow&#93;</font></div><div style="height:56.7pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div></div></div><div id="idf03dc7721b74624861dc941b5a4b80d_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed by their respective authorized officers as of the day and year first above written.</font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.208%"><tr><td style="width:1.0%"></td><td style="width:12.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.378%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">BRISTOL-MYERS SQUIBB COMPANY</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Sandra Ramos-Alves</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Sandra Ramos-Alves</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Vice President, Assistant Treasurer</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment to Bristol-Myers Squibb 2012 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div></div></div><div id="idf03dc7721b74624861dc941b5a4b80d_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CITIBANK, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, as Administrative Agent and as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Richard Rivera</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Richard Rivera</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Vice President</font></td></tr></table></div><div style="margin-bottom:6pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment to Bristol-Myers Squibb 2012 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div></div></div><div id="idf03dc7721b74624861dc941b5a4b80d_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">JPMORGAN CHASE BANK, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, as Administrative Agent and as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Stacey Zoland</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Stacey Zoland</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Executive Director</font></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment to Bristol-Myers Squibb 2012 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div></div></div><div id="idf03dc7721b74624861dc941b5a4b80d_169"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">BANK OF AMERICA, N.A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, as Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Darren Merten</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Darren Merten</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Director</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment to Bristol-Myers Squibb 2012 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div></div></div><div id="idf03dc7721b74624861dc941b5a4b80d_164"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">BARCLAYS BANK PLC, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Ronnie Glenn</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Ronnie Glenn</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Director</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment to Bristol-Myers Squibb 2012 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div></div></div><div id="idf03dc7721b74624861dc941b5a4b80d_159"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DEUTSCHE BANK AG NEW YORK BRANCH, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Ming K. Chu</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Ming K. Chu</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Director</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ming.k.chu&#64;db.com</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">+1-212-250-5451</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:right;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#91;FOR LENDERS REQUIRING TWO SIGNATURE BLOCKS&#93;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Marko Lukin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Marko Lukin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Vice President</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">marko.lukin&#64;db.com</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">+1-212-250-7283</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment to Bristol-Myers Squibb 2012 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div></div></div><div id="idf03dc7721b74624861dc941b5a4b80d_154"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Morgan Stanley Bank, N.A., as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Michael King</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Michael King</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Authorized Signatory</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment to Bristol-Myers Squibb 2012 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div></div></div><div id="idf03dc7721b74624861dc941b5a4b80d_149"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">MUFG Bank, LTD., as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Jack Lonker</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Jack Lonker</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Director</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment to Bristol-Myers Squibb 2012 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div><div><font><br></font></div></div></div><div id="idf03dc7721b74624861dc941b5a4b80d_144"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WELLS FARGO BANK, NATIONAL ASSOCIATION, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Jordan Harris</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Jordan Harris</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Managing Director</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment and Waiver under Bristol-Myers Squibb 2012 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div></div></div><div id="idf03dc7721b74624861dc941b5a4b80d_139"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">BNP Paribas, as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Michael Pearce</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Michael Pearce</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Managing Director</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:right;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; John Bosco</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; John Bosco</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Managing Director</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment to Bristol-Myers Squibb 2012 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div></div></div><div id="idf03dc7721b74624861dc941b5a4b80d_134"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Credit Suisse AG, New York Branch, as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Judith Smith</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Judith Smith</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Authorized Signatory</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:right;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Andrew Griffin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Andrew Griffin</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Authorized Signatory</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment to Bristol-Myers Squibb 2012 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div></div></div><div id="idf03dc7721b74624861dc941b5a4b80d_129"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GOLDMAN SACHS BANK USA, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Jacob Elder</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Jacob Elder</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Authorized Signatory</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment to Bristol-Myers Squibb 2012 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div></div></div><div id="idf03dc7721b74624861dc941b5a4b80d_124"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">MIZUHO BANK, LTD., as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; John Davies</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; John Davies</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Authorized Signatory</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment to Bristol-Myers Squibb 2012 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div></div></div><div id="idf03dc7721b74624861dc941b5a4b80d_119"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">U.S. Bank National Association, as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; David C. Mruk</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; David C. Mruk</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; SVP</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment to Bristol-Myers Squibb 2012 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div></div></div><div id="idf03dc7721b74624861dc941b5a4b80d_114"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SOCIETE GENERALE,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Kimberly Metzger</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Kimberly Metzger</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Director</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment to Bristol-Myers Squibb 2012 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div></div></div><div id="idf03dc7721b74624861dc941b5a4b80d_109"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SUMITOMO MITSUI BANKING CORPORATION,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Gail Motonaga</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Gail Motonaga</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Executive Director</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment to Bristol-Myers Squibb 2012 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div></div></div><div id="idf03dc7721b74624861dc941b5a4b80d_104"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">HSBC Bank USA, N.A., as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Iain P. Stewart</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Iain P. Stewart</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Managing Director</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment to Bristol-Myers Squibb 2012 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div></div></div><div id="idf03dc7721b74624861dc941b5a4b80d_99"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.604%"><tr><td style="width:1.0%"></td><td style="width:13.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.709%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:24pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">STANDARD CHARTERED BANK, as a Lender</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; Kristopher Tracy</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Kristopher Tracy</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Director, Financing Solutions</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Amendment to Bristol-Myers Squibb 2012 Credit Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.A
<SEQUENCE>6
<FILENAME>bmyex31a_20210630.htm
<DESCRIPTION>EXHIBIT 31.A
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i024c6edd9e4149b88a65e366933dcc0c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31a</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Giovanni Caforio, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">I have reviewed Bristol-Myers Squibb Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2021&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent function)&#58;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting, which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal controls over financial reporting.</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; July&#160;28, 2021 </font></div><div style="margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.666%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Giovanni Caforio, M.D.</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Giovanni Caforio, M.D.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chairman of the Board and Chief Executive Officer</font></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.B
<SEQUENCE>7
<FILENAME>bmyex31b_20210630.htm
<DESCRIPTION>EXHIBIT 31.B
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i85edc3f9aae74171b7a419903cf1b869_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31b</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION BY THE CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, David V. Elkins, certify that&#58;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">I have reviewed Bristol-Myers Squibb Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2021&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent function)&#58;</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:29.07pt">all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting, which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:90pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal controls over financial reporting.</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; July&#160;28, 2021 </font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:14pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.619%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; David V. Elkins</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David V. Elkins</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.A
<SEQUENCE>8
<FILENAME>bmyex32a_20210630.htm
<DESCRIPTION>EXHIBIT 32.A
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="id78a48b92af840779bab46777c0ccd50_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32a</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification by the Chief Executive Officer Pursuant to 18 U. S. C. Section&#160;1350, as</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. Section&#160;1350, I, Giovanni Caforio, hereby certify that, to the best of my knowledge, Bristol-Myers Squibb Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2021 (the &#34;Report&#34;), as filed with the Securities and Exchange Commission on July&#160;28, 2021, fully complies with the requirements of Section&#160;13(a) or Section&#160;15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Bristol-Myers Squibb Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:41.520%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Giovanni Caforio, M.D.</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Giovanni Caforio, M.D.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chairman of the Board and Chief Executive Officer</font></div></td></tr></table></div><div style="margin-top:4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">July&#160;28, 2021 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This written statement is being furnished to the Securities and Exchange Commission as an exhibit to the Report.&#160;A signed original of this written statement required by Section 906 has been provided to Bristol-Myers Squibb Company and will be retained by Bristol-Myers Squibb Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.B
<SEQUENCE>9
<FILENAME>bmyex32b_20210630.htm
<DESCRIPTION>EXHIBIT 32.B
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i9b71298e5d314d5ab21c9d5657bf70e8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32b</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification by the Chief Financial Officer Pursuant to 18 U. S. C. Section&#160;1350, as</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adopted Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. Section&#160;1350, I, David V. Elkins, hereby certify that, to the best of my knowledge, Bristol-Myers Squibb Company&#8217;s Quarterly Report on Form 10-Q for the quarter ended June&#160;30, 2021 (the &#34;Report&#34;), as filed with the Securities and Exchange Commission on July&#160;28, 2021, fully complies with the requirements of Section&#160;13(a) or Section&#160;15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Bristol-Myers Squibb Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.619%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; David V. Elkins</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David V. Elkins</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td></tr></table></div><div style="margin-top:4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">July&#160;28, 2021 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This written statement is being furnished to the Securities and Exchange Commission as an exhibit to the Report.&#160;A signed original of this written statement required by Section 906 has been provided to Bristol-Myers Squibb Company and will be retained by Bristol-Myers Squibb Company and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>bmy-20210630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:744431a9-b3ff-43bd-afc9-1af61fbf126c,g:9fbce200-03f4-4882-8b59-75e21adfdbca-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bmy="http://www.bms.com/20210630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bms.com/20210630">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bmy-20210630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bmy-20210630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bmy-20210630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bmy-20210630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="DocumentandEntityInformation" roleURI="http://www.bms.com/role/DocumentandEntityInformation">
        <link:definition>0001001 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED" roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED">
        <link:definition>1001002 - Statement - CONSOLIDATED STATEMENTS OF EARNINGS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED">
        <link:definition>1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSUNAUDITED" roleURI="http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED">
        <link:definition>1003004 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED">
        <link:definition>1004005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSNotes" roleURI="http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSNotes">
        <link:definition>2101101 - Disclosure - BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATIONPolicies" roleURI="http://www.bms.com/role/BASISOFPRESENTATIONPolicies">
        <link:definition>2202201 - Disclosure - BASIS OF PRESENTATION (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATIONNewAccountingPronouncementsDetails" roleURI="http://www.bms.com/role/BASISOFPRESENTATIONNewAccountingPronouncementsDetails">
        <link:definition>2403401 - Disclosure - BASIS OF PRESENTATION (New Accounting Pronouncements) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONRevenueRecognitionNotes" roleURI="http://www.bms.com/role/REVENUERECOGNITIONRevenueRecognitionNotes">
        <link:definition>2104102 - Disclosure - REVENUE RECOGNITION Revenue Recognition (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionTables" roleURI="http://www.bms.com/role/RevenueRecognitionTables">
        <link:definition>2305301 - Disclosure - Revenue Recognition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONRevenuebyNatureDetails" roleURI="http://www.bms.com/role/REVENUERECOGNITIONRevenuebyNatureDetails">
        <link:definition>2406402 - Disclosure - REVENUE RECOGNITION Revenue by Nature (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONGrosstoNetAdjustmentsDetails" roleURI="http://www.bms.com/role/REVENUERECOGNITIONGrosstoNetAdjustmentsDetails">
        <link:definition>2407403 - Disclosure - REVENUE RECOGNITION Gross-to-Net Adjustments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONRevenuebyProductbyRegionDetails" roleURI="http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails">
        <link:definition>2408404 - Disclosure - REVENUE RECOGNITION Revenue by Product by Region (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONNarrativesDetails" roleURI="http://www.bms.com/role/REVENUERECOGNITIONNarrativesDetails">
        <link:definition>2409405 - Disclosure - REVENUE RECOGNITION Narratives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ALLIANCES" roleURI="http://www.bms.com/role/ALLIANCES">
        <link:definition>2110103 - Disclosure - ALLIANCES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ALLIANCESPolicies" roleURI="http://www.bms.com/role/ALLIANCESPolicies">
        <link:definition>2211202 - Disclosure - ALLIANCES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ALLIANCESTables" roleURI="http://www.bms.com/role/ALLIANCESTables">
        <link:definition>2312302 - Disclosure - ALLIANCES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ALLIANCESDetails" roleURI="http://www.bms.com/role/ALLIANCESDetails">
        <link:definition>2413406 - Disclosure - ALLIANCES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DIVESTITURESLICENSINGANDOTHERARRANGEMENTSNotes" roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSNotes">
        <link:definition>2114104 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables" roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables">
        <link:definition>2315303 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSDetails" roleURI="http://www.bms.com/role/ACQUISITIONSDetails">
        <link:definition>2416407 - Disclosure - ACQUISITIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DIVESTITURESDetails" roleURI="http://www.bms.com/role/DIVESTITURESDetails">
        <link:definition>2417408 - Disclosure - DIVESTITURES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LICENSINGANDOTHERARRANGEMENTSDetails" roleURI="http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails">
        <link:definition>2418409 - Disclosure - LICENSING AND OTHER ARRANGEMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHEREXPENSEINCOMENET" roleURI="http://www.bms.com/role/OTHEREXPENSEINCOMENET">
        <link:definition>2119105 - Disclosure - OTHER EXPENSE (INCOME), NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHEREXPENSEINCOMENETTables" roleURI="http://www.bms.com/role/OTHEREXPENSEINCOMENETTables">
        <link:definition>2320304 - Disclosure - OTHER EXPENSE (INCOME), NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHEREXPENSEINCOMENETDetails" roleURI="http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails">
        <link:definition>2421410 - Disclosure - OTHER EXPENSE (INCOME), NET (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURING" roleURI="http://www.bms.com/role/RESTRUCTURING">
        <link:definition>2122106 - Disclosure - RESTRUCTURING</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGTables" roleURI="http://www.bms.com/role/RESTRUCTURINGTables">
        <link:definition>2323305 - Disclosure - RESTRUCTURING (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGNARRATIVEDetails" roleURI="http://www.bms.com/role/RESTRUCTURINGNARRATIVEDetails">
        <link:definition>2424411 - Disclosure - RESTRUCTURING NARRATIVE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails" roleURI="http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails">
        <link:definition>2425412 - Disclosure - RESTRUCTURING RESTRUCTURING AND RELATED COSTS TABLE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails" roleURI="http://www.bms.com/role/RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails">
        <link:definition>2426413 - Disclosure - RESTRUCTURING SCHEDULE OF RESTRUCTURING RESERVE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.bms.com/role/INCOMETAXES">
        <link:definition>2127107 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTables" roleURI="http://www.bms.com/role/INCOMETAXESTables">
        <link:definition>2328306 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetails" roleURI="http://www.bms.com/role/INCOMETAXESDetails">
        <link:definition>2429414 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSLOSSPERSHARE" roleURI="http://www.bms.com/role/EARNINGSLOSSPERSHARE">
        <link:definition>2130108 - Disclosure - EARNINGS/(LOSS) PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSLOSSPERSHARETables" roleURI="http://www.bms.com/role/EARNINGSLOSSPERSHARETables">
        <link:definition>2331307 - Disclosure - EARNINGS/(LOSS) PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSLOSSPERSHAREDetails" roleURI="http://www.bms.com/role/EARNINGSLOSSPERSHAREDetails">
        <link:definition>2432415 - Disclosure - EARNINGS/(LOSS) PER SHARE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS">
        <link:definition>2133109 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables">
        <link:definition>2334308 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails">
        <link:definition>2435416 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Fair Value Measurement) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails">
        <link:definition>2436417 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Derivatives and Hedging) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails" roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails">
        <link:definition>2437418 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Debt) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECEIVABLES" roleURI="http://www.bms.com/role/RECEIVABLES">
        <link:definition>2138110 - Disclosure - RECEIVABLES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECEIVABLESTables" roleURI="http://www.bms.com/role/RECEIVABLESTables">
        <link:definition>2339309 - Disclosure - RECEIVABLES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECEIVABLESDetails" roleURI="http://www.bms.com/role/RECEIVABLESDetails">
        <link:definition>2440419 - Disclosure - RECEIVABLES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIES" roleURI="http://www.bms.com/role/INVENTORIES">
        <link:definition>2141111 - Disclosure - INVENTORIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESTables" roleURI="http://www.bms.com/role/INVENTORIESTables">
        <link:definition>2342310 - Disclosure - INVENTORIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORIESDetails" roleURI="http://www.bms.com/role/INVENTORIESDetails">
        <link:definition>2443420 - Disclosure - INVENTORIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENT" roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT">
        <link:definition>2144112 - Disclosure - PROPERTY, PLANT AND EQUIPMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENTTables" roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables">
        <link:definition>2345311 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYPLANTANDEQUIPMENTDetails" roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails">
        <link:definition>2446421 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETS" roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS">
        <link:definition>2147113 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSTables" roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables">
        <link:definition>2348312 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSDetails" roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails">
        <link:definition>2449422 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATION" roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATION">
        <link:definition>2150114 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SupplementalFinancialInformationTables" roleURI="http://www.bms.com/role/SupplementalFinancialInformationTables">
        <link:definition>2351313 - Disclosure - Supplemental Financial Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails" roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails">
        <link:definition>2452423 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails" roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails">
        <link:definition>2453424 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION Other Non-Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails" roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails">
        <link:definition>2454425 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails" roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails">
        <link:definition>2455426 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION Other Non-Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITY" roleURI="http://www.bms.com/role/EQUITY">
        <link:definition>2156115 - Disclosure - EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYTables" roleURI="http://www.bms.com/role/EQUITYTables">
        <link:definition>2357314 - Disclosure - EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYChangesinEquityDetails" roleURI="http://www.bms.com/role/EQUITYChangesinEquityDetails">
        <link:definition>2458427 - Disclosure - EQUITY (Changes in Equity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYOtherComprehensiveIncomeLossDetails" roleURI="http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails">
        <link:definition>2459428 - Disclosure - EQUITY (Other Comprehensive Income/(Loss)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansNotes" roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansNotes">
        <link:definition>2160116 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS Employee Stock Benefit Plans (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansTables" roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansTables">
        <link:definition>2361315 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS Employee Stock Benefit Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails" roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails">
        <link:definition>2462429 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS Share-based Payment Arrangement, Cost by Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESTOCKBENEFITPLANSScheduleOfShareBasedCompensationAdditionalInformationDetails" roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleOfShareBasedCompensationAdditionalInformationDetails">
        <link:definition>2463430 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS Schedule Of Share Based Compensation Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails" roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails">
        <link:definition>2464431 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS Share-based Payment Arrangement, Nonvested Award, Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEGALPROCEEDINGSANDCONTINGENCIES" roleURI="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES">
        <link:definition>2165117 - Disclosure - LEGAL PROCEEDINGS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEGALPROCEEDINGSANDCONTINGENCIESDetails" roleURI="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails">
        <link:definition>2466432 - Disclosure - LEGAL PROCEEDINGS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bmy_ResearchandDevelopment" abstract="false" name="ResearchandDevelopment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_AmortizationofAcquiredIntangibleAssets" abstract="false" name="AmortizationofAcquiredIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments" abstract="false" name="EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_AcceleratedStockBasedCompensationMember" abstract="true" name="AcceleratedStockBasedCompensationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LegalProceedingsAndContingenciesLineItems" abstract="true" name="LegalProceedingsAndContingenciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_A1.750Notesdue2035Member" abstract="true" name="A1.750Notesdue2035Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_Totalinventories" abstract="false" name="Totalinventories" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_MyoKardiaAcquisitionPlanMember" abstract="true" name="MyoKardiaAcquisitionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LicensingCompaniesDomain" abstract="true" name="LicensingCompaniesDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_GrosstoNetAdjustments" abstract="false" name="GrosstoNetAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_OtherIncomeReceivedFromAlliancePartners" abstract="false" name="OtherIncomeReceivedFromAlliancePartners" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_OtherRegionMember" abstract="true" name="OtherRegionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_OpdivoMember" abstract="true" name="OpdivoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_GrosstoNetAdjustmentsAxis" abstract="true" name="GrosstoNetAdjustmentsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_Reversionexcisetax" abstract="false" name="Reversionexcisetax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_SalesRevenueGrossMember" abstract="true" name="SalesRevenueGrossMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ContingentAndRegulatoryMilestoneNonCash" abstract="false" name="ContingentAndRegulatoryMilestoneNonCash" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_AntiPD1AntibodyLitigationMember" abstract="true" name="AntiPD1AntibodyLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_UpfrontPaymentsMadeToCollaborativePartner" abstract="false" name="UpfrontPaymentsMadeToCollaborativePartner" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_AccruedRebatesAndReturns" abstract="false" name="AccruedRebatesAndReturns" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_AssetAcquisitionNameDomain" abstract="true" name="AssetAcquisitionNameDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_UpFrontLicensingFee" abstract="false" name="UpFrontLicensingFee" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_AllianceTransitionalServices" abstract="false" name="AllianceTransitionalServices" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_ReceivablesSoldOnNonrecourseBasis" abstract="false" name="ReceivablesSoldOnNonrecourseBasis" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_LicensingArrangementsLineItems" abstract="true" name="LicensingArrangementsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_ScheduleOfEquityInvestmentsTableTextBlock" abstract="false" name="ScheduleOfEquityInvestmentsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmy_ProjectedYearOfPaymentsMember" abstract="true" name="ProjectedYearOfPaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ChargebacksandcashdiscountsMember" abstract="true" name="ChargebacksandcashdiscountsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AvaproAvalideAndPlavixMember" abstract="true" name="AvaproAvalideAndPlavixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_UnamortizedBasisAdjustmentFromSwapTerminations" abstract="false" name="UnamortizedBasisAdjustmentFromSwapTerminations" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_Pensionsettlementsandamortization" abstract="false" name="Pensionsettlementsandamortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_GrosstoNetAdjustmentsDomain" abstract="true" name="GrosstoNetAdjustmentsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AlliancesAndCollaborationCompaniesAxis" abstract="true" name="AlliancesAndCollaborationCompaniesAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_IncomeTaxExpenseBenefitComponentDomain" abstract="true" name="IncomeTaxExpenseBenefitComponentDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_OtherRoyaltiesMember" abstract="true" name="OtherRoyaltiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_DeferredIncomeTaxExpenseBenefitComponentDomain" abstract="true" name="DeferredIncomeTaxExpenseBenefitComponentDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_BaracludeMember" abstract="true" name="BaracludeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AbecmaMember" abstract="true" name="AbecmaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_A1BillionMaximumBorrowingCapacityMember" abstract="true" name="A1BillionMaximumBorrowingCapacityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_BMSSecuritiesLitigationMember" abstract="true" name="BMSSecuritiesLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AgenusMember" abstract="true" name="AgenusMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_OtherNonCurrentAssetsAbstract" abstract="true" name="OtherNonCurrentAssetsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_AssetAcquisitionNameAxis" abstract="true" name="AssetAcquisitionNameAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" abstract="false" name="ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmy_EmplicitiMember" abstract="true" name="EmplicitiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_Assetacquisitioncharge" abstract="false" name="Assetacquisitioncharge" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_ZeposiaMember" abstract="true" name="ZeposiaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_RestructuringRelatedCostsAssetImpairments" abstract="false" name="RestructuringRelatedCostsAssetImpairments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_ReblozylMember" abstract="true" name="ReblozylMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_SprycelMember" abstract="true" name="SprycelMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ZeroCostCollarCurrencyContractsMember" abstract="true" name="ZeroCostCollarCurrencyContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_SharebasedPaymentArrangementCostbyPlanAbstract" abstract="true" name="SharebasedPaymentArrangementCostbyPlanAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_LicensingAndOtherArrangementsAxis" abstract="true" name="LicensingAndOtherArrangementsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_EliquisPatentLitigationMember" abstract="true" name="EliquisPatentLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_YervoyMember" abstract="true" name="YervoyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ScheduleOfOtherIncomeExpenseTextBlock" abstract="false" name="ScheduleOfOtherIncomeExpenseTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmy_MarketShareUnitsMember" abstract="true" name="MarketShareUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_DismissedMember" abstract="true" name="DismissedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LicenseAndOtherArrangementsUpfrontPayments" abstract="false" name="LicenseAndOtherArrangementsUpfrontPayments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_NumberOfLargestPharmaceuticalWholesalers" abstract="false" name="NumberOfLargestPharmaceuticalWholesalers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bmy_A1.000Notesdue2025Member" abstract="true" name="A1.000Notesdue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_SupplementalFinancialInformationAbstract" abstract="true" name="SupplementalFinancialInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_GrosstoNetAdjustmentsAbstract" abstract="true" name="GrosstoNetAdjustmentsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_DocumentAndEntityInformationAbstract" abstract="true" name="DocumentAndEntityInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_A2.875SeniorNotesdue2021Member" abstract="true" name="A2.875SeniorNotesdue2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_A1.5BillionMaximumBorrowingCapacityMember" abstract="true" name="A1.5BillionMaximumBorrowingCapacityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_EquityInvestmentsCurrent" abstract="false" name="EquityInvestmentsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" abstract="true" name="OtherrebatesreturnsdiscountsandadjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_CelgeneSecuritiesLitigationMember" abstract="true" name="CelgeneSecuritiesLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" abstract="false" name="ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmy_KeytrudaRoyaltiesMember" abstract="true" name="KeytrudaRoyaltiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_A2550SeniorNotesDue2021Member" abstract="true" name="A2550SeniorNotesDue2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_CommonStock0.10ParValueMember" abstract="true" name="CommonStock0.10ParValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_BreyanziMember" abstract="true" name="BreyanziMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AbilifyProductLiabilityLitigationMember" abstract="true" name="AbilifyProductLiabilityLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_GrosstoNetAdjustmentsTable" abstract="true" name="GrosstoNetAdjustmentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_TecentriqRoyaltiesMember" abstract="true" name="TecentriqRoyaltiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_IntangibleAssetNameDomain" abstract="true" name="IntangibleAssetNameDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ContingentAndRegulatoryMilestonePayments" abstract="false" name="ContingentAndRegulatoryMilestonePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_DiabetesbusinessMember" abstract="true" name="DiabetesbusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_InventorypurchasepricefairvalueadjustmentMember" abstract="true" name="InventorypurchasepricefairvalueadjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_OnglyzaProductLiabilityLitigationMember" abstract="true" name="OnglyzaProductLiabilityLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AlliancesAndCollaborationCompaniesDomain" abstract="true" name="AlliancesAndCollaborationCompaniesDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LicensingCompaniesAxis" abstract="true" name="LicensingCompaniesAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_LicensingAndOtherArrangementsIncome" abstract="false" name="LicensingAndOtherArrangementsIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSAbstract" abstract="true" name="BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_OtherrevenuesMember" abstract="true" name="OtherrevenuesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_CARTKiteLitigationMember" abstract="true" name="CARTKiteLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_CerclaMattersMember" abstract="true" name="CerclaMattersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_Divestitureandotherproceeds" abstract="false" name="Divestitureandotherproceeds" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_InrebicMember" abstract="true" name="InrebicMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_OrenciaMember" abstract="true" name="OrenciaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_EisaiMember" abstract="true" name="EisaiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_EquityInvestmentsNonCurrent" abstract="false" name="EquityInvestmentsNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_VidazaMember" abstract="true" name="VidazaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_MatureBrandsAndOtherMember" abstract="true" name="MatureBrandsAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_MatureProductsAndAllOtherMember" abstract="true" name="MatureProductsAndAllOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ContingentValueRightsMember" abstract="true" name="ContingentValueRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AllianceandotherrevenuesMember" abstract="true" name="AllianceandotherrevenuesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_IntangibleAssetNameAxis" abstract="true" name="IntangibleAssetNameAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_ContingentRegulatoryMilestoneIncome" abstract="false" name="ContingentRegulatoryMilestoneIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_OtherOtherIncomeExpense" abstract="false" name="OtherOtherIncomeExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_AccruedResearchAndDevelopment" abstract="false" name="AccruedResearchAndDevelopment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_OtezlaDivestitureMember" abstract="true" name="OtezlaDivestitureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_EliquisMember" abstract="true" name="EliquisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_OtherNonCurrentLiabilitiesAbstract" abstract="true" name="OtherNonCurrentLiabilitiesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_CashDiscounts" abstract="false" name="CashDiscounts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_RevlimidMember" abstract="true" name="RevlimidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_RestOfWorldMember" abstract="true" name="RestOfWorldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ByettaProductLiabilityLitigationMember" abstract="true" name="ByettaProductLiabilityLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LicensingAndOtherArrangementsTableTextBlock" abstract="false" name="LicensingAndOtherArrangementsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmy_LitigationTable" abstract="true" name="LitigationTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_A2BillionMaximumBorrowingCapacityMember" abstract="true" name="A2BillionMaximumBorrowingCapacityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_LicensingAndOtherArrangementsDomain" abstract="true" name="LicensingAndOtherArrangementsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_CelgeneContingentValueRightsMember" abstract="true" name="CelgeneContingentValueRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_OtherShutdownCosts" abstract="false" name="OtherShutdownCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_PercentageOfAggregateTotalTradeReceivablesDue" abstract="false" name="PercentageOfAggregateTotalTradeReceivablesDue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="bmy_AccruedInterest" abstract="false" name="AccruedInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_LicensingArrangementsTable" abstract="true" name="LicensingArrangementsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_RevenuebyProductbyRegionAbstract" abstract="true" name="RevenuebyProductbyRegionAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_Considerationforcontingentdevelopmentandregulatoryapproval" abstract="false" name="Considerationforcontingentdevelopmentandregulatoryapproval" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_PomalystImnovidMember" abstract="true" name="PomalystImnovidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_UpfrontmilestoneandotherlicensingreceiptsMember" abstract="true" name="UpfrontmilestoneandotherlicensingreceiptsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_CelgeneIntegrationMember" abstract="true" name="CelgeneIntegrationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AbraxaneMember" abstract="true" name="AbraxaneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_PlavixAustraliaIntellectualPropertyMember" abstract="true" name="PlavixAustraliaIntellectualPropertyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" abstract="false" name="RestructuringChargesExcludingAcceleratedStockbasedCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_ALLIANCESAbstract" abstract="true" name="ALLIANCESAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_NumberofRevolvingCreditFacilities" abstract="false" name="NumberofRevolvingCreditFacilities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="bmy_AbilifyProductLiabilityMember" abstract="true" name="AbilifyProductLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ProbabilityofpaymentMember" abstract="true" name="ProbabilityofpaymentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_InternalTransferOfProductRightsMember" abstract="true" name="InternalTransferOfProductRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_CompanyTransformationMember" abstract="true" name="CompanyTransformationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" abstract="true" name="AcquisitionsDivestituresandOtherArrangementsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_LicensingArrangementsCashFlowsReclassificationMember" abstract="true" name="LicensingArrangementsCashFlowsReclassificationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" abstract="false" name="ScheduleOfProvisionForIncomeTaxesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="bmy_DeferredIncomeTaxExpenseBenefitComponentAxis" abstract="true" name="DeferredIncomeTaxExpenseBenefitComponentAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_ErbituxBusinessMember" abstract="true" name="ErbituxBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_OtherCurrentAssetsAbstract" abstract="true" name="OtherCurrentAssetsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_AcquiredDevelopedProductRightsReclassedFromIPRD" abstract="false" name="AcquiredDevelopedProductRightsReclassedFromIPRD" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" abstract="false" name="AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_ResearchandDevelopmentExpenseCollaborativeArrangement" abstract="false" name="ResearchandDevelopmentExpenseCollaborativeArrangement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_Cashoutlays" abstract="false" name="Cashoutlays" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_GrosstoNetAdjustmentsLineItems" abstract="true" name="GrosstoNetAdjustmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="bmy_MedicaidandMedicarerebatesMember" abstract="true" name="MedicaidandMedicarerebatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_IncomeTaxExpenseBenefitComponentAxis" abstract="true" name="IncomeTaxExpenseBenefitComponentAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="bmy_NetproductsalesMember" abstract="true" name="NetproductsalesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_OnuregMember" abstract="true" name="OnuregMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement" abstract="false" name="SellingGeneralandAdministrativeExpenseCollaborativeArrangement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="bmy_Divestituregainsandroyalties" abstract="false" name="Divestituregainsandroyalties" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>bmy-20210630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:744431a9-b3ff-43bd-afc9-1af61fbf126c,g:9fbce200-03f4-4882-8b59-75e21adfdbca-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED" xlink:type="simple" xlink:href="bmy-20210630.xsd#CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_f2b22a5a-d6a2-454b-9474-9e1c088088fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_34512325-0fbe-40db-b1f3-42cf54a94759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f2b22a5a-d6a2-454b-9474-9e1c088088fb" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_34512325-0fbe-40db-b1f3-42cf54a94759" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ead29178-ee39-4d1a-bee4-e2445eb4f00c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f2b22a5a-d6a2-454b-9474-9e1c088088fb" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ead29178-ee39-4d1a-bee4-e2445eb4f00c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_b8065866-aece-4e90-a260-9b253000955e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f2b22a5a-d6a2-454b-9474-9e1c088088fb" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_b8065866-aece-4e90-a260-9b253000955e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationofAcquiredIntangibleAssets_7f236ad6-c9b3-4935-aec7-45c9cedb2935" xlink:href="bmy-20210630.xsd#bmy_AmortizationofAcquiredIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f2b22a5a-d6a2-454b-9474-9e1c088088fb" xlink:to="loc_bmy_AmortizationofAcquiredIntangibleAssets_7f236ad6-c9b3-4935-aec7-45c9cedb2935" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_510a26c7-a41d-4fd7-b25d-dc21e43f73f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_f2b22a5a-d6a2-454b-9474-9e1c088088fb" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_510a26c7-a41d-4fd7-b25d-dc21e43f73f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d93cb3fe-1bbb-4219-ae47-5485641ec684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_35b8864d-87fe-46e7-a0ed-071930917454" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d93cb3fe-1bbb-4219-ae47-5485641ec684" xlink:to="loc_us-gaap_Revenues_35b8864d-87fe-46e7-a0ed-071930917454" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_274c2617-6c4a-4b46-b02b-5246ec4f46d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d93cb3fe-1bbb-4219-ae47-5485641ec684" xlink:to="loc_us-gaap_CostsAndExpenses_274c2617-6c4a-4b46-b02b-5246ec4f46d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b4235d41-7815-4f51-ac40-02368640bbe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_908b71fd-e5c4-42b1-8b39-80dbf26a2766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b4235d41-7815-4f51-ac40-02368640bbe9" xlink:to="loc_us-gaap_ProfitLoss_908b71fd-e5c4-42b1-8b39-80dbf26a2766" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ec61971e-d527-470c-bae8-d64eafa6a215" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_b4235d41-7815-4f51-ac40-02368640bbe9" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ec61971e-d527-470c-bae8-d64eafa6a215" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_25404668-84c3-4ef5-a92c-4f849412fa92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_cc3e51d4-0bff-45b8-8efb-52d8441984e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_25404668-84c3-4ef5-a92c-4f849412fa92" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_cc3e51d4-0bff-45b8-8efb-52d8441984e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_53b01bad-0a65-4134-a99d-63c14d29dad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_25404668-84c3-4ef5-a92c-4f849412fa92" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_53b01bad-0a65-4134-a99d-63c14d29dad4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="simple" xlink:href="bmy-20210630.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6dfb0215-39d8-4611-998a-bcaca9037b40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_aff30048-d180-453e-94e0-87b3b40df1b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6dfb0215-39d8-4611-998a-bcaca9037b40" xlink:to="loc_us-gaap_ProfitLoss_aff30048-d180-453e-94e0-87b3b40df1b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e383ba7e-1df9-40a3-999a-4b30a6e573a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6dfb0215-39d8-4611-998a-bcaca9037b40" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e383ba7e-1df9-40a3-999a-4b30a6e573a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_6e421e12-d2d4-4d26-866b-b9ef4ab317e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2ef8506d-b6c1-4d61-84fc-c4611f1a96ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_6e421e12-d2d4-4d26-866b-b9ef4ab317e0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2ef8506d-b6c1-4d61-84fc-c4611f1a96ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8946c3af-3236-4d7f-81ff-42b86bf885dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_6e421e12-d2d4-4d26-866b-b9ef4ab317e0" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8946c3af-3236-4d7f-81ff-42b86bf885dd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="bmy-20210630.xsd#CONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_7aeac4c6-8eaa-4568-bd54-7fbf199f1ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_0d8e510d-3105-4433-b114-e64a104a3c39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7aeac4c6-8eaa-4568-bd54-7fbf199f1ea8" xlink:to="loc_us-gaap_Liabilities_0d8e510d-3105-4433-b114-e64a104a3c39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_82f49803-d3f3-4e77-ad1b-a749a44f1cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7aeac4c6-8eaa-4568-bd54-7fbf199f1ea8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_82f49803-d3f3-4e77-ad1b-a749a44f1cfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_70d5c22b-93de-47de-8ace-92915dc9b41a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_616151e0-0758-4a25-a13c-054d8828471a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_70d5c22b-93de-47de-8ace-92915dc9b41a" xlink:to="loc_us-gaap_AssetsCurrent_616151e0-0758-4a25-a13c-054d8828471a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_fb2502d7-4dc0-44ce-bc5f-37ff5f8d5b87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_70d5c22b-93de-47de-8ace-92915dc9b41a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_fb2502d7-4dc0-44ce-bc5f-37ff5f8d5b87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c6e0def4-84ff-46de-bd96-9f171d22a66c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_70d5c22b-93de-47de-8ace-92915dc9b41a" xlink:to="loc_us-gaap_Goodwill_c6e0def4-84ff-46de-bd96-9f171d22a66c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c2897be1-7590-48b3-973e-c9333a9f6cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_70d5c22b-93de-47de-8ace-92915dc9b41a" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c2897be1-7590-48b3-973e-c9333a9f6cc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_42782700-3152-4d01-b87b-dbba14eaf03b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_70d5c22b-93de-47de-8ace-92915dc9b41a" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_42782700-3152-4d01-b87b-dbba14eaf03b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_827e77f8-fed9-42ad-b5bf-c0d4ef5ebc6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_70d5c22b-93de-47de-8ace-92915dc9b41a" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_827e77f8-fed9-42ad-b5bf-c0d4ef5ebc6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_3fa07130-9066-4de3-8dd4-a256482531b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_70d5c22b-93de-47de-8ace-92915dc9b41a" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_3fa07130-9066-4de3-8dd4-a256482531b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_41e54ea1-0434-46ee-a8a8-4529fd5bbe14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_340c9e0a-27c9-4823-908f-3b930882a302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_41e54ea1-0434-46ee-a8a8-4529fd5bbe14" xlink:to="loc_us-gaap_PreferredStockValue_340c9e0a-27c9-4823-908f-3b930882a302" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c98007b6-2d34-478f-9149-a281401a758d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_41e54ea1-0434-46ee-a8a8-4529fd5bbe14" xlink:to="loc_us-gaap_CommonStockValue_c98007b6-2d34-478f-9149-a281401a758d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_c49003b3-0b0b-4dc8-a41f-8f99594285ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_41e54ea1-0434-46ee-a8a8-4529fd5bbe14" xlink:to="loc_us-gaap_AdditionalPaidInCapital_c49003b3-0b0b-4dc8-a41f-8f99594285ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b34484e8-33ef-4b3e-9daa-d8407d0d2781" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_41e54ea1-0434-46ee-a8a8-4529fd5bbe14" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b34484e8-33ef-4b3e-9daa-d8407d0d2781" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6d6f575d-5c75-4b76-8281-121ef2afa626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_41e54ea1-0434-46ee-a8a8-4529fd5bbe14" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6d6f575d-5c75-4b76-8281-121ef2afa626" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_4b0fce29-d217-4727-a682-f4b5489515db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_41e54ea1-0434-46ee-a8a8-4529fd5bbe14" xlink:to="loc_us-gaap_TreasuryStockValue_4b0fce29-d217-4727-a682-f4b5489515db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_193f6783-e321-422c-8a03-85280a1e8889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_84e65f99-972c-43ec-8264-3e0682b5ca15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_193f6783-e321-422c-8a03-85280a1e8889" xlink:to="loc_us-gaap_LiabilitiesCurrent_84e65f99-972c-43ec-8264-3e0682b5ca15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fb147b6d-d174-4291-8d5b-ca54f6903bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_193f6783-e321-422c-8a03-85280a1e8889" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fb147b6d-d174-4291-8d5b-ca54f6903bd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_76249510-615d-402d-8864-37ddc7057480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_193f6783-e321-422c-8a03-85280a1e8889" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_76249510-615d-402d-8864-37ddc7057480" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_772a0376-52bc-46a8-acaa-3af06e655ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_193f6783-e321-422c-8a03-85280a1e8889" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_772a0376-52bc-46a8-acaa-3af06e655ab9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c25f4c20-823d-4be4-bdc1-a05ed508dc53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_643a1e68-6df2-4ebd-a64e-4e6533414b84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c25f4c20-823d-4be4-bdc1-a05ed508dc53" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_643a1e68-6df2-4ebd-a64e-4e6533414b84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_825a16d2-d61a-4c62-a957-090b81ca6cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c25f4c20-823d-4be4-bdc1-a05ed508dc53" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_825a16d2-d61a-4c62-a957-090b81ca6cc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_4c0f96a0-f862-4b21-bcbe-a1b559b6db75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c25f4c20-823d-4be4-bdc1-a05ed508dc53" xlink:to="loc_us-gaap_ReceivablesNetCurrent_4c0f96a0-f862-4b21-bcbe-a1b559b6db75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_2bd3101b-6d02-424b-bfa5-9009f1f52f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c25f4c20-823d-4be4-bdc1-a05ed508dc53" xlink:to="loc_us-gaap_InventoryNet_2bd3101b-6d02-424b-bfa5-9009f1f52f9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_cce50cd7-beac-482d-899b-c8cfffaa569d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_c25f4c20-823d-4be4-bdc1-a05ed508dc53" xlink:to="loc_us-gaap_OtherAssetsCurrent_cce50cd7-beac-482d-899b-c8cfffaa569d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a46c9bc1-ffce-41f1-9dde-a047628b3623" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_1efd502a-2587-4104-871b-06d803170741" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a46c9bc1-ffce-41f1-9dde-a047628b3623" xlink:to="loc_us-gaap_DebtCurrent_1efd502a-2587-4104-871b-06d803170741" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_39b095a6-ea70-4046-86d6-b6065d678ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a46c9bc1-ffce-41f1-9dde-a047628b3623" xlink:to="loc_us-gaap_AccountsPayableCurrent_39b095a6-ea70-4046-86d6-b6065d678ce8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_a9dd0e3f-2fe2-4145-b5c5-895b5fbcd962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a46c9bc1-ffce-41f1-9dde-a047628b3623" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_a9dd0e3f-2fe2-4145-b5c5-895b5fbcd962" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_898afd33-c42b-4990-a596-53fd7591b30b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9450b56f-9e3c-4352-8be5-b382e6f3f7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_898afd33-c42b-4990-a596-53fd7591b30b" xlink:to="loc_us-gaap_StockholdersEquity_9450b56f-9e3c-4352-8be5-b382e6f3f7d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_3fc5203b-17af-476f-b653-9f2be5cd7276" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_898afd33-c42b-4990-a596-53fd7591b30b" xlink:to="loc_us-gaap_MinorityInterest_3fc5203b-17af-476f-b653-9f2be5cd7276" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="simple" xlink:href="bmy-20210630.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_24bc906c-0ddf-4e4d-9eda-a176c1c88de4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_141d5179-07f6-4cc1-92c3-7a8e0c70f07b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_24bc906c-0ddf-4e4d-9eda-a176c1c88de4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_141d5179-07f6-4cc1-92c3-7a8e0c70f07b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_199798f0-3727-452f-b02e-a35ecddd02c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_24bc906c-0ddf-4e4d-9eda-a176c1c88de4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_199798f0-3727-452f-b02e-a35ecddd02c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8eee713d-0eed-4735-ae0c-f46b26df4e39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_24bc906c-0ddf-4e4d-9eda-a176c1c88de4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8eee713d-0eed-4735-ae0c-f46b26df4e39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f01d5349-61c2-4a7b-a4f3-3283fa7b517e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_24bc906c-0ddf-4e4d-9eda-a176c1c88de4" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f01d5349-61c2-4a7b-a4f3-3283fa7b517e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_faad8b74-057a-448c-9c0e-0dfbfae156a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_b1979206-3813-4704-8960-907faacfb555" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_faad8b74-057a-448c-9c0e-0dfbfae156a1" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_b1979206-3813-4704-8960-907faacfb555" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_32d9aa08-3141-4491-b456-0afdecd847a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_faad8b74-057a-448c-9c0e-0dfbfae156a1" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_32d9aa08-3141-4491-b456-0afdecd847a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_9ef6971a-12f2-4df7-a3cb-b97ffb30aa15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_faad8b74-057a-448c-9c0e-0dfbfae156a1" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_9ef6971a-12f2-4df7-a3cb-b97ffb30aa15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_b812ffcd-b453-493a-a512-4a3d53e12612" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_faad8b74-057a-448c-9c0e-0dfbfae156a1" xlink:to="loc_us-gaap_PaymentsOfDividends_b812ffcd-b453-493a-a512-4a3d53e12612" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_81d9df68-d678-4af8-86d9-8787ee2793cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_faad8b74-057a-448c-9c0e-0dfbfae156a1" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_81d9df68-d678-4af8-86d9-8787ee2793cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_16ab3048-cc0f-44f9-bbf6-af2f17786962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_faad8b74-057a-448c-9c0e-0dfbfae156a1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_16ab3048-cc0f-44f9-bbf6-af2f17786962" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78622472-72a9-49bc-9690-7d4d3a7afee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_bb026eb3-3696-44a6-8c65-31793e312631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78622472-72a9-49bc-9690-7d4d3a7afee1" xlink:to="loc_us-gaap_ProfitLoss_bb026eb3-3696-44a6-8c65-31793e312631" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_e5a11abb-c215-4f06-821e-fdba6110cdd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78622472-72a9-49bc-9690-7d4d3a7afee1" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_e5a11abb-c215-4f06-821e-fdba6110cdd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_cefce853-1bdb-4518-b384-790f73746a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78622472-72a9-49bc-9690-7d4d3a7afee1" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_cefce853-1bdb-4518-b384-790f73746a7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_75586b4f-1df4-49d3-8d5e-68e8ceabf04b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78622472-72a9-49bc-9690-7d4d3a7afee1" xlink:to="loc_us-gaap_ShareBasedCompensation_75586b4f-1df4-49d3-8d5e-68e8ceabf04b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_23988252-aeee-48ee-ab69-7279ffbc6f15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78622472-72a9-49bc-9690-7d4d3a7afee1" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_23988252-aeee-48ee-ab69-7279ffbc6f15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Pensionsettlementsandamortization_44dc1769-fa21-41fd-99c1-49226b4b95e2" xlink:href="bmy-20210630.xsd#bmy_Pensionsettlementsandamortization"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78622472-72a9-49bc-9690-7d4d3a7afee1" xlink:to="loc_bmy_Pensionsettlementsandamortization_44dc1769-fa21-41fd-99c1-49226b4b95e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Divestituregainsandroyalties_0569e4aa-24a3-4668-8e07-50f88a20ae4c" xlink:href="bmy-20210630.xsd#bmy_Divestituregainsandroyalties"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78622472-72a9-49bc-9690-7d4d3a7afee1" xlink:to="loc_bmy_Divestituregainsandroyalties_0569e4aa-24a3-4668-8e07-50f88a20ae4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments_a7e6e0e3-101a-49e4-a3df-285179524fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78622472-72a9-49bc-9690-7d4d3a7afee1" xlink:to="loc_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments_a7e6e0e3-101a-49e4-a3df-285179524fa6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_63c5f242-f9d7-40b3-a730-0d2b8abdaa24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78622472-72a9-49bc-9690-7d4d3a7afee1" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_63c5f242-f9d7-40b3-a730-0d2b8abdaa24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_93970b4b-609f-467d-80ff-890ef1b2c7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78622472-72a9-49bc-9690-7d4d3a7afee1" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_93970b4b-609f-467d-80ff-890ef1b2c7d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_8f085d4c-a9cb-48ba-a855-0d8c9ce9dba9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78622472-72a9-49bc-9690-7d4d3a7afee1" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_8f085d4c-a9cb-48ba-a855-0d8c9ce9dba9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_5de8cee6-b392-4a4e-9d81-eee8eb11c890" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78622472-72a9-49bc-9690-7d4d3a7afee1" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_5de8cee6-b392-4a4e-9d81-eee8eb11c890" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3150d23a-01d1-4f8d-8f7d-8065ad5f8213" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78622472-72a9-49bc-9690-7d4d3a7afee1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3150d23a-01d1-4f8d-8f7d-8065ad5f8213" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_e57f18dc-5998-4dee-813a-e0c466353742" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78622472-72a9-49bc-9690-7d4d3a7afee1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_e57f18dc-5998-4dee-813a-e0c466353742" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_042b9583-1d26-4d51-9da6-b0ad589bbe89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78622472-72a9-49bc-9690-7d4d3a7afee1" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_042b9583-1d26-4d51-9da6-b0ad589bbe89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Assetacquisitioncharge_2656a892-b67f-495f-b576-99ed1e984149" xlink:href="bmy-20210630.xsd#bmy_Assetacquisitioncharge"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_78622472-72a9-49bc-9690-7d4d3a7afee1" xlink:to="loc_bmy_Assetacquisitioncharge_2656a892-b67f-495f-b576-99ed1e984149" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9691092a-b1b4-40cb-ab5d-f9bfd3ec4333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_86a39372-32ce-443a-b9ef-d9ee4e5481c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9691092a-b1b4-40cb-ab5d-f9bfd3ec4333" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_86a39372-32ce-443a-b9ef-d9ee4e5481c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_340e791e-20cd-4a12-beb3-768e10da5968" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9691092a-b1b4-40cb-ab5d-f9bfd3ec4333" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_340e791e-20cd-4a12-beb3-768e10da5968" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_22f9fd35-5e23-405e-a5c1-d1774e44f9b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9691092a-b1b4-40cb-ab5d-f9bfd3ec4333" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_22f9fd35-5e23-405e-a5c1-d1774e44f9b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Divestitureandotherproceeds_3405e0da-6a68-45c9-9302-f66242413428" xlink:href="bmy-20210630.xsd#bmy_Divestitureandotherproceeds"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9691092a-b1b4-40cb-ab5d-f9bfd3ec4333" xlink:to="loc_bmy_Divestitureandotherproceeds_3405e0da-6a68-45c9-9302-f66242413428" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ef171c98-c834-44e4-ad9a-da301a5de331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9691092a-b1b4-40cb-ab5d-f9bfd3ec4333" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ef171c98-c834-44e4-ad9a-da301a5de331" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity_68cd3d0c-2536-4484-8e38-c673f0bd25e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9691092a-b1b4-40cb-ab5d-f9bfd3ec4333" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity_68cd3d0c-2536-4484-8e38-c673f0bd25e1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#OTHEREXPENSEINCOMENETDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_c9d5916c-a3b3-420b-b5ed-5821cdf3866f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_60b1fdb1-56d1-4f28-9fcd-71b80851e06d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_c9d5916c-a3b3-420b-b5ed-5821cdf3866f" xlink:to="loc_us-gaap_InterestExpense_60b1fdb1-56d1-4f28-9fcd-71b80851e06d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_281dc41b-28b4-4fc7-9a42-9124a12d74ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_c9d5916c-a3b3-420b-b5ed-5821cdf3866f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_281dc41b-28b4-4fc7-9a42-9124a12d74ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherIncomeReceivedFromAlliancePartners_6ea722cd-0aa5-4e0b-af64-1af64253e27f" xlink:href="bmy-20210630.xsd#bmy_OtherIncomeReceivedFromAlliancePartners"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_c9d5916c-a3b3-420b-b5ed-5821cdf3866f" xlink:to="loc_bmy_OtherIncomeReceivedFromAlliancePartners_6ea722cd-0aa5-4e0b-af64-1af64253e27f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments_7fe9013d-63e7-4fa9-b664-3555e26b6fc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_c9d5916c-a3b3-420b-b5ed-5821cdf3866f" xlink:to="loc_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments_7fe9013d-63e7-4fa9-b664-3555e26b6fc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_8a552978-dc18-4e39-989d-d0bdfb6fb592" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_c9d5916c-a3b3-420b-b5ed-5821cdf3866f" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_8a552978-dc18-4e39-989d-d0bdfb6fb592" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_1d98f62a-0b67-4c50-9cb8-08d1c070cefa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_c9d5916c-a3b3-420b-b5ed-5821cdf3866f" xlink:to="loc_us-gaap_RestructuringCharges_1d98f62a-0b67-4c50-9cb8-08d1c070cefa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_73fb88c7-2377-4518-b8fa-f0367a22b425" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_c9d5916c-a3b3-420b-b5ed-5821cdf3866f" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_73fb88c7-2377-4518-b8fa-f0367a22b425" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AllianceTransitionalServices_f1ee87e7-960a-4312-8e76-0b84dab9c7e3" xlink:href="bmy-20210630.xsd#bmy_AllianceTransitionalServices"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_c9d5916c-a3b3-420b-b5ed-5821cdf3866f" xlink:to="loc_bmy_AllianceTransitionalServices_f1ee87e7-960a-4312-8e76-0b84dab9c7e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_0ad8fade-41d1-4d67-ac53-9576ec58f058" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_c9d5916c-a3b3-420b-b5ed-5821cdf3866f" xlink:to="loc_us-gaap_InvestmentIncomeInterest_0ad8fade-41d1-4d67-ac53-9576ec58f058" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Reversionexcisetax_6ca1e2c8-80aa-4097-b46b-79b118798731" xlink:href="bmy-20210630.xsd#bmy_Reversionexcisetax"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_c9d5916c-a3b3-420b-b5ed-5821cdf3866f" xlink:to="loc_bmy_Reversionexcisetax_6ca1e2c8-80aa-4097-b46b-79b118798731" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_c5dd141a-3b9a-4818-baad-3d4cff728bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_c9d5916c-a3b3-420b-b5ed-5821cdf3866f" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_c5dd141a-3b9a-4818-baad-3d4cff728bb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_c1c163e1-f190-475c-a7c4-080bc20d7f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_c9d5916c-a3b3-420b-b5ed-5821cdf3866f" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_c1c163e1-f190-475c-a7c4-080bc20d7f3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_076d2a6f-e5c2-48a9-9ea4-ded5d78ff706" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_c9d5916c-a3b3-420b-b5ed-5821cdf3866f" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_076d2a6f-e5c2-48a9-9ea4-ded5d78ff706" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherOtherIncomeExpense_ce724cba-d973-48b1-8fc4-ba77014da4ee" xlink:href="bmy-20210630.xsd#bmy_OtherOtherIncomeExpense"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_c9d5916c-a3b3-420b-b5ed-5821cdf3866f" xlink:to="loc_bmy_OtherOtherIncomeExpense_ce724cba-d973-48b1-8fc4-ba77014da4ee" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_5aa46375-db82-4076-97e1-3c96825c5959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_419393f2-12e8-4fcb-aa40-d403dcb6ba58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_5aa46375-db82-4076-97e1-3c96825c5959" xlink:to="loc_us-gaap_SeveranceCosts1_419393f2-12e8-4fcb-aa40-d403dcb6ba58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_b38f80fd-d5de-43e6-b794-9a05b3a34002" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCharges_5aa46375-db82-4076-97e1-3c96825c5959" xlink:to="loc_us-gaap_OtherRestructuringCosts_b38f80fd-d5de-43e6-b794-9a05b3a34002" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_472640b8-db60-4e3a-b37d-40da48a30e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringRelatedCostsAssetImpairments_cc81beac-80bf-4eee-9a31-b9c42c812a19" xlink:href="bmy-20210630.xsd#bmy_RestructuringRelatedCostsAssetImpairments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_472640b8-db60-4e3a-b37d-40da48a30e1e" xlink:to="loc_bmy_RestructuringRelatedCostsAssetImpairments_cc81beac-80bf-4eee-9a31-b9c42c812a19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherShutdownCosts_7a5bb3ea-f8cf-4cc5-b098-10c1c4fa7365" xlink:href="bmy-20210630.xsd#bmy_OtherShutdownCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_472640b8-db60-4e3a-b37d-40da48a30e1e" xlink:to="loc_bmy_OtherShutdownCosts_7a5bb3ea-f8cf-4cc5-b098-10c1c4fa7365" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_fc4c9b8c-a4f6-4f21-9da2-f77d420e6ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_472640b8-db60-4e3a-b37d-40da48a30e1e" xlink:to="loc_us-gaap_RestructuringCharges_fc4c9b8c-a4f6-4f21-9da2-f77d420e6ceb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_fadf6f7d-5802-4d9b-a2b7-6d86b3a0d665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_472640b8-db60-4e3a-b37d-40da48a30e1e" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_fadf6f7d-5802-4d9b-a2b7-6d86b3a0d665" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_55be5587-311a-4136-a0ea-878659238c24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveAcceleratedDepreciation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_472640b8-db60-4e3a-b37d-40da48a30e1e" xlink:to="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_55be5587-311a-4136-a0ea-878659238c24" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EARNINGSLOSSPERSHAREDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#EARNINGSLOSSPERSHAREDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/EARNINGSLOSSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e1afd038-ac7b-4cf4-9e27-b98f5496dc51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_791f2c1c-f3cf-42b9-a40b-adf924e11d98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e1afd038-ac7b-4cf4-9e27-b98f5496dc51" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_791f2c1c-f3cf-42b9-a40b-adf924e11d98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5435f185-3f4a-476b-b09c-487d433d0d04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e1afd038-ac7b-4cf4-9e27-b98f5496dc51" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5435f185-3f4a-476b-b09c-487d433d0d04" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_b4f26ebf-8e7a-43e8-b45e-08120b5cc963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBankLoansAndNotesPayable_20752012-f419-4e72-a360-f745bb30519d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBankLoansAndNotesPayable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortTermBorrowings_b4f26ebf-8e7a-43e8-b45e-08120b5cc963" xlink:to="loc_us-gaap_ShortTermBankLoansAndNotesPayable_20752012-f419-4e72-a360-f745bb30519d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_b2888954-5da9-4c18-890e-6bf451d25b40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortTermBorrowings_b4f26ebf-8e7a-43e8-b45e-08120b5cc963" xlink:to="loc_us-gaap_LongTermDebtCurrent_b2888954-5da9-4c18-890e-6bf451d25b40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermBorrowings_d813e1e0-86b0-4131-aa1b-956c8e08ef88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherShortTermBorrowings"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortTermBorrowings_b4f26ebf-8e7a-43e8-b45e-08120b5cc963" xlink:to="loc_us-gaap_OtherShortTermBorrowings_d813e1e0-86b0-4131-aa1b-956c8e08ef88" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RECEIVABLESDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#RECEIVABLESDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/RECEIVABLESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b77ca8ea-063e-4cd8-b43b-bc7f19674b00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_ec862b3a-d884-4e71-932f-99eff1da9498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_b77ca8ea-063e-4cd8-b43b-bc7f19674b00" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_ec862b3a-d884-4e71-932f-99eff1da9498" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CashDiscounts_6210af48-764d-47a4-9442-7909498c50cc" xlink:href="bmy-20210630.xsd#bmy_CashDiscounts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_b77ca8ea-063e-4cd8-b43b-bc7f19674b00" xlink:to="loc_bmy_CashDiscounts_6210af48-764d-47a4-9442-7909498c50cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_6dd2140a-1cb6-489e-be5e-b2e2d54cccb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_b77ca8ea-063e-4cd8-b43b-bc7f19674b00" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_6dd2140a-1cb6-489e-be5e-b2e2d54cccb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_53a1883b-91b8-4f72-a425-8f7e01bc1a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_7e853fd2-ea14-4dc0-8e24-d4f70dc2ef26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReceivablesNetCurrent_53a1883b-91b8-4f72-a425-8f7e01bc1a04" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_7e853fd2-ea14-4dc0-8e24-d4f70dc2ef26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_9c2efeaa-1c86-44c1-8590-807b081bd1e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReceivablesNetCurrent_53a1883b-91b8-4f72-a425-8f7e01bc1a04" xlink:to="loc_us-gaap_OtherReceivables_9c2efeaa-1c86-44c1-8590-807b081bd1e2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INVENTORIESDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#INVENTORIESDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/INVENTORIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Totalinventories_29812722-ff47-4cbc-bbf8-17640fd722b1" xlink:href="bmy-20210630.xsd#bmy_Totalinventories"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_61e497b9-8fa4-4aba-84d6-66d1af350ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_Totalinventories_29812722-ff47-4cbc-bbf8-17640fd722b1" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_61e497b9-8fa4-4aba-84d6-66d1af350ff2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_09ee65e6-c534-42a0-a922-bbfad1e79a72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_Totalinventories_29812722-ff47-4cbc-bbf8-17640fd722b1" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_09ee65e6-c534-42a0-a922-bbfad1e79a72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_de3c9813-2507-4acb-be27-04db571c474f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_bmy_Totalinventories_29812722-ff47-4cbc-bbf8-17640fd722b1" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_de3c9813-2507-4acb-be27-04db571c474f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#PROPERTYPLANTANDEQUIPMENTDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5a2714b1-0136-4058-b46a-f860b5030860" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_ec14f552-6695-4584-bd13-c3d556aef305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_5a2714b1-0136-4058-b46a-f860b5030860" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_ec14f552-6695-4584-bd13-c3d556aef305" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c4954f0a-b695-49c5-a6d7-4266e9f5ffe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_5a2714b1-0136-4058-b46a-f860b5030860" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c4954f0a-b695-49c5-a6d7-4266e9f5ffe8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_369f262b-b27d-4c77-b129-6dd3c521a0f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_79fb9a9a-b640-4dba-bc85-cc5bd4c1e2db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_369f262b-b27d-4c77-b129-6dd3c521a0f2" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_79fb9a9a-b640-4dba-bc85-cc5bd4c1e2db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f2a13600-f091-4943-8804-530e8ab723d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_369f262b-b27d-4c77-b129-6dd3c521a0f2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f2a13600-f091-4943-8804-530e8ab723d4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#EQUITYOtherComprehensiveIncomeLossDetails"/>
  <link:calculationLink xlink:role="http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_58dcd95a-7c1e-4c3e-b518-19e7ac70573c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_c8e42427-c12d-4021-b5e6-067c452d69ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_58dcd95a-7c1e-4c3e-b518-19e7ac70573c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_c8e42427-c12d-4021-b5e6-067c452d69ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax_742c6e4d-aa51-4e21-b100-a4b208a0f706" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_58dcd95a-7c1e-4c3e-b518-19e7ac70573c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax_742c6e4d-aa51-4e21-b100-a4b208a0f706" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_6b736096-888d-45cb-9fa8-e3f249a65144" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_6ef5fd31-a4b6-473a-875c-4cae6893dcdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_6b736096-888d-45cb-9fa8-e3f249a65144" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_6ef5fd31-a4b6-473a-875c-4cae6893dcdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax_eeb4aef5-31b9-4cc6-8406-128c8bcc9200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_6b736096-888d-45cb-9fa8-e3f249a65144" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax_eeb4aef5-31b9-4cc6-8406-128c8bcc9200" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7b793a25-5cf9-4fb5-b01b-5238b2ea082f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_32c8b43a-27ba-4193-9b0b-4f0cb37deafe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7b793a25-5cf9-4fb5-b01b-5238b2ea082f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_32c8b43a-27ba-4193-9b0b-4f0cb37deafe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_36625fb9-0ce2-42c4-8f40-816754399a15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7b793a25-5cf9-4fb5-b01b-5238b2ea082f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_36625fb9-0ce2-42c4-8f40-816754399a15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_f7d191ed-e64d-48f0-aa17-d289019fb6c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7b793a25-5cf9-4fb5-b01b-5238b2ea082f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_f7d191ed-e64d-48f0-aa17-d289019fb6c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_8315ed6e-612a-44b1-8a4d-c512d09966b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7b793a25-5cf9-4fb5-b01b-5238b2ea082f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_8315ed6e-612a-44b1-8a4d-c512d09966b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_53c76913-4a21-439f-83f7-60ec0327b9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_2ef10e5d-14e2-4148-ac4c-d05a3317dcaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax_53c76913-4a21-439f-83f7-60ec0327b9e3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_2ef10e5d-14e2-4148-ac4c-d05a3317dcaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_8096b042-bf82-4319-bd12-b506142ed847" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax_53c76913-4a21-439f-83f7-60ec0327b9e3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_8096b042-bf82-4319-bd12-b506142ed847" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_bb5d1539-9354-4973-a2fc-15e51b0410eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax_53c76913-4a21-439f-83f7-60ec0327b9e3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_bb5d1539-9354-4973-a2fc-15e51b0410eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_78ee72c1-366d-474b-b756-436fc64390ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax_53c76913-4a21-439f-83f7-60ec0327b9e3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_78ee72c1-366d-474b-b756-436fc64390ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_17f66bc6-04ab-425d-9be6-d4ad49633d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_ef5a54fb-56fa-4dfc-ac76-9b05fb01afc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_17f66bc6-04ab-425d-9be6-d4ad49633d8b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_ef5a54fb-56fa-4dfc-ac76-9b05fb01afc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_8d8ea6b3-f57e-4a79-b293-8fb474b633ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_17f66bc6-04ab-425d-9be6-d4ad49633d8b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_8d8ea6b3-f57e-4a79-b293-8fb474b633ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_06adb97d-309c-4633-9c72-706ea2f1433e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_8478d77e-cf51-4a7d-8398-12b845e5dea4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_06adb97d-309c-4633-9c72-706ea2f1433e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_8478d77e-cf51-4a7d-8398-12b845e5dea4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_b8e260a7-258c-49c5-b07e-3e85008eaba9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_06adb97d-309c-4633-9c72-706ea2f1433e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_b8e260a7-258c-49c5-b07e-3e85008eaba9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_6b98d94e-f9ea-42f0-9f7d-8372b3a19eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_06adb97d-309c-4633-9c72-706ea2f1433e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_6b98d94e-f9ea-42f0-9f7d-8372b3a19eb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_04dea120-2129-4d04-8231-571f6c7389c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_95f159a6-8aaa-4a66-a414-6e9ba11042a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_04dea120-2129-4d04-8231-571f6c7389c0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_95f159a6-8aaa-4a66-a414-6e9ba11042a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_81d67a31-b9cc-4eda-8af0-4f81aed14072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_04dea120-2129-4d04-8231-571f6c7389c0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_81d67a31-b9cc-4eda-8af0-4f81aed14072" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax_5a3e585d-805f-4ada-8453-e4fe6fc18e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_04dea120-2129-4d04-8231-571f6c7389c0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax_5a3e585d-805f-4ada-8453-e4fe6fc18e6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_fa96aaf0-a312-43ba-8cad-99febd7fdafb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_e6f52fff-8236-49ec-8712-995506c7fbec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_fa96aaf0-a312-43ba-8cad-99febd7fdafb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_e6f52fff-8236-49ec-8712-995506c7fbec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_a33bb8d4-5e06-44c9-8b42-5dd9060cf3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_fa96aaf0-a312-43ba-8cad-99febd7fdafb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_a33bb8d4-5e06-44c9-8b42-5dd9060cf3fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_5207e8ee-0d22-426f-a17f-037767885063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_ca7dc8d3-6157-4099-866b-19ab49a27b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_5207e8ee-0d22-426f-a17f-037767885063" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_ca7dc8d3-6157-4099-866b-19ab49a27b4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_9418d208-75a8-4c31-9e32-a2e5f32ca0b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_5207e8ee-0d22-426f-a17f-037767885063" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_9418d208-75a8-4c31-9e32-a2e5f32ca0b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_11ea09fc-2879-4452-b193-9eca6c17c70b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_5207e8ee-0d22-426f-a17f-037767885063" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_11ea09fc-2879-4452-b193-9eca6c17c70b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_7a341a86-201c-4ce9-bfa6-242b365418ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_5207e8ee-0d22-426f-a17f-037767885063" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_7a341a86-201c-4ce9-bfa6-242b365418ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1172a85d-0c9a-4c39-89fa-6cc177d27c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_0b7238f2-4005-4ea6-a6f4-9cbb90cdaa78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1172a85d-0c9a-4c39-89fa-6cc177d27c2d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_0b7238f2-4005-4ea6-a6f4-9cbb90cdaa78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_e68057f0-1270-4f0f-9a5a-013c450a031f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1172a85d-0c9a-4c39-89fa-6cc177d27c2d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_e68057f0-1270-4f0f-9a5a-013c450a031f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_e5729f29-01e7-4cb8-b8dd-b66bcc509fae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1172a85d-0c9a-4c39-89fa-6cc177d27c2d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_e5729f29-01e7-4cb8-b8dd-b66bcc509fae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_784fe09a-7353-4500-b7ca-7fa28093e9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1172a85d-0c9a-4c39-89fa-6cc177d27c2d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_784fe09a-7353-4500-b7ca-7fa28093e9ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_98dbae82-ce48-4853-be8f-32a9c369ead5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_30998e4c-7891-48be-b3a9-6b3e0e7c19c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_98dbae82-ce48-4853-be8f-32a9c369ead5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_30998e4c-7891-48be-b3a9-6b3e0e7c19c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_abe450c5-5bcb-4ed0-a715-e0928fc37bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_98dbae82-ce48-4853-be8f-32a9c369ead5" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_abe450c5-5bcb-4ed0-a715-e0928fc37bc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_a8142d96-aea9-4e0f-95cc-2f8a69c74413" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_98aef3c4-7857-49f6-9203-1633914a2d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_a8142d96-aea9-4e0f-95cc-2f8a69c74413" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_98aef3c4-7857-49f6-9203-1633914a2d5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_47270dc7-7ecb-4f78-a3bb-dc445b673f79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_a8142d96-aea9-4e0f-95cc-2f8a69c74413" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_47270dc7-7ecb-4f78-a3bb-dc445b673f79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_35f92000-ab71-47f8-9b3f-fc227023d933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_a8142d96-aea9-4e0f-95cc-2f8a69c74413" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_35f92000-ab71-47f8-9b3f-fc227023d933" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_667819dc-601b-48a4-a0de-7f60938bb91b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_590764bd-92fb-45d6-95b2-a25357ee9dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_667819dc-601b-48a4-a0de-7f60938bb91b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_590764bd-92fb-45d6-95b2-a25357ee9dc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_320a58ce-0756-47c0-a3b7-3080e78057b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_667819dc-601b-48a4-a0de-7f60938bb91b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_320a58ce-0756-47c0-a3b7-3080e78057b5" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>bmy-20210630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:744431a9-b3ff-43bd-afc9-1af61fbf126c,g:9fbce200-03f4-4882-8b59-75e21adfdbca-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.bms.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="bmy-20210630.xsd#DocumentandEntityInformation"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/DocumentandEntityInformation" xlink:type="extended" id="ic0e1fb075c9e470f8635638b57eece08_DocumentandEntityInformation">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1f1750d7-e0e5-4d50-8bab-2d03ef23f0bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_4c1bc827-e52b-4374-80ff-0e1661ee6614" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1f1750d7-e0e5-4d50-8bab-2d03ef23f0bb" xlink:to="loc_dei_Security12bTitle_4c1bc827-e52b-4374-80ff-0e1661ee6614" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_39fc470c-91d1-41c1-aca0-69c1fc05bb91" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1f1750d7-e0e5-4d50-8bab-2d03ef23f0bb" xlink:to="loc_dei_TradingSymbol_39fc470c-91d1-41c1-aca0-69c1fc05bb91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c69fb0f3-c336-457a-9db8-1e43ab986086" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1f1750d7-e0e5-4d50-8bab-2d03ef23f0bb" xlink:to="loc_dei_SecurityExchangeName_c69fb0f3-c336-457a-9db8-1e43ab986086" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e3877bbb-c03b-4258-9d4e-8ac9782e8df3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1f1750d7-e0e5-4d50-8bab-2d03ef23f0bb" xlink:to="loc_us-gaap_StatementTable_e3877bbb-c03b-4258-9d4e-8ac9782e8df3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_af655909-8fd1-475d-b581-63a4aaeaeeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e3877bbb-c03b-4258-9d4e-8ac9782e8df3" xlink:to="loc_us-gaap_StatementClassOfStockAxis_af655909-8fd1-475d-b581-63a4aaeaeeb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_af655909-8fd1-475d-b581-63a4aaeaeeb5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_af655909-8fd1-475d-b581-63a4aaeaeeb5" xlink:to="loc_us-gaap_ClassOfStockDomain_af655909-8fd1-475d-b581-63a4aaeaeeb5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_bc1214be-0e0b-4aa6-9bfc-544072826114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_af655909-8fd1-475d-b581-63a4aaeaeeb5" xlink:to="loc_us-gaap_ClassOfStockDomain_bc1214be-0e0b-4aa6-9bfc-544072826114" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CommonStock0.10ParValueMember_859a632d-a73b-407d-a05d-71018fee67cb" xlink:href="bmy-20210630.xsd#bmy_CommonStock0.10ParValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_bc1214be-0e0b-4aa6-9bfc-544072826114" xlink:to="loc_bmy_CommonStock0.10ParValueMember_859a632d-a73b-407d-a05d-71018fee67cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.000Notesdue2025Member_dae0d7e5-3f5a-4d8f-bad6-4a8500a2d2f1" xlink:href="bmy-20210630.xsd#bmy_A1.000Notesdue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_bc1214be-0e0b-4aa6-9bfc-544072826114" xlink:to="loc_bmy_A1.000Notesdue2025Member_dae0d7e5-3f5a-4d8f-bad6-4a8500a2d2f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.750Notesdue2035Member_1918dd6f-fb8e-4902-88f9-8a8d2f05f9cb" xlink:href="bmy-20210630.xsd#bmy_A1.750Notesdue2035Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_bc1214be-0e0b-4aa6-9bfc-544072826114" xlink:to="loc_bmy_A1.750Notesdue2035Member_1918dd6f-fb8e-4902-88f9-8a8d2f05f9cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneContingentValueRightsMember_8806454c-9fd2-4564-82bf-09ebd99c4b37" xlink:href="bmy-20210630.xsd#bmy_CelgeneContingentValueRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_bc1214be-0e0b-4aa6-9bfc-544072826114" xlink:to="loc_bmy_CelgeneContingentValueRightsMember_8806454c-9fd2-4564-82bf-09ebd99c4b37" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED" xlink:type="simple" xlink:href="bmy-20210630.xsd#CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED" xlink:type="extended" id="i01b09fb9977e4a07afd6aa05c009a11b_CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_697e8636-26df-44bf-8bfc-e2d071c662c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_Revenues_697e8636-26df-44bf-8bfc-e2d071c662c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_87fbe659-02d5-418c-bc27-9cf4d5f23cab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_87fbe659-02d5-418c-bc27-9cf4d5f23cab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7a2d13f0-ea03-4519-ac12-8416c73eaeaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7a2d13f0-ea03-4519-ac12-8416c73eaeaa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_4faa071d-60a3-405d-87c6-0500bb5f389b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_4faa071d-60a3-405d-87c6-0500bb5f389b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationofAcquiredIntangibleAssets_f02e530d-81f4-485d-8f97-8ba594904947" xlink:href="bmy-20210630.xsd#bmy_AmortizationofAcquiredIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_bmy_AmortizationofAcquiredIntangibleAssets_f02e530d-81f4-485d-8f97-8ba594904947" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ad0b107c-ad3d-4d25-a19a-95e21c6983d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ad0b107c-ad3d-4d25-a19a-95e21c6983d8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_fa0d79c5-815a-47f9-99cb-41a9f760e089" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_CostsAndExpenses_fa0d79c5-815a-47f9-99cb-41a9f760e089" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e673f513-fc19-46f5-93f6-15aef1b5c546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e673f513-fc19-46f5-93f6-15aef1b5c546" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f53e47a2-9153-4987-89ec-a4ef5d55e2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f53e47a2-9153-4987-89ec-a4ef5d55e2d4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7a2e3b17-dbad-4b6b-8ea0-7695b8825dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_ProfitLoss_7a2e3b17-dbad-4b6b-8ea0-7695b8825dbb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_bf0f9c91-5d88-45ba-9220-ef948a08e499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_bf0f9c91-5d88-45ba-9220-ef948a08e499" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fc88c63e-0bda-49e4-b72b-2e7c1d108eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_NetIncomeLoss_fc88c63e-0bda-49e4-b72b-2e7c1d108eb9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_0dad97e9-88b0-466d-be36-02540cf2a591" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_EarningsPerShareBasic_0dad97e9-88b0-466d-be36-02540cf2a591" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_6e173369-1525-43d5-88c1-eb1de5459f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_EarningsPerShareDiluted_6e173369-1525-43d5-88c1-eb1de5459f0b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2b7fdd17-bafe-4fac-ad2c-86eb2fc7bb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_StatementTable_2b7fdd17-bafe-4fac-ad2c-86eb2fc7bb0b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_a9d2fe55-01cb-48c8-a4a1-bcdd82d7d025" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2b7fdd17-bafe-4fac-ad2c-86eb2fc7bb0b" xlink:to="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_a9d2fe55-01cb-48c8-a4a1-bcdd82d7d025" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_a9d2fe55-01cb-48c8-a4a1-bcdd82d7d025_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_a9d2fe55-01cb-48c8-a4a1-bcdd82d7d025" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_a9d2fe55-01cb-48c8-a4a1-bcdd82d7d025_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_94184300-af2f-4dbd-a1f1-3cf6b10c5b64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_a9d2fe55-01cb-48c8-a4a1-bcdd82d7d025" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_94184300-af2f-4dbd-a1f1-3cf6b10c5b64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember_b8f77862-18f3-4873-84a6-19bdb3d1a44f" xlink:href="bmy-20210630.xsd#bmy_NetproductsalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_94184300-af2f-4dbd-a1f1-3cf6b10c5b64" xlink:to="loc_bmy_NetproductsalesMember_b8f77862-18f3-4873-84a6-19bdb3d1a44f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AllianceandotherrevenuesMember_5df4d1bc-99ed-4025-8ed3-3ba0129ffa95" xlink:href="bmy-20210630.xsd#bmy_AllianceandotherrevenuesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_94184300-af2f-4dbd-a1f1-3cf6b10c5b64" xlink:to="loc_bmy_AllianceandotherrevenuesMember_5df4d1bc-99ed-4025-8ed3-3ba0129ffa95" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/BASISOFPRESENTATIONNewAccountingPronouncementsDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#BASISOFPRESENTATIONNewAccountingPronouncementsDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/BASISOFPRESENTATIONNewAccountingPronouncementsDetails" xlink:type="extended" id="i53cc15e303ef4b67bbe67f6076422821_BASISOFPRESENTATIONNewAccountingPronouncementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationLineItems_0c815f1f-5cb7-479a-a580-502c04ef5a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustment_51371385-87ff-467e-96c3-39fd95b69ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationLineItems_0c815f1f-5cb7-479a-a580-502c04ef5a9f" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustment_51371385-87ff-467e-96c3-39fd95b69ec5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationTable_9e6bdd60-46f3-4b39-ae80-464f73bb5caf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationLineItems_0c815f1f-5cb7-479a-a580-502c04ef5a9f" xlink:to="loc_us-gaap_ReclassificationTable_9e6bdd60-46f3-4b39-ae80-464f73bb5caf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationTypeAxis_c00455f1-ea9f-43fa-b599-267d16bbd40c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationTable_9e6bdd60-46f3-4b39-ae80-464f73bb5caf" xlink:to="loc_us-gaap_ReclassificationTypeAxis_c00455f1-ea9f-43fa-b599-267d16bbd40c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationTypeDomain_c00455f1-ea9f-43fa-b599-267d16bbd40c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationTypeAxis_c00455f1-ea9f-43fa-b599-267d16bbd40c" xlink:to="loc_us-gaap_ReclassificationTypeDomain_c00455f1-ea9f-43fa-b599-267d16bbd40c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationTypeDomain_9d5a4e18-d1af-42cf-8bc5-b53bf85338ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationTypeAxis_c00455f1-ea9f-43fa-b599-267d16bbd40c" xlink:to="loc_us-gaap_ReclassificationTypeDomain_9d5a4e18-d1af-42cf-8bc5-b53bf85338ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsCashFlowsReclassificationMember_e846cd26-90c9-4eac-aa41-3d7d3d9db644" xlink:href="bmy-20210630.xsd#bmy_LicensingArrangementsCashFlowsReclassificationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationTypeDomain_9d5a4e18-d1af-42cf-8bc5-b53bf85338ba" xlink:to="loc_bmy_LicensingArrangementsCashFlowsReclassificationMember_e846cd26-90c9-4eac-aa41-3d7d3d9db644" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/REVENUERECOGNITIONRevenuebyNatureDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#REVENUERECOGNITIONRevenuebyNatureDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/REVENUERECOGNITIONRevenuebyNatureDetails" xlink:type="extended" id="iea7a70726fc94465858ca1a15e4648cd_REVENUERECOGNITIONRevenuebyNatureDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_8db82070-f2bf-43a2-aa8d-965601df5e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_3fde474c-4846-4855-8ecc-c93308aa0f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8db82070-f2bf-43a2-aa8d-965601df5e2d" xlink:to="loc_us-gaap_Revenues_3fde474c-4846-4855-8ecc-c93308aa0f1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_679ee640-f29c-482d-bb64-8144f38931fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8db82070-f2bf-43a2-aa8d-965601df5e2d" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_679ee640-f29c-482d-bb64-8144f38931fc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_d6a1989b-1831-4b26-870a-92e8bb0e2894" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_679ee640-f29c-482d-bb64-8144f38931fc" xlink:to="loc_us-gaap_TypeOfArrangementAxis_d6a1989b-1831-4b26-870a-92e8bb0e2894" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d6a1989b-1831-4b26-870a-92e8bb0e2894_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_d6a1989b-1831-4b26-870a-92e8bb0e2894" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d6a1989b-1831-4b26-870a-92e8bb0e2894_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ceb3548d-ed63-44ff-89d6-cfc7380f8bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_d6a1989b-1831-4b26-870a-92e8bb0e2894" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ceb3548d-ed63-44ff-89d6-cfc7380f8bb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_6d3709ba-a6a1-484a-9e6f-00e39a4c227a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ceb3548d-ed63-44ff-89d6-cfc7380f8bb9" xlink:to="loc_us-gaap_CollaborativeArrangementMember_6d3709ba-a6a1-484a-9e6f-00e39a4c227a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_9f3cc437-082b-4c83-a4bf-169679307245" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_679ee640-f29c-482d-bb64-8144f38931fc" xlink:to="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_9f3cc437-082b-4c83-a4bf-169679307245" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_9f3cc437-082b-4c83-a4bf-169679307245_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_9f3cc437-082b-4c83-a4bf-169679307245" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_9f3cc437-082b-4c83-a4bf-169679307245_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_6a831625-2b9d-4dbb-b089-cbfab7c04b77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_9f3cc437-082b-4c83-a4bf-169679307245" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_6a831625-2b9d-4dbb-b089-cbfab7c04b77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember_4c5d70b0-e9ff-464b-b22b-4f9e8f9b2821" xlink:href="bmy-20210630.xsd#bmy_NetproductsalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_6a831625-2b9d-4dbb-b089-cbfab7c04b77" xlink:to="loc_bmy_NetproductsalesMember_4c5d70b0-e9ff-464b-b22b-4f9e8f9b2821" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_a4500ce3-3e8a-424c-94ab-3e54210cdb89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_6a831625-2b9d-4dbb-b089-cbfab7c04b77" xlink:to="loc_us-gaap_CollaborativeArrangementMember_a4500ce3-3e8a-424c-94ab-3e54210cdb89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherrevenuesMember_6738b869-2dc7-404f-ae04-8804e569ceaa" xlink:href="bmy-20210630.xsd#bmy_OtherrevenuesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_6a831625-2b9d-4dbb-b089-cbfab7c04b77" xlink:to="loc_bmy_OtherrevenuesMember_6738b869-2dc7-404f-ae04-8804e569ceaa" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/REVENUERECOGNITIONGrosstoNetAdjustmentsDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#REVENUERECOGNITIONGrosstoNetAdjustmentsDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/REVENUERECOGNITIONGrosstoNetAdjustmentsDetails" xlink:type="extended" id="i6c573e45b06f455abf31bfd1ecf3b6fb_REVENUERECOGNITIONGrosstoNetAdjustmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsLineItems_31e8a435-ee61-49dc-b36a-0b3600509e91" xlink:href="bmy-20210630.xsd#bmy_GrosstoNetAdjustmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_033e25d1-29de-45d6-b2df-56123056a932" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_31e8a435-ee61-49dc-b36a-0b3600509e91" xlink:to="loc_us-gaap_Revenues_033e25d1-29de-45d6-b2df-56123056a932" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustments_a9ae6916-7ca6-4088-aaa0-c8a6079d1e5e" xlink:href="bmy-20210630.xsd#bmy_GrosstoNetAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_31e8a435-ee61-49dc-b36a-0b3600509e91" xlink:to="loc_bmy_GrosstoNetAdjustments_a9ae6916-7ca6-4088-aaa0-c8a6079d1e5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods_da1e32a3-8828-46ce-9eb1-a2c7472f58f4" xlink:href="bmy-20210630.xsd#bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_31e8a435-ee61-49dc-b36a-0b3600509e91" xlink:to="loc_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods_da1e32a3-8828-46ce-9eb1-a2c7472f58f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsTable_ab551ff5-8078-417c-9ed5-3facd5c3ef7c" xlink:href="bmy-20210630.xsd#bmy_GrosstoNetAdjustmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_31e8a435-ee61-49dc-b36a-0b3600509e91" xlink:to="loc_bmy_GrosstoNetAdjustmentsTable_ab551ff5-8078-417c-9ed5-3facd5c3ef7c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsAxis_41934941-93de-46e3-a72c-794236b5190a" xlink:href="bmy-20210630.xsd#bmy_GrosstoNetAdjustmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_GrosstoNetAdjustmentsTable_ab551ff5-8078-417c-9ed5-3facd5c3ef7c" xlink:to="loc_bmy_GrosstoNetAdjustmentsAxis_41934941-93de-46e3-a72c-794236b5190a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsDomain_41934941-93de-46e3-a72c-794236b5190a_default" xlink:href="bmy-20210630.xsd#bmy_GrosstoNetAdjustmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bmy_GrosstoNetAdjustmentsAxis_41934941-93de-46e3-a72c-794236b5190a" xlink:to="loc_bmy_GrosstoNetAdjustmentsDomain_41934941-93de-46e3-a72c-794236b5190a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsDomain_1510f06d-d5e3-491f-b852-9072e8263334" xlink:href="bmy-20210630.xsd#bmy_GrosstoNetAdjustmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bmy_GrosstoNetAdjustmentsAxis_41934941-93de-46e3-a72c-794236b5190a" xlink:to="loc_bmy_GrosstoNetAdjustmentsDomain_1510f06d-d5e3-491f-b852-9072e8263334" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ChargebacksandcashdiscountsMember_27d1621c-0a8e-46e1-b9d0-f320964f4232" xlink:href="bmy-20210630.xsd#bmy_ChargebacksandcashdiscountsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain_1510f06d-d5e3-491f-b852-9072e8263334" xlink:to="loc_bmy_ChargebacksandcashdiscountsMember_27d1621c-0a8e-46e1-b9d0-f320964f4232" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MedicaidandMedicarerebatesMember_616e6588-99c2-4e2c-9ca8-0d707e2a7b7b" xlink:href="bmy-20210630.xsd#bmy_MedicaidandMedicarerebatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain_1510f06d-d5e3-491f-b852-9072e8263334" xlink:to="loc_bmy_MedicaidandMedicarerebatesMember_616e6588-99c2-4e2c-9ca8-0d707e2a7b7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_0977f7e2-2a89-444b-ac22-e68312a8e214" xlink:href="bmy-20210630.xsd#bmy_OtherrebatesreturnsdiscountsandadjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain_1510f06d-d5e3-491f-b852-9072e8263334" xlink:to="loc_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_0977f7e2-2a89-444b-ac22-e68312a8e214" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_29f5739a-3050-49ca-aa43-f49a10de39e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_GrosstoNetAdjustmentsTable_ab551ff5-8078-417c-9ed5-3facd5c3ef7c" xlink:to="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_29f5739a-3050-49ca-aa43-f49a10de39e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_29f5739a-3050-49ca-aa43-f49a10de39e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_29f5739a-3050-49ca-aa43-f49a10de39e2" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_29f5739a-3050-49ca-aa43-f49a10de39e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_56d0927f-9b0d-4260-b563-874d83dabea2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_29f5739a-3050-49ca-aa43-f49a10de39e2" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_56d0927f-9b0d-4260-b563-874d83dabea2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SalesRevenueGrossMember_0f73e874-39f0-462f-956e-b40d53b411a4" xlink:href="bmy-20210630.xsd#bmy_SalesRevenueGrossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_56d0927f-9b0d-4260-b563-874d83dabea2" xlink:to="loc_bmy_SalesRevenueGrossMember_0f73e874-39f0-462f-956e-b40d53b411a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember_a83ff311-9c37-4c47-8faf-55f8b42b503f" xlink:href="bmy-20210630.xsd#bmy_NetproductsalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_56d0927f-9b0d-4260-b563-874d83dabea2" xlink:to="loc_bmy_NetproductsalesMember_a83ff311-9c37-4c47-8faf-55f8b42b503f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#REVENUERECOGNITIONRevenuebyProductbyRegionDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails" xlink:type="extended" id="i7a61bf02803f46579cff5be908f218c9_REVENUERECOGNITIONRevenuebyProductbyRegionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_4534a4a1-f225-4b25-bd3c-2f9c7844f2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_5bb2cca8-260a-422e-aed7-02e068766e80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_4534a4a1-f225-4b25-bd3c-2f9c7844f2b9" xlink:to="loc_us-gaap_Revenues_5bb2cca8-260a-422e-aed7-02e068766e80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_574a33db-d1d6-49c5-a7ee-110628d19bca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_4534a4a1-f225-4b25-bd3c-2f9c7844f2b9" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_574a33db-d1d6-49c5-a7ee-110628d19bca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d0cf1362-b2f6-4699-90a5-b23cd45ba8de" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_574a33db-d1d6-49c5-a7ee-110628d19bca" xlink:to="loc_srt_StatementGeographicalAxis_d0cf1362-b2f6-4699-90a5-b23cd45ba8de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d0cf1362-b2f6-4699-90a5-b23cd45ba8de_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_d0cf1362-b2f6-4699-90a5-b23cd45ba8de" xlink:to="loc_srt_SegmentGeographicalDomain_d0cf1362-b2f6-4699-90a5-b23cd45ba8de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e83db168-6abd-4f67-a26a-ade132fc7761" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_d0cf1362-b2f6-4699-90a5-b23cd45ba8de" xlink:to="loc_srt_SegmentGeographicalDomain_e83db168-6abd-4f67-a26a-ade132fc7761" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_0ac7e721-9383-43bd-82f8-8dd086e9f43d" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e83db168-6abd-4f67-a26a-ade132fc7761" xlink:to="loc_country_US_0ac7e721-9383-43bd-82f8-8dd086e9f43d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_c5435f07-982e-4163-b417-d634e585b297" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e83db168-6abd-4f67-a26a-ade132fc7761" xlink:to="loc_srt_EuropeMember_c5435f07-982e-4163-b417-d634e585b297" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestOfWorldMember_88ad7230-2c44-41b6-8fa0-685053ca73b6" xlink:href="bmy-20210630.xsd#bmy_RestOfWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e83db168-6abd-4f67-a26a-ade132fc7761" xlink:to="loc_bmy_RestOfWorldMember_88ad7230-2c44-41b6-8fa0-685053ca73b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRegionMember_97c912a1-b5eb-438b-97d1-e9c31f82de89" xlink:href="bmy-20210630.xsd#bmy_OtherRegionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e83db168-6abd-4f67-a26a-ade132fc7761" xlink:to="loc_bmy_OtherRegionMember_97c912a1-b5eb-438b-97d1-e9c31f82de89" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f6e6ee43-3e61-4bd4-9973-06e52100fdd0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_574a33db-d1d6-49c5-a7ee-110628d19bca" xlink:to="loc_srt_ProductOrServiceAxis_f6e6ee43-3e61-4bd4-9973-06e52100fdd0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f6e6ee43-3e61-4bd4-9973-06e52100fdd0_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f6e6ee43-3e61-4bd4-9973-06e52100fdd0" xlink:to="loc_srt_ProductsAndServicesDomain_f6e6ee43-3e61-4bd4-9973-06e52100fdd0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f6e6ee43-3e61-4bd4-9973-06e52100fdd0" xlink:to="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RevlimidMember_efbfbecb-0453-479b-a472-611ce7dc3fc8" xlink:href="bmy-20210630.xsd#bmy_RevlimidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_RevlimidMember_efbfbecb-0453-479b-a472-611ce7dc3fc8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EliquisMember_b5fd85d6-875a-414f-9fbe-ef8c31828371" xlink:href="bmy-20210630.xsd#bmy_EliquisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_EliquisMember_b5fd85d6-875a-414f-9fbe-ef8c31828371" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OpdivoMember_5815227a-bf95-4f21-90f0-2f274a326d42" xlink:href="bmy-20210630.xsd#bmy_OpdivoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_OpdivoMember_5815227a-bf95-4f21-90f0-2f274a326d42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OrenciaMember_2edb10cc-6f8b-4436-954e-e4cde8cfa40f" xlink:href="bmy-20210630.xsd#bmy_OrenciaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_OrenciaMember_2edb10cc-6f8b-4436-954e-e4cde8cfa40f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PomalystImnovidMember_3f3653a6-ffae-404f-bbd4-db6932357ad4" xlink:href="bmy-20210630.xsd#bmy_PomalystImnovidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_PomalystImnovidMember_3f3653a6-ffae-404f-bbd4-db6932357ad4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SprycelMember_438c7831-0abe-485b-911f-c4751b3290b0" xlink:href="bmy-20210630.xsd#bmy_SprycelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_SprycelMember_438c7831-0abe-485b-911f-c4751b3290b0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_YervoyMember_1f824440-dc7f-43c5-a5a0-9575b3316156" xlink:href="bmy-20210630.xsd#bmy_YervoyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_YervoyMember_1f824440-dc7f-43c5-a5a0-9575b3316156" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbraxaneMember_b58f25b1-fc17-4665-b235-8cb6fde9d6f2" xlink:href="bmy-20210630.xsd#bmy_AbraxaneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_AbraxaneMember_b58f25b1-fc17-4665-b235-8cb6fde9d6f2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EmplicitiMember_9db67239-111b-4555-bd64-1f72152bcc06" xlink:href="bmy-20210630.xsd#bmy_EmplicitiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_EmplicitiMember_9db67239-111b-4555-bd64-1f72152bcc06" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReblozylMember_d4e24a4f-c1b2-4bd9-9f97-4f8be7227e9d" xlink:href="bmy-20210630.xsd#bmy_ReblozylMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_ReblozylMember_d4e24a4f-c1b2-4bd9-9f97-4f8be7227e9d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InrebicMember_e2dd67bf-97de-4ea4-9408-20d513934680" xlink:href="bmy-20210630.xsd#bmy_InrebicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_InrebicMember_e2dd67bf-97de-4ea4-9408-20d513934680" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OnuregMember_605acb13-9334-4333-9a6a-51f18eb976d1" xlink:href="bmy-20210630.xsd#bmy_OnuregMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_OnuregMember_605acb13-9334-4333-9a6a-51f18eb976d1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ZeposiaMember_6fe29ade-bc72-4639-baf4-a63b433f5d8a" xlink:href="bmy-20210630.xsd#bmy_ZeposiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_ZeposiaMember_6fe29ade-bc72-4639-baf4-a63b433f5d8a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BreyanziMember_89302297-9a59-4d49-9777-89f1a74b85fd" xlink:href="bmy-20210630.xsd#bmy_BreyanziMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_BreyanziMember_89302297-9a59-4d49-9777-89f1a74b85fd" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbecmaMember_7811771e-0b6f-4538-aff3-c045245eb4d9" xlink:href="bmy-20210630.xsd#bmy_AbecmaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_AbecmaMember_7811771e-0b6f-4538-aff3-c045245eb4d9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_VidazaMember_294489fd-76c3-4258-98cf-7aabb41e6cd3" xlink:href="bmy-20210630.xsd#bmy_VidazaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_VidazaMember_294489fd-76c3-4258-98cf-7aabb41e6cd3" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BaracludeMember_299465a3-21eb-4b25-a6bc-9494a1ea468d" xlink:href="bmy-20210630.xsd#bmy_BaracludeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_BaracludeMember_299465a3-21eb-4b25-a6bc-9494a1ea468d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureProductsAndAllOtherMember_c5904bc5-0930-4c80-8aba-4aefbc199250" xlink:href="bmy-20210630.xsd#bmy_MatureProductsAndAllOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_MatureProductsAndAllOtherMember_c5904bc5-0930-4c80-8aba-4aefbc199250" xlink:type="arc" order="17"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/ALLIANCESDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#ALLIANCESDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/ALLIANCESDetails" xlink:type="extended" id="i12fd03dc6b124b5caf3c398f0914d736_ALLIANCESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_80593a94-076b-43e7-a22a-9d806df15ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0837d969-d2d7-4a0d-9c8c-2a7a21ae79b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_80593a94-076b-43e7-a22a-9d806df15ba5" xlink:to="loc_us-gaap_Revenues_0837d969-d2d7-4a0d-9c8c-2a7a21ae79b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_116b2ad3-e61d-4002-ae26-f5f4a143a3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_80593a94-076b-43e7-a22a-9d806df15ba5" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_116b2ad3-e61d-4002-ae26-f5f4a143a3cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement_2c9be6db-d6fa-4a15-bdba-abc64b40e262" xlink:href="bmy-20210630.xsd#bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_80593a94-076b-43e7-a22a-9d806df15ba5" xlink:to="loc_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement_2c9be6db-d6fa-4a15-bdba-abc64b40e262" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchandDevelopmentExpenseCollaborativeArrangement_86194e6a-9127-493e-bfd4-6dee02496df5" xlink:href="bmy-20210630.xsd#bmy_ResearchandDevelopmentExpenseCollaborativeArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_80593a94-076b-43e7-a22a-9d806df15ba5" xlink:to="loc_bmy_ResearchandDevelopmentExpenseCollaborativeArrangement_86194e6a-9127-493e-bfd4-6dee02496df5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_4781c909-1667-47f3-8611-20f377819cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_80593a94-076b-43e7-a22a-9d806df15ba5" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_4781c909-1667-47f3-8611-20f377819cd2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_ac138323-e403-423a-bdc6-b4a5da3a3502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_80593a94-076b-43e7-a22a-9d806df15ba5" xlink:to="loc_us-gaap_ReceivablesNetCurrent_ac138323-e403-423a-bdc6-b4a5da3a3502" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019644a2-8a51-4df0-8053-956b47bb63bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_80593a94-076b-43e7-a22a-9d806df15ba5" xlink:to="loc_us-gaap_AccountsPayableCurrent_019644a2-8a51-4df0-8053-956b47bb63bc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncome_68227547-926c-43be-bb7e-eb798b6177db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_80593a94-076b-43e7-a22a-9d806df15ba5" xlink:to="loc_us-gaap_DeferredIncome_68227547-926c-43be-bb7e-eb798b6177db" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_UpfrontPaymentsMadeToCollaborativePartner_c79f8080-c0d3-452b-ad81-d00f384e8b21" xlink:href="bmy-20210630.xsd#bmy_UpfrontPaymentsMadeToCollaborativePartner"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_80593a94-076b-43e7-a22a-9d806df15ba5" xlink:to="loc_bmy_UpfrontPaymentsMadeToCollaborativePartner_c79f8080-c0d3-452b-ad81-d00f384e8b21" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Considerationforcontingentdevelopmentandregulatoryapproval_86176c65-895b-4d9f-a5ec-1742f42a1bbf" xlink:href="bmy-20210630.xsd#bmy_Considerationforcontingentdevelopmentandregulatoryapproval"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_80593a94-076b-43e7-a22a-9d806df15ba5" xlink:to="loc_bmy_Considerationforcontingentdevelopmentandregulatoryapproval_86176c65-895b-4d9f-a5ec-1742f42a1bbf" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_5547e198-cab2-4a2b-ac6e-1b2c355dfdf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_80593a94-076b-43e7-a22a-9d806df15ba5" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_5547e198-cab2-4a2b-ac6e-1b2c355dfdf9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_81f55e1c-c918-48b1-b109-85eacbbab820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_5547e198-cab2-4a2b-ac6e-1b2c355dfdf9" xlink:to="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_81f55e1c-c918-48b1-b109-85eacbbab820" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_81f55e1c-c918-48b1-b109-85eacbbab820_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_81f55e1c-c918-48b1-b109-85eacbbab820" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_81f55e1c-c918-48b1-b109-85eacbbab820_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_aae35f3c-c52d-4003-a23e-7424d75b5201" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_81f55e1c-c918-48b1-b109-85eacbbab820" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_aae35f3c-c52d-4003-a23e-7424d75b5201" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember_defc1b63-b9df-442f-936d-4efaf2813f19" xlink:href="bmy-20210630.xsd#bmy_NetproductsalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_aae35f3c-c52d-4003-a23e-7424d75b5201" xlink:to="loc_bmy_NetproductsalesMember_defc1b63-b9df-442f-936d-4efaf2813f19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_b131cb6e-abe7-4bf5-a4a0-5f7b9e3b805a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_aae35f3c-c52d-4003-a23e-7424d75b5201" xlink:to="loc_us-gaap_CollaborativeArrangementMember_b131cb6e-abe7-4bf5-a4a0-5f7b9e3b805a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_72822373-0069-49f4-9f7f-f30aa0ffa5ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_5547e198-cab2-4a2b-ac6e-1b2c355dfdf9" xlink:to="loc_us-gaap_TypeOfArrangementAxis_72822373-0069-49f4-9f7f-f30aa0ffa5ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_72822373-0069-49f4-9f7f-f30aa0ffa5ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_72822373-0069-49f4-9f7f-f30aa0ffa5ad" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_72822373-0069-49f4-9f7f-f30aa0ffa5ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_dc87dc9b-f1ec-4c1a-96a9-2cebcc632ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_72822373-0069-49f4-9f7f-f30aa0ffa5ad" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_dc87dc9b-f1ec-4c1a-96a9-2cebcc632ca7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_2c9b3363-7de4-4be6-bec5-c9d3d9b1a667" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_dc87dc9b-f1ec-4c1a-96a9-2cebcc632ca7" xlink:to="loc_us-gaap_CollaborativeArrangementMember_2c9b3363-7de4-4be6-bec5-c9d3d9b1a667" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AlliancesAndCollaborationCompaniesAxis_7161cb13-730a-48f9-a5cf-5c530a024ded" xlink:href="bmy-20210630.xsd#bmy_AlliancesAndCollaborationCompaniesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_5547e198-cab2-4a2b-ac6e-1b2c355dfdf9" xlink:to="loc_bmy_AlliancesAndCollaborationCompaniesAxis_7161cb13-730a-48f9-a5cf-5c530a024ded" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AlliancesAndCollaborationCompaniesDomain_7161cb13-730a-48f9-a5cf-5c530a024ded_default" xlink:href="bmy-20210630.xsd#bmy_AlliancesAndCollaborationCompaniesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bmy_AlliancesAndCollaborationCompaniesAxis_7161cb13-730a-48f9-a5cf-5c530a024ded" xlink:to="loc_bmy_AlliancesAndCollaborationCompaniesDomain_7161cb13-730a-48f9-a5cf-5c530a024ded_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AlliancesAndCollaborationCompaniesDomain_c7102526-911f-4dbf-a7b2-82ff3d99e6e2" xlink:href="bmy-20210630.xsd#bmy_AlliancesAndCollaborationCompaniesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bmy_AlliancesAndCollaborationCompaniesAxis_7161cb13-730a-48f9-a5cf-5c530a024ded" xlink:to="loc_bmy_AlliancesAndCollaborationCompaniesDomain_c7102526-911f-4dbf-a7b2-82ff3d99e6e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EisaiMember_8b7df725-c9c5-4f3e-a4be-d2f9ecfe4ccd" xlink:href="bmy-20210630.xsd#bmy_EisaiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_AlliancesAndCollaborationCompaniesDomain_c7102526-911f-4dbf-a7b2-82ff3d99e6e2" xlink:to="loc_bmy_EisaiMember_8b7df725-c9c5-4f3e-a4be-d2f9ecfe4ccd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/ACQUISITIONSDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#ACQUISITIONSDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/ACQUISITIONSDetails" xlink:type="extended" id="i7ba244ed84354fabaf42bfea3cc009e5_ACQUISITIONSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_2c99896c-9e5b-4614-a6c9-20c817487ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_93151de5-c39e-43b7-8087-9065c1a40980" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_2c99896c-9e5b-4614-a6c9-20c817487ce7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_93151de5-c39e-43b7-8087-9065c1a40980" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AssetAcquisitionNameAxis_f60b4873-8e36-4c0c-9e71-b2534f2a01f1" xlink:href="bmy-20210630.xsd#bmy_AssetAcquisitionNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_93151de5-c39e-43b7-8087-9065c1a40980" xlink:to="loc_bmy_AssetAcquisitionNameAxis_f60b4873-8e36-4c0c-9e71-b2534f2a01f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AssetAcquisitionNameDomain_f60b4873-8e36-4c0c-9e71-b2534f2a01f1_default" xlink:href="bmy-20210630.xsd#bmy_AssetAcquisitionNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bmy_AssetAcquisitionNameAxis_f60b4873-8e36-4c0c-9e71-b2534f2a01f1" xlink:to="loc_bmy_AssetAcquisitionNameDomain_f60b4873-8e36-4c0c-9e71-b2534f2a01f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AssetAcquisitionNameDomain_b5a026ce-9fde-4723-9ed3-d7c9ded565c2" xlink:href="bmy-20210630.xsd#bmy_AssetAcquisitionNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bmy_AssetAcquisitionNameAxis_f60b4873-8e36-4c0c-9e71-b2534f2a01f1" xlink:to="loc_bmy_AssetAcquisitionNameDomain_b5a026ce-9fde-4723-9ed3-d7c9ded565c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_5fb3154f-e1a4-4c1a-8240-af697aeb318b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_93151de5-c39e-43b7-8087-9065c1a40980" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_5fb3154f-e1a4-4c1a-8240-af697aeb318b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5fb3154f-e1a4-4c1a-8240-af697aeb318b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5fb3154f-e1a4-4c1a-8240-af697aeb318b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5fb3154f-e1a4-4c1a-8240-af697aeb318b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f4765eee-9a41-48f8-a9b8-cdb6f05c27e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5fb3154f-e1a4-4c1a-8240-af697aeb318b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f4765eee-9a41-48f8-a9b8-cdb6f05c27e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4a5518f9-b3e3-4a34-9a9c-5a38ec154a95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f4765eee-9a41-48f8-a9b8-cdb6f05c27e7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4a5518f9-b3e3-4a34-9a9c-5a38ec154a95" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVESTITURESDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#DIVESTITURESDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/DIVESTITURESDetails" xlink:type="extended" id="ia67d2acd06764615976f7abb410f9148_DIVESTITURESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_55ed20c7-0cd6-4ad7-aa14-063d350fb7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_d1d9b5b9-e60b-4495-9d65-008918fe3035" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_55ed20c7-0cd6-4ad7-aa14-063d350fb7bc" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_d1d9b5b9-e60b-4495-9d65-008918fe3035" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_553ab3c8-50b3-4b3a-b372-d0727e219182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_55ed20c7-0cd6-4ad7-aa14-063d350fb7bc" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_553ab3c8-50b3-4b3a-b372-d0727e219182" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyIncomeNonoperating_c51b40a3-b534-462f-95c7-b30dd9238ace" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyIncomeNonoperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_55ed20c7-0cd6-4ad7-aa14-063d350fb7bc" xlink:to="loc_us-gaap_RoyaltyIncomeNonoperating_c51b40a3-b534-462f-95c7-b30dd9238ace" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_43c8ccc7-51f0-4063-afaa-e5d9ce3b301a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_55ed20c7-0cd6-4ad7-aa14-063d350fb7bc" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_43c8ccc7-51f0-4063-afaa-e5d9ce3b301a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b073f0f4-ff74-40c4-a358-f445b3b2b96b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_43c8ccc7-51f0-4063-afaa-e5d9ce3b301a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b073f0f4-ff74-40c4-a358-f445b3b2b96b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b073f0f4-ff74-40c4-a358-f445b3b2b96b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b073f0f4-ff74-40c4-a358-f445b3b2b96b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b073f0f4-ff74-40c4-a358-f445b3b2b96b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e41bfe02-ac76-4c78-bc11-72c63237293e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b073f0f4-ff74-40c4-a358-f445b3b2b96b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e41bfe02-ac76-4c78-bc11-72c63237293e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DiabetesbusinessMember_096e7962-f800-40c3-8bb8-68837845f610" xlink:href="bmy-20210630.xsd#bmy_DiabetesbusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e41bfe02-ac76-4c78-bc11-72c63237293e" xlink:to="loc_bmy_DiabetesbusinessMember_096e7962-f800-40c3-8bb8-68837845f610" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ErbituxBusinessMember_c7146add-e23c-42f0-9be3-e4e7005e1455" xlink:href="bmy-20210630.xsd#bmy_ErbituxBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e41bfe02-ac76-4c78-bc11-72c63237293e" xlink:to="loc_bmy_ErbituxBusinessMember_c7146add-e23c-42f0-9be3-e4e7005e1455" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManufacturingFacilityMember_c33d5902-1bd6-4036-b5e5-14aae2e25dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ManufacturingFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e41bfe02-ac76-4c78-bc11-72c63237293e" xlink:to="loc_us-gaap_ManufacturingFacilityMember_c33d5902-1bd6-4036-b5e5-14aae2e25dd7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AvaproAvalideAndPlavixMember_100f0499-2945-4c72-9aee-b137d1096e21" xlink:href="bmy-20210630.xsd#bmy_AvaproAvalideAndPlavixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e41bfe02-ac76-4c78-bc11-72c63237293e" xlink:to="loc_bmy_AvaproAvalideAndPlavixMember_100f0499-2945-4c72-9aee-b137d1096e21" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureBrandsAndOtherMember_35f8b2ea-2984-43ec-a92b-0d66480f6172" xlink:href="bmy-20210630.xsd#bmy_MatureBrandsAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e41bfe02-ac76-4c78-bc11-72c63237293e" xlink:to="loc_bmy_MatureBrandsAndOtherMember_35f8b2ea-2984-43ec-a92b-0d66480f6172" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#LICENSINGANDOTHERARRANGEMENTSDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails" xlink:type="extended" id="icd99c690534c40198f2654364068a39f_LICENSINGANDOTHERARRANGEMENTSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsLineItems_795b02e3-46d5-4a16-9234-1ce7a85c6fec" xlink:href="bmy-20210630.xsd#bmy_LicensingArrangementsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyIncomeNonoperating_3c5e8b60-d2ad-4885-a390-eba206e44eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyIncomeNonoperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_795b02e3-46d5-4a16-9234-1ce7a85c6fec" xlink:to="loc_us-gaap_RoyaltyIncomeNonoperating_3c5e8b60-d2ad-4885-a390-eba206e44eaf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_UpFrontLicensingFee_d2f7254d-fe20-4ac5-bbad-9b7843ac4d8e" xlink:href="bmy-20210630.xsd#bmy_UpFrontLicensingFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_795b02e3-46d5-4a16-9234-1ce7a85c6fec" xlink:to="loc_bmy_UpFrontLicensingFee_d2f7254d-fe20-4ac5-bbad-9b7843ac4d8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentRegulatoryMilestoneIncome_c5170f49-ea3d-4cd9-bcfe-b6e387637711" xlink:href="bmy-20210630.xsd#bmy_ContingentRegulatoryMilestoneIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_795b02e3-46d5-4a16-9234-1ce7a85c6fec" xlink:to="loc_bmy_ContingentRegulatoryMilestoneIncome_c5170f49-ea3d-4cd9-bcfe-b6e387637711" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges_edc30002-a900-41fc-9ac2-5c38be55e1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_795b02e3-46d5-4a16-9234-1ce7a85c6fec" xlink:to="loc_us-gaap_OtherAmortizationOfDeferredCharges_edc30002-a900-41fc-9ac2-5c38be55e1e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsIncome_e9808bc7-ba00-407d-8e05-23837c15f1b9" xlink:href="bmy-20210630.xsd#bmy_LicensingAndOtherArrangementsIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_795b02e3-46d5-4a16-9234-1ce7a85c6fec" xlink:to="loc_bmy_LicensingAndOtherArrangementsIncome_e9808bc7-ba00-407d-8e05-23837c15f1b9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments_a737105f-6b8b-47b4-9f2d-6de7da263814" xlink:href="bmy-20210630.xsd#bmy_LicenseAndOtherArrangementsUpfrontPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_795b02e3-46d5-4a16-9234-1ce7a85c6fec" xlink:to="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments_a737105f-6b8b-47b4-9f2d-6de7da263814" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentAndRegulatoryMilestonePayments_63df6bd5-279c-4aaa-b6d3-b21e95c16484" xlink:href="bmy-20210630.xsd#bmy_ContingentAndRegulatoryMilestonePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingArrangementsLineItems_795b02e3-46d5-4a16-9234-1ce7a85c6fec" xlink:to="loc_bmy_ContingentAndRegulatoryMilestonePayments_63df6bd5-279c-4aaa-b6d3-b21e95c16484" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsTable_95ec0da2-a640-47ca-91bb-98ecc309c85e" xlink:href="bmy-20210630.xsd#bmy_LicensingArrangementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bmy_LicensingArrangementsLineItems_795b02e3-46d5-4a16-9234-1ce7a85c6fec" xlink:to="loc_bmy_LicensingArrangementsTable_95ec0da2-a640-47ca-91bb-98ecc309c85e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingCompaniesAxis_67104d4d-4702-4187-8f20-acf40d15626e" xlink:href="bmy-20210630.xsd#bmy_LicensingCompaniesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LicensingArrangementsTable_95ec0da2-a640-47ca-91bb-98ecc309c85e" xlink:to="loc_bmy_LicensingCompaniesAxis_67104d4d-4702-4187-8f20-acf40d15626e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingCompaniesDomain_67104d4d-4702-4187-8f20-acf40d15626e_default" xlink:href="bmy-20210630.xsd#bmy_LicensingCompaniesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bmy_LicensingCompaniesAxis_67104d4d-4702-4187-8f20-acf40d15626e" xlink:to="loc_bmy_LicensingCompaniesDomain_67104d4d-4702-4187-8f20-acf40d15626e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingCompaniesDomain_3292f56c-da3c-4724-b007-f3f3e58ee459" xlink:href="bmy-20210630.xsd#bmy_LicensingCompaniesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bmy_LicensingCompaniesAxis_67104d4d-4702-4187-8f20-acf40d15626e" xlink:to="loc_bmy_LicensingCompaniesDomain_3292f56c-da3c-4724-b007-f3f3e58ee459" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b2f3ff98-f101-4030-9209-320abb6a960f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LicensingArrangementsTable_95ec0da2-a640-47ca-91bb-98ecc309c85e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b2f3ff98-f101-4030-9209-320abb6a960f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b2f3ff98-f101-4030-9209-320abb6a960f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b2f3ff98-f101-4030-9209-320abb6a960f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b2f3ff98-f101-4030-9209-320abb6a960f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f2b8882f-6724-4476-b6cf-4c8437dbf93a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b2f3ff98-f101-4030-9209-320abb6a960f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f2b8882f-6724-4476-b6cf-4c8437dbf93a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DiabetesbusinessMember_be950550-c1ac-47a8-a7b3-15ce0c26d9de" xlink:href="bmy-20210630.xsd#bmy_DiabetesbusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f2b8882f-6724-4476-b6cf-4c8437dbf93a" xlink:to="loc_bmy_DiabetesbusinessMember_be950550-c1ac-47a8-a7b3-15ce0c26d9de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsAxis_fd36d03e-191e-472d-b773-cc7ce6573d84" xlink:href="bmy-20210630.xsd#bmy_LicensingAndOtherArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LicensingArrangementsTable_95ec0da2-a640-47ca-91bb-98ecc309c85e" xlink:to="loc_bmy_LicensingAndOtherArrangementsAxis_fd36d03e-191e-472d-b773-cc7ce6573d84" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsDomain_fd36d03e-191e-472d-b773-cc7ce6573d84_default" xlink:href="bmy-20210630.xsd#bmy_LicensingAndOtherArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bmy_LicensingAndOtherArrangementsAxis_fd36d03e-191e-472d-b773-cc7ce6573d84" xlink:to="loc_bmy_LicensingAndOtherArrangementsDomain_fd36d03e-191e-472d-b773-cc7ce6573d84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsDomain_cb4c5f1b-c489-4e61-b2be-b81eb2fa22ac" xlink:href="bmy-20210630.xsd#bmy_LicensingAndOtherArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bmy_LicensingAndOtherArrangementsAxis_fd36d03e-191e-472d-b773-cc7ce6573d84" xlink:to="loc_bmy_LicensingAndOtherArrangementsDomain_cb4c5f1b-c489-4e61-b2be-b81eb2fa22ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRoyaltiesMember_43bd32e8-19ed-44b2-bddc-7c3fb111e393" xlink:href="bmy-20210630.xsd#bmy_OtherRoyaltiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_cb4c5f1b-c489-4e61-b2be-b81eb2fa22ac" xlink:to="loc_bmy_OtherRoyaltiesMember_43bd32e8-19ed-44b2-bddc-7c3fb111e393" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_KeytrudaRoyaltiesMember_f4f50464-0547-4bdb-80d5-200d6fb49e55" xlink:href="bmy-20210630.xsd#bmy_KeytrudaRoyaltiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_cb4c5f1b-c489-4e61-b2be-b81eb2fa22ac" xlink:to="loc_bmy_KeytrudaRoyaltiesMember_f4f50464-0547-4bdb-80d5-200d6fb49e55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_TecentriqRoyaltiesMember_6c19a46e-a48a-4402-91ca-9f3d8adc915f" xlink:href="bmy-20210630.xsd#bmy_TecentriqRoyaltiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_cb4c5f1b-c489-4e61-b2be-b81eb2fa22ac" xlink:to="loc_bmy_TecentriqRoyaltiesMember_6c19a46e-a48a-4402-91ca-9f3d8adc915f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_0a8e888d-8dbf-49f3-804c-df8f84472f34" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LicensingArrangementsTable_95ec0da2-a640-47ca-91bb-98ecc309c85e" xlink:to="loc_srt_CounterpartyNameAxis_0a8e888d-8dbf-49f3-804c-df8f84472f34" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0a8e888d-8dbf-49f3-804c-df8f84472f34_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_0a8e888d-8dbf-49f3-804c-df8f84472f34" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0a8e888d-8dbf-49f3-804c-df8f84472f34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4777ef4b-a91f-4b85-9fc0-a9dc525713fa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_0a8e888d-8dbf-49f3-804c-df8f84472f34" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4777ef4b-a91f-4b85-9fc0-a9dc525713fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AgenusMember_648d8e13-784f-4462-9a09-088062da6dc4" xlink:href="bmy-20210630.xsd#bmy_AgenusMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4777ef4b-a91f-4b85-9fc0-a9dc525713fa" xlink:to="loc_bmy_AgenusMember_648d8e13-784f-4462-9a09-088062da6dc4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGTables" xlink:type="simple" xlink:href="bmy-20210630.xsd#RESTRUCTURINGTables"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/RESTRUCTURINGTables" xlink:type="extended" id="i9518dec97e3c4a35b6d672a8a8735aae_RESTRUCTURINGTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_047c5fc4-f5ba-41fc-bd64-5ea76ccff9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_c64f2012-c156-4ddf-9d54-d0b2e58c706e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_047c5fc4-f5ba-41fc-bd64-5ea76ccff9ba" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_c64f2012-c156-4ddf-9d54-d0b2e58c706e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_9d675a91-1ad1-4505-bac6-d6555de0e218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_047c5fc4-f5ba-41fc-bd64-5ea76ccff9ba" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_9d675a91-1ad1-4505-bac6-d6555de0e218" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1e0fc346-9301-44e7-8b47-046ddeb5c5f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_047c5fc4-f5ba-41fc-bd64-5ea76ccff9ba" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1e0fc346-9301-44e7-8b47-046ddeb5c5f3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_4f049d01-87ca-4984-ac20-fc22e282366f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1e0fc346-9301-44e7-8b47-046ddeb5c5f3" xlink:to="loc_us-gaap_RestructuringPlanAxis_4f049d01-87ca-4984-ac20-fc22e282366f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_4f049d01-87ca-4984-ac20-fc22e282366f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_4f049d01-87ca-4984-ac20-fc22e282366f" xlink:to="loc_us-gaap_RestructuringPlanDomain_4f049d01-87ca-4984-ac20-fc22e282366f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_092c1137-17de-4d35-856a-52d653b4feab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_4f049d01-87ca-4984-ac20-fc22e282366f" xlink:to="loc_us-gaap_RestructuringPlanDomain_092c1137-17de-4d35-856a-52d653b4feab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_c65f41ad-52af-45b4-b335-91ddfd973085" xlink:href="bmy-20210630.xsd#bmy_CelgeneIntegrationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_092c1137-17de-4d35-856a-52d653b4feab" xlink:to="loc_bmy_CelgeneIntegrationMember_c65f41ad-52af-45b4-b335-91ddfd973085" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CompanyTransformationMember_b0922fef-318c-4d62-bb5a-2cbade0c7c92" xlink:href="bmy-20210630.xsd#bmy_CompanyTransformationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_092c1137-17de-4d35-856a-52d653b4feab" xlink:to="loc_bmy_CompanyTransformationMember_b0922fef-318c-4d62-bb5a-2cbade0c7c92" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGNARRATIVEDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#RESTRUCTURINGNARRATIVEDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/RESTRUCTURINGNARRATIVEDetails" xlink:type="extended" id="i5c399e6809274f978c2e50015e26f472_RESTRUCTURINGNARRATIVEDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_7ed525e9-9643-4429-9d94-02daf6e0457f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_f6fba430-c2d7-4d55-bfb3-f815df07992c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7ed525e9-9643-4429-9d94-02daf6e0457f" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_f6fba430-c2d7-4d55-bfb3-f815df07992c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_732a068b-ccaf-488a-b48a-87230483c4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7ed525e9-9643-4429-9d94-02daf6e0457f" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_732a068b-ccaf-488a-b48a-87230483c4a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Cashoutlays_dab006ef-36f8-4d15-a0d6-cbb14cb8c5c8" xlink:href="bmy-20210630.xsd#bmy_Cashoutlays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7ed525e9-9643-4429-9d94-02daf6e0457f" xlink:to="loc_bmy_Cashoutlays_dab006ef-36f8-4d15-a0d6-cbb14cb8c5c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_a721a124-17d5-48a8-81e3-79336629b637" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7ed525e9-9643-4429-9d94-02daf6e0457f" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_a721a124-17d5-48a8-81e3-79336629b637" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7f11554a-4179-48f0-a6c7-2601ac8ff7b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7ed525e9-9643-4429-9d94-02daf6e0457f" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7f11554a-4179-48f0-a6c7-2601ac8ff7b7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_7950e2f0-daf3-494a-bde8-58e3c05e63ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7f11554a-4179-48f0-a6c7-2601ac8ff7b7" xlink:to="loc_us-gaap_RestructuringPlanAxis_7950e2f0-daf3-494a-bde8-58e3c05e63ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_7950e2f0-daf3-494a-bde8-58e3c05e63ca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_7950e2f0-daf3-494a-bde8-58e3c05e63ca" xlink:to="loc_us-gaap_RestructuringPlanDomain_7950e2f0-daf3-494a-bde8-58e3c05e63ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_cd7eae2d-ed03-42c4-bd0c-43c4aaf17098" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_7950e2f0-daf3-494a-bde8-58e3c05e63ca" xlink:to="loc_us-gaap_RestructuringPlanDomain_cd7eae2d-ed03-42c4-bd0c-43c4aaf17098" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_03b37401-742a-467e-8ba9-cef4a6e60ad9" xlink:href="bmy-20210630.xsd#bmy_CelgeneIntegrationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_cd7eae2d-ed03-42c4-bd0c-43c4aaf17098" xlink:to="loc_bmy_CelgeneIntegrationMember_03b37401-742a-467e-8ba9-cef4a6e60ad9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MyoKardiaAcquisitionPlanMember_613cae79-c747-41f4-98a3-0a94fd7b859a" xlink:href="bmy-20210630.xsd#bmy_MyoKardiaAcquisitionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_cd7eae2d-ed03-42c4-bd0c-43c4aaf17098" xlink:to="loc_bmy_MyoKardiaAcquisitionPlanMember_613cae79-c747-41f4-98a3-0a94fd7b859a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CompanyTransformationMember_9405daee-7357-42cc-afab-417dbd7d07e1" xlink:href="bmy-20210630.xsd#bmy_CompanyTransformationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_cd7eae2d-ed03-42c4-bd0c-43c4aaf17098" xlink:to="loc_bmy_CompanyTransformationMember_9405daee-7357-42cc-afab-417dbd7d07e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_47c57858-0c34-4cb1-a909-81f8a6b031c8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7f11554a-4179-48f0-a6c7-2601ac8ff7b7" xlink:to="loc_srt_RangeAxis_47c57858-0c34-4cb1-a909-81f8a6b031c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_47c57858-0c34-4cb1-a909-81f8a6b031c8_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_47c57858-0c34-4cb1-a909-81f8a6b031c8" xlink:to="loc_srt_RangeMember_47c57858-0c34-4cb1-a909-81f8a6b031c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1b2e6d80-a9ee-45d9-9b3b-ed7f6ae2a971" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_47c57858-0c34-4cb1-a909-81f8a6b031c8" xlink:to="loc_srt_RangeMember_1b2e6d80-a9ee-45d9-9b3b-ed7f6ae2a971" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9df30c9a-2733-4579-954b-acca0862d3fe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1b2e6d80-a9ee-45d9-9b3b-ed7f6ae2a971" xlink:to="loc_srt_MinimumMember_9df30c9a-2733-4579-954b-acca0862d3fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1f9f3fac-afbd-4876-93d8-c6deeb47d7fc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1b2e6d80-a9ee-45d9-9b3b-ed7f6ae2a971" xlink:to="loc_srt_MaximumMember_1f9f3fac-afbd-4876-93d8-c6deeb47d7fc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails" xlink:type="extended" id="ieb526d94f420452294823dde4ef9dcd0_RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_4ed71245-328c-45ca-b135-8a410efd6774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_d2d9cf93-59fe-4ce2-8308-ae9309615428" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4ed71245-328c-45ca-b135-8a410efd6774" xlink:to="loc_us-gaap_SeveranceCosts1_d2d9cf93-59fe-4ce2-8308-ae9309615428" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_eb2c563f-37cd-420e-a189-7e546912791c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4ed71245-328c-45ca-b135-8a410efd6774" xlink:to="loc_us-gaap_OtherRestructuringCosts_eb2c563f-37cd-420e-a189-7e546912791c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_854a05d2-13ff-450f-861a-d763203113e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4ed71245-328c-45ca-b135-8a410efd6774" xlink:to="loc_us-gaap_RestructuringCharges_854a05d2-13ff-450f-861a-d763203113e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_cad9b69d-dfe7-4c28-b751-fa64905fa5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4ed71245-328c-45ca-b135-8a410efd6774" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_cad9b69d-dfe7-4c28-b751-fa64905fa5dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_186bd4e6-d8f0-4035-9896-072ab527a7de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveAcceleratedDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4ed71245-328c-45ca-b135-8a410efd6774" xlink:to="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_186bd4e6-d8f0-4035-9896-072ab527a7de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringRelatedCostsAssetImpairments_7fd03045-0aec-4ba2-8643-662c58e64e20" xlink:href="bmy-20210630.xsd#bmy_RestructuringRelatedCostsAssetImpairments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4ed71245-328c-45ca-b135-8a410efd6774" xlink:to="loc_bmy_RestructuringRelatedCostsAssetImpairments_7fd03045-0aec-4ba2-8643-662c58e64e20" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherShutdownCosts_a019252f-07cc-447b-b13f-e192cf42e988" xlink:href="bmy-20210630.xsd#bmy_OtherShutdownCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4ed71245-328c-45ca-b135-8a410efd6774" xlink:to="loc_bmy_OtherShutdownCosts_a019252f-07cc-447b-b13f-e192cf42e988" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_145dd48f-30ca-44e3-b6db-b90ebb18c070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4ed71245-328c-45ca-b135-8a410efd6774" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_145dd48f-30ca-44e3-b6db-b90ebb18c070" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_478f57bf-4854-41d5-9532-f3c864ccd906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4ed71245-328c-45ca-b135-8a410efd6774" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_478f57bf-4854-41d5-9532-f3c864ccd906" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_8ace93f1-8c97-45bf-9d09-9f1fc74f9f27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_478f57bf-4854-41d5-9532-f3c864ccd906" xlink:to="loc_us-gaap_RestructuringPlanAxis_8ace93f1-8c97-45bf-9d09-9f1fc74f9f27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_8ace93f1-8c97-45bf-9d09-9f1fc74f9f27_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_8ace93f1-8c97-45bf-9d09-9f1fc74f9f27" xlink:to="loc_us-gaap_RestructuringPlanDomain_8ace93f1-8c97-45bf-9d09-9f1fc74f9f27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_8871a114-276b-42fa-9ad2-ce57fe5c8556" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_8ace93f1-8c97-45bf-9d09-9f1fc74f9f27" xlink:to="loc_us-gaap_RestructuringPlanDomain_8871a114-276b-42fa-9ad2-ce57fe5c8556" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_833bcf63-60e2-4017-b244-e656776fc25b" xlink:href="bmy-20210630.xsd#bmy_CelgeneIntegrationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_8871a114-276b-42fa-9ad2-ce57fe5c8556" xlink:to="loc_bmy_CelgeneIntegrationMember_833bcf63-60e2-4017-b244-e656776fc25b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MyoKardiaAcquisitionPlanMember_d36a4ac0-1f2e-4a8a-b2f4-d6efedfb51f1" xlink:href="bmy-20210630.xsd#bmy_MyoKardiaAcquisitionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_8871a114-276b-42fa-9ad2-ce57fe5c8556" xlink:to="loc_bmy_MyoKardiaAcquisitionPlanMember_d36a4ac0-1f2e-4a8a-b2f4-d6efedfb51f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CompanyTransformationMember_20f92ec8-4b45-4418-94ac-12794d88c015" xlink:href="bmy-20210630.xsd#bmy_CompanyTransformationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_8871a114-276b-42fa-9ad2-ce57fe5c8556" xlink:to="loc_bmy_CompanyTransformationMember_20f92ec8-4b45-4418-94ac-12794d88c015" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_414d4c55-6b09-44c3-b7fa-d0dfc6981089" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_478f57bf-4854-41d5-9532-f3c864ccd906" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_414d4c55-6b09-44c3-b7fa-d0dfc6981089" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_414d4c55-6b09-44c3-b7fa-d0dfc6981089_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_414d4c55-6b09-44c3-b7fa-d0dfc6981089" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_414d4c55-6b09-44c3-b7fa-d0dfc6981089_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_47690492-b871-435c-9ad8-ee88ef4c9821" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_414d4c55-6b09-44c3-b7fa-d0dfc6981089" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_47690492-b871-435c-9ad8-ee88ef4c9821" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_da5f4ff4-2e5c-4d4b-8bbf-d5d5fbf5a6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_47690492-b871-435c-9ad8-ee88ef4c9821" xlink:to="loc_us-gaap_CostOfSalesMember_da5f4ff4-2e5c-4d4b-8bbf-d5d5fbf5a6fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_4fa366ec-8f06-43e9-9a48-0d1e49e5653e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_47690492-b871-435c-9ad8-ee88ef4c9821" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_4fa366ec-8f06-43e9-9a48-0d1e49e5653e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_bc1a5768-d230-46b6-a6f7-a710d62dcfa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_47690492-b871-435c-9ad8-ee88ef4c9821" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_bc1a5768-d230-46b6-a6f7-a710d62dcfa9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_8a8d8d8f-37b1-49d3-9e2e-dbc0b9843123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_47690492-b871-435c-9ad8-ee88ef4c9821" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_8a8d8d8f-37b1-49d3-9e2e-dbc0b9843123" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails" xlink:type="extended" id="if5ef9767e9344cd7ad846faf12abd228_RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5638b829-60c5-47b9-a69a-42d3f7469dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_7140cb0e-5d93-49f7-bea7-c371b0d2cbe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5638b829-60c5-47b9-a69a-42d3f7469dbd" xlink:to="loc_us-gaap_RestructuringReserve_7140cb0e-5d93-49f7-bea7-c371b0d2cbe7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_43304ada-a865-44fd-86aa-90da2f73774e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5638b829-60c5-47b9-a69a-42d3f7469dbd" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_43304ada-a865-44fd-86aa-90da2f73774e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_8d5cbb85-d862-4c7c-b34d-0970bbb40fd1" xlink:href="bmy-20210630.xsd#bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5638b829-60c5-47b9-a69a-42d3f7469dbd" xlink:to="loc_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_8d5cbb85-d862-4c7c-b34d-0970bbb40fd1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_5586770f-2530-474b-a969-b7281afeaab4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5638b829-60c5-47b9-a69a-42d3f7469dbd" xlink:to="loc_us-gaap_RestructuringCharges_5586770f-2530-474b-a969-b7281afeaab4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_f87ac26d-054e-429d-9884-40f6b34fe9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5638b829-60c5-47b9-a69a-42d3f7469dbd" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_f87ac26d-054e-429d-9884-40f6b34fe9e3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_0b5aee10-d5e1-4658-bafa-a840822886a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5638b829-60c5-47b9-a69a-42d3f7469dbd" xlink:to="loc_us-gaap_PaymentsForRestructuring_0b5aee10-d5e1-4658-bafa-a840822886a8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d173a0bd-413f-4469-8248-e2e75c83921a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5638b829-60c5-47b9-a69a-42d3f7469dbd" xlink:to="loc_us-gaap_StatementTable_d173a0bd-413f-4469-8248-e2e75c83921a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_e6ec63be-c34d-4429-ab54-c4201c4dd2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_d173a0bd-413f-4469-8248-e2e75c83921a" xlink:to="loc_us-gaap_RestructuringPlanAxis_e6ec63be-c34d-4429-ab54-c4201c4dd2ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_e6ec63be-c34d-4429-ab54-c4201c4dd2ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_e6ec63be-c34d-4429-ab54-c4201c4dd2ad" xlink:to="loc_us-gaap_RestructuringPlanDomain_e6ec63be-c34d-4429-ab54-c4201c4dd2ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_bb288beb-f301-4466-9e35-22becb10a016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_e6ec63be-c34d-4429-ab54-c4201c4dd2ad" xlink:to="loc_us-gaap_RestructuringPlanDomain_bb288beb-f301-4466-9e35-22becb10a016" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_1de3554c-5fb5-4553-b5a5-0496775adfd9" xlink:href="bmy-20210630.xsd#bmy_CelgeneIntegrationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_bb288beb-f301-4466-9e35-22becb10a016" xlink:to="loc_bmy_CelgeneIntegrationMember_1de3554c-5fb5-4553-b5a5-0496775adfd9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CompanyTransformationMember_ccd3d6d0-367f-411e-aeda-a0e16064b588" xlink:href="bmy-20210630.xsd#bmy_CompanyTransformationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_bb288beb-f301-4466-9e35-22becb10a016" xlink:to="loc_bmy_CompanyTransformationMember_ccd3d6d0-367f-411e-aeda-a0e16064b588" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_6926d2d7-9b9e-4e00-bb9d-721328764c28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_d173a0bd-413f-4469-8248-e2e75c83921a" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_6926d2d7-9b9e-4e00-bb9d-721328764c28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_6926d2d7-9b9e-4e00-bb9d-721328764c28_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_6926d2d7-9b9e-4e00-bb9d-721328764c28" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_6926d2d7-9b9e-4e00-bb9d-721328764c28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_5c007907-30e5-4f11-a83a-ecb59caf70eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_6926d2d7-9b9e-4e00-bb9d-721328764c28" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_5c007907-30e5-4f11-a83a-ecb59caf70eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcceleratedStockBasedCompensationMember_6a7e473a-31a1-47a3-bcd0-c6dc62820281" xlink:href="bmy-20210630.xsd#bmy_AcceleratedStockBasedCompensationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_5c007907-30e5-4f11-a83a-ecb59caf70eb" xlink:to="loc_bmy_AcceleratedStockBasedCompensationMember_6a7e473a-31a1-47a3-bcd0-c6dc62820281" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#INCOMETAXESDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/INCOMETAXESDetails" xlink:type="extended" id="i38759d3d8a814645bec58b173d94d7a0_INCOMETAXESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_0607c744-16ce-47fe-bde4-1b558a1f19ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_9af121b1-449a-4b81-b01f-64e0e3d0954c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_0607c744-16ce-47fe-bde4-1b558a1f19ee" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_9af121b1-449a-4b81-b01f-64e0e3d0954c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_63f994a4-61d0-4a0e-a855-187c57913bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_0607c744-16ce-47fe-bde4-1b558a1f19ee" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_63f994a4-61d0-4a0e-a855-187c57913bd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_10ebebc3-2723-42df-b2c0-580683cce317" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_0607c744-16ce-47fe-bde4-1b558a1f19ee" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_10ebebc3-2723-42df-b2c0-580683cce317" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_78b73f99-4160-4010-a754-12de7efa386b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_0607c744-16ce-47fe-bde4-1b558a1f19ee" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_78b73f99-4160-4010-a754-12de7efa386b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7123c666-7021-4e49-ba25-5f8d076fa1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_0607c744-16ce-47fe-bde4-1b558a1f19ee" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7123c666-7021-4e49-ba25-5f8d076fa1dc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_aae05100-1e58-4339-8cfb-f0250aea9ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_0607c744-16ce-47fe-bde4-1b558a1f19ee" xlink:to="loc_us-gaap_StatementTable_aae05100-1e58-4339-8cfb-f0250aea9ffb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a1c27900-a75c-4d50-bef8-bcd8532c0141" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_aae05100-1e58-4339-8cfb-f0250aea9ffb" xlink:to="loc_srt_RangeAxis_a1c27900-a75c-4d50-bef8-bcd8532c0141" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a1c27900-a75c-4d50-bef8-bcd8532c0141_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a1c27900-a75c-4d50-bef8-bcd8532c0141" xlink:to="loc_srt_RangeMember_a1c27900-a75c-4d50-bef8-bcd8532c0141_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4cf4601a-8239-4bf6-b6c1-604b4bcf6f97" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a1c27900-a75c-4d50-bef8-bcd8532c0141" xlink:to="loc_srt_RangeMember_4cf4601a-8239-4bf6-b6c1-604b4bcf6f97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7d5000ed-63e1-456e-9992-847d5ffbb110" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4cf4601a-8239-4bf6-b6c1-604b4bcf6f97" xlink:to="loc_srt_MinimumMember_7d5000ed-63e1-456e-9992-847d5ffbb110" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5b22c705-3a64-485a-8cd8-b7cfff7e9c1b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4cf4601a-8239-4bf6-b6c1-604b4bcf6f97" xlink:to="loc_srt_MaximumMember_5b22c705-3a64-485a-8cd8-b7cfff7e9c1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DeferredIncomeTaxExpenseBenefitComponentAxis_9bf69bbb-cd1f-4f99-98a1-177fb3a76249" xlink:href="bmy-20210630.xsd#bmy_DeferredIncomeTaxExpenseBenefitComponentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_aae05100-1e58-4339-8cfb-f0250aea9ffb" xlink:to="loc_bmy_DeferredIncomeTaxExpenseBenefitComponentAxis_9bf69bbb-cd1f-4f99-98a1-177fb3a76249" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DeferredIncomeTaxExpenseBenefitComponentDomain_9bf69bbb-cd1f-4f99-98a1-177fb3a76249_default" xlink:href="bmy-20210630.xsd#bmy_DeferredIncomeTaxExpenseBenefitComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bmy_DeferredIncomeTaxExpenseBenefitComponentAxis_9bf69bbb-cd1f-4f99-98a1-177fb3a76249" xlink:to="loc_bmy_DeferredIncomeTaxExpenseBenefitComponentDomain_9bf69bbb-cd1f-4f99-98a1-177fb3a76249_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DeferredIncomeTaxExpenseBenefitComponentDomain_ba28ac5f-6dfe-4963-9a2c-52ec6b911118" xlink:href="bmy-20210630.xsd#bmy_DeferredIncomeTaxExpenseBenefitComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bmy_DeferredIncomeTaxExpenseBenefitComponentAxis_9bf69bbb-cd1f-4f99-98a1-177fb3a76249" xlink:to="loc_bmy_DeferredIncomeTaxExpenseBenefitComponentDomain_ba28ac5f-6dfe-4963-9a2c-52ec6b911118" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InternalTransferOfProductRightsMember_0ce9b9de-29dc-4b26-ad28-88e049fff5a1" xlink:href="bmy-20210630.xsd#bmy_InternalTransferOfProductRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_DeferredIncomeTaxExpenseBenefitComponentDomain_ba28ac5f-6dfe-4963-9a2c-52ec6b911118" xlink:to="loc_bmy_InternalTransferOfProductRightsMember_0ce9b9de-29dc-4b26-ad28-88e049fff5a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtezlaDivestitureMember_d00eccb6-75b4-414c-8d5a-d88dffdf1113" xlink:href="bmy-20210630.xsd#bmy_OtezlaDivestitureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_DeferredIncomeTaxExpenseBenefitComponentDomain_ba28ac5f-6dfe-4963-9a2c-52ec6b911118" xlink:to="loc_bmy_OtezlaDivestitureMember_d00eccb6-75b4-414c-8d5a-d88dffdf1113" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IncomeTaxExpenseBenefitComponentAxis_d35e4e0f-db46-47db-bf31-dc5bcf6b82a1" xlink:href="bmy-20210630.xsd#bmy_IncomeTaxExpenseBenefitComponentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_aae05100-1e58-4339-8cfb-f0250aea9ffb" xlink:to="loc_bmy_IncomeTaxExpenseBenefitComponentAxis_d35e4e0f-db46-47db-bf31-dc5bcf6b82a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IncomeTaxExpenseBenefitComponentDomain_d35e4e0f-db46-47db-bf31-dc5bcf6b82a1_default" xlink:href="bmy-20210630.xsd#bmy_IncomeTaxExpenseBenefitComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bmy_IncomeTaxExpenseBenefitComponentAxis_d35e4e0f-db46-47db-bf31-dc5bcf6b82a1" xlink:to="loc_bmy_IncomeTaxExpenseBenefitComponentDomain_d35e4e0f-db46-47db-bf31-dc5bcf6b82a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IncomeTaxExpenseBenefitComponentDomain_4604c726-caf6-42e8-b089-a53b3c353279" xlink:href="bmy-20210630.xsd#bmy_IncomeTaxExpenseBenefitComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bmy_IncomeTaxExpenseBenefitComponentAxis_d35e4e0f-db46-47db-bf31-dc5bcf6b82a1" xlink:to="loc_bmy_IncomeTaxExpenseBenefitComponentDomain_4604c726-caf6-42e8-b089-a53b3c353279" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails" xlink:type="extended" id="i874cbef589a84303b258368bb8b15ed3_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_37fecfca-64a0-4df3-96dd-e9ec090724c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_37fecfca-64a0-4df3-96dd-e9ec090724c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_23034921-c424-4a04-82e1-44d401e53117" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_23034921-c424-4a04-82e1-44d401e53117" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_527cefc7-4731-4fa5-b7a7-82cedc3defce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_DerivativeAssets_527cefc7-4731-4fa5-b7a7-82cedc3defce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_fc9b5180-c068-4cc3-914e-707e6a49f54b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_fc9b5180-c068-4cc3-914e-707e6a49f54b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_9d3171eb-f52d-43bc-89a5-95639bab3030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_DerivativeLiabilities_9d3171eb-f52d-43bc-89a5-95639bab3030" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c2e4e408-c29c-4b30-ab49-90f2237bd9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c2e4e408-c29c-4b30-ab49-90f2237bd9c4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_686f4faa-dc45-4715-81cb-93cf65291086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_686f4faa-dc45-4715-81cb-93cf65291086" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange_c9d99b98-bbf1-4220-ac8d-2e2834710e31" xlink:href="bmy-20210630.xsd#bmy_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_bmy_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange_c9d99b98-bbf1-4220-ac8d-2e2834710e31" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMeasurementInput_672dd2a5-3f2d-464a-b2b1-bce1b54a6657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_DebtInstrumentMeasurementInput_672dd2a5-3f2d-464a-b2b1-bce1b54a6657" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_cd402dd7-5705-4919-bef8-1593cf669568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_cd402dd7-5705-4919-bef8-1593cf669568" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4beac689-838a-44f5-bb45-7c8f5a5659e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4beac689-838a-44f5-bb45-7c8f5a5659e2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_75467b36-09ec-4913-a516-8ae33ca5731e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_75467b36-09ec-4913-a516-8ae33ca5731e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_25cc29f8-7acf-4393-86a5-7e5cfe7b3c58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_25cc29f8-7acf-4393-86a5-7e5cfe7b3c58" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_fae32667-99df-44ac-98e2-130b2f8464ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_EquityMethodInvestments_fae32667-99df-44ac-98e2-130b2f8464ba" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_70cb2aaf-64a9-4f01-b537-ccc1a554b7f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_70cb2aaf-64a9-4f01-b537-ccc1a554b7f7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_13f599ee-e262-41cd-9d5d-6b4f060cd10c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_13f599ee-e262-41cd-9d5d-6b4f060cd10c" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_71c24b49-a239-4157-b2d5-6bb5b69e2ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_71c24b49-a239-4157-b2d5-6bb5b69e2ce5" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_14201ad3-95b0-4c0a-97be-87a45f4b5220" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_14201ad3-95b0-4c0a-97be-87a45f4b5220" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_2763501f-a695-46b1-a551-5059fe4cfd2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_2763501f-a695-46b1-a551-5059fe4cfd2a" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments_27829177-c768-4cfd-9129-00d10b3f34b6" xlink:href="bmy-20210630.xsd#bmy_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_bmy_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments_27829177-c768-4cfd-9129-00d10b3f34b6" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_2d3dd820-3607-42b4-a71c-1edff22eb07f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_2d3dd820-3607-42b4-a71c-1edff22eb07f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_423a9418-9eee-4ac4-849a-8d382e1a5086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_423a9418-9eee-4ac4-849a-8d382e1a5086" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_0206def4-244b-44a1-92c4-946422dfd585" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_0206def4-244b-44a1-92c4-946422dfd585" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_76fa45cc-704b-42c0-92ec-de83d450ea33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_76fa45cc-704b-42c0-92ec-de83d450ea33" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_aebbad68-1011-425d-a37f-541a0ce070ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_aebbad68-1011-425d-a37f-541a0ce070ab" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_5ad3df61-ffdb-4ced-a42a-96e713bdc71c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_5ad3df61-ffdb-4ced-a42a-96e713bdc71c" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_e224a277-43ff-4499-9178-517c76de4cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_e224a277-43ff-4499-9178-517c76de4cc2" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2484927a-de28-4c04-a9fa-f3d182f42155" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2484927a-de28-4c04-a9fa-f3d182f42155" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_dd15bd6e-4705-4b80-bb50-9d3a17229dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2484927a-de28-4c04-a9fa-f3d182f42155" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_dd15bd6e-4705-4b80-bb50-9d3a17229dc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_dd15bd6e-4705-4b80-bb50-9d3a17229dc0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_dd15bd6e-4705-4b80-bb50-9d3a17229dc0" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_dd15bd6e-4705-4b80-bb50-9d3a17229dc0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_e1bb9e4b-d552-4f0f-97ae-564e060e7298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_dd15bd6e-4705-4b80-bb50-9d3a17229dc0" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_e1bb9e4b-d552-4f0f-97ae-564e060e7298" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ProbabilityofpaymentMember_7fdb9d9d-7d94-4084-a3d6-b06ee0ad683a" xlink:href="bmy-20210630.xsd#bmy_ProbabilityofpaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_e1bb9e4b-d552-4f0f-97ae-564e060e7298" xlink:to="loc_bmy_ProbabilityofpaymentMember_7fdb9d9d-7d94-4084-a3d6-b06ee0ad683a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_5b834208-0d1f-4365-a20d-f80a78001f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_e1bb9e4b-d552-4f0f-97ae-564e060e7298" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_5b834208-0d1f-4365-a20d-f80a78001f8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ProjectedYearOfPaymentsMember_296f53a5-289b-468f-8c23-52c57b305eff" xlink:href="bmy-20210630.xsd#bmy_ProjectedYearOfPaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_e1bb9e4b-d552-4f0f-97ae-564e060e7298" xlink:to="loc_bmy_ProjectedYearOfPaymentsMember_296f53a5-289b-468f-8c23-52c57b305eff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5d838261-7683-4963-8dd6-4d5883357a58" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2484927a-de28-4c04-a9fa-f3d182f42155" xlink:to="loc_srt_RangeAxis_5d838261-7683-4963-8dd6-4d5883357a58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5d838261-7683-4963-8dd6-4d5883357a58_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5d838261-7683-4963-8dd6-4d5883357a58" xlink:to="loc_srt_RangeMember_5d838261-7683-4963-8dd6-4d5883357a58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d962bc97-8b97-4f98-9edd-19cfa4aab9c2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5d838261-7683-4963-8dd6-4d5883357a58" xlink:to="loc_srt_RangeMember_d962bc97-8b97-4f98-9edd-19cfa4aab9c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_18fb8c3b-19f5-4048-821a-7fe0eb3be037" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d962bc97-8b97-4f98-9edd-19cfa4aab9c2" xlink:to="loc_srt_MaximumMember_18fb8c3b-19f5-4048-821a-7fe0eb3be037" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_a5822a50-029c-4c30-882b-d1937c0942d3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d962bc97-8b97-4f98-9edd-19cfa4aab9c2" xlink:to="loc_srt_WeightedAverageMember_a5822a50-029c-4c30-882b-d1937c0942d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0fe9e3ec-1e60-4ef3-b57e-88be572f789b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d962bc97-8b97-4f98-9edd-19cfa4aab9c2" xlink:to="loc_srt_MinimumMember_0fe9e3ec-1e60-4ef3-b57e-88be572f789b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_1a370b1c-2b5b-4a8f-9169-dc4594a937f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2484927a-de28-4c04-a9fa-f3d182f42155" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_1a370b1c-2b5b-4a8f-9169-dc4594a937f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_1a370b1c-2b5b-4a8f-9169-dc4594a937f1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_1a370b1c-2b5b-4a8f-9169-dc4594a937f1" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_1a370b1c-2b5b-4a8f-9169-dc4594a937f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_5ecc9ebc-38dc-4eef-ad5f-6509ef2775aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_1a370b1c-2b5b-4a8f-9169-dc4594a937f1" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_5ecc9ebc-38dc-4eef-ad5f-6509ef2775aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentValueRightsMember_7d1caa93-c7da-4448-872b-0e4e25e11040" xlink:href="bmy-20210630.xsd#bmy_ContingentValueRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_5ecc9ebc-38dc-4eef-ad5f-6509ef2775aa" xlink:to="loc_bmy_ContingentValueRightsMember_7d1caa93-c7da-4448-872b-0e4e25e11040" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_1eb644f7-73f3-4282-b36d-3185037636c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2484927a-de28-4c04-a9fa-f3d182f42155" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_1eb644f7-73f3-4282-b36d-3185037636c5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1eb644f7-73f3-4282-b36d-3185037636c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1eb644f7-73f3-4282-b36d-3185037636c5" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1eb644f7-73f3-4282-b36d-3185037636c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_d691d0b3-781a-4560-a8a4-82e9926bf7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1eb644f7-73f3-4282-b36d-3185037636c5" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_d691d0b3-781a-4560-a8a4-82e9926bf7f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_0ba9ad78-a6a6-4025-86ba-631fd0479bec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_d691d0b3-781a-4560-a8a4-82e9926bf7f1" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_0ba9ad78-a6a6-4025-86ba-631fd0479bec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_2cbbc808-a868-438e-a097-43579ccebb58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_d691d0b3-781a-4560-a8a4-82e9926bf7f1" xlink:to="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_2cbbc808-a868-438e-a097-43579ccebb58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d38aae89-48a4-4c93-b553-020ffd8d915d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8a62bf61-db0e-44d9-a11e-25686224a8df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2484927a-de28-4c04-a9fa-f3d182f42155" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8a62bf61-db0e-44d9-a11e-25686224a8df" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8a62bf61-db0e-44d9-a11e-25686224a8df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8a62bf61-db0e-44d9-a11e-25686224a8df" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8a62bf61-db0e-44d9-a11e-25686224a8df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b16432bb-1fbe-46dd-a57c-cbf36db636f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8a62bf61-db0e-44d9-a11e-25686224a8df" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b16432bb-1fbe-46dd-a57c-cbf36db636f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_a40c9462-a0c4-4716-bd3a-7a60b908a3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b16432bb-1fbe-46dd-a57c-cbf36db636f3" xlink:to="loc_us-gaap_OtherAssetsMember_a40c9462-a0c4-4716-bd3a-7a60b908a3fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b5a49e00-1f5e-4a37-817f-73869a9a8288" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2484927a-de28-4c04-a9fa-f3d182f42155" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b5a49e00-1f5e-4a37-817f-73869a9a8288" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b5a49e00-1f5e-4a37-817f-73869a9a8288_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b5a49e00-1f5e-4a37-817f-73869a9a8288" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b5a49e00-1f5e-4a37-817f-73869a9a8288_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_37c87778-03ea-4057-adfa-55cc535dae3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b5a49e00-1f5e-4a37-817f-73869a9a8288" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_37c87778-03ea-4057-adfa-55cc535dae3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_25e4fd45-f185-479e-837d-b89467acd43f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_37c87778-03ea-4057-adfa-55cc535dae3e" xlink:to="loc_us-gaap_CertificatesOfDepositMember_25e4fd45-f185-479e-837d-b89467acd43f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_b463bc7a-51e4-4056-80c6-008db817ca95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_37c87778-03ea-4057-adfa-55cc535dae3e" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_b463bc7a-51e4-4056-80c6-008db817ca95" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8c9bada9-674d-4da7-a216-62c26c81f993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2484927a-de28-4c04-a9fa-f3d182f42155" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8c9bada9-674d-4da7-a216-62c26c81f993" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c9bada9-674d-4da7-a216-62c26c81f993_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8c9bada9-674d-4da7-a216-62c26c81f993" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8c9bada9-674d-4da7-a216-62c26c81f993_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b136dfb9-5047-49db-a428-9e95e7f22dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8c9bada9-674d-4da7-a216-62c26c81f993" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b136dfb9-5047-49db-a428-9e95e7f22dac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4f9ba9c3-a201-4205-ae6c-35111f0d13e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b136dfb9-5047-49db-a428-9e95e7f22dac" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4f9ba9c3-a201-4205-ae6c-35111f0d13e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c91be2ed-792d-4739-8fd6-0c52378832e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b136dfb9-5047-49db-a428-9e95e7f22dac" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c91be2ed-792d-4739-8fd6-0c52378832e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5794dbe3-4090-4da0-9de3-d3e3c01686b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b136dfb9-5047-49db-a428-9e95e7f22dac" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5794dbe3-4090-4da0-9de3-d3e3c01686b3" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails" xlink:type="extended" id="i6d4e2128dc034512baeb034681e07e4b_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_f6d7301e-d4d1-46db-b921-dde2e8b93a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:to="loc_us-gaap_DerivativeNotionalAmount_f6d7301e-d4d1-46db-b921-dde2e8b93a3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_c7d4443f-18ea-4a8a-9e21-f15d5bb1e1de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_c7d4443f-18ea-4a8a-9e21-f15d5bb1e1de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_b8cd7e8e-8d4c-4ff4-b87b-8e10e0628d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_b8cd7e8e-8d4c-4ff4-b87b-8e10e0628d0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_397b8bb5-b20e-4c08-b406-fcf5a24b6fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_397b8bb5-b20e-4c08-b406-fcf5a24b6fd2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_d96d25cd-3dff-4a59-95de-165df243489c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:to="loc_us-gaap_DerivativeAssets_d96d25cd-3dff-4a59-95de-165df243489c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_6c0e8c20-7ecd-46de-af37-7636aee2ce95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:to="loc_us-gaap_DerivativeLiabilities_6c0e8c20-7ecd-46de-af37-7636aee2ce95" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_71d11dbe-f806-4786-aed8-e927bded1d46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_71d11dbe-f806-4786-aed8-e927bded1d46" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_fcb27355-3e85-4eaa-93bc-779eb95e28c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_fcb27355-3e85-4eaa-93bc-779eb95e28c5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_5f7e1696-b441-45c8-abbc-fba0754e094b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_5f7e1696-b441-45c8-abbc-fba0754e094b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_953ce049-d53f-4205-b7d1-ece1a8de9b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_953ce049-d53f-4205-b7d1-ece1a8de9b5c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_f2d3f646-849e-493b-99dd-533d3d9e2675" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_f2d3f646-849e-493b-99dd-533d3d9e2675" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b6e41960-e667-48d7-bdd9-03f69a1641e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b6e41960-e667-48d7-bdd9-03f69a1641e2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_18a93983-8af3-4192-ad27-29cb3d622ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b6e41960-e667-48d7-bdd9-03f69a1641e2" xlink:to="loc_us-gaap_VariableRateAxis_18a93983-8af3-4192-ad27-29cb3d622ed3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_18a93983-8af3-4192-ad27-29cb3d622ed3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_18a93983-8af3-4192-ad27-29cb3d622ed3" xlink:to="loc_us-gaap_VariableRateDomain_18a93983-8af3-4192-ad27-29cb3d622ed3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_7b3df9e3-a14a-4330-a9b6-992b98ad3311" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_18a93983-8af3-4192-ad27-29cb3d622ed3" xlink:to="loc_us-gaap_VariableRateDomain_7b3df9e3-a14a-4330-a9b6-992b98ad3311" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_caab5c00-db78-485a-8b9c-a6ea58cfb61c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_7b3df9e3-a14a-4330-a9b6-992b98ad3311" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_caab5c00-db78-485a-8b9c-a6ea58cfb61c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_35b8238a-868f-48a6-96d0-48eaeef61af2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b6e41960-e667-48d7-bdd9-03f69a1641e2" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_35b8238a-868f-48a6-96d0-48eaeef61af2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_35b8238a-868f-48a6-96d0-48eaeef61af2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_35b8238a-868f-48a6-96d0-48eaeef61af2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_35b8238a-868f-48a6-96d0-48eaeef61af2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_895c5034-2f1e-45d3-8547-06ba270a5e17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_35b8238a-868f-48a6-96d0-48eaeef61af2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_895c5034-2f1e-45d3-8547-06ba270a5e17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_0362537c-2ff2-4aa8-ade6-2096ceef60da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_895c5034-2f1e-45d3-8547-06ba270a5e17" xlink:to="loc_us-gaap_CostOfSalesMember_0362537c-2ff2-4aa8-ade6-2096ceef60da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_04405914-2864-4d48-b436-ef62f2f75497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_895c5034-2f1e-45d3-8547-06ba270a5e17" xlink:to="loc_us-gaap_OtherIncomeMember_04405914-2864-4d48-b436-ef62f2f75497" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_15f9dfe6-0e96-402a-baa5-f7cbcf2147be" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b6e41960-e667-48d7-bdd9-03f69a1641e2" xlink:to="loc_srt_CurrencyAxis_15f9dfe6-0e96-402a-baa5-f7cbcf2147be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_15f9dfe6-0e96-402a-baa5-f7cbcf2147be_default" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_15f9dfe6-0e96-402a-baa5-f7cbcf2147be" xlink:to="loc_currency_AllCurrenciesDomain_15f9dfe6-0e96-402a-baa5-f7cbcf2147be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_055f5648-5b65-40f4-8941-c15bc0ec9a00" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_15f9dfe6-0e96-402a-baa5-f7cbcf2147be" xlink:to="loc_currency_AllCurrenciesDomain_055f5648-5b65-40f4-8941-c15bc0ec9a00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_a4b552c3-0434-4eb9-9ba9-c747dc77b435" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_055f5648-5b65-40f4-8941-c15bc0ec9a00" xlink:to="loc_currency_EUR_a4b552c3-0434-4eb9-9ba9-c747dc77b435" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_f4e8678f-d2aa-414e-b9ca-e91ec2b4aad5" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_JPY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_055f5648-5b65-40f4-8941-c15bc0ec9a00" xlink:to="loc_currency_JPY_f4e8678f-d2aa-414e-b9ca-e91ec2b4aad5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5328db88-5ce1-4c0c-83aa-77aba71e739e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b6e41960-e667-48d7-bdd9-03f69a1641e2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5328db88-5ce1-4c0c-83aa-77aba71e739e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5328db88-5ce1-4c0c-83aa-77aba71e739e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5328db88-5ce1-4c0c-83aa-77aba71e739e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5328db88-5ce1-4c0c-83aa-77aba71e739e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_56fe93ff-6f97-4e1e-90fa-5582b634f6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5328db88-5ce1-4c0c-83aa-77aba71e739e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_56fe93ff-6f97-4e1e-90fa-5582b634f6fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_766f2c75-bfaf-4343-9fa4-79ebb3de19fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_56fe93ff-6f97-4e1e-90fa-5582b634f6fd" xlink:to="loc_us-gaap_InterestRateSwapMember_766f2c75-bfaf-4343-9fa4-79ebb3de19fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_56f6862a-503e-4dd1-bd11-6218e0ec4830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_56fe93ff-6f97-4e1e-90fa-5582b634f6fd" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_56f6862a-503e-4dd1-bd11-6218e0ec4830" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_ef89266f-a30b-4e87-bd35-eb31134e38cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_56fe93ff-6f97-4e1e-90fa-5582b634f6fd" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_ef89266f-a30b-4e87-bd35-eb31134e38cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember_f5c44d73-90a3-4def-94f7-f5a03449f252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_56fe93ff-6f97-4e1e-90fa-5582b634f6fd" xlink:to="loc_us-gaap_OtherContractMember_f5c44d73-90a3-4def-94f7-f5a03449f252" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ZeroCostCollarCurrencyContractsMember_ce891e7e-8445-4eda-a6e1-30d256a192a1" xlink:href="bmy-20210630.xsd#bmy_ZeroCostCollarCurrencyContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_56fe93ff-6f97-4e1e-90fa-5582b634f6fd" xlink:to="loc_bmy_ZeroCostCollarCurrencyContractsMember_ce891e7e-8445-4eda-a6e1-30d256a192a1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0e32da7b-c9dc-44a8-b7c5-5588b131ed64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b6e41960-e667-48d7-bdd9-03f69a1641e2" xlink:to="loc_us-gaap_HedgingDesignationAxis_0e32da7b-c9dc-44a8-b7c5-5588b131ed64" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0e32da7b-c9dc-44a8-b7c5-5588b131ed64_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_0e32da7b-c9dc-44a8-b7c5-5588b131ed64" xlink:to="loc_us-gaap_HedgingDesignationDomain_0e32da7b-c9dc-44a8-b7c5-5588b131ed64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5b52bdd6-4fe7-441e-9883-c2ddbe4a5a29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_0e32da7b-c9dc-44a8-b7c5-5588b131ed64" xlink:to="loc_us-gaap_HedgingDesignationDomain_5b52bdd6-4fe7-441e-9883-c2ddbe4a5a29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_70246a28-162d-4243-9b60-ebeaf6c10da5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_5b52bdd6-4fe7-441e-9883-c2ddbe4a5a29" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_70246a28-162d-4243-9b60-ebeaf6c10da5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_f2bcafa4-8945-48bf-8964-4521c9227afe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_5b52bdd6-4fe7-441e-9883-c2ddbe4a5a29" xlink:to="loc_us-gaap_NondesignatedMember_f2bcafa4-8945-48bf-8964-4521c9227afe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f34b445a-46cf-46a7-a9ea-9ebdcd4dafe3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b6e41960-e667-48d7-bdd9-03f69a1641e2" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f34b445a-46cf-46a7-a9ea-9ebdcd4dafe3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f34b445a-46cf-46a7-a9ea-9ebdcd4dafe3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f34b445a-46cf-46a7-a9ea-9ebdcd4dafe3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f34b445a-46cf-46a7-a9ea-9ebdcd4dafe3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9a24813e-02b0-4fe8-8236-c1656cef46a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f34b445a-46cf-46a7-a9ea-9ebdcd4dafe3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9a24813e-02b0-4fe8-8236-c1656cef46a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_4002db88-56ea-420b-b283-054761c9ab1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9a24813e-02b0-4fe8-8236-c1656cef46a1" xlink:to="loc_us-gaap_AssetsMember_4002db88-56ea-420b-b283-054761c9ab1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_d4deb470-ac60-4e3a-8f53-7a2a1341f591" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9a24813e-02b0-4fe8-8236-c1656cef46a1" xlink:to="loc_us-gaap_LiabilityMember_d4deb470-ac60-4e3a-8f53-7a2a1341f591" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails" xlink:type="extended" id="i9bb4504958c74de89ba5f87df2bc7ae2_FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBankLoansAndNotesPayable_219ed3c0-a627-4d94-95b5-f1ab1088c85a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBankLoansAndNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_ShortTermBankLoansAndNotesPayable_219ed3c0-a627-4d94-95b5-f1ab1088c85a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_a44de414-0e10-49c5-8904-0ee6b5c6cbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_LongTermDebtCurrent_a44de414-0e10-49c5-8904-0ee6b5c6cbe5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermBorrowings_ee157358-487c-4245-acc5-53d9fcb34314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_OtherShortTermBorrowings_ee157358-487c-4245-acc5-53d9fcb34314" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_f96c8976-73c1-4783-9999-d1d6e05e96ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_ShortTermBorrowings_f96c8976-73c1-4783-9999-d1d6e05e96ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1098d47d-2cd6-4595-ae10-baa5b43c829e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1098d47d-2cd6-4595-ae10-baa5b43c829e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_e85c6471-e54d-45f9-915a-7854171bc998" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_DerivativeLiabilities_e85c6471-e54d-45f9-915a-7854171bc998" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_6f2b1f9a-38bb-4774-8505-b481be5b542b" xlink:href="bmy-20210630.xsd#bmy_UnamortizedBasisAdjustmentFromSwapTerminations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_6f2b1f9a-38bb-4774-8505-b481be5b542b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_64b6be6b-eb6f-4498-8440-b3009bdf6adc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_64b6be6b-eb6f-4498-8440-b3009bdf6adc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_58abc8a4-6f78-44aa-b471-5fe742458e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_58abc8a4-6f78-44aa-b471-5fe742458e4b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b91030a2-2622-4cc6-bc75-d371d7a48c09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_LongTermDebt_b91030a2-2622-4cc6-bc75-d371d7a48c09" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_d5e31930-e425-42e6-8abf-eb86079bdac6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_d5e31930-e425-42e6-8abf-eb86079bdac6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_5cd6d4f0-a360-417c-a754-8e4218769781" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_DebtInstrumentFairValue_5cd6d4f0-a360-417c-a754-8e4218769781" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_f5653e63-2260-4f13-a0f3-b4d5ae18f271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_InterestPaidNet_f5653e63-2260-4f13-a0f3-b4d5ae18f271" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6b34a4ae-d5ca-4d69-96de-e6bb87a3ad9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6b34a4ae-d5ca-4d69-96de-e6bb87a3ad9e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NumberofRevolvingCreditFacilities_bb3dde92-be3d-446b-aac4-a81bc8dd3680" xlink:href="bmy-20210630.xsd#bmy_NumberofRevolvingCreditFacilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_bmy_NumberofRevolvingCreditFacilities_bb3dde92-be3d-446b-aac4-a81bc8dd3680" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_1582861c-781c-4115-af6e-80b43828c044" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_1582861c-781c-4115-af6e-80b43828c044" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_9e1e3345-0098-477b-a3ec-4fd7ac7320a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_9e1e3345-0098-477b-a3ec-4fd7ac7320a4" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9c739472-b23a-49b6-8546-4e7ccf4c61d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9c739472-b23a-49b6-8546-4e7ccf4c61d2" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_a325399c-212a-45d0-abf7-8207dc338448" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_a325399c-212a-45d0-abf7-8207dc338448" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c4405455-d6e6-41f9-a5d2-7f75e7c58059" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_DebtInstrumentTable_c4405455-d6e6-41f9-a5d2-7f75e7c58059" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_d1adb8a4-3140-440c-9c5b-739608a5c873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c4405455-d6e6-41f9-a5d2-7f75e7c58059" xlink:to="loc_us-gaap_CreditFacilityAxis_d1adb8a4-3140-440c-9c5b-739608a5c873" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d1adb8a4-3140-440c-9c5b-739608a5c873_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_d1adb8a4-3140-440c-9c5b-739608a5c873" xlink:to="loc_us-gaap_CreditFacilityDomain_d1adb8a4-3140-440c-9c5b-739608a5c873_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7e513b09-778d-44e8-ae7a-7b762ead6814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_d1adb8a4-3140-440c-9c5b-739608a5c873" xlink:to="loc_us-gaap_CreditFacilityDomain_7e513b09-778d-44e8-ae7a-7b762ead6814" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2BillionMaximumBorrowingCapacityMember_6a9b19e4-d7ed-4b17-8765-a965b41bfc70" xlink:href="bmy-20210630.xsd#bmy_A2BillionMaximumBorrowingCapacityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_7e513b09-778d-44e8-ae7a-7b762ead6814" xlink:to="loc_bmy_A2BillionMaximumBorrowingCapacityMember_6a9b19e4-d7ed-4b17-8765-a965b41bfc70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1BillionMaximumBorrowingCapacityMember_3a6a06c8-a337-4045-84a1-6ac95c363a44" xlink:href="bmy-20210630.xsd#bmy_A1BillionMaximumBorrowingCapacityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_7e513b09-778d-44e8-ae7a-7b762ead6814" xlink:to="loc_bmy_A1BillionMaximumBorrowingCapacityMember_3a6a06c8-a337-4045-84a1-6ac95c363a44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.5BillionMaximumBorrowingCapacityMember_e2d5003a-c181-4027-835a-240b4fce16cc" xlink:href="bmy-20210630.xsd#bmy_A1.5BillionMaximumBorrowingCapacityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_7e513b09-778d-44e8-ae7a-7b762ead6814" xlink:to="loc_bmy_A1.5BillionMaximumBorrowingCapacityMember_e2d5003a-c181-4027-835a-240b4fce16cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8705339b-4294-43b0-950c-b2bbe34e60af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c4405455-d6e6-41f9-a5d2-7f75e7c58059" xlink:to="loc_us-gaap_DebtInstrumentAxis_8705339b-4294-43b0-950c-b2bbe34e60af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8705339b-4294-43b0-950c-b2bbe34e60af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8705339b-4294-43b0-950c-b2bbe34e60af" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8705339b-4294-43b0-950c-b2bbe34e60af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_be7ef9e6-e84a-4244-9544-8f40f09c8c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8705339b-4294-43b0-950c-b2bbe34e60af" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_be7ef9e6-e84a-4244-9544-8f40f09c8c7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2.875SeniorNotesdue2021Member_bd6e93b9-a813-4260-83ad-b67f92a9d129" xlink:href="bmy-20210630.xsd#bmy_A2.875SeniorNotesdue2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_be7ef9e6-e84a-4244-9544-8f40f09c8c7d" xlink:to="loc_bmy_A2.875SeniorNotesdue2021Member_bd6e93b9-a813-4260-83ad-b67f92a9d129" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2550SeniorNotesDue2021Member_e41654c1-f1b4-4d92-bc4b-af90e86939b5" xlink:href="bmy-20210630.xsd#bmy_A2550SeniorNotesDue2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_be7ef9e6-e84a-4244-9544-8f40f09c8c7d" xlink:to="loc_bmy_A2550SeniorNotesDue2021Member_e41654c1-f1b4-4d92-bc4b-af90e86939b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e2a1d8af-183c-48b6-8f2f-2093276f37c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c4405455-d6e6-41f9-a5d2-7f75e7c58059" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e2a1d8af-183c-48b6-8f2f-2093276f37c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e2a1d8af-183c-48b6-8f2f-2093276f37c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e2a1d8af-183c-48b6-8f2f-2093276f37c5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e2a1d8af-183c-48b6-8f2f-2093276f37c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_32602a1f-014a-4019-8ff4-88dd460c82a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e2a1d8af-183c-48b6-8f2f-2093276f37c5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_32602a1f-014a-4019-8ff4-88dd460c82a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_24b96f1b-328b-424f-be6a-ed74d792e92f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_32602a1f-014a-4019-8ff4-88dd460c82a5" xlink:to="loc_us-gaap_InterestRateSwapMember_24b96f1b-328b-424f-be6a-ed74d792e92f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_3b385ac6-5a71-4904-99de-9a21b9d2d22e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c4405455-d6e6-41f9-a5d2-7f75e7c58059" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_3b385ac6-5a71-4904-99de-9a21b9d2d22e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_3b385ac6-5a71-4904-99de-9a21b9d2d22e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_3b385ac6-5a71-4904-99de-9a21b9d2d22e" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_3b385ac6-5a71-4904-99de-9a21b9d2d22e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_284c14fa-a79f-44a8-8206-9ca22ebfdb46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_3b385ac6-5a71-4904-99de-9a21b9d2d22e" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_284c14fa-a79f-44a8-8206-9ca22ebfdb46" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/RECEIVABLESDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#RECEIVABLESDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/RECEIVABLESDetails" xlink:type="extended" id="i40a6a8789d7e4cf69d600402ab963212_RECEIVABLESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_da6e721e-504e-475e-8c19-e81c5051c9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_ce916c0e-9d44-4769-98c7-d38f9ab23959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_da6e721e-504e-475e-8c19-e81c5051c9f1" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_ce916c0e-9d44-4769-98c7-d38f9ab23959" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CashDiscounts_03629f62-6af5-405d-b0ad-9c75875f8e53" xlink:href="bmy-20210630.xsd#bmy_CashDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_da6e721e-504e-475e-8c19-e81c5051c9f1" xlink:to="loc_bmy_CashDiscounts_03629f62-6af5-405d-b0ad-9c75875f8e53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_caa1f642-0c54-49a1-b911-48eb0f7e94db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_da6e721e-504e-475e-8c19-e81c5051c9f1" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_caa1f642-0c54-49a1-b911-48eb0f7e94db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_21befb12-34f2-49dc-b4f3-e2b09c1ffdc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_da6e721e-504e-475e-8c19-e81c5051c9f1" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_21befb12-34f2-49dc-b4f3-e2b09c1ffdc8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_b0fcd7c5-d560-4518-acda-b42e50b34f02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_da6e721e-504e-475e-8c19-e81c5051c9f1" xlink:to="loc_us-gaap_OtherReceivables_b0fcd7c5-d560-4518-acda-b42e50b34f02" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_8cb4a362-4afc-4135-8a3e-8045f2f2423a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_da6e721e-504e-475e-8c19-e81c5051c9f1" xlink:to="loc_us-gaap_ReceivablesNetCurrent_8cb4a362-4afc-4135-8a3e-8045f2f2423a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReceivablesSoldOnNonrecourseBasis_2250a3d1-a942-4430-b25a-39f72fca47bf" xlink:href="bmy-20210630.xsd#bmy_ReceivablesSoldOnNonrecourseBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_da6e721e-504e-475e-8c19-e81c5051c9f1" xlink:to="loc_bmy_ReceivablesSoldOnNonrecourseBasis_2250a3d1-a942-4430-b25a-39f72fca47bf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NumberOfLargestPharmaceuticalWholesalers_88fde708-1800-48c3-8ac3-2df9ed9ddd10" xlink:href="bmy-20210630.xsd#bmy_NumberOfLargestPharmaceuticalWholesalers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_da6e721e-504e-475e-8c19-e81c5051c9f1" xlink:to="loc_bmy_NumberOfLargestPharmaceuticalWholesalers_88fde708-1800-48c3-8ac3-2df9ed9ddd10" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PercentageOfAggregateTotalTradeReceivablesDue_5c359d38-5ca8-4b19-ba1e-f2890def0ca9" xlink:href="bmy-20210630.xsd#bmy_PercentageOfAggregateTotalTradeReceivablesDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_da6e721e-504e-475e-8c19-e81c5051c9f1" xlink:to="loc_bmy_PercentageOfAggregateTotalTradeReceivablesDue_5c359d38-5ca8-4b19-ba1e-f2890def0ca9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_46441abc-137a-43d5-a9dd-24b63ff46ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_da6e721e-504e-475e-8c19-e81c5051c9f1" xlink:to="loc_us-gaap_ConcentrationRiskTable_46441abc-137a-43d5-a9dd-24b63ff46ea0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_f87eb67e-efee-43a8-99b9-3ac829644632" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_46441abc-137a-43d5-a9dd-24b63ff46ea0" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_f87eb67e-efee-43a8-99b9-3ac829644632" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f87eb67e-efee-43a8-99b9-3ac829644632_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_f87eb67e-efee-43a8-99b9-3ac829644632" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f87eb67e-efee-43a8-99b9-3ac829644632_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_539036a4-e24c-4193-b833-e9a250d7b84f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_f87eb67e-efee-43a8-99b9-3ac829644632" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_539036a4-e24c-4193-b833-e9a250d7b84f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_78d080a2-0e95-4ef1-89b9-e69ebde7c687" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_539036a4-e24c-4193-b833-e9a250d7b84f" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_78d080a2-0e95-4ef1-89b9-e69ebde7c687" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/INVENTORIESDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#INVENTORIESDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/INVENTORIESDetails" xlink:type="extended" id="i99b0ac58afd04751911fb5e744f8679a_INVENTORIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bba80b33-345b-4f19-be10-22242c2b4183" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_c1ef2fd5-9be5-4976-b750-b5f6701aa5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bba80b33-345b-4f19-be10-22242c2b4183" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_c1ef2fd5-9be5-4976-b750-b5f6701aa5dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_72a78b97-3536-44c9-950e-88d53ba580f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bba80b33-345b-4f19-be10-22242c2b4183" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_72a78b97-3536-44c9-950e-88d53ba580f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_de2c125b-8c96-4965-ab1a-186968d887b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bba80b33-345b-4f19-be10-22242c2b4183" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_de2c125b-8c96-4965-ab1a-186968d887b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Totalinventories_42607718-9b40-4816-a2e0-28072ecf335a" xlink:href="bmy-20210630.xsd#bmy_Totalinventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bba80b33-345b-4f19-be10-22242c2b4183" xlink:to="loc_bmy_Totalinventories_42607718-9b40-4816-a2e0-28072ecf335a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_37aef707-0010-4be2-9281-4de97e725a16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bba80b33-345b-4f19-be10-22242c2b4183" xlink:to="loc_us-gaap_InventoryNet_37aef707-0010-4be2-9281-4de97e725a16" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_75e537d0-605a-4edf-9f05-956681438329" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bba80b33-345b-4f19-be10-22242c2b4183" xlink:to="loc_us-gaap_InventoryNoncurrent_75e537d0-605a-4edf-9f05-956681438329" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_f451ddda-d1cb-4384-a87e-a7295f2de951" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_bba80b33-345b-4f19-be10-22242c2b4183" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_f451ddda-d1cb-4384-a87e-a7295f2de951" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_07f74f42-655e-4826-acdb-e137c1e77c53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_bba80b33-345b-4f19-be10-22242c2b4183" xlink:to="loc_us-gaap_StatementTable_07f74f42-655e-4826-acdb-e137c1e77c53" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_94dd00f0-2a8b-437e-b2ad-9b87403531e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_07f74f42-655e-4826-acdb-e137c1e77c53" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_94dd00f0-2a8b-437e-b2ad-9b87403531e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_94dd00f0-2a8b-437e-b2ad-9b87403531e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_94dd00f0-2a8b-437e-b2ad-9b87403531e9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_94dd00f0-2a8b-437e-b2ad-9b87403531e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9c3af2d9-dd9e-446f-9a2b-f63fdb55a9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_94dd00f0-2a8b-437e-b2ad-9b87403531e9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9c3af2d9-dd9e-446f-9a2b-f63fdb55a9e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InventorypurchasepricefairvalueadjustmentMember_9216d63e-8c4e-4c04-a0f0-d7df3a9f0d94" xlink:href="bmy-20210630.xsd#bmy_InventorypurchasepricefairvalueadjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9c3af2d9-dd9e-446f-9a2b-f63fdb55a9e1" xlink:to="loc_bmy_InventorypurchasepricefairvalueadjustmentMember_9216d63e-8c4e-4c04-a0f0-d7df3a9f0d94" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails" xlink:type="extended" id="i10552c4eef5f48e29bb1a8ef3996f0a0_GOODWILLANDOTHERINTANGIBLEASSETSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_97e0f482-7e53-41c4-b1ec-f4ee22769b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:to="loc_us-gaap_Goodwill_97e0f482-7e53-41c4-b1ec-f4ee22769b8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2629c2ba-93a0-45c0-a247-791ad446b25f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2629c2ba-93a0-45c0-a247-791ad446b25f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_30d2f52f-fe2b-47ba-86d7-25f30cb7e8c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_30d2f52f-fe2b-47ba-86d7-25f30cb7e8c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_ccf27f35-7d20-4f55-a1f1-4904f87f224e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_ccf27f35-7d20-4f55-a1f1-4904f87f224e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_467937b4-d251-4929-a14b-d022694506a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_467937b4-d251-4929-a14b-d022694506a4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a1a2620d-e5d3-4bd8-90c0-518057fdeaae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a1a2620d-e5d3-4bd8-90c0-518057fdeaae" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_bc07ccfb-a96a-45c6-8fb5-7fd2cabc8043" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_bc07ccfb-a96a-45c6-8fb5-7fd2cabc8043" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3a51838a-6919-4117-992d-ef5b3e9c85e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3a51838a-6919-4117-992d-ef5b3e9c85e8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquiredDevelopedProductRightsReclassedFromIPRD_52d93c28-bb75-402e-ba6f-317ce0cfe849" xlink:href="bmy-20210630.xsd#bmy_AcquiredDevelopedProductRightsReclassedFromIPRD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:to="loc_bmy_AcquiredDevelopedProductRightsReclassedFromIPRD_52d93c28-bb75-402e-ba6f-317ce0cfe849" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_d5e2c189-efc5-4cc0-9dc8-e93594c55944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_d5e2c189-efc5-4cc0-9dc8-e93594c55944" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_6f614207-323e-401b-92e3-d9f8f6780134" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_6f614207-323e-401b-92e3-d9f8f6780134" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentAndRegulatoryMilestoneNonCash_16b1a21d-d09c-4853-8f10-1070e29265ac" xlink:href="bmy-20210630.xsd#bmy_ContingentAndRegulatoryMilestoneNonCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:to="loc_bmy_ContingentAndRegulatoryMilestoneNonCash_16b1a21d-d09c-4853-8f10-1070e29265ac" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b44500d0-82bd-482c-836e-287beda871aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b44500d0-82bd-482c-836e-287beda871aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4ad5bd6e-8f4e-46cb-b4f4-b86dd38df3c5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b44500d0-82bd-482c-836e-287beda871aa" xlink:to="loc_srt_RangeAxis_4ad5bd6e-8f4e-46cb-b4f4-b86dd38df3c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4ad5bd6e-8f4e-46cb-b4f4-b86dd38df3c5_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4ad5bd6e-8f4e-46cb-b4f4-b86dd38df3c5" xlink:to="loc_srt_RangeMember_4ad5bd6e-8f4e-46cb-b4f4-b86dd38df3c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b6618ae0-ef28-4162-aca8-c71ecc32cf7d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4ad5bd6e-8f4e-46cb-b4f4-b86dd38df3c5" xlink:to="loc_srt_RangeMember_b6618ae0-ef28-4162-aca8-c71ecc32cf7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2f26c708-aa12-473a-bbad-cbdd23f770c2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b6618ae0-ef28-4162-aca8-c71ecc32cf7d" xlink:to="loc_srt_MinimumMember_2f26c708-aa12-473a-bbad-cbdd23f770c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d2883f8d-1f81-4f77-89ad-3e171fe5e9dc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b6618ae0-ef28-4162-aca8-c71ecc32cf7d" xlink:to="loc_srt_MaximumMember_d2883f8d-1f81-4f77-89ad-3e171fe5e9dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3e3e4726-a673-4db6-b193-6f466dc49ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b44500d0-82bd-482c-836e-287beda871aa" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3e3e4726-a673-4db6-b193-6f466dc49ca7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_3e3e4726-a673-4db6-b193-6f466dc49ca7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3e3e4726-a673-4db6-b193-6f466dc49ca7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_3e3e4726-a673-4db6-b193-6f466dc49ca7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0f1087d6-5edf-42b3-8f20-6475251ae08d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3e3e4726-a673-4db6-b193-6f466dc49ca7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0f1087d6-5edf-42b3-8f20-6475251ae08d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_3170b7da-02de-4bd0-9767-7611744316ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0f1087d6-5edf-42b3-8f20-6475251ae08d" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_3170b7da-02de-4bd0-9767-7611744316ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_09793fca-5948-4c7e-b8c3-0f50a301ed4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b44500d0-82bd-482c-836e-287beda871aa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_09793fca-5948-4c7e-b8c3-0f50a301ed4a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_09793fca-5948-4c7e-b8c3-0f50a301ed4a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_09793fca-5948-4c7e-b8c3-0f50a301ed4a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_09793fca-5948-4c7e-b8c3-0f50a301ed4a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_44e36cf0-fb36-4ef5-9d16-6fb45cae14d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_09793fca-5948-4c7e-b8c3-0f50a301ed4a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_44e36cf0-fb36-4ef5-9d16-6fb45cae14d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_3e053187-5de4-4174-995d-2a788b2e1b07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_44e36cf0-fb36-4ef5-9d16-6fb45cae14d0" xlink:to="loc_us-gaap_LicensingAgreementsMember_3e053187-5de4-4174-995d-2a788b2e1b07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_92c8e857-01c9-454a-98be-87894f1755ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_44e36cf0-fb36-4ef5-9d16-6fb45cae14d0" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_92c8e857-01c9-454a-98be-87894f1755ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_f4e7b25a-e245-4e41-acc2-cd433c32c1be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_44e36cf0-fb36-4ef5-9d16-6fb45cae14d0" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_f4e7b25a-e245-4e41-acc2-cd433c32c1be" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f616bf6c-ea24-427b-b476-9a88bd215774" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b44500d0-82bd-482c-836e-287beda871aa" xlink:to="loc_srt_ProductOrServiceAxis_f616bf6c-ea24-427b-b476-9a88bd215774" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f616bf6c-ea24-427b-b476-9a88bd215774_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f616bf6c-ea24-427b-b476-9a88bd215774" xlink:to="loc_srt_ProductsAndServicesDomain_f616bf6c-ea24-427b-b476-9a88bd215774_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4db5758a-83e3-46f9-948e-95500154abc4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f616bf6c-ea24-427b-b476-9a88bd215774" xlink:to="loc_srt_ProductsAndServicesDomain_4db5758a-83e3-46f9-948e-95500154abc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReblozylMember_aff2c1b9-0498-45e8-999a-c7a23fedaa1b" xlink:href="bmy-20210630.xsd#bmy_ReblozylMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4db5758a-83e3-46f9-948e-95500154abc4" xlink:to="loc_bmy_ReblozylMember_aff2c1b9-0498-45e8-999a-c7a23fedaa1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ZeposiaMember_c81585d0-cde8-49ca-beb8-b9cd5711f1a8" xlink:href="bmy-20210630.xsd#bmy_ZeposiaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4db5758a-83e3-46f9-948e-95500154abc4" xlink:to="loc_bmy_ZeposiaMember_c81585d0-cde8-49ca-beb8-b9cd5711f1a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IntangibleAssetNameAxis_617f133a-5ef5-40b2-a0ce-cf2716ad8a38" xlink:href="bmy-20210630.xsd#bmy_IntangibleAssetNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b44500d0-82bd-482c-836e-287beda871aa" xlink:to="loc_bmy_IntangibleAssetNameAxis_617f133a-5ef5-40b2-a0ce-cf2716ad8a38" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IntangibleAssetNameDomain_617f133a-5ef5-40b2-a0ce-cf2716ad8a38_default" xlink:href="bmy-20210630.xsd#bmy_IntangibleAssetNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_bmy_IntangibleAssetNameAxis_617f133a-5ef5-40b2-a0ce-cf2716ad8a38" xlink:to="loc_bmy_IntangibleAssetNameDomain_617f133a-5ef5-40b2-a0ce-cf2716ad8a38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IntangibleAssetNameDomain_fb692c0a-450a-4c03-b572-f758fb2e2aee" xlink:href="bmy-20210630.xsd#bmy_IntangibleAssetNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_bmy_IntangibleAssetNameAxis_617f133a-5ef5-40b2-a0ce-cf2716ad8a38" xlink:to="loc_bmy_IntangibleAssetNameDomain_fb692c0a-450a-4c03-b572-f758fb2e2aee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InrebicMember_ff7e7cc4-0688-4cb0-9df6-b5d14789d75e" xlink:href="bmy-20210630.xsd#bmy_InrebicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_IntangibleAssetNameDomain_fb692c0a-450a-4c03-b572-f758fb2e2aee" xlink:to="loc_bmy_InrebicMember_ff7e7cc4-0688-4cb0-9df6-b5d14789d75e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_4ff7013b-52a5-409d-8870-f9bf93a4e6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_IntangibleAssetNameDomain_fb692c0a-450a-4c03-b572-f758fb2e2aee" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_4ff7013b-52a5-409d-8870-f9bf93a4e6d3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails" xlink:type="extended" id="i3729ad296548480da54ad1717db1f6d0_SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_10de8733-c087-49e5-b8d6-0c360a641aab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_e5baa025-e61a-4325-877d-18e28abb1563" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_10de8733-c087-49e5-b8d6-0c360a641aab" xlink:to="loc_us-gaap_RestrictedCash_e5baa025-e61a-4325-877d-18e28abb1563" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_94a1e3b1-d3ef-4503-a560-33513634adab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_10de8733-c087-49e5-b8d6-0c360a641aab" xlink:to="loc_us-gaap_OtherAssetsCurrent_94a1e3b1-d3ef-4503-a560-33513634adab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9f47e869-7e67-401f-be47-228b520ea34f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_10de8733-c087-49e5-b8d6-0c360a641aab" xlink:to="loc_us-gaap_StatementTable_9f47e869-7e67-401f-be47-228b520ea34f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f8983e5d-7011-44be-9ab5-2cbf5f5e3f48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9f47e869-7e67-401f-be47-228b520ea34f" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f8983e5d-7011-44be-9ab5-2cbf5f5e3f48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f8983e5d-7011-44be-9ab5-2cbf5f5e3f48_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f8983e5d-7011-44be-9ab5-2cbf5f5e3f48" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f8983e5d-7011-44be-9ab5-2cbf5f5e3f48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1a213096-e8ca-49c3-930f-5810d214eccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f8983e5d-7011-44be-9ab5-2cbf5f5e3f48" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1a213096-e8ca-49c3-930f-5810d214eccd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_a863b4ba-36af-4095-a7a3-08475cb45ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1a213096-e8ca-49c3-930f-5810d214eccd" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_a863b4ba-36af-4095-a7a3-08475cb45ae7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails" xlink:type="extended" id="if652eb17066d4759b2f2e2f0f3e3cc2a_SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_278ffe0f-dd75-402a-b62b-597f878444eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d2d6d6d9-d9bc-4a3b-b71f-26ec3eb7db60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_278ffe0f-dd75-402a-b62b-597f878444eb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d2d6d6d9-d9bc-4a3b-b71f-26ec3eb7db60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_34315f84-1e16-4ca3-b3a1-1b1240b06dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_278ffe0f-dd75-402a-b62b-597f878444eb" xlink:to="loc_us-gaap_StatementTable_34315f84-1e16-4ca3-b3a1-1b1240b06dfd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c209707e-eba1-432a-8c65-5bee4dc5965e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_34315f84-1e16-4ca3-b3a1-1b1240b06dfd" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c209707e-eba1-432a-8c65-5bee4dc5965e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c209707e-eba1-432a-8c65-5bee4dc5965e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c209707e-eba1-432a-8c65-5bee4dc5965e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c209707e-eba1-432a-8c65-5bee4dc5965e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_cc2f3637-9516-46c2-b6f0-2cc49ce64e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c209707e-eba1-432a-8c65-5bee4dc5965e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_cc2f3637-9516-46c2-b6f0-2cc49ce64e36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_e7145f86-1c6d-4579-96e2-9d431650e873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_cc2f3637-9516-46c2-b6f0-2cc49ce64e36" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_e7145f86-1c6d-4579-96e2-9d431650e873" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_a0a227eb-052c-404a-bdbc-29fcd7b1d4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_34315f84-1e16-4ca3-b3a1-1b1240b06dfd" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_a0a227eb-052c-404a-bdbc-29fcd7b1d4a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_a0a227eb-052c-404a-bdbc-29fcd7b1d4a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_a0a227eb-052c-404a-bdbc-29fcd7b1d4a3" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_a0a227eb-052c-404a-bdbc-29fcd7b1d4a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_aa01eb4d-77f7-4e4a-af08-85c7b8958c00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_a0a227eb-052c-404a-bdbc-29fcd7b1d4a3" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_aa01eb4d-77f7-4e4a-af08-85c7b8958c00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentValueRightsMember_b2f6e05d-cb8d-4dc4-9c7e-03ac98b1a377" xlink:href="bmy-20210630.xsd#bmy_ContingentValueRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_aa01eb4d-77f7-4e4a-af08-85c7b8958c00" xlink:to="loc_bmy_ContingentValueRightsMember_b2f6e05d-cb8d-4dc4-9c7e-03ac98b1a377" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails" xlink:type="extended" id="i610767a340e94a249689da5ee8485d2e_SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d428e225-7595-4560-ad75-eeafdad6344f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_3ace602f-f335-4995-8179-19fea9b99aec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d428e225-7595-4560-ad75-eeafdad6344f" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_3ace602f-f335-4995-8179-19fea9b99aec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_cec77eb0-4f2b-45e1-9749-a1b40886b504" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d428e225-7595-4560-ad75-eeafdad6344f" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_cec77eb0-4f2b-45e1-9749-a1b40886b504" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_af398c22-95a1-4484-85ab-1b82bc7ca028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d428e225-7595-4560-ad75-eeafdad6344f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_af398c22-95a1-4484-85ab-1b82bc7ca028" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeNoncurrent_5068b5b5-96ea-461e-bdbd-6b4e8f2fffd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d428e225-7595-4560-ad75-eeafdad6344f" xlink:to="loc_us-gaap_DeferredIncomeNoncurrent_5068b5b5-96ea-461e-bdbd-6b4e8f2fffd5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_418939f7-a4b4-4ad6-a53a-b36d4e4c5d73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d428e225-7595-4560-ad75-eeafdad6344f" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_418939f7-a4b4-4ad6-a53a-b36d4e4c5d73" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_d4b9c0ea-d4b1-4745-ae86-9fdf20e9e60f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d428e225-7595-4560-ad75-eeafdad6344f" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_d4b9c0ea-d4b1-4745-ae86-9fdf20e9e60f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_e4b540de-8fda-4d07-b465-29c6cc81047f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d428e225-7595-4560-ad75-eeafdad6344f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_e4b540de-8fda-4d07-b465-29c6cc81047f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_bab77c2b-4230-4522-af15-968d93c0ec54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_d428e225-7595-4560-ad75-eeafdad6344f" xlink:to="loc_us-gaap_StatementTable_bab77c2b-4230-4522-af15-968d93c0ec54" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_467bc83b-fba8-470c-9292-4c9a35fa5ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_bab77c2b-4230-4522-af15-968d93c0ec54" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_467bc83b-fba8-470c-9292-4c9a35fa5ac5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_467bc83b-fba8-470c-9292-4c9a35fa5ac5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_467bc83b-fba8-470c-9292-4c9a35fa5ac5" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_467bc83b-fba8-470c-9292-4c9a35fa5ac5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_c95b4d74-d030-4a0e-bf03-acfa59ba12ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_467bc83b-fba8-470c-9292-4c9a35fa5ac5" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_c95b4d74-d030-4a0e-bf03-acfa59ba12ef" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYChangesinEquityDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#EQUITYChangesinEquityDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/EQUITYChangesinEquityDetails" xlink:type="extended" id="i998bc33056094a64ba7b51e6b9b42c21_EQUITYChangesinEquityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9a6a2e48-9ec8-49d1-85c0-4284def46065" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_425fa53d-693e-47b3-bd59-e1662f334acd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9a6a2e48-9ec8-49d1-85c0-4284def46065" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_425fa53d-693e-47b3-bd59-e1662f334acd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0c3a1b9c-be5a-4947-9e39-03837cd9de14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9a6a2e48-9ec8-49d1-85c0-4284def46065" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0c3a1b9c-be5a-4947-9e39-03837cd9de14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_78737e7f-e70e-4a2e-9aab-93459d095726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9a6a2e48-9ec8-49d1-85c0-4284def46065" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_78737e7f-e70e-4a2e-9aab-93459d095726" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9a6a2e48-9ec8-49d1-85c0-4284def46065" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_8a7d7e21-7426-41f3-865e-36628609c6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_SharesIssued_8a7d7e21-7426-41f3-865e-36628609c6d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_325d8d4e-b3b2-4992-8bc2-85d4cc92e05a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3a2a7bae-3622-4dac-a0aa-2cc4e86a2231" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_CommonStockValue_3a2a7bae-3622-4dac-a0aa-2cc4e86a2231" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_8c358612-7606-4ff0-be45-ebc912bef2c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_ed221d71-afc3-40f2-a051-0ed980278084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_AdditionalPaidInCapital_ed221d71-afc3-40f2-a051-0ed980278084" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_1ca1a574-5743-4757-9529-2866751e295a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_StockholdersEquityOther_1ca1a574-5743-4757-9529-2866751e295a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_d9529678-b3ff-4265-8136-7a2f712ffae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3988b00d-84c5-4e7f-a333-bc6b7f71b2f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3988b00d-84c5-4e7f-a333-bc6b7f71b2f8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9bb95644-b632-424e-88df-70935622d309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9bb95644-b632-424e-88df-70935622d309" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b722da06-c99f-49ea-8810-9e3657b11dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a9e4cc72-cbef-4173-85aa-d6e15b5f06e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a9e4cc72-cbef-4173-85aa-d6e15b5f06e0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b072af6b-89b5-4ec6-948b-f8763dee1690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_NetIncomeLoss_b072af6b-89b5-4ec6-948b-f8763dee1690" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_7f14080d-6d79-4188-a0b0-cea04595fc08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_DividendsCommonStockCash_7f14080d-6d79-4188-a0b0-cea04595fc08" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_e9279dca-e80a-42b9-8a47-05b5e099fe86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_e9279dca-e80a-42b9-8a47-05b5e099fe86" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f11f8434-e90e-45ba-bb23-f0e48d13ac9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_f0ebeaa4-1c9c-4536-a007-2e931095bc65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_TreasuryStockShares_f0ebeaa4-1c9c-4536-a007-2e931095bc65" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_a9954b95-e384-442b-bce4-457bf4c6862f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_a9954b95-e384-442b-bce4-457bf4c6862f" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_1a5a88af-d3af-465f-ae25-e823d36d0f51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_d7119ba1-13ca-4030-b80b-b3477d119270" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_TreasuryStockValue_d7119ba1-13ca-4030-b80b-b3477d119270" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_8107a5e6-b231-4476-8b07-c67f2f75bda0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_8107a5e6-b231-4476-8b07-c67f2f75bda0" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_c5bd973a-8b0f-49c2-90b1-d8aed51a030b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_3fa1b58a-a4c2-4320-9039-08a9b193c9df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_MinorityInterest_3fa1b58a-a4c2-4320-9039-08a9b193c9df" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0f5b2145-956c-468d-9dd5-a4d13e843407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0f5b2145-956c-468d-9dd5-a4d13e843407" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_79b222c5-c8a4-4f63-9314-e1f12c315271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_79b222c5-c8a4-4f63-9314-e1f12c315271" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_3d07dd87-5d0b-45d6-89fa-a8fcfac92c00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_1a9ee165-f03d-4319-8846-526e22eaa5d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9a6a2e48-9ec8-49d1-85c0-4284def46065" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_1a9ee165-f03d-4319-8846-526e22eaa5d3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_2ff6bce4-b0a2-440a-ab78-8963ea11c86b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9a6a2e48-9ec8-49d1-85c0-4284def46065" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_2ff6bce4-b0a2-440a-ab78-8963ea11c86b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ae53f516-a581-408e-beef-519ecf658861" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_9a6a2e48-9ec8-49d1-85c0-4284def46065" xlink:to="loc_us-gaap_StatementTable_ae53f516-a581-408e-beef-519ecf658861" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6e8fe308-cae4-4231-9eb1-cead94639f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ae53f516-a581-408e-beef-519ecf658861" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6e8fe308-cae4-4231-9eb1-cead94639f3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6e8fe308-cae4-4231-9eb1-cead94639f3a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6e8fe308-cae4-4231-9eb1-cead94639f3a" xlink:to="loc_us-gaap_EquityComponentDomain_6e8fe308-cae4-4231-9eb1-cead94639f3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d0d97605-d8cc-4c7f-99f1-b55a5763af61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6e8fe308-cae4-4231-9eb1-cead94639f3a" xlink:to="loc_us-gaap_EquityComponentDomain_d0d97605-d8cc-4c7f-99f1-b55a5763af61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_748e7f54-dfef-4dfd-aab4-f62f57292991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d0d97605-d8cc-4c7f-99f1-b55a5763af61" xlink:to="loc_us-gaap_CommonStockMember_748e7f54-dfef-4dfd-aab4-f62f57292991" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_492906a9-0567-4c97-beb5-6fe729e59b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d0d97605-d8cc-4c7f-99f1-b55a5763af61" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_492906a9-0567-4c97-beb5-6fe729e59b30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_898e12f5-7355-4153-a38b-1dc2425f56bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d0d97605-d8cc-4c7f-99f1-b55a5763af61" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_898e12f5-7355-4153-a38b-1dc2425f56bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_5b2ccdd9-e54f-4e83-bae5-af883c6697af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d0d97605-d8cc-4c7f-99f1-b55a5763af61" xlink:to="loc_us-gaap_RetainedEarningsMember_5b2ccdd9-e54f-4e83-bae5-af883c6697af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_96371fff-0d4d-4d1d-8ee7-129fee14946f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d0d97605-d8cc-4c7f-99f1-b55a5763af61" xlink:to="loc_us-gaap_TreasuryStockMember_96371fff-0d4d-4d1d-8ee7-129fee14946f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_49a0eafb-2d95-4772-8a0e-89cbfde56bed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d0d97605-d8cc-4c7f-99f1-b55a5763af61" xlink:to="loc_us-gaap_NoncontrollingInterestMember_49a0eafb-2d95-4772-8a0e-89cbfde56bed" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails" xlink:type="extended" id="id0f8c33b84a84d18a26db4aee717353a_EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fde950e1-a22c-4a39-8bc6-df3c66119c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_90fb9a5b-0a8d-43e9-b424-d7fb080ea8c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fde950e1-a22c-4a39-8bc6-df3c66119c3b" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_90fb9a5b-0a8d-43e9-b424-d7fb080ea8c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_f562a0c5-565f-4d05-ac85-a27a78c8cb52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fde950e1-a22c-4a39-8bc6-df3c66119c3b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_f562a0c5-565f-4d05-ac85-a27a78c8cb52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsAndExcessTaxBenefitFromSharebasedCompensation_f9646736-90d9-4274-bf07-ef288e0d890f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsAndExcessTaxBenefitFromSharebasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fde950e1-a22c-4a39-8bc6-df3c66119c3b" xlink:to="loc_us-gaap_ProceedsAndExcessTaxBenefitFromSharebasedCompensation_f9646736-90d9-4274-bf07-ef288e0d890f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ff7e301d-8b03-409a-9cc2-5e43ff54f64d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_fde950e1-a22c-4a39-8bc6-df3c66119c3b" xlink:to="loc_us-gaap_StatementTable_ff7e301d-8b03-409a-9cc2-5e43ff54f64d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_cac8f269-274a-4135-92e3-d820dea42ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ff7e301d-8b03-409a-9cc2-5e43ff54f64d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_cac8f269-274a-4135-92e3-d820dea42ebe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cac8f269-274a-4135-92e3-d820dea42ebe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cac8f269-274a-4135-92e3-d820dea42ebe" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cac8f269-274a-4135-92e3-d820dea42ebe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8cc1434c-0938-42a1-9954-b9629b3d6277" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cac8f269-274a-4135-92e3-d820dea42ebe" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8cc1434c-0938-42a1-9954-b9629b3d6277" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b0fe4eea-9d6b-4b3e-a30e-e36ba9e13ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ff7e301d-8b03-409a-9cc2-5e43ff54f64d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b0fe4eea-9d6b-4b3e-a30e-e36ba9e13ac4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b0fe4eea-9d6b-4b3e-a30e-e36ba9e13ac4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b0fe4eea-9d6b-4b3e-a30e-e36ba9e13ac4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b0fe4eea-9d6b-4b3e-a30e-e36ba9e13ac4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2f1233eb-c758-4743-a4f2-d9433eb5784a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b0fe4eea-9d6b-4b3e-a30e-e36ba9e13ac4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2f1233eb-c758-4743-a4f2-d9433eb5784a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_929a49a5-49e7-4d17-8010-4c10b7ae9907" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2f1233eb-c758-4743-a4f2-d9433eb5784a" xlink:to="loc_us-gaap_CostOfSalesMember_929a49a5-49e7-4d17-8010-4c10b7ae9907" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_35a0da2b-9de8-413d-9bff-a9edca9f0ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2f1233eb-c758-4743-a4f2-d9433eb5784a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_35a0da2b-9de8-413d-9bff-a9edca9f0ba5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_83a26dde-c674-4d4d-b0e8-608d7a573a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2f1233eb-c758-4743-a4f2-d9433eb5784a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_83a26dde-c674-4d4d-b0e8-608d7a573a9f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_e0781778-d1e5-444e-8d1d-4955e3e42fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2f1233eb-c758-4743-a4f2-d9433eb5784a" xlink:to="loc_us-gaap_OtherIncomeMember_e0781778-d1e5-444e-8d1d-4955e3e42fe1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c5132a28-f2b9-41dd-86fe-934f0e113ced" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ff7e301d-8b03-409a-9cc2-5e43ff54f64d" xlink:to="loc_us-gaap_AwardTypeAxis_c5132a28-f2b9-41dd-86fe-934f0e113ced" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c5132a28-f2b9-41dd-86fe-934f0e113ced_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c5132a28-f2b9-41dd-86fe-934f0e113ced" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c5132a28-f2b9-41dd-86fe-934f0e113ced_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_da11d524-6a3e-40e8-be9b-ab0671bcdfed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c5132a28-f2b9-41dd-86fe-934f0e113ced" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_da11d524-6a3e-40e8-be9b-ab0671bcdfed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneContingentValueRightsMember_ab0a5ddf-b127-4793-82ea-26d591070c56" xlink:href="bmy-20210630.xsd#bmy_CelgeneContingentValueRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_da11d524-6a3e-40e8-be9b-ab0671bcdfed" xlink:to="loc_bmy_CelgeneContingentValueRightsMember_ab0a5ddf-b127-4793-82ea-26d591070c56" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleOfShareBasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#EMPLOYEESTOCKBENEFITPLANSScheduleOfShareBasedCompensationAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleOfShareBasedCompensationAdditionalInformationDetails" xlink:type="extended" id="i2601992cba894c11b2bc486b5939b7ac_EMPLOYEESTOCKBENEFITPLANSScheduleOfShareBasedCompensationAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fe7d0d84-399b-4ce3-8b6d-e3708e9de8ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_127d351f-a6da-4ab3-9876-f688b7e762ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fe7d0d84-399b-4ce3-8b6d-e3708e9de8ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_127d351f-a6da-4ab3-9876-f688b7e762ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d3df2bce-bdc1-457e-ace3-7242c2922eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_fe7d0d84-399b-4ce3-8b6d-e3708e9de8ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d3df2bce-bdc1-457e-ace3-7242c2922eaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e20bf448-547e-4ceb-9c52-c46df2a67316" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_fe7d0d84-399b-4ce3-8b6d-e3708e9de8ba" xlink:to="loc_us-gaap_StatementTable_e20bf448-547e-4ceb-9c52-c46df2a67316" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1521668a-6bf0-4def-8f38-9f16843685fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e20bf448-547e-4ceb-9c52-c46df2a67316" xlink:to="loc_us-gaap_AwardTypeAxis_1521668a-6bf0-4def-8f38-9f16843685fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1521668a-6bf0-4def-8f38-9f16843685fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1521668a-6bf0-4def-8f38-9f16843685fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1521668a-6bf0-4def-8f38-9f16843685fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ab60bb2e-fac9-49c7-89b5-3ad3cb4ed10c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1521668a-6bf0-4def-8f38-9f16843685fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ab60bb2e-fac9-49c7-89b5-3ad3cb4ed10c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_964d3c48-92eb-402f-849f-0d4f0388e8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ab60bb2e-fac9-49c7-89b5-3ad3cb4ed10c" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_964d3c48-92eb-402f-849f-0d4f0388e8d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MarketShareUnitsMember_8c8d56cf-9899-4b6a-a79b-83fde25cf338" xlink:href="bmy-20210630.xsd#bmy_MarketShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ab60bb2e-fac9-49c7-89b5-3ad3cb4ed10c" xlink:to="loc_bmy_MarketShareUnitsMember_8c8d56cf-9899-4b6a-a79b-83fde25cf338" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_4879ac19-d5c0-4b5f-8c02-0895955f5abe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ab60bb2e-fac9-49c7-89b5-3ad3cb4ed10c" xlink:to="loc_us-gaap_PerformanceSharesMember_4879ac19-d5c0-4b5f-8c02-0895955f5abe" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails" xlink:type="extended" id="i1de68791c9694c06abf6a96cd7313b17_EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d6a90b5d-7285-4628-a1d3-ba0820b16820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_6ac52fb1-8e48-49c5-97ae-94a8ba1937dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d6a90b5d-7285-4628-a1d3-ba0820b16820" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_6ac52fb1-8e48-49c5-97ae-94a8ba1937dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e81a1a2a-40b0-46c7-a8d4-96dfe3f2b0c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d6a90b5d-7285-4628-a1d3-ba0820b16820" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e81a1a2a-40b0-46c7-a8d4-96dfe3f2b0c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2d6b0aac-53c0-4def-9173-e52310c77da3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_d6a90b5d-7285-4628-a1d3-ba0820b16820" xlink:to="loc_us-gaap_StatementTable_2d6b0aac-53c0-4def-9173-e52310c77da3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_362a3d87-9c7c-4c8a-8014-a60a2a1653b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2d6b0aac-53c0-4def-9173-e52310c77da3" xlink:to="loc_us-gaap_AwardTypeAxis_362a3d87-9c7c-4c8a-8014-a60a2a1653b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_362a3d87-9c7c-4c8a-8014-a60a2a1653b7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_362a3d87-9c7c-4c8a-8014-a60a2a1653b7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_362a3d87-9c7c-4c8a-8014-a60a2a1653b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d530372-00df-4e0e-80fb-9fbceeaf71e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_362a3d87-9c7c-4c8a-8014-a60a2a1653b7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d530372-00df-4e0e-80fb-9fbceeaf71e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_6068af0f-7ff3-4946-865e-ba05cb4ccca8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d530372-00df-4e0e-80fb-9fbceeaf71e6" xlink:to="loc_us-gaap_EmployeeStockOptionMember_6068af0f-7ff3-4946-865e-ba05cb4ccca8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a46f9402-5a65-4fa0-9611-66e99c44124a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d530372-00df-4e0e-80fb-9fbceeaf71e6" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a46f9402-5a65-4fa0-9611-66e99c44124a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MarketShareUnitsMember_1e91e7d0-112e-4f03-a60c-38ae0936dd6d" xlink:href="bmy-20210630.xsd#bmy_MarketShareUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d530372-00df-4e0e-80fb-9fbceeaf71e6" xlink:to="loc_bmy_MarketShareUnitsMember_1e91e7d0-112e-4f03-a60c-38ae0936dd6d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_b5276353-f518-4006-8572-4a169bb6d2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d530372-00df-4e0e-80fb-9fbceeaf71e6" xlink:to="loc_us-gaap_PerformanceSharesMember_b5276353-f518-4006-8572-4a169bb6d2c8" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#LEGALPROCEEDINGSANDCONTINGENCIESDetails"/>
  <link:definitionLink xlink:role="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails" xlink:type="extended" id="ifee38ebd2342439f92850123df5582a9_LEGALPROCEEDINGSANDCONTINGENCIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LegalProceedingsAndContingenciesLineItems_9692543b-b22f-4acd-a0e9-927a672d52bd" xlink:href="bmy-20210630.xsd#bmy_LegalProceedingsAndContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_c1eb4cb2-59ed-468c-8a69-6cb26c551199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_9692543b-b22f-4acd-a0e9-927a672d52bd" xlink:to="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_c1eb4cb2-59ed-468c-8a69-6cb26c551199" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_2e8bfc61-c9bc-4eea-a2fe-97766aba670a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_9692543b-b22f-4acd-a0e9-927a672d52bd" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_2e8bfc61-c9bc-4eea-a2fe-97766aba670a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_ed66369b-b9a7-4100-88e8-e0bc9b602764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_9692543b-b22f-4acd-a0e9-927a672d52bd" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_ed66369b-b9a7-4100-88e8-e0bc9b602764" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_14eca683-2f26-40be-803d-2c10d965e7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_9692543b-b22f-4acd-a0e9-927a672d52bd" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_14eca683-2f26-40be-803d-2c10d965e7f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LitigationTable_2a5c283e-665b-4972-8d77-3e5de23b80ba" xlink:href="bmy-20210630.xsd#bmy_LitigationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_9692543b-b22f-4acd-a0e9-927a672d52bd" xlink:to="loc_bmy_LitigationTable_2a5c283e-665b-4972-8d77-3e5de23b80ba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_77e326d4-55a5-4541-829a-470910646630" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LitigationTable_2a5c283e-665b-4972-8d77-3e5de23b80ba" xlink:to="loc_us-gaap_AwardTypeAxis_77e326d4-55a5-4541-829a-470910646630" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77e326d4-55a5-4541-829a-470910646630_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_77e326d4-55a5-4541-829a-470910646630" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77e326d4-55a5-4541-829a-470910646630_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f9fa5e9c-a16e-4fc0-8a62-19cdf625ae15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_77e326d4-55a5-4541-829a-470910646630" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f9fa5e9c-a16e-4fc0-8a62-19cdf625ae15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_UpfrontmilestoneandotherlicensingreceiptsMember_df388db5-39e9-42a5-af0f-db137abe29af" xlink:href="bmy-20210630.xsd#bmy_UpfrontmilestoneandotherlicensingreceiptsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f9fa5e9c-a16e-4fc0-8a62-19cdf625ae15" xlink:to="loc_bmy_UpfrontmilestoneandotherlicensingreceiptsMember_df388db5-39e9-42a5-af0f-db137abe29af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_791bcc54-a16a-44ae-8262-67de60eb75ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f9fa5e9c-a16e-4fc0-8a62-19cdf625ae15" xlink:to="loc_us-gaap_RoyaltyMember_791bcc54-a16a-44ae-8262-67de60eb75ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_bbd8c947-54da-4c91-b526-ee2d96ff1851" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LitigationTable_2a5c283e-665b-4972-8d77-3e5de23b80ba" xlink:to="loc_srt_LitigationCaseAxis_bbd8c947-54da-4c91-b526-ee2d96ff1851" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_bbd8c947-54da-4c91-b526-ee2d96ff1851_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_bbd8c947-54da-4c91-b526-ee2d96ff1851" xlink:to="loc_srt_LitigationCaseTypeDomain_bbd8c947-54da-4c91-b526-ee2d96ff1851_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_bbd8c947-54da-4c91-b526-ee2d96ff1851" xlink:to="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AntiPD1AntibodyLitigationMember_b217ffee-63c8-46c0-b48b-ff10d6625aa1" xlink:href="bmy-20210630.xsd#bmy_AntiPD1AntibodyLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:to="loc_bmy_AntiPD1AntibodyLitigationMember_b217ffee-63c8-46c0-b48b-ff10d6625aa1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CARTKiteLitigationMember_d6c698fe-1e06-42d5-b40f-24a51c97cef7" xlink:href="bmy-20210630.xsd#bmy_CARTKiteLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:to="loc_bmy_CARTKiteLitigationMember_d6c698fe-1e06-42d5-b40f-24a51c97cef7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EliquisPatentLitigationMember_a682f993-f2de-4943-b642-a37d67dcfe94" xlink:href="bmy-20210630.xsd#bmy_EliquisPatentLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:to="loc_bmy_EliquisPatentLitigationMember_a682f993-f2de-4943-b642-a37d67dcfe94" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PlavixAustraliaIntellectualPropertyMember_f33b7fbf-fc38-42f2-94da-cbbfa001424a" xlink:href="bmy-20210630.xsd#bmy_PlavixAustraliaIntellectualPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:to="loc_bmy_PlavixAustraliaIntellectualPropertyMember_f33b7fbf-fc38-42f2-94da-cbbfa001424a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbilifyProductLiabilityMember_f45dad8e-9baf-4134-802a-37c4aa7f9657" xlink:href="bmy-20210630.xsd#bmy_AbilifyProductLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:to="loc_bmy_AbilifyProductLiabilityMember_f45dad8e-9baf-4134-802a-37c4aa7f9657" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ByettaProductLiabilityLitigationMember_85469bc3-1ecb-4d86-81d8-0782971e26aa" xlink:href="bmy-20210630.xsd#bmy_ByettaProductLiabilityLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:to="loc_bmy_ByettaProductLiabilityLitigationMember_85469bc3-1ecb-4d86-81d8-0782971e26aa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BMSSecuritiesLitigationMember_13ef7611-06e2-4cb8-9f46-10cdf38ad69e" xlink:href="bmy-20210630.xsd#bmy_BMSSecuritiesLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:to="loc_bmy_BMSSecuritiesLitigationMember_13ef7611-06e2-4cb8-9f46-10cdf38ad69e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CerclaMattersMember_5a6616d0-9956-48cb-b9e2-51d3d186cc50" xlink:href="bmy-20210630.xsd#bmy_CerclaMattersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:to="loc_bmy_CerclaMattersMember_5a6616d0-9956-48cb-b9e2-51d3d186cc50" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbilifyProductLiabilityLitigationMember_5aa5931d-2d8b-4dbd-be15-e026bdc8251c" xlink:href="bmy-20210630.xsd#bmy_AbilifyProductLiabilityLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:to="loc_bmy_AbilifyProductLiabilityLitigationMember_5aa5931d-2d8b-4dbd-be15-e026bdc8251c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OnglyzaProductLiabilityLitigationMember_f3f3794d-7b30-4bb4-ad25-0c80c2bb8157" xlink:href="bmy-20210630.xsd#bmy_OnglyzaProductLiabilityLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:to="loc_bmy_OnglyzaProductLiabilityLitigationMember_f3f3794d-7b30-4bb4-ad25-0c80c2bb8157" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneSecuritiesLitigationMember_0314ff2e-73c5-4292-8c54-2e44bb0a7bc2" xlink:href="bmy-20210630.xsd#bmy_CelgeneSecuritiesLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:to="loc_bmy_CelgeneSecuritiesLitigationMember_0314ff2e-73c5-4292-8c54-2e44bb0a7bc2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_bd3275be-8074-42fd-91f8-c96d6709a232" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LitigationTable_2a5c283e-665b-4972-8d77-3e5de23b80ba" xlink:to="loc_srt_CurrencyAxis_bd3275be-8074-42fd-91f8-c96d6709a232" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_bd3275be-8074-42fd-91f8-c96d6709a232_default" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CurrencyAxis_bd3275be-8074-42fd-91f8-c96d6709a232" xlink:to="loc_currency_AllCurrenciesDomain_bd3275be-8074-42fd-91f8-c96d6709a232_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_76452f6c-8d7f-4c7c-8e22-d13da9e48a00" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CurrencyAxis_bd3275be-8074-42fd-91f8-c96d6709a232" xlink:to="loc_currency_AllCurrenciesDomain_76452f6c-8d7f-4c7c-8e22-d13da9e48a00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AUD_38d932f0-310c-4443-aaaf-244634470eec" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AUD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_76452f6c-8d7f-4c7c-8e22-d13da9e48a00" xlink:to="loc_currency_AUD_38d932f0-310c-4443-aaaf-244634470eec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_bd5fb4ab-3000-46af-91fe-ffc49a55f670" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currency_AllCurrenciesDomain_76452f6c-8d7f-4c7c-8e22-d13da9e48a00" xlink:to="loc_currency_USD_bd5fb4ab-3000-46af-91fe-ffc49a55f670" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_f32a461e-cf3d-48c5-a1b0-7fcf6953a877" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_bmy_LitigationTable_2a5c283e-665b-4972-8d77-3e5de23b80ba" xlink:to="loc_us-gaap_LitigationStatusAxis_f32a461e-cf3d-48c5-a1b0-7fcf6953a877" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_f32a461e-cf3d-48c5-a1b0-7fcf6953a877_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_f32a461e-cf3d-48c5-a1b0-7fcf6953a877" xlink:to="loc_us-gaap_LitigationStatusDomain_f32a461e-cf3d-48c5-a1b0-7fcf6953a877_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_050347b4-8daa-4947-8eef-80764c37d6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_f32a461e-cf3d-48c5-a1b0-7fcf6953a877" xlink:to="loc_us-gaap_LitigationStatusDomain_050347b4-8daa-4947-8eef-80764c37d6f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DismissedMember_b87895d3-8058-4617-a7f1-2b3bd0effe7c" xlink:href="bmy-20210630.xsd#bmy_DismissedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_050347b4-8daa-4947-8eef-80764c37d6f3" xlink:to="loc_bmy_DismissedMember_b87895d3-8058-4617-a7f1-2b3bd0effe7c" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>bmy-20210630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:744431a9-b3ff-43bd-afc9-1af61fbf126c,g:9fbce200-03f4-4882-8b59-75e21adfdbca-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax_91c86234-7be8-4ff9-a3ad-efa3ee3cea7a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-sale Securities, before Reclassification Adjustments, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_9eb72e25-aee5-4b7c-902d-98042265d7d1_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_7c5bf441-5454-4c0d-8449-c405019fba54_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_cde73cb4-a479-4fe7-8c68-66e2379b43f1_terseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Proceedings and Contingencies [Text Block]</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_087588da-da72-4122-b567-d2252f5c7022_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A2.875SeniorNotesdue2021Member_207485f4-2daa-4d3b-81e3-eb8dda595760_terseLabel_en-US" xlink:label="lab_bmy_A2.875SeniorNotesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% Senior Notes due 2021</link:label>
    <link:label id="lab_bmy_A2.875SeniorNotesdue2021Member_label_en-US" xlink:label="lab_bmy_A2.875SeniorNotesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% Senior Notes due 2021 [Member]</link:label>
    <link:label id="lab_bmy_A2.875SeniorNotesdue2021Member_documentation_en-US" xlink:label="lab_bmy_A2.875SeniorNotesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.875% Senior Notes due 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2.875SeniorNotesdue2021Member" xlink:href="bmy-20210630.xsd#bmy_A2.875SeniorNotesdue2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A2.875SeniorNotesdue2021Member" xlink:to="lab_bmy_A2.875SeniorNotesdue2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_162619d3-1b11-4883-bd19-0cb0e9faf942_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Integration expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a3165d81-01ef-4d88-9a90-0f75a6f343c3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_99a3ff81-4c77-4804-ae9e-45c0d103513c_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Earnings/(Loss) Attributable to BMS</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_54cf423a-870e-455b-abaf-8bc17fe55fa1_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Earnings/(Loss) Attributable to BMS Used for Basic and Diluted EPS Calculation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_54823bc5-5815-42dd-a955-c2e3a2e08465_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Earnings/(Loss) Attributable to BMS</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_b5d177ae-c7c6-4360-b121-fa663fa3308b_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue_a6307c5d-0d73-464c-8329-b27b012844fe_terseLabel_en-US" xlink:label="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of aggregate total trade receivables due from three pharmaceutical wholesalers</link:label>
    <link:label id="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue_label_en-US" xlink:label="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Aggregate Total Trade Receivables Due</link:label>
    <link:label id="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue_documentation_en-US" xlink:label="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percentage of aggregate trade receivables due from customers accounting for more than 10% of total trade receivables.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PercentageOfAggregateTotalTradeReceivablesDue" xlink:href="bmy-20210630.xsd#bmy_PercentageOfAggregateTotalTradeReceivablesDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_PercentageOfAggregateTotalTradeReceivablesDue" xlink:to="lab_bmy_PercentageOfAggregateTotalTradeReceivablesDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_133cc656-1035-4cf4-aab4-80c78ac19f6f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_9756f59b-ed58-4397-99c1-0980e1af6e27_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_224573f0-3fac-4e83-807a-8d1f1a567ff4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ad5db799-ab83-409c-a3a8-5719471d12e8_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentDetailAbstract_a7dfb073-182a-41d6-b630-a5551a96d0a7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentDetailAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument Detail [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentDetailAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentDetailAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument Detail [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentDetailAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentDetailAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentDetailAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_RestructuringRelatedCostsAssetImpairments_7fb5b621-cb51-47c2-a155-e4c84e165581_terseLabel_en-US" xlink:label="lab_bmy_RestructuringRelatedCostsAssetImpairments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairment</link:label>
    <link:label id="lab_bmy_RestructuringRelatedCostsAssetImpairments_label_en-US" xlink:label="lab_bmy_RestructuringRelatedCostsAssetImpairments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Related Costs, Asset Impairments</link:label>
    <link:label id="lab_bmy_RestructuringRelatedCostsAssetImpairments_documentation_en-US" xlink:label="lab_bmy_RestructuringRelatedCostsAssetImpairments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Related Costs, Asset Impairments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringRelatedCostsAssetImpairments" xlink:href="bmy-20210630.xsd#bmy_RestructuringRelatedCostsAssetImpairments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_RestructuringRelatedCostsAssetImpairments" xlink:to="lab_bmy_RestructuringRelatedCostsAssetImpairments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_0a568d94-1fb0-4b3d-9c45-9e90735819c6_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_92d0566c-c0c4-4e04-a797-d196085d5ee6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ContingentValueRightsMember_46a26d38-610c-4099-8a77-b778568f48cc_terseLabel_en-US" xlink:label="lab_bmy_ContingentValueRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Rights [Member]</link:label>
    <link:label id="lab_bmy_ContingentValueRightsMember_label_en-US" xlink:label="lab_bmy_ContingentValueRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Value Rights [Member]</link:label>
    <link:label id="lab_bmy_ContingentValueRightsMember_documentation_en-US" xlink:label="lab_bmy_ContingentValueRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BMY Contingent Value Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentValueRightsMember" xlink:href="bmy-20210630.xsd#bmy_ContingentValueRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ContingentValueRightsMember" xlink:to="lab_bmy_ContingentValueRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_404a1012-b150-4951-8a32-edd464f4dc85_terseLabel_en-US" xlink:label="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, Divestitures and Other Arrangements [Abstract]</link:label>
    <link:label id="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_label_en-US" xlink:label="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, Divestitures and Other Arrangements [Abstract]</link:label>
    <link:label id="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_documentation_en-US" xlink:label="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, Divestitures and Other Arrangements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" xlink:href="bmy-20210630.xsd#bmy_AcquisitionsDivestituresandOtherArrangementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" xlink:to="lab_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherRoyaltiesMember_76f44b4f-ec7b-4f4b-ac64-f656e8ce554a_terseLabel_en-US" xlink:label="lab_bmy_OtherRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Royalties</link:label>
    <link:label id="lab_bmy_OtherRoyaltiesMember_label_en-US" xlink:label="lab_bmy_OtherRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Royalties [Member]</link:label>
    <link:label id="lab_bmy_OtherRoyaltiesMember_documentation_en-US" xlink:label="lab_bmy_OtherRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRoyaltiesMember" xlink:href="bmy-20210630.xsd#bmy_OtherRoyaltiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherRoyaltiesMember" xlink:to="lab_bmy_OtherRoyaltiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_7e51c239-1be8-47ad-a89f-f9f8dda7f774_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_3fe6b18d-a655-44cc-9991-338536ed5288_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_f6616221-7560-4602-a985-9c2d5948a265_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_2353d7e9-12bd-4e21-8cb2-83b54e6acb11_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_MedicaidandMedicarerebatesMember_84663f9b-7f13-40f2-a7ab-bf9b9f235ca6_terseLabel_en-US" xlink:label="lab_bmy_MedicaidandMedicarerebatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Medicare rebates [Member]</link:label>
    <link:label id="lab_bmy_MedicaidandMedicarerebatesMember_label_en-US" xlink:label="lab_bmy_MedicaidandMedicarerebatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Medicare rebates [Member]</link:label>
    <link:label id="lab_bmy_MedicaidandMedicarerebatesMember_documentation_en-US" xlink:label="lab_bmy_MedicaidandMedicarerebatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Medicare rebates [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MedicaidandMedicarerebatesMember" xlink:href="bmy-20210630.xsd#bmy_MedicaidandMedicarerebatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_MedicaidandMedicarerebatesMember" xlink:to="lab_bmy_MedicaidandMedicarerebatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_23c0eec6-1d5a-40e0-aa76-f5f656140a0b_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c3687617-a634-4568-ad0c-bb17ecb10915_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_57c0920c-e3ae-4b1b-b0e3-0c1f8b6feff5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_e1245d6c-591d-44d0-b8eb-34eebd6a8a3c_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_7f9f4f9a-504d-4658-9be4-691b957f21f9_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_bacf1323-0bec-443c-9682-e712800d3dee_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_36307686-535c-48de-bdd6-89fba0970dc1_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Patents Allegedly Infringed, Number</link:label>
    <link:label id="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Patents Allegedly Infringed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:to="lab_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_f992e649-fb92-41d2-bbab-ad1967fa2a16_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_f8c691d5-f3d7-4e57-a4c8-137ebc75b72d_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_aea80b01-f85d-4491-afb8-a0a0768a02d3_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_70cd3f7e-d2e0-4c7b-9e17-8d7946c7725c_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_30728d83-3ee9-403a-a063-dc60e41c8acb_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw and packaging materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ZeroCostCollarCurrencyContractsMember_d884502e-6c19-4a81-bbc0-a81a657eb1a6_terseLabel_en-US" xlink:label="lab_bmy_ZeroCostCollarCurrencyContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero Cost Collar Currency Contracts</link:label>
    <link:label id="lab_bmy_ZeroCostCollarCurrencyContractsMember_label_en-US" xlink:label="lab_bmy_ZeroCostCollarCurrencyContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero Cost Collar Currency Contracts [Member]</link:label>
    <link:label id="lab_bmy_ZeroCostCollarCurrencyContractsMember_documentation_en-US" xlink:label="lab_bmy_ZeroCostCollarCurrencyContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero Cost Collar Currency Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ZeroCostCollarCurrencyContractsMember" xlink:href="bmy-20210630.xsd#bmy_ZeroCostCollarCurrencyContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ZeroCostCollarCurrencyContractsMember" xlink:to="lab_bmy_ZeroCostCollarCurrencyContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_f0c4f016-b71e-45ca-8e44-9ca8294503cb_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_f6324ff0-1b51-4a8f-90c4-f5c25ea1b6ee_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AbilifyProductLiabilityLitigationMember_36b4b505-efae-4080-9dde-b74dff005a5b_terseLabel_en-US" xlink:label="lab_bmy_AbilifyProductLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abilify Product Liability Litigation</link:label>
    <link:label id="lab_bmy_AbilifyProductLiabilityLitigationMember_label_en-US" xlink:label="lab_bmy_AbilifyProductLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abilify Product Liability Litigation [Member]</link:label>
    <link:label id="lab_bmy_AbilifyProductLiabilityLitigationMember_documentation_en-US" xlink:label="lab_bmy_AbilifyProductLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abilify Product Liability Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbilifyProductLiabilityLitigationMember" xlink:href="bmy-20210630.xsd#bmy_AbilifyProductLiabilityLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AbilifyProductLiabilityLitigationMember" xlink:to="lab_bmy_AbilifyProductLiabilityLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_bd729ee5-5def-4ba7-a0bc-064b8adf81f6_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AllianceTransitionalServices_71b2220c-bc6a-4a52-ab79-63285b5fcb9f_negatedTerseLabel_en-US" xlink:label="lab_bmy_AllianceTransitionalServices" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition and other service fees</link:label>
    <link:label id="lab_bmy_AllianceTransitionalServices_label_en-US" xlink:label="lab_bmy_AllianceTransitionalServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance Transitional Services</link:label>
    <link:label id="lab_bmy_AllianceTransitionalServices_documentation_en-US" xlink:label="lab_bmy_AllianceTransitionalServices" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents other income recognized during the period related to transitional services provided to a former alliance partner.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AllianceTransitionalServices" xlink:href="bmy-20210630.xsd#bmy_AllianceTransitionalServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AllianceTransitionalServices" xlink:to="lab_bmy_AllianceTransitionalServices" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_41f85560-a74d-49a6-bed7-7539074e43ea_terseLabel_en-US" xlink:label="lab_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Transaction Revenue, Description of Reporting Category [Axis]</link:label>
    <link:label id="lab_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_label_en-US" xlink:label="lab_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Transaction Revenue, Description of Reporting Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis" xlink:to="lab_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_52e1e4e0-ffbd-4565-9366-30ec5bcbcab9_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_694878f6-1a18-482a-8018-382819e7eb2c_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_a5625cc3-83c8-4f52-8c13-54a862baa550_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_bd946720-cb7c-47a7-863b-abcf94156b59_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_be1f874f-02ec-408f-a1ef-8c3f737ff711_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_767b8a89-5f54-49a8-90a9-d60e1d60b0f1_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AntiPD1AntibodyLitigationMember_e938e2f1-4127-4f8c-84b9-e4ce064f7f4b_terseLabel_en-US" xlink:label="lab_bmy_AntiPD1AntibodyLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-PD-1 Antibody Litigation [Member]</link:label>
    <link:label id="lab_bmy_AntiPD1AntibodyLitigationMember_label_en-US" xlink:label="lab_bmy_AntiPD1AntibodyLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-PD-1 Antibody Litigation [Member]</link:label>
    <link:label id="lab_bmy_AntiPD1AntibodyLitigationMember_documentation_en-US" xlink:label="lab_bmy_AntiPD1AntibodyLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-PD-1 Antibody Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AntiPD1AntibodyLitigationMember" xlink:href="bmy-20210630.xsd#bmy_AntiPD1AntibodyLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AntiPD1AntibodyLitigationMember" xlink:to="lab_bmy_AntiPD1AntibodyLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_87254850-a09f-4918-9ea2-5c6dd330c870_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsMember" xlink:to="lab_us-gaap_OtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ScheduleOfOtherIncomeExpenseTextBlock_d0c19298-d049-4224-bc2e-82a1ec56c6d2_terseLabel_en-US" xlink:label="lab_bmy_ScheduleOfOtherIncomeExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Income Expense [Table Text Block]</link:label>
    <link:label id="lab_bmy_ScheduleOfOtherIncomeExpenseTextBlock_label_en-US" xlink:label="lab_bmy_ScheduleOfOtherIncomeExpenseTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Other Income Expense [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfOtherIncomeExpenseTextBlock" xlink:href="bmy-20210630.xsd#bmy_ScheduleOfOtherIncomeExpenseTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ScheduleOfOtherIncomeExpenseTextBlock" xlink:to="lab_bmy_ScheduleOfOtherIncomeExpenseTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_00a3ce0a-f279-4152-a627-403812c2df1f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_4819585c-27a1-492f-bbdc-d9628a5f2ce3_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AccruedRebatesAndReturns_615ec6ad-1d5c-487d-ab2e-d8fdbc069f5e_terseLabel_en-US" xlink:label="lab_bmy_AccruedRebatesAndReturns" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebates and returns</link:label>
    <link:label id="lab_bmy_AccruedRebatesAndReturns_label_en-US" xlink:label="lab_bmy_AccruedRebatesAndReturns" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued rebates and returns</link:label>
    <link:label id="lab_bmy_AccruedRebatesAndReturns_documentation_en-US" xlink:label="lab_bmy_AccruedRebatesAndReturns" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of obligations incurred and payable pertaining to rebates to government programs and sales returns.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedRebatesAndReturns" xlink:href="bmy-20210630.xsd#bmy_AccruedRebatesAndReturns"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AccruedRebatesAndReturns" xlink:to="lab_bmy_AccruedRebatesAndReturns" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_c599100d-ad0c-4f2e-ba6f-5c7b1a4e3323_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits - Actuarial gains/(losses), After tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_04654a31-60ea-4d5d-87da-19c5dc15f6cf_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development [Member]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherrevenuesMember_93792763-e9c4-4f50-a076-1492be894853_terseLabel_en-US" xlink:label="lab_bmy_OtherrevenuesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues [Member]</link:label>
    <link:label id="lab_bmy_OtherrevenuesMember_label_en-US" xlink:label="lab_bmy_OtherrevenuesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues [Member]</link:label>
    <link:label id="lab_bmy_OtherrevenuesMember_documentation_en-US" xlink:label="lab_bmy_OtherrevenuesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenues [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherrevenuesMember" xlink:href="bmy-20210630.xsd#bmy_OtherrevenuesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherrevenuesMember" xlink:to="lab_bmy_OtherrevenuesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_NetproductsalesMember_ced1354a-2160-425f-9eca-b3013d415af1_terseLabel_en-US" xlink:label="lab_bmy_NetproductsalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net product sales [Member]</link:label>
    <link:label id="lab_bmy_NetproductsalesMember_label_en-US" xlink:label="lab_bmy_NetproductsalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net product sales [Member]</link:label>
    <link:label id="lab_bmy_NetproductsalesMember_documentation_en-US" xlink:label="lab_bmy_NetproductsalesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net product sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember" xlink:href="bmy-20210630.xsd#bmy_NetproductsalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_NetproductsalesMember" xlink:to="lab_bmy_NetproductsalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_a3f50860-6be9-450d-95fc-5129a3d46447_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrent" xlink:to="lab_us-gaap_DividendsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CompanyTransformationMember_8c727926-e4eb-447e-8deb-d8cdf0e04d32_terseLabel_en-US" xlink:label="lab_bmy_CompanyTransformationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Model 2020 [Member]</link:label>
    <link:label id="lab_bmy_CompanyTransformationMember_label_en-US" xlink:label="lab_bmy_CompanyTransformationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Transformation [Member]</link:label>
    <link:label id="lab_bmy_CompanyTransformationMember_documentation_en-US" xlink:label="lab_bmy_CompanyTransformationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Transformation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CompanyTransformationMember" xlink:href="bmy-20210630.xsd#bmy_CompanyTransformationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CompanyTransformationMember" xlink:to="lab_bmy_CompanyTransformationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidTaxes_1051a6b2-617c-49e7-a8b3-dd6e44575a0a_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid and refundable income taxes</link:label>
    <link:label id="lab_us-gaap_PrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_PrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidTaxes" xlink:to="lab_us-gaap_PrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsDomain_bb6ebfaf-9a89-4604-ab9b-fba084a4a674_terseLabel_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements [Domain]</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsDomain_label_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements [Domain]</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsDomain_documentation_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsDomain" xlink:href="bmy-20210630.xsd#bmy_LicensingAndOtherArrangementsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain" xlink:to="lab_bmy_LicensingAndOtherArrangementsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax_b20a2f04-6ea6-4181-8dab-07ca04c128a4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits - Curtailments and settlements, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Adjustment for Settlement or Curtailment Gain (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e1b43fc0-af5f-4c92-8ad3-60943d27a679_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_f3dd5a24-216e-488a-ab0f-fee922ade320_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_64fdb1b5-208c-4cc2-9d07-a1185e04ea6a_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsTable_f6ca4b52-eccd-467a-8800-ec60d400ca87_terseLabel_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Table]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsTable_label_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Table]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsTable_documentation_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsTable" xlink:href="bmy-20210630.xsd#bmy_GrosstoNetAdjustmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_GrosstoNetAdjustmentsTable" xlink:to="lab_bmy_GrosstoNetAdjustmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_476f604e-b996-40da-8af4-bf05f3815d8d_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax, Total</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_744c2a4c-8414-45c6-bf85-69114a3c2788_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_33e75c73-e991-467d-ae3d-397faa4b6dfa_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_1821f577-b08c-4fe8-b1ac-8d52c306d6fd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4e9b4caa-d4bd-4321-9bc8-68800f61d6b1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_4e07a848-d666-4eec-b19a-4be9874e38a0_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_05114e03-1aa8-4fe5-b631-82f8ff48f87c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherOtherIncomeExpense_d06daa94-fbe4-47a5-96fd-2e43b69258af_negatedTerseLabel_en-US" xlink:label="lab_bmy_OtherOtherIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_bmy_OtherOtherIncomeExpense_label_en-US" xlink:label="lab_bmy_OtherOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Other Income Expense</link:label>
    <link:label id="lab_bmy_OtherOtherIncomeExpense_documentation_en-US" xlink:label="lab_bmy_OtherOtherIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net amount of other (income)/expense which does not qualify for separate disclosure under materiality guidelines.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherOtherIncomeExpense" xlink:href="bmy-20210630.xsd#bmy_OtherOtherIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherOtherIncomeExpense" xlink:to="lab_bmy_OtherOtherIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange_0ac8cc81-54db-4bcc-9471-d09c9cf39e1a_terseLabel_en-US" xlink:label="lab_bmy_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings, Foreign Exchange</link:label>
    <link:label id="lab_bmy_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange_label_en-US" xlink:label="lab_bmy_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings, Foreign Exchange</link:label>
    <link:label id="lab_bmy_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange_documentation_en-US" xlink:label="lab_bmy_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings, Foreign Exchange</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange" xlink:href="bmy-20210630.xsd#bmy_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange" xlink:to="lab_bmy_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_893e260a-bb1a-44bc-bcd9-39fc8cb07bac_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_4fb706f4-15f9-4da7-bbe9-48a6a46ddf43_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_78bd00b5-b95c-4de5-a2af-05e92892f46f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_7f52164e-369a-47ff-b77c-eb358a1d8812_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_11021c6b-a9aa-4951-becd-d65c4342cee8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_da4e60d1-78f6-4d3a-9ca8-8b63e7ef1995_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CurrencyAxis_ce30f2dd-0aff-435b-b4fd-f0575e139430_terseLabel_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:label id="lab_srt_CurrencyAxis_label_en-US" xlink:label="lab_srt_CurrencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CurrencyAxis" xlink:to="lab_srt_CurrencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_d4d0b41b-f9a6-4edb-b1ec-ddcec8dbd63d_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_ee05b0bb-1d13-4d96-830b-ac89c21f656a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity_64dda573-45f0-49b6-88fd-c6377ba85c90_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of equity investment securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Available-for-sale Securities, Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_60036217-e487-409e-974a-c3165af46b37_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationTypeDomain_a69b194a-6ad1-4ee4-ac92-3ceb97735fa9_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ReclassificationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationTypeDomain" xlink:to="lab_us-gaap_ReclassificationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_IncomeTaxExpenseBenefitComponentAxis_4703a4a2-8936-4341-a1f0-0d29d6d9d770_terseLabel_en-US" xlink:label="lab_bmy_IncomeTaxExpenseBenefitComponentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense/Benefit Component [Axis]</link:label>
    <link:label id="lab_bmy_IncomeTaxExpenseBenefitComponentAxis_label_en-US" xlink:label="lab_bmy_IncomeTaxExpenseBenefitComponentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense/Benefit Component [Axis]</link:label>
    <link:label id="lab_bmy_IncomeTaxExpenseBenefitComponentAxis_documentation_en-US" xlink:label="lab_bmy_IncomeTaxExpenseBenefitComponentAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense/Benefit Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IncomeTaxExpenseBenefitComponentAxis" xlink:href="bmy-20210630.xsd#bmy_IncomeTaxExpenseBenefitComponentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_IncomeTaxExpenseBenefitComponentAxis" xlink:to="lab_bmy_IncomeTaxExpenseBenefitComponentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AllianceandotherrevenuesMember_50515841-8b8c-4756-8531-497bf258f518_terseLabel_en-US" xlink:label="lab_bmy_AllianceandotherrevenuesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance and other revenues [Member]</link:label>
    <link:label id="lab_bmy_AllianceandotherrevenuesMember_label_en-US" xlink:label="lab_bmy_AllianceandotherrevenuesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance and other revenues [Member]</link:label>
    <link:label id="lab_bmy_AllianceandotherrevenuesMember_documentation_en-US" xlink:label="lab_bmy_AllianceandotherrevenuesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance and other revenues [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AllianceandotherrevenuesMember" xlink:href="bmy-20210630.xsd#bmy_AllianceandotherrevenuesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AllianceandotherrevenuesMember" xlink:to="lab_bmy_AllianceandotherrevenuesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_9e2df315-6772-484f-8519-30ad9a054566_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsAbstract_2bc6a0d7-e63e-42c6-a3d9-de686843d895_terseLabel_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross-to-Net Adjustments [Abstract]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsAbstract_label_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross-to-Net Adjustments [Abstract]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsAbstract_documentation_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross-to-Net Adjustments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsAbstract" xlink:href="bmy-20210630.xsd#bmy_GrosstoNetAdjustmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_GrosstoNetAdjustmentsAbstract" xlink:to="lab_bmy_GrosstoNetAdjustmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_2a233049-fb61-4b07-ab0c-0a69153e57c2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input [Extensible List]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_370dcb62-db41-4dc1-b448-360bfd12b0c3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_c778649f-5e37-4bb1-9db3-3933bec2420b_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EquityInvestmentsCurrent_3cc56e82-26a9-4d51-8285-5f1fdedeb025_terseLabel_en-US" xlink:label="lab_bmy_EquityInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments</link:label>
    <link:label id="lab_bmy_EquityInvestmentsCurrent_label_en-US" xlink:label="lab_bmy_EquityInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments - current</link:label>
    <link:label id="lab_bmy_EquityInvestmentsCurrent_documentation_en-US" xlink:label="lab_bmy_EquityInvestmentsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments - current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestmentsCurrent" xlink:href="bmy-20210630.xsd#bmy_EquityInvestmentsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EquityInvestmentsCurrent" xlink:to="lab_bmy_EquityInvestmentsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_d5f83a70-8560-41f6-b70f-d01e56b3c40e_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6c4fecdd-8ed5-497d-8548-f2dec03f79a3_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1829e731-4998-42af-93ba-bd03c46cb980_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income/(Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_51053821-8584-461f-a0c3-721c62c68135_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits - Actuarial gains/(losses), Pre-tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_ad2483a1-eade-4573-aef2-1697b2a31316_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherShortTermBorrowings_8d5c6c7a-fe11-4a0d-9e47-03b4439c349d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Short-term Borrowings</link:label>
    <link:label id="lab_us-gaap_OtherShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_OtherShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Short-term Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherShortTermBorrowings" xlink:to="lab_us-gaap_OtherShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_76f2a2f4-8bb4-4241-87e3-17d79013d38d_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingArrangementsTable_e363ccf6-4c3f-45db-a5c5-9c97c0531831_terseLabel_en-US" xlink:label="lab_bmy_LicensingArrangementsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements [Table]</link:label>
    <link:label id="lab_bmy_LicensingArrangementsTable_label_en-US" xlink:label="lab_bmy_LicensingArrangementsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements [Table]</link:label>
    <link:label id="lab_bmy_LicensingArrangementsTable_documentation_en-US" xlink:label="lab_bmy_LicensingArrangementsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsTable" xlink:href="bmy-20210630.xsd#bmy_LicensingArrangementsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingArrangementsTable" xlink:to="lab_bmy_LicensingArrangementsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_4c17f04c-92e8-41e3-b7fb-9e25c3f4d90b_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income/(Loss), Pre-tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_NumberofRevolvingCreditFacilities_704e8104-e7bc-421f-81bc-85a7a99186cd_terseLabel_en-US" xlink:label="lab_bmy_NumberofRevolvingCreditFacilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Revolving Credit Facilities</link:label>
    <link:label id="lab_bmy_NumberofRevolvingCreditFacilities_label_en-US" xlink:label="lab_bmy_NumberofRevolvingCreditFacilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Revolving Credit Facilities</link:label>
    <link:label id="lab_bmy_NumberofRevolvingCreditFacilities_documentation_en-US" xlink:label="lab_bmy_NumberofRevolvingCreditFacilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Revolving Credit Facilities: Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NumberofRevolvingCreditFacilities" xlink:href="bmy-20210630.xsd#bmy_NumberofRevolvingCreditFacilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_NumberofRevolvingCreditFacilities" xlink:to="lab_bmy_NumberofRevolvingCreditFacilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_fe7abb2a-de22-47be-88f2-a875ff2ace4d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income)/expense,net [Member]</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_94cbf5f8-e8a0-4394-81fa-24a68fc65645_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings/(Loss) Per Share, Basic</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_729cb25b-5300-4454-af45-a76740695351_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_b05f55d7-1caf-431e-bfe3-fad6eb718c36_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_2a06b33d-a6cf-42cc-bbff-b1ca6fe2cab7_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_dafeea3c-c8c0-4353-9565-65e28dfef4d0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_299259b8-2489-4101-82b7-a4a8a644f623_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits, After tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_NumberOfLargestPharmaceuticalWholesalers_65f78113-fa19-4e15-a5fb-0906c039238a_terseLabel_en-US" xlink:label="lab_bmy_NumberOfLargestPharmaceuticalWholesalers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Largest Pharmaceutical Wholesalers</link:label>
    <link:label id="lab_bmy_NumberOfLargestPharmaceuticalWholesalers_label_en-US" xlink:label="lab_bmy_NumberOfLargestPharmaceuticalWholesalers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Largest Pharmaceutical Wholesalers</link:label>
    <link:label id="lab_bmy_NumberOfLargestPharmaceuticalWholesalers_documentation_en-US" xlink:label="lab_bmy_NumberOfLargestPharmaceuticalWholesalers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of the largest pharmaceutical wholesalers used by the company in the territory.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NumberOfLargestPharmaceuticalWholesalers" xlink:href="bmy-20210630.xsd#bmy_NumberOfLargestPharmaceuticalWholesalers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_NumberOfLargestPharmaceuticalWholesalers" xlink:to="lab_bmy_NumberOfLargestPharmaceuticalWholesalers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_b6406244-df5d-4f47-9965-1ae10095acc2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_8d4955df-7fab-42aa-84ef-f72d575a02a3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_f856ead5-e66a-4bd1-bac2-d69656d41837_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation and other</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveTranslationAdjustment_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveTranslationAdjustment" xlink:to="lab_us-gaap_RestructuringReserveTranslationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_878f4a03-faf6-40bb-a0ea-5748c3ed5c62_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AssetAcquisitionNameDomain_06abf63b-07d0-4624-83cd-1c6fcbd285df_terseLabel_en-US" xlink:label="lab_bmy_AssetAcquisitionNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition Name [Domain]</link:label>
    <link:label id="lab_bmy_AssetAcquisitionNameDomain_label_en-US" xlink:label="lab_bmy_AssetAcquisitionNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition Name [Domain]</link:label>
    <link:label id="lab_bmy_AssetAcquisitionNameDomain_documentation_en-US" xlink:label="lab_bmy_AssetAcquisitionNameDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AssetAcquisitionNameDomain" xlink:href="bmy-20210630.xsd#bmy_AssetAcquisitionNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AssetAcquisitionNameDomain" xlink:to="lab_bmy_AssetAcquisitionNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_RevlimidMember_ef39b6b2-35de-4555-bd3e-10508fabee1f_terseLabel_en-US" xlink:label="lab_bmy_RevlimidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revlimid [Member]</link:label>
    <link:label id="lab_bmy_RevlimidMember_label_en-US" xlink:label="lab_bmy_RevlimidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revlimid [Member]</link:label>
    <link:label id="lab_bmy_RevlimidMember_documentation_en-US" xlink:label="lab_bmy_RevlimidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revlimid [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RevlimidMember" xlink:href="bmy-20210630.xsd#bmy_RevlimidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_RevlimidMember" xlink:to="lab_bmy_RevlimidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_c144e6b5-a153-4cc0-b63b-d082d7f987b9_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_2d389f20-ad2e-411e-ab32-bbd16dd30f53_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_GrosstoNetAdjustments_3a63b487-245f-47ea-bf3d-f6c43bed052e_negatedTerseLabel_en-US" xlink:label="lab_bmy_GrosstoNetAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustments_label_en-US" xlink:label="lab_bmy_GrosstoNetAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustments_documentation_en-US" xlink:label="lab_bmy_GrosstoNetAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustments" xlink:href="bmy-20210630.xsd#bmy_GrosstoNetAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_GrosstoNetAdjustments" xlink:to="lab_bmy_GrosstoNetAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_f2f2a2d2-9136-47cc-b299-decd4d997f12_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_8cea3895-73fc-4069-a6f6-f8f7032105ea_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment and fixtures</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_63b5dfc5-ac48-47f5-bf84-bae8a999bdea_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_UpfrontPaymentsMadeToCollaborativePartner_c8c9cbff-17fb-4d92-aeb9-1caa4a2559f2_terseLabel_en-US" xlink:label="lab_bmy_UpfrontPaymentsMadeToCollaborativePartner" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront Payments Made To Collaborative Partner</link:label>
    <link:label id="lab_bmy_UpfrontPaymentsMadeToCollaborativePartner_label_en-US" xlink:label="lab_bmy_UpfrontPaymentsMadeToCollaborativePartner" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront Payments Made To Collaborative Partner</link:label>
    <link:label id="lab_bmy_UpfrontPaymentsMadeToCollaborativePartner_documentation_en-US" xlink:label="lab_bmy_UpfrontPaymentsMadeToCollaborativePartner" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payments made to partner as part of collaborative arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_UpfrontPaymentsMadeToCollaborativePartner" xlink:href="bmy-20210630.xsd#bmy_UpfrontPaymentsMadeToCollaborativePartner"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_UpfrontPaymentsMadeToCollaborativePartner" xlink:to="lab_bmy_UpfrontPaymentsMadeToCollaborativePartner" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AUD_03162fa0-896c-456f-938f-4ef973342b9d_terseLabel_en-US" xlink:label="lab_currency_AUD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australia, Dollars</link:label>
    <link:label id="lab_currency_AUD_label_en-US" xlink:label="lab_currency_AUD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Australia, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AUD" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AUD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AUD" xlink:to="lab_currency_AUD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_2c53c080-cb32-4625-95ee-a122e3e6f0e0_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt obligations, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_6d764833-d002-4f12-93a2-1b2772c2daf9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_12bca362-535c-4d43-8b0c-3dfc96f78d97_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_5a7df7fe-97c9-47a0-a443-39c12f1973b0_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Number of Positions Eliminated</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Number of Positions Eliminated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:to="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_325b72e4-af2e-495f-af90-9766e79e5e50_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges_ed9495e2-2b2b-4599-ba73-a4db602f6fcc_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs and Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:to="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_064eb26b-f1df-42bc-b31c-52aca1553cbc_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_c4498ece-a3bc-4288-aff8-ab1fb1322845_verboseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables - from alliance partners</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_0e395200-2f03-4507-9a06-06a0e18090bc_totalLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EliquisPatentLitigationMember_9fbacb61-77b6-4d04-acf1-f70f5adfc2aa_terseLabel_en-US" xlink:label="lab_bmy_EliquisPatentLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eliquis Patent Litigation [Member]</link:label>
    <link:label id="lab_bmy_EliquisPatentLitigationMember_label_en-US" xlink:label="lab_bmy_EliquisPatentLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eliquis Patent Litigation [Member]</link:label>
    <link:label id="lab_bmy_EliquisPatentLitigationMember_documentation_en-US" xlink:label="lab_bmy_EliquisPatentLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eliquis Patent Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EliquisPatentLitigationMember" xlink:href="bmy-20210630.xsd#bmy_EliquisPatentLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EliquisPatentLitigationMember" xlink:to="lab_bmy_EliquisPatentLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_fdba2298-0f91-4b0f-8f55-7a7c9408a936_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments_61da8b65-9152-4412-836a-d837375d5076_terseLabel_en-US" xlink:label="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License and Other Arrangements Upfront Payments</link:label>
    <link:label id="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments_label_en-US" xlink:label="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License and Other Arrangements Upfront Payments</link:label>
    <link:label id="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments_documentation_en-US" xlink:label="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License and Other Arrangements Upfront Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments" xlink:href="bmy-20210630.xsd#bmy_LicenseAndOtherArrangementsUpfrontPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments" xlink:to="lab_bmy_LicenseAndOtherArrangementsUpfrontPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_72463e29-b811-424c-9207-a3c18de59341_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in estimates</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveAccrualAdjustment1_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Accrual Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:to="lab_us-gaap_RestructuringReserveAccrualAdjustment1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_1a9a7091-a6b4-434f-a540-fac5edd2f4f6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_636d588e-a66d-4e6d-81ea-7e3ea13a4849_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6842ed63-2f3f-4514-a340-a05419482950_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows From Investing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_2603b541-14fe-41d7-ae69-ab645f700b2f_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_SalesRevenueGrossMember_440aff29-150c-4bb2-b3e2-f25eb7412a3e_terseLabel_en-US" xlink:label="lab_bmy_SalesRevenueGrossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Gross [Member]</link:label>
    <link:label id="lab_bmy_SalesRevenueGrossMember_label_en-US" xlink:label="lab_bmy_SalesRevenueGrossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Gross [Member]</link:label>
    <link:label id="lab_bmy_SalesRevenueGrossMember_documentation_en-US" xlink:label="lab_bmy_SalesRevenueGrossMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue, Gross [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SalesRevenueGrossMember" xlink:href="bmy-20210630.xsd#bmy_SalesRevenueGrossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_SalesRevenueGrossMember" xlink:to="lab_bmy_SalesRevenueGrossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_379de569-5023-4e8e-8b2e-d7144c433ae1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement_b77bc9c1-6119-4f24-b8f6-5c9bf184ec0b_terseLabel_en-US" xlink:label="lab_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:label id="lab_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement_label_en-US" xlink:label="lab_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense - Collaborative Arrangement</link:label>
    <link:label id="lab_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement_documentation_en-US" xlink:label="lab_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense - Collaborative Arrangement. The balance can be debit/credit based on the nature of the arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement" xlink:href="bmy-20210630.xsd#bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement" xlink:to="lab_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_BreyanziMember_29f2562e-4ab9-46bc-af25-1c16e479135c_terseLabel_en-US" xlink:label="lab_bmy_BreyanziMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breyanzi</link:label>
    <link:label id="lab_bmy_BreyanziMember_label_en-US" xlink:label="lab_bmy_BreyanziMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breyanzi [Member]</link:label>
    <link:label id="lab_bmy_BreyanziMember_documentation_en-US" xlink:label="lab_bmy_BreyanziMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breyanzi</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BreyanziMember" xlink:href="bmy-20210630.xsd#bmy_BreyanziMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_BreyanziMember" xlink:to="lab_bmy_BreyanziMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_4bce3c84-42da-4155-bf24-171341637eb6_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_9f7aa5d5-38e1-4cef-bffd-f88e62c9b352_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_786ac79d-0e3c-478e-b1bc-8c14de53eca6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives qualifying as cash flow hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_9d200694-f7d3-4867-aa48-fa7f5a7eb837_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_6b98d2fe-9011-444e-bcf2-2f49820eb050_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_c002a5b2-7b34-409d-afa9-94e6d2eaf181_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale and maturities of marketable debt securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock_686331fb-8de0-4555-a49d-e457748584a3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Valuation Techniques [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_1ca47fee-6675-47a2-bded-ae68c4b20a8e_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_SharebasedPaymentArrangementCostbyPlanAbstract_092db78b-0d70-4825-81b2-1e848459d91b_terseLabel_en-US" xlink:label="lab_bmy_SharebasedPaymentArrangementCostbyPlanAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Abstract]</link:label>
    <link:label id="lab_bmy_SharebasedPaymentArrangementCostbyPlanAbstract_label_en-US" xlink:label="lab_bmy_SharebasedPaymentArrangementCostbyPlanAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Abstract]</link:label>
    <link:label id="lab_bmy_SharebasedPaymentArrangementCostbyPlanAbstract_documentation_en-US" xlink:label="lab_bmy_SharebasedPaymentArrangementCostbyPlanAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SharebasedPaymentArrangementCostbyPlanAbstract" xlink:href="bmy-20210630.xsd#bmy_SharebasedPaymentArrangementCostbyPlanAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_SharebasedPaymentArrangementCostbyPlanAbstract" xlink:to="lab_bmy_SharebasedPaymentArrangementCostbyPlanAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_e9043878-0529-4377-8238-952586dde436_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in excess of par value of stock</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_fe7c51eb-f40b-472f-8a83-4b3fb1ef0623_periodStartLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in Excess of Par Value of Stock, Balance at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_108e86c2-cfea-48ad-8355-9b52f83fceec_periodEndLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in Excess of Par Value of Stock, Balance at End of Period</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_b770c063-a4e5-4488-b2f6-9ea077590930_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CelgeneContingentValueRightsMember_ea15fcc6-6e62-418f-8578-06330557b4f9_terseLabel_en-US" xlink:label="lab_bmy_CelgeneContingentValueRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Contingent Value Rights [Member]</link:label>
    <link:label id="lab_bmy_CelgeneContingentValueRightsMember_label_en-US" xlink:label="lab_bmy_CelgeneContingentValueRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Contingent Value Rights [Member]</link:label>
    <link:label id="lab_bmy_CelgeneContingentValueRightsMember_documentation_en-US" xlink:label="lab_bmy_CelgeneContingentValueRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Contingent Value Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneContingentValueRightsMember" xlink:href="bmy-20210630.xsd#bmy_CelgeneContingentValueRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CelgeneContingentValueRightsMember" xlink:to="lab_bmy_CelgeneContingentValueRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_8fedbf19-02c9-4dca-a899-71d63d511336_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_Divestituregainsandroyalties_1363c1c2-94de-4b3b-912e-aeeaa6ec9018_negatedTerseLabel_en-US" xlink:label="lab_bmy_Divestituregainsandroyalties" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture gains and royalties</link:label>
    <link:label id="lab_bmy_Divestituregainsandroyalties_label_en-US" xlink:label="lab_bmy_Divestituregainsandroyalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture gains and royalties</link:label>
    <link:label id="lab_bmy_Divestituregainsandroyalties_documentation_en-US" xlink:label="lab_bmy_Divestituregainsandroyalties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This represents the amount of gains and royalties as a result of business divestitures.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Divestituregainsandroyalties" xlink:href="bmy-20210630.xsd#bmy_Divestituregainsandroyalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_Divestituregainsandroyalties" xlink:to="lab_bmy_Divestituregainsandroyalties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_a42024e2-c0a1-42f0-9673-1b825365d0e9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_bfe77666-4663-4396-afc0-341efa140c99_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_56f556a8-df9b-4c4c-b8d7-d21863a7828d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_0ef8c762-31eb-4ea8-99e4-32953295733a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_33f04437-c6a1-4171-aba2-6a24821e77c9_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_a455fd82-5b0e-4926-b3ef-3f0cf59bc273_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings/(Loss) Per Share [Text Block]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_a3a06a80-4fdf-4931-91a9-b2bfc2afe20b_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Other than Fair Value Measurement [Member]</link:label>
    <link:label id="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Other than Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_YervoyMember_3a46ef68-7005-420c-ace3-c7899c18fb23_terseLabel_en-US" xlink:label="lab_bmy_YervoyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yervoy [Member]</link:label>
    <link:label id="lab_bmy_YervoyMember_label_en-US" xlink:label="lab_bmy_YervoyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Yervoy [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_YervoyMember" xlink:href="bmy-20210630.xsd#bmy_YervoyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_YervoyMember" xlink:to="lab_bmy_YervoyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_bad2c917-3342-4f80-8834-a1710a7a306c_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Financial Information Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Financial Information Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:to="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_25c190bc-40ce-47b4-9f3a-ce363f71b79c_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ProbabilityofpaymentMember_5fd74f87-6602-4e73-98f1-176acab34093_terseLabel_en-US" xlink:label="lab_bmy_ProbabilityofpaymentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Probability of payment [Member]</link:label>
    <link:label id="lab_bmy_ProbabilityofpaymentMember_label_en-US" xlink:label="lab_bmy_ProbabilityofpaymentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Probability of payment [Member]</link:label>
    <link:label id="lab_bmy_ProbabilityofpaymentMember_documentation_en-US" xlink:label="lab_bmy_ProbabilityofpaymentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Probability of payment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ProbabilityofpaymentMember" xlink:href="bmy-20210630.xsd#bmy_ProbabilityofpaymentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ProbabilityofpaymentMember" xlink:to="lab_bmy_ProbabilityofpaymentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_1d02bd9c-3729-4e15-9723-ea443670de12_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9e228983-5e36-4afb-8a2d-f06bfb9fd46f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration fair value adjustments</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_c4d57a36-d65c-4336-84cc-e1b7501ccfe5_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_a3148628-ce8d-453f-955a-b58fb589da14_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable debt securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_648eee41-455b-468a-b8f4-3d777d769e52_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_339ad20c-fb9e-48ed-b387-8b112791dee6_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AssetAcquisitionNameAxis_cceaaad7-899b-4d8c-a09d-b3798ea35106_terseLabel_en-US" xlink:label="lab_bmy_AssetAcquisitionNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition Name [Axis]</link:label>
    <link:label id="lab_bmy_AssetAcquisitionNameAxis_label_en-US" xlink:label="lab_bmy_AssetAcquisitionNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition Name [Axis]</link:label>
    <link:label id="lab_bmy_AssetAcquisitionNameAxis_documentation_en-US" xlink:label="lab_bmy_AssetAcquisitionNameAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AssetAcquisitionNameAxis" xlink:href="bmy-20210630.xsd#bmy_AssetAcquisitionNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AssetAcquisitionNameAxis" xlink:to="lab_bmy_AssetAcquisitionNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsAxis_6662f555-cb24-4cc3-b9a5-a7c315beeb83_terseLabel_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Axis]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsAxis_label_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Axis]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsAxis_documentation_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsAxis" xlink:href="bmy-20210630.xsd#bmy_GrosstoNetAdjustmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_GrosstoNetAdjustmentsAxis" xlink:to="lab_bmy_GrosstoNetAdjustmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ResearchandDevelopment_c8d15c72-9062-4d82-b215-d76254c15a69_terseLabel_en-US" xlink:label="lab_bmy_ResearchandDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development</link:label>
    <link:label id="lab_bmy_ResearchandDevelopment_label_en-US" xlink:label="lab_bmy_ResearchandDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development</link:label>
    <link:label id="lab_bmy_ResearchandDevelopment_documentation_en-US" xlink:label="lab_bmy_ResearchandDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchandDevelopment" xlink:href="bmy-20210630.xsd#bmy_ResearchandDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ResearchandDevelopment" xlink:to="lab_bmy_ResearchandDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c3c4868c-5695-4e10-9904-1879f8a73f1a_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ba41189e-b28d-4acc-b4f8-01439ea51a9a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Before Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_41620a90-93ad-4554-9bd4-37f331d2b951_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing, selling and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeNoncurrent_26a6b68b-f63e-42f0-b01a-a0a149a7f482_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeNoncurrent" xlink:to="lab_us-gaap_DeferredIncomeNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3956ce5c-5277-4963-a1db-5035c41d0034_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_MatureProductsAndAllOtherMember_5f31ca63-1a1b-467e-af4e-13aadce3095b_terseLabel_en-US" xlink:label="lab_bmy_MatureProductsAndAllOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature Products And All Other [Member]</link:label>
    <link:label id="lab_bmy_MatureProductsAndAllOtherMember_label_en-US" xlink:label="lab_bmy_MatureProductsAndAllOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature Products And All Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureProductsAndAllOtherMember" xlink:href="bmy-20210630.xsd#bmy_MatureProductsAndAllOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_MatureProductsAndAllOtherMember" xlink:to="lab_bmy_MatureProductsAndAllOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_39df3869-79c7-4e46-9767-ba1c25d838b0_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAmortizationOfDeferredCharges_427f897a-7bb7-46f9-aeea-0884f28a1b7a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Other Deferred Charges</link:label>
    <link:label id="lab_us-gaap_OtherAmortizationOfDeferredCharges_label_en-US" xlink:label="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Other Deferred Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAmortizationOfDeferredCharges" xlink:to="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CelgeneSecuritiesLitigationMember_1982ce1a-4185-4bc2-9f61-7957068c3fe3_terseLabel_en-US" xlink:label="lab_bmy_CelgeneSecuritiesLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Securities Litigation</link:label>
    <link:label id="lab_bmy_CelgeneSecuritiesLitigationMember_label_en-US" xlink:label="lab_bmy_CelgeneSecuritiesLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Securities Litigation [Member]</link:label>
    <link:label id="lab_bmy_CelgeneSecuritiesLitigationMember_documentation_en-US" xlink:label="lab_bmy_CelgeneSecuritiesLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Securities Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneSecuritiesLitigationMember" xlink:href="bmy-20210630.xsd#bmy_CelgeneSecuritiesLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CelgeneSecuritiesLitigationMember" xlink:to="lab_bmy_CelgeneSecuritiesLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CARTKiteLitigationMember_4b8db114-b92f-4364-8103-98e3fad2b55f_terseLabel_en-US" xlink:label="lab_bmy_CARTKiteLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAR T Kite Litigation [Member]</link:label>
    <link:label id="lab_bmy_CARTKiteLitigationMember_label_en-US" xlink:label="lab_bmy_CARTKiteLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAR T Kite Litigation [Member]</link:label>
    <link:label id="lab_bmy_CARTKiteLitigationMember_documentation_en-US" xlink:label="lab_bmy_CARTKiteLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CAR T Kite Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CARTKiteLitigationMember" xlink:href="bmy-20210630.xsd#bmy_CARTKiteLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CARTKiteLitigationMember" xlink:to="lab_bmy_CARTKiteLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_c57b3e7f-a9cb-4181-a691-3e422ba246c7_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_UpFrontLicensingFee_aa5f68cc-143f-442d-bd8f-512bc20a4838_negatedTerseLabel_en-US" xlink:label="lab_bmy_UpFrontLicensingFee" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Up-front Licensing Fee</link:label>
    <link:label id="lab_bmy_UpFrontLicensingFee_label_en-US" xlink:label="lab_bmy_UpFrontLicensingFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Up-front Licensing Fee</link:label>
    <link:label id="lab_bmy_UpFrontLicensingFee_documentation_en-US" xlink:label="lab_bmy_UpFrontLicensingFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Up-front Licensing Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_UpFrontLicensingFee" xlink:href="bmy-20210630.xsd#bmy_UpFrontLicensingFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_UpFrontLicensingFee" xlink:to="lab_bmy_UpFrontLicensingFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_d9112098-29dd-49d9-a82c-9c1dda5e1d1d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Liability</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_33f1a053-7887-4e52-90aa-d659f81cbc3f_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_86a16373-6bad-4c69-aed6-f9e563d55cb5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_Considerationforcontingentdevelopmentandregulatoryapproval_a38b09a5-5b9d-4ac4-bafb-af2257900a86_terseLabel_en-US" xlink:label="lab_bmy_Considerationforcontingentdevelopmentandregulatoryapproval" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration for contingent development and regulatory approval</link:label>
    <link:label id="lab_bmy_Considerationforcontingentdevelopmentandregulatoryapproval_label_en-US" xlink:label="lab_bmy_Considerationforcontingentdevelopmentandregulatoryapproval" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration for contingent development and regulatory approval</link:label>
    <link:label id="lab_bmy_Considerationforcontingentdevelopmentandregulatoryapproval_documentation_en-US" xlink:label="lab_bmy_Considerationforcontingentdevelopmentandregulatoryapproval" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents that additional aggregate consideration for contingent development and regulatory approval milestone payments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Considerationforcontingentdevelopmentandregulatoryapproval" xlink:href="bmy-20210630.xsd#bmy_Considerationforcontingentdevelopmentandregulatoryapproval"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_Considerationforcontingentdevelopmentandregulatoryapproval" xlink:to="lab_bmy_Considerationforcontingentdevelopmentandregulatoryapproval" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_974eb869-ecee-4f67-9603-9d9960a4928d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AcceleratedStockBasedCompensationMember_8f9bb4c0-64ae-4342-bbc2-6e4d794d30b7_terseLabel_en-US" xlink:label="lab_bmy_AcceleratedStockBasedCompensationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Stock Based Compensation [Member]</link:label>
    <link:label id="lab_bmy_AcceleratedStockBasedCompensationMember_label_en-US" xlink:label="lab_bmy_AcceleratedStockBasedCompensationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Stock Based Compensation [Member]</link:label>
    <link:label id="lab_bmy_AcceleratedStockBasedCompensationMember_documentation_en-US" xlink:label="lab_bmy_AcceleratedStockBasedCompensationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Stock Based Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcceleratedStockBasedCompensationMember" xlink:href="bmy-20210630.xsd#bmy_AcceleratedStockBasedCompensationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AcceleratedStockBasedCompensationMember" xlink:to="lab_bmy_AcceleratedStockBasedCompensationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ALLIANCESAbstract_4ff27a31-8532-4c48-8d95-a76848224c0c_terseLabel_en-US" xlink:label="lab_bmy_ALLIANCESAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ALLIANCES [Abstract]</link:label>
    <link:label id="lab_bmy_ALLIANCESAbstract_label_en-US" xlink:label="lab_bmy_ALLIANCESAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ALLIANCES [Abstract]</link:label>
    <link:label id="lab_bmy_ALLIANCESAbstract_documentation_en-US" xlink:label="lab_bmy_ALLIANCESAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ALLIANCES [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ALLIANCESAbstract" xlink:href="bmy-20210630.xsd#bmy_ALLIANCESAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ALLIANCESAbstract" xlink:to="lab_bmy_ALLIANCESAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_472983e5-94d9-461c-ac32-36bc039a5cee_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and other payments, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_e22f6e02-cd50-45e0-9c65-8cfb5b43a4bf_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_75fa93cd-db08-4eb5-826c-18d4b44f0dc1_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncome_88fe5d13-25b6-47e7-baf0-18fef8b849de_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income from alliance</link:label>
    <link:label id="lab_us-gaap_DeferredIncome_label_en-US" xlink:label="lab_us-gaap_DeferredIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncome" xlink:to="lab_us-gaap_DeferredIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_23eb9d4f-c8cf-467e-9ad9-93aa02703752_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_e6972ae0-837b-48e5-8287-48e2120774de_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories [Text Block]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_d84f6026-166c-4121-875c-c523d560c19b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale securities</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_bdde1f5c-6b00-4e5a-8ab9-881dc8d10fe6_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Fair Value By Derivative Instrument Risk [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_5023e25c-92c4-4bfe-98c9-809756bd0ef1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EquityInvestmentsNonCurrent_7de0b910-0268-4df2-8fb3-cae6fa9a1a6d_terseLabel_en-US" xlink:label="lab_bmy_EquityInvestmentsNonCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments</link:label>
    <link:label id="lab_bmy_EquityInvestmentsNonCurrent_label_en-US" xlink:label="lab_bmy_EquityInvestmentsNonCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments - non-current</link:label>
    <link:label id="lab_bmy_EquityInvestmentsNonCurrent_documentation_en-US" xlink:label="lab_bmy_EquityInvestmentsNonCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments - non-current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestmentsNonCurrent" xlink:href="bmy-20210630.xsd#bmy_EquityInvestmentsNonCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EquityInvestmentsNonCurrent" xlink:to="lab_bmy_EquityInvestmentsNonCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_BaracludeMember_515dcbb9-f7f4-4b35-9538-0e8dd6c7d59a_terseLabel_en-US" xlink:label="lab_bmy_BaracludeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baraclude [Member]</link:label>
    <link:label id="lab_bmy_BaracludeMember_label_en-US" xlink:label="lab_bmy_BaracludeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baraclude [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BaracludeMember" xlink:href="bmy-20210630.xsd#bmy_BaracludeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_BaracludeMember" xlink:to="lab_bmy_BaracludeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock_5a69a34d-a781-4600-9fa5-08537d01d8ee_terseLabel_en-US" xlink:label="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition Gross-To-Net Adjustments [Table Text Block]</link:label>
    <link:label id="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock_label_en-US" xlink:label="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Gross Product Sales to Net Product Sales [Table Text Block]</link:label>
    <link:label id="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock_documentation_en-US" xlink:label="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Gross Product Sales to Net Product Sales [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" xlink:href="bmy-20210630.xsd#bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" xlink:to="lab_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_b4b0a8c0-68e4-41df-99d3-ec688c0b83ed_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_2587fac7-365f-4802-a150-e859907ff44b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_139a7ee4-6b96-4422-910c-e21bd9ab0701_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued, Balance at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_0fc59270-c778-4598-91da-8eaeafb5273c_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued, Balance at End of Period</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_65ae2d8d-9fc7-4f82-bbd1-53d3a7c13e52_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_SupplementalFinancialInformationAbstract_538d024f-12de-47d9-ad11-826b97c569e2_terseLabel_en-US" xlink:label="lab_bmy_SupplementalFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Financial Information [Abstract]</link:label>
    <link:label id="lab_bmy_SupplementalFinancialInformationAbstract_label_en-US" xlink:label="lab_bmy_SupplementalFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Financial Information [Abstract]</link:label>
    <link:label id="lab_bmy_SupplementalFinancialInformationAbstract_documentation_en-US" xlink:label="lab_bmy_SupplementalFinancialInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Financial Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SupplementalFinancialInformationAbstract" xlink:href="bmy-20210630.xsd#bmy_SupplementalFinancialInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract" xlink:to="lab_bmy_SupplementalFinancialInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_7ac2098f-5e7d-497c-8c46-f9d6546fb8e7_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesTextBlock_713bac8f-0dca-40f2-8a45-d871e3659c50_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ab78d936-c58d-4868-b1a7-c37a273da7b0_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_7076e46d-8136-4e54-89a5-5c6e1fb0e50c_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_d31ffc41-5569-4070-bde1-da1e72cd4beb_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AccruedResearchAndDevelopment_a7820603-f62c-4136-93d9-b80248303b85_terseLabel_en-US" xlink:label="lab_bmy_AccruedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_bmy_AccruedResearchAndDevelopment_label_en-US" xlink:label="lab_bmy_AccruedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Research And Development</link:label>
    <link:label id="lab_bmy_AccruedResearchAndDevelopment_documentation_en-US" xlink:label="lab_bmy_AccruedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value as of the balance sheet date of obligations and payables pertaining to research and development.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedResearchAndDevelopment" xlink:href="bmy-20210630.xsd#bmy_AccruedResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AccruedResearchAndDevelopment" xlink:to="lab_bmy_AccruedResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_078dfacf-f55d-46ad-9566-0a3c35f3e9c9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses, Net of Cash Divested</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses, Net of Cash Divested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4a41ba6c-74cc-4085-be78-fcc9ba52c0b3_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c32ee247-be87-495b-bc7c-02b4e66a4e36_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss, Balance at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_e4414ca2-a89f-467b-b0d2-0c9f44eb51fc_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss, Balance at End of Period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_be0d6808-9797-4ca5-afc9-cdf3b7020cc8_totalLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_652f476c-e263-4d44-bf1e-ab73f94b2ad2_negatedLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less allowances for expected credit loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_2f74b297-0cc9-451c-b443-c323ac023346_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_PlavixAustraliaIntellectualPropertyMember_e8664d68-fd10-4d52-a198-6478efb05fd5_terseLabel_en-US" xlink:label="lab_bmy_PlavixAustraliaIntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plavix Australia Intellectual Property [Member]</link:label>
    <link:label id="lab_bmy_PlavixAustraliaIntellectualPropertyMember_label_en-US" xlink:label="lab_bmy_PlavixAustraliaIntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plavix Australia Intellectual Property [Member]</link:label>
    <link:label id="lab_bmy_PlavixAustraliaIntellectualPropertyMember_documentation_en-US" xlink:label="lab_bmy_PlavixAustraliaIntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plavix Australia Intellectual Property [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PlavixAustraliaIntellectualPropertyMember" xlink:href="bmy-20210630.xsd#bmy_PlavixAustraliaIntellectualPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_PlavixAustraliaIntellectualPropertyMember" xlink:to="lab_bmy_PlavixAustraliaIntellectualPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AvaproAvalideAndPlavixMember_39c4a356-a1eb-4f25-a3c9-85716bddf418_terseLabel_en-US" xlink:label="lab_bmy_AvaproAvalideAndPlavixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Avapro, Avalide, and Plavix [Member]</link:label>
    <link:label id="lab_bmy_AvaproAvalideAndPlavixMember_label_en-US" xlink:label="lab_bmy_AvaproAvalideAndPlavixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Avapro, Avalide, and Plavix [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AvaproAvalideAndPlavixMember" xlink:href="bmy-20210630.xsd#bmy_AvaproAvalideAndPlavixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AvaproAvalideAndPlavixMember" xlink:to="lab_bmy_AvaproAvalideAndPlavixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_0b64b5c9-4e52-4bad-b5ed-bbcd22d16c0c_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_dc777c1d-0b2e-4417-8fed-c0a7e8c0b1f7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Assets, Noncurrent [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentMeasurementInput_f8e61285-bcf6-4cc5-a5e0-4f88273cc34e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Measurement Input</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentMeasurementInput_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentMeasurementInput" xlink:to="lab_us-gaap_DebtInstrumentMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_d893953d-f16c-443d-9919-6dc82f0db9ff_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_13db15c0-7695-4bad-adee-f7befbc27773_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental shares attributable to share-based compensation plans</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingArrangementsLineItems_f43124fd-9e52-4124-933f-cf6cd637ea33_terseLabel_en-US" xlink:label="lab_bmy_LicensingArrangementsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements [Line Items]</link:label>
    <link:label id="lab_bmy_LicensingArrangementsLineItems_label_en-US" xlink:label="lab_bmy_LicensingArrangementsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements [Line Items]</link:label>
    <link:label id="lab_bmy_LicensingArrangementsLineItems_documentation_en-US" xlink:label="lab_bmy_LicensingArrangementsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsLineItems" xlink:href="bmy-20210630.xsd#bmy_LicensingArrangementsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingArrangementsLineItems" xlink:to="lab_bmy_LicensingArrangementsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_70fbc3e8-229c-4d91-ace5-d0d63b7a122d_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherCurrentAssetsAbstract_34d3cb2e-859a-4715-87ee-2664cff62f93_terseLabel_en-US" xlink:label="lab_bmy_OtherCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Abstract]</link:label>
    <link:label id="lab_bmy_OtherCurrentAssetsAbstract_label_en-US" xlink:label="lab_bmy_OtherCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Abstract]</link:label>
    <link:label id="lab_bmy_OtherCurrentAssetsAbstract_documentation_en-US" xlink:label="lab_bmy_OtherCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherCurrentAssetsAbstract" xlink:href="bmy-20210630.xsd#bmy_OtherCurrentAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherCurrentAssetsAbstract" xlink:to="lab_bmy_OtherCurrentAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_Cashoutlays_1f405524-b20b-4fe8-81be-3c4f6d2ecd98_terseLabel_en-US" xlink:label="lab_bmy_Cashoutlays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash outlays</link:label>
    <link:label id="lab_bmy_Cashoutlays_label_en-US" xlink:label="lab_bmy_Cashoutlays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash outlays</link:label>
    <link:label id="lab_bmy_Cashoutlays_documentation_en-US" xlink:label="lab_bmy_Cashoutlays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash outlays</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Cashoutlays" xlink:href="bmy-20210630.xsd#bmy_Cashoutlays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_Cashoutlays" xlink:to="lab_bmy_Cashoutlays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_6090cbb4-40a3-45d5-8d98-677ffab7fcbf_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_8f74c9c0-0abe-4f23-9ccf-8376c75e5e42_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_1612221a-c512-456d-a6a3-c86982fbe3ac_periodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Balance at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_0d887aba-0fcc-4794-9275-7cc574678cc2_periodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Balance at End of Period</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_8da15224-a5c4-4f59-a702-522063a6ac0b_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_cc246dde-be91-4548-ad4a-9ab0b0c1985b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits - Actuarial gains/(losses), Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_60932cfa-b61e-466d-9901-ce1b0fec24dc_terseLabel_en-US" xlink:label="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other rebates, returns, discounts and adjustments [Member]</link:label>
    <link:label id="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_label_en-US" xlink:label="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other rebates, returns, discounts and adjustments [Member]</link:label>
    <link:label id="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_documentation_en-US" xlink:label="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other rebates, returns, discounts and adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" xlink:href="bmy-20210630.xsd#bmy_OtherrebatesreturnsdiscountsandadjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" xlink:to="lab_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_3739221c-9e54-47f9-a0f0-cc49f3779f7c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AccruedInterest_aeead1e0-b6a9-4db1-82a2-609fd9d2093b_terseLabel_en-US" xlink:label="lab_bmy_AccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest</link:label>
    <link:label id="lab_bmy_AccruedInterest_label_en-US" xlink:label="lab_bmy_AccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest</link:label>
    <link:label id="lab_bmy_AccruedInterest_documentation_en-US" xlink:label="lab_bmy_AccruedInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedInterest" xlink:href="bmy-20210630.xsd#bmy_AccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AccruedInterest" xlink:to="lab_bmy_AccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsTableTextBlock_1f522293-d204-4777-a564-3bcaed61d93d_terseLabel_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements [Table Text Block]</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsTableTextBlock_label_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements [Table Text Block]</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsTableTextBlock_documentation_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsTableTextBlock" xlink:href="bmy-20210630.xsd#bmy_LicensingAndOtherArrangementsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingAndOtherArrangementsTableTextBlock" xlink:to="lab_bmy_LicensingAndOtherArrangementsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_MyoKardiaAcquisitionPlanMember_0c5ecff3-a620-4745-8567-924bb76e8428_terseLabel_en-US" xlink:label="lab_bmy_MyoKardiaAcquisitionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MyoKardia Acquisition Plan</link:label>
    <link:label id="lab_bmy_MyoKardiaAcquisitionPlanMember_label_en-US" xlink:label="lab_bmy_MyoKardiaAcquisitionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MyoKardia Acquisition Plan [Member]</link:label>
    <link:label id="lab_bmy_MyoKardiaAcquisitionPlanMember_documentation_en-US" xlink:label="lab_bmy_MyoKardiaAcquisitionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MyoKardia Acquisition Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MyoKardiaAcquisitionPlanMember" xlink:href="bmy-20210630.xsd#bmy_MyoKardiaAcquisitionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_MyoKardiaAcquisitionPlanMember" xlink:to="lab_bmy_MyoKardiaAcquisitionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_4326c0d9-4609-4372-a5fc-c184c2b3a29a_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_7adaa895-dfff-4312-9980-4af3091789b8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2bfdb698-040f-43a4-ad35-c00eefb173cd_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing, selling and administrative [Member]</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtezlaDivestitureMember_6e7addf9-47d9-455a-8157-05c49a5133dc_terseLabel_en-US" xlink:label="lab_bmy_OtezlaDivestitureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Otezla Divestiture</link:label>
    <link:label id="lab_bmy_OtezlaDivestitureMember_label_en-US" xlink:label="lab_bmy_OtezlaDivestitureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Otezla Divestiture [Member]</link:label>
    <link:label id="lab_bmy_OtezlaDivestitureMember_documentation_en-US" xlink:label="lab_bmy_OtezlaDivestitureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Otezla Divestiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtezlaDivestitureMember" xlink:href="bmy-20210630.xsd#bmy_OtezlaDivestitureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtezlaDivestitureMember" xlink:to="lab_bmy_OtezlaDivestitureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_30f4c25a-f5ed-4e28-9f78-a377bc4bfeed_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_3ba61cee-7caf-426c-a93f-df67d821c41f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_TecentriqRoyaltiesMember_b0297751-af7e-4908-8dd4-21330a3f17ab_terseLabel_en-US" xlink:label="lab_bmy_TecentriqRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tecentriq royalties</link:label>
    <link:label id="lab_bmy_TecentriqRoyaltiesMember_label_en-US" xlink:label="lab_bmy_TecentriqRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tecentriq royalties [Member]</link:label>
    <link:label id="lab_bmy_TecentriqRoyaltiesMember_documentation_en-US" xlink:label="lab_bmy_TecentriqRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tecentriq royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_TecentriqRoyaltiesMember" xlink:href="bmy-20210630.xsd#bmy_TecentriqRoyaltiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_TecentriqRoyaltiesMember" xlink:to="lab_bmy_TecentriqRoyaltiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_083a733f-b489-4fc2-ac86-c6cc632f922a_terseLabel_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Text Block]</link:label>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans, Notes, Trade and Other Receivables Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_ff2adf32-c37d-4d95-8793-feb9ea92581f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_457da0fa-3ff7-440e-a3d9-8420581ac6a2_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits - Amortization, After tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_6aadb58b-d942-4ba0-a0e1-d11a093202ad_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_1602570f-3874-496c-ac9f-646bb058d7ba_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_dbb2ccd9-0572-4546-ab73-607cc3d89f6f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_765a01d3-525a-4dbc-9ed0-9b0940ce6c7d_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_4937a131-a8f4-4fe8-a25f-e07ac70dad08_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_5e957309-97c7-4855-8737-1094ce3b5ffd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_99faf932-68e6-4e27-bca6-eb67557c0618_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_74a18dd9-e53c-45cf-ab4e-0e24bc0f6707_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_VidazaMember_2c9b009a-126b-49ac-8baa-8b018c2d670c_terseLabel_en-US" xlink:label="lab_bmy_VidazaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vidaza [Member]</link:label>
    <link:label id="lab_bmy_VidazaMember_label_en-US" xlink:label="lab_bmy_VidazaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vidaza [Member]</link:label>
    <link:label id="lab_bmy_VidazaMember_documentation_en-US" xlink:label="lab_bmy_VidazaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vidaza [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_VidazaMember" xlink:href="bmy-20210630.xsd#bmy_VidazaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_VidazaMember" xlink:to="lab_bmy_VidazaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_aca8e1f2-df58-47e1-af05-7c436a5af4b4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_e5958005-4545-40b2-ad1b-d459f5f456d8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3a7eb44b-b48d-47d5-b9d2-08b9bee53fb0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_67c0a96b-49d6-4bae-bcf7-e7cb4a0b725d_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Recently Issued Accounting Standards [Text Block]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_aaca3d80-4f70-44f2-899a-8cda5d61cb07_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cafc2a9b-019d-4216-8319-361e90642494_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_IntangibleAssetNameAxis_523935ac-8b03-4f47-8f63-9a8123212a60_terseLabel_en-US" xlink:label="lab_bmy_IntangibleAssetNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Name [Axis]</link:label>
    <link:label id="lab_bmy_IntangibleAssetNameAxis_label_en-US" xlink:label="lab_bmy_IntangibleAssetNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Name [Axis]</link:label>
    <link:label id="lab_bmy_IntangibleAssetNameAxis_documentation_en-US" xlink:label="lab_bmy_IntangibleAssetNameAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IntangibleAssetNameAxis" xlink:href="bmy-20210630.xsd#bmy_IntangibleAssetNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_IntangibleAssetNameAxis" xlink:to="lab_bmy_IntangibleAssetNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_cb146bf1-a84c-4d3a-8cb6-8625263489e6_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CommonStock0.10ParValueMember_0caf9628-694e-489e-805c-dae7e2aac854_terseLabel_en-US" xlink:label="lab_bmy_CommonStock0.10ParValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock $0.10 Par Value [Member]</link:label>
    <link:label id="lab_bmy_CommonStock0.10ParValueMember_label_en-US" xlink:label="lab_bmy_CommonStock0.10ParValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock $0.10 Par Value [Member]</link:label>
    <link:label id="lab_bmy_CommonStock0.10ParValueMember_documentation_en-US" xlink:label="lab_bmy_CommonStock0.10ParValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CommonStock010ParValueMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CommonStock0.10ParValueMember" xlink:href="bmy-20210630.xsd#bmy_CommonStock0.10ParValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CommonStock0.10ParValueMember" xlink:to="lab_bmy_CommonStock0.10ParValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_8d268c3b-5917-4ddd-9998-32e5e13d0f68_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_5cb01092-62f5-45bf-9f31-26a1006c91bf_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_16b6677a-661f-4a63-9d74-c221df66d53f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_96303d78-70b2-4d10-a982-8a352dbce0c1_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_e0414c99-0bba-4be3-9353-700ade33f1fe_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_BMSSecuritiesLitigationMember_d238227c-c1ca-4c31-9d5c-0bf628dc8e76_terseLabel_en-US" xlink:label="lab_bmy_BMSSecuritiesLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Litigation [Member]</link:label>
    <link:label id="lab_bmy_BMSSecuritiesLitigationMember_label_en-US" xlink:label="lab_bmy_BMSSecuritiesLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BMS Securities Litigation [Member]</link:label>
    <link:label id="lab_bmy_BMSSecuritiesLitigationMember_documentation_en-US" xlink:label="lab_bmy_BMSSecuritiesLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BMS Securities Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BMSSecuritiesLitigationMember" xlink:href="bmy-20210630.xsd#bmy_BMSSecuritiesLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_BMSSecuritiesLitigationMember" xlink:to="lab_bmy_BMSSecuritiesLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_33374451-1ef3-4620-82de-008ce09ed7c3_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in Excess of Par Value of Stock [Member]</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_14b465d2-e391-465d-bc30-d7a161798a10_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_1cf0f8f3-aad6-4ec6-8e88-0343ae623b89_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_de57fc09-e0ca-446f-ac42-7f1e31c77744_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives qualifying as cash flow hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_c6b44e5e-dcc2-424c-8ea8-d32ee415c44c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax, Parenthetical Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax, Parenthetical Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_7e7cc564-600b-4a31-bd3d-f5ada0104169_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired developed product rights [Member]</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_8c3f31ec-5bae-490f-aa6b-577c952678ba_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_InventorypurchasepricefairvalueadjustmentMember_15fcf9c2-8a03-4a2b-a46e-b5bda9fec575_terseLabel_en-US" xlink:label="lab_bmy_InventorypurchasepricefairvalueadjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory purchase price fair value adjustment [Member]</link:label>
    <link:label id="lab_bmy_InventorypurchasepricefairvalueadjustmentMember_label_en-US" xlink:label="lab_bmy_InventorypurchasepricefairvalueadjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory purchase price fair value adjustment [Member]</link:label>
    <link:label id="lab_bmy_InventorypurchasepricefairvalueadjustmentMember_documentation_en-US" xlink:label="lab_bmy_InventorypurchasepricefairvalueadjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory purchase price fair value adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InventorypurchasepricefairvalueadjustmentMember" xlink:href="bmy-20210630.xsd#bmy_InventorypurchasepricefairvalueadjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_InventorypurchasepricefairvalueadjustmentMember" xlink:to="lab_bmy_InventorypurchasepricefairvalueadjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_c4f1b4cc-f8be-4363-85a6-e138b4c76712_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_710f973f-5d06-4e3e-869f-205d66963b01_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_90c5aca4-f369-400e-bbb9-b1360ea582c8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_d9e843e7-acc2-4b48-857d-999c86213a22_terseLabel_en-US" xlink:label="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges Exclude Accelerated Stock-Based Compensation</link:label>
    <link:label id="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_label_en-US" xlink:label="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges Excluding Accelerated Stock-based Compensation</link:label>
    <link:label id="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_documentation_en-US" xlink:label="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges Excluding Accelerated Stock-based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" xlink:href="bmy-20210630.xsd#bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" xlink:to="lab_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_f6d63639-4ce3-4489-b845-0d07c9eec271_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_2f78b5df-e696-4e5c-a760-65fbd0d3f25c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income)/expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_a8a750c7-b040-4d33-a129-f31e121533ca_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income)/expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A2BillionMaximumBorrowingCapacityMember_2e59598c-3e33-4082-aa54-64720b0e673a_terseLabel_en-US" xlink:label="lab_bmy_A2BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2 Billion Maximum Borrowing Capacity</link:label>
    <link:label id="lab_bmy_A2BillionMaximumBorrowingCapacityMember_label_en-US" xlink:label="lab_bmy_A2BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2 Billion Maximum Borrowing Capacity [Member]</link:label>
    <link:label id="lab_bmy_A2BillionMaximumBorrowingCapacityMember_documentation_en-US" xlink:label="lab_bmy_A2BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$2 Billion Maximum Borrowing Capacity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2BillionMaximumBorrowingCapacityMember" xlink:href="bmy-20210630.xsd#bmy_A2BillionMaximumBorrowingCapacityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A2BillionMaximumBorrowingCapacityMember" xlink:to="lab_bmy_A2BillionMaximumBorrowingCapacityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsIncome_16ae19fb-da08-448d-9f13-2aa352f4af90_negatedTerseLabel_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements Income</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsIncome_label_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements Income</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsIncome_documentation_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsIncome" xlink:href="bmy-20210630.xsd#bmy_LicensingAndOtherArrangementsIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingAndOtherArrangementsIncome" xlink:to="lab_bmy_LicensingAndOtherArrangementsIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a01cf04c-bc2b-47e5-8544-a9b120c7fb57_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_165e4861-2592-4f90-b8ef-54c05d52dd3d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_16b93756-67bd-4ea8-83a6-46857c0dbda3_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_e912bbb4-2341-4c15-937a-aa0039d6573e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_8203167c-7866-4b1d-858e-0de318c6acf5_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsDomain_a6969124-075d-4f54-9548-89fa944ef045_terseLabel_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Domain]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsDomain_label_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Domain]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsDomain_documentation_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Gross to Net Adjustments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsDomain" xlink:href="bmy-20210630.xsd#bmy_GrosstoNetAdjustmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain" xlink:to="lab_bmy_GrosstoNetAdjustmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AcquiredDevelopedProductRightsReclassedFromIPRD_75a4504f-2b85-428d-81a7-d5b93f93bd13_terseLabel_en-US" xlink:label="lab_bmy_AcquiredDevelopedProductRightsReclassedFromIPRD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Developed Product Rights Reclassed From IPRD</link:label>
    <link:label id="lab_bmy_AcquiredDevelopedProductRightsReclassedFromIPRD_label_en-US" xlink:label="lab_bmy_AcquiredDevelopedProductRightsReclassedFromIPRD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Developed Product Rights Reclassed From IPRD</link:label>
    <link:label id="lab_bmy_AcquiredDevelopedProductRightsReclassedFromIPRD_documentation_en-US" xlink:label="lab_bmy_AcquiredDevelopedProductRightsReclassedFromIPRD" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Developed Product Rights Reclassed From IPRD</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquiredDevelopedProductRightsReclassedFromIPRD" xlink:href="bmy-20210630.xsd#bmy_AcquiredDevelopedProductRightsReclassedFromIPRD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AcquiredDevelopedProductRightsReclassedFromIPRD" xlink:to="lab_bmy_AcquiredDevelopedProductRightsReclassedFromIPRD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_9cfb1e06-9e5b-4991-8960-20e55c1cf979_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_ad2a2253-7f6b-4b3f-a48c-f7fc6d6e72c4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_a311cb13-48b7-4824-8046-4ce836266792_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EisaiMember_23505783-df97-467b-9453-6042b2cf5956_terseLabel_en-US" xlink:label="lab_bmy_EisaiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eisai</link:label>
    <link:label id="lab_bmy_EisaiMember_label_en-US" xlink:label="lab_bmy_EisaiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eisai [Member]</link:label>
    <link:label id="lab_bmy_EisaiMember_documentation_en-US" xlink:label="lab_bmy_EisaiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eisai</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EisaiMember" xlink:href="bmy-20210630.xsd#bmy_EisaiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EisaiMember" xlink:to="lab_bmy_EisaiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_645b6a90-2d43-46b7-99f5-82a3b12b9d94_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_1ead6ed7-0242-41a7-95d1-d1c1b44343f7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Current Liabilities [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_2c85d735-863a-43c2-a973-cfdeceef489f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_59a0b3ff-61c3-4e60-be2f-071aa942109d_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_28f7a667-b932-4c98-b5ee-c99cc8bea2d9_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows From Financing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_acadc04b-dde3-4c14-95a7-b39e3ee0317f_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_KeytrudaRoyaltiesMember_d202d2ea-6405-472c-aa87-108ccc787490_terseLabel_en-US" xlink:label="lab_bmy_KeytrudaRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Keytruda Royalties</link:label>
    <link:label id="lab_bmy_KeytrudaRoyaltiesMember_label_en-US" xlink:label="lab_bmy_KeytrudaRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Keytruda Royalties [Member]</link:label>
    <link:label id="lab_bmy_KeytrudaRoyaltiesMember_documentation_en-US" xlink:label="lab_bmy_KeytrudaRoyaltiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Keytruda Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_KeytrudaRoyaltiesMember" xlink:href="bmy-20210630.xsd#bmy_KeytrudaRoyaltiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_KeytrudaRoyaltiesMember" xlink:to="lab_bmy_KeytrudaRoyaltiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_a7b5b34a-5bb8-4bc6-9413-e29affc28a46_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Bristol-Myers Squibb Company Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_MarketShareUnitsMember_9e296d3d-957c-4e7f-b932-aa4703e91a3f_terseLabel_en-US" xlink:label="lab_bmy_MarketShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market share units [Member]</link:label>
    <link:label id="lab_bmy_MarketShareUnitsMember_label_en-US" xlink:label="lab_bmy_MarketShareUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market share units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MarketShareUnitsMember" xlink:href="bmy-20210630.xsd#bmy_MarketShareUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_MarketShareUnitsMember" xlink:to="lab_bmy_MarketShareUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_a2b83a08-d5b5-4147-acc2-7f9df9650412_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:to="lab_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_967eaeaf-1cc8-45ef-b7e7-661a57a54943_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_6a2accbd-edd0-4f86-b611-f5aecf5a78bd_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits, Pre-tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_af3c519a-6fa8-4203-a9e0-f1e1ee74239c_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_DeferredIncomeTaxExpenseBenefitComponentAxis_1f61da72-b94d-4580-b312-78a3dc7e0f30_terseLabel_en-US" xlink:label="lab_bmy_DeferredIncomeTaxExpenseBenefitComponentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense/Benefit Component [Axis]</link:label>
    <link:label id="lab_bmy_DeferredIncomeTaxExpenseBenefitComponentAxis_label_en-US" xlink:label="lab_bmy_DeferredIncomeTaxExpenseBenefitComponentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense/Benefit Component [Axis]</link:label>
    <link:label id="lab_bmy_DeferredIncomeTaxExpenseBenefitComponentAxis_documentation_en-US" xlink:label="lab_bmy_DeferredIncomeTaxExpenseBenefitComponentAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense/Benefit Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DeferredIncomeTaxExpenseBenefitComponentAxis" xlink:href="bmy-20210630.xsd#bmy_DeferredIncomeTaxExpenseBenefitComponentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_DeferredIncomeTaxExpenseBenefitComponentAxis" xlink:to="lab_bmy_DeferredIncomeTaxExpenseBenefitComponentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_655efea8-1bcc-4b5a-821a-875fec7fa6f3_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_e37308f5-9702-4baf-80f3-497d3893630c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_bbbf392d-a43f-48e8-8125-8aefa896b1a8_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AmortizationofAcquiredIntangibleAssets_6494d3b1-fab5-4885-83a8-878be241d165_terseLabel_en-US" xlink:label="lab_bmy_AmortizationofAcquiredIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_bmy_AmortizationofAcquiredIntangibleAssets_label_en-US" xlink:label="lab_bmy_AmortizationofAcquiredIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Acquired Intangible Assets</link:label>
    <link:label id="lab_bmy_AmortizationofAcquiredIntangibleAssets_documentation_en-US" xlink:label="lab_bmy_AmortizationofAcquiredIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Acquired Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationofAcquiredIntangibleAssets" xlink:href="bmy-20210630.xsd#bmy_AmortizationofAcquiredIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AmortizationofAcquiredIntangibleAssets" xlink:to="lab_bmy_AmortizationofAcquiredIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_dd72fdf9-8800-4cb1-99ff-d837e80f6f56_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Miscellaneous, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_8a63c1d4-0585-47e1-a601-638591382903_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_InrebicMember_81589f69-ac0b-4a98-86b6-152685cc29c2_terseLabel_en-US" xlink:label="lab_bmy_InrebicMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inrebic [Member]</link:label>
    <link:label id="lab_bmy_InrebicMember_label_en-US" xlink:label="lab_bmy_InrebicMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inrebic [Member]</link:label>
    <link:label id="lab_bmy_InrebicMember_documentation_en-US" xlink:label="lab_bmy_InrebicMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inrebic [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InrebicMember" xlink:href="bmy-20210630.xsd#bmy_InrebicMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_InrebicMember" xlink:to="lab_bmy_InrebicMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_86a7153a-cbd7-4e8d-8bd6-60a6d5bd056d_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bristol-Myers Squibb Company Shareholders' Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6754c7d9-ea3b-4714-b557-3750e89c4203_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income Loss [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_00db8100-8e19-4c64-9246-a27dd308004a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture losses/(gains)</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AlliancesAndCollaborationCompaniesDomain_c62cd1ba-f730-4702-ac2b-ebdd803b0ec8_terseLabel_en-US" xlink:label="lab_bmy_AlliancesAndCollaborationCompaniesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliances and Collaboration Companies [Domain]</link:label>
    <link:label id="lab_bmy_AlliancesAndCollaborationCompaniesDomain_label_en-US" xlink:label="lab_bmy_AlliancesAndCollaborationCompaniesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliances and Collaboration Companies [Domain]</link:label>
    <link:label id="lab_bmy_AlliancesAndCollaborationCompaniesDomain_documentation_en-US" xlink:label="lab_bmy_AlliancesAndCollaborationCompaniesDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliances and Collaboration Companies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AlliancesAndCollaborationCompaniesDomain" xlink:href="bmy-20210630.xsd#bmy_AlliancesAndCollaborationCompaniesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AlliancesAndCollaborationCompaniesDomain" xlink:to="lab_bmy_AlliancesAndCollaborationCompaniesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OnglyzaProductLiabilityLitigationMember_24933205-ab25-44b4-90f8-a6da0afbdd0d_terseLabel_en-US" xlink:label="lab_bmy_OnglyzaProductLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onglyza Product Liability Litigation</link:label>
    <link:label id="lab_bmy_OnglyzaProductLiabilityLitigationMember_label_en-US" xlink:label="lab_bmy_OnglyzaProductLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onglyza Product Liability Litigation [Member]</link:label>
    <link:label id="lab_bmy_OnglyzaProductLiabilityLitigationMember_documentation_en-US" xlink:label="lab_bmy_OnglyzaProductLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onglyza Product Liability Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OnglyzaProductLiabilityLitigationMember" xlink:href="bmy-20210630.xsd#bmy_OnglyzaProductLiabilityLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OnglyzaProductLiabilityLitigationMember" xlink:to="lab_bmy_OnglyzaProductLiabilityLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_a79faaf9-1470-451b-b357-6dd78e1a4489_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Performance Obligation Satisfied in Previous Period</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Performance Obligation Satisfied in Previous Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:to="lab_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_4e04af9a-9785-45b2-bff6-2bab2ef9ce0d_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_37ad6847-e045-4575-bb5b-642c6820879c_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_ff01d08a-ddb4-4667-bf26-33da3a42cbf2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments_8cbb9d4b-5ffa-483d-8eea-43d1c0e271b0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investment (gains)/losses</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments, Excluding Other than Temporary Impairments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments" xlink:to="lab_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NameOfReportingCategoryDomain_17a7e3af-1ac8-4625-b5b3-4efe0c34e839_terseLabel_en-US" xlink:label="lab_us-gaap_NameOfReportingCategoryDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Reporting Category [Domain]</link:label>
    <link:label id="lab_us-gaap_NameOfReportingCategoryDomain_label_en-US" xlink:label="lab_us-gaap_NameOfReportingCategoryDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Reporting Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain" xlink:to="lab_us-gaap_NameOfReportingCategoryDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_3fe76954-9207-4365-835f-2a31f6a6089f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_f0357e9d-9707-4cb2-a892-c4f6df7dc2fa_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_cf75e8d5-c680-4a8a-b6b8-6f42a22aae9d_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licenses [Member]</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_3ee00d60-8d8f-4f4f-b24b-aea81824ae29_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_538e07be-79cb-4204-843b-f5305d21bfec_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_266869d2-7933-42b8-a47c-c511b166a718_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_079ac083-fc69-4004-97d2-8124dbbf8a0d_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_823203b8-c7ee-4959-a6fc-14ea19b46dae_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_294a590b-3539-40e9-8e15-784701d12f0a_periodStartLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings, Balance at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_f71beb71-3283-4e3d-bdb1-8ee9999aaf1f_periodEndLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings, Balance at End of Period</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_f0ab2f8f-f7b2-4f48-8770-838ed16a7570_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Period Increase (Decrease)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_ef24c019-1a20-4db6-a31d-6be4a394ca9a_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LitigationTable_4b4c14b3-3a6f-45ec-a43f-05b9af9a54b6_terseLabel_en-US" xlink:label="lab_bmy_LitigationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation [Table]</link:label>
    <link:label id="lab_bmy_LitigationTable_label_en-US" xlink:label="lab_bmy_LitigationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LitigationTable" xlink:href="bmy-20210630.xsd#bmy_LitigationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LitigationTable" xlink:to="lab_bmy_LitigationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_a412d711-c889-4135-a855-9bf362d3a19a_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_414d8fed-eec0-4b3f-9a83-92ebd56225a1_terseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:to="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_ec358797-0981-4dfd-8615-849130924c21_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_114fc604-bf97-4c23-b038-785769d8a3ca_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_0d8732d5-af9c-43c6-89a3-5cbda98dabfb_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_fa329527-a2ca-4b0a-b171-c0319beb0a1d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_30806337-4480-4148-bf46-e5294723596a_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_bd8474af-934f-41ae-87f9-9ade892779fa_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_DismissedMember_d5252063-7627-4c5e-a9d4-0c68e1d30b7d_terseLabel_en-US" xlink:label="lab_bmy_DismissedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dismissed</link:label>
    <link:label id="lab_bmy_DismissedMember_label_en-US" xlink:label="lab_bmy_DismissedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dismissed [Member]</link:label>
    <link:label id="lab_bmy_DismissedMember_documentation_en-US" xlink:label="lab_bmy_DismissedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dismissed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DismissedMember" xlink:href="bmy-20210630.xsd#bmy_DismissedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_DismissedMember" xlink:to="lab_bmy_DismissedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_10e50b63-06fc-4632-a178-8ed6db39a2d2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationTable_611190a8-1d93-4d8c-a7eb-2f6c7c57f0be_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationTable" xlink:to="lab_us-gaap_ReclassificationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AlliancesAndCollaborationCompaniesAxis_cf2bdcf4-2535-498f-9a4e-5d0c86b029fa_terseLabel_en-US" xlink:label="lab_bmy_AlliancesAndCollaborationCompaniesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliances And Collaboration Companies [Axis]</link:label>
    <link:label id="lab_bmy_AlliancesAndCollaborationCompaniesAxis_label_en-US" xlink:label="lab_bmy_AlliancesAndCollaborationCompaniesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliances And Collaboration Companies [Axis]</link:label>
    <link:label id="lab_bmy_AlliancesAndCollaborationCompaniesAxis_documentation_en-US" xlink:label="lab_bmy_AlliancesAndCollaborationCompaniesAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliances And Collaboration Companies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AlliancesAndCollaborationCompaniesAxis" xlink:href="bmy-20210630.xsd#bmy_AlliancesAndCollaborationCompaniesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AlliancesAndCollaborationCompaniesAxis" xlink:to="lab_bmy_AlliancesAndCollaborationCompaniesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_e88d1a94-5466-4928-9b87-224cff804b30_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_103a4e87-cf81-4653-88aa-b176111154f4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b0e1433b-0ac5-4941-8f9d-1fdb275bf03f_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_6171247b-87e3-4050-ad27-3e2991842dfa_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock_3118bbaf-1667-4152-850d-8ccbf9b0a70b_terseLabel_en-US" xlink:label="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Provision for Income Taxes [Table Text Block]</link:label>
    <link:label id="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock_label_en-US" xlink:label="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Provision for Income Taxes [Table Text Block]</link:label>
    <link:label id="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock_documentation_en-US" xlink:label="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">-- None. No documentation exists for this element. --</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" xlink:href="bmy-20210630.xsd#bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" xlink:to="lab_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_725a8350-6fa0-4c53-9fd7-7e97ce2874fb_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net trade receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_b060ef96-c258-4e72-8d65-30194d15bbb8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsLineItems_af7e7396-f9d8-432c-b06d-9e49213192be_terseLabel_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Line Items]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsLineItems_label_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross to Net Adjustments [Line Items]</link:label>
    <link:label id="lab_bmy_GrosstoNetAdjustmentsLineItems_documentation_en-US" xlink:label="lab_bmy_GrosstoNetAdjustmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Gross to Net Adjustments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsLineItems" xlink:href="bmy-20210630.xsd#bmy_GrosstoNetAdjustmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems" xlink:to="lab_bmy_GrosstoNetAdjustmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_ebfcac8d-e7f0-4d1d-9755-f2bbf6ae69a3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_d6d9f025-1c74-4278-afc3-a95de15f160e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_758d725b-49cf-4864-9f7a-7b77a2e14ef3_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_da39e535-4141-4f9f-a91c-764dade6355e_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_797db5ec-6b88-401a-a182-670de9231ffa_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_cf240b3e-725f-4c8e-9ee2-34e8b8a00a8e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_6507e826-01c5-4ddf-a434-35241693a7b7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_cc73c524-c057-48ea-b172-7df2861831a0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders Equity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_3237f914-0569-46bc-814a-ec887a3e5d8f_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_2abe562e-2642-40d7-a7a2-797ae981f194_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d285690b-c740-4c1f-b818-76d81a0981dd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_9a85510b-d7ca-45a7-a03b-1aea8c47c461_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_cc333dac-5edf-4075-bf78-2ce55e85a1f6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_4fe4739d-17bb-49e0-b86f-443554c7ae71_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_RevenuebyProductbyRegionAbstract_dbb6baeb-7911-486e-8cd4-38acc23f51eb_terseLabel_en-US" xlink:label="lab_bmy_RevenuebyProductbyRegionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue by Product by Region [Abstract]</link:label>
    <link:label id="lab_bmy_RevenuebyProductbyRegionAbstract_label_en-US" xlink:label="lab_bmy_RevenuebyProductbyRegionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue by Product by Region [Abstract]</link:label>
    <link:label id="lab_bmy_RevenuebyProductbyRegionAbstract_documentation_en-US" xlink:label="lab_bmy_RevenuebyProductbyRegionAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue by Product by Region [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RevenuebyProductbyRegionAbstract" xlink:href="bmy-20210630.xsd#bmy_RevenuebyProductbyRegionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_RevenuebyProductbyRegionAbstract" xlink:to="lab_bmy_RevenuebyProductbyRegionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_7edc87e0-35af-4888-b42a-dad3b4891c14_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_d714cb1e-35fb-4e14-bdb5-e436521d3be2_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_998c9e16-adcf-4e3f-b727-cd708493c0e4_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_IncomeTaxExpenseBenefitComponentDomain_faef1696-1ae7-4aec-a6d6-96684a7d4e76_terseLabel_en-US" xlink:label="lab_bmy_IncomeTaxExpenseBenefitComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense/Benefit Component [Domain]</link:label>
    <link:label id="lab_bmy_IncomeTaxExpenseBenefitComponentDomain_label_en-US" xlink:label="lab_bmy_IncomeTaxExpenseBenefitComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense/Benefit Component [Domain]</link:label>
    <link:label id="lab_bmy_IncomeTaxExpenseBenefitComponentDomain_documentation_en-US" xlink:label="lab_bmy_IncomeTaxExpenseBenefitComponentDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense/Benefit Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IncomeTaxExpenseBenefitComponentDomain" xlink:href="bmy-20210630.xsd#bmy_IncomeTaxExpenseBenefitComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_IncomeTaxExpenseBenefitComponentDomain" xlink:to="lab_bmy_IncomeTaxExpenseBenefitComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_55f90c89-7e58-4a0c-ad40-775a20cfde63_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_a55d1189-cc82-46b3-a2cc-bda0ec4b0edf_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_47514a8b-32a3-4fb9-93c1-83e6ffba13c5_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_49a04816-4a66-43a8-a3c6-c69fd37e34aa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (Income)/Expense [Text Block]</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Other Expense Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:to="lab_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_RestOfWorldMember_aa9cccd4-b4c9-468c-9de3-e051ef871b29_terseLabel_en-US" xlink:label="lab_bmy_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of World [Member]</link:label>
    <link:label id="lab_bmy_RestOfWorldMember_label_en-US" xlink:label="lab_bmy_RestOfWorldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of World [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestOfWorldMember" xlink:href="bmy-20210630.xsd#bmy_RestOfWorldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_RestOfWorldMember" xlink:to="lab_bmy_RestOfWorldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_1b8c2bf6-da3c-4d4d-881c-2d938283da05_terseLabel_en-US" xlink:label="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Principal Value, Unamortized basis adjustment from swap terminations</link:label>
    <link:label id="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_label_en-US" xlink:label="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Basis Adjustment From Swap Terminations</link:label>
    <link:label id="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_documentation_en-US" xlink:label="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the adjustment to principal value of long term debt related to the unamortized basis adjustment from swap terminations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations" xlink:href="bmy-20210630.xsd#bmy_UnamortizedBasisAdjustmentFromSwapTerminations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations" xlink:to="lab_bmy_UnamortizedBasisAdjustmentFromSwapTerminations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_bbd3fa6e-6f6c-4c48-bf8e-f7679c7de2dc_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivables_f62a6155-0b0a-4d3b-80f6-28867d9c3e0c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance, royalties, VAT and other</link:label>
    <link:label id="lab_us-gaap_OtherReceivables_label_en-US" xlink:label="lab_us-gaap_OtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivables" xlink:to="lab_us-gaap_OtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_44096f31-c791-44f8-989b-7cc209be010a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock compensation</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_9f76ece6-e870-48cb-9cbd-4d648bbd9ac8_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, Shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9c1a2d14-c35a-48b2-b21e-81b970e9c42f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_ca378e57-9c3e-475c-aacf-82fa55ad3111_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:to="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A2550SeniorNotesDue2021Member_d3ae25a8-1ee4-4368-92a5-28847aac88c7_terseLabel_en-US" xlink:label="lab_bmy_A2550SeniorNotesDue2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.55% Senior Notes due 2021</link:label>
    <link:label id="lab_bmy_A2550SeniorNotesDue2021Member_label_en-US" xlink:label="lab_bmy_A2550SeniorNotesDue2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.550% Senior Notes due 2021 [Member]</link:label>
    <link:label id="lab_bmy_A2550SeniorNotesDue2021Member_documentation_en-US" xlink:label="lab_bmy_A2550SeniorNotesDue2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.550% Senior Notes due 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2550SeniorNotesDue2021Member" xlink:href="bmy-20210630.xsd#bmy_A2550SeniorNotesDue2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A2550SeniorNotesDue2021Member" xlink:to="lab_bmy_A2550SeniorNotesDue2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsAxis_74f046c3-18ce-4dd5-a62a-d95d98d698df_terseLabel_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements [Axis]</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsAxis_label_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements [Axis]</link:label>
    <link:label id="lab_bmy_LicensingAndOtherArrangementsAxis_documentation_en-US" xlink:label="lab_bmy_LicensingAndOtherArrangementsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing and Other Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsAxis" xlink:href="bmy-20210630.xsd#bmy_LicensingAndOtherArrangementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingAndOtherArrangementsAxis" xlink:to="lab_bmy_LicensingAndOtherArrangementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_Assetacquisitioncharge_81804641-ba0f-4433-93f8-176e6dd6a127_terseLabel_en-US" xlink:label="lab_bmy_Assetacquisitioncharge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset acquisition charges</link:label>
    <link:label id="lab_bmy_Assetacquisitioncharge_label_en-US" xlink:label="lab_bmy_Assetacquisitioncharge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset acquisition charge</link:label>
    <link:label id="lab_bmy_Assetacquisitioncharge_documentation_en-US" xlink:label="lab_bmy_Assetacquisitioncharge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the charge for an asset acquisition in the statement of cash flows.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Assetacquisitioncharge" xlink:href="bmy-20210630.xsd#bmy_Assetacquisitioncharge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_Assetacquisitioncharge" xlink:to="lab_bmy_Assetacquisitioncharge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_21c91399-3296-4d00-8ab0-b0ae463fd27b_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable debt securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:to="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_243c2b01-2163-4dff-80cd-645d7eaa1a28_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_0a3f8029-f541-473e-ab55-5998ad443f99_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_a318b254-835f-4195-bd2b-5940d1ed7de0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_Totalinventories_14718fd6-bb81-42e7-bee0-200fdd04a70c_totalLabel_en-US" xlink:label="lab_bmy_Totalinventories" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_bmy_Totalinventories_label_en-US" xlink:label="lab_bmy_Totalinventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_bmy_Totalinventories_documentation_en-US" xlink:label="lab_bmy_Totalinventories" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This represents the total inventory, current and non-current, as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Totalinventories" xlink:href="bmy-20210630.xsd#bmy_Totalinventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_Totalinventories" xlink:to="lab_bmy_Totalinventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_60275ba1-c11d-45b7-b1f7-237583bb6a2f_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset impairment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Finite-lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_4ee95d47-6bf9-4a1e-bd21-bb78dbb0414d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash - non current</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_IntangibleAssetNameDomain_9c7d0f2d-385e-4f20-8a18-e09a886133e9_terseLabel_en-US" xlink:label="lab_bmy_IntangibleAssetNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Name [Domain]</link:label>
    <link:label id="lab_bmy_IntangibleAssetNameDomain_label_en-US" xlink:label="lab_bmy_IntangibleAssetNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Name [Domain]</link:label>
    <link:label id="lab_bmy_IntangibleAssetNameDomain_documentation_en-US" xlink:label="lab_bmy_IntangibleAssetNameDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IntangibleAssetNameDomain" xlink:href="bmy-20210630.xsd#bmy_IntangibleAssetNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_IntangibleAssetNameDomain" xlink:to="lab_bmy_IntangibleAssetNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsMember_ecd80677-2f02-45c0-a28c-26feae9418df_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Member]</link:label>
    <link:label id="lab_us-gaap_AssetsMember_label_en-US" xlink:label="lab_us-gaap_AssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsMember" xlink:to="lab_us-gaap_AssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_85fb7ebb-4d26-4ce1-ab43-e7b8672e5438_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock compensation plans, Cost</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_e8a0ee2a-b2c9-46bf-8e15-c289850ef98f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionAbstract_91038062-f0e5-467c-b3e0-4d51ce5b3b8f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionAbstract" xlink:to="lab_us-gaap_RevenueRecognitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_73bfc55e-453a-4405-be2f-4718f9842737_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_250931a1-72b0-4860-b101-ad403d476fbb_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_JPY_2ad13be5-6111-4fba-a831-57ba9b800ad6_terseLabel_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Yen</link:label>
    <link:label id="lab_currency_JPY_label_en-US" xlink:label="lab_currency_JPY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Japan, Yen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_JPY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_JPY" xlink:to="lab_currency_JPY" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_6b6b79c5-6168-4fcd-baab-6a027c412070_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2edfe222-28cc-406b-906a-42f041599edd_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_828e4e6e-362a-44e4-b257-4b66efb8b003_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_7620e257-43dc-4465-9980-979d5e5e2e98_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_fc72f43f-a1c5-4c60-bdd2-b5f5ed8fe74f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AgenusMember_1be964ff-bdc0-4aba-b188-f56e1101691f_terseLabel_en-US" xlink:label="lab_bmy_AgenusMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agenus</link:label>
    <link:label id="lab_bmy_AgenusMember_label_en-US" xlink:label="lab_bmy_AgenusMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agenus [Member]</link:label>
    <link:label id="lab_bmy_AgenusMember_documentation_en-US" xlink:label="lab_bmy_AgenusMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agenus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AgenusMember" xlink:href="bmy-20210630.xsd#bmy_AgenusMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AgenusMember" xlink:to="lab_bmy_AgenusMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_4ffbefb0-5845-42ea-baeb-99b442209e36_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_e16b457c-677d-45ca-85c5-74bcceb31b7a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of marketable debt securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_fd30abc5-277f-42e3-9c23-c8c433461d4e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_92b83b74-5b60-45a7-8a2b-4ab052b8971a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Intangible Assets By Major Class [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeVariableInterestRate_c8c1f116-af57-439c-9d3d-22fefd574657_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeVariableInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Variable Interest Rate</link:label>
    <link:label id="lab_us-gaap_DerivativeVariableInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeVariableInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Variable Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeVariableInterestRate" xlink:to="lab_us-gaap_DerivativeVariableInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_PomalystImnovidMember_eb23a809-ee0c-4687-ab45-ec89961490ca_terseLabel_en-US" xlink:label="lab_bmy_PomalystImnovidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pomalyst/Imnovid [Member]</link:label>
    <link:label id="lab_bmy_PomalystImnovidMember_label_en-US" xlink:label="lab_bmy_PomalystImnovidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pomalyst/Imnovid [Member]</link:label>
    <link:label id="lab_bmy_PomalystImnovidMember_documentation_en-US" xlink:label="lab_bmy_PomalystImnovidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pomalyst/Imnovid [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PomalystImnovidMember" xlink:href="bmy-20210630.xsd#bmy_PomalystImnovidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_PomalystImnovidMember" xlink:to="lab_bmy_PomalystImnovidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_cc3b5635-fa55-4f61-bcbc-fd089edff31f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_b9e5a800-592f-4171-b3df-320579643d07_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b9a7076f-aa71-4113-8b3e-4d8648a30222_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ContingentAndRegulatoryMilestoneNonCash_ef4751d1-e70b-4f29-bf13-e7160f7ae1a9_terseLabel_en-US" xlink:label="lab_bmy_ContingentAndRegulatoryMilestoneNonCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent and Regulatory Milestone, Non-Cash</link:label>
    <link:label id="lab_bmy_ContingentAndRegulatoryMilestoneNonCash_label_en-US" xlink:label="lab_bmy_ContingentAndRegulatoryMilestoneNonCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent and Regulatory Milestone, Non-Cash</link:label>
    <link:label id="lab_bmy_ContingentAndRegulatoryMilestoneNonCash_documentation_en-US" xlink:label="lab_bmy_ContingentAndRegulatoryMilestoneNonCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent and Regulatory Milestone, Non-Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentAndRegulatoryMilestoneNonCash" xlink:href="bmy-20210630.xsd#bmy_ContingentAndRegulatoryMilestoneNonCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ContingentAndRegulatoryMilestoneNonCash" xlink:to="lab_bmy_ContingentAndRegulatoryMilestoneNonCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_5cf43538-4b8a-488a-b876-7c8177f96a0c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_cc6647fd-0018-4371-b5c7-7c225e74b86e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CerclaMattersMember_8fc6a482-004f-4666-bfac-d8cc394bd90d_terseLabel_en-US" xlink:label="lab_bmy_CerclaMattersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cercla Matters [Member]</link:label>
    <link:label id="lab_bmy_CerclaMattersMember_label_en-US" xlink:label="lab_bmy_CerclaMattersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cercla Matters [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CerclaMattersMember" xlink:href="bmy-20210630.xsd#bmy_CerclaMattersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CerclaMattersMember" xlink:to="lab_bmy_CerclaMattersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_08553a6f-ae84-474b-aae2-3d9e02be31b1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSAbstract_65c7a7b4-f942-40e1-8bc7-8c45ac83ef43_terseLabel_en-US" xlink:label="lab_bmy_BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS [Abstract]</link:label>
    <link:label id="lab_bmy_BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSAbstract_label_en-US" xlink:label="lab_bmy_BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS [Abstract]</link:label>
    <link:label id="lab_bmy_BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSAbstract_documentation_en-US" xlink:label="lab_bmy_BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSAbstract" xlink:href="bmy-20210630.xsd#bmy_BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSAbstract" xlink:to="lab_bmy_BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherNonCurrentLiabilitiesAbstract_3e956e56-3aa9-41b8-9e0c-fd2ccfe83183_terseLabel_en-US" xlink:label="lab_bmy_OtherNonCurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Current Liabilities [Abstract]</link:label>
    <link:label id="lab_bmy_OtherNonCurrentLiabilitiesAbstract_label_en-US" xlink:label="lab_bmy_OtherNonCurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Current Liabilities [Abstract]</link:label>
    <link:label id="lab_bmy_OtherNonCurrentLiabilitiesAbstract_documentation_en-US" xlink:label="lab_bmy_OtherNonCurrentLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Current Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherNonCurrentLiabilitiesAbstract" xlink:href="bmy-20210630.xsd#bmy_OtherNonCurrentLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherNonCurrentLiabilitiesAbstract" xlink:to="lab_bmy_OtherNonCurrentLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_11c69e2f-985b-4f6b-9f91-4e45105b0fe4_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3d2c4832-dfb5-4299-8d44-7bc77235034a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings/(Loss) Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_89749fcf-91dd-47ea-8ace-ef2d7d384667_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7cf1f355-708e-4327-b8fb-a6de0a1a9ad4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_f1b0fa85-a6bd-48c0-baa0-2909dee2b81c_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_622b611c-79a6-4cee-a231-381c6335f7f8_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income/(loss), Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_f9194ada-95ca-406b-84b4-4c20b8539d76_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_95806f6d-4982-45d9-bf24-8cc7da8756fd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_910a17e1-536a-412d-b1b1-16e5289d8e90_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation and other settlements</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_227eb708-963f-4fb2-8ae1-f3685f3c9aa7_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payments</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_Pensionsettlementsandamortization_bf959d08-7510-4b68-8d2b-7dfdf5d456a4_terseLabel_en-US" xlink:label="lab_bmy_Pensionsettlementsandamortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension settlements and amortization</link:label>
    <link:label id="lab_bmy_Pensionsettlementsandamortization_label_en-US" xlink:label="lab_bmy_Pensionsettlementsandamortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension settlements and amortization</link:label>
    <link:label id="lab_bmy_Pensionsettlementsandamortization_documentation_en-US" xlink:label="lab_bmy_Pensionsettlementsandamortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The aggregate amount of expense recognized due to defined benefit pension settlements and curtailments and the amortization of prior service credits and net actuarial loss.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Pensionsettlementsandamortization" xlink:href="bmy-20210630.xsd#bmy_Pensionsettlementsandamortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_Pensionsettlementsandamortization" xlink:to="lab_bmy_Pensionsettlementsandamortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_0cab6445-9300-45c4-ae82-3cb93dba6b95_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_67daf0e7-f9d0-4750-a46b-19e6ebaa37c6_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_14d8b3b0-a6ae-4e45-b255-e1c573411bc4_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CelgeneIntegrationMember_fb6949b6-2aa9-4646-b09c-4c043608e534_terseLabel_en-US" xlink:label="lab_bmy_CelgeneIntegrationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Integration [Member]</link:label>
    <link:label id="lab_bmy_CelgeneIntegrationMember_label_en-US" xlink:label="lab_bmy_CelgeneIntegrationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Integration [Member]</link:label>
    <link:label id="lab_bmy_CelgeneIntegrationMember_documentation_en-US" xlink:label="lab_bmy_CelgeneIntegrationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Celgene Integration [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember" xlink:href="bmy-20210630.xsd#bmy_CelgeneIntegrationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CelgeneIntegrationMember" xlink:to="lab_bmy_CelgeneIntegrationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_36589b64-6dc4-42c8-a76b-8b336e19043b_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_5515f723-c962-43aa-8fa5-d56b8c41e3c4_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_7351dafa-4d50-4849-a37d-f028d95388f0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Reclassification Adjustments, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_72a4ebdc-5c83-4670-bca8-8979e33ca4be_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Receivables [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_c0f727fe-9ed5-41fd-9007-57ae5af94cde_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract Type [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyIncomeNonoperating_aa7e2459-bcb9-45be-b78c-cd20c71c2dee_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyIncomeNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Income, Nonoperating</link:label>
    <link:label id="lab_us-gaap_RoyaltyIncomeNonoperating_label_en-US" xlink:label="lab_us-gaap_RoyaltyIncomeNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Income, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyIncomeNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyIncomeNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyIncomeNonoperating" xlink:to="lab_us-gaap_RoyaltyIncomeNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherShutdownCosts_2db0b4f6-055d-4788-821e-fb375c06d30f_terseLabel_en-US" xlink:label="lab_bmy_OtherShutdownCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other shutdown costs</link:label>
    <link:label id="lab_bmy_OtherShutdownCosts_label_en-US" xlink:label="lab_bmy_OtherShutdownCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other shutdown costs</link:label>
    <link:label id="lab_bmy_OtherShutdownCosts_documentation_en-US" xlink:label="lab_bmy_OtherShutdownCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other shutdown costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherShutdownCosts" xlink:href="bmy-20210630.xsd#bmy_OtherShutdownCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherShutdownCosts" xlink:to="lab_bmy_OtherShutdownCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A1.750Notesdue2035Member_93c241a5-dcf8-4a84-9711-d27a97bb7ee7_terseLabel_en-US" xlink:label="lab_bmy_A1.750Notesdue2035Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.750% Notes due 2035 [Member]</link:label>
    <link:label id="lab_bmy_A1.750Notesdue2035Member_label_en-US" xlink:label="lab_bmy_A1.750Notesdue2035Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.750% Notes due 2035 [Member]</link:label>
    <link:label id="lab_bmy_A1.750Notesdue2035Member_documentation_en-US" xlink:label="lab_bmy_A1.750Notesdue2035Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One750NotesDue2035Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.750Notesdue2035Member" xlink:href="bmy-20210630.xsd#bmy_A1.750Notesdue2035Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A1.750Notesdue2035Member" xlink:to="lab_bmy_A1.750Notesdue2035Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c34cacbd-196d-4256-8f9b-6e6203e35044_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8018a48f-9fc6-4b06-afc8-cdbdb02af381_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f41aac6f-587f-4f5a-b2d8-f0ab1be37e35_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_879a5132-d0d6-45a7-b136-567c475abc4b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_68ed0772-4100-4b98-a509-4796888754d7_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration fair value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_601f6e43-c331-49db-9817-013592b7a123_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent value rights</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock_fbd92b45-3a14-4887-97cc-d840ec88c29c_terseLabel_en-US" xlink:label="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Investments [Table Text Block]</link:label>
    <link:label id="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock_label_en-US" xlink:label="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Investments [Table Text Block]</link:label>
    <link:label id="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock_documentation_en-US" xlink:label="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfEquityInvestmentsTableTextBlock" xlink:href="bmy-20210630.xsd#bmy_ScheduleOfEquityInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ScheduleOfEquityInvestmentsTableTextBlock" xlink:to="lab_bmy_ScheduleOfEquityInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_ef1bc354-bf1d-4c95-b421-47eb15638083_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_AllCurrenciesDomain_15c6c72b-93fc-4e8a-8a05-3908f65db298_terseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_6032761b-fb6c-48c8-9d08-615555200a5c_verboseLabel_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:label id="lab_currency_AllCurrenciesDomain_label_en-US" xlink:label="lab_currency_AllCurrenciesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Currencies [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_AllCurrenciesDomain" xlink:to="lab_currency_AllCurrenciesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_5369443e-30a4-4f9b-b8b9-97b24e4a2238_totalLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank drafts and short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ErbituxBusinessMember_0c7efc63-117b-4fe6-b1a5-01abf6398f2c_terseLabel_en-US" xlink:label="lab_bmy_ErbituxBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erbitux [Member]</link:label>
    <link:label id="lab_bmy_ErbituxBusinessMember_label_en-US" xlink:label="lab_bmy_ErbituxBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erbitux Business [Member]</link:label>
    <link:label id="lab_bmy_ErbituxBusinessMember_documentation_en-US" xlink:label="lab_bmy_ErbituxBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erbitux Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ErbituxBusinessMember" xlink:href="bmy-20210630.xsd#bmy_ErbituxBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ErbituxBusinessMember" xlink:to="lab_bmy_ErbituxBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_d610f568-c279-46a9-9e51-150d445a4cf7_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_c71a8ca2-3196-4f46-bc39-f3b7c7416167_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_4037ac02-8bb5-4b59-9c90-deba7b191e24_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Account Receivables [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_9db115d0-6767-4e25-a320-e0c440468fd8_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e7c5b58f-09de-4fc1-a202-78100d2004c0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_e5590ede-3da8-42c2-8721-1e47c3a5bad1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_b0abb498-c0f4-451f-a127-429fb4466b78_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LegalProceedingsAndContingenciesLineItems_a961d9ae-a219-48e0-bb29-44f733d1dbc0_terseLabel_en-US" xlink:label="lab_bmy_LegalProceedingsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Proceedings And Contingencies [Line Items]</link:label>
    <link:label id="lab_bmy_LegalProceedingsAndContingenciesLineItems_label_en-US" xlink:label="lab_bmy_LegalProceedingsAndContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Proceedings And Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LegalProceedingsAndContingenciesLineItems" xlink:href="bmy-20210630.xsd#bmy_LegalProceedingsAndContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems" xlink:to="lab_bmy_LegalProceedingsAndContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_d4c89712-f4d0-4fde-a920-058be90b4358_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_e9352fdd-fcee-405a-8b13-063c3d8ac6c9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives Balance Sheet Location By Derivative Contract Type By Hedging Designation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ab2e3479-2c37-41ed-ba82-a5d367bde5fc_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding - basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_30ff7c93-9813-408b-b13f-091204e375bf_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings/(Loss) Per Share, Diluted</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OnuregMember_119f83af-dbe4-4f46-b5df-1b8621b84f3c_terseLabel_en-US" xlink:label="lab_bmy_OnuregMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onureg [Member]</link:label>
    <link:label id="lab_bmy_OnuregMember_label_en-US" xlink:label="lab_bmy_OnuregMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onureg [Member]</link:label>
    <link:label id="lab_bmy_OnuregMember_documentation_en-US" xlink:label="lab_bmy_OnuregMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Onureg</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OnuregMember" xlink:href="bmy-20210630.xsd#bmy_OnuregMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OnuregMember" xlink:to="lab_bmy_OnuregMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingArrangementsCashFlowsReclassificationMember_6e56ba21-2844-4063-812f-cfbeca9e82c9_terseLabel_en-US" xlink:label="lab_bmy_LicensingArrangementsCashFlowsReclassificationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements Cash Flows Reclassification</link:label>
    <link:label id="lab_bmy_LicensingArrangementsCashFlowsReclassificationMember_label_en-US" xlink:label="lab_bmy_LicensingArrangementsCashFlowsReclassificationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements Cash Flows Reclassification [Member]</link:label>
    <link:label id="lab_bmy_LicensingArrangementsCashFlowsReclassificationMember_documentation_en-US" xlink:label="lab_bmy_LicensingArrangementsCashFlowsReclassificationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Arrangements Cash Flows Reclassification</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsCashFlowsReclassificationMember" xlink:href="bmy-20210630.xsd#bmy_LicensingArrangementsCashFlowsReclassificationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingArrangementsCashFlowsReclassificationMember" xlink:to="lab_bmy_LicensingArrangementsCashFlowsReclassificationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_63583a29-76cd-4c52-8ee7-29ccaa2d9468_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestitures, Licensing and Other Arrangements [Text Block]</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_CashDiscounts_5a186668-9c90-4d3e-9a00-b72296436d99_negatedTerseLabel_en-US" xlink:label="lab_bmy_CashDiscounts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less charge-backs and cash discounts</link:label>
    <link:label id="lab_bmy_CashDiscounts_label_en-US" xlink:label="lab_bmy_CashDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Discounts</link:label>
    <link:label id="lab_bmy_CashDiscounts_documentation_en-US" xlink:label="lab_bmy_CashDiscounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of reductions to trade receivables incurred during the period attributable to cash discounts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CashDiscounts" xlink:href="bmy-20210630.xsd#bmy_CashDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_CashDiscounts" xlink:to="lab_bmy_CashDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherIncomeReceivedFromAlliancePartners_676db71e-8e90-47db-94cc-74fa847cb69b_negatedTerseLabel_en-US" xlink:label="lab_bmy_OtherIncomeReceivedFromAlliancePartners" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties and licensing income</link:label>
    <link:label id="lab_bmy_OtherIncomeReceivedFromAlliancePartners_label_en-US" xlink:label="lab_bmy_OtherIncomeReceivedFromAlliancePartners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income Received From Alliance Partners</link:label>
    <link:label id="lab_bmy_OtherIncomeReceivedFromAlliancePartners_documentation_en-US" xlink:label="lab_bmy_OtherIncomeReceivedFromAlliancePartners" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the amount of other income received during the period related to alliance partners and includes the amortization of milestone payments received and royalty income.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherIncomeReceivedFromAlliancePartners" xlink:href="bmy-20210630.xsd#bmy_OtherIncomeReceivedFromAlliancePartners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherIncomeReceivedFromAlliancePartners" xlink:to="lab_bmy_OtherIncomeReceivedFromAlliancePartners" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_c472fd1e-5293-4486-9dd5-1d41122c91d6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_7264347e-1f70-4ce8-8bb4-5cefc9cf89d1_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_778f1991-f9e4-4465-8765-e90340fe9318_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_8cbdbc66-5afe-4459-a19c-c7776b569dfb_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income/(Loss) Attributable to BMS</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_00ba783b-bcb7-4fdd-ba39-b0a98e9213e9_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestments" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_e525b275-0f8f-475a-844d-328273256995_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash (Used in)/Provided by Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ee2ab2d7-e0ac-4f1b-ad5b-a9e2e9a9ea29_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_5cf12486-e481-4b98-8e62-3ac35964a59c_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less cost of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_e783b6cb-f1a1-4bba-b154-0790a366aea9_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Treasury Stock, Balance at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_3ce082e5-0464-4b28-9c46-5e2481b48421_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Treasury Stock, Balance at End of Period</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_0b23e85d-1d7b-4bf7-a080-ffdc80bd14b9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_b7d02607-03f6-4dd1-be56-9fccb13970f2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Comprehensive Income Loss [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_c9f98cef-6dac-4933-a9c3-8a93a8418abe_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_3c0b63af-970b-4a86-afd6-87dbc44857e1_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_f46ad32b-8b0f-4593-9f6a-a8ccedcd6141_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_3555a2cf-0ce2-4b16-b3d4-de0a718f05a9_totalLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_2bac5bcb-c5bd-457d-9952-2aec20a871d8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_11c5b30c-3985-4197-901f-d2981354f245_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable - to alliance partners</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_72b2967c-3054-4e9b-b8f4-5b9908edf06c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OpdivoMember_11c519df-c5bd-4a7a-ae20-dff072f0ede3_terseLabel_en-US" xlink:label="lab_bmy_OpdivoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opdivo [Member]</link:label>
    <link:label id="lab_bmy_OpdivoMember_label_en-US" xlink:label="lab_bmy_OpdivoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opdivo [Member]</link:label>
    <link:label id="lab_bmy_OpdivoMember_documentation_en-US" xlink:label="lab_bmy_OpdivoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US"></link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OpdivoMember" xlink:href="bmy-20210630.xsd#bmy_OpdivoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OpdivoMember" xlink:to="lab_bmy_OpdivoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBankLoansAndNotesPayable_b6860d93-ea26-4c8c-9f96-2beabf72d935_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBankLoansAndNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Bank Loans and Notes Payable</link:label>
    <link:label id="lab_us-gaap_ShortTermBankLoansAndNotesPayable_label_en-US" xlink:label="lab_us-gaap_ShortTermBankLoansAndNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Bank Loans and Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBankLoansAndNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBankLoansAndNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBankLoansAndNotesPayable" xlink:to="lab_us-gaap_ShortTermBankLoansAndNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_ecd5d51b-e03a-4231-82c9-c36603848594_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization, net</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract_ed471305-155e-489b-98ba-4e9433a4bca7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract" xlink:to="lab_us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_e51ecd78-e60b-405d-8e98-b8ade9bc5b65_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_4d1507ad-848e-4934-90f7-1c9a5a33fe7d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_491af7d9-85a3-4bd0-bbae-7ed53575a73c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_5fee6e20-6371-40ff-8167-da006c27cec4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_a6f87512-27ed-44b1-985e-c595ffd4e7c7_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalties</link:label>
    <link:label id="lab_us-gaap_AccruedRoyaltiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Royalties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedRoyaltiesCurrent" xlink:to="lab_us-gaap_AccruedRoyaltiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_99feb71d-dbeb-47d0-a1a4-8487fdf9134b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringChargesAbstract_944875f3-fbb8-458b-867c-83b60251b8dc_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringChargesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringChargesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringChargesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringChargesAbstract" xlink:to="lab_us-gaap_RestructuringChargesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_01e479bc-b0df-4196-bc40-71dfebdd790b_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_6bca76cc-2cec-4c60-95d8-ea9f5066c004_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_Divestitureandotherproceeds_0dc2b874-869f-4261-b78a-640309e5791c_terseLabel_en-US" xlink:label="lab_bmy_Divestitureandotherproceeds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture and other proceeds</link:label>
    <link:label id="lab_bmy_Divestitureandotherproceeds_label_en-US" xlink:label="lab_bmy_Divestitureandotherproceeds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture and other proceeds</link:label>
    <link:label id="lab_bmy_Divestitureandotherproceeds_documentation_en-US" xlink:label="lab_bmy_Divestitureandotherproceeds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This element represents the cash inflow during the period from the sale of a business, asset or other proceeds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Divestitureandotherproceeds" xlink:href="bmy-20210630.xsd#bmy_Divestitureandotherproceeds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_Divestitureandotherproceeds" xlink:to="lab_bmy_Divestitureandotherproceeds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_022f6c9c-e85f-4c1c-a1d1-412aa023891c_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_Reversionexcisetax_4f0f4a36-d277-419f-8ebf-9b4a90a51a25_terseLabel_en-US" xlink:label="lab_bmy_Reversionexcisetax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversion excise tax</link:label>
    <link:label id="lab_bmy_Reversionexcisetax_label_en-US" xlink:label="lab_bmy_Reversionexcisetax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversion excise tax</link:label>
    <link:label id="lab_bmy_Reversionexcisetax_documentation_en-US" xlink:label="lab_bmy_Reversionexcisetax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Section 4980 Tax On Reversion Of Qualified Plan Assets To Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Reversionexcisetax" xlink:href="bmy-20210630.xsd#bmy_Reversionexcisetax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_Reversionexcisetax" xlink:to="lab_bmy_Reversionexcisetax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_0bd023b0-3bee-41f1-bef5-b6be4c4fc37d_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:label id="lab_us-gaap_ComputerSoftwareIntangibleAssetMember_label_en-US" xlink:label="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Software, Intangible Asset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:to="lab_us-gaap_ComputerSoftwareIntangibleAssetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_dc133d2f-9f7d-4a8b-b19d-5aeaeb6a92f1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustment_b1e8be17-ebda-4815-9e1d-f080e614cb1b_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Period Reclassification Adjustment</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustment_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Period Reclassification Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustment" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_4ff07266-d347-44d5-9418-469770d05b02_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationLineItems_88359f45-749c-4073-b5d2-5d12e1ca00f6_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationLineItems" xlink:to="lab_us-gaap_ReclassificationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_MatureBrandsAndOtherMember_dfa621ed-32a8-4e92-b2b4-2f70d287c51a_terseLabel_en-US" xlink:label="lab_bmy_MatureBrandsAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other divestitures [Member]</link:label>
    <link:label id="lab_bmy_MatureBrandsAndOtherMember_label_en-US" xlink:label="lab_bmy_MatureBrandsAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature Brands and Other [Member]</link:label>
    <link:label id="lab_bmy_MatureBrandsAndOtherMember_documentation_en-US" xlink:label="lab_bmy_MatureBrandsAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mature Brands and Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureBrandsAndOtherMember" xlink:href="bmy-20210630.xsd#bmy_MatureBrandsAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_MatureBrandsAndOtherMember" xlink:to="lab_bmy_MatureBrandsAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_SprycelMember_b229b6bd-5be2-4114-83cc-9cc6da2e1f5a_terseLabel_en-US" xlink:label="lab_bmy_SprycelMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sprycel [Member]</link:label>
    <link:label id="lab_bmy_SprycelMember_label_en-US" xlink:label="lab_bmy_SprycelMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sprycel [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SprycelMember" xlink:href="bmy-20210630.xsd#bmy_SprycelMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_SprycelMember" xlink:to="lab_bmy_SprycelMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_e778ede4-d3b5-48a0-955d-be10856fe84f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_45b65fc9-07e0-4460-bbd5-41799b48772c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_d771628a-599e-4530-a270-ac14e1cb2749_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationTypeAxis_56550ed7-f74a-42dd-ae66-c9588809da32_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ReclassificationTypeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationTypeAxis" xlink:to="lab_us-gaap_ReclassificationTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_ff4f614b-84eb-458b-bae0-996c186d7ebf_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_a6a8662c-6cf1-42b9-a2c1-ede972e83711_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetAbstract_1d72dd01-4327-4f1e-a768-b9cfa991ceeb_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetAbstract_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract" xlink:to="lab_us-gaap_AccountsReceivableNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_cfa748fc-2314-49a4-a94c-076ed0d57759_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_86491c90-f003-4f68-b649-edd7a1a3554a_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_da6975b0-541e-488c-8c14-c47b3bb06102_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherPrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPrepaidExpenseCurrent" xlink:to="lab_us-gaap_OtherPrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_941c99c4-bffa-4a7a-975a-35a043eb8786_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Text Block]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_225549ef-3bb9-4084-8631-430e240be746_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementAccountingPolicy_49f2b74d-5dae-4b81-b59d-37b3140c92e2_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Accounting Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementAccountingPolicy_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Accounting Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementAccountingPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:to="lab_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeMember_a3bb278f-6b09-4468-aba0-c50e87af360c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (Income)/expense, net [Member]</link:label>
    <link:label id="lab_us-gaap_OtherIncomeMember_label_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeMember" xlink:to="lab_us-gaap_OtherIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments_d6691fa5-9bce-4a42-b8c6-b9fe077a179b_terseLabel_en-US" xlink:label="lab_bmy_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments</link:label>
    <link:label id="lab_bmy_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments_label_en-US" xlink:label="lab_bmy_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments</link:label>
    <link:label id="lab_bmy_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments_documentation_en-US" xlink:label="lab_bmy_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments" xlink:href="bmy-20210630.xsd#bmy_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments" xlink:to="lab_bmy_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_901afab2-190b-4d2c-98aa-b5e754e1f2e7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value and Other Adjustments to Long Term Debt [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_0b50bf68-c8e4-472f-86d6-cc9c41ab4b31_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_6a250b5e-17a5-4615-89c5-8c703f2052d5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_05d2c5d4-98dd-43c8-ab9a-fa09085e99ee_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_bb18a30f-a317-4846-951d-d68b9f61414d_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_0c9d9b13-990e-4bc4-a53b-a2788c0a96c4_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement [Member]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_8c8af4b3-e646-40a9-ba7a-efea791a1893_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_2bf7d85f-1d6b-4848-bf04-8d6be68b940e_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_f15477b4-8e96-46fd-976a-9558e8306842_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_214c308e-7a62-403c-9437-24c5fd53caab_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits - Amortization, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_79a7c303-1850-447e-a7cd-1b20dbb54a74_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_d21a50f1-194c-4910-b9b0-f0bc039f0381_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_4cb6be1e-9c00-4920-a266-f924a7af934c_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_5de3121d-5f08-4242-b76f-0b7ddb87d452_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedPremium_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Premium</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedPremium" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_0f779594-e800-4cde-aec8-a09ee308c933_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_753774a0-61a5-47e4-b1ad-f174608867cb_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee termination costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_7f53d220-dd15-45b7-bfbd-299897b8200a_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits - Amortization, Pre-tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_ffb5f22f-8b59-42eb-848a-162964cc225e_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AbilifyProductLiabilityMember_2a7a0a0f-b078-4c32-a574-9d81ab1b0fe4_terseLabel_en-US" xlink:label="lab_bmy_AbilifyProductLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abilify Product Liability [Member]</link:label>
    <link:label id="lab_bmy_AbilifyProductLiabilityMember_label_en-US" xlink:label="lab_bmy_AbilifyProductLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abilify Product Liability [Member]</link:label>
    <link:label id="lab_bmy_AbilifyProductLiabilityMember_documentation_en-US" xlink:label="lab_bmy_AbilifyProductLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abilify Product Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbilifyProductLiabilityMember" xlink:href="bmy-20210630.xsd#bmy_AbilifyProductLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AbilifyProductLiabilityMember" xlink:to="lab_bmy_AbilifyProductLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_8953317f-48fb-49dd-95eb-f714fe01d8dc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingCompaniesDomain_530dfeed-f03c-4143-b7f8-4b65ac11d3a5_terseLabel_en-US" xlink:label="lab_bmy_LicensingCompaniesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Companies [Domain]</link:label>
    <link:label id="lab_bmy_LicensingCompaniesDomain_label_en-US" xlink:label="lab_bmy_LicensingCompaniesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Companies [Domain]</link:label>
    <link:label id="lab_bmy_LicensingCompaniesDomain_documentation_en-US" xlink:label="lab_bmy_LicensingCompaniesDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Companies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingCompaniesDomain" xlink:href="bmy-20210630.xsd#bmy_LicensingCompaniesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingCompaniesDomain" xlink:to="lab_bmy_LicensingCompaniesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuePerformanceObligationAbstract_bb91b33b-20e3-4662-95f6-5aeb4e5a7db8_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuePerformanceObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenuePerformanceObligationAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuePerformanceObligationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuePerformanceObligationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuePerformanceObligationAbstract" xlink:to="lab_us-gaap_RevenuePerformanceObligationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_916ffd7f-eb9e-4a68-a316-1996078d288c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_LicensingCompaniesAxis_a394990e-519c-4cc6-8038-3fe0dd6a0a37_terseLabel_en-US" xlink:label="lab_bmy_LicensingCompaniesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Companies [Axis]</link:label>
    <link:label id="lab_bmy_LicensingCompaniesAxis_label_en-US" xlink:label="lab_bmy_LicensingCompaniesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Companies [Axis]</link:label>
    <link:label id="lab_bmy_LicensingCompaniesAxis_documentation_en-US" xlink:label="lab_bmy_LicensingCompaniesAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Companies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingCompaniesAxis" xlink:href="bmy-20210630.xsd#bmy_LicensingCompaniesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_LicensingCompaniesAxis" xlink:to="lab_bmy_LicensingCompaniesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_98050723-e2da-4014-849b-1be274379abe_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_54f846ea-5fa5-4b7b-ac4e-d40375cd2c64_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_22225b95-96b7-4518-bbff-6437662e4d34_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a1394019-9103-43d1-8ece-8f12932d0aec_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Tax Rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_1a3ba72f-06b0-4879-9167-c44551d8080e_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, Estimate of possible loss</link:label>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_label_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:to="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_cf8751ed-505a-4a62-b050-3cae979f39bc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits - Curtailments and settlements, Pre-Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_a5526d90-e02e-4a1c-a9ed-e0f7085c0166_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_OtherLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_85a07a29-b2a3-423e-b43c-dd8bb842ac22_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain/(Loss) on Hedging Activity [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OrenciaMember_59c28c2b-194a-45ea-bc09-1bfcd5f8aa71_terseLabel_en-US" xlink:label="lab_bmy_OrenciaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orencia [Member]</link:label>
    <link:label id="lab_bmy_OrenciaMember_label_en-US" xlink:label="lab_bmy_OrenciaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orencia [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OrenciaMember" xlink:href="bmy-20210630.xsd#bmy_OrenciaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OrenciaMember" xlink:to="lab_bmy_OrenciaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_d9f209b8-96b4-42fa-9223-e6214af1fcf9_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Earnings/(Loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_5cecb1ee-fea0-498a-8e5a-2f3a58c5238a_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Earnings/(Loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_da8522c6-da6c-454b-a5cf-cf29aa901144_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:to="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_DiabetesbusinessMember_057d060b-51b9-426f-bae1-7765dbce3dd9_terseLabel_en-US" xlink:label="lab_bmy_DiabetesbusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diabetes business [Member]</link:label>
    <link:label id="lab_bmy_DiabetesbusinessMember_label_en-US" xlink:label="lab_bmy_DiabetesbusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diabetes business [Member]</link:label>
    <link:label id="lab_bmy_DiabetesbusinessMember_documentation_en-US" xlink:label="lab_bmy_DiabetesbusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diabetes business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DiabetesbusinessMember" xlink:href="bmy-20210630.xsd#bmy_DiabetesbusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_DiabetesbusinessMember" xlink:to="lab_bmy_DiabetesbusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_a3b66e21-f8ef-4bd8-bcd6-c0d04c22501f_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt obligations</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_d884a09a-dcfc-4ba3-9ff9-7b8e0c7a8eeb_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1864728b-fedd-4eae-8a0b-c1e9628ac402_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Restricted Cash at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1a6e19d5-2740-485a-a975-e02d44f3eab7_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Restricted Cash at End of Period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_3f59928a-ee88-4b2c-a0b4-6dcebb17d982_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Issued, Balance at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_SharesIssued_e70d556c-9e37-40c7-b802-37faa27085e2_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Issued, Balance at End of Period</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_32da9b55-e473-410f-82f5-7cfced09f334_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_a87cef80-cc48-407c-a2ef-9c35de9cdd3a_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_dba10eea-7d97-4547-9bab-0a228c2b74b2_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d41b989c-fa62-40f2-b18a-81d52ef70953_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_78069b35-c19e-45df-b496-82b1b19b777f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_50f28590-bb36-4773-8406-bf3fc723e7e9_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EliquisMember_3ac60367-48ab-431b-88e3-549004ce36fb_terseLabel_en-US" xlink:label="lab_bmy_EliquisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eliquis [Member]</link:label>
    <link:label id="lab_bmy_EliquisMember_label_en-US" xlink:label="lab_bmy_EliquisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eliquis [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EliquisMember" xlink:href="bmy-20210630.xsd#bmy_EliquisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EliquisMember" xlink:to="lab_bmy_EliquisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_a937182f-a304-4144-beb6-c24c6a17b2a2_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_c89a07cc-57c9-4e53-aa07-92d339e090b7_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_ce540352-ae6b-4512-8cb2-4fac98e375f3_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNoncurrent_5fd90fb4-c906-4ea4-b3f8-3015e8d21457_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories - other assets</link:label>
    <link:label id="lab_us-gaap_InventoryNoncurrent_595af63a-c72d-44fa-a6d2-f0ba5cac6fad_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNoncurrent_label_en-US" xlink:label="lab_us-gaap_InventoryNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNoncurrent" xlink:to="lab_us-gaap_InventoryNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6bf84e4e-91b6-4c77-a6d4-6ee6e31fb8d6_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding - diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_55d92743-be55-4992-9c44-b93f592b03ac_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_EmplicitiMember_49247464-d19e-4976-ba9c-937c1782e329_terseLabel_en-US" xlink:label="lab_bmy_EmplicitiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Empliciti [Member]</link:label>
    <link:label id="lab_bmy_EmplicitiMember_label_en-US" xlink:label="lab_bmy_EmplicitiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Empliciti [Member]</link:label>
    <link:label id="lab_bmy_EmplicitiMember_documentation_en-US" xlink:label="lab_bmy_EmplicitiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Empliciti [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EmplicitiMember" xlink:href="bmy-20210630.xsd#bmy_EmplicitiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_EmplicitiMember" xlink:to="lab_bmy_EmplicitiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f6d0becf-1fe6-4472-99bb-570bb14a0203_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income/(Loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_cc361b99-92b5-4cb9-8ab8-ab92bc79ba09_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income/(Loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_e7e3cb7e-1763-4df8-9dc7-529b89eaf802_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_0c33e315-f3a6-48c9-8082-badaf9bfd7f6_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_54d7bb0c-2832-41c5-8815-a848420acc43_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_b237bd5f-760e-423c-bf3b-243d74df58bb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_3a483924-52a3-42d1-887b-af8996ae1aa6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A1BillionMaximumBorrowingCapacityMember_5655670d-7691-40d6-aac9-d64e060873e3_terseLabel_en-US" xlink:label="lab_bmy_A1BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1 Billion Maximum Borrowing Capacity</link:label>
    <link:label id="lab_bmy_A1BillionMaximumBorrowingCapacityMember_label_en-US" xlink:label="lab_bmy_A1BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1 Billion Maximum Borrowing Capacity [Member]</link:label>
    <link:label id="lab_bmy_A1BillionMaximumBorrowingCapacityMember_documentation_en-US" xlink:label="lab_bmy_A1BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1 Billion Maximum Borrowing Capacity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1BillionMaximumBorrowingCapacityMember" xlink:href="bmy-20210630.xsd#bmy_A1BillionMaximumBorrowingCapacityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A1BillionMaximumBorrowingCapacityMember" xlink:to="lab_bmy_A1BillionMaximumBorrowingCapacityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_5dd602c5-3c97-4122-8718-26aef1bed43b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax_6cb6b513-d2d5-4513-a767-89e41b3c2204_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Reclassification Adjustments and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherNonCurrentAssetsAbstract_d723d67f-5204-4bac-9248-4fa42942dd31_terseLabel_en-US" xlink:label="lab_bmy_OtherNonCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Current Assets [Abstract]</link:label>
    <link:label id="lab_bmy_OtherNonCurrentAssetsAbstract_label_en-US" xlink:label="lab_bmy_OtherNonCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Current Assets [Abstract]</link:label>
    <link:label id="lab_bmy_OtherNonCurrentAssetsAbstract_documentation_en-US" xlink:label="lab_bmy_OtherNonCurrentAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non-Current Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherNonCurrentAssetsAbstract" xlink:href="bmy-20210630.xsd#bmy_OtherNonCurrentAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherNonCurrentAssetsAbstract" xlink:to="lab_bmy_OtherNonCurrentAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ReblozylMember_2ba9e903-5f73-43e6-9085-37e199f8d8eb_terseLabel_en-US" xlink:label="lab_bmy_ReblozylMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reblozyl [Member]</link:label>
    <link:label id="lab_bmy_ReblozylMember_label_en-US" xlink:label="lab_bmy_ReblozylMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reblozyl [Member]</link:label>
    <link:label id="lab_bmy_ReblozylMember_documentation_en-US" xlink:label="lab_bmy_ReblozylMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reblozyl [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReblozylMember" xlink:href="bmy-20210630.xsd#bmy_ReblozylMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ReblozylMember" xlink:to="lab_bmy_ReblozylMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_225add49-23ac-4e0c-aa1f-5cbb15ff4c21_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other termination costs</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringCosts_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringCosts" xlink:to="lab_us-gaap_OtherRestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyMember_ef254094-e026-4347-bd02-0a4043e26270_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty [Member]</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_label_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyMember" xlink:to="lab_us-gaap_RoyaltyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a9e7c885-3259-45da-98c4-0881459815dc_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_b246b673-a43d-4b36-9b6b-67a15ccd0946_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_72c204c4-e68f-4e23-a1fc-7c2487d9ecdc_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_393da21f-3462-4f08-9b73-d250f3179653_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_16129851-5095-4bbc-a593-b39e27451515_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueAbstract_87f3a3f0-abfe-4bb2-b2fc-a62b9313fdf6_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract" xlink:to="lab_us-gaap_DisaggregationOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_074583d2-3e0f-48e2-901d-1f4d73a9d52c_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_DeferredIncomeTaxExpenseBenefitComponentDomain_af19b067-27d6-4d76-92af-805078849230_terseLabel_en-US" xlink:label="lab_bmy_DeferredIncomeTaxExpenseBenefitComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense/Benefit Component [Domain]</link:label>
    <link:label id="lab_bmy_DeferredIncomeTaxExpenseBenefitComponentDomain_label_en-US" xlink:label="lab_bmy_DeferredIncomeTaxExpenseBenefitComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense/Benefit Component [Domain]</link:label>
    <link:label id="lab_bmy_DeferredIncomeTaxExpenseBenefitComponentDomain_documentation_en-US" xlink:label="lab_bmy_DeferredIncomeTaxExpenseBenefitComponentDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense/Benefit Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DeferredIncomeTaxExpenseBenefitComponentDomain" xlink:href="bmy-20210630.xsd#bmy_DeferredIncomeTaxExpenseBenefitComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_DeferredIncomeTaxExpenseBenefitComponentDomain" xlink:to="lab_bmy_DeferredIncomeTaxExpenseBenefitComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ReceivablesSoldOnNonrecourseBasis_a351a2d2-90bd-4877-b041-52a40f17f2bb_terseLabel_en-US" xlink:label="lab_bmy_ReceivablesSoldOnNonrecourseBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. receivables sold on a nonrecourse basis</link:label>
    <link:label id="lab_bmy_ReceivablesSoldOnNonrecourseBasis_label_en-US" xlink:label="lab_bmy_ReceivablesSoldOnNonrecourseBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables Sold On Nonrecourse Basis</link:label>
    <link:label id="lab_bmy_ReceivablesSoldOnNonrecourseBasis_documentation_en-US" xlink:label="lab_bmy_ReceivablesSoldOnNonrecourseBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of receivables sold on a nonrecourse basis during the year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReceivablesSoldOnNonrecourseBasis" xlink:href="bmy-20210630.xsd#bmy_ReceivablesSoldOnNonrecourseBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ReceivablesSoldOnNonrecourseBasis" xlink:to="lab_bmy_ReceivablesSoldOnNonrecourseBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bd200966-d7bd-4a81-a900-9fa057b51e37_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows From Operating Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock_3e3c0fb5-dfe4-40a6-8dd3-7bd4a69bae96_terseLabel_en-US" xlink:label="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Additional Information [Table Text Block]</link:label>
    <link:label id="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock_label_en-US" xlink:label="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Additional Information [Table Text Block]</link:label>
    <link:label id="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock_documentation_en-US" xlink:label="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of the total intrinsic value of options exercised (or share units converted), total fair value of shares vested during the year and the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" xlink:href="bmy-20210630.xsd#bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" xlink:to="lab_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_67ae0d0f-4a19-49cf-b235-372298143980_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherContractMember_fb26dcf5-5b92-4730-b7f9-45f51dfd6ec7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Contract</link:label>
    <link:label id="lab_us-gaap_OtherContractMember_label_en-US" xlink:label="lab_us-gaap_OtherContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherContractMember" xlink:to="lab_us-gaap_OtherContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_ce4090d7-9ede-46b1-b2d7-0d3e232be01d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_InternalTransferOfProductRightsMember_9d632df2-6502-4441-a7d3-591f31039a4f_terseLabel_en-US" xlink:label="lab_bmy_InternalTransferOfProductRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Transfer of Product Rights</link:label>
    <link:label id="lab_bmy_InternalTransferOfProductRightsMember_label_en-US" xlink:label="lab_bmy_InternalTransferOfProductRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Transfer of Product Rights [Member]</link:label>
    <link:label id="lab_bmy_InternalTransferOfProductRightsMember_documentation_en-US" xlink:label="lab_bmy_InternalTransferOfProductRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Transfer of Product Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InternalTransferOfProductRightsMember" xlink:href="bmy-20210630.xsd#bmy_InternalTransferOfProductRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_InternalTransferOfProductRightsMember" xlink:to="lab_bmy_InternalTransferOfProductRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_ab530466-ac30-4d03-8e21-1ba53ab747dc_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Current Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_1bcf5dea-6542-4e9c-8822-6552f85c9e55_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveAcceleratedDepreciation_1f876d56-8f31-4bf1-83d4-f571dd964182_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated depreciation</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveAcceleratedDepreciation_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveAcceleratedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Accelerated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAcceleratedDepreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveAcceleratedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveAcceleratedDepreciation" xlink:to="lab_us-gaap_RestructuringReserveAcceleratedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AbraxaneMember_9a7db279-54b5-4d64-bb47-2e63823110bd_terseLabel_en-US" xlink:label="lab_bmy_AbraxaneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abraxane [Member]</link:label>
    <link:label id="lab_bmy_AbraxaneMember_label_en-US" xlink:label="lab_bmy_AbraxaneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abraxane [Member]</link:label>
    <link:label id="lab_bmy_AbraxaneMember_documentation_en-US" xlink:label="lab_bmy_AbraxaneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abraxane [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbraxaneMember" xlink:href="bmy-20210630.xsd#bmy_AbraxaneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AbraxaneMember" xlink:to="lab_bmy_AbraxaneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods_f66648de-8e87-430e-90a8-2fbdda9af3dd_terseLabel_en-US" xlink:label="lab_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for Provisions for Product Sales made in Prior Periods</link:label>
    <link:label id="lab_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods_label_en-US" xlink:label="lab_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for Provisions for Product Sales made in Prior Periods</link:label>
    <link:label id="lab_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods_documentation_en-US" xlink:label="lab_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for Provisions for Product Sales made in Prior Periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" xlink:href="bmy-20210630.xsd#bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" xlink:to="lab_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_c81cf2e2-931d-46bc-84eb-0f9945c323da_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ByettaProductLiabilityLitigationMember_e9b97930-3139-48cb-8895-d6b4cc9260ec_terseLabel_en-US" xlink:label="lab_bmy_ByettaProductLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Byetta Product Liability Litigation [Member]</link:label>
    <link:label id="lab_bmy_ByettaProductLiabilityLitigationMember_label_en-US" xlink:label="lab_bmy_ByettaProductLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Byetta Product Liability Litigation [Member]</link:label>
    <link:label id="lab_bmy_ByettaProductLiabilityLitigationMember_documentation_en-US" xlink:label="lab_bmy_ByettaProductLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Byetta Product Liability Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ByettaProductLiabilityLitigationMember" xlink:href="bmy-20210630.xsd#bmy_ByettaProductLiabilityLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ByettaProductLiabilityLitigationMember" xlink:to="lab_bmy_ByettaProductLiabilityLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_bfe79a1a-8410-46cb-898b-d8e0f51a2d73_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ChargebacksandcashdiscountsMember_19a078a2-d747-475f-b613-2be77fe641c7_terseLabel_en-US" xlink:label="lab_bmy_ChargebacksandcashdiscountsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge-backs and cash discounts [Member]</link:label>
    <link:label id="lab_bmy_ChargebacksandcashdiscountsMember_label_en-US" xlink:label="lab_bmy_ChargebacksandcashdiscountsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge-backs and cash discounts [Member]</link:label>
    <link:label id="lab_bmy_ChargebacksandcashdiscountsMember_documentation_en-US" xlink:label="lab_bmy_ChargebacksandcashdiscountsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charge-backs and cash discounts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ChargebacksandcashdiscountsMember" xlink:href="bmy-20210630.xsd#bmy_ChargebacksandcashdiscountsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ChargebacksandcashdiscountsMember" xlink:to="lab_bmy_ChargebacksandcashdiscountsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_EUR_c3da8983-649a-47f3-af37-f850ef4a678f_terseLabel_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:label id="lab_currency_EUR_label_en-US" xlink:label="lab_currency_EUR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Member Countries, Euro</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_EUR" xlink:to="lab_currency_EUR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_0cfcc52b-3fad-41ab-8eb5-3319c6e7483f_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ZeposiaMember_14e0a2f5-bb44-45aa-8756-118712c3b099_terseLabel_en-US" xlink:label="lab_bmy_ZeposiaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zeposia [Member]</link:label>
    <link:label id="lab_bmy_ZeposiaMember_label_en-US" xlink:label="lab_bmy_ZeposiaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zeposia [Member]</link:label>
    <link:label id="lab_bmy_ZeposiaMember_documentation_en-US" xlink:label="lab_bmy_ZeposiaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zeposia</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ZeposiaMember" xlink:href="bmy-20210630.xsd#bmy_ZeposiaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ZeposiaMember" xlink:to="lab_bmy_ZeposiaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_def63e86-2b09-4a07-8466-ff8d713aaec5_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A1.000Notesdue2025Member_100d1e90-3ff9-4352-8492-86857c8a249d_terseLabel_en-US" xlink:label="lab_bmy_A1.000Notesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.000% Notes due 2025 [Member]</link:label>
    <link:label id="lab_bmy_A1.000Notesdue2025Member_label_en-US" xlink:label="lab_bmy_A1.000Notesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.000% Notes due 2025 [Member]</link:label>
    <link:label id="lab_bmy_A1.000Notesdue2025Member_documentation_en-US" xlink:label="lab_bmy_A1.000Notesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One000NotesDue2025Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.000Notesdue2025Member" xlink:href="bmy-20210630.xsd#bmy_A1.000Notesdue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A1.000Notesdue2025Member" xlink:to="lab_bmy_A1.000Notesdue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ResearchandDevelopmentExpenseCollaborativeArrangement_2c82741b-85ad-43e2-a0f2-b2d98c4e24e0_terseLabel_en-US" xlink:label="lab_bmy_ResearchandDevelopmentExpenseCollaborativeArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:label id="lab_bmy_ResearchandDevelopmentExpenseCollaborativeArrangement_label_en-US" xlink:label="lab_bmy_ResearchandDevelopmentExpenseCollaborativeArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense - Collaborative Arrangement</link:label>
    <link:label id="lab_bmy_ResearchandDevelopmentExpenseCollaborativeArrangement_documentation_en-US" xlink:label="lab_bmy_ResearchandDevelopmentExpenseCollaborativeArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense - Collaborative Arrangement. The balance can be debit/credit based on the nature of the arrangement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchandDevelopmentExpenseCollaborativeArrangement" xlink:href="bmy-20210630.xsd#bmy_ResearchandDevelopmentExpenseCollaborativeArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ResearchandDevelopmentExpenseCollaborativeArrangement" xlink:to="lab_bmy_ResearchandDevelopmentExpenseCollaborativeArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_889a7450-f0da-4e6b-b06a-c45241280068_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_DocumentAndEntityInformationAbstract_8b9c88c9-d5f2-4e5f-9cc6-ad7c7bcf460a_terseLabel_en-US" xlink:label="lab_bmy_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:label id="lab_bmy_DocumentAndEntityInformationAbstract_label_en-US" xlink:label="lab_bmy_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:label id="lab_bmy_DocumentAndEntityInformationAbstract_documentation_en-US" xlink:label="lab_bmy_DocumentAndEntityInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document and Entity Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DocumentAndEntityInformationAbstract" xlink:href="bmy-20210630.xsd#bmy_DocumentAndEntityInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract" xlink:to="lab_bmy_DocumentAndEntityInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_f2a09e07-e1bd-4d44-b0db-f7c018d47606_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_label_en-US" xlink:label="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:to="lab_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_6a3c3ede-1f72-44dc-a566-0be1c0f76115_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_ed943f01-7f6a-478c-bedc-dfa5330af7b2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_f7c85991-d0b4-44d6-969c-69d4d6be8d73_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_e405ad05-9411-4503-8b69-cdb0bb125e30_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_af7f7b27-9913-4e4b-a333-234db09ee1e0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityMember_865485af-1498-4510-a45c-efc99175a405_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability [Member]</link:label>
    <link:label id="lab_us-gaap_LiabilityMember_label_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityMember" xlink:to="lab_us-gaap_LiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_8949ede9-4c2e-4bf6-afd3-9275cb3afdc1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_df688616-99fb-497e-8c42-85081467fab9_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_AbecmaMember_d8b499a7-49e9-49fe-a9a7-5708fbcaa7f5_terseLabel_en-US" xlink:label="lab_bmy_AbecmaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abecma</link:label>
    <link:label id="lab_bmy_AbecmaMember_label_en-US" xlink:label="lab_bmy_AbecmaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abecma [Member]</link:label>
    <link:label id="lab_bmy_AbecmaMember_documentation_en-US" xlink:label="lab_bmy_AbecmaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abecma</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbecmaMember" xlink:href="bmy-20210630.xsd#bmy_AbecmaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_AbecmaMember" xlink:to="lab_bmy_AbecmaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_75119e86-561e-4cce-9f16-f2bdf53bf53a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_586b2b1a-f5f4-4d8e-9668-c8d4c32f54ad_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_3e9665fd-577c-47ae-88cd-8ea560738b40_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ProjectedYearOfPaymentsMember_d479cad8-5295-4df6-a471-7c9dd2f2b6a9_terseLabel_en-US" xlink:label="lab_bmy_ProjectedYearOfPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected Year of Payments</link:label>
    <link:label id="lab_bmy_ProjectedYearOfPaymentsMember_label_en-US" xlink:label="lab_bmy_ProjectedYearOfPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected Year of Payments [Member]</link:label>
    <link:label id="lab_bmy_ProjectedYearOfPaymentsMember_documentation_en-US" xlink:label="lab_bmy_ProjectedYearOfPaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected Year of Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ProjectedYearOfPaymentsMember" xlink:href="bmy-20210630.xsd#bmy_ProjectedYearOfPaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ProjectedYearOfPaymentsMember" xlink:to="lab_bmy_ProjectedYearOfPaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeBasisSpreadOnVariableRate_5e6a29bf-217e-441c-a138-648848bd3c6c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Basis Spread on Variable Rate</link:label>
    <link:label id="lab_us-gaap_DerivativeBasisSpreadOnVariableRate_label_en-US" xlink:label="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:to="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_A1.5BillionMaximumBorrowingCapacityMember_87793e3a-9aaa-424d-b61e-b6f2b90033ad_terseLabel_en-US" xlink:label="lab_bmy_A1.5BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1.5 Billion Maximum Borrowing Capacity</link:label>
    <link:label id="lab_bmy_A1.5BillionMaximumBorrowingCapacityMember_label_en-US" xlink:label="lab_bmy_A1.5BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1.5 Billion Maximum Borrowing Capacity [Member]</link:label>
    <link:label id="lab_bmy_A1.5BillionMaximumBorrowingCapacityMember_documentation_en-US" xlink:label="lab_bmy_A1.5BillionMaximumBorrowingCapacityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1.5 Billion Maximum Borrowing Capacity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.5BillionMaximumBorrowingCapacityMember" xlink:href="bmy-20210630.xsd#bmy_A1.5BillionMaximumBorrowingCapacityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_A1.5BillionMaximumBorrowingCapacityMember" xlink:to="lab_bmy_A1.5BillionMaximumBorrowingCapacityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_2013fdd3-7d4a-4584-91ad-e9ad7cdfefb5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_7057efb5-2bcd-4ff0-8769-382a722fe89d_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_713dba7b-fda4-4638-b6f7-0035f74f26c8_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_3cbfc9ac-be1c-4426-8c39-82b9d11370b9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ContingentAndRegulatoryMilestonePayments_088d53b9-f7e5-4fcc-b197-6db8503bc9fd_terseLabel_en-US" xlink:label="lab_bmy_ContingentAndRegulatoryMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent and Regulatory Milestone Payments</link:label>
    <link:label id="lab_bmy_ContingentAndRegulatoryMilestonePayments_label_en-US" xlink:label="lab_bmy_ContingentAndRegulatoryMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent and Regulatory Milestone Payments</link:label>
    <link:label id="lab_bmy_ContingentAndRegulatoryMilestonePayments_documentation_en-US" xlink:label="lab_bmy_ContingentAndRegulatoryMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent and Regulatory Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentAndRegulatoryMilestonePayments" xlink:href="bmy-20210630.xsd#bmy_ContingentAndRegulatoryMilestonePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ContingentAndRegulatoryMilestonePayments" xlink:to="lab_bmy_ContingentAndRegulatoryMilestonePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_44e8b870-6a0c-49e6-a206-0d92d2e11fd0_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_67e8d62d-0932-4d05-b016-186106e94412_periodStartLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_da3816ca-c4ed-42c2-be0f-08e05fff4593_periodEndLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsAndExcessTaxBenefitFromSharebasedCompensation_8aba3f1c-dfd8-409a-be7f-6f35c1670a86_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsAndExcessTaxBenefitFromSharebasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds and Excess Tax Benefit from Share-based Compensation</link:label>
    <link:label id="lab_us-gaap_ProceedsAndExcessTaxBenefitFromSharebasedCompensation_label_en-US" xlink:label="lab_us-gaap_ProceedsAndExcessTaxBenefitFromSharebasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds and Excess Tax Benefit from Share-based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsAndExcessTaxBenefitFromSharebasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsAndExcessTaxBenefitFromSharebasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsAndExcessTaxBenefitFromSharebasedCompensation" xlink:to="lab_us-gaap_ProceedsAndExcessTaxBenefitFromSharebasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_9fd88cc8-b5e1-490b-b374-c1f9b0fa92f7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement benefits - Curtailments and settlements, After tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_a7f3c8f5-b577-4235-b65f-6d7636af55e3_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_0141cac9-54ae-448c-b364-87069dd14fcb_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold [Member]</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_0fb87bea-8cce-4632-bf15-a6317412a5c5_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold [Member]</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_c5123e29-a1c6-4862-ab28-fba6f1c28fb9_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_currency_USD_d40d2928-28d5-4d5b-8465-dbea56fad407_terseLabel_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:label id="lab_currency_USD_label_en-US" xlink:label="lab_currency_USD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States of America, Dollars</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_currency_USD" xlink:to="lab_currency_USD" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_ContingentRegulatoryMilestoneIncome_51ecba16-2cd7-4ab9-953a-130cb5f7e565_negatedTerseLabel_en-US" xlink:label="lab_bmy_ContingentRegulatoryMilestoneIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent and Regulatory Milestone Income</link:label>
    <link:label id="lab_bmy_ContingentRegulatoryMilestoneIncome_label_en-US" xlink:label="lab_bmy_ContingentRegulatoryMilestoneIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Regulatory Milestone Income</link:label>
    <link:label id="lab_bmy_ContingentRegulatoryMilestoneIncome_documentation_en-US" xlink:label="lab_bmy_ContingentRegulatoryMilestoneIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Regulatory Milestone Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentRegulatoryMilestoneIncome" xlink:href="bmy-20210630.xsd#bmy_ContingentRegulatoryMilestoneIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_ContingentRegulatoryMilestoneIncome" xlink:to="lab_bmy_ContingentRegulatoryMilestoneIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_384e97ad-ffd6-4f33-a037-ac13f900191f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_9a321fe3-4aa6-4122-8389-b98795a65780_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivatives and Fair Value [Table Text Block]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_OtherRegionMember_923e9dae-003b-417d-91f3-746e2a1910b9_terseLabel_en-US" xlink:label="lab_bmy_OtherRegionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Region [Member]</link:label>
    <link:label id="lab_bmy_OtherRegionMember_label_en-US" xlink:label="lab_bmy_OtherRegionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Region [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRegionMember" xlink:href="bmy-20210630.xsd#bmy_OtherRegionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_OtherRegionMember" xlink:to="lab_bmy_OtherRegionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bmy_UpfrontmilestoneandotherlicensingreceiptsMember_34516ef6-be66-4b88-9b6e-81589289fe58_terseLabel_en-US" xlink:label="lab_bmy_UpfrontmilestoneandotherlicensingreceiptsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront, milestone and other licensing receipts [Member]</link:label>
    <link:label id="lab_bmy_UpfrontmilestoneandotherlicensingreceiptsMember_label_en-US" xlink:label="lab_bmy_UpfrontmilestoneandotherlicensingreceiptsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront, milestone and other licensing receipts [Member]</link:label>
    <link:label id="lab_bmy_UpfrontmilestoneandotherlicensingreceiptsMember_documentation_en-US" xlink:label="lab_bmy_UpfrontmilestoneandotherlicensingreceiptsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront, milestone and other licensing receipts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_UpfrontmilestoneandotherlicensingreceiptsMember" xlink:href="bmy-20210630.xsd#bmy_UpfrontmilestoneandotherlicensingreceiptsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bmy_UpfrontmilestoneandotherlicensingreceiptsMember" xlink:to="lab_bmy_UpfrontmilestoneandotherlicensingreceiptsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_69c39dd7-5625-4b60-983e-f5c45b4f0e10_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_0b8a8e88-cb45-4900-9c51-7e3840b4a1e8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ManufacturingFacilityMember_b4ce95f6-69d3-4243-9f7b-ca39c1e43e3d_terseLabel_en-US" xlink:label="lab_us-gaap_ManufacturingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Facility [Member]</link:label>
    <link:label id="lab_us-gaap_ManufacturingFacilityMember_label_en-US" xlink:label="lab_us-gaap_ManufacturingFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManufacturingFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ManufacturingFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ManufacturingFacilityMember" xlink:to="lab_us-gaap_ManufacturingFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d6bac330-b0b7-4e05-9eb7-3cc1c3b4b309_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_20923c49-8684-4b7f-8423-fc262c36ecf4_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alliance Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_f8c2b7d8-c0fd-421d-9580-257a8615c495_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>bmy-20210630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:744431a9-b3ff-43bd-afc9-1af61fbf126c,g:9fbce200-03f4-4882-8b59-75e21adfdbca-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bms.com/role/DocumentandEntityInformation" xlink:type="simple" xlink:href="bmy-20210630.xsd#DocumentandEntityInformation"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/DocumentandEntityInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:href="bmy-20210630.xsd#bmy_DocumentAndEntityInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e3877bbb-c03b-4258-9d4e-8ac9782e8df3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_us-gaap_StatementTable_e3877bbb-c03b-4258-9d4e-8ac9782e8df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_af655909-8fd1-475d-b581-63a4aaeaeeb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e3877bbb-c03b-4258-9d4e-8ac9782e8df3" xlink:to="loc_us-gaap_StatementClassOfStockAxis_af655909-8fd1-475d-b581-63a4aaeaeeb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_bc1214be-0e0b-4aa6-9bfc-544072826114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_af655909-8fd1-475d-b581-63a4aaeaeeb5" xlink:to="loc_us-gaap_ClassOfStockDomain_bc1214be-0e0b-4aa6-9bfc-544072826114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CommonStock0.10ParValueMember_859a632d-a73b-407d-a05d-71018fee67cb" xlink:href="bmy-20210630.xsd#bmy_CommonStock0.10ParValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_bc1214be-0e0b-4aa6-9bfc-544072826114" xlink:to="loc_bmy_CommonStock0.10ParValueMember_859a632d-a73b-407d-a05d-71018fee67cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.000Notesdue2025Member_dae0d7e5-3f5a-4d8f-bad6-4a8500a2d2f1" xlink:href="bmy-20210630.xsd#bmy_A1.000Notesdue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_bc1214be-0e0b-4aa6-9bfc-544072826114" xlink:to="loc_bmy_A1.000Notesdue2025Member_dae0d7e5-3f5a-4d8f-bad6-4a8500a2d2f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.750Notesdue2035Member_1918dd6f-fb8e-4902-88f9-8a8d2f05f9cb" xlink:href="bmy-20210630.xsd#bmy_A1.750Notesdue2035Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_bc1214be-0e0b-4aa6-9bfc-544072826114" xlink:to="loc_bmy_A1.750Notesdue2035Member_1918dd6f-fb8e-4902-88f9-8a8d2f05f9cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneContingentValueRightsMember_8806454c-9fd2-4564-82bf-09ebd99c4b37" xlink:href="bmy-20210630.xsd#bmy_CelgeneContingentValueRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_bc1214be-0e0b-4aa6-9bfc-544072826114" xlink:to="loc_bmy_CelgeneContingentValueRightsMember_8806454c-9fd2-4564-82bf-09ebd99c4b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1f1750d7-e0e5-4d50-8bab-2d03ef23f0bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e3877bbb-c03b-4258-9d4e-8ac9782e8df3" xlink:to="loc_us-gaap_StatementLineItems_1f1750d7-e0e5-4d50-8bab-2d03ef23f0bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_4c1bc827-e52b-4374-80ff-0e1661ee6614" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1f1750d7-e0e5-4d50-8bab-2d03ef23f0bb" xlink:to="loc_dei_Security12bTitle_4c1bc827-e52b-4374-80ff-0e1661ee6614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_39fc470c-91d1-41c1-aca0-69c1fc05bb91" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1f1750d7-e0e5-4d50-8bab-2d03ef23f0bb" xlink:to="loc_dei_TradingSymbol_39fc470c-91d1-41c1-aca0-69c1fc05bb91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c69fb0f3-c336-457a-9db8-1e43ab986086" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1f1750d7-e0e5-4d50-8bab-2d03ef23f0bb" xlink:to="loc_dei_SecurityExchangeName_c69fb0f3-c336-457a-9db8-1e43ab986086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_a2d53fce-3e93-4033-a7a1-2b931ce1d72f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_EntityIncorporationStateCountryCode_a2d53fce-3e93-4033-a7a1-2b931ce1d72f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_cc0d9658-3f11-445a-9bc7-f5a992c9dfe0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_DocumentType_cc0d9658-3f11-445a-9bc7-f5a992c9dfe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_83cca17e-148b-47d1-995a-838b0f9ad863" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_DocumentQuarterlyReport_83cca17e-148b-47d1-995a-838b0f9ad863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_559f53fc-cc00-4da0-8299-67209a09410f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_EntityFileNumber_559f53fc-cc00-4da0-8299-67209a09410f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_25a64e9c-5b6d-4097-ab99-9d8e2f4e025d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_EntityRegistrantName_25a64e9c-5b6d-4097-ab99-9d8e2f4e025d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f02b6a40-dc98-4d94-982b-9ccab138bc1b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_EntityAddressAddressLine1_f02b6a40-dc98-4d94-982b-9ccab138bc1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_02f2f2e2-faca-4b53-aeed-6970f11548bd" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_EntityAddressCityOrTown_02f2f2e2-faca-4b53-aeed-6970f11548bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_425912a4-e932-4f3e-b17c-ad645c306418" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_EntityAddressStateOrProvince_425912a4-e932-4f3e-b17c-ad645c306418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_748f735b-1481-4986-8de0-e2ff1727b6a3" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_EntityAddressPostalZipCode_748f735b-1481-4986-8de0-e2ff1727b6a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_17ad5e24-1ca2-404f-8a79-d7fb9a9c4224" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_CityAreaCode_17ad5e24-1ca2-404f-8a79-d7fb9a9c4224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_3d96a477-0e36-4b87-a046-0b550df4cd76" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_LocalPhoneNumber_3d96a477-0e36-4b87-a046-0b550df4cd76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_485719c2-f872-4e26-95ba-884106ce170a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_EntityCentralIndexKey_485719c2-f872-4e26-95ba-884106ce170a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_f03f078b-be26-4afc-bc03-0459a5409cff" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_EntityTaxIdentificationNumber_f03f078b-be26-4afc-bc03-0459a5409cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_fbf50fba-4161-4a8f-afeb-b792baeaacac" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_EntityCurrentReportingStatus_fbf50fba-4161-4a8f-afeb-b792baeaacac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_5b638b79-5d53-4522-b2f3-392e2d46ee9c" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_EntityInteractiveDataCurrent_5b638b79-5d53-4522-b2f3-392e2d46ee9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_d16318cf-51b6-4b28-988a-3c1cda117b52" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_EntityFilerCategory_d16318cf-51b6-4b28-988a-3c1cda117b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_2a546871-f0d6-4375-96f9-96e4d6b20fce" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_2a546871-f0d6-4375-96f9-96e4d6b20fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_58d1c459-b874-4753-be16-8ba28f3c17d0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_DocumentPeriodEndDate_58d1c459-b874-4753-be16-8ba28f3c17d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_80e76d4e-1bb3-459b-bf4d-fbb3a128d797" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_DocumentTransitionReport_80e76d4e-1bb3-459b-bf4d-fbb3a128d797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_72b4766b-10cb-41a3-9caa-51ed6f9cae0b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_DocumentFiscalYearFocus_72b4766b-10cb-41a3-9caa-51ed6f9cae0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_c3825db5-b61a-4246-b5a3-31dc4da25bb5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_DocumentFiscalPeriodFocus_c3825db5-b61a-4246-b5a3-31dc4da25bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_7084b169-0521-4818-91ee-debcc36ab308" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_CurrentFiscalYearEndDate_7084b169-0521-4818-91ee-debcc36ab308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_233613e2-51c1-4331-81f4-d2c0ae41bb4e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_AmendmentFlag_233613e2-51c1-4331-81f4-d2c0ae41bb4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_5dcb019a-aee8-44f8-9855-718a457c2728" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_EntitySmallBusiness_5dcb019a-aee8-44f8-9855-718a457c2728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_69a8ed6a-6359-4514-a42c-036e0c2829b5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_EntityShellCompany_69a8ed6a-6359-4514-a42c-036e0c2829b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_ba2d6d13-a974-4a9f-829b-e2fdc6c2240b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DocumentAndEntityInformationAbstract_5fa8f1c0-e3ef-482a-bc85-503f9bbb1b99" xlink:to="loc_dei_EntityEmergingGrowthCompany_ba2d6d13-a974-4a9f-829b-e2fdc6c2240b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED" xlink:type="simple" xlink:href="bmy-20210630.xsd#CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_0a2dd75a-e271-4937-b063-92602273e96f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2b7fdd17-bafe-4fac-ad2c-86eb2fc7bb0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0a2dd75a-e271-4937-b063-92602273e96f" xlink:to="loc_us-gaap_StatementTable_2b7fdd17-bafe-4fac-ad2c-86eb2fc7bb0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_a9d2fe55-01cb-48c8-a4a1-bcdd82d7d025" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2b7fdd17-bafe-4fac-ad2c-86eb2fc7bb0b" xlink:to="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_a9d2fe55-01cb-48c8-a4a1-bcdd82d7d025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_94184300-af2f-4dbd-a1f1-3cf6b10c5b64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_a9d2fe55-01cb-48c8-a4a1-bcdd82d7d025" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_94184300-af2f-4dbd-a1f1-3cf6b10c5b64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember_b8f77862-18f3-4873-84a6-19bdb3d1a44f" xlink:href="bmy-20210630.xsd#bmy_NetproductsalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_94184300-af2f-4dbd-a1f1-3cf6b10c5b64" xlink:to="loc_bmy_NetproductsalesMember_b8f77862-18f3-4873-84a6-19bdb3d1a44f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AllianceandotherrevenuesMember_5df4d1bc-99ed-4025-8ed3-3ba0129ffa95" xlink:href="bmy-20210630.xsd#bmy_AllianceandotherrevenuesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_94184300-af2f-4dbd-a1f1-3cf6b10c5b64" xlink:to="loc_bmy_AllianceandotherrevenuesMember_5df4d1bc-99ed-4025-8ed3-3ba0129ffa95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2b7fdd17-bafe-4fac-ad2c-86eb2fc7bb0b" xlink:to="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_697e8636-26df-44bf-8bfc-e2d071c662c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_Revenues_697e8636-26df-44bf-8bfc-e2d071c662c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_87fbe659-02d5-418c-bc27-9cf4d5f23cab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_87fbe659-02d5-418c-bc27-9cf4d5f23cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7a2d13f0-ea03-4519-ac12-8416c73eaeaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7a2d13f0-ea03-4519-ac12-8416c73eaeaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_4faa071d-60a3-405d-87c6-0500bb5f389b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_4faa071d-60a3-405d-87c6-0500bb5f389b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AmortizationofAcquiredIntangibleAssets_f02e530d-81f4-485d-8f97-8ba594904947" xlink:href="bmy-20210630.xsd#bmy_AmortizationofAcquiredIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_bmy_AmortizationofAcquiredIntangibleAssets_f02e530d-81f4-485d-8f97-8ba594904947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ad0b107c-ad3d-4d25-a19a-95e21c6983d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ad0b107c-ad3d-4d25-a19a-95e21c6983d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_fa0d79c5-815a-47f9-99cb-41a9f760e089" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_CostsAndExpenses_fa0d79c5-815a-47f9-99cb-41a9f760e089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e673f513-fc19-46f5-93f6-15aef1b5c546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e673f513-fc19-46f5-93f6-15aef1b5c546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f53e47a2-9153-4987-89ec-a4ef5d55e2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f53e47a2-9153-4987-89ec-a4ef5d55e2d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7a2e3b17-dbad-4b6b-8ea0-7695b8825dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_ProfitLoss_7a2e3b17-dbad-4b6b-8ea0-7695b8825dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_bf0f9c91-5d88-45ba-9220-ef948a08e499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_bf0f9c91-5d88-45ba-9220-ef948a08e499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fc88c63e-0bda-49e4-b72b-2e7c1d108eb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_NetIncomeLoss_fc88c63e-0bda-49e4-b72b-2e7c1d108eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_0dad97e9-88b0-466d-be36-02540cf2a591" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_EarningsPerShareBasic_0dad97e9-88b0-466d-be36-02540cf2a591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_6e173369-1525-43d5-88c1-eb1de5459f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9599c8cb-2568-47fa-a9bd-17ab38d3a5d4" xlink:to="loc_us-gaap_EarningsPerShareDiluted_6e173369-1525-43d5-88c1-eb1de5459f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="simple" xlink:href="bmy-20210630.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_61990f7e-02cc-4491-b1ae-ba00a0ab43f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8b689a76-26fd-4dd6-bcce-26354ebba9a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_61990f7e-02cc-4491-b1ae-ba00a0ab43f8" xlink:to="loc_us-gaap_ProfitLoss_8b689a76-26fd-4dd6-bcce-26354ebba9a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_842ae163-c5b8-404e-9265-2b6d3ac819f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_61990f7e-02cc-4491-b1ae-ba00a0ab43f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_842ae163-c5b8-404e-9265-2b6d3ac819f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_3f335219-acbd-403c-ba37-cb0df2165681" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_61990f7e-02cc-4491-b1ae-ba00a0ab43f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_3f335219-acbd-403c-ba37-cb0df2165681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_796015ce-2998-4d07-8818-1d80fd8fa4d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_61990f7e-02cc-4491-b1ae-ba00a0ab43f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_796015ce-2998-4d07-8818-1d80fd8fa4d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_f49e175e-0431-4fca-84d5-b0e87ee9fb34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_61990f7e-02cc-4491-b1ae-ba00a0ab43f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_f49e175e-0431-4fca-84d5-b0e87ee9fb34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_41d0519b-300e-4fda-8269-73cfcbbfa66c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_61990f7e-02cc-4491-b1ae-ba00a0ab43f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_41d0519b-300e-4fda-8269-73cfcbbfa66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e5500f24-811d-4f78-851e-3adb95c81158" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_61990f7e-02cc-4491-b1ae-ba00a0ab43f8" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e5500f24-811d-4f78-851e-3adb95c81158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6311e554-cbca-4678-8e8f-3a9bdf1beb22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_61990f7e-02cc-4491-b1ae-ba00a0ab43f8" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_6311e554-cbca-4678-8e8f-3a9bdf1beb22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e670865c-71d7-42b3-982c-c92db6208e66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_61990f7e-02cc-4491-b1ae-ba00a0ab43f8" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_e670865c-71d7-42b3-982c-c92db6208e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="bmy-20210630.xsd#CONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_3f6d4a2f-69af-4bf4-8abd-5ad78ee312a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_2809f657-a4c6-45e2-80e5-0b09921aa3bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3f6d4a2f-69af-4bf4-8abd-5ad78ee312a7" xlink:to="loc_us-gaap_AssetsAbstract_2809f657-a4c6-45e2-80e5-0b09921aa3bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_50a8d1f0-b92a-4a65-9571-e71ea1593461" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2809f657-a4c6-45e2-80e5-0b09921aa3bf" xlink:to="loc_us-gaap_AssetsCurrentAbstract_50a8d1f0-b92a-4a65-9571-e71ea1593461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_af21f0d5-17ef-4ed3-8252-eadf48fcf498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_50a8d1f0-b92a-4a65-9571-e71ea1593461" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_af21f0d5-17ef-4ed3-8252-eadf48fcf498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_c1002c9e-6234-4ac7-928b-21c431af824c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_50a8d1f0-b92a-4a65-9571-e71ea1593461" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_c1002c9e-6234-4ac7-928b-21c431af824c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_d0f01247-5542-4f09-9771-c34ebeace923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_50a8d1f0-b92a-4a65-9571-e71ea1593461" xlink:to="loc_us-gaap_ReceivablesNetCurrent_d0f01247-5542-4f09-9771-c34ebeace923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1ca6d220-d3a0-42ac-b90a-1f85b51eae23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_50a8d1f0-b92a-4a65-9571-e71ea1593461" xlink:to="loc_us-gaap_InventoryNet_1ca6d220-d3a0-42ac-b90a-1f85b51eae23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_027d08da-5b08-4606-86b6-689428f4db15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_50a8d1f0-b92a-4a65-9571-e71ea1593461" xlink:to="loc_us-gaap_OtherAssetsCurrent_027d08da-5b08-4606-86b6-689428f4db15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_efb13265-a972-43bc-8bd1-58397b4e71f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_50a8d1f0-b92a-4a65-9571-e71ea1593461" xlink:to="loc_us-gaap_AssetsCurrent_efb13265-a972-43bc-8bd1-58397b4e71f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ccf553e9-dd50-4712-bce5-41c02b017bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2809f657-a4c6-45e2-80e5-0b09921aa3bf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ccf553e9-dd50-4712-bce5-41c02b017bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c0683b31-5c29-4ded-acf9-0d12720118cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2809f657-a4c6-45e2-80e5-0b09921aa3bf" xlink:to="loc_us-gaap_Goodwill_c0683b31-5c29-4ded-acf9-0d12720118cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f2d8adc8-0740-4298-8769-1f9a0937c305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2809f657-a4c6-45e2-80e5-0b09921aa3bf" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f2d8adc8-0740-4298-8769-1f9a0937c305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_c4af9baf-76da-4ea8-b889-8d45cc63cdb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2809f657-a4c6-45e2-80e5-0b09921aa3bf" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_c4af9baf-76da-4ea8-b889-8d45cc63cdb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_b2f6db58-c2e6-4b17-a293-d0cc4a3f5364" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2809f657-a4c6-45e2-80e5-0b09921aa3bf" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_b2f6db58-c2e6-4b17-a293-d0cc4a3f5364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_f6980c6a-60e3-4a94-abe3-72e8f950c8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2809f657-a4c6-45e2-80e5-0b09921aa3bf" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_f6980c6a-60e3-4a94-abe3-72e8f950c8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_1f1f8770-feb4-491c-b5d0-565a9d528383" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_2809f657-a4c6-45e2-80e5-0b09921aa3bf" xlink:to="loc_us-gaap_Assets_1f1f8770-feb4-491c-b5d0-565a9d528383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_f53de9df-0b87-4708-81fc-0e59cd018524" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3f6d4a2f-69af-4bf4-8abd-5ad78ee312a7" xlink:to="loc_us-gaap_LiabilitiesAbstract_f53de9df-0b87-4708-81fc-0e59cd018524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_6d9c973c-4044-4a54-8ce5-eb75717d745c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_f53de9df-0b87-4708-81fc-0e59cd018524" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_6d9c973c-4044-4a54-8ce5-eb75717d745c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_3f265994-33ad-4fd7-9402-d5c4b697a077" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6d9c973c-4044-4a54-8ce5-eb75717d745c" xlink:to="loc_us-gaap_DebtCurrent_3f265994-33ad-4fd7-9402-d5c4b697a077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_0943143d-7758-4e04-8033-27b4e9d4379c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6d9c973c-4044-4a54-8ce5-eb75717d745c" xlink:to="loc_us-gaap_AccountsPayableCurrent_0943143d-7758-4e04-8033-27b4e9d4379c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_c195adde-f729-4b6e-a1d2-ebddc9b90401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6d9c973c-4044-4a54-8ce5-eb75717d745c" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_c195adde-f729-4b6e-a1d2-ebddc9b90401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_719afc97-db38-4524-a971-396d79dfb1db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_6d9c973c-4044-4a54-8ce5-eb75717d745c" xlink:to="loc_us-gaap_LiabilitiesCurrent_719afc97-db38-4524-a971-396d79dfb1db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_a6074046-0db3-478a-b17e-27e9ca67af14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_f53de9df-0b87-4708-81fc-0e59cd018524" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_a6074046-0db3-478a-b17e-27e9ca67af14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_cbb35af3-d166-4b0b-b14f-7e54d8b6f38d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_f53de9df-0b87-4708-81fc-0e59cd018524" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_cbb35af3-d166-4b0b-b14f-7e54d8b6f38d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_b1d1682b-d318-45d7-a706-8ed22333882d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_f53de9df-0b87-4708-81fc-0e59cd018524" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_b1d1682b-d318-45d7-a706-8ed22333882d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_61e0db6f-1306-439d-b7cb-81751153e12a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_f53de9df-0b87-4708-81fc-0e59cd018524" xlink:to="loc_us-gaap_Liabilities_61e0db6f-1306-439d-b7cb-81751153e12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_db7decd7-4bb7-4610-88c6-ad1772b2946a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3f6d4a2f-69af-4bf4-8abd-5ad78ee312a7" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_db7decd7-4bb7-4610-88c6-ad1772b2946a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_c3a577f9-46bd-4c38-9cf8-9bee58814550" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_db7decd7-4bb7-4610-88c6-ad1772b2946a" xlink:to="loc_us-gaap_StockholdersEquityAbstract_c3a577f9-46bd-4c38-9cf8-9bee58814550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_9d7887bc-4bf7-4368-9f82-1bf3db3345d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c3a577f9-46bd-4c38-9cf8-9bee58814550" xlink:to="loc_us-gaap_PreferredStockValue_9d7887bc-4bf7-4368-9f82-1bf3db3345d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_147ecd86-2c34-4713-a476-bed885a8f606" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c3a577f9-46bd-4c38-9cf8-9bee58814550" xlink:to="loc_us-gaap_CommonStockValue_147ecd86-2c34-4713-a476-bed885a8f606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_fbdd6ce4-3320-4daa-894d-1fcba1442b95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c3a577f9-46bd-4c38-9cf8-9bee58814550" xlink:to="loc_us-gaap_AdditionalPaidInCapital_fbdd6ce4-3320-4daa-894d-1fcba1442b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_acd53a55-5565-45ad-93fb-65826007f33d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c3a577f9-46bd-4c38-9cf8-9bee58814550" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_acd53a55-5565-45ad-93fb-65826007f33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0571885a-cac8-43a0-94ba-8bffc993604e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c3a577f9-46bd-4c38-9cf8-9bee58814550" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0571885a-cac8-43a0-94ba-8bffc993604e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_cbcedf7d-c572-4963-9f7e-3dc890742771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c3a577f9-46bd-4c38-9cf8-9bee58814550" xlink:to="loc_us-gaap_TreasuryStockValue_cbcedf7d-c572-4963-9f7e-3dc890742771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f4faf838-b150-4e04-8361-15e27ea15996" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c3a577f9-46bd-4c38-9cf8-9bee58814550" xlink:to="loc_us-gaap_StockholdersEquity_f4faf838-b150-4e04-8361-15e27ea15996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_21c6fb1c-37d3-4bbb-92f5-129d327fad2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_db7decd7-4bb7-4610-88c6-ad1772b2946a" xlink:to="loc_us-gaap_MinorityInterest_21c6fb1c-37d3-4bbb-92f5-129d327fad2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4b658d77-f021-40e5-8efb-f05d1e828432" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_db7decd7-4bb7-4610-88c6-ad1772b2946a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4b658d77-f021-40e5-8efb-f05d1e828432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_0f212a0d-dc99-42ca-8d21-e71c1626d650" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_3f6d4a2f-69af-4bf4-8abd-5ad78ee312a7" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_0f212a0d-dc99-42ca-8d21-e71c1626d650" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="simple" xlink:href="bmy-20210630.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_94b5dbf7-10cb-43ae-b86e-5dbf7f51e2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_234404a0-9cd8-48a7-90a2-3b1b93fdd8e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94b5dbf7-10cb-43ae-b86e-5dbf7f51e2b1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_234404a0-9cd8-48a7-90a2-3b1b93fdd8e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d20e7f0a-a864-4744-9413-44028d09048d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_234404a0-9cd8-48a7-90a2-3b1b93fdd8e3" xlink:to="loc_us-gaap_ProfitLoss_d20e7f0a-a864-4744-9413-44028d09048d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_313c6c13-af05-4c4e-bb3d-3cd0e3e9b9f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_234404a0-9cd8-48a7-90a2-3b1b93fdd8e3" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_313c6c13-af05-4c4e-bb3d-3cd0e3e9b9f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_fa60ef3d-86a0-4882-8e02-ef63c5138280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_313c6c13-af05-4c4e-bb3d-3cd0e3e9b9f3" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_fa60ef3d-86a0-4882-8e02-ef63c5138280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4bff1c0b-1350-4fd4-9183-f0025dcd976c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_313c6c13-af05-4c4e-bb3d-3cd0e3e9b9f3" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4bff1c0b-1350-4fd4-9183-f0025dcd976c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a57aa69c-9b97-46ef-b11b-0d66f328e92e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_313c6c13-af05-4c4e-bb3d-3cd0e3e9b9f3" xlink:to="loc_us-gaap_ShareBasedCompensation_a57aa69c-9b97-46ef-b11b-0d66f328e92e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_65a86c69-0f3c-4d5a-8bbb-5637f823b05f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_313c6c13-af05-4c4e-bb3d-3cd0e3e9b9f3" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_65a86c69-0f3c-4d5a-8bbb-5637f823b05f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Pensionsettlementsandamortization_a780692e-4691-48d7-9600-913b957e818b" xlink:href="bmy-20210630.xsd#bmy_Pensionsettlementsandamortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_313c6c13-af05-4c4e-bb3d-3cd0e3e9b9f3" xlink:to="loc_bmy_Pensionsettlementsandamortization_a780692e-4691-48d7-9600-913b957e818b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Divestituregainsandroyalties_fec0b9aa-98b0-4307-bcf6-8712dfb63967" xlink:href="bmy-20210630.xsd#bmy_Divestituregainsandroyalties"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_313c6c13-af05-4c4e-bb3d-3cd0e3e9b9f3" xlink:to="loc_bmy_Divestituregainsandroyalties_fec0b9aa-98b0-4307-bcf6-8712dfb63967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Assetacquisitioncharge_a7e06e04-1f68-47cc-98e0-9fbcdff6718a" xlink:href="bmy-20210630.xsd#bmy_Assetacquisitioncharge"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_313c6c13-af05-4c4e-bb3d-3cd0e3e9b9f3" xlink:to="loc_bmy_Assetacquisitioncharge_a7e06e04-1f68-47cc-98e0-9fbcdff6718a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments_b0224780-7d6f-4e66-8f11-34aa94a89c25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_313c6c13-af05-4c4e-bb3d-3cd0e3e9b9f3" xlink:to="loc_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments_b0224780-7d6f-4e66-8f11-34aa94a89c25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_6ce4aca7-f687-4384-80dd-4f7cc4f89f83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_313c6c13-af05-4c4e-bb3d-3cd0e3e9b9f3" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_6ce4aca7-f687-4384-80dd-4f7cc4f89f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_a20b6f71-51db-4231-9054-e6fb44ebd570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_313c6c13-af05-4c4e-bb3d-3cd0e3e9b9f3" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_a20b6f71-51db-4231-9054-e6fb44ebd570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_4f675b7f-3f74-4876-979b-3caf72ac64d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_234404a0-9cd8-48a7-90a2-3b1b93fdd8e3" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_4f675b7f-3f74-4876-979b-3caf72ac64d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_3468bd2a-0050-4046-8cd8-21dfbeebac85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_4f675b7f-3f74-4876-979b-3caf72ac64d1" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_3468bd2a-0050-4046-8cd8-21dfbeebac85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_6ac845df-e3d4-4d95-b933-13a64c30c401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_4f675b7f-3f74-4876-979b-3caf72ac64d1" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_6ac845df-e3d4-4d95-b933-13a64c30c401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_7c9347e0-a69e-4c4e-98dd-9632044a3eec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_4f675b7f-3f74-4876-979b-3caf72ac64d1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_7c9347e0-a69e-4c4e-98dd-9632044a3eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_a08ab86e-4274-4168-a9cd-80cbabb64271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_4f675b7f-3f74-4876-979b-3caf72ac64d1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_a08ab86e-4274-4168-a9cd-80cbabb64271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_5f3a44ff-4332-4af8-9960-4d57e91dc707" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_4f675b7f-3f74-4876-979b-3caf72ac64d1" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_5f3a44ff-4332-4af8-9960-4d57e91dc707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57f8706d-5a75-440a-909a-bf71201ee252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_4f675b7f-3f74-4876-979b-3caf72ac64d1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_57f8706d-5a75-440a-909a-bf71201ee252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5d388131-452d-497c-929b-ec41d11e0448" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94b5dbf7-10cb-43ae-b86e-5dbf7f51e2b1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5d388131-452d-497c-929b-ec41d11e0448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_814786d2-ebcc-44cb-860b-84d6968301b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5d388131-452d-497c-929b-ec41d11e0448" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_814786d2-ebcc-44cb-860b-84d6968301b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_91f0e32d-e6f1-42b2-9e95-52bbcb088148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5d388131-452d-497c-929b-ec41d11e0448" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_91f0e32d-e6f1-42b2-9e95-52bbcb088148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity_7be6f9f6-7b64-4cac-9ae8-a40b474a4bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5d388131-452d-497c-929b-ec41d11e0448" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity_7be6f9f6-7b64-4cac-9ae8-a40b474a4bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b2d13b1b-5a33-4ad4-ba90-89698baaedab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5d388131-452d-497c-929b-ec41d11e0448" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b2d13b1b-5a33-4ad4-ba90-89698baaedab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Divestitureandotherproceeds_4ddfde14-1ce7-4e52-96ea-169a7cecb4ee" xlink:href="bmy-20210630.xsd#bmy_Divestitureandotherproceeds"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5d388131-452d-497c-929b-ec41d11e0448" xlink:to="loc_bmy_Divestitureandotherproceeds_4ddfde14-1ce7-4e52-96ea-169a7cecb4ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8f2ce1da-04ee-4f93-80e2-295414642797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5d388131-452d-497c-929b-ec41d11e0448" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_8f2ce1da-04ee-4f93-80e2-295414642797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e1f78962-cdf0-4d0a-9ef1-4072cde70f11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5d388131-452d-497c-929b-ec41d11e0448" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e1f78962-cdf0-4d0a-9ef1-4072cde70f11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19338d43-ce71-4cda-ad21-64e7786eed1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94b5dbf7-10cb-43ae-b86e-5dbf7f51e2b1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19338d43-ce71-4cda-ad21-64e7786eed1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_739ce405-89d4-482f-983a-f213994b099e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19338d43-ce71-4cda-ad21-64e7786eed1a" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_739ce405-89d4-482f-983a-f213994b099e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_516b7b1f-7ef2-4d9f-a9e3-77ea32cf5d67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19338d43-ce71-4cda-ad21-64e7786eed1a" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_516b7b1f-7ef2-4d9f-a9e3-77ea32cf5d67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_62c02fc9-e0e0-4f06-8eda-c02620d1d95a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19338d43-ce71-4cda-ad21-64e7786eed1a" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_62c02fc9-e0e0-4f06-8eda-c02620d1d95a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_769a9d3b-1402-4189-af4b-1ca5b40384c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19338d43-ce71-4cda-ad21-64e7786eed1a" xlink:to="loc_us-gaap_PaymentsOfDividends_769a9d3b-1402-4189-af4b-1ca5b40384c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_2027d618-c6ac-49b4-b08d-f18298e64a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19338d43-ce71-4cda-ad21-64e7786eed1a" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_2027d618-c6ac-49b4-b08d-f18298e64a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b7014e27-67b9-4372-976c-7b396b54dc43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19338d43-ce71-4cda-ad21-64e7786eed1a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_b7014e27-67b9-4372-976c-7b396b54dc43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0ca4aa78-71af-43d5-9285-87dd7e70bd7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94b5dbf7-10cb-43ae-b86e-5dbf7f51e2b1" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0ca4aa78-71af-43d5-9285-87dd7e70bd7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_92efe29c-862d-429b-a697-b4fae9d067fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94b5dbf7-10cb-43ae-b86e-5dbf7f51e2b1" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_92efe29c-862d-429b-a697-b4fae9d067fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_aa3c2b52-0bf1-45a7-9242-4cc97abf7dda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94b5dbf7-10cb-43ae-b86e-5dbf7f51e2b1" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_aa3c2b52-0bf1-45a7-9242-4cc97abf7dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_75a3e42c-4750-4d0b-9d41-bf52f0e5a112" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_94b5dbf7-10cb-43ae-b86e-5dbf7f51e2b1" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_75a3e42c-4750-4d0b-9d41-bf52f0e5a112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSNotes" xlink:type="simple" xlink:href="bmy-20210630.xsd#BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSNotes"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSAbstract_bfdba682-83a3-4cf4-aa7c-e5345aaee95c" xlink:href="bmy-20210630.xsd#bmy_BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_79e823a6-fbdd-47d3-b77c-8361d8882f61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSAbstract_bfdba682-83a3-4cf4-aa7c-e5345aaee95c" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_79e823a6-fbdd-47d3-b77c-8361d8882f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/BASISOFPRESENTATIONPolicies" xlink:type="simple" xlink:href="bmy-20210630.xsd#BASISOFPRESENTATIONPolicies"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/BASISOFPRESENTATIONPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dbfe091a-98ca-4f78-8869-71496c4475d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_7d53573d-4f71-45de-b30e-b3a6a6ce40bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dbfe091a-98ca-4f78-8869-71496c4475d7" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_7d53573d-4f71-45de-b30e-b3a6a6ce40bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_f776c912-8e90-42f4-9569-0d82bac60abe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dbfe091a-98ca-4f78-8869-71496c4475d7" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_f776c912-8e90-42f4-9569-0d82bac60abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_c3270f0e-2915-4df0-8f71-dea3f5f128c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dbfe091a-98ca-4f78-8869-71496c4475d7" xlink:to="loc_us-gaap_UseOfEstimates_c3270f0e-2915-4df0-8f71-dea3f5f128c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_cc63ee5a-dddc-4fa5-ba14-e7e268df6b84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dbfe091a-98ca-4f78-8869-71496c4475d7" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_cc63ee5a-dddc-4fa5-ba14-e7e268df6b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1891ec46-b0da-4d7b-b18e-43d95abbf097" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dbfe091a-98ca-4f78-8869-71496c4475d7" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1891ec46-b0da-4d7b-b18e-43d95abbf097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/BASISOFPRESENTATIONNewAccountingPronouncementsDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#BASISOFPRESENTATIONNewAccountingPronouncementsDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/BASISOFPRESENTATIONNewAccountingPronouncementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3b348b18-ddda-4328-a05b-ee088a0b3e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationTable_9e6bdd60-46f3-4b39-ae80-464f73bb5caf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3b348b18-ddda-4328-a05b-ee088a0b3e4c" xlink:to="loc_us-gaap_ReclassificationTable_9e6bdd60-46f3-4b39-ae80-464f73bb5caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationTypeAxis_c00455f1-ea9f-43fa-b599-267d16bbd40c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationTable_9e6bdd60-46f3-4b39-ae80-464f73bb5caf" xlink:to="loc_us-gaap_ReclassificationTypeAxis_c00455f1-ea9f-43fa-b599-267d16bbd40c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationTypeDomain_9d5a4e18-d1af-42cf-8bc5-b53bf85338ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationTypeAxis_c00455f1-ea9f-43fa-b599-267d16bbd40c" xlink:to="loc_us-gaap_ReclassificationTypeDomain_9d5a4e18-d1af-42cf-8bc5-b53bf85338ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsCashFlowsReclassificationMember_e846cd26-90c9-4eac-aa41-3d7d3d9db644" xlink:href="bmy-20210630.xsd#bmy_LicensingArrangementsCashFlowsReclassificationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationTypeDomain_9d5a4e18-d1af-42cf-8bc5-b53bf85338ba" xlink:to="loc_bmy_LicensingArrangementsCashFlowsReclassificationMember_e846cd26-90c9-4eac-aa41-3d7d3d9db644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationLineItems_0c815f1f-5cb7-479a-a580-502c04ef5a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationTable_9e6bdd60-46f3-4b39-ae80-464f73bb5caf" xlink:to="loc_us-gaap_ReclassificationLineItems_0c815f1f-5cb7-479a-a580-502c04ef5a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustment_51371385-87ff-467e-96c3-39fd95b69ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationLineItems_0c815f1f-5cb7-479a-a580-502c04ef5a9f" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustment_51371385-87ff-467e-96c3-39fd95b69ec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/REVENUERECOGNITIONRevenueRecognitionNotes" xlink:type="simple" xlink:href="bmy-20210630.xsd#REVENUERECOGNITIONRevenueRecognitionNotes"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/REVENUERECOGNITIONRevenueRecognitionNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_345d4420-bade-43ad-83c1-4ae0a8b7a21b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_ff44d4f0-ebcc-478f-bcc7-74b55010af86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_345d4420-bade-43ad-83c1-4ae0a8b7a21b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_ff44d4f0-ebcc-478f-bcc7-74b55010af86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="bmy-20210630.xsd#RevenueRecognitionTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RevenueRecognitionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueAbstract_c9beed25-a417-433e-ba4f-4e83264d9a39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_bfe4cd07-7588-44b4-901e-910bc10afdc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract_c9beed25-a417-433e-ba4f-4e83264d9a39" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_bfe4cd07-7588-44b4-901e-910bc10afdc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock_0170e905-15cf-4f79-adc4-818ca5429a91" xlink:href="bmy-20210630.xsd#bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract_c9beed25-a417-433e-ba4f-4e83264d9a39" xlink:to="loc_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock_0170e905-15cf-4f79-adc4-818ca5429a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_46b0790d-4bc5-4a7e-a263-b713f2907ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueAbstract_c9beed25-a417-433e-ba4f-4e83264d9a39" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_46b0790d-4bc5-4a7e-a263-b713f2907ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/REVENUERECOGNITIONRevenuebyNatureDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#REVENUERECOGNITIONRevenuebyNatureDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/REVENUERECOGNITIONRevenuebyNatureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_57238925-d05b-43dc-b060-81283e2cd353" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_679ee640-f29c-482d-bb64-8144f38931fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_57238925-d05b-43dc-b060-81283e2cd353" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_679ee640-f29c-482d-bb64-8144f38931fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_d6a1989b-1831-4b26-870a-92e8bb0e2894" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_679ee640-f29c-482d-bb64-8144f38931fc" xlink:to="loc_us-gaap_TypeOfArrangementAxis_d6a1989b-1831-4b26-870a-92e8bb0e2894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ceb3548d-ed63-44ff-89d6-cfc7380f8bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_d6a1989b-1831-4b26-870a-92e8bb0e2894" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ceb3548d-ed63-44ff-89d6-cfc7380f8bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_6d3709ba-a6a1-484a-9e6f-00e39a4c227a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ceb3548d-ed63-44ff-89d6-cfc7380f8bb9" xlink:to="loc_us-gaap_CollaborativeArrangementMember_6d3709ba-a6a1-484a-9e6f-00e39a4c227a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_9f3cc437-082b-4c83-a4bf-169679307245" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_679ee640-f29c-482d-bb64-8144f38931fc" xlink:to="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_9f3cc437-082b-4c83-a4bf-169679307245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_6a831625-2b9d-4dbb-b089-cbfab7c04b77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_9f3cc437-082b-4c83-a4bf-169679307245" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_6a831625-2b9d-4dbb-b089-cbfab7c04b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember_4c5d70b0-e9ff-464b-b22b-4f9e8f9b2821" xlink:href="bmy-20210630.xsd#bmy_NetproductsalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_6a831625-2b9d-4dbb-b089-cbfab7c04b77" xlink:to="loc_bmy_NetproductsalesMember_4c5d70b0-e9ff-464b-b22b-4f9e8f9b2821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_a4500ce3-3e8a-424c-94ab-3e54210cdb89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_6a831625-2b9d-4dbb-b089-cbfab7c04b77" xlink:to="loc_us-gaap_CollaborativeArrangementMember_a4500ce3-3e8a-424c-94ab-3e54210cdb89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherrevenuesMember_6738b869-2dc7-404f-ae04-8804e569ceaa" xlink:href="bmy-20210630.xsd#bmy_OtherrevenuesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_6a831625-2b9d-4dbb-b089-cbfab7c04b77" xlink:to="loc_bmy_OtherrevenuesMember_6738b869-2dc7-404f-ae04-8804e569ceaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_8db82070-f2bf-43a2-aa8d-965601df5e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_679ee640-f29c-482d-bb64-8144f38931fc" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_8db82070-f2bf-43a2-aa8d-965601df5e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_3fde474c-4846-4855-8ecc-c93308aa0f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_8db82070-f2bf-43a2-aa8d-965601df5e2d" xlink:to="loc_us-gaap_Revenues_3fde474c-4846-4855-8ecc-c93308aa0f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/REVENUERECOGNITIONGrosstoNetAdjustmentsDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#REVENUERECOGNITIONGrosstoNetAdjustmentsDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/REVENUERECOGNITIONGrosstoNetAdjustmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsAbstract_f5b047f2-8851-4e73-9574-36b676d80e14" xlink:href="bmy-20210630.xsd#bmy_GrosstoNetAdjustmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsTable_ab551ff5-8078-417c-9ed5-3facd5c3ef7c" xlink:href="bmy-20210630.xsd#bmy_GrosstoNetAdjustmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsAbstract_f5b047f2-8851-4e73-9574-36b676d80e14" xlink:to="loc_bmy_GrosstoNetAdjustmentsTable_ab551ff5-8078-417c-9ed5-3facd5c3ef7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsAxis_41934941-93de-46e3-a72c-794236b5190a" xlink:href="bmy-20210630.xsd#bmy_GrosstoNetAdjustmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsTable_ab551ff5-8078-417c-9ed5-3facd5c3ef7c" xlink:to="loc_bmy_GrosstoNetAdjustmentsAxis_41934941-93de-46e3-a72c-794236b5190a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsDomain_1510f06d-d5e3-491f-b852-9072e8263334" xlink:href="bmy-20210630.xsd#bmy_GrosstoNetAdjustmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsAxis_41934941-93de-46e3-a72c-794236b5190a" xlink:to="loc_bmy_GrosstoNetAdjustmentsDomain_1510f06d-d5e3-491f-b852-9072e8263334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ChargebacksandcashdiscountsMember_27d1621c-0a8e-46e1-b9d0-f320964f4232" xlink:href="bmy-20210630.xsd#bmy_ChargebacksandcashdiscountsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain_1510f06d-d5e3-491f-b852-9072e8263334" xlink:to="loc_bmy_ChargebacksandcashdiscountsMember_27d1621c-0a8e-46e1-b9d0-f320964f4232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MedicaidandMedicarerebatesMember_616e6588-99c2-4e2c-9ca8-0d707e2a7b7b" xlink:href="bmy-20210630.xsd#bmy_MedicaidandMedicarerebatesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain_1510f06d-d5e3-491f-b852-9072e8263334" xlink:to="loc_bmy_MedicaidandMedicarerebatesMember_616e6588-99c2-4e2c-9ca8-0d707e2a7b7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_0977f7e2-2a89-444b-ac22-e68312a8e214" xlink:href="bmy-20210630.xsd#bmy_OtherrebatesreturnsdiscountsandadjustmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsDomain_1510f06d-d5e3-491f-b852-9072e8263334" xlink:to="loc_bmy_OtherrebatesreturnsdiscountsandadjustmentsMember_0977f7e2-2a89-444b-ac22-e68312a8e214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_29f5739a-3050-49ca-aa43-f49a10de39e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsTable_ab551ff5-8078-417c-9ed5-3facd5c3ef7c" xlink:to="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_29f5739a-3050-49ca-aa43-f49a10de39e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_56d0927f-9b0d-4260-b563-874d83dabea2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_29f5739a-3050-49ca-aa43-f49a10de39e2" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_56d0927f-9b0d-4260-b563-874d83dabea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SalesRevenueGrossMember_0f73e874-39f0-462f-956e-b40d53b411a4" xlink:href="bmy-20210630.xsd#bmy_SalesRevenueGrossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_56d0927f-9b0d-4260-b563-874d83dabea2" xlink:to="loc_bmy_SalesRevenueGrossMember_0f73e874-39f0-462f-956e-b40d53b411a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember_a83ff311-9c37-4c47-8faf-55f8b42b503f" xlink:href="bmy-20210630.xsd#bmy_NetproductsalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_56d0927f-9b0d-4260-b563-874d83dabea2" xlink:to="loc_bmy_NetproductsalesMember_a83ff311-9c37-4c47-8faf-55f8b42b503f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustmentsLineItems_31e8a435-ee61-49dc-b36a-0b3600509e91" xlink:href="bmy-20210630.xsd#bmy_GrosstoNetAdjustmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsTable_ab551ff5-8078-417c-9ed5-3facd5c3ef7c" xlink:to="loc_bmy_GrosstoNetAdjustmentsLineItems_31e8a435-ee61-49dc-b36a-0b3600509e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_033e25d1-29de-45d6-b2df-56123056a932" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_31e8a435-ee61-49dc-b36a-0b3600509e91" xlink:to="loc_us-gaap_Revenues_033e25d1-29de-45d6-b2df-56123056a932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_GrosstoNetAdjustments_a9ae6916-7ca6-4088-aaa0-c8a6079d1e5e" xlink:href="bmy-20210630.xsd#bmy_GrosstoNetAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_31e8a435-ee61-49dc-b36a-0b3600509e91" xlink:to="loc_bmy_GrosstoNetAdjustments_a9ae6916-7ca6-4088-aaa0-c8a6079d1e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods_da1e32a3-8828-46ce-9eb1-a2c7472f58f4" xlink:href="bmy-20210630.xsd#bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_GrosstoNetAdjustmentsLineItems_31e8a435-ee61-49dc-b36a-0b3600509e91" xlink:to="loc_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods_da1e32a3-8828-46ce-9eb1-a2c7472f58f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#REVENUERECOGNITIONRevenuebyProductbyRegionDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RevenuebyProductbyRegionAbstract_d19f1d2e-5cce-4f6e-8f1c-02552b5d2dda" xlink:href="bmy-20210630.xsd#bmy_RevenuebyProductbyRegionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_574a33db-d1d6-49c5-a7ee-110628d19bca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_RevenuebyProductbyRegionAbstract_d19f1d2e-5cce-4f6e-8f1c-02552b5d2dda" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_574a33db-d1d6-49c5-a7ee-110628d19bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d0cf1362-b2f6-4699-90a5-b23cd45ba8de" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_574a33db-d1d6-49c5-a7ee-110628d19bca" xlink:to="loc_srt_StatementGeographicalAxis_d0cf1362-b2f6-4699-90a5-b23cd45ba8de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e83db168-6abd-4f67-a26a-ade132fc7761" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_d0cf1362-b2f6-4699-90a5-b23cd45ba8de" xlink:to="loc_srt_SegmentGeographicalDomain_e83db168-6abd-4f67-a26a-ade132fc7761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_0ac7e721-9383-43bd-82f8-8dd086e9f43d" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e83db168-6abd-4f67-a26a-ade132fc7761" xlink:to="loc_country_US_0ac7e721-9383-43bd-82f8-8dd086e9f43d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_c5435f07-982e-4163-b417-d634e585b297" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e83db168-6abd-4f67-a26a-ade132fc7761" xlink:to="loc_srt_EuropeMember_c5435f07-982e-4163-b417-d634e585b297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestOfWorldMember_88ad7230-2c44-41b6-8fa0-685053ca73b6" xlink:href="bmy-20210630.xsd#bmy_RestOfWorldMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e83db168-6abd-4f67-a26a-ade132fc7761" xlink:to="loc_bmy_RestOfWorldMember_88ad7230-2c44-41b6-8fa0-685053ca73b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRegionMember_97c912a1-b5eb-438b-97d1-e9c31f82de89" xlink:href="bmy-20210630.xsd#bmy_OtherRegionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e83db168-6abd-4f67-a26a-ade132fc7761" xlink:to="loc_bmy_OtherRegionMember_97c912a1-b5eb-438b-97d1-e9c31f82de89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f6e6ee43-3e61-4bd4-9973-06e52100fdd0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_574a33db-d1d6-49c5-a7ee-110628d19bca" xlink:to="loc_srt_ProductOrServiceAxis_f6e6ee43-3e61-4bd4-9973-06e52100fdd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f6e6ee43-3e61-4bd4-9973-06e52100fdd0" xlink:to="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RevlimidMember_efbfbecb-0453-479b-a472-611ce7dc3fc8" xlink:href="bmy-20210630.xsd#bmy_RevlimidMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_RevlimidMember_efbfbecb-0453-479b-a472-611ce7dc3fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EliquisMember_b5fd85d6-875a-414f-9fbe-ef8c31828371" xlink:href="bmy-20210630.xsd#bmy_EliquisMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_EliquisMember_b5fd85d6-875a-414f-9fbe-ef8c31828371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OpdivoMember_5815227a-bf95-4f21-90f0-2f274a326d42" xlink:href="bmy-20210630.xsd#bmy_OpdivoMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_OpdivoMember_5815227a-bf95-4f21-90f0-2f274a326d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OrenciaMember_2edb10cc-6f8b-4436-954e-e4cde8cfa40f" xlink:href="bmy-20210630.xsd#bmy_OrenciaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_OrenciaMember_2edb10cc-6f8b-4436-954e-e4cde8cfa40f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PomalystImnovidMember_3f3653a6-ffae-404f-bbd4-db6932357ad4" xlink:href="bmy-20210630.xsd#bmy_PomalystImnovidMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_PomalystImnovidMember_3f3653a6-ffae-404f-bbd4-db6932357ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SprycelMember_438c7831-0abe-485b-911f-c4751b3290b0" xlink:href="bmy-20210630.xsd#bmy_SprycelMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_SprycelMember_438c7831-0abe-485b-911f-c4751b3290b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_YervoyMember_1f824440-dc7f-43c5-a5a0-9575b3316156" xlink:href="bmy-20210630.xsd#bmy_YervoyMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_YervoyMember_1f824440-dc7f-43c5-a5a0-9575b3316156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbraxaneMember_b58f25b1-fc17-4665-b235-8cb6fde9d6f2" xlink:href="bmy-20210630.xsd#bmy_AbraxaneMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_AbraxaneMember_b58f25b1-fc17-4665-b235-8cb6fde9d6f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EmplicitiMember_9db67239-111b-4555-bd64-1f72152bcc06" xlink:href="bmy-20210630.xsd#bmy_EmplicitiMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_EmplicitiMember_9db67239-111b-4555-bd64-1f72152bcc06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReblozylMember_d4e24a4f-c1b2-4bd9-9f97-4f8be7227e9d" xlink:href="bmy-20210630.xsd#bmy_ReblozylMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_ReblozylMember_d4e24a4f-c1b2-4bd9-9f97-4f8be7227e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InrebicMember_e2dd67bf-97de-4ea4-9408-20d513934680" xlink:href="bmy-20210630.xsd#bmy_InrebicMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_InrebicMember_e2dd67bf-97de-4ea4-9408-20d513934680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OnuregMember_605acb13-9334-4333-9a6a-51f18eb976d1" xlink:href="bmy-20210630.xsd#bmy_OnuregMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_OnuregMember_605acb13-9334-4333-9a6a-51f18eb976d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ZeposiaMember_6fe29ade-bc72-4639-baf4-a63b433f5d8a" xlink:href="bmy-20210630.xsd#bmy_ZeposiaMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_ZeposiaMember_6fe29ade-bc72-4639-baf4-a63b433f5d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BreyanziMember_89302297-9a59-4d49-9777-89f1a74b85fd" xlink:href="bmy-20210630.xsd#bmy_BreyanziMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_BreyanziMember_89302297-9a59-4d49-9777-89f1a74b85fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbecmaMember_7811771e-0b6f-4538-aff3-c045245eb4d9" xlink:href="bmy-20210630.xsd#bmy_AbecmaMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_AbecmaMember_7811771e-0b6f-4538-aff3-c045245eb4d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_VidazaMember_294489fd-76c3-4258-98cf-7aabb41e6cd3" xlink:href="bmy-20210630.xsd#bmy_VidazaMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_VidazaMember_294489fd-76c3-4258-98cf-7aabb41e6cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BaracludeMember_299465a3-21eb-4b25-a6bc-9494a1ea468d" xlink:href="bmy-20210630.xsd#bmy_BaracludeMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_BaracludeMember_299465a3-21eb-4b25-a6bc-9494a1ea468d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureProductsAndAllOtherMember_c5904bc5-0930-4c80-8aba-4aefbc199250" xlink:href="bmy-20210630.xsd#bmy_MatureProductsAndAllOtherMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_376f07c4-6229-46b5-bb6d-aa8f1d7641db" xlink:to="loc_bmy_MatureProductsAndAllOtherMember_c5904bc5-0930-4c80-8aba-4aefbc199250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_4534a4a1-f225-4b25-bd3c-2f9c7844f2b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_574a33db-d1d6-49c5-a7ee-110628d19bca" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_4534a4a1-f225-4b25-bd3c-2f9c7844f2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_5bb2cca8-260a-422e-aed7-02e068766e80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_4534a4a1-f225-4b25-bd3c-2f9c7844f2b9" xlink:to="loc_us-gaap_Revenues_5bb2cca8-260a-422e-aed7-02e068766e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/REVENUERECOGNITIONNarrativesDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#REVENUERECOGNITIONNarrativesDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/REVENUERECOGNITIONNarrativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationAbstract_2911126f-9ae9-4051-9958-6f2881cf7a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuePerformanceObligationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_618da77e-125b-4054-b7a8-0d5a6a0823da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuePerformanceObligationAbstract_2911126f-9ae9-4051-9958-6f2881cf7a5b" xlink:to="loc_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_618da77e-125b-4054-b7a8-0d5a6a0823da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/ALLIANCES" xlink:type="simple" xlink:href="bmy-20210630.xsd#ALLIANCES"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/ALLIANCES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ALLIANCESAbstract_2632aeba-a4e7-4feb-8223-7e4b7857adb3" xlink:href="bmy-20210630.xsd#bmy_ALLIANCESAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_a84694bf-0a7b-4a4c-9d38-ec1606b17ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_ALLIANCESAbstract_2632aeba-a4e7-4feb-8223-7e4b7857adb3" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_a84694bf-0a7b-4a4c-9d38-ec1606b17ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/ALLIANCESPolicies" xlink:type="simple" xlink:href="bmy-20210630.xsd#ALLIANCESPolicies"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/ALLIANCESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ALLIANCESAbstract_e0500a31-0b92-4c49-adc1-1f3214880b8e" xlink:href="bmy-20210630.xsd#bmy_ALLIANCESAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementAccountingPolicy_49f208f3-8cff-4fda-8dd8-e3fe5e4a2469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementAccountingPolicy"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_ALLIANCESAbstract_e0500a31-0b92-4c49-adc1-1f3214880b8e" xlink:to="loc_us-gaap_CollaborativeArrangementAccountingPolicy_49f208f3-8cff-4fda-8dd8-e3fe5e4a2469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/ALLIANCESTables" xlink:type="simple" xlink:href="bmy-20210630.xsd#ALLIANCESTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/ALLIANCESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ALLIANCESAbstract_3d92b453-bca9-4720-a14a-f26a1a865d5b" xlink:href="bmy-20210630.xsd#bmy_ALLIANCESAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_b3185917-2b25-47f8-b9a4-dbd67cd7aa35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_ALLIANCESAbstract_3d92b453-bca9-4720-a14a-f26a1a865d5b" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_b3185917-2b25-47f8-b9a4-dbd67cd7aa35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/ALLIANCESDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#ALLIANCESDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/ALLIANCESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ALLIANCESAbstract_fb7fe2d1-d67f-47eb-842b-6aaa45b43626" xlink:href="bmy-20210630.xsd#bmy_ALLIANCESAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_5547e198-cab2-4a2b-ac6e-1b2c355dfdf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_ALLIANCESAbstract_fb7fe2d1-d67f-47eb-842b-6aaa45b43626" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_5547e198-cab2-4a2b-ac6e-1b2c355dfdf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_81f55e1c-c918-48b1-b109-85eacbbab820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_5547e198-cab2-4a2b-ac6e-1b2c355dfdf9" xlink:to="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_81f55e1c-c918-48b1-b109-85eacbbab820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NameOfReportingCategoryDomain_aae35f3c-c52d-4003-a23e-7424d75b5201" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NameOfReportingCategoryDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis_81f55e1c-c918-48b1-b109-85eacbbab820" xlink:to="loc_us-gaap_NameOfReportingCategoryDomain_aae35f3c-c52d-4003-a23e-7424d75b5201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NetproductsalesMember_defc1b63-b9df-442f-936d-4efaf2813f19" xlink:href="bmy-20210630.xsd#bmy_NetproductsalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_aae35f3c-c52d-4003-a23e-7424d75b5201" xlink:to="loc_bmy_NetproductsalesMember_defc1b63-b9df-442f-936d-4efaf2813f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_b131cb6e-abe7-4bf5-a4a0-5f7b9e3b805a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NameOfReportingCategoryDomain_aae35f3c-c52d-4003-a23e-7424d75b5201" xlink:to="loc_us-gaap_CollaborativeArrangementMember_b131cb6e-abe7-4bf5-a4a0-5f7b9e3b805a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_72822373-0069-49f4-9f7f-f30aa0ffa5ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_5547e198-cab2-4a2b-ac6e-1b2c355dfdf9" xlink:to="loc_us-gaap_TypeOfArrangementAxis_72822373-0069-49f4-9f7f-f30aa0ffa5ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_dc87dc9b-f1ec-4c1a-96a9-2cebcc632ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_72822373-0069-49f4-9f7f-f30aa0ffa5ad" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_dc87dc9b-f1ec-4c1a-96a9-2cebcc632ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_2c9b3363-7de4-4be6-bec5-c9d3d9b1a667" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_dc87dc9b-f1ec-4c1a-96a9-2cebcc632ca7" xlink:to="loc_us-gaap_CollaborativeArrangementMember_2c9b3363-7de4-4be6-bec5-c9d3d9b1a667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AlliancesAndCollaborationCompaniesAxis_7161cb13-730a-48f9-a5cf-5c530a024ded" xlink:href="bmy-20210630.xsd#bmy_AlliancesAndCollaborationCompaniesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_5547e198-cab2-4a2b-ac6e-1b2c355dfdf9" xlink:to="loc_bmy_AlliancesAndCollaborationCompaniesAxis_7161cb13-730a-48f9-a5cf-5c530a024ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AlliancesAndCollaborationCompaniesDomain_c7102526-911f-4dbf-a7b2-82ff3d99e6e2" xlink:href="bmy-20210630.xsd#bmy_AlliancesAndCollaborationCompaniesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AlliancesAndCollaborationCompaniesAxis_7161cb13-730a-48f9-a5cf-5c530a024ded" xlink:to="loc_bmy_AlliancesAndCollaborationCompaniesDomain_c7102526-911f-4dbf-a7b2-82ff3d99e6e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EisaiMember_8b7df725-c9c5-4f3e-a4be-d2f9ecfe4ccd" xlink:href="bmy-20210630.xsd#bmy_EisaiMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AlliancesAndCollaborationCompaniesDomain_c7102526-911f-4dbf-a7b2-82ff3d99e6e2" xlink:to="loc_bmy_EisaiMember_8b7df725-c9c5-4f3e-a4be-d2f9ecfe4ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_80593a94-076b-43e7-a22a-9d806df15ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_5547e198-cab2-4a2b-ac6e-1b2c355dfdf9" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_80593a94-076b-43e7-a22a-9d806df15ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0837d969-d2d7-4a0d-9c8c-2a7a21ae79b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_80593a94-076b-43e7-a22a-9d806df15ba5" xlink:to="loc_us-gaap_Revenues_0837d969-d2d7-4a0d-9c8c-2a7a21ae79b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_116b2ad3-e61d-4002-ae26-f5f4a143a3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_80593a94-076b-43e7-a22a-9d806df15ba5" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_116b2ad3-e61d-4002-ae26-f5f4a143a3cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement_2c9be6db-d6fa-4a15-bdba-abc64b40e262" xlink:href="bmy-20210630.xsd#bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_80593a94-076b-43e7-a22a-9d806df15ba5" xlink:to="loc_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement_2c9be6db-d6fa-4a15-bdba-abc64b40e262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchandDevelopmentExpenseCollaborativeArrangement_86194e6a-9127-493e-bfd4-6dee02496df5" xlink:href="bmy-20210630.xsd#bmy_ResearchandDevelopmentExpenseCollaborativeArrangement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_80593a94-076b-43e7-a22a-9d806df15ba5" xlink:to="loc_bmy_ResearchandDevelopmentExpenseCollaborativeArrangement_86194e6a-9127-493e-bfd4-6dee02496df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_4781c909-1667-47f3-8611-20f377819cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_80593a94-076b-43e7-a22a-9d806df15ba5" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_4781c909-1667-47f3-8611-20f377819cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_ac138323-e403-423a-bdc6-b4a5da3a3502" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_80593a94-076b-43e7-a22a-9d806df15ba5" xlink:to="loc_us-gaap_ReceivablesNetCurrent_ac138323-e403-423a-bdc6-b4a5da3a3502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019644a2-8a51-4df0-8053-956b47bb63bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_80593a94-076b-43e7-a22a-9d806df15ba5" xlink:to="loc_us-gaap_AccountsPayableCurrent_019644a2-8a51-4df0-8053-956b47bb63bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncome_68227547-926c-43be-bb7e-eb798b6177db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncome"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_80593a94-076b-43e7-a22a-9d806df15ba5" xlink:to="loc_us-gaap_DeferredIncome_68227547-926c-43be-bb7e-eb798b6177db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_UpfrontPaymentsMadeToCollaborativePartner_c79f8080-c0d3-452b-ad81-d00f384e8b21" xlink:href="bmy-20210630.xsd#bmy_UpfrontPaymentsMadeToCollaborativePartner"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_80593a94-076b-43e7-a22a-9d806df15ba5" xlink:to="loc_bmy_UpfrontPaymentsMadeToCollaborativePartner_c79f8080-c0d3-452b-ad81-d00f384e8b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Considerationforcontingentdevelopmentandregulatoryapproval_86176c65-895b-4d9f-a5ec-1742f42a1bbf" xlink:href="bmy-20210630.xsd#bmy_Considerationforcontingentdevelopmentandregulatoryapproval"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_80593a94-076b-43e7-a22a-9d806df15ba5" xlink:to="loc_bmy_Considerationforcontingentdevelopmentandregulatoryapproval_86176c65-895b-4d9f-a5ec-1742f42a1bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSNotes" xlink:type="simple" xlink:href="bmy-20210630.xsd#DIVESTITURESLICENSINGANDOTHERARRANGEMENTSNotes"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_02b7f6a0-b401-47c8-96d9-b5be3cc6294b" xlink:href="bmy-20210630.xsd#bmy_AcquisitionsDivestituresandOtherArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_599576c3-42cd-47f5-93c5-68de75ebf768" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_02b7f6a0-b401-47c8-96d9-b5be3cc6294b" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_599576c3-42cd-47f5-93c5-68de75ebf768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables" xlink:type="simple" xlink:href="bmy-20210630.xsd#DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_45ba9d8a-bf0f-4139-ab43-87d5cd7a00ae" xlink:href="bmy-20210630.xsd#bmy_AcquisitionsDivestituresandOtherArrangementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_acd40e27-bb78-48e6-9c22-01c7a79ec7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_45ba9d8a-bf0f-4139-ab43-87d5cd7a00ae" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_acd40e27-bb78-48e6-9c22-01c7a79ec7cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsTableTextBlock_1b6a939c-066d-474d-8cc5-675a29a19ea4" xlink:href="bmy-20210630.xsd#bmy_LicensingAndOtherArrangementsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract_45ba9d8a-bf0f-4139-ab43-87d5cd7a00ae" xlink:to="loc_bmy_LicensingAndOtherArrangementsTableTextBlock_1b6a939c-066d-474d-8cc5-675a29a19ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/ACQUISITIONSDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#ACQUISITIONSDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/ACQUISITIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_46679db5-b0b4-46a2-915b-810df60f5a98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_93151de5-c39e-43b7-8087-9065c1a40980" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_46679db5-b0b4-46a2-915b-810df60f5a98" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_93151de5-c39e-43b7-8087-9065c1a40980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AssetAcquisitionNameAxis_f60b4873-8e36-4c0c-9e71-b2534f2a01f1" xlink:href="bmy-20210630.xsd#bmy_AssetAcquisitionNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_93151de5-c39e-43b7-8087-9065c1a40980" xlink:to="loc_bmy_AssetAcquisitionNameAxis_f60b4873-8e36-4c0c-9e71-b2534f2a01f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AssetAcquisitionNameDomain_b5a026ce-9fde-4723-9ed3-d7c9ded565c2" xlink:href="bmy-20210630.xsd#bmy_AssetAcquisitionNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_AssetAcquisitionNameAxis_f60b4873-8e36-4c0c-9e71-b2534f2a01f1" xlink:to="loc_bmy_AssetAcquisitionNameDomain_b5a026ce-9fde-4723-9ed3-d7c9ded565c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_5fb3154f-e1a4-4c1a-8240-af697aeb318b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_93151de5-c39e-43b7-8087-9065c1a40980" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_5fb3154f-e1a4-4c1a-8240-af697aeb318b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_f4765eee-9a41-48f8-a9b8-cdb6f05c27e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_5fb3154f-e1a4-4c1a-8240-af697aeb318b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_f4765eee-9a41-48f8-a9b8-cdb6f05c27e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4a5518f9-b3e3-4a34-9a9c-5a38ec154a95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_f4765eee-9a41-48f8-a9b8-cdb6f05c27e7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_4a5518f9-b3e3-4a34-9a9c-5a38ec154a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_2c99896c-9e5b-4614-a6c9-20c817487ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_93151de5-c39e-43b7-8087-9065c1a40980" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_2c99896c-9e5b-4614-a6c9-20c817487ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/DIVESTITURESDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#DIVESTITURESDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/DIVESTITURESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_ca08c696-8c7a-4357-ac98-39ab2a9e489f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_43c8ccc7-51f0-4063-afaa-e5d9ce3b301a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_ca08c696-8c7a-4357-ac98-39ab2a9e489f" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_43c8ccc7-51f0-4063-afaa-e5d9ce3b301a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b073f0f4-ff74-40c4-a358-f445b3b2b96b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_43c8ccc7-51f0-4063-afaa-e5d9ce3b301a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b073f0f4-ff74-40c4-a358-f445b3b2b96b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e41bfe02-ac76-4c78-bc11-72c63237293e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b073f0f4-ff74-40c4-a358-f445b3b2b96b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e41bfe02-ac76-4c78-bc11-72c63237293e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DiabetesbusinessMember_096e7962-f800-40c3-8bb8-68837845f610" xlink:href="bmy-20210630.xsd#bmy_DiabetesbusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e41bfe02-ac76-4c78-bc11-72c63237293e" xlink:to="loc_bmy_DiabetesbusinessMember_096e7962-f800-40c3-8bb8-68837845f610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ErbituxBusinessMember_c7146add-e23c-42f0-9be3-e4e7005e1455" xlink:href="bmy-20210630.xsd#bmy_ErbituxBusinessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e41bfe02-ac76-4c78-bc11-72c63237293e" xlink:to="loc_bmy_ErbituxBusinessMember_c7146add-e23c-42f0-9be3-e4e7005e1455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManufacturingFacilityMember_c33d5902-1bd6-4036-b5e5-14aae2e25dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ManufacturingFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e41bfe02-ac76-4c78-bc11-72c63237293e" xlink:to="loc_us-gaap_ManufacturingFacilityMember_c33d5902-1bd6-4036-b5e5-14aae2e25dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AvaproAvalideAndPlavixMember_100f0499-2945-4c72-9aee-b137d1096e21" xlink:href="bmy-20210630.xsd#bmy_AvaproAvalideAndPlavixMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e41bfe02-ac76-4c78-bc11-72c63237293e" xlink:to="loc_bmy_AvaproAvalideAndPlavixMember_100f0499-2945-4c72-9aee-b137d1096e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MatureBrandsAndOtherMember_35f8b2ea-2984-43ec-a92b-0d66480f6172" xlink:href="bmy-20210630.xsd#bmy_MatureBrandsAndOtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e41bfe02-ac76-4c78-bc11-72c63237293e" xlink:to="loc_bmy_MatureBrandsAndOtherMember_35f8b2ea-2984-43ec-a92b-0d66480f6172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_55ed20c7-0cd6-4ad7-aa14-063d350fb7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_43c8ccc7-51f0-4063-afaa-e5d9ce3b301a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_55ed20c7-0cd6-4ad7-aa14-063d350fb7bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_d1d9b5b9-e60b-4495-9d65-008918fe3035" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_55ed20c7-0cd6-4ad7-aa14-063d350fb7bc" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_d1d9b5b9-e60b-4495-9d65-008918fe3035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_553ab3c8-50b3-4b3a-b372-d0727e219182" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_55ed20c7-0cd6-4ad7-aa14-063d350fb7bc" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_553ab3c8-50b3-4b3a-b372-d0727e219182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyIncomeNonoperating_c51b40a3-b534-462f-95c7-b30dd9238ace" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyIncomeNonoperating"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_55ed20c7-0cd6-4ad7-aa14-063d350fb7bc" xlink:to="loc_us-gaap_RoyaltyIncomeNonoperating_c51b40a3-b534-462f-95c7-b30dd9238ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#LICENSINGANDOTHERARRANGEMENTSDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_66fa2049-e6ad-4a40-9f67-e35ccaa827ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsTable_95ec0da2-a640-47ca-91bb-98ecc309c85e" xlink:href="bmy-20210630.xsd#bmy_LicensingArrangementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_66fa2049-e6ad-4a40-9f67-e35ccaa827ac" xlink:to="loc_bmy_LicensingArrangementsTable_95ec0da2-a640-47ca-91bb-98ecc309c85e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingCompaniesAxis_67104d4d-4702-4187-8f20-acf40d15626e" xlink:href="bmy-20210630.xsd#bmy_LicensingCompaniesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsTable_95ec0da2-a640-47ca-91bb-98ecc309c85e" xlink:to="loc_bmy_LicensingCompaniesAxis_67104d4d-4702-4187-8f20-acf40d15626e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingCompaniesDomain_3292f56c-da3c-4724-b007-f3f3e58ee459" xlink:href="bmy-20210630.xsd#bmy_LicensingCompaniesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingCompaniesAxis_67104d4d-4702-4187-8f20-acf40d15626e" xlink:to="loc_bmy_LicensingCompaniesDomain_3292f56c-da3c-4724-b007-f3f3e58ee459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b2f3ff98-f101-4030-9209-320abb6a960f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsTable_95ec0da2-a640-47ca-91bb-98ecc309c85e" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b2f3ff98-f101-4030-9209-320abb6a960f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f2b8882f-6724-4476-b6cf-4c8437dbf93a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b2f3ff98-f101-4030-9209-320abb6a960f" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f2b8882f-6724-4476-b6cf-4c8437dbf93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DiabetesbusinessMember_be950550-c1ac-47a8-a7b3-15ce0c26d9de" xlink:href="bmy-20210630.xsd#bmy_DiabetesbusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f2b8882f-6724-4476-b6cf-4c8437dbf93a" xlink:to="loc_bmy_DiabetesbusinessMember_be950550-c1ac-47a8-a7b3-15ce0c26d9de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsAxis_fd36d03e-191e-472d-b773-cc7ce6573d84" xlink:href="bmy-20210630.xsd#bmy_LicensingAndOtherArrangementsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsTable_95ec0da2-a640-47ca-91bb-98ecc309c85e" xlink:to="loc_bmy_LicensingAndOtherArrangementsAxis_fd36d03e-191e-472d-b773-cc7ce6573d84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsDomain_cb4c5f1b-c489-4e61-b2be-b81eb2fa22ac" xlink:href="bmy-20210630.xsd#bmy_LicensingAndOtherArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingAndOtherArrangementsAxis_fd36d03e-191e-472d-b773-cc7ce6573d84" xlink:to="loc_bmy_LicensingAndOtherArrangementsDomain_cb4c5f1b-c489-4e61-b2be-b81eb2fa22ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherRoyaltiesMember_43bd32e8-19ed-44b2-bddc-7c3fb111e393" xlink:href="bmy-20210630.xsd#bmy_OtherRoyaltiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_cb4c5f1b-c489-4e61-b2be-b81eb2fa22ac" xlink:to="loc_bmy_OtherRoyaltiesMember_43bd32e8-19ed-44b2-bddc-7c3fb111e393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_KeytrudaRoyaltiesMember_f4f50464-0547-4bdb-80d5-200d6fb49e55" xlink:href="bmy-20210630.xsd#bmy_KeytrudaRoyaltiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_cb4c5f1b-c489-4e61-b2be-b81eb2fa22ac" xlink:to="loc_bmy_KeytrudaRoyaltiesMember_f4f50464-0547-4bdb-80d5-200d6fb49e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_TecentriqRoyaltiesMember_6c19a46e-a48a-4402-91ca-9f3d8adc915f" xlink:href="bmy-20210630.xsd#bmy_TecentriqRoyaltiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingAndOtherArrangementsDomain_cb4c5f1b-c489-4e61-b2be-b81eb2fa22ac" xlink:to="loc_bmy_TecentriqRoyaltiesMember_6c19a46e-a48a-4402-91ca-9f3d8adc915f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_0a8e888d-8dbf-49f3-804c-df8f84472f34" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsTable_95ec0da2-a640-47ca-91bb-98ecc309c85e" xlink:to="loc_srt_CounterpartyNameAxis_0a8e888d-8dbf-49f3-804c-df8f84472f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4777ef4b-a91f-4b85-9fc0-a9dc525713fa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_0a8e888d-8dbf-49f3-804c-df8f84472f34" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4777ef4b-a91f-4b85-9fc0-a9dc525713fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AgenusMember_648d8e13-784f-4462-9a09-088062da6dc4" xlink:href="bmy-20210630.xsd#bmy_AgenusMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4777ef4b-a91f-4b85-9fc0-a9dc525713fa" xlink:to="loc_bmy_AgenusMember_648d8e13-784f-4462-9a09-088062da6dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingArrangementsLineItems_795b02e3-46d5-4a16-9234-1ce7a85c6fec" xlink:href="bmy-20210630.xsd#bmy_LicensingArrangementsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsTable_95ec0da2-a640-47ca-91bb-98ecc309c85e" xlink:to="loc_bmy_LicensingArrangementsLineItems_795b02e3-46d5-4a16-9234-1ce7a85c6fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyIncomeNonoperating_3c5e8b60-d2ad-4885-a390-eba206e44eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyIncomeNonoperating"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_795b02e3-46d5-4a16-9234-1ce7a85c6fec" xlink:to="loc_us-gaap_RoyaltyIncomeNonoperating_3c5e8b60-d2ad-4885-a390-eba206e44eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_UpFrontLicensingFee_d2f7254d-fe20-4ac5-bbad-9b7843ac4d8e" xlink:href="bmy-20210630.xsd#bmy_UpFrontLicensingFee"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_795b02e3-46d5-4a16-9234-1ce7a85c6fec" xlink:to="loc_bmy_UpFrontLicensingFee_d2f7254d-fe20-4ac5-bbad-9b7843ac4d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentRegulatoryMilestoneIncome_c5170f49-ea3d-4cd9-bcfe-b6e387637711" xlink:href="bmy-20210630.xsd#bmy_ContingentRegulatoryMilestoneIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_795b02e3-46d5-4a16-9234-1ce7a85c6fec" xlink:to="loc_bmy_ContingentRegulatoryMilestoneIncome_c5170f49-ea3d-4cd9-bcfe-b6e387637711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges_edc30002-a900-41fc-9ac2-5c38be55e1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_795b02e3-46d5-4a16-9234-1ce7a85c6fec" xlink:to="loc_us-gaap_OtherAmortizationOfDeferredCharges_edc30002-a900-41fc-9ac2-5c38be55e1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicensingAndOtherArrangementsIncome_e9808bc7-ba00-407d-8e05-23837c15f1b9" xlink:href="bmy-20210630.xsd#bmy_LicensingAndOtherArrangementsIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_795b02e3-46d5-4a16-9234-1ce7a85c6fec" xlink:to="loc_bmy_LicensingAndOtherArrangementsIncome_e9808bc7-ba00-407d-8e05-23837c15f1b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments_a737105f-6b8b-47b4-9f2d-6de7da263814" xlink:href="bmy-20210630.xsd#bmy_LicenseAndOtherArrangementsUpfrontPayments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_795b02e3-46d5-4a16-9234-1ce7a85c6fec" xlink:to="loc_bmy_LicenseAndOtherArrangementsUpfrontPayments_a737105f-6b8b-47b4-9f2d-6de7da263814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentAndRegulatoryMilestonePayments_63df6bd5-279c-4aaa-b6d3-b21e95c16484" xlink:href="bmy-20210630.xsd#bmy_ContingentAndRegulatoryMilestonePayments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LicensingArrangementsLineItems_795b02e3-46d5-4a16-9234-1ce7a85c6fec" xlink:to="loc_bmy_ContingentAndRegulatoryMilestonePayments_63df6bd5-279c-4aaa-b6d3-b21e95c16484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/OTHEREXPENSEINCOMENET" xlink:type="simple" xlink:href="bmy-20210630.xsd#OTHEREXPENSEINCOMENET"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/OTHEREXPENSEINCOMENET" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_a2339a1d-693d-4382-8d08-57d3aedf6bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_febfcc94-1843-49c8-85cc-247624d4fd8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_a2339a1d-693d-4382-8d08-57d3aedf6bf4" xlink:to="loc_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock_febfcc94-1843-49c8-85cc-247624d4fd8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/OTHEREXPENSEINCOMENETTables" xlink:type="simple" xlink:href="bmy-20210630.xsd#OTHEREXPENSEINCOMENETTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/OTHEREXPENSEINCOMENETTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_cfb5edd2-bada-4612-99d0-a597829b657d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfOtherIncomeExpenseTextBlock_fd0b418e-5062-4f08-a7bb-3817acb75de1" xlink:href="bmy-20210630.xsd#bmy_ScheduleOfOtherIncomeExpenseTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_cfb5edd2-bada-4612-99d0-a597829b657d" xlink:to="loc_bmy_ScheduleOfOtherIncomeExpenseTextBlock_fd0b418e-5062-4f08-a7bb-3817acb75de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#OTHEREXPENSEINCOMENETDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_97ad6bf4-c0a4-47aa-9834-33dcaf6bd603" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_cb36e0d4-61c2-4f03-a9d3-497f4c4787ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_97ad6bf4-c0a4-47aa-9834-33dcaf6bd603" xlink:to="loc_us-gaap_InterestExpense_cb36e0d4-61c2-4f03-a9d3-497f4c4787ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_4f2e3f1c-7b78-46df-8d1b-afce5cad22bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_97ad6bf4-c0a4-47aa-9834-33dcaf6bd603" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_4f2e3f1c-7b78-46df-8d1b-afce5cad22bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherIncomeReceivedFromAlliancePartners_dfc88486-9a3e-4d50-a0de-f1cee78796d7" xlink:href="bmy-20210630.xsd#bmy_OtherIncomeReceivedFromAlliancePartners"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_97ad6bf4-c0a4-47aa-9834-33dcaf6bd603" xlink:to="loc_bmy_OtherIncomeReceivedFromAlliancePartners_dfc88486-9a3e-4d50-a0de-f1cee78796d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments_9548d7d1-8833-4eff-9d74-e0f854c62b32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_97ad6bf4-c0a4-47aa-9834-33dcaf6bd603" xlink:to="loc_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments_9548d7d1-8833-4eff-9d74-e0f854c62b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_d0253279-7a32-4fe7-89dd-9ff27bdd92cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_97ad6bf4-c0a4-47aa-9834-33dcaf6bd603" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_d0253279-7a32-4fe7-89dd-9ff27bdd92cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_e9dd6d56-ada9-43fa-9063-8656de4cfb43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_97ad6bf4-c0a4-47aa-9834-33dcaf6bd603" xlink:to="loc_us-gaap_RestructuringCharges_e9dd6d56-ada9-43fa-9063-8656de4cfb43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_fc01e4e1-b71e-43c2-887c-87db1e990706" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_97ad6bf4-c0a4-47aa-9834-33dcaf6bd603" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_fc01e4e1-b71e-43c2-887c-87db1e990706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AllianceTransitionalServices_fd88fb75-3493-42a1-9d52-119b26614582" xlink:href="bmy-20210630.xsd#bmy_AllianceTransitionalServices"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_97ad6bf4-c0a4-47aa-9834-33dcaf6bd603" xlink:to="loc_bmy_AllianceTransitionalServices_fd88fb75-3493-42a1-9d52-119b26614582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_c3816a08-642a-4b06-95dc-300b61f179de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_97ad6bf4-c0a4-47aa-9834-33dcaf6bd603" xlink:to="loc_us-gaap_InvestmentIncomeInterest_c3816a08-642a-4b06-95dc-300b61f179de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Reversionexcisetax_523250ca-a38c-41ae-8371-dec24f8942b0" xlink:href="bmy-20210630.xsd#bmy_Reversionexcisetax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_97ad6bf4-c0a4-47aa-9834-33dcaf6bd603" xlink:to="loc_bmy_Reversionexcisetax_523250ca-a38c-41ae-8371-dec24f8942b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_d32f6b76-dc9b-41b7-88f5-010012792fef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_97ad6bf4-c0a4-47aa-9834-33dcaf6bd603" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_d32f6b76-dc9b-41b7-88f5-010012792fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_cec122c2-32a1-4f02-a004-48855727bb2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_97ad6bf4-c0a4-47aa-9834-33dcaf6bd603" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_cec122c2-32a1-4f02-a004-48855727bb2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_43a3e920-e48e-4e73-88f3-0f0ff8f3c9c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_97ad6bf4-c0a4-47aa-9834-33dcaf6bd603" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_43a3e920-e48e-4e73-88f3-0f0ff8f3c9c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherOtherIncomeExpense_af6ad643-5864-4d85-bfee-74b9da8abc91" xlink:href="bmy-20210630.xsd#bmy_OtherOtherIncomeExpense"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_97ad6bf4-c0a4-47aa-9834-33dcaf6bd603" xlink:to="loc_bmy_OtherOtherIncomeExpense_af6ad643-5864-4d85-bfee-74b9da8abc91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a0ffd08b-659b-48fd-b83b-7e759bc46598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_97ad6bf4-c0a4-47aa-9834-33dcaf6bd603" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a0ffd08b-659b-48fd-b83b-7e759bc46598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURING" xlink:type="simple" xlink:href="bmy-20210630.xsd#RESTRUCTURING"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RESTRUCTURING" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_d391c106-43e1-4af1-9f35-b63fd4b256ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_b310239c-daf8-4f9a-a079-85927840f8d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_d391c106-43e1-4af1-9f35-b63fd4b256ef" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_b310239c-daf8-4f9a-a079-85927840f8d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGTables" xlink:type="simple" xlink:href="bmy-20210630.xsd#RESTRUCTURINGTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RESTRUCTURINGTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_ea706cbd-bcf5-488f-948b-e4115549c959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1e0fc346-9301-44e7-8b47-046ddeb5c5f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_ea706cbd-bcf5-488f-948b-e4115549c959" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1e0fc346-9301-44e7-8b47-046ddeb5c5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_4f049d01-87ca-4984-ac20-fc22e282366f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1e0fc346-9301-44e7-8b47-046ddeb5c5f3" xlink:to="loc_us-gaap_RestructuringPlanAxis_4f049d01-87ca-4984-ac20-fc22e282366f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_092c1137-17de-4d35-856a-52d653b4feab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_4f049d01-87ca-4984-ac20-fc22e282366f" xlink:to="loc_us-gaap_RestructuringPlanDomain_092c1137-17de-4d35-856a-52d653b4feab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_c65f41ad-52af-45b4-b335-91ddfd973085" xlink:href="bmy-20210630.xsd#bmy_CelgeneIntegrationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_092c1137-17de-4d35-856a-52d653b4feab" xlink:to="loc_bmy_CelgeneIntegrationMember_c65f41ad-52af-45b4-b335-91ddfd973085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CompanyTransformationMember_b0922fef-318c-4d62-bb5a-2cbade0c7c92" xlink:href="bmy-20210630.xsd#bmy_CompanyTransformationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_092c1137-17de-4d35-856a-52d653b4feab" xlink:to="loc_bmy_CompanyTransformationMember_b0922fef-318c-4d62-bb5a-2cbade0c7c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_047c5fc4-f5ba-41fc-bd64-5ea76ccff9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_1e0fc346-9301-44e7-8b47-046ddeb5c5f3" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_047c5fc4-f5ba-41fc-bd64-5ea76ccff9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_c64f2012-c156-4ddf-9d54-d0b2e58c706e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_047c5fc4-f5ba-41fc-bd64-5ea76ccff9ba" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock_c64f2012-c156-4ddf-9d54-d0b2e58c706e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_9d675a91-1ad1-4505-bac6-d6555de0e218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_047c5fc4-f5ba-41fc-bd64-5ea76ccff9ba" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_9d675a91-1ad1-4505-bac6-d6555de0e218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGNARRATIVEDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#RESTRUCTURINGNARRATIVEDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RESTRUCTURINGNARRATIVEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesAbstract_c7f7961b-a06a-4e51-bc50-a9ca0eb677a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringChargesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7f11554a-4179-48f0-a6c7-2601ac8ff7b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringChargesAbstract_c7f7961b-a06a-4e51-bc50-a9ca0eb677a2" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7f11554a-4179-48f0-a6c7-2601ac8ff7b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_7950e2f0-daf3-494a-bde8-58e3c05e63ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7f11554a-4179-48f0-a6c7-2601ac8ff7b7" xlink:to="loc_us-gaap_RestructuringPlanAxis_7950e2f0-daf3-494a-bde8-58e3c05e63ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_cd7eae2d-ed03-42c4-bd0c-43c4aaf17098" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_7950e2f0-daf3-494a-bde8-58e3c05e63ca" xlink:to="loc_us-gaap_RestructuringPlanDomain_cd7eae2d-ed03-42c4-bd0c-43c4aaf17098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_03b37401-742a-467e-8ba9-cef4a6e60ad9" xlink:href="bmy-20210630.xsd#bmy_CelgeneIntegrationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_cd7eae2d-ed03-42c4-bd0c-43c4aaf17098" xlink:to="loc_bmy_CelgeneIntegrationMember_03b37401-742a-467e-8ba9-cef4a6e60ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MyoKardiaAcquisitionPlanMember_613cae79-c747-41f4-98a3-0a94fd7b859a" xlink:href="bmy-20210630.xsd#bmy_MyoKardiaAcquisitionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_cd7eae2d-ed03-42c4-bd0c-43c4aaf17098" xlink:to="loc_bmy_MyoKardiaAcquisitionPlanMember_613cae79-c747-41f4-98a3-0a94fd7b859a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CompanyTransformationMember_9405daee-7357-42cc-afab-417dbd7d07e1" xlink:href="bmy-20210630.xsd#bmy_CompanyTransformationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_cd7eae2d-ed03-42c4-bd0c-43c4aaf17098" xlink:to="loc_bmy_CompanyTransformationMember_9405daee-7357-42cc-afab-417dbd7d07e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_47c57858-0c34-4cb1-a909-81f8a6b031c8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7f11554a-4179-48f0-a6c7-2601ac8ff7b7" xlink:to="loc_srt_RangeAxis_47c57858-0c34-4cb1-a909-81f8a6b031c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1b2e6d80-a9ee-45d9-9b3b-ed7f6ae2a971" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_47c57858-0c34-4cb1-a909-81f8a6b031c8" xlink:to="loc_srt_RangeMember_1b2e6d80-a9ee-45d9-9b3b-ed7f6ae2a971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9df30c9a-2733-4579-954b-acca0862d3fe" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1b2e6d80-a9ee-45d9-9b3b-ed7f6ae2a971" xlink:to="loc_srt_MinimumMember_9df30c9a-2733-4579-954b-acca0862d3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1f9f3fac-afbd-4876-93d8-c6deeb47d7fc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1b2e6d80-a9ee-45d9-9b3b-ed7f6ae2a971" xlink:to="loc_srt_MaximumMember_1f9f3fac-afbd-4876-93d8-c6deeb47d7fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_7ed525e9-9643-4429-9d94-02daf6e0457f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7f11554a-4179-48f0-a6c7-2601ac8ff7b7" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_7ed525e9-9643-4429-9d94-02daf6e0457f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_f6fba430-c2d7-4d55-bfb3-f815df07992c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7ed525e9-9643-4429-9d94-02daf6e0457f" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_f6fba430-c2d7-4d55-bfb3-f815df07992c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_732a068b-ccaf-488a-b48a-87230483c4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7ed525e9-9643-4429-9d94-02daf6e0457f" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_732a068b-ccaf-488a-b48a-87230483c4a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Cashoutlays_dab006ef-36f8-4d15-a0d6-cbb14cb8c5c8" xlink:href="bmy-20210630.xsd#bmy_Cashoutlays"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7ed525e9-9643-4429-9d94-02daf6e0457f" xlink:to="loc_bmy_Cashoutlays_dab006ef-36f8-4d15-a0d6-cbb14cb8c5c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_a721a124-17d5-48a8-81e3-79336629b637" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_7ed525e9-9643-4429-9d94-02daf6e0457f" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated_a721a124-17d5-48a8-81e3-79336629b637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0d970f18-43e9-4e66-858a-9094b55fc5f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_478f57bf-4854-41d5-9532-f3c864ccd906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_0d970f18-43e9-4e66-858a-9094b55fc5f0" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_478f57bf-4854-41d5-9532-f3c864ccd906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_8ace93f1-8c97-45bf-9d09-9f1fc74f9f27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_478f57bf-4854-41d5-9532-f3c864ccd906" xlink:to="loc_us-gaap_RestructuringPlanAxis_8ace93f1-8c97-45bf-9d09-9f1fc74f9f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_8871a114-276b-42fa-9ad2-ce57fe5c8556" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_8ace93f1-8c97-45bf-9d09-9f1fc74f9f27" xlink:to="loc_us-gaap_RestructuringPlanDomain_8871a114-276b-42fa-9ad2-ce57fe5c8556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_833bcf63-60e2-4017-b244-e656776fc25b" xlink:href="bmy-20210630.xsd#bmy_CelgeneIntegrationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_8871a114-276b-42fa-9ad2-ce57fe5c8556" xlink:to="loc_bmy_CelgeneIntegrationMember_833bcf63-60e2-4017-b244-e656776fc25b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MyoKardiaAcquisitionPlanMember_d36a4ac0-1f2e-4a8a-b2f4-d6efedfb51f1" xlink:href="bmy-20210630.xsd#bmy_MyoKardiaAcquisitionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_8871a114-276b-42fa-9ad2-ce57fe5c8556" xlink:to="loc_bmy_MyoKardiaAcquisitionPlanMember_d36a4ac0-1f2e-4a8a-b2f4-d6efedfb51f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CompanyTransformationMember_20f92ec8-4b45-4418-94ac-12794d88c015" xlink:href="bmy-20210630.xsd#bmy_CompanyTransformationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_8871a114-276b-42fa-9ad2-ce57fe5c8556" xlink:to="loc_bmy_CompanyTransformationMember_20f92ec8-4b45-4418-94ac-12794d88c015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_414d4c55-6b09-44c3-b7fa-d0dfc6981089" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_478f57bf-4854-41d5-9532-f3c864ccd906" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_414d4c55-6b09-44c3-b7fa-d0dfc6981089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_47690492-b871-435c-9ad8-ee88ef4c9821" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_414d4c55-6b09-44c3-b7fa-d0dfc6981089" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_47690492-b871-435c-9ad8-ee88ef4c9821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_da5f4ff4-2e5c-4d4b-8bbf-d5d5fbf5a6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_47690492-b871-435c-9ad8-ee88ef4c9821" xlink:to="loc_us-gaap_CostOfSalesMember_da5f4ff4-2e5c-4d4b-8bbf-d5d5fbf5a6fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_4fa366ec-8f06-43e9-9a48-0d1e49e5653e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_47690492-b871-435c-9ad8-ee88ef4c9821" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_4fa366ec-8f06-43e9-9a48-0d1e49e5653e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_bc1a5768-d230-46b6-a6f7-a710d62dcfa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_47690492-b871-435c-9ad8-ee88ef4c9821" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_bc1a5768-d230-46b6-a6f7-a710d62dcfa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_8a8d8d8f-37b1-49d3-9e2e-dbc0b9843123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_47690492-b871-435c-9ad8-ee88ef4c9821" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_8a8d8d8f-37b1-49d3-9e2e-dbc0b9843123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_4ed71245-328c-45ca-b135-8a410efd6774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_478f57bf-4854-41d5-9532-f3c864ccd906" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_4ed71245-328c-45ca-b135-8a410efd6774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_d2d9cf93-59fe-4ce2-8308-ae9309615428" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4ed71245-328c-45ca-b135-8a410efd6774" xlink:to="loc_us-gaap_SeveranceCosts1_d2d9cf93-59fe-4ce2-8308-ae9309615428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringCosts_eb2c563f-37cd-420e-a189-7e546912791c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestructuringCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4ed71245-328c-45ca-b135-8a410efd6774" xlink:to="loc_us-gaap_OtherRestructuringCosts_eb2c563f-37cd-420e-a189-7e546912791c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_854a05d2-13ff-450f-861a-d763203113e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4ed71245-328c-45ca-b135-8a410efd6774" xlink:to="loc_us-gaap_RestructuringCharges_854a05d2-13ff-450f-861a-d763203113e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_cad9b69d-dfe7-4c28-b751-fa64905fa5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4ed71245-328c-45ca-b135-8a410efd6774" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_cad9b69d-dfe7-4c28-b751-fa64905fa5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_186bd4e6-d8f0-4035-9896-072ab527a7de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveAcceleratedDepreciation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4ed71245-328c-45ca-b135-8a410efd6774" xlink:to="loc_us-gaap_RestructuringReserveAcceleratedDepreciation_186bd4e6-d8f0-4035-9896-072ab527a7de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringRelatedCostsAssetImpairments_7fd03045-0aec-4ba2-8643-662c58e64e20" xlink:href="bmy-20210630.xsd#bmy_RestructuringRelatedCostsAssetImpairments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4ed71245-328c-45ca-b135-8a410efd6774" xlink:to="loc_bmy_RestructuringRelatedCostsAssetImpairments_7fd03045-0aec-4ba2-8643-662c58e64e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherShutdownCosts_a019252f-07cc-447b-b13f-e192cf42e988" xlink:href="bmy-20210630.xsd#bmy_OtherShutdownCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4ed71245-328c-45ca-b135-8a410efd6774" xlink:to="loc_bmy_OtherShutdownCosts_a019252f-07cc-447b-b13f-e192cf42e988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_145dd48f-30ca-44e3-b6db-b90ebb18c070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_4ed71245-328c-45ca-b135-8a410efd6774" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_145dd48f-30ca-44e3-b6db-b90ebb18c070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_09e51068-7aa5-4844-8a7a-88aed2f94621" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d173a0bd-413f-4469-8248-e2e75c83921a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_09e51068-7aa5-4844-8a7a-88aed2f94621" xlink:to="loc_us-gaap_StatementTable_d173a0bd-413f-4469-8248-e2e75c83921a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_e6ec63be-c34d-4429-ab54-c4201c4dd2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d173a0bd-413f-4469-8248-e2e75c83921a" xlink:to="loc_us-gaap_RestructuringPlanAxis_e6ec63be-c34d-4429-ab54-c4201c4dd2ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_bb288beb-f301-4466-9e35-22becb10a016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_e6ec63be-c34d-4429-ab54-c4201c4dd2ad" xlink:to="loc_us-gaap_RestructuringPlanDomain_bb288beb-f301-4466-9e35-22becb10a016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneIntegrationMember_1de3554c-5fb5-4553-b5a5-0496775adfd9" xlink:href="bmy-20210630.xsd#bmy_CelgeneIntegrationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_bb288beb-f301-4466-9e35-22becb10a016" xlink:to="loc_bmy_CelgeneIntegrationMember_1de3554c-5fb5-4553-b5a5-0496775adfd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CompanyTransformationMember_ccd3d6d0-367f-411e-aeda-a0e16064b588" xlink:href="bmy-20210630.xsd#bmy_CompanyTransformationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_bb288beb-f301-4466-9e35-22becb10a016" xlink:to="loc_bmy_CompanyTransformationMember_ccd3d6d0-367f-411e-aeda-a0e16064b588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_6926d2d7-9b9e-4e00-bb9d-721328764c28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d173a0bd-413f-4469-8248-e2e75c83921a" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_6926d2d7-9b9e-4e00-bb9d-721328764c28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_5c007907-30e5-4f11-a83a-ecb59caf70eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_6926d2d7-9b9e-4e00-bb9d-721328764c28" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_5c007907-30e5-4f11-a83a-ecb59caf70eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcceleratedStockBasedCompensationMember_6a7e473a-31a1-47a3-bcd0-c6dc62820281" xlink:href="bmy-20210630.xsd#bmy_AcceleratedStockBasedCompensationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_5c007907-30e5-4f11-a83a-ecb59caf70eb" xlink:to="loc_bmy_AcceleratedStockBasedCompensationMember_6a7e473a-31a1-47a3-bcd0-c6dc62820281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5638b829-60c5-47b9-a69a-42d3f7469dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d173a0bd-413f-4469-8248-e2e75c83921a" xlink:to="loc_us-gaap_StatementLineItems_5638b829-60c5-47b9-a69a-42d3f7469dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_7140cb0e-5d93-49f7-bea7-c371b0d2cbe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5638b829-60c5-47b9-a69a-42d3f7469dbd" xlink:to="loc_us-gaap_RestructuringReserve_7140cb0e-5d93-49f7-bea7-c371b0d2cbe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveAccrualAdjustment1_43304ada-a865-44fd-86aa-90da2f73774e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveAccrualAdjustment1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5638b829-60c5-47b9-a69a-42d3f7469dbd" xlink:to="loc_us-gaap_RestructuringReserveAccrualAdjustment1_43304ada-a865-44fd-86aa-90da2f73774e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_8d5cbb85-d862-4c7c-b34d-0970bbb40fd1" xlink:href="bmy-20210630.xsd#bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5638b829-60c5-47b9-a69a-42d3f7469dbd" xlink:to="loc_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation_8d5cbb85-d862-4c7c-b34d-0970bbb40fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_5586770f-2530-474b-a969-b7281afeaab4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5638b829-60c5-47b9-a69a-42d3f7469dbd" xlink:to="loc_us-gaap_RestructuringCharges_5586770f-2530-474b-a969-b7281afeaab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveTranslationAdjustment_f87ac26d-054e-429d-9884-40f6b34fe9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringReserveTranslationAdjustment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5638b829-60c5-47b9-a69a-42d3f7469dbd" xlink:to="loc_us-gaap_RestructuringReserveTranslationAdjustment_f87ac26d-054e-429d-9884-40f6b34fe9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_0b5aee10-d5e1-4658-bafa-a840822886a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5638b829-60c5-47b9-a69a-42d3f7469dbd" xlink:to="loc_us-gaap_PaymentsForRestructuring_0b5aee10-d5e1-4658-bafa-a840822886a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INCOMETAXES" xlink:type="simple" xlink:href="bmy-20210630.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_54798e0f-d211-464b-8995-14f1af529bb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_47b7f2ed-2ae8-47df-acd8-4a8f35116af7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_54798e0f-d211-464b-8995-14f1af529bb5" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_47b7f2ed-2ae8-47df-acd8-4a8f35116af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="bmy-20210630.xsd#INCOMETAXESTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INCOMETAXESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_6dfab3f2-5f37-42a1-82cd-b7a9d6d59df4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock_0af717b9-eeef-42cf-9c8b-d3c5529133d0" xlink:href="bmy-20210630.xsd#bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_6dfab3f2-5f37-42a1-82cd-b7a9d6d59df4" xlink:to="loc_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock_0af717b9-eeef-42cf-9c8b-d3c5529133d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#INCOMETAXESDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_52ae6153-d6aa-46c3-9bcc-7849ebdcf4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_aae05100-1e58-4339-8cfb-f0250aea9ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_52ae6153-d6aa-46c3-9bcc-7849ebdcf4f9" xlink:to="loc_us-gaap_StatementTable_aae05100-1e58-4339-8cfb-f0250aea9ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a1c27900-a75c-4d50-bef8-bcd8532c0141" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_aae05100-1e58-4339-8cfb-f0250aea9ffb" xlink:to="loc_srt_RangeAxis_a1c27900-a75c-4d50-bef8-bcd8532c0141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4cf4601a-8239-4bf6-b6c1-604b4bcf6f97" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a1c27900-a75c-4d50-bef8-bcd8532c0141" xlink:to="loc_srt_RangeMember_4cf4601a-8239-4bf6-b6c1-604b4bcf6f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7d5000ed-63e1-456e-9992-847d5ffbb110" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4cf4601a-8239-4bf6-b6c1-604b4bcf6f97" xlink:to="loc_srt_MinimumMember_7d5000ed-63e1-456e-9992-847d5ffbb110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5b22c705-3a64-485a-8cd8-b7cfff7e9c1b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4cf4601a-8239-4bf6-b6c1-604b4bcf6f97" xlink:to="loc_srt_MaximumMember_5b22c705-3a64-485a-8cd8-b7cfff7e9c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DeferredIncomeTaxExpenseBenefitComponentAxis_9bf69bbb-cd1f-4f99-98a1-177fb3a76249" xlink:href="bmy-20210630.xsd#bmy_DeferredIncomeTaxExpenseBenefitComponentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_aae05100-1e58-4339-8cfb-f0250aea9ffb" xlink:to="loc_bmy_DeferredIncomeTaxExpenseBenefitComponentAxis_9bf69bbb-cd1f-4f99-98a1-177fb3a76249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DeferredIncomeTaxExpenseBenefitComponentDomain_ba28ac5f-6dfe-4963-9a2c-52ec6b911118" xlink:href="bmy-20210630.xsd#bmy_DeferredIncomeTaxExpenseBenefitComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DeferredIncomeTaxExpenseBenefitComponentAxis_9bf69bbb-cd1f-4f99-98a1-177fb3a76249" xlink:to="loc_bmy_DeferredIncomeTaxExpenseBenefitComponentDomain_ba28ac5f-6dfe-4963-9a2c-52ec6b911118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InternalTransferOfProductRightsMember_0ce9b9de-29dc-4b26-ad28-88e049fff5a1" xlink:href="bmy-20210630.xsd#bmy_InternalTransferOfProductRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DeferredIncomeTaxExpenseBenefitComponentDomain_ba28ac5f-6dfe-4963-9a2c-52ec6b911118" xlink:to="loc_bmy_InternalTransferOfProductRightsMember_0ce9b9de-29dc-4b26-ad28-88e049fff5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtezlaDivestitureMember_d00eccb6-75b4-414c-8d5a-d88dffdf1113" xlink:href="bmy-20210630.xsd#bmy_OtezlaDivestitureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_DeferredIncomeTaxExpenseBenefitComponentDomain_ba28ac5f-6dfe-4963-9a2c-52ec6b911118" xlink:to="loc_bmy_OtezlaDivestitureMember_d00eccb6-75b4-414c-8d5a-d88dffdf1113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IncomeTaxExpenseBenefitComponentAxis_d35e4e0f-db46-47db-bf31-dc5bcf6b82a1" xlink:href="bmy-20210630.xsd#bmy_IncomeTaxExpenseBenefitComponentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_aae05100-1e58-4339-8cfb-f0250aea9ffb" xlink:to="loc_bmy_IncomeTaxExpenseBenefitComponentAxis_d35e4e0f-db46-47db-bf31-dc5bcf6b82a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IncomeTaxExpenseBenefitComponentDomain_4604c726-caf6-42e8-b089-a53b3c353279" xlink:href="bmy-20210630.xsd#bmy_IncomeTaxExpenseBenefitComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_IncomeTaxExpenseBenefitComponentAxis_d35e4e0f-db46-47db-bf31-dc5bcf6b82a1" xlink:to="loc_bmy_IncomeTaxExpenseBenefitComponentDomain_4604c726-caf6-42e8-b089-a53b3c353279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_0607c744-16ce-47fe-bde4-1b558a1f19ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_aae05100-1e58-4339-8cfb-f0250aea9ffb" xlink:to="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_0607c744-16ce-47fe-bde4-1b558a1f19ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_9af121b1-449a-4b81-b01f-64e0e3d0954c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_0607c744-16ce-47fe-bde4-1b558a1f19ee" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_9af121b1-449a-4b81-b01f-64e0e3d0954c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_63f994a4-61d0-4a0e-a855-187c57913bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_0607c744-16ce-47fe-bde4-1b558a1f19ee" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_63f994a4-61d0-4a0e-a855-187c57913bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_10ebebc3-2723-42df-b2c0-580683cce317" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_0607c744-16ce-47fe-bde4-1b558a1f19ee" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_10ebebc3-2723-42df-b2c0-580683cce317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_78b73f99-4160-4010-a754-12de7efa386b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_0607c744-16ce-47fe-bde4-1b558a1f19ee" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_78b73f99-4160-4010-a754-12de7efa386b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7123c666-7021-4e49-ba25-5f8d076fa1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems_0607c744-16ce-47fe-bde4-1b558a1f19ee" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_7123c666-7021-4e49-ba25-5f8d076fa1dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EARNINGSLOSSPERSHARE" xlink:type="simple" xlink:href="bmy-20210630.xsd#EARNINGSLOSSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EARNINGSLOSSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_926977ab-cf26-4cc2-bb5c-f7031d4ef287" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_8e50424b-61be-486c-8574-db7c02ac8c83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_926977ab-cf26-4cc2-bb5c-f7031d4ef287" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_8e50424b-61be-486c-8574-db7c02ac8c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EARNINGSLOSSPERSHARETables" xlink:type="simple" xlink:href="bmy-20210630.xsd#EARNINGSLOSSPERSHARETables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EARNINGSLOSSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_37628ff3-3b9b-4846-9498-39f34c8315c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_5da3ff87-b2f0-43c7-8c14-99409bd1a288" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_37628ff3-3b9b-4846-9498-39f34c8315c5" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_5da3ff87-b2f0-43c7-8c14-99409bd1a288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EARNINGSLOSSPERSHAREDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#EARNINGSLOSSPERSHAREDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EARNINGSLOSSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_bb0662d0-e78d-4da8-8dbc-bc2fe84feedf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0ea5584e-01d7-4a5e-bdf1-38ee92270c40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bb0662d0-e78d-4da8-8dbc-bc2fe84feedf" xlink:to="loc_us-gaap_NetIncomeLoss_0ea5584e-01d7-4a5e-bdf1-38ee92270c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ecc3d096-bd83-4306-831d-b203f13b46c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bb0662d0-e78d-4da8-8dbc-bc2fe84feedf" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ecc3d096-bd83-4306-831d-b203f13b46c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_25787982-b000-4182-8550-d2102689e360" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bb0662d0-e78d-4da8-8dbc-bc2fe84feedf" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_25787982-b000-4182-8550-d2102689e360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3c4157f8-6cc1-47b8-be7a-d3c2ee8749ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bb0662d0-e78d-4da8-8dbc-bc2fe84feedf" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3c4157f8-6cc1-47b8-be7a-d3c2ee8749ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_d38ae9ec-029c-4348-9a95-f6eed127c6dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bb0662d0-e78d-4da8-8dbc-bc2fe84feedf" xlink:to="loc_us-gaap_EarningsPerShareBasic_d38ae9ec-029c-4348-9a95-f6eed127c6dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_b4365037-7cae-4949-8637-3f1647618bc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bb0662d0-e78d-4da8-8dbc-bc2fe84feedf" xlink:to="loc_us-gaap_EarningsPerShareDiluted_b4365037-7cae-4949-8637-3f1647618bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_99c2fcad-9ad0-4c9b-9bf2-bd5277fd0ddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bb0662d0-e78d-4da8-8dbc-bc2fe84feedf" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_99c2fcad-9ad0-4c9b-9bf2-bd5277fd0ddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="bmy-20210630.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_eeb80a36-a074-4a84-b75a-b8209c713c9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_f5723c75-9432-4543-a196-9c7ebcc8dcaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_eeb80a36-a074-4a84-b75a-b8209c713c9b" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_f5723c75-9432-4543-a196-9c7ebcc8dcaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="bmy-20210630.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f7df3124-e197-4cb4-83a1-b4c92a5a33e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_2e753696-26e1-4e51-88cc-cd864d918d87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f7df3124-e197-4cb4-83a1-b4c92a5a33e5" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_2e753696-26e1-4e51-88cc-cd864d918d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock_50d7ba8a-dc4b-4a8e-a71c-2f88a6991759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f7df3124-e197-4cb4-83a1-b4c92a5a33e5" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock_50d7ba8a-dc4b-4a8e-a71c-2f88a6991759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_bad95230-3b8d-4508-9f53-8c34bda6aa31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f7df3124-e197-4cb4-83a1-b4c92a5a33e5" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_bad95230-3b8d-4508-9f53-8c34bda6aa31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesTextBlock_526ce413-dc77-475d-babc-ca2a0065ef4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f7df3124-e197-4cb4-83a1-b4c92a5a33e5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesTextBlock_526ce413-dc77-475d-babc-ca2a0065ef4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfEquityInvestmentsTableTextBlock_ce8c2179-ebb0-4967-8dde-af695b719423" xlink:href="bmy-20210630.xsd#bmy_ScheduleOfEquityInvestmentsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f7df3124-e197-4cb4-83a1-b4c92a5a33e5" xlink:to="loc_bmy_ScheduleOfEquityInvestmentsTableTextBlock_ce8c2179-ebb0-4967-8dde-af695b719423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_37972e77-f15b-4de4-a636-e20451d983bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f7df3124-e197-4cb4-83a1-b4c92a5a33e5" xlink:to="loc_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock_37972e77-f15b-4de4-a636-e20451d983bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_aecc3477-7ec8-477d-ade0-a2957e0d5130" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f7df3124-e197-4cb4-83a1-b4c92a5a33e5" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_aecc3477-7ec8-477d-ade0-a2957e0d5130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_3ebbb89f-c738-4845-82e9-44c57960a6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f7df3124-e197-4cb4-83a1-b4c92a5a33e5" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_3ebbb89f-c738-4845-82e9-44c57960a6e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_00b7c40d-0d98-49cf-8035-b0effc1077e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f7df3124-e197-4cb4-83a1-b4c92a5a33e5" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock_00b7c40d-0d98-49cf-8035-b0effc1077e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_ed1dcc6d-7fd6-4a52-8b00-56362936d387" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f7df3124-e197-4cb4-83a1-b4c92a5a33e5" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTextBlock_ed1dcc6d-7fd6-4a52-8b00-56362936d387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_746ce526-6130-437e-a6e2-7bd9456464b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f7df3124-e197-4cb4-83a1-b4c92a5a33e5" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_746ce526-6130-437e-a6e2-7bd9456464b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0420942a-1c48-43dc-a213-61b4dd2c9161" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2484927a-de28-4c04-a9fa-f3d182f42155" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0420942a-1c48-43dc-a213-61b4dd2c9161" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2484927a-de28-4c04-a9fa-f3d182f42155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_dd15bd6e-4705-4b80-bb50-9d3a17229dc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2484927a-de28-4c04-a9fa-f3d182f42155" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_dd15bd6e-4705-4b80-bb50-9d3a17229dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_e1bb9e4b-d552-4f0f-97ae-564e060e7298" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_dd15bd6e-4705-4b80-bb50-9d3a17229dc0" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_e1bb9e4b-d552-4f0f-97ae-564e060e7298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ProbabilityofpaymentMember_7fdb9d9d-7d94-4084-a3d6-b06ee0ad683a" xlink:href="bmy-20210630.xsd#bmy_ProbabilityofpaymentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_e1bb9e4b-d552-4f0f-97ae-564e060e7298" xlink:to="loc_bmy_ProbabilityofpaymentMember_7fdb9d9d-7d94-4084-a3d6-b06ee0ad683a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_5b834208-0d1f-4365-a20d-f80a78001f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_e1bb9e4b-d552-4f0f-97ae-564e060e7298" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_5b834208-0d1f-4365-a20d-f80a78001f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ProjectedYearOfPaymentsMember_296f53a5-289b-468f-8c23-52c57b305eff" xlink:href="bmy-20210630.xsd#bmy_ProjectedYearOfPaymentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_e1bb9e4b-d552-4f0f-97ae-564e060e7298" xlink:to="loc_bmy_ProjectedYearOfPaymentsMember_296f53a5-289b-468f-8c23-52c57b305eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5d838261-7683-4963-8dd6-4d5883357a58" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2484927a-de28-4c04-a9fa-f3d182f42155" xlink:to="loc_srt_RangeAxis_5d838261-7683-4963-8dd6-4d5883357a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d962bc97-8b97-4f98-9edd-19cfa4aab9c2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5d838261-7683-4963-8dd6-4d5883357a58" xlink:to="loc_srt_RangeMember_d962bc97-8b97-4f98-9edd-19cfa4aab9c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_18fb8c3b-19f5-4048-821a-7fe0eb3be037" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d962bc97-8b97-4f98-9edd-19cfa4aab9c2" xlink:to="loc_srt_MaximumMember_18fb8c3b-19f5-4048-821a-7fe0eb3be037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_a5822a50-029c-4c30-882b-d1937c0942d3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d962bc97-8b97-4f98-9edd-19cfa4aab9c2" xlink:to="loc_srt_WeightedAverageMember_a5822a50-029c-4c30-882b-d1937c0942d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0fe9e3ec-1e60-4ef3-b57e-88be572f789b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d962bc97-8b97-4f98-9edd-19cfa4aab9c2" xlink:to="loc_srt_MinimumMember_0fe9e3ec-1e60-4ef3-b57e-88be572f789b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_1a370b1c-2b5b-4a8f-9169-dc4594a937f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2484927a-de28-4c04-a9fa-f3d182f42155" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_1a370b1c-2b5b-4a8f-9169-dc4594a937f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_5ecc9ebc-38dc-4eef-ad5f-6509ef2775aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_1a370b1c-2b5b-4a8f-9169-dc4594a937f1" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_5ecc9ebc-38dc-4eef-ad5f-6509ef2775aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentValueRightsMember_7d1caa93-c7da-4448-872b-0e4e25e11040" xlink:href="bmy-20210630.xsd#bmy_ContingentValueRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_5ecc9ebc-38dc-4eef-ad5f-6509ef2775aa" xlink:to="loc_bmy_ContingentValueRightsMember_7d1caa93-c7da-4448-872b-0e4e25e11040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_1eb644f7-73f3-4282-b36d-3185037636c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2484927a-de28-4c04-a9fa-f3d182f42155" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_1eb644f7-73f3-4282-b36d-3185037636c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_d691d0b3-781a-4560-a8a4-82e9926bf7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1eb644f7-73f3-4282-b36d-3185037636c5" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_d691d0b3-781a-4560-a8a4-82e9926bf7f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_0ba9ad78-a6a6-4025-86ba-631fd0479bec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_d691d0b3-781a-4560-a8a4-82e9926bf7f1" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_0ba9ad78-a6a6-4025-86ba-631fd0479bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_2cbbc808-a868-438e-a097-43579ccebb58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_d691d0b3-781a-4560-a8a4-82e9926bf7f1" xlink:to="loc_us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember_2cbbc808-a868-438e-a097-43579ccebb58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_d38aae89-48a4-4c93-b553-020ffd8d915d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8a62bf61-db0e-44d9-a11e-25686224a8df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2484927a-de28-4c04-a9fa-f3d182f42155" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8a62bf61-db0e-44d9-a11e-25686224a8df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b16432bb-1fbe-46dd-a57c-cbf36db636f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8a62bf61-db0e-44d9-a11e-25686224a8df" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b16432bb-1fbe-46dd-a57c-cbf36db636f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_a40c9462-a0c4-4716-bd3a-7a60b908a3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b16432bb-1fbe-46dd-a57c-cbf36db636f3" xlink:to="loc_us-gaap_OtherAssetsMember_a40c9462-a0c4-4716-bd3a-7a60b908a3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b5a49e00-1f5e-4a37-817f-73869a9a8288" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2484927a-de28-4c04-a9fa-f3d182f42155" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b5a49e00-1f5e-4a37-817f-73869a9a8288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_37c87778-03ea-4057-adfa-55cc535dae3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b5a49e00-1f5e-4a37-817f-73869a9a8288" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_37c87778-03ea-4057-adfa-55cc535dae3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_25e4fd45-f185-479e-837d-b89467acd43f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_37c87778-03ea-4057-adfa-55cc535dae3e" xlink:to="loc_us-gaap_CertificatesOfDepositMember_25e4fd45-f185-479e-837d-b89467acd43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_b463bc7a-51e4-4056-80c6-008db817ca95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_37c87778-03ea-4057-adfa-55cc535dae3e" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_b463bc7a-51e4-4056-80c6-008db817ca95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8c9bada9-674d-4da7-a216-62c26c81f993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2484927a-de28-4c04-a9fa-f3d182f42155" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8c9bada9-674d-4da7-a216-62c26c81f993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b136dfb9-5047-49db-a428-9e95e7f22dac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8c9bada9-674d-4da7-a216-62c26c81f993" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b136dfb9-5047-49db-a428-9e95e7f22dac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_4f9ba9c3-a201-4205-ae6c-35111f0d13e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b136dfb9-5047-49db-a428-9e95e7f22dac" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_4f9ba9c3-a201-4205-ae6c-35111f0d13e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_c91be2ed-792d-4739-8fd6-0c52378832e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b136dfb9-5047-49db-a428-9e95e7f22dac" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_c91be2ed-792d-4739-8fd6-0c52378832e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_5794dbe3-4090-4da0-9de3-d3e3c01686b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b136dfb9-5047-49db-a428-9e95e7f22dac" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_5794dbe3-4090-4da0-9de3-d3e3c01686b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2484927a-de28-4c04-a9fa-f3d182f42155" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_37fecfca-64a0-4df3-96dd-e9ec090724c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_37fecfca-64a0-4df3-96dd-e9ec090724c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_23034921-c424-4a04-82e1-44d401e53117" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_23034921-c424-4a04-82e1-44d401e53117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_527cefc7-4731-4fa5-b7a7-82cedc3defce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_DerivativeAssets_527cefc7-4731-4fa5-b7a7-82cedc3defce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_fc9b5180-c068-4cc3-914e-707e6a49f54b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_fc9b5180-c068-4cc3-914e-707e6a49f54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_9d3171eb-f52d-43bc-89a5-95639bab3030" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_DerivativeLiabilities_9d3171eb-f52d-43bc-89a5-95639bab3030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c2e4e408-c29c-4b30-ab49-90f2237bd9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_c2e4e408-c29c-4b30-ab49-90f2237bd9c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_686f4faa-dc45-4715-81cb-93cf65291086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_686f4faa-dc45-4715-81cb-93cf65291086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange_c9d99b98-bbf1-4220-ac8d-2e2834710e31" xlink:href="bmy-20210630.xsd#bmy_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_bmy_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange_c9d99b98-bbf1-4220-ac8d-2e2834710e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMeasurementInput_672dd2a5-3f2d-464a-b2b1-bce1b54a6657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMeasurementInput"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_DebtInstrumentMeasurementInput_672dd2a5-3f2d-464a-b2b1-bce1b54a6657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_cd402dd7-5705-4919-bef8-1593cf669568" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_cd402dd7-5705-4919-bef8-1593cf669568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4beac689-838a-44f5-bb45-7c8f5a5659e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4beac689-838a-44f5-bb45-7c8f5a5659e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_75467b36-09ec-4913-a516-8ae33ca5731e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_75467b36-09ec-4913-a516-8ae33ca5731e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_25cc29f8-7acf-4393-86a5-7e5cfe7b3c58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_25cc29f8-7acf-4393-86a5-7e5cfe7b3c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_fae32667-99df-44ac-98e2-130b2f8464ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_EquityMethodInvestments_fae32667-99df-44ac-98e2-130b2f8464ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_70cb2aaf-64a9-4f01-b537-ccc1a554b7f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_70cb2aaf-64a9-4f01-b537-ccc1a554b7f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_13f599ee-e262-41cd-9d5d-6b4f060cd10c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount_13f599ee-e262-41cd-9d5d-6b4f060cd10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_71c24b49-a239-4157-b2d5-6bb5b69e2ce5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount_71c24b49-a239-4157-b2d5-6bb5b69e2ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_14201ad3-95b0-4c0a-97be-87a45f4b5220" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_14201ad3-95b0-4c0a-97be-87a45f4b5220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_2763501f-a695-46b1-a551-5059fe4cfd2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_2763501f-a695-46b1-a551-5059fe4cfd2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments_27829177-c768-4cfd-9129-00d10b3f34b6" xlink:href="bmy-20210630.xsd#bmy_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_bmy_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments_27829177-c768-4cfd-9129-00d10b3f34b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_2d3dd820-3607-42b4-a71c-1edff22eb07f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_2d3dd820-3607-42b4-a71c-1edff22eb07f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_423a9418-9eee-4ac4-849a-8d382e1a5086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount_423a9418-9eee-4ac4-849a-8d382e1a5086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_0206def4-244b-44a1-92c4-946422dfd585" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_0206def4-244b-44a1-92c4-946422dfd585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_76fa45cc-704b-42c0-92ec-de83d450ea33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_76fa45cc-704b-42c0-92ec-de83d450ea33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_aebbad68-1011-425d-a37f-541a0ce070ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_aebbad68-1011-425d-a37f-541a0ce070ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_5ad3df61-ffdb-4ced-a42a-96e713bdc71c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_5ad3df61-ffdb-4ced-a42a-96e713bdc71c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_e224a277-43ff-4499-9178-517c76de4cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_063a71ab-5644-4654-8444-4cdf1e4e3be2" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_e224a277-43ff-4499-9178-517c76de4cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentDetailAbstract_5b543bb2-a594-4709-b0b0-4d61858fb1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentDetailAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b6e41960-e667-48d7-bdd9-03f69a1641e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_5b543bb2-a594-4709-b0b0-4d61858fb1c6" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b6e41960-e667-48d7-bdd9-03f69a1641e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_18a93983-8af3-4192-ad27-29cb3d622ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b6e41960-e667-48d7-bdd9-03f69a1641e2" xlink:to="loc_us-gaap_VariableRateAxis_18a93983-8af3-4192-ad27-29cb3d622ed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_7b3df9e3-a14a-4330-a9b6-992b98ad3311" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_18a93983-8af3-4192-ad27-29cb3d622ed3" xlink:to="loc_us-gaap_VariableRateDomain_7b3df9e3-a14a-4330-a9b6-992b98ad3311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_caab5c00-db78-485a-8b9c-a6ea58cfb61c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_7b3df9e3-a14a-4330-a9b6-992b98ad3311" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_caab5c00-db78-485a-8b9c-a6ea58cfb61c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_35b8238a-868f-48a6-96d0-48eaeef61af2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b6e41960-e667-48d7-bdd9-03f69a1641e2" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_35b8238a-868f-48a6-96d0-48eaeef61af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_895c5034-2f1e-45d3-8547-06ba270a5e17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_35b8238a-868f-48a6-96d0-48eaeef61af2" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_895c5034-2f1e-45d3-8547-06ba270a5e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_0362537c-2ff2-4aa8-ade6-2096ceef60da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_895c5034-2f1e-45d3-8547-06ba270a5e17" xlink:to="loc_us-gaap_CostOfSalesMember_0362537c-2ff2-4aa8-ade6-2096ceef60da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_04405914-2864-4d48-b436-ef62f2f75497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_895c5034-2f1e-45d3-8547-06ba270a5e17" xlink:to="loc_us-gaap_OtherIncomeMember_04405914-2864-4d48-b436-ef62f2f75497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_15f9dfe6-0e96-402a-baa5-f7cbcf2147be" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b6e41960-e667-48d7-bdd9-03f69a1641e2" xlink:to="loc_srt_CurrencyAxis_15f9dfe6-0e96-402a-baa5-f7cbcf2147be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_055f5648-5b65-40f4-8941-c15bc0ec9a00" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_15f9dfe6-0e96-402a-baa5-f7cbcf2147be" xlink:to="loc_currency_AllCurrenciesDomain_055f5648-5b65-40f4-8941-c15bc0ec9a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_EUR_a4b552c3-0434-4eb9-9ba9-c747dc77b435" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_055f5648-5b65-40f4-8941-c15bc0ec9a00" xlink:to="loc_currency_EUR_a4b552c3-0434-4eb9-9ba9-c747dc77b435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_JPY_f4e8678f-d2aa-414e-b9ca-e91ec2b4aad5" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_JPY"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_055f5648-5b65-40f4-8941-c15bc0ec9a00" xlink:to="loc_currency_JPY_f4e8678f-d2aa-414e-b9ca-e91ec2b4aad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_5328db88-5ce1-4c0c-83aa-77aba71e739e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b6e41960-e667-48d7-bdd9-03f69a1641e2" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_5328db88-5ce1-4c0c-83aa-77aba71e739e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_56fe93ff-6f97-4e1e-90fa-5582b634f6fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_5328db88-5ce1-4c0c-83aa-77aba71e739e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_56fe93ff-6f97-4e1e-90fa-5582b634f6fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_766f2c75-bfaf-4343-9fa4-79ebb3de19fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_56fe93ff-6f97-4e1e-90fa-5582b634f6fd" xlink:to="loc_us-gaap_InterestRateSwapMember_766f2c75-bfaf-4343-9fa4-79ebb3de19fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_56f6862a-503e-4dd1-bd11-6218e0ec4830" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_56fe93ff-6f97-4e1e-90fa-5582b634f6fd" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_56f6862a-503e-4dd1-bd11-6218e0ec4830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_ef89266f-a30b-4e87-bd35-eb31134e38cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_56fe93ff-6f97-4e1e-90fa-5582b634f6fd" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_ef89266f-a30b-4e87-bd35-eb31134e38cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherContractMember_f5c44d73-90a3-4def-94f7-f5a03449f252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherContractMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_56fe93ff-6f97-4e1e-90fa-5582b634f6fd" xlink:to="loc_us-gaap_OtherContractMember_f5c44d73-90a3-4def-94f7-f5a03449f252" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ZeroCostCollarCurrencyContractsMember_ce891e7e-8445-4eda-a6e1-30d256a192a1" xlink:href="bmy-20210630.xsd#bmy_ZeroCostCollarCurrencyContractsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_56fe93ff-6f97-4e1e-90fa-5582b634f6fd" xlink:to="loc_bmy_ZeroCostCollarCurrencyContractsMember_ce891e7e-8445-4eda-a6e1-30d256a192a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_0e32da7b-c9dc-44a8-b7c5-5588b131ed64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b6e41960-e667-48d7-bdd9-03f69a1641e2" xlink:to="loc_us-gaap_HedgingDesignationAxis_0e32da7b-c9dc-44a8-b7c5-5588b131ed64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5b52bdd6-4fe7-441e-9883-c2ddbe4a5a29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_0e32da7b-c9dc-44a8-b7c5-5588b131ed64" xlink:to="loc_us-gaap_HedgingDesignationDomain_5b52bdd6-4fe7-441e-9883-c2ddbe4a5a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_70246a28-162d-4243-9b60-ebeaf6c10da5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5b52bdd6-4fe7-441e-9883-c2ddbe4a5a29" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_70246a28-162d-4243-9b60-ebeaf6c10da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_f2bcafa4-8945-48bf-8964-4521c9227afe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5b52bdd6-4fe7-441e-9883-c2ddbe4a5a29" xlink:to="loc_us-gaap_NondesignatedMember_f2bcafa4-8945-48bf-8964-4521c9227afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f34b445a-46cf-46a7-a9ea-9ebdcd4dafe3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b6e41960-e667-48d7-bdd9-03f69a1641e2" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f34b445a-46cf-46a7-a9ea-9ebdcd4dafe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_9a24813e-02b0-4fe8-8236-c1656cef46a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f34b445a-46cf-46a7-a9ea-9ebdcd4dafe3" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_9a24813e-02b0-4fe8-8236-c1656cef46a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_4002db88-56ea-420b-b283-054761c9ab1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9a24813e-02b0-4fe8-8236-c1656cef46a1" xlink:to="loc_us-gaap_AssetsMember_4002db88-56ea-420b-b283-054761c9ab1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_d4deb470-ac60-4e3a-8f53-7a2a1341f591" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_9a24813e-02b0-4fe8-8236-c1656cef46a1" xlink:to="loc_us-gaap_LiabilityMember_d4deb470-ac60-4e3a-8f53-7a2a1341f591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_b6e41960-e667-48d7-bdd9-03f69a1641e2" xlink:to="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_f6d7301e-d4d1-46db-b921-dde2e8b93a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:to="loc_us-gaap_DerivativeNotionalAmount_f6d7301e-d4d1-46db-b921-dde2e8b93a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_c7d4443f-18ea-4a8a-9e21-f15d5bb1e1de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_c7d4443f-18ea-4a8a-9e21-f15d5bb1e1de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_b8cd7e8e-8d4c-4ff4-b87b-8e10e0628d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_b8cd7e8e-8d4c-4ff4-b87b-8e10e0628d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_397b8bb5-b20e-4c08-b406-fcf5a24b6fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_397b8bb5-b20e-4c08-b406-fcf5a24b6fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_d96d25cd-3dff-4a59-95de-165df243489c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:to="loc_us-gaap_DerivativeAssets_d96d25cd-3dff-4a59-95de-165df243489c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_6c0e8c20-7ecd-46de-af37-7636aee2ce95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:to="loc_us-gaap_DerivativeLiabilities_6c0e8c20-7ecd-46de-af37-7636aee2ce95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_71d11dbe-f806-4786-aed8-e927bded1d46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_71d11dbe-f806-4786-aed8-e927bded1d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_fcb27355-3e85-4eaa-93bc-779eb95e28c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_fcb27355-3e85-4eaa-93bc-779eb95e28c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_5f7e1696-b441-45c8-abbc-fba0754e094b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_5f7e1696-b441-45c8-abbc-fba0754e094b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_953ce049-d53f-4205-b7d1-ece1a8de9b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_953ce049-d53f-4205-b7d1-ece1a8de9b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_f2d3f646-849e-493b-99dd-533d3d9e2675" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_75b9c217-4ca7-4de6-ade4-1f5dbb638719" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_f2d3f646-849e-493b-99dd-533d3d9e2675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_04119e97-569a-43e3-92a0-426c3eb21e7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c4405455-d6e6-41f9-a5d2-7f75e7c58059" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_04119e97-569a-43e3-92a0-426c3eb21e7f" xlink:to="loc_us-gaap_DebtInstrumentTable_c4405455-d6e6-41f9-a5d2-7f75e7c58059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_d1adb8a4-3140-440c-9c5b-739608a5c873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c4405455-d6e6-41f9-a5d2-7f75e7c58059" xlink:to="loc_us-gaap_CreditFacilityAxis_d1adb8a4-3140-440c-9c5b-739608a5c873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7e513b09-778d-44e8-ae7a-7b762ead6814" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_d1adb8a4-3140-440c-9c5b-739608a5c873" xlink:to="loc_us-gaap_CreditFacilityDomain_7e513b09-778d-44e8-ae7a-7b762ead6814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2BillionMaximumBorrowingCapacityMember_6a9b19e4-d7ed-4b17-8765-a965b41bfc70" xlink:href="bmy-20210630.xsd#bmy_A2BillionMaximumBorrowingCapacityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_7e513b09-778d-44e8-ae7a-7b762ead6814" xlink:to="loc_bmy_A2BillionMaximumBorrowingCapacityMember_6a9b19e4-d7ed-4b17-8765-a965b41bfc70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1BillionMaximumBorrowingCapacityMember_3a6a06c8-a337-4045-84a1-6ac95c363a44" xlink:href="bmy-20210630.xsd#bmy_A1BillionMaximumBorrowingCapacityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_7e513b09-778d-44e8-ae7a-7b762ead6814" xlink:to="loc_bmy_A1BillionMaximumBorrowingCapacityMember_3a6a06c8-a337-4045-84a1-6ac95c363a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A1.5BillionMaximumBorrowingCapacityMember_e2d5003a-c181-4027-835a-240b4fce16cc" xlink:href="bmy-20210630.xsd#bmy_A1.5BillionMaximumBorrowingCapacityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_7e513b09-778d-44e8-ae7a-7b762ead6814" xlink:to="loc_bmy_A1.5BillionMaximumBorrowingCapacityMember_e2d5003a-c181-4027-835a-240b4fce16cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8705339b-4294-43b0-950c-b2bbe34e60af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c4405455-d6e6-41f9-a5d2-7f75e7c58059" xlink:to="loc_us-gaap_DebtInstrumentAxis_8705339b-4294-43b0-950c-b2bbe34e60af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_be7ef9e6-e84a-4244-9544-8f40f09c8c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8705339b-4294-43b0-950c-b2bbe34e60af" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_be7ef9e6-e84a-4244-9544-8f40f09c8c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2.875SeniorNotesdue2021Member_bd6e93b9-a813-4260-83ad-b67f92a9d129" xlink:href="bmy-20210630.xsd#bmy_A2.875SeniorNotesdue2021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_be7ef9e6-e84a-4244-9544-8f40f09c8c7d" xlink:to="loc_bmy_A2.875SeniorNotesdue2021Member_bd6e93b9-a813-4260-83ad-b67f92a9d129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_A2550SeniorNotesDue2021Member_e41654c1-f1b4-4d92-bc4b-af90e86939b5" xlink:href="bmy-20210630.xsd#bmy_A2550SeniorNotesDue2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_be7ef9e6-e84a-4244-9544-8f40f09c8c7d" xlink:to="loc_bmy_A2550SeniorNotesDue2021Member_e41654c1-f1b4-4d92-bc4b-af90e86939b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_e2a1d8af-183c-48b6-8f2f-2093276f37c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c4405455-d6e6-41f9-a5d2-7f75e7c58059" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_e2a1d8af-183c-48b6-8f2f-2093276f37c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_32602a1f-014a-4019-8ff4-88dd460c82a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_e2a1d8af-183c-48b6-8f2f-2093276f37c5" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_32602a1f-014a-4019-8ff4-88dd460c82a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_24b96f1b-328b-424f-be6a-ed74d792e92f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_32602a1f-014a-4019-8ff4-88dd460c82a5" xlink:to="loc_us-gaap_InterestRateSwapMember_24b96f1b-328b-424f-be6a-ed74d792e92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_3b385ac6-5a71-4904-99de-9a21b9d2d22e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c4405455-d6e6-41f9-a5d2-7f75e7c58059" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_3b385ac6-5a71-4904-99de-9a21b9d2d22e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_284c14fa-a79f-44a8-8206-9ca22ebfdb46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_3b385ac6-5a71-4904-99de-9a21b9d2d22e" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_284c14fa-a79f-44a8-8206-9ca22ebfdb46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c4405455-d6e6-41f9-a5d2-7f75e7c58059" xlink:to="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBankLoansAndNotesPayable_219ed3c0-a627-4d94-95b5-f1ab1088c85a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBankLoansAndNotesPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_ShortTermBankLoansAndNotesPayable_219ed3c0-a627-4d94-95b5-f1ab1088c85a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_a44de414-0e10-49c5-8904-0ee6b5c6cbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_LongTermDebtCurrent_a44de414-0e10-49c5-8904-0ee6b5c6cbe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherShortTermBorrowings_ee157358-487c-4245-acc5-53d9fcb34314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherShortTermBorrowings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_OtherShortTermBorrowings_ee157358-487c-4245-acc5-53d9fcb34314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_f96c8976-73c1-4783-9999-d1d6e05e96ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_ShortTermBorrowings_f96c8976-73c1-4783-9999-d1d6e05e96ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_1098d47d-2cd6-4595-ae10-baa5b43c829e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_1098d47d-2cd6-4595-ae10-baa5b43c829e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_e85c6471-e54d-45f9-915a-7854171bc998" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_DerivativeLiabilities_e85c6471-e54d-45f9-915a-7854171bc998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_6f2b1f9a-38bb-4774-8505-b481be5b542b" xlink:href="bmy-20210630.xsd#bmy_UnamortizedBasisAdjustmentFromSwapTerminations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_bmy_UnamortizedBasisAdjustmentFromSwapTerminations_6f2b1f9a-38bb-4774-8505-b481be5b542b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_64b6be6b-eb6f-4498-8440-b3009bdf6adc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_64b6be6b-eb6f-4498-8440-b3009bdf6adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedPremium_58abc8a4-6f78-44aa-b471-5fe742458e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedPremium"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedPremium_58abc8a4-6f78-44aa-b471-5fe742458e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b91030a2-2622-4cc6-bc75-d371d7a48c09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_LongTermDebt_b91030a2-2622-4cc6-bc75-d371d7a48c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_d5e31930-e425-42e6-8abf-eb86079bdac6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_d5e31930-e425-42e6-8abf-eb86079bdac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_5cd6d4f0-a360-417c-a754-8e4218769781" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_DebtInstrumentFairValue_5cd6d4f0-a360-417c-a754-8e4218769781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_f5653e63-2260-4f13-a0f3-b4d5ae18f271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_InterestPaidNet_f5653e63-2260-4f13-a0f3-b4d5ae18f271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6b34a4ae-d5ca-4d69-96de-e6bb87a3ad9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_6b34a4ae-d5ca-4d69-96de-e6bb87a3ad9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NumberofRevolvingCreditFacilities_bb3dde92-be3d-446b-aac4-a81bc8dd3680" xlink:href="bmy-20210630.xsd#bmy_NumberofRevolvingCreditFacilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_bmy_NumberofRevolvingCreditFacilities_bb3dde92-be3d-446b-aac4-a81bc8dd3680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_1582861c-781c-4115-af6e-80b43828c044" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_1582861c-781c-4115-af6e-80b43828c044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestments_9e1e3345-0098-477b-a3ec-4fd7ac7320a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrealizedGainLossOnInvestments"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestments_9e1e3345-0098-477b-a3ec-4fd7ac7320a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9c739472-b23a-49b6-8546-4e7ccf4c61d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9c739472-b23a-49b6-8546-4e7ccf4c61d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_a325399c-212a-45d0-abf7-8207dc338448" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9f4f8e55-c2f7-433a-a920-e6a1eeec9315" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_a325399c-212a-45d0-abf7-8207dc338448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RECEIVABLES" xlink:type="simple" xlink:href="bmy-20210630.xsd#RECEIVABLES"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RECEIVABLES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_b5e6f673-96a4-49bd-b64d-bcc050b8b287" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_47e232e3-c7c7-4995-a650-41cfde5c4648" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_b5e6f673-96a4-49bd-b64d-bcc050b8b287" xlink:to="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_47e232e3-c7c7-4995-a650-41cfde5c4648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RECEIVABLESTables" xlink:type="simple" xlink:href="bmy-20210630.xsd#RECEIVABLESTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RECEIVABLESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_d6cb7f1c-0987-4706-8881-b0c6a3b4dac2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_52b4624a-2a89-4fb8-947d-5e5e2163b059" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_d6cb7f1c-0987-4706-8881-b0c6a3b4dac2" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_52b4624a-2a89-4fb8-947d-5e5e2163b059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/RECEIVABLESDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#RECEIVABLESDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/RECEIVABLESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetAbstract_896856e6-ee0f-40c1-9aee-7572dbbeeb45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_46441abc-137a-43d5-a9dd-24b63ff46ea0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetAbstract_896856e6-ee0f-40c1-9aee-7572dbbeeb45" xlink:to="loc_us-gaap_ConcentrationRiskTable_46441abc-137a-43d5-a9dd-24b63ff46ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_f87eb67e-efee-43a8-99b9-3ac829644632" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_46441abc-137a-43d5-a9dd-24b63ff46ea0" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_f87eb67e-efee-43a8-99b9-3ac829644632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_539036a4-e24c-4193-b833-e9a250d7b84f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_f87eb67e-efee-43a8-99b9-3ac829644632" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_539036a4-e24c-4193-b833-e9a250d7b84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_78d080a2-0e95-4ef1-89b9-e69ebde7c687" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_539036a4-e24c-4193-b833-e9a250d7b84f" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_78d080a2-0e95-4ef1-89b9-e69ebde7c687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_da6e721e-504e-475e-8c19-e81c5051c9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_46441abc-137a-43d5-a9dd-24b63ff46ea0" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_da6e721e-504e-475e-8c19-e81c5051c9f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_ce916c0e-9d44-4769-98c7-d38f9ab23959" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_da6e721e-504e-475e-8c19-e81c5051c9f1" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_ce916c0e-9d44-4769-98c7-d38f9ab23959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CashDiscounts_03629f62-6af5-405d-b0ad-9c75875f8e53" xlink:href="bmy-20210630.xsd#bmy_CashDiscounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_da6e721e-504e-475e-8c19-e81c5051c9f1" xlink:to="loc_bmy_CashDiscounts_03629f62-6af5-405d-b0ad-9c75875f8e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_caa1f642-0c54-49a1-b911-48eb0f7e94db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_da6e721e-504e-475e-8c19-e81c5051c9f1" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_caa1f642-0c54-49a1-b911-48eb0f7e94db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_21befb12-34f2-49dc-b4f3-e2b09c1ffdc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_da6e721e-504e-475e-8c19-e81c5051c9f1" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_21befb12-34f2-49dc-b4f3-e2b09c1ffdc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivables_b0fcd7c5-d560-4518-acda-b42e50b34f02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivables"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_da6e721e-504e-475e-8c19-e81c5051c9f1" xlink:to="loc_us-gaap_OtherReceivables_b0fcd7c5-d560-4518-acda-b42e50b34f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_8cb4a362-4afc-4135-8a3e-8045f2f2423a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_da6e721e-504e-475e-8c19-e81c5051c9f1" xlink:to="loc_us-gaap_ReceivablesNetCurrent_8cb4a362-4afc-4135-8a3e-8045f2f2423a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReceivablesSoldOnNonrecourseBasis_2250a3d1-a942-4430-b25a-39f72fca47bf" xlink:href="bmy-20210630.xsd#bmy_ReceivablesSoldOnNonrecourseBasis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_da6e721e-504e-475e-8c19-e81c5051c9f1" xlink:to="loc_bmy_ReceivablesSoldOnNonrecourseBasis_2250a3d1-a942-4430-b25a-39f72fca47bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_NumberOfLargestPharmaceuticalWholesalers_88fde708-1800-48c3-8ac3-2df9ed9ddd10" xlink:href="bmy-20210630.xsd#bmy_NumberOfLargestPharmaceuticalWholesalers"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_da6e721e-504e-475e-8c19-e81c5051c9f1" xlink:to="loc_bmy_NumberOfLargestPharmaceuticalWholesalers_88fde708-1800-48c3-8ac3-2df9ed9ddd10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PercentageOfAggregateTotalTradeReceivablesDue_5c359d38-5ca8-4b19-ba1e-f2890def0ca9" xlink:href="bmy-20210630.xsd#bmy_PercentageOfAggregateTotalTradeReceivablesDue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_da6e721e-504e-475e-8c19-e81c5051c9f1" xlink:to="loc_bmy_PercentageOfAggregateTotalTradeReceivablesDue_5c359d38-5ca8-4b19-ba1e-f2890def0ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INVENTORIES" xlink:type="simple" xlink:href="bmy-20210630.xsd#INVENTORIES"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INVENTORIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_b002d867-2478-4729-8520-43afc0eabfb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_6546741a-a029-4d87-9d0d-335984cd62bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_b002d867-2478-4729-8520-43afc0eabfb8" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_6546741a-a029-4d87-9d0d-335984cd62bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INVENTORIESTables" xlink:type="simple" xlink:href="bmy-20210630.xsd#INVENTORIESTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INVENTORIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_7c7cd501-e100-4ee0-874a-c775fddef115" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_1da7e756-3b15-465b-afae-fdcc3c61d628" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_7c7cd501-e100-4ee0-874a-c775fddef115" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_1da7e756-3b15-465b-afae-fdcc3c61d628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/INVENTORIESDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#INVENTORIESDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/INVENTORIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_c6fa8056-331b-43bc-9f25-13a4ce70f5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_07f74f42-655e-4826-acdb-e137c1e77c53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_c6fa8056-331b-43bc-9f25-13a4ce70f5b4" xlink:to="loc_us-gaap_StatementTable_07f74f42-655e-4826-acdb-e137c1e77c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_94dd00f0-2a8b-437e-b2ad-9b87403531e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_07f74f42-655e-4826-acdb-e137c1e77c53" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_94dd00f0-2a8b-437e-b2ad-9b87403531e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9c3af2d9-dd9e-446f-9a2b-f63fdb55a9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_94dd00f0-2a8b-437e-b2ad-9b87403531e9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9c3af2d9-dd9e-446f-9a2b-f63fdb55a9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InventorypurchasepricefairvalueadjustmentMember_9216d63e-8c4e-4c04-a0f0-d7df3a9f0d94" xlink:href="bmy-20210630.xsd#bmy_InventorypurchasepricefairvalueadjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9c3af2d9-dd9e-446f-9a2b-f63fdb55a9e1" xlink:to="loc_bmy_InventorypurchasepricefairvalueadjustmentMember_9216d63e-8c4e-4c04-a0f0-d7df3a9f0d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_bba80b33-345b-4f19-be10-22242c2b4183" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_07f74f42-655e-4826-acdb-e137c1e77c53" xlink:to="loc_us-gaap_StatementLineItems_bba80b33-345b-4f19-be10-22242c2b4183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_c1ef2fd5-9be5-4976-b750-b5f6701aa5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bba80b33-345b-4f19-be10-22242c2b4183" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_c1ef2fd5-9be5-4976-b750-b5f6701aa5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_72a78b97-3536-44c9-950e-88d53ba580f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bba80b33-345b-4f19-be10-22242c2b4183" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_72a78b97-3536-44c9-950e-88d53ba580f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_de2c125b-8c96-4965-ab1a-186968d887b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bba80b33-345b-4f19-be10-22242c2b4183" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_de2c125b-8c96-4965-ab1a-186968d887b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_Totalinventories_42607718-9b40-4816-a2e0-28072ecf335a" xlink:href="bmy-20210630.xsd#bmy_Totalinventories"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bba80b33-345b-4f19-be10-22242c2b4183" xlink:to="loc_bmy_Totalinventories_42607718-9b40-4816-a2e0-28072ecf335a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_37aef707-0010-4be2-9281-4de97e725a16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bba80b33-345b-4f19-be10-22242c2b4183" xlink:to="loc_us-gaap_InventoryNet_37aef707-0010-4be2-9281-4de97e725a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_75e537d0-605a-4edf-9f05-956681438329" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bba80b33-345b-4f19-be10-22242c2b4183" xlink:to="loc_us-gaap_InventoryNoncurrent_75e537d0-605a-4edf-9f05-956681438329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_f451ddda-d1cb-4384-a87e-a7295f2de951" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_bba80b33-345b-4f19-be10-22242c2b4183" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_f451ddda-d1cb-4384-a87e-a7295f2de951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT" xlink:type="simple" xlink:href="bmy-20210630.xsd#PROPERTYPLANTANDEQUIPMENT"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_7c12a632-068f-43b8-96bf-cc251fe1eb45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_d1daf043-8a42-4f5f-9af3-965b12dfbb5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_7c12a632-068f-43b8-96bf-cc251fe1eb45" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_d1daf043-8a42-4f5f-9af3-965b12dfbb5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables" xlink:type="simple" xlink:href="bmy-20210630.xsd#PROPERTYPLANTANDEQUIPMENTTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_d0a40d9a-19e9-44c4-917c-ad0a0af5ceec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_c0d9152f-1fce-47fe-a8f9-7aaf78bba3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_d0a40d9a-19e9-44c4-917c-ad0a0af5ceec" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_c0d9152f-1fce-47fe-a8f9-7aaf78bba3aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#PROPERTYPLANTANDEQUIPMENTDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c744f1cf-3318-4ba7-9bac-21341fb2cc49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_7efd4818-b649-4c83-b189-f1e4814d3f74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Land"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c744f1cf-3318-4ba7-9bac-21341fb2cc49" xlink:to="loc_us-gaap_Land_7efd4818-b649-4c83-b189-f1e4814d3f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_8bde574b-e332-4b88-8a18-30ddd5048ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c744f1cf-3318-4ba7-9bac-21341fb2cc49" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_8bde574b-e332-4b88-8a18-30ddd5048ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_a0524237-4dfd-4b05-9862-d6dac91401d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c744f1cf-3318-4ba7-9bac-21341fb2cc49" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_a0524237-4dfd-4b05-9862-d6dac91401d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_fee192f7-4c15-4ec2-978a-896310806c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c744f1cf-3318-4ba7-9bac-21341fb2cc49" xlink:to="loc_us-gaap_ConstructionInProgressGross_fee192f7-4c15-4ec2-978a-896310806c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_9145405e-7f1e-4ea6-afc7-61c689b1d0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c744f1cf-3318-4ba7-9bac-21341fb2cc49" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_9145405e-7f1e-4ea6-afc7-61c689b1d0c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_166b9824-caa7-411d-8426-4a50858ed979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c744f1cf-3318-4ba7-9bac-21341fb2cc49" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_166b9824-caa7-411d-8426-4a50858ed979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0db41243-2a4c-410a-9fcf-d91418a8cbe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c744f1cf-3318-4ba7-9bac-21341fb2cc49" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0db41243-2a4c-410a-9fcf-d91418a8cbe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_94410d4b-b551-4815-b2bd-f50c9230fa17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c744f1cf-3318-4ba7-9bac-21341fb2cc49" xlink:to="loc_us-gaap_Depreciation_94410d4b-b551-4815-b2bd-f50c9230fa17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="simple" xlink:href="bmy-20210630.xsd#GOODWILLANDOTHERINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8516ec9f-0762-4b27-a401-affb11ff5496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_7ed0e3dd-b59f-47d5-b000-2d50dfb9582d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8516ec9f-0762-4b27-a401-affb11ff5496" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_7ed0e3dd-b59f-47d5-b000-2d50dfb9582d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="bmy-20210630.xsd#GOODWILLANDOTHERINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_727c0f14-42d0-4b8e-b07e-621ae53f91c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_756b2273-1163-4006-bf82-a7a6a0ed304e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_727c0f14-42d0-4b8e-b07e-621ae53f91c5" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_756b2273-1163-4006-bf82-a7a6a0ed304e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_75379437-72dc-40bf-a4cb-f83f09901474" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b44500d0-82bd-482c-836e-287beda871aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_75379437-72dc-40bf-a4cb-f83f09901474" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b44500d0-82bd-482c-836e-287beda871aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4ad5bd6e-8f4e-46cb-b4f4-b86dd38df3c5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b44500d0-82bd-482c-836e-287beda871aa" xlink:to="loc_srt_RangeAxis_4ad5bd6e-8f4e-46cb-b4f4-b86dd38df3c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b6618ae0-ef28-4162-aca8-c71ecc32cf7d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4ad5bd6e-8f4e-46cb-b4f4-b86dd38df3c5" xlink:to="loc_srt_RangeMember_b6618ae0-ef28-4162-aca8-c71ecc32cf7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2f26c708-aa12-473a-bbad-cbdd23f770c2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b6618ae0-ef28-4162-aca8-c71ecc32cf7d" xlink:to="loc_srt_MinimumMember_2f26c708-aa12-473a-bbad-cbdd23f770c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d2883f8d-1f81-4f77-89ad-3e171fe5e9dc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b6618ae0-ef28-4162-aca8-c71ecc32cf7d" xlink:to="loc_srt_MaximumMember_d2883f8d-1f81-4f77-89ad-3e171fe5e9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3e3e4726-a673-4db6-b193-6f466dc49ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b44500d0-82bd-482c-836e-287beda871aa" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3e3e4726-a673-4db6-b193-6f466dc49ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0f1087d6-5edf-42b3-8f20-6475251ae08d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3e3e4726-a673-4db6-b193-6f466dc49ca7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0f1087d6-5edf-42b3-8f20-6475251ae08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_3170b7da-02de-4bd0-9767-7611744316ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_0f1087d6-5edf-42b3-8f20-6475251ae08d" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_3170b7da-02de-4bd0-9767-7611744316ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_09793fca-5948-4c7e-b8c3-0f50a301ed4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b44500d0-82bd-482c-836e-287beda871aa" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_09793fca-5948-4c7e-b8c3-0f50a301ed4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_44e36cf0-fb36-4ef5-9d16-6fb45cae14d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_09793fca-5948-4c7e-b8c3-0f50a301ed4a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_44e36cf0-fb36-4ef5-9d16-6fb45cae14d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_3e053187-5de4-4174-995d-2a788b2e1b07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_44e36cf0-fb36-4ef5-9d16-6fb45cae14d0" xlink:to="loc_us-gaap_LicensingAgreementsMember_3e053187-5de4-4174-995d-2a788b2e1b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_92c8e857-01c9-454a-98be-87894f1755ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_44e36cf0-fb36-4ef5-9d16-6fb45cae14d0" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_92c8e857-01c9-454a-98be-87894f1755ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_f4e7b25a-e245-4e41-acc2-cd433c32c1be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerSoftwareIntangibleAssetMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_44e36cf0-fb36-4ef5-9d16-6fb45cae14d0" xlink:to="loc_us-gaap_ComputerSoftwareIntangibleAssetMember_f4e7b25a-e245-4e41-acc2-cd433c32c1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f616bf6c-ea24-427b-b476-9a88bd215774" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b44500d0-82bd-482c-836e-287beda871aa" xlink:to="loc_srt_ProductOrServiceAxis_f616bf6c-ea24-427b-b476-9a88bd215774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4db5758a-83e3-46f9-948e-95500154abc4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f616bf6c-ea24-427b-b476-9a88bd215774" xlink:to="loc_srt_ProductsAndServicesDomain_4db5758a-83e3-46f9-948e-95500154abc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ReblozylMember_aff2c1b9-0498-45e8-999a-c7a23fedaa1b" xlink:href="bmy-20210630.xsd#bmy_ReblozylMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4db5758a-83e3-46f9-948e-95500154abc4" xlink:to="loc_bmy_ReblozylMember_aff2c1b9-0498-45e8-999a-c7a23fedaa1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ZeposiaMember_c81585d0-cde8-49ca-beb8-b9cd5711f1a8" xlink:href="bmy-20210630.xsd#bmy_ZeposiaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4db5758a-83e3-46f9-948e-95500154abc4" xlink:to="loc_bmy_ZeposiaMember_c81585d0-cde8-49ca-beb8-b9cd5711f1a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IntangibleAssetNameAxis_617f133a-5ef5-40b2-a0ce-cf2716ad8a38" xlink:href="bmy-20210630.xsd#bmy_IntangibleAssetNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b44500d0-82bd-482c-836e-287beda871aa" xlink:to="loc_bmy_IntangibleAssetNameAxis_617f133a-5ef5-40b2-a0ce-cf2716ad8a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_IntangibleAssetNameDomain_fb692c0a-450a-4c03-b572-f758fb2e2aee" xlink:href="bmy-20210630.xsd#bmy_IntangibleAssetNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_IntangibleAssetNameAxis_617f133a-5ef5-40b2-a0ce-cf2716ad8a38" xlink:to="loc_bmy_IntangibleAssetNameDomain_fb692c0a-450a-4c03-b572-f758fb2e2aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_InrebicMember_ff7e7cc4-0688-4cb0-9df6-b5d14789d75e" xlink:href="bmy-20210630.xsd#bmy_InrebicMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_IntangibleAssetNameDomain_fb692c0a-450a-4c03-b572-f758fb2e2aee" xlink:to="loc_bmy_InrebicMember_ff7e7cc4-0688-4cb0-9df6-b5d14789d75e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_4ff7013b-52a5-409d-8870-f9bf93a4e6d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_IntangibleAssetNameDomain_fb692c0a-450a-4c03-b572-f758fb2e2aee" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_4ff7013b-52a5-409d-8870-f9bf93a4e6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b44500d0-82bd-482c-836e-287beda871aa" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_97e0f482-7e53-41c4-b1ec-f4ee22769b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:to="loc_us-gaap_Goodwill_97e0f482-7e53-41c4-b1ec-f4ee22769b8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2629c2ba-93a0-45c0-a247-791ad446b25f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2629c2ba-93a0-45c0-a247-791ad446b25f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_30d2f52f-fe2b-47ba-86d7-25f30cb7e8c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_30d2f52f-fe2b-47ba-86d7-25f30cb7e8c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_ccf27f35-7d20-4f55-a1f1-4904f87f224e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_ccf27f35-7d20-4f55-a1f1-4904f87f224e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_467937b4-d251-4929-a14b-d022694506a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_467937b4-d251-4929-a14b-d022694506a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a1a2620d-e5d3-4bd8-90c0-518057fdeaae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a1a2620d-e5d3-4bd8-90c0-518057fdeaae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_bc07ccfb-a96a-45c6-8fb5-7fd2cabc8043" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_bc07ccfb-a96a-45c6-8fb5-7fd2cabc8043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3a51838a-6919-4117-992d-ef5b3e9c85e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_3a51838a-6919-4117-992d-ef5b3e9c85e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AcquiredDevelopedProductRightsReclassedFromIPRD_52d93c28-bb75-402e-ba6f-317ce0cfe849" xlink:href="bmy-20210630.xsd#bmy_AcquiredDevelopedProductRightsReclassedFromIPRD"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:to="loc_bmy_AcquiredDevelopedProductRightsReclassedFromIPRD_52d93c28-bb75-402e-ba6f-317ce0cfe849" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_d5e2c189-efc5-4cc0-9dc8-e93594c55944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_d5e2c189-efc5-4cc0-9dc8-e93594c55944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_6f614207-323e-401b-92e3-d9f8f6780134" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease_6f614207-323e-401b-92e3-d9f8f6780134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentAndRegulatoryMilestoneNonCash_16b1a21d-d09c-4853-8f10-1070e29265ac" xlink:href="bmy-20210630.xsd#bmy_ContingentAndRegulatoryMilestoneNonCash"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_11d709a6-0416-4dd0-b8ca-710e951880a7" xlink:to="loc_bmy_ContingentAndRegulatoryMilestoneNonCash_16b1a21d-d09c-4853-8f10-1070e29265ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATION" xlink:type="simple" xlink:href="bmy-20210630.xsd#SUPPLEMENTALFINANCIALINFORMATION"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SupplementalFinancialInformationAbstract_bd6eb4f5-40ff-4e87-b913-586da12c67d4" xlink:href="bmy-20210630.xsd#bmy_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_f890479f-f537-4721-8bfd-b93559f2574d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_bd6eb4f5-40ff-4e87-b913-586da12c67d4" xlink:to="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_f890479f-f537-4721-8bfd-b93559f2574d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SupplementalFinancialInformationTables" xlink:type="simple" xlink:href="bmy-20210630.xsd#SupplementalFinancialInformationTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/SupplementalFinancialInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SupplementalFinancialInformationAbstract_f4626154-adf4-4bba-8342-35a96e68c946" xlink:href="bmy-20210630.xsd#bmy_SupplementalFinancialInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_874179d5-ce0c-4d80-9367-0758d8ebd379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_f4626154-adf4-4bba-8342-35a96e68c946" xlink:to="loc_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock_874179d5-ce0c-4d80-9367-0758d8ebd379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_8ac89c4d-57fa-4d8c-868d-85f5ac519ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_f4626154-adf4-4bba-8342-35a96e68c946" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_8ac89c4d-57fa-4d8c-868d-85f5ac519ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_54472eb0-8924-4c82-bd94-eafff6b87cad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_f4626154-adf4-4bba-8342-35a96e68c946" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_54472eb0-8924-4c82-bd94-eafff6b87cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_591b6dd2-0508-4536-9501-08fe58c037a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SupplementalFinancialInformationAbstract_f4626154-adf4-4bba-8342-35a96e68c946" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_591b6dd2-0508-4536-9501-08fe58c037a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherCurrentAssetsAbstract_f2e0959b-ed82-4b8d-a1ed-0e36b6b22eed" xlink:href="bmy-20210630.xsd#bmy_OtherCurrentAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidTaxes_33cef50c-bafb-4a7a-bffa-19ebdbb51c52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidTaxes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_OtherCurrentAssetsAbstract_f2e0959b-ed82-4b8d-a1ed-0e36b6b22eed" xlink:to="loc_us-gaap_PrepaidTaxes_33cef50c-bafb-4a7a-bffa-19ebdbb51c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ResearchandDevelopment_6f40d5ee-ab34-4f11-8471-df160a95d5bc" xlink:href="bmy-20210630.xsd#bmy_ResearchandDevelopment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_OtherCurrentAssetsAbstract_f2e0959b-ed82-4b8d-a1ed-0e36b6b22eed" xlink:to="loc_bmy_ResearchandDevelopment_6f40d5ee-ab34-4f11-8471-df160a95d5bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestmentsCurrent_86e36b84-4f9f-46cf-90b5-7de8f200169e" xlink:href="bmy-20210630.xsd#bmy_EquityInvestmentsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_OtherCurrentAssetsAbstract_f2e0959b-ed82-4b8d-a1ed-0e36b6b22eed" xlink:to="loc_bmy_EquityInvestmentsCurrent_86e36b84-4f9f-46cf-90b5-7de8f200169e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPrepaidExpenseCurrent_3c901616-0046-4c6c-9fe8-67d8faf4803d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherPrepaidExpenseCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_OtherCurrentAssetsAbstract_f2e0959b-ed82-4b8d-a1ed-0e36b6b22eed" xlink:to="loc_us-gaap_OtherPrepaidExpenseCurrent_3c901616-0046-4c6c-9fe8-67d8faf4803d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_18c0c4e9-cdd0-4d2a-bd3a-68b5010cd59c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_OtherCurrentAssetsAbstract_f2e0959b-ed82-4b8d-a1ed-0e36b6b22eed" xlink:to="loc_us-gaap_OtherAssetsCurrent_18c0c4e9-cdd0-4d2a-bd3a-68b5010cd59c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9f47e869-7e67-401f-be47-228b520ea34f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_OtherCurrentAssetsAbstract_f2e0959b-ed82-4b8d-a1ed-0e36b6b22eed" xlink:to="loc_us-gaap_StatementTable_9f47e869-7e67-401f-be47-228b520ea34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f8983e5d-7011-44be-9ab5-2cbf5f5e3f48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9f47e869-7e67-401f-be47-228b520ea34f" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f8983e5d-7011-44be-9ab5-2cbf5f5e3f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_1a213096-e8ca-49c3-930f-5810d214eccd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f8983e5d-7011-44be-9ab5-2cbf5f5e3f48" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_1a213096-e8ca-49c3-930f-5810d214eccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_a863b4ba-36af-4095-a7a3-08475cb45ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_1a213096-e8ca-49c3-930f-5810d214eccd" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_a863b4ba-36af-4095-a7a3-08475cb45ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_10de8733-c087-49e5-b8d6-0c360a641aab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9f47e869-7e67-401f-be47-228b520ea34f" xlink:to="loc_us-gaap_StatementLineItems_10de8733-c087-49e5-b8d6-0c360a641aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_e5baa025-e61a-4325-877d-18e28abb1563" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_10de8733-c087-49e5-b8d6-0c360a641aab" xlink:to="loc_us-gaap_RestrictedCash_e5baa025-e61a-4325-877d-18e28abb1563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_94a1e3b1-d3ef-4503-a560-33513634adab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_10de8733-c087-49e5-b8d6-0c360a641aab" xlink:to="loc_us-gaap_OtherAssetsCurrent_94a1e3b1-d3ef-4503-a560-33513634adab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherNonCurrentAssetsAbstract_5e442659-4349-413c-852d-85c68f0db2ce" xlink:href="bmy-20210630.xsd#bmy_OtherNonCurrentAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EquityInvestmentsNonCurrent_3c7f322b-95ab-483e-97ea-d33a25ca3bb0" xlink:href="bmy-20210630.xsd#bmy_EquityInvestmentsNonCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_OtherNonCurrentAssetsAbstract_5e442659-4349-413c-852d-85c68f0db2ce" xlink:to="loc_bmy_EquityInvestmentsNonCurrent_3c7f322b-95ab-483e-97ea-d33a25ca3bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNoncurrent_6d73dc56-56c1-4eb2-9ccd-a9f609099670" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_OtherNonCurrentAssetsAbstract_5e442659-4349-413c-852d-85c68f0db2ce" xlink:to="loc_us-gaap_InventoryNoncurrent_6d73dc56-56c1-4eb2-9ccd-a9f609099670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_328f3980-12cb-4ec9-b058-d44680ab4140" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_OtherNonCurrentAssetsAbstract_5e442659-4349-413c-852d-85c68f0db2ce" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_328f3980-12cb-4ec9-b058-d44680ab4140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_0bb51e38-9968-48ff-9a34-5dabc59e6341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_OtherNonCurrentAssetsAbstract_5e442659-4349-413c-852d-85c68f0db2ce" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_0bb51e38-9968-48ff-9a34-5dabc59e6341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_f765c3d4-5046-4a84-bdf5-7c24a637a187" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_OtherNonCurrentAssetsAbstract_5e442659-4349-413c-852d-85c68f0db2ce" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_f765c3d4-5046-4a84-bdf5-7c24a637a187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_fa162352-4535-4a5c-84f3-f211eafca682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_OtherNonCurrentAssetsAbstract_5e442659-4349-413c-852d-85c68f0db2ce" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_fa162352-4535-4a5c-84f3-f211eafca682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d521d921-4465-41b8-ba8c-bfa78c47b5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_OtherNonCurrentAssetsAbstract_5e442659-4349-413c-852d-85c68f0db2ce" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d521d921-4465-41b8-ba8c-bfa78c47b5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_cc73aabc-8227-4310-8980-2c4bccc7d892" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_OtherNonCurrentAssetsAbstract_5e442659-4349-413c-852d-85c68f0db2ce" xlink:to="loc_us-gaap_RestrictedCash_cc73aabc-8227-4310-8980-2c4bccc7d892" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrentAbstract_262fd6b3-da36-47a2-b84b-cdf18409a6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedRebatesAndReturns_2d54a4e5-a9ec-46ce-9c97-a57c0acef3dd" xlink:href="bmy-20210630.xsd#bmy_AccruedRebatesAndReturns"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_262fd6b3-da36-47a2-b84b-cdf18409a6ab" xlink:to="loc_bmy_AccruedRebatesAndReturns_2d54a4e5-a9ec-46ce-9c97-a57c0acef3dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_f558240a-77f9-4096-8691-285ce7239a78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_262fd6b3-da36-47a2-b84b-cdf18409a6ab" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_f558240a-77f9-4096-8691-285ce7239a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b5bb9fbc-3871-4ca2-a2ec-0ed0f333e4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_262fd6b3-da36-47a2-b84b-cdf18409a6ab" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b5bb9fbc-3871-4ca2-a2ec-0ed0f333e4e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedResearchAndDevelopment_2dc0a358-b0bd-4a80-a71c-627d091d23b8" xlink:href="bmy-20210630.xsd#bmy_AccruedResearchAndDevelopment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_262fd6b3-da36-47a2-b84b-cdf18409a6ab" xlink:to="loc_bmy_AccruedResearchAndDevelopment_2dc0a358-b0bd-4a80-a71c-627d091d23b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_ed0d182d-e86c-400b-ae19-dc33096c3c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_262fd6b3-da36-47a2-b84b-cdf18409a6ab" xlink:to="loc_us-gaap_DividendsPayableCurrent_ed0d182d-e86c-400b-ae19-dc33096c3c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AccruedInterest_cc01ea1a-b6a6-4e05-8376-77af411e8957" xlink:href="bmy-20210630.xsd#bmy_AccruedInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_262fd6b3-da36-47a2-b84b-cdf18409a6ab" xlink:to="loc_bmy_AccruedInterest_cc01ea1a-b6a6-4e05-8376-77af411e8957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedRoyaltiesCurrent_30d62cb8-0f49-4adb-b076-a5b86d7fd21a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_262fd6b3-da36-47a2-b84b-cdf18409a6ab" xlink:to="loc_us-gaap_AccruedRoyaltiesCurrent_30d62cb8-0f49-4adb-b076-a5b86d7fd21a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_79ea771b-d7af-4e70-bab7-7e4caeff7334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_262fd6b3-da36-47a2-b84b-cdf18409a6ab" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_79ea771b-d7af-4e70-bab7-7e4caeff7334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_cde8acd2-498c-489c-8b5f-a481e49c3425" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_262fd6b3-da36-47a2-b84b-cdf18409a6ab" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_cde8acd2-498c-489c-8b5f-a481e49c3425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_7970b29b-bf37-4ce2-9544-ee8a9cb54e07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_262fd6b3-da36-47a2-b84b-cdf18409a6ab" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_7970b29b-bf37-4ce2-9544-ee8a9cb54e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_34315f84-1e16-4ca3-b3a1-1b1240b06dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesCurrentAbstract_262fd6b3-da36-47a2-b84b-cdf18409a6ab" xlink:to="loc_us-gaap_StatementTable_34315f84-1e16-4ca3-b3a1-1b1240b06dfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_c209707e-eba1-432a-8c65-5bee4dc5965e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_34315f84-1e16-4ca3-b3a1-1b1240b06dfd" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_c209707e-eba1-432a-8c65-5bee4dc5965e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_cc2f3637-9516-46c2-b6f0-2cc49ce64e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_c209707e-eba1-432a-8c65-5bee4dc5965e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_cc2f3637-9516-46c2-b6f0-2cc49ce64e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_e7145f86-1c6d-4579-96e2-9d431650e873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_cc2f3637-9516-46c2-b6f0-2cc49ce64e36" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_e7145f86-1c6d-4579-96e2-9d431650e873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_a0a227eb-052c-404a-bdbc-29fcd7b1d4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_34315f84-1e16-4ca3-b3a1-1b1240b06dfd" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_a0a227eb-052c-404a-bdbc-29fcd7b1d4a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_aa01eb4d-77f7-4e4a-af08-85c7b8958c00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_a0a227eb-052c-404a-bdbc-29fcd7b1d4a3" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_aa01eb4d-77f7-4e4a-af08-85c7b8958c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ContingentValueRightsMember_b2f6e05d-cb8d-4dc4-9c7e-03ac98b1a377" xlink:href="bmy-20210630.xsd#bmy_ContingentValueRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_aa01eb4d-77f7-4e4a-af08-85c7b8958c00" xlink:to="loc_bmy_ContingentValueRightsMember_b2f6e05d-cb8d-4dc4-9c7e-03ac98b1a377" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_278ffe0f-dd75-402a-b62b-597f878444eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_34315f84-1e16-4ca3-b3a1-1b1240b06dfd" xlink:to="loc_us-gaap_StatementLineItems_278ffe0f-dd75-402a-b62b-597f878444eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d2d6d6d9-d9bc-4a3b-b71f-26ec3eb7db60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_278ffe0f-dd75-402a-b62b-597f878444eb" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_d2d6d6d9-d9bc-4a3b-b71f-26ec3eb7db60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OtherNonCurrentLiabilitiesAbstract_0baee48f-e9e3-41e2-abb2-8e602e29b431" xlink:href="bmy-20210630.xsd#bmy_OtherNonCurrentLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_bab77c2b-4230-4522-af15-968d93c0ec54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_OtherNonCurrentLiabilitiesAbstract_0baee48f-e9e3-41e2-abb2-8e602e29b431" xlink:to="loc_us-gaap_StatementTable_bab77c2b-4230-4522-af15-968d93c0ec54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_467bc83b-fba8-470c-9292-4c9a35fa5ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_bab77c2b-4230-4522-af15-968d93c0ec54" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_467bc83b-fba8-470c-9292-4c9a35fa5ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_c95b4d74-d030-4a0e-bf03-acfa59ba12ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_467bc83b-fba8-470c-9292-4c9a35fa5ac5" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_c95b4d74-d030-4a0e-bf03-acfa59ba12ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d428e225-7595-4560-ad75-eeafdad6344f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_bab77c2b-4230-4522-af15-968d93c0ec54" xlink:to="loc_us-gaap_StatementLineItems_d428e225-7595-4560-ad75-eeafdad6344f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_3ace602f-f335-4995-8179-19fea9b99aec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d428e225-7595-4560-ad75-eeafdad6344f" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_3ace602f-f335-4995-8179-19fea9b99aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_cec77eb0-4f2b-45e1-9749-a1b40886b504" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d428e225-7595-4560-ad75-eeafdad6344f" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_cec77eb0-4f2b-45e1-9749-a1b40886b504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_af398c22-95a1-4484-85ab-1b82bc7ca028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d428e225-7595-4560-ad75-eeafdad6344f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_af398c22-95a1-4484-85ab-1b82bc7ca028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeNoncurrent_5068b5b5-96ea-461e-bdbd-6b4e8f2fffd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d428e225-7595-4560-ad75-eeafdad6344f" xlink:to="loc_us-gaap_DeferredIncomeNoncurrent_5068b5b5-96ea-461e-bdbd-6b4e8f2fffd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_418939f7-a4b4-4ad6-a53a-b36d4e4c5d73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d428e225-7595-4560-ad75-eeafdad6344f" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_418939f7-a4b4-4ad6-a53a-b36d4e4c5d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_d4b9c0ea-d4b1-4745-ae86-9fdf20e9e60f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d428e225-7595-4560-ad75-eeafdad6344f" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesNoncurrent_d4b9c0ea-d4b1-4745-ae86-9fdf20e9e60f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_e4b540de-8fda-4d07-b465-29c6cc81047f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d428e225-7595-4560-ad75-eeafdad6344f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_e4b540de-8fda-4d07-b465-29c6cc81047f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITY" xlink:type="simple" xlink:href="bmy-20210630.xsd#EQUITY"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_74bcd3b9-fe76-4227-bebb-ed02413499cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_60f94fd0-590d-4466-9a3d-224106b64784" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_74bcd3b9-fe76-4227-bebb-ed02413499cb" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_60f94fd0-590d-4466-9a3d-224106b64784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYTables" xlink:type="simple" xlink:href="bmy-20210630.xsd#EQUITYTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EQUITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_fd523bbd-1590-47e5-b029-a63d2906cd9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_7d8811b0-677b-4182-8ea2-40b8ba2aebdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_fd523bbd-1590-47e5-b029-a63d2906cd9c" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityTableTextBlock_7d8811b0-677b-4182-8ea2-40b8ba2aebdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_7e233ffb-1278-4928-b354-0726ab9c1585" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_fd523bbd-1590-47e5-b029-a63d2906cd9c" xlink:to="loc_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock_7e233ffb-1278-4928-b354-0726ab9c1585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_426fa94e-7525-44f4-b650-088fe18a2f23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_fd523bbd-1590-47e5-b029-a63d2906cd9c" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_426fa94e-7525-44f4-b650-088fe18a2f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYChangesinEquityDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#EQUITYChangesinEquityDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EQUITYChangesinEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5761ca98-5f89-4f46-8201-dbb240487cb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ae53f516-a581-408e-beef-519ecf658861" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5761ca98-5f89-4f46-8201-dbb240487cb9" xlink:to="loc_us-gaap_StatementTable_ae53f516-a581-408e-beef-519ecf658861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6e8fe308-cae4-4231-9eb1-cead94639f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ae53f516-a581-408e-beef-519ecf658861" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6e8fe308-cae4-4231-9eb1-cead94639f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d0d97605-d8cc-4c7f-99f1-b55a5763af61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6e8fe308-cae4-4231-9eb1-cead94639f3a" xlink:to="loc_us-gaap_EquityComponentDomain_d0d97605-d8cc-4c7f-99f1-b55a5763af61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_748e7f54-dfef-4dfd-aab4-f62f57292991" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d0d97605-d8cc-4c7f-99f1-b55a5763af61" xlink:to="loc_us-gaap_CommonStockMember_748e7f54-dfef-4dfd-aab4-f62f57292991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_492906a9-0567-4c97-beb5-6fe729e59b30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d0d97605-d8cc-4c7f-99f1-b55a5763af61" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_492906a9-0567-4c97-beb5-6fe729e59b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_898e12f5-7355-4153-a38b-1dc2425f56bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d0d97605-d8cc-4c7f-99f1-b55a5763af61" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_898e12f5-7355-4153-a38b-1dc2425f56bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_5b2ccdd9-e54f-4e83-bae5-af883c6697af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d0d97605-d8cc-4c7f-99f1-b55a5763af61" xlink:to="loc_us-gaap_RetainedEarningsMember_5b2ccdd9-e54f-4e83-bae5-af883c6697af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_96371fff-0d4d-4d1d-8ee7-129fee14946f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d0d97605-d8cc-4c7f-99f1-b55a5763af61" xlink:to="loc_us-gaap_TreasuryStockMember_96371fff-0d4d-4d1d-8ee7-129fee14946f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_49a0eafb-2d95-4772-8a0e-89cbfde56bed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d0d97605-d8cc-4c7f-99f1-b55a5763af61" xlink:to="loc_us-gaap_NoncontrollingInterestMember_49a0eafb-2d95-4772-8a0e-89cbfde56bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9a6a2e48-9ec8-49d1-85c0-4284def46065" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ae53f516-a581-408e-beef-519ecf658861" xlink:to="loc_us-gaap_StatementLineItems_9a6a2e48-9ec8-49d1-85c0-4284def46065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_425fa53d-693e-47b3-bd59-e1662f334acd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9a6a2e48-9ec8-49d1-85c0-4284def46065" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_425fa53d-693e-47b3-bd59-e1662f334acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0c3a1b9c-be5a-4947-9e39-03837cd9de14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9a6a2e48-9ec8-49d1-85c0-4284def46065" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_0c3a1b9c-be5a-4947-9e39-03837cd9de14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_78737e7f-e70e-4a2e-9aab-93459d095726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9a6a2e48-9ec8-49d1-85c0-4284def46065" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_78737e7f-e70e-4a2e-9aab-93459d095726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9a6a2e48-9ec8-49d1-85c0-4284def46065" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_8a7d7e21-7426-41f3-865e-36628609c6d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_SharesIssued_8a7d7e21-7426-41f3-865e-36628609c6d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_325d8d4e-b3b2-4992-8bc2-85d4cc92e05a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_SharesIssued_325d8d4e-b3b2-4992-8bc2-85d4cc92e05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3a2a7bae-3622-4dac-a0aa-2cc4e86a2231" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_CommonStockValue_3a2a7bae-3622-4dac-a0aa-2cc4e86a2231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_8c358612-7606-4ff0-be45-ebc912bef2c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_CommonStockValue_8c358612-7606-4ff0-be45-ebc912bef2c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_ed221d71-afc3-40f2-a051-0ed980278084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_AdditionalPaidInCapital_ed221d71-afc3-40f2-a051-0ed980278084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_1ca1a574-5743-4757-9529-2866751e295a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_StockholdersEquityOther_1ca1a574-5743-4757-9529-2866751e295a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_d9529678-b3ff-4265-8136-7a2f712ffae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_AdditionalPaidInCapital_d9529678-b3ff-4265-8136-7a2f712ffae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3988b00d-84c5-4e7f-a333-bc6b7f71b2f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3988b00d-84c5-4e7f-a333-bc6b7f71b2f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9bb95644-b632-424e-88df-70935622d309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9bb95644-b632-424e-88df-70935622d309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b722da06-c99f-49ea-8810-9e3657b11dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b722da06-c99f-49ea-8810-9e3657b11dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a9e4cc72-cbef-4173-85aa-d6e15b5f06e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a9e4cc72-cbef-4173-85aa-d6e15b5f06e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b072af6b-89b5-4ec6-948b-f8763dee1690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_NetIncomeLoss_b072af6b-89b5-4ec6-948b-f8763dee1690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_7f14080d-6d79-4188-a0b0-cea04595fc08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_DividendsCommonStockCash_7f14080d-6d79-4188-a0b0-cea04595fc08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_e9279dca-e80a-42b9-8a47-05b5e099fe86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_e9279dca-e80a-42b9-8a47-05b5e099fe86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f11f8434-e90e-45ba-bb23-f0e48d13ac9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f11f8434-e90e-45ba-bb23-f0e48d13ac9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_f0ebeaa4-1c9c-4536-a007-2e931095bc65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_TreasuryStockShares_f0ebeaa4-1c9c-4536-a007-2e931095bc65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_a9954b95-e384-442b-bce4-457bf4c6862f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_a9954b95-e384-442b-bce4-457bf4c6862f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_1a5a88af-d3af-465f-ae25-e823d36d0f51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_TreasuryStockShares_1a5a88af-d3af-465f-ae25-e823d36d0f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_d7119ba1-13ca-4030-b80b-b3477d119270" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_TreasuryStockValue_d7119ba1-13ca-4030-b80b-b3477d119270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_8107a5e6-b231-4476-8b07-c67f2f75bda0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_8107a5e6-b231-4476-8b07-c67f2f75bda0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_c5bd973a-8b0f-49c2-90b1-d8aed51a030b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_TreasuryStockValue_c5bd973a-8b0f-49c2-90b1-d8aed51a030b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_3fa1b58a-a4c2-4320-9039-08a9b193c9df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_MinorityInterest_3fa1b58a-a4c2-4320-9039-08a9b193c9df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0f5b2145-956c-468d-9dd5-a4d13e843407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0f5b2145-956c-468d-9dd5-a4d13e843407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_79b222c5-c8a4-4f63-9314-e1f12c315271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_79b222c5-c8a4-4f63-9314-e1f12c315271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_3d07dd87-5d0b-45d6-89fa-a8fcfac92c00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_6b610aab-628d-474f-abdc-80e6c0ac9041" xlink:to="loc_us-gaap_MinorityInterest_3d07dd87-5d0b-45d6-89fa-a8fcfac92c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_1a9ee165-f03d-4319-8846-526e22eaa5d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9a6a2e48-9ec8-49d1-85c0-4284def46065" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_1a9ee165-f03d-4319-8846-526e22eaa5d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_2ff6bce4-b0a2-440a-ab78-8963ea11c86b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9a6a2e48-9ec8-49d1-85c0-4284def46065" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_2ff6bce4-b0a2-440a-ab78-8963ea11c86b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#EQUITYOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_683a6da3-56f5-4523-baa2-f49718dcd8bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a45693bb-d734-4dc2-8a3e-f67f2c808b68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_683a6da3-56f5-4523-baa2-f49718dcd8bd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a45693bb-d734-4dc2-8a3e-f67f2c808b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_4a9dc2e1-9ad8-424a-9efe-250c64a46e7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a45693bb-d734-4dc2-8a3e-f67f2c808b68" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_4a9dc2e1-9ad8-424a-9efe-250c64a46e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_477740b4-6ec9-4922-a6a4-0a323312f4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a45693bb-d734-4dc2-8a3e-f67f2c808b68" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax_477740b4-6ec9-4922-a6a4-0a323312f4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_ef794a1d-1d51-4c0f-863d-dd4f410acddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a45693bb-d734-4dc2-8a3e-f67f2c808b68" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax_ef794a1d-1d51-4c0f-863d-dd4f410acddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_c8809ac1-2729-4583-b4e1-e5671a8d8978" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a45693bb-d734-4dc2-8a3e-f67f2c808b68" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_c8809ac1-2729-4583-b4e1-e5671a8d8978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_4d8f5c77-d271-4f71-86f6-c9f766044f26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a45693bb-d734-4dc2-8a3e-f67f2c808b68" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_4d8f5c77-d271-4f71-86f6-c9f766044f26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_de19f2e7-caee-4c6d-abf1-12ba776d40fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a45693bb-d734-4dc2-8a3e-f67f2c808b68" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax_de19f2e7-caee-4c6d-abf1-12ba776d40fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_c347a9c8-04d5-443b-a936-729e11577ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a45693bb-d734-4dc2-8a3e-f67f2c808b68" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax_c347a9c8-04d5-443b-a936-729e11577ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax_3a420678-f126-48fb-996c-c3fd13b8a9da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a45693bb-d734-4dc2-8a3e-f67f2c808b68" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax_3a420678-f126-48fb-996c-c3fd13b8a9da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax_0a63b0f6-70b0-4c36-a525-da1c61fd07af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a45693bb-d734-4dc2-8a3e-f67f2c808b68" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax_0a63b0f6-70b0-4c36-a525-da1c61fd07af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_3e40cf45-4bc9-4f66-b27c-57a23600966c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a45693bb-d734-4dc2-8a3e-f67f2c808b68" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_3e40cf45-4bc9-4f66-b27c-57a23600966c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_9565c3a1-796a-436c-bd16-5b0f868db461" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a45693bb-d734-4dc2-8a3e-f67f2c808b68" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_9565c3a1-796a-436c-bd16-5b0f868db461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_58170551-81ed-4b52-b696-4ab08ac5a44d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a45693bb-d734-4dc2-8a3e-f67f2c808b68" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_58170551-81ed-4b52-b696-4ab08ac5a44d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_0c1f5378-2fa3-4172-bd6f-4999d59d38a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a45693bb-d734-4dc2-8a3e-f67f2c808b68" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax_0c1f5378-2fa3-4172-bd6f-4999d59d38a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_7e97a299-9ee0-4426-8823-d02cee169579" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a45693bb-d734-4dc2-8a3e-f67f2c808b68" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_7e97a299-9ee0-4426-8823-d02cee169579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_90cfdb58-812e-4964-ad37-c80c19d9367c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a45693bb-d734-4dc2-8a3e-f67f2c808b68" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_90cfdb58-812e-4964-ad37-c80c19d9367c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_a0b6c493-6ae8-4157-a0e9-d2cda0c6fe8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a45693bb-d734-4dc2-8a3e-f67f2c808b68" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_a0b6c493-6ae8-4157-a0e9-d2cda0c6fe8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_d8b38249-6f7c-4482-be1a-d051c092b126" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract_a45693bb-d734-4dc2-8a3e-f67f2c808b68" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeTax_d8b38249-6f7c-4482-be1a-d051c092b126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_83d3777f-c329-487f-8d51-59810a567d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_683a6da3-56f5-4523-baa2-f49718dcd8bd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_83d3777f-c329-487f-8d51-59810a567d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_b8fe0d3d-cda9-4aad-aeb5-02d1093f7a54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_83d3777f-c329-487f-8d51-59810a567d1f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax_b8fe0d3d-cda9-4aad-aeb5-02d1093f7a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_e12dd0d7-ccb9-495f-9bf7-d3568140e974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_83d3777f-c329-487f-8d51-59810a567d1f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax_e12dd0d7-ccb9-495f-9bf7-d3568140e974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_272d9885-a01d-475d-a217-7c2277bd3e60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_83d3777f-c329-487f-8d51-59810a567d1f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_272d9885-a01d-475d-a217-7c2277bd3e60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_32a96738-f0bc-4ff5-8d39-da8721a27855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_83d3777f-c329-487f-8d51-59810a567d1f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax_32a96738-f0bc-4ff5-8d39-da8721a27855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_eb29b8f3-e04b-4577-aefd-31985e658f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_83d3777f-c329-487f-8d51-59810a567d1f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_eb29b8f3-e04b-4577-aefd-31985e658f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax_e67335ce-cc88-41cd-928a-c61427f56b03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_83d3777f-c329-487f-8d51-59810a567d1f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax_e67335ce-cc88-41cd-928a-c61427f56b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_0b6a5fcb-89b3-4779-a205-71d15512967b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_83d3777f-c329-487f-8d51-59810a567d1f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_0b6a5fcb-89b3-4779-a205-71d15512967b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_12b630bb-7e3e-41e0-876c-f61d5c50889c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_83d3777f-c329-487f-8d51-59810a567d1f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax_12b630bb-7e3e-41e0-876c-f61d5c50889c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_d63fb160-7bb7-4efa-98c8-23413a56f068" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_83d3777f-c329-487f-8d51-59810a567d1f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_d63fb160-7bb7-4efa-98c8-23413a56f068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossTax_d29ca3a5-bddb-4d36-a70b-a3f64ca7ec69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract_83d3777f-c329-487f-8d51-59810a567d1f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossTax_d29ca3a5-bddb-4d36-a70b-a3f64ca7ec69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_279fb8b4-dcc3-420c-a2ac-f3b8b6373640" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_683a6da3-56f5-4523-baa2-f49718dcd8bd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_279fb8b4-dcc3-420c-a2ac-f3b8b6373640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_43eb59fb-3d86-4987-8df6-e3fbc295e383" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_279fb8b4-dcc3-420c-a2ac-f3b8b6373640" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_43eb59fb-3d86-4987-8df6-e3fbc295e383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_bfdbc8b8-810e-48ee-a2ed-cf2876d498e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_279fb8b4-dcc3-420c-a2ac-f3b8b6373640" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_bfdbc8b8-810e-48ee-a2ed-cf2876d498e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_221a0e72-db52-48e8-8316-1648d5f9713e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_279fb8b4-dcc3-420c-a2ac-f3b8b6373640" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_221a0e72-db52-48e8-8316-1648d5f9713e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_153d63c2-7f77-43fb-aa72-763228b943d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_279fb8b4-dcc3-420c-a2ac-f3b8b6373640" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_153d63c2-7f77-43fb-aa72-763228b943d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_16568f42-6697-4d2b-8f41-1cfca322d0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_279fb8b4-dcc3-420c-a2ac-f3b8b6373640" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_16568f42-6697-4d2b-8f41-1cfca322d0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_07ae38a8-da37-444f-8795-66849ac576e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_279fb8b4-dcc3-420c-a2ac-f3b8b6373640" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_07ae38a8-da37-444f-8795-66849ac576e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_520c436e-9a6d-4344-b096-6e971f0dfc16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_279fb8b4-dcc3-420c-a2ac-f3b8b6373640" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_520c436e-9a6d-4344-b096-6e971f0dfc16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_707d8336-adff-4fff-9c78-ee75cbc71e45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_279fb8b4-dcc3-420c-a2ac-f3b8b6373640" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax_707d8336-adff-4fff-9c78-ee75cbc71e45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4583cd00-3c97-4664-aa0e-436d3032d70b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_279fb8b4-dcc3-420c-a2ac-f3b8b6373640" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4583cd00-3c97-4664-aa0e-436d3032d70b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_6b3d1354-1f08-4929-b038-76b5e2662c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_683a6da3-56f5-4523-baa2-f49718dcd8bd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax_6b3d1354-1f08-4929-b038-76b5e2662c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_3d8327ae-e287-4657-988f-78e2abfa279b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_683a6da3-56f5-4523-baa2-f49718dcd8bd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_3d8327ae-e287-4657-988f-78e2abfa279b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_01ea138a-24fe-4e1d-9dba-a95164f00175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_683a6da3-56f5-4523-baa2-f49718dcd8bd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_01ea138a-24fe-4e1d-9dba-a95164f00175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_ce6ed5bf-6c6f-40dc-aa4a-366165044f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_683a6da3-56f5-4523-baa2-f49718dcd8bd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_ce6ed5bf-6c6f-40dc-aa4a-366165044f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cd688f37-7de5-4730-9347-75df3f40611e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_683a6da3-56f5-4523-baa2-f49718dcd8bd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_cd688f37-7de5-4730-9347-75df3f40611e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansNotes" xlink:type="simple" xlink:href="bmy-20210630.xsd#EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansNotes"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract_9f812530-63aa-4a83-9815-d1e8d53d1419" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_4be475ae-111e-4b3f-8d08-3fe8e42423e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract_9f812530-63aa-4a83-9815-d1e8d53d1419" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_4be475ae-111e-4b3f-8d08-3fe8e42423e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansTables" xlink:type="simple" xlink:href="bmy-20210630.xsd#EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansTables"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract_f87632a4-e54e-4a1f-87bc-2f52ab2fecc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_e100c632-c6a3-4d17-a65f-333afda6d897" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract_f87632a4-e54e-4a1f-87bc-2f52ab2fecc8" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_e100c632-c6a3-4d17-a65f-333afda6d897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock_535229b8-da8f-465a-8985-6a6ae1249f7a" xlink:href="bmy-20210630.xsd#bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract_f87632a4-e54e-4a1f-87bc-2f52ab2fecc8" xlink:to="loc_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock_535229b8-da8f-465a-8985-6a6ae1249f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_2bad64f2-c536-4db8-982b-abe17d5c64e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract_f87632a4-e54e-4a1f-87bc-2f52ab2fecc8" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_2bad64f2-c536-4db8-982b-abe17d5c64e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SharebasedPaymentArrangementCostbyPlanAbstract_ca7a8c94-fa7e-40fa-a1b5-9b965604bc71" xlink:href="bmy-20210630.xsd#bmy_SharebasedPaymentArrangementCostbyPlanAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ff7e301d-8b03-409a-9cc2-5e43ff54f64d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SharebasedPaymentArrangementCostbyPlanAbstract_ca7a8c94-fa7e-40fa-a1b5-9b965604bc71" xlink:to="loc_us-gaap_StatementTable_ff7e301d-8b03-409a-9cc2-5e43ff54f64d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_cac8f269-274a-4135-92e3-d820dea42ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ff7e301d-8b03-409a-9cc2-5e43ff54f64d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_cac8f269-274a-4135-92e3-d820dea42ebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8cc1434c-0938-42a1-9954-b9629b3d6277" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_cac8f269-274a-4135-92e3-d820dea42ebe" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8cc1434c-0938-42a1-9954-b9629b3d6277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b0fe4eea-9d6b-4b3e-a30e-e36ba9e13ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ff7e301d-8b03-409a-9cc2-5e43ff54f64d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b0fe4eea-9d6b-4b3e-a30e-e36ba9e13ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2f1233eb-c758-4743-a4f2-d9433eb5784a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b0fe4eea-9d6b-4b3e-a30e-e36ba9e13ac4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2f1233eb-c758-4743-a4f2-d9433eb5784a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_929a49a5-49e7-4d17-8010-4c10b7ae9907" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2f1233eb-c758-4743-a4f2-d9433eb5784a" xlink:to="loc_us-gaap_CostOfSalesMember_929a49a5-49e7-4d17-8010-4c10b7ae9907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_35a0da2b-9de8-413d-9bff-a9edca9f0ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2f1233eb-c758-4743-a4f2-d9433eb5784a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_35a0da2b-9de8-413d-9bff-a9edca9f0ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_83a26dde-c674-4d4d-b0e8-608d7a573a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2f1233eb-c758-4743-a4f2-d9433eb5784a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_83a26dde-c674-4d4d-b0e8-608d7a573a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_e0781778-d1e5-444e-8d1d-4955e3e42fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2f1233eb-c758-4743-a4f2-d9433eb5784a" xlink:to="loc_us-gaap_OtherIncomeMember_e0781778-d1e5-444e-8d1d-4955e3e42fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c5132a28-f2b9-41dd-86fe-934f0e113ced" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ff7e301d-8b03-409a-9cc2-5e43ff54f64d" xlink:to="loc_us-gaap_AwardTypeAxis_c5132a28-f2b9-41dd-86fe-934f0e113ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_da11d524-6a3e-40e8-be9b-ab0671bcdfed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c5132a28-f2b9-41dd-86fe-934f0e113ced" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_da11d524-6a3e-40e8-be9b-ab0671bcdfed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneContingentValueRightsMember_ab0a5ddf-b127-4793-82ea-26d591070c56" xlink:href="bmy-20210630.xsd#bmy_CelgeneContingentValueRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_da11d524-6a3e-40e8-be9b-ab0671bcdfed" xlink:to="loc_bmy_CelgeneContingentValueRightsMember_ab0a5ddf-b127-4793-82ea-26d591070c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fde950e1-a22c-4a39-8bc6-df3c66119c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ff7e301d-8b03-409a-9cc2-5e43ff54f64d" xlink:to="loc_us-gaap_StatementLineItems_fde950e1-a22c-4a39-8bc6-df3c66119c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_90fb9a5b-0a8d-43e9-b424-d7fb080ea8c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fde950e1-a22c-4a39-8bc6-df3c66119c3b" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_90fb9a5b-0a8d-43e9-b424-d7fb080ea8c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_f562a0c5-565f-4d05-ac85-a27a78c8cb52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fde950e1-a22c-4a39-8bc6-df3c66119c3b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_f562a0c5-565f-4d05-ac85-a27a78c8cb52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsAndExcessTaxBenefitFromSharebasedCompensation_f9646736-90d9-4274-bf07-ef288e0d890f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsAndExcessTaxBenefitFromSharebasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fde950e1-a22c-4a39-8bc6-df3c66119c3b" xlink:to="loc_us-gaap_ProceedsAndExcessTaxBenefitFromSharebasedCompensation_f9646736-90d9-4274-bf07-ef288e0d890f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleOfShareBasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#EMPLOYEESTOCKBENEFITPLANSScheduleOfShareBasedCompensationAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleOfShareBasedCompensationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SharebasedPaymentArrangementCostbyPlanAbstract_279dc691-0383-486f-9b9a-c0697b8716c2" xlink:href="bmy-20210630.xsd#bmy_SharebasedPaymentArrangementCostbyPlanAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e20bf448-547e-4ceb-9c52-c46df2a67316" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SharebasedPaymentArrangementCostbyPlanAbstract_279dc691-0383-486f-9b9a-c0697b8716c2" xlink:to="loc_us-gaap_StatementTable_e20bf448-547e-4ceb-9c52-c46df2a67316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1521668a-6bf0-4def-8f38-9f16843685fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e20bf448-547e-4ceb-9c52-c46df2a67316" xlink:to="loc_us-gaap_AwardTypeAxis_1521668a-6bf0-4def-8f38-9f16843685fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ab60bb2e-fac9-49c7-89b5-3ad3cb4ed10c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1521668a-6bf0-4def-8f38-9f16843685fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ab60bb2e-fac9-49c7-89b5-3ad3cb4ed10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_964d3c48-92eb-402f-849f-0d4f0388e8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ab60bb2e-fac9-49c7-89b5-3ad3cb4ed10c" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_964d3c48-92eb-402f-849f-0d4f0388e8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MarketShareUnitsMember_8c8d56cf-9899-4b6a-a79b-83fde25cf338" xlink:href="bmy-20210630.xsd#bmy_MarketShareUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ab60bb2e-fac9-49c7-89b5-3ad3cb4ed10c" xlink:to="loc_bmy_MarketShareUnitsMember_8c8d56cf-9899-4b6a-a79b-83fde25cf338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_4879ac19-d5c0-4b5f-8c02-0895955f5abe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ab60bb2e-fac9-49c7-89b5-3ad3cb4ed10c" xlink:to="loc_us-gaap_PerformanceSharesMember_4879ac19-d5c0-4b5f-8c02-0895955f5abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_fe7d0d84-399b-4ce3-8b6d-e3708e9de8ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e20bf448-547e-4ceb-9c52-c46df2a67316" xlink:to="loc_us-gaap_StatementLineItems_fe7d0d84-399b-4ce3-8b6d-e3708e9de8ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_127d351f-a6da-4ab3-9876-f688b7e762ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fe7d0d84-399b-4ce3-8b6d-e3708e9de8ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_127d351f-a6da-4ab3-9876-f688b7e762ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d3df2bce-bdc1-457e-ace3-7242c2922eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_fe7d0d84-399b-4ce3-8b6d-e3708e9de8ba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d3df2bce-bdc1-457e-ace3-7242c2922eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_bmy_SharebasedPaymentArrangementCostbyPlanAbstract_f5e7f154-2ab1-40eb-921d-e85144bbfd0e" xlink:href="bmy-20210630.xsd#bmy_SharebasedPaymentArrangementCostbyPlanAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2d6b0aac-53c0-4def-9173-e52310c77da3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_SharebasedPaymentArrangementCostbyPlanAbstract_f5e7f154-2ab1-40eb-921d-e85144bbfd0e" xlink:to="loc_us-gaap_StatementTable_2d6b0aac-53c0-4def-9173-e52310c77da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_362a3d87-9c7c-4c8a-8014-a60a2a1653b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2d6b0aac-53c0-4def-9173-e52310c77da3" xlink:to="loc_us-gaap_AwardTypeAxis_362a3d87-9c7c-4c8a-8014-a60a2a1653b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d530372-00df-4e0e-80fb-9fbceeaf71e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_362a3d87-9c7c-4c8a-8014-a60a2a1653b7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d530372-00df-4e0e-80fb-9fbceeaf71e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_6068af0f-7ff3-4946-865e-ba05cb4ccca8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d530372-00df-4e0e-80fb-9fbceeaf71e6" xlink:to="loc_us-gaap_EmployeeStockOptionMember_6068af0f-7ff3-4946-865e-ba05cb4ccca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a46f9402-5a65-4fa0-9611-66e99c44124a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d530372-00df-4e0e-80fb-9fbceeaf71e6" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a46f9402-5a65-4fa0-9611-66e99c44124a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_MarketShareUnitsMember_1e91e7d0-112e-4f03-a60c-38ae0936dd6d" xlink:href="bmy-20210630.xsd#bmy_MarketShareUnitsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d530372-00df-4e0e-80fb-9fbceeaf71e6" xlink:to="loc_bmy_MarketShareUnitsMember_1e91e7d0-112e-4f03-a60c-38ae0936dd6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_b5276353-f518-4006-8572-4a169bb6d2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8d530372-00df-4e0e-80fb-9fbceeaf71e6" xlink:to="loc_us-gaap_PerformanceSharesMember_b5276353-f518-4006-8572-4a169bb6d2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d6a90b5d-7285-4628-a1d3-ba0820b16820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2d6b0aac-53c0-4def-9173-e52310c77da3" xlink:to="loc_us-gaap_StatementLineItems_d6a90b5d-7285-4628-a1d3-ba0820b16820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_6ac52fb1-8e48-49c5-97ae-94a8ba1937dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d6a90b5d-7285-4628-a1d3-ba0820b16820" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_6ac52fb1-8e48-49c5-97ae-94a8ba1937dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e81a1a2a-40b0-46c7-a8d4-96dfe3f2b0c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d6a90b5d-7285-4628-a1d3-ba0820b16820" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e81a1a2a-40b0-46c7-a8d4-96dfe3f2b0c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES" xlink:type="simple" xlink:href="bmy-20210630.xsd#LEGALPROCEEDINGSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_838e5f65-92bc-4739-9c68-49e200fe3fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_220ca745-ea99-4425-9cc7-fde00af5c0a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_838e5f65-92bc-4739-9c68-49e200fe3fd1" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_220ca745-ea99-4425-9cc7-fde00af5c0a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="bmy-20210630.xsd#LEGALPROCEEDINGSANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0eaf6f5d-8ebe-461d-a9ac-5b479645c686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LitigationTable_2a5c283e-665b-4972-8d77-3e5de23b80ba" xlink:href="bmy-20210630.xsd#bmy_LitigationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0eaf6f5d-8ebe-461d-a9ac-5b479645c686" xlink:to="loc_bmy_LitigationTable_2a5c283e-665b-4972-8d77-3e5de23b80ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_77e326d4-55a5-4541-829a-470910646630" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LitigationTable_2a5c283e-665b-4972-8d77-3e5de23b80ba" xlink:to="loc_us-gaap_AwardTypeAxis_77e326d4-55a5-4541-829a-470910646630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f9fa5e9c-a16e-4fc0-8a62-19cdf625ae15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_77e326d4-55a5-4541-829a-470910646630" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f9fa5e9c-a16e-4fc0-8a62-19cdf625ae15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_UpfrontmilestoneandotherlicensingreceiptsMember_df388db5-39e9-42a5-af0f-db137abe29af" xlink:href="bmy-20210630.xsd#bmy_UpfrontmilestoneandotherlicensingreceiptsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f9fa5e9c-a16e-4fc0-8a62-19cdf625ae15" xlink:to="loc_bmy_UpfrontmilestoneandotherlicensingreceiptsMember_df388db5-39e9-42a5-af0f-db137abe29af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_791bcc54-a16a-44ae-8262-67de60eb75ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f9fa5e9c-a16e-4fc0-8a62-19cdf625ae15" xlink:to="loc_us-gaap_RoyaltyMember_791bcc54-a16a-44ae-8262-67de60eb75ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_bbd8c947-54da-4c91-b526-ee2d96ff1851" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LitigationTable_2a5c283e-665b-4972-8d77-3e5de23b80ba" xlink:to="loc_srt_LitigationCaseAxis_bbd8c947-54da-4c91-b526-ee2d96ff1851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_bbd8c947-54da-4c91-b526-ee2d96ff1851" xlink:to="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AntiPD1AntibodyLitigationMember_b217ffee-63c8-46c0-b48b-ff10d6625aa1" xlink:href="bmy-20210630.xsd#bmy_AntiPD1AntibodyLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:to="loc_bmy_AntiPD1AntibodyLitigationMember_b217ffee-63c8-46c0-b48b-ff10d6625aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CARTKiteLitigationMember_d6c698fe-1e06-42d5-b40f-24a51c97cef7" xlink:href="bmy-20210630.xsd#bmy_CARTKiteLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:to="loc_bmy_CARTKiteLitigationMember_d6c698fe-1e06-42d5-b40f-24a51c97cef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_EliquisPatentLitigationMember_a682f993-f2de-4943-b642-a37d67dcfe94" xlink:href="bmy-20210630.xsd#bmy_EliquisPatentLitigationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:to="loc_bmy_EliquisPatentLitigationMember_a682f993-f2de-4943-b642-a37d67dcfe94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_PlavixAustraliaIntellectualPropertyMember_f33b7fbf-fc38-42f2-94da-cbbfa001424a" xlink:href="bmy-20210630.xsd#bmy_PlavixAustraliaIntellectualPropertyMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:to="loc_bmy_PlavixAustraliaIntellectualPropertyMember_f33b7fbf-fc38-42f2-94da-cbbfa001424a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbilifyProductLiabilityMember_f45dad8e-9baf-4134-802a-37c4aa7f9657" xlink:href="bmy-20210630.xsd#bmy_AbilifyProductLiabilityMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:to="loc_bmy_AbilifyProductLiabilityMember_f45dad8e-9baf-4134-802a-37c4aa7f9657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_ByettaProductLiabilityLitigationMember_85469bc3-1ecb-4d86-81d8-0782971e26aa" xlink:href="bmy-20210630.xsd#bmy_ByettaProductLiabilityLitigationMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:to="loc_bmy_ByettaProductLiabilityLitigationMember_85469bc3-1ecb-4d86-81d8-0782971e26aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_BMSSecuritiesLitigationMember_13ef7611-06e2-4cb8-9f46-10cdf38ad69e" xlink:href="bmy-20210630.xsd#bmy_BMSSecuritiesLitigationMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:to="loc_bmy_BMSSecuritiesLitigationMember_13ef7611-06e2-4cb8-9f46-10cdf38ad69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CerclaMattersMember_5a6616d0-9956-48cb-b9e2-51d3d186cc50" xlink:href="bmy-20210630.xsd#bmy_CerclaMattersMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:to="loc_bmy_CerclaMattersMember_5a6616d0-9956-48cb-b9e2-51d3d186cc50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_AbilifyProductLiabilityLitigationMember_5aa5931d-2d8b-4dbd-be15-e026bdc8251c" xlink:href="bmy-20210630.xsd#bmy_AbilifyProductLiabilityLitigationMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:to="loc_bmy_AbilifyProductLiabilityLitigationMember_5aa5931d-2d8b-4dbd-be15-e026bdc8251c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_OnglyzaProductLiabilityLitigationMember_f3f3794d-7b30-4bb4-ad25-0c80c2bb8157" xlink:href="bmy-20210630.xsd#bmy_OnglyzaProductLiabilityLitigationMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:to="loc_bmy_OnglyzaProductLiabilityLitigationMember_f3f3794d-7b30-4bb4-ad25-0c80c2bb8157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_CelgeneSecuritiesLitigationMember_0314ff2e-73c5-4292-8c54-2e44bb0a7bc2" xlink:href="bmy-20210630.xsd#bmy_CelgeneSecuritiesLitigationMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ebfa8f5e-9853-4063-a680-d4783af0692d" xlink:to="loc_bmy_CelgeneSecuritiesLitigationMember_0314ff2e-73c5-4292-8c54-2e44bb0a7bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CurrencyAxis_bd3275be-8074-42fd-91f8-c96d6709a232" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LitigationTable_2a5c283e-665b-4972-8d77-3e5de23b80ba" xlink:to="loc_srt_CurrencyAxis_bd3275be-8074-42fd-91f8-c96d6709a232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AllCurrenciesDomain_76452f6c-8d7f-4c7c-8e22-d13da9e48a00" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CurrencyAxis_bd3275be-8074-42fd-91f8-c96d6709a232" xlink:to="loc_currency_AllCurrenciesDomain_76452f6c-8d7f-4c7c-8e22-d13da9e48a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_AUD_38d932f0-310c-4443-aaaf-244634470eec" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AUD"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_76452f6c-8d7f-4c7c-8e22-d13da9e48a00" xlink:to="loc_currency_AUD_38d932f0-310c-4443-aaaf-244634470eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_currency_USD_bd5fb4ab-3000-46af-91fe-ffc49a55f670" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currency_AllCurrenciesDomain_76452f6c-8d7f-4c7c-8e22-d13da9e48a00" xlink:to="loc_currency_USD_bd5fb4ab-3000-46af-91fe-ffc49a55f670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_f32a461e-cf3d-48c5-a1b0-7fcf6953a877" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LitigationTable_2a5c283e-665b-4972-8d77-3e5de23b80ba" xlink:to="loc_us-gaap_LitigationStatusAxis_f32a461e-cf3d-48c5-a1b0-7fcf6953a877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_050347b4-8daa-4947-8eef-80764c37d6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_f32a461e-cf3d-48c5-a1b0-7fcf6953a877" xlink:to="loc_us-gaap_LitigationStatusDomain_050347b4-8daa-4947-8eef-80764c37d6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_DismissedMember_b87895d3-8058-4617-a7f1-2b3bd0effe7c" xlink:href="bmy-20210630.xsd#bmy_DismissedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_050347b4-8daa-4947-8eef-80764c37d6f3" xlink:to="loc_bmy_DismissedMember_b87895d3-8058-4617-a7f1-2b3bd0effe7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bmy_LegalProceedingsAndContingenciesLineItems_9692543b-b22f-4acd-a0e9-927a672d52bd" xlink:href="bmy-20210630.xsd#bmy_LegalProceedingsAndContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LitigationTable_2a5c283e-665b-4972-8d77-3e5de23b80ba" xlink:to="loc_bmy_LegalProceedingsAndContingenciesLineItems_9692543b-b22f-4acd-a0e9-927a672d52bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_c1eb4cb2-59ed-468c-8a69-6cb26c551199" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPatentsAllegedlyInfringedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_9692543b-b22f-4acd-a0e9-927a672d52bd" xlink:to="loc_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber_c1eb4cb2-59ed-468c-8a69-6cb26c551199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_2e8bfc61-c9bc-4eea-a2fe-97766aba670a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_9692543b-b22f-4acd-a0e9-927a672d52bd" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_2e8bfc61-c9bc-4eea-a2fe-97766aba670a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_ed66369b-b9a7-4100-88e8-e0bc9b602764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_9692543b-b22f-4acd-a0e9-927a672d52bd" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_ed66369b-b9a7-4100-88e8-e0bc9b602764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_14eca683-2f26-40be-803d-2c10d965e7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_bmy_LegalProceedingsAndContingenciesLineItems_9692543b-b22f-4acd-a0e9-927a672d52bd" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_14eca683-2f26-40be-803d-2c10d965e7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>bmslogo2021.jpg
<TEXT>
begin 644 bmslogo2021.jpg
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ME'//GCZ51F#KELU4>FI*>49SGV&#!ZHI$\>KQ(1A*CTM55JN7J]$AW:MW:,
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M[]BN"O)OJ$)WFT$_-:+8!0N=W_E!(4)%_"$VB FH$D\DED@-*#8A C*UU:%
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MW/4#AU-LAI>]UA]H1F!=_>&):09Q#7^MM77+9FEGY^4ZA0B_,;_S%HQ9NH^
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MNOZ18,47K7W\P0OFS0FJM&K2:-/*FS9ELOR&"HN6-S,3EBU>Y/XBF%B,-K
M"5<4A8?G@1W;_Q9CT;EC>W79XQ8QW"N\I_IKN?(?!IV]@X65H;I&.QPL'#.&
MDSG5D6:1X)]>NV:5&#;DFW_]FOM-9!B8HX=!VD<,&ZI>%CF^>F9G<![94+E&
M MU9MF217".:T8[4$V:V"#U@?EM5HXW^+UNZ*.*@-"R8-U=Z9NA&SOGS[MF
MT>8ZY&6T\DPOF3+$M9B]$T\J;;3A\MRC*JW).I79)DEFA-Q:'9@F55NHBGN$
M <*>NLLL!D,;CWU[@EMX\3+:6S9ME!J;>Z3NC^SO2D]+U06DH1AN;\T/M(J9
M=H1B,#,A'$QEI*5!(<?PA@/#28L.9>N@#?/9,\'NJ)HTVL! *X-QS%R9I5_,
M*<8XAR)6HPW,E.!W5 9_+ELB1HC6'W['<%!94$"I+!F<#<=377%*"TP;,:;J
M4=$:*F.TB[119""3O$P8.KB\91L*#!XN#-*',6/ +Q+H#:X.RD./+IUU1771
M_28\S$9"KAAGYFP;8X>.T!.D0N796"D8CCNW;ZG>NL*D//F-MC0F="\(V71H
MUUK*:SC(/_[/JZI&FS1$T]O;MVY*!8*>,F[UT.,>-4:;-*!'+)L/!X.=,A58
M7Z>G[K'=JN3BF6A4R6@SX^-8O]WB9Y;9("TWJB>'HD\]^I$8HTV&X7=D-@#&
MP+QFS9@F4Z]8H$%&X4]&21F8ZM^GM[H2P@C$RV@SE8ZI@LTPQOJ>*"^#'@Q4
M,8+]\.$#=?+X<35AW&@Q-A3DN;-F5I@2Q^P5YHZC'%R'03M\J@R&H63,938P
M+;&E3@L#7<ACU\X=*C<W1^7DY,C<818340BY%C(+Y?^K::-=&2ICM/GMF)&)
MY8:;=&!$0TVI,^"R8E$)1@N9#>[?3Z8HYN7EBAOKS)G3:NGBA3(SB5[90-TR
MQT7BI;(M;?(<G26=]/:8(<(29^: X]:Z>O6RVI2T0>3/,W1JWU;=TH8F%D@S
M,R+X'P-DM):IF%@#D)MS7N;F8QQ9.8D\,7)41(L75FQ-%^K6-@:2YR*M$\>-
MD?$#EFJC4Z=.GA"W5#M=4>":([T\E]=H [,S>$[NQV_H"=&Z18ZTZ ]F9<F@
M. .EW(_?5<=H<RT&G:E<CV0[Z47W3QP_)F6;9T$VS)V_61"\M-P8;:Y#>K@.
M:3F<?4BN@7Q9Z<BL)>YG=*TRY216JF2TX=.#=^I(MQTJM>E:E=EVDTIIN%J=
MGY2IOKC3]?YM3AP[)L:8!18886H^_XN%)"CI\J6+U=8M6Z35$*G[1%>/C)BA
M#66HV25>6#PP?,A@4<IY<V8'N5D,CW6W;^.&=;(<FX%/%)>I860Z!C\Q89AN
M)6^6V 7A*/O^71>\4V+4:77U[=53:G>,E#^H$\_&M+J)X\?(_3IK@X,2HH"X
M$*@ 3IXX[OZZ(DP]Q$BAM":60BPPN#EA["@Q%!0<EO56%PS@;%W0>%:>)=I"
M!HP?O\5H=>O445V[%ELL&/S=^-M')2;(_\E_9,9<Y_Y]^\@T/@)7A>+1@P?B
MOJ*P$Z\BUJ!61[4!9- 1(R1&31L #!9&%[V=-WN6#-Y6!2K0/;MVJG%C1NH\
M[R$#C>@=+_*'Z\^9/4-<<>'FS1L8S,6_RS.23M$E74E1WG:Z4UE/:H,8RJ=M
MH%PD[]TKNHY\20>] M)"0XO5LRP&0A[H*0TF?^4X8]H4?5_'&"-S+]>N7I&!
M;"K/(X</21D@I@J];ZY'FOFNG]9I]/]2F%X(UT%W><Y5KBORZ.'#TCOBG!FT
MIFQ081T_&I\81J&HLM$6ONO:<M81&9#$59+)+(_&:V7:W\<'M<_/;?GODI61
M(:T?C+9_)HFEY@@W>\12=:IGM%T^/"U19Q)3Q7CC+L& ,TC)(IJ<T1GJXZW8
MPWA:+/'FUJU;TAIOT;2)FJ"[\I'<(I;X8HUV_(F+T39\+RU3SP_<5:=Z[I$!
M2EK=R?];H6YN#3]88;'4)$R3)&X),2)Z]^Q68>Z]I6;)/G! XN\PN+UOC^WA
MQ(.X&FT_WSY_C?NZ>XO%8ODO4Z-&VV*Q6"SQQ1IMB\5BJ4-8HVVQ6"QU"&NT
L+1:+I0YAC;;%8K'4(:S1ME@LECJ#4O\?3=5_+<GJ7;0     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>bmy-20210630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bmy="http://www.bms.com/20210630"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:currency="http://xbrl.sec.gov/currency/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bmy-20210630.xsd" xlink:type="simple"/>
    <context id="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i650335fbf368429d829c268d43369fd3_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:CommonStock0.10ParValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i09e7550d3d6747878d9932ee8f7b6612_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:A1.000Notesdue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie8f5c380201f42d0b61df63f743953bd_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:A1.750Notesdue2035Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia6d0ddad70114b6a83f55355ff735cf0_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:CelgeneContingentValueRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i84644a54c37541aab600ef4e9aeb7365_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8d9276ebf40046b4a41a5f19262377b1_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i693b996ab36a4cebaefd928a05970180_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie656e6b5b421495887e8721375eae829_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i70262bb79f2b4fb682856a49e0942b2a_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie92d7cecd5b8445a9169fd5dbf526e4c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibb180892039d4e5b82c0a8f7673aa38a_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if28849fb4b9345149f1a1b15340c1cee_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4be7577ef3cc4c838eb6fc6d157858b7_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8943ff94253b4ddda4084325c807b744_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4021bf9acd814a3785a7b2ac9255f519_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i519bf72bf2984b599bef546963ea4f65_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i711a50adb808497c9daf76647502dad6_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i1d96ff885f0c4029b9c659eb21e32c98_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationTypeAxis">bmy:LicensingArrangementsCashFlowsReclassificationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8ead8ffbd6a943f58695765106933642_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i74364a7590b441a4afd4e5e67a3b406e_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i87185b42e332422389a23e672417b431_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if25b0239054048e3b55eeb8500972cdf_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if2fb12a3531e4873be7be194483607ee_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:OtherrevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i688d430df875454b84b14f79015b6cf6_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:OtherrevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4ba774a2df9f40a8b6d19e1fba5043b7_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:OtherrevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i43a13af27d1448f7993f34c3dd68a67d_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:OtherrevenuesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i02cc001651e94e7295b1dcc33d5daaa2_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iba96fdc39cdc460db86d38cae38883fe_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic3be3517a7304e72b770f702ef97ea11_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i866d2af294a649c284a0a90628fcb561_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if22a4fc3cd8c4d6c8f43d5db96fc3d2b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic6aeff8b93aa4e498214da65e668a5e7_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4e43c6a8382640da95ba7937bc7cb901_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iaa953030056e4436b2eccb65049c20bd_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iaf1613c94e7c4ae1a97bd33c34b116b9_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i245bc87a8ea146ff89ba47f0050ab6cd_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ibc81985d98e0407586fee97e68186a0c_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1ee340e61c044b3ba36660dccc49b13e_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib8447393acf44143ae8dfb8c7ec2d04a_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie762049c148a4949bccc2fc010d4f185_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i48a97ba1d3f24c95846c59ad03ad5eb4_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic5651bce30274abea8e9658ea1ea4128_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i0049dfb3f51e491da124b097da74b773_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1059bee7d7c24aa5bf63443d6b0b117e_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i36a7c570203a43c085160c5d69d6dca2_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id5926634a97d45b588e22bc868140a71_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic8f5ba386b86453aa8abbb8d97ca5741_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i164732664a0649a0a6b4e3ec9a6ea675_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2b6d5b28fdeb4f539683764cb03f85e8_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idbc7c626226146c8acb2e1f9248526b5_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic7d7effc4e044286927c0d4994433271_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i883c2662484643f9900deb185df3f0b5_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia891b42d1c254df7ac3ac05d31574021_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if68d20cca08041c5aeb33c4b926b82ab_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i57080e1dcd264f6e99cf8bdd5c21742e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7ff9b249fad642bba5144d42b9faf6b5_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ibe37cb6ae8364432a34654315cc6e007_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0261661a5a7844cea6463d344c58d900_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i769e4009608641aca49eb76faa4ac197_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i73d23b416f674420956ecd71cdcf6b4c_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5f619ca1063a4a07992394e7c68f32ac_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibaf296c2ee0943818ce82515cb333687_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="icf093353fcce47c7993eff7bebb89352_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2ee1d7e1f63643b884515b06a03e4c60_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie0c81db46fa34735a7f2f312ec65bfc9_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i355ae2718e5a4c6c8a6e24afd38df6db_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i45aeed9ec2cc49a590adb6b58fd89ece_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5978a453566e4231add46eb89d653450_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i58d693cbcafe4995b93648810c7cae27_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i40a1ad24197f4b86a309b538c9a3c23c_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7a2c60c75c4141639d1b36723b3c4440_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i62694ce91ad14828b9c165bf7fa9940e_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2704f69ab750451ab3fb0492a99094c5_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2c439fd5488544099358a43dd1238104_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ifd53acf464ca462ab494301989157627_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EmplicitiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i758c9da23c8b4231951c6795184b15e5_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EmplicitiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3c7448d91de34141b4df1bd539a6dd86_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EmplicitiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5d84ed280193426fa6af996eda8b4c98_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EmplicitiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i563b393825ee449d9c71d5d4b26b3ddb_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3fd358ca344f4bf29febc48585056f4c_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i48e38a9edee64731bac94495a43d3800_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if45515056fde4687b5647faafd13b1a0_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2a59b7d82fa145d6928ff7f7639b512e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i635f3e7e28714d6681e5a0d547475b27_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iae2dcbf6bdff462caf99391d57dcb930_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4015345e26eb4c5c9aec15be9286e3cc_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i402f96e6f47248c3840081511c31fb5b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i59e2e714bfff471ab06edb2942342e5d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iedaae601ed8c4bf0b43e79604ef7f8c3_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i18b9ec08663241d5baf4a36c323d25b0_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i27c89651aa0f44449997627d1aeada5d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6ec04d6ebd5c416faf3fedff56490ed1_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if8f8d1746aa7460c854e59b73c091120_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7639067ff20c40aa9d69bd876327d377_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i65b1ff42f2504ce7ba28f0134f6df309_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i990e509044b44824a03594bbc939cd4f_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i94349bb9edeb4c06824d9d4dec376cdc_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia84f257000384cca8728724dd08e6d64_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i72da1784020e4fe5a077a56e08ed0e60_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icae526ef104c4610be5401f06e776271_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i954298aa47d340e4928578d10e3c2afb_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie64f9c3e74d24536bc5324f5a27f3f62_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i30700517c2d846dfaabb9f4e49100061_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:VidazaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4000e7937fbb4330b97ca4837c84abcf_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:VidazaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="icc46b46a188943daabd54f0555343036_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:VidazaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie163b63bb39b41b2a99d3894f000a52e_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:VidazaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i47d887259489478d9fb5e61b10d58a21_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BaracludeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i21b554fbfbe54be4938770b47e7e814e_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BaracludeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8752706d4f1046619f751bca78fe5b04_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BaracludeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibf8cc33c03864e6eb80a62a2becd8529_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BaracludeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id17f257f5a7c4dbc8345593202162a88_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureProductsAndAllOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4424c6dea9c7491f8f20e9c0433f13be_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureProductsAndAllOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id047abc4cf2849648778e6a0d818e9c3_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureProductsAndAllOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib254059b72c444bda04963c50ac8c3da_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureProductsAndAllOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ica56fd0d45ed404fb6d997d7a91e781b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5c042daa885246149bd4021e6291c95b_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id685a03ea1c045aaa5b4626cdeefcaeb_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib0fb978e8fe747c9942de2c291d92e42_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i672de761cf0f4f38b3c9fcf5888c38d2_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6096b3e3535b498a93924c5913231bb7_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ifd5c352a490f4e2d80f9f07d00ca9ed4_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i22bc054236924180897608070e385339_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if3e30ddc627e420a994afe10df2aeb8d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie307dc58932a4abc95b857fff6abe287_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i0c1f985c4a994e87afcfa3b123c94fb3_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i736f109d294c4ccf9f1668181dc764f4_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:RestOfWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i930c547a007949018cbf51ca4060480c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i903cb47a089e41dbbdc585ba01f93a76_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i99e18e918d4a4472baa5e49400a3c3fe_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i21843a9ab91b446ca3cce0aa09d0bc13_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5bfd0c3b7ba94dc99db7d1c79cf4109e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iaad82054f6c24b28998fd0cc54e5f466_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3f4e8798cace48da8096f3940c34286f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i62270f651833483897b7a99025a3c056_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis">bmy:NetproductsalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if0056c94875c46578f2a3c81dbf029ef_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ied2b977f33414172a10da815fe24fa5e_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i959465a12b7a4107bdb5a01d7bfcc532_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i987d81167423465fad588659146ecff3_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i883fc4c8bc0f4255aec7223cc0f262b4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia927d1d44e99489ca715bf69330b08ab_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaa8c668e967e4f73affcc1b178e53fd6_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bmy:AlliancesAndCollaborationCompaniesAxis">bmy:EisaiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1726e9653791462e88d1e8fa6b55d2bf_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="bmy:AlliancesAndCollaborationCompaniesAxis">bmy:EisaiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i97d8d3703ed04fed8d1982e8631612c5_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesbusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9130fda1c97a4512869f8c40ceda43a3_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesbusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i874255d4051145ffb584d5ace4120829_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:ErbituxBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3b10d04730ab481fa4a091d91c386131_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:ErbituxBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic600cede908c45fd9de219d601e19f65_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia149c1d5e9ac4dea84e8c70a697500b0_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib432c7d456164aba93e919e08338e013_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibb48dbce12f842488d8e56ebc0551af8_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie92eb5d3a8224bf48b897ca58fe4dc15_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesbusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9e04e6f0f1cb48e8ad1a548c38f665dc_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesbusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic7f237dfaf294517a6c993c23a19c5a8_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:ErbituxBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2e3fa03c07574d4fae920e7935e8a621_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:ErbituxBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ica3960bd33c645d1bf92833258f53c54_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3ff17e3e1d554be8a5a2f24d9b41e2a6_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">us-gaap:ManufacturingFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7c7d34b293eb4396be52fdac70722a24_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:AvaproAvalideAndPlavixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia34fe71a86434a37a78799df75ebb670_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:AvaproAvalideAndPlavixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i766f66d3a5564477a5cee03c3f5dbfe4_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i51508ada4a88448fa0d47dbd056ce19f_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie5168aa9c0f548cf89708d739d0fbf68_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i33dbe127e2a8431a8d4df6ef930b3c47_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic81b26b07c5c4e61941a1674d76cfe98_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ica7f052bd75f40ccbb4445d5f8e47381_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i5a4f553f8932405197ea119b17e8eca1_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i77b50711d0f2426ab381586aa8a781f4_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib483860a3a46419ea7cade23a1f57af8_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id4f9948a6cc44875bca5c798572cafe7_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i652d5c5a16f54d499f777b18da32cbf1_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iac41a45cb93d4b57847364ccda78f7ea_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i14b8f5fa9564459e9343a7fbfae773f2_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia1b8cdf4c8fd43e5940c861fd7075cc7_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3fb344c7b5984689b0e077d03d0f5e83_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:AgenusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i93047c5690bd4da0b6566915947d0bb6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="icb6143c62bc94de08946b50699d69bcf_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ide8bf9df7627455e8b1decf3f9977ac6_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i75070985c9424f3586afbe7c4c8bf69b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic41a1bc571fe4873a7258b43472f3a1e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CompanyTransformationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8c68d9932836432cae27f5f3320513f4_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idd2855f0217247dfb6ab35e107cd3274_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9e3436bd7185495999f6d1496751f496_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5f59683c007c4e6b9b0b8bc87e2e9c64_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie2bf4fd36e0b487cb4bc3cf29adddd55_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i52b957a2c68f452c8ed0ce9191019247_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iecfdd1291eba4609ac0bb3efec2bf1de_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CompanyTransformationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i92805409d0e6445bb29744ae8cb018b8_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CompanyTransformationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ibd4eecd0bba84eb6a04beb957de7a224_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CompanyTransformationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic77161109800434da68b989c381905e7_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CompanyTransformationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id5f7660b6eca475a9df8e628fa445af7_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i635494ce148e4ad7bd650508b31a47f5_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i458d77e2e80747db91d6733fb12cc6f3_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic61bae9f14c94630811f2853573f8ff6_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1dec6245873f4d98820e4a2b35667387_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id6778a15e516498f97f88c860749c6a2_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2d23efb083df4012b861cdd74c430462_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i33981b78822f4f77be3c382064085973_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4c126874d2714146b7bf5cbc485c1cf8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i41d5a334a6e142f8bd67b8e51060b87f_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4662da4bb2b6479993d2a5b55ba2078b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5431747aab134732bd974c5723251eef_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i704336f4184942a3983f50159a480277_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id1232e4b20d8401ba7060d232ed7fe2f_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8689b4d5000b4d5b8e0fc3554738970e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6931cd74ebe9437fa587ab6b851ccf58_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie5b48843789843e59015f89cfb97e96a_I20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2021-01-01</instant>
        </period>
    </context>
    <context id="i8b7251412f7b43c9817b299748e1d079_I20200101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <instant>2020-01-01</instant>
        </period>
    </context>
    <context id="i0a5a5daa7bb24250bb98daa1532976bb_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bmy:AcceleratedStockBasedCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i12fc955bf6c34929ae7dc5a546b6e0e2_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">bmy:AcceleratedStockBasedCompensationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4b0b5444987e49eba4f8bafbffef80f3_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:DeferredIncomeTaxExpenseBenefitComponentAxis">bmy:InternalTransferOfProductRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if7fd398a275d49b7ac8db542e423dabb_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:DeferredIncomeTaxExpenseBenefitComponentAxis">bmy:OtezlaDivestitureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id3a7e6213d5a4e98bdeddda2ad09db70_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i007d2ce5a6594dc2b97f4d6dde2a3170_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7e8abfc7c4684a2e80153d093765a7b0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ife50b98ec7264eb7a37a0b687539d4dd_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i281eaf8778b946efa6523d049bb63601_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i19f789ba573d4f3ea505980fcb78be12_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id7c1be369f724e7a955da101f61cd0cb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0afe166f4d814c949b6b416e46eb5544_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i295633493d6b475f86d6737b887dba92_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i45f649e8a6934c6bae4029abbff213fc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib7b083b368d44b519124184b6c12db87_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifa523e1aa7274232a186fcca3656cab6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icc71b68bc0be4ab58521b097b145bced_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7be4a1f26072441e8e2c3e8802de46f0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i06a7cf8e55bc4f11ae11dd2f4e67ba53_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i27ebf9edff0b44398e9b44f2f4a6f076_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2e46d25a491547498b733410813929a0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie66cb746be9f47e7ac4434960e977507_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4c8c40a0c0854d7fad1b783d8d1ad346_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0e8619d5b7674406b0c8e75b507643be_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9778045c333646e8abc7df95736d6051_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib5047f95b2d744b4b59d1b78d6a742f4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4783faea57834d3faef3b5be5df299e6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic82867d41cc6438396b8ea9165e07f1e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia0603128401446e3b0ba870450ab65d1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9be6d10579a84d6ba5f91b6e23177b72_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i39a1379770a94344b49dfe53b78ea4c4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i890225c6ebb14bdaa4c35b58daa47553_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i85ae89b3bbca4fbdae10aba3669ee6dc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4f39bf27565748b9ad84356a93cb08c7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie9602884451440a58383e854523622d4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1bacf915b38e4bef995b2dd60b16d847_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id75c7a7e91df4d63a4260a384377a6a3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ice980dd1a7be4e65a57342c85ac3474a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id818743065664bfbb207dcd02dc3e2b8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9d8a4ac8110a40668a2b2d95ce32cc86_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bmy:ProbabilityofpaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if862182d7eed4a4e9ea6d6d9a6f57901_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bmy:ProbabilityofpaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i11aaa3096c4a45f28755610b228eadd2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bmy:ProbabilityofpaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8707328f1c9f418da8c326940d5bd515_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bmy:ProjectedYearOfPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifb8b81529e9f4bf98e414922640a88dd_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">bmy:ProjectedYearOfPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i42b5dbab27a246b580a0579f0d96dee6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6b39484540fe4cbc883405fbdd50a2a3_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i223b2b374fb24a7d8be48fea190eedba_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3d5fac886ff9468f8c6b82d4defc7d36_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i7f6352735c144034ac2187ca79647025_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2fe27ed6226d4cfebeb1acc8eb2bb428_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i94c67e9d77694b95b51eb292c0bbabf3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idea685dade76458eab354edd649e002b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i49d5fe3c29f447488503ee61f2d0f306_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8d350c2a507842a4a422ebe184b11256_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:PortionAtOtherThanFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0001595c39db4736ad8e580f9c067231_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia798a6fcbfcc42a0999608b439adcc0c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib8f2c3191d174bad82233a9c00d673f4_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1a0fef7903e64aceba3bf6ce6985f3f8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1711123502af4500920896ecd1971e9f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i503baf5ee2d04e92a42c2e74373c367f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i51131dd320a4460191e1c989fc55992f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2128b1046e77449aa3d997f0af1b147f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibc20d792e8ad475b8810d5c836c79acb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia84e2ffbd828434c81d0e6e257c9513f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i720683b7e67645e39106e79e4bb6820e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1c833d9f2fd046aabaf2cff398ab0295_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia9a0e466309e459caa62b42f8c64930f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idbdf809d037e43b7a052e7b6ab343594_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6d2f391e801c437fa61b6d9d96a8e0b9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib4b905331bfb45eca6d2a44c4ebd6cac_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i169cfb4fb02c4b9893207821ae8f03d6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icaa06a3db7a24003a0dd163a30a2bef2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2b5f2855511343508c746e24df19dd1d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0eae85fd04334a66abd5610c6363b26e_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i24cf699361b744ed89ad8d71f69dd889_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if9865149104a462288aa6782497c61f0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5e53811b7cb644a29bf23fbcea6510f9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i87f0786ba2604a61a85c170d713e9a62_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i75483d744b7c4203b5ed365f7d3b3487_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0f35f618e55b455cae0cb2a21eedc388_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8954d0e37bc949059fbcfb86b9342723_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i47aba9a8009e43b09b026ddb97e17378_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i11a8aa24b66f48fa9bbbfce49c6808f3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieba83eb6b5174206bc5a3b89f15c45f9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic978b78a584f466288031da3261d83d1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib1241abc16f54f05b6af70bc4b195625_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i49e79afcda54470890d42c058ee6dc8c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib6b878c72f514738ab932426ec0acf2a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i999b17f195aa48cb93d5044e50370923_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2a01cd6e61f342ecb975f4ae6f8d59b1_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5e7f71ec07cc4f4c9afc10bc72f6c0e5_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i040292e730b343eb80b604d175386271_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i35ce00fcc7a44969901d544fba9f7b94_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i508f07be751744a09a404b382976e275_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4696e702fafb4492b4c7d9e523e4af6d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib7f3a7ad072c43a08ec6727c68cc2efd_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id07c76256d36464aa236c8edf59250ae_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i00823395d1374179823132245b682350_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icf03f7c455ce4b9d89fbb72f7c41488d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7ed527429005415da9fb10074bfa1097_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie95af335802a4c1e92654a4464170a9a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7d2fe3e02fb94bb984fa1b11e225751c_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i486c191850aa49a682074690ecb19563_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i077b4ec5d45b4aa3a708e5adcef3cb7c_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6dd4ff55ae1249c1ad68411a97f3e848_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i245e38fca4f8467e86cdbf4e1e5cc67b_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i21fe606592d3458e808226e33cf944a6_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i151fe4a021694b3b93a3419d9cc35d09_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ieec4fe8c5b2b4a388f9c647f9b3c0879_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i229107cac324432f8447407f665ddee5_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if631f8e8a60942b4802fe350a6de182a_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ife8a0faa825047398cc2bc639c58ec3a_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9b690964ca6348bc97ef500ba4781adf_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i660d02e3c5404f8c82f9d6bffa9d69a2_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bmy:ZeroCostCollarCurrencyContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iecad268758bf4f57961916a30d5b23bb_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bmy:ZeroCostCollarCurrencyContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i49ecccdb7d504e33ad7566e82d10b7af_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bmy:ZeroCostCollarCurrencyContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i97351a916177459f9564953cbd8db5b7_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">bmy:ZeroCostCollarCurrencyContractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic7532fb922404416bf6c1a4f59828fc3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6a94a414c588439da957589012a52bce_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9b8a19e9be6947c29fae71035f799b8b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie9967a3c6dc845d9ac2ae782bd268a81_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i907aadccc2844fa8b86616d86e1395f8_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5d7cbfcfe0e044538ff7a63b3ad018c3_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i85dd208285f94cd6aff62add53ee5706_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i47b91d980e0a450fa568fc15b6e2b9b0_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9f3f06024f654b51b3f6b0bca6aaa058_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5604822aa0b342079d2242f61089bf43_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3a7cece24b0c44179822ebe709140263_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie7daf934932b4999a9e8c82bfe559ddf_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i836ec8a900f94ab2a0cd3662c33ba2d1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i816b15b9810f468d87ef913a5c6b3461_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib87554b0ae72494ba6568a952ddc9510_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A2.875SeniorNotesdue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i18088008a5b7409bb866ff840040d19a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A2550SeniorNotesDue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i643fc6ba1c2a4f778dbb32207ff363ed_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A2BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3d62c55572e74536af7ed82dceb0ea9d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A1BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i48e73501dc964ac8b84b67b3240d49b3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A1.5BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i85e0ac7571b54abf896103b5b9c3df12_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7913fb01092e4ed1a1dc7490f44c3094_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i930ff8105ccb4bfdb0a95257468399ad_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:InventorypurchasepricefairvalueadjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4d1422bf6081497aa35d71735c851dc2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:InventorypurchasepricefairvalueadjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i63f5d7d2d5cf421986ebe6aec3d0d063_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if78324cfda1641a185f98458b48b3ecb_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idc8f651960ff49fb8e4847dbc3db39c8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4a2b2474f0d2424ba498502d3afdf9ac_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5d8e439af78d4f5092229ec245f1b0a5_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i626ddd6ff5464b57a8e4e7c44e82a64a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i102ed3efbe22488096250a07cec1ae7c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic566d16d5a584f8ba82df664242cf607_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5e217c9f1d8b4cc69ebcdebb33546c57_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i56178daf0b264e019ba2dccbd26473ad_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i815f8cb9efb94a46b64a44a73c8875bc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4cef45113fe040d78e64dcc2d006f97b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4d6ab1d8fecd41948785ff0b6c9a68b3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i290ccdb912fe48f08d595add1473c16b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i52bd0855efcc4aeeae1fe88706edf18e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:IntangibleAssetNameAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ieff455ef39df4956a451fdaf9767810c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:IntangibleAssetNameAxis">bmy:InrebicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i640a43d1b691485e977b3192bef77d58_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="bmy:IntangibleAssetNameAxis">bmy:InrebicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i934da5addaea4028be7894d0babddfe5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i11d3b9fc864643c6963d52987b8077d1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i740f1c260f5842e38801cdbe44935148_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i067540008559441b824143d0812aef90_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if693f3f9e803446e93591493d837c4d2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5e5310947a3340a3a0bcf32e64131e15_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic2634a7150984700b4940996575435e4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6796f93ba1454a58aa1ce90e9373d79e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib3a03601e6ad43e8a39684c20e526fc0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iab66f12d5bc4445bbf732048a5db1c7c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0bb4376df4e144078f75533316d9e77e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6c3370e41cf9405a9a160e64209a8f68_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1d8bd1acba944731b23be9a517a5eeb0_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ice500bf4ba6c4e908a4b5c93b15b7a60_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2be8a05661504ad99b17ef9c22efd9f7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib89fb11161f146d2a6fb0b08fa2ddbd7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i60e4a51934264054a72db8bb72b4bc16_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ief956f040cf142c48a760f89d051c7ba_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4a550b5d610e43ddacb1196fc31b2232_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i01588a18f30f4fa1ad0bd69b5101f669_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3e1bc2ac43bb413ca28382700af763ae_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1a4b6a65d77842f48e59e61b100ac7d3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9407dc04bd514a50a293bf46404d43d3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id929872bbc96437d9c359988e5567a7c_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2148fb9192764819b1bc0f8addaa98cb_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0a9500eccacc46d69322333bfa03f25d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i60767f8375e34e8a8c2ea7e77e7f3ec5_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ied5e0053e2f04982aa1a2cd60b3e95b3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i0daf74a0447c4e5786bd5ce58b6cc832_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i737d30e7e58d4ea790fbbd242d2423fd_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4bffcc25a557427c9a4c65a954674dca_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i43239b9f5ca7485fa0251240b365648a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifc37ebada08d41f5b8cef803d7d03074_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2981a3b1644448f6af2e5cb8836ff464_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i725849a6245d4c18813876f45d26ebdb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifca693e8a4cf43a3b6314d8fd10f8054_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iacdee3fad3484ddab95c12653c99c649_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic8ddca453e0f43dfa8c50a7b44bba5fa_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia6cc956e9fbd48ceb2f65194ea049395_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i003da07e864e44a69c31e7e8a1d52e15_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if5984e1f2ba843eb986403e94d6961c1_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6e4590ddb4bf4965b0a342ff22eaa166_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i0e96ce8b1bb142a2a63dcf6656d59225_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i5969c9dafdd447f18f7192246fac8838_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i5504708828644783aaf1fb1bdfaac8b9_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i6451959c27fd4a229abd87573f36e73a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iaf435eb9cba84175bb13fd5a7add0851_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ifb8aad97592342f69c4ee4f99b65f30e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i907bc8e8b73443428348fce6c8e4d9f2_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ic7672c07fdb549a49def19893f3bd52d_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i35a526307c454beb9945dbdb361e919a_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ibf55f775dda94251ae451da6e98bfa21_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if63b4ca36e134e4c93b3e20bfbe40fe3_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id4a97b03d1a440f9a8664a3da44ee846_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2ab20791a5084b878272689919dd7486_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i30ce3f779b954838bbbf7b6ff1bbd7e9_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i20caf63fbd6041669bb1f806943db28d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i695a7cf7ff314bec908a24d933d5cf63_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i235fc5676d984fff868b737072a6d629_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i4185f4aac2534ed88f533f59619f62a5_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i4276b9e3a3cd4405967f02d58a3d681d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iac2000f1209140fe919895b22d38de16_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ifbd79ec1a2164f3d8aefdbe1d165744d_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id74cc59095d040258cf00ef2e809efa0_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7ec7443f41ce4644b7444730381aeb04_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2da4dc33dbfe427290747f6b3396e0bc_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2c94d13219ab428992afd3b5b0c2e8aa_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i802d457ae3ce494fba78c18db7fb4724_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iae0c6db08abe4f8aaa95195fc68dcb83_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmy:MarketShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8a0d23cf191d49859d545cf81fc83b99_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icb9926c1623d4307b449847e25ccb9a6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2a59bc20a4164faa942cd6df346323f9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if2259fe062d9455c84a896e821c65d2f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmy:MarketShareUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8621d1eb8ad941d1b61fc0b3eb0c0104_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5d714c61f30d48e6a0408831871d837e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i00042bb08bc247c88f649c75d7bbb73f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AntiPD1AntibodyLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6f6c2befa4b34a0a81ba3b0e9556df39_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmy:UpfrontmilestoneandotherlicensingreceiptsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i2468cf0aaf4c49ab87c383ed553537e0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i64a8873ecda74aafb2ceeed0be390c87_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:EliquisPatentLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibd94bed0537c407e93ce5a3d80b707af_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:AUD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:PlavixAustraliaIntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia4e7cac4d7fc407bbf7a0cfcc8e6a83f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:PlavixAustraliaIntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i86db086f990f485eae2c529279a9b3be_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AbilifyProductLiabilityLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i69bcd074cc8f40729d45455b3b8c32f0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AbilifyProductLiabilityLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">bmy:DismissedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic26045979d2740d8b8904c0387c53e4a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AbilifyProductLiabilityLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">bmy:DismissedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if9edbfdefa9f4c869623f5989777a4d3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AbilifyProductLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if0ca0adab86748b08591cb41bae7063a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:ByettaProductLiabilityLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="icbb5732de29d4e31bb981cab01299d47_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:ByettaProductLiabilityLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic175769943af4209805f2855da447a24_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:OnglyzaProductLiabilityLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="icdc726e72d84409b8ca5e19dbe8e141c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:BMSSecuritiesLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie36b4dda4d274314992050f1a7686ae7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CelgeneSecuritiesLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ie5d797c7be774aa39277765dc8964e48_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000014272</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CerclaMattersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="percentage">
        <measure>bmy:percentage</measure>
    </unit>
    <unit id="y">
        <measure>utr:Y</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="lawsuits">
        <measure>bmy:lawsuits</measure>
    </unit>
    <unit id="numberofplaintiffs">
        <measure>bmy:numberOfPlaintiffs</measure>
    </unit>
    <dei:EntityRegistrantName
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80L2ZyYWc6MjhhMTI3MWEzMjZkNGU1NzgwYjc1NTY5ZGE0MDViY2IvdGFibGU6ZGY0ZDBkYzU5YzUzNDZkNzk2MTg5YWM0OGNmN2I2ZWQvdGFibGVyYW5nZTpkZjRkMGRjNTljNTM0NmQ3OTYxODlhYzQ4Y2Y3YjZlZF8zLTEtMS0xLTA_cae95193-8d1d-464a-af34-21114a58d4a8">BRISTOL MYERS SQUIBB CO</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80L2ZyYWc6MjhhMTI3MWEzMjZkNGU1NzgwYjc1NTY5ZGE0MDViY2IvdGFibGU6ZGY0ZDBkYzU5YzUzNDZkNzk2MTg5YWM0OGNmN2I2ZWQvdGFibGVyYW5nZTpkZjRkMGRjNTljNTM0NmQ3OTYxODlhYzQ4Y2Y3YjZlZF80LTEtMS0xLTA_c11e1e0a-7c55-4bd4-9c31-bfd0a62836b2">0000014272</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80L2ZyYWc6MjhhMTI3MWEzMjZkNGU1NzgwYjc1NTY5ZGE0MDViY2IvdGFibGU6ZGY0ZDBkYzU5YzUzNDZkNzk2MTg5YWM0OGNmN2I2ZWQvdGFibGVyYW5nZTpkZjRkMGRjNTljNTM0NmQ3OTYxODlhYzQ4Y2Y3YjZlZF82LTEtMS0xLTA_fd849ec4-327b-4d10-99b3-2147c6c901ac">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80L2ZyYWc6MjhhMTI3MWEzMjZkNGU1NzgwYjc1NTY5ZGE0MDViY2IvdGFibGU6ZGY0ZDBkYzU5YzUzNDZkNzk2MTg5YWM0OGNmN2I2ZWQvdGFibGVyYW5nZTpkZjRkMGRjNTljNTM0NmQ3OTYxODlhYzQ4Y2Y3YjZlZF83LTEtMS0xLTA_4f851c64-d88c-4668-a1b7-c43b8179f555">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80L2ZyYWc6MjhhMTI3MWEzMjZkNGU1NzgwYjc1NTY5ZGE0MDViY2IvdGFibGU6ZGY0ZDBkYzU5YzUzNDZkNzk2MTg5YWM0OGNmN2I2ZWQvdGFibGVyYW5nZTpkZjRkMGRjNTljNTM0NmQ3OTYxODlhYzQ4Y2Y3YjZlZF84LTEtMS0xLTA_18d73d25-4594-477f-89b9-c08547201f40">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:AmendmentFlag
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80L2ZyYWc6MjhhMTI3MWEzMjZkNGU1NzgwYjc1NTY5ZGE0MDViY2IvdGFibGU6ZGY0ZDBkYzU5YzUzNDZkNzk2MTg5YWM0OGNmN2I2ZWQvdGFibGVyYW5nZTpkZjRkMGRjNTljNTM0NmQ3OTYxODlhYzQ4Y2Y3YjZlZF85LTEtMS0xLTA_ef75446d-e263-4d8e-bcde-201f2c3d3318">false</dei:AmendmentFlag>
    <dei:EntitySmallBusiness
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80L2ZyYWc6MjhhMTI3MWEzMjZkNGU1NzgwYjc1NTY5ZGE0MDViY2IvdGFibGU6ZGY0ZDBkYzU5YzUzNDZkNzk2MTg5YWM0OGNmN2I2ZWQvdGFibGVyYW5nZTpkZjRkMGRjNTljNTM0NmQ3OTYxODlhYzQ4Y2Y3YjZlZF8xMC0xLTEtMS0w_ae467df2-c748-45d9-851c-3a7bd5a9ad6e">false</dei:EntitySmallBusiness>
    <dei:DocumentType
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDcx_bdce5614-0585-44bf-8031-ab8bf08d549b">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDY3_e49b2958-dd05-428b-ac1a-2f376f39ccb8">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNjg_3277279d-d96a-4899-be2c-11d875fffc6c">2021-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDcy_9adfbd05-a8f8-40d4-87a9-34a1c61b5a08">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDYx_428b93d8-9ff0-41c7-a59b-258f02043860">001-01136</dei:EntityFileNumber>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6YjE1MTE4NzA5NzViNDRkMmE0NWYyNjY3NTMzOTAzOGUvdGFibGVyYW5nZTpiMTUxMTg3MDk3NWI0NGQyYTQ1ZjI2Njc1MzM5MDM4ZV8wLTAtMS0xLTA_71b59a21-a6fe-4490-9e19-4e653f190ecf">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6YjE1MTE4NzA5NzViNDRkMmE0NWYyNjY3NTMzOTAzOGUvdGFibGVyYW5nZTpiMTUxMTg3MDk3NWI0NGQyYTQ1ZjI2Njc1MzM5MDM4ZV8wLTItMS0xLTA_4637fe8f-6aec-4aed-ad14-b1c4ae88544f">22-0790350</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDYy_6b01a61b-459f-43da-bb11-1b85d3fac6e3">430 E. 29th Street, 14FL</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDY4_75238035-c208-4430-8f3d-a0729e895fba">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDY2_51ed6a24-7152-46dd-b7a9-1c5d0724de53">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDY5_8b093843-f34c-4da8-915d-2d160e851df3">10016</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDcw_c3e01ead-6063-4489-a096-e1e85f46bbdb">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDcz_2447019e-74ff-4313-b5a9-cd38901d28ce">546-4000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i650335fbf368429d829c268d43369fd3_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6ZTE5NjhkYjU4MmQ4NDhlMzgwZGQ3ZDMyZTg4YjNjNWYvdGFibGVyYW5nZTplMTk2OGRiNTgyZDg0OGUzODBkZDdkMzJlODhiM2M1Zl8xLTAtMS0xLTA_713cb790-ac6f-4a8e-8d0f-1baa08c33676">Common Stock, $0.10 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i650335fbf368429d829c268d43369fd3_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6ZTE5NjhkYjU4MmQ4NDhlMzgwZGQ3ZDMyZTg4YjNjNWYvdGFibGVyYW5nZTplMTk2OGRiNTgyZDg0OGUzODBkZDdkMzJlODhiM2M1Zl8xLTEtMS0xLTA_44ef61b3-2ca3-410e-8c31-f1ccc9c0d5d3">BMY</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i650335fbf368429d829c268d43369fd3_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6ZTE5NjhkYjU4MmQ4NDhlMzgwZGQ3ZDMyZTg4YjNjNWYvdGFibGVyYW5nZTplMTk2OGRiNTgyZDg0OGUzODBkZDdkMzJlODhiM2M1Zl8xLTItMS0xLTA_8b75f6cb-6d28-476c-b6e7-15db093971e2">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i09e7550d3d6747878d9932ee8f7b6612_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6ZTE5NjhkYjU4MmQ4NDhlMzgwZGQ3ZDMyZTg4YjNjNWYvdGFibGVyYW5nZTplMTk2OGRiNTgyZDg0OGUzODBkZDdkMzJlODhiM2M1Zl8yLTAtMS0xLTA_f31f227c-c2f3-47a3-8698-48d60a6b97fc">1.000% Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i09e7550d3d6747878d9932ee8f7b6612_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6ZTE5NjhkYjU4MmQ4NDhlMzgwZGQ3ZDMyZTg4YjNjNWYvdGFibGVyYW5nZTplMTk2OGRiNTgyZDg0OGUzODBkZDdkMzJlODhiM2M1Zl8yLTEtMS0xLTA_dd8abae2-73c4-484f-8fab-2cfa684547b2">BMY25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i09e7550d3d6747878d9932ee8f7b6612_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6ZTE5NjhkYjU4MmQ4NDhlMzgwZGQ3ZDMyZTg4YjNjNWYvdGFibGVyYW5nZTplMTk2OGRiNTgyZDg0OGUzODBkZDdkMzJlODhiM2M1Zl8yLTItMS0xLTA_8b5816bc-d595-4f6c-9dfc-bbea2eefb935">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ie8f5c380201f42d0b61df63f743953bd_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6ZTE5NjhkYjU4MmQ4NDhlMzgwZGQ3ZDMyZTg4YjNjNWYvdGFibGVyYW5nZTplMTk2OGRiNTgyZDg0OGUzODBkZDdkMzJlODhiM2M1Zl8zLTAtMS0xLTA_4705c3cb-6d95-44ab-86f5-52d8c585ca79">1.750% Notes due 2035</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ie8f5c380201f42d0b61df63f743953bd_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6ZTE5NjhkYjU4MmQ4NDhlMzgwZGQ3ZDMyZTg4YjNjNWYvdGFibGVyYW5nZTplMTk2OGRiNTgyZDg0OGUzODBkZDdkMzJlODhiM2M1Zl8zLTEtMS0xLTA_a760befe-64a5-4091-94da-01ae1ceb9aa3">BMY35</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ie8f5c380201f42d0b61df63f743953bd_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6ZTE5NjhkYjU4MmQ4NDhlMzgwZGQ3ZDMyZTg4YjNjNWYvdGFibGVyYW5nZTplMTk2OGRiNTgyZDg0OGUzODBkZDdkMzJlODhiM2M1Zl8zLTItMS0xLTA_79f1ed29-76e4-42c7-bad2-80fe9a7ed14a">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ia6d0ddad70114b6a83f55355ff735cf0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6ZTE5NjhkYjU4MmQ4NDhlMzgwZGQ3ZDMyZTg4YjNjNWYvdGFibGVyYW5nZTplMTk2OGRiNTgyZDg0OGUzODBkZDdkMzJlODhiM2M1Zl80LTAtMS0xLTA_d142208c-1a62-4b86-af26-49e164bb4098">Celgene Contingent Value Rights</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ia6d0ddad70114b6a83f55355ff735cf0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6ZTE5NjhkYjU4MmQ4NDhlMzgwZGQ3ZDMyZTg4YjNjNWYvdGFibGVyYW5nZTplMTk2OGRiNTgyZDg0OGUzODBkZDdkMzJlODhiM2M1Zl80LTEtMS0xLTA_c97cfb11-1606-41e0-aa00-bee3f338e9c0">CELG RT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ia6d0ddad70114b6a83f55355ff735cf0_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGFibGU6ZTE5NjhkYjU4MmQ4NDhlMzgwZGQ3ZDMyZTg4YjNjNWYvdGFibGVyYW5nZTplMTk2OGRiNTgyZDg0OGUzODBkZDdkMzJlODhiM2M1Zl80LTItMS0xLTA_6ff69a9d-25e2-4a11-bf28-b4b0cf56ddff">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDc0_b757ca3c-50dd-4e49-ae65-62534925c4f5">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDYz_d227e917-265e-40e1-8eda-57dbea834617">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDY0_72cede2f-df28-4007-b486-a2490de41378">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDc1_b7b7551d-519d-4754-a8f2-26879e281934">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yNDY1_92a73013-cf9a-4437-818d-24a5af9a02cf">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xL2ZyYWc6ZTBkMzNjNjgyYWY2NDZjYmEwZmVjM2QxMTIzZDljNzcvdGV4dHJlZ2lvbjplMGQzM2M2ODJhZjY0NmNiYTBmZWMzZDExMjNkOWM3N18yMzg4_9d23fc3b-2963-4bda-b9f3-4607cd642c33"
      unitRef="shares">2222113553</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Revenues
      contextRef="i8d9276ebf40046b4a41a5f19262377b1_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMi0xLTEtMS0w_00e69cfa-9372-49f2-8519-a9501ab4fa3f"
      unitRef="usd">11405000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i693b996ab36a4cebaefd928a05970180_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMi0zLTEtMS0w_ab59e6bd-730c-4494-9b56-e8fa70a4c7e3"
      unitRef="usd">9817000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie656e6b5b421495887e8721375eae829_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMi01LTEtMS0w_d6987c1f-0a18-4f63-b075-7dd3290c1e5a"
      unitRef="usd">22203000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i70262bb79f2b4fb682856a49e0942b2a_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMi03LTEtMS0w_df9276c7-9ba1-43d0-9d2f-0390342687df"
      unitRef="usd">20358000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie92d7cecd5b8445a9169fd5dbf526e4c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMy0xLTEtMS0w_0758d695-f101-4f35-90ef-26fa421cc73e"
      unitRef="usd">298000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibb180892039d4e5b82c0a8f7673aa38a_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMy0zLTEtMS0w_e13966f3-7ab5-4a81-9040-a7825fc871aa"
      unitRef="usd">312000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if28849fb4b9345149f1a1b15340c1cee_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMy01LTEtMS0w_a283617d-7542-4048-b192-d391ba01f3e3"
      unitRef="usd">573000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4be7577ef3cc4c838eb6fc6d157858b7_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMy03LTEtMS0w_4bcf83e5-92e7-4431-be7c-454b64c8a3c1"
      unitRef="usd">552000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNC0xLTEtMS0w_99e5cbf6-b199-4b55-94f7-8a3832cefa61"
      unitRef="usd">11703000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNC0zLTEtMS0w_b8628e5c-b814-40da-a20f-fb8e7f7f6857"
      unitRef="usd">10129000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNC01LTEtMS0w_1a56576c-5ec3-46ee-8bab-ee488a2d6c7f"
      unitRef="usd">22776000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNC03LTEtMS0w_56075369-fd1d-46b4-9ad6-512bf564883c"
      unitRef="usd">20910000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNi0xLTEtMS0w_854dcc1c-daf5-4493-b28a-375e5aa89e7a"
      unitRef="usd">2452000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNi0zLTEtMS0w_7ec21314-9a79-4478-9828-3ae79b144f31"
      unitRef="usd">2699000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNi01LTEtMS0w_36d7e790-1e53-4df5-b2f7-b7fd854fcc84"
      unitRef="usd">5293000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNi03LTEtMS0w_3d14026d-5421-48f7-b0e4-36459f872b48"
      unitRef="usd">6361000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNy0xLTEtMS0w_1f29284a-2660-4fd6-895c-1190af92e23d"
      unitRef="usd">1882000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNy0zLTEtMS0w_f34f9f36-d14d-4a7f-9a1d-0fb3d0e398c4"
      unitRef="usd">1628000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNy01LTEtMS0w_9ff183b5-17b9-4829-8309-3cee1d3892fe"
      unitRef="usd">3548000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNy03LTEtMS0w_dc4b1b68-2647-43ee-9983-d7d29369017f"
      unitRef="usd">3234000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfOC0xLTEtMS0w_89a13833-3940-4ad4-b82b-0771f519e369"
      unitRef="usd">3271000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfOC0zLTEtMS0w_a89e9625-8179-4c5e-a836-bcf29ba4c22c"
      unitRef="usd">2522000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfOC01LTEtMS0w_96945ef2-2542-4116-bbd4-061f7e285cfc"
      unitRef="usd">5496000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfOC03LTEtMS0w_1b403d95-f536-4c45-b0b7-11662866b467"
      unitRef="usd">4894000000</us-gaap:ResearchAndDevelopmentExpense>
    <bmy:AmortizationofAcquiredIntangibleAssets
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfOS0xLTEtMS0w_328e84dc-6ab0-4ff2-89cb-794d5626e480"
      unitRef="usd">2547000000</bmy:AmortizationofAcquiredIntangibleAssets>
    <bmy:AmortizationofAcquiredIntangibleAssets
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfOS0zLTEtMS0w_12895560-7493-490a-bd5a-5f47ca93007e"
      unitRef="usd">2389000000</bmy:AmortizationofAcquiredIntangibleAssets>
    <bmy:AmortizationofAcquiredIntangibleAssets
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfOS01LTEtMS0w_961d1f9c-50d8-463d-be5f-44a2786e11ae"
      unitRef="usd">5060000000</bmy:AmortizationofAcquiredIntangibleAssets>
    <bmy:AmortizationofAcquiredIntangibleAssets
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfOS03LTEtMS0w_93f9f5d6-8c4f-40ad-be39-8c14c01b3e63"
      unitRef="usd">4671000000</bmy:AmortizationofAcquiredIntangibleAssets>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTAtMS0xLTEtMA_06bdd6ca-8eba-46c7-a8fa-4c542fff63ca"
      unitRef="usd">2000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTAtMy0xLTEtMA_02bc786f-ee8e-4e9e-95ba-21a7e06dbaec"
      unitRef="usd">736000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTAtNS0xLTEtMA_b71666d3-fd4a-4982-852e-3f30bb750e5b"
      unitRef="usd">704000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTAtNy0xLTEtMA_4b4f46e6-a619-4fd7-8a61-4cdfd7799474"
      unitRef="usd">-427000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTEtMS0xLTEtMA_9c5ab519-eab0-462b-b03f-46df93458296"
      unitRef="usd">10150000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTEtMy0xLTEtMA_13a98c3f-222a-45c4-9771-ebfd48638f56"
      unitRef="usd">8502000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTEtNS0xLTEtMTk3NA_aad35898-00e5-488f-b2b3-aaa360537f1d"
      unitRef="usd">18693000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTEtNy0xLTEtMTk3NA_f83af609-4029-4753-89b4-c42c3391bda2"
      unitRef="usd">19587000000</us-gaap:CostsAndExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTMtMS0xLTEtMA_e3536a23-0a27-4495-bfd1-f5d17abde2e4"
      unitRef="usd">1553000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTMtMy0xLTEtMA_f818e0a5-250a-4923-8021-699a0da4e4f8"
      unitRef="usd">1627000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTMtNS0xLTEtMA_48a8b3af-3b50-4dff-9865-aefaa5bd7d3d"
      unitRef="usd">4083000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTMtNy0xLTEtMA_ecd22322-9894-45b4-8889-ab8a04348ce4"
      unitRef="usd">1323000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTQtMS0xLTEtMA_13015e9e-a15e-4f01-9f3f-98bf300c5398"
      unitRef="usd">492000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTQtMy0xLTEtMA_e45c1c64-af44-4d9b-97bb-27ebe850fc4b"
      unitRef="usd">1707000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTQtNS0xLTEtMA_faa2a2ed-f5bf-44d1-a782-4330947e166e"
      unitRef="usd">993000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTQtNy0xLTEtMA_042ed61b-2ca8-44ed-a65e-8fe7a7d1ac11"
      unitRef="usd">2169000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTUtMS0xLTEtMA_e466d26a-d02c-4dcf-ae2f-9e79283b0793"
      unitRef="usd">1061000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTUtMy0xLTEtMA_1f19d942-3da6-4e76-a2ce-b69a457b7f55"
      unitRef="usd">-80000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTUtNS0xLTEtMTk3Ng_ddf52a24-9db9-479d-b558-0916c0709791"
      unitRef="usd">3090000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTUtNy0xLTEtMTk3Ng_731b895f-9ce9-42c1-ae57-986e311d74d8"
      unitRef="usd">-846000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTYtMS0xLTEtMA_da047a4b-8bfa-4355-9bcd-e9fb77b2623e"
      unitRef="usd">6000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTYtMy0xLTEtMA_c6c258fd-1aa2-43d3-a163-86491af640b7"
      unitRef="usd">5000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTYtNS0xLTEtMA_7d32ad19-1d1e-42bd-bc84-412497d12355"
      unitRef="usd">14000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTYtNy0xLTEtMA_931571d7-27d7-4df3-b1f7-deec15db1dbe"
      unitRef="usd">14000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTctMS0xLTEtMA_1e29fbe5-c968-409b-b997-4ff8aefe8c74"
      unitRef="usd">1055000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTctMy0xLTEtMA_2b15a518-5373-4175-94e9-a958b15e77ac"
      unitRef="usd">-85000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTctNS0xLTEtMTk3Ng_549f42f7-bdcd-412b-8916-1d0f2c027fc9"
      unitRef="usd">3076000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMTctNy0xLTEtMTk3Ng_825e3536-266f-47cc-a032-97563c08ca85"
      unitRef="usd">-860000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMjAtMS0xLTEtMA_6b7581d9-4899-4cb4-8c27-b25889d894b9"
      unitRef="usdPerShare">0.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMjAtMy0xLTEtMA_4a2dc41c-493b-42cc-9dfb-aed68b3ab8a0"
      unitRef="usdPerShare">-0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMjAtNS0xLTEtMA_ed7942be-b29e-40c2-929c-2876edcf6597"
      unitRef="usdPerShare">1.38</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMjAtNy0xLTEtMA_e38afe39-b228-4235-a93c-15b5aa2a71f5"
      unitRef="usdPerShare">-0.38</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMjEtMS0xLTEtMA_71b34a20-723e-477a-8806-759714c762ba"
      unitRef="usdPerShare">0.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMjEtMy0xLTEtMA_d7c5265c-672e-4595-a9e6-754a34e2aec4"
      unitRef="usdPerShare">-0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMjEtNS0xLTEtMA_7d3e0dd6-b4df-47a8-b7d6-8243c34eb9f9"
      unitRef="usdPerShare">1.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfMjEtNy0xLTEtMA_79b8446f-4884-4529-b8bc-523d62c9b9f2"
      unitRef="usdPerShare">-0.38</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ProfitLoss
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMi0xLTEtMS0w_a03e1731-5ae2-4fba-bd7c-eabebce1e536"
      unitRef="usd">1061000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMi0zLTEtMS0w_f080e8d3-cf58-4348-8219-b020c18dfc5b"
      unitRef="usd">-80000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMi01LTEtMS0w_12674bf0-8190-4fb9-9a48-fc16a5db92e4"
      unitRef="usd">3090000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMi03LTEtMS0w_7cca3464-ac31-4112-b05e-d5646473c713"
      unitRef="usd">-846000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNC0xLTEtMS0w_189a29e0-6f7d-47b7-9df7-eff3ed42167e"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNC0zLTEtMS0w_0fed6999-26f5-456f-9658-68d8ccc2e3f0"
      unitRef="usd">-59000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNC01LTEtMS0w_1931ef34-1233-4909-8225-583f48e5e90c"
      unitRef="usd">286000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNC03LTEtMS0w_abef496a-2cca-4f83-8bd3-b286b8f17721"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNS0xLTEtMS0w_5137ba05-4e7b-4188-9483-d06f9147ae06"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNS0zLTEtMS0w_d05b9f01-ca80-47ba-80f1-985314a375a4"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNS01LTEtMS0w_06ff238e-fac6-4f98-8630-931452dd7603"
      unitRef="usd">-38000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNS03LTEtMS0w_8d1af88f-2efb-4c8a-ad21-8b523d16f358"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNi0xLTEtMS0w_506cab50-5a86-4bd0-aac3-8fd1687d46d8"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNi0zLTEtMS0w_e8111a84-5428-4fc5-a0c5-f1e8d0a5b8d1"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNi01LTEtMS0w_9e87e7e1-c5bf-4202-942b-e981de586b98"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNi03LTEtMS0w_98c58f40-9ae5-41d8-9423-8ec0abf559fb"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNy0xLTEtMS0w_3fb3e4f8-3762-4f8e-8889-0a3d38b47333"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNy0zLTEtMS0w_5e782b0e-cb12-4bcb-8d5b-7e9e9f1b6161"
      unitRef="usd">51000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNy01LTEtMS0w_45de0912-ad22-4901-8924-779558734ede"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfNy03LTEtMS0w_18060ea7-6d97-44a5-b79c-9155e12de7b9"
      unitRef="usd">-65000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfOC0xLTEtMS0w_1791d68c-c762-4e4b-a43d-6d33b3a60860"
      unitRef="usd">26000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfOC0zLTEtMS0w_1dd52f07-459f-44d3-84ed-b8c3ef7e1810"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfOC01LTEtMS0xOTgw_2e6b1085-cce9-410c-a6c2-11c42fab6915"
      unitRef="usd">321000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfOC03LTEtMS0xOTgw_06b96e0c-b628-4c91-901b-c4d55b76cb2b"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMTAtMS0xLTEtMA_9867e740-d7ea-47c8-a579-7745123926c5"
      unitRef="usd">1087000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMTAtMy0xLTEtMA_5a8d46ff-93fb-4bee-9bef-95fbc370cbd4"
      unitRef="usd">-87000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMTAtNS0xLTEtMTk4MA_bcd6c8cf-866b-4106-acd3-7cfcdbb91abd"
      unitRef="usd">3411000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMTAtNy0xLTEtMTk4MA_6ec263fd-9e40-4b6f-ab4c-3bb18ac385e0"
      unitRef="usd">-882000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMTEtMS0xLTEtMA_da047a4b-8bfa-4355-9bcd-e9fb77b2623e"
      unitRef="usd">6000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMTEtMy0xLTEtMA_c6c258fd-1aa2-43d3-a163-86491af640b7"
      unitRef="usd">5000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMTEtNS0xLTEtMA_7d32ad19-1d1e-42bd-bc84-412497d12355"
      unitRef="usd">14000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMTEtNy0xLTEtMA_931571d7-27d7-4df3-b1f7-deec15db1dbe"
      unitRef="usd">14000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMTItMS0xLTEtMA_2ac7955f-3f96-49cb-ac0c-77e37ed26dc9"
      unitRef="usd">1081000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMTItMy0xLTEtMA_2b027f1c-d1ed-40a6-ab80-895fe841fc09"
      unitRef="usd">-92000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMTItNS0xLTEtMTk4MA_9e5030ac-cabd-4a53-a5ff-4c9fffd186bf"
      unitRef="usd">3397000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMWE2NDY2YjAzYjRmNDU5MjIxMGU1ODFmZGVlNDYzL3RhYmxlcmFuZ2U6OWIxYTY0NjZiMDNiNGY0NTkyMjEwZTU4MWZkZWU0NjNfMTItNy0xLTEtMTk4MA_5f6fc544-876c-419e-9d38-33f11a31dd9f"
      unitRef="usd">-896000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMi0xLTEtMS0w_64efd3a5-e606-42cf-bc9e-bb0b03df3e81"
      unitRef="usd">11024000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMi0zLTEtMS0w_d3c55a1f-9973-412f-af3b-b3052aff7033"
      unitRef="usd">14546000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMy0xLTEtMS0w_6eb75c71-5af7-4d44-9d88-99679f268336"
      unitRef="usd">1946000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMy0zLTEtMS0w_c381f28c-504e-49f1-830e-fcbf6202624b"
      unitRef="usd">1285000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfNC0xLTEtMS0w_1e0e24b7-0b84-454f-ae7c-ae8b9c968e36"
      unitRef="usd">9017000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfNC0zLTEtMS0w_4b6d3806-f23b-41bd-ba57-9614bdb1a37b"
      unitRef="usd">8501000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfNS0xLTEtMS0w_032f8c46-2853-41e4-b1d8-67521bf5d361"
      unitRef="usd">2137000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfNS0zLTEtMS0w_f3584fa6-fa80-4900-8d26-c74c75b0cdd7"
      unitRef="usd">2074000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfNi0xLTEtMS0w_1e632ce8-be3a-4039-99e6-0eee3ee16e36"
      unitRef="usd">5037000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfNi0zLTEtMS0w_80c419d4-ba8b-4f74-b434-7b6343344b82"
      unitRef="usd">3786000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfNy0xLTEtMS0w_3c7f6eea-b0e5-45ac-91e1-f5fef93cd3af"
      unitRef="usd">29161000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfNy0zLTEtMS0w_8e21561b-3614-425c-ace9-a202c5cb2a7f"
      unitRef="usd">30192000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfOC0xLTEtMS0w_1cedc368-81ca-4d78-9b72-d6cff5610d36"
      unitRef="usd">5795000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfOC0zLTEtMS0w_23f5faaf-a2ea-4843-81e7-2bcf52ce2575"
      unitRef="usd">5886000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfOS0xLTEtMS0w_6d36e51c-0c46-4341-9008-ed5c7abf006b"
      unitRef="usd">20529000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfOS0zLTEtMS0w_6713e13c-a880-4d5f-b117-59e915abc5d4"
      unitRef="usd">20547000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTAtMS0xLTEtMA_563c8836-e00f-4afa-9651-e413b6bf7b77"
      unitRef="usd">48065000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTAtMy0xLTEtMA_aaa31a4d-0dd4-40ee-b152-45bf24b02880"
      unitRef="usd">53243000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTEtMS0xLTEtMA_6b5dc4cd-06dc-48be-8607-312d0c818cea"
      unitRef="usd">650000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTEtMy0xLTEtMA_8252925f-d5d3-486b-8f81-80d71f27c05e"
      unitRef="usd">1161000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTItMS0xLTEtMA_6529495d-eecb-4ecd-8f4c-fa07bee2b09b"
      unitRef="usd">143000000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTItMy0xLTEtMA_77211637-564f-4816-9e5b-ed942d38d467"
      unitRef="usd">433000000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTMtMS0xLTEtMA_b048afa8-c44a-4964-8843-88a658b22c75"
      unitRef="usd">6454000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTMtMy0xLTEtMA_b7a39c74-4a9b-4514-9186-50d4aae8c848"
      unitRef="usd">7019000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTQtMS0xLTEtMA_9217d715-227b-4179-a081-e1940b69a0ae"
      unitRef="usd">110797000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTQtMy0xLTEtMA_d3133591-d3d2-4106-8ef7-68cfcdef0c26"
      unitRef="usd">118481000000</us-gaap:Assets>
    <us-gaap:DebtCurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTgtMS0xLTEtMA_82d6b2c8-8333-48cb-b865-967c4f2d62e4"
      unitRef="usd">2655000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTgtMy0xLTEtMA_c6e7b535-2938-4f4e-8a17-ff164f5cfdb8"
      unitRef="usd">2340000000</us-gaap:DebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTktMS0xLTEtMA_119f1a9d-78a4-4f6e-992c-2a31da6ea421"
      unitRef="usd">3609000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMTktMy0xLTEtMA_6e827e29-4a31-46e5-96e0-b026ba4e0ced"
      unitRef="usd">2713000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMjAtMS0xLTEtMA_70321243-ac5d-43b6-9849-0574a0166b3d"
      unitRef="usd">12727000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMjAtMy0xLTEtMA_a25c16d2-7b1f-40b5-9d34-22119894be54"
      unitRef="usd">14027000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMjEtMS0xLTEtMA_88681502-7247-4fa7-a4c3-4d6f04e7abc5"
      unitRef="usd">18991000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMjEtMy0xLTEtMA_8c666aa3-bf30-4041-a113-9d212e92488a"
      unitRef="usd">19080000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMjItMS0xLTEtMA_be1a5bf9-3042-453c-9e8c-b0a6e80f3d91"
      unitRef="usd">4931000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMjItMy0xLTEtMA_2ef13a4d-900a-4d18-a6e5-bb82d63698a6"
      unitRef="usd">5407000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMjMtMS0xLTEtMA_dca240ed-a396-40b8-89b4-42e27db867e0"
      unitRef="usd">42503000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMjMtMy0xLTEtMA_555e0e02-ab25-4a70-8164-48d6cdb60e0d"
      unitRef="usd">48336000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMjQtMS0xLTEtMA_63204836-abc5-496d-b368-550114784be0"
      unitRef="usd">7498000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMjQtMy0xLTEtMA_e4711ebe-4381-468a-abba-f2289aa27b4d"
      unitRef="usd">7776000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMjUtMS0xLTEtMA_965e455d-4878-4a6e-b118-ea6164666ad6"
      unitRef="usd">73923000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMjUtMy0xLTEtMA_0e73fde9-abc7-45d2-abd3-7703fa7a91c4"
      unitRef="usd">80599000000</us-gaap:Liabilities>
    <us-gaap:PreferredStockValue
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzEtMS0xLTEtMA_11652c3d-e931-4c9c-a8a2-5bbd8d414661"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzEtMy0xLTEtMA_e4d44544-2bca-49af-8180-2e28307da9d8"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzItMS0xLTEtMA_f6fd9229-2923-4342-8f07-7dac4204d3d1"
      unitRef="usd">292000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzItMy0xLTEtMA_53aa8ea1-8d45-445a-a71e-ae8157e1b19e"
      unitRef="usd">292000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzMtMS0xLTEtMA_34987a66-697e-4c61-ba13-c67f1f859e3c"
      unitRef="usd">44064000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzMtMy0xLTEtMA_b8c88fda-912d-4a52-a2c2-3882636964c8"
      unitRef="usd">44325000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzQtMS0xLTEtMA_c7583258-a43a-4f7f-87b0-505f82ee582b"
      unitRef="usd">-1518000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzQtMy0xLTEtMA_ac6f1958-c269-47cf-b11e-ff611ee1438d"
      unitRef="usd">-1839000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzUtMS0xLTEtMA_8928b40e-7a83-420e-8321-2a97f388d924"
      unitRef="usd">22168000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzUtMy0xLTEtMA_f8ea6feb-ec98-4ea4-ba5a-dc4e9ae8ac85"
      unitRef="usd">21281000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockValue
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzYtMS0xLTEtMA_6635fc2c-a4fb-447d-b3c6-1991808e1125"
      unitRef="usd">28198000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzYtMy0xLTEtMA_7571a9ff-a9c6-49ed-a20e-214fdd71a720"
      unitRef="usd">26237000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzctMS0xLTEtMA_018d5543-3f03-4def-b9bd-fde38266da6c"
      unitRef="usd">36808000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzctMy0xLTEtMA_e0a27ced-a25a-4c3a-8489-ca930f168c77"
      unitRef="usd">37822000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzgtMS0xLTEtMA_3a08cef9-b3f1-4696-a576-e612b46c06af"
      unitRef="usd">66000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzgtMy0xLTEtMA_4453ccef-abce-4f72-a5c0-a88fb4483443"
      unitRef="usd">60000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzktMS0xLTEtMA_833a78a9-1235-4a1d-9cbd-ff74cce3f579"
      unitRef="usd">36874000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfMzktMy0xLTEtMA_4d7a1a9b-dcc5-4678-a349-a865870bffe2"
      unitRef="usd">37882000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfNDAtMS0xLTEtMA_759619d9-807b-4b47-8464-789f21f71ddf"
      unitRef="usd">110797000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xOS9mcmFnOjFhMDZjZGE5MDBlNDRmNTY5YzZkNTMyYjIzMjg1NzUzL3RhYmxlOjJhNDZiNmRkODE0YjQ0MjZhOTU1ZGJhMzljNmJlYTM1L3RhYmxlcmFuZ2U6MmE0NmI2ZGQ4MTRiNDQyNmE5NTVkYmEzOWM2YmVhMzVfNDAtMy0xLTEtMA_53f7253e-619e-4142-a82c-567e74e0c85c"
      unitRef="usd">118481000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMy0xLTEtMS0w_fff4522e-3807-4c4f-a064-8cf348190b72"
      unitRef="usd">3090000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMy0zLTEtMS0w_1ef8c29b-809e-4675-b2dd-493554a72162"
      unitRef="usd">-846000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfNS0xLTEtMS0w_d51c519e-26f3-4dcc-81b9-3a8c1ecfd128"
      unitRef="usd">5380000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfNS0zLTEtMS0w_ab21575e-6014-41c0-b7ab-2cf219b18c69"
      unitRef="usd">5035000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfNi0xLTEtMS0w_ad54ecc6-a5d0-483f-b6f2-250dd940c9a3"
      unitRef="usd">-95000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfNi0zLTEtMS0w_207b45c6-05fe-4ce0-afef-6552c8c2f2ca"
      unitRef="usd">1365000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfNy0xLTEtMS0w_6d9c15bf-acee-4597-9986-294168ed2894"
      unitRef="usd">308000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfNy0zLTEtMS0w_c66e5d2e-fab5-4848-a8c0-69cda34bf955"
      unitRef="usd">423000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfOC0xLTEtMS0w_f624cb80-4024-45fc-8e54-5a6aaa6c21cf"
      unitRef="usd">579000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfOC0zLTEtMS0w_21449525-acb1-444e-b1c9-a3093f0548c8"
      unitRef="usd">116000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <bmy:Pensionsettlementsandamortization
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfOS0xLTEtMS0w_fb533a9a-7dbd-4441-b596-c061b7912390"
      unitRef="usd">25000000</bmy:Pensionsettlementsandamortization>
    <bmy:Pensionsettlementsandamortization
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfOS0zLTEtMS0w_a875007f-ce65-4fbc-b5cb-1068170c50bb"
      unitRef="usd">22000000</bmy:Pensionsettlementsandamortization>
    <bmy:Divestituregainsandroyalties
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTAtMS0xLTEtMA_c4594511-3f65-4ab7-9f22-df1a8c27ca67"
      unitRef="usd">302000000</bmy:Divestituregainsandroyalties>
    <bmy:Divestituregainsandroyalties
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTAtMy0xLTEtMA_3da988bb-c1d3-4407-aea3-b095b9a4e433"
      unitRef="usd">295000000</bmy:Divestituregainsandroyalties>
    <bmy:Assetacquisitioncharge
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTEtMS0xLTEtMA_5be6760e-be16-4491-87a4-97077b6b3f75"
      unitRef="usd">801000000</bmy:Assetacquisitioncharge>
    <bmy:Assetacquisitioncharge
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTEtMy0xLTEtMA_a073fe5c-7e36-4e31-b7bf-15b30fc1af3f"
      unitRef="usd">361000000</bmy:Assetacquisitioncharge>
    <us-gaap:GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTItMS0xLTEtMA_eabeb055-cb91-460d-946a-5e28d913caaa"
      unitRef="usd">749000000</us-gaap:GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments>
    <us-gaap:GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTItMy0xLTEtMA_c9cab140-3de1-4c50-ab6a-3e0c986b9abe"
      unitRef="usd">480000000</us-gaap:GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTMtMS0xLTEtMA_910a2cf5-2c0f-490a-b442-71c8e200e260"
      unitRef="usd">-510000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTMtMy0xLTEtMA_fa7cd7ca-75eb-4191-814f-6ed3cd68f578"
      unitRef="usd">391000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTQtMS0xLTEtMA_3becd959-0b62-4668-9aac-c3476127c2dc"
      unitRef="usd">-204000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTQtMy0xLTEtMA_15f5e469-e999-46fe-bb50-4a0073af57e8"
      unitRef="usd">91000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTYtMS0xLTEtMA_6980d775-2c9f-4171-8a49-52809cf43042"
      unitRef="usd">626000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTYtMy0xLTEtMA_c87200ab-7ca9-4a54-892b-a16f51b503bb"
      unitRef="usd">197000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTctMS0xLTEtMA_c1007294-0aed-46cb-8530-d6c9bab34584"
      unitRef="usd">-111000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTctMy0xLTEtMA_687b1643-2d82-45dc-b428-88f3376df400"
      unitRef="usd">-2090000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTgtMS0xLTEtMA_8fb30e59-f340-432a-9192-36405e6d25ac"
      unitRef="usd">158000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTgtMy0xLTEtMA_d89d1109-85b1-4c31-88c4-d1a9ecc95355"
      unitRef="usd">480000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTktMS0xLTEtMA_eee3638a-5ec2-4c00-8329-8a8ecd6cb8aa"
      unitRef="usd">-795000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMTktMy0xLTEtMA_9439dc5c-a5fb-4ea1-bae4-11df2ae9f431"
      unitRef="usd">185000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjAtMS0xLTEtMA_84fef887-d313-4030-9713-7e5b2ef16b3e"
      unitRef="usd">695000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjAtMy0xLTEtMA_a9f8d5a0-0f9c-4274-aab3-1237997b706c"
      unitRef="usd">129000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjEtMS0xLTEtMA_93e06302-8d92-4e2d-b54f-12ebd84a8f21"
      unitRef="usd">6884000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjEtMy0xLTEtMA_57b67ee5-b04a-4597-b782-43ee4aa30ee9"
      unitRef="usd">8430000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjMtMS0xLTEtMA_ed40c69b-bc96-4cdc-8651-8c193bd49d03"
      unitRef="usd">1968000000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjMtMy0xLTEtMA_18740c94-d8de-4d7f-b081-f3e90b1e7d31"
      unitRef="usd">3537000000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjQtMS0xLTEtMA_3ea7d21f-af35-424d-9d9a-0c8c81d14904"
      unitRef="usd">2343000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjQtMy0xLTEtMA_02e50c76-e59e-447f-be17-51f48a1d11e0"
      unitRef="usd">1957000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesEquity
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjUtMS0xLTEtMjQzNg_539637ac-1015-4179-82bd-05c428cce409"
      unitRef="usd">814000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesEquity>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesEquity
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjUtMy0xLTEtMjQ0MA_0e984132-3674-46ab-be0a-72a15d54bac1"
      unitRef="usd">12000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesEquity>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjUtMS0xLTEtMA_50cb68ce-89bb-47ac-acc7-68acd3a852b3"
      unitRef="usd">383000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjUtMy0xLTEtMA_a8aa80b6-e5c0-4bcb-9b8f-9298311e5878"
      unitRef="usd">317000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <bmy:Divestitureandotherproceeds
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjYtMS0xLTEtMA_f498d7d8-d09c-4a96-9c30-a2af384f3961"
      unitRef="usd">382000000</bmy:Divestitureandotherproceeds>
    <bmy:Divestitureandotherproceeds
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjYtMy0xLTEtMA_9ba4b3a8-2f80-4d41-a592-c81b523e35dd"
      unitRef="usd">336000000</bmy:Divestitureandotherproceeds>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjctMS0xLTEtMA_e1a4eec3-1736-403d-a74a-9cf24227f07a"
      unitRef="usd">401000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjctMy0xLTEtMA_a9b281e9-2e77-4708-86a3-280dea479b71"
      unitRef="usd">445000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjgtMS0xLTEtMA_3c5589d4-a9c4-4e45-9eb1-6faddf5c4103"
      unitRef="usd">37000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMjgtMy0xLTEtMA_abce6739-9d37-4330-ae89-9b0e1476bb87"
      unitRef="usd">1166000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzAtMS0xLTEtMA_becb34eb-f9cb-4e9b-b193-30034d166495"
      unitRef="usd">-185000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzAtMy0xLTEtMA_20ea2c92-5365-41ae-b36a-94e2b7d78aea"
      unitRef="usd">-22000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzItMS0xLTEtMA_7dee6cd1-21e7-4df5-947d-455f74b57dca"
      unitRef="usd">5522000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzItMy0xLTEtMA_1177075a-cb5c-418a-90e1-680df6b678c4"
      unitRef="usd">0</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzMtMS0xLTEtMA_49960715-a445-4244-91f1-d67d9cf12ff5"
      unitRef="usd">3011000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzMtMy0xLTEtMA_df7e9ec8-6b21-4f61-acf8-77a3036aa383"
      unitRef="usd">81000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividends
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzQtMS0xLTEtMA_22308b7f-f707-408c-9b88-ef0a8c69fad4"
      unitRef="usd">2207000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzQtMy0xLTEtMA_7bb3f585-d4f2-4a9c-ae31-59decb29d35d"
      unitRef="usd">2038000000</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzUtMS0xLTEtMA_b92795d7-f047-4c50-bae3-c7d3b8f18c57"
      unitRef="usd">448000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzUtMy0xLTEtMA_dc2488b1-704e-4af4-982e-c8d11aac0d42"
      unitRef="usd">94000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzYtMS0xLTEtMA_64620982-280b-4fdd-b7fd-8ebd50125904"
      unitRef="usd">-10477000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzYtMy0xLTEtMA_a6ed9e4b-2f9c-42c0-b99a-3cd686b73c77"
      unitRef="usd">-2047000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzctMS0xLTEtMA_4d49d715-a654-433f-98f3-7e705df65723"
      unitRef="usd">-20000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzctMy0xLTEtMA_e122f5ff-591e-4a0f-8cd0-23e94d009891"
      unitRef="usd">-7000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzgtMS0xLTEtMA_48bcaf50-75ee-4e3d-8000-931df37c530f"
      unitRef="usd">-3576000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzgtMy0xLTEtMA_0996e052-95bc-45b9-8620-1eddf50e14f3"
      unitRef="usd">7542000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzktMS0xLTEtMA_b280771a-a1fe-4ac5-aba0-7fcb73a8b534"
      unitRef="usd">14973000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i519bf72bf2984b599bef546963ea4f65_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfMzktMy0xLTEtMA_c1952529-9756-494e-9283-313b6db02a43"
      unitRef="usd">12820000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfNDAtMS0xLTEtMA_a720f179-1c6a-4127-b163-819b26cad7e3"
      unitRef="usd">11397000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i711a50adb808497c9daf76647502dad6_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8yNS9mcmFnOjg0ZGJmMjMxOTdmZTQ1NzdiZGJlNTI5MTM1ZmViYjUwL3RhYmxlOjI2YWJkYTdhOTBlNTQ2Yzg5NmU2NzM0ZDE2MDAxMjkwL3RhYmxlcmFuZ2U6MjZhYmRhN2E5MGU1NDZjODk2ZTY3MzRkMTYwMDEyOTBfNDAtMy0xLTEtMA_b7999008-04af-4cf1-bc11-98493b991176"
      unitRef="usd">20362000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zMS9mcmFnOmViNjU3ZjAxOTNiNTRlZTM4YTAwMDBiMDhmZjFjMDk1L3RleHRyZWdpb246ZWI2NTdmMDE5M2I1NGVlMzhhMDAwMGIwOGZmMWMwOTVfNDQwMw_b8dd7f11-403f-47df-b0b9-64298f005541">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Bristol-Myers Squibb Company (&#x201c;BMS&#x201d;) prepared these unaudited consolidated financial statements following the requirements of the SEC and U.S. GAAP for interim reporting. Under those rules, certain footnotes and other financial information that are normally required for annual financial statements can be condensed or omitted. The Company is responsible for the consolidated financial statements included in this Quarterly Report on Form 10-Q, which include all adjustments necessary for a fair presentation of the financial position at June&#160;30, 2021 and December&#160;31, 2020, the results of operations for the three and six months ended June&#160;30, 2021 and 2020, and cash flows for the six months ended June&#160;30, 2021 and 2020. All intercompany balances and transactions have been eliminated. These financial statements and the related notes should be read in conjunction with the audited consolidated financial statements for the year ended December&#160;31, 2020 included in the 2020 Form&#160;10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS operates in a single segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of innovative medicines that help patients prevail over serious diseases. A global research and development organization and supply chain organization are responsible for the discovery, development, manufacturing and supply of products. Regional commercial organizations market, distribute and sell the products. The business is also supported by global corporate staff functions. Consistent with BMS&#x2019;s operational structure, the Chief Executive Officer (&#x201c;CEO&#x201d;), as the chief operating decision maker, manages and allocates resources at the global corporate level. Managing and allocating resources at the global corporate level enables the CEO to assess both the overall level of resources available and how to best deploy these resources across functions, therapeutic areas, regional commercial organizations and research and development projects in line with our overarching long-term corporate-wide strategic goals, rather than on a product or franchise basis. The determination of a single segment is consistent with the financial information regularly reviewed by the CEO for purposes of evaluating performance, allocating resources, setting incentive compensation targets, and planning and forecasting future periods. For further information on product and regional revenue, see &#x201c;&#x2014;Note 2. Revenue.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates and Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues, expenses, assets and liabilities can vary during each quarter of the year. Accordingly, the results and trends in these unaudited consolidated financial statements may not be indicative of full year operating results. The preparation of financial statements requires the use of management estimates, judgments and assumptions. The most significant assumptions are estimates used in determining accounting for business combinations; impairments of intangible assets; sales rebate and return accruals; legal contingencies; and income taxes. Actual results may differ from estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain reclassifications were made to conform the prior period consolidated financial statements to the current period presentation. Cash payments resulting from licensing arrangements, including upfront and contingent milestones previously included in operating activities in the consolidated statements of cash flows are now presented in investing activities. The adjustment resulted in an increase to net cash provided by operating activities and net cash used in investing activities of $267&#160;million in the six months ended June 30, 2020. Proceeds received from the sale of equity investment securities previously presented in Divestiture and other proceeds in the consolidated statements of cash flows is now presented separately in Proceeds from sales of equity investment securities. These reclassifications did not have an impact on net assets or net earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued amended guidance on the accounting and reporting of income taxes. The guidance is intended to simplify the accounting for income taxes by removing exceptions related to certain intraperiod tax allocations and deferred tax liabilities; clarifying guidance primarily related to evaluating the step-up tax basis for goodwill in a business combination; and reflecting enacted changes in tax laws or rates in the annual effective tax rate. BMS adopted the new guidance effective January 1, 2021. The amended guidance did not have a material impact on BMS&#x2019;s results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zMS9mcmFnOmViNjU3ZjAxOTNiNTRlZTM4YTAwMDBiMDhmZjFjMDk1L3RleHRyZWdpb246ZWI2NTdmMDE5M2I1NGVlMzhhMDAwMGIwOGZmMWMwOTVfNDQyNA_4683c3d7-8c12-4435-952e-9c22ad95d66e">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Bristol-Myers Squibb Company (&#x201c;BMS&#x201d;) prepared these unaudited consolidated financial statements following the requirements of the SEC and U.S. GAAP for interim reporting. Under those rules, certain footnotes and other financial information that are normally required for annual financial statements can be condensed or omitted. The Company is responsible for the consolidated financial statements included in this Quarterly Report on Form 10-Q, which include all adjustments necessary for a fair presentation of the financial position at June&#160;30, 2021 and December&#160;31, 2020, the results of operations for the three and six months ended June&#160;30, 2021 and 2020, and cash flows for the six months ended June&#160;30, 2021 and 2020. All intercompany balances and transactions have been eliminated. These financial statements and the related notes should be read in conjunction with the audited consolidated financial statements for the year ended December&#160;31, 2020 included in the 2020 Form&#160;10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zMS9mcmFnOmViNjU3ZjAxOTNiNTRlZTM4YTAwMDBiMDhmZjFjMDk1L3RleHRyZWdpb246ZWI2NTdmMDE5M2I1NGVlMzhhMDAwMGIwOGZmMWMwOTVfNDQzMA_896867d8-5571-4efe-bccf-2b7c68af76ab">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS operates in a single segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of innovative medicines that help patients prevail over serious diseases. A global research and development organization and supply chain organization are responsible for the discovery, development, manufacturing and supply of products. Regional commercial organizations market, distribute and sell the products. The business is also supported by global corporate staff functions. Consistent with BMS&#x2019;s operational structure, the Chief Executive Officer (&#x201c;CEO&#x201d;), as the chief operating decision maker, manages and allocates resources at the global corporate level. Managing and allocating resources at the global corporate level enables the CEO to assess both the overall level of resources available and how to best deploy these resources across functions, therapeutic areas, regional commercial organizations and research and development projects in line with our overarching long-term corporate-wide strategic goals, rather than on a product or franchise basis. The determination of a single segment is consistent with the financial information regularly reviewed by the CEO for purposes of evaluating performance, allocating resources, setting incentive compensation targets, and planning and forecasting future periods. For further information on product and regional revenue, see &#x201c;&#x2014;Note 2. Revenue.&#x201d;&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zMS9mcmFnOmViNjU3ZjAxOTNiNTRlZTM4YTAwMDBiMDhmZjFjMDk1L3RleHRyZWdpb246ZWI2NTdmMDE5M2I1NGVlMzhhMDAwMGIwOGZmMWMwOTVfNDQwNA_9d1fa8c8-4b6b-46c0-b6a3-aa25b816b65a">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates and Judgments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues, expenses, assets and liabilities can vary during each quarter of the year. Accordingly, the results and trends in these unaudited consolidated financial statements may not be indicative of full year operating results. The preparation of financial statements requires the use of management estimates, judgments and assumptions. The most significant assumptions are estimates used in determining accounting for business combinations; impairments of intangible assets; sales rebate and return accruals; legal contingencies; and income taxes. Actual results may differ from estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zMS9mcmFnOmViNjU3ZjAxOTNiNTRlZTM4YTAwMDBiMDhmZjFjMDk1L3RleHRyZWdpb246ZWI2NTdmMDE5M2I1NGVlMzhhMDAwMGIwOGZmMWMwOTVfNDQyMw_3d5effe0-7926-4ed7-be8d-8ec85e4dbbb2">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain reclassifications were made to conform the prior period consolidated financial statements to the current period presentation. Cash payments resulting from licensing arrangements, including upfront and contingent milestones previously included in operating activities in the consolidated statements of cash flows are now presented in investing activities. The adjustment resulted in an increase to net cash provided by operating activities and net cash used in investing activities of $267&#160;million in the six months ended June 30, 2020. Proceeds received from the sale of equity investment securities previously presented in Divestiture and other proceeds in the consolidated statements of cash flows is now presented separately in Proceeds from sales of equity investment securities. These reclassifications did not have an impact on net assets or net earnings.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:PriorPeriodReclassificationAdjustment
      contextRef="i1d96ff885f0c4029b9c659eb21e32c98_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zMS9mcmFnOmViNjU3ZjAxOTNiNTRlZTM4YTAwMDBiMDhmZjFjMDk1L3RleHRyZWdpb246ZWI2NTdmMDE5M2I1NGVlMzhhMDAwMGIwOGZmMWMwOTVfMzYzMQ_f7fb758b-fd59-4228-93be-f0cd5c5c7a28"
      unitRef="usd">267000000</us-gaap:PriorPeriodReclassificationAdjustment>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zMS9mcmFnOmViNjU3ZjAxOTNiNTRlZTM4YTAwMDBiMDhmZjFjMDk1L3RleHRyZWdpb246ZWI2NTdmMDE5M2I1NGVlMzhhMDAwMGIwOGZmMWMwOTVfNDQxNw_cc1d8e7d-18f2-4bc8-9c78-2f652715a617">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued amended guidance on the accounting and reporting of income taxes. The guidance is intended to simplify the accounting for income taxes by removing exceptions related to certain intraperiod tax allocations and deferred tax liabilities; clarifying guidance primarily related to evaluating the step-up tax basis for goodwill in a business combination; and reflecting enacted changes in tax laws or rates in the annual effective tax rate. BMS adopted the new guidance effective January 1, 2021. The amended guidance did not have a material impact on BMS&#x2019;s results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RleHRyZWdpb246MDA4ZjY0YzkyYzk5NDNjYTllNTcyYTQ2YWNiODNiNGRfODU4_e744fa3f-3138-493b-a6f9-a990b85fc14f">REVENUE&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the disaggregation of revenue by nature:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alliance revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Products are sold principally to wholesalers, distributors, specialty pharmacies, and to a lesser extent, directly to retailers, hospitals, clinics and government agencies. Customer orders are generally fulfilled within a few days of receipt resulting in minimal order backlog. Contractual performance obligations are usually limited to transfer of control of the product to the customer. The transfer occurs either upon shipment, upon receipt of the product after considering when the customer obtains legal title to the product, or upon infusion for cell therapies and when BMS obtains a right of payment. At these points, customers are able to direct the use of and obtain substantially all of the remaining benefits of the product.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes GTN adjustments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GTN adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charge-backs and cash discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,720)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,632)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Medicare rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,482)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,857)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,980)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other rebates, returns, discounts and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,518)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,975)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total GTN adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,971)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes adjustments for provisions for product sales made in prior periods resulting from changes in estimates of $85 million and $302 million for the three and six months ended June&#160;30, 2021, and $44 million and $116 million for the three and six months ended June&#160;30, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the disaggregation of revenue by product and region:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prioritized Brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Revlimid&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Eliquis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Opdivo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Orencia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Pomalyst/Imnovid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Sprycel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Yervoy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Abraxane&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Empliciti&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Reblozyl&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Inrebic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Onureg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Zeposia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Breyanzi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Abecma&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Established Brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Vidaza&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Baraclude&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of the World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by BMS&#x2019;s regional commercial organizations.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue recognized from performance obligations satisfied in prior periods was $146 million and $430 million for the three and six months ended June&#160;30, 2021 and $98 million and $228 million for the three and six months ended June&#160;30, 2020, respectively, consisting primarily of revised estimates for GTN adjustments related to prior period sales and royalties for out-licensing arrangements. Contract assets were not material at June&#160;30, 2021 and December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RleHRyZWdpb246MDA4ZjY0YzkyYzk5NDNjYTllNTcyYTQ2YWNiODNiNGRfODQ1_d8f8c6c4-c254-46d8-8dd2-eee5bf24053c">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the disaggregation of revenue by nature:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alliance revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="i8d9276ebf40046b4a41a5f19262377b1_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfMi0xLTEtMS0w_00e69cfa-9372-49f2-8519-a9501ab4fa3f"
      unitRef="usd">11405000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i693b996ab36a4cebaefd928a05970180_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfMi0zLTEtMS0w_ab59e6bd-730c-4494-9b56-e8fa70a4c7e3"
      unitRef="usd">9817000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie656e6b5b421495887e8721375eae829_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfMi01LTEtMS0w_d6987c1f-0a18-4f63-b075-7dd3290c1e5a"
      unitRef="usd">22203000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i70262bb79f2b4fb682856a49e0942b2a_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfMi03LTEtMS0w_df9276c7-9ba1-43d0-9d2f-0390342687df"
      unitRef="usd">20358000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8ead8ffbd6a943f58695765106933642_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfMy0xLTEtMS0w_3bb7d100-f222-43bb-9d76-983ed49b8a98"
      unitRef="usd">159000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i74364a7590b441a4afd4e5e67a3b406e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfMy0zLTEtMS0w_9e9613a0-1aaa-433b-8483-2de37ada0012"
      unitRef="usd">163000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i87185b42e332422389a23e672417b431_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfMy01LTEtMS0w_1d2f9d10-a312-4e4a-a71b-86941aa50eda"
      unitRef="usd">301000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if25b0239054048e3b55eeb8500972cdf_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfMy03LTEtMS0w_7f61ef31-9bfd-4037-b924-fda56e998cfc"
      unitRef="usd">268000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if2fb12a3531e4873be7be194483607ee_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfNC0xLTEtMS0w_2709dcfd-0e4b-4a12-8605-40ff85c7d2b4"
      unitRef="usd">139000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i688d430df875454b84b14f79015b6cf6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfNC0zLTEtMS0w_70b1de46-d0fc-4666-83eb-657b5ae823b9"
      unitRef="usd">149000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4ba774a2df9f40a8b6d19e1fba5043b7_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfNC01LTEtMS0xNjM5_1efa5a97-0e9a-4419-a3a8-8a41f6c31850"
      unitRef="usd">272000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i43a13af27d1448f7993f34c3dd68a67d_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfNC03LTEtMS0xNjM1_6b12c116-a527-4a5b-829d-2d51e7ec3a09"
      unitRef="usd">284000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfNS0xLTEtMS0w_1460720a-b22d-4def-b4f3-f4b5704bf503"
      unitRef="usd">11703000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfNS0zLTEtMS0w_4ab48f03-ffb9-4395-983d-9dd678728c99"
      unitRef="usd">10129000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfNS01LTEtMS0w_71d12675-2889-4379-89c8-219988c4f6a7"
      unitRef="usd">22776000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjMwNmY3ZWQwOTk3ZDRiZTBiYjFhYzYyZWU4MjhjOGEwL3RhYmxlcmFuZ2U6MzA2ZjdlZDA5OTdkNGJlMGJiMWFjNjJlZTgyOGM4YTBfNS03LTEtMS0w_cb84eed0-75b3-4675-be5c-c3eeb8698501"
      unitRef="usd">20910000000</us-gaap:Revenues>
    <bmy:ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RleHRyZWdpb246MDA4ZjY0YzkyYzk5NDNjYTllNTcyYTQ2YWNiODNiNGRfODQ2_ab891f39-0c3b-469d-99e1-23e6d63d2721">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes GTN adjustments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GTN adjustments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charge-backs and cash discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,720)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,306)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,632)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and Medicare rebates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,139)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,482)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,857)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,980)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other rebates, returns, discounts and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,518)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,975)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total GTN adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,377)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,971)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,138)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes adjustments for provisions for product sales made in prior periods resulting from changes in estimates of $85 million and $302 million for the three and six months ended June&#160;30, 2021, and $44 million and $116 million for the three and six months ended June&#160;30, 2020, respectively.&lt;/span&gt;&lt;/div&gt;</bmy:ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock>
    <us-gaap:Revenues
      contextRef="i02cc001651e94e7295b1dcc33d5daaa2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfMi0xLTEtMS0w_8a438049-f14c-4b12-b03c-c8e28e59e9d8"
      unitRef="usd">16782000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iba96fdc39cdc460db86d38cae38883fe_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfMi0zLTEtMS0w_c1089e9f-9b17-4143-8299-7205b5963918"
      unitRef="usd">13788000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic3be3517a7304e72b770f702ef97ea11_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfMi01LTEtMS0w_7bd2f12c-5aea-4801-8aba-096f4f7402a0"
      unitRef="usd">32341000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i866d2af294a649c284a0a90628fcb561_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfMi03LTEtMS0w_00b9e92a-d13c-4eb6-9b38-cbe2f8034278"
      unitRef="usd">28474000000</us-gaap:Revenues>
    <bmy:GrosstoNetAdjustments
      contextRef="if22a4fc3cd8c4d6c8f43d5db96fc3d2b_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNC0xLTEtMS0w_78a56f8b-4c55-4dac-9ffd-3f5319a8a368"
      unitRef="usd">1720000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="ic6aeff8b93aa4e498214da65e668a5e7_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNC0zLTEtMS0w_69636cf2-fef0-46ab-933a-a28bb8c26656"
      unitRef="usd">1292000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="i4e43c6a8382640da95ba7937bc7cb901_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNC01LTEtMS0w_b8f42e15-93e8-4d1f-8dba-c479b564e117"
      unitRef="usd">3306000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="iaa953030056e4436b2eccb65049c20bd_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNC03LTEtMS0w_c6ad15c7-c7bd-4570-adfb-1d37251fd29d"
      unitRef="usd">2632000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="iaf1613c94e7c4ae1a97bd33c34b116b9_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNS0xLTEtMS0w_80c7e5d4-bdbf-41ed-b644-995af7d9a146"
      unitRef="usd">2139000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="i245bc87a8ea146ff89ba47f0050ab6cd_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNS0zLTEtMS0w_99c51840-ba01-402e-85fc-64a749e4f0a5"
      unitRef="usd">1482000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="ibc81985d98e0407586fee97e68186a0c_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNS01LTEtMS0w_658195d4-1024-485c-ade1-bb2bd14ef281"
      unitRef="usd">3857000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="i1ee340e61c044b3ba36660dccc49b13e_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNS03LTEtMS0w_20596267-b099-4aea-91e9-559e2d31bea8"
      unitRef="usd">2980000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="ib8447393acf44143ae8dfb8c7ec2d04a_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNi0xLTEtMS0w_684c07dc-c098-4e82-ac14-edc758375748"
      unitRef="usd">1518000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="ie762049c148a4949bccc2fc010d4f185_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNi0zLTEtMS0w_4dcadfb2-3673-4f97-8580-204dade26b1c"
      unitRef="usd">1197000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="i48a97ba1d3f24c95846c59ad03ad5eb4_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNi01LTEtMS0w_ecce2679-92f5-4121-b5af-9833fba6345b"
      unitRef="usd">2975000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="ic5651bce30274abea8e9658ea1ea4128_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNi03LTEtMS0w_fe458f8a-651d-4290-bbaa-d43efc1e8e3a"
      unitRef="usd">2504000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNy0xLTEtMS0w_eb5e1d46-f4d0-48d6-83b2-adeb2950dd10"
      unitRef="usd">5377000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNy0zLTEtMS0w_ee0f39ea-173e-4af6-a0c8-c544c68dea51"
      unitRef="usd">3971000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNy01LTEtMS0xNjQ5_90af67f4-d859-47c5-a946-1526d2ce1acd"
      unitRef="usd">10138000000</bmy:GrosstoNetAdjustments>
    <bmy:GrosstoNetAdjustments
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfNy03LTEtMS0xNjQz_d30c23f9-a0cd-460f-bf3e-611a83053931"
      unitRef="usd">8116000000</bmy:GrosstoNetAdjustments>
    <us-gaap:Revenues
      contextRef="i8d9276ebf40046b4a41a5f19262377b1_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfOC0xLTEtMS0w_ab230377-01bd-42a1-abcb-546090a6e2ea"
      unitRef="usd">11405000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i693b996ab36a4cebaefd928a05970180_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfOC0zLTEtMS0w_e168e053-61b7-442e-9305-9e2d24559168"
      unitRef="usd">9817000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie656e6b5b421495887e8721375eae829_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfOC01LTEtMS0xNjU0_06728e4c-c25b-4f52-a6a7-2be1922e94c5"
      unitRef="usd">22203000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i70262bb79f2b4fb682856a49e0942b2a_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOjEyOWRmY2FlOWM1YTRhZTI4NzIyNGE3OGU2MmM0MDRmL3RhYmxlcmFuZ2U6MTI5ZGZjYWU5YzVhNGFlMjg3MjI0YTc4ZTYyYzQwNGZfOC03LTEtMS0xNjQ3_b131672c-77a8-4ed4-8b15-281fda6d1391"
      unitRef="usd">20358000000</us-gaap:Revenues>
    <bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RleHRyZWdpb246MDA4ZjY0YzkyYzk5NDNjYTllNTcyYTQ2YWNiODNiNGRfMjY4_397c6911-ed57-4165-a8c5-28849a05f5e4"
      unitRef="usd">85000000</bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods>
    <bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RleHRyZWdpb246MDA4ZjY0YzkyYzk5NDNjYTllNTcyYTQ2YWNiODNiNGRfMjc1_d077c49d-1bf3-40a2-bcbd-5c52d544ef72"
      unitRef="usd">302000000</bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods>
    <bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RleHRyZWdpb246MDA4ZjY0YzkyYzk5NDNjYTllNTcyYTQ2YWNiODNiNGRfMTA5OTUxMTYyODc2NQ_6c18ebb6-28c2-4498-a883-9dd03f58738b"
      unitRef="usd">44000000</bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods>
    <bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RleHRyZWdpb246MDA4ZjY0YzkyYzk5NDNjYTllNTcyYTQ2YWNiODNiNGRfMTA5OTUxMTYyODgxMQ_61949b6f-8bbe-4c24-925b-ca8e8f21f684"
      unitRef="usd">116000000</bmy:AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RleHRyZWdpb246MDA4ZjY0YzkyYzk5NDNjYTllNTcyYTQ2YWNiODNiNGRfODY0_cc9491df-0d0c-40f3-b9b5-ef69e41de294">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the disaggregation of revenue by product and region:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prioritized Brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Revlimid&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Eliquis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Opdivo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Orencia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Pomalyst/Imnovid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Sprycel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Yervoy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Abraxane&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Empliciti&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Reblozyl&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Inrebic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Onureg&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Zeposia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Breyanzi&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Abecma&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Established Brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Vidaza&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Baraclude&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Brands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of the World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by BMS&#x2019;s regional commercial organizations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:Revenues
      contextRef="i0049dfb3f51e491da124b097da74b773_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMy0xLTEtMS0w_016bf866-bee3-4d21-8ff9-64b649578bea"
      unitRef="usd">3202000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1059bee7d7c24aa5bf63443d6b0b117e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMy0zLTEtMS0w_5ef37ae7-efd1-42e0-86ee-862d1ac67666"
      unitRef="usd">2884000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i36a7c570203a43c085160c5d69d6dca2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMy01LTEtMS0w_277ce485-cf6c-4ce5-82c9-891fbd273be1"
      unitRef="usd">6146000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id5926634a97d45b588e22bc868140a71_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMy03LTEtMS0w_d3165cc2-fd84-456d-8942-17f56a93406c"
      unitRef="usd">5799000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic8f5ba386b86453aa8abbb8d97ca5741_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNC0xLTEtMS0w_de290125-1e6c-4865-a58f-02a711eff86b"
      unitRef="usd">2792000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i164732664a0649a0a6b4e3ec9a6ea675_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNC0zLTEtMS0w_c4075d1d-643a-4d4f-ae82-26d5b8fb81de"
      unitRef="usd">2163000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2b6d5b28fdeb4f539683764cb03f85e8_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNC01LTEtMS0w_aa898a27-78a4-40cf-9588-fdd6dec2042e"
      unitRef="usd">5678000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idbc7c626226146c8acb2e1f9248526b5_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNC03LTEtMS0w_7b79bb5c-e29b-41ec-8d27-4ea4e9652ceb"
      unitRef="usd">4804000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic7d7effc4e044286927c0d4994433271_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNS0xLTEtMS0w_86b21eef-bae5-4901-8f93-9b694660f63c"
      unitRef="usd">1910000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i883c2662484643f9900deb185df3f0b5_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNS0zLTEtMS0w_ff1cdb07-8379-43e8-870e-1081a8759558"
      unitRef="usd">1653000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia891b42d1c254df7ac3ac05d31574021_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNS01LTEtMS0w_92dfcf35-69d8-47c0-8435-9ed3129c9e19"
      unitRef="usd">3630000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if68d20cca08041c5aeb33c4b926b82ab_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNS03LTEtMS0w_819e057c-729e-4fc1-82ba-57cf43e14630"
      unitRef="usd">3419000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i57080e1dcd264f6e99cf8bdd5c21742e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNi0xLTEtMS0w_bc162fd4-efab-4de2-86c4-2b75b7907d53"
      unitRef="usd">814000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7ff9b249fad642bba5144d42b9faf6b5_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNi0zLTEtMS0w_b38edacb-5272-46b1-a887-50a1599d0848"
      unitRef="usd">750000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibe37cb6ae8364432a34654315cc6e007_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNi01LTEtMS0w_b0e02c41-48ef-4162-b7af-686bc3404b9c"
      unitRef="usd">1572000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0261661a5a7844cea6463d344c58d900_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNi03LTEtMS0w_b11e750e-a83d-4811-aaa0-c0a2b8dba5a5"
      unitRef="usd">1464000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i769e4009608641aca49eb76faa4ac197_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNy0xLTEtMS0w_c30de88d-9ac0-4f8b-9249-ce59e29fa1cb"
      unitRef="usd">854000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i73d23b416f674420956ecd71cdcf6b4c_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNy0zLTEtMS0w_5b53eccd-4bf8-4f98-8692-c7159a7791a8"
      unitRef="usd">745000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5f619ca1063a4a07992394e7c68f32ac_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNy01LTEtMS0w_a035020a-2df0-4ea7-8e40-d491e5050a66"
      unitRef="usd">1627000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibaf296c2ee0943818ce82515cb333687_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfNy03LTEtMS0w_99f822de-6f1d-4498-88bc-5d71a012bf51"
      unitRef="usd">1458000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icf093353fcce47c7993eff7bebb89352_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfOC0xLTEtMS0w_d8427a61-46f4-4a2d-bc64-f3674cdf19e9"
      unitRef="usd">541000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2ee1d7e1f63643b884515b06a03e4c60_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfOC0zLTEtMS0w_deac8009-c9a2-4b9e-a5f6-594a1f86ec48"
      unitRef="usd">511000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie0c81db46fa34735a7f2f312ec65bfc9_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfOC01LTEtMS0w_41ac5602-24b9-4f95-9c95-e798d498bfb9"
      unitRef="usd">1011000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i355ae2718e5a4c6c8a6e24afd38df6db_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfOC03LTEtMS0w_c4652bf9-bb74-4170-9396-cd4af79af31a"
      unitRef="usd">1032000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i45aeed9ec2cc49a590adb6b58fd89ece_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfOS0xLTEtMS0w_3cc5e370-8599-4b06-ba25-49bfb0b60fdc"
      unitRef="usd">510000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5978a453566e4231add46eb89d653450_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfOS0zLTEtMS0w_905684bb-9304-43f7-84bd-2aa68443a4a2"
      unitRef="usd">369000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i58d693cbcafe4995b93648810c7cae27_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfOS01LTEtMS0w_905c527a-cd39-4994-8d2d-b932a5d8d6ab"
      unitRef="usd">966000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i40a1ad24197f4b86a309b538c9a3c23c_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfOS03LTEtMS0w_084c7232-34b9-4448-82ad-d2953b4d25a0"
      unitRef="usd">765000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7a2c60c75c4141639d1b36723b3c4440_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTAtMS0xLTEtMA_90ef16e4-6859-4647-aedc-a5878942b2e7"
      unitRef="usd">296000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i62694ce91ad14828b9c165bf7fa9940e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTAtMy0xLTEtMA_86cd0dab-4a95-4efd-a30e-3c82e88e3c85"
      unitRef="usd">308000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2704f69ab750451ab3fb0492a99094c5_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTAtNS0xLTEtMA_b659c307-1073-47ee-a68b-e809cd11acff"
      unitRef="usd">610000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2c439fd5488544099358a43dd1238104_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTAtNy0xLTEtMA_6efca90d-d739-41d9-9c68-0a82621d0827"
      unitRef="usd">608000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifd53acf464ca462ab494301989157627_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTEtMS0xLTEtMA_39975505-8740-4bfd-ac80-52a981ea78a0"
      unitRef="usd">86000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i758c9da23c8b4231951c6795184b15e5_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTEtMy0xLTEtMA_b4494226-db88-482c-aff3-160f7c4046f6"
      unitRef="usd">97000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3c7448d91de34141b4df1bd539a6dd86_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTEtNS0xLTEtMA_e97da34c-1fc4-42c5-addd-5fe61e4ad46d"
      unitRef="usd">171000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5d84ed280193426fa6af996eda8b4c98_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTEtNy0xLTEtMA_bd8baa97-ce19-4681-8c47-c24a3fcd0240"
      unitRef="usd">194000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i563b393825ee449d9c71d5d4b26b3ddb_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTItMS0xLTEtMA_da405b33-87d4-4a53-9e9b-6876366db8c6"
      unitRef="usd">128000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3fd358ca344f4bf29febc48585056f4c_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTItMy0xLTEtMA_a83b0b75-884c-4a97-b4ba-a0ff6fedbf64"
      unitRef="usd">55000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i48e38a9edee64731bac94495a43d3800_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTItNS0xLTEtMA_28d8ff82-7cb9-41e2-9f84-31ff4920900f"
      unitRef="usd">240000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if45515056fde4687b5647faafd13b1a0_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTItNy0xLTEtMA_9a53a99e-8c52-46bf-ba5b-9bd31c3bcec2"
      unitRef="usd">63000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2a59b7d82fa145d6928ff7f7639b512e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTMtMS0xLTEtMA_41ef34cd-3a14-4a15-973b-4e5a0a35f2f0"
      unitRef="usd">16000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i635f3e7e28714d6681e5a0d547475b27_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTMtMy0xLTEtMA_7bae3252-125a-48b1-8de1-df0eae113c2d"
      unitRef="usd">15000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iae2dcbf6bdff462caf99391d57dcb930_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTMtNS0xLTEtMA_46037a03-11f9-4272-a6c2-a828152007f7"
      unitRef="usd">32000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4015345e26eb4c5c9aec15be9286e3cc_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTMtNy0xLTEtMA_1adaf35f-cb41-480a-80b3-ed109df83527"
      unitRef="usd">27000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i402f96e6f47248c3840081511c31fb5b_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTQtMS0xLTEtMA_4f2d49bb-a6a4-42d1-8085-c225d82c547b"
      unitRef="usd">12000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i59e2e714bfff471ab06edb2942342e5d_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTQtMy0xLTEtMA_b85df81d-71dc-466b-ad0a-9e0422285a12"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iedaae601ed8c4bf0b43e79604ef7f8c3_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTQtNS0xLTEtMA_c55ba3b9-3d7b-4d58-8f39-836332aac498"
      unitRef="usd">27000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i18b9ec08663241d5baf4a36c323d25b0_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTQtNy0xLTEtMA_ba713a7a-a123-48ea-986b-ad8c702549e6"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i27c89651aa0f44449997627d1aeada5d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTUtMS0xLTEtMA_a99417a3-28c4-4a67-a26b-6e25b5bcea6e"
      unitRef="usd">28000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6ec04d6ebd5c416faf3fedff56490ed1_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTUtMy0xLTEtMA_2125a067-485d-4eae-a57b-25b6514b0cd9"
      unitRef="usd">1000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if8f8d1746aa7460c854e59b73c091120_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTUtNS0xLTEtMA_6ec14a24-022c-443d-a0fe-949f101e6b12"
      unitRef="usd">46000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7639067ff20c40aa9d69bd876327d377_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTUtNy0xLTEtMA_b4630e3b-8cde-4709-8f36-c73d5af76eb7"
      unitRef="usd">1000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i65b1ff42f2504ce7ba28f0134f6df309_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTYtMS0xLTEtMA_6faeec70-107f-40a2-80b4-62ab1454b43d"
      unitRef="usd">17000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i990e509044b44824a03594bbc939cd4f_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTYtMy0xLTEtMA_0ee21838-2917-4ebb-8f2b-75b0bb94600b"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i94349bb9edeb4c06824d9d4dec376cdc_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTYtNS0xLTEtMTU2Mg_da97f0bf-6952-49cd-a69c-16797a59c5ef"
      unitRef="usd">17000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia84f257000384cca8728724dd08e6d64_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTYtNy0xLTEtMTU3MA_5f26f010-20b6-4854-886c-b84034123eeb"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i72da1784020e4fe5a077a56e08ed0e60_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTctMS0xLTEtMTU1Nw_dad5b93c-87b0-4a80-b039-f3e796ba8506"
      unitRef="usd">24000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icae526ef104c4610be5401f06e776271_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTctMy0xLTEtMTU2NQ_e23032c7-5d80-466f-bca4-08836d996030"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i954298aa47d340e4928578d10e3c2afb_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTctNS0xLTEtMTU2Mg_183ff888-516e-4ce9-a451-ac2a2ea31ff8"
      unitRef="usd">24000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie64f9c3e74d24536bc5324f5a27f3f62_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTctNy0xLTEtMTU3MA_072664cb-d34f-489b-b8cb-14e5c6fa3ca4"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i30700517c2d846dfaabb9f4e49100061_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTktMS0xLTEtMA_7c3ace79-b2c9-4070-a50b-a8865f064de6"
      unitRef="usd">45000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4000e7937fbb4330b97ca4837c84abcf_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTktMy0xLTEtMA_a63902ee-143a-4a80-a8cb-cee8d56aa4d9"
      unitRef="usd">126000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icc46b46a188943daabd54f0555343036_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTktNS0xLTEtMA_0625ff51-4638-45e2-a9cd-363f919a28cc"
      unitRef="usd">99000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie163b63bb39b41b2a99d3894f000a52e_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMTktNy0xLTEtMA_7bbc276a-f4cc-46c4-8946-ca104ac761ad"
      unitRef="usd">284000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i47d887259489478d9fb5e61b10d58a21_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjAtMS0xLTEtMA_6b3f8efe-fb2c-403c-9d4f-9b938fe6a4e2"
      unitRef="usd">109000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i21b554fbfbe54be4938770b47e7e814e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjAtMy0xLTEtMA_62db6db1-0f97-41cf-bc35-e086023892f3"
      unitRef="usd">121000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8752706d4f1046619f751bca78fe5b04_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjAtNS0xLTEtMA_73ad5c26-171a-4177-a484-6f27e37e311c"
      unitRef="usd">222000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibf8cc33c03864e6eb80a62a2becd8529_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjAtNy0xLTEtMA_4254be73-dfa7-4e77-b25c-6e1f58f8a31a"
      unitRef="usd">243000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id17f257f5a7c4dbc8345593202162a88_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjEtMS0xLTEtMA_9aa1d308-f18d-40c3-bd21-51fb686642fe"
      unitRef="usd">319000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4424c6dea9c7491f8f20e9c0433f13be_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjEtMy0xLTEtMA_9278e9fb-d721-4d08-a244-6810244a0308"
      unitRef="usd">331000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id047abc4cf2849648778e6a0d818e9c3_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjEtNS0xLTEtMA_c93e74c3-dc1d-4019-9ec2-f659aa973508"
      unitRef="usd">658000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib254059b72c444bda04963c50ac8c3da_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjEtNy0xLTEtMA_50185a3b-7870-49bd-97bf-455935646f4d"
      unitRef="usd">749000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjItMS0xLTEtMA_ec38d4ed-881d-44e6-9872-367db7fb4c07"
      unitRef="usd">11703000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjItMy0xLTEtMA_37057d2e-341c-4ba3-a8c1-948a4c04ccfe"
      unitRef="usd">10129000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjMtNS0xLTEtMTY2Ng_2060671c-0ca0-467a-b16f-05120fe3b085"
      unitRef="usd">22776000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjMtNy0xLTEtMTY2MQ_cd1edb18-7b9f-4fae-a441-72c080990ea5"
      unitRef="usd">20910000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ica56fd0d45ed404fb6d997d7a91e781b_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjQtMS0xLTEtMA_f74dd2ef-788b-48cd-8059-64685d25fd58"
      unitRef="usd">7388000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5c042daa885246149bd4021e6291c95b_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjQtMy0xLTEtMA_561ddf9b-77db-479a-b089-d8c1a06340ca"
      unitRef="usd">6487000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id685a03ea1c045aaa5b4626cdeefcaeb_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjQtNS0xLTEtMA_d7017730-1685-47f9-acb3-2af83ee7046c"
      unitRef="usd">14398000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib0fb978e8fe747c9942de2c291d92e42_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjQtNy0xLTEtMA_220e8909-bb48-4f7b-8a3d-371e526fb172"
      unitRef="usd">13253000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i672de761cf0f4f38b3c9fcf5888c38d2_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjUtMS0xLTEtMA_bf94c0b1-a2e2-4bc5-b4ee-4a7fe8412dd4"
      unitRef="usd">2689000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6096b3e3535b498a93924c5913231bb7_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjUtMy0xLTEtMA_3de065bd-8414-4bae-8baa-d7a9af33f0e1"
      unitRef="usd">2136000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifd5c352a490f4e2d80f9f07d00ca9ed4_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjUtNS0xLTEtMA_75972d4f-d6ce-4e81-9361-f422bf0eb8b0"
      unitRef="usd">5242000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i22bc054236924180897608070e385339_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjUtNy0xLTEtMA_664552be-c737-4a23-8bc7-62ef9805a5b9"
      unitRef="usd">4703000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if3e30ddc627e420a994afe10df2aeb8d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjYtMS0xLTEtMA_e6a6421a-ab1f-45ef-a2d8-dcb0aa02ede7"
      unitRef="usd">1435000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie307dc58932a4abc95b857fff6abe287_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjYtMy0xLTEtMA_9b2162d1-e9e7-40c6-9d18-18a1eaf9326d"
      unitRef="usd">1334000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0c1f985c4a994e87afcfa3b123c94fb3_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjYtNS0xLTEtMA_ec86bc95-130d-4257-a6db-81572f98c3b6"
      unitRef="usd">2781000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i736f109d294c4ccf9f1668181dc764f4_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjYtNy0xLTEtMA_8ada9a30-a4a6-4e6f-9f73-b371c49ee5fa"
      unitRef="usd">2669000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i930c547a007949018cbf51ca4060480c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjctMS0xLTEtMA_32ef169f-341e-4a78-8189-fb82002b9bfb"
      unitRef="usd">191000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i903cb47a089e41dbbdc585ba01f93a76_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjctMy0xLTEtMA_e2e873f8-7e00-407a-b567-d1f466798510"
      unitRef="usd">172000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i99e18e918d4a4472baa5e49400a3c3fe_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjctNS0xLTEtMA_d5dbbb7c-d822-4bec-bec4-552d38b341dd"
      unitRef="usd">355000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i21843a9ab91b446ca3cce0aa09d0bc13_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjctNy0xLTEtMA_3fcc5cb3-1da4-4447-a778-4c9329f4dd65"
      unitRef="usd">285000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjgtMS0xLTEtMA_9eee9823-1d76-444c-bf80-cfa4b55b1cbf"
      unitRef="usd">11703000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjgtMy0xLTEtMA_241a5575-1da3-49fc-b9b2-a0da39490cc6"
      unitRef="usd">10129000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjktNS0xLTEtMTY3Mg_159af4d0-806e-4a2e-a144-41b988f18777"
      unitRef="usd">22776000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RhYmxlOmMwYzg2MGQzYmViOTQyMmQ5ZTkxNWUzZDA5NWUxY2JiL3RhYmxlcmFuZ2U6YzBjODYwZDNiZWI5NDIyZDllOTE1ZTNkMDk1ZTFjYmJfMjktNy0xLTEtMTY2OQ_cdde7bef-dd88-4341-acf0-ed348cad6ac5"
      unitRef="usd">20910000000</us-gaap:Revenues>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RleHRyZWdpb246MDA4ZjY0YzkyYzk5NDNjYTllNTcyYTQ2YWNiODNiNGRfNjE0_c65b2126-f699-4ec2-9b2a-1327e16ce5a9"
      unitRef="usd">146000000</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RleHRyZWdpb246MDA4ZjY0YzkyYzk5NDNjYTllNTcyYTQ2YWNiODNiNGRfNjIx_f2d76f7a-c04c-4ce5-8605-e8f1f0fc39fb"
      unitRef="usd">430000000</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RleHRyZWdpb246MDA4ZjY0YzkyYzk5NDNjYTllNTcyYTQ2YWNiODNiNGRfMTA5OTUxMTYyODg3MA_1714ff2f-5d06-4875-a20c-d9784014f9b3"
      unitRef="usd">98000000</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8zNC9mcmFnOjAwOGY2NGM5MmM5OTQzY2E5ZTU3MmE0NmFjYjgzYjRkL3RleHRyZWdpb246MDA4ZjY0YzkyYzk5NDNjYTllNTcyYTQ2YWNiODNiNGRfMTA5OTUxMTYyODg3OQ_2e394a2f-27a3-480e-aa75-bb91d3fa76af"
      unitRef="usd">228000000</us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RleHRyZWdpb246OTE4NTkwZDFiYmNhNDQzZjgyMGYxN2VhMjliYmFhM2RfMTY4MQ_cf559bad-e0a5-46f7-b146-c844caae7bf5">ALLIANCESBMS enters into collaboration arrangements with third parties for the development and commercialization of certain products. Although each of these arrangements is unique in nature, both parties are active participants in the operating activities of the collaboration and exposed to significant risks and rewards depending on the commercial success of the activities. BMS may either in-license intellectual property owned by the other party or out-license its intellectual property to the other party. These arrangements also typically include research, development, manufacturing, and/or commercial activities and can cover a single investigational compound or commercial product or multiple compounds and/or products in various life cycle stages. The rights and obligations of the parties can be global or limited to geographic regions. BMS refers to these collaborations as alliances and its partners as alliance partners.&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selected financial information pertaining to alliances was as follows, including net product sales when BMS is the principal in the third-party customer sale for products subject to the alliance. Expenses summarized below do not include all amounts attributed to the activities for the products in the alliance, but only the payments between the alliance partners or the related amortization if the payments were deferred or capitalized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenues from alliances:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alliance revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Payments to/(from) alliance partners:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing, selling and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Selected Alliance Balance Sheet information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables &#x2013; from alliance partners&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable &#x2013; to alliance partners&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income from alliances&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes unamortized upfront and milestone payments. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Specific information pertaining to significant alliances including their nature and purpose; the significant rights and obligations of the parties; and specific accounting policy elections are discussed in the 2020 Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Eisai&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In the second quarter of 2021, BMS and Eisai commenced an exclusive global strategic collaboration for the co-development and co-commercialization of MORAb-202, a selective folate receptor alpha antibody-drug conjugate being investigated in endometrial, ovarian, lung and breast cancers. MORAb-202 is currently in Phase I/II clinical trials for solid tumors.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;BMS and Eisai will jointly develop and commercialize MORAb-202 in the U.S., Canada, Europe, Russia, Japan, China and certain other countries in the Asia-Pacific region (the &#x201c;collaboration territory&#x201d;). Eisai will be responsible for the global manufacturing and supply. Profits, research and development and commercialization costs are shared in the collaboration territories. BMS will be responsible for development and commercialization outside of the collaboration territory and will pay a royalty on those sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;A $650&#160;million upfront collaboration fee was included in Research and development expense in the second quarter of 2021 and paid in the third quarter of 2021. BMS is also obligated to pay up to $2.5&#160;billion upon the achievement of contingent development, regulatory and sales-based milestones.&lt;/span&gt;&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:CollaborativeArrangementAccountingPolicy
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RleHRyZWdpb246OTE4NTkwZDFiYmNhNDQzZjgyMGYxN2VhMjliYmFhM2RfMTY5Ng_370b013f-d6e4-459b-9a31-8d538f8a5d6b">BMS enters into collaboration arrangements with third parties for the development and commercialization of certain products. Although each of these arrangements is unique in nature, both parties are active participants in the operating activities of the collaboration and exposed to significant risks and rewards depending on the commercial success of the activities. BMS may either in-license intellectual property owned by the other party or out-license its intellectual property to the other party. These arrangements also typically include research, development, manufacturing, and/or commercial activities and can cover a single investigational compound or commercial product or multiple compounds and/or products in various life cycle stages. The rights and obligations of the parties can be global or limited to geographic regions. BMS refers to these collaborations as alliances and its partners as alliance partners.</us-gaap:CollaborativeArrangementAccountingPolicy>
    <us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RleHRyZWdpb246OTE4NTkwZDFiYmNhNDQzZjgyMGYxN2VhMjliYmFhM2RfMjE5OTAyMzI5MjI0Ng_d1b741d6-1c56-4706-8ea1-bc411411f250">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selected financial information pertaining to alliances was as follows, including net product sales when BMS is the principal in the third-party customer sale for products subject to the alliance. Expenses summarized below do not include all amounts attributed to the activities for the products in the alliance, but only the payments between the alliance partners or the related amortization if the payments were deferred or capitalized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenues from alliances:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net product sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alliance revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Payments to/(from) alliance partners:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing, selling and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Selected Alliance Balance Sheet information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables &#x2013; from alliance partners&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable &#x2013; to alliance partners&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income from alliances&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(a)&#160;&#160;&#160;&#160;Includes unamortized upfront and milestone payments.</us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock>
    <us-gaap:Revenues
      contextRef="i5bfd0c3b7ba94dc99db7d1c79cf4109e_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfMy0xLTEtMS0w_b11c627a-1696-4aba-bb5b-95fc703fa5ed"
      unitRef="usd">2805000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaad82054f6c24b28998fd0cc54e5f466_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfMy0zLTEtMS0w_a257b006-4317-4d48-8b1f-431480d12044"
      unitRef="usd">2201000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3f4e8798cace48da8096f3940c34286f_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfMy01LTEtMS0w_fdab806d-daaf-48b9-81bb-6a00826de3eb"
      unitRef="usd">5687000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i62270f651833483897b7a99025a3c056_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfMy03LTEtMS0w_9ddd7378-1a95-47a8-8370-d5d2430225d4"
      unitRef="usd">4924000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8ead8ffbd6a943f58695765106933642_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfNC0xLTEtMS0w_3bb7d100-f222-43bb-9d76-983ed49b8a98"
      unitRef="usd">159000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i74364a7590b441a4afd4e5e67a3b406e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfNC0zLTEtMS0w_9e9613a0-1aaa-433b-8483-2de37ada0012"
      unitRef="usd">163000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i87185b42e332422389a23e672417b431_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfNC01LTEtMS0w_1d2f9d10-a312-4e4a-a71b-86941aa50eda"
      unitRef="usd">301000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if25b0239054048e3b55eeb8500972cdf_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfNC03LTEtMS0w_7f61ef31-9bfd-4037-b924-fda56e998cfc"
      unitRef="usd">268000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if0056c94875c46578f2a3c81dbf029ef_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfNS0xLTEtMS0w_fb73c904-8fbf-405a-afc4-e232d6f8b1a3"
      unitRef="usd">2964000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ied2b977f33414172a10da815fe24fa5e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfNS0zLTEtMS0w_3008ee12-92f8-4522-813a-c4cd6fc07321"
      unitRef="usd">2364000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i959465a12b7a4107bdb5a01d7bfcc532_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfNS01LTEtMS0xOTg0_4c917af3-7fe9-4a7f-ade0-5df13fcabfed"
      unitRef="usd">5988000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i987d81167423465fad588659146ecff3_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfNS03LTEtMS0xOTg0_a337a2fd-229c-44c6-a460-a762233f7f9a"
      unitRef="usd">5192000000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if0056c94875c46578f2a3c81dbf029ef_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfOC0xLTEtMS0w_64a91ed7-7844-4bdb-b9cc-b0f1fac8c99f"
      unitRef="usd">1346000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ied2b977f33414172a10da815fe24fa5e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfOC0zLTEtMS0w_3e8b8335-250a-4115-b772-143eb303740f"
      unitRef="usd">1050000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i959465a12b7a4107bdb5a01d7bfcc532_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfOC01LTEtMS0w_c56fdeb4-b0ac-478a-96b6-5d3393004312"
      unitRef="usd">2743000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i987d81167423465fad588659146ecff3_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfOC03LTEtMS0w_5bc3fb1f-9f40-41c1-96e1-37af5dffca93"
      unitRef="usd">2356000000</us-gaap:CostOfGoodsAndServicesSold>
    <bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement
      contextRef="if0056c94875c46578f2a3c81dbf029ef_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfOS0xLTEtMS0w_5ea45fe4-98b0-47f8-8c9e-b1910bf62caf"
      unitRef="usd">-48000000</bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement>
    <bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement
      contextRef="ied2b977f33414172a10da815fe24fa5e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfOS0zLTEtMS0w_475b4ac1-199d-4320-a1a1-ca96081586f2"
      unitRef="usd">-38000000</bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement>
    <bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement
      contextRef="i959465a12b7a4107bdb5a01d7bfcc532_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfOS01LTEtMS0w_06584e9e-5e35-4e71-95fd-c8050195a88d"
      unitRef="usd">-97000000</bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement>
    <bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement
      contextRef="i987d81167423465fad588659146ecff3_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfOS03LTEtMS0w_f9626947-2328-4ec7-ab62-3ea34ff7d8d8"
      unitRef="usd">-78000000</bmy:SellingGeneralandAdministrativeExpenseCollaborativeArrangement>
    <bmy:ResearchandDevelopmentExpenseCollaborativeArrangement
      contextRef="if0056c94875c46578f2a3c81dbf029ef_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfMTAtMS0xLTEtMA_6c67b4c2-3d06-4b3c-aa30-4577bd69ffeb"
      unitRef="usd">736000000</bmy:ResearchandDevelopmentExpenseCollaborativeArrangement>
    <bmy:ResearchandDevelopmentExpenseCollaborativeArrangement
      contextRef="ied2b977f33414172a10da815fe24fa5e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfMTAtMy0xLTEtMA_36f91927-a177-422e-97dc-886fcbdf7cd3"
      unitRef="usd">233000000</bmy:ResearchandDevelopmentExpenseCollaborativeArrangement>
    <bmy:ResearchandDevelopmentExpenseCollaborativeArrangement
      contextRef="i959465a12b7a4107bdb5a01d7bfcc532_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfMTAtNS0xLTEtMA_86ed7991-c293-408b-98e7-b599259336bb"
      unitRef="usd">743000000</bmy:ResearchandDevelopmentExpenseCollaborativeArrangement>
    <bmy:ResearchandDevelopmentExpenseCollaborativeArrangement
      contextRef="i987d81167423465fad588659146ecff3_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfMTAtNy0xLTEtMA_43fd7f38-7ee2-4f97-aed6-fbd32c18d6b8"
      unitRef="usd">279000000</bmy:ResearchandDevelopmentExpenseCollaborativeArrangement>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if0056c94875c46578f2a3c81dbf029ef_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfMTEtMS0xLTEtMA_03ef8837-6f71-486c-9c18-9f136e98f802"
      unitRef="usd">14000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ied2b977f33414172a10da815fe24fa5e_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfMTEtMy0xLTEtMA_aaa5cce7-66da-4b28-a2ea-c7d8e89f5117"
      unitRef="usd">16000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i959465a12b7a4107bdb5a01d7bfcc532_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfMTEtNS0xLTEtMA_fe7c3787-122d-4210-a8ff-faa95499b9b5"
      unitRef="usd">19000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i987d81167423465fad588659146ecff3_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjNhN2NkMzBjODVhOTQ3MzM5ZjU0N2UxZGY1OTlmODc3L3RhYmxlcmFuZ2U6M2E3Y2QzMGM4NWE5NDczMzlmNTQ3ZTFkZjU5OWY4NzdfMTEtNy0xLTEtMA_aa10fd35-9ee5-4dcf-bc00-2239bd6c7d52"
      unitRef="usd">31000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i883fc4c8bc0f4255aec7223cc0f262b4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjBmY2VkZWI1N2QwMDQ2YmZiYzIxNDFkNDNlM2FmNDQ1L3RhYmxlcmFuZ2U6MGZjZWRlYjU3ZDAwNDZiZmJjMjE0MWQ0M2UzYWY0NDVfMi0xLTEtMS0w_ed659fa6-ed02-43d2-9d00-a95d6dd68b3d"
      unitRef="usd">349000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="ia927d1d44e99489ca715bf69330b08ab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjBmY2VkZWI1N2QwMDQ2YmZiYzIxNDFkNDNlM2FmNDQ1L3RhYmxlcmFuZ2U6MGZjZWRlYjU3ZDAwNDZiZmJjMjE0MWQ0M2UzYWY0NDVfMi0zLTEtMS0w_b97d3768-d9ab-42b4-b7e9-3e9d9508c639"
      unitRef="usd">343000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i883fc4c8bc0f4255aec7223cc0f262b4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjBmY2VkZWI1N2QwMDQ2YmZiYzIxNDFkNDNlM2FmNDQ1L3RhYmxlcmFuZ2U6MGZjZWRlYjU3ZDAwNDZiZmJjMjE0MWQ0M2UzYWY0NDVfMy0xLTEtMS0w_58927130-815e-435b-87e9-abc49f7e640e"
      unitRef="usd">2032000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ia927d1d44e99489ca715bf69330b08ab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjBmY2VkZWI1N2QwMDQ2YmZiYzIxNDFkNDNlM2FmNDQ1L3RhYmxlcmFuZ2U6MGZjZWRlYjU3ZDAwNDZiZmJjMjE0MWQ0M2UzYWY0NDVfMy0zLTEtMS0w_71e681ab-2b0a-4335-bd6e-1833a810bf57"
      unitRef="usd">1093000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:DeferredIncome
      contextRef="i883fc4c8bc0f4255aec7223cc0f262b4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjBmY2VkZWI1N2QwMDQ2YmZiYzIxNDFkNDNlM2FmNDQ1L3RhYmxlcmFuZ2U6MGZjZWRlYjU3ZDAwNDZiZmJjMjE0MWQ0M2UzYWY0NDVfNC0xLTEtMS0w_824119d2-a45a-494e-9b3a-3f4f4cea8229"
      unitRef="usd">349000000</us-gaap:DeferredIncome>
    <us-gaap:DeferredIncome
      contextRef="ia927d1d44e99489ca715bf69330b08ab_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RhYmxlOjBmY2VkZWI1N2QwMDQ2YmZiYzIxNDFkNDNlM2FmNDQ1L3RhYmxlcmFuZ2U6MGZjZWRlYjU3ZDAwNDZiZmJjMjE0MWQ0M2UzYWY0NDVfNC0zLTEtMS0w_6003c6be-e758-4151-939a-6ccdb6cde18b"
      unitRef="usd">366000000</us-gaap:DeferredIncome>
    <bmy:UpfrontPaymentsMadeToCollaborativePartner
      contextRef="iaa8c668e967e4f73affcc1b178e53fd6_D20200101-20200630"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RleHRyZWdpb246OTE4NTkwZDFiYmNhNDQzZjgyMGYxN2VhMjliYmFhM2RfMjE5OTAyMzI4Nzk5Mg_5988cafc-f737-4422-8273-9f42a3b4c244"
      unitRef="usd">650000000</bmy:UpfrontPaymentsMadeToCollaborativePartner>
    <bmy:Considerationforcontingentdevelopmentandregulatoryapproval
      contextRef="i1726e9653791462e88d1e8fa6b55d2bf_D20210101-20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80MC9mcmFnOjkxODU5MGQxYmJjYTQ0M2Y4MjBmMTdlYTI5YmJhYTNkL3RleHRyZWdpb246OTE4NTkwZDFiYmNhNDQzZjgyMGYxN2VhMjliYmFhM2RfMjE5OTAyMzI4ODAwNg_5cd7fbf6-c7e2-42b1-9d02-a657cfdc962a"
      unitRef="usd">2500000000</bmy:Considerationforcontingentdevelopmentandregulatoryapproval>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RleHRyZWdpb246ZmJkNzU0NGYxZDQwNGNiZjljYTY0ZmQzZjNiMmRhNzdfNzQ0_977238f6-32a7-4698-830f-d9d4c304f8e6">DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Divestitures&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial impact of divestitures including royalties, which are included in Other (income)/expense, net. Revenue and pretax earnings related to all divestitures were not material in all periods presented (excluding divestiture gains or losses).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Proceeds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divestiture (Gains)/Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Royalty Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes Business&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Erbitux&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;* Business&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacturing Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature Brands and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Proceeds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divestiture (Gains)/Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Royalty Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes Business&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Erbitux&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;* Business&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacturing Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Plavix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;* and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Avapro*/Avalide*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature Brands and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes royalties received subsequent to the related sale of the asset or business.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Licensing and Other Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial impact of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Keytruda*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; royalties, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Tecentriq&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* royalties, up-front licensing fees and milestones for products that have not obtained commercial approval, which are included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Keytruda&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;* royalties&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(396)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(316)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Tecentriq&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;* royalties&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Up-front licensing fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent milestone income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(485)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Agenus&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, BMS obtained a global exclusive license to Agenus&#x2019; proprietary AGEN1777 bispecific antibody program that blocks TIGIT and an additional target. AGEN1777 is being studied in oncology and is in preclinical development. BMS will be responsible for the development and any subsequent commercialization of AGEN1777 and its related products worldwide, including strategic decisions, regulatory responsibilities, funding and manufacturing. BMS paid a $200&#160;million upfront licensing fee to Agenus and is obligated to pay up to $1.4&#160;billion upon achievement of contingent development, regulatory and sales-based milestones as well as royalties on global net sales.&lt;/span&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RleHRyZWdpb246ZmJkNzU0NGYxZDQwNGNiZjljYTY0ZmQzZjNiMmRhNzdfNzQw_d53471c9-7052-4975-a218-f0d0e0d1f07b">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial impact of divestitures including royalties, which are included in Other (income)/expense, net. Revenue and pretax earnings related to all divestitures were not material in all periods presented (excluding divestiture gains or losses).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Proceeds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divestiture (Gains)/Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Royalty Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes Business&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Erbitux&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;* Business&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacturing Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature Brands and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Proceeds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divestiture (Gains)/Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Royalty Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diabetes Business&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Erbitux&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;* Business&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacturing Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Plavix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;* and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Avapro*/Avalide*&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mature Brands and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(288)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes royalties received subsequent to the related sale of the asset or business.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i97d8d3703ed04fed8d1982e8631612c5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfMy0xLTEtMS0w_16ab7098-761a-41b4-832f-f30ac16b4464"
      unitRef="usd">132000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i9130fda1c97a4512869f8c40ceda43a3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfMy0zLTEtMS0w_38719b20-52ec-4437-91bd-9f37d1a3e9e8"
      unitRef="usd">127000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i97d8d3703ed04fed8d1982e8631612c5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfMy01LTEtMS0w_e51458ab-7e7b-40e4-bc99-960209465df2"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i9130fda1c97a4512869f8c40ceda43a3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfMy03LTEtMS0w_040c770d-757a-4045-9bd5-4ab1e37c19c5"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i97d8d3703ed04fed8d1982e8631612c5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfMy05LTEtMS0w_4e796959-db25-4297-a072-498deaeaf0a8"
      unitRef="usd">152000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i9130fda1c97a4512869f8c40ceda43a3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfMy0xMS0xLTEtMA_92b85d8f-4eac-4f36-9620-f468d3229870"
      unitRef="usd">129000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i874255d4051145ffb584d5ace4120829_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNC0xLTEtMS0w_e1443495-d604-498e-af54-713c7b7c1248"
      unitRef="usd">6000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i3b10d04730ab481fa4a091d91c386131_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNC0zLTEtMS0w_54d3a940-101d-413b-8adf-d53d623e5a1f"
      unitRef="usd">3000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i874255d4051145ffb584d5ace4120829_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNC01LTEtMS0w_7d2026f1-fe29-4452-a578-d27411f513ee"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i3b10d04730ab481fa4a091d91c386131_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNC03LTEtMS0w_448e19eb-7bf7-412e-aa5d-520925dd32bc"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i874255d4051145ffb584d5ace4120829_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNC05LTEtMS0w_2d2d6418-0fc6-4fbe-921b-f51e4cbc3098"
      unitRef="usd">0</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i3b10d04730ab481fa4a091d91c386131_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNC0xMS0xLTEtMA_38ac461c-b43c-4ae5-b0f0-8b8c6fc5032d"
      unitRef="usd">0</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="ic600cede908c45fd9de219d601e19f65_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNS0xLTEtMS0w_5b0046c1-a2ab-4551-bb07-fc8a843c0fe9"
      unitRef="usd">23000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="ia149c1d5e9ac4dea84e8c70a697500b0_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNS0zLTEtMS0w_de7291da-1489-4532-92ae-ff45b00ee307"
      unitRef="usd">10000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ic600cede908c45fd9de219d601e19f65_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNS01LTEtMS0w_18122dc7-bd4f-4e90-a324-9ffdb26e185c"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ia149c1d5e9ac4dea84e8c70a697500b0_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNS03LTEtMS0w_a9c58ff9-4d3b-47dd-80b6-9e2cbb5c3b3a"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="ic600cede908c45fd9de219d601e19f65_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNS05LTEtMS0w_189a7373-43a2-4b46-be7e-b1c1927dda2b"
      unitRef="usd">0</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="ia149c1d5e9ac4dea84e8c70a697500b0_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNS0xMS0xLTEtMA_618332c1-1298-457f-a2c8-b01c7af3a733"
      unitRef="usd">0</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="ib432c7d456164aba93e919e08338e013_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNy0xLTEtMS0w_3260623e-d93e-4226-abd7-388f5d5ad124"
      unitRef="usd">41000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="ibb48dbce12f842488d8e56ebc0551af8_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNy0zLTEtMS0w_3823ceca-f7e2-4505-a4d4-d6ada385b614"
      unitRef="usd">1000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ib432c7d456164aba93e919e08338e013_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNy01LTEtMS0w_98d6c73c-5a62-426d-b6f8-bec4cc19b6db"
      unitRef="usd">11000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ibb48dbce12f842488d8e56ebc0551af8_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNy03LTEtMS0w_5a08ad3c-afbf-4f94-84a1-078a641c5099"
      unitRef="usd">-9000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="ib432c7d456164aba93e919e08338e013_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNy05LTEtMS0w_63cb6301-6f5b-4ea9-a756-6c03cd58d366"
      unitRef="usd">0</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="ibb48dbce12f842488d8e56ebc0551af8_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfNy0xMS0xLTEtMA_65170afb-71f1-423b-b9be-28fa1924923f"
      unitRef="usd">1000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfOC0xLTEtMS0w_1a18231e-e1fa-450f-a7fe-72f66d5e8738"
      unitRef="usd">202000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfOC0zLTEtMS0w_bccb960a-99bd-4c87-959d-d9a132c6c8cf"
      unitRef="usd">141000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfOC01LTEtMS0w_3b2c5164-576d-402d-895b-c8c939c69ead"
      unitRef="usd">11000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfOC03LTEtMS0w_d9f40eab-9dab-4c4e-b939-909a7ffa4c5a"
      unitRef="usd">-9000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfOC05LTEtMS0w_82085923-df99-4212-ba68-af6c5c229f13"
      unitRef="usd">152000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOmI1NTc0NzA5MGY4ZDRhMGRhMmEwZTk4MjBhMTA4ZTVmL3RhYmxlcmFuZ2U6YjU1NzQ3MDkwZjhkNGEwZGEyYTBlOTgyMGExMDhlNWZfOC0xMS0xLTEtMA_fe200dc3-8f74-423c-9c05-67351f11a25a"
      unitRef="usd">130000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="ie92eb5d3a8224bf48b897ca58fe4dc15_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfMy0xLTEtMS0zNjA_4970dfa0-ab47-472a-8b43-a152e985985e"
      unitRef="usd">296000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i9e04e6f0f1cb48e8ad1a548c38f665dc_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfMy0zLTEtMS0zNzc_284fb370-b81d-45d0-9c15-b1b668520ad5"
      unitRef="usd">280000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ie92eb5d3a8224bf48b897ca58fe4dc15_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfMy01LTEtMS0zODE_7a192e19-2be7-4134-8eb8-600c22f6ce46"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i9e04e6f0f1cb48e8ad1a548c38f665dc_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfMy03LTEtMS0zODU_471700d4-f6b7-49b3-9752-859983f82b23"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="ie92eb5d3a8224bf48b897ca58fe4dc15_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfMy05LTEtMS0zODk_73e0bf4f-3c0d-49a9-aebd-b1d049181093"
      unitRef="usd">286000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i9e04e6f0f1cb48e8ad1a548c38f665dc_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfMy0xMS0xLTEtMzk0_6f1c9935-265e-48b5-9c33-c0c4bcdefa1a"
      unitRef="usd">256000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="ic7f237dfaf294517a6c993c23a19c5a8_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNC0xLTEtMS0zNjk_c576d96c-eb0d-4995-b800-6e5f85b0ebd8"
      unitRef="usd">6000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i2e3fa03c07574d4fae920e7935e8a621_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNC0zLTEtMS0zNzc_831c46b8-2bd7-47b4-8f4f-461fb0393a85"
      unitRef="usd">7000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ic7f237dfaf294517a6c993c23a19c5a8_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNC01LTEtMS0zODE_8f7cb505-7b27-4514-b3bb-b0943695a375"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i2e3fa03c07574d4fae920e7935e8a621_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNC03LTEtMS0zODU_a38f1ce3-6b00-4852-ab5e-43ae6d2da256"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="ic7f237dfaf294517a6c993c23a19c5a8_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNC05LTEtMS0zODk_3fa9ff62-2f0b-4110-b172-3a4601f6920d"
      unitRef="usd">0</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i2e3fa03c07574d4fae920e7935e8a621_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNC0xMS0xLTEtMzk0_5fa4c782-8d14-4061-a812-b1756bad416a"
      unitRef="usd">0</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="ica3960bd33c645d1bf92833258f53c54_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNS0xLTEtMS0zNzM_e8312874-236d-4660-a01f-c9e94930e3ca"
      unitRef="usd">23000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i3ff17e3e1d554be8a5a2f24d9b41e2a6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNS0zLTEtMS0zNzc_23e4dd93-04f8-4f48-9f7f-d3c1201e9331"
      unitRef="usd">10000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ica3960bd33c645d1bf92833258f53c54_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNS01LTEtMS0zODE_b297bc00-3e9c-462e-8550-508be8b1d7f6"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i3ff17e3e1d554be8a5a2f24d9b41e2a6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNS03LTEtMS0zODU_70f05e83-0169-4d86-ade4-66c672a7358b"
      unitRef="usd">1000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="ica3960bd33c645d1bf92833258f53c54_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNS05LTEtMS0zODk_b8edd32f-1797-4d57-a90d-b4df5921d740"
      unitRef="usd">0</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i3ff17e3e1d554be8a5a2f24d9b41e2a6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNS0xMS0xLTEtMzk0_0e40a02e-989d-4039-bb61-62714f2c3b93"
      unitRef="usd">0</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i7c7d34b293eb4396be52fdac70722a24_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNi0xLTEtMS0zNzM_c4559604-d78d-4251-9fcb-27320a02531d"
      unitRef="usd">5000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="ia34fe71a86434a37a78799df75ebb670_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNi0zLTEtMS0zNzc_14b31651-cd70-42e3-a878-c1b03912fdf4"
      unitRef="usd">7000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i7c7d34b293eb4396be52fdac70722a24_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNi01LTEtMS0zODE_808d24e6-b37b-4c5b-bc6a-4faa50b62dfb"
      unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ia34fe71a86434a37a78799df75ebb670_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNi03LTEtMS0zODU_497b5f21-1854-4796-9286-7e8a9a029fa6"
      unitRef="usd">12000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i7c7d34b293eb4396be52fdac70722a24_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNi05LTEtMS0zODk_4ac1aac5-d402-466e-a714-1c891e17452a"
      unitRef="usd">0</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="ia34fe71a86434a37a78799df75ebb670_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNi0xMS0xLTEtMzk0_0290b82e-47b4-4d37-ab2a-1ca78e51c2fd"
      unitRef="usd">0</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i766f66d3a5564477a5cee03c3f5dbfe4_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNy0xLTEtMS0zNzM_6cfad305-e392-42d5-9326-b70bf90444f0"
      unitRef="usd">52000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i51508ada4a88448fa0d47dbd056ce19f_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNy0zLTEtMS0zNzc_72a9f9c0-e43b-4e90-a8de-b633d42ddd2c"
      unitRef="usd">32000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i766f66d3a5564477a5cee03c3f5dbfe4_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNy01LTEtMS0zODE_cf6cd419-b16a-47ae-a823-fb7b02c19e32"
      unitRef="usd">11000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i51508ada4a88448fa0d47dbd056ce19f_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNy03LTEtMS0zODU_605d248c-b150-4285-abbe-5c20b83fc871"
      unitRef="usd">-6000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i766f66d3a5564477a5cee03c3f5dbfe4_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNy05LTEtMS0zODk_28e6fa7b-9dfa-40f1-9e81-e265ef5e9280"
      unitRef="usd">1000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i51508ada4a88448fa0d47dbd056ce19f_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfNy0xMS0xLTEtMzk0_7a8c5452-09f0-4b3a-9ae2-b098d7999d1f"
      unitRef="usd">32000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfOC0xLTEtMS0xOTg3_d9ab0a15-f610-4df3-b350-6502dd4a0e89"
      unitRef="usd">382000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfOC0zLTEtMS0xOTg3_d62ad68d-6d6c-4b0b-b05d-64e75c36002a"
      unitRef="usd">336000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfOC01LTEtMS0xOTg3_23eab65a-bd5e-4e84-ba5f-c80f2bd5344f"
      unitRef="usd">11000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfOC03LTEtMS0xOTg3_4dd3f818-7985-4d25-b06e-8ca7881d8dc3"
      unitRef="usd">7000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfOC05LTEtMS0xOTg3_3233a65b-515c-4ac6-8cc9-8502ee80c104"
      unitRef="usd">287000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjZkN2RiODg2MmNlZjQ4NmM4M2NjNzc4NzZhYzJmYmU3L3RhYmxlcmFuZ2U6NmQ3ZGI4ODYyY2VmNDg2YzgzY2M3Nzg3NmFjMmZiZTdfOC0xMS0xLTEtMTk4Nw_96c0e7f9-77c1-4ab1-801d-b6a1f34e2a47"
      unitRef="usd">288000000</us-gaap:RoyaltyIncomeNonoperating>
    <bmy:LicensingAndOtherArrangementsTableTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RleHRyZWdpb246ZmJkNzU0NGYxZDQwNGNiZjljYTY0ZmQzZjNiMmRhNzdfNzUx_af0a3ba9-36d6-4876-a774-137f53c8e199">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial impact of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Keytruda*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; royalties, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Tecentriq&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* royalties, up-front licensing fees and milestones for products that have not obtained commercial approval, which are included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Keytruda&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;* royalties&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(396)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(316)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Tecentriq&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;* royalties&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Up-front licensing fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent milestone income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(485)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bmy:LicensingAndOtherArrangementsTableTextBlock>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="ie5168aa9c0f548cf89708d739d0fbf68_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfMi0xLTEtMS0w_8408c4ba-4a48-47c1-a2c6-8bd4e0801029"
      unitRef="usd">204000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i33dbe127e2a8431a8d4df6ef930b3c47_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfMi0zLTEtMS0w_c2efffcb-1f5b-4efd-b457-f977aea1df01"
      unitRef="usd">155000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="ic81b26b07c5c4e61941a1674d76cfe98_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfMi01LTEtMS0w_ba722ff5-3968-4594-9000-fb3ae55d14ba"
      unitRef="usd">396000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="ica7f052bd75f40ccbb4445d5f8e47381_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfMi03LTEtMS0w_a4851e99-04e3-425d-8099-3483b3c3fd47"
      unitRef="usd">316000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i5a4f553f8932405197ea119b17e8eca1_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfMy0xLTEtMS0w_a9c8c4b0-30f6-4aaf-b4fc-52a14f93f70d"
      unitRef="usd">23000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i77b50711d0f2426ab381586aa8a781f4_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfMy0zLTEtMS0w_165c4d01-8c0d-47b1-9fc2-bfa94e70ea47"
      unitRef="usd">0</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="ib483860a3a46419ea7cade23a1f57af8_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfMy01LTEtMS0w_95dbd612-d9e0-4ab6-b718-77f9ff3fdb47"
      unitRef="usd">45000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="id4f9948a6cc44875bca5c798572cafe7_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfMy03LTEtMS0w_cad98ae2-0cae-43ca-8e7e-c1eef61a37f2"
      unitRef="usd">0</us-gaap:RoyaltyIncomeNonoperating>
    <bmy:UpFrontLicensingFee
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNC0xLTEtMS0w_b1bcdddf-9d07-4e56-9781-c7c88ba3f11e"
      unitRef="usd">0</bmy:UpFrontLicensingFee>
    <bmy:UpFrontLicensingFee
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNC0zLTEtMS0w_111affc8-20ec-4079-b138-a51317104870"
      unitRef="usd">0</bmy:UpFrontLicensingFee>
    <bmy:UpFrontLicensingFee
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNC01LTEtMS0w_3fda1801-66f1-4dac-9efd-885f6ea9621e"
      unitRef="usd">0</bmy:UpFrontLicensingFee>
    <bmy:UpFrontLicensingFee
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNC03LTEtMS0w_54b952af-fbb6-47bc-b39f-3635610de198"
      unitRef="usd">30000000</bmy:UpFrontLicensingFee>
    <bmy:ContingentRegulatoryMilestoneIncome
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNS0xLTEtMS0w_16fb4e69-d318-420a-8699-c467d0d580fd"
      unitRef="usd">2000000</bmy:ContingentRegulatoryMilestoneIncome>
    <bmy:ContingentRegulatoryMilestoneIncome
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNS0zLTEtMS0w_d26fc360-4398-4c0d-8656-495d176571c7"
      unitRef="usd">5000000</bmy:ContingentRegulatoryMilestoneIncome>
    <bmy:ContingentRegulatoryMilestoneIncome
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNS01LTEtMS0w_96a4e5ab-18d8-41e0-afd2-e97408792017"
      unitRef="usd">2000000</bmy:ContingentRegulatoryMilestoneIncome>
    <bmy:ContingentRegulatoryMilestoneIncome
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNS03LTEtMS0w_54310ba0-588f-4ae4-b94c-5265d7e32b87"
      unitRef="usd">46000000</bmy:ContingentRegulatoryMilestoneIncome>
    <us-gaap:OtherAmortizationOfDeferredCharges
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNi0xLTEtMS0w_cd66f06d-1df2-40a9-bff4-aaf33cf882df"
      unitRef="usd">15000000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:OtherAmortizationOfDeferredCharges
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNi0zLTEtMS0w_cc8c5330-3d02-44d5-a906-6ab7bd6adf56"
      unitRef="usd">15000000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:OtherAmortizationOfDeferredCharges
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNi01LTEtMS0w_d0f7e8b6-e8e7-49c5-b1ed-aba36482d885"
      unitRef="usd">30000000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:OtherAmortizationOfDeferredCharges
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNi03LTEtMS0w_ee00de3d-3a68-4fdf-932e-ab3c564e7f5a"
      unitRef="usd">30000000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i652d5c5a16f54d499f777b18da32cbf1_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNy0xLTEtMS0w_190c27c4-52c9-4a71-9d78-3b554b40d29d"
      unitRef="usd">9000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="iac41a45cb93d4b57847364ccda78f7ea_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNy0zLTEtMS0w_b0ceb005-e742-4e7a-8494-2b581bffde33"
      unitRef="usd">6000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="i14b8f5fa9564459e9343a7fbfae773f2_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNy01LTEtMS0w_7a91d90f-2ede-4e3b-89bc-e76300247aa4"
      unitRef="usd">12000000</us-gaap:RoyaltyIncomeNonoperating>
    <us-gaap:RoyaltyIncomeNonoperating
      contextRef="ia1b8cdf4c8fd43e5940c861fd7075cc7_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfNy03LTEtMS0w_8de37c58-04bf-4939-a1d5-c11bd47763ec"
      unitRef="usd">11000000</us-gaap:RoyaltyIncomeNonoperating>
    <bmy:LicensingAndOtherArrangementsIncome
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfOC0xLTEtMS0w_6a7725d6-0ded-4b81-ae54-02fc679dd94f"
      unitRef="usd">253000000</bmy:LicensingAndOtherArrangementsIncome>
    <bmy:LicensingAndOtherArrangementsIncome
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfOC0zLTEtMS0w_9e3a783f-a598-4af0-906e-94e6d83c547c"
      unitRef="usd">181000000</bmy:LicensingAndOtherArrangementsIncome>
    <bmy:LicensingAndOtherArrangementsIncome
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfOC01LTEtMS0xOTk0_5440cfdc-17a0-400e-ad55-9263ed9993b6"
      unitRef="usd">485000000</bmy:LicensingAndOtherArrangementsIncome>
    <bmy:LicensingAndOtherArrangementsIncome
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RhYmxlOjhmOGYwNWNmM2NhYTQ0NzBiZDE2ZGNjZGRkMWRkYmRiL3RhYmxlcmFuZ2U6OGY4ZjA1Y2YzY2FhNDQ3MGJkMTZkY2NkZGQxZGRiZGJfOC03LTEtMS0xOTk2_dc57f83a-d88b-4706-8b1c-1b22b67bb0c5"
      unitRef="usd">433000000</bmy:LicensingAndOtherArrangementsIncome>
    <bmy:LicenseAndOtherArrangementsUpfrontPayments
      contextRef="i3fb344c7b5984689b0e077d03d0f5e83_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RleHRyZWdpb246ZmJkNzU0NGYxZDQwNGNiZjljYTY0ZmQzZjNiMmRhNzdfMjE5OTAyMzI2MjE4OA_3b095b05-eda5-4c04-884a-b80472ca8edb"
      unitRef="usd">200000000</bmy:LicenseAndOtherArrangementsUpfrontPayments>
    <bmy:ContingentAndRegulatoryMilestonePayments
      contextRef="i3fb344c7b5984689b0e077d03d0f5e83_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80My9mcmFnOmZiZDc1NDRmMWQ0MDRjYmY5Y2E2NGZkM2YzYjJkYTc3L3RleHRyZWdpb246ZmJkNzU0NGYxZDQwNGNiZjljYTY0ZmQzZjNiMmRhNzdfMjE5OTAyMzI2MjIwMg_9fc4ca50-ed75-493f-9a27-82c78bbbd0b8"
      unitRef="usd">1400000000</bmy:ContingentAndRegulatoryMilestonePayments>
    <us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RleHRyZWdpb246MjFjNDNjOTc2NGY1NGY1NGFlMGU4ZmY3NzE0YWZiMTVfNDY_4a448523-c922-410e-876b-87821ac7aa1f">OTHER (INCOME)/EXPENSE, NET&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalties and licensing income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(405)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(311)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(772)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(721)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investment gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(818)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(749)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integration expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation and other settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transition and other service fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reversion excise tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestiture (gains)/losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on debt redemption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(736)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock>
    <bmy:ScheduleOfOtherIncomeExpenseTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RleHRyZWdpb246MjFjNDNjOTc2NGY1NGY1NGFlMGU4ZmY3NzE0YWZiMTVfNjA_ac71386d-2d0c-447f-937b-569a41ca6a84">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalties and licensing income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(405)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(311)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(772)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(721)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investment gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(818)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(749)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integration expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Litigation and other settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transition and other service fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(111)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reversion excise tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Divestiture (gains)/losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible asset impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on debt redemption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(736)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</bmy:ScheduleOfOtherIncomeExpenseTextBlock>
    <us-gaap:InterestExpense
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMi0xLTEtMS0w_1ab64f5a-ec63-4287-b377-2f995e1e9e7e"
      unitRef="usd">330000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMi0zLTEtMS0w_9d7e69c7-b005-41d4-bbed-2edf6270182f"
      unitRef="usd">357000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMi01LTEtMS0w_16731b61-bbc3-4df8-b14c-318cadd531ba"
      unitRef="usd">683000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMi03LTEtMS0w_cec33306-9a73-4525-b127-1b3632b88c06"
      unitRef="usd">719000000</us-gaap:InterestExpense>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMy0xLTEtMS0w_7f700dc1-fd34-4bfa-958c-2e6325bb3eb6"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMy0zLTEtMS0w_10890dd8-2a60-4dc2-b105-935e41ecf3ff"
      unitRef="usd">-165000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMy01LTEtMS0w_85402ee0-8b6d-43b0-9df6-4a15781671e8"
      unitRef="usd">-510000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMy03LTEtMS0w_6bce7e90-584b-47c1-a316-f4eedb63d39b"
      unitRef="usd">391000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <bmy:OtherIncomeReceivedFromAlliancePartners
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNC0xLTEtMS0w_bc26c90d-03e6-4026-8556-984de8ccfdac"
      unitRef="usd">405000000</bmy:OtherIncomeReceivedFromAlliancePartners>
    <bmy:OtherIncomeReceivedFromAlliancePartners
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNC0zLTEtMS0w_dbdac158-30a6-4605-a12b-ec23b68f22b1"
      unitRef="usd">311000000</bmy:OtherIncomeReceivedFromAlliancePartners>
    <bmy:OtherIncomeReceivedFromAlliancePartners
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNC01LTEtMS0w_3b938571-ec2b-4b15-ac00-7a98d789d9a8"
      unitRef="usd">772000000</bmy:OtherIncomeReceivedFromAlliancePartners>
    <bmy:OtherIncomeReceivedFromAlliancePartners
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNC03LTEtMS0w_9771ae80-7bdd-40e6-9e1a-311cfdf1d1ca"
      unitRef="usd">721000000</bmy:OtherIncomeReceivedFromAlliancePartners>
    <us-gaap:GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNS0xLTEtMS0w_3b4d20ea-17d3-4b95-afb2-c08930ee236c"
      unitRef="usd">148000000</us-gaap:GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments>
    <us-gaap:GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNS0zLTEtMS0w_f96fde91-e595-4589-ba0b-83ef54165155"
      unitRef="usd">818000000</us-gaap:GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments>
    <us-gaap:GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNS01LTEtMS0w_c2327653-ecce-40dd-b71a-0e3f4547c4de"
      unitRef="usd">749000000</us-gaap:GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments>
    <us-gaap:GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNS03LTEtMS0w_e3dc9bbf-fc37-4910-8ebe-8debedc48424"
      unitRef="usd">480000000</us-gaap:GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNi0xLTEtMS0w_61548b8e-bf1b-40b4-b4d1-04236b680d42"
      unitRef="usd">152000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNi0zLTEtMS0w_8d1d8050-c7b0-4719-af12-7db61b13fb08"
      unitRef="usd">166000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNi01LTEtMS0w_b10cd87a-fdda-4c34-b6cf-168c6ad703be"
      unitRef="usd">293000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNi03LTEtMS0w_046aa7f5-cb1c-463e-86ff-5fa74a16fd60"
      unitRef="usd">340000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:RestructuringCharges
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNy0xLTEtMS0w_0fac08a4-5d18-45c1-b104-57c914ea2127"
      unitRef="usd">78000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNy0zLTEtMS0w_e10f92d5-f23a-4b00-af5c-c4cd1273d0d6"
      unitRef="usd">115000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNy01LTEtMS0w_59dd5b00-e29a-4129-8226-74b089b07680"
      unitRef="usd">123000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfNy03LTEtMS0w_c6dde0f7-ca19-4372-a689-44ec2f1cd8ed"
      unitRef="usd">275000000</us-gaap:RestructuringCharges>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfOC0xLTEtMS0w_d57a4f56-1364-402f-87b7-d4d8bdd0a815"
      unitRef="usd">-44000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfOC0zLTEtMS0w_5d2d84de-55b4-4960-a6a7-29de09a7420f"
      unitRef="usd">1000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfOC01LTEtMS0w_be4ef093-600f-45b2-9aab-e6cb7cd7b6cb"
      unitRef="usd">-36000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfOC03LTEtMS0w_372d7ba4-8928-4c01-b473-d3360b0465f0"
      unitRef="usd">-31000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <bmy:AllianceTransitionalServices
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfOS0xLTEtMS0w_5d520fa3-447b-490c-a7b7-a60d16f86843"
      unitRef="usd">22000000</bmy:AllianceTransitionalServices>
    <bmy:AllianceTransitionalServices
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfOS0zLTEtMS0w_3e3823ae-ffad-4023-a4f8-157299c503be"
      unitRef="usd">50000000</bmy:AllianceTransitionalServices>
    <bmy:AllianceTransitionalServices
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfOS01LTEtMS0w_a82960c2-22a4-49e1-8502-eb43075b4f4d"
      unitRef="usd">37000000</bmy:AllianceTransitionalServices>
    <bmy:AllianceTransitionalServices
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfOS03LTEtMS0w_21b23da0-d5de-451c-99b0-28c5100176e6"
      unitRef="usd">111000000</bmy:AllianceTransitionalServices>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTAtMS0xLTEtMA_e849c9bf-fcc1-421c-8cdf-2c1560cfed4d"
      unitRef="usd">12000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTAtMy0xLTEtMA_595a7d3c-207b-42f3-800b-6ea5b36320e7"
      unitRef="usd">25000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTAtNS0xLTEtMA_831ba960-2420-4893-9bfc-62f565d6d183"
      unitRef="usd">21000000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTAtNy0xLTEtMA_f2a962e5-9506-4b08-9d11-c1ab42d03ba8"
      unitRef="usd">86000000</us-gaap:InvestmentIncomeInterest>
    <bmy:Reversionexcisetax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTEtMS0xLTEtMA_58c03eda-befe-411a-a39c-2610e60286e9"
      unitRef="usd">0</bmy:Reversionexcisetax>
    <bmy:Reversionexcisetax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTEtMy0xLTEtMA_e661ba2a-bd06-49b7-b050-50ef1a32013c"
      unitRef="usd">0</bmy:Reversionexcisetax>
    <bmy:Reversionexcisetax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTEtNS0xLTEtMA_22dcbdfe-9414-440d-b9f0-49104fb44fce"
      unitRef="usd">0</bmy:Reversionexcisetax>
    <bmy:Reversionexcisetax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTEtNy0xLTEtMA_fcac7b99-9329-4042-b4d1-4ba82bceb6db"
      unitRef="usd">76000000</bmy:Reversionexcisetax>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTItMS0xLTEtMA_baf74cc0-b506-4416-b89c-fdb6895723f5"
      unitRef="usd">11000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTItMy0xLTEtMA_f343ef3d-84a8-49e1-b7a1-c77ba398f593"
      unitRef="usd">-9000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTItNS0xLTEtMA_60554f3d-dab6-4afe-9693-ea279b7b65dd"
      unitRef="usd">11000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTItNy0xLTEtMA_ec995a43-40f2-4e65-b21e-738ce4bf4174"
      unitRef="usd">7000000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTMtMS0xLTEtMA_d3f75c37-16b2-4b2a-b83c-f475ffb40832"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTMtMy0xLTEtMA_fb028801-bc6b-4241-a308-fe048f4bb556"
      unitRef="usd">21000000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTMtNS0xLTEtMA_c380f3f4-d1b1-4988-aa1f-36d0c3bbc7c1"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTMtNy0xLTEtMA_f0859d82-091b-4d1d-810e-dd025273c37b"
      unitRef="usd">21000000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTUtMS0xLTEtMA_9d3b1ca0-6715-485f-a467-906d401e13a5"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTUtMy0xLTEtMA_6018c637-b813-4f17-9873-714b998432d0"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTUtNS0xLTEtMTYyNg_bdfe74ab-f4aa-4924-b957-eb66b5c7dba2"
      unitRef="usd">-281000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTUtNy0xLTEtMTYyOQ_dfe3c680-1df0-47b0-85cd-84a9c77690e7"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <bmy:OtherOtherIncomeExpense
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTgtMS0xLTEtMA_f984dba1-90e5-4724-93d1-0454765194e7"
      unitRef="usd">8000000</bmy:OtherOtherIncomeExpense>
    <bmy:OtherOtherIncomeExpense
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTgtMy0xLTEtMA_0c9bc33b-8178-4c80-ab0e-1140e7c87e57"
      unitRef="usd">34000000</bmy:OtherOtherIncomeExpense>
    <bmy:OtherOtherIncomeExpense
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTgtNS0xLTEtMA_473b5635-58e4-47ac-819e-76080df9fe59"
      unitRef="usd">20000000</bmy:OtherOtherIncomeExpense>
    <bmy:OtherOtherIncomeExpense
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTgtNy0xLTEtMA_adae831b-a835-41fd-9beb-cdefc68786e2"
      unitRef="usd">21000000</bmy:OtherOtherIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTktMS0xLTEtMA_bbf5c36d-136b-431d-82d8-95ef62245713"
      unitRef="usd">2000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTktMy0xLTEtMA_fc75c0a4-ca47-492e-b725-6450c7c9e7bb"
      unitRef="usd">736000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTktNS0xLTEtMjA1MA_f6b7e5eb-aa1d-4aa7-85ab-5a0a68938e0c"
      unitRef="usd">704000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80Ni9mcmFnOjIxYzQzYzk3NjRmNTRmNTRhZTBlOGZmNzcxNGFmYjE1L3RhYmxlOjkyYTVhMzU1OTIyNjQzYThhMzVjYzNmZDEwNTQ0YWMwL3RhYmxlcmFuZ2U6OTJhNWEzNTU5MjI2NDNhOGEzNWNjM2ZkMTA1NDRhYzBfMTktNy0xLTEtMjA1Mg_59d43da5-e430-4cf0-922d-e0320007fe7f"
      unitRef="usd">-427000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfMjE2Ng_163a1986-c282-4f6c-9370-e678b9435089">RESTRUCTURING&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Celgene Acquisition Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2019, a restructuring and integration plan was implemented as an initiative to realize sustainable run rate synergies resulting from cost savings and avoidance from the Celgene acquisition which is currently expected to be approximately $3.0&#160;billion. The synergies are expected to be realized in Cost of products sold (10%), Marketing, selling and administrative expenses (55%) and Research and development expenses (35%). Charges of approximately $3.0&#160;billion are expected to be incurred through 2022. Cumulative charges of approximately $2.3&#160;billion have been recognized including integration planning and execution expenses, employee termination benefit costs and accelerated stock-based compensation, contract termination costs and other shutdown costs associated with site exits. Cash outlays in connection with these actions are expected to be approximately $2.5&#160;billion. Employee workforce reductions were approximately 240 and 900 for the six months ended June&#160;30, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;MyoKardia Acquisition Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, a restructuring and integration plan was initiated to realize expected cost synergies resulting from cost savings and avoidance from the MyoKardia acquisition. Charges of approximately $150&#160;million are expected to be incurred through 2022, and consist of integration planning and execution expenses, employee termination benefit costs and other costs. Cumulative charges of approximately $95 million have been recognized for these actions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Company Transformation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2016, a restructuring plan was announced to evolve and streamline BMS&#x2019;s operating model. Cumulative charges of approximately $1.5&#160;billion were recognized for these actions since the announcement. Actions under the plan were completed as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following provides the charges related to restructuring initiatives by type of cost:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Celgene Acquisition Plan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MyoKardia Acquisition Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Company Transformation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other termination costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integration expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other shutdown costs, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing, selling and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the charges and spending related to restructuring plan activities:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability at December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for restructuring&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability at June 30&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes a reduction of the liability resulting from changes in estimates of $8 million and $6 million for the six months ended June 30, 2021 and 2020, respectively. Excludes $9 million and $47 million for the six months ended June 30, 2021 and 2020, respectively, of accelerated stock-based compensation relating to the Celgene Acquisition Plan.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i93047c5690bd4da0b6566915947d0bb6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfNDk2_74144404-f62d-4269-b0b2-46512caa0100"
      unitRef="usd">3000000000.0</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i93047c5690bd4da0b6566915947d0bb6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfNTc3_db118c7a-beba-47db-a5e4-4ac1a8a190ee"
      unitRef="usd">2300000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <bmy:Cashoutlays
      contextRef="i93047c5690bd4da0b6566915947d0bb6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfODky_541b447a-f1d6-4122-832b-7fc1d9441295"
      unitRef="usd">2500000000</bmy:Cashoutlays>
    <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated
      contextRef="icb6143c62bc94de08946b50699d69bcf_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfOTQ1_3e255c43-d9e8-4ed2-b99a-f1f7dc789214"
      unitRef="number">240</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated>
    <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated
      contextRef="ide8bf9df7627455e8b1decf3f9977ac6_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfOTUy_832ef274-fe51-4cc5-88bf-62bcd88f936b"
      unitRef="number">900</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminated>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i75070985c9424f3586afbe7c4c8bf69b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfMTIxNA_05c90f75-9882-411f-9a04-4aacd2316304"
      unitRef="usd">150000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i75070985c9424f3586afbe7c4c8bf69b_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfMTQwNw_741fff74-3350-4969-9e76-57b9b9ca4439"
      unitRef="usd">95000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="ic41a1bc571fe4873a7258b43472f3a1e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfMTYwMw_6a1427cf-ebc9-48cd-958a-90e1129f0b24"
      unitRef="usd">1500000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfMjE2NA_e3b273cc-2060-43be-b708-d7a32ee9c8c5">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following provides the charges related to restructuring initiatives by type of cost:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Celgene Acquisition Plan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MyoKardia Acquisition Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Company Transformation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee termination costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other termination costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Integration expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accelerated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset impairments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other shutdown costs, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing, selling and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total charges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i8c68d9932836432cae27f5f3320513f4_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMi0xLTEtMS0w_ed91372a-27e2-45d9-9f94-15613fbfdfc2"
      unitRef="usd">200000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="idd2855f0217247dfb6ab35e107cd3274_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMi0zLTEtMS0w_476f2287-251f-4bd5-b342-7bbe69ca318f"
      unitRef="usd">317000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="icb6143c62bc94de08946b50699d69bcf_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMi01LTEtMS0w_8e3cec95-0d58-4d3f-8459-3ed8b1941ddc"
      unitRef="usd">373000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ide8bf9df7627455e8b1decf3f9977ac6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMi03LTEtMS0w_40c87a82-db66-4eea-b99b-f6473b43886a"
      unitRef="usd">641000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i9e3436bd7185495999f6d1496751f496_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMy0xLTEtMS0w_cfaadfac-379b-424f-91b6-acf424e0ac32"
      unitRef="usd">19000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i5f59683c007c4e6b9b0b8bc87e2e9c64_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMy0zLTEtMS0w_8c74ffd4-0752-4f6a-8787-63d3650a4046"
      unitRef="usd">0</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ie2bf4fd36e0b487cb4bc3cf29adddd55_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMy01LTEtMS0w_272e94ac-1e3a-4ded-a38b-8d3f85ac56c3"
      unitRef="usd">56000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i52b957a2c68f452c8ed0ce9191019247_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMy03LTEtMS0w_0a53f11b-a2d3-4a31-ac24-15e5dcbe75dd"
      unitRef="usd">0</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="iecfdd1291eba4609ac0bb3efec2bf1de_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfNC0xLTEtMS0w_9147f679-688d-4d0d-8e4d-2065c6993084"
      unitRef="usd">0</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i92805409d0e6445bb29744ae8cb018b8_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfNC0zLTEtMS0w_465f4b33-82ba-48d7-9f72-28be8f47689a"
      unitRef="usd">23000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ibd4eecd0bba84eb6a04beb957de7a224_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfNC01LTEtMS0w_185f454c-f6c0-4cd3-b9ae-ddf8cb6b6b3e"
      unitRef="usd">0</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ic77161109800434da68b989c381905e7_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfNC03LTEtMS0w_0160ccc1-94e6-497b-b83a-7883f69ce9f3"
      unitRef="usd">105000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfNS0xLTEtMS0w_8eb4a3e0-8ffc-43f8-8f8f-5e50413a00fc"
      unitRef="usd">219000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfNS0zLTEtMS0w_077141d0-6310-4ef0-a3d4-28e7a6ff428b"
      unitRef="usd">340000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfNS01LTEtMS0yMDgz_03d64a83-aa23-44a5-8066-36c05c781b6e"
      unitRef="usd">429000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfNS03LTEtMS0yMDgz_94d391c8-1a89-47d3-b0bb-a83b3e9d06bd"
      unitRef="usd">746000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:SeveranceCosts1
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfNy0xLTEtMS0w_1f6c03c4-34ca-4bb7-ba21-323134196df5"
      unitRef="usd">75000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfNy0zLTEtMS0w_f86b0358-729c-44b9-9629-1094446d7583"
      unitRef="usd">107000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfNy01LTEtMS0w_1ad64eae-1472-4dbf-b351-5453cbeadf70"
      unitRef="usd">119000000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfNy03LTEtMS0w_7290c3d0-63a7-483f-9aaa-35b2c34234e7"
      unitRef="usd">256000000</us-gaap:SeveranceCosts1>
    <us-gaap:OtherRestructuringCosts
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfOC0xLTEtMS0w_c79d2659-2b8d-4f45-8042-faa6e242ee00"
      unitRef="usd">3000000</us-gaap:OtherRestructuringCosts>
    <us-gaap:OtherRestructuringCosts
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfOC0zLTEtMS0w_1f68e1f3-ef67-44a7-b4e7-e71018492d87"
      unitRef="usd">8000000</us-gaap:OtherRestructuringCosts>
    <us-gaap:OtherRestructuringCosts
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfOC01LTEtMS0w_77a483d6-c0ec-4894-ae80-4ae25224e1d6"
      unitRef="usd">4000000</us-gaap:OtherRestructuringCosts>
    <us-gaap:OtherRestructuringCosts
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfOC03LTEtMS0w_102b36a2-2ffe-4e0a-a75d-c4fa6ab94abd"
      unitRef="usd">19000000</us-gaap:OtherRestructuringCosts>
    <us-gaap:RestructuringCharges
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfOS0xLTEtMS0w_4a2b88c2-0650-4ebd-a3f0-039582f5c6f0"
      unitRef="usd">78000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfOS0zLTEtMS0w_27b0ce9a-7e95-4e96-87c6-f216cdd520d7"
      unitRef="usd">115000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfOS01LTEtMS0yMDgz_11e03b4e-ba51-4990-aa0d-cbce2263b6fa"
      unitRef="usd">123000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfOS03LTEtMS0yMDgz_806705fb-e623-4ef6-a93b-aa3d59d5cd99"
      unitRef="usd">275000000</us-gaap:RestructuringCharges>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTAtMS0xLTEtMA_bc13bff4-5cf2-4960-8834-47dca7c2e123"
      unitRef="usd">152000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTAtMy0xLTEtMA_336dca46-5ff3-48f2-9cf9-e383e808baec"
      unitRef="usd">166000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTAtNS0xLTEtMA_e133709d-37fd-4182-ae58-2588be128f5d"
      unitRef="usd">293000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTAtNy0xLTEtMA_89743023-5664-41c1-ad94-afe432741339"
      unitRef="usd">340000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:RestructuringReserveAcceleratedDepreciation
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTEtMS0xLTEtMA_f6284577-3110-46b0-af8d-001c9f891f5b"
      unitRef="usd">0</us-gaap:RestructuringReserveAcceleratedDepreciation>
    <us-gaap:RestructuringReserveAcceleratedDepreciation
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTEtMy0xLTEtMA_16cd7266-4fa9-43a6-a7dc-de1cdd87220c"
      unitRef="usd">11000000</us-gaap:RestructuringReserveAcceleratedDepreciation>
    <us-gaap:RestructuringReserveAcceleratedDepreciation
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTEtNS0xLTEtMA_abb684b0-a835-4634-8168-19700b24168d"
      unitRef="usd">0</us-gaap:RestructuringReserveAcceleratedDepreciation>
    <us-gaap:RestructuringReserveAcceleratedDepreciation
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTEtNy0xLTEtMA_3e295899-bc33-4339-9b8d-6deda14dd902"
      unitRef="usd">41000000</us-gaap:RestructuringReserveAcceleratedDepreciation>
    <bmy:RestructuringRelatedCostsAssetImpairments
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTItMS0xLTEtMA_033bb658-6104-4655-a687-2df06e378420"
      unitRef="usd">0</bmy:RestructuringRelatedCostsAssetImpairments>
    <bmy:RestructuringRelatedCostsAssetImpairments
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTItMy0xLTEtMA_5af51aad-06d1-438b-9db8-81e7b245eacf"
      unitRef="usd">39000000</bmy:RestructuringRelatedCostsAssetImpairments>
    <bmy:RestructuringRelatedCostsAssetImpairments
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTItNS0xLTEtMA_fdd2c867-7358-4c1b-9106-0d4f5f1758ac"
      unitRef="usd">24000000</bmy:RestructuringRelatedCostsAssetImpairments>
    <bmy:RestructuringRelatedCostsAssetImpairments
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTItNy0xLTEtMA_fdba13bd-e947-4728-aa50-b47908ba60ba"
      unitRef="usd">81000000</bmy:RestructuringRelatedCostsAssetImpairments>
    <bmy:OtherShutdownCosts
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTMtMS0xLTEtMA_99896842-5558-4f20-96bb-8a4ea5a033a0"
      unitRef="usd">-11000000</bmy:OtherShutdownCosts>
    <bmy:OtherShutdownCosts
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTMtMy0xLTEtMA_2ddf0a72-4611-4089-bfa6-926904958966"
      unitRef="usd">9000000</bmy:OtherShutdownCosts>
    <bmy:OtherShutdownCosts
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTMtNS0xLTEtMA_1ec7ad53-3dbf-4056-830c-628238e056fc"
      unitRef="usd">-11000000</bmy:OtherShutdownCosts>
    <bmy:OtherShutdownCosts
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTMtNy0xLTEtMA_1d55f634-a3c1-45f3-87a9-3f9b335648bd"
      unitRef="usd">9000000</bmy:OtherShutdownCosts>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTQtMS0xLTEtMA_2dc8ba0d-9a6a-4f79-9406-3276e176e76b"
      unitRef="usd">219000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTQtMy0xLTEtMA_74d12856-e2ed-458e-96fd-f0a780b0cbda"
      unitRef="usd">340000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTQtNS0xLTEtMjA4Mw_ecb2d6cc-24cf-40b9-82d7-86efba981a60"
      unitRef="usd">429000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTQtNy0xLTEtMjA4Mw_86e14434-aa43-461c-aa3f-ece66bceb0b4"
      unitRef="usd">746000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="id5f7660b6eca475a9df8e628fa445af7_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTYtMS0xLTEtMA_87ee1fc0-2324-4eed-9931-6e02e50e4c1c"
      unitRef="usd">0</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i635494ce148e4ad7bd650508b31a47f5_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTYtMy0xLTEtMA_e40d204f-9aa2-43df-8407-203b4abfd0af"
      unitRef="usd">11000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i458d77e2e80747db91d6733fb12cc6f3_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTYtNS0xLTEtMA_9a73f512-50af-4d55-b654-621ff5402fde"
      unitRef="usd">24000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ic61bae9f14c94630811f2853573f8ff6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTYtNy0xLTEtMA_d8ff5c83-39f9-4e70-bb8b-c0b91a33da08"
      unitRef="usd">27000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i1dec6245873f4d98820e4a2b35667387_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTctMS0xLTEtMA_e12c6da5-7e95-4a75-b69b-9b620ed57d06"
      unitRef="usd">0</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="id6778a15e516498f97f88c860749c6a2_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTctMy0xLTEtMA_2da03da6-9673-463f-9aee-15942816316f"
      unitRef="usd">1000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i2d23efb083df4012b861cdd74c430462_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTctNS0xLTEtMA_54060071-5fac-47d5-8759-bbb7600a0481"
      unitRef="usd">0</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i33981b78822f4f77be3c382064085973_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTctNy0xLTEtMA_2d69a870-d059-4718-996d-968c1a137edf"
      unitRef="usd">1000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i4c126874d2714146b7bf5cbc485c1cf8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTgtMS0xLTEtMA_25b83239-94fe-486f-94ec-2043131fac9c"
      unitRef="usd">0</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i41d5a334a6e142f8bd67b8e51060b87f_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTgtMy0xLTEtMA_d624ea56-f203-43da-9522-1b794688f94d"
      unitRef="usd">39000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i4662da4bb2b6479993d2a5b55ba2078b_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTgtNS0xLTEtMA_a1a705eb-4b51-4dd0-9351-f4f56ae72abd"
      unitRef="usd">0</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i5431747aab134732bd974c5723251eef_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTgtNy0xLTEtMA_adf8c561-aa24-4210-9e50-aef647111d61"
      unitRef="usd">95000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i704336f4184942a3983f50159a480277_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTktMS0xLTEtMA_27e0346f-6dd9-4366-b16e-d9de233eba67"
      unitRef="usd">219000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="id1232e4b20d8401ba7060d232ed7fe2f_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTktMy0xLTEtMA_ee47d1f4-2517-4b13-97eb-303ac56cf107"
      unitRef="usd">289000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i8689b4d5000b4d5b8e0fc3554738970e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTktNS0xLTEtMA_2315ac6f-76ad-4ea2-9b5d-cdfb87fd1c92"
      unitRef="usd">405000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i6931cd74ebe9437fa587ab6b851ccf58_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMTktNy0xLTEtMA_2f5f6567-e639-4e0d-a18a-cc5599f1dddd"
      unitRef="usd">623000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMjAtMS0xLTEtMA_e76d81c3-64ea-43cd-9096-46f5fbe456bb"
      unitRef="usd">219000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMjAtMy0xLTEtMA_778b6396-1d23-4214-9993-5c5f2cc2d97d"
      unitRef="usd">340000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMjAtNS0xLTEtMjA4NQ_61ab5b30-b563-43e6-bacb-b0267db6db7e"
      unitRef="usd">429000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjIzNmIxMmRhZWFkMDQxMDNiOGNmOGNhMzczMzlkNThiL3RhYmxlcmFuZ2U6MjM2YjEyZGFlYWQwNDEwM2I4Y2Y4Y2EzNzMzOWQ1OGJfMjAtNy0xLTEtMjA4NQ_e352d5e6-c28e-4bcc-b7a2-2a28e7cc7ba0"
      unitRef="usd">746000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfMjE2NQ_c8b5150b-da3c-4f04-8f36-075a2e768d0c">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the charges and spending related to restructuring plan activities:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability at December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for restructuring&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability at June 30&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Includes a reduction of the liability resulting from changes in estimates of $8 million and $6 million for the six months ended June 30, 2021 and 2020, respectively. Excludes $9 million and $47 million for the six months ended June 30, 2021 and 2020, respectively, of accelerated stock-based compensation relating to the Celgene Acquisition Plan.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="ie5b48843789843e59015f89cfb97e96a_I20210101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjE1NjE2Y2I5ZTc5MzQ2YzI5YTM0ZmQ0YzZmNzA3MDU2L3RhYmxlcmFuZ2U6MTU2MTZjYjllNzkzNDZjMjlhMzRmZDRjNmY3MDcwNTZfMi0xLTEtMS0w_cca48afd-377a-462e-8707-624899954485"
      unitRef="usd">148000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i8b7251412f7b43c9817b299748e1d079_I20200101"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjE1NjE2Y2I5ZTc5MzQ2YzI5YTM0ZmQ0YzZmNzA3MDU2L3RhYmxlcmFuZ2U6MTU2MTZjYjllNzkzNDZjMjlhMzRmZDRjNmY3MDcwNTZfMi0zLTEtMS0w_b5db83a2-2e92-4455-9245-a54d05107687"
      unitRef="usd">100000000</us-gaap:RestructuringReserve>
    <bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjE1NjE2Y2I5ZTc5MzQ2YzI5YTM0ZmQ0YzZmNzA3MDU2L3RhYmxlcmFuZ2U6MTU2MTZjYjllNzkzNDZjMjlhMzRmZDRjNmY3MDcwNTZfMy0xLTEtMS0w_ed302a94-9496-422c-a258-e6219b94175f"
      unitRef="usd">114000000</bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation>
    <bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjE1NjE2Y2I5ZTc5MzQ2YzI5YTM0ZmQ0YzZmNzA3MDU2L3RhYmxlcmFuZ2U6MTU2MTZjYjllNzkzNDZjMjlhMzRmZDRjNmY3MDcwNTZfMy0zLTEtMS0w_d902a8ab-59ff-41b7-9cb5-805389405698"
      unitRef="usd">228000000</bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjE1NjE2Y2I5ZTc5MzQ2YzI5YTM0ZmQ0YzZmNzA3MDU2L3RhYmxlcmFuZ2U6MTU2MTZjYjllNzkzNDZjMjlhMzRmZDRjNmY3MDcwNTZfNC0xLTEtMS0w_6170ece0-8c3e-43d0-b360-72c341b4596d"
      unitRef="usd">-2000000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:RestructuringReserveTranslationAdjustment
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjE1NjE2Y2I5ZTc5MzQ2YzI5YTM0ZmQ0YzZmNzA3MDU2L3RhYmxlcmFuZ2U6MTU2MTZjYjllNzkzNDZjMjlhMzRmZDRjNmY3MDcwNTZfNC0zLTEtMS0w_281ef0b2-f5ca-4d20-8f2a-1c02335bf238"
      unitRef="usd">1000000</us-gaap:RestructuringReserveTranslationAdjustment>
    <us-gaap:PaymentsForRestructuring
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjE1NjE2Y2I5ZTc5MzQ2YzI5YTM0ZmQ0YzZmNzA3MDU2L3RhYmxlcmFuZ2U6MTU2MTZjYjllNzkzNDZjMjlhMzRmZDRjNmY3MDcwNTZfNS0xLTEtMS0w_072d74d3-676b-4e5f-b0bc-56db21c3e849"
      unitRef="usd">134000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjE1NjE2Y2I5ZTc5MzQ2YzI5YTM0ZmQ0YzZmNzA3MDU2L3RhYmxlcmFuZ2U6MTU2MTZjYjllNzkzNDZjMjlhMzRmZDRjNmY3MDcwNTZfNS0zLTEtMS0w_8f20a69b-3fae-4f21-8261-ff3abcda209d"
      unitRef="usd">188000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserve
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjE1NjE2Y2I5ZTc5MzQ2YzI5YTM0ZmQ0YzZmNzA3MDU2L3RhYmxlcmFuZ2U6MTU2MTZjYjllNzkzNDZjMjlhMzRmZDRjNmY3MDcwNTZfNi0xLTEtMS0w_ff77c6f5-5bbf-4023-b9ab-9c08bb12b31d"
      unitRef="usd">126000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i711a50adb808497c9daf76647502dad6_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RhYmxlOjE1NjE2Y2I5ZTc5MzQ2YzI5YTM0ZmQ0YzZmNzA3MDU2L3RhYmxlcmFuZ2U6MTU2MTZjYjllNzkzNDZjMjlhMzRmZDRjNmY3MDcwNTZfNi0zLTEtMS0w_79888a1a-2aa6-4e7e-b2f4-55668fa5865c"
      unitRef="usd">141000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfMTA5OTUxMTYzMDA2OA_7c1efe0c-02d2-44f0-b3ba-8faaa1045ef1"
      unitRef="usd">8000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringReserveAccrualAdjustment1
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfMTA5OTUxMTYzMDA2Mg_c7e5abf2-88fb-45a7-b15f-e773d03ab3f7"
      unitRef="usd">6000000</us-gaap:RestructuringReserveAccrualAdjustment1>
    <us-gaap:RestructuringCharges
      contextRef="i0a5a5daa7bb24250bb98daa1532976bb_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfMTA5OTUxMTYzMDA3NQ_e28684ac-b9f2-49a2-bcf7-63266359403e"
      unitRef="usd">9000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i12fc955bf6c34929ae7dc5a546b6e0e2_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV80OS9mcmFnOjBmMTliZDYxZTA0NzQwY2VhN2VlMjg4NDNkZTI2MmRmL3RleHRyZWdpb246MGYxOWJkNjFlMDQ3NDBjZWE3ZWUyODg0M2RlMjYyZGZfMTA5OTUxMTYzMDA4Mg_fc5ed412-0198-47d2-b17b-602216ece371"
      unitRef="usd">47000000</us-gaap:RestructuringCharges>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RleHRyZWdpb246MjY4NzhlNjA2ZmQ0NDY5NThhNjRhNTlmN2Q4YjJmYTBfMjA1NA_ae3e8d41-e0f9-425a-b135-e0e50d71e0b0">INCOME TAXES&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings Before Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective Tax Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes in interim periods are determined based on the estimated annual effective tax rates and the tax impact of discrete items that are reflected immediately. The effective tax rates in 2021 and 2020 were impacted by low jurisdictional tax rates attributed to the unwinding of inventory fair value adjustments and intangible asset amortization and contingent value rights fair value adjustments that are not taxable or deductible. The three and six months ended June&#160;30, 2020 includes an $853&#160;million deferred tax charge resulting from an internal transfer of certain intangible assets to the U.S. and an additional $255&#160;million GILTI tax charge upon finalization of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Otezla&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* divestiture tax consequences with tax authorities. Additional changes to the effective tax rate may occur in future periods due to various reasons, including changes to the estimated pretax earnings mix and tax reserves and revised interpretations or changes to the relevant tax code.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;It is reasonably possible that the amount of unrecognized tax benefits at June&#160;30, 2021 could decrease in the range of approximately $430 million to $480 million in the next twelve months as a result of the settlement of certain tax audits and other events. The expected change in unrecognized tax benefits may result in the payment of additional taxes, adjustment of certain deferred taxes and/or recognition of tax benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS is currently under examination by a number of tax authorities, which have proposed or are considering proposing material adjustments to tax positions for issues such as transfer pricing, certain tax credits and the deductibility of certain expenses. As previously disclosed, BMS received several notices of proposed adjustments from the IRS related to transfer pricing and other tax positions for the 2008 to 2012 tax years. BMS disagrees with the IRS&#x2019;s positions and continues to work cooperatively with the IRS to resolve these open tax audits. It is reasonably possible that new issues will be raised by tax authorities that may increase unrecognized tax benefits; however, an estimate of such increases cannot reasonably be made at this time. BMS believes that it has adequately provided for all open tax years by tax jurisdiction.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RleHRyZWdpb246MjY4NzhlNjA2ZmQ0NDY5NThhNjRhNTlmN2Q4YjJmYTBfMjA0Ng_134ca38c-f330-41ae-822f-2b8823575bcf">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings Before Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective Tax Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RhYmxlOmRhMTE1OTFiNTdiYTRjYzk4MTAzMmZmNGNkN2E0NWFmL3RhYmxlcmFuZ2U6ZGExMTU5MWI1N2JhNGNjOTgxMDMyZmY0Y2Q3YTQ1YWZfMi0xLTEtMS0w_e3536a23-0a27-4495-bfd1-f5d17abde2e4"
      unitRef="usd">1553000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RhYmxlOmRhMTE1OTFiNTdiYTRjYzk4MTAzMmZmNGNkN2E0NWFmL3RhYmxlcmFuZ2U6ZGExMTU5MWI1N2JhNGNjOTgxMDMyZmY0Y2Q3YTQ1YWZfMi0zLTEtMS0w_f818e0a5-250a-4923-8021-699a0da4e4f8"
      unitRef="usd">1627000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RhYmxlOmRhMTE1OTFiNTdiYTRjYzk4MTAzMmZmNGNkN2E0NWFmL3RhYmxlcmFuZ2U6ZGExMTU5MWI1N2JhNGNjOTgxMDMyZmY0Y2Q3YTQ1YWZfMi01LTEtMS0w_48a8b3af-3b50-4dff-9865-aefaa5bd7d3d"
      unitRef="usd">4083000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RhYmxlOmRhMTE1OTFiNTdiYTRjYzk4MTAzMmZmNGNkN2E0NWFmL3RhYmxlcmFuZ2U6ZGExMTU5MWI1N2JhNGNjOTgxMDMyZmY0Y2Q3YTQ1YWZfMi03LTEtMS0w_ecd22322-9894-45b4-8889-ab8a04348ce4"
      unitRef="usd">1323000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RhYmxlOmRhMTE1OTFiNTdiYTRjYzk4MTAzMmZmNGNkN2E0NWFmL3RhYmxlcmFuZ2U6ZGExMTU5MWI1N2JhNGNjOTgxMDMyZmY0Y2Q3YTQ1YWZfMy0xLTEtMS0w_13015e9e-a15e-4f01-9f3f-98bf300c5398"
      unitRef="usd">492000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RhYmxlOmRhMTE1OTFiNTdiYTRjYzk4MTAzMmZmNGNkN2E0NWFmL3RhYmxlcmFuZ2U6ZGExMTU5MWI1N2JhNGNjOTgxMDMyZmY0Y2Q3YTQ1YWZfMy0zLTEtMS0w_e45c1c64-af44-4d9b-97bb-27ebe850fc4b"
      unitRef="usd">1707000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RhYmxlOmRhMTE1OTFiNTdiYTRjYzk4MTAzMmZmNGNkN2E0NWFmL3RhYmxlcmFuZ2U6ZGExMTU5MWI1N2JhNGNjOTgxMDMyZmY0Y2Q3YTQ1YWZfMy01LTEtMS0w_faa2a2ed-f5bf-44d1-a782-4330947e166e"
      unitRef="usd">993000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RhYmxlOmRhMTE1OTFiNTdiYTRjYzk4MTAzMmZmNGNkN2E0NWFmL3RhYmxlcmFuZ2U6ZGExMTU5MWI1N2JhNGNjOTgxMDMyZmY0Y2Q3YTQ1YWZfMy03LTEtMS0w_042ed61b-2ca8-44ed-a65e-8fe7a7d1ac11"
      unitRef="usd">2169000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RhYmxlOmRhMTE1OTFiNTdiYTRjYzk4MTAzMmZmNGNkN2E0NWFmL3RhYmxlcmFuZ2U6ZGExMTU5MWI1N2JhNGNjOTgxMDMyZmY0Y2Q3YTQ1YWZfNC0xLTEtMS0w_3a9d2f8a-b128-44e6-b4d0-5bd7006b1f40"
      unitRef="number">0.317</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RhYmxlOmRhMTE1OTFiNTdiYTRjYzk4MTAzMmZmNGNkN2E0NWFmL3RhYmxlcmFuZ2U6ZGExMTU5MWI1N2JhNGNjOTgxMDMyZmY0Y2Q3YTQ1YWZfNC0zLTEtMS0w_beb6bb47-0789-4bcb-8a31-3d80de6d880b"
      unitRef="number">1.049</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RhYmxlOmRhMTE1OTFiNTdiYTRjYzk4MTAzMmZmNGNkN2E0NWFmL3RhYmxlcmFuZ2U6ZGExMTU5MWI1N2JhNGNjOTgxMDMyZmY0Y2Q3YTQ1YWZfNC01LTEtMS0yMDg5_8d288f96-b8fe-40c6-8a04-a2d185c75b3c"
      unitRef="number">0.243</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RhYmxlOmRhMTE1OTFiNTdiYTRjYzk4MTAzMmZmNGNkN2E0NWFmL3RhYmxlcmFuZ2U6ZGExMTU5MWI1N2JhNGNjOTgxMDMyZmY0Y2Q3YTQ1YWZfNC03LTEtMS0yMDg5_e635f4bc-eb72-4130-845c-9394837ad8cd"
      unitRef="number">1.639</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i4b0b5444987e49eba4f8bafbffef80f3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RleHRyZWdpb246MjY4NzhlNjA2ZmQ0NDY5NThhNjRhNTlmN2Q4YjJmYTBfMjE5OTAyMzI1ODY0Mw_e655a2f1-7d56-4b49-8e45-d7d1f71c7175"
      unitRef="usd">853000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="if7fd398a275d49b7ac8db542e423dabb_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RleHRyZWdpb246MjY4NzhlNjA2ZmQ0NDY5NThhNjRhNTlmN2Q4YjJmYTBfMjE5OTAyMzI1ODY1Nw_93fc9163-e3d3-41ab-b902-feda9df76fb5"
      unitRef="usd">255000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="id3a7e6213d5a4e98bdeddda2ad09db70_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RleHRyZWdpb246MjY4NzhlNjA2ZmQ0NDY5NThhNjRhNTlmN2Q4YjJmYTBfOTI4_894c6136-6290-48c7-823a-c467bc9c6d34"
      unitRef="usd">430000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="i007d2ce5a6594dc2b97f4d6dde2a3170_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81Mi9mcmFnOjI2ODc4ZTYwNmZkNDQ2OTU4YTY0YTU5ZjdkOGIyZmEwL3RleHRyZWdpb246MjY4NzhlNjA2ZmQ0NDY5NThhNjRhNTlmN2Q4YjJmYTBfOTM0_1711259f-005d-47cb-8002-27d9f753fbc4"
      unitRef="usd">480000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RleHRyZWdpb246NjcwNDQ0MDQxOWZlNDg2YWEzYWY2NmQ3MDg3Nzc3MWFfMjYy_084bfd00-b01b-4b45-8b20-6d0fc806aa2e">EARNINGS/(LOSS) PER SHARE&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts in Millions, Except Per Share Data&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Earnings/(Loss) Attributable to BMS Used for Basic and Diluted EPS Calculation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average Common Shares Outstanding &#x2013; Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incremental Shares Attributable to Share-Based Compensation Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average Common Shares Outstanding &#x2013; Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings/(Loss) per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;The total number of potential shares of common stock excluded from the diluted earnings/(loss) per common share computation because of the antidilutive impact was 9&#160;million for both the three and six months ended June&#160;30, 2021 and 127&#160;million for both the three and six months ended June&#160;30, 2020.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RleHRyZWdpb246NjcwNDQ0MDQxOWZlNDg2YWEzYWY2NmQ3MDg3Nzc3MWFfMjY2_ea4f84b6-403b-4586-8706-31dc16dadcf5">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts in Millions, Except Per Share Data&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Earnings/(Loss) Attributable to BMS Used for Basic and Diluted EPS Calculation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(860)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average Common Shares Outstanding &#x2013; Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incremental Shares Attributable to Share-Based Compensation Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average Common Shares Outstanding &#x2013; Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings/(Loss) per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfMi0xLTEtMS0w_0594d7fd-8c73-45ce-bfff-9a0880f3ab5a"
      unitRef="usd">1055000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfMi0zLTEtMS0w_22e13f80-f76c-4f6d-ab6b-d1f977d07205"
      unitRef="usd">-85000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfMi01LTEtMS0w_5e3a9384-e2dd-4ddc-a436-3b0826748228"
      unitRef="usd">3076000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfMi03LTEtMS0w_743bcc1e-114c-4fe4-b60d-bb6cfb5197f5"
      unitRef="usd">-860000000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfNC0xLTEtMS0w_4531a4d6-3962-4dfc-b121-b2601fca2b53"
      unitRef="shares">2227000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfNC0zLTEtMS0w_95b53912-8c93-485b-b3b0-52aa821d6bf9"
      unitRef="shares">2263000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfNC01LTEtMS0w_8103b444-45a2-48a7-bad7-320b12bda596"
      unitRef="shares">2232000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfNC03LTEtMS0w_08b52e60-02b7-4b16-a0f9-6c067247efc3"
      unitRef="shares">2261000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfNS0xLTEtMS0w_0335d11d-c2fe-4970-8882-7b883c80507d"
      unitRef="shares">25000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfNS0zLTEtMS0w_d0aab245-58fc-4541-a3d0-580e4589da06"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfNS01LTEtMS0w_8a83ca3a-423a-451f-9309-01b565616cac"
      unitRef="shares">26000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfNS03LTEtMS0w_6f2cba0f-5cb0-451d-9afe-6d17ad90fcf6"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfNi0xLTEtMS0w_59db19ae-50a7-4685-ae3b-79ce1135897b"
      unitRef="shares">2252000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfNi0zLTEtMS0w_9bba0b34-2d85-4582-b7df-6422565713ab"
      unitRef="shares">2263000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfNi01LTEtMS0yMDk0_ea38b841-faa5-453d-9aa5-c645fc5a0dcf"
      unitRef="shares">2258000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfNi03LTEtMS0yMDk0_556fa5e7-0f1a-4a58-80cd-a3b0ce1d8ddc"
      unitRef="shares">2261000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfOS0xLTEtMS0w_6b7581d9-4899-4cb4-8c27-b25889d894b9"
      unitRef="usdPerShare">0.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfOS0zLTEtMS0w_4a2dc41c-493b-42cc-9dfb-aed68b3ab8a0"
      unitRef="usdPerShare">-0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfOS01LTEtMS0w_ed7942be-b29e-40c2-929c-2876edcf6597"
      unitRef="usdPerShare">1.38</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfOS03LTEtMS0w_e38afe39-b228-4235-a93c-15b5aa2a71f5"
      unitRef="usdPerShare">-0.38</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfMTAtMS0xLTEtMA_71b34a20-723e-477a-8806-759714c762ba"
      unitRef="usdPerShare">0.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfMTAtMy0xLTEtMA_d7c5265c-672e-4595-a9e6-754a34e2aec4"
      unitRef="usdPerShare">-0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfMTAtNS0xLTEtMA_7d3e0dd6-b4df-47a8-b7d6-8243c34eb9f9"
      unitRef="usdPerShare">1.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RhYmxlOjVjYTg3Yjg3NzA1YzRjZGU4NjNkNWRjMTlhZjk1ZDMxL3RhYmxlcmFuZ2U6NWNhODdiODc3MDVjNGNkZTg2M2Q1ZGMxOWFmOTVkMzFfMTAtNy0xLTEtMA_79b8446f-4884-4529-b8bc-523d62c9b9f2"
      unitRef="usdPerShare">-0.38</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RleHRyZWdpb246NjcwNDQ0MDQxOWZlNDg2YWEzYWY2NmQ3MDg3Nzc3MWFfMjA3_9987ff36-b717-4cd2-a4c0-7a38f8fee1ee"
      unitRef="shares">9000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RleHRyZWdpb246NjcwNDQ0MDQxOWZlNDg2YWEzYWY2NmQ3MDg3Nzc3MWFfMjA3_a12f918f-c409-42a4-bc88-dd2562f9b0fc"
      unitRef="shares">9000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RleHRyZWdpb246NjcwNDQ0MDQxOWZlNDg2YWEzYWY2NmQ3MDg3Nzc3MWFfMjE5OTAyMzI1NTkyMw_86d5b589-bee7-4686-8d29-647c5f526b71"
      unitRef="shares">127000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81NS9mcmFnOjY3MDQ0NDA0MTlmZTQ4NmFhM2FmNjZkNzA4Nzc3NzFhL3RleHRyZWdpb246NjcwNDQ0MDQxOWZlNDg2YWEzYWY2NmQ3MDg3Nzc3MWFfMjE5OTAyMzI1NTkyMw_f25b1cce-ada4-4ec2-b41a-22d88aafdd43"
      unitRef="shares">127000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfMjE5OTAyMzI2NjgwMQ_775a9682-3449-4802-8acb-f0b46eae7dc6">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities measured at fair value on a recurring basis are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents - money market and other securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liability:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent value rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other acquisition related contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As further described in &#x201c;Item 8. Financial Statements and Supplementary Data&#x2014;Note 9. Financial Instruments and Fair Value Measurements&#x201d; in the Company&#x2019;s 2020 Form 10-K, the Company&#x2019;s fair value estimates use inputs that are either (1) quoted prices for identical assets or liabilities in active markets (Level 1 inputs); (2) observable prices for similar assets or liabilities in active markets or for identical or similar assets or liabilities in markets that are not active (Level 2 inputs); or (3) unobservable inputs (Level 3 inputs).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contingent consideration obligations are recorded at their estimated fair values and these obligations are revalued each reporting period until the related contingencies are resolved. The contingent value rights are adjusted to fair value using the traded price of the securities at the end of each reporting period. The fair value measurements for other contingent consideration liabilities are estimated using probability-weighted discounted cash flow approaches that are based on significant unobservable inputs related to product candidates acquired in business combinations and are reviewed quarterly. These inputs include, as applicable, estimated probabilities and timing of achieving specified development and regulatory milestones and the discount rate used to calculate the present value of estimated future payments. Significant changes which increase or decrease the probabilities of achieving the related development and regulatory events or shorten or lengthen the time required to achieve such events would result in corresponding increases or decreases in the fair values of these obligations. The fair value of other acquisition related contingent consideration as of June&#160;30, 2021 was calculated using the following significant unobservable inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ranges (weighted average) utilized as of:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3% to 1.3% (0.6%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0% to 80% (2.4%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected year of payment for development and regulatory milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 to 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no transfers between levels 1, 2 and 3 during the six months ended&#160;June&#160;30, 2021. The following table represents a roll-forward of the fair value of level 3 instruments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value as of January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value as of June 30&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Available-for-sale Debt Securities and Equity Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes available-for-sale debt securities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.799%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale debt securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;All marketable debt securities mature within two years as of June&#160;30, 2021 and December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the carrying amount of equity investments:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments with readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments without readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the activity related to equity investments. Changes in fair value of equity investments are included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain/(loss) recognized on equity investments with readily determinable fair values&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Realized gain/(loss) recognized on equity investments with readily determinable fair value sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Upward adjustments on equity investments without readily determinable fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairments and downward adjustments on equity investments without readily determinable fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative upward adjustments on equity investments without readily determinable fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative impairments and downward adjustments on equity investments without readily determinable fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Net unrealized net gains on equity investments still held were $11 million and $353 million for the three and six months ended June&#160;30, 2021 and $778 million and $550 million for the three and six months ended June&#160;30, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Qualifying Hedges and Non-Qualifying Derivatives&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash Flow Hedges &#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign currency forward contracts are used to hedge certain forecasted intercompany inventory purchases and sales transactions and certain foreign currency transactions. The fair value for contracts designated as cash flow hedges are temporarily reported in Accumulated other comprehensive loss and included in earnings when the hedged item affects earnings. The net gain or loss on foreign currency forward contracts is expected to be reclassified to net earnings (primarily included in Cost of products sold and Other (income)/expense, net) within the next 12 months. The notional amount of outstanding foreign currency forward contracts was primarily attributed to the euro of $3.1 billion and Japanese yen of $1.1 billion at June&#160;30, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The earnings impact related to discontinued cash flow hedges and hedge ineffectiveness was not material during all periods presented. Cash flow hedge accounting is discontinued when the forecasted transaction is no longer probable of occurring within 60 days after the originally forecasted date or when the hedge is no longer effective. Assessments to determine whether derivatives designated as qualifying hedges are highly effective in offsetting changes in the cash flows of hedged items are performed at inception and on a quarterly basis. Foreign currency forward contracts not designated as hedging instruments are used to offset exposures in certain foreign currency denominated assets, liabilities and earnings. Changes in the fair value of these derivatives are recognized in earnings as they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS may hedge a portion of its future foreign currency exposure by utilizing a strategy that involves both a purchased local currency put option and a written local currency call option that are accounted for as hedges of future sales denominated in that local currency. Specifically, BMS sells (or writes) a local currency call option and purchases a local currency put option with the same expiration dates and local currency notional amounts but with different strike prices. The premium collected from the sale of the call option is equal to the premium paid for the purchased put option, resulting in no net premium being paid. This combination of transactions is generally referred to as a &#x201c;zero-cost collar.&#x201d; The expiration dates and notional amounts correspond to the amount and timing of forecasted foreign currency sales. If the U.S. Dollar weakens relative to the currency of the hedged anticipated sales, the purchased put option value reduces to zero and BMS benefits from the increase in the U.S. Dollar equivalent value of our anticipated foreign currency cash flows; however, this benefit would be capped at the strike level of the written call, which forms the upper end of the collar.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Net Investment Hedges &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Non-U.S. Dollar borrowings of &#x20ac;950 million ($1.1 billion) at June&#160;30, 2021 are designated as net investment hedges to hedge euro currency exposures of the net investment in certain foreign affiliates and are recognized in long-term debt. The effective portion of foreign exchange gain on the remeasurement of euro debt was included in the foreign currency translation component of Accumulated other comprehensive loss with the related offset in long-term debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cross-currency interest rate swap contracts of $400 million at June&#160;30, 2021 are designated to hedge Japanese yen currency exposure of BMS&#x2019;s net investment in its Japan subsidiaries. Contract fair value changes are recorded in the foreign currency translation component of Other Comprehensive Income/(Loss) with a related offset in Other non-current assets or Other non-current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Hedges &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Fixed to floating interest rate swap contracts are designated as fair value hedges and used as an interest rate risk management strategy to create an appropriate balance of fixed and floating rate debt. The contracts and underlying debt for the hedged benchmark risk are recorded at fair value. The effective interest rate for the contracts is one-month LIBOR (0.10% as of June&#160;30, 2021) plus an interest rate spread of 4.6%. Gains or losses resulting from changes in fair value of the underlying debt attributable to the hedged benchmark interest rate risk are recorded in interest expense with an associated offset to the carrying value of debt. Since the specific terms and notional amount of the swap are intended to align with the debt being hedged, all changes in fair value of the swap are recorded in interest expense with an associated offset to the derivative asset or liability on the consolidated balance sheet. As a result, there was no net impact in earnings. If the underlying swap is terminated prior to maturity, then the fair value adjustment to the underlying debt is amortized as a reduction to interest expense over the remaining term of the debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of outstanding derivatives:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.704%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Included in Other current assets and Other non-current assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;Included in Other current liabilities and Other non-current liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial statement classification and amount of (gain)/loss recognized on hedging instruments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency zero-cost collar contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effect of derivative and non-derivative instruments designated as hedging instruments in Other Comprehensive Income/(Loss):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts gain/(loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other Comprehensive Income/(Loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives qualifying as net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate swap contracts gain:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other Comprehensive Income/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-derivatives qualifying as net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. dollar borrowings gain:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other Comprehensive Income/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;The majority is expected to be reclassified into earnings in the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Debt Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term debt obligations include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. short-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt and the current portion of long-term debt include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal Value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to Principal Value:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized basis adjustment from swap terminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized bond discounts and issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized purchase price adjustments of Celgene debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of long-term debt was $50.6 billion at June&#160;30, 2021 and $58.5 billion at December&#160;31, 2020 valued using Level&#160;2 inputs, which are based upon the quoted market prices for the same or similar debt instruments. The fair value of short-term borrowings approximates the carrying value due to the short maturities of the debt instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, BMS purchased aggregate principal amount of $3.5&#160;billion of certain of its debt securities for approximately $4.0&#160;billion of cash in a series of tender offers and &#x201c;make whole&#x201d; redemptions. In connection with these transactions, a $281&#160;million loss on debt redemption was recognized based on the carrying value of the debt and included in Other (income)/expense, net. In addition, the $500&#160;million 2.875% Notes matured and were repaid.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2021, the $1.0&#160;billion 2.550% Notes matured and were repaid.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest payments were $807 million and $845 million for the six months ended June 30, 2021 and 2020, respectively, net of amounts related to interest rate swap contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, BMS had four separate revolving credit facilities totaling $6.0&#160;billion, which consisted of a 364-day $2.0&#160;billion facility expiring in January 2022, a three-year $1.0&#160;billion facility expiring in January 2022 and two five-year $1.5&#160;billion facilities that were extended to September 2025 and July 2026, respectively. The facilities provide for customary terms and conditions with no financial covenants and may be used to provide backup liquidity for BMS&#x2019;s commercial paper borrowings and are extendable annually by one year on the anniversary date with the consent of the lenders. No borrowings were outstanding under any revolving credit facility at June&#160;30, 2021 or December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTc0MA_b2a19428-ff76-4c31-a9f7-736aa2f576b8">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial assets and liabilities measured at fair value on a recurring basis are summarized below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents - money market and other securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration liability:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent value rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other acquisition related contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i7e8abfc7c4684a2e80153d093765a7b0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMi0xLTEtMS0w_82d5b727-4938-46b4-93ba-e4817544c04c"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ife50b98ec7264eb7a37a0b687539d4dd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMi0zLTEtMS0w_4a2acf95-0537-4bb7-b6f5-eba0241d5b4c"
      unitRef="usd">9246000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i281eaf8778b946efa6523d049bb63601_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMi01LTEtMS0w_efdb1e21-00ad-4ee1-8a7a-e1b559d3bb62"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i19f789ba573d4f3ea505980fcb78be12_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMi03LTEtMS0w_bd535e7e-1324-44a1-b2ff-9b69c0d8f469"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="id7c1be369f724e7a955da101f61cd0cb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMi05LTEtMS0w_15ac7fc2-565a-4022-8c20-3a02b92baaa8"
      unitRef="usd">12361000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i0afe166f4d814c949b6b416e46eb5544_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMi0xMS0xLTEtMA_2db289ad-48d0-41f7-9a01-9ee52e245aac"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i295633493d6b475f86d6737b887dba92_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNC0xLTEtMS0w_48568199-fe1b-4661-8cba-fa724000ca08"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i45f649e8a6934c6bae4029abbff213fc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNC0zLTEtMS0w_71a872b3-878e-41fe-96a9-fc0257a8e4d2"
      unitRef="usd">1591000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib7b083b368d44b519124184b6c12db87_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNC01LTEtMS0w_efd872d3-e70d-4d87-bb6a-8a1d1dc350dd"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifa523e1aa7274232a186fcca3656cab6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNC03LTEtMS0w_e890ce49-6149-49c0-9be8-0da69a537ebe"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icc71b68bc0be4ab58521b097b145bced_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNC05LTEtMS0w_1a30f4f5-81b2-4b46-99ae-7365683d60f2"
      unitRef="usd">1020000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7be4a1f26072441e8e2c3e8802de46f0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNC0xMS0xLTEtMA_45256d37-133e-4743-b914-13301d7737e5"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i06a7cf8e55bc4f11ae11dd2f4e67ba53_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNi0xLTEtMS0w_24e3f296-01eb-4300-bec3-485f23add6ae"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i27ebf9edff0b44398e9b44f2f4a6f076_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNi0zLTEtMS0w_959e62cf-3583-48dc-a86e-284f2e87f93b"
      unitRef="usd">498000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2e46d25a491547498b733410813929a0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNi01LTEtMS0w_ea457fc1-a937-4709-9c7c-1b4a30ad33e3"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie66cb746be9f47e7ac4434960e977507_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNi03LTEtMS0w_65772f34-27fe-4961-8f94-9dba7aeb63ad"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4c8c40a0c0854d7fad1b783d8d1ad346_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNi05LTEtMS0w_8a6b176d-fc6f-4e41-8f9e-0498683ae595"
      unitRef="usd">698000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0e8619d5b7674406b0c8e75b507643be_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNi0xMS0xLTEtMA_69c48c6d-bf35-42b0-aab2-8755a3549a4b"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DerivativeAssets
      contextRef="i7e8abfc7c4684a2e80153d093765a7b0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNy0xLTEtMS0w_6436546b-dce5-420d-8e47-799016c38622"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ife50b98ec7264eb7a37a0b687539d4dd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNy0zLTEtMS0w_747b8244-65de-425c-b3c5-a00458ea92a3"
      unitRef="usd">131000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i281eaf8778b946efa6523d049bb63601_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNy01LTEtMS0w_65dbdb65-d528-491b-849f-89db639b6387"
      unitRef="usd">19000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i19f789ba573d4f3ea505980fcb78be12_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNy03LTEtMS0w_913e94aa-abf9-495e-8c32-366841d911af"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="id7c1be369f724e7a955da101f61cd0cb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNy05LTEtMS0w_704d2140-c857-40fd-b768-7743f4410a1e"
      unitRef="usd">42000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i0afe166f4d814c949b6b416e46eb5544_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfNy0xMS0xLTEtMA_cf86e0ed-d920-4c70-811c-dd6b8ae5d18b"
      unitRef="usd">27000000</us-gaap:DerivativeAssets>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i9778045c333646e8abc7df95736d6051_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfOC0xLTEtMS0w_3d331e8a-8d76-4577-8760-dd65ea265fc4"
      unitRef="usd">3275000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ib5047f95b2d744b4b59d1b78d6a742f4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfOC0zLTEtMS0w_0be60793-9210-4b72-b200-00e2533910fb"
      unitRef="usd">139000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i4783faea57834d3faef3b5be5df299e6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfOC01LTEtMS0w_9086d769-030b-4ae2-a16f-974dea13813b"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ic82867d41cc6438396b8ea9165e07f1e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfOC03LTEtMS0w_7a9f2018-491b-4053-a063-ea82dd2c9d08"
      unitRef="usd">3314000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ia0603128401446e3b0ba870450ab65d1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfOC05LTEtMS0w_02c731bc-3031-4768-bb4a-75fa7358bfa7"
      unitRef="usd">138000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i9be6d10579a84d6ba5f91b6e23177b72_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfOC0xMS0xLTEtMA_11f081ac-6315-49be-928e-05edf85472ea"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:DerivativeLiabilities
      contextRef="i7e8abfc7c4684a2e80153d093765a7b0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfOS0xLTEtMS0w_f2364199-0c32-44af-bb94-e3fc64d15530"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ife50b98ec7264eb7a37a0b687539d4dd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfOS0zLTEtMS0w_33ed9dce-6ff8-4b58-938d-c43a625225ed"
      unitRef="usd">-42000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i281eaf8778b946efa6523d049bb63601_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfOS01LTEtMS0w_7266d44e-27b0-4bc7-836b-6cab34286fb9"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i19f789ba573d4f3ea505980fcb78be12_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfOS03LTEtMS0w_b8caa995-d94a-4be9-a700-dcfc759158c2"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="id7c1be369f724e7a955da101f61cd0cb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfOS05LTEtMS0w_e89d60e3-19f1-46d6-b44b-a11401ffc9b9"
      unitRef="usd">-270000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i0afe166f4d814c949b6b416e46eb5544_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfOS0xMS0xLTEtMA_47e11ee1-9493-4cf8-8b3e-1e9037159635"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i39a1379770a94344b49dfe53b78ea4c4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMTEtMS0xLTEtMA_d14393df-5393-44a6-a6ce-d46e478a7214"
      unitRef="usd">10000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i890225c6ebb14bdaa4c35b58daa47553_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMTEtMy0xLTEtMA_3c492d27-f070-4f8b-aa08-ec60392fec32"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i85ae89b3bbca4fbdae10aba3669ee6dc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMTEtNS0xLTEtMA_c6fefdbc-c13b-4813-bab1-d32705d611de"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i4f39bf27565748b9ad84356a93cb08c7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMTEtNy0xLTEtMA_a9447767-64f8-4be1-8083-7546948a7ca1"
      unitRef="usd">530000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ie9602884451440a58383e854523622d4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMTEtOS0xLTEtMA_eb52d2aa-4ddb-49db-9451-edc5ebdbe533"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1bacf915b38e4bef995b2dd60b16d847_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMTEtMTEtMS0xLTA_2d905b42-177d-4a1a-acbe-5d0d8e991aa6"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i7e8abfc7c4684a2e80153d093765a7b0_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMTItMS0xLTEtMA_266000e0-7aa8-4a7b-b58e-45c5675de693"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ife50b98ec7264eb7a37a0b687539d4dd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMTItMy0xLTEtMA_bda0a635-0d8f-4c73-8262-c479ba974a35"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i281eaf8778b946efa6523d049bb63601_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMTItNS0xLTEtMA_3fce6e78-f063-4259-8d15-f7e0e4bc433a"
      unitRef="usd">67000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i19f789ba573d4f3ea505980fcb78be12_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMTItNy0xLTEtMA_d60a6373-7cbb-4aec-b911-539058374d3d"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id7c1be369f724e7a955da101f61cd0cb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMTItOS0xLTEtMA_52d673a1-eeaf-461e-a813-60260c91f112"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i0afe166f4d814c949b6b416e46eb5544_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjgxZjA4MGM3NmJkOTRmZWFiMDM0MDc3NzlkODg4M2UzL3RhYmxlcmFuZ2U6ODFmMDgwYzc2YmQ5NGZlYWIwMzQwNzc3OWQ4ODgzZTNfMTItMTEtMS0xLTA_a661669e-69a8-431f-995a-98bf1ea5da18"
      unitRef="usd">78000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTc4NA_bdeae40d-3623-4307-9a38-49512d6cf9c6">The fair value of other acquisition related contingent consideration as of June&#160;30, 2021 was calculated using the following significant unobservable inputs:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ranges (weighted average) utilized as of:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3% to 1.3% (0.6%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0% to 80% (2.4%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected year of payment for development and regulatory milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022 to 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="id75c7a7e91df4d63a4260a384377a6a3_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjU1NTEzZTRiZGZhMjQ4MGQ4MGM0MDRlNTU4ZWU1M2ViL3RhYmxlcmFuZ2U6NTU1MTNlNGJkZmEyNDgwZDgwYzQwNGU1NThlZTUzZWJfMi0xLTEtMS0wL3RleHRyZWdpb246NTgxMDNmNDY4MTgwNGEyZDg3ODE0MTFkMGE3ZjI1MWZfNA_e7c02495-7740-4d83-94bd-96e5bee5bbfe"
      unitRef="percentage">0.003</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="ice980dd1a7be4e65a57342c85ac3474a_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjU1NTEzZTRiZGZhMjQ4MGQ4MGM0MDRlNTU4ZWU1M2ViL3RhYmxlcmFuZ2U6NTU1MTNlNGJkZmEyNDgwZDgwYzQwNGU1NThlZTUzZWJfMi0xLTEtMS0wL3RleHRyZWdpb246NTgxMDNmNDY4MTgwNGEyZDg3ODE0MTFkMGE3ZjI1MWZfMTA_3af6b760-4b16-4197-a1ce-907ec61479c4"
      unitRef="percentage">0.013</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="id818743065664bfbb207dcd02dc3e2b8_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjU1NTEzZTRiZGZhMjQ4MGQ4MGM0MDRlNTU4ZWU1M2ViL3RhYmxlcmFuZ2U6NTU1MTNlNGJkZmEyNDgwZDgwYzQwNGU1NThlZTUzZWJfMi0xLTEtMS0wL3RleHRyZWdpb246NTgxMDNmNDY4MTgwNGEyZDg3ODE0MTFkMGE3ZjI1MWZfMTQ_95c19ba9-0c55-4fe2-824b-91af40b1679c"
      unitRef="percentage">0.006</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="i9d8a4ac8110a40668a2b2d95ce32cc86_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjU1NTEzZTRiZGZhMjQ4MGQ4MGM0MDRlNTU4ZWU1M2ViL3RhYmxlcmFuZ2U6NTU1MTNlNGJkZmEyNDgwZDgwYzQwNGU1NThlZTUzZWJfMy0xLTEtMS0wL3RleHRyZWdpb246M2QzYzdhMWFiZGFmNDk5ODg0MDE4ZTc5OWZlZDc1NDhfNA_089607b8-61d7-4877-8432-87be738037b0"
      unitRef="percentage">0</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="if862182d7eed4a4e9ea6d6d9a6f57901_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjU1NTEzZTRiZGZhMjQ4MGQ4MGM0MDRlNTU4ZWU1M2ViL3RhYmxlcmFuZ2U6NTU1MTNlNGJkZmEyNDgwZDgwYzQwNGU1NThlZTUzZWJfMy0xLTEtMS0wL3RleHRyZWdpb246M2QzYzdhMWFiZGFmNDk5ODg0MDE4ZTc5OWZlZDc1NDhfMTA_ea81daa1-e7ce-420e-9c54-204c8bb90318"
      unitRef="percentage">0.80</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="i11aaa3096c4a45f28755610b228eadd2_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjU1NTEzZTRiZGZhMjQ4MGQ4MGM0MDRlNTU4ZWU1M2ViL3RhYmxlcmFuZ2U6NTU1MTNlNGJkZmEyNDgwZDgwYzQwNGU1NThlZTUzZWJfMy0xLTEtMS0wL3RleHRyZWdpb246M2QzYzdhMWFiZGFmNDk5ODg0MDE4ZTc5OWZlZDc1NDhfMTQ_d708d6fb-c17f-4e26-a322-a3eaa03292dc"
      unitRef="percentage">0.024</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i8707328f1c9f418da8c326940d5bd515_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjU1NTEzZTRiZGZhMjQ4MGQ4MGM0MDRlNTU4ZWU1M2ViL3RhYmxlcmFuZ2U6NTU1MTNlNGJkZmEyNDgwZDgwYzQwNGU1NThlZTUzZWJfNC0xLTEtMS0wL3RleHRyZWdpb246MzM1YTRhOGFlNjFhNGQzYmI5ZDY0NzBkZDJlZjU0NWRfNA_ee2857dc-bce9-4865-b16b-8a2f3b8d809d"
      unitRef="y">2022</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="ifb8b81529e9f4bf98e414922640a88dd_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjU1NTEzZTRiZGZhMjQ4MGQ4MGM0MDRlNTU4ZWU1M2ViL3RhYmxlcmFuZ2U6NTU1MTNlNGJkZmEyNDgwZDgwYzQwNGU1NThlZTUzZWJfNC0xLTEtMS0wL3RleHRyZWdpb246MzM1YTRhOGFlNjFhNGQzYmI5ZDY0NzBkZDJlZjU0NWRfMTA_2c395d54-5782-4243-9c43-d506b2f670fe"
      unitRef="y">2028</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTc3Mg_54f29a64-6e65-4d12-ae4e-69dd85ed4d02">The following table represents a roll-forward of the fair value of level 3 instruments:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value as of January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes in estimated fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value as of June 30&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i0afe166f4d814c949b6b416e46eb5544_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjQyNWRmYjE0NmZlNzQ3NGY4ODYyMGJkODFkNzlmMDM2L3RhYmxlcmFuZ2U6NDI1ZGZiMTQ2ZmU3NDc0Zjg4NjIwYmQ4MWQ3OWYwMzZfMi0xLTEtMS0w_c7061f33-a914-44ed-bd4c-96c7dc8abeeb"
      unitRef="usd">27000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i0afe166f4d814c949b6b416e46eb5544_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjQyNWRmYjE0NmZlNzQ3NGY4ODYyMGJkODFkNzlmMDM2L3RhYmxlcmFuZ2U6NDI1ZGZiMTQ2ZmU3NDc0Zjg4NjIwYmQ4MWQ3OWYwMzZfMi0zLTEtMS0w_8efb703d-4ba6-4747-b3bd-2c95ba3e7497"
      unitRef="usd">78000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i42b5dbab27a246b580a0579f0d96dee6_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjQyNWRmYjE0NmZlNzQ3NGY4ODYyMGJkODFkNzlmMDM2L3RhYmxlcmFuZ2U6NDI1ZGZiMTQ2ZmU3NDc0Zjg4NjIwYmQ4MWQ3OWYwMzZfMi03LTEtMS0w_e41dc293-abcf-4445-adf8-0bf94e14d156"
      unitRef="usd">106000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjQyNWRmYjE0NmZlNzQ3NGY4ODYyMGJkODFkNzlmMDM2L3RhYmxlcmFuZ2U6NDI1ZGZiMTQ2ZmU3NDc0Zjg4NjIwYmQ4MWQ3OWYwMzZfNC0xLTEtMS0w_21361e1e-8b68-4901-af75-e5c33dc1ccd0"
      unitRef="usd">-8000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i6b39484540fe4cbc883405fbdd50a2a3_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjQyNWRmYjE0NmZlNzQ3NGY4ODYyMGJkODFkNzlmMDM2L3RhYmxlcmFuZ2U6NDI1ZGZiMTQ2ZmU3NDc0Zjg4NjIwYmQ4MWQ3OWYwMzZfNC0zLTEtMS0w_a5468540-b1cc-42a5-b2e9-a36db3208fa0"
      unitRef="usd">2000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i223b2b374fb24a7d8be48fea190eedba_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjQyNWRmYjE0NmZlNzQ3NGY4ODYyMGJkODFkNzlmMDM2L3RhYmxlcmFuZ2U6NDI1ZGZiMTQ2ZmU3NDc0Zjg4NjIwYmQ4MWQ3OWYwMzZfNC03LTEtMS0w_67ab132e-0f94-4c48-b260-cf2501f7b3a0"
      unitRef="usd">-36000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i6b39484540fe4cbc883405fbdd50a2a3_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjQyNWRmYjE0NmZlNzQ3NGY4ODYyMGJkODFkNzlmMDM2L3RhYmxlcmFuZ2U6NDI1ZGZiMTQ2ZmU3NDc0Zjg4NjIwYmQ4MWQ3OWYwMzZfNS0zLTEtMS0w_90322471-88f7-42f6-b7ad-64d3d101e8b4"
      unitRef="usd">-12000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <bmy:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange
      contextRef="i6b39484540fe4cbc883405fbdd50a2a3_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjQyNWRmYjE0NmZlNzQ3NGY4ODYyMGJkODFkNzlmMDM2L3RhYmxlcmFuZ2U6NDI1ZGZiMTQ2ZmU3NDc0Zjg4NjIwYmQ4MWQ3OWYwMzZfNi0zLTEtMS0w_806be619-d8db-4e1a-8a7a-9c09c4bf4678"
      unitRef="usd">-1000000</bmy:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange>
    <bmy:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange
      contextRef="i223b2b374fb24a7d8be48fea190eedba_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjQyNWRmYjE0NmZlNzQ3NGY4ODYyMGJkODFkNzlmMDM2L3RhYmxlcmFuZ2U6NDI1ZGZiMTQ2ZmU3NDc0Zjg4NjIwYmQ4MWQ3OWYwMzZfNi03LTEtMS0w_9857486f-dd31-4a8e-8ef3-fcf22f99ad0e"
      unitRef="usd">1000000</bmy:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i281eaf8778b946efa6523d049bb63601_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjQyNWRmYjE0NmZlNzQ3NGY4ODYyMGJkODFkNzlmMDM2L3RhYmxlcmFuZ2U6NDI1ZGZiMTQ2ZmU3NDc0Zjg4NjIwYmQ4MWQ3OWYwMzZfNy0xLTEtMS0w_43bf8864-11d3-484b-a914-c984004971fb"
      unitRef="usd">19000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i281eaf8778b946efa6523d049bb63601_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjQyNWRmYjE0NmZlNzQ3NGY4ODYyMGJkODFkNzlmMDM2L3RhYmxlcmFuZ2U6NDI1ZGZiMTQ2ZmU3NDc0Zjg4NjIwYmQ4MWQ3OWYwMzZfNy0zLTEtMS0w_e9e980f7-84b3-47c3-bcd7-b6084865e26f"
      unitRef="usd">67000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i3d5fac886ff9468f8c6b82d4defc7d36_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjQyNWRmYjE0NmZlNzQ3NGY4ODYyMGJkODFkNzlmMDM2L3RhYmxlcmFuZ2U6NDI1ZGZiMTQ2ZmU3NDc0Zjg4NjIwYmQ4MWQ3OWYwMzZfNy03LTEtMS0w_440cc4cf-1011-4f4c-82a8-3dd75bfe1738"
      unitRef="usd">71000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:AvailableForSaleSecuritiesTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTc1OQ_e848bf49-abe7-4fbc-8e06-3b23665f199c">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes available-for-sale debt securities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.927%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.799%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Unrealized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total available-for-sale debt securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;All marketable debt securities mature within two years as of June&#160;30, 2021 and December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:AvailableForSaleSecuritiesTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7f6352735c144034ac2187ca79647025_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfMy0xLTEtMS0w_45ae3b02-8da6-45e0-bf09-479ef2d54caf"
      unitRef="usd">1591000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7f6352735c144034ac2187ca79647025_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfMy0zLTEtMS0w_3ddaedf1-ca45-4f9d-a3e8-6096d6e84e30"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7f6352735c144034ac2187ca79647025_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfMy01LTEtMS0w_3d29f6bb-79c5-4e79-b73e-5d774bed9e4c"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7f6352735c144034ac2187ca79647025_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfMy03LTEtMS0w_46c31313-02e1-47c3-8284-2ae1900c2f66"
      unitRef="usd">1591000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i2fe27ed6226d4cfebeb1acc8eb2bb428_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfMy05LTEtMS0w_181d9cfa-b755-4b1c-9e40-e8e50589e235"
      unitRef="usd">1020000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2fe27ed6226d4cfebeb1acc8eb2bb428_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfMy0xMS0xLTEtMA_d6207b78-f1a3-41da-9e25-e9dea2e25151"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2fe27ed6226d4cfebeb1acc8eb2bb428_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfMy0xMy0xLTEtMA_322e116d-5fb6-4346-a853-e735d1bc7d8b"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2fe27ed6226d4cfebeb1acc8eb2bb428_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfMy0xNS0xLTEtMA_f0c8c1ac-ef83-41c1-a23c-7e35dc8772f7"
      unitRef="usd">1020000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i94c67e9d77694b95b51eb292c0bbabf3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNS0xLTEtMS0w_82404bbc-b217-4904-80b3-1972f5ad15bb"
      unitRef="usd">490000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i94c67e9d77694b95b51eb292c0bbabf3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNS0zLTEtMS0w_515de4db-09ee-46cb-a8b6-f1833c29d636"
      unitRef="usd">8000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i94c67e9d77694b95b51eb292c0bbabf3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNS01LTEtMS0w_c6346f56-0ca3-4630-a2ab-c92076998eb6"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i94c67e9d77694b95b51eb292c0bbabf3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNS03LTEtMS0w_9e4e6868-77d8-4077-9efd-c67736ad96db"
      unitRef="usd">498000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="idea685dade76458eab354edd649e002b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNS05LTEtMS0w_6eaa6fef-6878-4133-b4dd-2bbaeaa4839e"
      unitRef="usd">684000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="idea685dade76458eab354edd649e002b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNS0xMS0xLTEtMA_ff9ee8c9-9f7a-4260-ba33-101071e7baf0"
      unitRef="usd">14000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="idea685dade76458eab354edd649e002b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNS0xMy0xLTEtMA_6e6b82a2-01ad-4eaf-8305-de99fba34154"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idea685dade76458eab354edd649e002b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNS0xNS0xLTEtMA_65ed8dc3-09b2-46c2-9311-b905611cefaa"
      unitRef="usd">698000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNi0xLTEtMS0w_90aa5ea4-4431-4e25-b1df-6d482721934f"
      unitRef="usd">2081000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNi0zLTEtMS0w_c90d3de6-e650-44b1-ba89-748ab7569c69"
      unitRef="usd">8000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNi01LTEtMS0w_5fd772d6-141a-428c-96a5-fe69fea638ad"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNi03LTEtMS0w_96caa554-f858-4289-b75f-a5b9f0c3d316"
      unitRef="usd">2089000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNi05LTEtMS0w_5a934acd-2522-494a-8001-db918af7d88c"
      unitRef="usd">1704000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNi0xMS0xLTEtMA_e3230a24-1bbe-4c62-8a59-3564fff60f47"
      unitRef="usd">14000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNi0xMy0xLTEtMA_4af5bebf-4099-453a-aa61-09ad66e98759"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmIxMDU2YmY4YzY4MjQ3Yzk4MjcwZTE4YjY2ZmRkZjJmL3RhYmxlcmFuZ2U6YjEwNTZiZjhjNjgyNDdjOTgyNzBlMThiNjZmZGRmMmZfNi0xNS0xLTEtMA_e59802b7-b24c-46a2-9961-3667afd4e8f7"
      unitRef="usd">1718000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <bmy:ScheduleOfEquityInvestmentsTableTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTc2Mg_0edfa005-3c71-4e1e-a661-d65acd363a41">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the carrying amount of equity investments:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments with readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments without readily determinable fair values&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total equity investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bmy:ScheduleOfEquityInvestmentsTableTextBlock>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmQyNjQ0NDRjNDhhYjRjOThhZDRmZjhkNzg5YTczZTQwL3RhYmxlcmFuZ2U6ZDI2NDQ0NGM0OGFiNGM5OGFkNGZmOGQ3ODlhNzNlNDBfMS0xLTEtMS0w_d74dfdd4-468b-4502-9ed8-df8bceeb3e58"
      unitRef="usd">3414000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmQyNjQ0NDRjNDhhYjRjOThhZDRmZjhkNzg5YTczZTQwL3RhYmxlcmFuZ2U6ZDI2NDQ0NGM0OGFiNGM5OGFkNGZmOGQ3ODlhNzNlNDBfMS0zLTEtMS0w_450bac33-b96e-44e9-9707-5f494f909e86"
      unitRef="usd">3452000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmQyNjQ0NDRjNDhhYjRjOThhZDRmZjhkNzg5YTczZTQwL3RhYmxlcmFuZ2U6ZDI2NDQ0NGM0OGFiNGM5OGFkNGZmOGQ3ODlhNzNlNDBfMi0xLTEtMS0w_11062c03-e795-4bb5-827f-137f6d424382"
      unitRef="usd">616000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmQyNjQ0NDRjNDhhYjRjOThhZDRmZjhkNzg5YTczZTQwL3RhYmxlcmFuZ2U6ZDI2NDQ0NGM0OGFiNGM5OGFkNGZmOGQ3ODlhNzNlNDBfMi0zLTEtMS0w_9d13beb1-e489-417a-a81e-bb7e671772ed"
      unitRef="usd">694000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquityMethodInvestments
      contextRef="i49d5fe3c29f447488503ee61f2d0f306_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmQyNjQ0NDRjNDhhYjRjOThhZDRmZjhkNzg5YTczZTQwL3RhYmxlcmFuZ2U6ZDI2NDQ0NGM0OGFiNGM5OGFkNGZmOGQ3ODlhNzNlNDBfMy0xLTEtMS0w_b99bd78f-726e-4999-9cc8-2267f9454578"
      unitRef="usd">638000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i8d350c2a507842a4a422ebe184b11256_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmQyNjQ0NDRjNDhhYjRjOThhZDRmZjhkNzg5YTczZTQwL3RhYmxlcmFuZ2U6ZDI2NDQ0NGM0OGFiNGM5OGFkNGZmOGQ3ODlhNzNlNDBfMy0zLTEtMS0w_2b07709e-c1fc-4cab-9030-a780ab4fe49b"
      unitRef="usd">549000000</us-gaap:EquityMethodInvestments>
    <bmy:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmQyNjQ0NDRjNDhhYjRjOThhZDRmZjhkNzg5YTczZTQwL3RhYmxlcmFuZ2U6ZDI2NDQ0NGM0OGFiNGM5OGFkNGZmOGQ3ODlhNzNlNDBfNC0xLTEtMS0w_6169ea65-ee38-420a-bb0c-118a3e3faa48"
      unitRef="usd">4668000000</bmy:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments>
    <bmy:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmQyNjQ0NDRjNDhhYjRjOThhZDRmZjhkNzg5YTczZTQwL3RhYmxlcmFuZ2U6ZDI2NDQ0NGM0OGFiNGM5OGFkNGZmOGQ3ODlhNzNlNDBfNC0zLTEtMS0w_32b1312d-31ff-4a3e-9312-cbb4430ebabf"
      unitRef="usd">4695000000</bmy:EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments>
    <us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTczNw_86018c66-6105-47b1-b628-60315e990656">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes the activity related to equity investments. Changes in fair value of equity investments are included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net gain/(loss) recognized on equity investments with readily determinable fair values&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Realized gain/(loss) recognized on equity investments with readily determinable fair value sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Upward adjustments on equity investments without readily determinable fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairments and downward adjustments on equity investments without readily determinable fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative upward adjustments on equity investments without readily determinable fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cumulative impairments and downward adjustments on equity investments without readily determinable fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Net unrealized net gains on equity investments still held were $11 million and $353 million for the three and six months ended June&#160;30, 2021 and $778 million and $550 million for the three and six months ended June&#160;30, 2020, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfMi0xLTEtMS0w_ee1a5f12-caa7-40be-bb91-13d891d383e3"
      unitRef="usd">11000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfMi0zLTEtMS0w_775c49a2-38e3-4425-b452-675f870734f5"
      unitRef="usd">778000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfMi01LTEtMS0w_2d59d3b3-258e-4262-8bb8-431e9d99e53d"
      unitRef="usd">448000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfMi03LTEtMS0w_67aa92bd-26de-4b7d-ae7a-97396c82ae2b"
      unitRef="usd">550000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfMy0xLTEtMS0w_b2379a6b-5b51-48cb-b377-30e32fa1c186"
      unitRef="usd">1000000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfMy0zLTEtMS0w_273c33ca-7b0f-47e6-9d80-5dd8a31e4cf9"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfMy01LTEtMS0w_d8b21f73-c3e0-4989-b09e-77133d1e088a"
      unitRef="usd">-2000000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfMy03LTEtMS0w_a00a7dc5-f8c0-4b75-a760-729efb0448c4"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfNS0xLTEtMS0w_a665f001-7cdc-45c2-aa23-4f5474516984"
      unitRef="usd">99000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfNS0zLTEtMS0w_ea1f8ad1-f75e-406e-8f88-0202c4d272ad"
      unitRef="usd">55000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfNS01LTEtMS0w_d0a3d0ff-11ca-4837-8998-5c2ee78c5069"
      unitRef="usd">130000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfNS03LTEtMS0w_e0875e24-957d-49e8-a688-730ed42ecea5"
      unitRef="usd">130000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfNi0xLTEtMS0w_c1518164-dcee-4a88-ac1e-9e7263df762b"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfNi0zLTEtMS0w_0e85c5fb-01c2-4020-8a9c-e9c066ec0653"
      unitRef="usd">14000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfNi01LTEtMS0w_72e93da3-65e3-4d16-9e88-2a60d80b9fce"
      unitRef="usd">1000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfNi03LTEtMS0w_d6a0ba24-f2ad-4c7d-b5fe-86269fed172f"
      unitRef="usd">202000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfOC01LTEtMS0yMDA3_f38f5487-28e5-4264-9351-b9889bf7d112"
      unitRef="usd">243000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjRmNTY0Mjg4MTgxNDQwZGZhY2NhODUxMTUyNWZiMDM0L3RhYmxlcmFuZ2U6NGY1NjQyODgxODE0NDBkZmFjY2E4NTExNTI1ZmIwMzRfOS01LTEtMS0yMDA3_78235b54-29f1-4830-bc0a-868cf97f7cc2"
      unitRef="usd">142000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfMjY0NA_bd1ffd7e-ed12-4ada-8c62-488671299d7b"
      unitRef="usd">11000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfMTA5OTUxMTYzNzYwNg_7d8c71e8-8135-4a54-91e3-4e84efc9b287"
      unitRef="usd">353000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfMTA5OTUxMTYzNzYxNQ_69a513f5-ee41-4a03-942d-7cc9213acba3"
      unitRef="usd">778000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:UnrealizedGainLossOnInvestments
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfMTA5OTUxMTYzNzYyMg_fc9ee54b-47fc-4c7f-b7d7-4eb56cb88128"
      unitRef="usd">550000000</us-gaap:UnrealizedGainLossOnInvestments>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0001595c39db4736ad8e580f9c067231_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfMzQzOA_ed89674c-bc40-4bc3-aa07-f6c47d6076d4"
      unitRef="usd">3100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ia798a6fcbfcc42a0999608b439adcc0c_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfMzQ2MQ_1eaa2bfa-1fbb-406d-b575-f423b2652dd5"
      unitRef="usd">1100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib8f2c3191d174bad82233a9c00d673f4_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfNTU0Mg_024ca388-926d-45da-9a26-d26968e57173"
      unitRef="eur">950000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib8f2c3191d174bad82233a9c00d673f4_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfNTU0Ng_d8479a66-ecef-4637-9ddc-fd5cd9539a5e"
      unitRef="usd">1100000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i1a0fef7903e64aceba3bf6ce6985f3f8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfNTk5MA_c6280224-ed12-42dd-8783-158d0be99c0f"
      unitRef="usd">400000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeVariableInterestRate
      contextRef="i1711123502af4500920896ecd1971e9f_I20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfNjY5NQ_538ca8ec-7c06-4cbf-b1db-5fcb5d8c1a82"
      unitRef="number">0.0010</us-gaap:DerivativeVariableInterestRate>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfNjc0MA_f9e15b44-bdfa-4012-b136-4300c911f698"
      unitRef="number">0.046</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTczOA_2055c7f0-a3ed-4552-94c6-f4f4afa45e5e">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the fair value of outstanding derivatives:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.704%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.312%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.499%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.319%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Asset&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Liability&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Notional&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Included in Other current assets and Other non-current assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&#160;&#160;&#160;&#160;Included in Other current liabilities and Other non-current liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i503baf5ee2d04e92a42c2e74373c367f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNC0xLTEtMS0w_7b157dc8-2a4d-43f5-a18b-843ab41575e6"
      unitRef="usd">255000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i51131dd320a4460191e1c989fc55992f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNC0zLTEtMS0w_cc24b861-4aa8-4dfb-a8a4-068decd75a98"
      unitRef="usd">16000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2128b1046e77449aa3d997f0af1b147f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNC01LTEtMS0w_37faa980-b28a-4ddd-8a8a-ceedad5158e1"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i51131dd320a4460191e1c989fc55992f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNC03LTEtMS0w_e737d7fe-ac4c-4d04-b17b-9a8964a6f9c7"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ibc20d792e8ad475b8810d5c836c79acb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNC05LTEtMS0w_c45f87e0-ac58-422d-a4e8-b42df1c8a855"
      unitRef="usd">255000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="ia84e2ffbd828434c81d0e6e257c9513f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNC0xMS0xLTEtMA_bba65b6a-e544-46e7-9a56-de166599f0b6"
      unitRef="usd">24000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i720683b7e67645e39106e79e4bb6820e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNC0xMy0xLTEtMA_df29ea90-a92b-4082-9274-4594e5184770"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="ia84e2ffbd828434c81d0e6e257c9513f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNC0xNS0xLTEtMA_b3c536fe-05eb-4f1e-8275-2fd2147add84"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i1c833d9f2fd046aabaf2cff398ab0295_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNS0xLTEtMS0w_d14d525a-ed56-4cd1-ac21-ab82354c6e1f"
      unitRef="usd">400000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="ia9a0e466309e459caa62b42f8c64930f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNS0zLTEtMS0w_b5dfa873-5e5c-4a11-9026-46666e354ed9"
      unitRef="usd">16000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="idbdf809d037e43b7a052e7b6ab343594_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNS01LTEtMS0w_40eba0ec-277c-412b-a0be-66eb347ba9c0"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="ia9a0e466309e459caa62b42f8c64930f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNS03LTEtMS0w_654d5a2d-91ef-41d0-b0a2-b85b05b1a800"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6d2f391e801c437fa61b6d9d96a8e0b9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNS05LTEtMS0w_60c02475-9a30-483f-8944-66e0e586f79c"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="ib4b905331bfb45eca6d2a44c4ebd6cac_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNS0xMS0xLTEtMA_fe217f6e-c7bb-4131-9687-719d52498f13"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i169cfb4fb02c4b9893207821ae8f03d6_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNS0xMy0xLTEtMA_bbb757d9-0f97-48dc-b145-8ad5ff6a07b3"
      unitRef="usd">400000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="ib4b905331bfb45eca6d2a44c4ebd6cac_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNS0xNS0xLTEtMA_4bfa0595-80cb-4573-a135-44ced7f56e6d"
      unitRef="usd">-10000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="icaa06a3db7a24003a0dd163a30a2bef2_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNi0xLTEtMS0w_8a485a59-b3ea-4fe3-9c12-9b297d21afe4"
      unitRef="usd">3776000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i2b5f2855511343508c746e24df19dd1d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNi0zLTEtMS0w_3d078fef-5d5b-4cba-b252-2d6f0cc94cee"
      unitRef="usd">90000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0eae85fd04334a66abd5610c6363b26e_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNi01LTEtMS0w_6a47ca76-ad03-402a-a07c-3d7e016d66cb"
      unitRef="usd">1445000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i2b5f2855511343508c746e24df19dd1d_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNi03LTEtMS0w_4321b1c3-6f5a-4516-ab8c-9282746f4b74"
      unitRef="usd">-36000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i24cf699361b744ed89ad8d71f69dd889_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNi05LTEtMS0w_3109688c-e3f4-405d-be00-0e2991c6723d"
      unitRef="usd">231000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="if9865149104a462288aa6782497c61f0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNi0xMS0xLTEtMA_f8784f08-b300-4ed1-ae9b-02558341a3fd"
      unitRef="usd">1000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5e53811b7cb644a29bf23fbcea6510f9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNi0xMy0xLTEtMA_24041975-f6dc-494a-bac7-e1781fae9024"
      unitRef="usd">5813000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="if9865149104a462288aa6782497c61f0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfNi0xNS0xLTEtMA_86a73ef5-1696-42b5-86d3-144ad25311b7"
      unitRef="usd">-259000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i87f0786ba2604a61a85c170d713e9a62_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfOS0xLTEtMS0w_4716678a-ab86-41ad-ab20-69982bfc99dc"
      unitRef="usd">932000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i75483d744b7c4203b5ed365f7d3b3487_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfOS0zLTEtMS0w_89a22982-2fec-4fb3-83f8-5144fd710c53"
      unitRef="usd">9000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i0f35f618e55b455cae0cb2a21eedc388_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfOS01LTEtMS0w_5a61732b-23e9-4ea5-b5a0-6fd31dd97c7e"
      unitRef="usd">531000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i75483d744b7c4203b5ed365f7d3b3487_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfOS03LTEtMS0w_ef38d30e-5a1f-454f-a9d8-d7e6557beba6"
      unitRef="usd">-6000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8954d0e37bc949059fbcfb86b9342723_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfOS05LTEtMS0w_8361fde6-b7d0-44a7-bf19-80d353d0c525"
      unitRef="usd">1104000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="i47aba9a8009e43b09b026ddb97e17378_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfOS0xMS0xLTEtMA_e55f64d3-4e98-4d8d-a0eb-6d50969adb6b"
      unitRef="usd">17000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i11a8aa24b66f48fa9bbbfce49c6808f3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfOS0xMy0xLTEtMA_e54c1242-37d6-4b86-91ea-a9f2f536892f"
      unitRef="usd">336000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i47aba9a8009e43b09b026ddb97e17378_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfOS0xNS0xLTEtMA_cb314eab-e55f-44a3-ae8f-e3a4931713e0"
      unitRef="usd">-1000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ieba83eb6b5174206bc5a3b89f15c45f9_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfMTEtMS0xLTEtMA_c8de99d5-8aea-435f-a0b6-e20180ce4351"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="ic978b78a584f466288031da3261d83d1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfMTEtMy0xLTEtMA_f6efad9a-88ed-46d6-ae28-dca249c1ddc0"
      unitRef="usd">19000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ib1241abc16f54f05b6af70bc4b195625_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfMTEtNS0xLTEtMA_7e2dcca3-6dbb-4f95-8477-c1e6a08e34aa"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="ic978b78a584f466288031da3261d83d1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfMTEtNy0xLTEtMA_4fb47595-3098-47a1-88f7-377ee99e7978"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i49e79afcda54470890d42c058ee6dc8c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfMTEtOS0xLTEtMA_1e2ca919-b8ba-4bc3-ab92-e0f5acd0b4c8"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeAssets
      contextRef="ib6b878c72f514738ab932426ec0acf2a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfMTEtMTEtMS0xLTA_33c268e5-604c-4c2d-b72e-021ed0fb5821"
      unitRef="usd">27000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i999b17f195aa48cb93d5044e50370923_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfMTEtMTMtMS0xLTA_05d39c7d-741f-4b8f-b9a7-a99cedce3d1c"
      unitRef="usd">0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="ib6b878c72f514738ab932426ec0acf2a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjFjYTIzOGNhMWU2NjRiZGE4OTkxYjQxOWNkMTU4ZTU1L3RhYmxlcmFuZ2U6MWNhMjM4Y2ExZTY2NGJkYTg5OTFiNDE5Y2QxNThlNTVfMTEtMTUtMS0xLTA_86071b61-d469-436e-a865-c587e084acb5"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTc2Mw_ed5c46bd-28dc-429b-818a-c6294d8053f8">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial statement classification and amount of (gain)/loss recognized on hedging instruments:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency zero-cost collar contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i2a01cd6e61f342ecb975f4ae6f8d59b1_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmI0ODAxMTFiMTI2NTQxYWI5M2ZlNjhiYTVmMWMyZDJmL3RhYmxlcmFuZ2U6YjQ4MDExMWIxMjY1NDFhYjkzZmU2OGJhNWYxYzJkMmZfMi0xLTEtMS0w_3e1b43e6-b90b-42c7-a5f7-90c158175d28"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i5e7f71ec07cc4f4c9afc10bc72f6c0e5_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmI0ODAxMTFiMTI2NTQxYWI5M2ZlNjhiYTVmMWMyZDJmL3RhYmxlcmFuZ2U6YjQ4MDExMWIxMjY1NDFhYjkzZmU2OGJhNWYxYzJkMmZfMi0zLTEtMS0w_b7a7b83c-9f71-495b-8b23-4056b2e32c51"
      unitRef="usd">-7000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i040292e730b343eb80b604d175386271_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmI0ODAxMTFiMTI2NTQxYWI5M2ZlNjhiYTVmMWMyZDJmL3RhYmxlcmFuZ2U6YjQ4MDExMWIxMjY1NDFhYjkzZmU2OGJhNWYxYzJkMmZfMi01LTEtMS0w_d77776fe-ad0e-4e21-b95b-36a74c4fa994"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i35ce00fcc7a44969901d544fba9f7b94_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmI0ODAxMTFiMTI2NTQxYWI5M2ZlNjhiYTVmMWMyZDJmL3RhYmxlcmFuZ2U6YjQ4MDExMWIxMjY1NDFhYjkzZmU2OGJhNWYxYzJkMmZfMi03LTEtMS0w_86326a11-d7b9-4a39-bfc6-8e0a2a961102"
      unitRef="usd">-15000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i508f07be751744a09a404b382976e275_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmI0ODAxMTFiMTI2NTQxYWI5M2ZlNjhiYTVmMWMyZDJmL3RhYmxlcmFuZ2U6YjQ4MDExMWIxMjY1NDFhYjkzZmU2OGJhNWYxYzJkMmZfMy0xLTEtMS0w_624ffb64-518f-4192-9678-718d365323c9"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i4696e702fafb4492b4c7d9e523e4af6d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmI0ODAxMTFiMTI2NTQxYWI5M2ZlNjhiYTVmMWMyZDJmL3RhYmxlcmFuZ2U6YjQ4MDExMWIxMjY1NDFhYjkzZmU2OGJhNWYxYzJkMmZfMy0zLTEtMS0w_4764f549-a818-4cc0-8b54-f862565cc9a5"
      unitRef="usd">-3000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ib7f3a7ad072c43a08ec6727c68cc2efd_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmI0ODAxMTFiMTI2NTQxYWI5M2ZlNjhiYTVmMWMyZDJmL3RhYmxlcmFuZ2U6YjQ4MDExMWIxMjY1NDFhYjkzZmU2OGJhNWYxYzJkMmZfMy01LTEtMS0w_8b845e4b-e6c2-4bb9-9684-c3a89aa1cfc8"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="id07c76256d36464aa236c8edf59250ae_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmI0ODAxMTFiMTI2NTQxYWI5M2ZlNjhiYTVmMWMyZDJmL3RhYmxlcmFuZ2U6YjQ4MDExMWIxMjY1NDFhYjkzZmU2OGJhNWYxYzJkMmZfMy03LTEtMS0w_db21c030-74aa-4c85-8762-252fb163f9fc"
      unitRef="usd">-6000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i00823395d1374179823132245b682350_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmI0ODAxMTFiMTI2NTQxYWI5M2ZlNjhiYTVmMWMyZDJmL3RhYmxlcmFuZ2U6YjQ4MDExMWIxMjY1NDFhYjkzZmU2OGJhNWYxYzJkMmZfNC0xLTEtMS0w_010d4e92-b16f-4679-b759-3d013d97ce6b"
      unitRef="usd">59000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="icf03f7c455ce4b9d89fbb72f7c41488d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmI0ODAxMTFiMTI2NTQxYWI5M2ZlNjhiYTVmMWMyZDJmL3RhYmxlcmFuZ2U6YjQ4MDExMWIxMjY1NDFhYjkzZmU2OGJhNWYxYzJkMmZfNC0zLTEtMS0w_0ad288f7-430b-4d17-9f52-f70a4638b88e"
      unitRef="usd">16000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i7ed527429005415da9fb10074bfa1097_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmI0ODAxMTFiMTI2NTQxYWI5M2ZlNjhiYTVmMWMyZDJmL3RhYmxlcmFuZ2U6YjQ4MDExMWIxMjY1NDFhYjkzZmU2OGJhNWYxYzJkMmZfNC01LTEtMS0w_48fbb0e7-c176-48ea-93ce-fcf3f37da452"
      unitRef="usd">126000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ie95af335802a4c1e92654a4464170a9a_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmI0ODAxMTFiMTI2NTQxYWI5M2ZlNjhiYTVmMWMyZDJmL3RhYmxlcmFuZ2U6YjQ4MDExMWIxMjY1NDFhYjkzZmU2OGJhNWYxYzJkMmZfNC03LTEtMS0w_bf44f3cf-b1f7-4133-80ff-0c43dfa9bf14"
      unitRef="usd">-16000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i7d2fe3e02fb94bb984fa1b11e225751c_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfMi0xLTEtMS02MDk_bf37e4b5-4af6-4671-9cc3-1f0c162fdef4"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i486c191850aa49a682074690ecb19563_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfMi0zLTEtMS02MTI_a16cfd7e-3a11-46fc-a1a4-63bd54d0f089"
      unitRef="usd">-7000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i077b4ec5d45b4aa3a708e5adcef3cb7c_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfMi01LTEtMS02MTU_af0aa673-a26d-489c-b821-c5e0b6ff7046"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i6dd4ff55ae1249c1ad68411a97f3e848_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfMi03LTEtMS02MTk_665cfb87-80ca-4322-b008-ab99c82eb655"
      unitRef="usd">-14000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i245e38fca4f8467e86cdbf4e1e5cc67b_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfMy0xLTEtMS02MDk_23f05b70-1a4d-4167-9d56-07852afbe981"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i21fe606592d3458e808226e33cf944a6_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfMy0zLTEtMS02MTI_8789f7e3-2b75-48ec-8005-6619991fd18d"
      unitRef="usd">-3000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i151fe4a021694b3b93a3419d9cc35d09_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfMy01LTEtMS02MTU_2be69845-2e19-4f6c-b6cf-aefec4aaa9fd"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ieec4fe8c5b2b4a388f9c647f9b3c0879_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfMy03LTEtMS02MTk_3b43219c-f102-4cb6-a95a-a2c00812f3ca"
      unitRef="usd">-5000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i229107cac324432f8447407f665ddee5_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfNC0xLTEtMS02MDk_7b5d1dca-78e5-4374-8e62-a16af9b06054"
      unitRef="usd">-35000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="if631f8e8a60942b4802fe350a6de182a_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfNC0zLTEtMS02MTI_99d0baed-b3cc-46ed-a3b7-a77f01b57cd7"
      unitRef="usd">21000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ife8a0faa825047398cc2bc639c58ec3a_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfNC01LTEtMS02MTU_2f5130c4-8368-43e2-874a-fbdd6516a35f"
      unitRef="usd">-58000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i9b690964ca6348bc97ef500ba4781adf_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfNC03LTEtMS02MTk_9393ad51-c852-447b-8d05-21ac94e910f8"
      unitRef="usd">-55000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i660d02e3c5404f8c82f9d6bffa9d69a2_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfNS0xLTEtMS02MDk_ce56daa6-24ba-4cd1-8a3f-52180e2abee7"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="iecad268758bf4f57961916a30d5b23bb_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfNS0zLTEtMS02MTI_853ae207-9f81-4a66-ac1d-450f23854021"
      unitRef="usd">10000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i49ecccdb7d504e33ad7566e82d10b7af_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfNS01LTEtMS02MTU_addedabf-2dd9-4beb-9775-8e061a9245b4"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i97351a916177459f9564953cbd8db5b7_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOmJhNjY0MTE4MjEwYzRhZjg5NDRjNTIxNWQyMDE1OWM1L3RhYmxlcmFuZ2U6YmE2NjQxMTgyMTBjNGFmODk0NGM1MjE1ZDIwMTU5YzVfNS03LTEtMS02MTk_cc0876ce-4d80-4124-94c1-fdef17ef7e64"
      unitRef="usd">1000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTc3NA_ae567c36-6f75-4716-94cf-abe40b7eb9e2">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the effect of derivative and non-derivative instruments designated as hedging instruments in Other Comprehensive Income/(Loss):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency forward contracts gain/(loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other Comprehensive Income/(Loss)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives qualifying as net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cross-currency interest rate swap contracts gain:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other Comprehensive Income/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-derivatives qualifying as net investment hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. dollar borrowings gain:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognized in Other Comprehensive Income/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;The majority is expected to be reclassified into earnings in the next 12 months.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ic7532fb922404416bf6c1a4f59828fc3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfNC0xLTEtMS0w_2c2c90b5-6abc-4f91-8c99-4afe5a21a2e7"
      unitRef="usd">-38000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i6a94a414c588439da957589012a52bce_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfNC0zLTEtMS0w_f651b90a-b98b-49ba-b127-67787947c910"
      unitRef="usd">-34000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i9b8a19e9be6947c29fae71035f799b8b_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfNC01LTEtMS0w_1156cf70-4938-47cf-8f33-cc22ced84aba"
      unitRef="usd">221000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ie9967a3c6dc845d9ac2ae782bd268a81_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfNC03LTEtMS0w_130e4035-2f0d-42c6-ac74-403f82686e42"
      unitRef="usd">63000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i00823395d1374179823132245b682350_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfNS0xLTEtMS0w_b6f5ebf8-8a94-4a20-8d17-2958be6fbaa8"
      unitRef="usd">-53000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i229107cac324432f8447407f665ddee5_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfNS0zLTEtMS0w_377407db-b141-4d44-9a3b-bcd13301dcfd"
      unitRef="usd">32000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i7ed527429005415da9fb10074bfa1097_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfNS01LTEtMS0w_015789b4-6360-48c6-85c1-c0d717e8b227"
      unitRef="usd">-89000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ife8a0faa825047398cc2bc639c58ec3a_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfNS03LTEtMS0w_20245747-6962-4b97-9930-066b1ce5ac2a"
      unitRef="usd">52000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i907aadccc2844fa8b86616d86e1395f8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfMTItMS0xLTEtMA_2d5a8b2f-ff48-4bf9-b380-7ebbb1f6e338"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i5d7cbfcfe0e044538ff7a63b3ad018c3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfMTItMy0xLTEtMA_1186681c-efcc-4eca-bf96-3da3269f8fd3"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i85dd208285f94cd6aff62add53ee5706_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfMTItNS0xLTEtMA_48b7129b-8adf-459f-bb92-d85eb9149323"
      unitRef="usd">26000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i47b91d980e0a450fa568fc15b6e2b9b0_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfMTItNy0xLTEtMA_942d220c-c179-484f-9016-c1aaef5f7a10"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i9f3f06024f654b51b3f6b0bca6aaa058_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfMTYtMS0xLTEtMA_834d233e-a947-42a5-8d19-00853ea06fa1"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i5604822aa0b342079d2242f61089bf43_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfMTYtMy0xLTEtMA_4c7b313f-f5e2-4470-bb4e-0d837705b4eb"
      unitRef="usd">-32000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i3a7cece24b0c44179822ebe709140263_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfMTYtNS0xLTEtMA_d84a674f-a607-44ae-88d0-54952aee50bc"
      unitRef="usd">25000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="ie7daf934932b4999a9e8c82bfe559ddf_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjYwYmZkNGEyYTc4ZTQ2MDk5MDM3ZWY3ODVlNTgxMmIzL3RhYmxlcmFuZ2U6NjBiZmQ0YTJhNzhlNDYwOTkwMzdlZjc4NWU1ODEyYjNfMTYtNy0xLTEtMA_f208fb50-ac4b-4120-86ad-99488cc0349b"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:ScheduleOfShortTermDebtTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTc4Nw_f0c7f847-c0aa-4a45-be76-9b03e68f5f2b">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term debt obligations include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-U.S. short-term borrowings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShortTermDebtTextBlock>
    <us-gaap:ShortTermBankLoansAndNotesPayable
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjllMzA0ZmY5NmU2ODQ4Mjk4MGE1ZWRjNDc1OTE0YTRmL3RhYmxlcmFuZ2U6OWUzMDRmZjk2ZTY4NDgyOTgwYTVlZGM0NzU5MTRhNGZfMS0xLTEtMS0w_6fea31e4-ed14-41c1-8144-6a182d92042b"
      unitRef="usd">63000000</us-gaap:ShortTermBankLoansAndNotesPayable>
    <us-gaap:ShortTermBankLoansAndNotesPayable
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjllMzA0ZmY5NmU2ODQ4Mjk4MGE1ZWRjNDc1OTE0YTRmL3RhYmxlcmFuZ2U6OWUzMDRmZjk2ZTY4NDgyOTgwYTVlZGM0NzU5MTRhNGZfMS0zLTEtMS0w_889b5399-5bae-4c36-aff4-51dd9c10577b"
      unitRef="usd">176000000</us-gaap:ShortTermBankLoansAndNotesPayable>
    <us-gaap:LongTermDebtCurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjllMzA0ZmY5NmU2ODQ4Mjk4MGE1ZWRjNDc1OTE0YTRmL3RhYmxlcmFuZ2U6OWUzMDRmZjk2ZTY4NDgyOTgwYTVlZGM0NzU5MTRhNGZfMi0xLTEtMS0w_5a937dcd-cae5-41ea-9187-d145ee34c464"
      unitRef="usd">2497000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjllMzA0ZmY5NmU2ODQ4Mjk4MGE1ZWRjNDc1OTE0YTRmL3RhYmxlcmFuZ2U6OWUzMDRmZjk2ZTY4NDgyOTgwYTVlZGM0NzU5MTRhNGZfMi0zLTEtMS0w_65ffed4f-f500-4541-a191-121ac9987497"
      unitRef="usd">2000000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OtherShortTermBorrowings
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjllMzA0ZmY5NmU2ODQ4Mjk4MGE1ZWRjNDc1OTE0YTRmL3RhYmxlcmFuZ2U6OWUzMDRmZjk2ZTY4NDgyOTgwYTVlZGM0NzU5MTRhNGZfMy0xLTEtMS0w_00bfe6b8-50c3-4f3f-b0bc-062e988c6c75"
      unitRef="usd">95000000</us-gaap:OtherShortTermBorrowings>
    <us-gaap:OtherShortTermBorrowings
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjllMzA0ZmY5NmU2ODQ4Mjk4MGE1ZWRjNDc1OTE0YTRmL3RhYmxlcmFuZ2U6OWUzMDRmZjk2ZTY4NDgyOTgwYTVlZGM0NzU5MTRhNGZfMy0zLTEtMS0w_51a785bb-103a-4093-b6d1-dc23f7d44eaa"
      unitRef="usd">164000000</us-gaap:OtherShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjllMzA0ZmY5NmU2ODQ4Mjk4MGE1ZWRjNDc1OTE0YTRmL3RhYmxlcmFuZ2U6OWUzMDRmZjk2ZTY4NDgyOTgwYTVlZGM0NzU5MTRhNGZfNC0xLTEtMS0w_1875758e-edbf-4ffc-8ed5-eb01a9f6bb8d"
      unitRef="usd">2655000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjllMzA0ZmY5NmU2ODQ4Mjk4MGE1ZWRjNDc1OTE0YTRmL3RhYmxlcmFuZ2U6OWUzMDRmZjk2ZTY4NDgyOTgwYTVlZGM0NzU5MTRhNGZfNC0zLTEtMS0w_4e5a7ee5-2c68-401f-b5d3-76e879415cd9"
      unitRef="usd">2340000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTcxNA_4fb2252c-8470-4a65-abc1-15a37c024ced">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt and the current portion of long-term debt include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal Value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to Principal Value:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of interest rate swap contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized basis adjustment from swap terminations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized bond discounts and issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized purchase price adjustments of Celgene debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfMS0xLTEtMS0w_43883987-89a1-41e6-97c7-25d8a745d7bb"
      unitRef="usd">43666000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfMS0zLTEtMS0w_81cb07ed-b4fe-4f97-a416-c4c07afb956a"
      unitRef="usd">48711000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DerivativeLiabilities
      contextRef="i836ec8a900f94ab2a0cd3662c33ba2d1_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfNC0xLTEtMS0w_772c72bb-dc51-4c00-8873-342ec4c71eb0"
      unitRef="usd">16000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i816b15b9810f468d87ef913a5c6b3461_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfNC0zLTEtMS0w_a629198f-fc4b-4495-9ffc-77ec56fa4d63"
      unitRef="usd">24000000</us-gaap:DerivativeLiabilities>
    <bmy:UnamortizedBasisAdjustmentFromSwapTerminations
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfNS0xLTEtMS0w_5970bf61-b3b6-4747-9977-39746756d6f6"
      unitRef="usd">131000000</bmy:UnamortizedBasisAdjustmentFromSwapTerminations>
    <bmy:UnamortizedBasisAdjustmentFromSwapTerminations
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfNS0zLTEtMS0w_4e94f87e-e31f-42c7-b116-2065e25073cc"
      unitRef="usd">149000000</bmy:UnamortizedBasisAdjustmentFromSwapTerminations>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfNi0xLTEtMS0w_9a008a4e-51dd-401a-af4d-39e6e5a42376"
      unitRef="usd">279000000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfNi0zLTEtMS0w_3f91b3fb-3666-459d-abc4-1a21d6a4b367"
      unitRef="usd">303000000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfNy0xLTEtMS0w_a2164a8b-2acf-41bb-a7ff-d4f0279daa79"
      unitRef="usd">1466000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:DebtInstrumentUnamortizedPremium
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfNy0zLTEtMS0w_c004a2e6-e8b1-45c9-b067-fca7b7979db1"
      unitRef="usd">1755000000</us-gaap:DebtInstrumentUnamortizedPremium>
    <us-gaap:LongTermDebt
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfOC0xLTEtMS0w_57920864-7629-43a2-b80c-debc8e44899f"
      unitRef="usd">45000000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfOC0zLTEtMS0w_4a70a8b9-f47c-481c-9df5-5d5ee585915d"
      unitRef="usd">50336000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfMTAtMS0xLTEtMA_863d8e25-41ab-4f55-b97e-f6aac7554340"
      unitRef="usd">2497000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfMTAtMy0xLTEtMA_def720c6-ffbe-42ff-a2de-c2cd4c74c558"
      unitRef="usd">2000000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfMTEtMS0xLTEtMA_3c47cf6f-d7bc-403d-a4aa-f5b3cf07f226"
      unitRef="usd">42503000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfMTEtMy0xLTEtMA_d096aa7c-8d8d-44a1-86ab-0232da4d13d1"
      unitRef="usd">48336000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebt
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfMTItMS0xLTEtMA_99164458-72f1-49bf-82f8-2c5f172afa6f"
      unitRef="usd">45000000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RhYmxlOjM1M2ZkMjU5ZGMzNzQ5Njk4M2FjMzlhMTU0MzhhMDgwL3RhYmxlcmFuZ2U6MzUzZmQyNTlkYzM3NDk2OTgzYWMzOWExNTQzOGEwODBfMTItMy0xLTEtMA_2b2d6c0d-04da-4986-9701-01f83b4ee3e0"
      unitRef="usd">50336000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfODI1NA_49500257-39b6-4be8-b2b3-2c4fafcd08b6"
      unitRef="usd">50600000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfODI2Nw_883e3d51-afde-4a28-8b68-4bb6d4affd95"
      unitRef="usd">58500000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfODYwNg_46dac7f7-5459-4b97-a1d5-f982f00b7733"
      unitRef="usd">3500000000</us-gaap:ExtinguishmentOfDebtAmount>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfODY2MQ_d32110c6-5d99-4b83-896f-ac625a6159dd"
      unitRef="usd">4000000000.0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfODc3Mg_21f2c3b9-b6ac-4f89-833c-c1da5ea0fe3b"
      unitRef="usd">-281000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib87554b0ae72494ba6568a952ddc9510_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfODkxNg_62d348ea-3914-4fbc-84dd-70a936c3963b"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i18088008a5b7409bb866ff840040d19a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfMjE5OTAyMzI2NjY3OA_66d52076-5bc9-4550-9d67-176a1035ba91"
      unitRef="usd">1000000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:InterestPaidNet
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfODk4MQ_3e5626ec-cb1d-4ae1-82d5-4dbf2b22b6fe"
      unitRef="usd">807000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfODk4OA_158353e1-454b-4d99-928d-c44f656f1bb1"
      unitRef="usd">845000000</us-gaap:InterestPaidNet>
    <bmy:NumberofRevolvingCreditFacilities
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTA5OQ_828d43e1-f2f2-466c-84ab-6455a7bcef6f"
      unitRef="number">4</bmy:NumberofRevolvingCreditFacilities>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTE0OA_c044e8b2-7887-495e-8aca-206be7de98e3"
      unitRef="usd">6000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i643fc6ba1c2a4f778dbb32207ff363ed_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTE4MQ_c4e960a0-2fb1-4973-85e5-20f11885a137"
      unitRef="usd">2000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i3d62c55572e74536af7ed82dceb0ea9d_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTIzMg_84df0275-c215-4d8b-8fae-dc294f97aed8"
      unitRef="usd">1000000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i48e73501dc964ac8b84b67b3240d49b3_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV81OC9mcmFnOjNhODZjM2QwMTZlNjQ3YzI4MWFkZjlhMDM5OWYyMzIwL3RleHRyZWdpb246M2E4NmMzZDAxNmU2NDdjMjgxYWRmOWEwMzk5ZjIzMjBfOTI4Nw_5c507fbf-5167-41a9-b3ff-b024cef50974"
      unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RleHRyZWdpb246NzlmYjIxMjAzZTAyNDJiOWE3OTBjYjAwNTdiODRjODhfMjgy_ddc26e55-59ff-4978-aee9-15b1a94d0b1a">RECEIVABLES&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less charge-backs and cash discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(569)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less allowance for expected credit loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alliance, royalties, VAT and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-U.S. receivables sold on a nonrecourse basis were $638 million and $464 million for the six months ended June 30, 2021 and 2020, respectively. Receivables from the three largest customers in the U.S. represented approximately 58% and 56% of total trade receivables at June&#160;30, 2021 and December&#160;31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RleHRyZWdpb246NzlmYjIxMjAzZTAyNDJiOWE3OTBjYjAwNTdiODRjODhfMjgx_059c3ad9-c969-45ef-8019-107ab0b25ad0">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less charge-backs and cash discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(569)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(645)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less allowance for expected credit loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,713&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Alliance, royalties, VAT and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RhYmxlOjk2ODIyODUxNmMyZjQ1YjA4NzU5YWRlNTIyYjU2OThlL3RhYmxlcmFuZ2U6OTY4MjI4NTE2YzJmNDViMDg3NTlhZGU1MjJiNTY5OGVfMS0xLTEtMS0w_aa822b36-4176-48df-aa3f-b757e0013d59"
      unitRef="usd">8309000000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RhYmxlOjk2ODIyODUxNmMyZjQ1YjA4NzU5YWRlNTIyYjU2OThlL3RhYmxlcmFuZ2U6OTY4MjI4NTE2YzJmNDViMDg3NTlhZGU1MjJiNTY5OGVfMS0zLTEtMS0w_ae5322c4-6581-46a3-989b-c9fb716d62ec"
      unitRef="usd">7882000000</us-gaap:AccountsReceivableGrossCurrent>
    <bmy:CashDiscounts
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RhYmxlOjk2ODIyODUxNmMyZjQ1YjA4NzU5YWRlNTIyYjU2OThlL3RhYmxlcmFuZ2U6OTY4MjI4NTE2YzJmNDViMDg3NTlhZGU1MjJiNTY5OGVfMi0xLTEtMS0w_eef2afb4-b6a6-4f76-8605-36ec460d3b1d"
      unitRef="usd">569000000</bmy:CashDiscounts>
    <bmy:CashDiscounts
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RhYmxlOjk2ODIyODUxNmMyZjQ1YjA4NzU5YWRlNTIyYjU2OThlL3RhYmxlcmFuZ2U6OTY4MjI4NTE2YzJmNDViMDg3NTlhZGU1MjJiNTY5OGVfMi0zLTEtMS0w_c471aa18-372a-4d1c-aced-cb8861b48f40"
      unitRef="usd">645000000</bmy:CashDiscounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RhYmxlOjk2ODIyODUxNmMyZjQ1YjA4NzU5YWRlNTIyYjU2OThlL3RhYmxlcmFuZ2U6OTY4MjI4NTE2YzJmNDViMDg3NTlhZGU1MjJiNTY5OGVfMy0xLTEtMS0w_a792d2cc-1f6a-4e8d-8ba7-914ae6690dba"
      unitRef="usd">27000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RhYmxlOjk2ODIyODUxNmMyZjQ1YjA4NzU5YWRlNTIyYjU2OThlL3RhYmxlcmFuZ2U6OTY4MjI4NTE2YzJmNDViMDg3NTlhZGU1MjJiNTY5OGVfMy0zLTEtMS0w_e07ebccc-4ffb-462b-abc6-91b93d38bc1b"
      unitRef="usd">18000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RhYmxlOjk2ODIyODUxNmMyZjQ1YjA4NzU5YWRlNTIyYjU2OThlL3RhYmxlcmFuZ2U6OTY4MjI4NTE2YzJmNDViMDg3NTlhZGU1MjJiNTY5OGVfNC0xLTEtMS0w_4b794121-f86b-4c40-8104-227ad6bb198e"
      unitRef="usd">7713000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RhYmxlOjk2ODIyODUxNmMyZjQ1YjA4NzU5YWRlNTIyYjU2OThlL3RhYmxlcmFuZ2U6OTY4MjI4NTE2YzJmNDViMDg3NTlhZGU1MjJiNTY5OGVfNC0zLTEtMS0w_665b3fb2-b47e-4cb6-b4b3-37fa20255746"
      unitRef="usd">7219000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivables
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RhYmxlOjk2ODIyODUxNmMyZjQ1YjA4NzU5YWRlNTIyYjU2OThlL3RhYmxlcmFuZ2U6OTY4MjI4NTE2YzJmNDViMDg3NTlhZGU1MjJiNTY5OGVfNS0xLTEtMS0w_db32a00f-b6f3-45ac-8303-e1c862d21c38"
      unitRef="usd">1304000000</us-gaap:OtherReceivables>
    <us-gaap:OtherReceivables
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RhYmxlOjk2ODIyODUxNmMyZjQ1YjA4NzU5YWRlNTIyYjU2OThlL3RhYmxlcmFuZ2U6OTY4MjI4NTE2YzJmNDViMDg3NTlhZGU1MjJiNTY5OGVfNS0zLTEtMS0w_f3e209ff-8a71-469c-8412-321e49ae2bdd"
      unitRef="usd">1282000000</us-gaap:OtherReceivables>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RhYmxlOjk2ODIyODUxNmMyZjQ1YjA4NzU5YWRlNTIyYjU2OThlL3RhYmxlcmFuZ2U6OTY4MjI4NTE2YzJmNDViMDg3NTlhZGU1MjJiNTY5OGVfNi0xLTEtMS0w_4c749f0a-269c-43df-8240-20d57b86dbd0"
      unitRef="usd">9017000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RhYmxlOjk2ODIyODUxNmMyZjQ1YjA4NzU5YWRlNTIyYjU2OThlL3RhYmxlcmFuZ2U6OTY4MjI4NTE2YzJmNDViMDg3NTlhZGU1MjJiNTY5OGVfNi0zLTEtMS0w_d4c53e65-a3da-46bd-bb38-73a443e6fea4"
      unitRef="usd">8501000000</us-gaap:ReceivablesNetCurrent>
    <bmy:ReceivablesSoldOnNonrecourseBasis
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RleHRyZWdpb246NzlmYjIxMjAzZTAyNDJiOWE3OTBjYjAwNTdiODRjODhfODQ_367314e0-36a8-4a82-b831-1e5ef9406b16"
      unitRef="usd">638000000</bmy:ReceivablesSoldOnNonrecourseBasis>
    <bmy:ReceivablesSoldOnNonrecourseBasis
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RleHRyZWdpb246NzlmYjIxMjAzZTAyNDJiOWE3OTBjYjAwNTdiODRjODhfOTE_5e3677f6-ed02-46de-b675-3a49ccb88a2f"
      unitRef="usd">464000000</bmy:ReceivablesSoldOnNonrecourseBasis>
    <bmy:NumberOfLargestPharmaceuticalWholesalers
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RleHRyZWdpb246NzlmYjIxMjAzZTAyNDJiOWE3OTBjYjAwNTdiODRjODhfMTQ4_d0cd705b-04e6-46be-b51d-183e2613956a"
      unitRef="number">3</bmy:NumberOfLargestPharmaceuticalWholesalers>
    <bmy:PercentageOfAggregateTotalTradeReceivablesDue
      contextRef="i85e0ac7571b54abf896103b5b9c3df12_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RleHRyZWdpb246NzlmYjIxMjAzZTAyNDJiOWE3OTBjYjAwNTdiODRjODhfMjA3_c501a82b-de7b-4ffa-bdfe-5e55bb81f313"
      unitRef="number">0.58</bmy:PercentageOfAggregateTotalTradeReceivablesDue>
    <bmy:PercentageOfAggregateTotalTradeReceivablesDue
      contextRef="i7913fb01092e4ed1a1dc7490f44c3094_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82NC9mcmFnOjc5ZmIyMTIwM2UwMjQyYjlhNzkwY2IwMDU3Yjg0Yzg4L3RleHRyZWdpb246NzlmYjIxMjAzZTAyNDJiOWE3OTBjYjAwNTdiODRjODhfMjE0_b4656099-5bbd-4a97-a307-5777661fc0ce"
      unitRef="number">0.56</bmy:PercentageOfAggregateTotalTradeReceivablesDue>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RleHRyZWdpb246OTk5MmNhNWZiMTM3NGRhODk4YmZmMmQyNDk4MjY3YjFfMjUx_7d8a1d3b-77aa-41b3-bb36-b4e6d9693337">INVENTORIES&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw and packaging materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total inventories include fair value adjustments resulting from the Celgene acquisition of $606 million at June&#160;30, 2021 and $774 million at December&#160;31, 2020. Other non-current assets include inventory expected to remain on hand beyond one year in both periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RleHRyZWdpb246OTk5MmNhNWZiMTM3NGRhODk4YmZmMmQyNDk4MjY3YjFfMjU3_02d052bb-1a18-44a1-9bca-0cb89dabd4a3">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw and packaging materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,074&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RhYmxlOjlhMmEyNmFlYzlkZTRiM2Q4M2ExZGNhYmEyOTU0MzZiL3RhYmxlcmFuZ2U6OWEyYTI2YWVjOWRlNGIzZDgzYTFkY2FiYTI5NTQzNmJfMS0xLTEtMS0w_ae5d1f93-4456-4ce1-8242-d73442b2b466"
      unitRef="usd">891000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RhYmxlOjlhMmEyNmFlYzlkZTRiM2Q4M2ExZGNhYmEyOTU0MzZiL3RhYmxlcmFuZ2U6OWEyYTI2YWVjOWRlNGIzZDgzYTFkY2FiYTI5NTQzNmJfMS0zLTEtMS0w_5b0100fc-125d-46e6-8cd4-0f08bcdebb24"
      unitRef="usd">932000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RhYmxlOjlhMmEyNmFlYzlkZTRiM2Q4M2ExZGNhYmEyOTU0MzZiL3RhYmxlcmFuZ2U6OWEyYTI2YWVjOWRlNGIzZDgzYTFkY2FiYTI5NTQzNmJfMi0xLTEtMS0w_e22bc4c6-1dea-4961-a5b4-01b8de7330ea"
      unitRef="usd">1852000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RhYmxlOjlhMmEyNmFlYzlkZTRiM2Q4M2ExZGNhYmEyOTU0MzZiL3RhYmxlcmFuZ2U6OWEyYTI2YWVjOWRlNGIzZDgzYTFkY2FiYTI5NTQzNmJfMi0zLTEtMS0w_527a2b20-d948-437a-a54d-56111cfaa617"
      unitRef="usd">2015000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RhYmxlOjlhMmEyNmFlYzlkZTRiM2Q4M2ExZGNhYmEyOTU0MzZiL3RhYmxlcmFuZ2U6OWEyYTI2YWVjOWRlNGIzZDgzYTFkY2FiYTI5NTQzNmJfMy0xLTEtMS0w_935d93f0-92c3-4a30-b6e4-b5f0841fd0c5"
      unitRef="usd">270000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RhYmxlOjlhMmEyNmFlYzlkZTRiM2Q4M2ExZGNhYmEyOTU0MzZiL3RhYmxlcmFuZ2U6OWEyYTI2YWVjOWRlNGIzZDgzYTFkY2FiYTI5NTQzNmJfMy0zLTEtMS0w_b3336f24-8bd4-4895-8596-cfd3d22a45a2"
      unitRef="usd">207000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <bmy:Totalinventories
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RhYmxlOjlhMmEyNmFlYzlkZTRiM2Q4M2ExZGNhYmEyOTU0MzZiL3RhYmxlcmFuZ2U6OWEyYTI2YWVjOWRlNGIzZDgzYTFkY2FiYTI5NTQzNmJfNC0xLTEtMS0w_6db8076a-08e6-4735-aaae-eaacadb70c60"
      unitRef="usd">3013000000</bmy:Totalinventories>
    <bmy:Totalinventories
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RhYmxlOjlhMmEyNmFlYzlkZTRiM2Q4M2ExZGNhYmEyOTU0MzZiL3RhYmxlcmFuZ2U6OWEyYTI2YWVjOWRlNGIzZDgzYTFkY2FiYTI5NTQzNmJfNC0zLTEtMS0w_ecdfa645-dc87-444b-a49b-b5271d0a7a12"
      unitRef="usd">3154000000</bmy:Totalinventories>
    <us-gaap:InventoryNet
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RhYmxlOjlhMmEyNmFlYzlkZTRiM2Q4M2ExZGNhYmEyOTU0MzZiL3RhYmxlcmFuZ2U6OWEyYTI2YWVjOWRlNGIzZDgzYTFkY2FiYTI5NTQzNmJfNi0xLTEtMS0w_032f8c46-2853-41e4-b1d8-67521bf5d361"
      unitRef="usd">2137000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RhYmxlOjlhMmEyNmFlYzlkZTRiM2Q4M2ExZGNhYmEyOTU0MzZiL3RhYmxlcmFuZ2U6OWEyYTI2YWVjOWRlNGIzZDgzYTFkY2FiYTI5NTQzNmJfNi0zLTEtMS0w_f3584fa6-fa80-4900-8d26-c74c75b0cdd7"
      unitRef="usd">2074000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNoncurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RhYmxlOjlhMmEyNmFlYzlkZTRiM2Q4M2ExZGNhYmEyOTU0MzZiL3RhYmxlcmFuZ2U6OWEyYTI2YWVjOWRlNGIzZDgzYTFkY2FiYTI5NTQzNmJfNy0xLTEtMS0w_a1702756-d193-4141-9c16-89c80c7a7db7"
      unitRef="usd">876000000</us-gaap:InventoryNoncurrent>
    <us-gaap:InventoryNoncurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RhYmxlOjlhMmEyNmFlYzlkZTRiM2Q4M2ExZGNhYmEyOTU0MzZiL3RhYmxlcmFuZ2U6OWEyYTI2YWVjOWRlNGIzZDgzYTFkY2FiYTI5NTQzNmJfNy0zLTEtMS0w_95ee907f-bb72-4d6e-a82a-f59c1fed2b1a"
      unitRef="usd">1080000000</us-gaap:InventoryNoncurrent>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i930ff8105ccb4bfdb0a95257468399ad_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RleHRyZWdpb246OTk5MmNhNWZiMTM3NGRhODk4YmZmMmQyNDk4MjY3YjFfMTIx_6e1f10c1-dec4-4455-bef4-ddc48256aa15"
      unitRef="usd">606000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i4d1422bf6081497aa35d71735c851dc2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV82Ny9mcmFnOjk5OTJjYTVmYjEzNzRkYTg5OGJmZjJkMjQ5ODI2N2IxL3RleHRyZWdpb246OTk5MmNhNWZiMTM3NGRhODk4YmZmMmQyNDk4MjY3YjFfMTM0_361f835f-dda4-46a9-8028-cd6e159eb0c7"
      unitRef="usd">774000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RleHRyZWdpb246Nzg1ZDYwODI3NWJhNGFhYTgyOTMxN2UwMWEwZmExZTBfMTI4_716bb957-74e6-42f8-8fab-ef82bed7c561">PROPERTY, PLANT AND EQUIPMENT&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery, equipment and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense was $143 million and $278 million for the three and six months ended June&#160;30, 2021 and $145 million and $315 million for the three and six months ended June&#160;30, 2020, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RleHRyZWdpb246Nzg1ZDYwODI3NWJhNGFhYTgyOTMxN2UwMWEwZmExZTBfMTI1_7b1e2761-0069-4a76-a6ac-557a4b97131f">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery, equipment and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:Land
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfMS0xLTEtMS0w_9667b99e-7978-403c-828f-34daf3d6ca7b"
      unitRef="usd">169000000</us-gaap:Land>
    <us-gaap:Land
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfMS0zLTEtMS0w_9db7d592-b837-454a-9502-09df6eae74ec"
      unitRef="usd">189000000</us-gaap:Land>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfMi0xLTEtMS0w_5af97e6b-2308-4656-a5e5-0ece1d4e2853"
      unitRef="usd">5705000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfMi0zLTEtMS0w_281e5799-2b3b-43ea-89d0-5698d00a12f6"
      unitRef="usd">5732000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfMy0xLTEtMS0w_a58c17d3-4595-4a94-805c-b2737472a91a"
      unitRef="usd">3194000000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfMy0zLTEtMS0w_bef35ec6-e5a0-4f47-81f6-0de72df21366"
      unitRef="usd">3063000000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfNC0xLTEtMS0w_4a71e81d-e115-404b-b633-ba4f8ad0cea1"
      unitRef="usd">565000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfNC0zLTEtMS0w_aee3ddd0-23e0-478c-b8c2-68b610558e30"
      unitRef="usd">487000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfNS0xLTEtMS0w_fb52ea7b-d0fc-4b32-81fa-abca70907840"
      unitRef="usd">9633000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfNS0zLTEtMS0w_ec261b92-4826-403d-96bf-71a9772372b3"
      unitRef="usd">9471000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfNi0xLTEtMS0w_9a32b891-20b4-4e22-bbee-f80d4382e1de"
      unitRef="usd">3838000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfNi0zLTEtMS0w_17744ce5-f717-4920-88d9-6f11ba54da14"
      unitRef="usd">3585000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfNy0xLTEtMS0w_bfc4062e-27d4-4523-84ce-0ef643d1b438"
      unitRef="usd">5795000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RhYmxlOjNiZDA2YzNhMDc1YjQ5MTc5Y2Q0M2E1ZTBiYjJjN2M1L3RhYmxlcmFuZ2U6M2JkMDZjM2EwNzViNDkxNzljZDQzYTVlMGJiMmM3YzVfNy0zLTEtMS0w_045faca5-4f7c-4ecf-8107-dc9004245a28"
      unitRef="usd">5886000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RleHRyZWdpb246Nzg1ZDYwODI3NWJhNGFhYTgyOTMxN2UwMWEwZmExZTBfNzM_b264ed55-5cd1-4ee5-ab52-0c274cea10b7"
      unitRef="usd">143000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RleHRyZWdpb246Nzg1ZDYwODI3NWJhNGFhYTgyOTMxN2UwMWEwZmExZTBfMTA5OTUxMTYyNzk1Mw_1901405e-1b08-4aa4-82c5-2eafe25f1b1e"
      unitRef="usd">278000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RleHRyZWdpb246Nzg1ZDYwODI3NWJhNGFhYTgyOTMxN2UwMWEwZmExZTBfMTA5OTUxMTYyNzkxNw_71072c84-cf0c-40a7-ae32-a2cd75685388"
      unitRef="usd">145000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83MC9mcmFnOjc4NWQ2MDgyNzViYTRhYWE4MjkzMTdlMDFhMGZhMWUwL3RleHRyZWdpb246Nzg1ZDYwODI3NWJhNGFhYTgyOTMxN2UwMWEwZmExZTBfMTA5OTUxMTYyNzkzMA_30e50537-3d2c-45a5-9b8d-7c4b615ffe6d"
      unitRef="usd">315000000</us-gaap:Depreciation>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RleHRyZWdpb246ZGM0YWE3MzhkNWQzNGU3NDg2NWE5NjJmNjM5NDFmODVfODQy_18c3e03e-dba7-4bf3-b0f9-436b1456b468">GOODWILL AND OTHER INTANGIBLE ASSETS&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&#x2013;&#160;15&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired marketed product rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&#x2013;&#160;15&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&#x2013;&#160;10&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPRD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the six months ended June&#160;30, 2021, $1.5&#160;billion of IPRD was reclassified to acquired marketed product rights upon approval of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Breyanzi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Abecma&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the U.S. Amortization expense of other intangible assets was $2.5 billion and $5.1 billion for the three and six months ended June&#160;30, 2021 and $2.5 billion and $4.8 billion for the three and six months ended June&#160;30, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2021, a $230&#160;million IPRD impairment charge was recorded in Research and development expense following a decision to discontinue development of an investigational compound in connection with the prioritization of current pipeline opportunities. The compound was being studied as a potential treatment for fibrotic diseases and was acquired in the acquisition of Celgene. The charge represented a full write-down based on the estimated fair value determined using discounted cash flow projections.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2021, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Inrebic&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; EU regulatory approval milestones of $300&#160;million were achieved resulting in a $385&#160;million increase to the acquired marketed product rights intangible asset, after establishing the applicable deferred tax liability. An impairment charge of $315&#160;million was recognized in Cost of products sold as the carrying value of this asset exceeded the projected undiscounted cash flows of the asset. The charge was equal to the excess of the asset's carrying value over its estimated fair value using discounted cash flow projections.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RleHRyZWdpb246ZGM0YWE3MzhkNWQzNGU3NDg2NWE5NjJmNjM5NDFmODVfODMx_350f55ef-99ce-418b-9ca5-3f644620e526">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&#x2013;&#160;15&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired marketed product rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&#x2013;&#160;15&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&#x2013;&#160;10&#160;years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IPRD&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,739)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,616)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:Goodwill
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfMS0zLTEtMS0w_e5f3787a-b5b3-4e0c-bf23-df3e117e868d"
      unitRef="usd">20529000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfMS01LTEtMS0w_9ee18329-c19b-4abd-a430-3714653b4674"
      unitRef="usd">20547000000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i63f5d7d2d5cf421986ebe6aec3d0d063_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNC0xLTEtMS0wL3RleHRyZWdpb246ZjdjYzE0MDU3ZDQ2NDVjNWE4ZmM0ODA5YWYwY2FmMTBfNA_10e9a543-117e-4bc4-852e-be08d20c16c5">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="if78324cfda1641a185f98458b48b3ecb_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNC0xLTEtMS0wL3RleHRyZWdpb246ZjdjYzE0MDU3ZDQ2NDVjNWE4ZmM0ODA5YWYwY2FmMTBfOQ_76bc5d03-a405-43ce-8b25-7dcc8a120957">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="idc8f651960ff49fb8e4847dbc3db39c8_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNC0zLTEtMS0w_f2222419-8a6c-42ad-85a1-5e2fe30e51a9"
      unitRef="usd">327000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4a2b2474f0d2424ba498502d3afdf9ac_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNC01LTEtMS0w_1d3a20f8-222f-4731-91c2-825948bca7ab"
      unitRef="usd">328000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i5d8e439af78d4f5092229ec245f1b0a5_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNS0xLTEtMS0wL3RleHRyZWdpb246NTUzZTYwYzk5YjNjNGNhODg4Nzk4NWNlZDVhMzVlYWVfNA_b4474111-1f52-4aa8-9aa7-176afb3d985f">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i626ddd6ff5464b57a8e4e7c44e82a64a_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNS0xLTEtMS0wL3RleHRyZWdpb246NTUzZTYwYzk5YjNjNGNhODg4Nzk4NWNlZDVhMzVlYWVfOQ_c84a4a7d-7e3b-4c9c-b1dc-caba1d50511b">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i102ed3efbe22488096250a07cec1ae7c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNS0zLTEtMS0w_0441a409-ba2e-4415-9c50-abcfc9a72516"
      unitRef="usd">60712000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic566d16d5a584f8ba82df664242cf607_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNS01LTEtMS0w_172271bc-7b0c-483f-b942-f78ed14228ce"
      unitRef="usd">59076000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i5e217c9f1d8b4cc69ebcdebb33546c57_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNi0xLTEtMS0wL3RleHRyZWdpb246MGVjZTg1YmNhY2M2NGI0MDhlMzQ3OWQxOGUzMTA1Y2RfNA_0ee70999-5019-4dcb-b698-4a1489ea4179">P3Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i56178daf0b264e019ba2dccbd26473ad_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNi0xLTEtMS0wL3RleHRyZWdpb246MGVjZTg1YmNhY2M2NGI0MDhlMzQ3OWQxOGUzMTA1Y2RfOQ_0983f3ae-2c67-479a-9a7c-f598ab0443c9">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i815f8cb9efb94a46b64a44a73c8875bc_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNi0zLTEtMS0w_10ad6c31-52d5-4332-aff5-23c726e52ef5"
      unitRef="usd">1405000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4cef45113fe040d78e64dcc2d006f97b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNi01LTEtMS0w_2a064ca5-4ee1-4e6f-98c6-d06496b3a96a"
      unitRef="usd">1325000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i4d6ab1d8fecd41948785ff0b6c9a68b3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNy0zLTEtMS0w_2b1ccf41-6d58-438b-9a90-4580b7604c80"
      unitRef="usd">4360000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i290ccdb912fe48f08d595add1473c16b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfNy01LTEtMS0w_bd8559df-e92b-4ee7-b6b7-80a5d2ec5a32"
      unitRef="usd">6130000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfOC0zLTEtMS0w_e2d04002-e69d-49cb-89d3-1263982a4d6a"
      unitRef="usd">66804000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfOC01LTEtMS0w_72ae9013-1fbe-49cd-b17c-db5a8d421e39"
      unitRef="usd">66859000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfOS0zLTEtMS0w_f93dbda3-e0c5-4b84-afe0-c05800dacccd"
      unitRef="usd">18739000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfOS01LTEtMS0w_d3d3a1a4-ca27-4621-ae2a-889f11e6beff"
      unitRef="usd">13616000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfMTAtMy0xLTEtMA_d6d84ea2-fc03-4c5d-ba37-6350ad33046f"
      unitRef="usd">48065000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RhYmxlOmJjZWMwNzlmMzM2YjQ4NjI5OWYxMmU4OGRhZjllMTVhL3RhYmxlcmFuZ2U6YmNlYzA3OWYzMzZiNDg2Mjk5ZjEyZTg4ZGFmOWUxNWFfMTAtNS0xLTEtMA_0d5abaec-210e-4b2e-a11d-d953ebab26db"
      unitRef="usd">53243000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <bmy:AcquiredDevelopedProductRightsReclassedFromIPRD
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RleHRyZWdpb246ZGM0YWE3MzhkNWQzNGU3NDg2NWE5NjJmNjM5NDFmODVfODU_ca052351-7e09-4355-9148-b75dffa75d61"
      unitRef="usd">1500000000</bmy:AcquiredDevelopedProductRightsReclassedFromIPRD>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RleHRyZWdpb246ZGM0YWE3MzhkNWQzNGU3NDg2NWE5NjJmNjM5NDFmODVfMjUw_6ac6c03f-0b1c-4ed6-8b66-d5260cab3cf1"
      unitRef="usd">2500000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RleHRyZWdpb246ZGM0YWE3MzhkNWQzNGU3NDg2NWE5NjJmNjM5NDFmODVfMTA5OTUxMTYyODY3Mw_74359d75-462f-407d-8a0f-3bc8ecc65208"
      unitRef="usd">5100000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RleHRyZWdpb246ZGM0YWE3MzhkNWQzNGU3NDg2NWE5NjJmNjM5NDFmODVfMTA5OTUxMTYyODY0NA_52a440ee-9ff4-40cb-af2e-c089303fecb0"
      unitRef="usd">2500000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RleHRyZWdpb246ZGM0YWE3MzhkNWQzNGU3NDg2NWE5NjJmNjM5NDFmODVfMTA5OTUxMTYyODYyOQ_754970bb-2bb4-48a6-8f07-456ec681d798"
      unitRef="usd">4800000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i52bd0855efcc4aeeae1fe88706edf18e_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RleHRyZWdpb246ZGM0YWE3MzhkNWQzNGU3NDg2NWE5NjJmNjM5NDFmODVfMjE5OTAyMzI1ODA3NQ_9d3c2164-619a-47f6-a5e1-1027bf5879eb"
      unitRef="usd">230000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <bmy:ContingentAndRegulatoryMilestoneNonCash
      contextRef="ieff455ef39df4956a451fdaf9767810c_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RleHRyZWdpb246ZGM0YWE3MzhkNWQzNGU3NDg2NWE5NjJmNjM5NDFmODVfMzcy_17e5bad1-f3aa-4d29-a1a5-a7628db4acc7"
      unitRef="usd">300000000</bmy:ContingentAndRegulatoryMilestoneNonCash>
    <us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease
      contextRef="i640a43d1b691485e977b3192bef77d58_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RleHRyZWdpb246ZGM0YWE3MzhkNWQzNGU3NDg2NWE5NjJmNjM5NDFmODVfNDA0_eaf6b4be-a2f7-41c7-9fe8-fd211d86976d"
      unitRef="usd">385000000</us-gaap:FiniteLivedIntangibleAssetsPeriodIncreaseDecrease>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
      contextRef="i640a43d1b691485e977b3192bef77d58_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83Ni9mcmFnOmRjNGFhNzM4ZDVkMzRlNzQ4NjVhOTYyZjYzOTQxZjg1L3RleHRyZWdpb246ZGM0YWE3MzhkNWQzNGU3NDg2NWE5NjJmNjM5NDFmODVfNTU2_2dd5eecd-4677-4ed9-8513-7c144bb194e1"
      unitRef="usd">315000000</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:AdditionalFinancialInformationDisclosureTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RleHRyZWdpb246ZTFlYTgxODdiMzg5NDA5NWFkZDkxMGRmYThkMzBiNmNfMzk4_8103c2b6-ba11-4114-8fbf-88166098afa6">SUPPLEMENTAL FINANCIAL INFORMATION&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Restricted cash consists of funds restricted for annual Company contributions to the defined contribution plan in the U.S. and escrow for litigation settlements. Restricted cash of $373 million at June&#160;30, 2021 and $428&#160;million at June&#160;30, 2020 was included in cash, cash equivalents and restricted cash in the consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates and returns&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent value rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RleHRyZWdpb246ZTFlYTgxODdiMzg5NDA5NWFkZDkxMGRmYThkMzBiNmNfNDA2_a7603052-dd20-418c-b3a7-4b6238510600">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock>
    <us-gaap:PrepaidTaxes
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmNmZDNjN2MxNGU0YTQyMmFiYmU0NTE0YWJmMDJmNTRhL3RhYmxlcmFuZ2U6Y2ZkM2M3YzE0ZTRhNDIyYWJiZTQ1MTRhYmYwMmY1NGFfMS0xLTEtMS0w_3ea898ad-2499-4981-8440-a46388d88c61"
      unitRef="usd">2258000000</us-gaap:PrepaidTaxes>
    <us-gaap:PrepaidTaxes
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmNmZDNjN2MxNGU0YTQyMmFiYmU0NTE0YWJmMDJmNTRhL3RhYmxlcmFuZ2U6Y2ZkM2M3YzE0ZTRhNDIyYWJiZTQ1MTRhYmYwMmY1NGFfMS0zLTEtMS0w_32cd6d31-7314-4f7f-b0d0-11d8fb79157b"
      unitRef="usd">1799000000</us-gaap:PrepaidTaxes>
    <bmy:ResearchandDevelopment
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmNmZDNjN2MxNGU0YTQyMmFiYmU0NTE0YWJmMDJmNTRhL3RhYmxlcmFuZ2U6Y2ZkM2M3YzE0ZTRhNDIyYWJiZTQ1MTRhYmYwMmY1NGFfMi0xLTEtMS0w_e37f3c8e-bffd-49ce-b330-1a07c84b3062"
      unitRef="usd">576000000</bmy:ResearchandDevelopment>
    <bmy:ResearchandDevelopment
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmNmZDNjN2MxNGU0YTQyMmFiYmU0NTE0YWJmMDJmNTRhL3RhYmxlcmFuZ2U6Y2ZkM2M3YzE0ZTRhNDIyYWJiZTQ1MTRhYmYwMmY1NGFfMi0zLTEtMS0w_87bd084e-f886-41de-a2c3-425996b8be92"
      unitRef="usd">492000000</bmy:ResearchandDevelopment>
    <bmy:EquityInvestmentsCurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmNmZDNjN2MxNGU0YTQyMmFiYmU0NTE0YWJmMDJmNTRhL3RhYmxlcmFuZ2U6Y2ZkM2M3YzE0ZTRhNDIyYWJiZTQ1MTRhYmYwMmY1NGFfMy0xLTEtMS0w_d6923c77-d99a-4790-875a-7b5525cc0fc5"
      unitRef="usd">1046000000</bmy:EquityInvestmentsCurrent>
    <bmy:EquityInvestmentsCurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmNmZDNjN2MxNGU0YTQyMmFiYmU0NTE0YWJmMDJmNTRhL3RhYmxlcmFuZ2U6Y2ZkM2M3YzE0ZTRhNDIyYWJiZTQ1MTRhYmYwMmY1NGFfMy0zLTEtMS0w_4f34a8a9-1076-44f1-b435-414536da96e6"
      unitRef="usd">619000000</bmy:EquityInvestmentsCurrent>
    <us-gaap:RestrictedCash
      contextRef="i934da5addaea4028be7894d0babddfe5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmNmZDNjN2MxNGU0YTQyMmFiYmU0NTE0YWJmMDJmNTRhL3RhYmxlcmFuZ2U6Y2ZkM2M3YzE0ZTRhNDIyYWJiZTQ1MTRhYmYwMmY1NGFfNC0xLTEtMS0w_45beff5c-3c6a-48c6-9f01-e30207b41d6e"
      unitRef="usd">174000000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="i11d3b9fc864643c6963d52987b8077d1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmNmZDNjN2MxNGU0YTQyMmFiYmU0NTE0YWJmMDJmNTRhL3RhYmxlcmFuZ2U6Y2ZkM2M3YzE0ZTRhNDIyYWJiZTQ1MTRhYmYwMmY1NGFfNC0zLTEtMS0w_0927c470-b4b6-4678-88d6-990b7eaf7b09"
      unitRef="usd">89000000</us-gaap:RestrictedCash>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmNmZDNjN2MxNGU0YTQyMmFiYmU0NTE0YWJmMDJmNTRhL3RhYmxlcmFuZ2U6Y2ZkM2M3YzE0ZTRhNDIyYWJiZTQ1MTRhYmYwMmY1NGFfNS0xLTEtMS0w_b9d8eea4-b7d5-4cf9-9159-a2f86f7140ab"
      unitRef="usd">983000000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmNmZDNjN2MxNGU0YTQyMmFiYmU0NTE0YWJmMDJmNTRhL3RhYmxlcmFuZ2U6Y2ZkM2M3YzE0ZTRhNDIyYWJiZTQ1MTRhYmYwMmY1NGFfNS0zLTEtMS0w_8171db65-b50e-40c4-878d-69ae84b985e1"
      unitRef="usd">787000000</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmNmZDNjN2MxNGU0YTQyMmFiYmU0NTE0YWJmMDJmNTRhL3RhYmxlcmFuZ2U6Y2ZkM2M3YzE0ZTRhNDIyYWJiZTQ1MTRhYmYwMmY1NGFfNi0xLTEtMS0w_b3e1a7fa-15d5-4f65-8b84-3120e3399a56"
      unitRef="usd">5037000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmNmZDNjN2MxNGU0YTQyMmFiYmU0NTE0YWJmMDJmNTRhL3RhYmxlcmFuZ2U6Y2ZkM2M3YzE0ZTRhNDIyYWJiZTQ1MTRhYmYwMmY1NGFfNi0zLTEtMS0w_c0fc3290-ac99-409c-8008-456099e1c4fa"
      unitRef="usd">3786000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RleHRyZWdpb246ZTFlYTgxODdiMzg5NDA5NWFkZDkxMGRmYThkMzBiNmNfMzky_d45721eb-cf09-4a49-9c90-28ed9d087b97">&lt;div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Restricted cash consists of funds restricted for annual Company contributions to the defined contribution plan in the U.S. and escrow for litigation settlements. Restricted cash of $373 million at June&#160;30, 2021 and $428&#160;million at June&#160;30, 2020 was included in cash, cash equivalents and restricted cash in the consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock>
    <bmy:EquityInvestmentsNonCurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfMS0xLTEtMS0w_9aa40600-6a48-4357-824c-fe7b92f14f4f"
      unitRef="usd">3622000000</bmy:EquityInvestmentsNonCurrent>
    <bmy:EquityInvestmentsNonCurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfMS0zLTEtMS0w_9f7dccec-cfad-4f8a-ba60-71d8ddf261a0"
      unitRef="usd">4076000000</bmy:EquityInvestmentsNonCurrent>
    <us-gaap:InventoryNoncurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfMi0xLTEtMS0w_5153ba19-03d5-457e-8208-a6746c4fafc5"
      unitRef="usd">876000000</us-gaap:InventoryNoncurrent>
    <us-gaap:InventoryNoncurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfMi0zLTEtMS0w_1eef57de-8365-4e74-a02b-89583f3ec6b0"
      unitRef="usd">1080000000</us-gaap:InventoryNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfMy0xLTEtMS0w_b37998e8-2fcb-4898-81be-625b860e6671"
      unitRef="usd">1006000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfMy0zLTEtMS0w_d4886091-950c-4446-b6cc-e95912c178a2"
      unitRef="usd">859000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfNC0xLTEtMS0w_97a17c2f-1a4c-410c-b59a-3d3818b40f0a"
      unitRef="usd">234000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfNC0zLTEtMS0w_cd1e5f0d-fb70-495d-8e6b-7b2954b53580"
      unitRef="usd">208000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfNS0xLTEtMS0w_c4433135-4f49-4580-b08c-a7e55f81a939"
      unitRef="usd">199000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfNS0zLTEtMS0w_0aba5669-a3ec-4346-beb5-401f64d8d70a"
      unitRef="usd">338000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfNi0xLTEtMS0w_3c4700ec-b681-4a4b-81cc-be06bff1098c"
      unitRef="usd">517000000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfNi0zLTEtMS0w_e44d3aaa-846c-4e81-ab53-731c7b0256b3"
      unitRef="usd">458000000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfNy0xLTEtMS0w_420fa375-10db-4560-a584-7b9ad56331ab"
      unitRef="usd">6454000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjYyMmJiOGEzZDU5MDQ0NjI5NGMwMmIwNjkzZDI2NDk0L3RhYmxlcmFuZ2U6NjIyYmI4YTNkNTkwNDQ2Mjk0YzAyYjA2OTNkMjY0OTRfNy0zLTEtMS0w_e619cb49-f5ee-445c-9273-46f6b120bd8d"
      unitRef="usd">7019000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:RestrictedCash
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RleHRyZWdpb246ZTFlYTgxODdiMzg5NDA5NWFkZDkxMGRmYThkMzBiNmNfMjQy_0351fb18-a4df-4a94-9d42-370ccf2c7ac3"
      unitRef="usd">373000000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="i711a50adb808497c9daf76647502dad6_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RleHRyZWdpb246ZTFlYTgxODdiMzg5NDA5NWFkZDkxMGRmYThkMzBiNmNfMjU1_cb5bda2e-7078-434e-bbba-d1df214ed6a4"
      unitRef="usd">428000000</us-gaap:RestrictedCash>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RleHRyZWdpb246ZTFlYTgxODdiMzg5NDA5NWFkZDkxMGRmYThkMzBiNmNfMzk3_6d02b977-f346-4e4d-8983-277b1857794d">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rebates and returns&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalties&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent value rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <bmy:AccruedRebatesAndReturns
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfMS0xLTEtMS0w_a1fe1bce-5321-4127-a9d0-bd66be2bafd9"
      unitRef="usd">5665000000</bmy:AccruedRebatesAndReturns>
    <bmy:AccruedRebatesAndReturns
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfMS0zLTEtMS0w_af67b859-7ad1-45da-8449-18a94665bd46"
      unitRef="usd">5688000000</bmy:AccruedRebatesAndReturns>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfMi0xLTEtMS0w_d1409e7a-fcf9-4bee-8cf4-abc3fbdca032"
      unitRef="usd">638000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfMi0zLTEtMS0w_702a30ea-1878-41b7-b650-fcda8d047af9"
      unitRef="usd">647000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfMy0xLTEtMS0w_4488a901-cfe2-4328-884a-f762e211f160"
      unitRef="usd">896000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfMy0zLTEtMS0w_3be9d4c7-27a3-45c4-b655-99927e174d7d"
      unitRef="usd">1412000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <bmy:AccruedResearchAndDevelopment
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfNC0xLTEtMS0w_f23feb13-e449-47e4-903c-eee426c25047"
      unitRef="usd">1469000000</bmy:AccruedResearchAndDevelopment>
    <bmy:AccruedResearchAndDevelopment
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfNC0zLTEtMS0w_0fbb18c6-8f56-4fcd-89ab-8e0278994da2"
      unitRef="usd">1423000000</bmy:AccruedResearchAndDevelopment>
    <us-gaap:DividendsPayableCurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfNS0xLTEtMS0w_feab83b4-2d5c-4388-bb85-83409dfcfa6a"
      unitRef="usd">1107000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfNS0zLTEtMS0w_c2b778e4-fb29-432c-bc93-fd968d771a19"
      unitRef="usd">1129000000</us-gaap:DividendsPayableCurrent>
    <bmy:AccruedInterest
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfNi0xLTEtMS0w_7ae80f1e-6804-408d-bf4c-e0de403b121f"
      unitRef="usd">373000000</bmy:AccruedInterest>
    <bmy:AccruedInterest
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfNi0zLTEtMS0w_4d811496-4dbe-4e5b-8c3a-9f06fe588eaa"
      unitRef="usd">434000000</bmy:AccruedInterest>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfNy0xLTEtMS0w_bd528e88-118b-40cc-8678-81ad7e4a5658"
      unitRef="usd">386000000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:AccruedRoyaltiesCurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfNy0zLTEtMS0w_05c1eca8-b336-432d-a108-11ee0b131777"
      unitRef="usd">461000000</us-gaap:AccruedRoyaltiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfOC0xLTEtMS0w_9cbcefbc-7139-49c8-8eb9-5d6d9eb9f5a4"
      unitRef="usd">173000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfOC0zLTEtMS0w_05db83fd-cc80-4744-87fd-1264c154ea83"
      unitRef="usd">164000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i740f1c260f5842e38801cdbe44935148_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfOS0xLTEtMS0w_7623f89d-853d-4b1c-91de-618ee5051827"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i067540008559441b824143d0812aef90_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfOS0zLTEtMS0w_af7d7ece-594a-4da9-bfd5-860d2f9e7b7d"
      unitRef="usd">515000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfMTAtMS0xLTEtMA_a752218a-864b-4098-884e-61d8962229e1"
      unitRef="usd">2020000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfMTAtMy0xLTEtMA_9d5f2592-ba47-4a3b-a496-a2b8a05ffd80"
      unitRef="usd">2154000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfMTEtMS0xLTEtMA_ba749d42-6cc0-46cd-99b2-09640527fb26"
      unitRef="usd">12727000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOjJjOTBiMWFlNmRjMjRlYmI5YjA4MjRlZjg0ZjVmYjZhL3RhYmxlcmFuZ2U6MmM5MGIxYWU2ZGMyNGViYjliMDgyNGVmODRmNWZiNmFfMTEtMy0xLTEtMA_35096a1c-7c63-4d4f-b167-b6e12214a757"
      unitRef="usd">14027000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RleHRyZWdpb246ZTFlYTgxODdiMzg5NDA5NWFkZDkxMGRmYThkMzBiNmNfNDA0_ffa6dc5c-9a7a-464a-8061-9de014a7ba6c">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfMS0xLTEtMS0w_bc939634-358a-4186-a0a0-8f23c87ead67"
      unitRef="usd">4690000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfMS0zLTEtMS0w_4a52c32a-8b55-4ef8-8633-07f2762b93ec"
      unitRef="usd">5017000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfMi0xLTEtMS0w_ad30ec3b-02bb-4891-a74e-b1c2fdfdf203"
      unitRef="usd">838000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfMi0zLTEtMS0w_0abb7302-3ffd-493d-a75b-49417bba2174"
      unitRef="usd">899000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfMy0xLTEtMS0w_0c7556e6-b6f5-4a91-a2b4-bdfcf1e03466"
      unitRef="usd">962000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfMy0zLTEtMS0w_fdb5d31d-861d-4ce4-87bc-08707da4318b"
      unitRef="usd">833000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredIncomeNoncurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfNC0xLTEtMS0w_89159b6b-05f7-4dee-98ab-c5b5752dbbd4"
      unitRef="usd">324000000</us-gaap:DeferredIncomeNoncurrent>
    <us-gaap:DeferredIncomeNoncurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfNC0zLTEtMS0w_d4fe58d1-511f-4197-883d-d9c65d63f6b6"
      unitRef="usd">357000000</us-gaap:DeferredIncomeNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfNS0xLTEtMS0w_53e3cbdf-d4fb-4cab-aa24-e94293a59a5d"
      unitRef="usd">416000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfNS0zLTEtMS0w_176a2266-eb34-4815-bf29-ca505f3ab96d"
      unitRef="usd">344000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfNi0xLTEtMS0w_98e77e71-409d-420d-9641-b764ad05f503"
      unitRef="usd">268000000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfNi0zLTEtMS0w_a06e3088-8475-4113-8d85-c35872a72821"
      unitRef="usd">326000000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfNy0xLTEtMS0w_d7c3526b-ed04-45da-a742-d11956b2cd58"
      unitRef="usd">7498000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV83OS9mcmFnOmUxZWE4MTg3YjM4OTQwOTVhZGQ5MTBkZmE4ZDMwYjZjL3RhYmxlOmVmNzJmYzljMDU4NTRlNjhhZTQ1MTIxZTdlMTM4NDA0L3RhYmxlcmFuZ2U6ZWY3MmZjOWMwNTg1NGU2OGFlNDUxMjFlN2UxMzg0MDRfNy0zLTEtMS0w_d64ef0dd-ed8c-46ca-af9d-c4affaeefffe"
      unitRef="usd">7776000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMTU1Mw_3798661f-a2a5-49a5-8778-d1b95535ee09">EQUITY&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in equity for the six months ended June 30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Capital&#160;in Excess of Par Value of&#160;Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars and Shares in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(473)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,544)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,091)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,235)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,518)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $0.49 for the three months ended March 31, 2021 and June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in equity for the six months ended June 30, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Capital&#160;in Excess of Par Value of&#160;Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars and Shares in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(775)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,028)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(455)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,757)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $0.45 for the three months ended March 31, 2020 and June&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS has a share repurchase program, authorized by its Board of Directors, allowing for repurchases of its shares. The share repurchase program does not obligate us to repurchase any specific number of shares, does not have a specific expiration date and may be suspended or discontinued at any time. Treasury stock is recognized at the cost to reacquire the shares. Shares issued from treasury are recognized utilizing the first-in first-out method.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The outstanding share repurchase authority authorization under the program was $4.4 billion as of December 31, 2020. In January 2021, the Board of Directors approved an increase of $2.0&#160;billion to the share repurchase authorization for BMS&#x2019;s common stock. BMS repurchased approximately 47 million shares of its common stock for $3.0 billion during the six months ended June&#160;30, 2021. The remaining share repurchase capacity under the share repurchase program was approximately $3.4 billion as of June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS repurchased 1.4&#160;million shares of its common stock for $81&#160;million in the six months ended June&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2019, BMS executed accelerated share repurchase (&#x201c;ASR&#x201d;) agreements to repurchase an aggregate $7&#160;billion of common stock. The ASR was funded with cash on-hand. In the fourth quarter of 2019, approximately 99&#160;million shares of common stock (80% of the $7&#160;billion aggregate repurchase price) were received by BMS and included in treasury stock. In the second quarter of 2020, the agreement was settled and approximately 16&#160;million shares of common stock were received by BMS and transferred to treasury stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of Other Comprehensive Income/(Loss) were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;After&#160;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;After&#160;Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gain/(losses)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to net earnings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains/(losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Realized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;After&#160;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;After&#160;Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gain/(losses)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to net earnings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains/(losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Realized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt"&gt;Included in Cost of products sold.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accumulated balances related to each component of Other Comprehensive Income/(Loss), net of taxes, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(936)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(974)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(638)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,518)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityTableTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMTU1OA_e69b5f9c-e477-4e6a-a6d8-e570cbc3941f">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in equity for the six months ended June 30, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Capital&#160;in Excess of Par Value of&#160;Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars and Shares in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,098)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,768)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(473)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,544)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,199)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,091)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,235)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,518)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $0.49 for the three months ended March 31, 2021 and June&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes changes in equity for the six months ended June 30, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.302%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.860%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Capital&#160;in Excess of Par Value of&#160;Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Retained Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Treasury Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Noncontrolling Interest&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars and Shares in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Par&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(775)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,028)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(455)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,757)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash dividends declared&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,021)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock repurchase program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,556)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25,651)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $0.45 for the three months ended March 31, 2020 and June&#160;30, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityTableTextBlock>
    <us-gaap:SharesIssued
      contextRef="if693f3f9e803446e93591493d837c4d2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMi0xLTEtMS0w_98fdc0d5-bf24-4c6c-8220-cdbb2f462439"
      unitRef="shares">2923000000</us-gaap:SharesIssued>
    <us-gaap:CommonStockValue
      contextRef="if693f3f9e803446e93591493d837c4d2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMi0zLTEtMS0w_1ed3750d-715c-4236-9a01-73904f363125"
      unitRef="usd">292000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i5e5310947a3340a3a0bcf32e64131e15_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMi01LTEtMS0w_56ec4a4a-8d88-40d6-8e14-bc411b098b1f"
      unitRef="usd">44325000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic2634a7150984700b4940996575435e4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMi03LTEtMS0w_8c7f4c1e-fd13-4631-ad4a-ce70a76585a7"
      unitRef="usd">-1839000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i6796f93ba1454a58aa1ce90e9373d79e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMi05LTEtMS0w_036f2f85-338d-4f65-849e-c2ddfda1f6f5"
      unitRef="usd">21281000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares
      contextRef="ib3a03601e6ad43e8a39684c20e526fc0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMi0xMS0xLTEtMA_181cf245-0871-460f-a525-619103e2b0af"
      unitRef="shares">679000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="ib3a03601e6ad43e8a39684c20e526fc0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMi0xMy0xLTEtMA_507db415-b9b1-48d2-8d44-90b628cb2182"
      unitRef="usd">26237000000</us-gaap:TreasuryStockValue>
    <us-gaap:MinorityInterest
      contextRef="iab66f12d5bc4445bbf732048a5db1c7c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMi0xNS0xLTEtMA_ec3c2eb3-04cd-413e-a6f0-7d8576029766"
      unitRef="usd">60000000</us-gaap:MinorityInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i0bb4376df4e144078f75533316d9e77e_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMy05LTEtMS0w_b8091bef-aaee-4945-8d2f-2e1fe04030ed"
      unitRef="usd">2021000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6c3370e41cf9405a9a160e64209a8f68_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMy0xNS0xLTEtMA_035b92e6-7805-43c1-98c2-7569eca21442"
      unitRef="usd">-8000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1d8bd1acba944731b23be9a517a5eeb0_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfNC03LTEtMS0w_db00e584-119f-40be-bdfa-d197435a9546"
      unitRef="usd">295000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i0bb4376df4e144078f75533316d9e77e_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfNS05LTEtMS0w_46087d9f-ba2a-4b5c-b7b0-d9f17f82749b"
      unitRef="usd">1098000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ice500bf4ba6c4e908a4b5c93b15b7a60_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfNi0xMS0xLTEtMA_ee318bec-bfd0-444d-bb0e-6aafcb4d4238"
      unitRef="shares">28000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ice500bf4ba6c4e908a4b5c93b15b7a60_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfNi0xMy0xLTEtMA_672f95bb-f960-4ee3-8f9e-ee615faaf954"
      unitRef="usd">1768000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockholdersEquityOther
      contextRef="i2be8a05661504ad99b17ef9c22efd9f7_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfNy01LTEtMS0w_7cfc3cc8-4b7c-47eb-9c09-7ba9b853ba06"
      unitRef="usd">473000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ice500bf4ba6c4e908a4b5c93b15b7a60_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfNy0xMS0xLTEtMA_5c12f8bf-2998-45bb-b0b8-8cc6e8e24b17"
      unitRef="shares">-15000000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ice500bf4ba6c4e908a4b5c93b15b7a60_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfNy0xMy0xLTEtMA_3d2dea02-ae2d-4838-80e3-aeab07c6f8ba"
      unitRef="usd">806000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesIssued
      contextRef="ib89fb11161f146d2a6fb0b08fa2ddbd7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfOS0xLTEtMS0w_9fa4d2c0-9cf1-4dbc-97ed-a4142a420430"
      unitRef="shares">2923000000</us-gaap:SharesIssued>
    <us-gaap:CommonStockValue
      contextRef="ib89fb11161f146d2a6fb0b08fa2ddbd7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfOS0zLTEtMS0w_61e5c9c1-6e5b-45cd-8b15-c1bb8c0a07f2"
      unitRef="usd">292000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i60e4a51934264054a72db8bb72b4bc16_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfOS01LTEtMS0w_07e6efb1-89a0-47b9-b95e-0e4975e7773d"
      unitRef="usd">43852000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ief956f040cf142c48a760f89d051c7ba_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfOS03LTEtMS0w_3deadf2d-00b6-4ac7-8a48-69bad2c99eae"
      unitRef="usd">-1544000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i4a550b5d610e43ddacb1196fc31b2232_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfOS05LTEtMS0w_303ea937-ff85-4213-9347-1626a622e205"
      unitRef="usd">22204000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares
      contextRef="i01588a18f30f4fa1ad0bd69b5101f669_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfOS0xMS0xLTEtMA_03e0fa4e-22aa-4269-ae2a-364113e1a062"
      unitRef="shares">692000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i01588a18f30f4fa1ad0bd69b5101f669_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfOS0xMy0xLTEtMA_50834b13-c743-4eeb-af91-dd3ded8ef0ef"
      unitRef="usd">27199000000</us-gaap:TreasuryStockValue>
    <us-gaap:MinorityInterest
      contextRef="i3e1bc2ac43bb413ca28382700af763ae_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfOS0xNS0xLTEtMA_7a1ef1e0-84e9-47bd-90bb-1b2537372da5"
      unitRef="usd">68000000</us-gaap:MinorityInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i1a4b6a65d77842f48e59e61b100ac7d3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTAtOS0xLTEtMA_9aa95e75-8d0b-4fc4-8b5b-6455551c852e"
      unitRef="usd">1055000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i9407dc04bd514a50a293bf46404d43d3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTAtMTUtMS0xLTA_ed2cc7b7-38f6-4163-8737-82e559f16d0c"
      unitRef="usd">-6000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id929872bbc96437d9c359988e5567a7c_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTEtNy0xLTEtMA_b773d7ad-b426-4fe6-9a47-8903d4cf6a97"
      unitRef="usd">26000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i1a4b6a65d77842f48e59e61b100ac7d3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTItOS0xLTEtMA_0ca76b55-5ea5-4602-b583-b9c77be7d279"
      unitRef="usd">1091000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i2148fb9192764819b1bc0f8addaa98cb_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTMtMTEtMS0xLTA_a1b875d2-e3f3-4d2a-bcf0-e8605379dad8"
      unitRef="shares">19000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i2148fb9192764819b1bc0f8addaa98cb_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTMtMTMtMS0xLTA_3a3e30a7-f604-4865-b31d-2e363e8870d7"
      unitRef="usd">1235000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockholdersEquityOther
      contextRef="i0a9500eccacc46d69322333bfa03f25d_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTQtNS0xLTEtMA_95e0de11-ee49-4a44-9b2c-e13bfd8bf783"
      unitRef="usd">-212000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i2148fb9192764819b1bc0f8addaa98cb_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTQtMTEtMS0xLTA_89623b56-3b08-4d5a-941e-a4690a199010"
      unitRef="shares">-10000000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i2148fb9192764819b1bc0f8addaa98cb_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTQtMTMtMS0xLTA_72d95aea-46ab-4829-8b2c-5b6024ad4507"
      unitRef="usd">236000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i9407dc04bd514a50a293bf46404d43d3_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTUtMTUtMS0xLTA_c22193ae-c5b6-4b34-9a2e-dc8050903210"
      unitRef="usd">8000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:SharesIssued
      contextRef="i60767f8375e34e8a8c2ea7e77e7f3ec5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTYtMS0xLTEtMjEwOA_254a8583-8718-410e-9e65-4ae1da8dd1ed"
      unitRef="shares">2923000000</us-gaap:SharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i60767f8375e34e8a8c2ea7e77e7f3ec5_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTYtMy0xLTEtMjEwOA_bc9ac7f3-a0f1-4263-866d-c84ee69df3b7"
      unitRef="usd">292000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ied5e0053e2f04982aa1a2cd60b3e95b3_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTYtNS0xLTEtMjEwOA_52e139f1-7655-4321-906b-fbe558e63b91"
      unitRef="usd">44064000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i0daf74a0447c4e5786bd5ce58b6cc832_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTYtNy0xLTEtMjEwOA_a3b06d5a-60d6-4c66-8d2c-4cc816b713ae"
      unitRef="usd">-1518000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i737d30e7e58d4ea790fbbd242d2423fd_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTYtOS0xLTEtMjEwOA_167a62e4-99fe-4bc2-b4b9-d01037be64d7"
      unitRef="usd">22168000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares
      contextRef="i4bffcc25a557427c9a4c65a954674dca_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTYtMTEtMS0xLTIxMDg_cb1e9590-90f1-490e-b33f-751e43dcfa39"
      unitRef="shares">701000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i4bffcc25a557427c9a4c65a954674dca_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTYtMTMtMS0xLTIxMDg_2a58d506-add5-4a6b-9510-d795b938f480"
      unitRef="usd">28198000000</us-gaap:TreasuryStockValue>
    <us-gaap:MinorityInterest
      contextRef="i43239b9f5ca7485fa0251240b365648a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjA3YWMzMmI0NjQzZDQ4ZGQ4NjYxNmE1NTViNGEzYjIxL3RhYmxlcmFuZ2U6MDdhYzMyYjQ2NDNkNDhkZDg2NjE2YTU1NWI0YTNiMjFfMTYtMTUtMS0xLTIxMDg_1e66821f-dacc-408d-a9c0-eece5cd76947"
      unitRef="usd">66000000</us-gaap:MinorityInterest>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ifc37ebada08d41f5b8cef803d7d03074_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMTM1_262e3d1c-e0ab-4312-bcd6-e04902b90c9e"
      unitRef="usdPerShare">0.49</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMTM1_38042128-2dba-4b1b-b582-291bd830a0ca"
      unitRef="usdPerShare">0.49</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:SharesIssued
      contextRef="i2981a3b1644448f6af2e5cb8836ff464_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMi0xLTEtMS0w_c1c2ac55-df2f-4d68-83f2-967332b094de"
      unitRef="shares">2923000000</us-gaap:SharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i2981a3b1644448f6af2e5cb8836ff464_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMi0zLTEtMS0w_4c0fb983-1ed9-43ab-92ce-99d90d109583"
      unitRef="usd">292000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i725849a6245d4c18813876f45d26ebdb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMi01LTEtMS0w_70af48cc-1623-4ebf-af6a-cd87ab07fb22"
      unitRef="usd">43709000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ifca693e8a4cf43a3b6314d8fd10f8054_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMi03LTEtMS0w_67650b53-3127-4929-bb2b-e5e016b7b056"
      unitRef="usd">-1520000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="iacdee3fad3484ddab95c12653c99c649_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMi05LTEtMS0w_49e988fe-a907-4917-b34c-fb29b8fc2b00"
      unitRef="usd">34474000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares
      contextRef="ic8ddca453e0f43dfa8c50a7b44bba5fa_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMi0xMS0xLTEtMA_2e7e7e02-249e-458f-98ee-31dc83417a51"
      unitRef="shares">672000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="ic8ddca453e0f43dfa8c50a7b44bba5fa_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMi0xMy0xLTEtMA_5ff30b6b-88eb-45e0-804e-ea41ebcab3fe"
      unitRef="usd">25357000000</us-gaap:TreasuryStockValue>
    <us-gaap:MinorityInterest
      contextRef="ia6cc956e9fbd48ceb2f65194ea049395_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMi0xNS0xLTEtMA_4a401f80-f529-4dc8-943c-274cf858228a"
      unitRef="usd">100000000</us-gaap:MinorityInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i003da07e864e44a69c31e7e8a1d52e15_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMy05LTEtMS0w_a8b5dc2e-a54f-433d-b32e-8b808d54455d"
      unitRef="usd">-775000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if5984e1f2ba843eb986403e94d6961c1_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMy0xNS0xLTEtMA_4700f823-6fcb-4f08-9b22-012fdb3eabc5"
      unitRef="usd">-9000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6e4590ddb4bf4965b0a342ff22eaa166_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfNC03LTEtMS0w_e4ded8b1-14e1-416d-bff6-a4496b46a270"
      unitRef="usd">-29000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i003da07e864e44a69c31e7e8a1d52e15_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfNS05LTEtMS0w_1977ae01-1ef5-4ad1-b795-6dc236a8040c"
      unitRef="usd">1028000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i0e96ce8b1bb142a2a63dcf6656d59225_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfNi0xMS0xLTEtMA_1c8a0a02-b50e-454a-9fa4-097627538dae"
      unitRef="shares">1000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i0e96ce8b1bb142a2a63dcf6656d59225_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfNi0xMy0xLTEtMA_4a8f0f2b-a42b-410c-9476-20dfe2629e3c"
      unitRef="usd">81000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockholdersEquityOther
      contextRef="i5969c9dafdd447f18f7192246fac8838_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfNy01LTEtMS0w_f4e4159d-3b54-4451-9625-47289446cc9f"
      unitRef="usd">455000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i0e96ce8b1bb142a2a63dcf6656d59225_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfNy0xMS0xLTEtMA_2ff446b7-461f-4176-a9cb-c8810b0d520c"
      unitRef="shares">-13000000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0e96ce8b1bb142a2a63dcf6656d59225_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfNy0xMy0xLTEtMA_9dd2d120-ef3b-4a5a-8b01-3a8c164e0a15"
      unitRef="usd">681000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="if5984e1f2ba843eb986403e94d6961c1_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfOC0xNS0xLTEtMA_fc0d1145-4cea-48b2-a5be-1959f5216ccf"
      unitRef="usd">43000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:SharesIssued
      contextRef="i5504708828644783aaf1fb1bdfaac8b9_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfOS0xLTEtMS0w_8d7aaf1b-843e-4e55-a77f-829cfb09bedd"
      unitRef="shares">2923000000</us-gaap:SharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i5504708828644783aaf1fb1bdfaac8b9_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfOS0zLTEtMS0w_d11dd71e-e3b3-49a8-92c3-32b35db491dd"
      unitRef="usd">292000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i6451959c27fd4a229abd87573f36e73a_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfOS01LTEtMS0w_53b792fa-f776-4b71-9fc5-7c886c463402"
      unitRef="usd">43254000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iaf435eb9cba84175bb13fd5a7add0851_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfOS03LTEtMS0w_dbf5b01a-673c-4dc5-b361-cdecacf274cc"
      unitRef="usd">-1549000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ifb8aad97592342f69c4ee4f99b65f30e_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfOS05LTEtMS0w_49b3cc07-ce0e-489d-ad1b-06cf7107ee66"
      unitRef="usd">32671000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares
      contextRef="i907bc8e8b73443428348fce6c8e4d9f2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfOS0xMS0xLTEtMA_decef44f-f728-4bf8-9e0a-bbb688d411af"
      unitRef="shares">660000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i907bc8e8b73443428348fce6c8e4d9f2_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfOS0xMy0xLTEtMA_9b77533a-c4bb-4840-9157-ae90aa5ee6db"
      unitRef="usd">24757000000</us-gaap:TreasuryStockValue>
    <us-gaap:MinorityInterest
      contextRef="ic7672c07fdb549a49def19893f3bd52d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfOS0xNS0xLTEtMA_319c8c62-9b42-466d-a0e4-d92c45138b0a"
      unitRef="usd">66000000</us-gaap:MinorityInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i35a526307c454beb9945dbdb361e919a_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTAtOS0xLTEtMA_e256a4c1-99ab-4e07-a5d0-31d67e76fd8c"
      unitRef="usd">-85000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ibf55f775dda94251ae451da6e98bfa21_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTAtMTUtMS0xLTA_4a631d35-fc55-4098-a075-749c2135970d"
      unitRef="usd">-5000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if63b4ca36e134e4c93b3e20bfbe40fe3_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTEtNy0xLTEtMA_3191d03b-454d-498c-9073-5cec718c5688"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i35a526307c454beb9945dbdb361e919a_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTItOS0xLTEtMA_39a781a9-167f-4659-88da-3aec96fd1428"
      unitRef="usd">1021000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTMtNS0xLTEtMA_b251983e-efd3-414e-b161-15b25c9d710e"
      unitRef="usd">1400000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="id4a97b03d1a440f9a8664a3da44ee846_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTMtMTEtMS0xLTA_a1087027-72d2-4953-9d25-a380d6eaeb8b"
      unitRef="shares">16000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="id4a97b03d1a440f9a8664a3da44ee846_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTMtMTMtMS0xLTA_fc69e98a-78ba-49f2-94b8-8ba5d5e18451"
      unitRef="usd">1400000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockholdersEquityOther
      contextRef="i2ab20791a5084b878272689919dd7486_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTQtNS0xLTEtMA_25aecc7e-89f9-4983-bd93-82df0ff3aae6"
      unitRef="usd">210000000</us-gaap:StockholdersEquityOther>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="id4a97b03d1a440f9a8664a3da44ee846_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTQtMTEtMS0xLTA_943a1e48-6419-4f11-9b96-1d0829f424ea"
      unitRef="shares">-7000000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="id4a97b03d1a440f9a8664a3da44ee846_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTQtMTMtMS0xLTA_5b73a4d3-e9e3-4511-a1cf-a2dd1b251715"
      unitRef="usd">506000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ibf55f775dda94251ae451da6e98bfa21_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTUtMTUtMS0xLTA_85ce605e-8a07-41e9-ae8f-00791e301d9a"
      unitRef="usd">5000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:SharesIssued
      contextRef="i30ce3f779b954838bbbf7b6ff1bbd7e9_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTYtMS0xLTEtMjExMg_6652c6fc-bfe1-495e-81d3-6192d8513de6"
      unitRef="shares">2923000000</us-gaap:SharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i30ce3f779b954838bbbf7b6ff1bbd7e9_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTYtMy0xLTEtMjExMg_ab2a5655-98f1-45d4-bd09-eaae332e1642"
      unitRef="usd">292000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i20caf63fbd6041669bb1f806943db28d_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTYtNS0xLTEtMjExMg_19d2e492-ea06-467b-bb34-b5b459159ab4"
      unitRef="usd">44444000000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i695a7cf7ff314bec908a24d933d5cf63_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTYtNy0xLTEtMjExMg_3bac38e5-b235-489e-8960-ee386448feea"
      unitRef="usd">-1556000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i235fc5676d984fff868b737072a6d629_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTYtOS0xLTEtMjExMg_f883fe05-339a-4671-aeb4-d15adf963e75"
      unitRef="usd">31565000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares
      contextRef="i4185f4aac2534ed88f533f59619f62a5_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTYtMTEtMS0xLTIxMTI_edc147ba-3f7f-44e9-bd50-c83473d9d4ff"
      unitRef="shares">669000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i4185f4aac2534ed88f533f59619f62a5_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTYtMTMtMS0xLTIxMTI_bd9b9e17-944f-483f-a0d8-9627a200a9fc"
      unitRef="usd">25651000000</us-gaap:TreasuryStockValue>
    <us-gaap:MinorityInterest
      contextRef="i4276b9e3a3cd4405967f02d58a3d681d_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjk1Y2I5M2JmYmMzMjQxOTZiYzNiZDljZDU3NzkwZDg1L3RhYmxlcmFuZ2U6OTVjYjkzYmZiYzMyNDE5NmJjM2JkOWNkNTc3OTBkODVfMTYtMTUtMS0xLTIxMTI_8a7d8689-a279-4bb3-9992-cfe329a6bda3"
      unitRef="usd">66000000</us-gaap:MinorityInterest>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMjY0_a3605531-32c6-48de-b32d-0919b53c9c84"
      unitRef="usdPerShare">0.45</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iac2000f1209140fe919895b22d38de16_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMjY0_e3d6ee26-ffc4-4227-9d75-d2acb356f63c"
      unitRef="usdPerShare">0.45</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfODEw_aa9ee3ab-a0ef-4595-81e3-a5774c4952e9"
      unitRef="usd">4400000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfODg3_ec3a0b15-e588-462d-874f-8e9113402738"
      unitRef="usd">2000000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfOTgy_2e3d8ee5-2947-4164-a588-2bc48060d285"
      unitRef="shares">47000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMTAxNg_c433e56e-2646-4984-8b9a-1dad48e6299d"
      unitRef="usd">3000000000.0</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMTE0Ng_755433be-ab4e-403d-abb4-9e47a5cd89d8"
      unitRef="usd">3400000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="iac2000f1209140fe919895b22d38de16_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMTE3Ng_d10f1cbf-3afb-40f3-8dbe-b1f3136e2541"
      unitRef="shares">1400000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMTIxMA_e3aa7915-8340-464d-bc36-3c238b6c3e1b"
      unitRef="usd">81000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i519bf72bf2984b599bef546963ea4f65_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMjE5OTAyMzI1Nzc4NQ_45257b2f-a9d0-4378-8f60-1d15b17e517d"
      unitRef="usd">7000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ifbd79ec1a2164f3d8aefdbe1d165744d_D20191001-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMjE5OTAyMzI1Nzc5Nw_396eab6f-8c2c-4374-a53a-bdfa1913fc18"
      unitRef="shares">99000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i519bf72bf2984b599bef546963ea4f65_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMjc0ODc3OTA3MTcyMg_45257b2f-a9d0-4378-8f60-1d15b17e517d"
      unitRef="usd">7000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMjE5OTAyMzI1NzgyMQ_63519ebb-1c01-4ef0-a439-3df30a8f4f93"
      unitRef="shares">16000000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMTU1NQ_4fcd75fd-8387-4c1a-b6e7-e3bbf32f73c7">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of Other Comprehensive Income/(Loss) were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;After&#160;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;After&#160;Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gain/(losses)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to net earnings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains/(losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Realized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.796%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;After&#160;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pretax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;After&#160;Tax&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gain/(losses)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassified to net earnings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Actuarial losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains/(losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Realized losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt"&gt;Included in Cost of products sold.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt"&gt;Included in Other (income)/expense, net.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNC0xLTEtMS0w_d8ca2126-c814-437e-bf1d-1062bf1f08c4"
      unitRef="usd">-38000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNC0zLTEtMS0w_19f8b6f5-05ef-4daf-824c-bc5d10ff92ca"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNC01LTEtMS0w_7a91cabc-ce0a-40f3-a1f4-08368a64bc5d"
      unitRef="usd">-41000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNC03LTEtMS0w_c3240d64-5577-4dbf-8687-90731a3e773b"
      unitRef="usd">-34000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNC05LTEtMS0w_0ab4ac40-2ac6-40f0-a45b-c16152e6cd0f"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNC0xMS0xLTEtMA_42f5eeb9-573e-446a-9577-95ec32d47ffe"
      unitRef="usd">-30000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNS0xLTEtMS0w_eba70928-784b-40db-95e3-dd9f9ad09f82"
      unitRef="usd">-53000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNS0zLTEtMS0w_03f3346a-0031-4ad3-8117-9d74bd42fdf4"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNS01LTEtMS0w_29a1e586-5e22-45f1-a38e-45518f4210bc"
      unitRef="usd">-47000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNS03LTEtMS0w_dcff0953-e03e-4e5c-8dd1-569ba527b7ee"
      unitRef="usd">32000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNS05LTEtMS0w_92189f44-9468-4c6f-a009-a3edb735b78c"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNS0xMS0xLTEtMA_d1130e94-9244-4545-be92-26f740178f12"
      unitRef="usd">29000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNi0xLTEtMS0w_fd0e7444-2098-40b8-9a41-4b0e18c45c41"
      unitRef="usd">15000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNi0zLTEtMS0w_8a38dac9-ce1f-42f1-89cc-dec9e0938e60"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNi01LTEtMS0w_39e96af6-8c39-41c9-9909-4e5d947d8683"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNi03LTEtMS0w_8e4ab0e7-f652-4ec9-a44a-898cd54f7e6f"
      unitRef="usd">-66000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNi05LTEtMS0w_71e8db7f-966d-4c81-8e4d-73fb308797ed"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfNi0xMS0xLTEtMA_12e2c36c-28aa-4d29-906f-69580d0fb9e0"
      unitRef="usd">-59000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfOS0xLTEtMS0w_d08b2199-5d0a-44c2-b32b-287c52a3e806"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfOS0zLTEtMS0w_ff07c9f7-9934-40bb-86ed-0cc34f33544e"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfOS01LTEtMS0w_7d7a62b4-2579-4086-ac07-9aa84ba942be"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfOS03LTEtMS0w_a8ddf4d8-8351-4e7d-a0f6-5c420f28cbab"
      unitRef="usd">-20000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfOS05LTEtMS0w_145e6fd4-219a-4c97-b089-4d59d20437d3"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfOS0xMS0xLTEtMA_01f2d380-221e-49a7-82ef-82e965a18bcd"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTAtMS0xLTEtMA_3c4f3e1c-0e13-4c8c-a3d5-7f98a95e2d01"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTAtMy0xLTEtMA_843a4224-ac2c-43da-8eb9-7fe75f697230"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTAtNS0xLTEtMA_46045492-66a0-4795-988a-f751adcb7a7a"
      unitRef="usd">-8000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTAtNy0xLTEtMA_d924b416-bd4f-4fb2-8911-ae2cbbd4f5bd"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTAtOS0xLTEtMA_aefb8369-68cb-49b1-9de3-4365dcf3d4cd"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTAtMTEtMS0xLTA_580c0ab5-41b9-483b-ac17-5eeb04585235"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTEtMS0xLTEtMA_20440847-9506-4880-a847-d0b39e7ab4f5"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTEtMy0xLTEtMA_4af6d190-7b76-4559-b9ac-a30f5e385080"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTEtNS0xLTEtMA_7da8de85-0781-4bcb-9066-ca035343380b"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTEtNy0xLTEtMA_200b8ef2-e790-45fa-98e3-c29c6b047397"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTEtOS0xLTEtMA_72cf7309-22a7-47ac-b5f3-6b02e87456c9"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTEtMTEtMS0xLTA_9ab83db9-2c1a-4f62-a246-f7e71e48103b"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTItMS0xLTEtMA_61405dba-359d-4dc4-9ac9-b9e570d7f2e3"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTItMy0xLTEtMA_956fd72b-1b02-4484-beef-f3ae87e8a307"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTItNS0xLTEtMA_28cfff84-c1e1-4248-93bf-10939978de7a"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTItNy0xLTEtMA_094e76cf-d0c3-47d9-8543-ff0d775b6889"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTItOS0xLTEtMA_3e2c4e95-0de1-4278-bc1f-5438f375d052"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTItMTEtMS0xLTA_36f2e623-d3d6-47c2-9005-cd65522a4ee4"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTUtMS0xLTEtMA_681e114b-e84a-417f-9f75-004e79b0ca3a"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTUtMy0xLTEtMA_1622f5d1-b39a-4520-934e-76820ebef687"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTUtNS0xLTEtMA_0a5ebf53-96c8-48f0-a8d3-81d200b92650"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTUtNy0xLTEtMA_fd1c51a4-79f5-403e-9cf2-a22ced4837b8"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTUtOS0xLTEtMA_a096ca22-4158-4b51-a295-710a4cdf6a4f"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTUtMTEtMS0xLTA_4ac817e4-1468-466f-8bc5-4b3aec66bbba"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTYtMS0xLTEtODMy_6ed7307f-01ef-45c0-9177-90ac34ddc6c9"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTYtMy0xLTEtODM2_a6dadd59-4249-40dd-b075-10ec33980abb"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTYtNS0xLTEtODQw_10d4c443-56aa-495e-92d2-850fc7d8dde4"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTYtNy0xLTEtODEw_701d1108-432a-440a-89f2-a173e8311aa4"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTYtOS0xLTEtODE0_d166ac42-1314-45cf-a89a-35818117ff1d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTYtMTEtMS0xLTIxMTk_ba0f800c-356f-4b12-a641-cca3208256fb"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTctMS0xLTEtMjM0Nw_fd974b85-9875-4534-8b36-36afe4bf97ff"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTctMy0xLTEtMjM0Nw_1595262b-8136-4f8b-acaa-fb5e3490bd84"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTctNS0xLTEtMjM0Nw_be92dbf4-e046-4e48-b4ab-63374eed6191"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTctNy0xLTEtMjEyMQ_399e152d-a822-4db1-b6f7-630735e06ba4"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTctOS0xLTEtMjEyMQ_7b9e664d-c979-4253-bd23-8b3c5fdf9d0a"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTctMTEtMS0xLTIxMjE_90c62760-357f-4f6b-928d-6cde4edc1c80"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTctMS0xLTEtMA_719cf28a-7460-428f-9fc1-fe3d4e56e826"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTctMy0xLTEtMA_cf0312a0-8ccf-4ee5-9eaf-9b6ab14cf3a6"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTctNS0xLTEtMA_e060a756-93ab-4302-b36b-14f74650c0d2"
      unitRef="usd">7000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTctNy0xLTEtMA_cf315955-43e7-4e2d-9930-9eb23d326b4f"
      unitRef="usd">45000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTctOS0xLTEtMA_b1f6f69e-7e5b-4b56-a1a8-7ff71f734f01"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTctMTEtMS0xLTA_ed40721f-d82b-4d69-8616-e0ecd2b02789"
      unitRef="usd">51000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTktMS0xLTEtMA_398aa620-cfbf-46a4-b003-b707abb557f1"
      unitRef="usd">31000000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTktMy0xLTEtMA_da9a91a2-4dfe-4c0f-8bd3-41ce90695fec"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTktNS0xLTEtMA_0c4dec67-dd9a-46ea-9865-3d9fd15ebb24"
      unitRef="usd">26000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTktNy0xLTEtMA_d924372c-b106-4f6e-9d8f-81f03bcbef73"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTktOS0xLTEtMA_d45fabbf-f39a-4d61-9ca0-19b3699abc14"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmJmNjM5MzIzOTZhNjQ0MDViNDE3NDIxNjZkNDkwZDAzL3RhYmxlcmFuZ2U6YmY2MzkzMjM5NmE2NDQwNWI0MTc0MjE2NmQ0OTBkMDNfMTktMTEtMS0xLTA_d90604a7-54de-4351-9faf-2cfee6452a5e"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNC0xLTEtMS04NzY_f3a078a0-5b75-464d-bbc4-b38a4b4e442c"
      unitRef="usd">221000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNC0zLTEtMS04Nzk_35813e1a-6e71-435a-bc4c-fa779624b1a9"
      unitRef="usd">14000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNC01LTEtMS0yMTI0_1eefc209-ecb8-46bd-80c5-dccae4d6b3a1"
      unitRef="usd">207000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNC03LTEtMS03Mzk_7a140d88-49c8-4509-baee-fa90ddb4bd8a"
      unitRef="usd">63000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNC05LTEtMS04NzM_13f254d9-8466-4e83-8101-c1c0dd21073e"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNC0xMS0xLTEtMjEyNA_3dea4fb9-14f6-4bbf-8f78-78fca1979a99"
      unitRef="usd">57000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNS0xLTEtMS04NzY_99e1f722-4b79-44a6-8830-6a0605f2e012"
      unitRef="usd">-89000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNS0zLTEtMS04Nzk_0e04073e-1ffd-458d-917b-0d65fcef72a9"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNS01LTEtMS0yMTI0_610dbc0e-b360-4955-9a92-84713ec1fe3d"
      unitRef="usd">-79000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNS03LTEtMS03Mzk_01fab043-1bec-472d-8785-2c2fc1721afd"
      unitRef="usd">52000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNS05LTEtMS04NzM_a730c8f4-7532-478f-b962-8a155734286a"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNS0xMS0xLTEtMjEyNA_7a6bf37c-854e-448a-b5e1-b95ae83c16f1"
      unitRef="usd">46000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNi0xLTEtMS0yMTI0_d8c98b64-ecef-4cb5-a9c3-2c8545be13a8"
      unitRef="usd">310000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNi0zLTEtMS0yMTI0_5af29e19-334e-4d09-8163-aa2d8283ef3f"
      unitRef="usd">24000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNi01LTEtMS0yMTI0_49447977-9158-40de-9cbf-751ebf24e859"
      unitRef="usd">286000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNi03LTEtMS0yMTI0_3e00c352-0382-4321-81cb-c1efa6c0bf41"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNi05LTEtMS0yMTI0_cfba9907-f7f8-47e2-9c8a-a3a236a60bb7"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfNi0xMS0xLTEtMjEyNA_8f4a73cb-7d8f-4ace-b7af-d805a4968c7e"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfOS0xLTEtMS04ODI_44d24947-7edd-42f8-b520-e0e29695acc6"
      unitRef="usd">22000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfOS0zLTEtMS04ODU_2e51a5be-bdc4-42d1-9007-2aefc7b5a134"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfOS01LTEtMS0yMTI2_f496bc65-e445-44e8-a51a-35dfd313832a"
      unitRef="usd">19000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfOS03LTEtMS03NDI_8162d4a6-d189-49c7-a950-1d00906f0194"
      unitRef="usd">-12000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfOS05LTEtMS04NDk_4d989bf8-c8ed-4fc4-a983-d10c83c5ac1b"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfOS0xMS0xLTEtMjEyNg_073527b8-f184-465b-b78e-dce7f752c55c"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTAtMS0xLTEtODgy_5a7b06a3-bcde-48b3-b6cb-36bd5a944e55"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTAtMy0xLTEtODg1_bf6df821-3f5d-4d77-8e6f-4df47940ebf9"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTAtNS0xLTEtMjEyNg_6d20929c-4b42-4ee8-9228-290184b1f5a6"
      unitRef="usd">-14000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTAtNy0xLTEtNzQy_dcdaf23b-3daf-45a1-9a16-984725ad98d2"
      unitRef="usd">-18000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTAtOS0xLTEtODQ5_02117eba-cdad-4182-bfa3-edeab28f7381"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTAtMTEtMS0xLTIxMjY_d92341c1-a6c9-44b8-824a-a96273a64ada"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTEtMS0xLTEtODgy_0ffc43b2-48f5-43c6-b91c-66e92f2eba25"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTEtMy0xLTEtODg1_6ffb5f1e-bc13-45de-9390-e032889badeb"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTEtNS0xLTEtMjEyNg_881c2308-104f-43db-8b4a-8597e2f9c5ca"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTEtNy0xLTEtNzQy_4c7892aa-4be2-4f99-8df9-6ac44a5c2f0e"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax>
    <us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTEtOS0xLTEtODQ5_fd4a50b3-e8c9-4a66-8bee-9eceeff7b253"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTEtMTEtMS0xLTIxMjY_78caa8df-6375-4f57-aa17-89c65b56adc7"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTItMS0xLTEtMjEyNg_5c0b896f-d877-4425-86b7-396be1c619ec"
      unitRef="usd">-47000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTItMy0xLTEtMjEyNg_ba07c33f-2453-4f54-92e9-a3b32669a85f"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTItNS0xLTEtMjEyNg_e7d52837-6954-47fc-93a3-bb7d186ddfcf"
      unitRef="usd">-38000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTItNy0xLTEtMjEyNg_8375f3e4-1110-4145-9fae-9996ac3b508b"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTItOS0xLTEtMjEyNg_01166415-f745-4024-b0f8-7afb8f502b96"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTItMTEtMS0xLTIxMjY_12138cd0-57f6-4802-bc95-7e727d783d99"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTUtMS0xLTEtODg4_fd0f362d-de99-4f80-acb9-58a0a45fc568"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTUtMy0xLTEtODkx_304e48b2-a350-4e77-93c2-dc93a8171d81"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTUtNS0xLTEtODk0_ba13611c-2e1b-42c2-b2a9-70b47e482229"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTUtNy0xLTEtODUy_3f19d5b0-e7c8-4291-bd56-70f670fba781"
      unitRef="usd">14000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTUtOS0xLTEtODU4_e7449d60-fc1e-408c-acaa-b45031ca91d6"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTUtMTEtMS0xLTg2MQ_1cf6efd9-e006-4c68-b92d-210577cdfaca"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTYtMS0xLTEtODg4_ce591d06-ada6-434f-a8cf-b477f436273d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTYtMy0xLTEtODkx_2fbf743e-9afb-4a3f-aa74-5889430ad7ba"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTYtNS0xLTEtODk0_91f367fe-b225-43f0-a808-5a9e864d5a44"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTYtNy0xLTEtODUy_2d27852b-3fe8-42f3-8e87-f07cda2c9fdd"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTYtOS0xLTEtODU4_e69d5019-8043-4b56-9bf6-5882731b30af"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTYtMTEtMS0xLTg2MQ_b8de9899-3889-4f33-9d05-3d7977a65b81"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTctMS0xLTEtMjEyOA_5e163283-2e98-4051-a289-fa985b623319"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTctMy0xLTEtMjEyOA_fe809c00-d43b-4069-8eec-7a14078e2beb"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTctNS0xLTEtMjEyOA_30778ba1-b279-4d8c-b7a4-1cd9ad3e69c2"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTctNy0xLTEtMjEyOA_806ff115-c799-4b22-b806-b0a4f5ad70f3"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTctOS0xLTEtMjEyOA_b5d10837-3f52-413b-a164-53881d46aec6"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTctMTEtMS0xLTIxMjg_24c1e161-1d54-4cb0-8b97-62dfc8912c55"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTktMS0xLTEtOTAx_04e63f78-29ad-43ea-b965-5e158cba93f2"
      unitRef="usd">12000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTktMy0xLTEtOTA0_bf4bc0da-88e2-4d3f-8a11-a05273a8ac0f"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTktNS0xLTEtOTA3_45de0912-ad22-4901-8924-779558734ede"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTctNy0xLTEtNzQ0_955035a3-0197-4983-8b13-5204e2d8ed70"
      unitRef="usd">-65000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTktOS0xLTEtODY1_42a8eecc-844e-49e3-8808-d21e5570a0e1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMTktMTEtMS0xLTIxMzA_01b9b645-1d8f-4237-b8ca-32dd42ca562a"
      unitRef="usd">-65000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMjEtMS0xLTEtMjEzMA_c62dc9f1-f567-4819-8ea9-88eaeff54988"
      unitRef="usd">363000000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMjEtMy0xLTEtMjEzMA_6026c026-21ad-4070-ae00-8dddd972e13a"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMjEtNS0xLTEtMjEzMA_788dea03-9281-41fb-bedc-c720e6821694"
      unitRef="usd">321000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMjEtNy0xLTEtMjEzMA_3bb7fd92-d104-45f2-a3ab-d32b7ceca437"
      unitRef="usd">-31000000</us-gaap:OtherComprehensiveIncomeLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMjEtOS0xLTEtMjEzMA_1592399c-120c-4fc5-bc50-d51c6d5e9c99"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOmU0MTNjZmQ5ZWRjYzQ5YWI5ZWMxMjE3MTllNjhjYTM3L3RhYmxlcmFuZ2U6ZTQxM2NmZDllZGNjNDlhYjllYzEyMTcxOWU2OGNhMzdfMjEtMTEtMS0xLTIxMzA_773726c1-6250-48a4-906c-3665863f5297"
      unitRef="usd">-36000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RleHRyZWdpb246M2EzNTMxOGY0N2Y1NDg5YzhkZDAwOWI5MjExMDc2ZDFfMTU1MQ_eae4d2ad-089e-4ece-8073-635ac4eac045">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accumulated balances related to each component of Other Comprehensive Income/(Loss), net of taxes, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives qualifying as cash flow hedges&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pension and postretirement benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(936)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(974)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(638)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(639)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,518)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,839)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjkzMmFkOGIwMjMwMDRhOWZiMWZkYmEwZTg1OGZhOWJjL3RhYmxlcmFuZ2U6OTMyYWQ4YjAyMzAwNGE5ZmIxZmRiYTBlODU4ZmE5YmNfMS0xLTEtMS0w_2c08c082-34d0-4d47-b571-8b372a260658"
      unitRef="usd">49000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjkzMmFkOGIwMjMwMDRhOWZiMWZkYmEwZTg1OGZhOWJjL3RhYmxlcmFuZ2U6OTMyYWQ4YjAyMzAwNGE5ZmIxZmRiYTBlODU4ZmE5YmNfMS0zLTEtMS0w_4dd85c4d-c35c-44f3-a16a-b8faaf43b8fb"
      unitRef="usd">-237000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjkzMmFkOGIwMjMwMDRhOWZiMWZkYmEwZTg1OGZhOWJjL3RhYmxlcmFuZ2U6OTMyYWQ4YjAyMzAwNGE5ZmIxZmRiYTBlODU4ZmE5YmNfMi0xLTEtMS0w_be4a5e7c-24b1-4c7b-96f1-42cee5634c38"
      unitRef="usd">936000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjkzMmFkOGIwMjMwMDRhOWZiMWZkYmEwZTg1OGZhOWJjL3RhYmxlcmFuZ2U6OTMyYWQ4YjAyMzAwNGE5ZmIxZmRiYTBlODU4ZmE5YmNfMi0zLTEtMS0w_ad774f40-bf62-4993-a97a-48c831a2afb5"
      unitRef="usd">974000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjkzMmFkOGIwMjMwMDRhOWZiMWZkYmEwZTg1OGZhOWJjL3RhYmxlcmFuZ2U6OTMyYWQ4YjAyMzAwNGE5ZmIxZmRiYTBlODU4ZmE5YmNfMy0xLTEtMS0w_b48ac37e-2219-4c74-b5d7-7ca915a27625"
      unitRef="usd">7000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjkzMmFkOGIwMjMwMDRhOWZiMWZkYmEwZTg1OGZhOWJjL3RhYmxlcmFuZ2U6OTMyYWQ4YjAyMzAwNGE5ZmIxZmRiYTBlODU4ZmE5YmNfMy0zLTEtMS0w_ed1d6d9a-8029-4eb0-8323-fc87a2bfbdf6"
      unitRef="usd">11000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjkzMmFkOGIwMjMwMDRhOWZiMWZkYmEwZTg1OGZhOWJjL3RhYmxlcmFuZ2U6OTMyYWQ4YjAyMzAwNGE5ZmIxZmRiYTBlODU4ZmE5YmNfNC0xLTEtMS0w_1facffcb-f82e-4254-9128-b9ac8884bb61"
      unitRef="usd">-638000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjkzMmFkOGIwMjMwMDRhOWZiMWZkYmEwZTg1OGZhOWJjL3RhYmxlcmFuZ2U6OTMyYWQ4YjAyMzAwNGE5ZmIxZmRiYTBlODU4ZmE5YmNfNC0zLTEtMS0w_b3ed0033-f387-481a-bb3a-9426db454f68"
      unitRef="usd">-639000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i84644a54c37541aab600ef4e9aeb7365_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjkzMmFkOGIwMjMwMDRhOWZiMWZkYmEwZTg1OGZhOWJjL3RhYmxlcmFuZ2U6OTMyYWQ4YjAyMzAwNGE5ZmIxZmRiYTBlODU4ZmE5YmNfNS0xLTEtMS0w_6ca4f1d7-cafd-4ef1-ac8d-e73869d2f358"
      unitRef="usd">-1518000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4021bf9acd814a3785a7b2ac9255f519_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84Mi9mcmFnOjNhMzUzMThmNDdmNTQ4OWM4ZGQwMDliOTIxMTA3NmQxL3RhYmxlOjkzMmFkOGIwMjMwMDRhOWZiMWZkYmEwZTg1OGZhOWJjL3RhYmxlcmFuZ2U6OTMyYWQ4YjAyMzAwNGE5ZmIxZmRiYTBlODU4ZmE5YmNfNS0zLTEtMS0w_46442cb6-95ff-47c7-9c52-fe28f973b0e7"
      unitRef="usd">-1839000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RleHRyZWdpb246YjcyOTg1NTI3ZjJjNDExMTk5YmIyNDdhMTM5ZjA3OTRfMzg1_82b3283e-62a6-4420-a643-d53d2cc90125">EMPLOYEE STOCK BENEFIT PLANS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing, selling and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Income tax benefit excludes excess tax benefits from share-based compensation awards that were vested or exercised of $12 million and $29 million for the three and six months ended June&#160;30, 2021 and $5 million and $28 million for the three and six months ended June&#160;30, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The number of units granted and the weighted-average fair value on the grant date for the six months ended June 30, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Units in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Market share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.082%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock&#160;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Market Share&#160;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance Share Units&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized compensation cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected weighted-average period in years of compensation cost to be recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RleHRyZWdpb246YjcyOTg1NTI3ZjJjNDExMTk5YmIyNDdhMTM5ZjA3OTRfMzg5_024dcda9-2768-4ba9-b435-10b5ce15018a">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.571%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six Months Ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of products sold&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing, selling and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income)/expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(a)&#160;&#160;&#160;&#160;Income tax benefit excludes excess tax benefits from share-based compensation awards that were vested or exercised of $12 million and $29 million for the three and six months ended June&#160;30, 2021 and $5 million and $28 million for the three and six months ended June&#160;30, 2020, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id5f7660b6eca475a9df8e628fa445af7_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfMi0xLTEtMS0w_b3a0dcb8-4ab5-46cf-8d3d-450a9dd51382"
      unitRef="usd">15000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i635494ce148e4ad7bd650508b31a47f5_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfMi0zLTEtMS0w_16506dc5-e46a-410b-b399-6a8f473c6398"
      unitRef="usd">9000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i458d77e2e80747db91d6733fb12cc6f3_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfMi01LTEtMS0w_93e6c1ef-9a1b-4262-95fe-51786c0be242"
      unitRef="usd">30000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic61bae9f14c94630811f2853573f8ff6_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfMi03LTEtMS0w_59dc588b-48f7-438f-8e88-d8504ae2c9f9"
      unitRef="usd">19000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1dec6245873f4d98820e4a2b35667387_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfMy0xLTEtMS0w_b4c3969d-d133-4a3f-bac2-0027b97179cb"
      unitRef="usd">65000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id6778a15e516498f97f88c860749c6a2_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfMy0zLTEtMS0w_e87fc75e-7761-4084-a109-a5905dafd0be"
      unitRef="usd">86000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2d23efb083df4012b861cdd74c430462_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfMy01LTEtMS0w_bca217aa-8464-4db9-83a7-e3123ee78cc2"
      unitRef="usd">125000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i33981b78822f4f77be3c382064085973_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfMy03LTEtMS0w_6abc0c5b-51b6-43f4-8caa-b2e89f79deb9"
      unitRef="usd">174000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4c126874d2714146b7bf5cbc485c1cf8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfNC0xLTEtMS0w_d859ff73-c95e-462e-9953-7a88be05c683"
      unitRef="usd">74000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i41d5a334a6e142f8bd67b8e51060b87f_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfNC0zLTEtMS0w_cc6dd573-81a0-4046-a3f0-ffe86a6390aa"
      unitRef="usd">89000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4662da4bb2b6479993d2a5b55ba2078b_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfNC01LTEtMS0w_2e6756fd-8269-4c10-9157-9ee5f07aad29"
      unitRef="usd">144000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5431747aab134732bd974c5723251eef_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfNC03LTEtMS0w_ffd26b92-e251-4e24-8551-63c54d70c2d3"
      unitRef="usd">183000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id74cc59095d040258cf00ef2e809efa0_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfNS0xLTEtMS0w_1da6464d-ece6-418c-9741-0e86187cf9c2"
      unitRef="usd">3000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7ec7443f41ce4644b7444730381aeb04_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfNS0zLTEtMS0w_e119bb04-3262-487b-a2e6-b275cd459298"
      unitRef="usd">29000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2da4dc33dbfe427290747f6b3396e0bc_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfNS01LTEtMS0w_ebb62f39-bf32-4736-94e5-c763148f19f9"
      unitRef="usd">9000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2c94d13219ab428992afd3b5b0c2e8aa_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfNS03LTEtMS0w_f1a05bd1-80f4-4961-82b6-615875fabdbf"
      unitRef="usd">47000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfNi0xLTEtMS0w_6d306dfe-4e90-4a0f-9707-6bc3a6748271"
      unitRef="usd">157000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfNi0zLTEtMS0w_c26ae1d7-14ca-429c-82e4-975d0dbe70f8"
      unitRef="usd">213000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfNi01LTEtMS0yMTM1_850193e6-7759-43b1-b046-0f3f3cf39abb"
      unitRef="usd">308000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfNi03LTEtMS0yMTM1_86333117-39c7-415a-847b-93b21519f6cb"
      unitRef="usd">423000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfOC0xLTEtMS0w_216b9752-2bd2-4018-92d9-f6227f7144f4"
      unitRef="usd">33000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfOC0zLTEtMS0w_8e8cfa2f-54b6-4772-b491-20c0ae355b61"
      unitRef="usd">40000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfOC01LTEtMS0w_feaa5b1b-f3c5-4de8-957c-ca67d89bf4ea"
      unitRef="usd">64000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjgyZDBlZDUxNDlhNjQyYWI4NzFhN2VkYzgyNzQ2MzY3L3RhYmxlcmFuZ2U6ODJkMGVkNTE0OWE2NDJhYjg3MWE3ZWRjODI3NDYzNjdfOC03LTEtMS0w_d61244ed-822b-4ea1-89d0-00dfd0572c69"
      unitRef="usd">86000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:ProceedsAndExcessTaxBenefitFromSharebasedCompensation
      contextRef="ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RleHRyZWdpb246YjcyOTg1NTI3ZjJjNDExMTk5YmIyNDdhMTM5ZjA3OTRfMjE3_bbfb83bb-6370-4239-beb5-194a7bed93e6"
      unitRef="usd">12000000</us-gaap:ProceedsAndExcessTaxBenefitFromSharebasedCompensation>
    <us-gaap:ProceedsAndExcessTaxBenefitFromSharebasedCompensation
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RleHRyZWdpb246YjcyOTg1NTI3ZjJjNDExMTk5YmIyNDdhMTM5ZjA3OTRfMjI0_b2ad16e5-f918-483e-9b2f-bf18cd177c10"
      unitRef="usd">29000000</us-gaap:ProceedsAndExcessTaxBenefitFromSharebasedCompensation>
    <us-gaap:ProceedsAndExcessTaxBenefitFromSharebasedCompensation
      contextRef="ibce83b495011409cb9f1bc6143aa6648_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RleHRyZWdpb246YjcyOTg1NTI3ZjJjNDExMTk5YmIyNDdhMTM5ZjA3OTRfMTA5OTUxMTYyODIxMA_fc133dad-9a06-4293-afb9-e5927aea4996"
      unitRef="usd">5000000</us-gaap:ProceedsAndExcessTaxBenefitFromSharebasedCompensation>
    <us-gaap:ProceedsAndExcessTaxBenefitFromSharebasedCompensation
      contextRef="i8943ff94253b4ddda4084325c807b744_D20200101-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RleHRyZWdpb246YjcyOTg1NTI3ZjJjNDExMTk5YmIyNDdhMTM5ZjA3OTRfMTA5OTUxMTYyODIwMQ_13082c1b-b1c3-4af6-adaf-ce0ad95aec13"
      unitRef="usd">28000000</us-gaap:ProceedsAndExcessTaxBenefitFromSharebasedCompensation>
    <bmy:ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RleHRyZWdpb246YjcyOTg1NTI3ZjJjNDExMTk5YmIyNDdhMTM5ZjA3OTRfMzg3_7f75c764-fc8a-4638-a0d0-d39939adc459">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The number of units granted and the weighted-average fair value on the grant date for the six months ended June 30, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.568%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Units in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Market share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</bmy:ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i802d457ae3ce494fba78c18db7fb4724_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjk5YzA0NWMyYzg5MDRhNTJhOGI4MGUwMzFiMWY2ZThhL3RhYmxlcmFuZ2U6OTljMDQ1YzJjODkwNGE1MmE4YjgwZTAzMWIxZjZlOGFfMi0xLTEtMS0w_6bda3707-23fa-4876-b387-e6fa377d12f0"
      unitRef="shares">8200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i802d457ae3ce494fba78c18db7fb4724_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjk5YzA0NWMyYzg5MDRhNTJhOGI4MGUwMzFiMWY2ZThhL3RhYmxlcmFuZ2U6OTljMDQ1YzJjODkwNGE1MmE4YjgwZTAzMWIxZjZlOGFfMi0zLTEtMS0w_72e8ae24-6f26-422c-9dfa-b56ae3dbdabe"
      unitRef="usdPerShare">56.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="iae0c6db08abe4f8aaa95195fc68dcb83_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjk5YzA0NWMyYzg5MDRhNTJhOGI4MGUwMzFiMWY2ZThhL3RhYmxlcmFuZ2U6OTljMDQ1YzJjODkwNGE1MmE4YjgwZTAzMWIxZjZlOGFfMy0xLTEtMS0w_d48bf36e-f436-48f1-816c-43cca8ed42e0"
      unitRef="shares">1000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="iae0c6db08abe4f8aaa95195fc68dcb83_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjk5YzA0NWMyYzg5MDRhNTJhOGI4MGUwMzFiMWY2ZThhL3RhYmxlcmFuZ2U6OTljMDQ1YzJjODkwNGE1MmE4YjgwZTAzMWIxZjZlOGFfMy0zLTEtMS0w_e23697e6-d1c1-4d23-ab55-f9ba303c3a7d"
      unitRef="usdPerShare">58.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i8a0d23cf191d49859d545cf81fc83b99_D20210401-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjk5YzA0NWMyYzg5MDRhNTJhOGI4MGUwMzFiMWY2ZThhL3RhYmxlcmFuZ2U6OTljMDQ1YzJjODkwNGE1MmE4YjgwZTAzMWIxZjZlOGFfNC0xLTEtMS0w_da0a9dfc-cf30-4295-81be-2906fa5bc8e9"
      unitRef="shares">1500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i8a0d23cf191d49859d545cf81fc83b99_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjk5YzA0NWMyYzg5MDRhNTJhOGI4MGUwMzFiMWY2ZThhL3RhYmxlcmFuZ2U6OTljMDQ1YzJjODkwNGE1MmE4YjgwZTAzMWIxZjZlOGFfNC0zLTEtMS0w_c8c5e5d5-5fd0-4916-bec0-3fb59a572a0d"
      unitRef="usdPerShare">59.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RleHRyZWdpb246YjcyOTg1NTI3ZjJjNDExMTk5YmIyNDdhMTM5ZjA3OTRfMzg4_1173e4cc-2d2f-4974-b723-1680ac1c9163">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.082%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.582%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.495%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Dollars in Millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock&#160;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Market Share&#160;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Performance Share Units&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrecognized compensation cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected weighted-average period in years of compensation cost to be recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="icb9926c1623d4307b449847e25ccb9a6_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjY5ZDUxMTg4ZTgxMDQ4MTJiMTFiZDlhMjg1OThhYzdkL3RhYmxlcmFuZ2U6NjlkNTExODhlODEwNDgxMmIxMWJkOWEyODU5OGFjN2RfMS0xLTEtMS0w_39d19951-dbe8-4f9b-9d94-001138a0be90"
      unitRef="usd">20000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i2a59bc20a4164faa942cd6df346323f9_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjY5ZDUxMTg4ZTgxMDQ4MTJiMTFiZDlhMjg1OThhYzdkL3RhYmxlcmFuZ2U6NjlkNTExODhlODEwNDgxMmIxMWJkOWEyODU5OGFjN2RfMS0zLTEtMS0w_742015a4-0792-4b85-ba95-8c30cf389ef4"
      unitRef="usd">953000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="if2259fe062d9455c84a896e821c65d2f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjY5ZDUxMTg4ZTgxMDQ4MTJiMTFiZDlhMjg1OThhYzdkL3RhYmxlcmFuZ2U6NjlkNTExODhlODEwNDgxMmIxMWJkOWEyODU5OGFjN2RfMS01LTEtMS0w_aea0570a-e1e2-4850-a02a-ef2f73e3629b"
      unitRef="usd">73000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i8621d1eb8ad941d1b61fc0b3eb0c0104_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjY5ZDUxMTg4ZTgxMDQ4MTJiMTFiZDlhMjg1OThhYzdkL3RhYmxlcmFuZ2U6NjlkNTExODhlODEwNDgxMmIxMWJkOWEyODU5OGFjN2RfMS03LTEtMS0w_5796d1b9-9d80-4d2e-a391-947a94c0361b"
      unitRef="usd">124000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i5d714c61f30d48e6a0408831871d837e_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjY5ZDUxMTg4ZTgxMDQ4MTJiMTFiZDlhMjg1OThhYzdkL3RhYmxlcmFuZ2U6NjlkNTExODhlODEwNDgxMmIxMWJkOWEyODU5OGFjN2RfMi0xLTEtMS0w_72635115-7a2c-436b-91c3-1f2373cbc138">P0Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i802d457ae3ce494fba78c18db7fb4724_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjY5ZDUxMTg4ZTgxMDQ4MTJiMTFiZDlhMjg1OThhYzdkL3RhYmxlcmFuZ2U6NjlkNTExODhlODEwNDgxMmIxMWJkOWEyODU5OGFjN2RfMi0zLTEtMS0w_c7056674-ca36-4a3a-ad1b-c9af4b93484e">P2Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="iae0c6db08abe4f8aaa95195fc68dcb83_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjY5ZDUxMTg4ZTgxMDQ4MTJiMTFiZDlhMjg1OThhYzdkL3RhYmxlcmFuZ2U6NjlkNTExODhlODEwNDgxMmIxMWJkOWEyODU5OGFjN2RfMi01LTEtMS0w_1fcab79b-426f-4482-b1d3-91318e1bc248">P3Y2M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i8a0d23cf191d49859d545cf81fc83b99_D20210401-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV84OC9mcmFnOmI3Mjk4NTUyN2YyYzQxMTE5OWJiMjQ3YTEzOWYwNzk0L3RhYmxlOjY5ZDUxMTg4ZTgxMDQ4MTJiMTFiZDlhMjg1OThhYzdkL3RhYmxlcmFuZ2U6NjlkNTExODhlODEwNDgxMmIxMWJkOWEyODU5OGFjN2RfMi03LTEtMS0w_4785df13-eaa6-4c3f-bdc0-68bfed572abc">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:LegalMattersAndContingenciesTextBlock
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfMzgxNzk_5cf39342-a887-4029-838e-13b82c14b850">LEGAL PROCEEDINGS AND CONTINGENCIES&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS and certain of its subsidiaries are involved in various lawsuits, claims, government investigations and other legal proceedings that arise in the ordinary course of business. These claims or proceedings can involve various types of parties, including governments, competitors, customers, suppliers, service providers, licensees, employees, or shareholders, among others. These matters may involve patent infringement, antitrust, securities, pricing, sales and marketing practices, environmental, commercial, contractual rights, licensing obligations, health and safety matters, consumer fraud, employment matters, product liability and insurance coverage, among others. The resolution of these matters often develops over a long period of time and expectations can change as a result of new findings, rulings, appeals or settlement arrangements. Legal proceedings that are significant or that BMS believes could become significant or material are described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While BMS does not believe that any of these matters, except as otherwise specifically noted below, will have a material adverse effect on its financial position or liquidity as BMS believes it has substantial defenses in the matters, the outcomes of BMS&#x2019;s legal proceedings and other contingencies are inherently unpredictable and subject to significant uncertainties. There can be no assurance that there will not be an increase in the scope of one or more of these pending matters or any other or future lawsuits, claims, government investigations or other legal proceedings will not be material to BMS&#x2019;s financial position, results of operations or cash flows for a particular period. Furthermore, failure to enforce BMS&#x2019;s patent rights would likely result in substantial decreases in the respective product revenues from generic competition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless otherwise noted, BMS is unable to assess the outcome of the respective matters nor is it able to estimate the possible loss or range of losses that could potentially result for such matters. Contingency accruals are recognized when it is probable that a liability will be incurred and the amount of the related loss can be reasonably estimated. Developments in legal proceedings and other matters that could cause changes in the amounts previously accrued are evaluated each reporting period. For a discussion of BMS&#x2019;s tax contingencies, see &#x201c;&#x2014;Note&#160;7. Income Taxes&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;INTELLECTUAL PROPERTY&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Anti-PD-1 Antibody Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2015, Dana-Farber Cancer Institute (&#x201c;Dana-Farber&#x201d;) filed a complaint in the U.S. District Court for the District of Massachusetts seeking to correct the inventorship on up to six related U.S. patents directed to methods of treating cancer using PD-1 and PD-L1 antibodies. Specifically, Dana-Farber is seeking to add two scientists as inventors to these patents. In October 2017, Pfizer was allowed to intervene in this case alleging that one of the scientists identified by Dana-Farber was employed by a company eventually acquired by Pfizer during the relevant period. In February 2019, BMS settled the lawsuit with Pfizer. A bench trial in the lawsuit with Dana-Farber took place in February 2019. In May 2019, the District Court issued an opinion ruling that the two scientists should be added as inventors to the patents, which was affirmed on appeal. In May 2021, the U.S. Supreme Court declined to consider the case. In June 2019, Dana-Farber filed a new lawsuit in the District of Massachusetts against BMS seeking damages as a result of the Court&#x2019;s decision adding the scientists as inventors. In February 2021, BMS filed a motion to dismiss the complaint.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;CAR T&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2017, Juno and Sloan Kettering Institute for Cancer Research (&#x201c;SKI&#x201d;) filed a complaint for patent infringement against Kite Pharma, Inc. (&#x201c;Kite&#x201d;) in the U.S. District Court for the Central District of California. The complaint alleged that Kite&#x2019;s &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Yescarta*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; product infringes certain claims of U.S. Patent No. 7,446,190 (the &#x201c;&#x2019;190 Patent&#x201d;) concerning CAR T cell technologies. Kite filed an answer and counterclaims asserting non-infringement and invalidity of the &#x2019;190 Patent. In December 2019, following an eight-day trial, the jury rejected Kite&#x2019;s defenses, finding that Kite willfully infringed the &#x2019;190 Patent and awarding to Juno and SKI a reasonable royalty consisting of a $585 million upfront payment and a 27.6% running royalty on Kite&#x2019;s sales of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Yescarta*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; through the expiration of the &#x2019;190 Patent in August 2024. In January 2020, Kite renewed its previous motion for judgment as a matter of law and also moved for a new trial, and Juno filed a motion seeking enhanced damages, supplemental damages, ongoing royalties, and prejudgment interest. In March 2020, the Court denied both of Kite&#x2019;s motions in their entirety. In April 2020, the Court granted in part Juno&#x2019;s motion and entered a final judgment awarding to Juno and SKI approximately $1.2 billion in royalties, interest and enhanced damages and a 27.6% running royalty on Kite&#x2019;s sales of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Yescarta&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* from December 13, 2019 through the expiration of the &#x2019;190 Patent in August 2024. In April 2020, Kite appealed the final judgment to the U.S. Court of Appeals for the Federal Circuit and the Court held an oral hearing on July 6, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Eliquis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &#x2013; Europe&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2020 and January 2021, Sandoz Limited (&#x201c;Sandoz&#x201d;) and Teva Pharmaceutical Industries Ltd. (&#x201c;Teva Limited&#x201d;), respectively, filed lawsuits in the United Kingdom seeking revocation of the UK apixaban composition of matter patent and related Supplementary Protection Certificate. BMS subsequently filed counterclaims for infringement in both actions. A trial is scheduled to begin in early 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There are similar lawsuits filed in the Republic of Ireland, the Netherlands and Sweden seeking revocation of a composition of matter patent relating to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Eliquis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional infringement and invalidity actions involving &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Eliquis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; patents may be filed in various countries in Europe in the coming months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Eliquis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; - U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2017, BMS received Notice Letters from twenty-five&#160;generic companies notifying BMS that they had filed aNDAs containing paragraph IV certifications seeking approval of generic versions of&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Eliquis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. As a result, two&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Eliquis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;patents listed in the FDA Orange Book are being challenged: the composition of matter patent claiming apixaban specifically and a formulation patent. In response, BMS, along with its partner Pfizer, initiated patent infringement actions under the Hatch-Waxman Act against all generic filers in the U.S. District Court for the District of Delaware in April 2017. In August 2017, the U.S. Patent and Trademark Office granted patent term restoration to the composition of matter patent to November 2026, thereby restoring the term of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Eliquis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; composition of matter patent, which is BMS&#x2019;s basis for projected LOE. BMS settled with a number of aNDA filers. These settlements do not affect BMS&#x2019;s projected LOE for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Eliquis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. A trial with the remaining aNDA filers took place in late 2019. In August 2020, the U.S. District Court issued a decision finding that the remaining aNDA filers&#x2019; products infringed the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Eliquis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; composition of matter and formulation patents and that both &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Eliquis&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; patents are not invalid. The remaining aNDA filers have appealed to the U.S. Court of Appeals for the Federal Circuit. The oral argument for the appeal is scheduled to occur in September 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Plavix*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; - Australia&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sanofi was notified that, in August 2007, GenRx Proprietary Limited (&#x201c;GenRx&#x201d;) obtained regulatory approval of an application for clopidogrel bisulfate 75mg tablets in Australia. GenRx, formerly a subsidiary of Apotex Inc., subsequently changed its name to Apotex (&#x201c;GenRx-Apotex&#x201d;). In August 2007, GenRx-Apotex filed an application in the Federal Court of Australia seeking revocation of Sanofi&#x2019;s Australian Patent No.&#160;597784 (Case No. NSD 1639 of 2007). Sanofi filed counterclaims of infringement and sought an injunction. On September&#160;21, 2007, the Federal Court of Australia granted Sanofi&#x2019;s injunction. A subsidiary of BMS was subsequently added as a party to the proceedings. In February 2008, a second company, Spirit Pharmaceuticals Pty. Ltd., also filed a revocation suit against the same patent. This case was consolidated with the GenRx-Apotex case. On August&#160;12, 2008, the Federal Court of Australia held that claims of Patent No.&#160;597784 covering clopidogrel bisulfate, hydrochloride, hydrobromide, and taurocholate salts were valid. The Federal Court also held that the process claims, pharmaceutical composition claims, and claim directed to clopidogrel and its pharmaceutically acceptable salts were invalid. BMS and Sanofi filed notices of appeal in the Full Court of the Federal Court of Australia (&#x201c;Full Court&#x201d;) appealing the holding of invalidity of the claim covering clopidogrel and its pharmaceutically acceptable salts, process claims, and pharmaceutical composition claims. GenRx-Apotex appealed the holding of validity of the clopidogrel bisulfate, hydrochloride, hydrobromide, and taurocholate claims. On September&#160;29, 2009, the Full Court held all of the claims of Patent No.&#160;597784 invalid. In March 2010, the High Court of Australia denied a request by BMS and Sanofi to hear an appeal of the Full Court decision. The case was remanded to the Federal Court for further proceedings related to damages sought by GenRx-Apotex. BMS and GenRx-Apotex settled, and the GenRx-Apotex case was dismissed. The Australian government intervened in this matter seeking maximum damages up to 449 million AUD ($341 million), plus interest, which would be split between BMS and Sanofi, for alleged losses experienced for paying a higher price for branded &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Plavix*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; during the period when the injunction was in place. BMS and Sanofi dispute that the Australian government is entitled to any damages. A trial was concluded in September 2017. In April 2020, the Federal Court issued a decision dismissing the Australian government&#x2019;s claim for damages. In May 2020, the Australian government appealed the Federal Court&#x2019;s decision and an appeal hearing concluded in February 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pomalyst &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;- Canada&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Celgene received a Notice of Allegation in January 2020 from Natco Pharma (Canada) Inc. (&#x201c;Natco Canada&#x201d;) notifying Celgene that it had filed an Abbreviated New Drug Submission (&#x201c;aNDS&#x201d;) with Canada&#x2019;s Minister of Health with respect to certain of Celgene&#x2019;s Canadian patents. Natco Canada is seeking to market a generic version of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pomalyst&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in Canada. In response, Celgene initiated a patent infringement action in the Federal Court of Canada. Natco Canada alleges that the asserted patents are invalid and/or not infringed. A trial is scheduled to begin in November 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Celgene received a second Notice of Allegation in November 2020 from Natco Canada notifying Celgene that it had filed a second aNDS with Canada&#x2019;s Minister of Health with respect to certain of Celgene&#x2019;s Canadian patents. In response, Celgene initiated a patent infringement action in the Federal Court of Canada. Natco Canada alleges that the asserted patents are invalid and/or not infringed. A trial is scheduled to begin in May 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Celgene received four Notices of Allegation in February 2021 from Apotex Inc. notifying Celgene that it had filed two aNDSs with Canada&#x2019;s Minister of Health with respect to certain of Celgene&#x2019;s Canadian patents. Apotex Inc. is seeking to market a generic version of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pomalyst&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in Canada. In response, in April 2021, Celgene initiated patent infringement actions against Apotex Inc. in the Federal Court of Canada. In July 2021, Celgene and Apotex Inc. entered into a confidential settlement agreement and the cases were discontinued.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pomalyst&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; - U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in 2017, Celgene received Notice letters on behalf of Apotex Inc. and Apotex Corp. (together, &#x201c;Apotex&#x201d;); Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero Drugs Limited, Hetero USA, Inc. (collectively, &#x201c;Hetero&#x201d;); Eugia Pharma Specialities Limited, Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., and Aurolife Pharma LLC (collectively, &#x201c;Aurobindo&#x201d;); and Mylan Pharmaceuticals Inc. notifying Celgene that they had filed aNDAs containing paragraph IV certifications seeking approval to market generic versions of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pomalyst&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the U.S. In response, Celgene filed patent infringement actions against the companies in the U.S. District Court for the District of New Jersey asserting certain FDA Orange Book-listed patents and the companies filed answers, counterclaims and declaratory judgment actions alleging that the asserted patents are invalid, unenforceable, and not infringed. These litigations were subsequently consolidated. In March 2020, Celgene subsequently filed additional patent infringement actions in the U.S. District Court for the District of New Jersey against each of the companies asserting a newly-issued patent that is listed in the FDA Orange Book and that covers formulations comprising pomalidomide. The companies each filed responsive pleadings alleging that the patent is invalid and not infringed. The Court has consolidated these additional litigations with the previously-consolidated litigations. In September 2020, the Court granted Mylan Pharmaceuticals Inc.&#x2019;s motion to dismiss, which decision Celgene has appealed. In October 2020, Aurobindo received final approval from the FDA of its aNDA. In April and July 2021, Celgene entered into confidential settlement agreements with Apotex and Aurobindo, respectively, settling all outstanding claims in the litigation with Apotex and Aurobindo. Trial against the remaining defendant, Hetero, is set for November 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February and March 2019, Celgene filed additional patent infringement actions in the U.S. District Court for the District of New Jersey against the companies asserting certain patents that are not listed in the FDA Orange Book and that cover polymorphic forms of pomalidomide, and the companies filed answers and/or counterclaims alleging that each of these patents is invalid and/or not infringed. These actions have been consolidated with the earlier-filed actions against the companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2019, Celgene received a Notice Letter from Dr. Reddy&#x2019;s Laboratories, Ltd. and Dr. Reddy&#x2019;s Laboratories, Inc. (together, &#x201c;DRL&#x201d;) notifying Celgene that they had filed an aNDA containing paragraph IV certifications seeking approval to market a generic version of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pomalyst&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the U.S. In response, Celgene initiated a patent infringement action against DRL in the U.S. District Court for the District of New Jersey asserting certain FDA Orange Book-listed patents, and DRL filed an answer and counterclaims alleging that each of the patents is invalid and/or not infringed. In March 2020, Celgene filed an additional patent infringement action in the U.S. District Court for the District of New Jersey against DRL asserting a newly-issued patent that is listed in the FDA Orange Book and that covers formulations comprising pomalidomide, which has been consolidated with the above DRL case. In April 2021, DRL received tentative approval from the FDA of its aNDA. The Court has not set a trial date in this consolidated action.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, Celgene filed an additional patent infringement action in the U.S. District Court for the District of New Jersey against DRL asserting certain patents that are not listed in the FDA Orange Book and that cover polymorphic forms of pomalidomide. No trial date has been set for this matter.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; - U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Celgene has received Notice Letters on behalf of Sun Pharma Global FZE, Sun Pharma Global Inc., Sun Pharmaceutical Industries, Inc., and Sun Pharmaceutical Industries Limited (collectively, &#x201c;Sun&#x201d;); Hetero; Mylan Pharmaceuticals Inc., Mylan Inc., and Mylan N.V. (collectively, &#x201c;Mylan&#x201d;); Aurobindo; Lupin Limited (&#x201c;Lupin&#x201d;); Hikma Pharmaceuticals USA, Inc.; Biocon Pharma Limited, Biocon Limited, and Biocon Pharma, Inc.; and Torrent Pharmaceuticals Limited and Torrent Pharma Inc. notifying Celgene that they had filed aNDAs containing paragraph IV certifications seeking approval to market generic versions of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the U.S. In response, Celgene filed patent infringement actions against the companies in the U.S. District Court for the District of New Jersey asserting certain FDA Orange Book-listed patents as well as other litigations asserting other non-FDA Orange Book-listed patents against certain defendants, who have filed answers and/or counterclaims alleging that the asserted patents are invalid and/or not infringed. No trial date has been scheduled in any of these New Jersey actions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Celgene also filed a patent infringement action against Mylan in the U.S. District Court for the Northern District of West Virginia asserting certain FDA Orange Book-listed patents and other non-FDA Orange Book-listed patents. Mylan filed its answer and counterclaims alleging that the patents are invalid and/or not infringed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June and July 2021, Celgene entered into confidential settlement agreements with Sun, Aurobindo, and Mylan, respectively, settling all outstanding claims in the litigations with Sun, Aurobindo, and Mylan.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Sprycel&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; - U.S.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2019, BMS received a Notice Letter from Dr. Reddy&#x2019;s Laboratories, Inc. notifying BMS that it had filed an aNDA containing paragraph IV certifications seeking approval of a generic version of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sprycel&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the U.S. and challenging two FDA Orange Book-listed monohydrate form patents expiring in 2025 and 2026. In response, BMS filed a patent infringement action in the U.S. District Court for the District of New Jersey.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, BMS received a Notice Letter from Lupin notifying BMS that it had filed an aNDA containing paragraph IV certifications seeking approval of a generic version of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sprycel&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the U.S. and challenging two FDA Orange Book-listed monohydrate form patents expiring in 2025 and 2026. In response, BMS filed patent infringement actions in the U.S. District Courts for the District of New Jersey and Delaware. The case in Delaware has been dismissed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, BMS entered into confidential settlement agreements with Dr. Reddy&#x2019;s Laboratories, Inc. and Lupin, settling all outstanding claims in the litigations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;PRICING, SALES AND PROMOTIONAL PRACTICES LITIGATION&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Plavix*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; State Attorneys General Lawsuits&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS and certain Sanofi entities are defendants in consumer protection actions brought by the attorneys general of Hawaii and New Mexico relating to the labeling, sales and/or promotion of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Plavix&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*. A trial in the Hawaii matter occurred in 2020. In February 2021, the Court issued a decision against Sanofi and BMS, imposing penalties in the total amount of $834 million, with $417&#160;million attributed to BMS. Sanofi and BMS disagree with the decision and are appealing it. BMS remains confident in the merits of its case and its likelihood of success on appeal and BMS does not believe establishing a reserve is warranted for this matter. A trial in the New Mexico matter is scheduled to begin in April 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;PRODUCT LIABILITY LITIGATION&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS is a party to various product liability lawsuits. Plaintiffs in these cases seek damages and other relief on various grounds for alleged personal injury and economic loss. As previously disclosed, in addition to lawsuits, BMS also faces unfiled claims involving its products.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Abilify*&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS and Otsuka are co-defendants in product liability litigation related to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Abilify*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Plaintiffs allege &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Abilify*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; caused them to engage in compulsive gambling and other impulse control disorders. There have been over 2,500 cases filed in state and federal courts and additional cases are pending in Canada. The Judicial Panel on Multidistrict Litigation consolidated the federal court cases for pretrial purposes in the U.S. District Court for the Northern District of Florida. In February 2019, BMS and Otsuka entered into a master settlement agreement establishing a proposed settlement program to resolve all &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Abilify*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; compulsivity claims filed as of January 28, 2019 in the MDL as well as various state courts, including California and New Jersey. To date, approximately 2,700 cases, comprising approximately 3,900 plaintiffs, have been dismissed based on participation in the settlement program or failure to comply with settlement related court orders. In the U.S., less than 20 cases remain pending on behalf of plaintiffs, who either chose not to participate in the settlement program or filed their claims after the settlement cut-off date. There are eleven cases pending in Canada (four class actions, seven individual injury claims). Out of the eleven cases, only two are active (the class actions in Quebec and Ontario). Both class actions have now been certified and will proceed separately, subject to a pending appeal of the Ontario class certification decision.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Byetta*&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amylin, a former subsidiary of BMS, and Lilly are co-defendants in product liability litigation related to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Byetta*.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; As of June 2021, there are approximately 590 separate lawsuits pending on behalf of approximately 2,250 active plaintiffs (including pending settlements), which include injury plaintiffs as well as claims by spouses and/or other beneficiaries, in various courts in the U.S. The majority of these cases have been brought by individuals who allege personal injury sustained after using &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Byetta&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*, primarily pancreatic cancer, and, in some cases, claiming alleged wrongful death. The majority of cases are pending in Federal Court in San Diego in an MDL or in a coordinated proceeding in California Superior Court in Los Angeles (&#x201c;JCCP&#x201d;). In April 2020 the defendants filed a motion for summary judgment based on federal preemption and a motion for summary judgment based on the absence of general causation evidence in the MDL and JCCP. Both motions were granted in March 2021 and April 2021, respectively. The orders will result in the dismissal of all claims alleging an injury of pancreatic cancer in the MDL and JCCP. Plaintiffs have appealed the MDL order and may seek appeals in the JCCP. BMS sold &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Byetta&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* to AstraZeneca in February 2014 as part of BMS&#x2019;s global diabetes business divestiture and any additional liability to Amylin with respect to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Byetta&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* is expected to be shared with AstraZeneca.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Onglyza*&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS and AstraZeneca are co-defendants in product liability litigation related to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Onglyza*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Plaintiffs assert claims, including claims for wrongful death, as a result of heart failure or other cardiovascular injuries they allege were caused by their use of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Onglyza*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. As of June 2021, claims are pending in state and federal court on behalf of approximately 270 individuals who allege they ingested the product and suffered an injury. In February 2018, the Judicial Panel on Multidistrict Litigation ordered all federal cases to be transferred to an MDL in the U.S. District Court for the Eastern District of Kentucky. A significant majority of the claims are pending in the MDL.&#160;As part of BMS&#x2019;s global diabetes business divestiture, BMS sold &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Onglyza*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to AstraZeneca in February 2014 and any potential liability with respect to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Onglyza*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; is expected to be shared with AstraZeneca.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SECURITIES LITIGATION&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;BMS Securities Class Action&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since February 2018, two separate putative class action complaints were filed in the U.S. District for the Northern District of California and in the U.S. District Court for the Southern District of New York against BMS, BMS&#x2019;s Chief Executive Officer, Giovanni Caforio, BMS&#x2019;s Chief Financial Officer at the time, Charles A. Bancroft and certain former and current executives of BMS.&#160;The case in California has been voluntarily dismissed. The remaining complaint alleges violations of securities laws for BMS&#x2019;s disclosures related to the CheckMate-026 clinical trial in lung cancer. In September 2019, the Court granted BMS&#x2019;s motion to dismiss, but allowed the plaintiffs leave to file an amended complaint. In October 2019, the plaintiffs filed an amended complaint. In September 2020, the Court granted BMS&#x2019;s motion to dismiss the amended complaint with prejudice. The plaintiffs appealed the Court&#x2019;s decision in October 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Celgene Securities Class Action&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in March 2018, two putative class actions were filed against Celgene and certain of its officers in the U.S. District Court for the District of New Jersey (the &#x201c;Celgene Securities Class Action&#x201d;).&#160;The complaints allege that the defendants violated federal securities laws by making misstatements and/or omissions concerning (1) trials of GED-0301, (2) Celgene&#x2019;s 2020 outlook and projected sales of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Otezla*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and (3) the new drug application for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Zeposia&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Court consolidated the two actions and appointed a lead plaintiff, lead counsel, and co-liaison counsel for the putative class. In February 2019, the defendants filed a motion to dismiss plaintiff&#x2019;s amended complaint in full. In December 2019, the Court denied the motion to dismiss in part and granted the motion to dismiss in part (including all claims arising from alleged misstatements regarding GED-0301). Although the Court gave the plaintiff leave to re-plead the dismissed claims, it elected not to do so, and the dismissed claims are now dismissed with prejudice. In November 2020, the Court granted class certification with respect to the remaining claims. In December 2020, the defendants sought leave to appeal the Court&#x2019;s class certification decision, which was denied without prejudice in March 2021. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, certain Schwab management investment companies on behalf of certain Schwab funds filed an individual action in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action against the same remaining defendants in that action. In July 2020, the defendants filed a motion to dismiss the plaintiffs&#x2019; complaint in full. In March 2021, the Court granted in part and denied in part defendants&#x2019; motion to dismiss consistent with its decision in the Celgene Securities Class Action.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The California Public Employees&#x2019; Retirement System in April 2021 and DFA Investment Dimensions Group Inc., on behalf of certain of its funds, and American Century Mutual Funds, Inc., on behalf of certain of its funds, in July 2021 filed separate individual actions in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action and the Schwab individual action against the same remaining defendants in those actions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contingent Value Rights Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2021, an action was filed against BMS in the U.S. District Court for the Southern District of New York asserting claims of alleged breaches of a Contingent Value Rights Agreement (&#x201c;CVR Agreement&#x201d;) entered into in connection with the closing of BMS&#x2019;s acquisition of Celgene Corporation in November 2019. The successor trustee under the CVR Agreement alleges that BMS breached the CVR Agreement by allegedly failing to use &#x201c;diligent efforts&#x201d; to obtain FDA approval of liso-cel (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Breyanzi&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) before a contractual milestone date, thereby avoiding a $6.4 billion potential obligation to holders of the contingent value rights governed by the CVR Agreement and by allegedly failing to permit inspection of records in response to a request by the successor trustee. The successor trustee seeks damages in an amount to be determined at trial and other relief, including interest and attorneys&#x2019; fees. BMS disputes the successor trustee&#x2019;s allegations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;OTHER LITIGATION&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Average Manufacturer Price Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS is a defendant in a qui tam (whistleblower) lawsuit in the U.S. District Court for the Eastern District of Pennsylvania, in which the U.S. Government declined to intervene. The complaint alleges that BMS inaccurately reported its average manufacturer prices to the Centers for Medicare and Medicaid Services to lower what it owed. Similar claims have been filed against other companies. In January 2020, BMS reached an agreement in principle to resolve this matter subject to the negotiation of a definitive settlement agreement and other contingencies. In March 2021, BMS finalized an agreement with the U.S. government and qui tam relator to resolve the claims asserted in the lawsuit. BMS has paid $75 million plus interest to the federal and state governments. Individual agreements will be negotiated with participating states based on the federal agreement. To the extent BMS does not finalize a settlement agreement with any state, that state&#x2019;s share of the settlement will revert to BMS.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;HIV Medication Antitrust Lawsuits&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BMS and two other manufacturers of HIV medications are defendants in related lawsuits pending in the Northern District of California. The lawsuits allege that the defendants&#x2019; agreements to develop and sell fixed-dose combination products for the treatment of HIV, including &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Atripla*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Evotaz&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, violate antitrust laws. The currently pending actions, asserted on behalf of indirect purchasers, were initiated in 2019 in the Northern District of California and in 2020 in the Southern District of Florida. The Florida matter was transferred to the Northern District of California. In July 2020, the Court granted in part defendants&#x2019; motion to dismiss, including dismissing with prejudice plaintiffs&#x2019; claims as to an overarching conspiracy and plaintiffs&#x2019; theories based on the alleged payment of royalties after patent expiration. Other claims, however, remain. In September and October 2020, two purported class actions have also been filed asserting similar claims on behalf of direct purchasers. In March 2021, the Court dismissed one of the direct purchaser cases and limited the claims of the remaining direct purchaser case to those arising in 2016 or later. However, the Court gave plaintiffs leave to amend their complaints, and one plaintiff filed an amended complaint on March 16, 2021. A trial on both the direct and indirect purchaser claims is scheduled for November 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, BMS and two other manufacturers of HIV medications were sued in State Court in New Mexico by the Attorney General of the State of New Mexico in a case alleging that the defendants&#x2019; agreements to develop and sell various fixed-dose combination products for the treatment of HIV, including &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Atripla*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and agreements to settle certain patent litigation violate the antitrust laws of the State of New Mexico. No schedule has been set for the case.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; Litigations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning in November 2014, certain putative class action lawsuits were filed against Celgene in the U.S. District Court for the District of New Jersey alleging that Celgene violated various antitrust, consumer protection, and unfair competition laws by (a) allegedly securing an exclusive supply contract for the alleged purpose of preventing a generic manufacturer from securing its own supply of thalidomide active pharmaceutical ingredient, (b) allegedly refusing to sell samples of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brand drugs to various generic manufacturers for the alleged purpose of bioequivalence testing necessary for aNDAs to be submitted to the FDA for approval to market generic versions of these products, (c) allegedly bringing unjustified patent infringement lawsuits in order to allegedly delay approval for proposed generic versions of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and/or (d) allegedly entering into settlements of patent infringement lawsuits with certain generic manufacturers that allegedly have had anticompetitive effects. The plaintiffs, on behalf of themselves and putative classes of third-party payers, sought injunctive relief and damages. The various lawsuits were consolidated into a master action for all purposes. In March 2020, Celgene reached a settlement with the class plaintiffs. In October 2020, the Court entered a final order approving the settlement and dismissed the matter. That settlement does not resolve the claims of certain entities that opted out of the settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2018, Humana, Inc. (&#x201c;Humana&#x201d;) filed a lawsuit against Celgene in the Pike County Circuit Court of the Commonwealth of Kentucky.&#160;Humana&#x2019;s complaint alleges Celgene engaged in unlawful off-label marketing in connection with sales of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and asserts claims against Celgene for fraud, breach of contract, negligent misrepresentation, unjust enrichment and violations of New Jersey&#x2019;s Racketeer Influenced and Corrupt Organizations Act. The complaint seeks, among other things, treble and punitive damages, injunctive relief and attorneys&#x2019; fees and costs. In April 2019, Celgene filed a motion to dismiss Humana&#x2019;s complaint, which the Court denied in January 2020. No trial date has been scheduled. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2019, Humana filed a lawsuit against Celgene in the U.S. District Court for the District of New Jersey. Humana&#x2019;s complaint makes largely the same claims and allegations as were made in the class action litigation. The complaint purports to assert claims on behalf of Humana and its subsidiaries in several capacities, including as a direct purchaser and as an indirect purchaser, and seeks, among other things, treble and punitive damages, injunctive relief and attorneys&#x2019; fees and costs. In May 2019, Celgene filed a motion to dismiss Humana&#x2019;s complaint, and the Court has stayed discovery pending adjudication of that motion. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, United HealthCare Services, Inc. (&#x201c;UHS&#x201d;), affiliates of which opted out of the first settlement in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Antitrust Class Action Litigation, filed a lawsuit against Celgene in the U.S. District Court for the District of Minnesota. UHS&#x2019;s complaint makes largely the same claims and allegations as were made in the class action litigation in addition to certain claims regarding donations directed to copay assistance. The complaint purports to assert claims on behalf of UHS and its subsidiaries in several capacities, including as a direct purchaser and as an indirect purchaser, and seeks, among other things, treble and punitive damages, injunctive relief and attorneys&#x2019; fees and costs. In December 2020, Celgene&#x2019;s motion to transfer the action to the District of New Jersey was granted and the case is now pending in that Court. In January 2021, Celgene filed a motion to dismiss UHS&#x2019;s complaint, which the Court administratively terminated in June 2021 pending its decision on Celgene&#x2019;s pending motion to dismiss Humana&#x2019;s complaint. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, Celgene filed suit against Humana Pharmacy, Inc. (&#x201c;HPI&#x201d;), a Humana subsidiary, in Delaware Superior Court. Celgene&#x2019;s complaint alleges that HPI breached its contractual obligations to Celgene by assigning claims to Humana that Humana is now asserting. The complaint seeks damages for HPI&#x2019;s breach as well as a declaratory judgment. In September 2020, HPI filed a motion to dismiss Celgene&#x2019;s complaint, which was denied in February 2021. A trial has been scheduled for March 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2020, Blue Cross Blue Shield Association (&#x201c;BCBSA&#x201d;) sued Celgene and BMS on behalf of the Federal Employee Program in the U.S. District Court for the District of Columbia. BCBSA&#x2019;s complaint makes largely the same claims and allegations as were made in the class action litigation. In April 2021, the parties&#x2019; joint motion to transfer the action to the District of New Jersey was granted and the case is now pending in that Court. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, BCBSM Inc., Health Care Service Corporation (&#x201c;HCSC&#x201d;), Blue Cross and Blue Shield of Florida Inc.,  and Molina Healthcare, Inc. (&#x201c;Molina&#x201d;) sued Celgene and BMS in a Minnesota state court. The complaint makes largely the same claims and allegations as were made in the class action litigation but adds allegations on behalf of HCSC only as to alleged off-label marketing of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Thalomid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revlimid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. In September 2020, Celgene and BMS removed the action to the U.S. District Court for the District of Minnesota. In March 2021, that Court denied plaintiffs&#x2019; motion to remand the action to state court, dismissed Molina for lack of personal jurisdiction and granted defendants&#x2019; motion to transfer the action to the District of New Jersey. The case is now pending in the District of New Jersey. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, Cigna Corporation (&#x201c;Cigna&#x201d;) sued Celgene and BMS in the U.S. District Court for the Eastern District of Pennsylvania. Cigna&#x2019;s complaint makes largely the same claims and allegations as were made in the class action litigation. Cigna&#x2019;s complaint purports to assert claims on behalf of Cigna and its subsidiaries in several capacities, including as a direct purchaser and as an indirect purchaser. In May 2021, the parties&#x2019; joint motion to transfer the action to the District of New Jersey was granted and the case is now pending in that Court. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, Molina sued Celgene and BMS in San Francisco Superior Court. Molina&#x2019;s complaint makes largely the same claims and allegations as were made in the class action litigation. No trial date has been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;GOVERNMENT INVESTIGATIONS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Like other pharmaceutical companies, BMS and certain of its subsidiaries are subject to extensive regulation by national, state and local authorities in the U.S. and other countries in which BMS operates. As a result, BMS, from time to time, is subject to various governmental and regulatory inquiries and investigations as well as threatened legal actions and proceedings. It is possible that criminal charges, substantial fines and/or civil penalties, could result from government or regulatory investigations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;ENVIRONMENTAL PROCEEDINGS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As previously reported, BMS is a party to several environmental proceedings and other matters, and is responsible under various state, federal and foreign laws, including CERCLA, for certain costs of investigating and/or remediating contamination resulting from past industrial activity at BMS&#x2019;s current or former sites or at waste disposal or reprocessing facilities operated by third parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;CERCLA Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With respect to CERCLA matters for which BMS is responsible under various state, federal and foreign laws, BMS typically estimates potential costs based on information obtained from the U.S. Environmental Protection Agency, or counterpart state or foreign agency and/or studies prepared by independent consultants, including the total estimated costs for the site and the expected cost-sharing, if any, with other &#x201c;potentially responsible parties,&#x201d; and BMS accrues liabilities when they are probable and reasonably estimable. BMS estimated its share of future costs for these sites to be $75 million at June&#160;30, 2021, which represents the sum of best estimates or, where no best estimate can reasonably be made, estimates of the minimal probable amount among a range of such costs (without taking into account any potential recoveries from other parties). The amount includes the estimated costs for any additional probable loss associated with the previously disclosed North Brunswick Township High School Remediation Site.&lt;/span&gt;&lt;/div&gt;</us-gaap:LegalMattersAndContingenciesTextBlock>
    <us-gaap:LossContingencyPatentsAllegedlyInfringedNumber
      contextRef="i00042bb08bc247c88f649c75d7bbb73f_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfMjY4NA_cea46598-0c06-48cd-8f23-601a38556fa1"
      unitRef="number">6</us-gaap:LossContingencyPatentsAllegedlyInfringedNumber>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i6f6c2befa4b34a0a81ba3b0e9556df39_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfNTE4Ng_a5b78ab3-2894-4e30-8158-9d41755897f4"
      unitRef="usd">1200000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i2468cf0aaf4c49ab87c383ed553537e0_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfNTIzOQ_8b4bc53e-ce71-4836-9f9b-18552d6858d3"
      unitRef="usd">0.276</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="i64a8873ecda74aafb2ceeed0be390c87_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfNjA5Ng_159473ed-6a66-4df2-b02c-8932a78ce777"
      unitRef="number">25</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyPatentsAllegedlyInfringedNumber
      contextRef="i64a8873ecda74aafb2ceeed0be390c87_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfNjI1OA_912c8422-cf75-414e-9fa6-ab9abf1a0e24"
      unitRef="number">2</us-gaap:LossContingencyPatentsAllegedlyInfringedNumber>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="ibd94bed0537c407e93ce5a3d80b707af_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfOTQ5NA_97f19b97-706c-4266-b586-9376d620b369"
      unitRef="usd">449000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="ia4e7cac4d7fc407bbf7a0cfcc8e6a83f_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfOTUwMg_6e9e094f-ba8b-4450-9a1f-29f265dbc4c0"
      unitRef="usd">341000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i86db086f990f485eae2c529279a9b3be_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfMjAyNjQ_8d857132-034b-45b3-b447-55bfa98da6bf"
      unitRef="lawsuits">2500</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i69bcd074cc8f40729d45455b3b8c32f0_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfMjA4MTg_8dfff0d2-57d4-443b-bbb6-be7eba6b3ce5"
      unitRef="lawsuits">2700</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="ic26045979d2740d8b8904c0387c53e4a_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfMjA4NTM_ec548410-ebde-4ca6-baca-6f65f3c221ad"
      unitRef="numberofplaintiffs">3900</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="if9edbfdefa9f4c869623f5989777a4d3_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfMjEwMTk_88821249-11e8-4834-a0c3-3a5971a98366"
      unitRef="lawsuits">20</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="if0ca0adab86748b08591cb41bae7063a_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfMjE3MDQ_de0936c5-0dd6-4673-bc03-9a8fa1badfd0"
      unitRef="lawsuits">590</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="icbb5732de29d4e31bb981cab01299d47_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfMjE3NjA_a9778d1f-cbd4-4db1-bcb5-dff09ef0f948"
      unitRef="numberofplaintiffs">2250</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="ic175769943af4209805f2855da447a24_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfMjM0NTE_89c01ecf-58c4-441f-b31e-1815aee376c5"
      unitRef="numberofplaintiffs">270</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="icdc726e72d84409b8ca5e19dbe8e141c_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfMjQwNDY_a280a248-8b86-4357-ac65-25a62afdcc10"
      unitRef="lawsuits">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ie36b4dda4d274314992050f1a7686ae7_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfMjUwMzI_bfb9aa8a-d3e4-431d-86d8-50c5491df3bd"
      unitRef="lawsuits">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="ie5d797c7be774aa39277765dc8964e48_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV85MS9mcmFnOmRhOTYzNTA5OWJhZjRiODU4N2I4NzMxZGU2MDdmYjcyL3RleHRyZWdpb246ZGE5NjM1MDk5YmFmNGI4NTg3Yjg3MzFkZTYwN2ZiNzJfMzc3NTk_adb274f2-6288-4e47-92cd-baf2f1d03fd0"
      unitRef="usd">75000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <dei:DocumentFiscalYearFocus
      contextRef="i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xMDkvZnJhZzpkMTQ3N2FlN2JmZWE0MDQ1YWJhZWFhZTg1OGFmYjg1My90ZXh0cmVnaW9uOmQxNDc3YWU3YmZlYTQwNDVhYmFlYWFlODU4YWZiODUzXzI2MA_fd849ec4-327b-4d10-99b3-2147c6c901ac">2021</dei:DocumentFiscalYearFocus>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNi0xLTEtMS0w_854dcc1c-daf5-4493-b28a-375e5aa89e7a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNi0xLTEtMS0w_854dcc1c-daf5-4493-b28a-375e5aa89e7a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNi0zLTEtMS0w_7ec21314-9a79-4478-9828-3ae79b144f31"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNi0zLTEtMS0w_7ec21314-9a79-4478-9828-3ae79b144f31"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RleHRyZWdpb246ODk5ZTdlNGQyZjRhNGI4YTg5NjA1NzdiMWNiODY3ZTlfMzY0_a4610352-7756-429b-a9c8-7581cfff2dd4" xlink:label="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RleHRyZWdpb246ODk5ZTdlNGQyZjRhNGI4YTg5NjA1NzdiMWNiODY3ZTlfMzY0_a4610352-7756-429b-a9c8-7581cfff2dd4" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Excludes amortization of acquired intangible assets</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNi0xLTEtMS0w_854dcc1c-daf5-4493-b28a-375e5aa89e7a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RleHRyZWdpb246ODk5ZTdlNGQyZjRhNGI4YTg5NjA1NzdiMWNiODY3ZTlfMzY0_a4610352-7756-429b-a9c8-7581cfff2dd4"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RhYmxlOjliMjVmNzZjZDQyYjRlNWRhMWNmNGIwNjNkNTliZmU5L3RhYmxlcmFuZ2U6OWIyNWY3NmNkNDJiNGU1ZGExY2Y0YjA2M2Q1OWJmZTlfNi0zLTEtMS0w_7ec21314-9a79-4478-9828-3ae79b144f31"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOmQ2NmY0ZWNjODlhYTQ1YmNhNzc1NjQyMGM2MDk2NmY1L3NlYzpkNjZmNGVjYzg5YWE0NWJjYTc3NTY0MjBjNjA5NjZmNV8xNi9mcmFnOjg5OWU3ZTRkMmY0YTRiOGE4OTYwNTc3YjFjYjg2N2U5L3RleHRyZWdpb246ODk5ZTdlNGQyZjRhNGI4YTg5NjA1NzdiMWNiODY3ZTlfMzY0_a4610352-7756-429b-a9c8-7581cfff2dd4"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120048081064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-01136<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BRISTOL MYERS SQUIBB CO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">430 E. 29th Street, 14FL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10016<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">212<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">546-4000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000014272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">22-0790350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">2,222,113,553<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bmy_CommonStock0.10ParValueMember', window );">Common Stock $0.10 Par Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.10 Par Value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BMY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bmy_A1.000Notesdue2025Member', window );">1.000% Notes due 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.000% Notes due 2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BMY25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bmy_A1.750Notesdue2035Member', window );">1.750% Notes due 2035 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.750% Notes due 2035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BMY35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bmy_CelgeneContingentValueRightsMember', window );">Celgene Contingent Value Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Celgene Contingent Value Rights<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CELG RT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bmy_CommonStock0.10ParValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bmy_CommonStock0.10ParValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bmy_A1.000Notesdue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bmy_A1.000Notesdue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bmy_A1.750Notesdue2035Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bmy_A1.750Notesdue2035Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bmy_CelgeneContingentValueRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bmy_CelgeneContingentValueRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120049088968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF EARNINGS (UNAUDITED) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Jun. 30, 2021</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">$ 11,703<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 10,129<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 22,776<span></span>
</td>
<td class="nump">$ 20,910<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">2,452<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,699<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">5,293<span></span>
</td>
<td class="nump">6,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Marketing, selling and administrative</a></td>
<td class="nump">1,882<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,628<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,548<span></span>
</td>
<td class="nump">3,234<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">3,271<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,522<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,496<span></span>
</td>
<td class="nump">4,894<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_AmortizationofAcquiredIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">2,547<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,389<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,060<span></span>
</td>
<td class="nump">4,671<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income)/expense, net</a></td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(736)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(704)<span></span>
</td>
<td class="nump">427<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Expenses</a></td>
<td class="nump">10,150<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,502<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">18,693<span></span>
</td>
<td class="nump">19,587<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Earnings Before Income Taxes</a></td>
<td class="nump">1,553<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,627<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,083<span></span>
</td>
<td class="nump">1,323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for Income Taxes</a></td>
<td class="nump">492<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,707<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">993<span></span>
</td>
<td class="nump">2,169<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Earnings/(Loss)</a></td>
<td class="nump">1,061<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(80)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,090<span></span>
</td>
<td class="num">(846)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Noncontrolling Interest</a></td>
<td class="nump">6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Earnings/(Loss) Attributable to BMS</a></td>
<td class="nump">$ 1,055<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (85)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 3,076<span></span>
</td>
<td class="num">$ (860)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings/(Loss) Per Share, Basic</a></td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (0.04)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1.38<span></span>
</td>
<td class="num">$ (0.38)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings/(Loss) Per Share, Diluted</a></td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">$ (0.04)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 1.36<span></span>
</td>
<td class="num">$ (0.38)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember', window );">Net product sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">$ 11,405<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9,817<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 22,203<span></span>
</td>
<td class="nump">$ 20,358<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_AllianceandotherrevenuesMember', window );">Alliance and other revenues [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">$ 298<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 312<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 573<span></span>
</td>
<td class="nump">$ 552<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Excludes amortization of acquired intangible assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AmortizationofAcquiredIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization of Acquired Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AmortizationofAcquiredIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_AllianceandotherrevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_AllianceandotherrevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120054407416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Earnings/(Loss)</a></td>
<td class="nump">$ 1,061<span></span>
</td>
<td class="num">$ (80)<span></span>
</td>
<td class="nump">$ 3,090<span></span>
</td>
<td class="num">$ (846)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Derivatives qualifying as cash flow hedges</a></td>
<td class="nump">6<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="nump">286<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and postretirement benefits</a></td>
<td class="nump">15<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Available-for-sale debt securities</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(65)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income/(Loss)</a></td>
<td class="nump">26<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">321<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive Income/(Loss)</a></td>
<td class="nump">1,087<span></span>
</td>
<td class="num">(87)<span></span>
</td>
<td class="nump">3,411<span></span>
</td>
<td class="num">(882)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Comprehensive Income Attributable to Noncontrolling Interest</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive Income/(Loss) Attributable to BMS</a></td>
<td class="nump">$ 1,081<span></span>
</td>
<td class="num">$ (92)<span></span>
</td>
<td class="nump">$ 3,397<span></span>
</td>
<td class="num">$ (896)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120050673784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 11,024<span></span>
</td>
<td class="nump">$ 14,546<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable debt securities</a></td>
<td class="nump">1,946<span></span>
</td>
<td class="nump">1,285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables</a></td>
<td class="nump">9,017<span></span>
</td>
<td class="nump">8,501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">2,137<span></span>
</td>
<td class="nump">2,074<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">5,037<span></span>
</td>
<td class="nump">3,786<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">29,161<span></span>
</td>
<td class="nump">30,192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment</a></td>
<td class="nump">5,795<span></span>
</td>
<td class="nump">5,886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">20,529<span></span>
</td>
<td class="nump">20,547<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets</a></td>
<td class="nump">48,065<span></span>
</td>
<td class="nump">53,243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes</a></td>
<td class="nump">650<span></span>
</td>
<td class="nump">1,161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Marketable debt securities</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">433<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">6,454<span></span>
</td>
<td class="nump">7,019<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">110,797<span></span>
</td>
<td class="nump">118,481<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Short-term debt obligations</a></td>
<td class="nump">2,655<span></span>
</td>
<td class="nump">2,340<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">3,609<span></span>
</td>
<td class="nump">2,713<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">12,727<span></span>
</td>
<td class="nump">14,027<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">18,991<span></span>
</td>
<td class="nump">19,080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">4,931<span></span>
</td>
<td class="nump">5,407<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">42,503<span></span>
</td>
<td class="nump">48,336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">7,498<span></span>
</td>
<td class="nump">7,776<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">73,923<span></span>
</td>
<td class="nump">80,599<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Bristol-Myers Squibb Company Shareholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">292<span></span>
</td>
<td class="nump">292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Capital in excess of par value of stock</a></td>
<td class="nump">44,064<span></span>
</td>
<td class="nump">44,325<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(1,518)<span></span>
</td>
<td class="num">(1,839)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">22,168<span></span>
</td>
<td class="nump">21,281<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Less cost of treasury stock</a></td>
<td class="num">(28,198)<span></span>
</td>
<td class="num">(26,237)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Bristol-Myers Squibb Company Shareholders' Equity</a></td>
<td class="nump">36,808<span></span>
</td>
<td class="nump">37,822<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling Interest</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total Equity</a></td>
<td class="nump">36,874<span></span>
</td>
<td class="nump">37,882<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Equity</a></td>
<td class="nump">$ 110,797<span></span>
</td>
<td class="nump">$ 118,481<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120050128632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows From Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Earnings/(Loss)</a></td>
<td class="nump">$ 3,090<span></span>
</td>
<td class="num">$ (846)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization, net</a></td>
<td class="nump">5,380<span></span>
</td>
<td class="nump">5,035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(95)<span></span>
</td>
<td class="nump">1,365<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">308<span></span>
</td>
<td class="nump">423<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Impairment charges</a></td>
<td class="nump">579<span></span>
</td>
<td class="nump">116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_Pensionsettlementsandamortization', window );">Pension settlements and amortization</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_Divestituregainsandroyalties', window );">Divestiture gains and royalties</a></td>
<td class="num">(302)<span></span>
</td>
<td class="num">(295)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_Assetacquisitioncharge', window );">Asset acquisition charges</a></td>
<td class="nump">801<span></span>
</td>
<td class="nump">361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments', window );">Equity investment (gains)/losses</a></td>
<td class="num">(749)<span></span>
</td>
<td class="num">(480)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration fair value adjustments</a></td>
<td class="num">(510)<span></span>
</td>
<td class="nump">391<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other adjustments</a></td>
<td class="nump">204<span></span>
</td>
<td class="num">(91)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract', window );"><strong>Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables</a></td>
<td class="num">(626)<span></span>
</td>
<td class="num">(197)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="nump">111<span></span>
</td>
<td class="nump">2,090<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">158<span></span>
</td>
<td class="nump">480<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="num">(795)<span></span>
</td>
<td class="nump">185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other</a></td>
<td class="num">(695)<span></span>
</td>
<td class="num">(129)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Provided by Operating Activities</a></td>
<td class="nump">6,884<span></span>
</td>
<td class="nump">8,430<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows From Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Sale and maturities of marketable debt securities</a></td>
<td class="nump">1,968<span></span>
</td>
<td class="nump">3,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable debt securities</a></td>
<td class="num">(2,343)<span></span>
</td>
<td class="num">(1,957)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity', window );">Proceeds from sales of equity investment securities</a></td>
<td class="nump">814<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(383)<span></span>
</td>
<td class="num">(317)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_Divestitureandotherproceeds', window );">Divestiture and other proceeds</a></td>
<td class="nump">382<span></span>
</td>
<td class="nump">336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition and other payments, net of cash acquired</a></td>
<td class="num">(401)<span></span>
</td>
<td class="num">(445)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Provided by Investing Activities</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">1,166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows From Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Short-term debt obligations, net</a></td>
<td class="num">(185)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of Long-term Debt</a></td>
<td class="num">(5,522)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(3,011)<span></span>
</td>
<td class="num">(81)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends</a></td>
<td class="num">(2,207)<span></span>
</td>
<td class="num">(2,038)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="nump">448<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash (Used in)/Provided by Financing Activities</a></td>
<td class="num">(10,477)<span></span>
</td>
<td class="num">(2,047)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</a></td>
<td class="num">(3,576)<span></span>
</td>
<td class="nump">7,542<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents and Restricted Cash at Beginning of Period</a></td>
<td class="nump">14,973<span></span>
</td>
<td class="nump">12,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, Cash Equivalents and Restricted Cash at End of Period</a></td>
<td class="nump">$ 11,397<span></span>
</td>
<td class="nump">$ 20,362<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_Assetacquisitioncharge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the charge for an asset acquisition in the statement of cash flows.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_Assetacquisitioncharge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_Divestitureandotherproceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a business, asset or other proceeds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_Divestitureandotherproceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_Divestituregainsandroyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This represents the amount of gains and royalties as a result of business divestitures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_Divestituregainsandroyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_Pensionsettlementsandamortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of expense recognized due to defined benefit pension settlements and curtailments and the amortization of prior service credits and net actuarial loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_Pensionsettlementsandamortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the net total realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including the unrealized holding gain (loss) of held-to-maturity securities transferred to the trading security category and the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders' equity) for available-for-sale securities transferred to trading securities during the period. Additionally, this item would include any gains (losses) realized during the period from the sale of investments accounted for under the cost method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of equity securities classified as available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120047244376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Notes)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSAbstract', window );"><strong>BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Basis of Presentation and Recently Issued Accounting Standards [Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Consolidation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bristol-Myers Squibb Company (&#8220;BMS&#8221;) prepared these unaudited consolidated financial statements following the requirements of the SEC and U.S. GAAP for interim reporting. Under those rules, certain footnotes and other financial information that are normally required for annual financial statements can be condensed or omitted. The Company is responsible for the consolidated financial statements included in this Quarterly Report on Form 10-Q, which include all adjustments necessary for a fair presentation of the financial position at June&#160;30, 2021 and December&#160;31, 2020, the results of operations for the three and six months ended June&#160;30, 2021 and 2020, and cash flows for the six months ended June&#160;30, 2021 and 2020. All intercompany balances and transactions have been eliminated. These financial statements and the related notes should be read in conjunction with the audited consolidated financial statements for the year ended December&#160;31, 2020 included in the 2020 Form&#160;10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Segment Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS operates in a single segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of innovative medicines that help patients prevail over serious diseases. A global research and development organization and supply chain organization are responsible for the discovery, development, manufacturing and supply of products. Regional commercial organizations market, distribute and sell the products. The business is also supported by global corporate staff functions. Consistent with BMS&#8217;s operational structure, the Chief Executive Officer (&#8220;CEO&#8221;), as the chief operating decision maker, manages and allocates resources at the global corporate level. Managing and allocating resources at the global corporate level enables the CEO to assess both the overall level of resources available and how to best deploy these resources across functions, therapeutic areas, regional commercial organizations and research and development projects in line with our overarching long-term corporate-wide strategic goals, rather than on a product or franchise basis. The determination of a single segment is consistent with the financial information regularly reviewed by the CEO for purposes of evaluating performance, allocating resources, setting incentive compensation targets, and planning and forecasting future periods. For further information on product and regional revenue, see &#8220;&#8212;Note 2. Revenue.&#8221;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates and Judgments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues, expenses, assets and liabilities can vary during each quarter of the year. Accordingly, the results and trends in these unaudited consolidated financial statements may not be indicative of full year operating results. The preparation of financial statements requires the use of management estimates, judgments and assumptions. The most significant assumptions are estimates used in determining accounting for business combinations; impairments of intangible assets; sales rebate and return accruals; legal contingencies; and income taxes. Actual results may differ from estimates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications were made to conform the prior period consolidated financial statements to the current period presentation. Cash payments resulting from licensing arrangements, including upfront and contingent milestones previously included in operating activities in the consolidated statements of cash flows are now presented in investing activities. The adjustment resulted in an increase to net cash provided by operating activities and net cash used in investing activities of $267&#160;million in the six months ended June 30, 2020. Proceeds received from the sale of equity investment securities previously presented in Divestiture and other proceeds in the consolidated statements of cash flows is now presented separately in Proceeds from sales of equity investment securities. These reclassifications did not have an impact on net assets or net earnings.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued amended guidance on the accounting and reporting of income taxes. The guidance is intended to simplify the accounting for income taxes by removing exceptions related to certain intraperiod tax allocations and deferred tax liabilities; clarifying guidance primarily related to evaluating the step-up tax basis for goodwill in a business combination; and reflecting enacted changes in tax laws or rates in the annual effective tax rate. BMS adopted the new guidance effective January 1, 2021. The amended guidance did not have a material impact on BMS&#8217;s results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120144178872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION Revenue Recognition (Notes)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue from Contract with Customer [Text Block]</a></td>
<td class="text">REVENUE<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by nature:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,405&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,817&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,358&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,703&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,129&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,776&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,910&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products are sold principally to wholesalers, distributors, specialty pharmacies, and to a lesser extent, directly to retailers, hospitals, clinics and government agencies. Customer orders are generally fulfilled within a few days of receipt resulting in minimal order backlog. Contractual performance obligations are usually limited to transfer of control of the product to the customer. The transfer occurs either upon shipment, upon receipt of the product after considering when the customer obtains legal title to the product, or upon infusion for cell therapies and when BMS obtains a right of payment. At these points, customers are able to direct the use of and obtain substantially all of the remaining benefits of the product.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes GTN adjustments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,782&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,788&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,341&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,474&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,720)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,292)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,632)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Medicare rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,482)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,857)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,980)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other rebates, returns, discounts and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,518)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,197)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,975)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,504)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total GTN adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,377)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,971)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,138)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,116)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,405&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,817&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,203&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,358&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes adjustments for provisions for product sales made in prior periods resulting from changes in estimates of $85 million and $302 million for the three and six months ended June&#160;30, 2021, and $44 million and $116 million for the three and six months ended June&#160;30, 2020, respectively.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by product and region:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prioritized Brands</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Revlimid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,884&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Eliquis</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Orencia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pomalyst/Imnovid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sprycel</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yervoy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abraxane</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Empliciti</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Reblozyl</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Inrebic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Onureg</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Zeposia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Breyanzi</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abecma</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Established Brands</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Vidaza</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Baraclude</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,703&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,129&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,776&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,910&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of the World</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,781&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,703&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,129&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,776&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,910&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by BMS&#8217;s regional commercial organizations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized from performance obligations satisfied in prior periods was $146 million and $430 million for the three and six months ended June&#160;30, 2021 and $98 million and $228 million for the three and six months ended June&#160;30, 2020, respectively, consisting primarily of revised estimates for GTN adjustments related to prior period sales and royalties for out-licensing arrangements. Contract assets were not material at June&#160;30, 2021 and December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120047447576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ALLIANCES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ALLIANCESAbstract', window );"><strong>ALLIANCES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Collaborative Arrangement Disclosure [Text Block]</a></td>
<td class="text">ALLIANCESBMS enters into collaboration arrangements with third parties for the development and commercialization of certain products. Although each of these arrangements is unique in nature, both parties are active participants in the operating activities of the collaboration and exposed to significant risks and rewards depending on the commercial success of the activities. BMS may either in-license intellectual property owned by the other party or out-license its intellectual property to the other party. These arrangements also typically include research, development, manufacturing, and/or commercial activities and can cover a single investigational compound or commercial product or multiple compounds and/or products in various life cycle stages. The rights and obligations of the parties can be global or limited to geographic regions. BMS refers to these collaborations as alliances and its partners as alliance partners.<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected financial information pertaining to alliances was as follows, including net product sales when BMS is the principal in the third-party customer sale for products subject to the alliance. Expenses summarized below do not include all amounts attributed to the activities for the products in the alliance, but only the payments between the alliance partners or the related amortization if the payments were deferred or capitalized.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues from alliances:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,964&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,364&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,988&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,192&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payments to/(from) alliance partners:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Selected Alliance Balance Sheet information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables &#8211; from alliance partners</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable &#8211; to alliance partners</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,032&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income from alliances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes unamortized upfront and milestone payments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specific information pertaining to significant alliances including their nature and purpose; the significant rights and obligations of the parties; and specific accounting policy elections are discussed in the 2020 Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Eisai</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In the second quarter of 2021, BMS and Eisai commenced an exclusive global strategic collaboration for the co-development and co-commercialization of MORAb-202, a selective folate receptor alpha antibody-drug conjugate being investigated in endometrial, ovarian, lung and breast cancers. MORAb-202 is currently in Phase I/II clinical trials for solid tumors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">BMS and Eisai will jointly develop and commercialize MORAb-202 in the U.S., Canada, Europe, Russia, Japan, China and certain other countries in the Asia-Pacific region (the &#8220;collaboration territory&#8221;). Eisai will be responsible for the global manufacturing and supply. Profits, research and development and commercialization costs are shared in the collaboration territories. BMS will be responsible for development and commercialization outside of the collaboration territory and will pay a royalty on those sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A $650&#160;million upfront collaboration fee was included in Research and development expense in the second quarter of 2021 and paid in the third quarter of 2021. BMS is also obligated to pay up to $2.5&#160;billion upon the achievement of contingent development, regulatory and sales-based milestones.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ALLIANCESAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ALLIANCES [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ALLIANCESAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI http://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120046033032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Notes)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract', window );"><strong>Acquisitions, Divestitures and Other Arrangements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Divestitures, Licensing and Other Arrangements [Text Block]</a></td>
<td class="text">DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Divestitures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of divestitures including royalties, which are included in Other (income)/expense, net. Revenue and pretax earnings related to all divestitures were not material in all periods presented (excluding divestiture gains or losses).</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Proceeds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divestiture (Gains)/Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Royalty Income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Business</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Erbitux</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* Business</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing Operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature Brands and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Proceeds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divestiture (Gains)/Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Royalty Income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Business</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(286)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Erbitux</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* Business</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing Operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Plavix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Avapro*/Avalide*</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature Brands and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(288)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes royalties received subsequent to the related sale of the asset or business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Licensing and Other Arrangements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Keytruda*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> royalties, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* royalties, up-front licensing fees and milestones for products that have not obtained commercial approval, which are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Keytruda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(396)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(316)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up-front licensing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent milestone income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other royalties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(485)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(433)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Agenus</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, BMS obtained a global exclusive license to Agenus&#8217; proprietary AGEN1777 bispecific antibody program that blocks TIGIT and an additional target. AGEN1777 is being studied in oncology and is in preclinical development. BMS will be responsible for the development and any subsequent commercialization of AGEN1777 and its related products worldwide, including strategic decisions, regulatory responsibilities, funding and manufacturing. BMS paid a $200&#160;million upfront licensing fee to Agenus and is obligated to pay up to $1.4&#160;billion upon achievement of contingent development, regulatory and sales-based milestones as well as royalties on global net sales.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisitions, Divestitures and Other Arrangements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AcquisitionsDivestituresandOtherArrangementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120047836856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER EXPENSE (INCOME), NET<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Nonoperating Income (Expense) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock', window );">Other (Income)/Expense [Text Block]</a></td>
<td class="text">OTHER (INCOME)/EXPENSE, NET<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(510)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties and licensing income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(405)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(772)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(721)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(818)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(749)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(480)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and other settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition and other service fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reversion excise tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture (gains)/losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt redemption</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(736)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(704)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -URI http://asc.fasb.org/topic&amp;trid=2122503<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 610<br> -URI http://asc.fasb.org/topic&amp;trid=49130413<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120047486120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringChargesAbstract', window );"><strong>Restructuring Charges [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring and Related Activities Disclosure [Text Block]</a></td>
<td class="text">RESTRUCTURING<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Celgene Acquisition Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, a restructuring and integration plan was implemented as an initiative to realize sustainable run rate synergies resulting from cost savings and avoidance from the Celgene acquisition which is currently expected to be approximately $3.0&#160;billion. The synergies are expected to be realized in Cost of products sold (10%), Marketing, selling and administrative expenses (55%) and Research and development expenses (35%). Charges of approximately $3.0&#160;billion are expected to be incurred through 2022. Cumulative charges of approximately $2.3&#160;billion have been recognized including integration planning and execution expenses, employee termination benefit costs and accelerated stock-based compensation, contract termination costs and other shutdown costs associated with site exits. Cash outlays in connection with these actions are expected to be approximately $2.5&#160;billion. Employee workforce reductions were approximately 240 and 900 for the six months ended June&#160;30, 2021 and 2020, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">MyoKardia Acquisition Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, a restructuring and integration plan was initiated to realize expected cost synergies resulting from cost savings and avoidance from the MyoKardia acquisition. Charges of approximately $150&#160;million are expected to be incurred through 2022, and consist of integration planning and execution expenses, employee termination benefit costs and other costs. Cumulative charges of approximately $95 million have been recognized for these actions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Company Transformation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2016, a restructuring plan was announced to evolve and streamline BMS&#8217;s operating model. Cumulative charges of approximately $1.5&#160;billion were recognized for these actions since the announcement. Actions under the plan were completed as of December 31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following provides the charges related to restructuring initiatives by type of cost:</span></div><div style="margin-bottom:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celgene Acquisition Plan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MyoKardia Acquisition Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company Transformation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other termination costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other shutdown costs, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the charges and spending related to restructuring plan activities:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability at December 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability at June 30</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes a reduction of the liability resulting from changes in estimates of $8 million and $6 million for the six months ended June 30, 2021 and 2020, respectively. Excludes $9 million and $47 million for the six months ended June 30, 2021 and 2020, respectively, of accelerated stock-based compensation relating to the Celgene Acquisition Plan.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120046089432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax Disclosure [Text Block]</a></td>
<td class="text">INCOME TAXES<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings Before Income Taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,553&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,627&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,083&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for Income Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Tax Rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes in interim periods are determined based on the estimated annual effective tax rates and the tax impact of discrete items that are reflected immediately. The effective tax rates in 2021 and 2020 were impacted by low jurisdictional tax rates attributed to the unwinding of inventory fair value adjustments and intangible asset amortization and contingent value rights fair value adjustments that are not taxable or deductible. The three and six months ended June&#160;30, 2020 includes an $853&#160;million deferred tax charge resulting from an internal transfer of certain intangible assets to the U.S. and an additional $255&#160;million GILTI tax charge upon finalization of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Otezla</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* divestiture tax consequences with tax authorities. Additional changes to the effective tax rate may occur in future periods due to various reasons, including changes to the estimated pretax earnings mix and tax reserves and revised interpretations or changes to the relevant tax code.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that the amount of unrecognized tax benefits at June&#160;30, 2021 could decrease in the range of approximately $430 million to $480 million in the next twelve months as a result of the settlement of certain tax audits and other events. The expected change in unrecognized tax benefits may result in the payment of additional taxes, adjustment of certain deferred taxes and/or recognition of tax benefits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS is currently under examination by a number of tax authorities, which have proposed or are considering proposing material adjustments to tax positions for issues such as transfer pricing, certain tax credits and the deductibility of certain expenses. As previously disclosed, BMS received several notices of proposed adjustments from the IRS related to transfer pricing and other tax positions for the 2008 to 2012 tax years. BMS disagrees with the IRS&#8217;s positions and continues to work cooperatively with the IRS to resolve these open tax audits. It is reasonably possible that new issues will be raised by tax authorities that may increase unrecognized tax benefits; however, an estimate of such increases cannot reasonably be made at this time. BMS believes that it has adequately provided for all open tax years by tax jurisdiction.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120047830184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS/(LOSS) PER SHARE<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings/(Loss) Per Share [Text Block]</a></td>
<td class="text">EARNINGS/(LOSS) PER SHARE<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts in Millions, Except Per Share Data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings/(Loss) Attributable to BMS Used for Basic and Diluted EPS Calculation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(860)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Common Shares Outstanding &#8211; Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental Shares Attributable to Share-Based Compensation Plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Common Shares Outstanding &#8211; Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,258&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings/(Loss) per Common Share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table>The total number of potential shares of common stock excluded from the diluted earnings/(loss) per common share computation because of the antidilutive impact was 9&#160;million for both the three and six months ended June&#160;30, 2021 and 127&#160;million for both the three and six months ended June&#160;30, 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120044906424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</a></td>
<td class="text">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis are summarized below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents - money market and other securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent value rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other acquisition related contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in &#8220;Item 8. Financial Statements and Supplementary Data&#8212;Note 9. Financial Instruments and Fair Value Measurements&#8221; in the Company&#8217;s 2020 Form 10-K, the Company&#8217;s fair value estimates use inputs that are either (1) quoted prices for identical assets or liabilities in active markets (Level 1 inputs); (2) observable prices for similar assets or liabilities in active markets or for identical or similar assets or liabilities in markets that are not active (Level 2 inputs); or (3) unobservable inputs (Level 3 inputs).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration obligations are recorded at their estimated fair values and these obligations are revalued each reporting period until the related contingencies are resolved. The contingent value rights are adjusted to fair value using the traded price of the securities at the end of each reporting period. The fair value measurements for other contingent consideration liabilities are estimated using probability-weighted discounted cash flow approaches that are based on significant unobservable inputs related to product candidates acquired in business combinations and are reviewed quarterly. These inputs include, as applicable, estimated probabilities and timing of achieving specified development and regulatory milestones and the discount rate used to calculate the present value of estimated future payments. Significant changes which increase or decrease the probabilities of achieving the related development and regulatory events or shorten or lengthen the time required to achieve such events would result in corresponding increases or decreases in the fair values of these obligations. The fair value of other acquisition related contingent consideration as of June&#160;30, 2021 was calculated using the following significant unobservable inputs:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.373%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ranges (weighted average) utilized as of:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3% to 1.3% (0.6%)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0% to 80% (2.4%)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected year of payment for development and regulatory milestones</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 to 2028</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers between levels 1, 2 and 3 during the six months ended&#160;June&#160;30, 2021. The following table represents a roll-forward of the fair value of level 3 instruments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value as of January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in estimated fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value as of June 30</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available-for-sale Debt Securities and Equity Investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes available-for-sale debt securities:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.799%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,020&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,020&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale debt securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,081&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,089&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,704&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,718&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All marketable debt securities mature within two years as of June&#160;30, 2021 and December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the carrying amount of equity investments:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments with readily determinable fair values</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,452&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,668&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,695&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the activity related to equity investments. Changes in fair value of equity investments are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain/(loss) recognized on equity investments with readily determinable fair values</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized gain/(loss) recognized on equity investments with readily determinable fair value sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upward adjustments on equity investments without readily determinable fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments and downward adjustments on equity investments without readily determinable fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative upward adjustments on equity investments without readily determinable fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative impairments and downward adjustments on equity investments without readily determinable fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Net unrealized net gains on equity investments still held were $11 million and $353 million for the three and six months ended June&#160;30, 2021 and $778 million and $550 million for the three and six months ended June&#160;30, 2020, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Qualifying Hedges and Non-Qualifying Derivatives</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges &#8212; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency forward contracts are used to hedge certain forecasted intercompany inventory purchases and sales transactions and certain foreign currency transactions. The fair value for contracts designated as cash flow hedges are temporarily reported in Accumulated other comprehensive loss and included in earnings when the hedged item affects earnings. The net gain or loss on foreign currency forward contracts is expected to be reclassified to net earnings (primarily included in Cost of products sold and Other (income)/expense, net) within the next 12 months. The notional amount of outstanding foreign currency forward contracts was primarily attributed to the euro of $3.1 billion and Japanese yen of $1.1 billion at June&#160;30, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The earnings impact related to discontinued cash flow hedges and hedge ineffectiveness was not material during all periods presented. Cash flow hedge accounting is discontinued when the forecasted transaction is no longer probable of occurring within 60 days after the originally forecasted date or when the hedge is no longer effective. Assessments to determine whether derivatives designated as qualifying hedges are highly effective in offsetting changes in the cash flows of hedged items are performed at inception and on a quarterly basis. Foreign currency forward contracts not designated as hedging instruments are used to offset exposures in certain foreign currency denominated assets, liabilities and earnings. Changes in the fair value of these derivatives are recognized in earnings as they occur.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS may hedge a portion of its future foreign currency exposure by utilizing a strategy that involves both a purchased local currency put option and a written local currency call option that are accounted for as hedges of future sales denominated in that local currency. Specifically, BMS sells (or writes) a local currency call option and purchases a local currency put option with the same expiration dates and local currency notional amounts but with different strike prices. The premium collected from the sale of the call option is equal to the premium paid for the purchased put option, resulting in no net premium being paid. This combination of transactions is generally referred to as a &#8220;zero-cost collar.&#8221; The expiration dates and notional amounts correspond to the amount and timing of forecasted foreign currency sales. If the U.S. Dollar weakens relative to the currency of the hedged anticipated sales, the purchased put option value reduces to zero and BMS benefits from the increase in the U.S. Dollar equivalent value of our anticipated foreign currency cash flows; however, this benefit would be capped at the strike level of the written call, which forms the upper end of the collar.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Hedges &#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Non-U.S. Dollar borrowings of &#8364;950 million ($1.1 billion) at June&#160;30, 2021 are designated as net investment hedges to hedge euro currency exposures of the net investment in certain foreign affiliates and are recognized in long-term debt. The effective portion of foreign exchange gain on the remeasurement of euro debt was included in the foreign currency translation component of Accumulated other comprehensive loss with the related offset in long-term debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cross-currency interest rate swap contracts of $400 million at June&#160;30, 2021 are designated to hedge Japanese yen currency exposure of BMS&#8217;s net investment in its Japan subsidiaries. Contract fair value changes are recorded in the foreign currency translation component of Other Comprehensive Income/(Loss) with a related offset in Other non-current assets or Other non-current liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hedges &#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Fixed to floating interest rate swap contracts are designated as fair value hedges and used as an interest rate risk management strategy to create an appropriate balance of fixed and floating rate debt. The contracts and underlying debt for the hedged benchmark risk are recorded at fair value. The effective interest rate for the contracts is one-month LIBOR (0.10% as of June&#160;30, 2021) plus an interest rate spread of 4.6%. Gains or losses resulting from changes in fair value of the underlying debt attributable to the hedged benchmark interest rate risk are recorded in interest expense with an associated offset to the carrying value of debt. Since the specific terms and notional amount of the swap are intended to align with the debt being hedged, all changes in fair value of the swap are recorded in interest expense with an associated offset to the derivative asset or liability on the consolidated balance sheet. As a result, there was no net impact in earnings. If the underlying swap is terminated prior to maturity, then the fair value adjustment to the underlying debt is amortized as a reduction to interest expense over the remaining term of the debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of outstanding derivatives:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"/><td style="width:34.704%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.319%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Included in Other current assets and Other non-current assets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Included in Other current liabilities and Other non-current liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial statement classification and amount of (gain)/loss recognized on hedging instruments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency zero-cost collar contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effect of derivative and non-derivative instruments designated as hedging instruments in Other Comprehensive Income/(Loss):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts gain/(loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income/(Loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives qualifying as net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts gain:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income/(Loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-derivatives qualifying as net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. dollar borrowings gain:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income/(Loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The majority is expected to be reclassified into earnings in the next 12 months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt Obligations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term debt obligations include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. short-term borrowings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,655&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,340&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt and the current portion of long-term debt include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,666&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to Principal Value:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized basis adjustment from swap terminations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized bond discounts and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized purchase price adjustments of Celgene debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,336&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,336&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of long-term debt was $50.6 billion at June&#160;30, 2021 and $58.5 billion at December&#160;31, 2020 valued using Level&#160;2 inputs, which are based upon the quoted market prices for the same or similar debt instruments. The fair value of short-term borrowings approximates the carrying value due to the short maturities of the debt instruments. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, BMS purchased aggregate principal amount of $3.5&#160;billion of certain of its debt securities for approximately $4.0&#160;billion of cash in a series of tender offers and &#8220;make whole&#8221; redemptions. In connection with these transactions, a $281&#160;million loss on debt redemption was recognized based on the carrying value of the debt and included in Other (income)/expense, net. In addition, the $500&#160;million 2.875% Notes matured and were repaid.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2021, the $1.0&#160;billion 2.550% Notes matured and were repaid.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest payments were $807 million and $845 million for the six months ended June 30, 2021 and 2020, respectively, net of amounts related to interest rate swap contracts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, BMS had four separate revolving credit facilities totaling $6.0&#160;billion, which consisted of a 364-day $2.0&#160;billion facility expiring in January 2022, a three-year $1.0&#160;billion facility expiring in January 2022 and two five-year $1.5&#160;billion facilities that were extended to September 2025 and July 2026, respectively. The facilities provide for customary terms and conditions with no financial covenants and may be used to provide backup liquidity for BMS&#8217;s commercial paper borrowings and are extendable annually by one year on the anniversary date with the consent of the lenders. No borrowings were outstanding under any revolving credit facility at June&#160;30, 2021 or December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120047465112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECEIVABLES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetAbstract', window );"><strong>Accounts Receivable, after Allowance for Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">Receivables [Text Block]</a></td>
<td class="text">RECEIVABLES<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,309&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,882&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(569)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(645)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less allowance for expected credit loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net trade receivables</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,713&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,219&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance, royalties, VAT and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,017&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,501&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-U.S. receivables sold on a nonrecourse basis were $638 million and $464 million for the six months ended June 30, 2021 and 2020, respectively. Receivables from the three largest customers in the U.S. represented approximately 58% and 56% of total trade receivables at June&#160;30, 2021 and December&#160;31, 2020, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI http://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120045798360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventory, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories [Text Block]</a></td>
<td class="text">INVENTORIES<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">891&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw and packaging materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,013&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,154&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total inventories include fair value adjustments resulting from the Celgene acquisition of $606 million at June&#160;30, 2021 and $774 million at December&#160;31, 2020. Other non-current assets include inventory expected to remain on hand beyond one year in both periods.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120047361608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment [Text Block]</a></td>
<td class="text">PROPERTY, PLANT AND EQUIPMENT<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,633&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,838)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,585)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,795&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,886&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $143 million and $278 million for the three and six months ended June&#160;30, 2021 and $145 million and $315 million for the three and six months ended June&#160;30, 2020, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120046131320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Intangible Assets Disclosure [Text Block]</a></td>
<td class="text">GOODWILL AND OTHER INTANGIBLE ASSETS<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:62.460%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.586%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Lives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;&#8211;&#160;15&#160;years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired marketed product rights</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;&#8211;&#160;15&#160;years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;&#8211;&#160;10&#160;years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPRD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,804&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,859&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,616)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,065&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,243&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the six months ended June&#160;30, 2021, $1.5&#160;billion of IPRD was reclassified to acquired marketed product rights upon approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. Amortization expense of other intangible assets was $2.5 billion and $5.1 billion for the three and six months ended June&#160;30, 2021 and $2.5 billion and $4.8 billion for the three and six months ended June&#160;30, 2020, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2021, a $230&#160;million IPRD impairment charge was recorded in Research and development expense following a decision to discontinue development of an investigational compound in connection with the prioritization of current pipeline opportunities. The compound was being studied as a potential treatment for fibrotic diseases and was acquired in the acquisition of Celgene. The charge represented a full write-down based on the estimated fair value determined using discounted cash flow projections.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inrebic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> EU regulatory approval milestones of $300&#160;million were achieved resulting in a $385&#160;million increase to the acquired marketed product rights intangible asset, after establishing the applicable deferred tax liability. An impairment charge of $315&#160;million was recognized in Cost of products sold as the carrying value of this asset exceeded the projected undiscounted cash flows of the asset. The charge was equal to the excess of the asset's carrying value over its estimated fair value using discounted cash flow projections.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120048029416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">Additional Financial Information Disclosure [Text Block]</a></td>
<td class="text">SUPPLEMENTAL FINANCIAL INFORMATION<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,258&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,799&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,037&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,786&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,622&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,454&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,019&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Restricted cash consists of funds restricted for annual Company contributions to the defined contribution plan in the U.S. and escrow for litigation settlements. Restricted cash of $373 million at June&#160;30, 2021 and $428&#160;million at June&#160;30, 2020 was included in cash, cash equivalents and restricted cash in the consolidated statements of cash flows.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates and returns</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,665&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,688&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent value rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,727&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,027&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,690&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,017&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,498&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,776&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalFinancialInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120047356424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity Note Disclosure [Text Block]</a></td>
<td class="text">EQUITY<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the six months ended June 30, 2021:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"/><td style="width:30.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.626%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.721%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.860%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.660%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and Shares in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,839)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,281&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,098)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,768)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(473)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,852&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,544)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,199)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,091)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,235)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,064&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,518)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,168&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,198)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $0.49 for the three months ended March 31, 2021 and June&#160;30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the six months ended June 30, 2020:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"/><td style="width:30.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.626%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.721%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.860%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.660%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and Shares in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,709&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,520)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,474&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,357)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(775)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,028)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(455)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,254&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,549)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,671&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,757)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,021)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock repurchase program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(210)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,444&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,556)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,565&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,651)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $0.45 for the three months ended March 31, 2020 and June&#160;30, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS has a share repurchase program, authorized by its Board of Directors, allowing for repurchases of its shares. The share repurchase program does not obligate us to repurchase any specific number of shares, does not have a specific expiration date and may be suspended or discontinued at any time. Treasury stock is recognized at the cost to reacquire the shares. Shares issued from treasury are recognized utilizing the first-in first-out method.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The outstanding share repurchase authority authorization under the program was $4.4 billion as of December 31, 2020. In January 2021, the Board of Directors approved an increase of $2.0&#160;billion to the share repurchase authorization for BMS&#8217;s common stock. BMS repurchased approximately 47 million shares of its common stock for $3.0 billion during the six months ended June&#160;30, 2021. The remaining share repurchase capacity under the share repurchase program was approximately $3.4 billion as of June&#160;30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS repurchased 1.4&#160;million shares of its common stock for $81&#160;million in the six months ended June&#160;30, 2020.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2019, BMS executed accelerated share repurchase (&#8220;ASR&#8221;) agreements to repurchase an aggregate $7&#160;billion of common stock. The ASR was funded with cash on-hand. In the fourth quarter of 2019, approximately 99&#160;million shares of common stock (80% of the $7&#160;billion aggregate repurchase price) were received by BMS and included in treasury stock. In the second quarter of 2020, the agreement was settled and approximately 16&#160;million shares of common stock were received by BMS and transferred to treasury stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of Other Comprehensive Income/(Loss) were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain/(losses)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to net earnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains/(losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized Losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income/(Loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain/(losses)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to net earnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains/(losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income/(Loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Included in Cost of products sold.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Included in Other (income)/expense, net.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accumulated balances related to each component of Other Comprehensive Income/(Loss), net of taxes, were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(936)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(974)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(638)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,518)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,839)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120045775912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE STOCK BENEFIT PLANS Employee Stock Benefit Plans (Notes)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract', window );"><strong>Share-based Payment Arrangement, Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-based Payment Arrangement [Text Block]</a></td>
<td class="text">EMPLOYEE STOCK BENEFIT PLANS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense was as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.571%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Income tax benefit excludes excess tax benefits from share-based compensation awards that were vested or exercised of $12 million and $29 million for the three and six months ended June&#160;30, 2021 and $5 million and $28 million for the three and six months ended June&#160;30, 2020, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of units granted and the weighted-average fair value on the grant date for the six months ended June 30, 2021 were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Units in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:50.082%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.587%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock&#160;Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Market Share&#160;Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Share Units</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized compensation cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected weighted-average period in years of compensation cost to be recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120046097016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEGAL PROCEEDINGS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">Legal Proceedings and Contingencies [Text Block]</a></td>
<td class="text">LEGAL PROCEEDINGS AND CONTINGENCIES<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and certain of its subsidiaries are involved in various lawsuits, claims, government investigations and other legal proceedings that arise in the ordinary course of business. These claims or proceedings can involve various types of parties, including governments, competitors, customers, suppliers, service providers, licensees, employees, or shareholders, among others. These matters may involve patent infringement, antitrust, securities, pricing, sales and marketing practices, environmental, commercial, contractual rights, licensing obligations, health and safety matters, consumer fraud, employment matters, product liability and insurance coverage, among others. The resolution of these matters often develops over a long period of time and expectations can change as a result of new findings, rulings, appeals or settlement arrangements. Legal proceedings that are significant or that BMS believes could become significant or material are described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While BMS does not believe that any of these matters, except as otherwise specifically noted below, will have a material adverse effect on its financial position or liquidity as BMS believes it has substantial defenses in the matters, the outcomes of BMS&#8217;s legal proceedings and other contingencies are inherently unpredictable and subject to significant uncertainties. There can be no assurance that there will not be an increase in the scope of one or more of these pending matters or any other or future lawsuits, claims, government investigations or other legal proceedings will not be material to BMS&#8217;s financial position, results of operations or cash flows for a particular period. Furthermore, failure to enforce BMS&#8217;s patent rights would likely result in substantial decreases in the respective product revenues from generic competition.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise noted, BMS is unable to assess the outcome of the respective matters nor is it able to estimate the possible loss or range of losses that could potentially result for such matters. Contingency accruals are recognized when it is probable that a liability will be incurred and the amount of the related loss can be reasonably estimated. Developments in legal proceedings and other matters that could cause changes in the amounts previously accrued are evaluated each reporting period. For a discussion of BMS&#8217;s tax contingencies, see &#8220;&#8212;Note&#160;7. Income Taxes&#8221;.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTELLECTUAL PROPERTY</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-PD-1 Antibody Litigation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2015, Dana-Farber Cancer Institute (&#8220;Dana-Farber&#8221;) filed a complaint in the U.S. District Court for the District of Massachusetts seeking to correct the inventorship on up to six related U.S. patents directed to methods of treating cancer using PD-1 and PD-L1 antibodies. Specifically, Dana-Farber is seeking to add two scientists as inventors to these patents. In October 2017, Pfizer was allowed to intervene in this case alleging that one of the scientists identified by Dana-Farber was employed by a company eventually acquired by Pfizer during the relevant period. In February 2019, BMS settled the lawsuit with Pfizer. A bench trial in the lawsuit with Dana-Farber took place in February 2019. In May 2019, the District Court issued an opinion ruling that the two scientists should be added as inventors to the patents, which was affirmed on appeal. In May 2021, the U.S. Supreme Court declined to consider the case. In June 2019, Dana-Farber filed a new lawsuit in the District of Massachusetts against BMS seeking damages as a result of the Court&#8217;s decision adding the scientists as inventors. In February 2021, BMS filed a motion to dismiss the complaint.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAR T</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2017, Juno and Sloan Kettering Institute for Cancer Research (&#8220;SKI&#8221;) filed a complaint for patent infringement against Kite Pharma, Inc. (&#8220;Kite&#8221;) in the U.S. District Court for the Central District of California. The complaint alleged that Kite&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product infringes certain claims of U.S. Patent No. 7,446,190 (the &#8220;&#8217;190 Patent&#8221;) concerning CAR T cell technologies. Kite filed an answer and counterclaims asserting non-infringement and invalidity of the &#8217;190 Patent. In December 2019, following an eight-day trial, the jury rejected Kite&#8217;s defenses, finding that Kite willfully infringed the &#8217;190 Patent and awarding to Juno and SKI a reasonable royalty consisting of a $585 million upfront payment and a 27.6% running royalty on Kite&#8217;s sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> through the expiration of the &#8217;190 Patent in August 2024. In January 2020, Kite renewed its previous motion for judgment as a matter of law and also moved for a new trial, and Juno filed a motion seeking enhanced damages, supplemental damages, ongoing royalties, and prejudgment interest. In March 2020, the Court denied both of Kite&#8217;s motions in their entirety. In April 2020, the Court granted in part Juno&#8217;s motion and entered a final judgment awarding to Juno and SKI approximately $1.2 billion in royalties, interest and enhanced damages and a 27.6% running royalty on Kite&#8217;s sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* from December 13, 2019 through the expiration of the &#8217;190 Patent in August 2024. In April 2020, Kite appealed the final judgment to the U.S. Court of Appeals for the Federal Circuit and the Court held an oral hearing on July 6, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8211; Europe</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020 and January 2021, Sandoz Limited (&#8220;Sandoz&#8221;) and Teva Pharmaceutical Industries Ltd. (&#8220;Teva Limited&#8221;), respectively, filed lawsuits in the United Kingdom seeking revocation of the UK apixaban composition of matter patent and related Supplementary Protection Certificate. BMS subsequently filed counterclaims for infringement in both actions. A trial is scheduled to begin in early 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are similar lawsuits filed in the Republic of Ireland, the Netherlands and Sweden seeking revocation of a composition of matter patent relating to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional infringement and invalidity actions involving </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patents may be filed in various countries in Europe in the coming months.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2017, BMS received Notice Letters from twenty-five&#160;generic companies notifying BMS that they had filed aNDAs containing paragraph IV certifications seeking approval of generic versions of&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As a result, two&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;patents listed in the FDA Orange Book are being challenged: the composition of matter patent claiming apixaban specifically and a formulation patent. In response, BMS, along with its partner Pfizer, initiated patent infringement actions under the Hatch-Waxman Act against all generic filers in the U.S. District Court for the District of Delaware in April 2017. In August 2017, the U.S. Patent and Trademark Office granted patent term restoration to the composition of matter patent to November 2026, thereby restoring the term of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> composition of matter patent, which is BMS&#8217;s basis for projected LOE. BMS settled with a number of aNDA filers. These settlements do not affect BMS&#8217;s projected LOE for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A trial with the remaining aNDA filers took place in late 2019. In August 2020, the U.S. District Court issued a decision finding that the remaining aNDA filers&#8217; products infringed the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> composition of matter and formulation patents and that both </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patents are not invalid. The remaining aNDA filers have appealed to the U.S. Court of Appeals for the Federal Circuit. The oral argument for the appeal is scheduled to occur in September 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - Australia</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sanofi was notified that, in August 2007, GenRx Proprietary Limited (&#8220;GenRx&#8221;) obtained regulatory approval of an application for clopidogrel bisulfate 75mg tablets in Australia. GenRx, formerly a subsidiary of Apotex Inc., subsequently changed its name to Apotex (&#8220;GenRx-Apotex&#8221;). In August 2007, GenRx-Apotex filed an application in the Federal Court of Australia seeking revocation of Sanofi&#8217;s Australian Patent No.&#160;597784 (Case No. NSD 1639 of 2007). Sanofi filed counterclaims of infringement and sought an injunction. On September&#160;21, 2007, the Federal Court of Australia granted Sanofi&#8217;s injunction. A subsidiary of BMS was subsequently added as a party to the proceedings. In February 2008, a second company, Spirit Pharmaceuticals Pty. Ltd., also filed a revocation suit against the same patent. This case was consolidated with the GenRx-Apotex case. On August&#160;12, 2008, the Federal Court of Australia held that claims of Patent No.&#160;597784 covering clopidogrel bisulfate, hydrochloride, hydrobromide, and taurocholate salts were valid. The Federal Court also held that the process claims, pharmaceutical composition claims, and claim directed to clopidogrel and its pharmaceutically acceptable salts were invalid. BMS and Sanofi filed notices of appeal in the Full Court of the Federal Court of Australia (&#8220;Full Court&#8221;) appealing the holding of invalidity of the claim covering clopidogrel and its pharmaceutically acceptable salts, process claims, and pharmaceutical composition claims. GenRx-Apotex appealed the holding of validity of the clopidogrel bisulfate, hydrochloride, hydrobromide, and taurocholate claims. On September&#160;29, 2009, the Full Court held all of the claims of Patent No.&#160;597784 invalid. In March 2010, the High Court of Australia denied a request by BMS and Sanofi to hear an appeal of the Full Court decision. The case was remanded to the Federal Court for further proceedings related to damages sought by GenRx-Apotex. BMS and GenRx-Apotex settled, and the GenRx-Apotex case was dismissed. The Australian government intervened in this matter seeking maximum damages up to 449 million AUD ($341 million), plus interest, which would be split between BMS and Sanofi, for alleged losses experienced for paying a higher price for branded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> during the period when the injunction was in place. BMS and Sanofi dispute that the Australian government is entitled to any damages. A trial was concluded in September 2017. In April 2020, the Federal Court issued a decision dismissing the Australian government&#8217;s claim for damages. In May 2020, the Australian government appealed the Federal Court&#8217;s decision and an appeal hearing concluded in February 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pomalyst </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">- Canada</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Celgene received a Notice of Allegation in January 2020 from Natco Pharma (Canada) Inc. (&#8220;Natco Canada&#8221;) notifying Celgene that it had filed an Abbreviated New Drug Submission (&#8220;aNDS&#8221;) with Canada&#8217;s Minister of Health with respect to certain of Celgene&#8217;s Canadian patents. Natco Canada is seeking to market a generic version of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Canada. In response, Celgene initiated a patent infringement action in the Federal Court of Canada. Natco Canada alleges that the asserted patents are invalid and/or not infringed. A trial is scheduled to begin in November 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Celgene received a second Notice of Allegation in November 2020 from Natco Canada notifying Celgene that it had filed a second aNDS with Canada&#8217;s Minister of Health with respect to certain of Celgene&#8217;s Canadian patents. In response, Celgene initiated a patent infringement action in the Federal Court of Canada. Natco Canada alleges that the asserted patents are invalid and/or not infringed. A trial is scheduled to begin in May 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Celgene received four Notices of Allegation in February 2021 from Apotex Inc. notifying Celgene that it had filed two aNDSs with Canada&#8217;s Minister of Health with respect to certain of Celgene&#8217;s Canadian patents. Apotex Inc. is seeking to market a generic version of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Canada. In response, in April 2021, Celgene initiated patent infringement actions against Apotex Inc. in the Federal Court of Canada. In July 2021, Celgene and Apotex Inc. entered into a confidential settlement agreement and the cases were discontinued.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in 2017, Celgene received Notice letters on behalf of Apotex Inc. and Apotex Corp. (together, &#8220;Apotex&#8221;); Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero Drugs Limited, Hetero USA, Inc. (collectively, &#8220;Hetero&#8221;); Eugia Pharma Specialities Limited, Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., and Aurolife Pharma LLC (collectively, &#8220;Aurobindo&#8221;); and Mylan Pharmaceuticals Inc. notifying Celgene that they had filed aNDAs containing paragraph IV certifications seeking approval to market generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. In response, Celgene filed patent infringement actions against the companies in the U.S. District Court for the District of New Jersey asserting certain FDA Orange Book-listed patents and the companies filed answers, counterclaims and declaratory judgment actions alleging that the asserted patents are invalid, unenforceable, and not infringed. These litigations were subsequently consolidated. In March 2020, Celgene subsequently filed additional patent infringement actions in the U.S. District Court for the District of New Jersey against each of the companies asserting a newly-issued patent that is listed in the FDA Orange Book and that covers formulations comprising pomalidomide. The companies each filed responsive pleadings alleging that the patent is invalid and not infringed. The Court has consolidated these additional litigations with the previously-consolidated litigations. In September 2020, the Court granted Mylan Pharmaceuticals Inc.&#8217;s motion to dismiss, which decision Celgene has appealed. In October 2020, Aurobindo received final approval from the FDA of its aNDA. In April and July 2021, Celgene entered into confidential settlement agreements with Apotex and Aurobindo, respectively, settling all outstanding claims in the litigation with Apotex and Aurobindo. Trial against the remaining defendant, Hetero, is set for November 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February and March 2019, Celgene filed additional patent infringement actions in the U.S. District Court for the District of New Jersey against the companies asserting certain patents that are not listed in the FDA Orange Book and that cover polymorphic forms of pomalidomide, and the companies filed answers and/or counterclaims alleging that each of these patents is invalid and/or not infringed. These actions have been consolidated with the earlier-filed actions against the companies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2019, Celgene received a Notice Letter from Dr. Reddy&#8217;s Laboratories, Ltd. and Dr. Reddy&#8217;s Laboratories, Inc. (together, &#8220;DRL&#8221;) notifying Celgene that they had filed an aNDA containing paragraph IV certifications seeking approval to market a generic version of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. In response, Celgene initiated a patent infringement action against DRL in the U.S. District Court for the District of New Jersey asserting certain FDA Orange Book-listed patents, and DRL filed an answer and counterclaims alleging that each of the patents is invalid and/or not infringed. In March 2020, Celgene filed an additional patent infringement action in the U.S. District Court for the District of New Jersey against DRL asserting a newly-issued patent that is listed in the FDA Orange Book and that covers formulations comprising pomalidomide, which has been consolidated with the above DRL case. In April 2021, DRL received tentative approval from the FDA of its aNDA. The Court has not set a trial date in this consolidated action.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, Celgene filed an additional patent infringement action in the U.S. District Court for the District of New Jersey against DRL asserting certain patents that are not listed in the FDA Orange Book and that cover polymorphic forms of pomalidomide. No trial date has been set for this matter.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Celgene has received Notice Letters on behalf of Sun Pharma Global FZE, Sun Pharma Global Inc., Sun Pharmaceutical Industries, Inc., and Sun Pharmaceutical Industries Limited (collectively, &#8220;Sun&#8221;); Hetero; Mylan Pharmaceuticals Inc., Mylan Inc., and Mylan N.V. (collectively, &#8220;Mylan&#8221;); Aurobindo; Lupin Limited (&#8220;Lupin&#8221;); Hikma Pharmaceuticals USA, Inc.; Biocon Pharma Limited, Biocon Limited, and Biocon Pharma, Inc.; and Torrent Pharmaceuticals Limited and Torrent Pharma Inc. notifying Celgene that they had filed aNDAs containing paragraph IV certifications seeking approval to market generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. In response, Celgene filed patent infringement actions against the companies in the U.S. District Court for the District of New Jersey asserting certain FDA Orange Book-listed patents as well as other litigations asserting other non-FDA Orange Book-listed patents against certain defendants, who have filed answers and/or counterclaims alleging that the asserted patents are invalid and/or not infringed. No trial date has been scheduled in any of these New Jersey actions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Celgene also filed a patent infringement action against Mylan in the U.S. District Court for the Northern District of West Virginia asserting certain FDA Orange Book-listed patents and other non-FDA Orange Book-listed patents. Mylan filed its answer and counterclaims alleging that the patents are invalid and/or not infringed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June and July 2021, Celgene entered into confidential settlement agreements with Sun, Aurobindo, and Mylan, respectively, settling all outstanding claims in the litigations with Sun, Aurobindo, and Mylan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sprycel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2019, BMS received a Notice Letter from Dr. Reddy&#8217;s Laboratories, Inc. notifying BMS that it had filed an aNDA containing paragraph IV certifications seeking approval of a generic version of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sprycel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. and challenging two FDA Orange Book-listed monohydrate form patents expiring in 2025 and 2026. In response, BMS filed a patent infringement action in the U.S. District Court for the District of New Jersey.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, BMS received a Notice Letter from Lupin notifying BMS that it had filed an aNDA containing paragraph IV certifications seeking approval of a generic version of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sprycel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. and challenging two FDA Orange Book-listed monohydrate form patents expiring in 2025 and 2026. In response, BMS filed patent infringement actions in the U.S. District Courts for the District of New Jersey and Delaware. The case in Delaware has been dismissed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, BMS entered into confidential settlement agreements with Dr. Reddy&#8217;s Laboratories, Inc. and Lupin, settling all outstanding claims in the litigations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRICING, SALES AND PROMOTIONAL PRACTICES LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> State Attorneys General Lawsuits</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and certain Sanofi entities are defendants in consumer protection actions brought by the attorneys general of Hawaii and New Mexico relating to the labeling, sales and/or promotion of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*. A trial in the Hawaii matter occurred in 2020. In February 2021, the Court issued a decision against Sanofi and BMS, imposing penalties in the total amount of $834 million, with $417&#160;million attributed to BMS. Sanofi and BMS disagree with the decision and are appealing it. BMS remains confident in the merits of its case and its likelihood of success on appeal and BMS does not believe establishing a reserve is warranted for this matter. A trial in the New Mexico matter is scheduled to begin in April 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRODUCT LIABILITY LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS is a party to various product liability lawsuits. Plaintiffs in these cases seek damages and other relief on various grounds for alleged personal injury and economic loss. As previously disclosed, in addition to lawsuits, BMS also faces unfiled claims involving its products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Abilify*</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and Otsuka are co-defendants in product liability litigation related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Plaintiffs allege </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> caused them to engage in compulsive gambling and other impulse control disorders. There have been over 2,500 cases filed in state and federal courts and additional cases are pending in Canada. The Judicial Panel on Multidistrict Litigation consolidated the federal court cases for pretrial purposes in the U.S. District Court for the Northern District of Florida. In February 2019, BMS and Otsuka entered into a master settlement agreement establishing a proposed settlement program to resolve all </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> compulsivity claims filed as of January 28, 2019 in the MDL as well as various state courts, including California and New Jersey. To date, approximately 2,700 cases, comprising approximately 3,900 plaintiffs, have been dismissed based on participation in the settlement program or failure to comply with settlement related court orders. In the U.S., less than 20 cases remain pending on behalf of plaintiffs, who either chose not to participate in the settlement program or filed their claims after the settlement cut-off date. There are eleven cases pending in Canada (four class actions, seven individual injury claims). Out of the eleven cases, only two are active (the class actions in Quebec and Ontario). Both class actions have now been certified and will proceed separately, subject to a pending appeal of the Ontario class certification decision.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Byetta*</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amylin, a former subsidiary of BMS, and Lilly are co-defendants in product liability litigation related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta*.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of June 2021, there are approximately 590 separate lawsuits pending on behalf of approximately 2,250 active plaintiffs (including pending settlements), which include injury plaintiffs as well as claims by spouses and/or other beneficiaries, in various courts in the U.S. The majority of these cases have been brought by individuals who allege personal injury sustained after using </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*, primarily pancreatic cancer, and, in some cases, claiming alleged wrongful death. The majority of cases are pending in Federal Court in San Diego in an MDL or in a coordinated proceeding in California Superior Court in Los Angeles (&#8220;JCCP&#8221;). In April 2020 the defendants filed a motion for summary judgment based on federal preemption and a motion for summary judgment based on the absence of general causation evidence in the MDL and JCCP. Both motions were granted in March 2021 and April 2021, respectively. The orders will result in the dismissal of all claims alleging an injury of pancreatic cancer in the MDL and JCCP. Plaintiffs have appealed the MDL order and may seek appeals in the JCCP. BMS sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* to AstraZeneca in February 2014 as part of BMS&#8217;s global diabetes business divestiture and any additional liability to Amylin with respect to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Byetta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* is expected to be shared with AstraZeneca.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Onglyza*</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and AstraZeneca are co-defendants in product liability litigation related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Plaintiffs assert claims, including claims for wrongful death, as a result of heart failure or other cardiovascular injuries they allege were caused by their use of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of June 2021, claims are pending in state and federal court on behalf of approximately 270 individuals who allege they ingested the product and suffered an injury. In February 2018, the Judicial Panel on Multidistrict Litigation ordered all federal cases to be transferred to an MDL in the U.S. District Court for the Eastern District of Kentucky. A significant majority of the claims are pending in the MDL.&#160;As part of BMS&#8217;s global diabetes business divestiture, BMS sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to AstraZeneca in February 2014 and any potential liability with respect to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is expected to be shared with AstraZeneca.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BMS Securities Class Action</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since February 2018, two separate putative class action complaints were filed in the U.S. District for the Northern District of California and in the U.S. District Court for the Southern District of New York against BMS, BMS&#8217;s Chief Executive Officer, Giovanni Caforio, BMS&#8217;s Chief Financial Officer at the time, Charles A. Bancroft and certain former and current executives of BMS.&#160;The case in California has been voluntarily dismissed. The remaining complaint alleges violations of securities laws for BMS&#8217;s disclosures related to the CheckMate-026 clinical trial in lung cancer. In September 2019, the Court granted BMS&#8217;s motion to dismiss, but allowed the plaintiffs leave to file an amended complaint. In October 2019, the plaintiffs filed an amended complaint. In September 2020, the Court granted BMS&#8217;s motion to dismiss the amended complaint with prejudice. The plaintiffs appealed the Court&#8217;s decision in October 2020.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Celgene Securities Class Action</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in March 2018, two putative class actions were filed against Celgene and certain of its officers in the U.S. District Court for the District of New Jersey (the &#8220;Celgene Securities Class Action&#8221;).&#160;The complaints allege that the defendants violated federal securities laws by making misstatements and/or omissions concerning (1) trials of GED-0301, (2) Celgene&#8217;s 2020 outlook and projected sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Otezla*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and (3) the new drug application for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Court consolidated the two actions and appointed a lead plaintiff, lead counsel, and co-liaison counsel for the putative class. In February 2019, the defendants filed a motion to dismiss plaintiff&#8217;s amended complaint in full. In December 2019, the Court denied the motion to dismiss in part and granted the motion to dismiss in part (including all claims arising from alleged misstatements regarding GED-0301). Although the Court gave the plaintiff leave to re-plead the dismissed claims, it elected not to do so, and the dismissed claims are now dismissed with prejudice. In November 2020, the Court granted class certification with respect to the remaining claims. In December 2020, the defendants sought leave to appeal the Court&#8217;s class certification decision, which was denied without prejudice in March 2021. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, certain Schwab management investment companies on behalf of certain Schwab funds filed an individual action in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action against the same remaining defendants in that action. In July 2020, the defendants filed a motion to dismiss the plaintiffs&#8217; complaint in full. In March 2021, the Court granted in part and denied in part defendants&#8217; motion to dismiss consistent with its decision in the Celgene Securities Class Action.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The California Public Employees&#8217; Retirement System in April 2021 and DFA Investment Dimensions Group Inc., on behalf of certain of its funds, and American Century Mutual Funds, Inc., on behalf of certain of its funds, in July 2021 filed separate individual actions in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action and the Schwab individual action against the same remaining defendants in those actions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Value Rights Litigation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, an action was filed against BMS in the U.S. District Court for the Southern District of New York asserting claims of alleged breaches of a Contingent Value Rights Agreement (&#8220;CVR Agreement&#8221;) entered into in connection with the closing of BMS&#8217;s acquisition of Celgene Corporation in November 2019. The successor trustee under the CVR Agreement alleges that BMS breached the CVR Agreement by allegedly failing to use &#8220;diligent efforts&#8221; to obtain FDA approval of liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) before a contractual milestone date, thereby avoiding a $6.4 billion potential obligation to holders of the contingent value rights governed by the CVR Agreement and by allegedly failing to permit inspection of records in response to a request by the successor trustee. The successor trustee seeks damages in an amount to be determined at trial and other relief, including interest and attorneys&#8217; fees. BMS disputes the successor trustee&#8217;s allegations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Average Manufacturer Price Litigation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS is a defendant in a qui tam (whistleblower) lawsuit in the U.S. District Court for the Eastern District of Pennsylvania, in which the U.S. Government declined to intervene. The complaint alleges that BMS inaccurately reported its average manufacturer prices to the Centers for Medicare and Medicaid Services to lower what it owed. Similar claims have been filed against other companies. In January 2020, BMS reached an agreement in principle to resolve this matter subject to the negotiation of a definitive settlement agreement and other contingencies. In March 2021, BMS finalized an agreement with the U.S. government and qui tam relator to resolve the claims asserted in the lawsuit. BMS has paid $75 million plus interest to the federal and state governments. Individual agreements will be negotiated with participating states based on the federal agreement. To the extent BMS does not finalize a settlement agreement with any state, that state&#8217;s share of the settlement will revert to BMS.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HIV Medication Antitrust Lawsuits</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and two other manufacturers of HIV medications are defendants in related lawsuits pending in the Northern District of California. The lawsuits allege that the defendants&#8217; agreements to develop and sell fixed-dose combination products for the treatment of HIV, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Atripla*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evotaz</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, violate antitrust laws. The currently pending actions, asserted on behalf of indirect purchasers, were initiated in 2019 in the Northern District of California and in 2020 in the Southern District of Florida. The Florida matter was transferred to the Northern District of California. In July 2020, the Court granted in part defendants&#8217; motion to dismiss, including dismissing with prejudice plaintiffs&#8217; claims as to an overarching conspiracy and plaintiffs&#8217; theories based on the alleged payment of royalties after patent expiration. Other claims, however, remain. In September and October 2020, two purported class actions have also been filed asserting similar claims on behalf of direct purchasers. In March 2021, the Court dismissed one of the direct purchaser cases and limited the claims of the remaining direct purchaser case to those arising in 2016 or later. However, the Court gave plaintiffs leave to amend their complaints, and one plaintiff filed an amended complaint on March 16, 2021. A trial on both the direct and indirect purchaser claims is scheduled for November 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, BMS and two other manufacturers of HIV medications were sued in State Court in New Mexico by the Attorney General of the State of New Mexico in a case alleging that the defendants&#8217; agreements to develop and sell various fixed-dose combination products for the treatment of HIV, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Atripla*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and agreements to settle certain patent litigation violate the antitrust laws of the State of New Mexico. No schedule has been set for the case.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Litigations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in November 2014, certain putative class action lawsuits were filed against Celgene in the U.S. District Court for the District of New Jersey alleging that Celgene violated various antitrust, consumer protection, and unfair competition laws by (a) allegedly securing an exclusive supply contract for the alleged purpose of preventing a generic manufacturer from securing its own supply of thalidomide active pharmaceutical ingredient, (b) allegedly refusing to sell samples of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand drugs to various generic manufacturers for the alleged purpose of bioequivalence testing necessary for aNDAs to be submitted to the FDA for approval to market generic versions of these products, (c) allegedly bringing unjustified patent infringement lawsuits in order to allegedly delay approval for proposed generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and/or (d) allegedly entering into settlements of patent infringement lawsuits with certain generic manufacturers that allegedly have had anticompetitive effects. The plaintiffs, on behalf of themselves and putative classes of third-party payers, sought injunctive relief and damages. The various lawsuits were consolidated into a master action for all purposes. In March 2020, Celgene reached a settlement with the class plaintiffs. In October 2020, the Court entered a final order approving the settlement and dismissed the matter. That settlement does not resolve the claims of certain entities that opted out of the settlement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, Humana, Inc. (&#8220;Humana&#8221;) filed a lawsuit against Celgene in the Pike County Circuit Court of the Commonwealth of Kentucky.&#160;Humana&#8217;s complaint alleges Celgene engaged in unlawful off-label marketing in connection with sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and asserts claims against Celgene for fraud, breach of contract, negligent misrepresentation, unjust enrichment and violations of New Jersey&#8217;s Racketeer Influenced and Corrupt Organizations Act. The complaint seeks, among other things, treble and punitive damages, injunctive relief and attorneys&#8217; fees and costs. In April 2019, Celgene filed a motion to dismiss Humana&#8217;s complaint, which the Court denied in January 2020. No trial date has been scheduled. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, Humana filed a lawsuit against Celgene in the U.S. District Court for the District of New Jersey. Humana&#8217;s complaint makes largely the same claims and allegations as were made in the class action litigation. The complaint purports to assert claims on behalf of Humana and its subsidiaries in several capacities, including as a direct purchaser and as an indirect purchaser, and seeks, among other things, treble and punitive damages, injunctive relief and attorneys&#8217; fees and costs. In May 2019, Celgene filed a motion to dismiss Humana&#8217;s complaint, and the Court has stayed discovery pending adjudication of that motion. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, United HealthCare Services, Inc. (&#8220;UHS&#8221;), affiliates of which opted out of the first settlement in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Antitrust Class Action Litigation, filed a lawsuit against Celgene in the U.S. District Court for the District of Minnesota. UHS&#8217;s complaint makes largely the same claims and allegations as were made in the class action litigation in addition to certain claims regarding donations directed to copay assistance. The complaint purports to assert claims on behalf of UHS and its subsidiaries in several capacities, including as a direct purchaser and as an indirect purchaser, and seeks, among other things, treble and punitive damages, injunctive relief and attorneys&#8217; fees and costs. In December 2020, Celgene&#8217;s motion to transfer the action to the District of New Jersey was granted and the case is now pending in that Court. In January 2021, Celgene filed a motion to dismiss UHS&#8217;s complaint, which the Court administratively terminated in June 2021 pending its decision on Celgene&#8217;s pending motion to dismiss Humana&#8217;s complaint. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, Celgene filed suit against Humana Pharmacy, Inc. (&#8220;HPI&#8221;), a Humana subsidiary, in Delaware Superior Court. Celgene&#8217;s complaint alleges that HPI breached its contractual obligations to Celgene by assigning claims to Humana that Humana is now asserting. The complaint seeks damages for HPI&#8217;s breach as well as a declaratory judgment. In September 2020, HPI filed a motion to dismiss Celgene&#8217;s complaint, which was denied in February 2021. A trial has been scheduled for March 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, Blue Cross Blue Shield Association (&#8220;BCBSA&#8221;) sued Celgene and BMS on behalf of the Federal Employee Program in the U.S. District Court for the District of Columbia. BCBSA&#8217;s complaint makes largely the same claims and allegations as were made in the class action litigation. In April 2021, the parties&#8217; joint motion to transfer the action to the District of New Jersey was granted and the case is now pending in that Court. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, BCBSM Inc., Health Care Service Corporation (&#8220;HCSC&#8221;), Blue Cross and Blue Shield of Florida Inc.,  and Molina Healthcare, Inc. (&#8220;Molina&#8221;) sued Celgene and BMS in a Minnesota state court. The complaint makes largely the same claims and allegations as were made in the class action litigation but adds allegations on behalf of HCSC only as to alleged off-label marketing of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In September 2020, Celgene and BMS removed the action to the U.S. District Court for the District of Minnesota. In March 2021, that Court denied plaintiffs&#8217; motion to remand the action to state court, dismissed Molina for lack of personal jurisdiction and granted defendants&#8217; motion to transfer the action to the District of New Jersey. The case is now pending in the District of New Jersey. No trial date has been scheduled.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, Cigna Corporation (&#8220;Cigna&#8221;) sued Celgene and BMS in the U.S. District Court for the Eastern District of Pennsylvania. Cigna&#8217;s complaint makes largely the same claims and allegations as were made in the class action litigation. Cigna&#8217;s complaint purports to assert claims on behalf of Cigna and its subsidiaries in several capacities, including as a direct purchaser and as an indirect purchaser. In May 2021, the parties&#8217; joint motion to transfer the action to the District of New Jersey was granted and the case is now pending in that Court. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, Molina sued Celgene and BMS in San Francisco Superior Court. Molina&#8217;s complaint makes largely the same claims and allegations as were made in the class action litigation. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOVERNMENT INVESTIGATIONS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Like other pharmaceutical companies, BMS and certain of its subsidiaries are subject to extensive regulation by national, state and local authorities in the U.S. and other countries in which BMS operates. As a result, BMS, from time to time, is subject to various governmental and regulatory inquiries and investigations as well as threatened legal actions and proceedings. It is possible that criminal charges, substantial fines and/or civil penalties, could result from government or regulatory investigations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ENVIRONMENTAL PROCEEDINGS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously reported, BMS is a party to several environmental proceedings and other matters, and is responsible under various state, federal and foreign laws, including CERCLA, for certain costs of investigating and/or remediating contamination resulting from past industrial activity at BMS&#8217;s current or former sites or at waste disposal or reprocessing facilities operated by third parties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERCLA Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to CERCLA matters for which BMS is responsible under various state, federal and foreign laws, BMS typically estimates potential costs based on information obtained from the U.S. Environmental Protection Agency, or counterpart state or foreign agency and/or studies prepared by independent consultants, including the total estimated costs for the site and the expected cost-sharing, if any, with other &#8220;potentially responsible parties,&#8221; and BMS accrues liabilities when they are probable and reasonably estimable. BMS estimated its share of future costs for these sites to be $75 million at June&#160;30, 2021, which represents the sum of best estimates or, where no best estimate can reasonably be made, estimates of the minimal probable amount among a range of such costs (without taking into account any potential recoveries from other parties). The amount includes the estimated costs for any additional probable loss associated with the previously disclosed North Brunswick Township High School Remediation Site.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120047149752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation, Policy [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Consolidation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bristol-Myers Squibb Company (&#8220;BMS&#8221;) prepared these unaudited consolidated financial statements following the requirements of the SEC and U.S. GAAP for interim reporting. Under those rules, certain footnotes and other financial information that are normally required for annual financial statements can be condensed or omitted. The Company is responsible for the consolidated financial statements included in this Quarterly Report on Form 10-Q, which include all adjustments necessary for a fair presentation of the financial position at June&#160;30, 2021 and December&#160;31, 2020, the results of operations for the three and six months ended June&#160;30, 2021 and 2020, and cash flows for the six months ended June&#160;30, 2021 and 2020. All intercompany balances and transactions have been eliminated. These financial statements and the related notes should be read in conjunction with the audited consolidated financial statements for the year ended December&#160;31, 2020 included in the 2020 Form&#160;10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting, Policy [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Segment Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS operates in a single segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of innovative medicines that help patients prevail over serious diseases. A global research and development organization and supply chain organization are responsible for the discovery, development, manufacturing and supply of products. Regional commercial organizations market, distribute and sell the products. The business is also supported by global corporate staff functions. Consistent with BMS&#8217;s operational structure, the Chief Executive Officer (&#8220;CEO&#8221;), as the chief operating decision maker, manages and allocates resources at the global corporate level. Managing and allocating resources at the global corporate level enables the CEO to assess both the overall level of resources available and how to best deploy these resources across functions, therapeutic areas, regional commercial organizations and research and development projects in line with our overarching long-term corporate-wide strategic goals, rather than on a product or franchise basis. The determination of a single segment is consistent with the financial information regularly reviewed by the CEO for purposes of evaluating performance, allocating resources, setting incentive compensation targets, and planning and forecasting future periods. For further information on product and regional revenue, see &#8220;&#8212;Note 2. Revenue.&#8221;</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates, Policy [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates and Judgments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues, expenses, assets and liabilities can vary during each quarter of the year. Accordingly, the results and trends in these unaudited consolidated financial statements may not be indicative of full year operating results. The preparation of financial statements requires the use of management estimates, judgments and assumptions. The most significant assumptions are estimates used in determining accounting for business combinations; impairments of intangible assets; sales rebate and return accruals; legal contingencies; and income taxes. Actual results may differ from estimates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification, Policy [Policy Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications were made to conform the prior period consolidated financial statements to the current period presentation. Cash payments resulting from licensing arrangements, including upfront and contingent milestones previously included in operating activities in the consolidated statements of cash flows are now presented in investing activities. The adjustment resulted in an increase to net cash provided by operating activities and net cash used in investing activities of $267&#160;million in the six months ended June 30, 2020. Proceeds received from the sale of equity investment securities previously presented in Divestiture and other proceeds in the consolidated statements of cash flows is now presented separately in Proceeds from sales of equity investment securities. These reclassifications did not have an impact on net assets or net earnings.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements, Policy [Policy Text Block]</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued amended guidance on the accounting and reporting of income taxes. The guidance is intended to simplify the accounting for income taxes by removing exceptions related to certain intraperiod tax allocations and deferred tax liabilities; clarifying guidance primarily related to evaluating the step-up tax basis for goodwill in a business combination; and reflecting enacted changes in tax laws or rates in the annual effective tax rate. BMS adopted the new guidance effective January 1, 2021. The amended guidance did not have a material impact on BMS&#8217;s results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429488&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120144934728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ALLIANCES (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ALLIANCESAbstract', window );"><strong>ALLIANCES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementAccountingPolicy', window );">Collaborative Arrangement, Accounting Policy [Policy Text Block]</a></td>
<td class="text">BMS enters into collaboration arrangements with third parties for the development and commercialization of certain products. Although each of these arrangements is unique in nature, both parties are active participants in the operating activities of the collaboration and exposed to significant risks and rewards depending on the commercial success of the activities. BMS may either in-license intellectual property owned by the other party or out-license its intellectual property to the other party. These arrangements also typically include research, development, manufacturing, and/or commercial activities and can cover a single investigational compound or commercial product or multiple compounds and/or products in various life cycle stages. The rights and obligations of the parties can be global or limited to geographic regions. BMS refers to these collaborations as alliances and its partners as alliance partners.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ALLIANCESAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ALLIANCES [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ALLIANCESAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementAccountingPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for collaborative arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementAccountingPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120047389928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueAbstract', window );"><strong>Disaggregation of Revenue [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by nature:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,405&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,817&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,358&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,703&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,129&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,776&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,910&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock', window );">Revenue Recognition Gross-To-Net Adjustments [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes GTN adjustments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,782&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,788&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,341&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,474&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,720)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,292)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,306)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,632)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Medicare rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,139)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,482)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,857)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,980)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other rebates, returns, discounts and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,518)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,197)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,975)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,504)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total GTN adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,377)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,971)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,138)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,116)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,405&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,817&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,203&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,358&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes adjustments for provisions for product sales made in prior periods resulting from changes in estimates of $85 million and $302 million for the three and six months ended June&#160;30, 2021, and $44 million and $116 million for the three and six months ended June&#160;30, 2020, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Revenue from External Customers by Products and Services [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by product and region:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prioritized Brands</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Revlimid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,884&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Eliquis</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,910&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,419&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Orencia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pomalyst/Imnovid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">854&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sprycel</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yervoy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abraxane</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Empliciti</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Reblozyl</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Inrebic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Onureg</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Zeposia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Breyanzi</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abecma</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Established Brands</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Vidaza</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Baraclude</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Brands</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,703&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,129&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,776&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,910&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,689&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of the World</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,334&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,781&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,703&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,129&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,776&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,910&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by BMS&#8217;s regional commercial organizations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reconciliation of Gross Product Sales to Net Product Sales [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120046034152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ALLIANCES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ALLIANCESAbstract', window );"><strong>ALLIANCES [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock', window );">Collaborative Arrangement and Arrangement Other than Collaborative [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selected financial information pertaining to alliances was as follows, including net product sales when BMS is the principal in the third-party customer sale for products subject to the alliance. Expenses summarized below do not include all amounts attributed to the activities for the products in the alliance, but only the payments between the alliance partners or the related amortization if the payments were deferred or capitalized.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues from alliances:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,964&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,364&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,988&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,192&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payments to/(from) alliance partners:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Selected Alliance Balance Sheet information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables &#8211; from alliance partners</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable &#8211; to alliance partners</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,032&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income from alliances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>(a)&#160;&#160;&#160;&#160;Includes unamortized upfront and milestone payments.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ALLIANCESAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ALLIANCES [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ALLIANCESAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120047346072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract', window );"><strong>Acquisitions, Divestitures and Other Arrangements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Disposal Groups, Including Discontinued Operations [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of divestitures including royalties, which are included in Other (income)/expense, net. Revenue and pretax earnings related to all divestitures were not material in all periods presented (excluding divestiture gains or losses).</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Proceeds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divestiture (Gains)/Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Royalty Income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Business</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Erbitux</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* Business</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing Operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature Brands and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(152)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Proceeds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divestiture (Gains)/Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Royalty Income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes Business</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(286)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Erbitux</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* Business</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacturing Operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Plavix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Avapro*/Avalide*</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature Brands and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(287)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(288)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes royalties received subsequent to the related sale of the asset or business.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LicensingAndOtherArrangementsTableTextBlock', window );">Licensing and Other Arrangements [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Keytruda*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> royalties, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* royalties, up-front licensing fees and milestones for products that have not obtained commercial approval, which are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Keytruda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(396)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(316)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Up-front licensing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent milestone income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other royalties</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(253)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(485)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(433)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AcquisitionsDivestituresandOtherArrangementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisitions, Divestitures and Other Arrangements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AcquisitionsDivestituresandOtherArrangementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingAndOtherArrangementsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing and Other Arrangements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingAndOtherArrangementsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120047403176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER EXPENSE (INCOME), NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Nonoperating Income (Expense) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ScheduleOfOtherIncomeExpenseTextBlock', window );">Schedule Of Other Income Expense [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(510)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties and licensing income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(405)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(311)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(772)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(721)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(818)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(749)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(480)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and other settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition and other service fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(111)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reversion excise tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture (gains)/losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible asset impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt redemption</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(736)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(704)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ScheduleOfOtherIncomeExpenseTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ScheduleOfOtherIncomeExpenseTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120047378952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock', window );">Restructuring and Related Costs [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following provides the charges related to restructuring initiatives by type of cost:</span></div><div style="margin-bottom:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celgene Acquisition Plan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MyoKardia Acquisition Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company Transformation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other termination costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other shutdown costs, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the charges and spending related to restructuring plan activities:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability at December 31</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability at June 30</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes a reduction of the liability resulting from changes in estimates of $8 million and $6 million for the six months ended June 30, 2021 and 2020, respectively. Excludes $9 million and $47 million for the six months ended June 30, 2021 and 2020, respectively, of accelerated stock-based compensation relating to the Celgene Acquisition Plan.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120156824248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock', window );">Schedule of Provision for Income Taxes [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings Before Income Taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,553&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,627&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,083&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for Income Taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective Tax Rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>-- None. No documentation exists for this element. --</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120047156424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS/(LOSS) PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings/(Loss) Per Share, Basic and Diluted [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts in Millions, Except Per Share Data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Earnings/(Loss) Attributable to BMS Used for Basic and Diluted EPS Calculation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(860)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Common Shares Outstanding &#8211; Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental Shares Attributable to Share-Based Compensation Plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average Common Shares Outstanding &#8211; Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,258&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings/(Loss) per Common Share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120133087208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis are summarized below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents - money market and other securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,361&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration liability:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent value rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other acquisition related contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock', window );">Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Valuation Techniques [Table Text Block]</a></td>
<td class="text">The fair value of other acquisition related contingent consideration as of June&#160;30, 2021 was calculated using the following significant unobservable inputs:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.373%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ranges (weighted average) utilized as of:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Inputs</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3% to 1.3% (0.6%)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of payment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0% to 80% (2.4%)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected year of payment for development and regulatory milestones</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 to 2028</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</a></td>
<td class="text">The following table represents a roll-forward of the fair value of level 3 instruments:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value as of January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in estimated fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value as of June 30</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesTextBlock', window );">Available-for-sale Securities [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes available-for-sale debt securities:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.799%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,020&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,020&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">684&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total available-for-sale debt securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,081&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,089&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,704&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,718&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All marketable debt securities mature within two years as of June&#160;30, 2021 and December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ScheduleOfEquityInvestmentsTableTextBlock', window );">Schedule of Equity Investments [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the carrying amount of equity investments:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments with readily determinable fair values</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,452&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,668&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,695&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock', window );">Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the activity related to equity investments. Changes in fair value of equity investments are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain/(loss) recognized on equity investments with readily determinable fair values</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">778&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">448&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized gain/(loss) recognized on equity investments with readily determinable fair value sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upward adjustments on equity investments without readily determinable fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments and downward adjustments on equity investments without readily determinable fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative upward adjustments on equity investments without readily determinable fair value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative impairments and downward adjustments on equity investments without readily determinable fair value</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Net unrealized net gains on equity investments still held were $11 million and $353 million for the three and six months ended June&#160;30, 2021 and $778 million and $550 million for the three and six months ended June&#160;30, 2020, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivatives and Fair Value [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the fair value of outstanding derivatives:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"/><td style="width:34.704%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.312%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.499%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.319%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,813&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Included in Other current assets and Other non-current assets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Included in Other current liabilities and Other non-current liabilities.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Derivative Instruments, Gain (Loss) [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial statement classification and amount of (gain)/loss recognized on hedging instruments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency zero-cost collar contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock', window );">Gain/(Loss) on Hedging Activity [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effect of derivative and non-derivative instruments designated as hedging instruments in Other Comprehensive Income/(Loss):</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency forward contracts gain/(loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income/(Loss)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives qualifying as net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency interest rate swap contracts gain:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income/(Loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-derivatives qualifying as net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. dollar borrowings gain:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other Comprehensive Income/(Loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The majority is expected to be reclassified into earnings in the next 12 months.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShortTermDebtTextBlock', window );">Schedule of Short-term Debt [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term debt obligations include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. short-term borrowings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,655&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,340&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Fair Value and Other Adjustments to Long Term Debt [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt and the current portion of long-term debt include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal Value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,666&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to Principal Value:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized basis adjustment from swap terminations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized bond discounts and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized purchase price adjustments of Celgene debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,755&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,336&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,336&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ScheduleOfEquityInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Equity Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ScheduleOfEquityInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique used to measure similar asset in prior period by class of asset or liability on non-recurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120047151320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECEIVABLES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetAbstract', window );"><strong>Accounts Receivable, after Allowance for Credit Loss [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule Of Receivables [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,309&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,882&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(569)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(645)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less allowance for expected credit loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net trade receivables</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,713&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,219&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance, royalties, VAT and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,017&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,501&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120047841608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventory, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">891&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw and packaging materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,013&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,154&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,074&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120046054680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,633&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,838)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,585)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,795&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,886&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120047462136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule Of Intangible Assets By Major Class [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:62.460%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.586%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Lives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,529&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,547&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;&#8211;&#160;15&#160;years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired marketed product rights</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;&#8211;&#160;15&#160;years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,076&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;&#8211;&#160;10&#160;years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPRD</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,360&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,804&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,859&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,616)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,065&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,243&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120045777320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Supplemental Financial Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_SupplementalFinancialInformationAbstract', window );"><strong>Supplemental Financial Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock', window );">Schedule of Other Current Assets [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,258&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,799&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">983&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,037&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,786&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock', window );">Schedule of Other Assets, Noncurrent [Table Text Block]</a></td>
<td class="text"><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,622&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,076&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">876&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,454&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,019&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Restricted cash consists of funds restricted for annual Company contributions to the defined contribution plan in the U.S. and escrow for litigation settlements. Restricted cash of $373 million at June&#160;30, 2021 and $428&#160;million at June&#160;30, 2020 was included in cash, cash equivalents and restricted cash in the consolidated statements of cash flows.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Other Current Liabilities [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates and returns</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,665&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,688&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent value rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,727&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,027&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Other Noncurrent Liabilities [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,690&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,017&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">833&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,498&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,776&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_SupplementalFinancialInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Supplemental Financial Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_SupplementalFinancialInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120050657848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock', window );">Schedule of Stock by Class [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the six months ended June 30, 2021:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"/><td style="width:30.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.626%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.721%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.860%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.660%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and Shares in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,325&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,839)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,281&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,098)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,768)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(473)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,852&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,544)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,199)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,091)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,235)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,064&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,518)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,168&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,198)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $0.49 for the three months ended March 31, 2021 and June&#160;30, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the six months ended June 30, 2020:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"/><td style="width:30.324%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.626%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.721%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.302%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.346%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.860%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.498%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.660%"/><td style="width:0.1%"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and Shares in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,709&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,520)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,474&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">672&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,357)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(775)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,028)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(455)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,254&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,549)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,671&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,757)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,021)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock repurchase program</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(210)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,923&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,444&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,556)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,565&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,651)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Cash dividends declared per common share were $0.45 for the three months ended March 31, 2020 and June&#160;30, 2020.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock', window );">Schedule of Comprehensive Income Loss [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of Other Comprehensive Income/(Loss) were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain/(losses)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to net earnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains/(losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized Losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income/(Loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.094%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain/(losses)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">221&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to net earnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains/(losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities:</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income/(Loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Included in Cost of products sold.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Included in Other (income)/expense, net.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income Loss [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accumulated balances related to each component of Other Comprehensive Income/(Loss), net of taxes, were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(936)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(974)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(638)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,518)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,839)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e526-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120045739720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE STOCK BENEFIT PLANS Employee Stock Benefit Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract', window );"><strong>Share-based Payment Arrangement, Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense was as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.571%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six Months Ended June 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Income tax benefit excludes excess tax benefits from share-based compensation awards that were vested or exercised of $12 million and $29 million for the three and six months ended June&#160;30, 2021 and $5 million and $28 million for the three and six months ended June&#160;30, 2020, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock', window );">Schedule Of Share Based Compensation Additional Information [Table Text Block]</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of units granted and the weighted-average fair value on the grant date for the six months ended June 30, 2021 were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.568%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Units in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock', window );">Share-based Payment Arrangement, Nonvested Award, Cost [Table Text Block]</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:50.082%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.582%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.587%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock&#160;Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Market Share&#160;Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Share Units</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized compensation cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected weighted-average period in years of compensation cost to be recognized</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the total intrinsic value of options exercised (or share units converted), total fair value of shares vested during the year and the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120045995704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION (New Accounting Pronouncements) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationTypeAxis=bmy_LicensingArrangementsCashFlowsReclassificationMember', window );">Licensing Arrangements Cash Flows Reclassification</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationLineItems', window );"><strong>Reclassification [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustment', window );">Prior Period Reclassification Adjustment</a></td>
<td class="nump">$ 267<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of a reclassification adjustment made to prior period financial statement amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationTypeAxis=bmy_LicensingArrangementsCashFlowsReclassificationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationTypeAxis=bmy_LicensingArrangementsCashFlowsReclassificationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120048464664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION Revenue by Nature (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">$ 11,703<span></span>
</td>
<td class="nump">$ 10,129<span></span>
</td>
<td class="nump">$ 22,776<span></span>
</td>
<td class="nump">$ 20,910<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember', window );">Net product sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">11,405<span></span>
</td>
<td class="nump">9,817<span></span>
</td>
<td class="nump">22,203<span></span>
</td>
<td class="nump">20,358<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_OtherrevenuesMember', window );">Other revenues [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">139<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="nump">272<span></span>
</td>
<td class="nump">284<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaborative Arrangement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">2,964<span></span>
</td>
<td class="nump">2,364<span></span>
</td>
<td class="nump">5,988<span></span>
</td>
<td class="nump">5,192<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaborative Arrangement [Member] | Net product sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">2,805<span></span>
</td>
<td class="nump">2,201<span></span>
</td>
<td class="nump">5,687<span></span>
</td>
<td class="nump">4,924<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaborative Arrangement [Member] | Collaborative Arrangement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">$ 159<span></span>
</td>
<td class="nump">$ 163<span></span>
</td>
<td class="nump">$ 301<span></span>
</td>
<td class="nump">$ 268<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_OtherrevenuesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_OtherrevenuesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120048489688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION Gross-to-Net Adjustments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsLineItems', window );"><strong>Gross to Net Adjustments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">$ 11,703<span></span>
</td>
<td class="nump">$ 10,129<span></span>
</td>
<td class="nump">$ 22,776<span></span>
</td>
<td class="nump">$ 20,910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustments', window );">Gross to Net Adjustments</a></td>
<td class="num">(5,377)<span></span>
</td>
<td class="num">(3,971)<span></span>
</td>
<td class="num">(10,138)<span></span>
</td>
<td class="num">(8,116)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods', window );">Adjustments for Provisions for Product Sales made in Prior Periods</a></td>
<td class="nump">85<span></span>
</td>
<td class="nump">44<span></span>
</td>
<td class="nump">302<span></span>
</td>
<td class="nump">116<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_SalesRevenueGrossMember', window );">Sales Revenue, Gross [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsLineItems', window );"><strong>Gross to Net Adjustments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">16,782<span></span>
</td>
<td class="nump">13,788<span></span>
</td>
<td class="nump">32,341<span></span>
</td>
<td class="nump">28,474<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember', window );">Net product sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsLineItems', window );"><strong>Gross to Net Adjustments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">11,405<span></span>
</td>
<td class="nump">9,817<span></span>
</td>
<td class="nump">22,203<span></span>
</td>
<td class="nump">20,358<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsAxis=bmy_ChargebacksandcashdiscountsMember', window );">Charge-backs and cash discounts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsLineItems', window );"><strong>Gross to Net Adjustments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustments', window );">Gross to Net Adjustments</a></td>
<td class="num">(1,720)<span></span>
</td>
<td class="num">(1,292)<span></span>
</td>
<td class="num">(3,306)<span></span>
</td>
<td class="num">(2,632)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsAxis=bmy_MedicaidandMedicarerebatesMember', window );">Medicaid and Medicare rebates [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsLineItems', window );"><strong>Gross to Net Adjustments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustments', window );">Gross to Net Adjustments</a></td>
<td class="num">(2,139)<span></span>
</td>
<td class="num">(1,482)<span></span>
</td>
<td class="num">(3,857)<span></span>
</td>
<td class="num">(2,980)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsAxis=bmy_OtherrebatesreturnsdiscountsandadjustmentsMember', window );">Other rebates, returns, discounts and adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustmentsLineItems', window );"><strong>Gross to Net Adjustments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_GrosstoNetAdjustments', window );">Gross to Net Adjustments</a></td>
<td class="num">$ (1,518)<span></span>
</td>
<td class="num">$ (1,197)<span></span>
</td>
<td class="num">$ (2,975)<span></span>
</td>
<td class="num">$ (2,504)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for Provisions for Product Sales made in Prior Periods</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_GrosstoNetAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross to Net Adjustments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_GrosstoNetAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_GrosstoNetAdjustmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Gross to Net Adjustments [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_GrosstoNetAdjustmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_SalesRevenueGrossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_SalesRevenueGrossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_GrosstoNetAdjustmentsAxis=bmy_ChargebacksandcashdiscountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_GrosstoNetAdjustmentsAxis=bmy_ChargebacksandcashdiscountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_GrosstoNetAdjustmentsAxis=bmy_MedicaidandMedicarerebatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_GrosstoNetAdjustmentsAxis=bmy_MedicaidandMedicarerebatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_GrosstoNetAdjustmentsAxis=bmy_OtherrebatesreturnsdiscountsandadjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_GrosstoNetAdjustmentsAxis=bmy_OtherrebatesreturnsdiscountsandadjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120054122456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION Revenue by Product by Region (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">$ 11,703<span></span>
</td>
<td class="nump">$ 10,129<span></span>
</td>
<td class="nump">$ 22,776<span></span>
</td>
<td class="nump">$ 20,910<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_RevlimidMember', window );">Revlimid [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">3,202<span></span>
</td>
<td class="nump">2,884<span></span>
</td>
<td class="nump">6,146<span></span>
</td>
<td class="nump">5,799<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_EliquisMember', window );">Eliquis [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">2,792<span></span>
</td>
<td class="nump">2,163<span></span>
</td>
<td class="nump">5,678<span></span>
</td>
<td class="nump">4,804<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_OpdivoMember', window );">Opdivo [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">1,910<span></span>
</td>
<td class="nump">1,653<span></span>
</td>
<td class="nump">3,630<span></span>
</td>
<td class="nump">3,419<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_OrenciaMember', window );">Orencia [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">814<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="nump">1,572<span></span>
</td>
<td class="nump">1,464<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_PomalystImnovidMember', window );">Pomalyst/Imnovid [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">854<span></span>
</td>
<td class="nump">745<span></span>
</td>
<td class="nump">1,627<span></span>
</td>
<td class="nump">1,458<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_SprycelMember', window );">Sprycel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">541<span></span>
</td>
<td class="nump">511<span></span>
</td>
<td class="nump">1,011<span></span>
</td>
<td class="nump">1,032<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_YervoyMember', window );">Yervoy [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">510<span></span>
</td>
<td class="nump">369<span></span>
</td>
<td class="nump">966<span></span>
</td>
<td class="nump">765<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_AbraxaneMember', window );">Abraxane [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">296<span></span>
</td>
<td class="nump">308<span></span>
</td>
<td class="nump">610<span></span>
</td>
<td class="nump">608<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_EmplicitiMember', window );">Empliciti [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="nump">171<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_ReblozylMember', window );">Reblozyl [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="nump">240<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_InrebicMember', window );">Inrebic [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_OnuregMember', window );">Onureg [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_ZeposiaMember', window );">Zeposia [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_BreyanziMember', window );">Breyanzi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_AbecmaMember', window );">Abecma</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_VidazaMember', window );">Vidaza [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">284<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_BaracludeMember', window );">Baraclude [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">109<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="nump">222<span></span>
</td>
<td class="nump">243<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=bmy_MatureProductsAndAllOtherMember', window );">Mature Products And All Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">319<span></span>
</td>
<td class="nump">331<span></span>
</td>
<td class="nump">658<span></span>
</td>
<td class="nump">749<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">7,388<span></span>
</td>
<td class="nump">6,487<span></span>
</td>
<td class="nump">14,398<span></span>
</td>
<td class="nump">13,253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">2,689<span></span>
</td>
<td class="nump">2,136<span></span>
</td>
<td class="nump">5,242<span></span>
</td>
<td class="nump">4,703<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bmy_RestOfWorldMember', window );">Rest Of World [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">1,435<span></span>
</td>
<td class="nump">1,334<span></span>
</td>
<td class="nump">2,781<span></span>
</td>
<td class="nump">2,669<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=bmy_OtherRegionMember', window );">Other Region [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">$ 191<span></span>
</td>
<td class="nump">$ 172<span></span>
</td>
<td class="nump">$ 355<span></span>
</td>
<td class="nump">$ 285<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_RevlimidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_RevlimidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_EliquisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_EliquisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_OpdivoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_OpdivoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_OrenciaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_OrenciaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_PomalystImnovidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_PomalystImnovidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_SprycelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_SprycelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_YervoyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_YervoyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_AbraxaneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_AbraxaneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_EmplicitiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_EmplicitiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_ReblozylMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_ReblozylMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_InrebicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_InrebicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_OnuregMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_OnuregMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_ZeposiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_ZeposiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_BreyanziMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_BreyanziMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_AbecmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_AbecmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_VidazaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_VidazaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_BaracludeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_BaracludeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=bmy_MatureProductsAndAllOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=bmy_MatureProductsAndAllOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bmy_RestOfWorldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bmy_RestOfWorldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=bmy_OtherRegionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=bmy_OtherRegionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120056256632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION Narratives (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuePerformanceObligationAbstract', window );"><strong>Revenue, Performance Obligation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod', window );">Contract with Customer, Performance Obligation Satisfied in Previous Period</a></td>
<td class="nump">$ 146<span></span>
</td>
<td class="nump">$ 98<span></span>
</td>
<td class="nump">$ 430<span></span>
</td>
<td class="nump">$ 228<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12A<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL108322424-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuePerformanceObligationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuePerformanceObligationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120133195992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ALLIANCES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th" colspan="2"><div>Jun. 30, 2021</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Alliance Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">$ 11,703<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 10,129<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 22,776<span></span>
</td>
<td class="nump">$ 20,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">2,452<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,699<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">5,293<span></span>
</td>
<td class="nump">6,361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income)/expense, net</a></td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(736)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(704)<span></span>
</td>
<td class="nump">427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables - from alliance partners</a></td>
<td class="nump">9,017<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,501<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable - to alliance partners</a></td>
<td class="nump">3,609<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,713<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaborative Arrangement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Alliance Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">2,964<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,364<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,988<span></span>
</td>
<td class="nump">5,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">1,346<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,050<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,743<span></span>
</td>
<td class="nump">2,356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement', window );">Selling, General and Administrative Expense</a></td>
<td class="num">(48)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(38)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(97)<span></span>
</td>
<td class="num">(78)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ResearchandDevelopmentExpenseCollaborativeArrangement', window );">Research and Development Expense</a></td>
<td class="nump">736<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">233<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">743<span></span>
</td>
<td class="nump">279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income)/expense, net</a></td>
<td class="num">(14)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(16)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(19)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables - from alliance partners</a></td>
<td class="nump">349<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">343<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable - to alliance partners</a></td>
<td class="nump">2,032<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,093<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncome', window );">Deferred income from alliance</a></td>
<td class="nump">349<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">349<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 366<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaborative Arrangement [Member] | Eisai</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Alliance Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_UpfrontPaymentsMadeToCollaborativePartner', window );">Upfront Payments Made To Collaborative Partner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_Considerationforcontingentdevelopmentandregulatoryapproval', window );">Consideration for contingent development and regulatory approval</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember', window );">Net product sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Alliance Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">11,405<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,817<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">22,203<span></span>
</td>
<td class="nump">20,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember', window );">Net product sales [Member] | Collaborative Arrangement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Alliance Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">2,805<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,201<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,687<span></span>
</td>
<td class="nump">4,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=us-gaap_CollaborativeArrangementMember', window );">Collaborative Arrangement [Member] | Collaborative Arrangement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Alliance Statement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues</a></td>
<td class="nump">$ 159<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 163<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 301<span></span>
</td>
<td class="nump">$ 268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Excludes amortization of acquired intangible assets</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_Considerationforcontingentdevelopmentandregulatoryapproval">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents that additional aggregate consideration for contingent development and regulatory approval milestone payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_Considerationforcontingentdevelopmentandregulatoryapproval</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ResearchandDevelopmentExpenseCollaborativeArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and Development Expense - Collaborative Arrangement. The balance can be debit/credit based on the nature of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ResearchandDevelopmentExpenseCollaborativeArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Selling, General and Administrative Expense - Collaborative Arrangement. The balance can be debit/credit based on the nature of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_UpfrontPaymentsMadeToCollaborativePartner">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Upfront payments made to partner as part of collaborative arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_UpfrontPaymentsMadeToCollaborativePartner</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=28183603&amp;loc=d3e692-112598<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AlliancesAndCollaborationCompaniesAxis=bmy_EisaiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AlliancesAndCollaborationCompaniesAxis=bmy_EisaiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=bmy_NetproductsalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120051684072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DIVESTITURES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from Divestiture of Businesses, Net of Cash Divested</a></td>
<td class="nump">$ 202<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
<td class="nump">$ 382<span></span>
</td>
<td class="nump">$ 336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Divestiture losses/(gains)</a></td>
<td class="num">(11)<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty Income, Nonoperating</a></td>
<td class="num">(152)<span></span>
</td>
<td class="num">(130)<span></span>
</td>
<td class="num">(287)<span></span>
</td>
<td class="num">(288)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_DiabetesbusinessMember', window );">Diabetes business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from Divestiture of Businesses, Net of Cash Divested</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="nump">296<span></span>
</td>
<td class="nump">280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Divestiture losses/(gains)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty Income, Nonoperating</a></td>
<td class="num">(152)<span></span>
</td>
<td class="num">(129)<span></span>
</td>
<td class="num">(286)<span></span>
</td>
<td class="num">(256)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_ErbituxBusinessMember', window );">Erbitux [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from Divestiture of Businesses, Net of Cash Divested</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Divestiture losses/(gains)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty Income, Nonoperating</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=us-gaap_ManufacturingFacilityMember', window );">Manufacturing Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from Divestiture of Businesses, Net of Cash Divested</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Divestiture losses/(gains)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty Income, Nonoperating</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_AvaproAvalideAndPlavixMember', window );">Avapro, Avalide, and Plavix [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from Divestiture of Businesses, Net of Cash Divested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Divestiture losses/(gains)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty Income, Nonoperating</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember', window );">Other divestitures [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from Divestiture of Businesses, Net of Cash Divested</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Divestiture losses/(gains)</a></td>
<td class="num">(11)<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty Income, Nonoperating</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">$ (32)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyIncomeNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ancillary revenue earned during the period from the consideration paid to the entity for the use of its rights and property by another party. Examples include licensing the use of copyrighted materials and leasing the extraction of natural resources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyIncomeNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_DiabetesbusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_DiabetesbusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_ErbituxBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_ErbituxBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=us-gaap_ManufacturingFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=us-gaap_ManufacturingFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_AvaproAvalideAndPlavixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_AvaproAvalideAndPlavixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_MatureBrandsAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120053131608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LICENSING AND OTHER ARRANGEMENTS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty Income, Nonoperating</a></td>
<td class="num">$ (152)<span></span>
</td>
<td class="num">$ (130)<span></span>
</td>
<td class="num">$ (287)<span></span>
</td>
<td class="num">$ (288)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_UpFrontLicensingFee', window );">Up-front Licensing Fee</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ContingentRegulatoryMilestoneIncome', window );">Contingent and Regulatory Milestone Income</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAmortizationOfDeferredCharges', window );">Amortization of Other Deferred Charges</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LicensingAndOtherArrangementsIncome', window );">Licensing and Other Arrangements Income</a></td>
<td class="num">(253)<span></span>
</td>
<td class="num">(181)<span></span>
</td>
<td class="num">(485)<span></span>
</td>
<td class="num">(433)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=bmy_AgenusMember', window );">Agenus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LicenseAndOtherArrangementsUpfrontPayments', window );">License and Other Arrangements Upfront Payments</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ContingentAndRegulatoryMilestonePayments', window );">Contingent and Regulatory Milestone Payments</a></td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LicensingAndOtherArrangementsAxis=bmy_OtherRoyaltiesMember', window );">Other Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty Income, Nonoperating</a></td>
<td class="num">(9)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LicensingAndOtherArrangementsAxis=bmy_KeytrudaRoyaltiesMember', window );">Keytruda Royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty Income, Nonoperating</a></td>
<td class="num">(204)<span></span>
</td>
<td class="num">(155)<span></span>
</td>
<td class="num">(396)<span></span>
</td>
<td class="num">(316)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LicensingAndOtherArrangementsAxis=bmy_TecentriqRoyaltiesMember', window );">Tecentriq royalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty Income, Nonoperating</a></td>
<td class="num">(23)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_DiabetesbusinessMember', window );">Diabetes business [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LicensingArrangementsLineItems', window );"><strong>Licensing Arrangements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyIncomeNonoperating', window );">Royalty Income, Nonoperating</a></td>
<td class="num">$ (152)<span></span>
</td>
<td class="num">$ (129)<span></span>
</td>
<td class="num">$ (286)<span></span>
</td>
<td class="num">$ (256)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ContingentAndRegulatoryMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent and Regulatory Milestone Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ContingentAndRegulatoryMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ContingentRegulatoryMilestoneIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent Regulatory Milestone Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ContingentRegulatoryMilestoneIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicenseAndOtherArrangementsUpfrontPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License and Other Arrangements Upfront Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicenseAndOtherArrangementsUpfrontPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingAndOtherArrangementsIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing and Other Arrangements Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingAndOtherArrangementsIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingArrangementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Licensing Arrangements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingArrangementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_UpFrontLicensingFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Up-front Licensing Fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_UpFrontLicensingFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAmortizationOfDeferredCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization of other deferred costs recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAmortizationOfDeferredCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyIncomeNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ancillary revenue earned during the period from the consideration paid to the entity for the use of its rights and property by another party. Examples include licensing the use of copyrighted materials and leasing the extraction of natural resources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyIncomeNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=bmy_AgenusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=bmy_AgenusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingAndOtherArrangementsAxis=bmy_OtherRoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingAndOtherArrangementsAxis=bmy_OtherRoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingAndOtherArrangementsAxis=bmy_KeytrudaRoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingAndOtherArrangementsAxis=bmy_KeytrudaRoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LicensingAndOtherArrangementsAxis=bmy_TecentriqRoyaltiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LicensingAndOtherArrangementsAxis=bmy_TecentriqRoyaltiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_DiabetesbusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=bmy_DiabetesbusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120050966456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER EXPENSE (INCOME), NET (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other Nonoperating Income (Expense) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">$ 330<span></span>
</td>
<td class="nump">$ 357<span></span>
</td>
<td class="nump">$ 683<span></span>
</td>
<td class="nump">$ 719<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(165)<span></span>
</td>
<td class="num">(510)<span></span>
</td>
<td class="nump">391<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_OtherIncomeReceivedFromAlliancePartners', window );">Royalties and licensing income</a></td>
<td class="num">(405)<span></span>
</td>
<td class="num">(311)<span></span>
</td>
<td class="num">(772)<span></span>
</td>
<td class="num">(721)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments', window );">Equity investment (gains)/losses</a></td>
<td class="num">(148)<span></span>
</td>
<td class="num">(818)<span></span>
</td>
<td class="num">(749)<span></span>
</td>
<td class="num">(480)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Integration expenses</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="nump">340<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Provision for restructuring</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="nump">123<span></span>
</td>
<td class="nump">275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation and other settlements</a></td>
<td class="nump">44<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_AllianceTransitionalServices', window );">Transition and other service fees</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="num">(111)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Investment income</a></td>
<td class="num">(12)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(86)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_Reversionexcisetax', window );">Reversion excise tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Divestiture losses/(gains)</a></td>
<td class="num">(11)<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Intangible asset impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">281<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_OtherOtherIncomeExpense', window );">Other</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income)/expense, net</a></td>
<td class="num">$ (2)<span></span>
</td>
<td class="num">$ (736)<span></span>
</td>
<td class="num">$ (704)<span></span>
</td>
<td class="nump">$ 427<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AllianceTransitionalServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents other income recognized during the period related to transitional services provided to a former alliance partner.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AllianceTransitionalServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_OtherIncomeReceivedFromAlliancePartners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of other income received during the period related to alliance partners and includes the amortization of milestone payments received and royalty income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_OtherIncomeReceivedFromAlliancePartners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_OtherOtherIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other (income)/expense which does not qualify for separate disclosure under materiality guidelines.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_OtherOtherIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_Reversionexcisetax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Section 4980 Tax On Reversion Of Qualified Plan Assets To Employer</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_Reversionexcisetax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the net total realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including the unrealized holding gain (loss) of held-to-maturity securities transferred to the trading security category and the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders' equity) for available-for-sale securities transferred to trading securities during the period. Additionally, this item would include any gains (losses) realized during the period from the sale of investments accounted for under the cost method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120048042312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING NARRATIVE (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember', window );">Celgene Integration [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and Related Cost, Expected Cost</a></td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="nump">2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_Cashoutlays', window );">Cash outlays</a></td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated', window );">Restructuring and Related Cost, Number of Positions Eliminated</a></td>
<td class="nump">240<span></span>
</td>
<td class="nump">900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bmy_MyoKardiaAcquisitionPlanMember', window );">MyoKardia Acquisition Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and Related Cost, Expected Cost</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bmy_CompanyTransformationMember', window );">Operating Model 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Restructuring and Related Cost, Cost Incurred to Date</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_Cashoutlays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outlays</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_Cashoutlays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of costs incurred to date for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostCostIncurredToDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of positions eliminated during the period as a result of restructuring activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bmy_MyoKardiaAcquisitionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bmy_MyoKardiaAcquisitionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bmy_CompanyTransformationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bmy_CompanyTransformationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120049165912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING RESTRUCTURING AND RELATED COSTS TABLE (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Employee termination costs</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 107<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
<td class="nump">$ 256<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherRestructuringCosts', window );">Other termination costs</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Provision for restructuring</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="nump">123<span></span>
</td>
<td class="nump">275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Integration expenses</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="nump">340<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAcceleratedDepreciation', window );">Accelerated depreciation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_RestructuringRelatedCostsAssetImpairments', window );">Asset impairment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_OtherShutdownCosts', window );">Other shutdown costs</a></td>
<td class="num">(11)<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">219<span></span>
</td>
<td class="nump">340<span></span>
</td>
<td class="nump">429<span></span>
</td>
<td class="nump">746<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of products sold [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Marketing, selling and administrative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other (income)/expense,net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">219<span></span>
</td>
<td class="nump">289<span></span>
</td>
<td class="nump">405<span></span>
</td>
<td class="nump">623<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember', window );">Celgene Integration [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">317<span></span>
</td>
<td class="nump">373<span></span>
</td>
<td class="nump">641<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bmy_MyoKardiaAcquisitionPlanMember', window );">MyoKardia Acquisition Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">56<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bmy_CompanyTransformationMember', window );">Operating Model 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Total charges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 105<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_OtherShutdownCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other shutdown costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_OtherShutdownCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_RestructuringRelatedCostsAssetImpairments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring Related Costs, Asset Impairments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_RestructuringRelatedCostsAssetImpairments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAcceleratedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accelerated depreciation charged against earnings associated with exit from or disposal of business activities or restructuring plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAcceleratedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bmy_MyoKardiaAcquisitionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bmy_MyoKardiaAcquisitionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bmy_CompanyTransformationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bmy_CompanyTransformationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120054196168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RESTRUCTURING SCHEDULE OF RESTRUCTURING RESERVE (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jan. 01, 2021</div></th>
<th class="th"><div>Jan. 01, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Restructuring Liability</a></td>
<td class="nump">$ 126<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
<td class="nump">$ 126<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
<td class="nump">$ 148<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAccrualAdjustment1', window );">Change in estimates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation', window );">Restructuring Charges Exclude Accelerated Stock-Based Compensation</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Provision for restructuring</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="nump">123<span></span>
</td>
<td class="nump">275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveTranslationAdjustment', window );">Foreign currency translation and other</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="num">$ (134)<span></span>
</td>
<td class="num">$ (188)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember', window );">Celgene Integration [Member] | Accelerated Stock Based Compensation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Provision for restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring Charges Excluding Accelerated Stock-based Compensation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAccrualAdjustment1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAccrualAdjustment1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveTranslationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveTranslationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=bmy_CelgeneIntegrationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=bmy_AcceleratedStockBasedCompensationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=bmy_AcceleratedStockBasedCompensationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120050628520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Earnings Before Income Taxes</a></td>
<td class="nump">$ 1,553<span></span>
</td>
<td class="nump">$ 1,627<span></span>
</td>
<td class="nump">$ 4,083<span></span>
</td>
<td class="nump">$ 1,323<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for Income Taxes</a></td>
<td class="nump">$ 492<span></span>
</td>
<td class="nump">$ 1,707<span></span>
</td>
<td class="nump">$ 993<span></span>
</td>
<td class="nump">$ 2,169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective Tax Rate</a></td>
<td class="nump">31.70%<span></span>
</td>
<td class="nump">104.90%<span></span>
</td>
<td class="nump">24.30%<span></span>
</td>
<td class="nump">163.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (95)<span></span>
</td>
<td class="nump">$ 1,365<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_DeferredIncomeTaxExpenseBenefitComponentAxis=bmy_InternalTransferOfProductRightsMember', window );">Internal Transfer of Product Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_DeferredIncomeTaxExpenseBenefitComponentAxis=bmy_OtezlaDivestitureMember', window );">Otezla Divestiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Decrease in Unrecognized Tax Benefits is Reasonably Possible</a></td>
<td class="nump">$ 430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems', window );"><strong>Income Tax Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Decrease in Unrecognized Tax Benefits is Reasonably Possible</a></td>
<td class="nump">$ 480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_DeferredIncomeTaxExpenseBenefitComponentAxis=bmy_InternalTransferOfProductRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_DeferredIncomeTaxExpenseBenefitComponentAxis=bmy_InternalTransferOfProductRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_DeferredIncomeTaxExpenseBenefitComponentAxis=bmy_OtezlaDivestitureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_DeferredIncomeTaxExpenseBenefitComponentAxis=bmy_OtezlaDivestitureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120133589576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS/(LOSS) PER SHARE (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Earnings/(Loss) Attributable to BMS Used for Basic and Diluted EPS Calculation</a></td>
<td class="nump">$ 1,055<span></span>
</td>
<td class="num">$ (85)<span></span>
</td>
<td class="nump">$ 3,076<span></span>
</td>
<td class="num">$ (860)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding - basic</a></td>
<td class="nump">2,227<span></span>
</td>
<td class="nump">2,263<span></span>
</td>
<td class="nump">2,232<span></span>
</td>
<td class="nump">2,261<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Incremental shares attributable to share-based compensation plans</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding - diluted</a></td>
<td class="nump">2,252<span></span>
</td>
<td class="nump">2,263<span></span>
</td>
<td class="nump">2,258<span></span>
</td>
<td class="nump">2,261<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings/(Loss) Per Share, Basic</a></td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="num">$ (0.04)<span></span>
</td>
<td class="nump">$ 1.38<span></span>
</td>
<td class="num">$ (0.38)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings/(Loss) Per Share, Diluted</a></td>
<td class="nump">$ 0.47<span></span>
</td>
<td class="num">$ (0.04)<span></span>
</td>
<td class="nump">$ 1.36<span></span>
</td>
<td class="num">$ (0.38)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120052069992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Fair Value Measurement) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>percentage </div>
<div>yr</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>percentage </div>
<div>yr</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">$ 2,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,718<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">3,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost</a></td>
<td class="nump">2,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,704<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity Securities without Readily Determinable Fair Value, Amount</a></td>
<td class="nump">616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">694<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount', window );">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="nump">$ 130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount', window );">Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(202)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss', window );">Equity Securities, FV-NI, Realized Gain (Loss)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Equity Securities, FV-NI, Unrealized Gain (Loss)</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">778<span></span>
</td>
<td class="nump">448<span></span>
</td>
<td class="nump">550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments', window );">Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments</a></td>
<td class="nump">4,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount', window );">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount</a></td>
<td class="nump">243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount', window );">Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount</a></td>
<td class="num">(142)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(142)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized Gain (Loss) on Investments</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">778<span></span>
</td>
<td class="nump">353<span></span>
</td>
<td class="nump">550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and Cash Equivalents, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and Cash Equivalents, Fair Value Disclosure</a></td>
<td class="nump">9,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and Cash Equivalents, Fair Value Disclosure</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration fair value</a></td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange', window );">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings, Foreign Exchange</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</a></td>
<td class="nump">67<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">67<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="nump">$ 106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">$ (36)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of Deposit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">1,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost</a></td>
<td class="nump">1,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of Deposit [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of Deposit [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">1,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of Deposit [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Debt Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost</a></td>
<td class="nump">490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Debt Securities [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Debt Securities [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate Debt Securities [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt Securities, Available-for-sale</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">3,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Equity Securities, FV-NI</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember', window );">Portion at Other than Fair Value Measurement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity Method Investments</a></td>
<td class="nump">638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=bmy_ContingentValueRightsMember', window );">Contingent Value Rights [Member] | Fair Value, Inputs, Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration fair value</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=bmy_ContingentValueRightsMember', window );">Contingent Value Rights [Member] | Fair Value, Inputs, Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationByTypeAxis=bmy_ContingentValueRightsMember', window );">Contingent Value Rights [Member] | Fair Value, Inputs, Level 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration fair value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=bmy_ProbabilityofpaymentMember', window );">Probability of payment [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt Instrument, Measurement Input | percentage</a></td>
<td class="nump">0.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=bmy_ProbabilityofpaymentMember', window );">Probability of payment [Member] | Weighted Average [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt Instrument, Measurement Input | percentage</a></td>
<td class="nump">0.024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=bmy_ProbabilityofpaymentMember', window );">Probability of payment [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt Instrument, Measurement Input | percentage</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt Instrument, Measurement Input | percentage</a></td>
<td class="nump">0.013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate [Member] | Weighted Average [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt Instrument, Measurement Input | percentage</a></td>
<td class="nump">0.006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Debt Instrument, Measurement Input | percentage</a></td>
<td class="nump">0.003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=bmy_ProjectedYearOfPaymentsMember', window );">Projected Year of Payments | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input [Extensible List] | yr</a></td>
<td class="nump">2,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=bmy_ProjectedYearOfPaymentsMember', window );">Projected Year of Payments | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Business Combination, Contingent Consideration, Liability, Measurement Input [Extensible List] | yr</a></td>
<td class="nump">2,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings, Foreign Exchange</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from downward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain from upward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=bmy_ContingentValueRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=bmy_ContingentValueRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=bmy_ProbabilityofpaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=bmy_ProbabilityofpaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=bmy_ProjectedYearOfPaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=bmy_ProjectedYearOfPaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120049885272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Derivatives and Hedging) (Details)<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">$ 43,666.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,666.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48,711.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Derivative, Basis Spread on Variable Rate</a></td>
<td class="nump">4.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="num">$ (38.0)<span></span>
</td>
<td class="num">$ (34.0)<span></span>
</td>
<td class="nump">$ 221.0<span></span>
</td>
<td class="nump">$ 63.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="nump">53.0<span></span>
</td>
<td class="num">(32.0)<span></span>
</td>
<td class="nump">89.0<span></span>
</td>
<td class="num">(52.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">45.0<span></span>
</td>
<td class="nump">12.0<span></span>
</td>
<td class="num">(65.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">1,100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax</a></td>
<td class="num">(16.0)<span></span>
</td>
<td class="num">(32.0)<span></span>
</td>
<td class="nump">25.0<span></span>
</td>
<td class="num">(12.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">16.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member] | Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="nump">16.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member] | Designated as Hedging Instrument [Member] | Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">255.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">255.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">255.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member] | Designated as Hedging Instrument [Member] | Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross Currency Interest Rate Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">26.0<span></span>
</td>
<td class="nump">10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross Currency Interest Rate Contract [Member] | Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="nump">16.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross Currency Interest Rate Contract [Member] | Designated as Hedging Instrument [Member] | Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross Currency Interest Rate Contract [Member] | Designated as Hedging Instrument [Member] | Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="num">(38.0)<span></span>
</td>
<td class="num">(34.0)<span></span>
</td>
<td class="nump">221.0<span></span>
</td>
<td class="nump">63.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward [Member] | Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="nump">90.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="num">(36.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(259.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward [Member] | Designated as Hedging Instrument [Member] | Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">3,776.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,776.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">231.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward [Member] | Designated as Hedging Instrument [Member] | Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">1,445.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,445.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,813.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward [Member] | Not Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="nump">9.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="num">(6.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward [Member] | Not Designated as Hedging Instrument [Member] | Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">932.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">932.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,104.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward [Member] | Not Designated as Hedging Instrument [Member] | Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">531.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">531.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">336.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OtherContractMember', window );">Other Contract | Not Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative asset</a></td>
<td class="nump">19.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OtherContractMember', window );">Other Contract | Not Designated as Hedging Instrument [Member] | Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OtherContractMember', window );">Other Contract | Not Designated as Hedging Instrument [Member] | Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_EUR', window );">Euro Member Countries, Euro | Foreign Exchange Forward [Member] | Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">3,100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_JPY', window );">Japan, Yen | Cross Currency Interest Rate Contract [Member] | Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=currency_JPY', window );">Japan, Yen | Foreign Exchange Forward [Member] | Designated as Hedging Instrument [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">1,100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of products sold [Member] | Interest Rate Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Derivative, Gain (Loss) on Derivative, Net</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of products sold [Member] | Cross Currency Interest Rate Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Derivative, Gain (Loss) on Derivative, Net</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of products sold [Member] | Foreign Exchange Forward [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Derivative, Gain (Loss) on Derivative, Net</a></td>
<td class="nump">59.0<span></span>
</td>
<td class="num">(35.0)<span></span>
</td>
<td class="nump">126.0<span></span>
</td>
<td class="num">(58.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="nump">53.0<span></span>
</td>
<td class="num">(32.0)<span></span>
</td>
<td class="nump">89.0<span></span>
</td>
<td class="num">(52.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of products sold [Member] | Zero Cost Collar Currency Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Derivative, Gain (Loss) on Derivative, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember', window );">Other (Income)/expense, net [Member] | Interest Rate Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Derivative, Gain (Loss) on Derivative, Net</a></td>
<td class="num">(7.0)<span></span>
</td>
<td class="num">(7.0)<span></span>
</td>
<td class="num">(15.0)<span></span>
</td>
<td class="num">(14.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember', window );">Other (Income)/expense, net [Member] | Cross Currency Interest Rate Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Derivative, Gain (Loss) on Derivative, Net</a></td>
<td class="num">(3.0)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="num">(6.0)<span></span>
</td>
<td class="num">(5.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember', window );">Other (Income)/expense, net [Member] | Foreign Exchange Forward [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Derivative, Gain (Loss) on Derivative, Net</a></td>
<td class="nump">$ 16.0<span></span>
</td>
<td class="nump">21.0<span></span>
</td>
<td class="num">$ (16.0)<span></span>
</td>
<td class="num">(55.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember', window );">Other (Income)/expense, net [Member] | Zero Cost Collar Currency Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Derivative, Gain (Loss) on Derivative, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember', window );">London Interbank Offered Rate (LIBOR) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeVariableInterestRate', window );">Derivative, Variable Interest Rate</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeBasisSpreadOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeBasisSpreadOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeVariableInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeVariableInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OtherContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_OtherContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_JPY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_JPY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=bmy_ZeroCostCollarCurrencyContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=bmy_ZeroCostCollarCurrencyContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120133777512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Debt) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBankLoansAndNotesPayable', window );">Short-term Bank Loans and Notes Payable</a></td>
<td class="nump">$ 63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">2,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,497<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherShortTermBorrowings', window );">Other Short-term Borrowings</a></td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Bank drafts and short-term borrowings</a></td>
<td class="nump">2,655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,340<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">43,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,711<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_UnamortizedBasisAdjustmentFromSwapTerminations', window );">Adjustments to Principal Value, Unamortized basis adjustment from swap terminations</a></td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt Instrument, Unamortized Discount</a></td>
<td class="num">(279)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(279)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(303)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedPremium', window );">Debt Instrument, Unamortized Premium</a></td>
<td class="nump">1,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,755<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total Debt</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">42,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Long-term debt, fair value</a></td>
<td class="nump">50,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest payments</a></td>
<td class="nump">807<span></span>
</td>
<td class="nump">$ 845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_NumberofRevolvingCreditFacilities', window );">Number of Revolving Credit Facilities</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Payment for Debt Extinguishment or Debt Prepayment Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestments', window );">Unrealized Gain (Loss) on Investments</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">778<span></span>
</td>
<td class="nump">353<span></span>
</td>
<td class="nump">$ 550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (Loss) on Extinguishment of Debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(281)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of Debt, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmy_A2.875SeniorNotesdue2021Member', window );">2.875% Senior Notes due 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=bmy_A2550SeniorNotesDue2021Member', window );">2.55% Senior Notes due 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt Instrument, Face Amount</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=bmy_A2BillionMaximumBorrowingCapacityMember', window );">$2 Billion Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=bmy_A1BillionMaximumBorrowingCapacityMember', window );">$1 Billion Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=bmy_A1.5BillionMaximumBorrowingCapacityMember', window );">$1.5 Billion Maximum Borrowing Capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of Credit Facility, Maximum Borrowing Capacity</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_NumberofRevolvingCreditFacilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Revolving Credit Facilities: Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_NumberofRevolvingCreditFacilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_UnamortizedBasisAdjustmentFromSwapTerminations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the adjustment to principal value of long term debt related to the unamortized basis adjustment from swap terminations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_UnamortizedBasisAdjustmentFromSwapTerminations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowings classified as other, maturing within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBankLoansAndNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBankLoansAndNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmy_A2.875SeniorNotesdue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmy_A2.875SeniorNotesdue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=bmy_A2550SeniorNotesDue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=bmy_A2550SeniorNotesDue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=bmy_A2BillionMaximumBorrowingCapacityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=bmy_A2BillionMaximumBorrowingCapacityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=bmy_A1BillionMaximumBorrowingCapacityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=bmy_A1BillionMaximumBorrowingCapacityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=bmy_A1.5BillionMaximumBorrowingCapacityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=bmy_A1.5BillionMaximumBorrowingCapacityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120050929240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECEIVABLES (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Account Receivables [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Trade receivables</a></td>
<td class="nump">$ 8,309<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,882<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_CashDiscounts', window );">Less charge-backs and cash discounts</a></td>
<td class="num">(569)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(645)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Less allowances for expected credit loss</a></td>
<td class="num">(27)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Net trade receivables</a></td>
<td class="nump">7,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivables', window );">Alliance, royalties, VAT and other</a></td>
<td class="nump">1,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,282<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables</a></td>
<td class="nump">9,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,501<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ReceivablesSoldOnNonrecourseBasis', window );">Non-U.S. receivables sold on a nonrecourse basis</a></td>
<td class="nump">$ 638<span></span>
</td>
<td class="nump">$ 464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_NumberOfLargestPharmaceuticalWholesalers', window );">Number Of Largest Pharmaceutical Wholesalers</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Account Receivables [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_PercentageOfAggregateTotalTradeReceivablesDue', window );">Percent of aggregate total trade receivables due from three pharmaceutical wholesalers</a></td>
<td class="nump">58.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_CashDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of reductions to trade receivables incurred during the period attributable to cash discounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_CashDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_NumberOfLargestPharmaceuticalWholesalers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of the largest pharmaceutical wholesalers used by the company in the territory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_NumberOfLargestPharmaceuticalWholesalers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_PercentageOfAggregateTotalTradeReceivablesDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of aggregate trade receivables due from customers accounting for more than 10% of total trade receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_PercentageOfAggregateTotalTradeReceivablesDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ReceivablesSoldOnNonrecourseBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of receivables sold on a nonrecourse basis during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ReceivablesSoldOnNonrecourseBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from parties in nontrade transactions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120133508008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">$ 891<span></span>
</td>
<td class="nump">$ 932<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">1,852<span></span>
</td>
<td class="nump">2,015<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves', window );">Raw and packaging materials</a></td>
<td class="nump">270<span></span>
</td>
<td class="nump">207<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_Totalinventories', window );">Total inventories</a></td>
<td class="nump">3,013<span></span>
</td>
<td class="nump">3,154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">2,137<span></span>
</td>
<td class="nump">2,074<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNoncurrent', window );">Inventories - other assets</a></td>
<td class="nump">876<span></span>
</td>
<td class="nump">1,080<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=bmy_InventorypurchasepricefairvalueadjustmentMember', window );">Inventory purchase price fair value adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</a></td>
<td class="nump">$ 606<span></span>
</td>
<td class="nump">$ 774<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_Totalinventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This represents the total inventory, current and non-current, as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_Totalinventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=bmy_InventorypurchasepricefairvalueadjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=bmy_InventorypurchasepricefairvalueadjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120050929240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY, PLANT AND EQUIPMENT (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">$ 169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 189<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings</a></td>
<td class="nump">5,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,732<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Machinery and equipment and fixtures</a></td>
<td class="nump">3,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress</a></td>
<td class="nump">565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Gross property, plant and equipment</a></td>
<td class="nump">9,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="num">(3,838)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,838)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,585)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment</a></td>
<td class="nump">5,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,886<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 143<span></span>
</td>
<td class="nump">$ 145<span></span>
</td>
<td class="nump">$ 278<span></span>
</td>
<td class="nump">$ 315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120133386440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 20,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,547<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross other intangible assets</a></td>
<td class="nump">66,804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,859<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(18,739)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,739)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,616)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets</a></td>
<td class="nump">48,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53,243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="nump">5,100<span></span>
</td>
<td class="nump">$ 4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_AcquiredDevelopedProductRightsReclassedFromIPRD', window );">Acquired Developed Product Rights Reclassed From IPRD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_IntangibleAssetNameAxis=bmy_InrebicMember', window );">Inrebic [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of Intangible Assets (Excluding Goodwill)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease', window );">Finite-Lived Intangible Assets, Period Increase (Decrease)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ContingentAndRegulatoryMilestoneNonCash', window );">Contingent and Regulatory Milestone, Non-Cash</a></td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_IntangibleAssetNameAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In Process Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment of Intangible Assets (Excluding Goodwill)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Licenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">328<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Acquired developed product rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">60,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,076<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember', window );">Capitalized software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">1,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,405<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,325<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In Process Research and Development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">In-process research and development</a></td>
<td class="nump">$ 4,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,130<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Licenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Acquired developed product rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member] | Capitalized software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Licenses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Acquired developed product rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Capitalized software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Asset, Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AcquiredDevelopedProductRightsReclassedFromIPRD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquired Developed Product Rights Reclassed From IPRD</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AcquiredDevelopedProductRightsReclassedFromIPRD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ContingentAndRegulatoryMilestoneNonCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contingent and Regulatory Milestone, Non-Cash</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ContingentAndRegulatoryMilestoneNonCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in carrying value of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_IntangibleAssetNameAxis=bmy_InrebicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_IntangibleAssetNameAxis=bmy_InrebicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_IntangibleAssetNameAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_IntangibleAssetNameAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120054447400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION Other Current Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_OtherCurrentAssetsAbstract', window );"><strong>Other Current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidTaxes', window );">Prepaid and refundable income taxes</a></td>
<td class="nump">$ 2,258<span></span>
</td>
<td class="nump">$ 1,799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_ResearchandDevelopment', window );">Research and Development</a></td>
<td class="nump">576<span></span>
</td>
<td class="nump">492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_EquityInvestmentsCurrent', window );">Equity investments</a></td>
<td class="nump">1,046<span></span>
</td>
<td class="nump">619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Other</a></td>
<td class="nump">983<span></span>
</td>
<td class="nump">787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">5,037<span></span>
</td>
<td class="nump">3,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted Cash</a></td>
<td class="nump">373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">5,037<span></span>
</td>
<td class="nump">3,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember', window );">Other Current Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted Cash</a></td>
<td class="nump">$ 174<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_EquityInvestmentsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity investments - current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_EquityInvestmentsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_OtherCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Current Assets [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_OtherCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_ResearchandDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and Development</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_ResearchandDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120054137784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION Other Non-Current Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_OtherNonCurrentAssetsAbstract', window );"><strong>Other Non-Current Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_EquityInvestmentsNonCurrent', window );">Equity investments</a></td>
<td class="nump">$ 3,622<span></span>
</td>
<td class="nump">$ 4,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNoncurrent', window );">Inventories</a></td>
<td class="nump">876<span></span>
</td>
<td class="nump">1,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating leases</a></td>
<td class="nump">1,006<span></span>
</td>
<td class="nump">859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Pension and postretirement</a></td>
<td class="nump">234<span></span>
</td>
<td class="nump">208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash - non current</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousNoncurrent', window );">Other</a></td>
<td class="nump">517<span></span>
</td>
<td class="nump">458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">6,454<span></span>
</td>
<td class="nump">$ 7,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted Cash</a></td>
<td class="nump">$ 373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 428<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_EquityInvestmentsNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity investments - non-current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_EquityInvestmentsNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_OtherNonCurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Non-Current Assets [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_OtherNonCurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120049096104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION Other Current Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrentAbstract', window );"><strong>Other Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_AccruedRebatesAndReturns', window );">Rebates and returns</a></td>
<td class="nump">$ 5,665<span></span>
</td>
<td class="nump">$ 5,688<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes payable</a></td>
<td class="nump">638<span></span>
</td>
<td class="nump">647<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee compensation and benefits</a></td>
<td class="nump">896<span></span>
</td>
<td class="nump">1,412<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_AccruedResearchAndDevelopment', window );">Research and development</a></td>
<td class="nump">1,469<span></span>
</td>
<td class="nump">1,423<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividends</a></td>
<td class="nump">1,107<span></span>
</td>
<td class="nump">1,129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_AccruedInterest', window );">Interest</a></td>
<td class="nump">373<span></span>
</td>
<td class="nump">434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedRoyaltiesCurrent', window );">Royalties</a></td>
<td class="nump">386<span></span>
</td>
<td class="nump">461<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating leases</a></td>
<td class="nump">173<span></span>
</td>
<td class="nump">164<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">2,020<span></span>
</td>
<td class="nump">2,154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">12,727<span></span>
</td>
<td class="nump">14,027<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other Current Liabilities [Member] | Contingent Value Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent value rights</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 515<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AccruedRebatesAndReturns">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable pertaining to rebates to government programs and sales returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AccruedRebatesAndReturns</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_AccruedResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to research and development.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_AccruedResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=bmy_ContingentValueRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=bmy_ContingentValueRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120044045048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUPPLEMENTAL FINANCIAL INFORMATION Other Non-Current Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Income taxes payable</a></td>
<td class="nump">$ 4,690<span></span>
</td>
<td class="nump">$ 5,017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Pension and postretirement</a></td>
<td class="nump">838<span></span>
</td>
<td class="nump">899<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating leases</a></td>
<td class="nump">962<span></span>
</td>
<td class="nump">833<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeNoncurrent', window );">Deferred Income</a></td>
<td class="nump">324<span></span>
</td>
<td class="nump">357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation</a></td>
<td class="nump">416<span></span>
</td>
<td class="nump">344<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Other</a></td>
<td class="nump">268<span></span>
</td>
<td class="nump">326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">$ 7,498<span></span>
</td>
<td class="nump">$ 7,776<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=28183603&amp;loc=d3e692-112598<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120052941496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY (Changes in Equity) (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="5">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Common Stock, Dividends, Per Share, Declared</a></td>
<td class="nump">$ 0.49<span></span>
</td>
<td class="nump">$ 0.49<span></span>
</td>
<td class="nump">$ 0.45<span></span>
</td>
<td class="nump">$ 0.45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock Repurchase Program, Remaining Authorized Repurchase Amount</a></td>
<td class="nump">$ 3,400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,400.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount</a></td>
<td class="nump">2,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000.0<span></span>
</td>
<td class="nump">2,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value, Issued, Balance at Beginning of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 292.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value, Issued, Balance at End of Period</a></td>
<td class="nump">292.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Capital in Excess of Par Value of Stock, Balance at Beginning of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,325.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,325.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Capital in Excess of Par Value of Stock, Balance at End of Period</a></td>
<td class="nump">44,064.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,064.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Loss, Balance at Beginning of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,839.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,839.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income/(Loss)</a></td>
<td class="nump">26.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">321.0<span></span>
</td>
<td class="num">$ (36.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Loss, Balance at End of Period</a></td>
<td class="num">(1,518.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,518.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings, Balance at Beginning of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,281.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,281.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Earnings/(Loss) Attributable to BMS</a></td>
<td class="nump">1,055.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(85.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,076.0<span></span>
</td>
<td class="num">(860.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Treasury Stock, Value, Acquired, Cost Method</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings, Balance at End of Period</a></td>
<td class="nump">22,168.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,168.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Cost of Treasury Stock, Balance at Beginning of Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,237.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,237.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Cost of Treasury Stock, Balance at End of Period</a></td>
<td class="num">(28,198.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28,198.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Noncontrolling Interest</a></td>
<td class="num">(6.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (5.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14.0)<span></span>
</td>
<td class="num">$ (14.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="nump">$ 66.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchase program, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.0<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">99.0<span></span>
</td>
<td class="nump">47.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock Repurchased During Period, Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 81.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Common Stock, Shares Issued, Balance at Beginning of Period</a></td>
<td class="nump">2,923.0<span></span>
</td>
<td class="nump">2,923.0<span></span>
</td>
<td class="nump">2,923.0<span></span>
</td>
<td class="nump">2,923.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,923.0<span></span>
</td>
<td class="nump">2,923.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Common Stock, Shares Issued, Balance at End of Period</a></td>
<td class="nump">2,923.0<span></span>
</td>
<td class="nump">2,923.0<span></span>
</td>
<td class="nump">2,923.0<span></span>
</td>
<td class="nump">2,923.0<span></span>
</td>
<td class="nump">2,923.0<span></span>
</td>
<td class="nump">2,923.0<span></span>
</td>
<td class="nump">2,923.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value, Issued, Balance at Beginning of Period</a></td>
<td class="nump">$ 292.0<span></span>
</td>
<td class="nump">$ 292.0<span></span>
</td>
<td class="nump">$ 292.0<span></span>
</td>
<td class="nump">$ 292.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 292.0<span></span>
</td>
<td class="nump">$ 292.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value, Issued, Balance at End of Period</a></td>
<td class="nump">292.0<span></span>
</td>
<td class="nump">292.0<span></span>
</td>
<td class="nump">292.0<span></span>
</td>
<td class="nump">292.0<span></span>
</td>
<td class="nump">$ 292.0<span></span>
</td>
<td class="nump">292.0<span></span>
</td>
<td class="nump">292.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember', window );">Capital in Excess of Par Value of Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Capital in Excess of Par Value of Stock, Balance at Beginning of Period</a></td>
<td class="nump">43,852.0<span></span>
</td>
<td class="nump">44,325.0<span></span>
</td>
<td class="nump">43,254.0<span></span>
</td>
<td class="nump">43,709.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,325.0<span></span>
</td>
<td class="nump">43,709.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Stock compensation</a></td>
<td class="nump">212.0<span></span>
</td>
<td class="num">(473.0)<span></span>
</td>
<td class="num">(210.0)<span></span>
</td>
<td class="num">(455.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Capital in Excess of Par Value of Stock, Balance at End of Period</a></td>
<td class="nump">44,064.0<span></span>
</td>
<td class="nump">43,852.0<span></span>
</td>
<td class="nump">44,444.0<span></span>
</td>
<td class="nump">43,254.0<span></span>
</td>
<td class="nump">43,709.0<span></span>
</td>
<td class="nump">44,064.0<span></span>
</td>
<td class="nump">44,444.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Loss, Balance at Beginning of Period</a></td>
<td class="num">(1,544.0)<span></span>
</td>
<td class="num">(1,839.0)<span></span>
</td>
<td class="num">(1,549.0)<span></span>
</td>
<td class="num">(1,520.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,839.0)<span></span>
</td>
<td class="num">(1,520.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income/(Loss)</a></td>
<td class="nump">26.0<span></span>
</td>
<td class="nump">295.0<span></span>
</td>
<td class="num">(7.0)<span></span>
</td>
<td class="num">(29.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Loss, Balance at End of Period</a></td>
<td class="num">(1,518.0)<span></span>
</td>
<td class="num">(1,544.0)<span></span>
</td>
<td class="num">(1,556.0)<span></span>
</td>
<td class="num">(1,549.0)<span></span>
</td>
<td class="num">(1,520.0)<span></span>
</td>
<td class="num">(1,518.0)<span></span>
</td>
<td class="num">(1,556.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember', window );">Retained Earnings [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings, Balance at Beginning of Period</a></td>
<td class="nump">22,204.0<span></span>
</td>
<td class="nump">21,281.0<span></span>
</td>
<td class="nump">32,671.0<span></span>
</td>
<td class="nump">34,474.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,281.0<span></span>
</td>
<td class="nump">34,474.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Earnings/(Loss) Attributable to BMS</a></td>
<td class="nump">1,055.0<span></span>
</td>
<td class="nump">2,021.0<span></span>
</td>
<td class="num">(85.0)<span></span>
</td>
<td class="num">(775.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="num">(1,091.0)<span></span>
</td>
<td class="num">(1,098.0)<span></span>
</td>
<td class="num">(1,021.0)<span></span>
</td>
<td class="num">(1,028.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Earnings, Balance at End of Period</a></td>
<td class="nump">$ 22,168.0<span></span>
</td>
<td class="nump">$ 22,204.0<span></span>
</td>
<td class="nump">$ 31,565.0<span></span>
</td>
<td class="nump">$ 32,671.0<span></span>
</td>
<td class="nump">$ 34,474.0<span></span>
</td>
<td class="nump">$ 22,168.0<span></span>
</td>
<td class="nump">$ 31,565.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury Stock, Shares, Balance at Beginning of Period</a></td>
<td class="nump">692.0<span></span>
</td>
<td class="nump">679.0<span></span>
</td>
<td class="nump">660.0<span></span>
</td>
<td class="nump">672.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">679.0<span></span>
</td>
<td class="nump">672.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</a></td>
<td class="num">(10.0)<span></span>
</td>
<td class="num">(15.0)<span></span>
</td>
<td class="num">(7.0)<span></span>
</td>
<td class="num">(13.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury Stock, Shares, Balance at End of Period</a></td>
<td class="nump">701.0<span></span>
</td>
<td class="nump">692.0<span></span>
</td>
<td class="nump">669.0<span></span>
</td>
<td class="nump">660.0<span></span>
</td>
<td class="nump">672.0<span></span>
</td>
<td class="nump">701.0<span></span>
</td>
<td class="nump">669.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Cost of Treasury Stock, Balance at Beginning of Period</a></td>
<td class="num">$ (27,199.0)<span></span>
</td>
<td class="num">$ (26,237.0)<span></span>
</td>
<td class="num">$ (24,757.0)<span></span>
</td>
<td class="num">$ (25,357.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (26,237.0)<span></span>
</td>
<td class="num">$ (25,357.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Employee stock compensation plans, Cost</a></td>
<td class="nump">236.0<span></span>
</td>
<td class="nump">806.0<span></span>
</td>
<td class="nump">506.0<span></span>
</td>
<td class="nump">681.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Cost of Treasury Stock, Balance at End of Period</a></td>
<td class="num">$ (28,198.0)<span></span>
</td>
<td class="num">$ (27,199.0)<span></span>
</td>
<td class="num">$ (25,651.0)<span></span>
</td>
<td class="num">$ (24,757.0)<span></span>
</td>
<td class="num">$ (25,357.0)<span></span>
</td>
<td class="num">(28,198.0)<span></span>
</td>
<td class="num">(25,651.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock repurchase program, Shares</a></td>
<td class="nump">19.0<span></span>
</td>
<td class="nump">28.0<span></span>
</td>
<td class="nump">16.0<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock Repurchased During Period, Value</a></td>
<td class="nump">$ 1,235.0<span></span>
</td>
<td class="nump">$ 1,768.0<span></span>
</td>
<td class="nump">$ 1,400.0<span></span>
</td>
<td class="nump">$ 81.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="nump">68.0<span></span>
</td>
<td class="nump">60.0<span></span>
</td>
<td class="nump">66.0<span></span>
</td>
<td class="nump">100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.0<span></span>
</td>
<td class="nump">100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Noncontrolling Interest</a></td>
<td class="nump">6.0<span></span>
</td>
<td class="nump">8.0<span></span>
</td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</a></td>
<td class="num">(8.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.0)<span></span>
</td>
<td class="num">(43.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="nump">$ 66.0<span></span>
</td>
<td class="nump">$ 68.0<span></span>
</td>
<td class="nump">$ 66.0<span></span>
</td>
<td class="nump">$ 66.0<span></span>
</td>
<td class="nump">$ 100.0<span></span>
</td>
<td class="nump">$ 66.0<span></span>
</td>
<td class="nump">$ 66.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120133684728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY (Other Comprehensive Income/(Loss)) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other Comprehensive Income (Loss), before Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</a></td>
<td class="num">$ (38)<span></span>
</td>
<td class="num">$ (34)<span></span>
</td>
<td class="nump">$ 221<span></span>
</td>
<td class="nump">$ 63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax</a></td>
<td class="nump">53<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax</a></td>
<td class="nump">15<span></span>
</td>
<td class="num">(66)<span></span>
</td>
<td class="nump">310<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Pension and postretirement benefits - Actuarial gains/(losses), Pre-tax</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Pension and postretirement benefits - Amortization, Pre-tax</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax', window );">Pension and postretirement benefits - Curtailments and settlements, Pre-Tax</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax', window );">Pension and postretirement benefits, Pre-tax</a></td>
<td class="nump">16<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax', window );">Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Reclassification Adjustments and Tax</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax', window );">Other Comprehensive Income (Loss), Available-for-sale Securities, before Reclassification Adjustments, Tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax', window );">Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Tax</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax', window );">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax', window );">Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Reclassification Adjustments, after Tax</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax', window );">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Available-for-sale debt securities</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax', window );">Other Comprehensive Income/(Loss), Pre-tax</a></td>
<td class="nump">31<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="nump">363<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract', window );"><strong>Other Comprehensive Income (Loss), Tax, Parenthetical Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax</a></td>
<td class="num">(6)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</a></td>
<td class="num">(9)<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax', window );">Pension and postretirement benefits - Actuarial gains/(losses), Tax</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax', window );">Pension and postretirement benefits - Amortization, Tax</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax', window );">Pension and postretirement benefits - Curtailments and settlements, Tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax', window );">Pension and postretirement benefits, Tax</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax', window );">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax, Total</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign currency translation, Tax</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossTax', window );">Other comprehensive income/(loss), Tax</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other Comprehensive Income (Loss), Net of Tax [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</a></td>
<td class="nump">47<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</a></td>
<td class="nump">6<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="nump">286<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Pension and postretirement benefits - Actuarial gains/(losses), After tax</a></td>
<td class="nump">3<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax', window );">Pension and postretirement benefits - Amortization, After tax</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax', window );">Pension and postretirement benefits - Curtailments and settlements, After tax</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension and postretirement benefits, After tax</a></td>
<td class="nump">15<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax', window );">Foreign currency translation</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other Comprehensive Income/(Loss)</a></td>
<td class="nump">26<span></span>
</td>
<td class="num">$ (7)<span></span>
</td>
<td class="nump">321<span></span>
</td>
<td class="num">$ (36)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax', window );">Derivatives qualifying as cash flow hedges</a></td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (237)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Pension and postretirement benefits</a></td>
<td class="num">(936)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(936)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(974)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Available-for-sale securities</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax', window );">Foreign currency translation</a></td>
<td class="num">(638)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(638)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(639)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">$ (1,518)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,518)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,839)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change, net of tax, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=123594809&amp;loc=SL116692626-108610<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a-c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28129-110885<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30304-110892<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33775-111570<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e39076-109324<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120051345560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE STOCK BENEFIT PLANS Share-based Payment Arrangement, Cost by Plan (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based Payment Arrangement, Expense</a></td>
<td class="nump">$ 157<span></span>
</td>
<td class="nump">$ 213<span></span>
</td>
<td class="nump">$ 308<span></span>
</td>
<td class="nump">$ 423<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Share-based Payment Arrangement, Expense, Tax Benefit</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsAndExcessTaxBenefitFromSharebasedCompensation', window );">Proceeds and Excess Tax Benefit from Share-based Compensation</a></td>
<td class="nump">12<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of products sold [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based Payment Arrangement, Expense</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Marketing, selling and administrative [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based Payment Arrangement, Expense</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="nump">174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based Payment Arrangement, Expense</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="nump">183<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember', window );">Other (Income)/expense, net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based Payment Arrangement, Expense</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsAndExcessTaxBenefitFromSharebasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cash inflow comprised of the amount received from (a) employees to acquire the entity's shares under incentive awards, including stock option exercises and restricted stock arrangements, and (b) the excess tax benefit arising from such transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsAndExcessTaxBenefitFromSharebasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120047201432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE STOCK BENEFIT PLANS Schedule Of Share Based Compensation Additional Information (Details)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares</a></td>
<td class="nump">8.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares</a></td>
<td class="nump">$ 56.62<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=bmy_MarketShareUnitsMember', window );">Market share units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares</a></td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares</a></td>
<td class="nump">$ 58.04<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares</a></td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares</a></td>
<td class="nump">$ 59.04<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=bmy_MarketShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=bmy_MarketShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120133499048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE STOCK BENEFIT PLANS Share-based Payment Arrangement, Nonvested Award, Cost (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</a></td>
<td class="nump">$ 20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">10 months 24 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</a></td>
<td class="nump">$ 953<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">2 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=bmy_MarketShareUnitsMember', window );">Market share units [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</a></td>
<td class="nump">$ 73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">3 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</a></td>
<td class="nump">$ 124<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=bmy_MarketShareUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=bmy_MarketShareUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140120139818728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEGAL PROCEEDINGS AND CONTINGENCIES (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>lawsuits</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>lawsuits </div>
<div>numberOfPlaintiffs</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_AntiPD1AntibodyLitigationMember', window );">Anti-PD-1 Antibody Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber', window );">Loss Contingency, Patents Allegedly Infringed, Number</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_EliquisPatentLitigationMember', window );">Eliquis Patent Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber', window );">Loss Contingency, Patents Allegedly Infringed, Number</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Loss Contingency, Number of Plaintiffs</a></td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_PlavixAustraliaIntellectualPropertyMember', window );">Plavix Australia Intellectual Property [Member] | Australia, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Loss contingency, Estimate of possible loss | $</a></td>
<td class="nump">$ 449,000,000<span></span>
</td>
<td class="nump">$ 449,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_PlavixAustraliaIntellectualPropertyMember', window );">Plavix Australia Intellectual Property [Member] | United States of America, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Loss contingency, Estimate of possible loss | $</a></td>
<td class="nump">$ 341,000,000<span></span>
</td>
<td class="nump">$ 341,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_AbilifyProductLiabilityMember', window );">Abilify Product Liability [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Loss Contingency, Pending Claims, Number</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_ByettaProductLiabilityLitigationMember', window );">Byetta Product Liability Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Loss Contingency, Number of Plaintiffs | numberOfPlaintiffs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Loss Contingency, Pending Claims, Number</a></td>
<td class="nump">590<span></span>
</td>
<td class="nump">590<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_BMSSecuritiesLitigationMember', window );">Securities Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Loss Contingency, Pending Claims, Number</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_CerclaMattersMember', window );">Cercla Matters [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Loss contingency, Estimate of possible loss | $</a></td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_AbilifyProductLiabilityLitigationMember', window );">Abilify Product Liability Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Loss Contingency, Pending Claims, Number</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_AbilifyProductLiabilityLitigationMember', window );">Abilify Product Liability Litigation | Dismissed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Loss Contingency, Number of Plaintiffs | numberOfPlaintiffs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Loss Contingency, Pending Claims, Number</a></td>
<td class="nump">2,700<span></span>
</td>
<td class="nump">2,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_OnglyzaProductLiabilityLitigationMember', window );">Onglyza Product Liability Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Loss Contingency, Number of Plaintiffs | numberOfPlaintiffs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=bmy_CelgeneSecuritiesLitigationMember', window );">Celgene Securities Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Loss Contingency, Pending Claims, Number</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=bmy_UpfrontmilestoneandotherlicensingreceiptsMember', window );">Upfront, milestone and other licensing receipts [Member] | CAR T Kite Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Loss contingency, Estimate of possible loss | $</a></td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RoyaltyMember', window );">Royalty [Member] | CAR T Kite Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_bmy_LegalProceedingsAndContingenciesLineItems', window );"><strong>Legal Proceedings And Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Loss contingency, Estimate of possible loss | $</a></td>
<td class="nump">$ 0.276<span></span>
</td>
<td class="nump">$ 0.276<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_bmy_LegalProceedingsAndContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">bmy_LegalProceedingsAndContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>bmy_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPatentsAllegedlyInfringedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of another entity's patents that the entity has allegedly infringed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPatentsAllegedlyInfringedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_AntiPD1AntibodyLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_AntiPD1AntibodyLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_EliquisPatentLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_EliquisPatentLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_PlavixAustraliaIntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_PlavixAustraliaIntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_AUD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_AUD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_AbilifyProductLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_AbilifyProductLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_ByettaProductLiabilityLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_ByettaProductLiabilityLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_BMSSecuritiesLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_BMSSecuritiesLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_CerclaMattersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_CerclaMattersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_AbilifyProductLiabilityLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_AbilifyProductLiabilityLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=bmy_DismissedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=bmy_DismissedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_OnglyzaProductLiabilityLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_OnglyzaProductLiabilityLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_CelgeneSecuritiesLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_CelgeneSecuritiesLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=bmy_UpfrontmilestoneandotherlicensingreceiptsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=bmy_UpfrontmilestoneandotherlicensingreceiptsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=bmy_CARTKiteLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=bmy_CARTKiteLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>87
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MX:+2SCZL]L& (=8D-F,;F/[[M4.:@FVRG=F7)':^\YWS'=O'=N]$V7>>(B3
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M.C)4=K[JG!N"[HNS_(H*>3,H/E-Y/41, >3_+:7BK:$<5!?.P;]02P,$%
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MP8F)R3(KU^9[#\.1@^!PJ-%DAHEM7T4[LE W66[K/$A%I>KY5Y*S:B=?[8E
M=7*<@0JM)!KM0D(MC*$=8ZB;,6U1_.VR8QR+3AD:QIXV%(-9%!/+<J2]RS$W
MC.X$L+Q44N3P98UN2B GKXS8I#I@PN&-D\G&4LUHAR!Z"H(<(=2Q B&,M%L[
M@UD4Q[80=O2AIYQ:>H1L[B<<<@/3):-^BC':&4XQX]YM<WW5#^?2=596*.<K
M:.A]CL"#;&_/VQ<EMLT%]$(H)8KF<<,9)&IM -]70JBWE_I.^_A_&)?_ U!+
M P04    " "85/Q2],E_\6L'  !5'@  &    'AL+W=O<FMS:&5E=',O<VAE
M970U+GAM;*V976_;N!*&_PIA[$4#Q+5(2K9<) $<)\%FD39!W)Z].-@+6:9M
M;?7AI>A\[*\_0\JQ%''(ML"Y22QY2+T<#>>9,<^>*_F]W@JAR$N1E_7Y8*O4
M[M-H5*=;423UQVHG2OAF7<DB47 I-Z-Z)T6R,H.*?,2"8#PJDJP<7)R9>P_R
MXJS:JSPKQ8,D];XH$OEZ*?+J^7Q !V\W'K/-5ND;HXNS7;(1"Z&^[1XD7(V.
MLZRR0I1U5I5$BO7Y8$8_S4,SP%C\)Q//=><ST4M95M5W?7&[.A\$6I'(1:KT
M% G\>Q)SD>=Z)M#QSV'2P?&9>F#W\]OL-V;QL)AE4HMYE?^9K=3V?! /R$JL
MDWVN'JOGW\5A09&>+ZWRVOPESP?;8$#2?:VJXC 8%!19V?Q/7@Z.Z R >? !
M[#" ]0>$C@'\,(";A3;*S+*N$I5<G,GJF4AM#;/I#\8W9C2L)BOU:UPH"=]F
M,$Y=S.^_+.[O;J]F7Z^OR.(K_/M\_>7K@MS?D/EL\3NYN;O_<T$^?/LR^W9U
M"S8G9$B^+:[(A]].R&\D*\GG+,_A?=1G(P5R]*2C]/#HR^;1S/'H,?E<E6I;
MD^MR)5;OQX]@&<>UL+>U7#+OA'_LRX^$!Z>$!8PB>N8_/SSPR.%'UW(SW\3E
MVJ3>DAO8)S6YD55![G=")BHK-V2F8S=3F:@_>9X3'I\3FN=PQW.^P&:_3F0)
M,]>C#W=579]@+Z.9)#*3Z,W]=,&#*:SSJ>LAVV@8A^.CT3M]T5%?Y/7#;/4W
MQ#%L?54359%'D59EFN6":.&W95H5@C2R]=?&:P^R>LH@*,CR%6*OA@]9>8(Z
MD/QWMJR5A&SPE\>5XZ/4L=>55P)R89HE388I5R0I*JFR?\V-4U(*A7FVF3/L
M."WB<=^SB%' (]RSDZ/<R0_DKH64QCO&BRIY$>A&G%@/'TZCGD#;AO*Q0V!\
M%!A[!2ZVB11#G697!!0">VKC2DQC;#V?!W%/HVT3,HY+G!XE3KT2;XM=DDD=
MG20%M1O<@5/[[4VF/7&V#:6.K4.#-CT'7GD/!V+60JE<-)NH'YAHZ@TL-:S_
MQC$;YA#<X0GUQR10N5:9VDM!-E!&-')E]9KD>K^B6JD=GCQ@?;6(%9LZ I2R
M5B_SZIW5X%JH)O[99W5F]KTG# YS=37$ >T+M8WXF#ITMC"AW*OS&@2J5]CI
MVKTF7#\8]YZ,<DB=#KG<=MDD[,<M9A5V\M=[P2V5J!]+<X [Y&JSL: ^@'0N
MF[RZAOU&GI)\+TC2H@'5']K*(MK/K(@5G[K\W4*+1E[Y]VHKY \%1O8."L*^
M/MMHZ-37DHJ.O50%<$+97@,ZKT3SZ4278XWL#BEU>#=[\"Y+EEENJ'EJV/M3
MZ*0MC*B?1@!VD3TER]P1C B$QFS<=Q9B1:<3A[=:#E$_B&YAVY2JDJX,9(.%
M4FM?VT:L6T&]E];RA_H!-$O3:J_3^BYYU<Y#]2%LB?IP1(R<VYBU &)^ -UV
M2@N?1&;#9#BQB@S$BL:.',Y:YC _<TS0HZ(09HQM48@595.'JI8LS$\6O<6L
M:A:K85'E-D3&<=Q/+8A5''+7.V]9PWZM<[DUT/GYSH6UD&!^2"P2Z -T<H*&
M?"^;BKY:PY7\+I0.-6C)EPJJG_3P+>HK&P!T.NYO#\2*1]R165C+">;GQ,->
M0L$ >?C792-<8#SD?=V(&9U&+N$M0)B_UX&H3(58U62M7W$-+\*X7EAUQ@]6
M83<V,;7BU#:BCDJ3M;QA?M[,DUVFDIR(%^@K5J;BQ!4B2.&QY6;,BKJ\W(*'
M^<'3+8=UG%>&S[N#[U&Y2",4]XMAS(@[F@W6HHC]"$5M%=P1F[R: LCTOSI$
M4IT>3,4L^[_;')9@DV@86G4R:A4Z8,!;8'$_L-"TBV4P3#FW^=1)$8UNQ 8:
M/8?S>0LQ3G\IZ=YD95*F/Y]T>0LF[@?38@N]XU )631IJEKFV<;4YK7S-PYN
MDV;8)??!-8B5JZ7DG=_1_*W/HW@+01U]=U6Y:<1?@7A4*]+01!'K[R'$S$%.
MWO*,^WD&4CL\@,JIT+V[JM+OJ%"DO^&!57AB9K&C@> MN+@?7)"98'>4>!+B
M&)M88&T%S"S@L4-;RR;N9Y.SH.,V2,*P3WK$:!HZ)+6TX7[:'-/*\??(43?!
M8+L570#6WP3AQ/(L8@>MI8-'O.41]_/H>KT6J<GBUR\0I]"?D\=$0;269G6G
MS1KUCPW0H3=9_Q$RI\Q2!0LU7VHR].]U!J"KMG$U9/T^'C-RK;=%&O<C[?^T
MJ%/R(&16K0C2=I_JF_E^I5_^>Z<VSD8=@K"/1Y-^-XR83:+0D5##%I&A'Y&X
M4U ?)(I<BDU6ZM,%'36-&]#S!02+X732K[,P,Q8S1^8-6WR&_A[PU]9TK:L;
M[VJH=1)"*9_VMREB!OEOW']#H\X!72'DQIQ;UL0T_LWYUO'N\6QT9DX$>_<O
MZ:=Y<\+93M,<N'Y.Y$;_VIJ+-4P9?)R )MF<8387JMJ98\!EI515F(];D:R$
MU ;P_;JJU-N%?L#Q)/GB?U!+ P04    " "85/Q2?MV_7+()  "M%P  &
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MY??E)_"A=V3:.7(R_:+"=ZT9B^?[>V*Z/SWX@K[G?6">L[Y7_Y_ _#Y;^."
MN3^^8,N+WI87;,OSIVR17GMA"W'EE%<FR AHDXMKE>&]VH@+[UN5BUF6V=8$
M;4HQ#U@@7>[%[S?J+HB3RF:?_MB5J6_<_-0:;RN=Q]U/G 8XJV?O-\IY,?_<
MZL4"2^I&FHWXX1]_>SV=[A^>O)_ST\'ACP*<T4@'&\,23HC6R#;7 >]9KQ<O
MA3;29%I6PL--A?(/7A2V GF04Y %%6 SEWZ"7?1M?G[*\;@=S\?BE]GL"C).
M:!.4TS4D&NLH*&-Q"[@YB%B8X-I*^3V1*1? 7I"PP1"<69.%6C<P1YO(@.1[
M6,H@X(LP]*E"^)--.6\KC6DAL=.53!JQ4.1S#F:# -;;6@?X/A8W\*0+(6*.
M9#>(C5Y4BO62HU\/EC99U:*F\  )J/FME0YQ@)77' <!#XC1Q,'^L]_VQ'JI
MLV4G)>"-D/E'$$_49@ P[T'7T3-12.THE5L8I@QL;6FLUQ&@0: J55^5'-<S
M**P7".WS _Z*WV)2/7B4\XF&XUBU[[T.2Z<4BWM])^K('(J88\<.42D]9=(O
M10'H;#5]H_Q8S*HJXB=+"5G("@XF=*"TC9=9M'(I5PI)54:H2H.C99=,KW:G
MB#6PTQ7G,:+.+VU;Y80.ZJZ4/B3[8VMB^UKKL&2A[RF;Z/-&29>\?13]!W!1
M\6,'CW^-@9F""L;&,HNMF[(T6RR<6FG>_4:YVE.Z:8VBXBF^ 7K1/A9M/?."
MLVV)($0]N<U:\F,L3EH/3O)@&572%W$QJ$503$*,(NP#HEA<HF)\6JQ,B>FB
M]R_7/K,KY39[:-XK#"4-K=H3E<YHU##E'MJK:0LDMW7IU7U2@1\A')Q>M#W_
M>HF=X*TVQJXD#1BB5KG.R-Y($TM5-:+!3YP25,Y*ZDJ0!;#0:=MZTJHP6'B
M3I25!="H') TU"5M,K 3=%%*H__<=@#?-@WBFRV)PN[_ZM1."GDJ O?<'NJ&
M?XVS>9MA_$,B2RB'B:B+&M5!F!MNZU.\!L%*E8O)B_??ZB*^6W3)!5QDY2UO
M"J@@8XM-%X[,.GQ#B@G>12&*5!7005T)&U%LN$12RSEX=>BW3,)UX5KR346^
M.5UJ58CS.Y6UG+4/10$ N+YSG9Y_Z#H7N,1'[F69I!0ARE6F>3BMY2?E.(!
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MKI1?FVJU9H)G:]H"7D[L2Y6.55K^J 3T8YI[V)ZPU$"51@D.;\3<BY\R6?)
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M2 LP/]/:;09DH/ZWYN0O4$L#!!0    ( )A4_%*:+R=G-08  !L.   9
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MC([QH6'CITA<>%.%U_^%\?B8")<YOM[(\@'<7QKCVP4[Z+X'+_X#4$L#!!0
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M$?OM)=R_M73);'^.;@,EE\#B<T9LAX+N)$<(\G"Q6DJDM N9[22T(R*02%9
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MP*ZXR3>4PU#=FO_5-+JCH0T__,\3">) $VD/*69>!:+8Z.FQ#9 _P-NN)12
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MIE_'*WYDR9;_0, BR2!D_KJ6'JBC!;B_3. VS _:H/R+$:__#U!+ P04
M" "85/Q2QGLB]S0#  #-!@  &0   'AL+W=O<FMS:&5E=',O<VAE970Q-2YX
M;6R%5=ENVS 0_)6%D ()H%J'SP2V 3M)T11)$3A''XH^T-+:(D*1*DG7SM]W
M22E*C#KIB\1K9F='R]5XJ_23*1 M[$HAS20HK*W.HLAD!9;,=%2%DG962I?,
MTE2O(U-I9+D'E2)*XW@0E8S+8#KV:[=Z.E8;*[C$6PUF4Y9,/\]1J.TD2(*7
MA05?%]8M1--QQ=9XA_:ANM4TBUJ6G)<H#5<2-*XFP2PYF_?<>7_@D>/6O!F#
MRV2IU).;7.63(':"4&!F'0.CUQ\\1R$<$<GXW7 &;4@'?#M^8?_B<Z=<ELS@
MN1(_>&Z+23 *(,<5VPB[4-NOV.33=WR9$L8_85N?'?0"R#;&JK(!DX*2R_K-
M=HT/;P"C^!U V@!2K[L.Y%5>,,NF8ZVVH-UI8G,#GZI'DS@NW4>YLYIV.>'L
M='%Y?GGU.)M?7]Z-(TN$;CG*&O"\!J?O@ =PHZ0M#%S*'/-]?$1"6C7IBYIY
M^B'AMXWL0#<.(8W3Y .^;IM=U_,-W^&;99G:2&M@@1GR/VPI, 2VLJAA)J@>
MF<P0J++A7&/.+5PK8^#G;&FLIG+Y]8&"7JN@YQ5TW_.W#4S$][BS,!<J>_IU
MR.S_,+U^*;A00C!M@$NXX4)0>1L@[]![=T$ARR6EV$U"N-<L1[H]KRJ.8!1V
MXU-Z#\/1*(5KI)RS@NDU?EZR[,D DSEDS!20<]/X=]P?G)[ \:#7/ZD!;,\^
MW%5TRY!@M8_"^7B<#@F2C$[@.S47^X^083A,NO1,DU/W-;AC"T&K9R8L1Q/"
MX^S>:U&VH&P24MVC9TJ:%WOYG(9Q,O1Y]>,$OBOY^:%SU]F+990@'FH"()6D
M#;71!MUUY@:VJ!&.!MT1W2_OI0]ZU!OTV@67(XD PW=0UB6/KN1?37<%ZW$T
MH*E&XQRAAB.>.WMR5UJ5GLL6&A&$\]W8YJIC_4W==I,"=5J#TEG+JDJK':=&
M1)S0'WWRX?J#3Z!68)5EXH#'S!Z0N%<@!_0>*OOH38LAF6O?2*EN7'G4W:9=
M;7OUK&Y1K\?K1G]#*7,J6($K@L:=83\ 73?/>F)5Y1O64EGRQ \+^M^@=@=H
M?Z64?9FX .T?;/H74$L#!!0    ( )A4_%)X?YPV]@(  #4&   9    >&PO
M=V]R:W-H965T<R]S:&5E=#$V+GAM;(55VT[C,!#]E5'$8[>Y]09J*U$N6E;B
M(F#A ?'@)M/&6\<.MD/;O]^QTY8B47B);W..S\QX)L.ET@M3(%I8E4*:45!8
M6YV$H<D*+)EIJPHEG<R4+IFEI9Z'IM+(<@\J19A$42\L&9?!>.CW[O1XJ&HK
MN,0[#:8N2Z;7$Q1J.0KB8+MQS^>%=1OA>%BQ.3Z@_5O=:5J%.Y:<ER@-5Q(T
MSD;!:7PRZ3A[;_#$<6GVYN \F2JU<(NK?!1$3A *S*QC8#2\XQD*X8A(QMN&
M,]A=Z8#[\RW[I?>=?)DR@V=*///<%J-@$$".,U8+>Z^6OW'C3]?Q94H8_X5E
M8YOT LAJ8U6Y 9."DLMF9*M-'/8 @^@ (-D $J^[N<BK/&>6C8=:+4$[:V)S
M$^^J1Y,X+EU2'JRF4TXX.[ZZ>;JX>;R]O[IX&(:6"-UVF&W DP:<' #WX%I)
M6QBXD#GFG_$A"=FI2;9J)LFWA']JV88T:D$2)?$W?.G.N]3S]0]Y)]]16J77
M+;BA!_YR.C56TT-X_8:[L^/N>.[T!VZ.!EX><65A(E2V>/TJC#\P?>0 SI40
M3!O@$JZY$/1P#5!4T$?E'#,LIZ@AC5MPR26GO.<P5RHW< 2#XYB^QVD"SU0(
MCJ'2*D-C(&X-N@DDK2CNPCU; I,Y5"Q;L#F7<WI-%C5GPD#2CRCR?7A4E@DB
M^'#P"%)"IWZ,NQVX^G26M.*T[\>HWX%;6Y!$J>2OK-::S( 9@]; H-\C*=$@
M^N("+C-1YP@SQC6\,U$CL/P?O7]J  35:*C,G-J95B70#4"5/$<*#,O>:FZX
MKW$U@Z->U*-"\:$#9C^"YYZ4]_RH3R+W+#Y%E:RB]F$7MC*WTM> JXH:#*7!
M*E+IVB 0;>$NFN):T:!(P!J9=AF9*EM 1>&FE+6_>H3A7BF7J.>^81G(5"UM
M4]6[W5U//&U:P8=YTU"OF:;\&A X(VC4[G<#T$V3:A965;XQD"AJ,WY:4%]'
M[0SH?*:4W2[<!;L_Q?@_4$L#!!0    ( )A4_%(+1(MJ]P(  (,&   9
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M)?TE4%D#NM]*:9X4&Z#_[\Q^ E!+ P04    " "85/Q24C^#95X%   >#
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M4?=8E:>F[;A^)'G<G?<^A,T;0.-TVF&]-<\VH5-<4XQ)X-/!W4%P5KB:>H2
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M#;^)LI'TX.:=YWE3-:6P2.]?N(LF,A@#9N2<MQ)^5;CTD[08 W#&.Z%KY-K
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M;UBZR&7/Q7#T%%G<NM!*BJ.PA)Y2-L0VV6,CZ*S8-A@I<.8&VX'G_'"E0=:
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M%$37(HY(K&&@__J/'_9V]U\W \HE*)X\T;>LU.![H!HLM*M ;Q8&6&-2,J<
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M(H,@@_+NJC8LN52H00A^D1*DAD5TK?QB@0<.68&S:P:4NDN2'?:BU>>J0Z>
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M;LVB6WA0>8/N^?-7/H,Y_G28/?[NV?-=]\T38-NR:WSBR6^BN&V7!JPIEA%
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M:F+K/4 [%]#WTV5<'AD1(*&PRZ6%,MRMY.WHX>U^=>MPH<5FE=(ONPBE:2Y
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M<]P);Y20]&".V8NC6\ #K88[2X#7\ '%O*H,@ )3&#OTVGO?X59>RUR30;/
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M'6[M/-L! _]X[\G:>1_RV?$R%%<6%#JV^ YK9ZW^O02-SQ'LXV=/:!78-J_
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MBF^,X8*FUD;C%.!-1DW@Y8(#+I,>@FH8R2.WK_:XB(&DB$]B<QM7.G*5UAW
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MR;15"V*;<^ 2"+#?5::![6/U'I9T+H3/D44U?&,6)0E?-O3[SC(V*UO4#1Y
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M728YB1"XU@NRQ<K[RJ:2HS!6KYF\<WVBY]<?9(!$UPAS5!7J,ZCH$-BU"Y?
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MR=&-PY!:!\J#WX#'#&A'<>%9CPO/CE;N&]I(7TG ")LLGK.N%AX&$L=% 23
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MZ'D#OO.U:/?" OI?>Z[^!U!+ P04    " "85/Q2-V4D$ZP#   &"   &0
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MGPP<[X0K/"2CCQ41UIH>ZZ 9'4E*]D.48]PQQ7S78D^,9+(#Q]]QA^A)45Y
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;+576V_;-A3^*P=>,+2
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M[P:@Z\&N#:NV?IC6RM)H>K6@OQ"U<Z#S7"E[-%R"YG<=_P=02P,$%     @
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M2<EB]7-!?8!]G #/9XS)]0TRR#\BO/@O4$L#!!0    ( )A4_%(/ L7?Q0(
M *\%   9    >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;'U4VVX:,1#]E=&J
M#R!MLQ?N$2 !H6JKI(V I@]5'LSNP%IXU]0V@?Q]QU[8$#7PXOLY/F?LF?Y>
MJHW.$ T<<E'H@9<9L[T- IUDF#-]([=8T,Y*JIP9FJIUH+<*6>I N0CB,&P'
M.>.%-^R[M4<U[,N=$;S 1P5ZE^=,O8Y1R/W B[S3PHRO,V,7@F%_R]8X1_-K
M^ZAH%E0L*<^QT%P6H' U\$;1[;AIS[L#3QSW^FP,ULE2RHV=?$L'7F@%H<#$
M6 9&W0M.4 A+1#+^'CF]ZDH+/!^?V+\X[^1ER31.I/C-4Y,-O*X'*:[83IB9
MW'_%HY^6Y4NDT*Z%?7FVW?0@V6DC\R.8%.2\*'MV.,;A#- -+P#B(R!VNLN+
MG,H[9MBPK^0>E#U-;';@K#HTB>.%?92Y4;3+"6>&L^ED^NUI-+Z?SJ&V8$N!
MNMX/##';_2 YLHQ+EO@"2QL>9&$R#=,BQ?0]/B!%E:SX)&L<7R7\OBMNH!'Z
M$(=Q=(6O4=EL.+[.!;Y1DLA=833,,$'^8GWZP%8&%8P$?4Q6) CTQ6&B,.4&
M[J76\&>TU$;1OWF^HJ!9*6@Z!8T+"N:43NE.(/Q<G8F@2US088$' V,AD\WS
M1^&_RFT3]U9O68(#CS)3HWI!;W@GA6!* R_@@0M!*:"!PHHNK'>D(%^2^T;D
MPT*Q%"G#WD1]@J[?"'O4=_QN-X9[I' D&5-K_+QDR48#*U)(F,X@Y?H8VEJK
MW:M#K=ULU4L >Q=9/&PI$Y%@98B%#7$M[A DZM;A!Q4@\Y^0CM^)&M3&4<\^
M%+=L/BCYRH3AJ'UX&BV<%FDR<A.1ZB:U,6F>O?/3\\.HXWRUP@@^>L_@+(ER
M)*>V5)!K:Z[,IVJUJD:C,@G?CI>E[($"Q2G< E<$#6\Z+0]461[*B9%;EY)+
M:2C!W3"CBHK*'J#]E93F-+$75#5Z^ ]02P,$%     @ F%3\4F)=Q-:6 @
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M\]."7CK4SH'VETK9G>$.:-_.\3]02P,$%     @ F%3\4JOQXTS" @  P 4
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M+"KK0.\K*<W!L +UT![^!5!+ P04    " "85/Q2SAGOG"T#  !<!@  &0
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MSQ3/LV+A=.:?1 OMZ('EIVMZT:)A CI?:NV>%ZQ@]T8>_@M02P,$%     @
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M3G(-4,\?&9.O$VV@_1@S_A=02P,$%     @ F%3\4K6K%0<I!P  >2L  !D
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M *K6CAHJ %&4[&%+J3^QJ__?,G_*7CN1I626L"'(4@I,[$O;#F1Q@ =] @-
M5.@K> #D"WUA"(!<P?=0I82?V(7_9)J'+V$U=%W(4BI+W"'(4KI+[ O<#F1Y
MYKK/%SI9)H@ZGDZ6"1(Z[0$$<O:IH))[8I?[(%G&T2PJHRYL426NU!F +:IT
ME]H7N.^SU2;8F;5TL@",K\U&$P"#75T$(9"_9Z%!E=A3N]C?R&F<_7SM-&71
M+1MC"!^#*M6E?9V,-L'.Z!%/Y\H$<7U] 6 (TY\K +3U\K9;I))Z:I?Z\S27
MTVC6B2DEK'0(&X,JR:5]C0QJ6@O8>*@ C$$4Y(CH/ &&B+N')Z7RU*[R5^DJ
MEX^=:%*22H?P,9C26M;7QV"FJX!U%P/ Z&]9 ,18K%O3[!:HQ)W9Q?T?N<R*
M;J_#3(DI&\*^8$IF65_[@IEF@J%Z $9?I@,0PQ&TIMDM<,N@MNOZ:2Y?P_1G
M9!LMI9]L"+."*6EE?<T*!I@'KLZ.B3&>H??3!-8TNP4J+6=V+3^9RED2VL9*
M:28;PI%@2D]97T>"F0X!T0T) &-P\WZ:P)IF]X.'$G!N%_ OT3S\V4G>N-),
M/H01P96<\KY&!#>- =T0.@,PF&CB-0% OO;Z&P 8XNU9@'.EX=RNX:=A'L[B
MU;S3JRU7RLF'\"'XUA>VOCX$-XT![/@Z60"(Z+,1 ")$7]I!(+9G#<Z5IG.[
MIE^$9;6X>_M47Z"3=(Y.XAA=E8MZ5#LPJ-25#V%.<"7!O*\YP0'? 1L, B!J
M, CX#ES_;@6 7+;G.PA7RL_MRG]_>7X73-#MW<E=<&O[#JRD5@SA2P@EPZ*O
M+R%,J\"EGK[N U"">;HW : PH[Y.%@2CA.]YX(2: X1]#@A6>;:4MG%32BN&
M,"6$DF#1UY00@)<@//V)@E"8ZC,8@.*$Z:H(H-CVAH[=4I7ZB_<V6!0ENGI
M7[,\[K;+8FN;Q1 &A5"R*_H:% (P'QC5EQT0BE)]KP6 (JZG6W\02H@]4BB4
MXHMWC(IFTFKWFG4A38FL&,*N<)4$NWWMBC;!SB8E7_]D!8'T+[X3 $1UES
M0,33OX*,M[825L/RV.SA+- L6Z7E>L_8YNIFG^A)LSM2NWZ*#\XP<'V"#X+U
M+E"5?KTI]2+,'Z.T0+%\J)IR/KM53_/U/L_U29DMFXV,TZRL.&L.%S*<R[P&
M5+\_9%GY=E(WL-EM>_P?4$L#!!0    ( )A4_%)1:KI3E0(  -,&   9
M>&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;*55WV_:,!#^5ZRH#ZW4-2%):8="
MI!*RK95*$8SN8=J#20YBU;&9[4#WW\]V0DI;0-7V$O^Z[_ONSN=+M.'B218
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MDG-<[]/C>I_UTT<T4G1HHN_-)=ZN'%S:\[M6CEH5)(\HN)-$4A7.)/CV26'
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M:)Q?K@@.",L \O<%I>+M)IN@.DP<_P=02P,$%     @ F%3\4HS,#NY[!
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MD$KD^%4WEELJUL4"9DL4D1G,W6Q\&MQG)1$@<<+&-'?Y.>4^=%BXN\4J/DM
M+JA',L$ C>N9:(#(:<PI)&J;U$,?A;L;J?*;JU^6WX%5]5*?44[@J0P;GR@7
MC5H,: )S+XU E>V9T$V5YYCKUCHZ?\@(7Q4'/T)][VQS67Y]UD_KPZ6;XDC%
M>'Z+KZ88>![IPZCBO./@OCS)ND_X2M4WE)*E"F5?!FJDO#P<*F\DVQ2G'S,F
M)<N*RS5)U%>8%JC?EXS)]QL=H#ZBF_P+4$L#!!0    ( )A4_%+++L]V,P,
M +@*   9    >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;+U6WT_;,!#^5ZR(
M!Y 0B9/^ -16*H5MW596%<H>T![<Y-I:.'9G.Q3^^]E.2 MM(B0T7AK;\7WW
MW>7NZW760CZH)8!&3RGCJNLMM5Z=^[Z*EY 2=2)6P,V;N9 IT68K%[Y:22")
M,TJ9'P9!RT\)Y5ZOX\[&LM<1F6:4PU@BE:4ID<\7P,2ZZV'OY6!"%TMM#_Q>
M9T46< -ZNAI+L_-+E(2FP!45'$F8=[T^/A_@IC5P-^XHK-76&ME09D(\V,TP
MZ7J!900,8FTAB'D\P@ 8LTB&Q]\"U"M]6L/M]0OZ%Q>\"69&% P$^TT3O>QZ
MIQY*8$XRIB=B_0V*@!S!6##E?M$ZO]N*/!1G2HNT,#8,4LKS)WDJ$K%E$.(*
M@[ P"-\8X$:%05081"[0G)D+ZY)HTNM(L4;2WC9H=N%RXZQ--)3;SWBCI7E+
MC9WN3:YN;B?3P>UT,KS^BJ[[DTG_=GAWA0XO01/*U!$Z0)2C$67,9%UU?&V<
M6E,_+AQ<Y [""@<M-!)<+Q6ZX@DDK^U]0[9D'+XPO@AK ;]G_ 1%P3$*@Q!/
M;R[1X<'1'EJ#]Z,$-:RB,H^1PXLJ\$PA+H #&G(-"TE<B=Z/()V!_%,#WRCA
M&PZ^7?690&F9Q3J3E"_00"B-"$^0.0;Y".C^)[6^-:2JSENS]-:L#>:UM]P1
M(QH2Y_D873VM3!<6VWTED<,W';P5DL=>% 0FS8][2+5*4JT/D7))&?(XD]*<
M:8%,/\ ^<KF;QA:Y,*HBUR[)M>L_/U%+9%62/._MD?9.0L)FE<_3TN?IAQ)R
MG=GJ0V*.QD)16Y&F"1DU(F(O[6-YNIN9QH9DWE:[=\ZJ CDK SFK#63T+'X0
MF5""^O'?C.9<T9@17E/+.-@H7/ )O8.W%!7_W^XI\+>K!3<K<HS##:WP<_JG
M\/.J!)H5[#;RB>OU\]<*K&H:9B.1 '.R_!X!Q1L%Q9\AH7BCH?AC(OK^?.^J
M*=X5#W]K!DA!+MQHI% L,J[S/]?RM!R_^F[H>'-^8<<R-UML8/*9;D3D@AH1
M83 WD,%)VU"2^9B4;[18N4EC)K296]QR:49+D/:">3\70K]LK(-R6.W] U!+
M P04    " "85/Q2#:SQH5X%   $&0  &0   'AL+W=O<FMS:&5E=',O<VAE
M970U,"YX;6R]6=MNVS@0_17"Z$,+M)%(R;? ,>#8VMWL)FV0R^Y#L0^,Q-A"
M)=$EZ3CY^R5E19))FC*V@%\2BSXSY)D1YPSIR9:R'WQ%B "O>5;PB]Y*B/6Y
MY_%X17+,S^B:%/*;9\IR+.0C6WI\S0A.2J,\\Y#O#[P<IT5O.BG';MET0C<B
M2PMRRP#?Y#EF;Y<DH]N+'NR]#]RERY50 ]YTLL9+<D_$X_J6R2>O]I*D.2EX
M2@O R/-%;P;/HP I@Q+Q=TJVO/49*"I/E/Y0#U?)1<]7*R(9B85R@>6_%S(G
M6:8\R77\K)SVZCF58?OSN_??2O*2S!/F9$ZS?])$K"YZHQY(R#/>9.*.;O\@
M%:&^\A?3C)=_P;;"^CT0;[B@>64L5Y"GQ>X_?JT"T3*0?NP&J#) ND%XP""H
M#()C9P@K@_#8&?J504G=VW$O [?  D\GC&X!4VCI37THHU]:RWBEA7I1[@63
MWZ;23DSOHON'N\?YP^/=U=??P?[3[.M"CES/'J(%F'^[?[@'#[/+ZPA\7!"!
MTXQ_ E_ X_T"?/SP"7P :0%NTBR3V><33\BEJ0F\N%K&Y6X9Z, R G!#"['B
M("H2DECL%V[[@</>DR&IXX+>XW*)G [_W!1G(/ _ ^0C:%G/_'ASWT;GUV:/
M_O?L>\$(ZI<D*/T-#[TDA NVB<6&I<42S"D7 !<)D,.$O1#P_5KBP94@.?_7
M,5M8SQ:6LP4'9HOR=4;?" &",/G&X[*@Q')2ZWNU\]4O?:FJ^#(=]B?>2SM5
M)@3ZPWW,PH*!XWU,9&)0?U!C]KCV:ZY])]=O8D78<41WCL+6[('&TT2,-)8F
M(M0XFHA6&/8H#FJ* R?%6T9?TE)7I*Q);6F]2C:: V,!0XW%W(1 J.5\8<$@
M+5Z1B4&M=V>/[+ F.W22O2H$6;)=)LFK5'-.K,D<FLOK(XVF!3,8:#1-#!KK
M-$U,$/IVFJ.:YLA)<Q;'4NHE3Y)(598=2IR6G&U41\;TOD;41$"H\>QT$IF(
M$-I)CFN28S=)SF6CEN9KG#+9&@D;N7$G.1,1:'5E84*0OBU-R.@ .^@WRN\?
M47OX:B,2NG44GLI->_(O>H+F%I!.\Q@_D=///M%6BP.=1!^HP!F(5Y@M[;NQ
MLM_+@%[]YQ90>Q]5'$U0B'0=L8"&X0$A@:AAB9PL2UFFSV#-:"(++ ><9@GX
M?D/R)\)<N@R;-@">H@^ 32, W9U =^+"SOUG@1C5Q8(Q=J -,SR0LT;]H5O^
M;S#[080,YF<@STZ9BJH**$YD.Y#*6&-UBCHJAXT:P\$I<M@((G0K8G<.37TR
M<FB10CV%G5XBIY=]=HT.0K<0JK!A%J_*&";D11Z\UTHKCLI9(T1P?(*<H489
MD%L9.G.&S"JMY\P",82OVTUD@8P/]&BH$03D%H2=\GU,BYCFY)-7-6J?"W)4
MWE!3DA$Z1=Z:^HR"7\Q;<(30V4 C(W4F*/3[>O),T*#5A>^S;%0!N55A3K(E
M48%K]=K'I*VIRJA_BK0U)1FY3TC=:;.<5'QCPYF@ .K'7!MHJ!\8+*#!H68:
M-4* W$)P\T;_PBQ),9C%/S?R1%@F[C;#A2N(325&HU,DK:G)R'TZZ$Z:V;.;
M6ZWS_+"P0/H#/6$N-_LW/HT&!!VG@[4ZWZE8WM"$9.55TC';+&BJ< !/D+&@
MJ<:!NT'NS%AEWW>HF@6B7RLLNMU$%@CT=5GS6K>Z.9&+5M?I7)[3-H78W=W5
MH_65_:R\J-;&+^'Y'%K&%_ \VEW(-^YWOP_(OG29%AQDY%E.Y9\-Y4K9[LI]
M]R#HNKQ3?J)"T+S\N"(X(4P!Y/?/E(KW!S5!_</']#]02P,$%     @ F%3\
M4KJNJKR> P  .@P  !D   !X;"]W;W)K<VAE971S+W-H965T-3$N>&ULK5==
M;^(X%/TK5C0/,]*V^0 "K0"I0-KI:+I;P3#[L-H'DUS :F*SMBFMM#]^KY,T
M0Q.3937[4F+GG.MS/YQ[.SP(^:2V )J\9"E7(V>K]>[:=56\A8RJ2[$#CF_6
M0F94XU)N7+630).<E*5NX'FAFU'&G?$PWWN4XZ'8ZY1Q>)1$[;.,RM<)I.(P
M<GSG;6/.-EMM-MSQ<$<WL "]W#U*7+F5E81EP!43G$A8CYP;__K.]PPA1WQG
M<%!'S\2XLA+BR2SNDY'C&4600JR-"8H_SS"%-#664,=?I5&G.M,0CY_?K-_F
MSJ,S*ZI@*M+?6:*W(V?@D 36=)_JN3A\AM*AGK$7BU3E?\FAQ'H.B?=*BZPD
MHX*,\>*7OI2!."*@'3LA* E!G= ]0>B4A,ZY)W1+0O?<$WHEH7<N(2P)X;F$
M?DGHY\DJHING9D8U'0^E.!!IT&C-/.3YS=F8$<9-*2ZTQ+<,>7H\CQ;?YLOI
MM^7\_M<[LIA^CF;+KQ'Y[9:\?X.K:/X](A]GH"E+U2=R09:+&?GXX1/Y0!@G
M#RQ-L;;4T-4HRQAWXU+"I) 0G)#0(0^"ZZTB$4\@L?!G[?RPA>]B.*J8!&\Q
MF02M!K_L^27I>+^0P M\BY[I^73/YL[/G1[]W.FW_T*G2/?\DZ??G4_W6E+1
MJ<JSD]OKG"I/4%KN8[V7C&_(5T97+&7ZU59DA:%>;LA\@)_'?A .W>?CQ%DP
M7?\]9G:&G>@,.[<VS. ]YLZ"\;P*\RYBW2IBW=:(3;>4;\#<2 P=PV\UV*[D
MK##2/3JYIBUJ(D*[LEZEK/<?<HDZY0;PTK[$Z3X!<A/'V)\DZDW(0HOXZ6*"
M'28A4Y%AVU74-"Y;VGL-F;[?K:6]B0F"@=V9L'(F;'7F48IGEO=C' >P)Q^Y
M9E,9-A3T:_&>-B&^WZO5I@43=&IY:V*"?L_N;+]RMM_J+#9];.D<^Y&4P.-7
MHB7E*J7%,,$3(O06I,WO?D/,15#SNPGQ[6H'E=I!>VKH*\Y*VMJ)!HT+=^%W
MZN5B PU.U,M5)>JJ_5I"N@$.Y)YKV,@B<G\\0+8"^2?YNUG]I%G]%;[EN^I[
M/_J^]S\6\*RT=AR4JUKA62#=?BUJ[M&DD@%^ ,P0JD@L]EP77:':K0;=FWR\
MJ^U/_.NI;]F?^==1,<;^,%],U0_XO6%<D136>)1WV4>ALAA4BX46NWQ.6@F-
M4U?^N,7A'J0!X/NU$/IM80ZH_ET8_P-02P,$%     @ F%3\4J3BJA?> P
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MYX"=.+_#E]\2CT1N6*Z TS6Z\KM#[/"R',_+A18[.W^NA,9IUCYN\9.&2J.
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M&LR91A\W]B:-FDQYU#0,\WGUL.I#N<B?R6XB*172R*F-HGP:I^4P17/>5(9
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MUP1DU@1T9O](KO..CH;OD6N<=TW\G>\_1W*-ZVT.UB>&8ZARL'FGP^9.=X+
M=?*-M?6<4[Y3WLHP>I>\%S[X'1G^WV: P_69'FG*<015YI"W2VQNER?P)\N1
M]S1LOTLY\IZ&_Y=Y&FN^IFG*<015YI"W36QNFR?PS/[)@N1]#P_>I2!YX\/F
M4?:M"J(9;.O:< R5<.@6=IA\*I[BO< 0Q%^(DD_]V=ELOW$4[[)5SE_#\S'4
MG)_ \VFRFYB[3S8W;XEX8D$(/+I6M[+.^BI4D>P7)@>2;^/]K067DOOQSPTE
M*RHB@+J^YDJ;TH/H!MFN[=5_4$L#!!0    ( )A4_%)X'$U*S ,  /8+   9
M    >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;+66VV[B2!"&7Z6$9J49*<$G
M#B8") )9;5;)+H))YF*T%XU=X%;:;K:["9FWWVJ;F)-Q<K,WX$/5WU]7M:NJ
MOY7J12>(!MY2D>E!(S%F?>,X.DHP9;HIUYC1FZ54*3-TJU:.7BMD<>Z4"L=W
MW8Z3,IXUAOW\V50-^W)C!,]PJD!OTI2I7[<HY';0\!KO#V9\E1C[P!GVUVR%
M<S1/ZZFB.Z=4B7F*F>8R X7+06/DW4R\EG7(+9XY;O7!-=BM+*1\L3?W\:#A
M6B(4&!DKP>CO%<<HA%4BCG]WHHUR3>MX>/VN_GN^>=K,@FD<2_&#QR89-,(&
MQ+AD&V%F<OL'[C;4MGJ1%#K_A>W.UFU M-%&ICMG(DAY5ORSMUT@#AQ\[X*#
MOW/P/^L0[!R"SSJT=@YYJ)UB*WD<)LRP85_)+2AK36KV(@]F[DW;YYG-^]PH
M>LO)SPQG=^.[^^?1[</='+Y.T# N]#?X CR#1RX$I4;W'4,+67,GVHG>%J+^
M!=$./,K,)!KNLACC8W^' $M*_YWRUJ\5_'.3-2%PK\!W?>]I/H&O7[Y58(T_
MK^)>5IG4JTPP(A6O1N5HBT&9B""7[5Z0'461W&0&9A@A?V4+@1I^/I 1W!M,
M]3\U2[3*)5KY$L&%);XK%B-]K.4"59DM)-JYA"T:K\,P<'M]Y_4P0N=&W3#T
M2Z,CNG9)UZZE>T"M(4J86N'U@D4O&E@60\1T C'7>7 J@0O5U@'+=;MS"EQA
MU&FUJX$[)7#G8V FJ'*R+*)L41$&?%M304/B5AAS T+J2NC..8_?/6&NL/'"
M:N1NB=RM1?Z+&HGYS"GHGJW=[7K!"6"%D>_UJ@G#DC"L)1Q1S;'AO (E?S%A
M..HK>!Y]SP^#- FJ*MSPC,0+W-8);H61?^G0]DK<7BWNK#Z,O;,E>ZYWFN?>
M^1?7=KUJ+L_=UW6W/M4RNWYJSIN'F08M!461NBUD,J,7<J,TVK[)JZN\>X;6
M"<)C_'&%4:O3NH!_T):\>OQ-ND %?R_AP58$;6!*I2%E$6X,CYB 'XFD'3&!
MJAK=.PM]<(')WS/YM4SCO!T3U5C2"<WH0\I'EQG7+_#S$2UP79GV]JW ^]]Z
M@;=O!EY]-YBBLIL N02V6BE<,8-@I*'8GI4(B#<(2R53,(E"A/5Q+K8?Y*(>
MI!TV7?>WJD;\D6/GW+$(AG,P$%'"5OE@2=W%1K68.LJGY? ZRD>VD^>WWLVX
M&$'W,L5$_$C'DF<:!"Y)TFUVZ0-0Q9!9W!BYSL>NA31T:O++A 9S5-: WB^E
M-.\W=H%RU!_^!U!+ P04    " "85/Q2 2JEP @#  !V"   &0   'AL+W=O
M<FMS:&5E=',O<VAE970U."YX;6R-EMMNXC 0AE_%BGK12MWF! 0J0&IIJV6U
M[5;0P\5J+TPR$&^=.+4=:/?I=QS2B)(0]8;X,/_,-T/LR7 CY(N* 31Y2WBJ
M1E:L=79NVRJ,(:'J3&20XLY2R(1JG,J5K3()-"I$";<]Q^G9"66I-1X6:_=R
M/!2YYBR%>TE4GB14OE\"%YN1Y5H?"S.VBK59L,?#C*Y@#OHQNY<XLRLO$4L@
M54RD1,)R9%VXYY.!L2\,GAALU,Z8F$P60KR8R30:68X! @ZA-AXH/M8P <Z-
M(\1X+7U:54@CW!U_>+\I<L=<%E3!1/!G%NEX9/4M$L&2YES/Q.8[E/ETC;]0
M<%7\DDUIZU@DS)4622E&@H2EVR=]*^NP(W [!P1>*?"^*O!+@5\DNB4KTKJB
MFHZ'4FR(--;HS0R*VA1JS(:EYE^<:XF[#'5Z/+U[NKY[^#6;7L_)\15HRK@Z
M(=_(X_R*'!^=D"/"4G++.,>:JZ&M,:01VF'I_G+KWCO@_D>>GA'?.26>X[D-
M\DF[_ I"E+N%W/DLMS'1*ENORM8K_/D'_-VPE&&M(K(2(FI,9ZOO%GIS M;C
M_@#!U[O,=9N![U4VG\#\"LQO!7O&=]U4.I,B!-5(MG70V8GJ]KO>'EK=R'/<
M;C-;IV+KM++-Z(;0-"(9#5_HBJ4K?/\T2$9Y(V>GCA X>Y@--D[03-FM*+NM
ME ]"4XXE7$.JA630R-:MQ?4=U]^#:S!RNYUFNEY%UVNEF[9S]>KU</U@CZO!
MR D.< 455_!5+CST0L<@"54*="-F4"/H![T]RKJ-Z_2=9LI^1=G_$N4[R7(9
MQGAKXT%A(9 E99*L*<^!T.@OWI;87S3Y?0O) N2?E@MC4$4>M$:^S!6N*$4F
M(EFPE)K6<TIF$(I5RO[A13*-,");,KK@0"Z*RI&+\#5G$C?-J?F)6XPS;2J,
M^WD"T2FI$FJJ\J!VO?2<_2K7;8+:JV#O= 73D6^IQ-.K"(<EJIRS .5RV^6V
M$RVRHE$LA,:V4PQC_#  :0QP?RF$_IB8WE-]:HS_ U!+ P04    " "85/Q2
M06?-\98#  "7#   &0   'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6RE5]MN
MVS@0_15"Z$,+M-']XL VX)MVNZB[WJ39HBCZP$BT350259**D[]?DE(41:8%
M+?IBD]0Y,W-F2&HT/1'ZDQT1XN QSPHV,XZ<E]>FR9(CRB&[(B4JQ),]H3GD
M8DH/)BLI@JDBY9GI6%9@YA 7QGRJUG9T/B45SW"!=A2P*L\A?5JBC)QFAFT\
M+]S@PY'+!7,^+>$!W2)^5^ZHF)FME13GJ&"8%("B_<Q8V->QK0@*\2]&)]89
M RGEGI"?<O(QG1F6C AE*.'2!!1_#VB%LDQ:$G'\:HP:K4])[(Z?K<=*O!!S
M#QE:D>PK3OEQ9D0&2-$>5AF_(:<_42/(E_82DC'U"TXU-O ,D%2,D[PABPAR
M7-3_\+%)1(<@[.@)3D-P^H1+'MR&X([UX#4$;ZP'OR'X8PE!0PA4[NMDJ4RO
M(8?S*24G0"5:6),#52[%%@G&A=Q9MYR*IUCP^'QW\_=N<_/EVWNP^[3X_ 4L
M/J_!YI^[C[OM1LS>KA&'.&/OP =P=[L&;]^\ V\ +L 69YG8&&QJ<A&$-&4F
MC<-E[="YX- %6U+P(P.;(D6IAK\>Y@<#?%.(;S/@/&=@Z0P:_*LJKH!KO0>.
MY=B:>%;CZ99.SN]YW_R>]WB8OD:)H-LZ^JM<NNUN<I6]\-)NHN+*H_Q)[*8,
M%AS (@6;7Q4NQ5W$P??%/>-4W"4_!EQYK2M/N7(ON/HD;.MV7\WR%4M>JP]S
M.YA,S8=N249@8@TF>L&\"MEO0_8'0UY6.$MQ<=">FIKJ=?SYH>7W A\#BG4@
MU]&''K2A!X.A;V%R%$OT2944M265LSU^Y!5%6E7!62RN/?%ZJL: 8@W("ER]
MJK!5%0ZJ6HD;C-.J?L>)6ZVDY""$:)6$YUD-^N49@8G/,5X4ZF5$K8QH4,8?
ME# F@V_.7MF>O;90.D716223P'5[DL: 8@W("VV]J$DK:C)\OD4=1-^15'F5
M08Y2T2Z(UBG!4!9+)V=R%L0'-W*CGIY1J%B'\B-?K\BV7MZUUJ"FW?\M46/O
M]5F>]+?=*%3<H+HWFA]%P05-G?[!'M2T[I0%H$?1\3*DE6*?7ZA>;R.MM* S
MN><@)^Q5<*,!N7:_@&:G;\H1/:@.EX&$5 6O7WKM:MM%+U3OV%M?VM<K6[.^
MMJ\W=8_\8KYNV;>0'G#!0(;VPI5U%8I(:=T%UQ-.2M6UW1,N>D U/(HO!T0E
M0#S?$\*?)])!^RTR_P]02P,$%     @ F%3\4B.4Z6_N!0  MQ\  !D   !X
M;"]W;W)K<VAE971S+W-H965T-C N>&ULO5E;<]HX%/XK&J8/[4Q2+,DVD"',
M$"XM.^0R2;M]Z.R#8@OPU+:H)$+:V1^_LG$L@H7PE@POP9=S_Z3OG%C=->,_
MQ()2"9Z3.!67C864RXMF4P0+FA#QD2UIJM[,&$^(5+=\WA1+3DF8*R5Q$SF.
MWTQ(E#9ZW?S9'>]UV4K&44KO.!"K)"'\UQ6-V?JR 1LO#^ZC^4)F#YJ][I+,
MZ0.57Y=W7-TU2RMAE-!41"P%G,XN&WUX,79;F4(N\7=$UV+K&F2I/#+V([N9
MA)<-)XN(QC20F0FB?I[H@,9Q9DG%\;,PVBA]9HK;UR_6QWGR*IE'(NB Q=^B
M4"XN&^T&".F,K&)YS]:?:9&0E]D+6"SROV"]D6TIC\%*2)84RNH^B=+-+WDN
M"K&EH.R8%5"A@'85W#T*N%# =3VXA8);UX-7*'AU%?Q"P<]KORE67NDAD:37
MY6P->":MK&47.5RYMBIPE&8KZT%R]392>K+WZ?9V^&TRG8+^S1#<?OD\N@>3
MFR_]FT^3J^D(]!\>1E\>P/LAE22*Q0=P#KX^#,'[=Q_ .Q"EX#J*8[4^1+<I
M52R9Q690^+W:^$5[_&)PS5*Y$&"4AC0TZ _M^KY%OZEJ4!8"O13B"ED-_K5*
M/P+LG 'D(&B(9U!?W3&E<YSWT7'>QW;U(0V4.C2IOZHE+A<5SNVU]MCK!S]7
M$:<A&$=I).GY5)%'"":I).D\>HPIZ M!I0#?ITH13"1-Q#\6MV[IULW=XGUK
MF;%PK5:D:35N-+U<,V/;IQYR/-3I-I^V0:HE-39*N:U2ZE7P7AF\9P^>,R$
MDPO*U<XJ*T7R2IDRVIASMZ+P_;;C[F142VILE/(ZYHS\,B/?FM&4"G&A6D>P
M2E8QD6H%D(1Q&?TF64\QI>17PCB'[1;>1:F>V-@DAGWHF[-JE5FUK%G=UD>H
M50G ;3N^MY--+:EQ5<K#R,7F7-IE+FUK+OTM/ !]5M.*H*9$VA7GR'.<UQ$.
MVM5=41$:5BUY<%=H5+6D*N*84^V4J7;LJ;Y0TI ^J7%JJ:[N. M7@03Y-"7
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MK='D83H?]Y]&TPF8R@1S,&'T>K#E'%,)^D)@*<#E$$M$4G$%KL'S8@@N+Z[
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M5E_#((Q _U]SKCXZIM+7%WO_+U!+ P04    " "85/Q29!]K1W\*   L/P
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M_,A5\Z/O/-KJI ]VN_+1U@*$27,O!&".[?E2"  P>>ZM(!@T]XQ,B+2Z#0>
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M#6"_WQ8%??Q2=W!X0?[T'U!+ P04    " "85/Q2AFTBF9$(   &-   &0
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M)'TSBFZ%HGL2A5X'Z1)M&$VVL>"(TRQ!?\X@?P+VUXE/K5<%Z'W8I]9K8VU
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M1HYL(5>!GN!ZHJ#+8XS_CO>-T$(M6:KMD%+ SS-^ )5@'TA PIOA&>SN[)7
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MDLQ1.B>^7V,=\Q]+H* (%*2!VOO&!9XC"L:<A1A'))D+%3 " R6&NL%)2+
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M3Q3!JF+:L!V,(TF"(5"+_AJ-8R0[,;S\ZX/MDBA*$C\"F%]!%&$([$8<P12
M!@R)HNHYN/,\"E?/J7#]#]_P-U!+ P04    " "85/Q2EXJ[',     3 @
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M4$L! A0#%     @ F%3\4@=!36*!    L0   !               ( !
M &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " "85/Q2MW&9NN\    K @
M$0              @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4
M" "85/Q2F5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O
M=&AE;64Q+GAM;%!+ 0(4 Q0    ( )A4_%)-]D)5Y04  )@;   8
M      " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M" "85/Q27(&HM[<%  ! %P  &               @($I#@  >&PO=V]R:W-H
M965T<R]S:&5E=#(N>&UL4$L! A0#%     @ F%3\4C!ZGRD<!   ? X  !@
M             ("!%A0  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4
M Q0    ( )A4_%(F.SDR]@4  ,\8   8              " @6@8  !X;"]W
M;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " "85/Q2],E_\6L'  !5
M'@  &               @(&4'@  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL
M4$L! A0#%     @ F%3\4G[=OURR"0  K1<  !@              ("!-28
M 'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( )A4_%)HJ9XN
MQ@<   \2   8              " @1TP  !X;"]W;W)K<VAE971S+W-H965T
M-RYX;6Q02P$"% ,4    " "85/Q2COR>C=@'  !$$@  &
M@($9.   >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ F%3\
M4@RJZ+47!@  ,@\  !@              ("!)T   'AL+W=O<FMS:&5E=',O
M<VAE970Y+GAM;%!+ 0(4 Q0    ( )A4_%*G%,+EKP,  *H'   9
M      " @71&  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%
M  @ F%3\4AE>"%"'!@  N1$  !D              ("!6DH  'AL+W=O<FMS
M:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " "85/Q2FB\G9S4&   ;#@
M&0              @($840  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+
M 0(4 Q0    ( )A4_%+MU!3/!P,  , &   9              " @817  !X
M;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ F%3\4F=@ [>>
M%   /4(  !D              ("!PEH  'AL+W=O<FMS:&5E=',O<VAE970Q
M-"YX;6Q02P$"% ,4    " "85/Q2QGLB]S0#  #-!@  &0
M@(&7;P  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( )A4
M_%)X?YPV]@(  #4&   9              " @0)S  !X;"]W;W)K<VAE971S
M+W-H965T,38N>&UL4$L! A0#%     @ F%3\4@M$BVKW @  @P8  !D
M         ("!+W8  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4
M    " "85/Q24C^#95X%   >#   &0              @(%=>0  >&PO=V]R
M:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( )A4_%(,$)5EH00  %\*
M   9              " @?)^  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL
M4$L! A0#%     @ F%3\4GBBZO&;"0  IA\  !D              ("!RH,
M 'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " "85/Q2UJQL
MK$($  "B"0  &0              @(&<C0  >&PO=V]R:W-H965T<R]S:&5E
M=#(Q+GAM;%!+ 0(4 Q0    ( )A4_%)0+EN7)R@  #N'   9
M  " @162  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @
MF%3\4C#\F +L"0  ^1D  !D              ("!<[H  'AL+W=O<FMS:&5E
M=',O<VAE970R,RYX;6Q02P$"% ,4    " "85/Q2-V4D$ZP#   &"   &0
M            @(&6Q   >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4
M Q0    ( )A4_%*J!/22$08  ,L.   9              " @7G(  !X;"]W
M;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ F%3\4KX8A@H_!
M(PD  !D              ("!P<X  'AL+W=O<FMS:&5E=',O<VAE970R-BYX
M;6Q02P$"% ,4    " "85/Q2ZNS)8P(%  #<#   &0              @($W
MTP  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( )A4_%)I
M12TOM@,  *<'   9              " @7#8  !X;"]W;W)K<VAE971S+W-H
M965T,C@N>&UL4$L! A0#%     @ F%3\4IVA'7#4!   ?@L  !D
M     ("!7=P  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( )A4_%)B7<36E@(  $<%   9              "
M@0+V  !X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ F%3\
M4JOQXTS" @  P 4  !D              ("!S_@  'AL+W=O<FMS:&5E=',O
M<VAE970S-2YX;6Q02P$"% ,4    " "85/Q2SAGOG"T#  !<!@  &0
M        @('(^P  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0
M   ( )A4_%+D)^2GS 0  &8,   9              " @2S_  !X;"]W;W)K
M<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ F%3\4DL>AC6*!P  N!H
M !D              ("!+P0! 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q0
M2P$"% ,4    " "85/Q2&16=[I\$   O"P  &0              @('P"P$
M>&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( )A4_%(HUZI3
M50(   $%   9              " @<80 0!X;"]W;W)K<VAE971S+W-H965T
M-# N>&UL4$L! A0#%     @ F%3\4C1<IBFU P  < \  !D
M ("!4A,! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " "8
M5/Q2= J%FE($  "8$0  &0              @($^%P$ >&PO=V]R:W-H965T
M<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( )A4_%*UJQ4'*0<  'DK   9
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M970T-RYX;6Q02P$"% ,4    " "85/Q2O? ?)_ $  "N$P  &0
M    @(%+-@$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    (
M )A4_%+++L]V,P,  +@*   9              " @7([ 0!X;"]W;W)K<VAE
M971S+W-H965T-#DN>&UL4$L! A0#%     @ F%3\4@VL\:%>!0  !!D  !D
M             ("!W#X! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"
M% ,4    " "85/Q2NJZJO)X#   Z#   &0              @(%Q1 $ >&PO
M=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( )A4_%*DXJH7W@,
M .P.   9              " @49( 0!X;"]W;W)K<VAE971S+W-H965T-3(N
M>&UL4$L! A0#%     @ F%3\4C:TS93M P  , T  !D              ("!
M6TP! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    " "85/Q2
M+A!T<DD,   (6P  &0              @(%_4 $ >&PO=V]R:W-H965T<R]S
M:&5E=#4T+GAM;%!+ 0(4 Q0    ( )A4_%+4=GLK/PH  !-*   9
M      " @?]< 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%
M  @ F%3\4G/ --Y@!@  P1T  !D              ("!=6<! 'AL+W=O<FMS
M:&5E=',O<VAE970U-BYX;6Q02P$"% ,4    " "85/Q2>!Q-2LP#  #V"P
M&0              @($,;@$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+
M 0(4 Q0    ( )A4_%(!*J7 " ,  '8(   9              " @0]R 0!X
M;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ F%3\4D%GS?&6
M P  EPP  !D              ("!3G4! 'AL+W=O<FMS:&5E=',O<VAE970U
M.2YX;6Q02P$"% ,4    " "85/Q2(Y3I;^X%  "W'P  &0
M@($;>0$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( )A4
M_%*,9M<[$P,  +4)   9              " @4!_ 0!X;"]W;W)K<VAE971S
M+W-H965T-C$N>&UL4$L! A0#%     @ F%3\4I87PD$5 P  4PD  !D
M         ("!BH(! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"% ,4
M    " "85/Q2GH@,\8T#  !2"P  &0              @('6A0$ >&PO=V]R
M:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( )A4_%*Q,8C4T@(  .0'
M   9              " @9J) 0!X;"]W;W)K<VAE971S+W-H965T-C0N>&UL
M4$L! A0#%     @ F%3\4F0?:T=_"@  +#\  !D              ("!HXP!
M 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4    " "85/Q2AFTB
MF9$(   &-   &0              @(%9EP$ >&PO=V]R:W-H965T<R]S:&5E
M=#8V+GAM;%!+ 0(4 Q0    ( )A4_%)U?YELS0,   H.   9
M  " @2&@ 0!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%     @
MF%3\4ON"9[LX P  #@L  !D              ("!):0! 'AL+W=O<FMS:&5E
M=',O<VAE970V."YX;6Q02P$"% ,4    " "85/Q2S8?$:",#  #@"P  &0
M            @(&4IP$ >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4
M Q0    ( )A4_%(-ZQJ=< 4  -T<   9              " @>ZJ 0!X;"]W
M;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ F%3\4K,!+0E# P
M[A,   T              ( !E; ! 'AL+W-T>6QE<RYX;6Q02P$"% ,4
M" "85/Q2EXJ[',     3 @  "P              @ $#M $ 7W)E;',O+G)E
M;'-02P$"% ,4    " "85/Q2BG/P0K %   A+@  #P              @ 'L
MM $ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ F%3\4MMVL'$Q @  B2D
M !H              ( !R;H! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS
M4$L! A0#%     @ F%3\4J3(PW?Z 0  M"@  !,              ( !,KT!
J %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     $X 3@!9%0  7;\!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>457</ContextCount>
  <ElementCount>451</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>124</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/DocumentandEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONSOLIDATED STATEMENTS OF EARNINGS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF EARNINGS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSNotes</Role>
      <ShortName>BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2104102 - Disclosure - REVENUE RECOGNITION Revenue Recognition (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.bms.com/role/REVENUERECOGNITIONRevenueRecognitionNotes</Role>
      <ShortName>REVENUE RECOGNITION Revenue Recognition (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2110103 - Disclosure - ALLIANCES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/ALLIANCES</Role>
      <ShortName>ALLIANCES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2114104 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSNotes</Role>
      <ShortName>DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2119105 - Disclosure - OTHER EXPENSE (INCOME), NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/OTHEREXPENSEINCOMENET</Role>
      <ShortName>OTHER EXPENSE (INCOME), NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2122106 - Disclosure - RESTRUCTURING</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RESTRUCTURING</Role>
      <ShortName>RESTRUCTURING</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2127107 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2130108 - Disclosure - EARNINGS/(LOSS) PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EARNINGSLOSSPERSHARE</Role>
      <ShortName>EARNINGS/(LOSS) PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2133109 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2138110 - Disclosure - RECEIVABLES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RECEIVABLES</Role>
      <ShortName>RECEIVABLES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2141111 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INVENTORIES</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2144112 - Disclosure - PROPERTY, PLANT AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2147113 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2150114 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATION</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2156115 - Disclosure - EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EQUITY</Role>
      <ShortName>EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2160116 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS Employee Stock Benefit Plans (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansNotes</Role>
      <ShortName>EMPLOYEE STOCK BENEFIT PLANS Employee Stock Benefit Plans (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2165117 - Disclosure - LEGAL PROCEEDINGS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES</Role>
      <ShortName>LEGAL PROCEEDINGS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - BASIS OF PRESENTATION (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/BASISOFPRESENTATIONPolicies</Role>
      <ShortName>BASIS OF PRESENTATION (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2211202 - Disclosure - ALLIANCES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/ALLIANCESPolicies</Role>
      <ShortName>ALLIANCES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Revenue Recognition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RevenueRecognitionTables</Role>
      <ShortName>Revenue Recognition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2312302 - Disclosure - ALLIANCES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/ALLIANCESTables</Role>
      <ShortName>ALLIANCES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/ALLIANCES</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2315303 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables</Role>
      <ShortName>DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSNotes</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2320304 - Disclosure - OTHER EXPENSE (INCOME), NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/OTHEREXPENSEINCOMENETTables</Role>
      <ShortName>OTHER EXPENSE (INCOME), NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/OTHEREXPENSEINCOMENET</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2323305 - Disclosure - RESTRUCTURING (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RESTRUCTURINGTables</Role>
      <ShortName>RESTRUCTURING (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/RESTRUCTURING</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2328306 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/INCOMETAXES</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2331307 - Disclosure - EARNINGS/(LOSS) PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EARNINGSLOSSPERSHARETables</Role>
      <ShortName>EARNINGS/(LOSS) PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/EARNINGSLOSSPERSHARE</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2334308 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2339309 - Disclosure - RECEIVABLES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RECEIVABLESTables</Role>
      <ShortName>RECEIVABLES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/RECEIVABLES</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2342310 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INVENTORIESTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/INVENTORIES</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2345311 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2348312 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2351313 - Disclosure - Supplemental Financial Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/SupplementalFinancialInformationTables</Role>
      <ShortName>Supplemental Financial Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2357314 - Disclosure - EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EQUITYTables</Role>
      <ShortName>EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/EQUITY</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2361315 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS Employee Stock Benefit Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansTables</Role>
      <ShortName>EMPLOYEE STOCK BENEFIT PLANS Employee Stock Benefit Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansNotes</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2403401 - Disclosure - BASIS OF PRESENTATION (New Accounting Pronouncements) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/BASISOFPRESENTATIONNewAccountingPronouncementsDetails</Role>
      <ShortName>BASIS OF PRESENTATION (New Accounting Pronouncements) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/BASISOFPRESENTATIONPolicies</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - REVENUE RECOGNITION Revenue by Nature (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/REVENUERECOGNITIONRevenuebyNatureDetails</Role>
      <ShortName>REVENUE RECOGNITION Revenue by Nature (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - REVENUE RECOGNITION Gross-to-Net Adjustments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/REVENUERECOGNITIONGrosstoNetAdjustmentsDetails</Role>
      <ShortName>REVENUE RECOGNITION Gross-to-Net Adjustments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - REVENUE RECOGNITION Revenue by Product by Region (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails</Role>
      <ShortName>REVENUE RECOGNITION Revenue by Product by Region (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2409405 - Disclosure - REVENUE RECOGNITION Narratives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/REVENUERECOGNITIONNarrativesDetails</Role>
      <ShortName>REVENUE RECOGNITION Narratives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2413406 - Disclosure - ALLIANCES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/ALLIANCESDetails</Role>
      <ShortName>ALLIANCES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/ALLIANCESTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2417408 - Disclosure - DIVESTITURES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/DIVESTITURESDetails</Role>
      <ShortName>DIVESTITURES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2418409 - Disclosure - LICENSING AND OTHER ARRANGEMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails</Role>
      <ShortName>LICENSING AND OTHER ARRANGEMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2421410 - Disclosure - OTHER EXPENSE (INCOME), NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails</Role>
      <ShortName>OTHER EXPENSE (INCOME), NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/OTHEREXPENSEINCOMENETTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2424411 - Disclosure - RESTRUCTURING NARRATIVE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RESTRUCTURINGNARRATIVEDetails</Role>
      <ShortName>RESTRUCTURING NARRATIVE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2425412 - Disclosure - RESTRUCTURING RESTRUCTURING AND RELATED COSTS TABLE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails</Role>
      <ShortName>RESTRUCTURING RESTRUCTURING AND RELATED COSTS TABLE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2426413 - Disclosure - RESTRUCTURING SCHEDULE OF RESTRUCTURING RESERVE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails</Role>
      <ShortName>RESTRUCTURING SCHEDULE OF RESTRUCTURING RESERVE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2429414 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INCOMETAXESDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/INCOMETAXESTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2432415 - Disclosure - EARNINGS/(LOSS) PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EARNINGSLOSSPERSHAREDetails</Role>
      <ShortName>EARNINGS/(LOSS) PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/EARNINGSLOSSPERSHARETables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2435416 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Fair Value Measurement) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Fair Value Measurement) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2436417 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Derivatives and Hedging) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Derivatives and Hedging) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2437418 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Debt) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Debt) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2440419 - Disclosure - RECEIVABLES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/RECEIVABLESDetails</Role>
      <ShortName>RECEIVABLES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/RECEIVABLESTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2443420 - Disclosure - INVENTORIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/INVENTORIESDetails</Role>
      <ShortName>INVENTORIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/INVENTORIESTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2446421 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails</Role>
      <ShortName>PROPERTY, PLANT AND EQUIPMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2449422 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2452423 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2453424 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION Other Non-Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION Other Non-Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2454425 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2455426 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION Other Non-Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails</Role>
      <ShortName>SUPPLEMENTAL FINANCIAL INFORMATION Other Non-Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2458427 - Disclosure - EQUITY (Changes in Equity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EQUITYChangesinEquityDetails</Role>
      <ShortName>EQUITY (Changes in Equity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/EQUITYTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2459428 - Disclosure - EQUITY (Other Comprehensive Income/(Loss)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>EQUITY (Other Comprehensive Income/(Loss)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/EQUITYTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2462429 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS Share-based Payment Arrangement, Cost by Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails</Role>
      <ShortName>EMPLOYEE STOCK BENEFIT PLANS Share-based Payment Arrangement, Cost by Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2463430 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS Schedule Of Share Based Compensation Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleOfShareBasedCompensationAdditionalInformationDetails</Role>
      <ShortName>EMPLOYEE STOCK BENEFIT PLANS Schedule Of Share Based Compensation Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2464431 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS Share-based Payment Arrangement, Nonvested Award, Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails</Role>
      <ShortName>EMPLOYEE STOCK BENEFIT PLANS Share-based Payment Arrangement, Nonvested Award, Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="bmy-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2466432 - Disclosure - LEGAL PROCEEDINGS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails</Role>
      <ShortName>LEGAL PROCEEDINGS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES</ParentRole>
      <Position>70</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="bmy-20210630.htm">bmy-20210630.htm</File>
    <File>bmy-20210630.xsd</File>
    <File>bmy-20210630_cal.xml</File>
    <File>bmy-20210630_def.xml</File>
    <File>bmy-20210630_lab.xml</File>
    <File>bmy-20210630_pre.xml</File>
    <File>bmyex10f20210630.htm</File>
    <File>bmyex10g20210620.htm</File>
    <File>bmyex10h20210630.htm</File>
    <File>bmyex10i20210630.htm</File>
    <File>bmyex31a_20210630.htm</File>
    <File>bmyex31b_20210630.htm</File>
    <File>bmyex32a_20210630.htm</File>
    <File>bmyex32b_20210630.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2021</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/currency/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>93
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "bmy-20210630.htm": {
   "axisCustom": 5,
   "axisStandard": 32,
   "contextCount": 457,
   "dts": {
    "calculationLink": {
     "local": [
      "bmy-20210630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "bmy-20210630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "bmy-20210630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "bmy-20210630_lab.xml"
     ],
     "remote": [
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-doc-2021-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bmy-20210630_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-ref-2021-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "bmy-20210630.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-parts-codification-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd"
     ]
    }
   },
   "elementCount": 676,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 7,
    "total": 7
   },
   "keyCustom": 47,
   "keyStandard": 404,
   "memberCustom": 71,
   "memberStandard": 50,
   "nsprefix": "bmy",
   "nsuri": "http://www.bms.com/20210630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityIncorporationStateCountryCode",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Document and Entity Information",
     "role": "http://www.bms.com/role/DocumentandEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityIncorporationStateCountryCode",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119105 - Disclosure - OTHER EXPENSE (INCOME), NET",
     "role": "http://www.bms.com/role/OTHEREXPENSEINCOMENET",
     "shortName": "OTHER EXPENSE (INCOME), NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122106 - Disclosure - RESTRUCTURING",
     "role": "http://www.bms.com/role/RESTRUCTURING",
     "shortName": "RESTRUCTURING",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127107 - Disclosure - INCOME TAXES",
     "role": "http://www.bms.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130108 - Disclosure - EARNINGS/(LOSS) PER SHARE",
     "role": "http://www.bms.com/role/EARNINGSLOSSPERSHARE",
     "shortName": "EARNINGS/(LOSS) PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133109 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2138110 - Disclosure - RECEIVABLES",
     "role": "http://www.bms.com/role/RECEIVABLES",
     "shortName": "RECEIVABLES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141111 - Disclosure - INVENTORIES",
     "role": "http://www.bms.com/role/INVENTORIES",
     "shortName": "INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2144112 - Disclosure - PROPERTY, PLANT AND EQUIPMENT",
     "role": "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147113 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS",
     "role": "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2150114 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION",
     "role": "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATION",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONSOLIDATED STATEMENTS OF EARNINGS (UNAUDITED)",
     "role": "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
     "shortName": "CONSOLIDATED STATEMENTS OF EARNINGS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:SellingGeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2156115 - Disclosure - EQUITY",
     "role": "http://www.bms.com/role/EQUITY",
     "shortName": "EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2160116 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS Employee Stock Benefit Plans (Notes)",
     "role": "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansNotes",
     "shortName": "EMPLOYEE STOCK BENEFIT PLANS Employee Stock Benefit Plans (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2165117 - Disclosure - LEGAL PROCEEDINGS AND CONTINGENCIES",
     "role": "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES",
     "shortName": "LEGAL PROCEEDINGS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - BASIS OF PRESENTATION (Policies)",
     "role": "http://www.bms.com/role/BASISOFPRESENTATIONPolicies",
     "shortName": "BASIS OF PRESENTATION (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementAccountingPolicy",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2211202 - Disclosure - ALLIANCES (Policies)",
     "role": "http://www.bms.com/role/ALLIANCESPolicies",
     "shortName": "ALLIANCES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementAccountingPolicy",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Revenue Recognition (Tables)",
     "role": "http://www.bms.com/role/RevenueRecognitionTables",
     "shortName": "Revenue Recognition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312302 - Disclosure - ALLIANCES (Tables)",
     "role": "http://www.bms.com/role/ALLIANCESTables",
     "shortName": "ALLIANCES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315303 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Tables)",
     "role": "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables",
     "shortName": "DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmy:ScheduleOfOtherIncomeExpenseTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320304 - Disclosure - OTHER EXPENSE (INCOME), NET (Tables)",
     "role": "http://www.bms.com/role/OTHEREXPENSEINCOMENETTables",
     "shortName": "OTHER EXPENSE (INCOME), NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmy:ScheduleOfOtherIncomeExpenseTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2323305 - Disclosure - RESTRUCTURING (Tables)",
     "role": "http://www.bms.com/role/RESTRUCTURINGTables",
     "shortName": "RESTRUCTURING (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)",
     "role": "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2328306 - Disclosure - INCOME TAXES (Tables)",
     "role": "http://www.bms.com/role/INCOMETAXESTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331307 - Disclosure - EARNINGS/(LOSS) PER SHARE (Tables)",
     "role": "http://www.bms.com/role/EARNINGSLOSSPERSHARETables",
     "shortName": "EARNINGS/(LOSS) PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2334308 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2339309 - Disclosure - RECEIVABLES (Tables)",
     "role": "http://www.bms.com/role/RECEIVABLESTables",
     "shortName": "RECEIVABLES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2342310 - Disclosure - INVENTORIES (Tables)",
     "role": "http://www.bms.com/role/INVENTORIESTables",
     "shortName": "INVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2345311 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Tables)",
     "role": "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2348312 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "role": "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2351313 - Disclosure - Supplemental Financial Information (Tables)",
     "role": "http://www.bms.com/role/SupplementalFinancialInformationTables",
     "shortName": "Supplemental Financial Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2357314 - Disclosure - EQUITY (Tables)",
     "role": "http://www.bms.com/role/EQUITYTables",
     "shortName": "EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2361315 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS Employee Stock Benefit Plans (Tables)",
     "role": "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansTables",
     "shortName": "EMPLOYEE STOCK BENEFIT PLANS Employee Stock Benefit Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i84644a54c37541aab600ef4e9aeb7365_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "role": "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
     "shortName": "CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i84644a54c37541aab600ef4e9aeb7365_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:PriorPeriodReclassificationAdjustmentDescription",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i1d96ff885f0c4029b9c659eb21e32c98_D20200401-20200630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PriorPeriodReclassificationAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403401 - Disclosure - BASIS OF PRESENTATION (New Accounting Pronouncements) (Details)",
     "role": "http://www.bms.com/role/BASISOFPRESENTATIONNewAccountingPronouncementsDetails",
     "shortName": "BASIS OF PRESENTATION (New Accounting Pronouncements) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:PriorPeriodReclassificationAdjustmentDescription",
       "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i1d96ff885f0c4029b9c659eb21e32c98_D20200401-20200630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PriorPeriodReclassificationAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - REVENUE RECOGNITION Revenue by Nature (Details)",
     "role": "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyNatureDetails",
     "shortName": "REVENUE RECOGNITION Revenue by Nature (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "if2fb12a3531e4873be7be194483607ee_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - REVENUE RECOGNITION Gross-to-Net Adjustments (Details)",
     "role": "http://www.bms.com/role/REVENUERECOGNITIONGrosstoNetAdjustmentsDetails",
     "shortName": "REVENUE RECOGNITION Gross-to-Net Adjustments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmy:ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "bmy:GrosstoNetAdjustments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - REVENUE RECOGNITION Revenue by Product by Region (Details)",
     "role": "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails",
     "shortName": "REVENUE RECOGNITION Revenue by Product by Region (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i0049dfb3f51e491da124b097da74b773_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409405 - Disclosure - REVENUE RECOGNITION Narratives (Details)",
     "role": "http://www.bms.com/role/REVENUERECOGNITIONNarrativesDetails",
     "shortName": "REVENUE RECOGNITION Narratives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413406 - Disclosure - ALLIANCES (Details)",
     "role": "http://www.bms.com/role/ALLIANCESDetails",
     "shortName": "ALLIANCES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "if0056c94875c46578f2a3c81dbf029ef_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417408 - Disclosure - DIVESTITURES (Details)",
     "role": "http://www.bms.com/role/DIVESTITURESDetails",
     "shortName": "DIVESTITURES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RoyaltyIncomeNonoperating",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418409 - Disclosure - LICENSING AND OTHER ARRANGEMENTS (Details)",
     "role": "http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails",
     "shortName": "LICENSING AND OTHER ARRANGEMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmy:LicensingAndOtherArrangementsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "bmy:UpFrontLicensingFee",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bmy:ScheduleOfOtherIncomeExpenseTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421410 - Disclosure - OTHER EXPENSE (INCOME), NET (Details)",
     "role": "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails",
     "shortName": "OTHER EXPENSE (INCOME), NET (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bmy:ScheduleOfOtherIncomeExpenseTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i93047c5690bd4da0b6566915947d0bb6_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostExpectedCost1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424411 - Disclosure - RESTRUCTURING NARRATIVE (Details)",
     "role": "http://www.bms.com/role/RESTRUCTURINGNARRATIVEDetails",
     "shortName": "RESTRUCTURING NARRATIVE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i93047c5690bd4da0b6566915947d0bb6_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedCostExpectedCost1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "role": "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425412 - Disclosure - RESTRUCTURING RESTRUCTURING AND RELATED COSTS TABLE (Details)",
     "role": "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails",
     "shortName": "RESTRUCTURING RESTRUCTURING AND RELATED COSTS TABLE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SeveranceCosts1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i84644a54c37541aab600ef4e9aeb7365_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426413 - Disclosure - RESTRUCTURING SCHEDULE OF RESTRUCTURING RESERVE (Details)",
     "role": "http://www.bms.com/role/RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails",
     "shortName": "RESTRUCTURING SCHEDULE OF RESTRUCTURING RESERVE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ie5b48843789843e59015f89cfb97e96a_I20210101",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringReserve",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429414 - Disclosure - INCOME TAXES (Details)",
     "role": "http://www.bms.com/role/INCOMETAXESDetails",
     "shortName": "INCOME TAXES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432415 - Disclosure - EARNINGS/(LOSS) PER SHARE (Details)",
     "role": "http://www.bms.com/role/EARNINGSLOSSPERSHAREDetails",
     "shortName": "EARNINGS/(LOSS) PER SHARE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AvailableForSaleSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i84644a54c37541aab600ef4e9aeb7365_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435416 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Fair Value Measurement) (Details)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Fair Value Measurement) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AvailableForSaleSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i4021bf9acd814a3785a7b2ac9255f519_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i84644a54c37541aab600ef4e9aeb7365_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436417 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Derivatives and Hedging) (Details)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Derivatives and Hedging) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib8f2c3191d174bad82233a9c00d673f4_I20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "eur",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShortTermDebtTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i84644a54c37541aab600ef4e9aeb7365_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermBankLoansAndNotesPayable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437418 - Disclosure - FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Debt) (Details)",
     "role": "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails",
     "shortName": "FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS (Debt) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShortTermDebtTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i4021bf9acd814a3785a7b2ac9255f519_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ShortTermBankLoansAndNotesPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i84644a54c37541aab600ef4e9aeb7365_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440419 - Disclosure - RECEIVABLES (Details)",
     "role": "http://www.bms.com/role/RECEIVABLESDetails",
     "shortName": "RECEIVABLES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i84644a54c37541aab600ef4e9aeb7365_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i84644a54c37541aab600ef4e9aeb7365_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443420 - Disclosure - INVENTORIES (Details)",
     "role": "http://www.bms.com/role/INVENTORIESDetails",
     "shortName": "INVENTORIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i84644a54c37541aab600ef4e9aeb7365_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i84644a54c37541aab600ef4e9aeb7365_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446421 - Disclosure - PROPERTY, PLANT AND EQUIPMENT (Details)",
     "role": "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails",
     "shortName": "PROPERTY, PLANT AND EQUIPMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i4021bf9acd814a3785a7b2ac9255f519_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Land",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Notes)",
     "role": "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSNotes",
     "shortName": "BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i84644a54c37541aab600ef4e9aeb7365_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449422 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details)",
     "role": "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i4021bf9acd814a3785a7b2ac9255f519_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i84644a54c37541aab600ef4e9aeb7365_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452423 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION Other Current Assets (Details)",
     "role": "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION Other Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i84644a54c37541aab600ef4e9aeb7365_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PrepaidTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i84644a54c37541aab600ef4e9aeb7365_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bmy:EquityInvestmentsNonCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453424 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION Other Non-Current Assets (Details)",
     "role": "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION Other Non-Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i84644a54c37541aab600ef4e9aeb7365_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bmy:EquityInvestmentsNonCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i84644a54c37541aab600ef4e9aeb7365_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bmy:AccruedRebatesAndReturns",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454425 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION Other Current Liabilities (Details)",
     "role": "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i84644a54c37541aab600ef4e9aeb7365_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "bmy:AccruedRebatesAndReturns",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i84644a54c37541aab600ef4e9aeb7365_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedIncomeTaxesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455426 - Disclosure - SUPPLEMENTAL FINANCIAL INFORMATION Other Non-Current Liabilities (Details)",
     "role": "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails",
     "shortName": "SUPPLEMENTAL FINANCIAL INFORMATION Other Non-Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i84644a54c37541aab600ef4e9aeb7365_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedIncomeTaxesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockDividendsPerShareDeclared",
       "span",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458427 - Disclosure - EQUITY (Changes in Equity) (Details)",
     "role": "http://www.bms.com/role/EQUITYChangesinEquityDetails",
     "shortName": "EQUITY (Changes in Equity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockDividendsPerShareDeclared",
       "span",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459428 - Disclosure - EQUITY (Other Comprehensive Income/(Loss)) (Details)",
     "role": "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails",
     "shortName": "EQUITY (Other Comprehensive Income/(Loss)) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462429 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS Share-based Payment Arrangement, Cost by Plan (Details)",
     "role": "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails",
     "shortName": "EMPLOYEE STOCK BENEFIT PLANS Share-based Payment Arrangement, Cost by Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "ib0e2064f07684fcb8f695e734284cce8_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmy:ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i802d457ae3ce494fba78c18db7fb4724_D20210401-20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463430 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS Schedule Of Share Based Compensation Additional Information (Details)",
     "role": "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleOfShareBasedCompensationAdditionalInformationDetails",
     "shortName": "EMPLOYEE STOCK BENEFIT PLANS Schedule Of Share Based Compensation Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "bmy:ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i802d457ae3ce494fba78c18db7fb4724_D20210401-20210630",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "icb9926c1623d4307b449847e25ccb9a6_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2464431 - Disclosure - EMPLOYEE STOCK BENEFIT PLANS Share-based Payment Arrangement, Nonvested Award, Cost (Details)",
     "role": "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails",
     "shortName": "EMPLOYEE STOCK BENEFIT PLANS Share-based Payment Arrangement, Nonvested Award, Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "icb9926c1623d4307b449847e25ccb9a6_I20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104102 - Disclosure - REVENUE RECOGNITION Revenue Recognition (Notes)",
     "role": "http://www.bms.com/role/REVENUERECOGNITIONRevenueRecognitionNotes",
     "shortName": "REVENUE RECOGNITION Revenue Recognition (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i00042bb08bc247c88f649c75d7bbb73f_D20210401-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPatentsAllegedlyInfringedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466432 - Disclosure - LEGAL PROCEEDINGS AND CONTINGENCIES (Details)",
     "role": "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails",
     "shortName": "LEGAL PROCEEDINGS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i00042bb08bc247c88f649c75d7bbb73f_D20210401-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPatentsAllegedlyInfringedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110103 - Disclosure - ALLIANCES",
     "role": "http://www.bms.com/role/ALLIANCES",
     "shortName": "ALLIANCES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114104 - Disclosure - DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Notes)",
     "role": "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSNotes",
     "shortName": "DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "bmy-20210630.htm",
      "contextRef": "i052f0b036b6b40b5992a70ff101398e1_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 124,
   "tag": {
    "bmy_A1.000Notesdue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One000NotesDue2025Member",
        "label": "1.000% Notes due 2025 [Member]",
        "terseLabel": "1.000% Notes due 2025 [Member]"
       }
      }
     },
     "localname": "A1.000Notesdue2025Member",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A1.5BillionMaximumBorrowingCapacityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$1.5 Billion Maximum Borrowing Capacity [Member]",
        "label": "$1.5 Billion Maximum Borrowing Capacity [Member]",
        "terseLabel": "$1.5 Billion Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "A1.5BillionMaximumBorrowingCapacityMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A1.750Notesdue2035Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One750NotesDue2035Member",
        "label": "1.750% Notes due 2035 [Member]",
        "terseLabel": "1.750% Notes due 2035 [Member]"
       }
      }
     },
     "localname": "A1.750Notesdue2035Member",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A1BillionMaximumBorrowingCapacityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$1 Billion Maximum Borrowing Capacity [Member]",
        "label": "$1 Billion Maximum Borrowing Capacity [Member]",
        "terseLabel": "$1 Billion Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "A1BillionMaximumBorrowingCapacityMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A2.875SeniorNotesdue2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.875% Senior Notes due 2021 [Member]",
        "label": "2.875% Senior Notes due 2021 [Member]",
        "terseLabel": "2.875% Senior Notes due 2021"
       }
      }
     },
     "localname": "A2.875SeniorNotesdue2021Member",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A2550SeniorNotesDue2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.550% Senior Notes due 2021",
        "label": "2.550% Senior Notes due 2021 [Member]",
        "terseLabel": "2.55% Senior Notes due 2021"
       }
      }
     },
     "localname": "A2550SeniorNotesDue2021Member",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_A2BillionMaximumBorrowingCapacityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "$2 Billion Maximum Borrowing Capacity [Member]",
        "label": "$2 Billion Maximum Borrowing Capacity [Member]",
        "terseLabel": "$2 Billion Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "A2BillionMaximumBorrowingCapacityMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ALLIANCESAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ALLIANCES [Abstract]",
        "label": "ALLIANCES [Abstract]",
        "terseLabel": "ALLIANCES [Abstract]"
       }
      }
     },
     "localname": "ALLIANCESAbstract",
     "nsuri": "http://www.bms.com/20210630",
     "xbrltype": "stringItemType"
    },
    "bmy_AbecmaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Abecma",
        "label": "Abecma [Member]",
        "terseLabel": "Abecma"
       }
      }
     },
     "localname": "AbecmaMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AbilifyProductLiabilityLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Abilify Product Liability Litigation",
        "label": "Abilify Product Liability Litigation [Member]",
        "terseLabel": "Abilify Product Liability Litigation"
       }
      }
     },
     "localname": "AbilifyProductLiabilityLitigationMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AbilifyProductLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Abilify Product Liability [Member]",
        "label": "Abilify Product Liability [Member]",
        "terseLabel": "Abilify Product Liability [Member]"
       }
      }
     },
     "localname": "AbilifyProductLiabilityMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AbraxaneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Abraxane [Member]",
        "label": "Abraxane [Member]",
        "terseLabel": "Abraxane [Member]"
       }
      }
     },
     "localname": "AbraxaneMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AcceleratedStockBasedCompensationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Stock Based Compensation [Member]",
        "label": "Accelerated Stock Based Compensation [Member]",
        "terseLabel": "Accelerated Stock Based Compensation [Member]"
       }
      }
     },
     "localname": "AcceleratedStockBasedCompensationMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AccruedInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Interest",
        "label": "Accrued Interest",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "AccruedInterest",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AccruedRebatesAndReturns": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable pertaining to rebates to government programs and sales returns.",
        "label": "Accrued rebates and returns",
        "terseLabel": "Rebates and returns"
       }
      }
     },
     "localname": "AccruedRebatesAndReturns",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AccruedResearchAndDevelopment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to research and development.",
        "label": "Accrued Research And Development",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopment",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AcquiredDevelopedProductRightsReclassedFromIPRD": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired Developed Product Rights Reclassed From IPRD",
        "label": "Acquired Developed Product Rights Reclassed From IPRD",
        "terseLabel": "Acquired Developed Product Rights Reclassed From IPRD"
       }
      }
     },
     "localname": "AcquiredDevelopedProductRightsReclassedFromIPRD",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AcquisitionsDivestituresandOtherArrangementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisitions, Divestitures and Other Arrangements [Abstract]",
        "label": "Acquisitions, Divestitures and Other Arrangements [Abstract]",
        "terseLabel": "Acquisitions, Divestitures and Other Arrangements [Abstract]"
       }
      }
     },
     "localname": "AcquisitionsDivestituresandOtherArrangementsAbstract",
     "nsuri": "http://www.bms.com/20210630",
     "xbrltype": "stringItemType"
    },
    "bmy_AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments for Provisions for Product Sales made in Prior Periods",
        "label": "Adjustments for Provisions for Product Sales made in Prior Periods",
        "terseLabel": "Adjustments for Provisions for Product Sales made in Prior Periods"
       }
      }
     },
     "localname": "AdjustmentsForProvisionsForProductSalesMadeInPriorPeriods",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONGrosstoNetAdjustmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AgenusMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agenus",
        "label": "Agenus [Member]",
        "terseLabel": "Agenus"
       }
      }
     },
     "localname": "AgenusMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AllianceTransitionalServices": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents other income recognized during the period related to transitional services provided to a former alliance partner.",
        "label": "Alliance Transitional Services",
        "negatedTerseLabel": "Transition and other service fees"
       }
      }
     },
     "localname": "AllianceTransitionalServices",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AllianceandotherrevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Alliance and other revenues [Member]",
        "label": "Alliance and other revenues [Member]",
        "terseLabel": "Alliance and other revenues [Member]"
       }
      }
     },
     "localname": "AllianceandotherrevenuesMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AlliancesAndCollaborationCompaniesAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Alliances And Collaboration Companies",
        "label": "Alliances And Collaboration Companies [Axis]",
        "terseLabel": "Alliances And Collaboration Companies [Axis]"
       }
      }
     },
     "localname": "AlliancesAndCollaborationCompaniesAxis",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_AlliancesAndCollaborationCompaniesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Alliances and Collaboration Companies",
        "label": "Alliances and Collaboration Companies [Domain]",
        "terseLabel": "Alliances and Collaboration Companies [Domain]"
       }
      }
     },
     "localname": "AlliancesAndCollaborationCompaniesDomain",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AmortizationofAcquiredIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization of Acquired Intangible Assets",
        "label": "Amortization of Acquired Intangible Assets",
        "terseLabel": "Amortization of acquired intangible assets"
       }
      }
     },
     "localname": "AmortizationofAcquiredIntangibleAssets",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AntiPD1AntibodyLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anti-PD-1 Antibody Litigation [Member]",
        "label": "Anti-PD-1 Antibody Litigation [Member]",
        "terseLabel": "Anti-PD-1 Antibody Litigation [Member]"
       }
      }
     },
     "localname": "AntiPD1AntibodyLitigationMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_AssetAcquisitionNameAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition Name",
        "label": "Asset Acquisition Name [Axis]",
        "terseLabel": "Asset Acquisition Name [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionNameAxis",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_AssetAcquisitionNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition Name",
        "label": "Asset Acquisition Name [Domain]",
        "terseLabel": "Asset Acquisition Name [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionNameDomain",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_Assetacquisitioncharge": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the charge for an asset acquisition in the statement of cash flows.",
        "label": "Asset acquisition charge",
        "terseLabel": "Asset acquisition charges"
       }
      }
     },
     "localname": "Assetacquisitioncharge",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_AvaproAvalideAndPlavixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Avapro, Avalide, and Plavix [Member]",
        "terseLabel": "Avapro, Avalide, and Plavix [Member]"
       }
      }
     },
     "localname": "AvaproAvalideAndPlavixMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS [Abstract]",
        "label": "BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS [Abstract]",
        "terseLabel": "BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS [Abstract]"
       }
      }
     },
     "localname": "BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSAbstract",
     "nsuri": "http://www.bms.com/20210630",
     "xbrltype": "stringItemType"
    },
    "bmy_BMSSecuritiesLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BMS Securities Litigation [Member]",
        "label": "BMS Securities Litigation [Member]",
        "terseLabel": "Securities Litigation [Member]"
       }
      }
     },
     "localname": "BMSSecuritiesLitigationMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_BaracludeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Baraclude [Member]",
        "terseLabel": "Baraclude [Member]"
       }
      }
     },
     "localname": "BaracludeMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_BreyanziMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Breyanzi",
        "label": "Breyanzi [Member]",
        "terseLabel": "Breyanzi"
       }
      }
     },
     "localname": "BreyanziMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ByettaProductLiabilityLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Byetta Product Liability Litigation [Member]",
        "label": "Byetta Product Liability Litigation [Member]",
        "terseLabel": "Byetta Product Liability Litigation [Member]"
       }
      }
     },
     "localname": "ByettaProductLiabilityLitigationMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_CARTKiteLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CAR T Kite Litigation [Member]",
        "label": "CAR T Kite Litigation [Member]",
        "terseLabel": "CAR T Kite Litigation [Member]"
       }
      }
     },
     "localname": "CARTKiteLitigationMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_CashDiscounts": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/RECEIVABLESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of reductions to trade receivables incurred during the period attributable to cash discounts.",
        "label": "Cash Discounts",
        "negatedTerseLabel": "Less charge-backs and cash discounts"
       }
      }
     },
     "localname": "CashDiscounts",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_Cashoutlays": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outlays",
        "label": "Cash outlays",
        "terseLabel": "Cash outlays"
       }
      }
     },
     "localname": "Cashoutlays",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGNARRATIVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_CelgeneContingentValueRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Celgene Contingent Value Rights [Member]",
        "label": "Celgene Contingent Value Rights [Member]",
        "terseLabel": "Celgene Contingent Value Rights [Member]"
       }
      }
     },
     "localname": "CelgeneContingentValueRightsMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_CelgeneIntegrationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Celgene Integration [Member]",
        "label": "Celgene Integration [Member]",
        "terseLabel": "Celgene Integration [Member]"
       }
      }
     },
     "localname": "CelgeneIntegrationMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGNARRATIVEDetails",
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails",
      "http://www.bms.com/role/RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails",
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_CelgeneSecuritiesLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Celgene Securities Litigation",
        "label": "Celgene Securities Litigation [Member]",
        "terseLabel": "Celgene Securities Litigation"
       }
      }
     },
     "localname": "CelgeneSecuritiesLitigationMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_CerclaMattersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cercla Matters [Member]",
        "terseLabel": "Cercla Matters [Member]"
       }
      }
     },
     "localname": "CerclaMattersMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ChargebacksandcashdiscountsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Charge-backs and cash discounts [Member]",
        "label": "Charge-backs and cash discounts [Member]",
        "terseLabel": "Charge-backs and cash discounts [Member]"
       }
      }
     },
     "localname": "ChargebacksandcashdiscountsMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONGrosstoNetAdjustmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_CommonStock0.10ParValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CommonStock010ParValueMember",
        "label": "Common Stock $0.10 Par Value [Member]",
        "terseLabel": "Common Stock $0.10 Par Value [Member]"
       }
      }
     },
     "localname": "CommonStock0.10ParValueMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_CompanyTransformationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Company Transformation",
        "label": "Company Transformation [Member]",
        "terseLabel": "Operating Model 2020 [Member]"
       }
      }
     },
     "localname": "CompanyTransformationMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGNARRATIVEDetails",
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails",
      "http://www.bms.com/role/RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails",
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_Considerationforcontingentdevelopmentandregulatoryapproval": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that additional aggregate consideration for contingent development and regulatory approval milestone payments.",
        "label": "Consideration for contingent development and regulatory approval",
        "terseLabel": "Consideration for contingent development and regulatory approval"
       }
      }
     },
     "localname": "Considerationforcontingentdevelopmentandregulatoryapproval",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_ContingentAndRegulatoryMilestoneNonCash": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent and Regulatory Milestone, Non-Cash",
        "label": "Contingent and Regulatory Milestone, Non-Cash",
        "terseLabel": "Contingent and Regulatory Milestone, Non-Cash"
       }
      }
     },
     "localname": "ContingentAndRegulatoryMilestoneNonCash",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_ContingentAndRegulatoryMilestonePayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent and Regulatory Milestone Payments",
        "label": "Contingent and Regulatory Milestone Payments",
        "terseLabel": "Contingent and Regulatory Milestone Payments"
       }
      }
     },
     "localname": "ContingentAndRegulatoryMilestonePayments",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_ContingentRegulatoryMilestoneIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Regulatory Milestone Income",
        "label": "Contingent Regulatory Milestone Income",
        "negatedTerseLabel": "Contingent and Regulatory Milestone Income"
       }
      }
     },
     "localname": "ContingentRegulatoryMilestoneIncome",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_ContingentValueRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BMY Contingent Value Rights [Member]",
        "label": "Contingent Value Rights [Member]",
        "terseLabel": "Contingent Value Rights [Member]"
       }
      }
     },
     "localname": "ContingentValueRightsMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_DeferredIncomeTaxExpenseBenefitComponentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Income Tax Expense/Benefit Component",
        "label": "Deferred Income Tax Expense/Benefit Component [Axis]",
        "terseLabel": "Deferred Income Tax Expense/Benefit Component [Axis]"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitComponentAxis",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_DeferredIncomeTaxExpenseBenefitComponentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Income Tax Expense/Benefit Component",
        "label": "Deferred Income Tax Expense/Benefit Component [Domain]",
        "terseLabel": "Deferred Income Tax Expense/Benefit Component [Domain]"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitComponentDomain",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_DiabetesbusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diabetes business [Member]",
        "label": "Diabetes business [Member]",
        "terseLabel": "Diabetes business [Member]"
       }
      }
     },
     "localname": "DiabetesbusinessMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESDetails",
      "http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_DismissedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dismissed",
        "label": "Dismissed [Member]",
        "terseLabel": "Dismissed"
       }
      }
     },
     "localname": "DismissedMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_Divestitureandotherproceeds": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the cash inflow during the period from the sale of a business, asset or other proceeds.",
        "label": "Divestiture and other proceeds",
        "terseLabel": "Divestiture and other proceeds"
       }
      }
     },
     "localname": "Divestitureandotherproceeds",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_Divestituregainsandroyalties": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents the amount of gains and royalties as a result of business divestitures.",
        "label": "Divestiture gains and royalties",
        "negatedTerseLabel": "Divestiture gains and royalties"
       }
      }
     },
     "localname": "Divestituregainsandroyalties",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_DocumentAndEntityInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Document and Entity Information [Abstract]",
        "label": "Document and Entity Information [Abstract]",
        "terseLabel": "Document and Entity Information [Abstract]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationAbstract",
     "nsuri": "http://www.bms.com/20210630",
     "xbrltype": "stringItemType"
    },
    "bmy_EisaiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eisai",
        "label": "Eisai [Member]",
        "terseLabel": "Eisai"
       }
      }
     },
     "localname": "EisaiMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_EliquisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Eliquis [Member]",
        "terseLabel": "Eliquis [Member]"
       }
      }
     },
     "localname": "EliquisMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_EliquisPatentLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliquis Patent Litigation [Member]",
        "label": "Eliquis Patent Litigation [Member]",
        "terseLabel": "Eliquis Patent Litigation [Member]"
       }
      }
     },
     "localname": "EliquisPatentLitigationMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_EmplicitiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Empliciti [Member]",
        "label": "Empliciti [Member]",
        "terseLabel": "Empliciti [Member]"
       }
      }
     },
     "localname": "EmplicitiMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_EquityInvestmentsCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity investments - current",
        "label": "Equity investments - current",
        "terseLabel": "Equity investments"
       }
      }
     },
     "localname": "EquityInvestmentsCurrent",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_EquityInvestmentsNonCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity investments - non-current",
        "label": "Equity investments - non-current",
        "terseLabel": "Equity investments"
       }
      }
     },
     "localname": "EquityInvestmentsNonCurrent",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments",
        "label": "Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments",
        "terseLabel": "Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, and Equity Method Investments"
       }
      }
     },
     "localname": "EquitySecuritiesFVNIEquitySecuritiesWithoutReadilyDeterminableFairValueAndEquityMethodInvestments",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_ErbituxBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Erbitux Business",
        "label": "Erbitux Business [Member]",
        "terseLabel": "Erbitux [Member]"
       }
      }
     },
     "localname": "ErbituxBusinessMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings, Foreign Exchange",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings, Foreign Exchange",
        "terseLabel": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings, Foreign Exchange"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarningsForeignExchange",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_GrosstoNetAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross to Net Adjustments",
        "label": "Gross to Net Adjustments",
        "negatedTerseLabel": "Gross to Net Adjustments"
       }
      }
     },
     "localname": "GrosstoNetAdjustments",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONGrosstoNetAdjustmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_GrosstoNetAdjustmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross-to-Net Adjustments [Abstract]",
        "label": "Gross-to-Net Adjustments [Abstract]",
        "terseLabel": "Gross-to-Net Adjustments [Abstract]"
       }
      }
     },
     "localname": "GrosstoNetAdjustmentsAbstract",
     "nsuri": "http://www.bms.com/20210630",
     "xbrltype": "stringItemType"
    },
    "bmy_GrosstoNetAdjustmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross to Net Adjustments [Axis]",
        "label": "Gross to Net Adjustments [Axis]",
        "terseLabel": "Gross to Net Adjustments [Axis]"
       }
      }
     },
     "localname": "GrosstoNetAdjustmentsAxis",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONGrosstoNetAdjustmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_GrosstoNetAdjustmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Gross to Net Adjustments [Axis]",
        "label": "Gross to Net Adjustments [Domain]",
        "terseLabel": "Gross to Net Adjustments [Domain]"
       }
      }
     },
     "localname": "GrosstoNetAdjustmentsDomain",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONGrosstoNetAdjustmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_GrosstoNetAdjustmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Gross to Net Adjustments [Table]",
        "label": "Gross to Net Adjustments [Line Items]",
        "terseLabel": "Gross to Net Adjustments [Line Items]"
       }
      }
     },
     "localname": "GrosstoNetAdjustmentsLineItems",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONGrosstoNetAdjustmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_GrosstoNetAdjustmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross to Net Adjustments [Table]",
        "label": "Gross to Net Adjustments [Table]",
        "terseLabel": "Gross to Net Adjustments [Table]"
       }
      }
     },
     "localname": "GrosstoNetAdjustmentsTable",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONGrosstoNetAdjustmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_IncomeTaxExpenseBenefitComponentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Expense/Benefit Component",
        "label": "Income Tax Expense/Benefit Component [Axis]",
        "terseLabel": "Income Tax Expense/Benefit Component [Axis]"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitComponentAxis",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_IncomeTaxExpenseBenefitComponentDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Tax Expense/Benefit Component",
        "label": "Income Tax Expense/Benefit Component [Domain]",
        "terseLabel": "Income Tax Expense/Benefit Component [Domain]"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitComponentDomain",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_InrebicMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inrebic [Member]",
        "label": "Inrebic [Member]",
        "terseLabel": "Inrebic [Member]"
       }
      }
     },
     "localname": "InrebicMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails",
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_IntangibleAssetNameAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Asset Name",
        "label": "Intangible Asset Name [Axis]",
        "terseLabel": "Intangible Asset Name [Axis]"
       }
      }
     },
     "localname": "IntangibleAssetNameAxis",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_IntangibleAssetNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Asset Name",
        "label": "Intangible Asset Name [Domain]",
        "terseLabel": "Intangible Asset Name [Domain]"
       }
      }
     },
     "localname": "IntangibleAssetNameDomain",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_InternalTransferOfProductRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internal Transfer of Product Rights",
        "label": "Internal Transfer of Product Rights [Member]",
        "terseLabel": "Internal Transfer of Product Rights"
       }
      }
     },
     "localname": "InternalTransferOfProductRightsMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_InventorypurchasepricefairvalueadjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory purchase price fair value adjustment [Member]",
        "label": "Inventory purchase price fair value adjustment [Member]",
        "terseLabel": "Inventory purchase price fair value adjustment [Member]"
       }
      }
     },
     "localname": "InventorypurchasepricefairvalueadjustmentMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_KeytrudaRoyaltiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Keytruda Royalties",
        "label": "Keytruda Royalties [Member]",
        "terseLabel": "Keytruda Royalties"
       }
      }
     },
     "localname": "KeytrudaRoyaltiesMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_LegalProceedingsAndContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Proceedings And Contingencies [Line Items]",
        "terseLabel": "Legal Proceedings And Contingencies [Line Items]"
       }
      }
     },
     "localname": "LegalProceedingsAndContingenciesLineItems",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_LicenseAndOtherArrangementsUpfrontPayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License and Other Arrangements Upfront Payments",
        "label": "License and Other Arrangements Upfront Payments",
        "terseLabel": "License and Other Arrangements Upfront Payments"
       }
      }
     },
     "localname": "LicenseAndOtherArrangementsUpfrontPayments",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_LicensingAndOtherArrangementsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing and Other Arrangements",
        "label": "Licensing and Other Arrangements [Axis]",
        "terseLabel": "Licensing and Other Arrangements [Axis]"
       }
      }
     },
     "localname": "LicensingAndOtherArrangementsAxis",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_LicensingAndOtherArrangementsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing and Other Arrangements",
        "label": "Licensing and Other Arrangements [Domain]",
        "terseLabel": "Licensing and Other Arrangements [Domain]"
       }
      }
     },
     "localname": "LicensingAndOtherArrangementsDomain",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_LicensingAndOtherArrangementsIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing and Other Arrangements Income",
        "label": "Licensing and Other Arrangements Income",
        "negatedTerseLabel": "Licensing and Other Arrangements Income"
       }
      }
     },
     "localname": "LicensingAndOtherArrangementsIncome",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_LicensingAndOtherArrangementsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing and Other Arrangements",
        "label": "Licensing and Other Arrangements [Table Text Block]",
        "terseLabel": "Licensing and Other Arrangements [Table Text Block]"
       }
      }
     },
     "localname": "LicensingAndOtherArrangementsTableTextBlock",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmy_LicensingArrangementsCashFlowsReclassificationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing Arrangements Cash Flows Reclassification",
        "label": "Licensing Arrangements Cash Flows Reclassification [Member]",
        "terseLabel": "Licensing Arrangements Cash Flows Reclassification"
       }
      }
     },
     "localname": "LicensingArrangementsCashFlowsReclassificationMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_LicensingArrangementsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing Arrangements",
        "label": "Licensing Arrangements [Line Items]",
        "terseLabel": "Licensing Arrangements [Line Items]"
       }
      }
     },
     "localname": "LicensingArrangementsLineItems",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_LicensingArrangementsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing Arrangements [Table]",
        "label": "Licensing Arrangements [Table]",
        "terseLabel": "Licensing Arrangements [Table]"
       }
      }
     },
     "localname": "LicensingArrangementsTable",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_LicensingCompaniesAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing Companies",
        "label": "Licensing Companies [Axis]",
        "terseLabel": "Licensing Companies [Axis]"
       }
      }
     },
     "localname": "LicensingCompaniesAxis",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_LicensingCompaniesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Licensing Companies",
        "label": "Licensing Companies [Domain]",
        "terseLabel": "Licensing Companies [Domain]"
       }
      }
     },
     "localname": "LicensingCompaniesDomain",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_LitigationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation [Table]",
        "terseLabel": "Litigation [Table]"
       }
      }
     },
     "localname": "LitigationTable",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "bmy_MarketShareUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Market share units [Member]",
        "terseLabel": "Market share units [Member]"
       }
      }
     },
     "localname": "MarketShareUnitsMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleOfShareBasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_MatureBrandsAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mature Brands and Other",
        "label": "Mature Brands and Other [Member]",
        "terseLabel": "Other divestitures [Member]"
       }
      }
     },
     "localname": "MatureBrandsAndOtherMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_MatureProductsAndAllOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mature Products And All Other [Member]",
        "terseLabel": "Mature Products And All Other [Member]"
       }
      }
     },
     "localname": "MatureProductsAndAllOtherMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_MedicaidandMedicarerebatesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicaid and Medicare rebates [Member]",
        "label": "Medicaid and Medicare rebates [Member]",
        "terseLabel": "Medicaid and Medicare rebates [Member]"
       }
      }
     },
     "localname": "MedicaidandMedicarerebatesMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONGrosstoNetAdjustmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_MyoKardiaAcquisitionPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MyoKardia Acquisition Plan",
        "label": "MyoKardia Acquisition Plan [Member]",
        "terseLabel": "MyoKardia Acquisition Plan"
       }
      }
     },
     "localname": "MyoKardiaAcquisitionPlanMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGNARRATIVEDetails",
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_NetproductsalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net product sales [Member]",
        "label": "Net product sales [Member]",
        "terseLabel": "Net product sales [Member]"
       }
      }
     },
     "localname": "NetproductsalesMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/REVENUERECOGNITIONGrosstoNetAdjustmentsDetails",
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyNatureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_NumberOfLargestPharmaceuticalWholesalers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of the largest pharmaceutical wholesalers used by the company in the territory.",
        "label": "Number Of Largest Pharmaceutical Wholesalers",
        "terseLabel": "Number Of Largest Pharmaceutical Wholesalers"
       }
      }
     },
     "localname": "NumberOfLargestPharmaceuticalWholesalers",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bmy_NumberofRevolvingCreditFacilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Revolving Credit Facilities: Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Number of Revolving Credit Facilities",
        "terseLabel": "Number of Revolving Credit Facilities"
       }
      }
     },
     "localname": "NumberofRevolvingCreditFacilities",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "bmy_OnglyzaProductLiabilityLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Onglyza Product Liability Litigation",
        "label": "Onglyza Product Liability Litigation [Member]",
        "terseLabel": "Onglyza Product Liability Litigation"
       }
      }
     },
     "localname": "OnglyzaProductLiabilityLitigationMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OnuregMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Onureg",
        "label": "Onureg [Member]",
        "terseLabel": "Onureg [Member]"
       }
      }
     },
     "localname": "OnuregMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OpdivoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "",
        "label": "Opdivo [Member]",
        "terseLabel": "Opdivo [Member]"
       }
      }
     },
     "localname": "OpdivoMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OrenciaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Orencia [Member]",
        "terseLabel": "Orencia [Member]"
       }
      }
     },
     "localname": "OrenciaMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OtezlaDivestitureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Otezla Divestiture",
        "label": "Otezla Divestiture [Member]",
        "terseLabel": "Otezla Divestiture"
       }
      }
     },
     "localname": "OtezlaDivestitureMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OtherCurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Current Assets [Abstract]",
        "label": "Other Current Assets [Abstract]",
        "terseLabel": "Other Current Assets [Abstract]"
       }
      }
     },
     "localname": "OtherCurrentAssetsAbstract",
     "nsuri": "http://www.bms.com/20210630",
     "xbrltype": "stringItemType"
    },
    "bmy_OtherIncomeReceivedFromAlliancePartners": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the amount of other income received during the period related to alliance partners and includes the amortization of milestone payments received and royalty income.",
        "label": "Other Income Received From Alliance Partners",
        "negatedTerseLabel": "Royalties and licensing income"
       }
      }
     },
     "localname": "OtherIncomeReceivedFromAlliancePartners",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_OtherNonCurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Non-Current Assets [Abstract]",
        "label": "Other Non-Current Assets [Abstract]",
        "terseLabel": "Other Non-Current Assets [Abstract]"
       }
      }
     },
     "localname": "OtherNonCurrentAssetsAbstract",
     "nsuri": "http://www.bms.com/20210630",
     "xbrltype": "stringItemType"
    },
    "bmy_OtherNonCurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Non-Current Liabilities [Abstract]",
        "label": "Other Non-Current Liabilities [Abstract]",
        "terseLabel": "Other Non-Current Liabilities [Abstract]"
       }
      }
     },
     "localname": "OtherNonCurrentLiabilitiesAbstract",
     "nsuri": "http://www.bms.com/20210630",
     "xbrltype": "stringItemType"
    },
    "bmy_OtherOtherIncomeExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails": {
       "order": 14.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other (income)/expense which does not qualify for separate disclosure under materiality guidelines.",
        "label": "Other Other Income Expense",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "OtherOtherIncomeExpense",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_OtherRegionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Region [Member]",
        "terseLabel": "Other Region [Member]"
       }
      }
     },
     "localname": "OtherRegionMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OtherRoyaltiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Royalties",
        "label": "Other Royalties [Member]",
        "terseLabel": "Other Royalties"
       }
      }
     },
     "localname": "OtherRoyaltiesMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OtherShutdownCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other shutdown costs",
        "label": "Other shutdown costs",
        "terseLabel": "Other shutdown costs"
       }
      }
     },
     "localname": "OtherShutdownCosts",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_OtherrebatesreturnsdiscountsandadjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other rebates, returns, discounts and adjustments [Member]",
        "label": "Other rebates, returns, discounts and adjustments [Member]",
        "terseLabel": "Other rebates, returns, discounts and adjustments [Member]"
       }
      }
     },
     "localname": "OtherrebatesreturnsdiscountsandadjustmentsMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONGrosstoNetAdjustmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_OtherrevenuesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other revenues [Member]",
        "label": "Other revenues [Member]",
        "terseLabel": "Other revenues [Member]"
       }
      }
     },
     "localname": "OtherrevenuesMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyNatureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_Pensionsettlementsandamortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of expense recognized due to defined benefit pension settlements and curtailments and the amortization of prior service credits and net actuarial loss.",
        "label": "Pension settlements and amortization",
        "terseLabel": "Pension settlements and amortization"
       }
      }
     },
     "localname": "Pensionsettlementsandamortization",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_PercentageOfAggregateTotalTradeReceivablesDue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of aggregate trade receivables due from customers accounting for more than 10% of total trade receivables.",
        "label": "Percentage Of Aggregate Total Trade Receivables Due",
        "terseLabel": "Percent of aggregate total trade receivables due from three pharmaceutical wholesalers"
       }
      }
     },
     "localname": "PercentageOfAggregateTotalTradeReceivablesDue",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "bmy_PlavixAustraliaIntellectualPropertyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plavix Australia Intellectual Property [Member]",
        "label": "Plavix Australia Intellectual Property [Member]",
        "terseLabel": "Plavix Australia Intellectual Property [Member]"
       }
      }
     },
     "localname": "PlavixAustraliaIntellectualPropertyMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_PomalystImnovidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pomalyst/Imnovid [Member]",
        "label": "Pomalyst/Imnovid [Member]",
        "terseLabel": "Pomalyst/Imnovid [Member]"
       }
      }
     },
     "localname": "PomalystImnovidMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ProbabilityofpaymentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Probability of payment [Member]",
        "label": "Probability of payment [Member]",
        "terseLabel": "Probability of payment [Member]"
       }
      }
     },
     "localname": "ProbabilityofpaymentMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ProjectedYearOfPaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Projected Year of Payments",
        "label": "Projected Year of Payments [Member]",
        "terseLabel": "Projected Year of Payments"
       }
      }
     },
     "localname": "ProjectedYearOfPaymentsMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ReblozylMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reblozyl [Member]",
        "label": "Reblozyl [Member]",
        "terseLabel": "Reblozyl [Member]"
       }
      }
     },
     "localname": "ReblozylMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails",
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ReceivablesSoldOnNonrecourseBasis": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of receivables sold on a nonrecourse basis during the year.",
        "label": "Receivables Sold On Nonrecourse Basis",
        "terseLabel": "Non-U.S. receivables sold on a nonrecourse basis"
       }
      }
     },
     "localname": "ReceivablesSoldOnNonrecourseBasis",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation of Gross Product Sales to Net Product Sales [Table Text Block]",
        "label": "Reconciliation of Gross Product Sales to Net Product Sales [Table Text Block]",
        "terseLabel": "Revenue Recognition Gross-To-Net Adjustments [Table Text Block]"
       }
      }
     },
     "localname": "ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmy_ResearchandDevelopment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and Development",
        "label": "Research and Development",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchandDevelopment",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_ResearchandDevelopmentExpenseCollaborativeArrangement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and Development Expense - Collaborative Arrangement. The balance can be debit/credit based on the nature of the arrangement.",
        "label": "Research and Development Expense - Collaborative Arrangement",
        "terseLabel": "Research and Development Expense"
       }
      }
     },
     "localname": "ResearchandDevelopmentExpenseCollaborativeArrangement",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_RestOfWorldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rest Of World [Member]",
        "terseLabel": "Rest Of World [Member]"
       }
      }
     },
     "localname": "RestOfWorldMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_RestructuringChargesExcludingAcceleratedStockbasedCompensation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Charges Excluding Accelerated Stock-based Compensation",
        "label": "Restructuring Charges Excluding Accelerated Stock-based Compensation",
        "terseLabel": "Restructuring Charges Exclude Accelerated Stock-Based Compensation"
       }
      }
     },
     "localname": "RestructuringChargesExcludingAcceleratedStockbasedCompensation",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_RestructuringRelatedCostsAssetImpairments": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restructuring Related Costs, Asset Impairments",
        "label": "Restructuring Related Costs, Asset Impairments",
        "terseLabel": "Asset impairment"
       }
      }
     },
     "localname": "RestructuringRelatedCostsAssetImpairments",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_RevenuebyProductbyRegionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue by Product by Region [Abstract]",
        "label": "Revenue by Product by Region [Abstract]",
        "terseLabel": "Revenue by Product by Region [Abstract]"
       }
      }
     },
     "localname": "RevenuebyProductbyRegionAbstract",
     "nsuri": "http://www.bms.com/20210630",
     "xbrltype": "stringItemType"
    },
    "bmy_Reversionexcisetax": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Section 4980 Tax On Reversion Of Qualified Plan Assets To Employer",
        "label": "Reversion excise tax",
        "terseLabel": "Reversion excise tax"
       }
      }
     },
     "localname": "Reversionexcisetax",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_RevlimidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revlimid [Member]",
        "label": "Revlimid [Member]",
        "terseLabel": "Revlimid [Member]"
       }
      }
     },
     "localname": "RevlimidMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_SalesRevenueGrossMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Revenue, Gross [Member]",
        "label": "Sales Revenue, Gross [Member]",
        "terseLabel": "Sales Revenue, Gross [Member]"
       }
      }
     },
     "localname": "SalesRevenueGrossMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONGrosstoNetAdjustmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ScheduleOfEquityInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Equity Investments",
        "label": "Schedule of Equity Investments [Table Text Block]",
        "terseLabel": "Schedule of Equity Investments [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfEquityInvestmentsTableTextBlock",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmy_ScheduleOfOtherIncomeExpenseTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Other Income Expense [Text Block]",
        "terseLabel": "Schedule Of Other Income Expense [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfOtherIncomeExpenseTextBlock",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmy_ScheduleOfProvisionForIncomeTaxesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "-- None. No documentation exists for this element. --",
        "label": "Schedule of Provision for Income Taxes [Table Text Block]",
        "terseLabel": "Schedule of Provision for Income Taxes [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfProvisionForIncomeTaxesTableTextBlock",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmy_ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the total intrinsic value of options exercised (or share units converted), total fair value of shares vested during the year and the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.",
        "label": "Schedule Of Share Based Compensation Additional Information [Table Text Block]",
        "terseLabel": "Schedule Of Share Based Compensation Additional Information [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "bmy_SellingGeneralandAdministrativeExpenseCollaborativeArrangement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Selling, General and Administrative Expense - Collaborative Arrangement. The balance can be debit/credit based on the nature of the arrangement.",
        "label": "Selling, General and Administrative Expense - Collaborative Arrangement",
        "terseLabel": "Selling, General and Administrative Expense"
       }
      }
     },
     "localname": "SellingGeneralandAdministrativeExpenseCollaborativeArrangement",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_SharebasedPaymentArrangementCostbyPlanAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Payment Arrangement, Cost by Plan [Abstract]",
        "label": "Share-based Payment Arrangement, Cost by Plan [Abstract]",
        "terseLabel": "Share-based Payment Arrangement, Cost by Plan [Abstract]"
       }
      }
     },
     "localname": "SharebasedPaymentArrangementCostbyPlanAbstract",
     "nsuri": "http://www.bms.com/20210630",
     "xbrltype": "stringItemType"
    },
    "bmy_SprycelMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sprycel [Member]",
        "terseLabel": "Sprycel [Member]"
       }
      }
     },
     "localname": "SprycelMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_SupplementalFinancialInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplemental Financial Information [Abstract]",
        "label": "Supplemental Financial Information [Abstract]",
        "terseLabel": "Supplemental Financial Information [Abstract]"
       }
      }
     },
     "localname": "SupplementalFinancialInformationAbstract",
     "nsuri": "http://www.bms.com/20210630",
     "xbrltype": "stringItemType"
    },
    "bmy_TecentriqRoyaltiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tecentriq royalties",
        "label": "Tecentriq royalties [Member]",
        "terseLabel": "Tecentriq royalties"
       }
      }
     },
     "localname": "TecentriqRoyaltiesMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_Totalinventories": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/INVENTORIESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This represents the total inventory, current and non-current, as of the balance sheet date.",
        "label": "Total inventories",
        "totalLabel": "Total inventories"
       }
      }
     },
     "localname": "Totalinventories",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_UnamortizedBasisAdjustmentFromSwapTerminations": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the adjustment to principal value of long term debt related to the unamortized basis adjustment from swap terminations.",
        "label": "Unamortized Basis Adjustment From Swap Terminations",
        "terseLabel": "Adjustments to Principal Value, Unamortized basis adjustment from swap terminations"
       }
      }
     },
     "localname": "UnamortizedBasisAdjustmentFromSwapTerminations",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_UpFrontLicensingFee": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Up-front Licensing Fee",
        "label": "Up-front Licensing Fee",
        "negatedTerseLabel": "Up-front Licensing Fee"
       }
      }
     },
     "localname": "UpFrontLicensingFee",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_UpfrontPaymentsMadeToCollaborativePartner": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront payments made to partner as part of collaborative arrangement.",
        "label": "Upfront Payments Made To Collaborative Partner",
        "terseLabel": "Upfront Payments Made To Collaborative Partner"
       }
      }
     },
     "localname": "UpfrontPaymentsMadeToCollaborativePartner",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "bmy_UpfrontmilestoneandotherlicensingreceiptsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront, milestone and other licensing receipts [Member]",
        "label": "Upfront, milestone and other licensing receipts [Member]",
        "terseLabel": "Upfront, milestone and other licensing receipts [Member]"
       }
      }
     },
     "localname": "UpfrontmilestoneandotherlicensingreceiptsMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_VidazaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vidaza [Member]",
        "label": "Vidaza [Member]",
        "terseLabel": "Vidaza [Member]"
       }
      }
     },
     "localname": "VidazaMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_YervoyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Yervoy [Member]",
        "terseLabel": "Yervoy [Member]"
       }
      }
     },
     "localname": "YervoyMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ZeposiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zeposia",
        "label": "Zeposia [Member]",
        "terseLabel": "Zeposia [Member]"
       }
      }
     },
     "localname": "ZeposiaMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails",
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "bmy_ZeroCostCollarCurrencyContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zero Cost Collar Currency Contracts [Member]",
        "label": "Zero Cost Collar Currency Contracts [Member]",
        "terseLabel": "Zero Cost Collar Currency Contracts"
       }
      }
     },
     "localname": "ZeroCostCollarCurrencyContractsMember",
     "nsuri": "http://www.bms.com/20210630",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "UNITED STATES"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AUD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Australia, Dollars",
        "terseLabel": "Australia, Dollars"
       }
      }
     },
     "localname": "AUD",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Currencies [Domain]",
        "terseLabel": "Currency [Domain]",
        "verboseLabel": "All Currencies [Domain]"
       }
      }
     },
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails",
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro",
        "terseLabel": "Euro Member Countries, Euro"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_JPY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Japan, Yen",
        "terseLabel": "Japan, Yen"
       }
      }
     },
     "localname": "JPY",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_USD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States of America, Dollars",
        "terseLabel": "United States of America, Dollars"
       }
      }
     },
     "localname": "USD",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r693"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r86",
      "r88",
      "r159",
      "r160",
      "r343",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]",
        "terseLabel": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails",
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r342",
      "r367",
      "r425",
      "r427",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r602",
      "r650",
      "r653",
      "r678",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails",
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails",
      "http://www.bms.com/role/INCOMETAXESDetails",
      "http://www.bms.com/role/RESTRUCTURINGNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r342",
      "r367",
      "r425",
      "r427",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r602",
      "r650",
      "r653",
      "r678",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails",
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails",
      "http://www.bms.com/role/INCOMETAXESDetails",
      "http://www.bms.com/role/RESTRUCTURINGNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r236",
      "r399",
      "r401",
      "r604",
      "r649",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails",
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r236",
      "r399",
      "r401",
      "r604",
      "r649",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails",
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r342",
      "r367",
      "r413",
      "r425",
      "r427",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r602",
      "r650",
      "r653",
      "r678",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails",
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails",
      "http://www.bms.com/role/INCOMETAXESDetails",
      "http://www.bms.com/role/RESTRUCTURINGNARRATIVEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r342",
      "r367",
      "r413",
      "r425",
      "r427",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r602",
      "r650",
      "r653",
      "r678",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails",
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails",
      "http://www.bms.com/role/INCOMETAXESDetails",
      "http://www.bms.com/role/RESTRUCTURINGNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r87",
      "r88",
      "r159",
      "r160",
      "r343",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r237",
      "r238",
      "r399",
      "r402",
      "r652",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r237",
      "r238",
      "r399",
      "r402",
      "r652",
      "r663",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r578",
      "r580",
      "r583",
      "r678",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average [Member]",
        "terseLabel": "Weighted Average [Member]"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Account Receivables [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r66",
      "r571"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "verboseLabel": "Accounts payable - to alliance partners"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableGrossCurrent": {
     "auth_ref": [
      "r240",
      "r241"
     ],
     "calculation": {
      "http://www.bms.com/role/RECEIVABLESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, before Allowance for Credit Loss, Current",
        "terseLabel": "Trade receivables"
       }
      }
     },
     "localname": "AccountsReceivableGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, after Allowance for Credit Loss [Abstract]",
        "terseLabel": "Accounts Receivable, after Allowance for Credit Loss [Abstract]"
       }
      }
     },
     "localname": "AccountsReceivableNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r17",
      "r43",
      "r240",
      "r241"
     ],
     "calculation": {
      "http://www.bms.com/role/RECEIVABLESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ReceivablesNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "totalLabel": "Net trade receivables"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r37",
      "r613",
      "r631"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r39",
      "r613",
      "r631"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedRoyaltiesCurrent": {
     "auth_ref": [
      "r28",
      "r29",
      "r72"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Royalties, Current",
        "terseLabel": "Royalties"
       }
      }
     },
     "localname": "AccruedRoyaltiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r62",
      "r297"
     ],
     "calculation": {
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "AOCI, Debt Securities, Available-for-sale, Adjustment, after Tax",
        "terseLabel": "Available-for-sale securities"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax": {
     "auth_ref": [
      "r92",
      "r98",
      "r100"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change, net of tax, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax",
        "terseLabel": "Derivatives qualifying as cash flow hedges"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r96",
      "r101",
      "r422"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedLabel": "Pension and postretirement benefits"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r90",
      "r98",
      "r100",
      "r101",
      "r542"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.",
        "label": "Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r46",
      "r98",
      "r100",
      "r101",
      "r635",
      "r658",
      "r659"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      },
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Accumulated Other Comprehensive Loss, Balance at End of Period",
        "periodStartLabel": "Accumulated Other Comprehensive Loss, Balance at Beginning of Period",
        "terseLabel": "Accumulated other comprehensive loss",
        "totalLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/EQUITYChangesinEquityDetails",
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r97",
      "r101",
      "r110",
      "r111",
      "r112",
      "r163",
      "r164",
      "r165",
      "r497",
      "r654",
      "r655",
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.",
        "label": "Additional Financial Information Disclosure [Text Block]",
        "terseLabel": "Additional Financial Information Disclosure [Text Block]"
       }
      }
     },
     "localname": "AdditionalFinancialInformationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r44",
      "r443",
      "r571"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "periodEndLabel": "Capital in Excess of Par Value of Stock, Balance at End of Period",
        "periodStartLabel": "Capital in Excess of Par Value of Stock, Balance at Beginning of Period",
        "terseLabel": "Capital in excess of par value of stock"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r163",
      "r164",
      "r165",
      "r440",
      "r441",
      "r442",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Capital in Excess of Par Value of Stock [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r429",
      "r437",
      "r444"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Share-based Payment Arrangement, Expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r50",
      "r242",
      "r262"
     ],
     "calculation": {
      "http://www.bms.com/role/RECEIVABLESDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "negatedLabel": "Less allowances for expected credit loss"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r146",
      "r281",
      "r288"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "verboseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyNatureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r155",
      "r218",
      "r228",
      "r234",
      "r260",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r491",
      "r498",
      "r547",
      "r569",
      "r571",
      "r611",
      "r630"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r21",
      "r23",
      "r83",
      "r155",
      "r260",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r491",
      "r498",
      "r547",
      "r569",
      "r571"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets [Member]",
        "terseLabel": "Assets [Member]"
       }
      }
     },
     "localname": "AssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r249"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r250"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r247",
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "terseLabel": "Debt Securities, Available-for-sale, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r245",
      "r248",
      "r268",
      "r617"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Debt Securities, Available-for-sale"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Available-for-sale Securities [Table Text Block]",
        "terseLabel": "Available-for-sale Securities [Table Text Block]"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r431",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleOfShareBasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails",
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r507",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r26",
      "r296"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Buildings"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r424",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails",
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r424",
      "r426",
      "r471",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails",
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r145",
      "r481"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration fair value adjustments",
        "verboseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r478",
      "r479",
      "r480"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent value rights",
        "verboseLabel": "Contingent consideration fair value"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Business Combination, Contingent Consideration, Liability, Measurement Input [Extensible List]"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      },
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Combination, Integration Related Costs",
        "terseLabel": "Integration expenses"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails",
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r473",
      "r474"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r15",
      "r59",
      "r148"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash and Cash Equivalents, Fair Value Disclosure"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r142",
      "r148",
      "r150"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, Cash Equivalents and Restricted Cash at End of Period",
        "periodStartLabel": "Cash, Cash Equivalents and Restricted Cash at Beginning of Period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r142",
      "r551"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CertificatesOfDepositMember": {
     "auth_ref": [
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.",
        "label": "Certificates of Deposit [Member]",
        "terseLabel": "Certificates of Deposit [Member]"
       }
      }
     },
     "localname": "CertificatesOfDepositMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r152",
      "r155",
      "r179",
      "r183",
      "r184",
      "r186",
      "r188",
      "r196",
      "r197",
      "r198",
      "r260",
      "r328",
      "r332",
      "r333",
      "r334",
      "r337",
      "r338",
      "r365",
      "r366",
      "r370",
      "r374",
      "r547",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementAccountingPolicy": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for collaborative arrangements.",
        "label": "Collaborative Arrangement, Accounting Policy [Policy Text Block]",
        "terseLabel": "Collaborative Arrangement, Accounting Policy [Policy Text Block]"
       }
      }
     },
     "localname": "CollaborativeArrangementAccountingPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r483",
      "r484",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Collaborative Arrangement Disclosure [Text Block]"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementMember": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity.",
        "label": "Collaborative Arrangement [Member]",
        "terseLabel": "Collaborative Arrangement [Member]"
       }
      }
     },
     "localname": "CollaborativeArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyNatureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "terseLabel": "Alliance Statement [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Common Stock, Dividends, Per Share, Declared"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r163",
      "r164",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r42",
      "r571"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "periodEndLabel": "Common Stock, Value, Issued, Balance at End of Period",
        "periodStartLabel": "Common Stock, Value, Issued, Balance at Beginning of Period",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r106",
      "r108",
      "r109",
      "r119",
      "r621",
      "r645"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive Income/(Loss) Attributable to BMS"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r106",
      "r108",
      "r118",
      "r490",
      "r502",
      "r620",
      "r644"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive Income/(Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerSoftwareIntangibleAssetMember": {
     "auth_ref": [
      "r282",
      "r286",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.",
        "label": "Computer Software, Intangible Asset [Member]",
        "terseLabel": "Capitalized software [Member]"
       }
      }
     },
     "localname": "ComputerSoftwareIntangibleAssetMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r205",
      "r206",
      "r239",
      "r544",
      "r545",
      "r661",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r203",
      "r205",
      "r206",
      "r207",
      "r544",
      "r546",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r205",
      "r206",
      "r239",
      "r544",
      "r545",
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r151",
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Consolidation, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r296"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type [Domain]"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod": {
     "auth_ref": [
      "r396"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.",
        "label": "Contract with Customer, Performance Obligation Satisfied in Previous Period",
        "terseLabel": "Contract with Customer, Performance Obligation Satisfied in Previous Period"
       }
      }
     },
     "localname": "ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONNarrativesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r414",
      "r423",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate Debt Securities [Member]"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r122",
      "r604"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of products sold [Member]",
        "verboseLabel": "Cost of products sold [Member]"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails",
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total Expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CrossCurrencyInterestRateContractMember": {
     "auth_ref": [
      "r414",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.",
        "label": "Cross Currency Interest Rate Contract [Member]",
        "terseLabel": "Cross Currency Interest Rate Contract [Member]"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r204",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk [Member]"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.",
        "label": "Debt, Current",
        "verboseLabel": "Short-term debt obligations"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r36",
      "r37",
      "r38",
      "r154",
      "r161",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r358",
      "r359",
      "r360",
      "r361",
      "r565",
      "r612",
      "r614",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r339",
      "r358",
      "r359",
      "r563",
      "r565",
      "r566"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Debt Instrument, Face Amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r348",
      "r358",
      "r359",
      "r543"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Long-term debt, fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMeasurementInput": {
     "auth_ref": [
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt.",
        "label": "Debt Instrument, Measurement Input",
        "terseLabel": "Debt Instrument, Measurement Input"
       }
      }
     },
     "localname": "DebtInstrumentMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r74",
      "r154",
      "r161",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r358",
      "r359",
      "r360",
      "r361",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r74",
      "r154",
      "r161",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r358",
      "r359",
      "r360",
      "r361",
      "r382",
      "r383",
      "r384",
      "r385",
      "r562",
      "r563",
      "r565",
      "r566",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r346",
      "r562",
      "r566"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedTerseLabel": "Debt Instrument, Unamortized Discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedPremium": {
     "auth_ref": [
      "r346",
      "r562",
      "r566"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt premium.",
        "label": "Debt Instrument, Unamortized Premium",
        "terseLabel": "Debt Instrument, Unamortized Premium"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r453"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Decrease in Unrecognized Tax Benefits is Reasonably Possible"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "terseLabel": "Deferred compensation"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncome": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Deferred Income",
        "terseLabel": "Deferred income from alliance"
       }
      }
     },
     "localname": "DeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeNoncurrent": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Deferred Income, Noncurrent",
        "terseLabel": "Deferred Income"
       }
      }
     },
     "localname": "DeferredIncomeNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r448",
      "r449"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r146",
      "r156",
      "r456",
      "r461",
      "r462",
      "r463"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://www.bms.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r448",
      "r449"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "auth_ref": [
      "r34",
      "r410",
      "r411",
      "r412",
      "r423",
      "r610",
      "r629"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "terseLabel": "Pension and postretirement"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r146",
      "r295"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r146",
      "r216"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization, net"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r84",
      "r85",
      "r88",
      "r543"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Derivative asset",
        "verboseLabel": "Derivative asset"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeBasisSpreadOnVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.",
        "label": "Derivative, Basis Spread on Variable Rate",
        "terseLabel": "Derivative, Basis Spread on Variable Rate"
       }
      }
     },
     "localname": "DerivativeBasisSpreadOnVariableRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract Type [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r509"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Derivative, Gain (Loss) on Derivative, Net"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentDetailAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instrument Detail [Abstract]",
        "terseLabel": "Derivative Instrument Detail [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentDetailAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r88",
      "r508",
      "r511",
      "r516",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]",
        "verboseLabel": "Derivatives Fair Value By Derivative Instrument Risk [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r84",
      "r85",
      "r88",
      "r543"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "negatedTerseLabel": "Derivative Liability",
        "terseLabel": "Derivative Liability"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r504",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeVariableInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.",
        "label": "Derivative, Variable Interest Rate",
        "terseLabel": "Derivative, Variable Interest Rate"
       }
      }
     },
     "localname": "DerivativeVariableInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument [Member]"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disaggregation of Revenue [Abstract]",
        "terseLabel": "Disaggregation of Revenue [Abstract]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyNatureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r399",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyNatureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue [Table Text Block]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Share-based Payment Arrangement [Text Block]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "auth_ref": [
      "r146",
      "r294",
      "r299"
     ],
     "calculation": {
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "negatedTerseLabel": "Divestiture losses/(gains)"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESDetails",
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r424",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESDetails",
      "http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Cash dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrent": {
     "auth_ref": [
      "r29",
      "r72"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Dividends Payable, Current",
        "terseLabel": "Dividends"
       }
      }
     },
     "localname": "DividendsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r120",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r177",
      "r179",
      "r186",
      "r187",
      "r188",
      "r192",
      "r193",
      "r527",
      "r528",
      "r622",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Earnings/(Loss) Per Share, Basic"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r120",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r179",
      "r186",
      "r187",
      "r188",
      "r192",
      "r193",
      "r527",
      "r528",
      "r622",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Earnings/(Loss) Per Share, Diluted"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r189",
      "r190",
      "r191",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings/(Loss) Per Share [Text Block]"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EARNINGSLOSSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r551"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective Tax Rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r72"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Employee compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r438"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r437"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expense, Tax Benefit",
        "terseLabel": "Share-based Payment Arrangement, Expense, Tax Benefit"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Share-based Payment Arrangement, Option [Member]"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue from External Customer [Line Items]",
        "terseLabel": "Revenue from External Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r110",
      "r111",
      "r112",
      "r163",
      "r164",
      "r165",
      "r167",
      "r173",
      "r175",
      "r195",
      "r261",
      "r381",
      "r386",
      "r440",
      "r441",
      "r442",
      "r457",
      "r458",
      "r526",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r560",
      "r654",
      "r655",
      "r656",
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r60",
      "r219",
      "r258"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r540"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Equity Securities, FV-NI"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiRealizedGainLoss": {
     "auth_ref": [
      "r257",
      "r647"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Realized Gain (Loss)",
        "terseLabel": "Equity Securities, FV-NI, Realized Gain (Loss)"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "auth_ref": [
      "r257",
      "r647"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "terseLabel": "Equity Securities, FV-NI, Unrealized Gain (Loss)"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Equity Securities without Readily Determinable Fair Value, Amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount": {
     "auth_ref": [
      "r255"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from downward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount",
        "negatedTerseLabel": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount": {
     "auth_ref": [
      "r255"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative impairment loss on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount",
        "negatedTerseLabel": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount": {
     "auth_ref": [
      "r256"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain from upward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount",
        "terseLabel": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount": {
     "auth_ref": [
      "r256"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount",
        "terseLabel": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Extinguishment of Debt, Amount"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAxis": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information pertaining to the debt extinguished including the amount of gain (loss), the income tax effect on the gain (loss), and the amount of gain (loss), net or the related income tax, by debt instrument.",
        "label": "Extinguishment of Debt [Axis]",
        "terseLabel": "Extinguishment of Debt [Axis]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ExtinguishmentOfDebtTypeDomain": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of debt extinguished.",
        "label": "Extinguishment of Debt, Type [Domain]",
        "terseLabel": "Extinguishment of Debt, Type [Domain]"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r529",
      "r530",
      "r531",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique used to measure similar asset in prior period by class of asset or liability on non-recurring basis.",
        "label": "Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Valuation Techniques [Table Text Block]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Valuation Techniques [Table Text Block]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r348",
      "r358",
      "r359",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r423",
      "r530",
      "r575",
      "r576",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r348",
      "r358",
      "r359",
      "r529",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r348",
      "r358",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r348",
      "r414",
      "r415",
      "r420",
      "r423",
      "r530",
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r348",
      "r358",
      "r359",
      "r414",
      "r415",
      "r420",
      "r423",
      "r530",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r348",
      "r358",
      "r359",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r423",
      "r530",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r534",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "terseLabel": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": {
     "auth_ref": [
      "r535"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings",
        "terseLabel": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": {
     "auth_ref": [
      "r534"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value",
        "terseLabel": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r535"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r536"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "terseLabel": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r534"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "terseLabel": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r348",
      "r358",
      "r359",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r423",
      "r575",
      "r576",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r507",
      "r513",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives Balance Sheet Location By Derivative Contract Type By Hedging Designation [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r251",
      "r252",
      "r254",
      "r255",
      "r256",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r269",
      "r270",
      "r271",
      "r272",
      "r356",
      "r379",
      "r525",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Finite-Lived Intangible Asset, Useful Life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r287"
     ],
     "calculation": {
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Less: accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r282",
      "r284",
      "r287",
      "r290",
      "r605",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r282",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r287",
      "r605"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Finite-Lived Intangible Assets, Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsPeriodIncreaseDecrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in carrying value of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Period Increase (Decrease)",
        "terseLabel": "Finite-Lived Intangible Assets, Period Increase (Decrease)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Foreign Exchange Forward [Member]"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments": {
     "auth_ref": [
      "r146"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the net total realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including the unrealized holding gain (loss) of held-to-maturity securities transferred to the trading security category and the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders' equity) for available-for-sale securities transferred to trading securities during the period. Additionally, this item would include any gains (losses) realized during the period from the sale of investments accounted for under the cost method of accounting.",
        "label": "Gain (Loss) on Investments, Excluding Other than Temporary Impairments",
        "negatedTerseLabel": "Equity investment (gains)/losses"
       }
      }
     },
     "localname": "GainLossOnInvestmentsExcludingOtherThanTemporaryImpairments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r321"
     ],
     "calculation": {
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "negatedTerseLabel": "Litigation and other settlements"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r146",
      "r362",
      "r363"
     ],
     "calculation": {
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Gain (Loss) on Extinguishment of Debt",
        "terseLabel": "Gain (Loss) on Extinguishment of Debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails",
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r277",
      "r278",
      "r571",
      "r609"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Text Block]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r506",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r146",
      "r291"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Impairment of Intangible Assets (Excluding Goodwill)"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "auth_ref": [
      "r146",
      "r291"
     ],
     "calculation": {
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.",
        "label": "Impairment of Intangible Assets, Finite-lived",
        "terseLabel": "Intangible asset impairment"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r146",
      "r293"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "terseLabel": "Impairment charges"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In Process Research and Development [Member]"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r218",
      "r227",
      "r230",
      "r233",
      "r235"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "Earnings Before Income Taxes",
        "totalLabel": "Earnings Before Income Taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r424",
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESDetails",
      "http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r301",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r300",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails",
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails",
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r157",
      "r452",
      "r454",
      "r455",
      "r459",
      "r464",
      "r468",
      "r469",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Tax Disclosure [Text Block]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r158",
      "r174",
      "r175",
      "r217",
      "r450",
      "r460",
      "r466",
      "r648"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r145"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r145"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r145"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]",
        "terseLabel": "Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r145"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r145"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedTerseLabel": "Receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r180",
      "r181",
      "r182",
      "r188"
     ],
     "calculation": {
      "http://www.bms.com/role/EARNINGSLOSSPERSHAREDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Incremental shares attributable to share-based compensation plans"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r283",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r289"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r283",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Gross other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r280",
      "r285"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other intangible assets",
        "totalLabel": "Other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r114",
      "r215",
      "r561",
      "r564",
      "r623"
     ],
     "calculation": {
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r139",
      "r143",
      "r149"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest payments"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap [Member]",
        "verboseLabel": "Interest Rate Swap [Member]"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories [Text Block]"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/INVENTORIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r52",
      "r273"
     ],
     "calculation": {
      "http://www.bms.com/role/INVENTORIESDetails": {
       "order": 1.0,
       "parentTag": "bmy_Totalinventories",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r16",
      "r80",
      "r571"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Net [Abstract]",
        "terseLabel": "Inventory, Net [Abstract]"
       }
      }
     },
     "localname": "InventoryNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryNoncurrent": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle.",
        "label": "Inventory, Noncurrent",
        "terseLabel": "Inventories - other assets",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": {
     "auth_ref": [
      "r54",
      "r55",
      "r273"
     ],
     "calculation": {
      "http://www.bms.com/role/INVENTORIESDetails": {
       "order": 3.0,
       "parentTag": "bmy_Totalinventories",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.",
        "label": "Inventory, Raw Materials and Supplies, Net of Reserves",
        "terseLabel": "Raw and packaging materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r53",
      "r273"
     ],
     "calculation": {
      "http://www.bms.com/role/INVENTORIESDetails": {
       "order": 2.0,
       "parentTag": "bmy_Totalinventories",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r125",
      "r214"
     ],
     "calculation": {
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "negatedTerseLabel": "Investment income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r25",
      "r61"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.",
        "label": "Legal Matters and Contingencies [Text Block]",
        "terseLabel": "Legal Proceedings and Contingencies [Text Block]"
       }
      }
     },
     "localname": "LegalMattersAndContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r70",
      "r155",
      "r229",
      "r260",
      "r328",
      "r329",
      "r330",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r492",
      "r498",
      "r499",
      "r547",
      "r569",
      "r570"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r49",
      "r155",
      "r260",
      "r547",
      "r571",
      "r616",
      "r638"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r73",
      "r155",
      "r260",
      "r328",
      "r329",
      "r330",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r492",
      "r498",
      "r499",
      "r547",
      "r569",
      "r570",
      "r571"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liability [Member]",
        "terseLabel": "Liability [Member]"
       }
      }
     },
     "localname": "LiabilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Licenses [Member]"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r67"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.",
        "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]",
        "terseLabel": "Receivables [Text Block]"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR) [Member]"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r38",
      "r347",
      "r357",
      "r358",
      "r359",
      "r614",
      "r633"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Total Debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ShortTermBorrowings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "auth_ref": [
      "r323",
      "r324",
      "r326"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.",
        "label": "Loss Contingency, Estimate of Possible Loss",
        "verboseLabel": "Loss contingency, Estimate of possible loss"
       }
      }
     },
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNumberOfPlaintiffs": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Number of Plaintiffs",
        "terseLabel": "Loss Contingency, Number of Plaintiffs"
       }
      }
     },
     "localname": "LossContingencyNumberOfPlaintiffs",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyPatentsAllegedlyInfringedNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of another entity's patents that the entity has allegedly infringed.",
        "label": "Loss Contingency, Patents Allegedly Infringed, Number",
        "terseLabel": "Loss Contingency, Patents Allegedly Infringed, Number"
       }
      }
     },
     "localname": "LossContingencyPatentsAllegedlyInfringedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Loss Contingency, Pending Claims, Number"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "auth_ref": [
      "r26",
      "r296"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment, Gross",
        "terseLabel": "Machinery and equipment and fixtures"
       }
      }
     },
     "localname": "MachineryAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ManufacturingFacilityMember": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure used in the manufacturing of goods.",
        "label": "Manufacturing Facility [Member]",
        "terseLabel": "Manufacturing Facility [Member]"
       }
      }
     },
     "localname": "ManufacturingFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r18",
      "r71"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Marketable debt securities"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as noncurrent.",
        "label": "Marketable Securities, Noncurrent",
        "terseLabel": "Marketable debt securities"
       }
      }
     },
     "localname": "MarketableSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Measurement Input, Discount Rate [Member]"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r14",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "Divestitures, Licensing and Other Arrangements [Text Block]"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r79",
      "r155",
      "r260",
      "r328",
      "r332",
      "r333",
      "r334",
      "r337",
      "r338",
      "r547",
      "r615",
      "r637"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "periodEndLabel": "Noncontrolling interest",
        "periodStartLabel": "Noncontrolling interest",
        "terseLabel": "Noncontrolling Interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedTerseLabel": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NameOfReportingCategoryDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of reporting category or type of financial instrument.",
        "label": "Name of Reporting Category [Domain]",
        "terseLabel": "Name of Reporting Category [Domain]"
       }
      }
     },
     "localname": "NameOfReportingCategoryDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/REVENUERECOGNITIONGrosstoNetAdjustmentsDetails",
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyNatureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net Cash (Used in)/Provided by Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash Flows From Financing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r142"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net Cash Provided by Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash Flows From Investing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r142",
      "r144",
      "r147"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net Cash Provided by Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash Flows From Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r13",
      "r104",
      "r107",
      "r112",
      "r116",
      "r147",
      "r155",
      "r166",
      "r168",
      "r169",
      "r170",
      "r171",
      "r174",
      "r175",
      "r185",
      "r218",
      "r227",
      "r230",
      "r233",
      "r235",
      "r260",
      "r328",
      "r329",
      "r330",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r528",
      "r547",
      "r618",
      "r642"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net Earnings/(Loss) Attributable to BMS",
        "totalLabel": "Net Earnings/(Loss) Attributable to BMS",
        "verboseLabel": "Net Earnings/(Loss) Attributable to BMS Used for Basic and Diluted EPS Calculation"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/EARNINGSLOSSPERSHAREDetails",
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r104",
      "r107",
      "r112",
      "r174",
      "r175",
      "r495",
      "r501"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      },
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Noncontrolling Interest",
        "terseLabel": "Noncontrolling Interest",
        "verboseLabel": "Comprehensive Income Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r163",
      "r164",
      "r165",
      "r386",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interest [Member]"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument [Member]"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r568"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r568"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r567"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r162",
      "r176",
      "r211",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "terseLabel": "Basis of Presentation and Recently Issued Accounting Standards [Text Block]"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONANDRECENTLYISSUEDACCOUNTINGSTANDARDSNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r28",
      "r29",
      "r30",
      "r72"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Noncurrent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAmortizationOfDeferredCharges": {
     "auth_ref": [
      "r123",
      "r146"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization of other deferred costs recognized in the income statement.",
        "label": "Amortization of Other Deferred Charges",
        "negatedTerseLabel": "Amortization of Other Deferred Charges"
       }
      }
     },
     "localname": "OtherAmortizationOfDeferredCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r82",
      "r571"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r507",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets [Member]"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsMiscellaneousNoncurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.",
        "label": "Other Assets, Miscellaneous, Noncurrent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsMiscellaneousNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r95",
      "r98",
      "r421"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax",
        "terseLabel": "Pension and postretirement benefits - Actuarial gains/(losses), After tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, Tax",
        "negatedTerseLabel": "Pension and postretirement benefits - Actuarial gains/(losses), Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax": {
     "auth_ref": [
      "r99",
      "r490"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Adjustment for Settlement or Curtailment Gain (Loss), Tax",
        "negatedTerseLabel": "Pension and postretirement benefits - Curtailments and settlements, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r91",
      "r98",
      "r548",
      "r549",
      "r552"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED",
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r90",
      "r98",
      "r548",
      "r549",
      "r552"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax": {
     "auth_ref": [
      "r93",
      "r94"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Reclassification Adjustments and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax": {
     "auth_ref": [
      "r93",
      "r94"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Reclassification Adjustments, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax": {
     "auth_ref": [
      "r93",
      "r94",
      "r98"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax",
        "totalLabel": "Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r93",
      "r94",
      "r98"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "totalLabel": "Available-for-sale debt securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED",
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Available-for-sale Securities, before Reclassification Adjustments, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax": {
     "auth_ref": [
      "r93",
      "r94",
      "r99"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after adjustment, of tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax",
        "totalLabel": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax, Total"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTax": {
     "auth_ref": [
      "r110",
      "r111",
      "r117",
      "r259",
      "r553",
      "r558",
      "r560",
      "r619",
      "r643"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Tax",
        "totalLabel": "Other Comprehensive Income/(Loss), Pre-tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), before Tax [Abstract]",
        "terseLabel": "Other Comprehensive Income (Loss), before Tax [Abstract]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r92",
      "r98"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "terseLabel": "Derivatives qualifying as cash flow hedges",
        "totalLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED",
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax": {
     "auth_ref": [
      "r92",
      "r98"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and after reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax",
        "totalLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "negatedTotalLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r92",
      "r98"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r92",
      "r98",
      "r510",
      "r514",
      "r524"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r98",
      "r102"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax": {
     "auth_ref": [
      "r98",
      "r102",
      "r515"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) for reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax": {
     "auth_ref": [
      "r98",
      "r102",
      "r421"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax",
        "terseLabel": "Pension and postretirement benefits - Curtailments and settlements, Pre-Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax": {
     "auth_ref": [
      "r98",
      "r102",
      "r421"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax",
        "terseLabel": "Pension and postretirement benefits - Curtailments and settlements, After tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "auth_ref": [
      "r90",
      "r99",
      "r550",
      "r559"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax",
        "negatedTerseLabel": "Foreign currency translation, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r517"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r105",
      "r108",
      "r110",
      "r111",
      "r113",
      "r117",
      "r381",
      "r553",
      "r558",
      "r560",
      "r619",
      "r643"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other Comprehensive Income/(Loss)",
        "totalLabel": "Other Comprehensive Income/(Loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED",
      "http://www.bms.com/role/EQUITYChangesinEquityDetails",
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": {
     "auth_ref": [
      "r96",
      "r98",
      "r421",
      "r423"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax",
        "negatedTotalLabel": "Pension and postretirement benefits, Pre-tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r96",
      "r98"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Pension and postretirement benefits",
        "negatedTotalLabel": "Pension and postretirement benefits, After tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED",
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r95",
      "r98",
      "r421"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax",
        "terseLabel": "Pension and postretirement benefits - Actuarial gains/(losses), Pre-tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
     "auth_ref": [
      "r96",
      "r99",
      "r490"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
        "totalLabel": "Pension and postretirement benefits, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax": {
     "auth_ref": [
      "r98",
      "r102",
      "r103",
      "r253"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": {
     "auth_ref": [
      "r98",
      "r102",
      "r103",
      "r253"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax": {
     "auth_ref": [
      "r99",
      "r253"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax": {
     "auth_ref": [
      "r98",
      "r102",
      "r103",
      "r421"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax",
        "negatedLabel": "Pension and postretirement benefits - Amortization, Pre-tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": {
     "auth_ref": [
      "r98",
      "r102",
      "r103",
      "r421"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax",
        "negatedLabel": "Pension and postretirement benefits - Amortization, After tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax",
        "terseLabel": "Pension and postretirement benefits - Amortization, Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTax": {
     "auth_ref": [
      "r99",
      "r110",
      "r117",
      "r450",
      "r465",
      "r467",
      "r553",
      "r556",
      "r560",
      "r619",
      "r643"
     ],
     "calculation": {
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Tax",
        "negatedTotalLabel": "Other comprehensive income/(loss), Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Tax, Parenthetical Disclosures [Abstract]",
        "terseLabel": "Other Comprehensive Income (Loss), Tax, Parenthetical Disclosures [Abstract]"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossTaxParentheticalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherContractMember": {
     "auth_ref": [
      "r88",
      "r414",
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is classified as other.",
        "label": "Other Contract [Member]",
        "terseLabel": "Other Contract"
       }
      }
     },
     "localname": "OtherContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCurrentAssetsMember": {
     "auth_ref": [
      "r507",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current assets.",
        "label": "Other Current Assets [Member]",
        "terseLabel": "Other Current Assets [Member]"
       }
      }
     },
     "localname": "OtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities [Member]"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock": {
     "auth_ref": [
      "r409",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.",
        "label": "Other Income and Other Expense Disclosure [Text Block]",
        "terseLabel": "Other (Income)/Expense [Text Block]"
       }
      }
     },
     "localname": "OtherIncomeAndOtherExpenseDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/OTHEREXPENSEINCOMENET"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherIncomeMember": {
     "auth_ref": [
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other revenue.",
        "label": "Other Income [Member]",
        "terseLabel": "Other (Income)/expense, net [Member]"
       }
      }
     },
     "localname": "OtherIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r27",
      "r28",
      "r72",
      "r571"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Current [Abstract]",
        "terseLabel": "Other Liabilities, Current [Abstract]"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r147"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other adjustments"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "terseLabel": "Other Noncurrent Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SupplementalFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r127"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      },
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other (income)/expense, net",
        "negatedTotalLabel": "Other (income)/expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other (income)/expense,net [Member]"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "auth_ref": [
      "r19",
      "r22",
      "r276"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Other Prepaid Expense, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherPrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivables": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.bms.com/role/RECEIVABLESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ReceivablesNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from parties in nontrade transactions, classified as other.",
        "label": "Other Receivables",
        "terseLabel": "Alliance, royalties, VAT and other"
       }
      }
     },
     "localname": "OtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestructuringCosts": {
     "auth_ref": [
      "r146"
     ],
     "calculation": {
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses associated with a discontinued operation or an asset retirement obligation.",
        "label": "Other Restructuring Costs",
        "terseLabel": "Other termination costs"
       }
      }
     },
     "localname": "OtherRestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherShortTermBorrowings": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_ShortTermBorrowings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowings classified as other, maturing within one year or the normal operating cycle, if longer.",
        "label": "Other Short-term Borrowings",
        "terseLabel": "Other Short-term Borrowings"
       }
      }
     },
     "localname": "OtherShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r135"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r140",
      "r307"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "auth_ref": [
      "r137"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.",
        "label": "Payment for Debt Extinguishment or Debt Prepayment Cost",
        "terseLabel": "Payment for Debt Extinguishment or Debt Prepayment Cost"
       }
      }
     },
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r135"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedTerseLabel": "Dividends"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r131"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisition and other payments, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r246"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedTerseLabel": "Purchase of marketable debt securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r39",
      "r410",
      "r411",
      "r412",
      "r423"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "terseLabel": "Pension and postretirement"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares [Member]"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleOfShareBasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement [Member]"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtOtherThanFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Not measured at fair value.",
        "label": "Portion at Other than Fair Value Measurement [Member]",
        "terseLabel": "Portion at Other than Fair Value Measurement [Member]"
       }
      }
     },
     "localname": "PortionAtOtherThanFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r41",
      "r571"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidTaxes": {
     "auth_ref": [
      "r20",
      "r22",
      "r275",
      "r276"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Taxes",
        "terseLabel": "Prepaid and refundable income taxes"
       }
      }
     },
     "localname": "PrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reporting category or type of financial instruments related to a group of items that represent revenue.",
        "label": "Principal Transaction Revenue, Description of Reporting Category [Axis]",
        "terseLabel": "Principal Transaction Revenue, Description of Reporting Category [Axis]"
       }
      }
     },
     "localname": "PrincipleTransactionRevenueDescriptionOfReportingCategoryAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/REVENUERECOGNITIONGrosstoNetAdjustmentsDetails",
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyNatureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of a reclassification adjustment made to prior period financial statement amounts.",
        "label": "Prior Period Reclassification Adjustment",
        "terseLabel": "Prior Period Reclassification Adjustment"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassification, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsAndExcessTaxBenefitFromSharebasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cash inflow comprised of the amount received from (a) employees to acquire the entity's shares under incentive awards, including stock option exercises and restricted stock arrangements, and (b) the excess tax benefit arising from such transactions.",
        "label": "Proceeds and Excess Tax Benefit from Share-based Compensation",
        "terseLabel": "Proceeds and Excess Tax Benefit from Share-based Compensation"
       }
      }
     },
     "localname": "ProceedsAndExcessTaxBenefitFromSharebasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": {
     "auth_ref": [
      "r130"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.",
        "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested",
        "terseLabel": "Proceeds from Divestiture of Businesses, Net of Cash Divested"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt."
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r134",
      "r138"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from (Repayments of) Short-term Debt",
        "terseLabel": "Short-term debt obligations, net"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r128",
      "r129",
      "r246"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-sale",
        "terseLabel": "Sale and maturities of marketable debt securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesEquity": {
     "auth_ref": [
      "r130",
      "r246"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of equity securities classified as available-for-sale securities.",
        "label": "Proceeds from Sale of Available-for-sale Securities, Equity",
        "terseLabel": "Proceeds from sales of equity investment securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r13",
      "r104",
      "r107",
      "r112",
      "r141",
      "r155",
      "r166",
      "r174",
      "r175",
      "r218",
      "r227",
      "r230",
      "r233",
      "r235",
      "r260",
      "r328",
      "r329",
      "r330",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r490",
      "r494",
      "r496",
      "r501",
      "r502",
      "r528",
      "r547",
      "r624"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net Earnings/(Loss)",
        "totalLabel": "Net Earnings/(Loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEUNAUDITED",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r303",
      "r666",
      "r667",
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Plant and Equipment [Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r61",
      "r296"
     ],
     "calculation": {
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Gross property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r32",
      "r33",
      "r298",
      "r571",
      "r625",
      "r640"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment",
        "totalLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r32",
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment [Table Text Block]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/PROPERTYPLANTANDEQUIPMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r43",
      "r51",
      "r571",
      "r639",
      "r662"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.bms.com/role/RECEIVABLESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Receivables",
        "totalLabel": "Receivables",
        "verboseLabel": "Receivables - from alliance partners"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/RECEIVABLESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification [Line Items]",
        "terseLabel": "Reclassification [Line Items]"
       }
      }
     },
     "localname": "ReclassificationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationTable": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about reclassification adjustment affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification [Table]",
        "terseLabel": "Reclassification [Table]"
       }
      }
     },
     "localname": "ReclassificationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationTypeAxis": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of reclassification adjustment affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Type [Axis]",
        "terseLabel": "Reclassification, Type [Axis]"
       }
      }
     },
     "localname": "ReclassificationTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationTypeDomain": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of reclassification adjustment affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Type [Domain]",
        "terseLabel": "Reclassification, Type [Domain]"
       }
      }
     },
     "localname": "ReclassificationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONNewAccountingPronouncementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Repayments of Long-term Debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r447",
      "r603",
      "r680"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development [Member]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails",
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r150",
      "r608",
      "r634"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r24",
      "r34",
      "r150",
      "r664"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash - non current"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs) [Member]"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleOfShareBasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r305",
      "r307",
      "r310",
      "r319",
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring and Related Activities Disclosure [Text Block]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURING"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": {
     "auth_ref": [
      "r306",
      "r309",
      "r316",
      "r318"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of costs incurred to date for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Cost Incurred to Date",
        "terseLabel": "Restructuring and Related Cost, Cost Incurred to Date"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostCostIncurredToDate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGNARRATIVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r306",
      "r309",
      "r316",
      "r318"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Restructuring and Related Cost, Expected Cost"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGNARRATIVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of positions eliminated during the period as a result of restructuring activities.",
        "label": "Restructuring and Related Cost, Number of Positions Eliminated",
        "terseLabel": "Restructuring and Related Cost, Number of Positions Eliminated"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostNumberOfPositionsEliminated",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGNARRATIVEDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r146",
      "r304",
      "r313",
      "r316"
     ],
     "calculation": {
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0
      },
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Provision for restructuring",
        "totalLabel": "Provision for restructuring"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/OTHEREXPENSEINCOMENETDetails",
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails",
      "http://www.bms.com/role/RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringChargesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Charges [Abstract]",
        "terseLabel": "Restructuring Charges [Abstract]"
       }
      }
     },
     "localname": "RestructuringChargesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r306",
      "r307",
      "r316",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGNARRATIVEDetails",
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails",
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostsAndAssetImpairmentCharges": {
     "auth_ref": [
      "r146"
     ],
     "calculation": {
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs and Asset Impairment Charges",
        "totalLabel": "Total charges"
       }
      }
     },
     "localname": "RestructuringCostsAndAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGNARRATIVEDetails",
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails",
      "http://www.bms.com/role/RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails",
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGNARRATIVEDetails",
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails",
      "http://www.bms.com/role/RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails",
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r307",
      "r314"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "terseLabel": "Restructuring Liability"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveAcceleratedDepreciation": {
     "auth_ref": [],
     "calculation": {
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_RestructuringCostsAndAssetImpairmentCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accelerated depreciation charged against earnings associated with exit from or disposal of business activities or restructuring plan.",
        "label": "Restructuring and Related Cost, Accelerated Depreciation",
        "terseLabel": "Accelerated depreciation"
       }
      }
     },
     "localname": "RestructuringReserveAcceleratedDepreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveAccrualAdjustment1": {
     "auth_ref": [
      "r307",
      "r317"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.",
        "label": "Restructuring Reserve, Accrual Adjustment",
        "terseLabel": "Change in estimates"
       }
      }
     },
     "localname": "RestructuringReserveAccrualAdjustment1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveTranslationAdjustment": {
     "auth_ref": [
      "r307",
      "r317"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which decreases (increases) the restructuring reserve.",
        "label": "Restructuring Reserve, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation and other"
       }
      }
     },
     "localname": "RestructuringReserveTranslationAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r45",
      "r386",
      "r443",
      "r571",
      "r636",
      "r657",
      "r659"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "periodEndLabel": "Retained Earnings, Balance at End of Period",
        "periodStartLabel": "Retained Earnings, Balance at Beginning of Period",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r163",
      "r164",
      "r165",
      "r167",
      "r173",
      "r175",
      "r261",
      "r440",
      "r441",
      "r442",
      "r457",
      "r458",
      "r526",
      "r654",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r397",
      "r398",
      "r400",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue from Contract with Customer [Text Block]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenueRecognitionNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuePerformanceObligationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue, Performance Obligation [Abstract]",
        "terseLabel": "Revenue, Performance Obligation [Abstract]"
       }
      }
     },
     "localname": "RevenuePerformanceObligationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRecognitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition [Abstract]",
        "terseLabel": "Revenue Recognition [Abstract]"
       }
      }
     },
     "localname": "RevenueRecognitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r115",
      "r155",
      "r212",
      "r213",
      "r226",
      "r231",
      "r232",
      "r236",
      "r237",
      "r239",
      "r260",
      "r328",
      "r329",
      "r330",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r547",
      "r624"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Total Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/REVENUERECOGNITIONGrosstoNetAdjustmentsDetails",
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyNatureDetails",
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RoyaltyIncomeNonoperating": {
     "auth_ref": [
      "r126"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ancillary revenue earned during the period from the consideration paid to the entity for the use of its rights and property by another party. Examples include licensing the use of copyrighted materials and leasing the extraction of natural resources.",
        "label": "Royalty Income, Nonoperating",
        "negatedTerseLabel": "Royalty Income, Nonoperating"
       }
      }
     },
     "localname": "RoyaltyIncomeNonoperating",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESDetails",
      "http://www.bms.com/role/LICENSINGANDOTHERARRANGEMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RoyaltyMember": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money for usage-based right to asset.",
        "label": "Royalty [Member]",
        "terseLabel": "Royalty [Member]"
       }
      }
     },
     "localname": "RoyaltyMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule Of Receivables [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RECEIVABLESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Other Current Liabilities [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SupplementalFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r101",
      "r558",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income Loss [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r471",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ACQUISITIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table Text Block]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions  designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans.",
        "label": "Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Comprehensive Income Loss [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r74",
      "r161",
      "r358",
      "r360",
      "r382",
      "r383",
      "r384",
      "r385",
      "r562",
      "r563",
      "r566",
      "r627"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Fair Value and Other Adjustments to Long Term Debt [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period.",
        "label": "Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Gain/(Loss) on Hedging Activity [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r508",
      "r516",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivatives and Fair Value [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r301",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DIVESTITURESLICENSINGANDOTHERARRANGEMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings/(Loss) Per Share, Basic and Diluted [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EARNINGSLOSSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table]",
        "terseLabel": "Revenue from External Customers by Products and Services [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyProductbyRegionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Revenue from External Customers by Products and Services [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r529",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r282",
      "r286",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule Of Intangible Assets By Major Class [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r31",
      "r56",
      "r57",
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventories [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/INVENTORIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of noncurrent assets.",
        "label": "Schedule of Other Assets, Noncurrent [Table Text Block]",
        "terseLabel": "Schedule of Other Assets, Noncurrent [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SupplementalFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amounts of other current assets.",
        "label": "Schedule of Other Current Assets [Table Text Block]",
        "terseLabel": "Schedule of Other Current Assets [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/SupplementalFinancialInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r306",
      "r307",
      "r308",
      "r309",
      "r316",
      "r317",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGNARRATIVEDetails",
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails",
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": {
     "auth_ref": [
      "r311",
      "r312",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.",
        "label": "Restructuring and Related Costs [Table Text Block]",
        "terseLabel": "Restructuring and Related Costs [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r307",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTextBlock": {
     "auth_ref": [
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Short-term Debt [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.",
        "label": "Schedule of Stockholders Equity [Table Text Block]",
        "terseLabel": "Schedule of Stock by Class [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Nonvested Award, Cost [Table Text Block]"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSEmployeeStockBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Reporting, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r124"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Marketing, selling and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Marketing, selling and administrative [Member]"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails",
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r146"
     ],
     "calculation": {
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestructuringCharges",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Employee termination costs"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGRESTRUCTURINGANDRELATEDCOSTSTABLEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedArrangementsToObtainGoodsAndServicesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement, Disclosure [Abstract]",
        "terseLabel": "Share-based Payment Arrangement, Disclosure [Abstract]"
       }
      }
     },
     "localname": "ShareBasedArrangementsToObtainGoodsAndServicesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r145"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleOfShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleOfShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r428",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleOfShareBasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails",
      "http://www.bms.com/role/LEGALPROCEEDINGSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Common Stock, Shares Issued, Balance at End of Period",
        "periodStartLabel": "Common Stock, Shares Issued, Balance at Beginning of Period"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "terseLabel": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermBankLoansAndNotesPayable": {
     "auth_ref": [
      "r64",
      "r641"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ShortTermBorrowings",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer.",
        "label": "Short-term Bank Loans and Notes Payable",
        "terseLabel": "Short-term Bank Loans and Notes Payable"
       }
      }
     },
     "localname": "ShortTermBankLoansAndNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r35",
      "r571",
      "r612",
      "r632"
     ],
     "calculation": {
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-term Debt",
        "totalLabel": "Bank drafts and short-term borrowings"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]",
        "terseLabel": "Income Tax Disclosure [Line Items]"
       }
      }
     },
     "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r40",
      "r41",
      "r42",
      "r152",
      "r155",
      "r179",
      "r183",
      "r184",
      "r186",
      "r188",
      "r196",
      "r197",
      "r198",
      "r260",
      "r328",
      "r332",
      "r333",
      "r334",
      "r337",
      "r338",
      "r365",
      "r366",
      "r370",
      "r374",
      "r381",
      "r547",
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/DocumentandEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r77",
      "r110",
      "r111",
      "r112",
      "r163",
      "r164",
      "r165",
      "r167",
      "r173",
      "r175",
      "r195",
      "r261",
      "r381",
      "r386",
      "r440",
      "r441",
      "r442",
      "r457",
      "r458",
      "r526",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r560",
      "r654",
      "r655",
      "r656",
      "r694"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/DocumentandEntityInformation",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleOfShareBasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails",
      "http://www.bms.com/role/EQUITYChangesinEquityDetails",
      "http://www.bms.com/role/INVENTORIESDetails",
      "http://www.bms.com/role/RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r163",
      "r164",
      "r165",
      "r195",
      "r604"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDSTATEMENTSOFEARNINGSUNAUDITED",
      "http://www.bms.com/role/DocumentandEntityInformation",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSScheduleOfShareBasedCompensationAdditionalInformationDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementCostbyPlanDetails",
      "http://www.bms.com/role/EMPLOYEESTOCKBENEFITPLANSSharebasedPaymentArrangementNonvestedAwardCostDetails",
      "http://www.bms.com/role/EQUITYChangesinEquityDetails",
      "http://www.bms.com/role/INCOMETAXESDetails",
      "http://www.bms.com/role/INVENTORIESDetails",
      "http://www.bms.com/role/RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentAssetsDetails",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherCurrentLiabilitiesDetails",
      "http://www.bms.com/role/SUPPLEMENTALFINANCIALINFORMATIONOtherNonCurrentLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r41",
      "r42",
      "r386",
      "r430",
      "r434"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Employee stock compensation plans, Cost"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock Repurchase Program, Authorized Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock Repurchase Program, Remaining Authorized Repurchase Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r41",
      "r42",
      "r381",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Stock repurchase program, Shares"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r41",
      "r42",
      "r381",
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "terseLabel": "Stock Repurchased During Period, Value"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r42",
      "r47",
      "r48",
      "r155",
      "r243",
      "r260",
      "r547",
      "r571"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Bristol-Myers Squibb Company Shareholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Bristol-Myers Squibb Company Shareholders' Equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r111",
      "r155",
      "r163",
      "r164",
      "r165",
      "r167",
      "r173",
      "r260",
      "r261",
      "r386",
      "r440",
      "r441",
      "r442",
      "r457",
      "r458",
      "r488",
      "r489",
      "r500",
      "r526",
      "r547",
      "r553",
      "r554",
      "r560",
      "r655",
      "r656",
      "r694"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Total Equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r153",
      "r366",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r380",
      "r386",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity Note Disclosure [Text Block]"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Stock compensation"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Acquired developed product rights [Member]"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingSecuritiesAndCertainTradingAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]",
        "terseLabel": "Debt Securities, Trading, and Equity Securities, FV-NI [Table Text Block]"
       }
      }
     },
     "localname": "TradingSecuritiesAndCertainTradingAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r251",
      "r252",
      "r254",
      "r255",
      "r256",
      "r356",
      "r379",
      "r525",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r76",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r76",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "periodEndLabel": "Treasury Stock, Shares, Balance at End of Period",
        "periodStartLabel": "Treasury Stock, Shares, Balance at Beginning of Period"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r76",
      "r387",
      "r388"
     ],
     "calculation": {
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Less cost of treasury stock",
        "negatedPeriodEndLabel": "Cost of Treasury Stock, Balance at End of Period",
        "negatedPeriodStartLabel": "Cost of Treasury Stock, Balance at Beginning of Period"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/CONSOLIDATEDBALANCESHEETSUNAUDITED",
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r381",
      "r386",
      "r387"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "terseLabel": "Treasury Stock, Value, Acquired, Cost Method"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EQUITYChangesinEquityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/ALLIANCESDetails",
      "http://www.bms.com/role/REVENUERECOGNITIONRevenuebyNatureDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r306",
      "r307",
      "r316",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/RESTRUCTURINGSCHEDULEOFRESTRUCTURINGRESERVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestments": {
     "auth_ref": [
      "r146"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment.",
        "label": "Unrealized Gain (Loss) on Investments",
        "terseLabel": "Unrealized Gain (Loss) on Investments"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDebtDetails",
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r199",
      "r200",
      "r201",
      "r202",
      "r208",
      "r209",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates, Policy [Policy Text Block]"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/BASISOFPRESENTATIONPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/FINANCIALINSTRUMENTSANDFAIRVALUEMEASUREMENTSDerivativesandHedgingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r178",
      "r188"
     ],
     "calculation": {
      "http://www.bms.com/role/EARNINGSLOSSPERSHAREDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted-average common shares outstanding - diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r177",
      "r188"
     ],
     "calculation": {
      "http://www.bms.com/role/EARNINGSLOSSPERSHAREDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-average common shares outstanding - basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.bms.com/role/EARNINGSLOSSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=124429488&loc=d3e326-107755"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/subtopic&trid=2196772"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117546-209714"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33775-111570"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2611-110228"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=28183603&loc=d3e692-112598"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=7516071&loc=d3e13374-112631"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL108322424-203045"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "610",
   "URI": "http://asc.fasb.org/topic&trid=49130413"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "720",
   "URI": "http://asc.fasb.org/topic&trid=2122503"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e39076-109324"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "http://asc.fasb.org/topic&trid=5833765"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(6)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624186-113959"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "http://asc.fasb.org/topic&trid=2155941"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594809&loc=SL116692626-108610"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28129-110885"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30304-110892"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=35711157&loc=d3e42567-110969"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a)(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r681": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r682": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r683": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r684": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r685": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r686": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r687": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r688": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r689": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r690": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r691": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r692": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r693": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(d))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e526-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a-c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>94
<FILENAME>0000014272-21-000186-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000014272-21-000186-xbrl.zip
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M[W=_J!D;40QHR7D,E344R_)B#"[YV&$&59=##("35%Q:"YA2MTN68'JSRQC
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M:DE*+@ NBZNH)8T-:3-$T1E8RPT3[<U:C&_00:HQQ@QY3!ZJI75*)>:67?I
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MKCKJC"-)&H+MSLNO7Y[J3TJ4Y[NSS<G%7BGOGSP3F(IIZ2Z6N5)0T.;9G*H
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MW=:;H[TOC?B=C9^-J.-L?6F0)I*GS77[\ZMQUC,>U3W(9-)/3  2$@2TD29
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M)N16.S9W>2Q^D*=6C:5WV5ZZ:2_I;"L('_\LKO5Z7QGT[O'C+Z3P4<R.?DK
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M*VX3,!J?QHAHW42+QG"))8L*G/)046RP'JEM**MM3\=M9,QM(3D0K(C*FD:
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MD"M*0E 4L[C*.^<TA9(2S*R$P@A*\W;]T^-][&9@' I&N +!(0=2Q#]0VG'
M$#:!175,$EMMURL$YP7O]\AU=W_?87[&8CWCL0^&/4+>E^LI_6VW/[B0@"D"
MT9UA>:8-XBOL-GFVKB9'2A0!R,HUZ2R,[OMA.K 7^E*2C?LLUXN](C^FARW-
MJJWPOMMU_;6.V_&][Z7U_9TXM?(:?9<U>O*4EV3468LL<#JP=!*" (.E!BFZ
MFVDME1<I7'B93K\9\!N'_!QHW0L.XT=TG&48SPK&8U>:\!8C@I*"+52$L9!
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MX$Q4_(BHA<@0STER"?#I-]SR_O^=P+A5E:9X479L]\C_]=(/G5_+1<<_MQ"
M%X_K!+CHBJS$T(SD<^Q3R%%G?[,22/9%WB/M;VLMD<[0TE_["KEQCEL-I#<Z
M:A)6 "V#3GN%%$>FX,2FT_Y7:.>OO)VP$$B=WK[/2'U(I)Z.D8J-C;I] -Y+
M#ZA7'B@6,8N1%AYR9[2W2ZN"7-W_RUA="*S.P'C/6'U K#;'JZH1B'/N" B.
MQK54R50I'7M  H'&" 8],Q&K\.H.7\9J;;'ZN(9Y/_8W_I8Q^["8':^OU-!
MN>= <Z32Z=>49IZCJ F[^+M0B@H:C7 \J_K?-=J5G[,2&*/)/M4N_#-.F?O8
M"?I2%I$SD66"NA-!;4R:ZLHR;5CD)E]MR7-L0-0&0_S-A53@3&+%A\GQV:R\
M_K5)ECW#+8'GC/Q'SNF7D3\-\L>J"2):21NACC&.Y@2S%"@A$/ FVA>2$QE8
M1+Y<9G!6B3DR\!<*^(^=!3 #?PK@G_L16M](<^VKUHXPJ22 T#- I0S 8$.
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MCC"9WEWR+.(B9WXPZ)R=1OL-;WS'AW*0&>=.C/-ITG^!"$0LG2[0\1\0986
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M 9:">V<#9THLK:(5(K,"E-EGWA2@*;<>L@+TP#PTD1Z52!T\49&'L(P*$&%
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M1%E! =4JZO<,4:"0Y(!!1[7VTDHJEU;%,D1UBCUZ#OZ$X0'.ZP]N_JF?S[8
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MU[U.[,!4QSOFD*/JY=8XD\;&2!@33+7N0VG+?.#L;F1TX6"'5%@:"CT06A)
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M&6C4<RWJ.5,PMH!WR2;'$J]G,= ;YJ/B#"46Y: H;^K&K5LGYZ7%(-8U!M&
MNF2@+IRS#@B!-#R3Q9%&2" 8:B]9=")HJ;+2*1%0U?G*SBW*L+H2;Z?-R!>%
MPDQ#;_:&^;!N>-1&&CV<ZNG4HA!W&(4X::F6)SNY]D:CB9F]DAI778NKSM28
MS0(AYZB8L+6//%>)H04D95$D2&D+M[BQ!7Q-NINT.,3]BT,TY"X1N8M'LX-T
M(GLFL[4,+'?,&51,.IXR@O7!DCL L"8E%=K1['!\X1FE=C1[/9(J+CEL>3IE
M[;#E=[+6F1*T*FKM? *&/@*##)KY' 0SA59KT1%$/6.RM-3S=OCZ08%^#0Y?
M-SY8 A\LJ)@0L['*,Y\4J1A5XYG9T8^!9P'6A.!LS0059EG1DG;X^A8.7__2
M'^(PML/7[?#U-X>O]T;C0W:8Q_O3HTNC0/?4=;&?QM@>V8[<>I1)7DP[?)U/
M8IZO2C=9;VFNGM-4-:-V':/V]4RUPY!C4) #*S[60JOU2+7PBBG.%20R9>#U
MQ8566X'D!X'=939M:MA= 7;G@E3RC#)ZR;0R-=,?,PO*(/.09;#).LRXL27/
M;[+?"73_1D^D_N1@@,?U/O-_1ONJWOG8]AE/,5IW$P>CX>Y<#+7MQ+4XO+W(
MHO^/)JB1Z'>1Z,M% 613SB8FFAV1R:M/11-_VL1 ZV(A:)LBD:C>U#?BT;:O
M^&@B=5_S>)1PLM? >UO@72@0(ZSE5B.+04=20([$#\^"&<=3(4:V+L+&UO_^
M7TX*^5-K.W67TF*A2$P<[>^/ZCV,XI\MJK(6RN(D$^*7T7@^5Z_*LVZFWM2)
M:C1U+9HZ4ZT.O#?<"LT0H*L) \R+(E@R-OE8A"Q%USI6_(+^V"W,\B# ?&NY
M2PVQRT/L0B_+8K//T3$3I&!0C& 8BV/6HB)&1E1.U2(*ZP'7QQ:I>-ZO^]S#
M[SPE=7^=FG57#Z_*Z<PT\KD6^9PI(2>EXB[8P@HY-XP,1:P'-QW+A:.+QA=,
M70DYR=?DZ&8+2:RA7&CH725ZY]+!AJ"*=IHE*+*>?8P,LQ),>QK_('U2.E7T
M<G6^-/6]3W>^#^KA^_M6WE]795U*P"UX+=TTG"9CM13%[^2>,Z5:@I?6ZV19
MX4#*(6I>V^8J%FU2P17AHK;UH$4KBO^  7RKM=\:@&\!P MQARC!N2"8Y9!)
M/!1@WLG,HDM"($:>0&YL^76JW;C,X,.].BU5D^Q[_>&%"<4W"4P\M$,3=Y5)
M>M/C$XW:;DIM9VK"&#"2$YG54Y^!04F)!5L2<SDDS87476%\P3?!+B&LL3:G
MJ988\WC,Q+#,--5&#&M # OGJDQ./D-@<MJX.Y+3XCTR%9-Q)E@5K>T")G ?
M>&%)T92UED O2LFQ2Q-]\5?<P^%N[KW&PUIW?]A)H\VI0*I5'#\3*LA=Z K7
MO,Z3PW$_'I)LJJ^WT^1WKY'.\MUT7E^5DUFMD_IJ6.>J_G]A.N<SV97(&*:S
MOUAX9R/&:Q'CF8(W4/L8=FDC1D,]<%K(&2R*V6RY3L5H*Q41X_E6O]?>A%X;
MM=3.GJ^=6FH4L784<;Q0$TO*HDMAVHL:+^*%N9@XDRI[2)S\+2\VMFZBF]I1
M]"5"^'F.XXR3_*\?7@ZG_ZH!I%N63,U[O)NPTHU(\3<:E%$Z624GZX9^'AS5
MB5JDWRDE-Q:]%HN>J?0#+D0LFC.K,[%H5HDY6KS,*Y&*LE$K7KH^L_9\98_U
M\T!;9.J>[;8U1GD@C++0-=)[D\GJ,*]#9*"#9\Y(SD2NI<-JO:!"KIO=U'#C
M$N@ML+7,ADY756(]/.S]G'?[PV'=^!N5WA1>+:WH,IX$TE6A>(S)"4!EG48;
M)$8OM2Y:^(\O*ST*J<3=T&-CNVNQW9]GTHXD&3LKD*$HU0N-FF% DE,E!JO0
M!:WJUAYL>GN^253+/'HP&"<8AV)E*-([J%Y6R$6#\49EA&)TQ;CP#>/W!^-S
M11.%UU)+S[S5AH&'S+QTBBFA@DF!2P15VU%NN@L"TO<^.^D!J987M87$97KE
MBBIS.L8_*IJ4-#H*@WRJ-&_F"5XTM'=*?O^XPP%Z,&;!@0% #5%9#0(Q&,YS
M@>PQDSR8FH4;GD!K9F%59F'G^9GZ@6@E+[7'N(@&&0AI61!&,4=20)J(R>9J
M%L2F\C<NE+UTB-UQA*V1;2/;I9.M%0(UQQ0<=^!M] F+-0:LYC)A,E,_NY'M
M_2';N08/UGO/N6,<L#"(1; 0A6#D;7D5O!?"FIH0LJG,DL.*=TBVG8+_X1#I
M2^GOU/^\]5_TQ\F-+UPKTO+*X]4C5%:$OMW+/8QQM$_??5Q#@L-138C#KKEK
MKT]WMCO&0>\ QUW>W.%>GN0*W&Z\L.KS,LTJI3=-#ND7W2F;)Z?3]>US[^-X
MMS_LAEV=I?4SP[#U7V'\P]:E5YD]@C)TB8/1M,?<C^,\P,/^Y_S3EWXZW#MA
MH(5/S18#GW\$ SW'T>'E'UF7:=*7#L5U1G#QSWJ)*8\90YHV1N<108>(EAQE
MD#P:[NDE_5&ZC9,/[8U/OO8 =S,+XXQ_,BSTK3_BX L>3S9^.#O;--6+<_7M
M,/_=K9Z^9=7%]W<(!3WQI/?STS<OW_1>_=+[[?6+-R]VWCY]^_+53N_ISO/>
MZQ?/Z.?_][[W\LV;=R^>]YX^>_;J'?'NSJ^]-V_I#4]?/W]S;M+^\^*^VG0H
M<3H=4Z;<.=JGAXQ+R!PX:RY?C7=QV/_:E9)_=HIX^N%GG/0GK\IO8^*"X>'T
M5[,&9,_S)([[!_579$R?$K$<#6LGC]_HP[&?)V_I!G\>=$5^[M*(?MT^,:)D
M('<^O5,?/CTE([K3WWG[>O#A[3:\?_N4C-G/_>WG>_L?/OWRB;Z+ON?U(/^?
MU\<?_D@'08+Y\,=+N4.&EXR>WI8O!7WW8/OKWAX9T"_;O[[\\NK7#_O;?VQ_
M>?7VO\D@_OYE^\O'X%*RA2P?<$6&T*;" @^>T01[5SC7Y&=N]&@,\:!">WR4
M-VY[EL_,;#=-QX]XDHYWGGX$XU14R3(7A60 2C.O968^2HG):T)H/C=)%S/R
MIZ/)8;\<K[Z#2&<T.IQ6JWUFCJ]B2<[>]]\8XSMXWHN-Y,_C_N1P-&#;QWD\
MZ;TA[1X"/7LG;7K_K-4T)?_IY^TWW;_$3__J'8PS"1O2,%-9<S3$H]2OFN9O
M!0XY'8/!Z$L53/39WCAWS1:G+TUE4N_-BV==*//=DS=/>K\^??I;=50Z137N
M[],G#D;CRHQ/>N^&)$3I(R.ZA?'1($\V>Y&$)?:'](G1X4R0G3;0G=].?SAU
M?:IG=;B'AYUJ&]9?#0;')_>4NJ_%X?"(/G'AHT2:J=")NI2']6PHO7^TWS^D
M9W_2J_KP9 AI,1'E']#8]*N2KM>M#_KW@]7ODC6FITX/]^@ROQ^1GLQCNLO7
MW3C4 QB_T(WW!&>_;_:^[/7CWLFG>O0T/4QU:4VO-LR1+ V.CZ=/UBO8']>I
M/#5&)S,POY<3P5?CR/\^&N:I3Z'X9J_28C>XS^FJ^R&/9R^)[B5ZPW1Z)T>#
MZ<R.#O)XVESE]/D/]\8Y=]>8]/_J[=,RW9OT\K ^[R7?-;UR_5?7_+AT37Y.
M+G>=BSSI/1T,IFMJ)N%[ 0?TT+,5<S@F.$W]J$EO#S]GFN@\[.5!GY09GDSP
M)%\\;=T5NL<?=',[78F3O='1(-450^JOFU): )^.AE,/_TO_<*_[T'6@-'WP
MXXSCV2-?/!G?K*,\_65=-]/WT>+YOT]H194*I]$4A$?[^W6ET,P]#217/_>[
M^Z@UC"=U,=3WY.G&PM\OS.F==A\]FG2L09[G+@W']#II%(_J$WWC_/QPQGY_
M/^/>K@QXDW?KO;\^H:6I$GCT>N#K]M./SAMG;'),:TO*C987"S$6)H.-QM4H
M%8;[H0=F(KTWF^S>R[D!><"J8/O-C+5SM41D,&@4=LE^36:CD(>[Y,R>DDKJ
M3^+H<QX?;_92_IP'HX/ZKLT>(8',(WUTLT?W=%2(5H_&LQ_'?^;#[I_TX<-Q
M/QR=-KV?X*"K'=T?#D>?N_!$;S\G\H5H(J9&>R\/#GH']%)'AF3'/F-_T*MW
MT*M//#J:U*O6G,<)T7UO=S BBJ\FB>B2K&3]DH7[).,]]]JF=W!T<$!\%O>J
MH#C[ZCA?:- O&X$SC[UX;7J^@_$H'<7#2>7?7;HXW6(METUVJ;+]XM=.9N.U
M,%@SZYG)EM7OGU^KJH]PLFJ)GG$P&75?2B0U;?<[&XXX&M/O:(JK82FE5V;V
MB*Y1Q2]]41V;SCC-!*"P/TWFUKRS2..C^FQY:O.?[?5S/2>:XU$W:Z]*H04P
M/M61SUZ\.M&19,HG4R74?69V41JB&H>>U)'>QS_SN!M 6FE3PTJJ9A2[-4E3
M,#H:=R9[:DC./=.@SL*3WG;]^,G0SSY??[SB!6BAUV#D]%;I]JN-Q-HS?-(+
MHYG5KM->]=;T S2O"]>NZ[)>H/OZO=&7^OF0)X?TF >#T?%,1"]\((Y'=.W3
MJ>C&=4PD20,:Z^)#^M7X;U=+_;9+5SLME4\Y=A*S5Z$_G6*Z@>F3T$?J ,V;
MPIP."?O23W6QU'_OTNWLCFAMT>U@I[$)F,-J^O%D+59-7$A,T?7H&4-UK*:K
M,^5ZW2JF9L+S'+W0LHW?+,&SXG11QM-P' UPW,GWS_W\9;K(3R:L O3@B)Y@
MDCLQ2E0Q.)JN 5ISW55(^FU>N#8VZ88.NU^1BJ([J6NZ:D;BM)D'@>/=?#B9
MZM(#$I'#DZ5&%\XD5+L/EZ,*D?IU_5&B,?BE#LS1N!NUQ0>A_TZ&;CJ!LVFF
MQ\K#HUSO)O=F4)KU.>AB;K(22/>6)S-XW4<U]:Z6M'Y!][!?$?[X9-.7G:<?
M?1(%770,:!P9F%H>P:!BB%(')VAT-=X+V?1NVOWA=#J[!?WOH]3!>_)PA=,,
MA\0(^:]*$_5?U5[,/,-!'T-_T%41Z4((GZN?E:;:("-Q]?],?:D3;[RZ=R1@
M(E%PW5L;')_UK:?N:BWB.A-BUPS([.-Q=5"K7]H?DL"::JU1E0)DSSK?<FZ8
M9U\ZI?!I%.B4P"^\^BR8,K6=1],%,;7F4PEYLC8V>Y].%L;42D\F1_L',R52
MOVQ_1 :SGLGKDYQ ^NC".SI!=GJIJ8])8W%B8CHZ/HVH=\;@5!L1DX>9$9K\
MU.OO'V!_?!J-Z@\/<;C;2;SI_/W4R=+Z5 %GXFN<B=>']?KC([*$/Y$"V.VL
M<O=E>5B#]S]U[R3S,=K/9"[^Z@0I2::I'.UFL<Y"ZI?J@9?:M/CT:>ZE4_P;
M&;GQ-.'P=8X#&KQNUKK=C=. U,*6Q^,C^N/M+Q]5TIEFG#/KI2'_.%D6LJL%
MLJ+3&5((0=X+HO]VCA\PMS^;!9C'WSYR[TLF$MI'$L<D[PE05=+-O+)^E9\=
M&J[ Q[, 7#P:CSNA/OW<8ICVR32U]Z2[V(Q#.FJKU''J;Q,MCNL)O^Y=F[,@
M8/W]T0&]<3@5F*=$==BCX2+:&54'NWK3U8,F/;T8.YP; CRMA'7B_I]YLH7G
MJ?V?YL':::3]R\GS3"_;'W[.DV\N.V7]>?AZ]I33#W09%K/S]#1>PWPX_8Z#
M6>&NJOTOO-?ZQ*?O/K$3%WU]O>U_7",+2R1O2G%.%QZ!2Q]\--KG($56,GHW
M.Q4*2ZG??A5V79>TJY63Z_;7]U^W?_]8; E6N\!*TIZ!E(YY%3*C^4DZZFBQ
MIF=(<UF2*H%A4.=\MKHOW%SHS?85^)/>2<G<2@R9!%2:8K'[Z"R25970X?%L
MM75+>I()Y=/EM@"X,]!XWN_69N<[SK>R#DZ^[5K8(X?Z+/0F4_V6.Y3/'Z&[
M\ZG0^9O;/MD%.<^&J=]M>TSW3BI<25G%;E>@PF^FAHD6ZT\D,:M&NY]2A^S*
M0K8&T2K],TZ'OVT%=%+GKYTO'V,4R66;F'"U1T(@[]9'ZY@L1DLK-!IA+Y(Z
M=Z9G:/X(%4_3Z* "93[#O3?D$B0<I_,:YWX)F9?#T\W"7CVD-W4J?WGZYF?B
MB<D1/30M\X[I=H^(6&A-]T93LEEPI:8.T&SG:^HQ+?HXU8*??KH_Z?9;NTN2
MS9X0(PSH\;^]Y'2O?WZ5:LK'>9_L>G6/_XIYYO*=[*U6L3739'3Y&B7M]!)]
M]C2:=Q(,376#L\M:H!<7O/"?>L1>-(A=&N?I_9)LVZ??=A'%TZ]:"!QVU'Z8
M#]C107?!+K;9W?[N:)2^]+O]Y1Y>Z&K^-!NY,LBQNU@>8G=F:UJ28<KK]2;Q
M2\>2IWLPW6!-4Q)R5[.A^NKUG?4=3VJ(GB33=,W6MPYIK9P^T/P#_T:ZPOBX
M-]T>%C.I]>UTGZ7P7O5&QUW8]93*%W<$+MSJ_QM&OX#A6Q;K16 U=YC%6D]R
MWUT6Z]KYNB?!]EN6%;,88NW \&Q4>2T>_M$_W'M&ST[4.%X7.;'S[.1,Q5,R
M^^_ESJ_;>GM_6[]Z^_O7]_*%_O#VG=K>IVOL__+I_:?=K^\_O?[S6SE!L@$^
M?'K/WW_]\YC^KW>>[]#W#08[;^/Q^WK.XH^=_JOG)%%^?5U>/7\''[,%**A*
M/8KL6#T)P= 4S]!['L@#BP+*QLRQ)4/VM/I4)=F2'-('BH;@DP]&EQ)--#)Q
MP'-YB:]?_/>+G7<OSE/6,@(;=,W9W4V#I]T4_OT=GGTB$9(G]T6$H"T(&[VQ
M22?C44A+KJB\]038Y_T)[NZ.\V[W$*_*;,F^K5N=CW=]_BX^)E<<S1NP*&L9
M5Y,<<RE)EG/6H4C@6L4UB^M=?L9E(5^SV\.>=(EA=)')2<K#PB*8;GQWRZ#J
M-A([Y+?^>)4S+=\T 9D_]^Q;3TQX=_:(GG^ !Y/\X\D_?J+;.!C@\8_]8?<4
MW8=^FEU^9O?K-WQS[JC[PNG+<]OTA$_MTZR&P.R;9R\_Z5[ZYBS5]#7-GPA]
M^<OTZJ6O_:?+"OY$&_-=E_W/KX&'=K/WZF;MU5;7WU3 ^-NJ-O[<6R\X2SP5
MFZLY,^NN=/+H;9=-O#V-T;TX$Z.[M$C7PQ^5-_V_KC F*RKUMIJ!N*2%=#45
MX\Z)WIZ&=B_OV72%)[_.*=CU7B%5WMWZ2%P*J\<VU'P97/38!JVMSSM:GX^A
MF%9M[W>2<=EM>MU:(=:'793E,=5<<<E+:W(H="4P 1 $ZB*\-%)9&TZB)_ ?
MRLM?>;?_))MP;3;TOS.F,JNCLOV%OE=]^./W+Z_>_JD^/'_=__#VY_[[3[_L
MO?_Z_OC#'^]@^]/>IU>_OCA?1^7K4_GA4QI\>/Z4OBO]N?/KOP?;O_Z[O_W'
M+W1__QY\>+M[_.K7NH7Y<]GNSVJHO.%?/G*>C8\%F5=6,O!%,J=%C1=J+C!T
ML<2N9!5P?5^*,Z^V(E7CML?#;::K+&0P*(,0<\!<B.T<<NTM%XXO,Y.I<=OW
M<=O74V[#H'TV(3&K>&0 'I@/VK#L"EI.$]B5X_.;3BRY&E^CMO5">*.VOZ>V
M;+0AL.@ 4H#7SMGLK!3*ZHS927^%KD"-VFZ9VL0IM27CG8VB,([",2A&L<"M
M9C8E)3V/(FLDGU5N2G[C(O.-VQJWW6]NLYR<SQ L>3?DT03CI-,DX'SF'F20
MN,RV1(W;OH_;U)S;2@T@1$MB#04#E3CS21+5*<\52.-L*M/"GMK=%VY[#/V"
MG@X&_2XY<I;E</D>TJ/O#>(R)E=*2 9KQS3MC-?6:%)57BD#\@HQLL8Z-V>=
MXX5 F"+[D&@B69%2$NN$0*QC#?-.Y00^./1N8TMHOT;]/%K/GF4+!2#TH=6>
M!P"!@"5!UME85 &XR5>([S1<+@.7\R".S]X(A9P)1*Q]WP-SX!23*2N+"4FV
M2<*E:;VT'C NG16N1B:R4A*D5,ZC5 1+"<(&4%=I6=QPN0Q<SB,0@B2Y)X/)
M4-6"MAF0H14$3N-K6QO-<\*-+<5%P^7#Q661.G!)?ID&#BZKH'7.P6G.O94Q
ME2LXU@V7R\#EW'NVQ8A<E"#ON:1:$MRRX"6PDE";[+V+)=:SW3=VG5M?NFNA
MZE5W./U&KO$%3_T0*:4$(5%I)3(XJT*V(0L/I/D,MSDWUW@5E++S;,$UEI;[
M%(E->(;  ,G>.\,UD4LI3D>;9*@=;=6-7>.+87V7FPD-EZ>I#\XE4#P59S5H
M" Z"@&(]%SJ86$QSC5>$R[EK;'D0*8-AB9?(P!C#G,J!&6V#KINV*OC::;KA
M\@'C$@):"RA3\04XNF"2\%F40"X8J&";:[PB7)ZXQG_M?-K6'TF#HT9OR69Z
M9  UI5*A8PY!%!.5(">)9+A=5FNZALUUQ*9"H;!(FP3I5S*67A4%4:5D'!J;
MFGN\(FRJ!6R*CX8<C"B$8:BE)3VK W/2)R:3%MGFJ)"3W90.U@B;2]I GD),
M/I%ZS=WEMZ-#')Q4[;[ZL9.SQXY:L^ 5#-"#8>O L^0&"K?&08G!%>-UM@J(
M"0C)KAU<N6LB?[,0E!!@N)4<69 R,4BYL !%L0)!6PZA:#[MM6YOG@&Y=-#<
M\09&H\]&G\NG3Z)(%:">&Q/ ?0R^B!"-(!&,QL!2J_PV^OP^^IS'C@ #>22<
M^+($ST!Y73.=$O/DFUAGI8N^QH[XII#+RGAJ]-GHL]'G9?3Y747G&GVNE#[G
MV2]6)"&-U4PZ5^G3>N9\=$P*[YV+4 S:[OR-M:;19Z//1I^WG2%8\^B+!ZE)
M@Z:4$+@#)75TW 8+T([XW#U]SI.48G"0<^+,ZJ 85"(-64<654T?,]Z1$]$=
M\?&"/QCZ[$*X/W3E-Y?=QF$="Z3^-FNXVK6UH=&L?7KZP]@_Z!K)'XYZ7_9&
M@URK"HTG"VU;1_6GR4&NK7\.CWL'>TBHK(W"ICTD:WO1'GV,;JI'3]JUD$W]
M<8Z'TXN.\R'VIY?<&TT.^H==!\Y(M]>/TTKWN[6)Y[!KUH&S'F1/>B>UHWO=
M(IC>,[W8]2T]KMW>2G\PR*GKM-E5KB\T2 F/)].JKC'W#PX7>@W16VIOM?VN
M[RA=L%>7Y6"TVS6.[0I6URKU"^TU>Z- 4W92CW]<V\$==5]=FZK/ZNMW?=?+
MM/==Y;[Q:'#2!N^D1M-I?Z3ITTR+U\\_%^,1/5ON=ZEH1P?$J).]_JP/;_?C
MR9-\<]FNC/FTX2@]3'W +WMY>.:KZ %JGX')K,7;8?]PD$]N9W:9S5JMO_N:
M_K <=2UL:T> ..O0.\:#DRY$W=6[%LNSBV*OPU?7$WC:V>E)[^GAK*'?P:C?
M]7 ZN97I ':E<>D&IHMCL<5>URJFNW!O<A0FAS@\['=C77O4SIY\G/=QVAPO
MT"HH_6GQ_H6'>7)] *ZN_TK8/R8C15>+_4&_6U2C\FOMFSO#Y!OLFEGMY,/%
M7SSVXM3R(P;G15&>\:AJ=U&?F/>9QE=EDXQ*TDKQ$(I3__IV9Z%[V*05H7Y4
MI9+;S;8BU*T(];J,REH5H;Z=E(]6A+H5^;TW0]V*4+?UN<Y#_?B*4'>>:RM#
MW6I^76\_5<;(N3!:9 _92J^#2#$JE71"Q*N4V'FL&P(OCE_]\7K_O?QE\.J/
M;?'^[>N]#V]?PL[7E\<[O[Y0KWY])^E:?/OYZ_US&P)O7^H/OW[X]/Z/=_K]
MU__>V_GUE\'VIUVU_>DEIWN%#V_?'[__^ON7G5\_G"U#[1"4X^!9$1 9!"%9
MX"JRZ+)T6?OL4ZV^8S:M6]:)B;79+FWU#!NW73/5#KTI*2H?4P3#4W F*1<Q
M*^><*E<I4]2X[9:Y;9YJ%P5W1&"%^2 L P&J'C?QS$JN@_9&>5&Y31&WW9MZ
MAHW;&K?=#K=%%;+2PJ)5O.JV8"TOELM<O,TH6A[<&G#;0AY<2+((&9G&C P<
MS8K#@(R3@8)B@4OD&UM*;BJX<2&HQFV-V^XWMSECDL0B/: !'Z4#Y.BYD:[$
MH(UH26IWSVUJH352(-DFD25!GBCD8$C!*<=BR+*X6HK:NGI,>!/LLDX*/[@Z
MU%U"P9T$#<^F.)Q,Q%)OQ3S15[B7GPY&DWY=$S^.\P /^Y_S3W5^F7IR0<)#
MP$FN%]C8^B?^ZVQ:QJU4,&S76)]K+"F6?V^.^#_;P_%N9O6YIFE_$2=[-1$T
MTD,>/K82>?^\5HT\B5"BBLE%2":Z C6L'4AT1Y5D6$9LN^80=CLO79[@TSF5
M-D%Q#4%QIHZ>=:A-<8%!U)I!PLA\*8FIHI7PZ%"9&@C:M/)\TON_KBLEUL@3
M:LB=1S<,TE.ZX!4B9/!."EH'1F=C:'%DNXS(;4/NDI [#^$:;Y2)1;*2"V=@
M,#"O%#*4+@07I3':5.1*?WYWJB'W02"7T*H(O4XY:8 G]#J@]<J&:&/P?"EQ
MR8;<)2%W'J ,I(UD%IKPFAW97%&82P%9!%M[@4(6PFYLJ4W%SY_3;<A]$,A%
MPJKBBG-M,H R0>88@]&\AN!XN$H5OH;<52%WX8RHP21TM"S:D!AHRQFF$IA(
MRDHM2I(^;6S)3:/6Q.8^MA)]VSG1K?13Y[M/?QC7DW,!#Q]=[[=K\5$11JA8
ML](B8!;H:8$K%14$(4SPS7M?&SY:+#CG>+19)V AA<) Y,2" 6#>:RPV>11@
M*A]=5 ?_ZGST'SBA=;NY:^1*T"$ZBR[7R28_W@<$6TA9< PFIN:]KQ%R%UK(
M^:B% \X"TLP EYDY72*KK?[ 9R@<=?7>X8+<TH;<!X%<@JWP3B?O,L'3:F=*
MSMYFXX0SR&/SWM<(N7/OW6B:MFIS!9? P.E(/D 6+ 09DH!<I!/5>W?:-N0^
M3.2*G!7P;$3D $$%5,88GF*,X(-0N7GO:X3<N?<NN?9&&LL"]YY!S0[T(GNF
MM<\R*1$RUN293>]NLM>U1.0^MMWWDWYTG;>^6>LF'8V'TT),T_WWSJV_((6F
M11C/JPL'8)57& O4_'[,+I7@R%^,,G' YM&O#4<M'CHS#B*W*;+(O6.0G608
M!;"<(BE$9;6%;C^>G(?UB#"VO8%E(S=;(^L^@ "'X$E1D*Z0)9*<2%"$T\VC
M7R/D+E0O3['N!4BFC%4,BK?DT3M.<P2)' 1I@H@5N<+?Q"]HR%UCY!)@O0TH
MDBH2HM<.3-0>$U>8= [0//HU0N[<H\^T.LDM\,S+HAD(2<Z\QE*;#Z@2T"C0
MH?,+K&[(?9C(C=IH$6)67%K Z@AF;W2-J6>D!>&:1[]&R)U[]"6#=L4AH]E+
M#*3G+ 1$ED#E$D5V66%%KN;G3\/<Y_WXM?;BIVWR+CGL\CW1Q)N=2KS?Q+2*
M!G"-F)9"3,<+;GP..HL$AA5(G(%+M0TV^0;D" 3I-4])\(TMO:GL$C8)UN;T
M\1)W$!XUYE?0M:QA?DF8GP< <N9%^8Q,6)498#$,>70L:H!H7,JHNXU!;\^7
M'6B8?^287T6KK8;Y)6%>S%MW_ZX_>DY0MP58<MHSL%$S]&3ZA98FR9@%QC1M
M6ZAN$K-OP'^0P%]%DZ@&_"4!7RT _^O'I'B4JOAJYA,#PPL+A4R_$0*=XEIY
M10;?;0IQDW,\J\+]8RC;2ZM_*45[6Q_ %0S0>G/\=2@^>6E-#H6N!"3O$ 3J
M(KPTDOS_(%K9WSMF]E>+%1$P2,5I7A@7]8R71,$PQ, T$3Q)/9-E1I)S8A/X
M^>V@&Y58N@=M5)=37Z[19Z//J].G\2IX;S H@Q!SP%R(4!UR[2T7CK?*PG=/
MGPM1,&%<)NU+*CA8!B S\Z2%64VQE:"U%[6@C-]TXGSDN[%G8\_&GLMESVRT
MR2;H %* U\[9[*P4RNJ,V4G?:A??/7LNQ!/?\8_<6.DR1!:E#@R*E@P-6B9#
M)I]!9@]1;VQ)N2FY:A3:*+11Z"U3J.7DJ8=@?9$!2C!..DU2U&?N00:)K43R
MW5/H8F16?0Q""6+1R*S%>HHB 7-!:":=* E-$LJ+VKEL4^DEM[>X0PKM K@_
M=%V,M\ZW39Y] ZL4]:-P%W9.GOZJ/TQY>/@CJV]:>=O-KE7T/_%?TTDX_^?+
M81P<I=J3?;Z+T;5L/QB//O<G7:_ZV8_S*&]O'U.N33P/QOWZ&MW4*$UZXSPY
M&AS6;M1E/-KOQ3T<[N:NV6>FX=BOA]!JA_5_K&&ZUL(>SB^C\6^GSS[]X;1]
M^C8]]\OA;_6I?YL^]'WGE>]NIK[]Z3U\5-Y&XX5@.>G:]L9HABY67G#@D>NB
M,VQLN?-QO=[^M/UK=P#Q.@MB5?OZ;4%<?T%$\3%Q:R/XQ$0HB@%'R4(,B>FH
M9=( N5BYL:7X^2(<IRNBLLWA7J;_UU;2=7U,^G_U]D==^^1\VCYY2E^*;_;J
M/&]>>R&M*BFL+:1K+Z2W3^G:[_[:)D7RZGF4.[]_-%&X'((A8HF2 7A'/.,4
M\REQ5;2SRH6-+3B?E/[=/+.J-(*V/&ZV/';_VJ;E(>JQ3E-(E(;,($I@OOKZ
M$5UV18I"XJ%N,9U/&[@1Z_!ZI'YRD&-M^# X?O)-+X?I5^T<[=.$Q>G/=8GU
MAT?8??>BFCRO'6=*<>N_POB'K;-77OC<3.8I0SKP? ^*+_UTN'?BGRU\:B:J
M^?PC&$@_'QU>_I%S+9-7[V9V4M9>.A27W>%%([CXY]YX+NEKJX)QQC\9%KK
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M/]5#.DQUG_YVCG"2ZP4VMOZ)_SI=%MW8M1#FMT3I%8\:+')N/7@N7 Q%BXC
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MQV',K$NFRFG^?D)B[V \2D?Q<-(;CKII2+UPW/MY^\W__E]."OO3A-Z]2^L
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MN+M71>OWQDE[^O'\5^M^5OO^.XS9A]&Q Z#(%Y7K0E-.&V%!.MI&C(_^Y&L
M6'ZRT[2M"Y+8-F*]N:ENGADG"+K06VAY_';8[8_D>!]@6Z?:P\NJ7MW_,A;C
M\<CV0A^Z? B:17YMMS-^UYD/JS_T/O;/OC+Y[G)V?X$8/ZYBW?C7ZLY8"\C=
M&\1V&_21(;SA,.<4[@U  3GJQ,9OUG2E>29W$BY,ZQ#P=-/AJ]X /;GP['*U
M=7F<00V&&X\/L]<3%)\S?Q_<:'M^[\7T'+^ +G2&"?HU[,$(O,@#\Q(:-#4$
M4V/=+ B@/-_]"BVP5=9XVKF_7[-*-=*41S[ P^SNK<Z_:+Q:\E\/AJ _';;C
MV:W]TP^?>1IASK^"Y@:*=M6N$]QY[.'^_L#NYL&';E>-?W?4J&E7V7BJ3M=4
M;J^+U6Z[ZQJ?)+SMH![K=[NQN]NSAWO ;R,'YGA:>S%E&(W&NW]A<<$7^V?N
MTM'G\Y3E[W7R4U-7S_ZX?%D^75+<9BVQQE*#21 KEX_*'M5AL'>ZLS/UU-@9
MCR>/6-?OMH>#ZQ^9:J!O".B1)*.^R1">:^%5(SC][UYOXI3>C<CUHOV";((7
MO++M(WO<7WIY[CL'0 +3PWYQQ'[TU2M%^Z.+ZH]^+X9A.VZFZX1V?[436MV.
MO^;R%OS4'UEZ_:V\U_)L->/]=;"95X\W3MZ)C?UW&"1]($YQ$B0B7DC$%99(
M1TN0\YP0^%^B E]4WJAA3B3)*!&6TYSN+>A$=<CK0RG"+VH&<ZG'?HQ9ON5]
MC[H#7)D%1-T9.6[RTC\<J1A9*@,-3^@V[W;8K*ZTV]VC_HNQ=,NW=>+@3,2,
M;/6CO=AI^!PTCT8D@(C+*D7[5*%H5" TDL)^[/YIGCV_Z=4?NGUHZZG\/6W,
M<K7^[3"+['S'078SY&T<!Z+UJ K=QLP_E;WP2&4/LF(+K1\,>K4;CD70>:WB
M3 V;%H/3WP2%:0@2M-,^'@NYXY',=W%P%./Y>R<B:?S24\\&M 1DXUB=J]/Y
M-S4NBI %8"^.)+@]K =9_8MA^5J&A=[O OGEG5IQY8Y=+M>;H3^1,\W6;D,9
MA_WXZO2'UZ'N'[;M\:NZTZR9YJ'7X]>/A=,5^1V:#XXN3UAW&8^8=WQF9_SE
M\>7EYM*%K>K1-8&7B;C^,ER]]MKW7DOPLI#RIU[[_6O<\-+8)]58=;/5]8,3
M9S\\^VDNW7I%"-9((WJ84*.+L0R7/'BC@V>-\W=CY/1=/W/Z5@R_N#8%[.*/
MRL?ZVPW&Y(9+YE'S__XPHJ7I[UJ6"(TSH]H8[0Y<.H-X50#D+4*&YGN^LSH^
MJP[?I #Z(@T<G@5/+.C8E$4UDT6U6 71KN[TA[,8P!R;=F:$O;K)"KJN_S-;
M6C^=$:,T<JX;^1Q*&[0N^BKN5,MT,0]6+.;1".%2P)XYY:SAP1L3G K$*^,3
M)]C$1<YP\+/^UM'1B'UH!VU]V6B..?R]M[GUGFV<;(B=_4^X13]]VWF[33:W
MV@>;:YY=/!JQ0=?9-GU_ NWGK7_616O-GVR<M ]:\(Z=K3^^P#O$YC_;O'42
MTMGAW(_XZ+,C)-?4L(A((Q&WSB+GA$-&)*\P2U;$D%/0:KR =1H*!RTH!UD;
M-,6")^DI=U0;HS,I><&CR"D+%SE)P%/AH),S#K)4*(=S\"TC"O' -=)-U1A&
MN,:!4,R;*JX4+V#V^L)!"\I!+.7*&49[ZR/7P6IL9&*&@V[$J99ID<_9/Q4.
M(F<<E()U&LN @K7 /-H9I(ES2%J,-94ALNAR;4NI5>&@PD%/A(,DI0HG*8AF
MC&NFC7+*&H.IL,QC(1?YF/I3X2!VQD$FA*"8THA8(Q!7%O0@IC *(E#.,*4B
M5[/G+PR=I^);B^4FOAIRJZ<!)[UK<H669,1GA]LBV%XIN2!M/N8FM#1" 0-A
M:1B3G#[YTAI/@E=:;Z9\/,QE#QS&*-&<)!Q^129GLS2:Q<"-T];HI14B[IQ_
MK20)GU]<*@[HLTH8[#@GEML4>!11*LL<QS(^^<(:3P67$[^'B4829C'(>VL!
ME\PA#5H:HF!M*!O \B 4<"GGJ2QWP>6LY:4B6CA.(V.44PHZNJ4,8$DY48ZS
MFV2C*+B<!2XGO@ 2:#(@,)%E!.1EY!9910"<T@!S6H%CL$LK[.[>R(++^<5E
MHL)AR@P6'',=F1,B1J<%QD91']*3+ZKQ5' YL8]5DB0F1I!Q*2".F4(.;&&4
M@A4R&J-]\DLK5%[.OK 8)34(7:;/HJ3&<T^U^9PR:2:,A?0FY]WQ7 JE$[7,
M:Q)<PM3$5,)%'IN"/TZY$I)3S!O,D4XN 04+4(V2YRA21H-,VA'+\E:MD;-R
M42Y8FN%";<^'VF*@SBB5&.,$K#EJ"0Y6$Y$BY3FPJD2A/#ZU3;PQ#&,=(QA\
MAB:-N* 4:<(L\MP#LWFL&"69VEBAMD)MSYW:C#"@K%E"G;*<8.6"$Q:3H%PN
M>\AH"6YY?&H[=6A]V]S:Q9^Y-T39Q)!*T>3JZ@G9$#$2(1&6O'4I!_J*%T;?
MV7PN]%;H[8G3FU9!$R(5IPQX+MD@M);"$"ZC3^DF%74+O=TSO;%S]&894Y:F
M@"@U'G'N);)<8F25I)2QI)*QF=Z(N7.1^H>BM['K\+0A9[EE&O)ZW(-N5U2R
MF,/C>*65#]_*Q3K;>/6AX;].,PD-NB]_R0>'?[V<D>CG3A#_0%,I[YC#=SR'
M^,<WW?X@IYV<) SKML-=MM,6356^JHL+HPT_Y!9-7FF;Z6VW&W+*Q8^Q][7V
ML?\1EEO1CV^A'V].QW]*;@V)02&E<\U(%QQRQGOD<"+)>NV-R37,7[ KJNP\
M^8B6PDH+RDH/N;M26&E6K#2UWQ*UTXP)1 6VB!,BD%.*(L)9= PSQ7'#2EC<
MN1IC8:7"2@NX,5)8:5:L-(G]]4*F$!T'Y<AZQ)6VR$@GD0B,&0;BA.68?/I"
M\06,RB^LM*BL](#[&8659L5*D\AGX3Q+.26*21R#KN0)L%(DB"F;1$C)6].$
MW3$Q3Q;<8OF"KP;AANU]B8.FL$P_MMM-Z9Y<;#H<U)VZ/QA5BOBIT\(WS;TP
M?\3TR\/ZEG+M(_CIE(?<P?&KCZ.I>!L[L6?;,"&KY^9C7-7@S375/ I/W8:G
MIL.#1;0<#'".C'; 4RIII+V)R!%#L$N2^EP?DU^.,/GU"6=/*6B>I4^FH/F1
MT3SQT' E'+>@:Q!C N*,8F2))0BT#8EA5K5,8 NQ@N8%1?,,?!D%S8^,YHEG
M TNA>01A+"(3B$=%<I)76-(:"TR,L%J'I15S.;U90?-BH/GN/H""YD=&\\0C
MD(RDTG"%**,:T.P5LDY2Q*)E/"68ZJ"75M2<R.;G$"/S85Q]MK'_IPK0EE1A
M]VC[3XCH=/AA]-<F@U_X9X:Y"K=6FWCKAH-6/TLOE>,>*"?DU,V.>60M ZM?
M*- 4I4DI9TQ5;)X\DB5+ROP%810(/S"$C\\@S&0RQ%!0'8A2B%,:D5'!(] +
MDW<A*1_RM@);P*W. N$96OD%P@\+X=9$"FL9@S*&($\-0QQKAXR."C5UT$5.
MN>JR%%[$:(4"X1F:]@7"#PSAB13F+ 70H#12,5+$DP%Y'(-$R05&/=%!.C#E
MJ9JG]+S/86M_<[ 7>]4O=<=W#^*O+^,( 2^J3OPYF_YYN!EG9M2?QA,UT]#J
M=KJ',=-.9_==,R%C0BK$<ROB69^VX#&+26NFD$R*(*ZE1P;X!IE$F(Q&)XUS
M_N'+Z6[*CL!"0'5FQGN!ZOU =:(C6&L%B&^ J@P6Y9)VR-)HD0?%+VJ3!"$J
MIPHO4%U,J,[,2"]0O1>H3EGD*2K/E%:(4!H0ISF/N$X)UI U@AOCC!, U<O:
M?('J8D!U5L9X@>K]0'5:JA*< A/(Q"@0#SXAYS%&E#+C@@3A*G* V^4\_X^W
MB?YR8%T[PG]#_77E-_CG]--3[]H?]@=U.LY9@O+-9XT;97/QV85SV(^O3G]X
M'>K^8=L>OZH[S<IO'GI]8'N[=0>-FO JIQV_T+CF@Z/+KX_J,-C+6%G&(]_5
MV#4P_O+X\G)SZ<*0C:XIOJP5O?8R7B;77OO>:PE>%E+^U&N_?XT;?C^-U3=Z
M[0_<+W/A9=$W8M:UO A[_:KN5!MUNPW@NKZVVHTZZ"-P<>]AI,?%+EZ=+NC/
M82=6#+_XS?5>KF3M[!8=O$&VFB<U%FO1QP,7>Q4C9^.!SXW'8H4*73T*'V,[
M^D$,U5E=P=]S[!S\]^->C , P^BT':#AY_)(7<[?=7V*NCE*,G;#1CX'Y_,'
M $K]-4OB?O7__W^:$O*ZRJG&+F<:NU.EVP4[Q'M5%^?;LKA-I3#-DN=>@XJ:
M.!7"1J] 4_7P*Y74\<_O;EH@[&QIM>+@S;#76YP-O-\/MNG?7W;^>4=:]/W1
MQMI[NGVP4V^?O/O66OOC2VNMU=Z@?QRTUMZ32V;$VYW]G7\^M+?W/[&=M=6C
MUMI.O0/?W=A?QQO_Y&]_.MG^9QNWUOY.&_74F;<8P+A+5J(8<*ZN&2@R 8P(
ML/:##$%JQP(8$?S.VW?S9_47JEE0JK&&JD "Y]$8KHVWB@B7<@5?[+"VKJ$:
M3"@CA6KNG6HF!_*<48$IJ5$PUB%.<YH2%0UBT00CL/:2F4PU=P[V*:'_MRL/
M[CWT8- 'G>RX\;B<:FR#[H_UM1+&='<%Y\;)24YGZJ_11!5&^@E&.IX^\*]!
M4A"&D28B@O(C'-*9D:SSW"05)<<Q)R;![,YIUTL XOPB]^?UA8+<!T7N1)=0
M)$I-0(V@#C?%QP5R049$-&-6YVP=0C7I%\T\A0X_M.NGV65Y#/"MQ11AA8=J
M%'YXWO=SID/,M&5R6=R@::\/N_VZ\4SV8KL) WZ=77>(+5^Q1^1L/^87+*W\
M8B=[9LV@/I.=XT?P[YPNG=$V<6'(6S!D:SIMMJ:<$!,HLEP 0QH>D7',(I9X
MXCY:3:E94,=. >6L/2$%E'<!Y41MD1@S+UU$40F-.!$$&68LDMX')WV(1#L
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M?3 R^UOPY=_;7?_EL=%U/$;7P4Z]LP;O7/MPT/B;UC[L;Q]LBVVZ3EMO=[X
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M_]FI-[;^3JVU[<_<<JX%9<@;2A$G."*MI(-_0#.R7EE+TM(8-,,85C/=!0<
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M EE"'8J>,B=UHM01T!;NE,&ZP'6.X3K3!'0%KO<"UXDYSYQA6BB2\0G*O2,
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M=F%)_9E+8>@S^!$A@6&15;:LK5T(9=X66*W61]=K'-?7A]*;&\P>LW8<;<^
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MU"*J(D5<!(-,,AP1(6'27 K)YZQ3MVS@/^HHU,^7A1=P6+3PVC+P6@A4"Y&
MLA3E*B0GK6,B$JQ\8%3Q!V<4*;PV,UX[O^0UKF2B5"M$!4F(NR"08YPBY5R4
MQEM&=%I98V3*1SP+K\T+P@NO_6QG]'$QLX77GI#7R"6OZ<A\]$8@'(1&/+"$
M-!<&L1BT(X:3$#SPFKKKE$+AM<)KB\UKCPP,+[SVA+S&QOH:]EI935%P4B(>
MH\UG!QQ*,N<MYTQK:5?6))]6W;K9\MHRE!.Z1R#Z<B1A?\BYM<@XDRXHH@4W
MPAB39"#<2 56"OQ3?&3SPDUG$SXRGZP-R7K$%#!2CFM&ACB)K$_P(6+K&5U9
M(^:QU%3*)\PO<D421FKF,5:>1^F,PTZ[7-6&1N/E?;Q ]RFI6? \,SR/?4/:
M*YY2X @K4:>AL4@KK9!D@4F!+<=<3JVL9@'U_((Z4I=X@DF/V'&MO./.,Y^H
M@;<.08CB ID?^(Y=(%0!Y7)8CDED%O$0 [),.Z0#2UI8+Z1G*VOB9MKH@MR%
M0:Z@N:JYI5[JQ 7U.@;LHR$&L&HH5U.J<%WP/#,\CTU_; 5+)!<^HH$A;AD!
MS9KF+>@H@G=1B1#F<3E>BDB@'Q]P>P@OW?+VB\=+T:<0"#4D.LLE-M9CYUA,
MT8.J04*\AX%?>.GY>*GY9L+L-X2K))5!4NL >@8.2$<>\GDAX:4Q#&L^-5ZZ
MG1N><U.E@/K2:T<U%AR;@*/D7#A'C>+<1NT=)MH]O*9,@>_,X#L1 2)%XHXQ
MI&G.YZ:#0B8IBJAV$91&);6Q*VMT6ANE!;ESB%P7>(P^IX2SFD<G+>8N9LLA
M1# >*+^'@5^6XV?%\]CL)QKP++A'2?J<M!]L!6=L1"$D(.)\6IK%LAPO :B]
M4D02@HV&-9?Q8*5V1AO/-#%8Q/O8_@6^3P3?"2L?\.>])\CP*!$WRB&GF45*
M:Y:D\=$DELLGW)7WX3F@.Z5M_"$"V9R;^CO=@6U?9 QXJ#]E.2.L'O;R"T/
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M<0G4[B(7TLTB@?.C4#/G)T0+9Q;.+*FA%XXS)U)#*^U WY6(!,KRAA5'.8@
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M?](>Y&-=J=<]RB?!.ODD6*M3 ;H >@/X #?]KZ=-?S%9NJ9S<A2Z@]'U^W#
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M*^BDW>_%2V5P^+C_]__1E*@_^Q.-C5T4)T.=ZK3;^PI_Z0Z=L#DU]94F\E<
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M/.>HU4&3XWY]R'[VU/M,^U,/Z[^NB>B0L(A1 4Q2($P5N)3.<A(M:#V)>:K
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M:CER7FL4 A42+CF<_,J:N:$GW*'S'PTKKM?5>V&=/*BY97#0B[$NX]MO?:^
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M/:R^W$@<C5("J^+>F4<@C_=<I%"*)L8152DBF#B"=#(<F>"LLM%)4*(+D)<
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M^IK"IV[U0WP8KE._72H4%CIG]R-HPJ!_03MAB+RKV0;N.5CW3+3PG.^_53/
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MQV 34U;S%[&:L\O5/'(2/#5@SCB?P)SA MF0-,(N&1X)#T3(7,OVYH&1.67
MG[BD'A< LLS?7(9S.V]&Z7!:G5O31"U9.92[8^%O,?9^)4SGZCJ1LY_ ;S-T
M?;VSK<Z_N_W^UC"C4]CJ;-I>![[2)V4%>< *,AGU]X42)DDD$6DG<SX>F&&;
ME$!1>,:")]X'O+)VTQS\_=Y+1TGZ.K]JH73,<,T%QRER[[S6C&.17 @"6VK9
M/7 _"[A?JH=W0[X@_F&('WN K.!2PXPC!^!&G%J!'(T&62:#8Q3K9 'Q-P/"
M2Z[G^8;]K[DVRC3-L5I&*7/4,<63H]RJH%WD.D5+#(X1S/F:GO$%/>,G5\L*
M3T^=I\>VO536$48CPF#+(^ZY!IZ6&/E$!29).99YFMTT[9]%-5N&6))_1DE8
M?\F0?+F5@1_E,Y\CM_B"3]-#%I8IZ/U/L[!\C(/!,/=]64D>M))\G-#X#6:4
M<D60UDF!QI\D<LH&)'/))ICCJ%U.4W53Y;__2E+07DBY3-,<3M,R^/W?=GOP
ML5/%[\.$^$OFZ"^&_XN8IN?5S]S1V=,9_2- ;H[P6#2WAVAN5Z+UL'11$H."
M#@[Q2"S25EED/#:>N\2ETJ"YS8<+H-! 8>N%F::G]=(6CGYI'#WVTQHM%-<R
MH1 80=SJB'1,#"6?*$W&V(#C;1S]S/47%]Q7>_/<W_"D^2]&O(T2=S 8\= ]
MR6E ZD.@]SL>NMAAM(\;FL59!32)-FFEM#-<QF2EH"Q@;IR33-Z5EK:<%9PO
M8I_(._J%,Y>TEAP1$A@"<\P-3PUZHT%:N%$D.2!V,]W8VD?!Z64</"AD6LAT
MOLFT'%>8(J..W1G1Y(HX*>>'=\"HRC/D?%#(2:QS<M)(95I9DU,^?5T8M3#J
M8C+J-$XS%G04="PF.AZ@;[ @DO6@[*<$^H9.VDNG:> A)J\"&Y:H^8'GKN@;
M<Z1OC%USG&/ON4^(8$(03]PC3:U&+ 0E7(I$,;VRIA[MFYL#1KU7<NN;?Y]"
MNNL1YI@$4!YWAX6V7]>%MEO?XCB7;0;DQ%VC0<+C6ZR#(3D9W'W+'-1?J--J
M$W:?U-]7NGC;$$[^/.B-\_GM1^1ZT7Y%-D$#KVW[U)[U5_ZXFN6XU4&3XWY]
MR'[VU%LS(!NKHE"2L\@]CYQ;S1/S'#N;8I0DW4@-C3FN2](90GG"7ENFX)./
MGOHHQ/_/WILVM94D;<-_Y03OS!O=$2ZZ]L5]!Q%N8WO<T<#8QNV +XY:0;86
M1A+-\NN?K",)22RV! *$J.D8&R.I5*<JKRN7RLHD-^[>0U5%OU(+K]Z^5__8
M1C/C)%>A1CU@UBJW[JD^90JNJXO7Q=#?_.\X]W][W_XG]OK3:;]W*A1_O\72
M+Q[N;:?["1YM_%#/N/8YV?GP-8*#Z1(WR+JH0!4X4 412\0<95**1(SQEVN9
M+VM1_RL%UGO'K9;MPB @NE>E.V3I[ET(PLL;Y7B6VNE/I@8ZI>N&JH47OU;K
M2NLG4JB[S+7,M<RUS!7F:LR#U.NGY&G6I5]X??ZGNA";T<>6B]V*D9MK\E_R
M_ BMU^#22G4[)Y?SPV[;@^]>UV$A-?NO>=AY2B4MMTR\:G5@+N<Q5*\[O3M5
M7I]\]!E:6ZS.$K[K=GJ]ZG,;_/IF7LE[7\3%CS/+6PL,"@Q6!@;S*+LY,+)Z
MFVH;=VMH<Q\[^216+B=FS]35^!8T_206H$[2_?N'M?GNM C/2IH*#@L.%XO#
MYW!/X'6>2X+9]&-]32#$^D"R- >ZK^=?F9P1E2035#'A">>8<>LIT<I;9217
MF(J;<U13I]NR^03UM/^R?=P*G?[P]9^=YN5SRO&)WH5#DOV1.F]D-3)%6N]/
MMS8_T[W6'M\[W^-;]6>^P]_^9'_W#=_[MD?W6Q_A\W^V+F>*['U[<[*]N]_8
M_W8(\SDXRP>#.[OP]_D?S:W=PT:>W_Z[CZVMUG[:FLKU%S8RARG2(;?%$!$C
ME[!!7)F8:!#<V[2V05X(L^!DD=),8+D(H##?0S'?>>QV@NT=SDEZWA^WCINY
MM'<=31@'$[+]^T>$;XB[]K0PX7Q,.,[19R'8&!)!WG*!>#(!618UDMC((*/F
M=2_T8>9QX<+"A84+EX\+LT=;N/"67$@FN)":))U#RGC@PJ@,<HI%)()2W,5@
M(O>%"PL7%BY\+(]X3(;3U%@X;S[.F[@S(3TC\!_"-)+!'4U--4?41F(P]C1)
M63SAPGB%\?(]]12IBD%2*@/W*;KHB/5>1T>=XU3?W"2WQ "7A/G$!?,138+Q
MR8*-)\#:<\0C,/ PBCH*++2)E(G,?'567&&^PGR%^>[*?"4&N$1,> HL.#@1
M>?45-A8KIS1*Q#+$2;# A52@:$*T%'XB^7Y?\7P+&Q8V7%HV+%' .['AV04;
M,@J^,)$!B>0DXHQ+9+5@*"HF G$^UWPM;%C8L+#A8WG%)0ZX(-;;'MN N:2#
MAXU#,>EL WJ"+&4>J0BLY[52-*DGY@^7]O+EG4_BG<^A;<_K3O>HTP6[]7*%
MBF?6OV<.S6JXEPI\<*6DX<X()P@H54,]=LZZQ&:MBUJ"RO>H1B]4:-W!A7+,
MG?/(4:(0-Y@CC1U#Q(#Z%#80X<!U@-\O47^ 6W).Z1#RR+ M8='[P/(X-5(0
M$2(/#F$3(^+2.V2UDR@1S9BG)D@FUS9T07)!<DGW>S+X'J?[><FX3$(B[/.A
M!VPB.+S6(6\HAOTV.CJYL#!?0?DJHKQ$J1X"LA/-MR*/4DN-E H:<:P4,C&!
MM$JEF+3!R%";UT4IKS!<0[12BV!#5)(+':UC@L<0)#<18^INCC<7K_@A83M.
MM9+16IEB0E(K@"UA##D> J+ K_ 2U\S$M0VI>8%M@>T=85N\XGN)<$TD"Z4$
M_K#V!IFD+.)48N0L0#J7JE8D*F<37ML@!<P%S"4#YBE!?)P!(V-NB&(IPL0&
MQ*--2#,L4(C&)  [)X(7U[C@_-9*N[C&"P+M1 *'%#'HX!G"QM$<KZ;(,$*0
M,UA(0GQ,UH*5O53.\4/7G)IH?S < N7WC^H\/@8:=SM]VYRAD<-H>Q8Z1[DN
M9ICD-8U^<M(.8NO7M'5PMA?S &L;O]A?+W6CF2\QZ/K.2OE)2Y;APA9H9525
MYI)S*[AG2G!BK9,8Q\2CL=$I)DN!KF779HV)/ J#K171<L0Y(V" 4H$<"0G)
MP#55E!C&T]H&?8'U@W1SFPM23R-#NY!K(=>'(-<2O'MT6AVGM'B# PM1HB@%
M!FYUX!U8;9#BVCHEI/'2+""EI5!JH=1"J0]BKY80ZA(1[3BW2*2@% T2$=A:
MQ*GVR$@K4(K2I&@ETS;<TQ7"0K>%;@O=+D-XH 2Y%T.K$_E?TELK!$=)"YUI
M-5=H% E9X4S"G@5&Y" L8 JI%E(MI'K/I,J!,ETRU@=-N&5*"ZL<M=Y0(9(@
MIA1$6WIR'6?I"6MR$<^ J* 4<<,MTA@3%)PAVB85M/;Y KC"=T[M*>1:R+60
MZ[V1:XFY/CJM3B9,1D89MI0CXEQ$W$N*M!4&,2%Y2DGBQ-4B$B8+JQ96+:SZ
M("9K";LN%=>.,U>Y3<)%EQ#'QB NF$762H*PL4'*:+02I@1>"^$6PGU:A%L"
MKX]!K!/9Q5$8C:E3R%'N$9>6(F. 6)F4RJ; HQZ4AU-D==('ZNSDW_I9LD8I
MK#<F$.MI+OMVW.LWTMG@5XUVB.W^2Y3?M&C 7F[Y>P6O-./U%_OK8!.N_OFJ
MV:Q:MOL]UL]Y.>L87NH?=V-UTN@?-MI5_Z13G47;[56V[I_[YW$[#H9A^$65
M3U JVP[59O2QY6)W^!*I7\+KE[*!!U*R?=R"1_)32WMU(8?+MO%_KOO;QO0X
M4\-,<P\6-&&'F732<>R$,=0JG!+!A!D=R=?-^M '_D/CTY\!M[C6V<M/_C"&
MXV;<26_^=]SHG[UO_Q-[_1;L96\W+]8N?-$?S8[__C3II!G_\_%L_TLX DC+
M+?J&;[>VSO<W7YUNMS[33 U;WPY.][Y\;.U\>7.R=?Y=['][?P[?G79V/=TZ
M^(IC2!9C@9A7.4F31&0E4$*0 MB>268Y<'H$SCW*>]H]OI2!?^,N/Z VJ]&Q
M>QA!V32;G1/ <]4[;@$>X..]J@\O>-OMGN7?VQ:05#]+?:REH6J,Q>'EM$C^
M["$'4!L1X(#&X&&;]J@77XY^^'U4*;#1KJ=<?^AWF-I!HSUBQ6OR[^LO'+S\
M^TDC] ^SRE[' [4]O&HQ_.;AR^OU2Y=H>?":XNM:T1M?QNODQM=^-"S!ZT+*
M6PW[X]>XX?<S63W3L#^YSC+GK96'Z1%_O8&WF840:!XX?ZO1;((6O[E.XTP/
MZ $FL?LXCZBN?<2LNRI06[5*R?0_QP/>>&/PB:[%2&%7H*M'ZX&GUN.A;VH]
MAE?SY@JOUW9/U8TVP+>!;03;UFJT:_9.MM&M_K'-XZL53&>T;)^[F_R<O. '
M2#\:2._8VWW[SW9C13S>#V?P/KR]^?';]N;AX=ZWC^"U'A[N;WYL@2?[?3M_
M_ZX_W]_]<'+9X]W?? ^F+'SVW1;>>?>V 7\+^/O[]KO]ULZ[#RP_Z_;Y=G-[
M\X^T-5G)-2@>4@@<7%WM$!<8_-T8- I).Y!BQZ+0:QOL!5_TN<VJ1 D+NST?
M=GN &%]AM[NSV_@B$/ 9R&^NPV5D1!ST$#(**R02>%#)8!.UK-E-T*?";L^A
MAOX-!FKGN#^WC5IJG"SZ;N-EAOHRV)F/@XW9G-B7M[ M?^==>56'E J-S4-C
MD]?$"6P+]3BWYC*YAZL32%.5$&$JR< I9YJN;4@BEZCD2:E1M#3&1\'OH^!W
M;(:80%AN%X8BUP9QHBRRFD3DG(I2$:5H#+EDT3+5$GQ&@;!6! 2$27/C5E;$
M-0NP@BQD@D@Q]X5(G"NNM< L1DD2#3@Q+.>S(K;JE9\X;RP<,P_'G$W8",X8
M%Y1.2-'LZA@#KH[W&E$J53)<<*$T< Q;5-K"$D5J"CHO;/S !/;4"JPTIY9;
M3FETD6CN"*%"SF<C%'3>$9UC"X ZK!0V$7F2/.+>.F1P[L2A-+:.I\B-6]L0
M?%'W.9<HTC  &5MR4V!0GO!JQL.\IM</L[ENC@ZM=,!XD4NS.E1]?R=E.:?K
M2ASY[^WWM_'\VJ'H@KOK@NW7$Y::)-)$*P6*D>7;_=B"(X@](D1;%EG*G2+6
M-O@+*1=5PG81R'OD.%#AW<*[RWZ&5WAW"7EW;(,SZ@@C-"!&4D*P]S$7#J?(
M.\<YPS$W0:MYUX@5X-UKDOJ7.Q-]Y'ON=FU^^(GKA.WP&I[4-MK#EU[U>K'?
M>\99Z>?;)U^UQ$1[*9$D6""N<HU+2362F!$1C<%2R*>?E9[A]T]VR>J*[#%4
M_<XU3MIZ]?K0M@]BG<<[/@R^/H>]LMT(__;-XQ!ST+?:@2_J5K_ KSJM^.MO
M\?0HMGOQ1=6._?45S7<7>)V(FU]^/OGN9;+W-%DUFW3->)/@QHBO>9IYZ+N'
MW1BK+7C?8:]ZT\Y$=)&FOX#L_">Z*I\:IS.LR6(OG]Q/T/$^+Y_,DV&VW/L]
MXV64F1YXAILJ*[5P>+&W>%9J;8I0+42H'J%IU>-$C[9COSH ]_*W7YJ=7N]7
M\#5\YZ"=Z]54G?9U'L1<MZ46^D1+W<BJ7(5X/E<A'(X42YZPDIHG[W221D3%
M.-4<5D4/ SU\*M S3UIBOO@P7:0O%X]:C>CGMX^MP9@'?&OWX'1[\\/)_KO]
MPSV:Q_I\NK7[^6S[RWX#/HLO1S^WW^W5\]_9/#C=V80Y;O[Q?;_U]MM>CB#M
MOCG=WGU/]EOO3[;./T[G$,=(K$@YW&FM0AR[G'YH""(L:$,"TRRRM0VRX#Y3
MY9;7<B&\4-L,U ;TQ1PW A/"L?'.).*\))Q9*R4?4!L>41LNU/8XU#8^V%%*
M>&XL14Q'ACC/7?2XH$@JD;3"H)226-M0:L$5FPJW+1?$"[?]G-MN=3Y7N.VA
MN6W<88D&80)S#%&A(^(T%U5V3B/.2#3!F"A86-O@O'!;X;9GSFW:<):2 ?4/
MUEL(P7*L.:/":ZR<XGQHMY%BMSTJMXW;'$EEK:$N("H#<)M3 =FH+#**&>DU
MM9'FI'B!GPJW/8>[^1^'XK_XB&G>D%#N[S]JQ.UC(;<[D-O4?3S*E+'2(>$$
M05Q[AQQ3"C$<&4V6>))+C]PYW%9N["\Q8N\>2)JE&4/!\>)Q/'%S3S'/F+=(
M.9P05U$B$S1&(@1MP0GC/BVNTT)!\P.C^9>'C9WTX('AIX+@^T?P.(02M*,D
M*88\BQAQD[NIYJNX2A'& HE8:[NV<;4 V*\%MLL*VX>-"A0E_#@0'D<*+,96
M!2]0TA[G2(% 5DF,%#4Q.<S!O.;+J(2' 8'1=UW<>ZBQNNCJ%V6,U1KC.423
M/A^=V&ZH;,B7: :AHIL#2#/4?RSAHT<+'\UPJW6PV__M-GQ\=;'CK]KM8]M<
MI1)S#Z0AMR?K>%LI1<IMK)4/'G'A*;*6,L23X(H+(HT&#6GN7%^FF+I+#/'[
M3EPJ$']XB(\C4=&2I&T@*"D1$<<R(IVT1K"5U/- %;4A'Y<5B*\NQ.\]?Z=
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M\<NZ:L"(ESY\R56"9871ZF%" Q0+O*F?-Z#Q/69_R,>AAP4ZNM4X;N63P^;
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M"O1J\,@1+I"V0:0D+5:.E8CP4P3HS6VU%JE4<ZT5^*FXK?>!TXD#9.Z2Q<(
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M2M7:AC9%;3\QA#]P*;2"[.5 ]CB@ #O%A>(*22,IXLXH9 S#"$OIB(\B!X[
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M:[(BH4S1,A(YBH%P\)T]09IPCJ0EF@9#,0<C=7$55>?I7[C,E:$+F3T[,N-
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M)0[+QSMD$[@S'FO# %^B=WC&.#)MP^RR$&:]$,XRU;+@1F'G$'4.%H*VL*'
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M1*C<J&Y9F:EY<)X+U694 S[71N9#>10/>AYOGN-]<COK^CSY<M9ATM>OY[R
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M6B.=3$0Q2B(2*+,1/(=0E9PFA%JT^(V816^!>:3"(WBZSG$\ZMNL"85_I$2
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MH\H2Z2%0125+*D224;=:TIRPBE<5KZI^52W".=WL>Q<3TK>/!,LR)6]!:IY
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M1I3QBT0A#!L"KOPS$L]MTLZCL5:3<%9/XAO9R',A<:^"/H>@7_EDA,LJ4DM
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M<P0A301+M0<2E<PAH>B/PH-D\4D_5;3K^3V+9%=C:C[QG@ZI*4JB#R2!YXJ
ML%("6D\,C-"4IT!SXG%C2]?S>]6$?+6<NE4Y7Y)T3P6@",W.$\&!^A1 :!;!
M:".!!98#U8RZC,(M;\XEK8=W8^5ZI<6Z"O3, CT5I7&:DV"R "TYFMS:9/!6
MX6GMJ)2:"V:4NRU*4P_K9@OU:A_651.?TY%V+:RAG?*9ZP!&B@1"& =>)HHB
M+ETR/%"5Z<:66"0(NT3)?E[5Y8M6;MY9N/D]P)JE:G:%T&RE\G5'X%7-CZ5
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MB+99>A,4%U$%I7S<N.AS<,Y/K<4;&TR7@+P)QRF>=M)!W@[A].0462C%[U?
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M27)Y['_\$D""A T"+!R2Z4^_$9&9.'A(E*R#HM"[TRT35QZ1<<<OGI#/GGR
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M.\.P.XYC##!4TG<' Q!+0[??]?J.X_0M_QI,F</C-\O>?/C099QX*8^6W(G
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M6CC,\7H8^+QXZMW>FC$5;RJ'A2\XFH<8T5V(0EXEINZT J.4,"L*,1H!LU+
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M@K4)A9\'#R!&NO*IP"]1[8(4!W:2 K2$W#K%PHSEPF"E#;#3(*"/XAR.^/?
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MDH%@G-5:-ZR0$ C&S8(P3ZAS!-(>4!KY%"LW*\M""$JEV1V60K&EA>@5S";
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M%7G3R.TVX>$,*Z #.B2H/K @)%A"#2>(IAN\FC,J^#W)$X6[3(<+[?[Q7(Y
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M@X[6;,=];L<[B65(:( 4WREQS?V0?P]$L*?9A/O<A*,8VQ7 +GSC<T27%*'
M1A&\9T40N^J&!7R[&R1N/L5F,*Y2"!$F%G4U-\&F72BZT3W 2<<C^R..$%44
M=TXXQ OO7;J6G6G4V2N<2[>V0ITC52!DHBTO*8>@FI&WW55>>:9%P52U]A-G
M,T0;"-3.I+$:[MG<K'J^4;.O>IW+&'1I:\K.YE7K$F8 9WN,SG%I-E0S 40W
M)?D76:O8HN.?/)!PAH7=.9O,4Y*;7D#$&B *HVQJ!%0<BFXC@J01Y%:$79+8
M@;TN/5^7W"'#!<- P/'1YJ@:'$_;!WAG/J&SPJI'?G%4:_=P)D$:807?2QV^
MI;VGS0F89  C[P+X@CO7WH*1-KO[\&MSN'_^<(^JF-)<MC"#'?_&^:S@S$D\
M16#GBD>'8)F#1*-QJ@[K>&_%=2P[I&$0+16MQV2G'":.FW0:N1.,RF$/7G%(
M18@GX1AMHA8$;,P]T=K'A3D)I9G\_44[GMJ;,LZF4H*1DP%9"4;&D )$\@V,
M4 1XJ:L4DZ'':7RA)IRPRR*"4'B81=!0>B%4<Q(:B!J5;$.-+:B$SP1F(_"2
M:RWN92!*!"5@Y86SG 9, 3V.CI-H7@GR%ETAU)?B9.WT982QZK1IQ.-]ZU+*
M<Z'++EJ%0TQTZYC.PG@N))%H^51T @LB7=PK8XA3BF.C9[62'R /3CTV@LP7
MR;9^X'Q.!@R0;:N((^,UT00>(=33DH9+ABY4//Q11H D?8L *_Q /0,=GETB
M<:X<-(_&LE$4GF70'6G"XCVB'1C]573!WEAE;(0Q"6,DLSUU_L]+SG0J(: ;
MZ;J%O$%:2JA8%FX&Y7&KI <)GS7V  K&C(+L%54:3V5&L6Q"TL86AD7<LV0S
MF>B0K@(WBE#$@R286HLAG$H7+'1]A $=<@6RC4QHG%2ZUZ4NI;LTPN2>"49I
M+J*[[,).UJF$Z E9)C* >D!#L-,\\&A38:NQR4899"=@=669U3Z1BCC*)7P=
MU8X0!US-!I.2).$K.XH77Z3<D&525TW0P<8'AH@I\'?/WI]?_K&YR1K>*/_X
MF602WS"I]FTUOW,D%+0GK9U<G2Y4=G24HF(IWQ1S^F+7S9,B%Y1R\:J>G8I^
M"C8=9ED%F%% AQ%S_V3Y@\II(P?3=RUDE\KP"DBC+G^(,?\P$&E]:+>2*HUQ
M8[A3)KF1B8EC2S@P.GY5,J3\F_H9R;3"ED;M8CR4??7DIDI(0)1Z\.\,!"?-
M5SO&U%.1C-PQRB62Z<-5U39(4]3BJXM:,FAZR$MR8N8N5RFA<WJ2>AS5FP(K
MR[2ZYM4WXUJ\TEX&OP!?QP0YN20SY:J!'X*IDR<I+[Z@,F7)XX,;1WE[O].H
M8#P>'/9 -H1"@S,N,_?ZK[')!PT;39,XG>'92D6ZM4P"G,9@%OOL(L;GI25$
M4U5I>1Z8WU&97(BYLFDF;H&%""B.7];T@-1)9$M"O/LD&3,8G7@M3J:H!]B+
M]6+C:5'WJ_U20#=R)W*)&)G39+. &>ZB/)/6DEC3U["<Q7I*X?:#B_SP@FHO
MT'U-&IN@ZFIWZV"JFL7#[HT3]%? '8*>*WG*/'630#@ Q-*+K&(6,8^)B*UL
MUCBM'LK7= E&6-ER.G>4NYIRT>W>8:*3_,(F[PN++\XS4 EYZ:FHTZI('LXC
M-=2%%C!Q-([IS :DJ:CU%I55,HWT=KFG\AY>- XFB+KT9]--#XN6-HK=X.*G
MJK6R&'B5Q2PEW3/J25/SDZO4: QVR.33:I,MZ57R ^14V$7FH=-2GY^:U'G4
M,JU>4Z95V8RS2@#IO6STA$?BO>J1/E(=7W=7P3JO):-A=KN6ELW,1<>]<I7*
M%KA%6VY1G&*N3U[;J?979K_=L:R[[WO4:0\[_3M_;:_7[MIWTDY)[HE<Y64H
M5GE=^!'67=WJ5A'7\PRB&,DG-N^ST2S9/JAY#[5>B?CN+B^G$DK+'4MNAN?0
M\-R&YVY,\?>-AK6Y$\PHF[K_GWHK\R?"BQ\56(S:S=VL4=1V,>0KH=JV3,&F
M%3_8V\Z^])5S]$@!*!J!J*/9KE6ILY5'6175[CS#_$&5#\4\=&[5^\M/@W3*
M,G>"6$/8ZMGC8*I1R@6F$P685 'J5Q@&E-.!W:C)=:QC]V-MNG<*U$G=EV=8
MD*'Y81XG\6R>8(-R')5(E:@FC+@3S+68\(3-Y@L.H483:321)R\^;ZJ)1'G"
MQXT*TJ@@C0IR.Q6D=H >1=A2Z(@JV7E$B2-2O%')QPJ9.SIZIUU.,.%D$O +
M(1]G(<^H?CD0U5LB.W;Q5WH\B(HK3AC'G@@@5L!;2G<LY<@$(N)$(Q+9-@G]
M;RS@@(ANA6PNM05T8],0$Y'0Z\(/>!?!7B35."V\)^5TKSN)\4^\7:1^N9Q0
MJEH:B'P&QR0.>(;EUQC%<BGLE\"R8\V,B( WZD"C#NR:*&L<$XU6T&@%#Z\5
M-(Z)[79,$."B3E'R91^%U)/R"-&/72'/IT3S&$0&U2=/"#<X14="&,"PKE4=
MGI)28 SM)Z04]/K#^U8*KN#(Z_GM]@FP&^H"GSGF)[&?%&@[LG97<I4C-K\+
MV;_!4JV2^K=;QBO;#A4)40^]DF_V1ULLU1=.Q)9YUI5'/<9DZ8R+]%O"C:3\
M28$'\&'O&5JYC4#;3:9\*^.VD6?/4IYMG?TZBJ(X)\25/QE\ODC6/Z+*$)&_
M^H=$X7W''$QG1Z_H1Q[Z3%3_;:F4%,?LO@=UY1!PH;9K4;; ]*52GS(0KESR
MUUG$-2N80&:19@DKW<V3!._Z2=NX43@:A>-I2,U&X6@4CL: ?M)N<27N$#@1
M =/KPJX>*%=Q[A"KH%/1W@$$VVS"QEP@2(T9J&IQY;>OH-*)/#-1\DKO@8<#
M+R?TD6P"$QT'+B)38;FD3%^+>%P,B#+4$N8%39K:$Q&@35SZ24C275O#J\W+
M61*$342ZD;U;)'L7+% A8ROYV *;HR:"JP;GE&<, 2) >I+<A?\54K9UK1P6
MB$N5Z\SC4>RRQ TBF%A+@H>$U+'-U][OZ^],[$^7""Q #3^;IXT@;@3QK@F1
M1A W@GC7!'&3&G9S.;Q=B[3'G!C$_?S[8Z[3_USK&U^CJYSN/<<H>Z,J[+B8
MNZ&J,'*X._W9]+%=6\-KW.").VE4A0=:<K.[S38[C:Y^A!YC?;27@<==YF!C
M49!^%X$;\MSEX6ML!J'#'[]L7NN-P'BS5 6/_83P ^?:%%MASS#%>LY#&+%T
MB6,7>;+Z8X+EQ_)NT6I)X'JAOZ!:!\:P"<<T!VL^]A0D-XXY ]-?X("S%.$8
M@V@2.-AS28(P(ZYB%NA[^]8 &TW$;DAHK?BC$WN-[[V1XSLG@VXHQW]/^)Q%
M/X)&DC>2?(LE^2[FT]'$%L_?XZ@!89#&I1X 0HD)1>"5AE>NT 0VT@%"$')<
M^UVGLNQP/IU-2!&@UC@K'\ B\\ %09\4MS>BNA'5NR9D;BBJ#Z.$.X';2.H;
M!&VYD^0(%]P(ZP>4)]OJH:?!+9RB1Y&W*T6IS!G3"6$>>]B!U0P&+Q\S;#&:
M:"E(0J#*=!WP"UC1A(Q-AK8?.$F<!MCD+DXS?1:'<W>>31B?!DS#?DCUV_#]
M="-/4]D\))LD\=2)RZ<6WJL 7/YD49YJHQ04B(#&_9\@PM2WPA37(O;?_]6Q
MAJ^I&X'HWN1@ESR:/3P@5(?\>XSM$*+ :41](^IW34HU5GDCZW=2UF^WBWV[
MK>O7UUG7-_"SK[&QR=F>7<:%K[WPLJ=SA$H+7*W)0V^D[H[*BR;][9YE+BK_
MC<A]:$5G6T5NDP'79,#=3%L0[]CZ9F1FY]^B&1D>O0E#%PSUNL0.8]BM5'15
ME.V>,5<A\G*,2NF7V"0ZX1<!# '64SY6M!TM&Y4Q%Q0W0O;QRK--O5413Y=:
M;\K&U+!74Y$ D6:YA[TS/>!SB(L[Y3S#NX*D\ 7QR)O% >P@=JV$<<+_QSO3
M&7>Q:QIB"/U^=-;2G#S3+F5G;=06M^:TT,H_*DNA$2SO'+J^TMSYBFTKL24O
MKJ[<:&=.>X6T(KM@PM7$6W&^SO;>[<D^I=AR?,4=?\!1TPXC@E(&6Z#"T.0G
M6L6^X:^B,RQ>:G9P[0YNLBMMK6SN',YID3TX,QYA3A=+W:ST9BM])7GO;OO*
M4^ZC]1VK=KNRF>[*;IZ57LM%GUOD_4!^JM>E5[E%]< %+O^-9]275W2YIK=B
M  $(AXVY-E,?D*TPFS:Y/]\FUWK4-KG#%^JIIDWNB]_V@<C@^UF>\+2EO0M@
MV5.AA7G:";6E'B4)B\;437R'6^76UR&LK8-HS\TJZX!L);[4<FJK[L<N_"%Z
M;Z?P/]B<WN&3 )^$'\=)?(E]'6;8?#V/ M&O'74@+T'0261-8PKEI9D6QM%8
M!P*<:J# YKRM5=L84T<&)AN$T_&@%KW8V3W2_F_P_5441\?YE%/M+\P8UA98
M*)P*H]OQ#<>P>D[/L0VG.QQV6-_P?=,PK>& FU_VD;49\/]T^J-G&2^TB$UA
M_3T>O-J'">*TWP0IF/B?.$O>X)1?R"-G_3UW]N.+=YW3BT_64>Y]/;CX_';X
M]63Z5^=X^LGX_/'XZ\E^./ET_I?Y:7H\.?[AFL=?_YH?O3WJ'.U_PWO,=]9Q
M^.G'[-OQU\_3X[=_?_WT8]S]]/' ./[XY]=/YZYU?/[)./KZ^]?CKZ,NW?/W
MX#L\>_$Y^G/R&9X[.O_+.NZ\"8\[?TX_PW-'^_"MCW#MXYO)Y_.Q>?+VS?33
MU[%Y-!\:G_]W8KC3OR/V<9C#&+\?[[O6IX\?K$_3SR&,\?)X_^_)I^F;\-/'
M-^')_@?[T\?/ ?SOC__]<=@Y&GWQO8$]Y*ZM6YV^H]N>:>C#H6/I'=/NNSUW
M:)C,??&;<.C4MN0WJ?-B_V4@3 ]H!&BHK2U*.=%'OJV]";!?"8:2ST!OY85D
M PEX'&=<LT#'"L, 3<I"XB&UUH4EW6JWM9N=\ZH$]?.$K@<1_&NZJA?(CO !
MT+Z$7PLTU3BAB;XBPQ3O>O';:,RC/'U4S5#7/G(M=C(&E\#.U<9A[ !]\.]N
MF*?(2P3?XDA-8K@RT1/5&[!I>89&K1,4]JM*Y,?KXX1-6]KH[<&QV>_W6X)%
M.6'L?DNU\\.WA^=%24"AV6L91DVR=O$4&L@.1[H2QC5U$(\C7*#QG)X/2/6:
M@>$.\T./854MVTVZ OER%5T=!"E[K  ;B3Y!5FX\A2U ]Q2,H*0H26)IAKZ5
M,0F6,&2.G(<PI6D&A3/,C?7*EM*FPT_T^@396?!#/ I:^=')Z<A!D8-E*"D/
MN8!A]F-4P,FY,\M(AY]-6$&KNI?D8Y1O7_,QWB;H+8B(OXV%4RE"SPUZ"!/X
M8$N++X#EL@CD>BY9'NIZ:2;Q+])V.1(D4(G<&%*/J/<3S,8Y_/7P4"M(EEY+
MS9:DFSS+IW&RB("Q(^1[#5L$:PQV/7JT.JR2,?+O2& 4VL7BJ!E1&8U4Z%B"
MDB.>)W&*731=3L!E5(R -%&EVCJ5 SLE=4LH6[7S\:%]UB[8+A+$^]/_-8QN
MJZB=REA>LEGBJ8K[HF=$<M"4;@>:I ,EK7YJ\)GE3AX"D:-3 &@W@3,( U)G
M;0;27::;5=T"H_ 'K ^<MR+/7R;' :=6!+U S>(DB\&3BY92S )45_%([29I
M7\.93T'V@7(6AK#S'R+8[01,[<>"J:VPZIKJCX0#Y@/I;6(35P^[!48&TB$0
M$9HMY8%8J3W(L]#28,BY#S9'CE4@Q,I+/LZKGRI(+8KAT575@IJ7QQ4ZI;,
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M/"O+&B5XO(/1V5@J?Z5B8EW>U21PP4*.B:C(^9=T,G$KK>L+0O2G2/_W?DT
M+AE*-W%(H *>M&R*9I-I'$S(: )1' LL$9"N$B2NU[\=Y-W\_=XLV\$T\&8H
MQ9W$$Z'UR[N+ZLHYD],^-OETO0>EVX.2;6?EJJ66%E%:<Z:B<;.R+4),2R2
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M)CEZ*7E:290U-<EE,1EF4GT0PR?94!>5R0X:Z%X8*@ZFK\];]/3J'!*0RK@
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MV4=>_W2Y]$6F51MDU%FJI,&BH7E@<5,])P(=V^=CC3Q652(UP.UT#5"*J+P
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M,?:9E)F4CY^4>[5>PU0#P[29!+D/7BD.R']QV1WZ>9>E[K(*_NV_Z1?IGE_
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MX@>&! ) O/(3^%W$]#X M=0[SR,G?1JD-: 1;LZ80:",&8(RH)<A"GT2GI,
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MX0]=QQ<YU5'+\2/OI<4N)._HUEEFD!: J7IOF78102)3,);A*>F)J#3[P#O
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M-Y!./GE:LX!^;JUK/8O#N6?1:GR_JK9OF_76HS-9O)L-NV6@C=R$GA]BT?'
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M$;R%@+8QK4.6=[?/Q8GOFB\Z>BYT/Z$C4 $T)H&6$:&>QXJJ&*X',=K$1;'
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MQ$Y@)3H*6+<+W27T8/5=#0E$!=0[Z>J.RN5@3Z"MQD+D#[@E[!T@N>=="JZ
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M_.($:3@C*L@HQU!&H63]0 4D4;:T5APT!53;+^]90G.*EO?"L[\\% 542I=
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M;O?6UW2ZYEV?M68WOL<?YOB>5#_^>&9!R \X*(0(^C0YJ:D4;^H9*Z%\'9?
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M)U^/P&'54_7<D#HHK&G4LZBP1@+V[N?*^<EX\?Z4VE63269-%L$40%T''[A
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M?[^_/IYW0=SEGN**I^QX5?$^7#>[/L8@E,+LE-2JA%J+0L2"0:;$F$<]6/7
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MCJ8P6OAL([_K =3DGA.SA]&230AHH!W+F^@'JVZB+PO.!ZUYC<5%B1)4D(K
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MD7S/.C(_IAN%DT62)D[>EG>3<3Y+L_?#CY]FRW)(+*&//B,(GVM?&&$@9.'
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M;^_+FMM(DC3?][_X;-S'RYI1$JN&-BI)*ZFZK?>%%H>'A&V(T "@NM2_?CP
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MMX9KO:^>5LE_+:5?2(YO1K/E"D@_LTTK^,^E',^MCT*(I"$Y\OE4,742$5>
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M4ST=C^K$P&7,^0$P6I8HWDLH(F--YI00C1(0I,UD$*:"7G70YZ,O>>%*'4Z
M UI<%1AY"#]&?YQ<UG$[XU$XNYCC>(QI?KF(*I Q>F/R%RFC+;% 28O1D$6
MKX=0BB03QKAZD!6[5LN=7_C"-=Y&L /'P4[B:#PJ/PE0ODS$RU!_?PM,Z1RR
MHZ7'4.JL)06.B0#2)A6"+=[H+OOTHR]YX5H>3H /-:OZ:/;53YS/PRJN!SN/
MT\KXF"2=*8G<QNP,.)X=,.N$MQR%"5T^ZFYO>^&Z;B#2ATK7O93^VZ=/F"ZG
M!*E&?E> <4D&0DV(9P8%^0ZQ]DM3!CA+]<HO9..W)8UN?<E+5_%@ GRH6=-O
MZ,4TC<-O83['Z?4]K0[&<)-9G=!,]J!+-?N&@&F>9>;.I*19%S/ZX:-?N!;[
M"NNA[FR#0_8!O<@5TU[R#"*[NG'$#!&Y!F3"Q)R<("O_Z<?MD7VI+83Z4.^N
MC][?7WP9__SW]@.CR"(M67Q@HZP-NJ*"D(4&EAQ+(D;'.YE9'5_WPO7>0J@/
M]>X'&%#TR$'")%>E" 0KDR:+WPMP-9@B4!%2%FQ,HM/.O>5%+US7PPIRS97(
MDZ^WZG)?7TZG-;5Q>2^;I;!ZD<%8YXR*DL'SXB!Y0QX\\T'(%8WVN*"^^^:7
M''MZL@0'](+3%8;SD_'X"@\1[3HDT@%3AZC3#--_?)G\^-_7[UIJ^/IW"PTO
M=/L8EOW'G)ZNG4DCT0YXJ?DH-FN4%L6DRF)RVVOK!8="0.8R!X_*!?98?NCS
M5?<CL::VVMY%HDVT_/N;<^FREZ(PJ-V&ZD1@.H5"J-?GRDBE+$-\K#?B[EK]
M_<W^SM_AI/] G3N*;L @T@V&WS^](4[J$E6((!FKC=Y";1]5$$I)R@>M"Q%S
M2/71.X]!?;N*KD4UUXVY4#N"7<X66TR1(BC#$5*1N?KC&@*/#&Q)Q7@M@[-M
M6J.M0_-2C:C!)#S@Y?,F3-<I:!U0-<VI7X_K,%GQ_?6VA0@]A+Z'C> *'=-,
M*DL.NLLAU.BGI?VM3O1@M/.E&@(M;9IF[I,*6U+,]\6$760]< [!F]'LVV@V
MPWR=F>*L\SI+>K>NF2G<0K"%@X@R9H:EH.URW;GRV/UGZ@XAZ<DP8MIH>VUH
M1W+UQ_6'VN#]__RO_P%02P,$%     @ F53\4JG10H]$-0$ 22,- !0   !B
M;7DM,C R,3 V,S!?;&%B+GAM;-R]:W/<.+8E^GU^!6Y/3$15A-#F R#!CCEG
M0I;M/H[KA\)VG9ZY%3<R\)1X.I6I)E,JJW_]!?C(9$J93( )4NS[H5RR3!)K
M+Y +&\#&WO_S?_V\6X)'693Y>O5O?PK_'/P)R!5?BWQU\V]_^NW'!TC^]+_^
M_;_]M__Y?T'XO]]^^P3>K?G#G5QMP%4AZ48*\$>^N05_$[+\.U#%^@[\;5W\
M/7^D$/Y[==/5^OZIR&]N-R *HO#YOQ9_21%"<4@SR&*E((J9@%3Q#(94):%B
M*HP2?G'SETPQ+J,@@$&L$$2$1) PG,$4RRBD0@G&ZX<N\]7?_V+^8+240!NW
M*JN__MN?;C>;^[^\>?/''W_\^2<KEG]>%S=O]!/C-^W5?VHN__GB^C_BZNHP
MR[(WU;]N+RWS0Q?JQX9O_O?G3]_YK;RC,%^5&[KBIH$R_TM9_?+3FM--Q?E)
M7.#H%>9OL+T,FE_!,()Q^.>?I?C3O_\W &HZBO52?I,*F/__]NWCT2:S-^:*
M-RMY8WKV6A;Y6GS?T&+SB3*YU.BKIVV>[N6__:G,[^Z7LOW=;2'5X<<NBV+O
MJ09E9E"&B4'YWX\U]N8,^)[P;EYB]0"N,O>++XQ]G'[Q!O>'U@<Y/N!.,V=#
MKE^H]RLQU;N[;>ILZ.,C]O5:K#=T.<%KL6NF WEI?O%)_]0T8Q[4(Z95.XUT
M=Z#*GQNY$K)6R[U'@US\VY_T3XN'$MY0>K_XNKF5Q=7Z[KZ0MW)5YH_RHQXH
M[^2G=5E>/M)<7[N4'];%=[J4WR5_*/)-+LNW4JT+S2U?TK+,55ZK_J7XKX=R
M8\;1\@?]N<A"3I(H1C!EDD"D5 9I3 64BL92QES2E"XVVZ]C(5?PM^^M(17:
MJ:#^R8'MS1'5*&2Y?BCX;KR]6QX:1/7X:49<\F9%[V1Y3YL;M+W&-:DI^/?*
M4K!G*JAM!;\8:W^] %N#H38/EMIDL+/Y K#*:O#<;-"Q^P)HR__GFQW;K_JR
M+/^%7H'ER+U_]?$"O)-LL]>C^QUN#+P ?Z7Y:OM&-%V^,ZN_@]=\SX"E\=S6
MQ7/NUWQ"[G>:6FK:*N(5+5G%7(/BC?&WW\CEIFQ_ \UO8! V#N)_GP#NFQ=?
MRF71LDD+?N(5:JYXP]?:>;[?P+VWR4PVIJ9]LY[Z(ZM?.4W$G\"Z$++04[0#
MI+Z0G^^;-?_[-WFO/[1;/36X+M8W!;V[?-C<KHO\GU)<WJT?5IMPD4F61C+"
MD$J)(6(IAUD0"9B1 $51@D4J0I>!Q[+=N8TB%6RPPPT:X%I+MM!!C=UM&+#M
M!SM-'X'=D07:!['.\NM(DU<MM6U[4F%T).2YRKG>/DRR_D.*FWQU\TZ6^<VJ
M4L1WZSL]:B]2CIE"*(088001#P0D"&60HP '8:88Q<A%HXXU-#=1:G""#E#P
M>PWU_W53H:/4VLF.#\)&UIE!7#D+RRDBO"K)T<8FE8Y3)C_7BI/7#Q.'3_*&
M+C_3C?GN+E?B:KW:Z%;DBFMWZH>>P[_5F/^^X$*F,6<(4I1F>AHM4TAX0F"2
MR"A.,X9BY>3-6+4Z-]FH0)MQEDMI5O%+0%<"[&$'OQOTH(+O*"5V'6&G*][I
M'5ED:F8;P$-9=18=)Y:\*I!=RY/*D1,9S[7)[>9A0J7G?X743M([6?__XZJ:
M(WZ]EP4UK5V6I=R8UC_EE.7+:C[X16XN6;DI*-\L I)B0@2%@J811&$408:3
M%(HHPI'"/ VBR$7"SL0S-W%KS0&_M ;]"O(5J%<!MT:!VJKJ$^W8=0&T9>#W
MUC9'Y3NW9^TT<<+^&EDMI^DJ9SGU1+!7H3T7TZ02[(G Y^+LZ[%NLLWNGA:7
MT9^UZ'Z7JWQ=?%EO9"D>I.FHS_*.R6(1!2DB6"$8"4HA$C&#))0QE(P(07&&
MTR2P4>333<U-;"NP_P/4<$&%%VC 52"'G79:T-LOBWY)&UGQ^O@"O]=P+0<=
M"^)$$XA33;(F(G"OS;D2:3TDV'-3J[V^OE+P((F#2K\M'C")--L;TJJNPQW#
M_."W#V6^DF5YM;YC>;T0\'&UD3=%]>,WN30;^U?K<E,NPB1*PDS$,&1A:$*[
M8LA$F,& LT!FBJH,.;F\]DW/37 [,('\>2]7I2S=G%0'VNW\T7'('%F(6]"@
M@_H"=-EM@(,*N3_GTITMKWZD0_.3NHSNM#SW#@<\89AN?:!Y\9]T^2 _:R?T
MH9#5?NSVE_^1:V^TX+=/S?HYC<,$"V+Z0BKM&Q(",YH%,% IIHF*4<QC%^ER
M:GUNZF5P@@HHV"*MYG5?+O]SX,:%6V_8*=IH'(\L:N?1ZRQE@VCRJF9N""85
MM$'D/->T80\9)FMZIKR+3%ED&8V5TK*%>)IJCRM D,I,0H1Y(,(@QF',%YMM
MU.7)3VKOZ4ZR="2 U.=W8Q:2WM-B9;9"WM018.!RLRER]K QX3E@LP9O/W]W
M$Z9]/C'B"D4QA20-#(N80<JH@H3Q,%428T7#Q:,LV-IV(!C,:+>55^<4_%9J
M'TOI.=Q;6N:\4JMW^?+!>%[OK[^#*[KD#\MJ"#^/?A+%C&.(28@ABH2 -,,8
M\DC&-)(!00EV&86'O\X3C+(3O,YVX^A@ED8>)PU!>Q' +^BYIH7T&6]TD FO
M0^%^"Y,.=0>->SZ4';[(;:@2,E^\7VWRS=/[.UF8((*_%NL_-K<FO)*NGA8,
MBS!-J80\Y0E$<1) %FJV%$V26-$X#@BS^<I/M#.W[[V&"EJLH 8+&K1VG_DI
M:OL_>(^$C?SI#^3*^H.W9.+ IU]*_N>;]>,;_83ZJ]<_5!][]9F?>NXD'[RE
M<>VG;WNY^W[,M=2OPVI#;^17=7ES4U2'@*HS0#\**DS<M,P?C9:7[Q[D@B9Q
MD'(L8"#2&*($<4CB*(,L2ED01@0A)6VW9YQ:GIM0-.#!6@':8@>5@PTV!CTH
M=O"KU?3JM.Y&OZP2W-_2XDX_]F&3<WW]'[<:M#DH4U@N/[IWV^EMG]$Z8V01
MVN$&7Q78(@<5=%!A!QWP0*,?BV3[+:+1R)YHQ^C'K7Z)=\3O?P/'WW[^4&ZT
MUV*BN3@W0<QFU##SE3MS/FAS2U<@#/Z'>=R1#^G/?G:A!M'?LRGE]KS)]J@&
MF=G=LAKV@&%+)MO(@T\F'.&;26'P5>D);16(L CCF/,$)] LET S_X>4,@1)
MP%-">9BI1#F=V.QK;6Y#S2YZ9VG0.NY1]1-K-_GT1M?(@\&.J0KH!:B@PK6"
M&FP=^^3QV*$-*7Y/#O:V..WA/QOC7YS?L[IIF'Z\O[M?KI^D;#:G.F%+5P^%
M68!89"E.%,X8E (3/:/-4IAE7/.<D4":_"<R2ETTY&2+<].1%C#@>M(@5V6]
M-VM6"9E<297W;,T.I-Q.7;P2.?:<M\$*BV9+>R^*LL'K3V.LJ?&J,Z=;G51K
MK$EXKC?V-PZ./M?N['?M;5>[26V.H<N?>;F((H336 4P5I1#)$FLG9640B)"
M%5*<I$HY':/K:6MN.M,L!V^Q@A8L^-W =0\$/TJRG;YXHFYD91G,VI"8[%-\
M^(ZW/MK>U+'4IPP_$"=]\I:!H2_Y*M_(3_FC%!_U'&MUD^N)5!-VS?4L_J'2
MK$L]-=[D_ZR7%*C @J59!BG3<H*"C)N\-03B-,Q0&HHPDF31S3ET.CK#&835
M%W,RP9+?<V)E^1>SHM#"!;2#US$"QKU3[#1H)*(GBH6IP,,*/=C!;PZ37(".
M!>#2AGOW\)C!]/F-D7&',6V@S&":7D3+#'_2,#E\)XO\43_(Y'0I-T6UBOE.
M;FB^W![IHJE0+$AC&)*(0A2*!+(D#B#%&(<T2T1 G29PIYN<FV>U0PQVD$&-
M>?!).POF[33.+Y\C:]JY5#I+F#T[7B7+HME))<J>AN>2Y'"G^R[H-VD>R3</
M1;ZZZ08X5YKW\>Z>YD45,;A(%<,LT5QSAD.(4AY!&F(,)>($R3#!F%AE/7!J
M=6Y"5.$#^1:@_9::/=&G]RQ'H6]DW=G#O'\PXJ)VJ$ '^!B\VF]3CL+O1%N4
MGGAVVE=TYJMG3]'^69/M)SJ;U]U+=+_93<3+8K/XIE\ V9S7#"A.B,@0#+7/
M"!&+!<PXPC"3F78AM49G/+&1Z6?/G9L0FY6)O*SC2#J![8X'0)Z3UR^]9U R
MLK@.9L/Z,S]B>Y_+IF_IN&OZ;\]=M>?/G.2#/F)(^\D>^^>A0::70NB.+IO_
M?<I7,EQDD0APDG#( XX@DN9<1)JE4(19$A LL)16GVAO*W/[8)N@R0;B1?L#
M,&#!UY5E<%(_L?V?KS>ZQMYJ&\K4@ #3'B;.""\]]-2)@TM[#'L96MIWL?N4
M:IOP:5.=L*JV^\MF@$$)C1(1$YB$ 3<KV1DD-$TA2U.BQVV%".>VDZB>=N;V
M\>^@-D<+:[ #LE7TD7MZXN2)LI$%8!JV[*=#GEB;: +T]O/_ 8,9=)KV6/#2
M,]'INWNRJ8V%"=W)C,WE S(C\7\\Y&5N7HOR7?ZH)TRYGB[)DJY$E9SILBB,
M1U;-DK9+LRA - S""+(0ZWE.AD.MI'$$I1 H00H)3JQ.XPT%,#>)[=IP ;I6
M5)%.=3ZTKB'.Z^:#N^JT+H_= 2,+]HRY=TC?-'(?3"3_H_2%6ZZG,XCLRP U
MY+'3Y84ZP^B];%'G/,=]Z*F>^6W]1)<F.J[QC-)$(<20@I*G#.JQA$'*$P15
M@A-)N,08695).M; W(:.^IO8@K17I(/LG5;[<SD96<V?T3' [3[(B[T2G\O/
M1$IK^]HXB6>?[3WB>/"VR<2O#W17W'JO.S=\I!/ENT@E#GD49S"L"KVE5$!*
M,@55IDPVT52E*5J\J(;H$.C0:<SJS;2K\SA2G$,+UO(8>S^UL9()"XDF-,$8
M(L0YS+(LA'%,<)Q(@2-"A@7CN'+Z.O$W7LGL'RN\433R@.'$SAGQ,P>L'RED
MIMO2*T7)'##V>&#,H8L'5C23-V;H_";O383?ZN9ZO<SY4_WGKO"$2I(PB32)
M*4X"B)(@@C0C&&8\$CA#A$9NJ8"L6IV;*#2@P1;U!:@1@]^;_P\N_V'7"W;J
MX9W;D=7$#ZWNU<Q<:/);R\RJY6DKF;F0\:*.F=/- ]V^_#$7<B5,IM*[]:HJ
MG79%R]M%%.-8I-*4-V8"(JD9)YQ%D,0,(YE0SL+0[:C$L:8&^'UC[S)I5$"T
M<($PE2\+*1P=E6/,6OHJY[ UD;O20KP -4A0H=1_TS@]^BTGF/#KNAQK;%KO
MY83)+QR84]>[+VA]EB+G-!=T)>H?"UE(IC^^=AF"()/'+&,P5:$Y2Z6TZY)2
M!IG^7::T?'!J%7QBT]C</)86;[42W"(&#>0!ZSPGR3Z]%N:3PI%U8W+V[%?,
M?+(XT>K9F6PZ+:K9TM.SP';R$9,MMMD:TUUXL[YG8 Z.?SSH*?^N\O:'QR^Y
M]L1X("5/8"@PU4(K TAIFD"%S3Y"B (:6"62[&MD;@);8P0[D!?@PW_"+Q\=
M\VL<HM/._3J7I)$E]!@_8V30Z&'";]*,0PU-FR>CQ]07J3'ZKAV8P<NLZIM\
ME(6\E:NR.J?5)JG]L"YD?K.J>U=/_PJZ*NM,U)?BOQ[*C1EH?M"?"QXG)$W"
M%-(D1A#AA$ J @X9"U.IYVQ!%N(!"_8>H,UT>;]!#W@#W^3,:_%? (W;,5F8
MASZT4ZBINF3*O=(]<_:S8FN!:WJJM0ITS ([N_H[S3U)F3^:_:8R\X!KVH1G
M_HA\D1;-XZ.'2?<W^2A7#_*#MMJ$-II@DK_EF]NK)E_G-HH*ISS((JW',J82
M(A;J^7(@8QCP4!&6**F4TWJ_9;MS<^\:V'52TQ8X^",WR:\;Z(-/X]MVA9W*
MCD#PR$KJB5MGH71DRJL8VK8]J> Y$O)<U%QO'WJP[$.^U.*IW:V;=?&TD&&$
ML$@XQ%DH($(B@(Q(!F,D)1,))32V.E=RY/ES$Z+FB%2%$;0@74^0[3/8KRL>
M>!E[:NE$R8"C8@<-/^.0V/[S)CX>=M"8EP?##E\V,&GB]JCW5_4\M=#[GWSY
M($QQ@_5:_)$OEXM490JIC$(<(/U!)YC C$D$DRQD&4Y5%*K,*8VB2^MS^]QW
MX$V.]!>)N, O6PM :\*OCLD6G3K'S@<9C?*1E<0KV^Y)&H>PYC=MHQ.":1,Y
M#B'G16K'00\9.L'J9+\P:2\N5T+_3A:/LDIDRBA781SIF1237/LM,8=90B(H
MTS B02!B(:W*JEBV-S=AVT_6\D,_?U"JV%,LV\Z9O'$W^ES)E;8!TR(K,CQ/
MA_K;G'@:9$7 R^F/W6W#Y,2L#&W/H/*G:^V9F7- RZ6\D6+Y]'&E3+-2?'FH
M-I!C4[0I(0G$,=;J0H2$3(@$DDPQ&F1I(+A5RK)AS<]-; QZT(%_ 1H#P-8"
ML#7A M1&N F18__8Z=)XK(\L4WX)=Y:P8;QY531'"),*W#!ZGNO=P*><L=-8
M.VI?M)%-L0F599%,4 85RR*3'C:"C%$&J<DGE"H:T= JHJNWE;F)6;WQM%JO
M8 ,0T KQ@&V_%X0Z;.2=0],D6W-MJNH=1,][;,<8\+]K]J*EZ??!CAE[<&?K
MZ,5#BVY<%VLNR]*X4Z9DN_:LWLE'N5S?F[E<$S.G"$^R4&"H8I%")'$**>($
MAG$J&4\Q2R/A5G[#HM6YB</'%6A0@Q9V711\!]PQ7M&M$RS7AWQ3._:ZD ]6
M!Q3M<&#)<_D.FY8G+N3A0,;+DAXN-P\3*1.];OXS85:/=&E\H6I&F'.3]E3_
M0ST=[/RB<^6U+/*U^+CBA2F3]D[6_]=_KY>DWO_DMR;WPS?M8[U72IK,^)*2
M@.FN4P2;;:\LA%0Q FE S<2/!I&(%U5-33NUFQ:^DVQNC1CO S?VU*= 0,>L
M"["SN/Y'\]$__]W>#343H*4"_-*2\>L%V/(!6D* 8034E+BI\<1OFYVLS_<=
M&GE\F//KXSSLO$XO>AV_)C9ATH'P=;KG^8CZ2BB&#<U59J5"BIX*-Y_RE?RX
MD7?E(@VXB%4JH8AD )')@Y3),(5$I!E*>)I&V"J>9$CC<YM-M-A!?SDH\+NQ
M %0F.,XJG+K&;A0:B_"1QQ"O7#N+_A#2O$JV$X!)!7<(-<_E<M SABZ6/&J-
M71=/W^@?G[6"%CE=EEJ-OS_<WR]S67Z1FZ^JV9<J%W&01D20&,929A %,=4S
MB"2&@B>!1"$GE#L=U7)J?6YRIS%7+IK^Y[_3&^-IW;4FN*Z5N/2![9K)2,R.
MOG;2X-;NL.9W"[UBN@5_ 31\$W/3&N!S%64 ;YY74UP03+RJ,H"<EZLK0Q[B
M?L#__Y'%VNRK7ZV72UJTYR/:4./MT6E"$ XB"1,>:D6C)(2,\0#J'VB"4\E"
M^U/^5BW.3<4,Z*KJ$:AA[XX?;8';GU2WX[Q?P49A<F35LB!QP+E_RS?8^O"_
M=U8GR@#@A5VG/ !.3/4D [![SF09 9S,ZJ8%<+MQJ"?Z?()_R7GQ8%Q?<];M
M!_TIRVOZ1+4+O% !1RH($\C24$*$.85$(@0S3DF4:4&/7?U0Z[;GIM_-(=*-
M@:A=T0JCJ_MI3[RM\SD*G:.[GB^644&^:D_I5J#!]0F"!_B;SE1Y]C;MVY_8
MUW0FYJ6GZ?Z(8=KU@>9%5>BC4U/.'&;[;;5FQI$U37Q<W3^894]C?[[,JS'S
MFTFO8.*>WM(R+[<Y4?]*\Y6)EZK7. W>][18Z<O*A4KB""D5P+ J+DN)@IDI
MCJ8PC["D(4O<XL G0SXWW32&US5O+O8J 58'2;O6@]I\L&^_V:UI&  5!1>[
ME+87P-#0G.L'+15&2UHRW 1ZNK?+3MYG^<Z,/#C,\W5Q'FXF[SJO@]5TZ"<=
MZB;OE.<#Y?0 !M2^,L]63]?%6CSPS;:M3_DFOZG --/A.&&(X0!#J4P&BH $
M,!/F/$.*A!XW TRQU=3 H<VY#6T-;-#@WBD-V"%WJ*9D2?SI59T1Z!Q[E\V"
MR0$+.[:4.M2D\D_M5&6HSGE9W<I-N7'45V'*\DG3%95R,VVOCI3CK0/#'66Q
MR57.32;)K^J=O%^7>1L$S$0:95)BB(54$#&:0AHP#H,$,4*%(J%R.I;1T];<
ME+H+U>QG-6 'QESWD6SGV7NB;F15'LR:>W#;:3[\1J+UM#=MV-AIPU_$>%G<
M,L#M6VI?4T.N\II5U>[H\KMV27-NJC>%+(I,MC'&$PH1Q1&D+,U@$D<$,ZPX
MRY1#,LA3[5E] M-G>-Q!K3;)U]5QIK+&#)1TJ5/7R[:%@W<N>1-Y=0U,T,4)
M6J">V'+PW3RQ-I'#]N,V+X%<ULL?A;S7SZZ.ZM;O75ZOEA=ZGGBSRO\I!1!U
M\@']K^"^CE<NY-)\&V"SKI.1MCW0O+,EN"_6)M]_=04%:EV8G&ZT[;5[6FQ6
MLOBS)Z_0@OT^5[#O]NG\/PLC]IP^F^N'>7K7NK=Y?K^LGTUYO4Y0I7I[)TM>
MY/?F-R;"HZGZTF:-JA)PH% 1;$I%T=1D<\IH ID4*4QQG 4IDBB65A5%O:"9
MF[?8&*._E(XUH#'G G0,JF.C&I.V2<X&I4PYKS_MW,[)>FGD@67L#G+V7[T0
MZ]7#/0_1I#ZP%_*>>\E^'NJ>"_-=XQQ\R$M.E_]'TN*#_DVYP)$,)9(!5,J4
MP<()AEF<)# .),>,,TZ95?J\GC;F)J,M3%#C! 8HJ)#:)\8\1F>_WGDB:605
M&\"/4Y;,$PP,RI1Y[)F39<L\850W8^:I2P>F/"ENJ':X*^?_:KTJU\M<U&G
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M(S2A*!%"(:NJN6>AF-N0UQIA!*9KACE8VX;A:_4Q$X;6%-#:XEC=;5"GV8U
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M-F -Y10;GM=1CC8W\5K**;-?KJ><O,,]_42=QN('_=EDLFABA<W)C?6J71A
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M>:*<+S+$F<**0$EH %&<(>VB*@HC1!.B>((3Y!2 >+"5N:E."[*9')LHKOK
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ML=1(N]H[0N(2.U+\9RX\WN3TJ0A/FG\PM^#INR;*/'NI]%=[)-]H2A+*TTS
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MY%;5XD@[<QL,&EA5'MF?7);5 ND]+<"C<<?-7TH33>GF#Q[C6,F4XU RJ%#
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M5+?J0!MS\^!V$,'O!B2H4#J&]Q[BTLYU.Y.AL?74D1QGYZS'?*_NV*%V)G7
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MV'W!.S>;41'Q+$QA'*-(>R':%2$D1I"&:1C0E,9!8E6\;#""N7VFG?-^6PM
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MG=,>E24K/9M5IYXPV:Z5I2G=[2O;6P9F+"_R=7$M]9_BF^1&;W*5U_&ANYB
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MPZ?$HZ []L' ZP/K?I@\"L 3'2S' MKK8-@;L)Y#8O=G379@[*U>]_#8_^:
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MP%X23)L8' +.2;)PT$-"H@+5OY?,,*FJMHOMTT;M@O^4L;ZD-MLR;#=H1<$
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M%(ER\?HP4OBM[I%1;VD^K!Z?MK:N_;OU#[.7N<-EP=),0E#80%<DN2W-*%-
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MM%$C>:CU&"7\\\I7P'&C-;>)'7O#YA<B>M [:16WFV8;#]KI59584FD,,XM
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MWM?+Q=:FK'KV5G*?!+<]?F1,)^JVU J=;-=)*W9RU('IYF4+IHA]E[P!B]N
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M-/?]D4ZLV.AH>K2=BH[J5-VFKD?7K\64%U!]G:7<'C1=0RDOQ5[TD?*[\XI
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M8E[MBN!\6'W;&@:S/_NLWR]6;"46;-FI*GQH&YEE2(LR18!K:K/'<PAX"@G
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M3ST4'ZX^=VT?U-V3S5Z/W=]O5-/F\;/^JGZJU9-J"D5@BB6W[5!+3@A :<8
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M(0",<PYHG#, 4QW#!%&JI%<DMYO8J5%/I67=3"\JCE)-/(LS.>+NMLP(C^;
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MN &0'BAJ+J2FKQ17-P#8ER/OAA#68\="K<2<_<+6EBJ;V :B1<X@2<TT #6
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MDE) )(0 <X%QFJ$X@ST+LWCI,37Z:-<%V1KRUR85S!@451;=195-U7Y@8U7
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M4)T4?WU>J61*;^ N5T_I_\A^I/M.K<P#UV92L*UX;<G>;^9!S2Z=B#5.L5:
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MD0N<<D S+0!4A '"8N.ETYCH'$F>4N+"SUU"ID:XC7XOGDDWG3CF<9;B/.%
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MLKS@P%=A3ON\08YEG.8Q!G&F<P"E3 !7* =4"\&3C.)8I_T"+9WD3XUUVC&
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M8!(XU*]+XLC!?@[&GX;[N=S4CU .$E;>5K47RIF&.9-9R@'AL080V2JU.F>
M$2&4%#)/H!>/G!,R-?JH(@-*FSJJEZMHU=;8CS?.(IHAA%@J-(B%2@'D20YX
M)B&0*F8X(3I&C/I$,=V,Z CQ2L,BZD; M^(T,.\>9@$V^H6CVB[K@S+L64&C
M$FN7J<=\VGEM/QJ]%W5EC,_LQ:XTW]J:(XOU+.5,("XX,/^5ADBQ!)2B%*1,
MB31F!"?2J]39>3%3H]*MEC;OWJKI][5?@#))#(99+$!&"0(PH1C0.-% IK:
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M]KG1/9IWE8R_81Q<CW\"8SOX:9 !]>TE4+=*1Q^#UN'W BGPV9"+Y)&/BCS
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MBM]RQK!S;>IN\TAL(M);Z^BHU3-;K5\^F0&LL]D)@2RF#$BAS3J'LPQ0K2G
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M>Z6< X1CSA/(XC3V.NAQ$3HU\KK<Y:A7-P(GW(7(\H13"LP*P:P:!*> ,$X
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M?ZC,??*FF,\-3?W"_BA^;'Z\6:Y6R]\-Y;UEYBTQRX F!@+E".4XEL:'I@F
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M8-A*W.XK:YG!3F@'C_(RX)>=<Z\P3FPFGP-!<W?<*Y(S>>)7(VKEA1LC-.*
M7VYC-M_;6)VAVVW^DIT!9NTA2_:X>OWYPXK%G"@7.88IRHFRLS*&1,89E#@)
MA$0DS;#1=91AHTLSIZ\?JA)TD"G/Z4&7W= G>_6OS>;_ 6+CAM(5AXGMH0L$
MQA/VE,XG?+=:L#_?EE__TC_>^6[]IW;^MG/WH+E9IN@I!?J9>/)OCASE926*
MV\WK[^R+&ANA/GXC54\M&3#)6!)1&$O"(0J)"ET%36 <ASE+189P;#0133I;
MV@3=R@IZ8<%66D>2JE&<S:)&7^A-/*W=@;/G"3= Q"\I^%B'\S* &ZA^1/=M
M\HY]X/0/<5_6!>F#)"0"$LE$GQ%$$"6$0)PE*0Q#G(41BVF0YZ9!TD'+2S,0
M6^$<W/9#P"X'.<XP3#S3?2%@'J0X(S%30+*5ST^\<5+9D=CB\/G9XHB38@YC
MAM,/N)ZLV(AW\I"Y_#?RO;A[N/NIK*KR6[&Y?4G4Z*C?K[B0:2QP"B-E=" B
M00:QOE$I)>99&!,BF-4%*YO.EV:MM.SZ>E$G/>C%OP%;!<!. ]"K8'L\PV)D
MS!R>J?">V"SZA-KAC(<]9IY/?E@(,/-Y$'MHCD^).+3A< 8Z_',0!&_+1M3\
M02BDD]Z["@(>BCQ0$9DN"!8G$=2D21"G.,D8)A'*S8\XG^ED:::K%?._02LH
M4)("+:K+[81SH%[VP'Q -;'5F1PEBV/!'M":R6%[MQ&]J*^&HGHZRWL!B+&C
MNN=>G>\D[@7A#P[:7GK6A32H%NH%%:GR5^*K6)<M4]V6HNAEN5;/E;K6^U?Q
MHJIT.-MR2T8,1QD**<2)SEC%(H(DD)JNF.>8(1&IZ-2<2,A!@J49SUZ)=GMD
MH$;/PV7#AN,R()=MZ^0P3VQX+R$,(#C0 @S4F!I]&WZBB4=A)H-^S6C\&6C&
M(TI4@TP 1C: "L %+9J_L,Z7IVVA^W+3%A+?D&90/YT,VO%%>73%D(S2(+FT
M.R,UTA5J'](E7=.0W8K%1;%ZO6F4U_^"<_5]KM^7=4/6_RCN7Y9<K##.28:2
M ,J $XA$2B$-4@(92B(41C@(4FRR+(UWL[2UIY,4;$75E:VUL$!)"[2X9L;O
M K+CZXL_O"9>1%RA,C8H9DB,[)"J!KHD@/IAOR]ZH=E9C(:9:KUE,'S:@0EY
MN\!I8N6V_0$3P8Z3"].<8<QRR!.I:SXE$N:,I9#PC&64290&1E? 3#M<FDGH
M9>Y(S+LO_0$_S&5R+C?@+_NAON&<V&(\&Y(6_,6>$9V+M?AZ9.THBRU@&B,J
M-FEF/GIB"Z4.2(EMWG,LR%[<;MHSPYOF9;L1_F;SN>715+_^M^"?R/<M W+]
MIOX@2%UN"%T_JF6B+NA:Z SPFT;<U2L9D2 7009%J+DO.4+*J>,4RHP%(>8H
M2P,C2C?/<BW-Y ^XOU_M6:=^;W=)6H%M2[I[&CZS/:AG&)2)%XZ!1J!325<R
M&"K5CE6O%BAJL%<,])J9#:!]%7F_</LM-N])MGEKTOL%]*ATO>?FW2SZ3P_%
MFA>;VUJM&F_N[JOR:QO+U[]4JJ-52F(6:VJ-4&:ZNCUGD"1I"@,J0A;(+ U#
MJV, H[TMS?KNA+4SLN.(FIE.;SA-;!!W<K8.WU#2&]#*ZL^\&4'BU6B-]SBK
M*3)2_JF!,7O)S6QHDHTW.[+(M^HKLJTI(GB.8JG S&2J+R!@!JE09H-+DL1Q
M0&1&K:JSGNMH:<:B)8G9"WH#M*B.Y5K.@FMF/'Q -G4$[H:6M=&X!(57>W&V
MLUE-Q265GUJ)B\_;9_,_"O90J?@SC.BGHEF+E0KK<)+G(>0!1=J-2&&>Y@RF
M.5<_4X$-[_&?:GQIAJ 52N]LA=$/]$?0BVN>L3]"[W*>_AI,)I[IMG!89>7/
MZ>V4BS]J;+8,_#DUAGGWL\]<49[C15V+9L?T(5"0$!XD,$=A"%&B65-HFD/&
M:4!I&"4BMB+B/>YB:5.U*[[ MJPII!75H?#%(8QF:_1UX$P\9SM<.NDF8$PY
MK[O_"A&'W<Q?[^&DFB>K-YQ^TC%-VY"F]?5;TL*5<KJUVYU!M03'$ E$(8GC
M&$8Q4G,[%R(T.]EUNOFES>J==%O.1ML<Z2%VAJE.9T2FSE@:@V&?;SRIL]^T
MX6$7\V;_3JIWE,0[_=1U5&:/VV/#.$T03HB$(<JQ6I'# !*4,"@D4S,Y2XA:
ML>TNX1RTO[2)NZ\&YW9/^"E\9E/W"E FGKL6>#BSECV>.E7M[3K+81_/PE?V
M>/KD]:7'KN6K/G=&3N?BWBH-SORY)4HD3._8UMWZ@W.DN:USB%@D--M1"HGD
M,<RC+&$T5C^ST(WAVI>(2S,C9\^HMCGJX>?.SVV^D,V3@ZUNCH/_P3=T/IYU
M2"<V@C.,YA5\W;X!GXCAVYN8S\0)[AOF\RSBWGMR6TC>BF\O6%L;JMC<OJ_*
MC?J1=8*\+]<%>^S^W=&<K[A,,4[#5(5XDD*49P)BAB*(DP"'*,TDH4:E(UP%
M6-HBH.0'>P7 H0;ZC+"6'OR^_;]6 [1Z6-I\ZW$RL^A3HC^QO?8/O+5Y=D7/
MJ_&U%F)6T^H*T5/#Z=R."[.>8'>[LB>8HCPGF;)TVC7.I8!$?TRR $O*",FD
M463\M.&EF;%.-AL6N0%(X[;F&M4GMB&=6$XD>L/OB 6%GAL,LQ'HC7X)+%GS
MCE4=Y<P;/#XC8]ZQD(=\>2?^[H%X6/EX6\973?BJ_WNS:7>'^*?RE?IUN,J2
M,,QU69PD#54TSIB N51>EXPHETE,U7]6-$1VW2_-.ETBS-7_@EX'T)1 :W$%
M-_'E\3%SKZ9#?6+#Z!?PZ^B)C7&;CJ'XL@C/1U)L#,\H3[%Y*V[F[_7=_;I\
M%.*CJ+X63'S\0BKQD[ZHK6O)"Q72ZI5-Q;U?E5""O] U#^M/94/6P[]KL=Z6
MS=]%\V%W>GF5X)1&-"10)A)!Q+&RE&F*(<,<L3B2"2)&U78FEW1I1K75#':W
MY=^3QS:U-<@TW("=DJ#5<COKE5K@431@K]@->'&G/7,[@SO=-\+,-B]BG"<V
MX_,-L;6)GQQ^KZO!=-+.NG!,#OK3-6;Z#NV6H[IJ5A_TU__%]Z)>Q4*M%(GD
M*IK/&$09$1!CQB$6)$F#+%:QO]%QE8-6%V?F==18-P4C:_";(/IB7W=,0PMK
M&/(>PC9N7YW!F-H6NN%@;-A.ZCUFA-0+ P.D/CTU/H<MSF(H3BK13^K3?[1/
ML+VORG\*IN;[WP6IWLGMPK1C0T%9S@C',(GR1/ES>A\:92',6,YYI.+?E!C7
MIA[M:6D3=2<LT-+JD\R]O.9YJ7%H+^?IO $V\60^CY5#,N_"]]$XN^<-O)G2
M?0Y?.*L4H!$>(SG!\?=G2Q(:J3',&IJ]X'H=KBJ^MIO"RHTJZH_WE2#\W>9O
MI"KT;O '%:JO$I&2**<21F$F($(A@R2,,4P1Q@A3'K/4B*W8HL^EV=*]R#>@
M%1IT4NNR<+W<X(-UDM $?;/HTS.F$YO;Z^%TN%!G#)#GNW67^YWYFITQ$,<W
M[LQ?=:I_G?Q4K->:R/=,=>W^>'&6Y;&("<P)(1!%B&M.1J'^4>Y<KC")S5)T
M5KTNS23]EQ(<;"6_NJ"_'?X&^[-3H#JQ43($U*V\MB&R5O6V_2,\DZ/H#6G;
MPMQVB(U7ZC9L:\[2W7;J/:GE;?FR(_-<L2D:\:M:0?@;]37;W.J*,-T%LK>B
M645!&$O.8YAQI Q[@A',0\*AR'6M1"Z%I%;W1L:[6YI%[Z2%K;A@+^_N/J,2
MV9)_;AQM,\_2'X83V^]KX+-GH3-"Q2\/W7B7\S+1&:E_Q$5G]I:;:?FE+/DW
M9<)669!DVE# B#(.D90!Q%F:PQA')(LB*; 97<K3AI=F+GJY[&S"#B:SV>^B
M_,3S_*+>UI/YJ9)>I^VN\5DGZ%.5GD[%H[\['L/XKL_//A3U%^TVOI.Z)DNW
ML[O*PIA3DE$H.4$0I3'6\5D&E3*)S)",4F94_OQR5TN;F(>2ZCRHEM7Q5,-Y
M@,TFL!_8)I[2CHC9'Q*X"(;?7?[SW<V[37]1[:-]]LMO7%&^16_&5^*+V-3*
M%>A*Q?Y:UO5+4G_Y>5U^^U_!;\4OI-CH7WX0;$WJNJTWJ:/2GX0L*_&)?%_%
MC$J6$UVF+600H2B%F,4YQ!'->1C&64#SU4;<ZD-HGRRKOWB1T&B"Y=T$.Y)S
MNLG673<\T!!LZ_7^H/7Y\09H/8%6%+2:W@"MZ^ZO3Q6^ ;1569>0=:A"X^?;
M8&8-9Q[<.:O>S#V@;M5SO&+OO^J.'_'FK];C%=:357[\]F"_._"R;*]J=57B
M/XC;A[7^NCW^5JQ%W90;T>^*K@*,>1+3',I,)"K\8VJ!"/,,IISB)(@IRZ7Q
MYH!IITOS0/=R;\_:]Y*#G>@.AT&,A^#R_L 4P$YL99\94_.=@2FPG6ECP O&
M5IL"MF"-[ D8-S7;EH"M<L,= >MWW>*!WXI-6;6,'\HNJI97" E,<1; E 1,
MWY)-(8F"% 8\CW@DPE!RJY)O3SM8FJEN:S-L&M7?6N]]]6+:^=%'**:9P#R-
M. SR.()(%\>D09C"$*?J2RMRA,)H=2^JHN0?&U(UTV/YM+/9$"W\(,I)C,.4
M:?H^P2&*6*3BSD#" (L@D5*B)(^WB+[>\+GP[+OZHZ%I%JU=@\_$WL#'IF3_
M^E*NE:6K_P>\_O^'ELFO::J"/C3M\:6F!+9SVSJD.@>0U\#HJ)-9PYMS*CX-
M4LX^Y[8NO:]*)@37U7->?V>BKO>L)C\K&=N+)_3IQ9,5)I3$,M2D 1Q#%.1$
M&8E,PE3&"0O3+"#8BAW*28JEK7"]$AVU6JO&D&P(Z#$'PYME0V7L[(S;J)D9
MH\G'8F*+-<TP6)NLJV#T:M?<))G5^%T%UE,+>5UC_M/]/Q<;LB[^W7;S3K[7
M?RXW7;6R[0?-TEJ)INAN5KU77^>_D?5#=\=/-.^DSOOFRM)BQC"DB0A5O!!0
M2.,,01;*G :2Y)',K(N_3RGQXLQS)WEK%NX/Q >TIX.#NI9Z0XIU=R5&/UJ+
MIEGWQ;%>R$97,/29_O?S[;A^5V#V,7_^S8)7:M W:@'H5P:MT@WXN!OP=OP'
M7XC#S032?A=FVSGP.CZS;2CXD7HQ^PQ>!\%F^\%OQVYKW,MRTQ4^44V^V:A5
M]E8SC'>D>223,<,R4:M3ED$4Q>JG-%$! <_2."4R2801?Y!!7TM;5X:B:K+1
M^ZVP=DO$&+AFQMT39-/O+AR@U<OIG8W0  ZO5G"LOUGMEX'B3RV/R2NN-J-6
MMN<C68O^6G 0HI 1EL,$$7W)4M,/QBF". O2G/,024;M+,63'I9G'^KVI)>R
M"UQ!7(.Z7'-' H43<$J*,RH(Q+K4'4KC"%(9)I"D<9BA,"()2U9?147+60 =
M]O1'A=34W%X!T^1&ML.GE6X";HJSNGNVJ$][F=F.GE'RV'J>>]#-9KY@K'K0
M-P>T\Z?<-K%C+F-)&,4BRB$)60H13B-(:(2AI"25(8NPM*LA?K:GI=G0;>#6
M:!'!/7G4&P]VT_P\J&;3W0M4$T_[K8Q]F-M*.0$[W$4HO%J!\[W-:@TN*OW4
M*EQ^P<XZ="2([''U^>.K%4<!CW(U\R/,=:V?A$*,T@1RJBMP2:+^;I0,'#:Z
MM#G_6=^AXJ#E[ZKU:O;B3E0%(S?@E>9XJ P#K /<QN>Z*QH33VMW((RG]BG-
M1RA:^\>[6=Q_VI.U'C0WRS0]I4 _(T_^[9J#F2=."773?)6$@E$2IC!B/(.(
MT!SF24Q@& >,)OJ@9II8'-4W[-;HNSK_^7N30VZ= B['",\/PO@D]XGI[ <R
M9\/0Y12F%RSG/X#I@JGCT<N+"!F=NCS?RC,<N+RHTNFSEI=?<XR=^#\?ZJ;=
MK?M4ZJJG&Z;:?RN:?2K]4ZG/\K^ORJ\%%_RGQ\^U]M+>W0O-&;6Y?<&:XFO1
M%*)^0>NF(JQ9Q1B)/",<2LE5V"7C&)(@SB!A82SS( CS4%J%71,(N33O;:"C
M/B&VTU)7)SC<A]-_;J_M]-H"^@A^T J#8O,CV.D,]DJ#WWNU+9,]DWP]# /(
M9Q[TJ6//YQYO^S!VP@'Q&P%/(>B\P?.$4!_%W5/V=2WI[+ZPW)MVQZ45\\UF
MQU']3NJ-7B4Q6;\OZT+[0#^3HM([N6)/49>3. JEB%6 0=1Z%$81Q#'.(<UQ
MEB<D33)LQQ;O5[ZE+46]>MUU^U[![G2/EAZTXF])2-V9!GV/LMFR\HQC-_&*
M<GK8P$ YO7^\4T\_ME,0]!K>.([P%8RS7L=A(KI9/S(^$]>L5X#/$\WZ[<8^
MW]0>!U)QDBY5UVU,YE$L<DZ$+BU#E=W/.%211PPSE(J(J"@D,-O^.=GZTJQV
M=WZOD]"A%.4Q>I?30E=A,K$UM(/#*C]Q5NV1;,3Q.[/E'LZ*.\PTG'_(?B)^
MOE<";)J[/E&A_(92-[\NF#YZM[FM!!/%_:[P?8R2,!4RA52DRCVC&,.<I@+B
M,,%YA',I$J."4 Y]+VT2;\6_ 3L%6J^K50'L= "]$@[SW'9P+EN!"2&?>J-H
M<6B;IY$G1'VFE+)W]*V,N"-^(R;>ML79%@!'58?+@VL3CL4#VUNS'P5[J-JT
MPO\5S9?RH?D@""_6CZ^$LL1WRI54L<G.@?Q\KRF]WE=*GGU"X^7#G4Z:*X]T
M6QDOS5F<<Y[!)(T2M=*D <QQ+*!,&$HHDH$(K1(!4PFZM&5I>XUYKRCXUFD*
MMJJ"H:Z#$/(&=/J"5F&PUU@?L^EU=JM_.-5WQ"R-L(21GWAU?-Y!MR_A./&(
M^"T .96P\Y:/G!CRH^*34_?G2I5$FWW*X[.:4V75:.[(5T7-6IL24$RP4'$-
MHRC1=U'5NL.2$&8BQBB@B(0".U2DO-CQ0@^Z:+D'>4EE+_:B@UYV6\*D2V-@
M9M?]0#H76=(U,#H0)1E"XYDFZ5*O,Y,D&8)P3)%D^J)CO2RR>9!D2[+^,V'%
M>D\>0Q$3>2)3F.8\UK1(,<QE1B$C<<Y"@6(16Q6^'^EK:9[K@:B@E]7QZLL8
MQF;FQ1-R$QL65]#LRQ1=AL-OQ:*1_N8M7G19\:,Z1@:O7+O=/L+#T6X%KGA*
M"8OC -* 9A")((&Y4#_%C(4LIHC&@=6%&O.NEV98AKNMXP0SVVU4Y]WQBX-B
MN_'M$^H9][2O1/F*'6I3P";:?+[8_3/M*YO"<G[+V+@%U\O4:_6QK+I0KZHT
MI7B[*]T5@F!G_OQ)_523]G)W_6NQ$6\:<5>OHB"/8H9RB%.,(**9A!A%,90L
M2B,6IX))9'</VY]P2S..+];K@JAOT^"TR>]:6-!*:WWAV.,HFMG*YQJ;B:WI
M@5I@('B[\3+\W.V>-U_(!AR^9#2,#O>C_>/M^6JU1P%GOI7M']KC"]T3].&:
MBY.BJ@;72%]_UR7KQ+9DU4IB%M&,8\@"J:OUAASF"0Y@E&0$IV&B#+P5D>2%
M_I9FF'MQ03&X(&Z;:1M'V#3/Y@VWR;-L6\CVM\3!5ECPPU;<'WUFV8R \9QC
M&^]SY@R;$0#'^36SU\Z9E>$(*F/TK[_^J?^-^D=7O_SKG_X#4$L#!!0    (
M )E4_%+^=*(]?;P  (5A"  4    8FUY+3(P,C$P-C,P7W!R92YX;6SLO6M3
M8TF2)OQ]?D6]O5_7N^)^&9N9-9*DJM,F"W(3JGMFO\CB2NIM(3&2R$[ZUZ^'
M+B! P)%T#B?H'6OK+!!PCH?[$Q[N'G[YE__UXVKTT_<TG0TGXW_] _TC^<-/
M:1PF<3B^_-<__'[Q"Y@__*]_^Z=_^I?_#^ _/GS]_-/'2;BY2N/Y3\?3Y.8I
M_O2WX?S;3W^):?;7G_)T<O737R;3OPZ_.X!_6_S1\>3Z=CJ\_#;_B1%&'_]T
M^L]:",&IL^!YSB"XC^!RL$!=5C3[3)D*__/RGVWV(3%"@/ L0!C#P'AI0<O$
MJ(LY^K!\Z&@X_NL_EW^\FZ6?<''CV>+;?_W#M_G\^I]__OEO?_O;'W_XZ>B/
MD^GES_A$_O/ZM_^P^O4?3W[_;WSQV]1:^_/BIW>_.AMN^T5\+/WY/W[[?!Z^
MI2L'P_%L[L:AO& V_.?9XL//D^#F"YZ_2M=/S_Y&^0[6OP;E(Z ,./WCCUG\
MP[_]TT\_+=DQG8S2UY1_*O_]_>NG!Z_T5[,_ALG5S^5G/Z^%Z\;Q9#P?SF\_
MC?-D>K4@%(E?/&Q^>YW^]0^SX=7U**T_^S9-^5__X*]NH0B9*$X*!?_CQ<?]
M?$_?]33-RJ^5SS_C!ZNG%I+:H#7]F*=Q3$N.K-\YFH0'OS0J\IA,UW\Y<CZ-
M%I\.<%F#]<N.MKSLR,_F4Q?F YF=R3002#PAE USX(.1(!&SUGM/O;6O<*SI
MNY;<VWTM-S.X=.YZ<([,3N4E%\Z/TB!QHS52"(%P#X)) S:*!,8%JPU+)F;^
MD/(BE1F*98''[&9^ <K5XW\N:_HYC>:S]2>+50*A*VS^C^UT/%S5)BJ.IN&G
MR32F*:JH-2%N&IX@Y.'V6/W&S]=NB@^"\&TXBNN_+KJJ0_G.)ZTQ?"E37,L?
M?D*6Y#2=IOAY*=)G5[Y8]ARU>EK\9FMP.1ZYV>PLG\\GX:]'/X:S 6II*2VQ
M8'*D(+2,X*6AH+@3SB67DI?=(N<Q2?V J TY/P>9@YA> 7HVZ?\XN7+#\< '
MRJCP"4@BR!?G%%B? T@AB&:&*4I%)[!Y2DLE>#E,R)-6.=XC9HHR/IY<74W&
M"^+)'RGYXJ9_=J.;]%NZ\FDZ,-(ZQ1F:B;IL*:+Q*X+,T910DU-2.O@&I^R+
M+^D7$X=*;](%*WO&Q!%Z)H2<3N9I%F_0$6!RM8;H$HDZ2>!9.A#19/ N*N21
MD80X%EFF#>#PW/,;(8&] R2TPL#^0:#EQAKX>@W44A.CRI"]22 L0>_09%2=
MSB#Y1&;;2"<\]_Q&(.#O P2',[#OTR&-+M,X'4_03A_C5_.%1OM:0@RSM5XS
M1 DI M@<&0BI!!CF,Q";?+0V",]UDR/BU3<U H9X!\!HF:D5&)UWAM7GX3A]
MPB]G YHIHC]J2 35G8B2@/'. XL$'3K&,_&^$Z/S*2W]'BM=."G[L;E'H,0T
M')RG<#-%;Y\R?S&<(RM$H.C2,Z1=,F0%UPARDA'DB2I%T2)2+_HELQ3^>#GY
M_C,^>XD._&(!B@4<MKVQ$N]C3^E-6F)ESS"XF+H2[SZ_O?*3T8#;'(0FJ.AH
M<;QHH.""(Z!LH#D0Z;VE!V'@P>LJT02' V!_)E:B!$Y^A&\.#[]3=Y4&0=GL
M2>80.$=;6&J'.M$;H$EPYZU1Q*A6%,'F6_NU,SM0!GNSM&=(K&/ 83*]GDP7
M$EAPYWAR,YY/;X\G,0W0,Y(\AP0\68[.,^?H1CL*S%M.0Z)1LWP00AH0T8_R
MZ#1@W@7[>T;3FE<7^+N#$$BT"DTLGBDJ1H$^M_5! SK?UK)@8T[D(-ALOJT?
MA=(Y/O9F:"5 ^-\W;HI/'-U^38CO^<#P$!S5":@P:"II/#&MQ748;E!A6A>-
M>NGZK3DF'KVX'_?US>!Q")NK.(!^&8[2Z<W"^Y;2YJ+O .%.\"1&4\HP:T%I
M1JPC5E#2QFES_\9&V)#O#AL',;8*4'Q-E\/"A/%\854QZ91(-H#T*N(Y:#6@
M,671M#*)99$(D[$%8#Q\:R-PJ'<*C@,87 5 CF)$@<Q6_RG&/!UDPKQR@D ,
MUB#*K0!KT"VWJ!$]1?V'SGH+*-GRZD90T>\4*H>RNB:\'..79].+R=_& \(R
M_B\QR.BS@_ 2;>N4(CKOFJ"1)?'X;$.G/'EQ(ZR8]XV5/=E<$U(6OMC9],MT
M\GTX#FD@F+24.0'HB3$0F2?P5 =P40D9.%&"FO;@\NCMC3!CWS=F#F%X3<#Y
M,IG-W>C_#*\7'KP6)FLN?3''T7&S1H&)"3G%<J:::=2BAWD]S[^[6=2=O&_4
M[,_MGC%35.31-+D%W52[*!,30(-#K!.1P3AM(>KLK;-!,';8C<SFVYKAXGUE
MH![$T9Z14)+D1U^^3<9K;XU'B[:5UD!2B2%[@\8X$0J(EY+$+$+4AX7E'[^Q
M&2+>7XCU(,Y6<:8<(VNF;O1I'-./?T^W V&DIC:@-64TPCHQ!59Z!\:@"Z]"
MHIJX%HZ31Z]MAH_W%V(]G,=5@.3"_?@4<1'#/%R6VZS0GG'Y1!L/OJQ!N!R0
M+80#$=(ZB4Y^R&V$TYYY?3/0O+_ :WL\KP(\QS?3PLYE]+A<;:.,;F:#[+,D
M&5$OJ*(E33*#RPF7I2WS+CETYD(;BF;KVYM!Y[W&95O@>!7(^33&IR$[AM_3
M1S=WJV4-I%?<(-$@(_KZ0C(&GF4.W++$HE IV3:0L_WMS9#S7H.V+7"\"N24
MFXGI,;K[EY/I[2!2Q:D)&23UQ2AC!JPQ#GB@(3I*M9>L!< \>&DSG+S7B.W^
M_*T"'AOU'.??D)^SLYMYJ2TNF5<#AJ>H,II")B5_GVL)5F6+_R01E6<DA]3&
MP?0"#<W \UY#N*UQOY(\A"]I.IP@MR*JS#20)M* MAB@[R=*P1E'2XVJDO'%
M3,8MH6,[F2D/7ML,,>\O@'LXCRL!R<74C6?#PI-U&@5)6I7\<.I].5,M&F)9
M1,CXK:/,1&UU*SAY_.9FV6[O+VK;"J<K0<LOPUEPH_],;OH+?C(;:.:%5LH#
M)<&C_>XXV. <'K@IHG8,+I'#+IZ?>7$SK+R_2&X;?*X**DO]N%Q$X(;)Z"5X
M1='98T*!E[@23F,0T3'I7VPFL"M8-E[=#"[O+\S;#J_[O@]:.G/WD%^?IIH8
MX:FR0"2CR!6*YCM-"6+R(7#E/">'73P_]^9F<'E_4=]6.-TS6HZ0.W&!^9%#
MJYQS17EBJ @#$LXY!4.S@,@"<4G@P2H.\XD>O*X9+MY?8'=_GE;A-9]?N='H
MP\UL.$ZSV4#&X FUKB3;&! B%Z=?2M#4."%U8)JUD:[RX*7-@/%>P[;[\[<.
M>'Q+HQ'Z]M=N?#M0UADTF1PHCFZ:D%2 $RP X2J1P RS!]H@3]_9#!SO-3*[
M-W>KP,;)59I>#L>7OTXG?YM_6R\#O?6H(N7@;''CG<TE:=R79)H85&!,'.C5
MO/#R9FAYK_'9P_G=&FS^Y><G'/Z,'^S15O'X[/3\[/.GCT<7)Q_/+_#?WTY.
M+\[/?CDY^GKZZ?37\]]/CW[_^ E_^' -C7HL-G_VH0T7]US%@=T7U]6II1KP
M*MW5J-[!K72HB5HZQ((N>6U<@T?F@&6*,*9YLNJEF_S]FSH\0U#+G1F9USE&
MBHMR.8'(KF1YHL(T*GF6@_;^14WSOCLSMBG[5QHR[L+G"KJ;?)D.QV&(VF$1
M,RSWGB5H^#V-;]+'- O3X77YY"S?W:2OK[R6K>5L9#FA249H"1:98/ 4=A3U
M=(R&11T)ZZ9IXT%D5](J8P^\3/H27@5(+3546Y:RZE=D!36"$P(N,S068NG^
M3#/B)F3E*0G2JV[Z0+Y(5K](>T-X3+J25<\]PD[3_'HZB3=A/G.CM.Y@Y4W6
MVB@&U&2.K-$<C' *J/71\T@=^JJO6%O//KQ?R+0HN$F;7.R[7^!H-"Q]U]TX
M3N;?RML7NVB]$AFSB-0'L#:5RDXF 9U3#MP[0IG-V5G9  \OOZ7?_C[= *-%
MOE9P0FWI>V.EM<&@_F12&1 Z._0\D3M4.\]-Y$[&;HZERCO%'6+U',CF"H"R
M.H1G V5U,HHK8"KBOA$^@RE=%A.+1-.@% LO94#L#X\U!968PGM*<M("6RN
MP_%D-C_+OTXF<78TCN=I^GT8TNQ\,HH#H[-/2EH@+$I +5M2W9D&&U SRLQX
M<-UX[<_35(D>:0<R+;&^ A"=)SQ+QY>_IG&:NA$NYBA>#<>+_A,EE_GDQW4:
MS]) .Q8ISP22(R43B%IP@3*TO*@*FJ>2!-_-@=2(ONH:UQT"K@Y$4@'0OJ),
MD(!ON)Z/J'!'D^O"L?5B\"AWJ&,C*.)*-S49P>B@@$A"O)>9&]N-PGJ1K'[;
M*[=^S+4E@+Z]JJOB3/Q](8=)/@K_=3-$ CZ524R70[02CV:S-)^5/BA)<A*7
MN0'"E!5EJTNJJ[3"$F%%DR;<S=[63[>JEI'2$7,K4#YGQ4L\Q15=IZ)$QY?+
MB/X:_"X2=#<7#2PX.HP1'497$@AL&>X6E#4\OI21L;_V>9FN?KI<=:1^6A3!
M[H"R2T"-TV49&7C1J@E>+,#5*G!?.!*U#1+W11EFH4O]A5TFQ-JL%4G$V,X,
M[TU*^FE[U:&YO3>;]U<_D[D;M0*3)=0_3V:S7Y!5RR$'-[@%SI9[83*>?4AY
M,DW+W[MP/]+LM^%X,EW7%:9927EX^)03U,SSV]_2_-L$?_(=?Z7P>S9(2O,L
M*8<<T"(4*DNP/"M 1J5,O0Q2O-2AXM#[Z#=99#]]NCH"=ZW@J&;?X))7&_\#
MND1Y.!]DR9- _P<L+56UUJ#A81.>'2)E&:4LI;4=8OP)0?WT .L4CX<QO0*3
M[\MT@E27#5$\Y<0]U1"]0]O"*P\&G6;0RDIO%F4(W3B7]S3TU/"K(XCLR=L*
M-,IIFM]KRJ/Y?#KT-_-RM7 Q0=LTH/+%%XX6UNE2M0Y\)MD&2T%&@WPJW68L
M8P12ML(X8I)X/%2WK0R!74GMJ7E81QCK5E(5**@'"QSD8$Q0/ 'Q$2U:FP1X
MS9!S20<:*5+OWP!F/74;>PL([<3A"C35B9N.$=VS+VFZJ/7_X&;#,"#11:N3
M!6,\00-.1?"E7QIA4I"0F9,OS@;:'R9;R>FI^5A'<#F<XQ5HE<>+^#@<W<Q3
M'*A$->?*HJG/) @>T7<V@4+R-"8II,T=Y?$^0U!/+<C>"#K[</T=U0T<G_WV
MY>O)GTY.SS_]^>33*7Y[TD4)P8NOZ:J:H/G:6BHLN(/B65Z>5NC-E[J3:?J&
M[M?P^\KQOTLZ5]1:DC6>8RP$$ (-'D]= N\(<<1YP7,WP>H="6W1@3->&>MT
M2<S()3@<%?@0$G[+I4C>.^NZRA??S8'K7%UU@)$7G+M=^%[!V;>X8MC"EK*6
M8S?[]LMH\K<_I7B9?G7#\<*MR/CRKRF4.;9WW2*1M1?NQ\ (YA)5' +ZL:5+
M<2IE'1*85W@6!$-1=W=W)]32*BI)NGD#U/8F^\IQ_Z5\L%C8XK=*3_9IF@^G
M"[FL0GM?1FX\.XK__\TR3(QNTUDN;."9<\D6>26^Y-'R@*+@&H(G,3.JT$[J
MQMGH:$&59 GUO!O>"A'UW-*^Q(VC[VXX*F&E7R;3<S=*J\FAP[1M^=HJ0F4Y
M .UBM [1:,Y3 S0:DJ/)3L1N[)"V5E!)0E//.Z SF5<0-GINW;C4-+P<+QOL
MA-N-TJYRYI7O1@L<W!V/T^$,/=J/R)CQY;)OTQU+LK#HUTJ4B^ 41 X.#'(!
M/$E&IV2SY]U<O[W!XBI)Y.IQA_2%E,H-J;LU"1J)I-8#)Z34H$1<$U,6- \Y
M>)^=4B\UT>[F$-@)OMVGC/6LX/>2507XV[*<]5+PN]%-Z?/[I>1GHCB;W(@E
M*0G)3("A%,VUK T821-P%[V5Z,=0V4VHJ.6%5)+,]@:H[A,!%5@ONU_Z*DXI
M+E*@"U)F&*JRP&0R+M#ZF*E/_KYKYCNXGN\^:>T-0-RM%/>&Z?<T]9/N-75)
MLB-&R0":1@V">5X&L 8(ED6O&#%)=9.!^0)1E62H]:M!=Y),:]JPF^NX#T>?
MCTZ/3\[_=')RT5K_KF<>VN956Q.ZV[]8^V4X=N,P=*,ODV6#\SNH\:RB<"R#
MLBZ#\!F/2N<C2!>U28E3YKHII6Y"W:%::EFL<[=69HC-2FIP(B@0,C$P)$D@
MGEC+J'/<=].J["$=U5REM8.*QPKH *97X((LJ5_U8;[OJ4B<B303\);A^>R4
M!"LUA:1I<E1:+E0W-P%;R>D70(?(=RM4#F%V!8@IMVOE/,?_E+*#[VY42@V.
MYL=N.KU%(^_/;G23!BXS7%*40'7IREG:L1@F&207LS Y9&$[<D6;D%<#H@Z"
MP6,CJ'695 "TW]STKVGA1]P'[-=SU@(E:"O:!(KQTJ U:+#,>& T"$Y=-DQT
M$Y1[@:A^+]_;!U5;_*\ 2E]32+@K<"DE5KA>1"294"8TH"=:QMH3"U8C<P(7
MR2<7DF4O#80_I G!%G+ZO:UN'SZ'\[P"X)1BNC'^RBTN84"#4[%4&$3N"+J3
M+B!?B .:C?02.9(ZPLLF%?U>Z;8/D[TY7 $Z%G<2#U@R($Q'8J(#Z8D!H8@"
MH[P"9:Q@)HOH:8<I P]HZ?=JLWVD',CM"O#RD/B4/>4ES<S9,MR<^P#&1PK2
M<*N]0);D;J"R.THZNT%L'R7[\[B"^Y OT](N8WY;\K$64P_0F+]>I:<,0LA2
M\F0A1HG*45,&/J32<RP0Y@G5OB.\O$15#49O*[YY:ZRO0,^41G5_&XY&@T"4
MX9XCW@.S(&**X$*V0")EFA%*3>C&35I34(-1VPH\]F)I!5!XW,D)T7SR8W6Q
M?+>FS*)Q,1@@6A2SRQHPNE0Q9>N(Y3IPTHUF:4)=#09O*Q!J7105P.OCZK5W
M323NEC8(PF7K70:M2OUM<@:\,19,%#($Q4/TW114/$]3#19Q*U!JB>T5 &A;
MD*DD#:SL-\^RBEX:""PADTKC"<<LAT@"+I1GR3N:U_ R7348S:T J47V5P"F
M#0]Q8Q%964-"F0%'$B_#O 3@GW+0+)EL)0DFOS22LQ67?$?H=);;UB)T#F=V
M!8A9M;>DF6:C-8&<O !A:0 O(P&II+-1,L---Y&]';J)=I8JUOH%YT[LK,#K
M_CQT?CA:%H2LN8"J+28;,R[;:/3XB"FM3P,@)VR(A!K)NCEXMA!3355G-PD4
MA[*_ C6RL83'L2P5;;":AU)66F[*)'*FA Z2UU)3'36:95T#J:I\BH/%_3Q\
M#N%]!2CZF/S=/1G/3$F+IR?GI<]:CAJL( RB#,(KJQW1W>2I;1!1#4X.DNL3
MUVD_)E>1AGP4PN1F/)]]<;?%9K^[!K&"4\$C:(VVND@$^4$X!U9"W#8*KFTW
M.F8[/?V>5QWAI@765Z!B%D;[4PX- K5X5,<$69>HIE<)'(T,.1-CL-X203HL
M_7]*4+]QXXX@U ;S*\#0EA5HBF8?\@6BYZ45(Q/EP@V%;574>*Y[&KOI-K8G
M<CH+%W>$G -97H&/]21BN;&D$K9TJ@2\A0*"ZT$+T#CP5"?4H\D&I[3+M!M_
MZQ7"JCG+6K&5VY1"#9IH,KZ\2-.K8M-MQ*""]URZS"%25:*6Q.,J1 :=I(C&
MJ\Q-[$8;;:6GFK.L'7?K<)Y7@)S'1_%FS)OB$@SS$#DMBA6= J=+8E&*C''.
MC6'=H.=YFJHYTUI!4$N\KP!%&XL8*)I0::H,E"/!@ML(7@>/;-&24LD39=U,
MS-L@HM_[S0X#.SMQMP)KYWP^"7_]-ADAPV?+V1S[5//?<3%Z'5,H):S>XS^*
MDM)65H&+5&OFF16JHVF,K:ZCFGYLW<2Q>Q1Z!;KPZ>KO5A*XD[K,;!*J=)$+
MZ*_8D/$?GY(TA@HIN\D$>9ZFOFM2^T/*JZ#=2VP5 /#+^KV+)2TKWBSN6J-]
M*#L9.<,54I\- ^HS1P^'HX71317B%F)J@]Q^<GZ2-7L8TRO S?'DZFHRWJ"?
M"HV[R2A@H=2V:<K!":W IVB,="8KTED_CP>4]'WOVPEB#F)W!7 YBG%A,J#Q
MX(;QT_C870_1;!QD'Z,*J=PE,0(B.@?&B@AH[7I'A6#>=E3-L9V@OHVM3L#3
M!O-KP% (-U<WH]+UME%;.Q>B1*Y)D%))=(M=+&/\/"AIF")$9\Z["4GL2&C?
M[6:[P5R'PJH BU_3W W'*:Y'FFPL]V/*PS"<#XC4M*AB""X8/- = 2L\;C&?
M<["6*R*Z2:!\G;:^V[=V@KB615(!R"ZFR<UNIK<;QW[P(<6L(P19*O.LXF@E
MZ@0\!F.)%DSK;FZ<G]+2=Q/53D!T(,L/[>;>44QAD$5VV2 C/"V5>(M\"ZXH
M4)F87A2'VFZ,\Z>T]-VEM!/8',CR"F*OCX<E#\H\^>QI *XC+S$2#Y9E"939
MR)G.+G84F7],26W^7&]!IX-$5,%QU@XK!\*C31BUAESP(TJ2O4EH*68B(TV&
M&<&[Z67;#OVU>9@5Q5 [AT,%>G;SNF\<MYP;)#/*'(D0T2(%P<HP@,@671P"
M54Q%U5'8_S7*^G93W[">XF#!5-X6]\$DQZ/S/_WR^>POK;7'?>7AG4VD?&4=
M[;?+70],N[^W1V=2QA*^IR3XXE\F\$8E6'R8)4W,=^.=O415"]WFRS._3"??
MA\B_#[>_STHJW-EUFJ+DQI='83[\_C!_@7$AB"C>=8CH9QNGP1+'@'OJ+<\Q
MFM1-8>#NM/9]O]02FK8TE^]2:%64=6R,X(R,))V) V=4N0T1 JR@:!,+PDPD
MEHB.<A=K&7W:M;R?GWZZ"^LK<$+N9Y?-+B9?$UJ483A*#V8Q7$QV926G/*A0
MKN#0Z@01!.Y4SR/P$$GBR7J;.RJ$[F U_?K;;PSDWN%0P9;XF/#-:$\7$>/7
MH[2:8G9T5=RPOR\^'V2G2,JX"*-*CTEC&+I9A$'*B@=).3I:7?6E>9VZGAM3
M]XZA)_4*+0NT"I ^JL$X^7&=QK.T&L4Z0&<OTT \4%["K3GB,40-ATP(DS%$
MJSN:-_<*83UW^JL/FNV)L0)4GG]#,7QPR+)ROXT+6>XM)[5SR@9 7I2P6,K@
M*?5 HE*9,Y,LZ^;J=SL]/;<3K V#+0BM NA]NKIVP^G2=RS519^'WU-<=I*Y
MF'Q('X>S:W2TXED>*(FF>5 62"YUE%&6"V_O02JNLV'<$]G-0)O&)/;<K+ V
M@'8CVAXQZZ]N!ZN!ZKB(^6@1\IBY<72;%HG3ABC<9+CW+$6+I/254 3->LJ]
ME3H9:AZ50S^)0S9Z4<_]#&M!6_M"Z1EA'W&;S.;#^<TT7;KAN"QE.KEUHT4I
M5$YH55CGP!J/A@4G&GS("HRF+&:ON%6Z ;A>>D?/[0UKPE5KHC@TH>:B%60M
M=*\+_W4S7%XX!;0@+A/NC4142>R@61D0.J#M@#X4V.Q#S%EI:EP#3&U_>L\=
M#VM"4POLK\!@6T^"/QN7X1TKYMZU,EXDR5Y\<^.+='4]F;KI[;T5,!MXPIA
M30PZJC*#2N%NR10-+N&<%<[8P+I)DS^ Z)[;,]8"X+<6?_\:<[WB#S>SX3C-
M9NAE^>%X(?GCR;BP%A>%7\V0[=,5(*8./UTL]OA;^?+3^.BJ-(XZR\_\R?JZ
M_I8.2@F#"TX#JH%2.65*,ZFXF.,=@LC&YH[:D+[1 ON=2ES=1JH15A4<+PL-
M4G*D4!1+T:Q":P/'B%=94Y T>A",4[!$"D@J>R&2CU)W$[I_EJ1F\7KR_PRD
MVY%=/9H?UU#RZ-/'M/PO<JZL\)Y]R][)X_BPD=(=+P4:;]+K##QK@4ZG5F"U
M]<A+ES5S08G831[-@83W&VA]XZO3MQ1R!?KUZ7(W1C4.N%#&1^: D')O49J!
MF<)21M&C3<F[8+J:!?,"6?W>B[XI0%X%Y[[2JEFKKJ= +GK](-%"Q@R)1^16
MM!)P"W.@W"D1. E=]2)]D:Q^KS_K0N"^TJH9@8_Z^PYTL%SH1, IFY96D#5H
M-%O%&1'"\92ZN89_E;1^S^:ZD'B(U*H\BG%!TYN-K()TMS1'C%MDS0I6&$>5
M 8?&#KIRP3OO%7[\5FKQ62+[O?ZL#IHM2+)*D#YDZZH)1^D?*S-W0N0,@G,&
MPI6B4ZM*1PZIDZ4Q:-+-U(+F-/9[9UH71%N18SV'>G.W<2!U-IJH4E"E9<GP
M=N@N6@<^:\H(38G);DHOF]/8[R5LGT#M2(X5U$P^L[+E/<KVP(:,W!C*:6GQ
M'D%8'< R9&0*@D9*$UHUW;2PVYW6ONO;W[8"J2VA57#"X])"2G'V"S+UW(T2
M;NO?W+R,@[P]RT??W7!4[)9?)M/RP_M!D0-#A39J,:DB!-Q]I2&O(OB/B,HJ
MPPGUW6C1/0FNLK*I-1P]K6SJ7*@U8-?=KNX_CDI>Q31M&VDZL#23Q)&'267D
M)O,,;+(2)/,^>%*:HG34"+0)>546*G6&R]8%5H\%^GC/O;315L7XVN,*;5:@
M?:DZ# Y9Z1)ZA()XH843OK,6M;O26N6ET%NISY9%6:/FQ"6CB3V__3)RXSD>
M%V59UU>+N0PLTG*3AF8V+U-]HP#O+ %CE37>N11=-_.=FM/8;^BI;QW:CNCZ
M5Z2/4F[=.$Z*VWF]VHP#$6..B0J@(6D02>*QH)(#JJS3(04OTFL=/EYY1;_Q
MH3?"49MLKE&3K3.KTK(M:V'IZB=Q8#(+B48'!!<!(EM>YELS8%8**DKPU783
MH]R%RGZ#/WUKL[;$U[\^VYVC@T2S1N7,(,1<(JXEI)6*#4PT"S%IDFDW]SS-
M:>PWH_^-T=F1Z.J-1JZZDFUE)+6<FR@XX+F ZPJX#UUI':9$TMHH/#QH-[TT
M=Z>U[_:$;QN-;$MH-9SF&Y[7UW2].AS.\OFWR72^'CTXT-R&)(A$0[;DG1B6
MP1KN(#/*+3*86-M-97HC\JJ,-+:&D1=<Y78$5@$*-Q>R.?-R(*GRVM,RVC*S
MDO"4P=G$0>OD. M9QL?UEZUUP]].4971PZZPUHI8ZK$+UZ;O+Y,IKNQF&KZY
M62HU'7=#<@:*!<)RL)!(*HU$EN,P'>"GBI%(HY7='+FOTU9E0+ S+=>NJ.K#
MX%G^."R<',?90*.C;R/W0 7!W42-!9<%?AN<]()P(T(W;?:W$%-E9*]KE.TK
MC(I@M6$5;.R=11K)%NX-$! Z*FH@*!?01_,"/#$1,C7,FJ2$,]T;= T(K3)
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MV 8^\@ LVZ"-$)EU-,AN;Y+[;3-?3Q;>V\J^ I#?=3Z0WK-0NA4R1<I(#Y;
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M3N.OR^0HI\&CXL:_U"!\EN"$(R"S]C9Q;XCLZA[N);IJ'G2S#YPZD$8%V+K
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MVI+9-ACLS\#J(+ *OG%F698J0'3E\D<S 9X0#9EGGJ1)2<@F$W:?>WX%,#A
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MEI_YD\]#YQ?M)NE 9/1_,PV@%^.:5<QH6U(/+H<D@XN,^6[,]#=:8+\];=X
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MNJQ3*;S7P%6ANT<+'Z-N<H0>(6J<,3JW?OIZWSN= 5L$9A !'9V(7""D[.I
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M=7/8[EV%)T86[U508'AFH$*=M.VT!NYLTM9S&;-H>##N$33QTUPW(#Y,4QT
M[FTI6"=H71^V8[HP'SJ3)YQAQ)@D""MD+>@M$$5BH!TS3J:$DK<I9!Q.X\21
M5 >P;*3/#I#Z!M.2A+:;4$^LB[:>2%#<U&'*?)W:)5F*C!9+D,ZTJ739B]R)
M?>4.\-M>RUU ^=&GNA/+A4S&&+ 56PJ5AQB$!EU<9M:4P!LM#GB"L(F[E[J
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ML& W'S).HN=,LB! &"% I60@UH6J65J>;5 NL39=@C>IF'PP0-O7HIV$W!E
M/BSFZ>*Q*VN4W$OB7PD-2J ! GXAP^H,LV1+0VJ31GN8GLE;Y]N"9D_!=P"?
MNP'GQ5SP$TUA9E:%09!UW#NW"8+5Y.T16]Q9XZUK,UM_"T'# /2BWJC'$'T'
M"+JL:OD49KE.<"O::(E&@JAUO*IP"8$52;=LU@&Y*\*V0<X=0H8AYD4]2Q\B
MZ@Z04H7PL=SN=MK6HW1BHE1!!82L4P"5C0=?!TU2=!"=#3+D1H^-NU Y#&,O
MZ@&[F9(F?EKZ<%Z+[1;E&'\N3G]6)FZR6-_)8I0Y8ZTP1UD[[B@,#2&IVI1
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MB2<@M_4)QA)K?\BX."0E&@K,6" #5O^0F 0Z-0(*G9P2!8J 3]7F/OJ!:2Z
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MC71?$00^+@]_L-(DK1$5S]#&'SX[D^=G.9ZTZNU.\V+[\GNMU6;M?WVMGYR
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M)=8;,>[!=P,?%.!1N]GI7IQMGG\'%F>=?UTUCXY8_>+\LM;Z7F*<'0N7W_-
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MOFY@E42^BPMK\L.^S$QFMEH#Y*-*))-=AM(.X).8!V#%T.>3YG&\9B5O+6<
M;R=4KI3O8D1Z7+SS[2(SQE"UK"5J, @</(T$+I[LL)0!=!UQG?D^"=0'0PW6
MB.SL@-\F;MO$!,K/W_1CV26BOS02L5_>WB&1R'&5/.I+=5]ES(C+[PF23H;5
M5;,7QM(4!,8'(A,0?)X%RDJJBXLB*!1Q"9.X2NI]TQ<E&I9&0Y:,$9JHOVS1
M%UY(PJ<>V\<B@4V_WU=5O7X\5!AYLMM+9GE*:J(XX\S@N0Q1ODL.[YV4FFP)
ML>Y@NL_V(TB[0Z\4Z&'T"_0X25F2/TCU"C[^CKNQT%LM*O$*84B7!^ N6%$
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MDUD8;U5$O?> J.=@D2[^D46[M"'/  \L&+HB&Q\)2PF0'3O /D'J& 5V@$3
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M09Z_%O*\^GRB\.99]]C@38,WGXDW_^36+3OSO=MIV\$:N#D.-U^?7(4ABBG
M-0CSUT&818UV&H1I$.:S"G"_-<[..NQSK7URH7<LJ^$9<[4S5NMT+NI-^LN4
MX1K06XQ7RH%>4'K<8Z<\"!QSTL8\L/<-"%88LF2 [SGW^#46*1L$O'((&+?!
M_$;'43(ZL;2X>/B9F'>GJ%%5D^$W*/BE@%#K$E1#X/1X:&*L!F[^7$[_4O#
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M1F,2C2D5Q^(R81AHEB7.9("^8)+U^5;'C+,I/AG)%8MYA*\,TU/IF--![H%
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MW.-='KM#\N@UH/PW7$KRUZ-._@!02P,$%     @ F53\4NJG"752"   U"8
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M]^\(6VHQ382<]UZ-1,(-N>0S<JT2FKZJ&@A#S7 M8B]HQ!\<; +SW./,FWP
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M$/5F8)IBX.84NC$2SM=/R#-!9?OO@TI.8I%"M!$XR^A6 8@@#LUZI5VDP"X
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M &)M>2TR,#(Q,#8S,"YX<V102P$"% ,4    " "95/Q2VZBNYMDH  "5J0$
M%               @ '[6@, 8FUY+3(P,C$P-C,P7V-A;"YX;6Q02P$"% ,4
M    " "95/Q2%(3R<1U\  "X.P4 %               @ $&A , 8FUY+3(P
M,C$P-C,P7V1E9BYX;6Q02P$"% ,4    " "95/Q2J=%"CT0U 0!)(PT %
M            @ %5  0 8FUY+3(P,C$P-C,P7VQA8BYX;6Q02P$"% ,4
M" "95/Q2_G2B/7V\  "%80@ %               @ '+-04 8FUY+3(P,C$P
M-C,P7W!R92YX;6Q02P$"% ,4    " "95/Q2C5%5_RL'  "_10  %
M        @ %Z\@4 8FUY97@Q,&8R,#(Q,#8S,"YH=&U02P$"% ,4    " "9
M5/Q2)KB0 7PA  "VB0$ %               @ '7^04 8FUY97@Q,&<R,#(Q
M,#8R,"YH=&U02P$"% ,4    " "95/Q2EFMP1"<'  "P10  %
M    @ &%&P8 8FUY97@Q,&@R,#(Q,#8S,"YH=&U02P$"% ,4    " "95/Q2
M_^KHQ?(@  "@AP$ %               @ '>(@8 8FUY97@Q,&DR,#(Q,#8S
M,"YH=&U02P$"% ,4    " "95/Q2[9J.Q% (  !Y)0  %0
M@ $"1 8 8FUY97@S,6%?,C R,3 V,S N:'1M4$L! A0#%     @ F53\4NJG
M"752"   U"8  !4              ( !A4P& &)M>65X,S%B7S(P,C$P-C,P
M+FAT;5!+ 0(4 Q0    ( )E4_%)"=U)LY00  /\/   5              "
M 0I5!@!B;7EE>#,R85\R,#(Q,#8S,"YH=&U02P$"% ,4    " "95/Q2W(2@
MF-H$  #6#P  %0              @ $B6@8 8FUY97@S,F)?,C R,3 V,S N
9:'1M4$L%!@     .  X F ,  "]?!@    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
